FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Muller, LT
   Gombos, DS
   Mishra, CK
   Gunderson, CA
   Calvano, CJ
AF Muller, LT
   Gombos, DS
   Mishra, CK
   Gunderson, CA
   Calvano, CJ
TI Biocompatability studies of a novel biomaterial for ocular surface
   reconstruction
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology
CY MAY 05-10, 2002
CL FT LAUDERDALE, FLORIDA
SP Assoc Res Vis & Ophthalmol
C1 Univ Texas, Med Branch, Galveston, TX 77550 USA.
   MD Anderson, Dept Plast Surg, Div Ophthalmol, Houston, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD MAY
PY 2002
VL 43
SU 1
MA 1110
BP U242
EP U242
PG 1
WC Ophthalmology
SC Ophthalmology
GA 709CF
UT WOS:000184606601067
DA 2018-10-19
ER

PT J
AU Hardouin, P
   Fayada, P
   Leclet, H
   Chopin, D
AF Hardouin, P
   Fayada, P
   Leclet, H
   Chopin, D
TI Kyphoplasty
SO JOINT BONE SPINE
LA English
DT Review
DE biomaterial; kyphoplasty; osteoporosis; vertebroplasty; vertebral
   collapse
ID PERCUTANEOUS VERTEBROPLASTY; FRACTURES; BONE; VIVO
AB A variant of vertebroplasty known as "kyphoplasty" has been suggested for correcting vertebral compression fractures. A balloon placed inside the vertebral body is inflated to create a cavity, thereby restoring vertebral body height and allowing low-pressure cement injection. This procedure is gaining popularity in the United States. Over 1000 patients had been treated by the end of 2000. However, kyphoplasty is costly (chiefly because the balloon is disposable) and has not been evaluated in carefully designed studies. Although retrospective findings have been reported as highly promising, they are not sufficient to validate this procedure. The principle is innovative and the procedure deserves further investigation as a potentially effective means of correcting loss of vertebral height. Furthermore, use of a bone substitute instead of cement deserves investigation. (C) 2002 Editions scientificlues et medicales Elsevier SAS.
C1 Inst Calot, Serv Rhumatol, Grp Hopale, F-62608 Berck Sur Mer, France.
   Univ Littoral Cote Opale, Inst Rech Biomat & Biotechnol IR2B, F-62608 Berck Sur Mer, France.
   Inst Calot, Serv Chirurg Rachis, Grp Hopale, F-62608 Berck Sur Mer, France.
   Inst Calot, Serv Radiol, Grp Hopale, F-62608 Berck Sur Mer, France.
RP Hardouin, P (reprint author), Inst Calot, Serv Rhumatol, Grp Hopale, F-62608 Berck Sur Mer, France.
CR Belkoff SM, 2001, SPINE, V26, P151, DOI 10.1097/00007632-200101150-00008
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Cortet B, 1999, J RHEUMATOL, V26, P2222
   DUDENEY S, 2000, 1 WORLD C OST CHIC 2, V11
   GALIBERT P, 1987, NEUROCHIRURGIE, V33, P166
   Garfin S, 1998, CHALLENGES SPINE FIX
   GARFIN SR, 2000, EARLY OUTCOMES FIRST
   GARFIN SR, IN PRESS SPINE
   HARDOUIN P, 1997, SEMIN MUSCULOSKELETA, V1, P319
   HARDOUIN P, 2001, REV RHUM, V68, P392
   Lane JM, 2000, J BONE MINER RES, V15, pS198
   Lieberman IH, 2000, J BONE MINER RES, V15, pS560
   LIEBERMAN IH, IN PRESS SPINE
   Maus T, 2000, J BONE MINER RES, V15, pS580
   Ohura K, 1996, J BIOMED MATER RES, V30, P193, DOI 10.1002/(SICI)1097-4636(199602)30:2<193::AID-JBM9>3.0.CO;2-M
   Schlaich C, 1998, OSTEOPOROSIS INT, V8, P261, DOI 10.1007/s001980050063
   SILVERSTEIN H, 1992, AM J OTOL, V13, P23
   Wilson DR, 2000, SPINE, V25, P158, DOI 10.1097/00007632-200001150-00004
   Wong X, 2000, J WOMENS IMAGING, P117
   YUAN HA, 2000, AANS CNS SECT DIS SP, P23
NR 20
TC 31
Z9 38
U1 0
U2 1
PU EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS CEDEX 15
PA 23 RUE LINOIS, 75724 PARIS CEDEX 15, FRANCE
SN 1297-319X
J9 JOINT BONE SPINE
JI Joint Bone Spine
PD MAY
PY 2002
VL 69
IS 3
BP 256
EP 261
AR UNSP S1297319X02003901/REV
DI 10.1016/S1297-319X(02)00390-1
PG 6
WC Rheumatology
SC Rheumatology
GA 582KP
UT WOS:000177349900005
PM 12102271
DA 2018-10-19
ER

PT J
AU Rowley, JA
   Mooney, DJ
AF Rowley, JA
   Mooney, DJ
TI Alginate type and RGD density control myoblast phenotype
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE tissue engineering; RGD; alginates; skeletal muscle; biomaterial design
ID EXTRACELLULAR-MATRIX; GROWTH-FACTOR; GEL BEADS; CELL; DIFFERENTIATION;
   HEPATOCYTES; INDUCTION
AB Alginates are being increasingly used for cell encapsulation and tissue engineering applications; however, these materials cannot specifically interact with mammalian cells. We have covalently modified alginates of varying monomeric ratio with RGD-containing cell adhesion ligands using carbodiimide chemistry to initiate cell adhesion to these polymers. We hypothesized that we could control the function of cells adherent to RGD-modified alginate hydrogels by varying alginate polymer type and cell adhesion ligand density, and we have addressed this possibility by studying the proliferation and differentiation of C2C12 skeletal myoblasts adherent to these materials. RGD density on alginates of varying monomeric ratio could be controlled over several orders of magnitude, creating a range of surface densities from 1-100 fmol/cm(2). Myoblast adhesion to these materials was specific to the RGD ligand, because adhesion could be competed away with soluble RGD in a dose-dependent manner. Myoblast proliferation and differentiation could be regulated by varying the alginate monomeric ratio and the density of RGD ligands at the substrate surface, and specific combinations of alginate type and RGD density were required to obtain efficient myoblast differentiation on these materials. (C) 2002 John Wiley Sons, Inc.
C1 Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Coll Dent, Dept Biomed Engn, Ann Arbor, MI USA.
   Univ Michigan, Coll Engn, Dept Chem Engn, Ann Arbor, MI USA.
   Univ Michigan, Coll Dent, Dept Chem Engn, Ann Arbor, MI USA.
   Univ Michigan, Coll Dent, Dept Biol & Mat Sci, Ann Arbor, MI USA.
   Univ Michigan, Coll Engn, Dept Biol & Mat Sci, Ann Arbor, MI USA.
RP Mooney, DJ (reprint author), Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
FU NIDCR NIH HHS [R01-DE13349]
CR Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   CHAMBERLAIN JS, 1985, MOL CELL BIOL, V5, P484, DOI 10.1128/MCB.5.3.484
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   ESPEVIK T, 1993, EUR J IMMUNOL, V23, P255, DOI 10.1002/eji.1830230140
   FREMOND B, 1993, CELL TRANSPLANT, V2, P453, DOI 10.1177/096368979300200603
   Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114
   Hauselmann H. J., 1996, AM J PHYSIOL, V271, P742
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LIN CQ, 1993, FASEB J, V7, P737
   Loebsack A, 2001, J BIOMED MATER RES, V57, P575, DOI 10.1002/1097-4636(20011215)57:4<575::AID-JBM1204>3.0.CO;2-9
   Marler JJ, 2000, PLAST RECONSTR SURG, V105, P2049, DOI 10.1097/00006534-200005000-00020
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MOONEY DJ, 1994, MOL BIOL CELL, V5, P1281
   OTTERLEI M, 1991, J IMMUNOTHER, V10, P286, DOI 10.1097/00002371-199108000-00007
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Thomas A, 2000, BIOMATERIALS, V21, P1797, DOI 10.1016/S0142-9612(00)00072-7
   Yao CC, 1996, J CELL SCI, V109, P3139
NR 30
TC 255
Z9 260
U1 2
U2 63
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 2002
VL 60
IS 2
BP 217
EP 223
DI 10.1002/jbm.1287
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 527YM
UT WOS:000174215600001
PM 11857427
DA 2018-10-19
ER

PT J
AU Vehof, JWM
   Fisher, JP
   Dean, D
   van der Waerden, JPCM
   Spauwen, PHM
   Mikos, AG
   Jansen, JA
AF Vehof, JWM
   Fisher, JP
   Dean, D
   van der Waerden, JPCM
   Spauwen, PHM
   Mikos, AG
   Jansen, JA
TI Bone formation in transforming growth factor beta-1-coated porous
   poly(propylene fumarate) scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bone regeneration; transforming growth factor-beta; recombinant
   proteins; osteoinduction; porous poly(propylene fumarate); scaffolds
ID RAT ECTOPIC MODEL; IN-VIVO; BIOMATERIAL CARRIERS; TRANSGENIC MICE;
   IMPLANTS; GROWTH-FACTOR-BETA-1; CEMENT; PHARMACOKINETICS;
   HYDROXYAPATITE; REGENERATION
AB This study determined the bone growth into pretreated poly(propylene fumarate) (PPF) scaffolds implanted into a subcritical size, ribbit cranial defect. PPF scaffolds were constructed by using a photocrosslinking-porogen leaching technique. These scaffolds were then either prewetted (PPF-Pw), treated with RF glow-discharge (PPF-Gd), coated with fibronectin (PPF-Fn), or coated with rhTGF-beta(1) (PPF-TGF-beta(1)). One of each scaffold type was then placed into the cranium of nine rabbits. The rabbits were sacrificed after 8 weeks, and the scaffolds were retrieved for histological analysis. The most bone formation was present in the PPF-TGF-beta(1) implants; the newly formed bone had a trabecular appearance together with bone marrow-like tissue. Little or no bone formation was observed in implants without rhTGF-beta(1). These histological findings were confirmed by image analysis. Bone surface area, bone area percentage, pore fill percentage, and pore area percentage were significantly higher in the rhTGF-beta(1)-coated implants than in the noncoated implants. No statistical difference was seen between the PPF-Fn, PPF-Pw, or PPF-Gd scaffolds for these parameters. Quadruple fluorochrome labeling showed that in PPF-TGF-beta(1) implants bone formation mainly started in the interior of a pore and proceeded toward the scaffold. We conclude that (a) PPF-TGF-beta(1) scaffolds can indeed adequately induce bone formation in porous PPF, and (b) PPF scaffolds prepared by the photocrosslinking-porogen leaching technique are good candidates for the creation of bone graft substitutes. (C) 2002 John Wiley Sons, Inc.
C1 Univ Nijmegen, Ctr Med, Coll Dent Sci, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   Case Western Reserve Univ, Univ Hosp Cleveland, Dept Neurol Surg, Cleveland, OH USA.
   Univ Nijmegen, Ctr Med, Dept Plast & Reconstruct Surg, Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Univ Nijmegen, Ctr Med, Coll Dent Sci, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
RI Jansen, John/H-8055-2014; Fisher, John/F-8078-2012; Dean,
   David/F-9605-2017
OI Dean, David/0000-0002-1217-3764
FU NIAMS NIH HHS [R01-AR44381]; NIDCR NIH HHS [R01-DE13031, R01-DE13740]
CR ARNAUD E, 1994, CALCIFIED TISSUE INT, V54, P493, DOI 10.1007/BF00334331
   BECK LS, 1993, J BONE MINER RES, V8, P753
   BLOM EJ, 2000, P 6 WORLD C BIOM KAM
   Calabresi PA, 1998, NEUROLOGY, V51, P289, DOI 10.1212/WNL.51.1.289
   Clouthier DE, 1997, J CLIN INVEST, V100, P2697, DOI 10.1172/JCI119815
   Dennis J E, 1993, J Oral Implantol, V19, P106
   Fisher JP, 2001, ANN REV MATER RES, V31, P171, DOI 10.1146/annurev.matsci.31.1.171
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Goldstein AS, 1999, TISSUE ENG, V5, P421, DOI 10.1089/ten.1999.5.421
   GOMBOTZ WR, 1994, J APPL BIOMATER, V5, P141, DOI 10.1002/jab.770050207
   GRESSER JD, 1995, J BIOMED MATER RES, V29, P1241, DOI 10.1002/jbm.820291011
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Heckman JD, 1999, J BONE JOINT SURG AM, V81A, P1717, DOI 10.2106/00004623-199912000-00009
   Kopp JB, 1996, LAB INVEST, V74, P991
   Kornu R, 1996, J ORTHOPAED RES, V14, P871, DOI 10.1002/jor.1100140605
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Ledbetter S, 2000, KIDNEY INT, V58, P2367, DOI 10.1046/j.1523-1755.2000.00420.x
   Lewandrowski KU, 2000, BIOMATERIALS, V21, P757, DOI 10.1016/S0142-9612(99)00179-9
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P611, DOI 10.3109/17453679608997766
   McKinney L, 1996, J CRANIOFAC SURG, V7, P36, DOI 10.1097/00001665-199601000-00010
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   Moxham JP, 1996, J OTOLARYNGOL, V25, P82
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Peter SJ, 1999, J BIOMAT SCI-POLYM E, V10, P363, DOI 10.1163/156856299X00423
   Peter SJ, 1997, J BIOMAT SCI-POLYM E, V8, P893, DOI 10.1163/156856297X00074
   Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304
   SUMNER DR, 1995, J BONE JOINT SURG AM, V77A, P1135, DOI 10.2106/00004623-199508000-00001
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   VANDERLUBBE HBM, 1988, STAIN TECHNOL, V63, P171, DOI 10.3109/10520298809107179
   Vehof JWM, 2001, PLAST RECONSTR SURG, V108, P434, DOI 10.1097/00006534-200108000-00024
   Vehof JWM, 2000, BIOMATERIALS, V21, P2003, DOI 10.1016/S0142-9612(00)00094-6
   VEHOF JWM, 2001, IN PRESS CLIN ORAL I
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   Yaszemski M J, 1995, Tissue Eng, V1, P41, DOI 10.1089/ten.1995.1.41
   Zellin G, 1998, BONE, V22, P613, DOI 10.1016/S8756-3282(98)00059-3
NR 38
TC 81
Z9 83
U1 0
U2 12
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 2002
VL 60
IS 2
BP 241
EP 251
DI 10.1002/jbm.10073
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 527YM
UT WOS:000174215600004
PM 11857430
DA 2018-10-19
ER

PT J
AU Kang, SB
   Yoon, KS
   Nam, TH
   Kim, JS
   Gjunter, VE
AF Kang, SB
   Yoon, KS
   Nam, TH
   Kim, JS
   Gjunter, VE
TI Fracture treatment using TiNi shape memory alloy bone fixater (BRM-SH
   system)
SO MATERIALS TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT 4th Pacific Rim International Conference on Advanced Materials and
   Processing (PRICM4)
CY DEC 11-15, 2001
CL HONOLULU, HI
SP Japan Inst Met, Chinese Soc Met, Korean Inst Met & Mat, Minerals, Met & Mat Soc, Iketani Sci & Technol Fdn, USN, Off Naval Res Int Field Off, Asian Off Aerosp Res & Dev, USA Res Off Far E
DE shape memory alloy; fracture; bone fixater
ID IN-VITRO BIOCOMPATIBILITY; NICKEL-TITANIUM; METAL
AB Titanium-Nickel shape memory alloy (TiNi SMA) has great potential as a biomaterial in orthopaedic applications due to its unique thermal shape memory effects, superelasticity and high damping properties. We designed and manufactured bone fixaters using newly developed TiNi SMA wire (Af, 35 +/- 2degreesC). Two bone fixater designs (single and double ring) were prepared for the treatment of bone fracture in twenty patients (6 distal femur, 5 distal fibular, 4 distal tibia, 2 metacarpal bone, 2 periprosthetic fracture and 1 subtrochanter of femur). Serial radiographs, complete blood count (CBC) and urine analysis were performed postoperatively. Radiological union was achieved without complications in approximate eight weeks after operation. There were no abnormal findings on follow-up CBC or urine analysis. On a subjective level, use and application of the TiNi SMA fixater was not as demanding as conventional fixation methods, such as cerclage or the Dall-Miles technique. The efficacy of SMA bone fixater in this study is very excellent as demonstrated in this clinical study. It gives the new armament to orthopedic surgeon.
C1 Seoul Natl Univ, Coll Med, Dept Orthopaed Surg, Dongjakgu, Seoul 156012, South Korea.
   Seoul Municipal Boramae Hosp, Seoul 156012, South Korea.
   Gyeongsang Natl Univ, Dept Mat Sci & Engn, Gyeongnam 660701, South Korea.
   Univ Ulsan, Sch mat & Met Engn, Ulsan 680749, South Korea.
   Inst Med Mat & Shape Memory Implants, Tomsk, Russia.
RP Kang, SB (reprint author), Seoul Natl Univ, Coll Med, Dept Orthopaed Surg, Dongjakgu, 395 Shindaebangdong, Seoul 156012, South Korea.
RI Kang, Seung Baik/J-5362-2012; Gunther, Viktor/O-6678-2014
CR Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   Assad M, 1999, BIO-MED MATER ENG, V9, P1
   Banim RH, 2000, J ARTHROPLASTY, V15, P131, DOI 10.1016/S0883-5403(00)91493-1
   BergerGorbet M, 1996, J BIOMED MATER RES, V32, P243, DOI 10.1002/(SICI)1097-4636(199610)32:2<243::AID-JBM14>3.0.CO;2-K
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   Gil FJ, 1998, P I MECH ENG H, V212, P473, DOI 10.1243/0954411981534231
   Nam TH, 2002, MATER LETT, V52, P234, DOI 10.1016/S0167-577X(01)00424-4
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0
   Zehntner M K, 1992, J Orthop Trauma, V6, P318, DOI 10.1097/00005131-199209000-00009
NR 11
TC 5
Z9 5
U1 0
U2 1
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD MAY
PY 2002
VL 43
IS 5
SI SI
BP 1049
EP 1051
DI 10.2320/matertrans.43.1049
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 562RE
UT WOS:000176212100046
OA Bronze
DA 2018-10-19
ER

PT J
AU Stolt, UG
   Liss, PE
   Svensson, T
   Ludvigsson, J
AF Stolt, UG
   Liss, PE
   Svensson, T
   Ludvigsson, J
TI Attitudes to bioethical issues: a case study of a screening project
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE ethics; screening; neonatal; informed consent; diabetes; ABIS; Sweden
ID DUCHENNE MUSCULAR-DYSTROPHY
AB Commonly expressed in theoretical discussions about ethical problems in the context of epidemiology and screening is the need for more data. A study was carried out involving 21 explorative interviews with participant and nonparticipant mothers in a neonatal research screening project in progress in Sweden, ABIS (All Babies in Southeast Sweden). The respondents were asked, by way of open-ended questions, to give their opinions about certain ethical issues: informed consent; reasons for joining/declining: surrogate decisions the collection, analysis and storage of written and "live" material (biobanks); intervention etc.
   The ethical implications mentioned in the literature mostly concern the risk of creating distress and anxiety (anxiety and possible stigmatisation in respect of positive or false-positive results, worry about material collected and stored, distress caused by blood sampling procedures. etc.). Our results do not support the idea that the risks are substantial. The respondents rather indicate an attitude of benevolence-they are positive both to the current research on children, to the material they contribute (both written material and "biomaterial"), to possible results and intervention plans. On the other hand the participants expressed concern about the storage of material and the right to be informed of any screening/project results. Further studies in this field are needed and would be of help in theoretical discussion, the work of ethical committees and the designing of, for example, screening and research projects, (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Linkoping Univ, Fac Hlth Sci, Div Paediat, Dept Hlth & Environm, S-58185 Linkoping, Sweden.
   Linkoping Univ, Dept Hlth & Soc, S-58183 Linkoping, Sweden.
   Linkoping Univ, Dept Behav Sci, S-58183 Linkoping, Sweden.
RP Ludvigsson, J (reprint author), Linkoping Univ, Fac Hlth Sci, Div Paediat, Dept Hlth & Environm, S-58185 Linkoping, Sweden.
CR [Anonymous], 1989, PAEDIATR PERINAT EP, V3, P460, DOI DOI 10.1111/J.1365-3016.1989.TB00533.X
   Beauchamp T, 1994, PRINCIPLES BIOMEDICA
   Beauchamp TL, 1997, MED ETHICS
   BRADLEY DM, 1993, BRIT MED J, V306, P357, DOI 10.1136/bmj.306.6874.357
   BRODY H, 1997, MED ETHICS
   Childress J, 1997, PRACTICAL REASONING
   FADEN RR, 1982, AM J PUBLIC HEALTH, V72, P1396, DOI 10.2105/AJPH.72.12.1396
   FADEN RR, 1985, AM J PUBLIC HEALTH, V75, P1381, DOI 10.2105/AJPH.75.12.1381
   FENTONMAY J, 1994, ARCH DIS CHILD, V70, P551, DOI 10.1136/adc.70.6.551
   FOST N, 1999, NEW ETHICS PUBLICS H
   GOLDING J, 1996, CONT REV OBSTET GYNA, V8, P89
   HARTH SC, 1992, J MED ETHICS, V18, P86, DOI 10.1136/jme.18.2.86
   HERMEREN G, 1999, ACTA PAEDIATR, V432, P99
   HOLM S, 1996, THESIS U COPENHAGEN
   HOLTZMAN NA, 1983, PEDIATRICS, V72, P807
   HOLTZMAN NA, 1988, AM J HUM GENET, V42, P642
   Kvale S., 1997, KVALITATIVA FORSKNIN
   MUMFORD SE, 1999, ARCH DIS CHILDHOOD N, V81, P228
   MUMFORD SE, 1999, ARCH DIS CHILDHOOD N, V81, P146
   Parsons E, 1996, ARCH DIS CHILD, V74, P550, DOI 10.1136/adc.74.6.550
   PATTON MQ, 1980, QUALITATIVE EVALUATI
   RIIS P, 1999, ACTA PAEDIATR, V432, P96
   Schulte P. A., 1996, ETHICS EPIDEMIOLOGY, P178
   SCHULTE PA, 1985, AM J EPIDEMIOL, V121, P351, DOI 10.1093/oxfordjournals.aje.a114006
   SHICKLE D, 1994, J MED ETHICS, V20, P12, DOI 10.1136/jme.20.1.12
   SMITH RA, 1990, BRIT MED J, V300, P1112, DOI 10.1136/bmj.300.6732.1112
   STOLT UG, 2001, IN PRESS PERSPECTIVE
   Trost J., 1997, KVALITATIVA INTERVJU
   VEATCH RM, 1989, MED ETHICS
   WALTERS L, 1997, MED ETHICS
NR 30
TC 16
Z9 16
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD MAY
PY 2002
VL 54
IS 9
BP 1333
EP 1344
AR PII S0277-9536(01)00099-5
PG 12
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 548GG
UT WOS:000175379800003
PM 12058850
DA 2018-10-19
ER

PT J
AU Brown-Etris, M
   Cutshall, WD
   Hiles, MC
AF Brown-Etris, M
   Cutshall, WD
   Hiles, MC
TI A new biomaterial derived from small intestine submucosa and developed
   into a wound matrix device
SO WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE
LA English
DT Review
ID FIBROBLAST GROWTH-FACTOR; ACHILLES-TENDON REPAIR; EXTRACELLULAR-MATRIX;
   VASCULAR GRAFT; DOG-MODEL; IN-VITRO; GENE-EXPRESSION; CAROTID-ARTERY;
   CELL-GROWTH; REGENERATION
AB A biomaterial derived from porcine intestinal submucosa has been used in the development of a new biologic wound matrix. This review describes the origin of the wound matrix device, including the discovery of the biomaterial and its properties, to the development of the commercial product currently in clinical use. The composition and structure of this biomaterial are described and considered as mechanisms that contribute to its effectiveness in wound management. The wound matrix developed from this unique biomaterial was evaluated in a pilot study of human partial-thickness dermal wounds and was found to be beneficial, especially in its dehydrated form. Other applications of this biomaterial, as well as its limitations, are also discussed.
C1 Etris Associates Inc, Philadelphia, PA 19116 USA.
   Cook Biotech Inc, W Lafayette, IN USA.
RP Brown-Etris, M (reprint author), Etris Associates Inc, 14450 Bustleton Ave, Philadelphia, PA 19116 USA.
EM mbeetris@aol.com
CR AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   ALLMAN AJ, UNPUB IMMUNOLOGY
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   BADYLAK SF, 2001, IN PRESS TISSUE ENG
   BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5
   BROMBERG B E, 1965, Plast Reconstr Surg, V36, P80, DOI 10.1097/00006534-196507000-00011
   Brown-Etris M, 1995, Adv Wound Care, V8, P53
   BROWNETRIS M, 1994, WOUNDS, V6, P54
   BROWNETRIS M, 2001, S ADV WOUND CAR LAS
   Calvin M, 1998, WOUNDS, V10, P12
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   COLTRINI D, 1993, EUR J BIOCHEM, V214, P51, DOI 10.1111/j.1432-1033.1993.tb17895.x
   Dalla Vecchia LD, 1999, J PEDIATR SURG, V34, P167, DOI 10.1016/S0022-3468(99)90250-6
   Eaglstein W H, 1998, Adv Wound Care, V11, P1
   ELLIOTT RA, 1973, PLAST RECONSTR SURG, V52, P401, DOI 10.1097/00006534-197352040-00013
   FERRAND BK, 1993, J BIOMED MATER RES, V27, P1235, DOI 10.1002/jbm.820271004
   Greenfield E, 1996, Crit Care Nurs Clin North Am, V8, P203
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   HILES MC, 1993, J BIOMED MATER RES, V27, P139, DOI 10.1002/jbm.820270202
   HINMAN CD, 1963, NATURE, V200, P377, DOI 10.1038/200377a0
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 1997, TISSUE ENG, V3, P27, DOI 10.1089/ten.1997.3.27
   HODDE JP, 1998, 2 SIS S ORL FL, P92
   HODDE JP, 2001, S ADV WOUND CAR LAS
   KAJIO T, 1992, FEBS LETT, V306, P243, DOI 10.1016/0014-5793(92)81009-B
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   Knoll LD, 2001, UROLOGY, V57, P753, DOI 10.1016/S0090-4295(00)01079-7
   Kosir MA, 2000, J SURG RES, V92, P45, DOI 10.1006/jsre.2000.5840
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   LEIPZIGER LS, 1985, J AM ACAD DERMATOL, V12, P409, DOI 10.1016/S0190-9622(85)80004-9
   McGrath JA, 1997, J PATHOL, V183, P251
   MCPHERSON JM, 1988, COLLAGEN REL RES, V8, P65
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   MURPHY GF, 1990, LAB INVEST, V62, P305
   NAKAGAWA S, 1989, EXP CELL RES, V182, P572, DOI 10.1016/0014-4827(89)90260-7
   NIEZGODA JA, 2001, S ADV WOUND CAR LAS
   PARMENTER MA, 2001, ACFAS PRS JOINT ANN
   Peel SAF, 1998, TISSUE ENG, V4, P143, DOI 10.1089/ten.1998.4.143
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   PREVEL CD, 1994, MICROSURG, V15, P586, DOI 10.1002/micr.1920150812
   Robotin-Johnson MC, 1998, J THORAC CARDIOV SUR, V116, P805, DOI 10.1016/S0022-5223(98)00436-X
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   SHETTIGAR UR, 1982, ARTIF ORGANS, V6, P256
   Suckow MA, 1999, J INVEST SURG, V12, P277, DOI 10.1080/089419399272395
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
   Voytik-Harbin SL, 1998, IN VITRO CELL DEV-AN, V34, P239
   Voytik-Harbin SL, 1998, TISSUE ENG, V4, P157, DOI 10.1089/ten.1998.4.157
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   VOYTIKHARBIN SL, COMMUNICATION
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
NR 68
TC 37
Z9 43
U1 0
U2 6
PU H M P COMMUNICATIONS
PI MALVERN
PA 83 GENERAL WARREN BLVD, STE 100, MALVERN, PA 19355 USA
SN 1044-7946
EI 1943-2704
J9 WOUNDS
JI Wounds-Compend. Clin. Res. Pract.
PD MAY
PY 2002
VL 14
IS 4
BP 150
EP 166
PG 17
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 607QJ
UT WOS:000178802000005
DA 2018-10-19
ER

PT J
AU Liu, GY
   Amro, NA
AF Liu, GY
   Amro, NA
TI Positioning protein molecules on surfaces: A nanoengineering approach to
   supramolecular chemistry
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE MICROSCOPY;
   SCANNING-TUNNELING-MICROSCOPY; DIP-PEN NANOLITHOGRAPHY; NANOMETER-SCALE;
   PROBE LITHOGRAPHY; ALKANETHIOLATE MONOLAYERS; CHEMICAL SYNTHESIS;
   FABRICATION; IMMOBILIZATION
AB We discuss a nanoengineering approach for supramolecular chemistry and self assembly. The collective properties and biofunctionalities of molecular ensembles depend not only on individual molecular building blocks but also on organization at the molecular or nanoscopic level. Complementary to "bottom-up" approaches, which construct supramolecular ensembles by the design and synthesis of functionalized small molecular units or large molecular motifs, nanofabrication explores whether individual units, such as small molecular ligands, or large molecules, such as proteins, can be positioned with nanometer precision. The separation and local environment can be engineered to control subsequent intermolecular interactions. Feature sizes as small as 2 x 4 nm(2) (32 alkanethiol molecules) are produced. Proteins may be aligned along a 10-nm-wide line or within two-dimensional islands of desired geometry. These high-resolution engineering and imaging studies provide new and molecular-level insight into supramolecular chemistry and self-assembly processes in bioscience that are otherwise unobtainable, e.g., the influence of size, separation, orientation, and local environment of reaction sites. This nanofabrication methodology also offers a new strategy in construction of two- and three-dimensional supramolecular structures for cell, virus, and bacterial adhesion, as well as biomaterial and biodevice engineering.
C1 Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.
RP Liu, GY (reprint author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.
EM liu@chem.ucdavis.edu
CR Amro NA, 2000, LANGMUIR, V16, P3006, DOI 10.1021/la000079l
   Atwood J. L., 1996, COMPREHENSIVE SUPRAM
   AVOURIS P, 1995, ACCOUNTS CHEM RES, V28, P95, DOI 10.1021/ar00051a002
   Baker A, 1998, CHEM RES TOXICOL, V11, P730, DOI 10.1021/tx970167e
   Baur C, 1997, J VAC SCI TECHNOL B, V15, P1577, DOI 10.1116/1.589404
   Binnig G, 2000, IBM J RES DEV, V44, P279, DOI 10.1147/rd.441.0279
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57
   BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0
   BrowningKelley ME, 1997, LANGMUIR, V13, P343, DOI 10.1021/la960918x
   Buijs J, 1998, LANGMUIR, V14, P335, DOI 10.1021/la970669s
   Chen C. J., 1993, INTRO SCANNING TUNNE
   CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218
   Cruchon-Dupeyrat S, 2001, APPL SURF SCI, V175, P636, DOI 10.1016/S0169-4332(01)00076-9
   Dagata JA, 1998, J APPL PHYS, V84, P6891, DOI 10.1063/1.368986
   Delamarche E, 1996, ADV MATER, V8, P719, DOI 10.1002/adma.19960080903
   Despont M, 2000, SENSOR ACTUAT A-PHYS, V80, P100, DOI 10.1016/S0924-4247(99)00254-X
   Dinolfo PH, 2001, CHEM MATER, V13, P3113, DOI 10.1021/cm010176f
   EIGLER DM, 1970, NATURE, V244, P524
   FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438
   FROMMER J, 1992, ANGEW CHEM INT EDIT, V31, P1298, DOI 10.1002/anie.199212981
   Greig LM, 2001, CHEM SOC REV, V30, P287, DOI 10.1039/b104962n
   Hamers RJ, 1996, J PHYS CHEM-US, V100, P13103, DOI 10.1021/jp960054o
   HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4
   Hong SH, 2000, SCIENCE, V288, P1808, DOI 10.1126/science.288.5472.1808
   Hong SH, 1999, SCIENCE, V286, P523, DOI 10.1126/science.286.5439.523
   Hu K, 1997, LANGMUIR, V13, P5114, DOI 10.1021/la9700782
   HUANG JY, 1994, LANGMUIR, V10, P626, DOI 10.1021/la00015a005
   IMOTO T, 1972, VERTEBRATE LYSOZYMES
   Kang J, 1996, LANGMUIR, V12, P2813, DOI 10.1021/la951015r
   KOLBE WF, 1992, ULTRAMICROSCOPY, V42, P1113, DOI 10.1016/0304-3991(92)90411-C
   LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003
   LEHN JM, 1995, SUBRAMOLECULAR CHEM
   Leininger S, 2000, CHEM REV, V100, P853, DOI 10.1021/cr9601324
   Liu GY, 2000, ACCOUNTS CHEM RES, V33, P457, DOI 10.1021/ar980081s
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P10774, DOI 10.1021/ja00076a038
   LYO IW, 1991, SCIENCE, V253, P173, DOI 10.1126/science.253.5016.173
   Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755
   Miller SA, 1999, CURR OPIN COLLOID IN, V4, P338, DOI 10.1016/S1359-0294(99)90018-3
   MULLER WT, 1995, SCIENCE, V268, P272, DOI 10.1126/science.268.5208.272
   Nguyen SBT, 2001, P NATL ACAD SCI USA, V98, P11849, DOI 10.1073/pnas.201373898
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Norde W, 1995, COLLOID SURFACE B, V5, P255, DOI 10.1016/0927-7765(95)01223-9
   Patel N, 1997, LANGMUIR, V13, P6485, DOI 10.1021/la970933h
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Poirier GE, 1996, J CHEM PHYS, V105, P2089, DOI 10.1063/1.472078
   POIRIER GE, 1994, LANGMUIR, V10, P2853, DOI 10.1021/la00021a001
   Ramachandran TR, 1998, NANOTECHNOLOGY, V9, P237, DOI 10.1088/0957-4484/9/3/015
   ROSS CB, 1993, LANGMUIR, V9, P632, DOI 10.1021/la00027a002
   Sarid D., 1991, SCANNING FORCE MICRO
   Schoer JK, 1996, J PHYS CHEM-US, V100, P11086, DOI 10.1021/jp960271p
   Schwartz PV, 2001, LANGMUIR, V17, P5971, DOI 10.1021/la001625d
   SILVERTON EW, 1977, P NATL ACAD SCI USA, V74, P5140, DOI 10.1073/pnas.74.11.5140
   SNOW ES, 1995, SCIENCE, V270, P1639, DOI 10.1126/science.270.5242.1639
   Stipe BC, 1997, PHYS REV LETT, V78, P4410, DOI 10.1103/PhysRevLett.78.4410
   TARLOV MJ, 1993, J AM CHEM SOC, V115, P5305, DOI 10.1021/ja00065a056
   Wadu-Mesthrige K, 2000, SCANNING, V22, P380
   Wadu-Mesthrige K, 1999, LANGMUIR, V15, P8580, DOI 10.1021/la991196n
   Wadu-Mesthrige K, 2001, BIOPHYS J, V80, P1891, DOI 10.1016/S0006-3495(01)76158-9
   Wagner P, 1996, BIOPHYS J, V70, P2052, DOI 10.1016/S0006-3495(96)79810-7
   WAGNER P, 1995, LANGMUIR, V11, P3867, DOI 10.1021/la00010a043
   WEISS PS, 1995, ANAL CHIM ACTA, V307, P355, DOI 10.1016/0003-2670(94)00555-Z
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198
   Xu S, 1999, LANGMUIR, V15, P7244, DOI 10.1021/la9906727
   Xu S, 1997, LANGMUIR, V13, P127, DOI 10.1021/la962029f
   ZEPPENFELD P, 1992, ULTRAMICROSCOPY, V42, P128, DOI 10.1016/0304-3991(92)90256-J
   Zhang X, 1999, ADV MATER, V11, P1139, DOI 10.1002/(SICI)1521-4095(199909)11:13<1139::AID-ADMA1139>3.0.CO;2-7
NR 67
TC 151
Z9 152
U1 1
U2 31
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 16
PY 2002
VL 99
IS 8
BP 5165
EP 5170
DI 10.1073/pnas.072695699
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 543DX
UT WOS:000175087000081
PM 11959965
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Miyamoto, K
   Kanemoto, A
   Hashimoto, K
   Tokita, M
   Komai, T
AF Miyamoto, K
   Kanemoto, A
   Hashimoto, K
   Tokita, M
   Komai, T
TI Immobilized gellan sulfate surface for cell adhesion and multiplication:
   development of cell-hybrid biomaterials using self-produced fibronectin
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE gellan sulfated; extra domain A containing fibronectin; human unbilical
   vein endothelial cells
ID MOLECULES
AB A new concept for cell-hybrid biomaterial is proposed in which human unbilical vein endothelial cells (HUVEC) are adhered to an immobilized gellan sulfate (GS) surface. Extra domain A containing fibronectin (EDA(+)FN) released from HUVEC is necessary for cell adhesion and multiplication, The material design in this study is based on these self-released cell adhesion proteins. The interaction between GS and EDA(+)FN was evaluated using the affinity constant (KA); the value obtained was 1.03 x 10(8) (M-1). These results suggest that the adhesion of HUVEC to GS may be supported by the adhesion of EDA(+)FN to GS. We also found that this new material adheres to HUVEC, allowing the reintroduction of EDA(+)FN, which is self-produced by the cell. This material is relatively easy to produce, not requiring the usual coating of adhesion proteins in pretreatment. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Mie Univ, Fac Engn, Dept Chem Mat, Tsu, Mie 5148507, Japan.
RP Miyamoto, K (reprint author), Mie Univ, Fac Engn, Dept Chem Mat, 1515 Kamihama Cho, Tsu, Mie 5148507, Japan.
CR CUNANAN CM, 1991, J CATARACT REFR SURG, V17, P767
   DAVIS LS, 1990, J IMMUNOL, V145, P785
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Guidoin R, 1996, ASAIO J, V42, P974, DOI 10.1097/00002480-199642060-00010
   HIRANO H, 1992, J CLIN LAB INSTRUM R, V15, P179
   Hynes RO, 1990, FIBRONECTINS
   KOBAYASHI K, 1988, J MACROMOL SCI CHEM, VA25, P655, DOI 10.1080/00222338808053391
   MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705
   Miyamoto K, 2001, INT J BIOL MACROMOL, V28, P381, DOI 10.1016/S0141-8130(01)00135-0
   MIYAMOTO K, UNPUB GELLAN SULFATE
   MIYAMOTO K, UNPUB ADHESION ACTIV
   MIYAMOTO K, 1999, JPN J ARTIF ORGANS, V28, P191
   Miyashita K, 1998, INT J BIOL MACROMOL, V22, P91, DOI 10.1016/S0141-8130(97)00093-7
   NOSE K, 1971, T AM SOC ART INT ORG, V17, P482
   OCONNOR CM, 1994, THORAX, V49, P602, DOI 10.1136/thx.49.6.602
   PETERS JH, 1990, BLOOD, V75, P1801
   RICHARD AJ, 1986, ANN THORAC SURG, V41, P657
   SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x
   Shibuya M, 1999, CURR TOP MICROBIOL, V237, P59
   TRELSTAD RL, 1990, ANN NY ACAD SCI, V580, P391, DOI 10.1111/j.1749-6632.1990.tb17947.x
   Vladkova T, 1999, J BIOMAT SCI-POLYM E, V10, P609, DOI 10.1163/156856299X00838
NR 21
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR 8
PY 2002
VL 30
IS 2
BP 75
EP 80
AR PII S0141-8130(02)00013-2
DI 10.1016/S0141-8130(02)00013-2
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 543NJ
UT WOS:000175107800002
PM 11911896
DA 2018-10-19
ER

PT J
AU Pierre, S
   Jean-Claude, V
   Frederic, C
   Gero, D
   Bernard, T
AF Pierre, S
   Jean-Claude, V
   Frederic, C
   Gero, D
   Bernard, T
TI Fundamental aspects of polyelectrolytes multilayers used as biomaterial
   coatings.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 CNRS, Inst Charles Sadron, F-67083 Strasbourg, France.
   INSERM, Strasbourg, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 7
PY 2002
VL 223
MA 396-COLL
BP U445
EP U446
PN 1
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 564CD
UT WOS:000176296702473
DA 2018-10-19
ER

PT J
AU Gretzer, C
   Werthen, M
   Thomsen, P
AF Gretzer, C
   Werthen, M
   Thomsen, P
TI Apoptosis and cytokine release in human monocytes cultured on
   polystyrene and fibrinogen-coated polystyrene surfaces
SO BIOMATERIALS
LA English
DT Article
DE mononuclear cells; adhesion; apoptosis; cytokines; biomaterial;
   particles; fibrinogen
ID IN-VITRO; POLYETHYLENE PARTICLES; PHOSPHATIDYLSERINE RECEPTOR;
   INFLAMMATORY RESPONSES; VITRONECTIN RECEPTOR; HUMAN MACROPHAGES;
   BONE-RESORPTION; WEAR DEBRIS; CELLS; CD14
AB The effects of polystyrene (PS) material surface preadsorption with fibrinogen (3mg/ml) and a low concentration of lipopolysaccharide (LPS: 10 ng/ml) and polystyrene particles (PS: 10(5)/ml) on human monocyte adhesion, viability and cytokine release were Studied during 24h culture in vitro. LPS caused an upregulation of CD14 in adherent cells. In comparison with unstimulated cells on uncoated polystyrene surfaces, LPS did not alter the number of adherent cells but caused a markedly increased release of the proinflammatory cytokines (IL-1alpha and TNF-alpha)) and the down-regulating IL-10. The expression of indicators of various stages of cell death, TdT, annexin-V, propidium iodide (M) and lactate dehydrogenase (LDH), were unaltered, decreased, decreased and increased, respectively, after LPS stimulation. PS particles (3mum phi) caused an increased DNA fragmentation but had a reduced proportion of annexin-V and PI positive cells in comparison with unstimulated cells on uncoated PS. In contrast, 1 mum phi particles had a similar proportion of TdT, annexin-V and PI expressing cells as unstimulated controls. Cultures stimulated with particles (irrespective of size), had a similar concentration of proinflammatory cytokines as unstimulated controls, whereas a higher level of IL-10 was detected. Precoating of PS with fibrinogen revealed an enhanced cell adhesion and a concomitant reduction of CD 14 expression, irrespective of stimulation with various agonists. The proportions of TdT, annexin-V and PI positive cells were unaltered or reduced on fibrinogen-coated PS in both unstimulated and agonist-challenged Cultures. However, depending on the presence and type of agonist, fibrinogen mediated either a markedly increased (LPS) or equivalent (particles and unstimulated) IL-1alpha and TNFalpha release. Further, in comparison with uncoated substrates, fibrinogen was associated with a reduction of IL-10 release, irrespective of the type of stimuli. These observations, using low concentrations of bacterial and material products, indicate that fibrinogen modulates cell material interactions and up- and down-regulates specific events depending on the nature/type of immediate stimuli. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Gothenburg, Inst Anat & Cell Biol, S-40530 Gothenburg, Sweden.
   Univ Gothenburg, Dept Cell & Mol Biol Microbiol, S-40530 Gothenburg, Sweden.
RP Gretzer, C (reprint author), Univ Gothenburg, Inst Anat & Cell Biol, Box 420 Med Gatan 3, S-40530 Gothenburg, Sweden.
OI Thomsen, Peter/0000-0003-3910-6665
CR Al-Saffar N, 1999, J LONG-TERM EFF MED, V9, P319
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   ANDERSON JM, 1988, ASAIO, V11, P101
   ANDREE HAM, 1990, J BIOL CHEM, V265, P4923
   Baran J, 1996, INFECT IMMUN, V64, P4242
   BAZIL V, 1991, J IMMUNOL, V147, P1567
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BRANDSLUND I, 1982, J IMMUNOL METHODS, V48, P199, DOI 10.1016/0022-1759(82)90194-6
   Catelas I, 1999, BIOMATERIALS, V20, P625, DOI 10.1016/S0142-9612(98)00214-2
   Catelas I, 1998, J BIOMED MATER RES, V41, P600, DOI 10.1002/(SICI)1097-4636(19980915)41:4<600::AID-JBM12>3.3.CO;2-7
   DE WMR, 1991, J EXP MED, V174, P1209
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DeFife KM, 1999, FASEB J, V13, P823
   Devitt A, 1998, NATURE, V392, P505
   Dinarello CA, 1996, BLOOD, V87, P2095
   FADOK VA, 1992, J IMMUNOL, V149, P4029
   Fadok VA, 1998, J IMMUNOL, V161, P6250
   Flad HD, 1998, RES IMMUNOL, V149, P733, DOI 10.1016/S0923-2494(99)80048-0
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Gonzalez O, 1996, J BIOMED MATER RES, V30, P463, DOI 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.3.CO;2-I
   Goodier MR, 2000, J IMMUNOL, V165, P139, DOI 10.4049/jimmunol.165.1.139
   Goodman SB, 1996, J BIOMED MATER RES, V31, P421, DOI 10.1002/(SICI)1097-4636(199607)31:3<421::AID-JBM17>3.0.CO;2-L
   Gretzer C, 1996, BIOMATERIALS, V17, P851, DOI 10.1016/0142-9612(96)83279-0
   Gretzer C, 2000, CYTOKINE, V12, P32, DOI 10.1006/cyto.1999.0523
   Gretzer C, 2000, BIOMATERIALS, V21, P1047, DOI 10.1016/S0142-9612(99)00279-3
   GRETZER C, UNPUB H2O2 PRODUCTIO
   Grunwald U, 1996, J IMMUNOL, V157, P4119
   Hahn DW, 1996, J BIOMED MATER RES, V31, P355
   HASKILL S, 1988, J IMMUNOL, V140, P1690
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   Heidenreich S, 1999, J LEUKOCYTE BIOL, V65, P737
   Horowitz SM, 1996, CALCIFIED TISSUE INT, V59, P392, DOI 10.1007/s002239900145
   Horowitz SM, 1998, J BIOMED MATER RES, V41, P468, DOI 10.1002/(SICI)1097-4636(19980905)41:3<468::AID-JBM17>3.3.CO;2-7
   HOROWITZ SM, 1995, J BIOMED MATER RES, V29, P477, DOI 10.1002/jbm.820290407
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   Kitchens RL, 2000, CHEM IMMUNOL, V74, P61
   Kreuzer J, 1996, J MOL MED-JMM, V74, P161
   MANGAN DF, 1991, J IMMUNOL, V146, P1541
   MARCHANT A, 1992, EUR J IMMUNOL, V22, P1663, DOI 10.1002/eji.1830220650
   Matthews JB, 2000, BIOMATERIALS, V21, P2033, DOI 10.1016/S0142-9612(00)00089-2
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7
   Paysant J, 1998, BRIT J HAEMATOL, V100, P45, DOI 10.1046/j.1365-2141.1998.00528.x
   PERTOFT H, 1980, J IMMUNOL METHODS, V33, P221, DOI 10.1016/0022-1759(80)90209-4
   Pollice PF, 1998, J ORTHOP RES, V16, P697, DOI 10.1002/jor.1100160611
   Prabhu A, 1998, J BIOMED MATER RES, V42, P655, DOI 10.1002/(SICI)1097-4636(19981215)42:4<655::AID-JBM23>3.3.CO;2-2
   SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7
   Schmidt M, 2000, EUR J IMMUNOL, V30, P1769, DOI 10.1002/1521-4141(200006)30:6<1769::AID-IMMU1769>3.0.CO;2-9
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   SIMON DI, 1993, BLOOD, V82, P2414
   Stea S, 2000, BIOMATERIALS, V21, P1393, DOI 10.1016/S0142-9612(00)00041-7
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TANG LP, 1994, CELL MATER, V4, P429
   Volk HD, 2000, CHEM IMMUNOL, V74, P162
   WERTHEN M, 2001, BIOMATERIALS, V8, P827
   WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   Zhang XS, 1999, J MATER SCI-MATER M, V10, P879, DOI 10.1023/A:1008937419664
   ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4
NR 64
TC 12
Z9 16
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2002
VL 23
IS 7
BP 1639
EP 1648
AR PII S0142-9612(01)00290-3
DI 10.1016/S0142-9612(01)00290-3
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 527PX
UT WOS:000174196100010
PM 11922467
DA 2018-10-19
ER

PT J
AU Handschel, J
   Wiesmann, HP
   Stratmann, U
   Kleinheinz, J
   Meyer, U
   Joos, U
AF Handschel, J
   Wiesmann, HP
   Stratmann, U
   Kleinheinz, J
   Meyer, U
   Joos, U
TI TCP is hardly resorbed and not osteoconductive in a non-loading
   calvarial model
SO BIOMATERIALS
LA English
DT Article
DE tricalciumphosphate; non-loaded bone; biodegredation; biomaterial;
   tissue engineering
ID CALCIUM-PHOSPHATE CEMENT; TISSUE-RESPONSE; MONOXIDE CEMENT; BONE
   INTERFACE; IN-VIVO; IMPLANTATION; OSTEOBLASTS; DEFECTS; STRAIN;
   BIOMATERIALS
AB Tricalciumphosphate (TCP) has been used as a ceramic bone substitute material in the orthopedic field as well as in craniofacial surgery. Sonic controversies exist concerning the osteoconductive potential of this material in different implantation sites. This study was designed to evaluate the biological response of calvarial bone towards TCP granules under non-loading conditions to assess the potential of TCP as a biodegredable and osteoconductive bone substitue material for the cranial vault.
   Full-thickness non-critical size defects were made bilaterally in the calvaria of 21 adult Wistar rats. One side was filled by TCP granules, the contralateral side was left empty and used as a control. Animals were sacrificed in defined time intervals up to 6 months. Bone regeneration was analyzed with special respect toward the micromorphological and microanalytical features of the material-bone interaction by electron microscopy and electron diffraction analysis.
   Histologic examination revealed no TCP degradation even after 6 months of implantation. In contrast, a nearly complete bone regeneration of control defects was found after 6 months. At all times TCP was surrounded by a thin fibrous layer without presence of osteoblasts and features of regular mineralization. As far as degradation and substitution are concerned, TCP is a less favourable material under conditions of non-loading. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Munster, Dept Cranio & Maxillofacial Surg, D-48129 Munster, Germany.
   Univ Munster, Biomineralizat Res Unit, D-48129 Munster, Germany.
   Univ Munster, Dept Anat, D-48129 Munster, Germany.
RP Handschel, J (reprint author), Univ Munster, Dept Cranio & Maxillofacial Surg, Waldeyerstr 30, D-48129 Munster, Germany.
CR BHASKAR SN, 1971, ORAL SURG ORAL MED O, V32, P336, DOI 10.1016/0030-4220(71)90238-6
   Bidwell JP, 1998, J BONE MINER RES, V13, P155, DOI 10.1359/jbmr.1998.13.2.155
   Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   DELANGE GL, 1990, J BIOMED MATER RES, V24, P829, DOI 10.1002/jbm.820240704
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   FOITZIK C, 1997, QUINTESSENZ, V48, P1365
   Frayssinet P, 1998, BIOMATERIALS, V19, P971, DOI 10.1016/S0142-9612(97)00163-4
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   Kurashina K, 1997, BIOMATERIALS, V18, P539, DOI 10.1016/S0142-9612(96)00162-7
   Kurashina K, 1998, BIOMATERIALS, V19, P701, DOI 10.1016/S0142-9612(97)00178-6
   LANYON LE, 1996, BONE S1, V18, P37
   Marie PJ, 2000, CALCIFIED TISSUE INT, V67, P2, DOI 10.1007/s00223001088
   MEYER U, 1993, CELL MATER, V3, P129
   Meyer U, 1997, BIOCHEM CELL BIOL, V75, P81, DOI 10.1139/bcb-75-1-81
   Meyer U, 1999, J ORAL MAXIL SURG, V57, P1331, DOI 10.1016/S0278-2391(99)90872-8
   MOLLER K, 1994, CELL MATER, V4, P263
   MUNTING E, 1993, J MATER SCI-MATER M, V4, P337, DOI 10.1007/BF00122290
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   Neo M, 1996, J BIOMED MATER RES, V30, P485, DOI 10.1002/(SICI)1097-4636(199604)30:4<485::AID-JBM6>3.0.CO;2-L
   Neo M, 1998, J BIOMED MATER RES, V39, P71, DOI 10.1002/(SICI)1097-4636(199801)39:1<71::AID-JBM9>3.0.CO;2-F
   Pioletti DP, 2000, BIOMATERIALS, V21, P1103, DOI 10.1016/S0142-9612(99)00250-1
   RAMSELAAR MMA, 1991, J MATER SCI-MATER M, V2, P63, DOI 10.1007/BF00703460
   REJDA BV, 1977, J BIOENG, V1, P93
   Schliephake H, 1997, Mund Kiefer Gesichtschir, V1, P115
   Schmitt JM, 1997, J PERIODONTOL, V68, P1043, DOI 10.1902/jop.1997.68.11.1043
   Yao JL, 1997, J BONE JOINT SURG AM, V79A, P107, DOI 10.2106/00004623-199701000-00011
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
NR 29
TC 69
Z9 73
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2002
VL 23
IS 7
BP 1689
EP 1695
AR PII S0142-9612(01)00296-4
DI 10.1016/S0142-9612(01)00296-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 527PX
UT WOS:000174196100016
PM 11922472
DA 2018-10-19
ER

PT J
AU Nimeri, G
   Ohman, L
   Elwing, H
   Wettero, J
   Bengtsson, T
AF Nimeri, G
   Ohman, L
   Elwing, H
   Wettero, J
   Bengtsson, T
TI The influence of plasma proteins and platelets on oxygen radical
   production and F-actin distribution in neutrophils adhering to polymer
   surfaces
SO BIOMATERIALS
LA English
DT Article
DE neutrophil; platelet; polymer; plasma protein; oxygen radicals; actin
ID ENHANCED ALBUMIN AFFINITY; P-SELECTIN; ADHERENT PLATELETS; RESPIRATORY
   BURST; INFLAMMATORY RESPONSES; IMMUNOGLOBULIN-G; ACTIVATION; ADHESION;
   FIBRINOGEN; BIOMATERIALS
AB It is well known that blood cell interactions with artificial surfaces might have deleterious effects on host tissue, however. the mechanisms involved are far from understood. In this study, neutrophil platelet interaction on uncoated or protein-coated polymer surfaces was investigated. Cell spreading, reorganization of actin filaments and release of oxygen metabolites (measured as luminol-amplified chemiluminescence) were used as criteria for cell activation on positively charged, hydrophilic 1,2-diaminocyclohexane, and negatively charged, hydrophobic hexamethylene-disiloxane. The model surfaces were made by radio frequency plasma discharge polymerization. Neutrophil contact with the uncoated polymers induced a prolonged generation of oxygen radicals. Precoating of the polymer surfaces with human serum albumin (HSA) or fibrinogen, markedly reduced neutrophil activation, whereas coating with human immunoglobulin G (IgG), a well-known opsonin. resulted in significantly higher levels of cell activation. Consequently, protein coating overruled the activating effects of the polymer surfaces. The presence of unstimulated or thrombin-stimulated platelets markedly increased the reactivity of neutrophils against fibrinogen- and I-G-coated surfaces. However, neutrophils remained relatively unreactive in the presence of platelets on HSA-treated surfaces. Comparison of the different types of surfaces used, reveals a correlation between the degree of cell spreading, reorganization of the actin cytoskeleton and the amount of oxygen radicals produced. Our results suggest that the acute inflammatory reaction on a biomaterial surface is highly dependent on the nature and composition of the first adsorbed protein layer and the extent of platelet activation. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Linkoping Univ, Fac Hlth Sci, Dept Hlth & Environm, Div Med Microbiol, SE-58185 Linkoping, Sweden.
   Univ Gothenburg, Dept Cell & Mol Biol, SE-40530 Gothenburg, Sweden.
RP Bengtsson, T (reprint author), Linkoping Univ, Fac Hlth Sci, Dept Hlth & Environm, Div Med Microbiol, SE-58185 Linkoping, Sweden.
RI Wettero, Jonas/C-9578-2009
OI Wettero, Jonas/0000-0002-6916-5490
CR Bengtsson T, 1996, BLOOD, V87, P4411
   BENGTSSON T, 1993, EUR J CELL BIOL, V62, P49
   Bengtsson T, 1999, SCAND J CLIN LAB INV, V59, P439, DOI 10.1080/00365519950185463
   BENGTSSON T, 1994, EUR J CELL BIOL, V63, P345
   Berton G, 1996, INT J CLIN LAB RES, V26, P160, DOI 10.1007/BF02592978
   BERTON G, 1994, J CELL BIOL, V126, P1111, DOI 10.1083/jcb.126.4.1111
   BORREGAARD N, 1991, Journal of Cell Biology, V115, p257A
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   Brown KK, 1998, AM J RESP CELL MOL, V18, P100, DOI 10.1165/ajrcmb.18.1.2314
   Cerletti C, 1999, THROMB HAEMOSTASIS, V82, P787
   CHUANG HYK, 1980, THROMB RES, V19, P1, DOI 10.1016/0049-3848(80)90398-9
   DAHLGREN C, 1983, IMMUNOLOGY, V49, P329
   DELAHARPE J, 1989, J IMMUNOL, V143, P596
   DEUEL TF, 1981, P NATL ACAD SCI-BIOL, V78, P4584, DOI 10.1073/pnas.78.7.4584
   DEUEL TF, 1982, J CLIN INVEST, V69, P1046, DOI 10.1172/JCI110509
   Diacovo TG, 1996, BLOOD, V88, P146
   DRI P, 1991, INT J TISSUE REACT, V13, P193
   FALCK P, 1995, BIOMATERIALS, V16, P61, DOI 10.1016/0142-9612(95)91097-I
   FRAUTSCHI JR, 1983, T AM SOC ART INT ORG, V29, P242
   GOETZL EJ, 1977, J CLIN INVEST, V59, P179, DOI 10.1172/JCI108617
   GOLANDER CG, 1993, J APPL POLYM SCI, V49, P39, DOI 10.1002/app.1993.070490106
   Hartwig JH, 1999, THROMB HAEMOSTASIS, V82, P392
   HIGAZI AA, 1994, INFLAMMATION, V18, P525, DOI 10.1007/BF01560699
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   Jirouskova M, 1997, THROMB HAEMOSTASIS, V78, P1125
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   KATZ DA, 1995, SURGERY, V118, P154, DOI 10.1016/S0039-6060(05)80318-6
   Klinger MHF, 1997, ANAT EMBRYOL, V196, P1, DOI 10.1007/s004290050075
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   LASSEN B, 1992, Clinical Materials, V11, P99, DOI 10.1016/0267-6605(92)90034-Q
   Lassen B, 1997, J COLLOID INTERF SCI, V186, P9, DOI 10.1006/jcis.1996.4529
   Liu L, 1997, CLIN EXP IMMUNOL, V109, P204, DOI 10.1046/j.1365-2249.1997.4311329.x
   MORLEY DJ, 1989, THROMB HAEMOSTASIS, V62, P1023
   MUNRO MS, 1981, T AM SOC ART INT ORG, V27, P499
   NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P741
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P573, DOI 10.1163/156856294X00527
   NYGREN H, 1995, J VAC SCI TECHNOL A, V13, P2613, DOI 10.1116/1.579459
   PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TANG LP, 1994, CELL MATER, V4, P429
   TSUJI T, 1994, J LEUKOCYTE BIOL, V56, P583
   Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742
   WEKSLER B. B., 1992, INFLAMMATION BASIC P, P727
   Wettero J, 2000, J BIOMED MATER RES, V51, P742, DOI 10.1002/1097-4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D
   Zalavary S, 1996, J LEUKOCYTE BIOL, V60, P58
NR 49
TC 40
Z9 42
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2002
VL 23
IS 8
BP 1785
EP 1795
AR PII S0142-9612(01)00305-2
DI 10.1016/S0142-9612(01)00305-2
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536FD
UT WOS:000174689300008
PM 11950049
DA 2018-10-19
ER

PT J
AU Park, JH
   Bae, YH
AF Park, JH
   Bae, YH
TI Hydrogels based on poly(ethylene oxide) and poly(tetramethylene oxide)
   or poly(dimethyl siloxane): synthesis, characterization, in vitro
   protein adsorption and platelet adhesion
SO BIOMATERIALS
LA English
DT Article
DE poly(ethylene oxide); poly(tetramethylene oxide); poly(dimethyl
   siloxane); hydrogel; protein adsorption; platelet adhesion
ID POLYDIMETHYLSILOXANE POLYUREA-URETHANES; POLYMERIC BIOMATERIALS;
   SILICONE-RUBBER; SURFACES; FIBRINOGEN; COPOLYMERS; BIOCOMPATIBILITY;
   COEFFICIENT; WETTABILITY; ACTIVATION
AB In vitro protein adsorption, platelet adhesion and activation on now hydrogel surfaces, composed of poly(ethylene oxide) (PEO) and poly(tetramethylene oxide) (PTMO) or poly(dimethyl siloxane) (PDMS), were investigated. By varying PEO length (MW = 2000 or 3400), hydrophobic components (PTMO or PDMS) or polymer topology (block or graft copolymers), various physical hydrogels were produced. Their structures were verified by, H-1 NMR and ATR-IR and the molecular weights were determined by gel permeation chromatography. The hydrogels were soluble in a variety of organic solvents, while absorbed a significant amount of water with preserved three-dimensional structure by physical crosslinking. The dynamic contact angle measurement revealed that the surface hydrophilicity increased by incorporating longer PEO, PEO grafting, and adopting PDMS as a hydrophobic segment instead of PTMO. It was observed from in vitro protein adsorption Study that the hydrogels exhibited significantly lower adsorption Of human scrum albumin (HSA), human fibrinogen (HFg), and IgG, when compared with Pellethane (H), a commercial polyurethane taken as a control. The hydrogels were attractive for HSA but not sensitive to HFg and I-G. And more than 65% of the proteins detected on the surfaces of the hydrogels were reversibly detached by being treated with an SDS solution. It was evident that the hydrogels synthesized in this Study were much more resistant to platelet adhesion than the control, which might depend on the composition of proteins adsorbed on the surfaces and their degree of denaturation, Among the hydrogels tested, PE03.4kPDMS exhibited albumin-rich and platelet-resistant surfaces, implying a potential candidate for biomaterial. (C) 2002 Published by Elsevier Science Ltd.
C1 Kwangju Inst Sci & Technol, Dept Mat Sci & Engn, Ctr Biomat & Biotechnol, Puk Gu, Kwangju 500712, South Korea.
RP Bae, YH (reprint author), Kwangju Inst Sci & Technol, Dept Mat Sci & Engn, Ctr Biomat & Biotechnol, Puk Gu, 1 Oryong Dong, Kwangju 500712, South Korea.
RI byun, jaehyun/G-5584-2014; Park, Jae Hyung/B-5967-2018
CR Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   Bell CL, 1996, BIOMATERIALS, V17, P1203, DOI 10.1016/0142-9612(96)84941-6
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   Chinn JA, 1996, J COLLOID INTERF SCI, V184, P11, DOI 10.1006/jcis.1996.0592
   DETTRE RH, 1965, J PHYS CHEM-US, V69, P1507, DOI 10.1021/j100889a012
   DUST JM, 1990, MACROMOLECULES, V23, P3742, DOI 10.1021/ma00218a005
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRAIVER D, 1993, BIOMATERIALS, V14, P465, DOI 10.1016/0142-9612(93)90150-Z
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   GUTOWSKA A, 1994, MACROMOLECULES, V27, P4167, DOI 10.1021/ma00093a018
   Han DK, 1996, J BIOMED MATER RES, V30, P23, DOI 10.1002/(SICI)1097-4636(199601)30:1<23::AID-JBM4>3.0.CO;2-T
   Hanson S. R., 1996, BIOMATERIALS SCI INT, P193
   HERGENROTHER RW, 1994, BIOMATERIALS, V15, P635, DOI 10.1016/0142-9612(94)90215-1
   Hoffman AS, 1982, ADV CHEM SER, V199, P3
   HOGT AH, 1985, J COLLOID INTERF SCI, V106, P289, DOI 10.1016/S0021-9797(85)80002-3
   Horak D, 1997, J BIOMED MATER RES, V34, P183, DOI 10.1002/(SICI)1097-4636(199702)34:2<183::AID-JBM7>3.0.CO;2-M
   Hsiue GH, 1998, J BIOMED MATER RES, V42, P134, DOI 10.1002/(SICI)1097-4636(199810)42:1<134::AID-JBM17>3.0.CO;2-L
   Irvine DJ, 1996, MACROMOLECULES, V29, P6037, DOI 10.1021/ma951903t
   Iza M, 1998, J CONTROL RELEASE, V52, P41, DOI 10.1016/S0168-3659(97)00191-0
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Karadag E, 1996, BIOMATERIALS, V17, P67, DOI 10.1016/0142-9612(96)80757-5
   Kidane A, 2000, COLLOID SURFACE B, V18, P347, DOI 10.1016/S0927-7765(99)00160-5
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   LI C, 1988, J POLYM SCI POL PHYS, V26, P315, DOI 10.1002/polb.1988.090260209
   LIM F, 1994, BIOMATERIALS, V15, P408, DOI 10.1016/0142-9612(94)90218-6
   LINDON JN, 1986, BLOOD, V68, P355
   Mackay TG, 1996, ARTIF ORGANS, V20, P1017, DOI 10.1111/j.1525-1594.1996.tb04589.x
   MAJERUS PW, 1980, REGULATION COAGULATI, P215
   Naim JO, 1998, COLLOID SURFACE B, V11, P79, DOI 10.1016/S0927-7765(98)00023-X
   NICKEL JC, 1987, UROLOGY, V29, P501, DOI 10.1016/0090-4295(87)90037-9
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   PEPPAS NA, 1987, HYDROGELS MED PHARM, V3
   PEZRON E, 1988, MACROMOLECULES, V21, P1121, DOI 10.1021/ma00182a045
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Renken J, 1996, ANAL CHEM, V68, P176, DOI 10.1021/ac9504777
   RISBUD MV, DRUG DELIV, V200, P69
   SEIFERT LM, 1985, J BIOMED MATER RES, V19, P1043, DOI 10.1002/jbm.820190916
   TALJA M, 1990, BRIT J UROL, V66, P652, DOI 10.1111/j.1464-410X.1990.tb07203.x
   TANAKA F, 1992, MACROMOLECULES, V25, P1516, DOI 10.1021/ma00031a024
   van der Heiden AP, 1998, J BIOMED MATER RES, V40, P195, DOI 10.1002/(SICI)1097-4636(199805)40:2<195::AID-JBM4>3.0.CO;2-G
   Welle A, 1998, J COLLOID INTERF SCI, V197, P263, DOI 10.1006/jcis.1997.5238
   WILLARD JE, 1994, CIRCULATION, V89, P2190, DOI 10.1161/01.CIR.89.5.2190
   YU XH, 1985, J POLYM SCI POL PHYS, V23, P2319, DOI 10.1002/pol.1985.180231106
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 51
TC 105
Z9 110
U1 10
U2 93
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2002
VL 23
IS 8
BP 1797
EP 1808
AR PII S0142-9612(01)00306-4
DI 10.1016/S0142-9612(01)00306-4
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536FD
UT WOS:000174689300009
PM 11950050
DA 2018-10-19
ER

PT J
AU Murata, M
   Arisue, M
   Sato, D
   Sasaki, T
   Shibata, T
   Kuboki, Y
AF Murata, M
   Arisue, M
   Sato, D
   Sasaki, T
   Shibata, T
   Kuboki, Y
TI Bone induction in subcutaneous tissue in rats by a newly developed
   DNA-coated atelocollagen and bone morphogenetic protein
SO BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
LA English
DT Article
ID RECOMBINANT HUMAN BMP-2; ARTIFICIAL SKIN; ECTOPIC SITES; I COLLAGEN;
   DIFFERENTIATION; AUGMENTATION; FIBRILLAR; RHBMP-2; IMPLANT; CARRIER
AB A unique biomaterial, a mixture of DNA and collagen (DNA/collagen), was developed and its efficacy as a carrier matrix for bone morphogenetic protein (BMP) was evaluated histologically. The material was prepared as a composite of DNA from salmon milt and pepsin-digested type I collagen (atelocollagen) from bovine dermis. Phase-contrast and fluorescence microscopy showed atelocollagen fibres with DNA coating. The dose-response and time-course of bone induction by BMP in DNA/collagen (5 x 10 x 1 mm) in the subcutaneous tissue was investigated in 20 male Wistar rats. The BMP/DNA/collagen induced new bone in a dose-dependent manner (0, 25, 50 or 100 mug of BMP). Histological examination in the time-course study showed that the BMP (100 mug)/DNA/collagen induced bone formation, while the DNA/collagen alone resulted in the accumulation of fibroblasts. These results indicate that the DNA/collagen is effective as a carrier matrix for BMP. It provides a cell anchorage for differentiation of osteoblasts and is absorbed as bone matures. (C) 2002 The British Association of Oral and Maxillofacial Surgeons.
C1 Hokkaido Univ, Sch Dent, Dept Oral & Maxillofacial Surg 2, Tobetsu, Hokkaido 060, Japan.
   Hokkaido Univ, Grad Sch Dent Med, Dept Oral Hlth Sci, Sapporo, Hokkaido, Japan.
RP Murata, M (reprint author), Hokkaido Univ, Sch Dent, Dept Oral & Maxillofacial Surg 2, Tobetsu, Hokkaido 060, Japan.
CR AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712
   BASSETT CA, 1961, NATURE, V190, P460, DOI 10.1038/190460a0
   BERNSTEIN KA, 1995, J IMMUNOL, V154, P2424
   Boyne PJ, 1999, BRIT J ORAL MAX SURG, V37, P344, DOI 10.1054/bjom.1999.0205
   HEY KB, 1990, BIOTECHNOL APPL BIOC, V12, P85
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   IZUI S, 1976, J EXP MED, V144, P28
   KAWAI T, 1993, CLIN ORTHOP RELAT R, P296
   Kitamura H, 1997, INT J BIOL MACROMOL, V20, P241, DOI 10.1016/S0141-8130(97)00021-4
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   KUBOKI Y, 1995, CONNECT TISSUE RES, V31, P1
   Kusumoto K, 1997, BRIT J ORAL MAX SURG, V35, P433, DOI 10.1016/S0266-4356(97)90722-1
   Ma Q, 2000, BRIT J ORAL MAX SURG, V38, P561, DOI 10.1054/bjom.2000.0458
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   Murata M, 1998, INT J ORAL MAX SURG, V27, P391, DOI 10.1016/S0901-5027(98)80071-4
   Murata M, 1999, INT J ORAL MAX SURG, V28, P232, DOI 10.1034/j.1399-0020.1999.283280316.x
   Murata M, 2000, CLIN ORAL IMPLAN RES, V11, P289, DOI 10.1034/j.1600-0501.2000.011004289.x
   Nagai N, 1999, INT J ORAL MAX SURG, V28, P143
   Omura S, 1998, INT J ORAL MAX SURG, V27, P129, DOI 10.1016/S0901-5027(98)80312-3
   REDDI AH, 1985, BONE MINERAL RES, V3, P27
   RHODES RK, 1978, BIOCHEMISTRY-US, V17, P3442, DOI 10.1021/bi00610a003
   RIPAMONTI U, 1992, MATRIX, V12, P202, DOI 10.1016/S0934-8832(11)80063-6
   SAMPATH TK, 1983, P NATL ACAD SCI-BIOL, V80, P6591, DOI 10.1073/pnas.80.21.6591
   SASANO Y, 1993, ANAT REC, V236, P373, DOI 10.1002/ar.1092360211
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
NR 31
TC 8
Z9 8
U1 0
U2 0
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0266-4356
J9 BRIT J ORAL MAX SURG
JI Br. J. Oral Maxillofac. Surg.
PD APR
PY 2002
VL 40
IS 2
BP 131
EP 135
DI 10.1054/bjom.2001.0743
PG 5
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 557ZR
UT WOS:000175940000008
PM 12180204
DA 2018-10-19
ER

PT J
AU Tegoulia, VA
   Cooper, SL
AF Tegoulia, VA
   Cooper, SL
TI Staphylococcus aureus adhesion to self-assembled monolayers: effect of
   surface chemistry and fibrinogen presence
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE bacterial adhesion; self-assembled monolayers; Staphylococcus aureus;
   well-defined flow field; automated videomicroscopy
ID BACTERIAL ADHESION; PROTEIN ADSORPTION; POLYETHYLENE OXIDE; FREE-ENERGY;
   OLIGO(ETHYLENE GLYCOL); POLYURETHANE SURFACES; BIOMATERIAL SURFACES;
   SILICONE-RUBBER; SOLID-SURFACES; PARALLEL-PLATE
AB Staphylococcus aureus adhesion on self-assembled monolayers (SAMs) formed by the adsorption of alkanethiols on transparent gold films has been studied in real time under well-defined flow conditions using a radial flow chamber and an automated videornicroscopy system. SAMs terminated with methyl, hydroxyl, carboxylic acid and tri(ethylene oxide) groups were investigated. SAMs were characterized using contact angle measurements, ellipsometry and X-ray photoelectron spectroscopy. Adhesion experiments using the Newman strain of S. aureits were performed on bare monolayers and monolayers pre-incubated with fibrinogen. Adhesion was round to be lowest on the ethylene oxide-bearing surfaces, followed by the hydroxyl surfaces. Adhesion on the carboxylic- and methyl-terminated SAMs was much higher. Bacterial adhesion was higher on the hydrophobic surfaces. Pre-incubation of surfaces with fibrinogen minimized the effect of the surface properties of the substrate. Adhesion was increased on all surfaces when fibrinogen was present and no significant differences were observed between adhesion to the different SAMs. This study showed that surfaces rich in ethylene oxide groups can be effectively used to prevent bacterial adhesion. However, under physiological conditions, most of the substrate properties are masked by the presence of the adsorbed protein layer and the effect of substrate properties on bacteria adhesion under flow is minimal. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
   N Carolina State Univ, Raleigh, NC 27695 USA.
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   Alberte RS, 1992, BIOFOULING, V6, P91, DOI 10.1080/08927019209386214
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   BAIN CD, 1989, LANGMUIR, V5, P1370, DOI 10.1021/la00090a019
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   Baumgartner JN, 1998, J BIOMED MATER RES, V40, P660, DOI 10.1002/(SICI)1097-4636(19980615)40:4<660::AID-JBM18>3.0.CO;2-J
   Bos R, 1996, MICROBIOL-UK, V142, P2355, DOI 10.1099/00221287-142-9-2355
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   BUSSCHER HJ, 1999, PHYSICAL CHEM BIOL I
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J
   DICKINSON RB, 1995, INFECT IMMUN, V63, P3143
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   EGINTON PJ, 1995, COLLOID SURFACE B, V5, P153, DOI 10.1016/0927-7765(95)01219-9
   Everaert EPJM, 1998, COLLOID SURFACE B, V10, P179, DOI 10.1016/S0927-7765(98)00003-4
   FERREIROS CM, 1989, FEMS MICROBIOL LETT, V60, P89, DOI 10.1016/0378-1097(89)90083-9
   FLETCHER M, 1985, J COLLOID INTERF SCI, V104, P5, DOI 10.1016/0021-9797(85)90004-9
   Fletcher M, 1996, BACTERIAL ADHESION M, P1
   Hashimoto N, 1998, J FERMENT BIOENG, V86, P424, DOI 10.1016/S0922-338X(99)89019-9
   HERRMANN M, 1993, J INFECT DIS, V167, P312, DOI 10.1093/infdis/167.2.312
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   Higashi JM, 1998, J BIOMED MATER RES, V39, P341, DOI 10.1002/(SICI)1097-4636(19980305)39:3<341::AID-JBM1>3.0.CO;2-J
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   LAIBINIS PE, 1995, J PHYS CHEM-US, V99, P7663, DOI 10.1021/j100019a054
   Lappin-Scott H. M., 1989, Biofouling, V1, P323
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P468
   LEE TR, 1994, LANGMUIR, V10, P741, DOI 10.1021/la00015a024
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   MCCRACKIN FL, 1963, J RES NBS A PHYS CH, VA 67, P363, DOI 10.6028/jres.067A.040
   MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x
   MEINDERS JM, 1994, J COLLOID INTERF SCI, V164, P355, DOI 10.1006/jcis.1994.1177
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   Mittelman M. W., 1996, BACTERIAL ADHESION M, P89
   MOHAMMAD SF, 1988, T AM SOC ART INT ORG, V34, P573
   MOLLER PS, 1963, AERONAUT QUART, V14, P163, DOI 10.1017/S0001925900002742
   Mrksich M, 1997, CURR OPIN COLLOID IN, V2, P83, DOI 10.1016/S1359-0294(97)80012-X
   Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   Petas A, 1998, BIOMATERIALS, V19, P677, DOI 10.1016/S0142-9612(97)00171-3
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   RIJNAARTS HHM, 1995, COLLOID SURFACE B, V4, P5, DOI DOI 10.1016/0927-7765(94)01146-V
   RUTTER P R, 1984, P21
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   SLACK SM, 1993, CARDIOVASC PATHOL, V2, pS11
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   Wadstrom T., 1990, MICROBIAL CELL SURFA, P315
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
   Wassall MA, 1997, J BIOMED MATER RES, V36, P325, DOI 10.1002/(SICI)1097-4636(19970905)36:3<325::AID-JBM7>3.3.CO;2-L
   WHICHER SJ, 1978, J BIOMED MATER RES, V12, P181, DOI 10.1002/jbm.820120205
   WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995
   Yang JL, 1999, J COLLOID INTERF SCI, V220, P410, DOI 10.1006/jcis.1999.6539
NR 60
TC 63
Z9 64
U1 3
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR
PY 2002
VL 24
IS 3-4
BP 217
EP 228
AR PII S0927-7765(01)00240-5
DI 10.1016/S0927-7765(01)00240-5
PG 12
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 533XN
UT WOS:000174555700006
DA 2018-10-19
ER

PT J
AU Ma, DHK
   Wang, SF
   Su, WY
   Tsai, RJF
AF Ma, DHK
   Wang, SF
   Su, WY
   Tsai, RJF
TI Amniotic membrane graft for the management of scleral melting and
   corneal perforation in recalcitrant infectious scleral and corneoscleral
   ulcers
SO CORNEA
LA English
DT Article
DE amniotic membrane graft; scleral ulcer; corneoscleral ulcer
ID OCULAR SURFACE RECONSTRUCTION; STEVENS-JOHNSON-SYNDROME; TOPICAL
   MITOMYCIN-C; PTERYGIUM EXCISION; THERMAL BURNS; TRANSPLANTATION;
   SCLERITIS; COMPLICATIONS; ULCERATION; PROTEINS
AB Purpose. To study the efficacy and safety of using cryopreserved human amniotic membrane (AM) graft as a patch graft to reduce stromal melting and promote reepithelialization in extensive infectious scleral and corneoscleral ulcers. Methods. Four cases of infectious scleral ulcers with persistent scleral melting and no sign of reepithelialization and three cases of corneoscleral ulcers with corneal perforation were studied. All patients had previously undergone pterygium excision, and infections were caused by Pseudomonas (n = 4), fungi (n = 2), and atypical Mycobacterium (n = 1). The area of limbus involved ranged from 3 to 9 (mean, 4.7) o'clock positions. Repeated debridements were performed, the causative microorganisms were identified, and the appropriate topical and systemic antibiotics were given to all patients before AM grafting. Postoperatively, the speed of reepithelialization, changes in the severity of scleral melting and inflammation recurrence of infection, and visual acuity were documented. Results. Melting and inflammation at the lesion site decreased after AM grafting. Reepithelialization of the scleral lesions was complete at an average 15.7 +/- 8.7 days (range, 5-31) postoperatively. Focal melting of the AM graft occurred in two cases, and in one case, it was necessary to perform further corneoscleral graft. No recurrent infection was encountered, but sterile abscess occurred in three cases that were located away from the original lesion. Useful vision above 201400 was maintained in all patients at the end of follow-up. Conclusion. The AM graft is effective in promoting conjunctival reepithelialization and reducing scleral melting and inflammation and can be considered as an alternative biomaterial to improve wound healing in scleral and comeoscleral ulcerations.
C1 Chang Gung Mem Hosp, Dept Ophthalmol, Taoyuan, Taiwan.
   Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan.
   Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.
RP Tsai, RJF (reprint author), 2F 350 Sect 4,Cheng Kung Rd, Taipei 114, Taiwan.
CR ALTMAN AJ, 1991, CORNEA, V10, P341, DOI 10.1097/00003226-199107000-00010
   Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.399
   BUTLMANN S, 1999, INVEST OPHTHALMOL  S, V40, pS578
   Casey ML, 1997, J CLIN ENDOCR METAB, V82, P3319, DOI 10.1210/jc.82.10.3319
   Chen HJ, 2000, BRIT J OPHTHALMOL, V84, P826, DOI 10.1136/bjo.84.8.826
   Dua HS, 1999, BRIT J OPHTHALMOL, V83, P748, DOI 10.1136/bjo.83.6.748
   EIFERMAN RA, 1979, ARCH OPHTHALMOL-CHIC, V97, P1637
   FARRELL PLR, 1989, AM J OPHTHALMOL, V107, P515, DOI 10.1016/0002-9394(89)90496-0
   Foster CS, 1994, SCLERA, P242
   Fukuda K, 1999, CORNEA, V18, P73, DOI 10.1097/00003226-199901000-00013
   Hanada K, 2001, AM J OPHTHALMOL, V131, P324, DOI 10.1016/S0002-9394(00)00825-4
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Heiligenhaus A, 2001, INVEST OPHTH VIS SCI, V42, P1969
   Helm CJ, 1997, OPHTHALMOLOGY, V104, P838, DOI 10.1016/S0161-6420(97)30225-5
   Honavar SG, 2000, OPHTHALMOLOGY, V107, P975, DOI 10.1016/S0161-6420(00)00026-9
   Hsiao CH, 1998, BRIT J OPHTHALMOL, V82, P29, DOI 10.1136/bjo.82.1.29
   Huang FC, 2000, CORNEA, V19, P34, DOI 10.1097/00003226-200001000-00008
   Huang SCM, 1999, CORNEA, V18, P608, DOI 10.1097/00003226-199909000-00016
   KERNACKI KA, 1995, INVEST OPHTH VIS SCI, V36, P1371
   Kim HS, 2001, CORNEA, V20, P628, DOI 10.1097/00003226-200108000-00014
   KIM JC, 1995, CORNEA, V14, P473
   KIM JC, 2000, INVEST OPHTHALMOL  S, V4, pS265
   Kim JS, 2000, EXP EYE RES, V70, P329, DOI 10.1006/exer.1999.0794
   Kim JS, 2001, CORNEA, V20, P720, DOI 10.1097/00003226-200110000-00010
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   KRUSE FE, 1999, OPHTHALMOLOGY, V106, P1505
   Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4
   Lin CP, 1997, BRIT J OPHTHALMOL, V81, P980, DOI 10.1136/bjo.81.11.980
   Ma DHK, 2000, BRIT J OPHTHALMOL, V84, P973, DOI 10.1136/bjo.84.9.973
   Meller D, 1999, INVEST OPHTH VIS SCI, V40, P878
   Meller D, 2000, OPHTHALMOLOGY, V107, P980, DOI 10.1016/S0161-6420(00)00024-5
   MORIARTY AP, 1993, EYE, V7, P525, DOI 10.1038/eye.1993.114
   MORIARTY AP, 1993, ARCH OPHTHALMOL-CHIC, V111, P947, DOI 10.1001/archopht.1993.01090070065021
   Na BK, 1999, TROPHOBLAST RES, P453
   OBRIEN TP, 1997, CORNEA, P1144
   Prabhasawat P, 1997, OPHTHALMOLOGY, V104, P974, DOI 10.1016/S0161-6420(97)30197-3
   RABER IM, 1981, AM J OPHTHALMOL, V92, P353, DOI 10.1016/0002-9394(81)90524-9
   RAO TV, 1981, ARCH SURG-CHICAGO, V116, P891
   REYNOLDSMG, 1991, AM J OPHTHALMOL, V112, P353
   ROBSON MC, 1973, ANN SURG, V177, P144, DOI 10.1097/00000658-197302000-00003
   Rodriguez-Ares MT, 1999, OPHTHALMIC SURG LAS, V30, P485
   RUBINFELD RS, 1992, OPHTHALMOLOGY, V99, P1647
   SCHWAM BL, 1997, CORNEA, P1485
   Shimazaki J, 1997, OPHTHALMOLOGY, V104, P2068, DOI 10.1016/S0161-6420(97)30057-8
   Shimmura S, 2001, CORNEA, V20, P408, DOI 10.1097/00003226-200105000-00015
   Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444
   Solomon A, 2001, OPHTHALMOLOGY, V108, P449, DOI 10.1016/S0161-6420(00)00567-4
   Solomon A, 2001, INVEST OPHTH VIS SCI, V42, pS270
   Stark WJ, 1999, INVEST OPHTH VIS SCI, V40, pS690
   Svinarich DM, 1997, AM J REPROD IMMUNOL, V38, P252
   TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D
   TARR KH, 1980, BRIT J OPHTHALMOL, V64, P496, DOI 10.1136/bjo.64.7.496
   THADEPALLI H, 1977, AM J OBSTET GYNECOL, V127, P250, DOI 10.1016/0002-9378(77)90463-X
   THADEPALLI H, 1978, OBSTET GYNECOL, V52, P198
   TRELFORD JD, 1979, AM J OBSTET GYNECOL, V134, P833, DOI 10.1016/0002-9378(79)90957-8
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Tseng SCG, 1997, AM J OPHTHALMOL, V124, P765, DOI 10.1016/S0002-9394(14)71693-9
   Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
   Tsubota K, 1996, AM J OPHTHALMOL, V122, P38, DOI 10.1016/S0002-9394(14)71962-2
   TWINING SS, 1993, INVEST OPHTH VIS SCI, V34, P2699
NR 61
TC 42
Z9 51
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0277-3740
J9 CORNEA
JI Cornea
PD APR
PY 2002
VL 21
IS 3
BP 275
EP 283
DI 10.1097/00003226-200204000-00008
PG 9
WC Ophthalmology
SC Ophthalmology
GA 536BR
UT WOS:000174681300007
PM 11917176
DA 2018-10-19
ER

PT J
AU Xu, DH
   Mei, XT
   Zhang, CH
   Xu, SB
AF Xu, DH
   Mei, XT
   Zhang, CH
   Xu, SB
TI Anti-myocardial ischemia effects of marine biomaterial C01
SO DRUG DEVELOPMENT RESEARCH
LA English
DT Meeting Abstract
DE anti-ischemia; starfish; sterol; C01
C1 Zhongshan Univ, Dept Pharm, Guangzhou 510275, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0272-4391
J9 DRUG DEVELOP RES
JI Drug Dev. Res.
PD APR
PY 2002
VL 55
IS 4
MA P19
BP 265
EP 265
PG 1
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 569RL
UT WOS:000176615900073
DA 2018-10-19
ER

PT J
AU Chotard-Ghodsnia, R
   Drochon, A
   Grebe, R
AF Chotard-Ghodsnia, R
   Drochon, A
   Grebe, R
TI New flow chamber for the study of shear stress and transmural pressure
   upon cells adhering to a porous biomaterial
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
ID CULTURED ENDOTHELIAL-CELLS; HYDROSTATIC-PRESSURE; HEMODIALYSIS;
   ADHESION; SURFACES
AB Biomaterials used in some biomedical devices are porous and exposed to normal and tangential flow of biofluids. To examine the influence of flow induced forces on the morphology and the biochemical responses of cells adhering to such biomaterials, a Hele-Shaw cell with a porous bottom wall was designed and characterized experimentally. Theoretical predictions for the flow in the chamber are provided and allow to quantify the shear stress and/or transmural pressure exerted on cells. It is thus possible to follow up continuously the shape changes of cells that are adherent on a permeable membrane used in bioreactors.
C1 Univ Technol Compiegne, CNRS, UMR Biomecan & Genie Biomed 6600, F-60205 Compiegne, France.
RP Chotard-Ghodsnia, R (reprint author), Univ Technol Compiegne, CNRS, UMR Biomecan & Genie Biomed 6600, BP 20529, F-60205 Compiegne, France.
EM roxana.ghodsnia@utc.fr; agnes.drochon@utc.fr; reinhard.grebe@utc.fr
CR ACEVEDO AD, 1993, J CELL PHYSIOL, V157, P603, DOI 10.1002/jcp.1041570321
   ARTMANN GM, 1995, BIORHEOLOGY, V32, P553, DOI 10.1016/0006-355X(95)00032-5
   DEEN WM, 1998, ANAL TRANSPORT PHENO, P274
   DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276
   HONIGER J, 1994, INT J ARTIF ORGANS, V17, P46
   JAFFRIN MY, 1988, J BIOMECH ENG-T ASME, V110, P1, DOI 10.1115/1.3108400
   LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567
   LEW HS, 1969, J APPL MATH PHYS, V20, P750
   LUNDBERG L, 1994, INT J ARTIF ORGANS, V17, P131
   MULVIHILL J, 1992, BIOMATERIALS, V13, P527, DOI 10.1016/0142-9612(92)90104-V
   OFSTHUN NJ, 1995, ARTIF ORGANS, V19, P1143, DOI 10.1111/j.1525-1594.1995.tb02276.x
   STILL HW, 1995, AM J PHYSIOL-HEART C, V268, pH535
   Tarbell JM, 1999, J APPL PHYSIOL, V87, P261
   THOUMINE O, 1995, IN VITRO CELL DEV-AN, V31, P45
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
NR 16
TC 12
Z9 12
U1 0
U2 0
PU ASME
PI NEW YORK
PA TWO PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
EI 1528-8951
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD APR
PY 2002
VL 124
IS 2
BP 258
EP 261
DI 10.1115/1.1448520
PG 4
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 547QT
UT WOS:000175343800015
PM 12002137
DA 2018-10-19
ER

PT J
AU Price, C
   Waters, MGJ
   Williams, DW
   Lewis, MAO
   Stickler, D
AF Price, C
   Waters, MGJ
   Williams, DW
   Lewis, MAO
   Stickler, D
TI Surface modification of an experimental silicone rubber aimed at
   reducing initial candidal adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE Candida albicans; silicone rubber; water wettability; surface chemistry
ID DENTURE-LINING MATERIALS; ACRYLIC SURFACES; ADHERENCE; ALBICANS;
   INVITRO; HYDROPHOBICITY; YEASTS
AB Silicone rubber, which is a widely used biomaterial, is often used to make soft liners for permanent denture. Colonization of denture soft lining materials by Candida albicans can result in clinical problems. The aim of this study was to chemically modify the surface of an experimental silicone rubber in order to produce a silicone that was less susceptible to candidal colonization. Surface modification was carried out with the use of argon-plasma bombardment followed by silane treatment, which caused the incorporation of either hydrophilic or hydrophobic functional groups onto the surface. Changes in water contact angles and chemical analysis of the materials with scanning ion mass spectroscopy confirmed surface changes. In vitro assays were carried out using C. albicans to measure levels of adherence to the surface-modified silicone after I h. C. albicans exhibited very low adherence to all silane-treated surfaces, whether hydrophobic or hydrophilic. This led to the conclusion that incorporated long-chain functional groups were inhibiting the adherence of the yeast, possibly by the formation of a barrier between the surface of the material and the yeast. In conclusion, silane surface treatment of an experimental silicone rubber has been successful in reducing candidal adherence. (C) 2002 John Wiley Sons, Inc.
C1 Univ Wales Coll Cardiff, Coll Med, Sch Dent, Dept Dent Hlth & Biol Sci, Cardiff CF14 4XY, S Glam, Wales.
   Univ Wales Coll Cardiff, Coll Med, Dept Oral Surg Med & Pathol, Cardiff CF14 4XY, S Glam, Wales.
   Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.
RP Waters, MGJ (reprint author), Univ Wales Coll Cardiff, Coll Med, Sch Dent, Dept Dent Hlth & Biol Sci, Heath Pk, Cardiff CF14 4XY, S Glam, Wales.
RI Williams, David/E-5506-2012
OI Williams, David/0000-0002-7351-5131
CR Allison R T, 1973, J Dent, V1, P198, DOI 10.1016/0300-5712(73)90059-6
   Baillie GS, 1999, J MED MICROBIOL, V48, P671, DOI 10.1099/00222615-48-7-671
   BURNS DR, 1987, J PROSTHET DENT, V57, P507, DOI 10.1016/0022-3913(87)90026-6
   EVERAERT EP, 1995, J ADHES SCI TECHNOL, V9, P1263, DOI 10.1163/156856195X01030
   Everaert EPJM, 1998, COLLOID SURFACE B, V10, P179, DOI 10.1016/S0927-7765(98)00003-4
   GIBBONS P, 1965, J MICHIGAN DENT ASS, V47, P64
   GRUBER RG, 1966, J AM DENT ASSOC, V73, P641, DOI 10.14219/jada.archive.1966.0276
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   MAKILA E, 1977, ACTA ODONTOL SCAND, V35, P197, DOI 10.3109/00016357709004655
   MCCOURTIE J, 1985, J MED MICROBIOL, V20, P97, DOI 10.1099/00222615-20-1-97
   MCCOURTIE J, 1984, INFECT IMMUN, V45, P6
   MINAGI S, 1985, INFECT IMMUN, V47, P11
   MIYAKE Y, 1986, MICROBIOS, V46, P7
   NIKAWA H, 1992, J PROSTHET DENT, V68, P804, DOI 10.1016/0022-3913(92)90206-P
   OKITA N, 1991, DENT MATER, V7, P155, DOI 10.1016/0109-5641(91)90035-W
   OLSEN I, 1974, ACTA ODONTOL SCAND, V32, P329, DOI 10.3109/00016357409002556
   OLSSON J, 1990, J DENT RES, V69, P1586, DOI 10.1177/00220345900690091001
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   Samaranayake YH, 1995, APMIS, V103, P707, DOI 10.1111/j.1699-0463.1995.tb01427.x
   SILVER JH, 1995, J BIOMED MATER RES, V29, P535, DOI 10.1002/jbm.820290414
   VASILAS A, 1992, ARCH ORAL BIOL, V37, P613, DOI 10.1016/0003-9969(92)90123-P
   WATERS MGJ, 2000, J BIOMED MAT RES APP, V48, P765
   Williams DW, 1998, J CLIN PATHOL, V51, P390, DOI 10.1136/jcp.51.5.390
   WRIGHT PS, 1985, J DENT RES, V64, P122, DOI 10.1177/00220345850640020501
NR 24
TC 28
Z9 33
U1 2
U2 10
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2002
VL 63
IS 2
BP 122
EP 128
DI 10.1002/jbm.10094
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 535JK
UT WOS:000174641300006
PM 11870644
DA 2018-10-19
ER

PT J
AU Lindfors, NC
   Tallroth, K
   Aho, AJ
AF Lindfors, NC
   Tallroth, K
   Aho, AJ
TI Bioactive glass as bone-graft substitute for posterior spinal fusion in
   rabbit
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bioactive glass; spinal fusion; biomaterial; autograft bone; bone
   substitute
ID OSTEOINDUCTIVE GROWTH-FACTOR; IN-VIVO EVALUATION; MODEL
AB Bioactive glass S53P4 and autogenous bone were studied as bone graft materials for spinal fusion in a rabbit model. Sixteen rabbits underwent surgery by a dorsal approach. A bioactive glass, a combination of bioactive glass and autogenous bone (70/30 vol%), and autogenous bone were implanted at two thoracolumbar vertebraes for 4 and 12 weeks. The volume, consolidation to vertebrae, and fusion of the graft material were evaluated with plain-film radiology, computed tomography (CT) and bone-mineral density measurements, and compared with histomorphometrical measurements. Radiological consolidation by CT of bone graft to underlying vertebrae at 12 weeks was observable in all groups. This was histologically confirmed as bone was growing from the vertebrae into the graft material. Radiologic fusion of vertebraes was, at 12 weeks, observable in all groups in 50-75% of the cases. The radiologic fusion seen at the CT scans could, however, not be confirmed by histology in any of the three groups. Significant differences for graft material and observation period with the use of bone-mineral density measurements (Hounsfield units) were also observable, with the highest measured values for the bioactive glass group and the lowest for the autogenous bone group. The results indicate that bioactive glass have potential as bone-graft material in spinal fusion. The reliability of radiologic evaluation methods in spinal surgery using bone substitutes is also questioned and discussed. (C) 2002 John Wiley Sons, Inc.
C1 Turku Univ, Biomat Project Turku, Turku 20520, Finland.
   Orton Res Inst, Invalid Fdn, Helsinki 00280, Finland.
   Univ Turku, Cent Hosp, Dept Surg, FIN-20520 Turku, Finland.
RP Lindfors, NC (reprint author), Missnebacken 9D2, Espoo 02180, Finland.
CR ANDERSSON OH, 1991, J BIOMED MATER RES, V25, P1019, DOI 10.1002/jbm.820250808
   BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003
   Boden SD, 1995, SPINE, V20, P2626, DOI 10.1097/00007632-199512150-00003
   Boden SD, 1995, SPINE, V20, P2633, DOI 10.1097/00007632-199512150-00004
   Brodsky AE, 1991, SPINE S, V16, P261
   COOK SD, 1995, SPINE, V20, P877, DOI 10.1097/00007632-199504150-00002
   COOK SD, 1994, SPINE, V19, P1655, DOI 10.1097/00007632-199408000-00002
   FLATLEY TJ, 1983, CLIN ORTHOP RELAT R, P246
   FRYMOYER JW, 1978, CLIN ORTHOP RELAT R, P196
   GATTI AM, 1993, CELL MATER, V3, P283
   GUIGUI P, 1994, SPINE, V19, P2798, DOI 10.1097/00007632-199412150-00012
   Hench L.L., 1973, J BIOMED MATER RES S, V4, P25
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Lindfors NC, 2000, EUR SPINE J, V9, P30, DOI 10.1007/s005860050005
   LINDHOLM TS, 1988, CLIN ORTHOP RELAT R, P296
   MONTGOMERY DM, 1990, J SPINAL DISORD, V3, P370
   MUSCHLER GF, 1993, J ORTHOPAED RES, V11, P514, DOI 10.1002/jor.1100110406
   STEINMANN JC, 1992, CLIN ORTHOP RELAT R, P80
   YAMAMURO T, 1990, J BONE JOINT SURG BR, V72, P814
NR 19
TC 9
Z9 9
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2002
VL 63
IS 2
BP 237
EP 244
DI 10.1002/jbm.10177
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 535JK
UT WOS:000174641300021
PM 11870659
DA 2018-10-19
ER

PT J
AU Rosenson-Schloss, RS
   Chang, CC
   Constantinides, A
   Moghe, PV
AF Rosenson-Schloss, RS
   Chang, CC
   Constantinides, A
   Moghe, PV
TI Alteration of leukocyte motility on plasma-conditioned prosthetic
   biomaterial, ePTFE, via a flow-responsive cell adhesion molecule, CD43
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE leukocytes; physiologic shear; CD43; cell migration; prosthetic
   biomaterial; ePTFE
ID CROSS-LINKING; EXPANDED POLYTETRAFLUOROETHYLENE; SURFACE
   SIALOGLYCOPROTEIN; CHEMOSENSORY MIGRATION; NEUTROPHIL ACTIVATION;
   SIALOPHORIN CD43; IN-VITRO; LEUKOSIALIN; INDUCTION; PHOSPHORYLATION
AB The physiologic determinants of leukocyte migration on vascular prosthetic biomaterials remain poorly understood, despite their relevance to the control of periprosthetic infection. Using hemodynamic exposure of human polymorphonuclear leukocytes adherent to expanded polytetrafluoroethylene (ePTFE) in vitro, we investigated the role of fluid shear in regulating leukocyte migratory behavior on plasma-adsorbed, prosthetic vascular biomaterial. The presence of flow at a wall shear stress of 25 dyn/cm(2) increased the degree of leukocyte displacement along the flow direction without altering the degree of overall cell attachment. Moreover, plasma-ePTFE elicited a lower overall degree of displacement under flow in comparison with untreated ePTFE. We further probed the molecular level regulation of leukocyte migratory responses under flow through the immunocytochemical quantification of specific leukocyte adhesion molecules and determined that CD43, a cell adhesion molecule, was upregulated via flow exposure for leukocytes adherent to plasma-ePTFE, whereas basal levels of CD43 expression were not significantly altered on untreated ePTFE. When flow-exposed, adherent leukocytes were incubated in the presence of substrate immobilized anti-CD43 immunoglobulin, the degree of cell displacement along flow was found to be significantly enhanced on plasma-cPTFE. Quantification of the cell population redistribution under flow using a modified random motility model, indicated that the incorporation of anti-CD43 on plasma-ePTFE led to a significant increase (243 +/- 60%) in the cell dispersion coefficient, mu(D), whereas only a minimal increase (61 +/- 30%) was detected on non-adsorbed ePTFE. Overall, our results suggest that flow exposure can induce the migration of leukocytes adherent to prosthetic materials in a substrate-dependent manner, An important implication of our study is that, although biomaterials exposed to plasma intrinsically passivate leukocyte migration even under hemodynamic conditions, it may be possible to promote cell motility by targeting a specific, flow-responsive, adhesion molecule. (C) 2002 John Wiley & Sons, Inc. J Biomed Mater Res 60: 8-19, 2002.
C1 Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
RP Moghe, PV (reprint author), Rutgers State Univ, Dept Chem & Biochem Engn, C230,98 Brett Rd, Piscataway, NJ 08854 USA.
EM moghe@rci.rutgers.edu
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   Benton LD, 1996, J SURG RES, V64, P116, DOI 10.1006/jsre.1996.0316
   BOYCE B, 1982, BIOL SYNTHETIC VASCU, P553
   CAMPOCCIA D, 1993, BIOMATERIALS, V14, P1135, DOI 10.1016/0142-9612(93)90156-V
   Cenni E, 1997, BIOMATERIALS, V18, P489, DOI 10.1016/S0142-9612(96)00160-3
   Chang CC, 1999, BIOMATERIALS, V20, P273, DOI 10.1016/S0142-9612(98)00171-9
   Chang CC, 2000, J MATER SCI-MATER M, V11, P337, DOI 10.1023/A:1008925722623
   Chang CC, 2000, BIOMATERIALS, V21, P2305, DOI 10.1016/S0142-9612(00)00157-5
   CHANG JK, 1996, TISS ENG SOC C P ORL, P59
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x
   CYSTER JG, 1992, EUR J IMMUNOL, V22, P2565, DOI 10.1002/eji.1830221015
   DICKINSON RB, 1994, ANN BIOMED ENG, V22, P342, DOI 10.1007/BF02368241
   FRANGOS JA, 1988, BIOTECHNOL BIOENG, V32, P1053, DOI 10.1002/bit.260320812
   GOLDSTONE J, 1974, AM J SURG, V128, P225
   Gopalan PK, 1997, J IMMUNOL, V158, P367
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   Granchi D, 1998, J BIOMED MATER RES, V39, P549, DOI 10.1002/(SICI)1097-4636(19980315)39:4<549::AID-JBM7>3.0.CO;2-J
   Hammer DA, 1996, ANNU REV MATER SCI, V26, P651
   HAMMER DA, 1994, KINETICS MECH CELL A, P121
   KATZ DA, 1994, SURGERY, V116, P446
   KAWAGUCHI H, 1986, BIOMATERIALS, V7, P61, DOI 10.1016/0142-9612(86)90091-8
   KUIJPERS TW, 1992, J IMMUNOL, V149, P998
   Lopez S, 1998, CELL ADHES COMMUN, V5, P151, DOI 10.3109/15419069809040288
   MCINTIRE LV, 1994, ANN BIOMED ENG, V22, P2, DOI 10.1007/BF02368217
   NATHAN C, 1993, J CELL BIOL, V122, P243, DOI 10.1083/jcb.122.1.243
   PILLER V, 1989, J BIOL CHEM, V264, P18824
   Rainger GE, 1999, AM J PHYSIOL-HEART C, V276, pH858, DOI 10.1152/ajpheart.1999.276.3.H858
   ROSENKRANZ AR, 1993, IMMUNOLOGY, V80, P431
   Rosenson-Schloss RS, 1999, MED BIOL ENG COMPUT, V37, P257, DOI 10.1007/BF02513296
   Seveau S, 1997, J CELL SCI, V110, P1465
   Sundaram S, 1996, BIOMATERIALS, V17, P1041, DOI 10.1016/0142-9612(96)84681-3
   Swartbol P, 1996, J BIOMED MATER RES, V32, P669, DOI 10.1002/(SICI)1097-4636(199612)32:4<669::AID-JBM21>3.0.CO;2-7
   Tomczok J, 1996, BIOMATERIALS, V17, P1359, DOI 10.1016/0142-9612(96)87275-9
   TRANQUILLO RT, 1988, CELL MOTIL CYTOSKEL, V11, P1, DOI 10.1002/cm.970110102
   YOUNG EJ, 1988, SURG CLIN N AM, V68, P167
   Zigmond S H, 1980, Ciba Found Symp, V71, P299, DOI 10.1002/9780470720547.ch16
NR 38
TC 1
Z9 1
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2002
VL 60
IS 1
BP 8
EP 19
DI 10.1002/jbm.1278
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 518VC
UT WOS:000173687700002
PM 11835154
DA 2018-10-19
ER

PT J
AU Sanders, JE
   Baker, AB
   Golledge, SL
AF Sanders, JE
   Baker, AB
   Golledge, SL
TI Control of in vivo microvessel ingrowth by modulation of biomaterial
   local architecture and chemistry
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE laser machining; surface grafting; secreted protein acidic and rich in
   cysteine (SPARC); thrombospondin; angiogenesis
ID FIBROBLAST GROWTH-FACTOR; POLYTETRAFLUOROETHYLENE ARTERIAL GRAFTS;
   ENHANCES VASCULARIZATION; ANGIOGENESIS; POROSITY; SURFACE; TISSUE;
   NEOVASCULARIZATION; THROMBOSPONDIN-2; POLYPROPYLENE
AB We developed a method for controlling local architecture and chemistry simultaneously in biomaterial implants to control microvessel ingrowth in vivo. Porous polypropylene disks (5 mm in diameter and 40 mum thick) were plasma-coated with a fluoropolymer and then laser-drilled with 50-mum-diameter holes through their thickness. We then oxidized the disks to create hydroxyl functionality on the exposed polypropylene (inside the holes). Acrylamide was grafted to the hydroxyl groups through polymerization in the presence of activating ceric ions. Staining with toluidine blue O demonstrated that grafting occurred only inside the holes. We used the Hoffman degradation reaction to convert the amide groups of acrylamide to amine groups, and then we used ethylene glycol diglycidyl ether to attach biomolecules of interest inside the holes: secreted protein acidic and rich in cysteine (SPARC) peptide Lys-Gly-His-Lys (KGHK; angiogenic), thrombospondin-2 (TSP; antiangiogenic), or albumin (rat; neutral). In vivo testing in a rat subcutaneous dorsum model for a 3-week interval demonstrated a greater vessel surface area (p = 0.032) and a greater number of vessels (p = 0.043) in tissue local to the holes with KGHK-immobilized disks than with TSP-immobilized disks. However, differences between KGHK-immobilized and albumin-immobilized disks were less significant (p = 0.120 and p = 0.289 for the vessel surface area and number of vessels, respectively). The developed methods have potential applications in biomaterial design applications for which selective neovascularization is desired. (C) 2002 John Wiley & Sons, Inc. J Biomed Mater Res 00: 36-43, 2002.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Sanders, JE (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
FU NCRR NIH HHS [RR-01296]
CR Atici OG, 1999, J APPL POLYM SCI, V71, P1385, DOI 10.1002/(SICI)1097-4628(19990228)71:9<1385::AID-APP4>3.0.CO;2-F
   BAMFORD CH, 1994, POLYMER, V35, P2844, DOI 10.1016/0032-3861(94)90316-6
   BOLENDER RP, 1993, AM J PHYSIOL, V265, pL521
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Doi K, 1997, J BIOMED MATER RES, V34, P361, DOI 10.1002/(SICI)1097-4636(19970305)34:3<361::AID-JBM11>3.0.CO;2-J
   Doi K, 1996, ASAIO J, V42, pM394, DOI 10.1097/00002480-199609000-00018
   Favia P., 1996, PLASMAS POLYM, V1, P299
   Fournier N, 1996, BIOMATERIALS, V17, P1659, DOI 10.1016/0142-9612(96)87645-9
   GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047
   Hazama K, 1999, J SURG RES, V81, P174, DOI 10.1006/jsre.1998.5497
   HIRABAYASHI K, 1992, J BIOMED MATER RES, V26, P1433, DOI 10.1002/jbm.820261104
   Hunter SK, 1999, ASAIO J, V45, P37, DOI 10.1097/00002480-199901000-00009
   JONES MEB, 1973, BRIT J SURG, V60, P305
   Klein S, 1997, EXS, V79, P159
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   LANE TF, 1994, J CELL BIOL, V125, P929, DOI 10.1083/jcb.125.4.929
   LEE KW, 1988, MACROMOLECULES, V21, P309, DOI 10.1021/ma00180a005
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Masuda S, 1997, ASAIO J, V43, pM530
   Nagae T, 1995, Cardiovasc Surg, V3, P479, DOI 10.1016/0967-2109(95)94445-3
   Nishibe T, 1997, SURG TODAY, V27, P149, DOI 10.1007/BF02385905
   Ohkashiwa H, 1997, SURG TODAY, V27, P846, DOI 10.1007/BF02385276
   Rubin PAD, 1997, OPHTHALMIC PLAST REC, V13, P8, DOI 10.1097/00002341-199703000-00002
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   SANO S, 1993, BIOMATERIALS, V14, P817, DOI 10.1016/0142-9612(93)90003-K
   SCHLAUDRAFF K, 1993, EUR J CARDIO-THORAC, V7, P637, DOI 10.1016/1010-7940(93)90258-D
   SINGH RP, 1992, PROG POLYM SCI, V17, P251, DOI 10.1016/0079-6700(92)90024-S
   STERPETTI AV, 1992, SURGERY, V111, P677
   Streit M, 1999, P NATL ACAD SCI USA, V96, P14888, DOI 10.1073/pnas.96.26.14888
   Tomizawa Y, 1996, ASAIO J, V42, pM698, DOI 10.1097/00002480-199609000-00077
   Veikkola T, 1999, SEMIN CANCER BIOL, V9, P211, DOI 10.1006/scbi.1998.0091
NR 31
TC 9
Z9 9
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2002
VL 60
IS 1
BP 36
EP 43
DI 10.1002/jbm.1279
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 518VC
UT WOS:000173687700005
PM 11835157
DA 2018-10-19
ER

PT J
AU Kanno, M
   Kawakami, H
   Nagaoka, S
   Kubota, S
AF Kanno, M
   Kawakami, H
   Nagaoka, S
   Kubota, S
TI Biocompatibility of fluorinated polyimide
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE fluorinated polyimide; protein adsorption; neutrophil adhesion;
   complement activation; curing
ID SULFONE DIAMINE MOIETIES; GAS-TRANSPORT PROPERTIES; COMPLEMENT
   ACTIVATION; AROMATIC POLYIMIDES; MEMBRANE-OXYGENATOR; CELL-ADHESION;
   HOLLOW-FIBER; PLATELET; BLOOD; HEMODIALYSIS
AB Contact between blood and biomaterial triggers a complex series of events including protein adsorption, leukocyte adhesion and activation, and complement activation. In this article, a series of fluorinated polyimides cured at a different temperatures was prepared, and the biocompatibility of the membranes was evaluated using in vitro protein adsorption, neutrophil adhesion, and complement activation experiments under static conditions. We found that protein adsorption, neutrophil adhesion, and complement activation for the polyimides significantly depends on the curing temperature and decreases with an increase in the temperature and that the polyimide has a good biocompatibility compared with poly(styrene) and polydimethylsiloxane. We concluded that the rearrangement of molecules such as CF3, sulfone, and ketone at the outermost surface occurs because of curing, which induces an increase in the hydrophobicity and that the cured polyimide suppresses protein adsorption, neutrophil adhesion, and complement activation because of its high hydrophobicity and low surface free energy. (C) 2002 John Wiley & Sons, Inc. J Biomed Mater Res 60: 53-60, 2002.
C1 Tokyo Metropolitan Univ, Dept Ind Chem, Hachioji, Tokyo 1920397, Japan.
   St Marianna Univ, Sch Med, Dept Surg 1, Kawasaki, Kanagawa 2168511, Japan.
RP Kawakami, H (reprint author), Tokyo Metropolitan Univ, Dept Ind Chem, Hachioji, Tokyo 1920397, Japan.
CR Bahulekar R, 1999, BIOMATERIALS, V20, P357, DOI 10.1016/S0142-9612(98)00176-8
   CRISTOL JP, 1994, NEPHROL DIAL TRANSPL, V9, P389
   FINN A, 1993, AGENTS ACTIONS, V38, P44
   Frautschi JR, 1996, J BIOMAT SCI-POLYM E, V7, P707, DOI 10.1163/156856296X00471
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   Goodman S L, 1991, J Biomater Sci Polym Ed, V2, P147, DOI 10.1163/156856291X00133
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   HAKIM RM, 1993, CARDIOVASC PATHOL, V2, pS187
   HAMMER DA, 1993, BLOOD CELLS, V19, P261
   INAGAKI N, 1994, J ADHES SCI TECHNOL, V8, P395, DOI 10.1163/156856194X00302
   INNES A, 1994, J CLIN PATHOL, V47, P155, DOI 10.1136/jcp.47.2.155
   Jahns Gerlinde, 1993, Clinical Materials, V14, P303, DOI 10.1016/0267-6605(93)90017-2
   JOHNSON RJ, 1994, NEPHROL DIAL TRANSPL, V9, P36
   Kawakami H, 1996, J MEMBRANE SCI, V118, P223, DOI 10.1016/0376-7388(96)00115-9
   Kawakami H, 1996, J APPL POLYM SCI, V62, P965, DOI 10.1002/(SICI)1097-4628(19961114)62:7<965::AID-APP2>3.0.CO;2-Q
   KAWAKAMI H, 1995, J APPL POLYM SCI, V57, P789, DOI 10.1002/app.1995.070570703
   Kawakami H, 1997, ASAIO J, V43, pM490
   KAWAKAMI H, 1995, ASAIO J, V41, pM379, DOI 10.1097/00002480-199507000-00035
   Kawakami H, 1996, ASAIO J, V42, pM871, DOI 10.1097/00002480-199609000-00116
   Kawakami H., 1995, Japanese Journal of Artificial Organs, V24, P65
   KAWAKAMI H, 2001, J ADV TECH, V12, P244
   KIAEI D, 1995, J BIOMED MATER RES, V29, P729, DOI 10.1002/jbm.820290609
   KIMURA H, 1988, FEBS LETT, V239, P347, DOI 10.1016/0014-5793(88)80949-9
   Krajewski A, 1996, BIOMATERIALS, V17, P53, DOI 10.1016/0142-9612(96)80755-1
   LAWRENCE MB, 1987, BLOOD, V70, P1284
   LOFTUS JC, 1984, J CELL BIOL, V99, P822, DOI 10.1083/jcb.99.3.822
   NAGAOKA S, 1981, JPN J ARTIF ORGANS, V10, P1058
   NAKANO M, 1990, ANAL BIOCHEM, V187, P277, DOI 10.1016/0003-2697(90)90457-K
   Sueda T, 1997, ARTIF ORGANS, V21, P75
   WILLEMS GM, 1993, BLOOD, V82, P497
   WOFFINDIN C, 1992, NEPHROL DIAL TRANSPL, V7, P340, DOI 10.1093/oxfordjournals.ndt.a092139
   Yamane S, 1998, ASAIO J, V44, pM384, DOI 10.1097/00002480-199809000-00011
NR 32
TC 48
Z9 55
U1 1
U2 11
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2002
VL 60
IS 1
BP 53
EP 60
DI 10.1002/jbm.1280
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 518VC
UT WOS:000173687700007
PM 11835159
DA 2018-10-19
ER

PT J
AU Poelstra, KA
   Barekzi, NA
   Rediske, AM
   Felts, AG
   Slunt, JB
   Grainger, DW
AF Poelstra, KA
   Barekzi, NA
   Rediske, AM
   Felts, AG
   Slunt, JB
   Grainger, DW
TI Prophylactic treatment of gram-positive and gram-negative abdominal
   implant infections using locally delivered polyclonal antibodies
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE antibody; infection; biomaterials; implant; abdominal surgery; local
   delivery; gram-positive
ID PSEUDOMONAS-AERUGINOSA; BACTERIAL ADHESION; IMMUNE GLOBULIN;
   STAPHYLOCOCCUS-EPIDERMIDIS; ANTIBIOTIC-RESISTANCE; IMMUNOGLOBULIN-G;
   MODEL; PREVENTION; THERAPY; HYDROPHOBICITY
AB The increasing clinical incidence and host risk of biomaterial-centered infections, as well as the reduced effectiveness of clinically relevant antibiotics to treat such infections, provide compelling reasons to develop new approaches for treating implanted biomaterials in a surgical context. We describe the direct local delivery of polyclonal human antibodies to abdominal surgical implant sites to reduce infection severity and mortality in a lethal murine model of surgical implant-centered peritoneal infection. Surgical implant-centered peritonitis was produced in 180 female CF-1 mice by the direct inoculation of surgical-grade polypropylene mesh disks placed in the peritoneal cavity with lethal doses of either methicillin-resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa. Mice randomly received a resorbable antibody delivery vehicle at the implant site: either a blank carboxymethylcellulose (CMC) aqueous get or the same CMC gel containing 10 mg of pooled polyclonal human immunoglobulin G locally on the implant after infection, either alone or in combination with systemic doses of cefazolin or vancomycin antibiotics. Human antibodies were rapidly released (first-order kinetics) from the gel carrier to both peritoneal fluids and serum in both infection senarios. Inocula required for lethal infection were substantially reduced by surgery and the presence of the implant versus a closed lethal peritonitis model. Survival to 10 days with two different gram-negative P. aeruginosa strains was significantly enhanced (p < 0.01) by the direct application of CMC gel containing antibodies alone to the surgical implant site. Human-equivalent doses of systemic vancomycin provided a significantly improved benefit (p < 0.01) against lethal, implant-centered, gram-positive MRSA infection. However, locally delivered polyclonal human antibodies in combination with a range of systemic vancomycin doses against MRSA failed to improve host survival. Successful antibody therapy against gram-negative, implant-centered infections complements the clinically routine use of systemic antibiotics, providing a mechanism of protection independent of antibiotic resistance. (C) 2002 John Wiley Sons, Inc.
C1 Anthony G Gristina Inst Biomed Res, Herndon, VA 20170 USA.
   Gamma A Technol Incorp, Herndon, VA 20170 USA.
RP Grainger, DW (reprint author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
FU NIAMS NIH HHS [R01 AR26957-11A1]
CR ABSOLOM DR, 1988, CAN J MICROBIOL, V34, P287, DOI 10.1139/m88-054
   ABSOLOM DR, 1982, J RETICULOENDOTH SOC, V31, P59
   Anderson RM, 1999, NAT MED, V5, P147, DOI 10.1038/5507
   Anglen J, 1996, J ORTHOPAED RES, V14, P251, DOI 10.1002/jor.1100140213
   BAREKZI N, 2001, UNPUB LOCALLY DELIVE
   Barekzi NA, 1999, ANTIMICROB AGENTS CH, V43, P1609, DOI 10.1128/AAC.43.7.1609
   BARTLETT JG, 1998, POCKET BOOK INFECT D, P125
   Bax RP, 1998, NAT MED, V4, P545, DOI 10.1038/nm0598-545
   CALANDRA T, 1991, AM J MED, V91, P23, DOI 10.1016/0002-9343(91)90069-A
   CASADEVALL A, 1995, CLIN INFECT DIS, V21, P150, DOI 10.1093/clinids/21.1.150
   Casadevall A, 1996, EMERG INFECT DIS, V2, P200, DOI 10.3201/eid0203.960306
   CASADEVALL A, 1994, ANTIMICROB AGENTS CH, V38, P1695, DOI 10.1128/AAC.38.8.1695
   CLAPP DW, 1989, J PEDIATR-US, V115, P973, DOI 10.1016/S0022-3476(89)80753-X
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   DALHOFF A, 1984, AM J MED, V76, P91, DOI 10.1016/0002-9343(84)90326-7
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DIAMOND MP, 1988, INT J FERTIL, V33, P372
   Donta ST, 1996, J INFECT DIS, V174, P537, DOI 10.1093/infdis/174.3.537
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   EMMERSON MA, 1998, NEW HORIZONS S, V3, P6
   Falagas ME, 1996, EUR J CLIN MICROBIOL, V15, P913, DOI 10.1007/BF01690508
   Felts AG, 1999, BURNS, V25, P415, DOI 10.1016/S0305-4179(99)00017-0
   FISCHER GW, 1994, J INFECT DIS, V169, P324, DOI 10.1093/infdis/169.2.324
   GAGNON RF, 1993, INT J ARTIF ORGANS, V16, P789
   Gemmell CG, 1996, DRUG EXP CLIN RES, V22, P51
   Gould IM, 1998, NAT MED, V4, P985, DOI 10.1038/1955
   GRIFFITHS HJ, 1995, RADIOL CLIN N AM, V33, P401
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Gristina Anthony G., 1994, Clinical Microbiology Newsletter, V16, P171, DOI 10.1016/0196-4399(94)90037-X
   HAMMARSTROM L, 1990, INFECTION, V18, P70
   Holmdahl Lena E., 1994, Wound Repair and Regeneration, V2, P171, DOI 10.1046/j.1524-475X.1994.20306.x
   Holmes C J, 1994, Kidney Int Suppl, V48, pS58
   HOLMES CJ, 1994, KIDNEY INT, V46, pS59
   John SF, 1996, FEMS MICROBIOL LETT, V144, P241, DOI 10.1016/0378-1097(96)00352-7
   LAMPERI S, 1986, PERITON DIALYSIS INT, V6, P87
   LAMPERI S, 1986, PERITON DIALYSIS B, V6, P110
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   LOWRY FD, 1998, NEW ENGL J MED, V339, P520
   MAGNY JF, 1991, PEDIATRICS, V88, P437
   Moussa FW, 1996, CLIN ORTHOP RELAT R, P255, DOI 10.1097/00003086-199608000-00032
   PECK LS, 1995, J INVEST SURG, V8, P337, DOI 10.3109/08941939509015380
   Poelstra KA, 2000, TISSUE ENG, V6, P401, DOI 10.1089/107632700418100
   Poelstra KA, 2000, J BIOMED MATER RES, V51, P224, DOI 10.1002/(SICI)1097-4636(200008)51:2<224::AID-JBM11>3.0.CO;2-G
   Reijnen MMPJ, 1999, ARCH SURG-CHICAGO, V134, P997, DOI 10.1001/archsurg.134.9.997
   Rojas IA, 2000, J CONTROL RELEASE, V63, P175, DOI 10.1016/S0168-3659(99)00195-9
   Sheridan R L, 1994, Adv Surg, V27, P43
   SIBER GR, 1992, NEW ENGL J MED, V327, P269, DOI 10.1056/NEJM199207233270409
   SIBER GR, 1992, CURRENT CLIN TOPICS, P208
   Smith ME, 1999, LAT AM ANTIQ, V10, P330, DOI 10.2307/972049
   Twardowski ZJ, 1996, AM J KIDNEY DIS, V27, P99, DOI 10.1016/S0272-6386(96)90036-0
   WARD KH, 1992, J MED MICROBIOL, V36, P406, DOI 10.1099/00222615-36-6-406
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   1985, RENAL INSUFFICIENCY, P518
NR 53
TC 98
Z9 101
U1 0
U2 13
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2002
VL 60
IS 1
BP 206
EP 215
DI 10.1002/jbm.10069
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 518VC
UT WOS:000173687700025
PM 11835177
DA 2018-10-19
ER

PT J
AU Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Asahina, T
   Mabuchi, M
AF Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Asahina, T
   Mabuchi, M
TI Processing and mechanical properties of autogenous titanium implant
   materials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ALLOYS
AB Pure titanium and some of its alloys are currently considered as the most attractive metallic materials for biomedical applications due to their excellent mechanical properties, corrosion resistance, and biocompatibility. It has been demonstrated that titanium and titanium alloys are well accepted by human tissues as compared to other metals such as SUS316L stainless steel and Co-Cr-Mo type alloy. In the present study, highly porous titanium foams with porosities less than or equal to80% are produced by using a novel powder metallurgical process, which includes the adding of the selected spacers into the starting powders. The optimal process parameters are investigated. The porous titanium foams are characterized by using optical microscopy and scanning electron microscopy. The distribution of the pore size is measured by quantitative image analyses. The mechanical properties are investigated by compressive tests. This open-cellular titanium foams, with the pore size of 200-500 mum are expected to be a very promising biomaterial candidates for bone implants because its porous structure permits the ingrowths of new-bone tissues and the transport of body fluids. (C) 2002 Kluwer Academic Publisher.
C1 Natl Inst Adv Ind Sci & Techol, Inst Struct & Engn Mat, Kita Ku, Nagoya, Aichi 4628510, Japan.
RP Wen, CE (reprint author), Natl Inst Adv Ind Sci & Techol, Inst Struct & Engn Mat, Kita Ku, Hirate Cho, Nagoya, Aichi 4628510, Japan.
RI Chino, Yasumasa/L-9782-2018
OI Chino, Yasumasa/0000-0002-0725-8237; Wen, Cuie/0000-0001-8008-3536
CR *ASTM, 1994, F6789 ASTM
   *ASTM, 1994, F13682 ASTM
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Chang YS, 1996, BIOMATERIALS, V17, P1141, DOI 10.1016/0142-9612(96)85917-5
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   Cornell CN, 1999, ORTHOP CLIN N AM, V30, P591, DOI 10.1016/S0030-5898(05)70112-7
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Gibson L. J., 1997, CELLULAR SOLIDS STRU, P1
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hiromoto S, 2000, CORROS SCI, V42, P1651, DOI 10.1016/S0010-938X(00)00022-6
   LEMONS JE, 1987, ASTM STP, V953, P185
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 2001, BIOMATERIALS, V22, P599, DOI 10.1016/S0142-9612(00)00221-0
   Pineda LM, 1996, J BIOMED MATER RES, V31, P385
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   TAKADAMA H, 2001, KEY ENG MATER, V192, P51
   Wen C, 2000, MATER T JIM, V41, P1192, DOI 10.2320/matertrans1989.41.1192
   Yamada Y, 2000, PHIL MAG LETT, V80, P215, DOI 10.1080/095008300176182
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
NR 22
TC 166
Z9 172
U1 2
U2 30
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2002
VL 13
IS 4
BP 397
EP 401
DI 10.1023/A:1014344819558
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 542PX
UT WOS:000175054400008
PM 15348615
DA 2018-10-19
ER

PT J
AU Korovessis, PG
   Deligianni, DD
   Lenke, LG
AF Korovessis, PG
   Deligianni, DD
   Lenke, LG
TI Role of surface roughness of titanium versus hydroxyapatite on human
   bone marrow cells response
SO JOURNAL OF SPINAL DISORDERS & TECHNIQUES
LA English
DT Article
DE bone marrow cell culture; osteoblasts; titanium; hydroxyapatite; surface
   roughness
ID OSTEOBLAST-LIKE CELLS; IN-VITRO; PROLIFERATION; BIOMATERIALS;
   FIBROBLASTS; INVITRO; DIFFERENTIATION; ATTACHMENT; CULTURE; MATRIX
AB This study was designed to assess human bone marrow cell response and particularly cell adhesion. proliferation, and differentiation, when cultured in vitro on titanium alloy and hydroxyapatite With different values of surface roughness. A further aim was to compare the cell response on the two materials, currently used in spinal surgery. Cell adhesion was determined after 0.5, 2, 4, and 18 hours of incubation; proliferation after 8, 11, 14, and 16 days of culture; and differentiation was evaluated with the expression of alkaline phosphatase activity after 8 and 16 days of culture. This study showed that bone marrow cells grew faster on titanium alloy than on hydroxyapatite, although fewer cells attached to titanium, compared to those attached to hydroxyapatite. No statistically significant difference was observed as the expression of alkaline phosphatase activity on hydroxyapatite and titanium alloy of the same roughness. Cell adhesion, proliferation, and differentiation are dependent on surface roughness of the biomaterial, and all three increased as the roughness of titanium alloy increased. Conclusively, surface roughness of titanium and hydroxyapatite significantly influences bone marrow cell response, and therefore these biomaterials should be used with rough outer surface, if a significant cell response on them is desired. These advantages of titanium and hydroxyapatite theoretically seem to be of particular importance in the following situations: long fusions, lumbosacral fusion, revision surgery with poor bone bank, neuropathic scoliosis associated with few bone graft reserves, and adult patients with severe osteoporosis.
C1 Gen Hosp Agios Andreas, Dept Orthopaed, Spine Unit, Patras, Greece.
   Univ Patras, Dept Mech & Aeronaut Engn, Biomed Engn Lab, GR-26110 Patras, Greece.
   Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO USA.
RP Korovessis, PG (reprint author), Gen Hosp Agios Andreas, Dept Orthopaed, Spine Unit, 65-67 Haralabi Str, Patras, Greece.
CR Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   BUSHER D, 1991, J BIOMED MATER RES, V25, P889
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1289
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1067
   DONLEY TG, 1991, J PERIODONTOL, V62, P153, DOI 10.1902/jop.1991.62.2.153
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   INOUE T, 1987, J BIOMED MATER RES, V21, P107, DOI 10.1002/jbm.820210114
   KAPLOW LS, 1968, ANN NY ACAD SCI, V155, P911, DOI 10.1111/j.1749-6632.1968.tb55077.x
   Keller JC, 1997, DENT MATER, V13, P62, DOI 10.1016/S0109-5641(97)80010-3
   Klokkevold PR, 1997, CLIN ORAL IMPLAN RES, V8, P442, DOI 10.1034/j.1600-0501.1997.080601.x
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MCAUSLAN BR, 1998, J BIOMED MATER RES, V22, P905
   Michaels C. M., 1989, J DENT RES, V68, P278
   NANCOLLAS GH, 1970, ARCH ORAL BIOL, V15, P731, DOI 10.1016/0003-9969(70)90037-3
   OKUMURA M, 1997, J BIOMED MATER RES, V39, P176
   Ong J L, 1996, Implant Dent, V5, P83, DOI 10.1097/00008505-199600520-00002
   Ong J.L., 1998, J BIOMED MATER RES, V29, P389
   ONG JL, 1995, J BIOMED MATER RES, V29, P165, DOI 10.1002/jbm.820290205
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
   Wilke A, 1998, J BIOMED MATER RES, V40, P301, DOI 10.1002/(SICI)1097-4636(199805)40:2<301::AID-JBM15>3.0.CO;2-O
   Williams D.F, 1981, BIOCOMPATIBILITY CLI, V1, P9
   Yliheikkila P K, 1995, Int J Oral Maxillofac Implants, V10, P655
   Yliheikkila P K, 1996, Int J Oral Maxillofac Implants, V11, P456
   ZAMBONIN G, 1995, BIOMATERIALS, V16, P397, DOI 10.1016/0142-9612(95)98857-A
NR 31
TC 26
Z9 26
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1536-0652
J9 J SPINAL DISORD TECH
JI J. Spinal Disord. Tech.
PD APR
PY 2002
VL 15
IS 2
BP 175
EP 183
DI 10.1097/00024720-200204000-00015
PG 9
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 539AT
UT WOS:000174847800014
PM 11927830
DA 2018-10-19
ER

PT J
AU Badylak, S
   Kokini, K
   Tullius, B
   Simmons-Byrd, A
   Morff, R
AF Badylak, S
   Kokini, K
   Tullius, B
   Simmons-Byrd, A
   Morff, R
TI Morphologic study of small intestinal submucosa as a body wall repair
   device
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE small intestinal submucosa (SIS); extracellular matrix (ECM);
   biomaterial; scaffold; remodeling; tissue engineering
ID ANIMAL-MODEL; DOGS; BIOMATERIAL; REPLACEMENT; DEFECTS; GRAFTS
AB Background. The extracellular matrix (ECM) derived from porcine small intestinal submucosa (SIS) has been used as a constructive scaffold for tissue repair in both preclinical animal studies and human clinical trials. Quantitative characterization of the host tissue response to this xenogeneic scaffold material has been lacking.
   Materials and methods. The morphologic response to a multilaminate form of the SIS-ECM was evaluated in a chronic, 2-year study of body wall repair in two separate species: the dog and the rat. Morphologic response to the SIS-ECM was compared to that for three other commonly used bioscaffold materials including Marlex mesh, Dexon, and Perigard. Quantitative measurements were made of tissue consistency, polymorphonuclear cell response, mononuclear cell response, tissue organization, and vascularity at five time points after surgical implantation: 1 week, 1, 3, and 6 dmonths, and 2 years.
   Results. All bioscaffold materials functioned well as a repair device for large ventral abdominal wall defects created in these two animal models. The SIS-ECM bioscaffold showed a greater number of polymorphonuclear leukocytes at the 1-week time point and a greater degree of graft site tissue organization after 3 months compared to the other three scaffold materials. There was no evidence for local infection or other detrimental local pathology to any of the graft materials at any time point.
   Conclusions. Like Marlex, Dexon, and Perigard, the SIS-ECM is an effective bioscaffold for long-term repair of body wall defects. Unlike the other scaffold materials, the resorbable SIS-ECM scaffold was replaced by well-organized host tissues including differentiated skeletal muscle. (C) 2002 Elsevier Science (USA).
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Mech Engn, W Lafayette, IN 47907 USA.
   Sentron Med Ventures, Cincinnati, OH 45242 USA.
RP Badylak, S (reprint author), Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
OI Badylak, Stephen/0000-0003-3555-0689
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   DEBORD J, 1994, PROTHESES ABDOMINAL, P1
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   DELANY HM, 1982, ANN SURG, V196, P187, DOI 10.1097/00000658-198208000-00011
   Gloeckner DC, 2000, J BIOMED MATER RES, V52, P365, DOI 10.1002/1097-4636(200011)52:2<365::AID-JBM17>3.0.CO;2-3
   GREISLER HP, 1994, PROTHESES ABDOMINAL, P180
   JAMES NL, 1991, BIOMATERIALS, V12, P801, DOI 10.1016/0142-9612(91)90065-I
   Kropp BP, 1999, ADV EXP MED BIOL, V462, P129
   LAMB JP, 1983, SURGERY, V93, P643
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Portis AJ, 2000, J UROLOGY, V164, P1405, DOI 10.1016/S0022-5347(05)67207-2
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   READ RC, 1994, PROTHESES ABDOMINAL, P1
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   Shalhav AL, 1999, J ENDOUROL, V13, P241, DOI 10.1089/end.1999.13.241
   USHER F, 1962, ARCH SURG-CHICAGO, V84, P73
   WALKER PM, 1976, CAN J SURG, V19, P211
NR 27
TC 214
Z9 222
U1 2
U2 15
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
EI 1095-8673
J9 J SURG RES
JI J. Surg. Res.
PD APR
PY 2002
VL 103
IS 2
BP 190
EP 202
DI 10.1006/jsre.2001.6349
PG 13
WC Surgery
SC Surgery
GA 539BD
UT WOS:000174848900010
PM 11922734
DA 2018-10-19
ER

PT J
AU Wefer, J
   Schlote, N
   Sekido, N
   Sievert, KD
   Bakircioglu, ME
   Nunes, L
   Dahiya, R
   Jonas, U
   Tanagho, EA
AF Wefer, J
   Schlote, N
   Sekido, N
   Sievert, KD
   Bakircioglu, ME
   Nunes, L
   Dahiya, R
   Jonas, U
   Tanagho, EA
TI Acellular tissue matrix as a new biomaterial for vaginal reconstruction:
   A pilotstudy in rats
SO JOURNAL OF UROLOGY
LA English
DT Meeting Abstract
CT 97th Annual Meeting of the American-Urological-Association
CY MAY 25-30, 2002
CL ORLANDO, FLORIDA
SP Amer Urol Assoc
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2002
VL 167
IS 4
SU S
BP 76
EP 76
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA 708KU
UT WOS:000184566700303
DA 2018-10-19
ER

PT J
AU Pariente, JL
   Kim, BS
   Atala, A
AF Pariente, JL
   Kim, BS
   Atala, A
TI In vitro biocompatibility evaluation of naturally derived and synthetic
   biomaterials using normal human bladder smooth muscle cells
SO JOURNAL OF UROLOGY
LA English
DT Article
DE bladder; muscle, smooth; biocompatible materials; cell culture
ID SMALL-INTESTINAL SUBMUCOSA; HUMAN UROTHELIAL CELLS; VESICOURETERAL
   REFLUX; COLORIMETRIC ASSAY; COLLAGEN MATRIX; URINARY-BLADDER;
   CYTO-TOXICITY; CULTURE; CHONDROCYTES; POLYMERS
AB Purpose: Tissue engineering of the urinary tract often requires the use of various biomaterials. Adequate biomaterial biocompatibility is necessary for successful urinary reconstruction. In this study using a primary normal human bladder smooth muscle cell culture system we evaluated the in vitro biocompatibility of a number of naturally derived biomaterials, including bladder submucosa, small intestinal submucosa, collagen and alginate, and polymeric biomaterials, including polyglycolic acid, poly(L-lactic acid) and poly(lactic-co-glycolic acid, which have been used for urinary reconstruction experimentally or clinically.
   Materials and Methods: To determine the cytotoxic and bioactive effects of bladder submucosa, small intestinal submucosa, collagen, alginate, polyglycolic acid, poly(L-lactic acid) and poly(lactic-co-glycolic acid) we measured cell viability, metabolic activity, apoptotic properties and DNA synthesis activity with 4 types of assays, namely Neutral Red (Sigma Chemical Co., St. Louis, Missouri), 3-(4,5-dimethyltliiazol-2-yl)-2,5-diphenyl tetrazolium bromide (Sigma Chemical Co.), apoptotic activity and tritiated thymidine incorporation (Dupont NEN, Boston, Massachusetts) assays. Normal human bladder smooth muscle cells were cultured with the extracts of the biomaterials or cultured in direct contact with the biomaterials.
   Results: All naturally derived and synthetic biomaterials tested in this study except alginate exhibited nontoxic and bioactive effects on human bladder smooth muscle cells (HBSMCs) in vitro, as indicated by the 4 types of biocompatibility assays using the extract and direct contact methods. Cell viability, apoptotic properties, metabolic activity and DNA synthesis activity of HBSMCs cultured with the extracts of the biomaterials or cultured in direct contact with the biomaterials were not significantly different from those of negative controls (fresh medium with no extracts or tissue culture plates without biomaterials).
   Conclusions: All naturally derived and synthetic biomaterials tested in this study except alginate exhibited nontoxic and bioactive effects on HBSMCs in vitro. This normal primary human bladder smooth muscle cell culture model is suitable for in vitro biocompatibility assessment. It provides information on cell-biomaterial interactions and on the ability of biomaterials to support bioactive cell functions.
C1 Childrens Hosp, Lab Tissue Engn & Cellular Therapeut, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA USA.
RP Atala, A (reprint author), 300 Longwood Ave, Boston, MA 02115 USA.
RI Kim, Byung-Soo/O-2352-2013
OI Atala, Anthony/0000-0001-8186-2160
CR *ANN SOC TEST MAT, 1991, ANN BOOK AM SOC TEST
   [Anonymous], 1992, ISO109935
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   ATALA A, 1993, J UROLOGY, V150, P745, DOI 10.1016/S0022-5347(17)35603-3
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   Atala A, 2000, J ENDOUROL, V14, P49, DOI 10.1089/end.2000.14.49
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   Brauers A, 1998, Tech Urol, V4, P214
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   Diamond DA, 1999, J UROLOGY, V162, P1185, DOI 10.1016/S0022-5347(01)68124-2
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Kassaby El A., 2000, Journal of Urology, V163, P70
   Kershen RT, 1999, UROL CLIN N AM, V26, P81, DOI 10.1016/S0094-0143(99)80008-1
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   KIM BS, WORLD J UROL, V18, P2000
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lattari Vincent, 1997, Journal of Burn Care and Rehabilitation, V18, P147, DOI 10.1097/00004630-199703000-00010
   MOHAMMED R, 1987, UROL RES, V15, P239
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   OZTURK SS, 1990, BIOTECHNOL PROGR, V6, P121, DOI 10.1021/bp00002a005
   Pariente JL, 1998, J BIOMED MATER RES, V40, P31, DOI 10.1002/(SICI)1097-4636(199804)40:1<31::AID-JBM4>3.0.CO;2-S
   Pariente JL, 1998, UROLOGY, V52, P524, DOI 10.1016/S0090-4295(98)00198-8
   Pariente JL, 2000, BIOMATERIALS, V21, P835, DOI 10.1016/S0142-9612(99)00253-7
   PARISH CR, 1983, J IMMUNOL METHODS, V58, P225, DOI 10.1016/0022-1759(83)90277-6
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shive M. S., 1997, ADV DRUG DELIV REV, V28, P5
   TACHIBANA M, 1985, J UROLOGY, V133, P866, DOI 10.1016/S0022-5347(17)49268-8
   UPHILL PF, 1990, MED DEVICE TECHN NOV, P24
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
   Winfrey M E, 1999, Dimens Crit Care Nurs, V18, P14, DOI 10.1097/00003465-199901000-00003
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 36
TC 98
Z9 108
U1 1
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2002
VL 167
IS 4
BP 1867
EP 1871
DI 10.1016/S0022-5347(05)65251-2
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 531VB
UT WOS:000174437000107
PM 11912450
DA 2018-10-19
ER

PT J
AU Ektessabi, AM
   Hamdi, M
AF Ektessabi, AM
   Hamdi, M
TI Characterization of calcium phosphate bioceramic films using ion beam
   analysis techniques
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE hydroxyapatite; ion beam analysis; PIXE; RBS; ERDA; RE-RBS
ID ASSISTED SPUTTER-DEPOSITION; RESONANCE SCATTERING; CERAMIC COATINGS;
   THIN-FILMS; TITANIUM; OXYGEN; SURFACE; HYDROXYAPATITE; BIOMATERIALS;
   IMPLANTS
AB The analytical techniques using ion beams are powerful tools for surface analysis of solid materials. Constituent elements are important in determining the biocompatibility and corrosion resistance of a biomaterial implant. The focus of this article is on the application of ion beam analysis towards quantifying the composition of calcium phosphate based biomaterials. Thin films of calcium phosphate bioceramics were prepared on Si and Ti substrates using ion beam sputter deposition (IBSD) and ion beam assisted sputter deposition (IBASD) methods. Precise amounts of calcium, phosphorus, oxygen and hydrogen in these thin films are determined by combining four ion beam analysis techniques. The simultaneous application of proton induced X-ray emission (PIXE) and Rutherford backscattering spectrometry (RBS) were utilized to quantify composition and amounts of elements heavier than helium. Elastic recoil detection analysis (ERDA) was used to determine hydrogen content while resonance-enhanced RBS (RE-RBS) was utilized to measure oxygen concentration. The amount of assisting ion beam current density during deposition affected the concentration ratios of Ca, O and H to P. Combination of different ion beam analysis methods is useful in characterizing the elemental composition and distribution of composite biomaterials. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Kyoto Univ, Int Innovat Ctr, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Engn, Dept Precis Engn, Sakyo Ku, Kyoto 6068501, Japan.
RP Ektessabi, AM (reprint author), Kyoto Univ, Int Innovat Ctr, Sakyo Ku, Kyoto 6068501, Japan.
RI shukor, hamdi/B-9093-2010
CR ALMEIDA FJD, 1993, NUCL INSTRUM METH B, V82, P393, DOI 10.1016/0168-583X(93)95986-F
   Barradas NP, 2000, NUCL INSTRUM METH B, V161, P308, DOI 10.1016/S0168-583X(99)00976-3
   Bender SA, 2000, BIOMATERIALS, V21, P299, DOI 10.1016/S0142-9612(99)00183-0
   CAMERON JR, 1953, PHYS REV, V90, P839, DOI 10.1103/PhysRev.90.839
   CHEN CM, 2000, MAT SCI ENG B-FLUID, V27, P113
   COOK SD, 1988, CLIN ORTHOP RELAT R, P225
   Cui FZ, 1999, SURF COAT TECH, V112, P278, DOI 10.1016/S0257-8972(98)00763-4
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   Ektessabi AM, 1997, NUCL INSTRUM METH B, V127, P1008, DOI 10.1016/S0168-583X(97)00049-9
   EKTESSABI AM, 1994, SURF COAT TECH, V68, P208, DOI 10.1016/0257-8972(94)90162-7
   Ektessabi AM, 1995, THIN SOLID FILMS, V270, P335, DOI 10.1016/0040-6090(95)06714-0
   Ektessabi AM, 1996, NUCL INSTRUM METH B, V109, P278, DOI 10.1016/0168-583X(95)00922-1
   EKTESSABI AM, 1995, NUCL INSTRUM METH B, V99, P610, DOI 10.1016/0168-583X(94)00568-0
   EKTESSABI AM, 1994, INT J PIXE, V4, P81
   FUJINO Y, 1982, J APPL PHYS, V51, P1047
   Jansen J A, 1993, Clin Oral Implants Res, V4, P28, DOI 10.1034/j.1600-0501.1993.040104.x
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   LEAVITT JA, 1990, NUCL INSTRUM METH B, V44, P260, DOI 10.1016/0168-583X(90)90637-A
   OHTSUKA Y, 1994, SURF COAT TECH, V65, P224, DOI 10.1016/S0257-8972(94)80037-5
   Russell SW, 1996, J BIOMED MATER RES, V30, P165
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   SOROKA VI, 1993, NUCL INSTRUM METH B, V83, P311, DOI 10.1016/0168-583X(93)95848-Y
   van Dijk K, 1998, J BIOMED MATER RES, V42, P266, DOI 10.1002/(SICI)1097-4636(199811)42:2<266::AID-JBM11>3.3.CO;2-U
   VAUGHN B K, 1992, Dental Clinics of North America, V36, P263
   WANG ZL, 1983, NUCL INSTRUM METHODS, V211, P193, DOI 10.1016/0167-5087(83)90569-0
   Yang Guohua, 1991, Nuclear Science and Techniques, V2, P29
   Zeng H, 1999, BIOMATERIALS, V20, P443, DOI 10.1016/S0142-9612(98)00190-2
NR 28
TC 12
Z9 13
U1 0
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD APR 1
PY 2002
VL 153
IS 1
BP 10
EP 15
AR PII S0257-8972(01)01519-5
DI 10.1016/S0257-8972(01)01519-5
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 538BY
UT WOS:000174795200002
DA 2018-10-19
ER

PT J
AU Xiang, Z
   Spector, M
AF Xiang, Z
   Spector, M
TI A glimpse of tissue engineering in China
SO TISSUE ENGINEERING
LA English
DT Review
AB Tissue engineering activities in China have expanded and advanced to the extent that it is not possible to acknowledge all of the work in one review. Substantial progress has been made in the development of novel biomaterial scaffolds and in the genetic manipulation of cells in vitro. Moreover, certain aspects of tissue engineering strategies have begun to undergo clinical trial. A glimpse of tissue engineering in China was afforded at the First International Conference on Biomaterials (China) held in Beijing, July 24-26, 2001. Several papers presented at the meeting, which was conducted in English only, reflected many of the tissue engineering activities in the country. A brief summary of some of the papers may begin to suggest possibilities for collaboration between tissue engineers inside and outside of China, as well as to facilitate dissemination of important findings.
C1 Harvard Univ, Brigham & Womens Hosp, Dept Orthopaed Surg, Sch Med, Boston, MA 02115 USA.
   W China Univ Med Sci, Dept Orthopaed Surg, Univ Hosp 1, Chengdu 610041, Sichuan, Peoples R China.
RP Spector, M (reprint author), Harvard Univ, Brigham & Womens Hosp, Dept Orthopaed Surg, Sch Med, MRB 106,75 Francis St, Boston, MA 02115 USA.
OI Spector, Myron/0000-0003-3328-4858
CR CAI Q, 2001, P 1 INT C BIOM CHIN, P20
   Fu X, 1995, Wound Repair Regen, V3, P237, DOI 10.1046/j.1524-475X.1995.30216.x
   FU XB, 1999, MODERN WOUND HEALING, P1
   GE XM, 2001, P 1 INT C BIOM CHIN, P28
   MAO JS, 2001, P 1 INT C BIOM CHIN, P51
   REN X, 1988, CHIN J MED HIST, V18, P81
   SANG GW, 2001, P 1 INT C BIOM CHIN, P1
   WANG CY, 2001, P 1 INT C BIOM CHIN, P55
   WANG XJ, 2001, P 1 INT C BIOM CHIN, P199
   XIANG Z, 2001, P 1 INT C BIOM CHIN, pS1
   XIONG Z, 2001, P 1 INT C BIOM CHIN, P77
   YANG J, 2001, P 1 INT C BIOM CHIN, P45
   YANG ZH, 2001, P 1 INT C BIOM CHIN, pS2
   YANG ZM, 2000, CHINESE J SCI, V6, P914
   YANG ZM, 2000, CHINESE J REPARAT RE, V14, P365
   YUAN XY, 2001, P 1 INT C BIOM CHIN, P150
   ZHAO FY, 2001, P 1 INT C BIOM CHIN, P23
   ZHOU CR, 2001, P 1 INT C BIOM CHIN, P329
NR 18
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD APR
PY 2002
VL 8
IS 2
BP 169
EP 174
DI 10.1089/107632702753724941
PG 6
WC Cell & Tissue Engineering
SC Cell Biology
GA 549KN
UT WOS:000175443200001
PM 12031107
DA 2018-10-19
ER

PT J
AU Halberstadt, C
   Austin, C
   Rowley, J
   Culberson, C
   Loebsack, A
   Wyatt, S
   Coleman, S
   Blacksten, L
   Burg, K
   Mooney, D
   Holder, W
AF Halberstadt, C
   Austin, C
   Rowley, J
   Culberson, C
   Loebsack, A
   Wyatt, S
   Coleman, S
   Blacksten, L
   Burg, K
   Mooney, D
   Holder, W
TI A hydrogel material for plastic and reconstructive applications injected
   into the subcutaneous space of a sheep
SO TISSUE ENGINEERING
LA English
DT Article
ID TISSUE-ENGINEERED GROWTH; ALGINATE HYDROGELS; LIVER-TISSUE; CARTILAGE;
   TRANSPLANTATION; MATRIX; PEPTIDES; POLYMERS; GRAFTS; FLAPS
AB Soft tissue reconstruction using tissue-engineered constructs requires the development of materials that are biocompatible and support cell adhesion and growth. The objective of this study was to evaluate the use of macroporous hydrogel fragments that were formed using either unmodified alginate or alginate covalently linked with the fibronectin cell adhesion peptide RGD (alginate-RGD). These materials were injected into the subcutaneous space of adult, domesticated female sheep and harvested for histological comparisons at 1 and 3 months. In addition, the alginate-RGD porous fragments were seeded with autologous sheep preadipocytes isolated from the omentum, and these cell-based constructs were also implanted. The results from this study indicate that both the alginate and alginate-RGD subcutaneous implants supported tissue and vascular ingrowth. Furthermore, at all time points of the experiment, a minimal inflammatory response and capsule formation surrounding the implant were observed. The implanted materials also maintained their sizes over the 3-month study period. In addition, the alginate-RGD fragments supported the adhesion and proliferation of sheep preadipocytes, and adipose tissue was present within the transplant site of these cellular constructs, which was not present within the biomaterial control sites.
C1 Carolinas Med Ctr, Charlotte, NC 28232 USA.
   Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA.
   Clemson Univ, Dept Bioengn, Clemson, SC USA.
RP Halberstadt, C (reprint author), Carolinas Med Ctr, Cannon Res Bldg,POB 32861, Charlotte, NC 28232 USA.
EM chalberstadt@carolinas.org
CR Arnez ZM, 1999, BRIT J PLAST SURG, V52, P351, DOI 10.1054/bjps.1999.3099
   Austin C., 2000, Tissue Engineering, V6, P662
   BURG KJL, 2000, 6 WORLD BIOM C
   Clugston PA, 2000, PLAST RECONSTR SURG, V105, P77, DOI 10.1097/00006534-200001000-00013
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   FONTAINE M, 1995, J PEDIATR SURG, V30, P56, DOI 10.1016/0022-3468(95)90610-X
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GREENE KG, 2000, 6 WORLD BIOM C
   Griffith LG, 1997, ANN NY ACAD SCI, V831, P382
   HALBERSTADT CR, 2000, 6 WORLD BIOM C
   HANSBROUGH JF, 1992, SURGERY, V111, P438
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hofmann C, 1999, J AM ACAD DERMATOL, V40, P100, DOI 10.1016/S0190-9622(99)70536-0
   Kao WYJ, 1998, BIOTECHNOL BIOENG, V59, P2, DOI 10.1002/(SICI)1097-0290(19980705)59:1<2::AID-BIT2>3.0.CO;2-G
   KIM WS, 1994, PLAST RECONSTR SURG, V94, P233, DOI 10.1097/00006534-199408000-00001
   LUM H, 1985, AM REV RESPIR DIS, V132, P1078
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MOONEY DJ, 1994, TRANSPLANT P, V26, P3425
   NAUGHTON BA, 1995, APPL BIOCHEM BIOTECH, V54, P65, DOI 10.1007/BF02787912
   OZGENTAS HE, 1994, ANN PLAS SURG, V33, P171
   Parenteau N, 1999, SCI AM, V280, P83
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Shanklin DR, 1999, EXP MOL PATHOL, V67, P26, DOI 10.1006/exmp.1999.2269
   STICKLAND NC, 1975, STAIN TECHNOL, V50, P255, DOI 10.3109/10520297509117068
   Urry DW, 1998, J BIOMAT SCI-POLYM E, V9, P1015, DOI 10.1163/156856298X00316
   VACANTI CA, 1993, TRANSPLANT P, V25, P1019
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   Wyatt LE, 1998, PLAST RECONSTR SURG, V102, P1922, DOI 10.1097/00006534-199811000-00017
NR 30
TC 103
Z9 104
U1 1
U2 12
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD APR
PY 2002
VL 8
IS 2
BP 309
EP 319
DI 10.1089/107632702753725067
PG 11
WC Cell & Tissue Engineering
SC Cell Biology
GA 549KN
UT WOS:000175443200013
PM 12031119
DA 2018-10-19
ER

PT J
AU Suh, H
   Lee, JE
AF Suh, H
   Lee, JE
TI Behavior of fibroblasts on a porous hyaluronic acid incorporated
   collagen matrix
SO YONSEI MEDICAL JOURNAL
LA English
DT Article
DE hyaluronic acid; atelocollagen; biodegradation; mechanical properties;
   ultraviolet irradiation; fibroblast growing behavior
ID CONTAINING ARTIFICIAL SKIN; CROSS-LINKING; EXTRACELLULAR-MATRIX; PORE
   STRUCTURE; SPONGE; BURN; ATELOCOLLAGEN; REGENERATION; BIOMATERIAL;
   THICKNESS
AB A hyaluronic acid (HA) incorporated porous collagen matrix was fabricated at -70degreesC by lyophilization. The HA incorporated collagen matrix showed increased pore size in comparison with collagen matrix. Biodegradability and mechanical properties of matrices were controllable by varying the ultraviolet (UV) irradiation time for cross-linking collagen molecules. Addition of HA to collagen matrix did not effect ultimate tensile stress after UV irradiation. HA incorporated collagen matrices demonstrated a higher resistance against the collagenase degradation than collagen matrix. In an in vitro investigation of cellular behavior using dermal fibroblasts on the porous matrix, HA incorporated collagen matrix induced increased dermal fibroblast migration and proliferation in comparison with collagen matrix. These results suggest that the HA incorporated collagen porous matrix assumes to enhance dermal fibroblast adaptation and regenerative potential.
C1 Yonsei Univ, Coll Med, Dept Med Engn, Seoul 120752, South Korea.
   Yonsei Ctr Nano Technol, Nano Biomat Grp, Seoul, South Korea.
RP Suh, H (reprint author), Yonsei Univ, Coll Med, Dept Med Engn, CPO Box 8044, Seoul 120752, South Korea.
CR ABRAMO AC, 1992, BRIT J PLAST SURG, V45, P117, DOI 10.1016/0007-1226(92)90170-3
   AHN S, 1996, J KOSOMBE, V17, P479
   AKIYAMA SK, 1990, BIOCHIM BIOPHYS ACTA, V1031, P91, DOI 10.1016/0304-4157(90)90004-V
   Balazs Endre A., 1995, P1693
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   Choi YS, 1999, J BIOMED MATER RES, V48, P631, DOI 10.1002/(SICI)1097-4636(1999)48:5<631::AID-JBM6>3.0.CO;2-Y
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   FRESHNEY RI, 1994, CULTURE ANIMAL CELLS
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   HIROSHI K, 1992, JPN J ORAL BIOL, V34, P331
   Horch RE, 1998, SCAND J PLAST RECONS, V32, P407, DOI 10.1080/02844319850158499
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Koide T, 1997, Dent Mater J, V16, P1
   KUROYANAGI Y, 1993, ANN PLAS SURG, V31, P340, DOI 10.1097/00000637-199310000-00011
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903
   LARSEN NE, 1993, J BIOMED MATER RES, V27, P1129, DOI 10.1002/jbm.820270903
   LINGE C, 1989, EXP CELL RES, V185, P519, DOI 10.1016/0014-4827(89)90320-0
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Lorenz C, 1997, BURNS, V23, P505, DOI 10.1016/S0305-4179(97)00022-3
   Malette W.G., 1986, CHITIN NATURE TECHNO, P435
   MENTER JM, 1995, PHOTOCHEM PHOTOBIOL, V62, P402, DOI 10.1111/j.1751-1097.1995.tb02360.x
   MOONEY DJ, 1996, BIOMATERIALS, V17, P1427
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   OLIVE RF, 1987, BURNS, V12, P49
   OLIVER RF, 1980, BRIT J EXP PATHOL, V61, P544
   Park JC, 2000, J BIOMED MATER RES, V52, P669, DOI 10.1002/1097-4636(20001215)52:4<669::AID-JBM11>3.3.CO;2-L
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   SEAGER H, 1985, Journal of Parenteral Science and Technology, V39, P161
   STMENKOVIC I, 1994, METHODS ENZYMOLOGY E, V245, P195
   SUH H, 1995, ASAIO J, V41, pM652, DOI 10.1097/00002480-199507000-00091
   SUH H, 1998, BIOMATER RES, V2, P95
   SUH H, 1999, BIOMED ENG APPL BASI, V11, P167
   SUZUKI S, 1990, BIOMATERIALS, V11, P356, DOI 10.1016/0142-9612(90)90114-6
   SUZUKI S, 1990, BRIT J PLAST SURG, V43, P47, DOI 10.1016/0007-1226(90)90044-Z
   VIZAROVA K, 1995, BIOMATERIALS, V16, P1217, DOI 10.1016/0142-9612(95)98127-Z
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
NR 45
TC 10
Z9 11
U1 2
U2 5
PU YONSEI UNIV COLLEGE MEDICINE
PI SEOUL
PA C/O KYUN0-IL IM, M.D., PH.D, SHINCHON DONG 134, SEODAEMOON KU, SEOUL
   120-752, SOUTH KOREA
SN 0513-5796
J9 YONSEI MED J
JI Yonsei Med. J.
PD APR
PY 2002
VL 43
IS 2
BP 193
EP 202
DI 10.3349/ymj.2002.43.2.193
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA 549QJ
UT WOS:000175455500008
PM 11971213
OA Bronze
DA 2018-10-19
ER

PT J
AU Rose, FRAJ
   Oreffo, ROC
AF Rose, FRAJ
   Oreffo, ROC
TI Bone tissue engineering: Hope vs hype
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE osteoprogenitor; bone marrow; bio-degradable polymer; tissue
   engineering; scaffold; artificial bone; bone regeneration; stem cell
ID MESENCHYMAL STEM-CELLS; IN-VITRO; MORPHOGENETIC PROTEIN-2; POLYMER
   SCAFFOLDS; MARROW; VIVO; OSTEOGENESIS; REGENERATION; BIOMATERIAL;
   CARTILAGE
AB The requirement for new bone to replace or restore the function of traumatised, damaged, or lost bone is a major clinical and socioeconomic need. Bone formation strategies, although attractive, have yet to yield functional and mechanically competent bone. Bone tissue engineering has been heralded as the alternative strategy to regenerate bone. In essence, the discipline aims to combine progenitor or mature cells with biocompatible materials or scaffolds, with or without appropriate growth factors, to initiate repair and regeneration. This brief review outlines the concepts, challenges, and limitations in bone tissue engineering and the potential that could improve the quality of life for many as a result of interdisciplinary collaboration. (C) 2002 Elsevier Science (USA).
C1 Univ Southampton, Gen Hosp, Southampton SO16 6YD, Hants, England.
   Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England.
RP Oreffo, ROC (reprint author), Univ Southampton, Gen Hosp, MP817 CF86, Southampton SO16 6YD, Hants, England.
EM roco@soton.ac.uk
RI Oreffo, Richard/A-4615-2011; Xu, Qingguo/C-1962-2014
OI Oreffo, Richard/0000-0001-5995-6726; Xu, Qingguo/0000-0003-3191-0771;
   Rose, Felicity/0000-0001-6640-8840
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Almqvist N, 1999, MAT SCI ENG C-BIO S, V7, P37, DOI 10.1016/S0928-4931(98)00072-1
   Andriano KP, 1999, J BIOMED MATER RES, V48, P602, DOI 10.1002/(SICI)1097-4636(1999)48:5<602::AID-JBM3>3.0.CO;2-6
   ASHTON BA, 1980, CLIN ORTHOP RELAT R, P294
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   BODEN SD, 1999, CLIN ORTHOP S, V367, pS84
   Breitbart AS, 1999, ANN PLAS SURG, V42, P488, DOI 10.1097/00000637-199905000-00005
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   CHRISCHILLES E, 1994, BONE, V15, P377, DOI 10.1016/8756-3282(94)90813-3
   COHEN S, 1993, CLIN MATER, V13, P3, DOI 10.1016/0267-6605(93)90082-I
   CONNOLLY JF, 1995, CLIN ORTHOP RELAT R, V313, P8
   Cooper AI, 2000, J MATER CHEM, V10, P207, DOI 10.1039/a906486i
   DOLL BA, 1990, J PERIODONTOL, V61, P745, DOI 10.1902/jop.1990.61.12.745
   Einhorn TA, 1999, CLIN ORTHOP RELAT R, pS59, DOI 10.1097/00003086-199910001-00007
   FIALKOV KA, 2000, BONE ENG, P548
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3
   GUNDLE R, 1995, BONE, V16, P597, DOI 10.1016/8756-3282(95)00112-Q
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   HORISAKA Y, 1991, CLIN ORTHOP RELAT R, V268, P303
   Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529
   Howdle SM, 2001, CHEM COMMUN, P109, DOI 10.1039/b008188o
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Jackson D W, 1999, Clin Orthop Relat Res, pS31, DOI 10.1097/00003086-199910001-00005
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Joyner CJ, 1997, BONE, V21, P1, DOI 10.1016/S8756-3282(97)00074-4
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1
   Kawakami Y, 1996, DEVELOPMENT, V122, P3557
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2000, NATURE, V408, P998
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Louisia S, 1999, J BONE JOINT SURG BR, V81B, P719, DOI 10.1302/0301-620X.81B4.9358
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mori M, 2000, J BIOMED MATER RES, V50, P191, DOI 10.1002/(SICI)1097-4636(200005)50:2<191::AID-JBM14>3.0.CO;2-0
   Musgrave DS, 1999, BONE, V24, P541, DOI 10.1016/S8756-3282(99)00086-1
   NAKAHARA H, 1990, BONE, V11, P181, DOI 10.1016/8756-3282(90)90212-H
   Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   Okubo Y, 2001, J BONE JOINT SURG AM, V83A, pS99
   Olmsted EA, 2001, J CELL BIOCHEM, V82, P11, DOI 10.1002/jcb.1106
   Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6
   Park SR, 1999, BONE, V24, P549, DOI 10.1016/S8756-3282(99)00084-8
   Patel N, 1998, FASEB J, V12, P1447
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Reddi A. Hari, 1992, Current Opinion in Cell Biology, V4, P850
   Reeve J., 1998, AGENET REPORT, P1
   Saad B, 1998, J BIOMED MATER RES, V39, P594, DOI 10.1002/(SICI)1097-4636(19980315)39:4<594::AID-JBM14>3.0.CO;2-7
   Sakkers RJB, 2000, J BIOMED MATER RES, V49, P312, DOI 10.1002/(SICI)1097-4636(20000305)49:3<312::AID-JBM3>3.3.CO;2-5
   Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   SIMMONS PJ, 1991, BLOOD, V78, P55
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   SPECTOR M, 1992, ORTHOP CLIN N AM, V23, P211
   Stewart K, 1999, J BONE MINER RES, V14, P1345, DOI 10.1359/jbmr.1999.14.8.1345
   Tabata Yasuhiko, 2000, Pharmaceutical Science and Technology Today, V3, P80, DOI 10.1016/S1461-5347(00)00242-X
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   TRIFFITT JT, 1998, ADV ORGAN BIOL SERIE, P429
   Turgeman G, 2001, J GENE MED, V3, P240
   VACANTI CA, 2000, PRINCIPLES TISSUE EN
   Whitaker MJ, 2001, J PHARM PHARMACOL, V53, P1427, DOI 10.1211/0022357011777963
   Wilson JM, 1996, NEW ENGL J MED, V334, P1185, DOI 10.1056/NEJM199605023341809
   Winn SR, 1999, CLIN ORTHOP RELAT R, pS95
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   2001, TIMES M, V4, P15
NR 76
TC 333
Z9 360
U1 1
U2 60
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR 22
PY 2002
VL 292
IS 1
BP 1
EP 7
DI 10.1006/bbrc.2002.6519
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 534NF
UT WOS:000174591900001
PM 11890663
DA 2018-10-19
ER

PT J
AU Lay, AN
   Gentleman, ED
   Dee, KC
   Livesay, GA
AF Lay, AN
   Gentleman, ED
   Dee, KC
   Livesay, GA
TI Evaluation of a collageneous biomaterial for soft tissue engineering
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD MAR 20
PY 2002
VL 16
IS 4
BP A37
EP A37
PN 1
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 533MG
UT WOS:000174533600204
DA 2018-10-19
ER

PT J
AU Yamada, M
   Kato, K
   Nomizu, M
   Sakairi, N
   Ohkawa, K
   Yamamoto, H
   Nishi, N
AF Yamada, M
   Kato, K
   Nomizu, M
   Sakairi, N
   Ohkawa, K
   Yamamoto, H
   Nishi, N
TI Preparation and characterization of DNA films induced by UV irradiation
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE DNA structures; environmental chemistry; functional materials;
   intercalations; water-insolubilized DNA
ID SCANNING FORCE MICROSCOPY; DOUBLE-STRANDED DNA; NUCLEIC-ACIDS; LIPID
   COMPLEX; CAST FILM; BINDING; AFFINITY; SEPARATION; MOLECULES; MODE
AB Large amounts of DNA-enriched materials, such as salmon milts and shellfish gonads, are discarded as industrial waste. We have been able to convert the discarded DNA to a useful material by preparing novel DNA films by UV irradiation. When DNA films were irradiated with UV light, the molecular weight of DNA was greatly increased. The reaction was inhibited by addition of the radical scavenger galvinoxyl suggesting that the DNA polymerization with UV irradiation proceeded by a radical reaction. Although this UV-irradiated DNA film was water-insoluble and resistant to hydrolysis by nuclease, the structure of the DNA film in water was similar to non-irradiated DNA and maintained B-form structure. In addition, the UV-irradiated DNA film could effectively accumulate and condense harmful DNA-intercalating compounds, such as ethidium bromide and acridine orange, from diluted aqueous solutions. The binding constant and exclusion number of ethidium bromide for UV-irradiated DNA were determined to be 6.8+/-0.3 x 10(4) M-1 and 1.6+/-0.2, respectively; these values are consisted with reported results for non-irradiated DNA. The UV-irradiated DNA films have potential uses as a biomaterial filter for the removal of harmful DNA intercalating compounds.
C1 Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Lab Biomat Chem,Kita Ku, Sapporo, Hokkaido 0600810, Japan.
   Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan.
RP Nishi, N (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Lab Biomat Chem,Kita Ku, Kita 10,Nishi 5, Sapporo, Hokkaido 0600810, Japan.
RI Ohkawa, Kousaku/E-1497-2014
OI Ohkawa, Kousaku/0000-0001-5199-092X
CR Alberts B., 1971, METHOD ENZYMOL, V21, P198
   Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0
   ALLEN FS, 1972, BIOPOLYMERS, V11, P853, DOI 10.1002/bip.1972.360110410
   ARMSTRONG RW, 1970, J AM CHEM SOC, V92, P3174, DOI 10.1021/ja00713a041
   BARTLETT PD, 1962, J AM CHEM SOC, V84, P2596, DOI 10.1021/ja00872a026
   BERMAN HM, 1981, ANNU REV BIOPHYS BIO, V10, P87, DOI 10.1146/annurev.bb.10.060181.000511
   BEUKERS R, 1960, BIOCHIM BIOPHYS ACTA, V41, P550, DOI 10.1016/0006-3002(60)90063-9
   BEUKERS R, 1958, RECL TRAV CHIM PAY B, V77, P729
   Coury JE, 1996, P NATL ACAD SCI USA, V93, P12283, DOI 10.1073/pnas.93.22.12283
   FULLER W, 1964, BERICH BUNSEN GESELL, V68, P805, DOI 10.1002/bbpc.19640680830
   GOPALAKRISHNAN S, 1989, BIOCHEMISTRY-US, V28, P726, DOI 10.1021/bi00428a047
   Iwata K, 1996, INT J BIOL MACROMOL, V18, P149, DOI 10.1016/0141-8130(95)01073-4
   Joseph A, 2000, J AM CHEM SOC, V122, P11219, DOI 10.1021/ja002541u
   Kawabe Y, 2000, ADV MATER, V12, P1281, DOI 10.1002/1521-4095(200009)12:17<1281::AID-ADMA1281>3.0.CO;2-0
   Kitamura H, 1997, INT J BIOL MACROMOL, V20, P75, DOI 10.1016/S0141-8130(97)01146-X
   Kitamura H, 1997, INT J BIOL MACROMOL, V20, P241, DOI 10.1016/S0141-8130(97)00021-4
   KITAMURA H, 1997, NUCL ACIDS S SER, V37, P273
   LEPECQ JB, 1967, J MOL BIOL, V27, P87, DOI 10.1016/0022-2836(67)90353-1
   LITMAN RM, 1968, J BIOL CHEM, V243, P6222
   Machida S, 1999, POLYM J, V31, P1179, DOI 10.1295/polymj.31.1179
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   Mucic RC, 1998, J AM CHEM SOC, V120, P12674, DOI 10.1021/ja982721s
   MULLER W, 1975, EUR J BIOCHEM, V54, P267, DOI 10.1111/j.1432-1033.1975.tb04137.x
   NISHI N, 1989, PEPT CHEM, P325
   Okahata Y, 1998, J AM CHEM SOC, V120, P6165, DOI 10.1021/ja980165w
   Qu XG, 1999, J AM CHEM SOC, V121, P2649, DOI 10.1021/ja984366b
   Rippe K, 1997, NUCLEIC ACIDS RES, V25, P1736, DOI 10.1093/nar/25.9.1736
   Saenger W., 1987, PRINCIPLES NUCL ACID
   Samori B, 1996, ANGEW CHEM INT EDIT, V35, P529, DOI 10.1002/anie.199605291
   SAMORI B, 1996, ANGEW CHEM, V108, P569
   Sugiki T, 1996, B CHEM SOC JPN, V69, P1777, DOI 10.1246/bcsj.69.1777
   Tanaka K, 1996, J AM CHEM SOC, V118, P10679, DOI 10.1021/ja9617855
   Tanigawa M, 1998, ANAL CHIM ACTA, V365, P19, DOI 10.1016/S0003-2670(97)00709-5
   Tohnai N, 1999, B CHEM SOC JPN, V72, P1143, DOI 10.1246/bcsj.72.1143
   Umeno D, 1998, ANAL CHIM ACTA, V365, P101, DOI 10.1016/S0003-2670(98)00094-4
   Umeno D, 1998, BIOCONJUGATE CHEM, V9, P719, DOI 10.1021/bc980019f
   WARING MJ, 1965, J MOL BIOL, V13, P269, DOI 10.1016/S0022-2836(65)80096-1
   WARING MJ, 1981, ANNU REV BIOCHEM, V50, P159, DOI 10.1146/annurev.bi.50.070181.001111
   Yamada M, 2001, BIOMATERIALS, V22, P3121, DOI 10.1016/S0142-9612(01)00061-8
   YAMADA M, IN PRESS ENV SCI TEC
   YOUNG T, 1990, PHOTOCHEM PHOTOBIOL, V52, P661, DOI 10.1111/j.1751-1097.1990.tb08664.x
   ZHONG Q, 1993, SURF SCI, V290, pL688, DOI 10.1016/0167-2584(93)90906-Y
NR 42
TC 78
Z9 81
U1 3
U2 10
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0947-6539
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD MAR 15
PY 2002
VL 8
IS 6
BP 1407
EP 1412
DI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 533XK
UT WOS:000174555400016
PM 11921224
DA 2018-10-19
ER

PT J
AU Goldstein, AS
   DiMilla, PA
AF Goldstein, AS
   DiMilla, PA
TI Effect of adsorbed fibronectin concentration on cell adhesion and
   deformation under shear on hydrophobic surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE radial-flow chamber; fibronectin; detachment; deformation
ID SELF-ASSEMBLED MONOLAYERS; PLATE FLOW CHAMBER; BONE-DERIVED CELLS;
   EXTRACELLULAR-MATRIX; RADIAL-FLOW; CHEMICAL MODIFICATION;
   ENDOTHELIAL-CELLS; SOLID-SURFACES; STRENGTH; INTEGRIN
AB To facilitate tissue integration with biomaterials proteins and peptides frequently are immobilized on the biomaterial surface. In particular, extracellular matrix proteins-which interact specifically with integrin adhesion receptors on the cell surface-can stimulate initial cell attachment by serving both as a ligand for receptor-mediated attachment and as a stimulant of focal adhesion formation and cytoskeletal reorganization. Consequently, the strength of cell adhesion should depend both on the strength of cell/surface contacts and cytoskeleton-dependent properties of the cell (i.e., morphology, compliance). To examine this dual role of extracellular matrix proteins, murine fibroblasts were seeded onto self-assembled monolayers (SAMs) of dodecanethiolate coated with 0 to 0.45 mug/cm(2) of fibronectin (Fn) and then detached by hydrodynamic shear using a radial-flow chamber (RFC). Cell adhesion was characterized in terms of the critical wall shear stress for detachment (tau (wc)), and the compliance was evaluated from measurements of cell displacement and elongation as a function of the fibronectin concentration. Critical wall shear stress and cell displacement were found to be insensitive to Fn at concentrations below 0.23 mug/cm(2) while above this threshold tau (wc) increased and displacement decreased with increasing Fn concentration. Elongation of the cells in the direction of flow was independent of Fn concentration, but correlated linearly with tau (wc) for Fn densities below 0.23 mug/cm(2). These studies show that Fn concentration affects both tau (wc) and cell displacement under shear, and that tau (wc) is sensitive to cell compliance. In addition, they suggest that the dominant mechanism of cell detachment from hydrophobic substrates involves cell displacement. (C) 2001 John Wiley Sons, Inc.
C1 Carnegie Mellon Univ, Dept Chem Engn, Ctr Light Microscope Imaging & Biotechnol, Colloids Polymers & Surfaces Program, Pittsburgh, PA 15213 USA.
RP Goldstein, AS (reprint author), Virginia Polytech Inst & State Univ, Dept Chem Engn, 0211, Blacksburg, VA 24061 USA.
CR ABBOTT NL, 1992, SCIENCE, V257, P1380, DOI 10.1126/science.257.5075.1380
   ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   BAIN CD, 1989, J AM CHEM SOC, V111, P7164, DOI 10.1021/ja00200a040
   Burmeister JS, 1996, J BIOMED MATER RES, V30, P13, DOI 10.1002/(SICI)1097-4636(199601)30:1<13::AID-JBM3>3.0.CO;2-U
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393
   CHENG SS, 1994, J COLLOID INTERF SCI, V162, P135, DOI 10.1006/jcis.1994.1018
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P107, DOI 10.1016/S0006-3495(90)82357-2
   Dean D, 1999, PLAST RECONSTR SURG, V104, P705, DOI 10.1097/00006534-199909030-00014
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   DIMILLA PA, 1992, J COLLOID INTERF SCI, V153, P212, DOI 10.1016/0021-9797(92)90313-B
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   Dong C, 1999, ANN BIOMED ENG, V27, P298, DOI 10.1114/1.143
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 1997, TISSUE ENG, V3, P197, DOI 10.1089/ten.1997.3.197
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   GIROUX TA, 1990, J COLLOID INTERF SCI, V139, P351, DOI 10.1016/0021-9797(90)90109-2
   Goldstein AS, 1998, AICHE J, V44, P465, DOI 10.1002/aic.690440222
   Goldstein AS, 1997, BIOTECHNOL BIOENG, V55, P616, DOI 10.1002/(SICI)1097-0290(19970820)55:4<616::AID-BIT4>3.0.CO;2-K
   HAMMER DA, 1987, BIOPHYS J, V52, P475, DOI 10.1016/S0006-3495(87)83236-8
   HERTZ CM, 1985, BIOTECHNOL BIOENG, V27, P603, DOI 10.1002/bit.260270509
   Hulshoff JEG, 1998, J BIOMED MATER RES, V40, P464, DOI 10.1002/(SICI)1097-4636(19980605)40:3<464::AID-JBM18>3.0.CO;2-J
   Irvine DJ, 1998, J BIOMED MATER RES, V40, P498, DOI 10.1002/(SICI)1097-4636(19980605)40:3<498::AID-JBM21>3.0.CO;2-E
   IULIANO DJ, 1993, J BIOMED MAT RES, V27
   Jalali S, 2001, P NATL ACAD SCI USA, V98, P1042, DOI 10.1073/pnas.031562998
   KUO SC, 1993, BIOPHYS J, V65, P2191, DOI 10.1016/S0006-3495(93)81277-3
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   LOK BK, 1983, J COLLOID INTERF SCI, V91, P87, DOI 10.1016/0021-9797(83)90316-8
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P10774, DOI 10.1021/ja00076a038
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MOONEY DJ, 1995, J CELL SCI, V108, P2311
   NARASIMHAN C, 1989, BIOCHEMISTRY-US, V28, P5041, DOI 10.1021/bi00438a021
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   OLIVIER LA, 1993, BIOTECHNOL BIOENG, V42, P963, DOI 10.1002/bit.260420807
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Peel MM, 1999, ANN BIOMED ENG, V27, P236, DOI 10.1114/1.178
   PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349
   REUTELINGSPERGER CPM, 1994, J MATER SCI-MATER M, V5, P361, DOI 10.1007/BF00058964
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Rezania A, 1997, ANN BIOMED ENG, V25, P190, DOI 10.1007/BF02738550
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Short SM, 1998, MOL BIOL CELL, V9, P1969, DOI 10.1091/mbc.9.8.1969
   SINGHVI R, 1994, SCIENCE, P264
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   Thoumine O, 1996, CELL MOTIL CYTOSKEL, V33, P276
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
   USAMI S, 1993, ANN BIOMED ENG, V21, P77, DOI 10.1007/BF02368167
   VANKOOTEN TG, 1992, J BIOMED MATER RES, V26, P725, DOI 10.1002/jbm.820260604
   VANKOOTEN TG, 1994, COLLOID SURFACE B, V3, P147
   Xu JH, 1996, J CELL BIOL, V132, P239, DOI 10.1083/jcb.132.1.239
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
NR 57
TC 42
Z9 42
U1 1
U2 8
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 15
PY 2002
VL 59
IS 4
BP 665
EP 675
DI 10.1002/jbm.1276
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 507LQ
UT WOS:000173030300009
PM 11774328
DA 2018-10-19
ER

PT J
AU Lahann, J
   Pluster, W
   Rodon, T
   Fabry, M
   Klee, D
   Gattner, HG
   Hocker, H
AF Lahann, J
   Pluster, W
   Rodon, T
   Fabry, M
   Klee, D
   Gattner, HG
   Hocker, H
TI Universal approach towards r-Hirudin derivatives with high anti-thrombin
   activity based on chemical differentiation of primary amino groups
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterials; biotinylation; MALDI; protein derivatization; r-Hirudin
ID HUMAN ALPHA-THROMBIN; RECOMBINANT HIRUDIN; SANDWICH ELISAS;
   IMMUNOCHEMISTRY; INHIBITOR; COMPLEX; SYSTEM
AB Chemical modification of recombinant hirudin (r-hirudin) is necessary whenever surface-confinement to a biomaterial or biotinylation for subsequent conjugation with carriers is intended. Here, we report a modification strategy that permits chemical discrimination between r-hirudin's amino groups and preserves its thrombin inhibitor activity. By reaction with Msc-ONSu, protective groups were successively introduced in r-hirudin yielding four derivatives (Msc)(x)-hirudin (1 less than or equal to x less than or equal to 4) and pure fractions were isolated by ion exchange chromatography. Structure-function relationships were studied for all derivatives and revealed a decrease in activity of more than 90% as compared to unprotected r-hirudin. MALDI-TOF MS was used to determine the locations of the Msc groups. Furthermore, evidence was provided that r-hirudin's N-terminal amino group is highly important for its anti-thrombin activity. Selective modification of the lysine residues which maintained the free N-terminal amino group preserved the anti-thrombin activity of r-hirudin even after biotinylation and subsequent linkage to streptavidin or confinement to a polymer surface.
C1 Rhein Westfal TH Aachen, Dept Macromol & Text Chem, D-52062 Aachen, Germany.
RP Hocker, H (reprint author), Rhein Westfal TH Aachen, Dept Macromol & Text Chem, Veltmanpl 8, D-52062 Aachen, Germany.
RI Lahann, Joerg/J-7663-2013
CR Agnelli G, 1996, CARDIOVASC RES, V31, P232, DOI 10.1016/S0008-6363(96)00004-1
   BAYKAL D, 1995, AM J CARDIOL, V75, pB82, DOI 10.1016/0002-9149(95)80019-O
   Black FE, 1999, LANGMUIR, V15, P3157, DOI 10.1021/la9803575
   CHANG JY, 1989, J BIOL CHEM, V264, P7141
   CHANG JY, 1983, FEBS LETT, V164, P307, DOI 10.1016/0014-5793(83)80307-X
   DODT J, 1984, FEBS LETT, V165, P180, DOI 10.1016/0014-5793(84)80165-9
   DODT J, 1995, ANGEW CHEM, V107, P867
   FENTON JW, 1992, SEMIN THROMBOSIS HAE, V18, P193
   FOLKERS PJM, 1989, BIOCHEMISTRY-US, V28, P2601, DOI 10.1021/bi00432a038
   Huang RP, 2001, ANAL BIOCHEM, V294, P55, DOI 10.1006/abio.2001.5156
   Lahann J, 2001, ANGEW CHEM INT EDIT, V40, P3166, DOI 10.1002/1521-3773(20010903)40:17<3166::AID-ANIE3166>3.0.CO;2-#
   MARCKWARDT F, 1970, METHOD ENZYMOL, V19, P924
   McNamara CA, 1996, SEMIN THROMB HEMOST, V22, P139, DOI 10.1055/s-2007-999001
   RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926
   SCHMITZ T, 1991, EUR J BIOCHEM, V195, P251, DOI 10.1111/j.1432-1033.1991.tb15701.x
   Seiler SM, 1996, SEMIN THROMB HEMOST, V22, P223, DOI 10.1055/s-2007-999012
   SUTER M, 1986, IMMUNOL LETT, V13, P313, DOI 10.1016/0165-2478(86)90064-7
   SUTER M, 1989, MOL IMMUNOL, V26, P221, DOI 10.1016/0161-5890(89)90075-8
   WALKER JU, 1988, METHODS MOL BIOL, V5
   Warkentin TE, 1997, DRUG SAFETY, V17, P325, DOI 10.2165/00002018-199717050-00005
NR 20
TC 7
Z9 7
U1 0
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAR 15
PY 2002
VL 2
IS 2
BP 82
EP 87
PG 6
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 533MD
UT WOS:000174533200004
DA 2018-10-19
ER

PT J
AU Demers, CN
   Tabrizian, M
   Petit, A
   Hamdy, RC
   Yahia, L
AF Demers, CN
   Tabrizian, M
   Petit, A
   Hamdy, RC
   Yahia, L
TI Effect of experimental parameters on the in vitro release kinetics of
   transforming growth factor beta 1 from coral particles
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE coral particles; transforming growth factor beta 1; protein adsorption;
   growth factor delivery system; coral degradation
ID BONE MORPHOGENETIC PROTEINS; RAT ECTOPIC MODEL; BIOMATERIAL CARRIERS;
   DELIVERY SYSTEM; TGF-BETA; ADSORPTION; IMPLANT; PHARMACOKINETICS;
   REGENERATION; TISSUE
AB Coral bone graft substitutes have been supplemented in the past with growth factors to further enhance bone regeneration in defects. Little is known, however, on the dynamics of protein release from coral. Coral particles were studied for their ability to release transforming growth factor beta 1 (TGF-beta1) in vitro, under different adsorption conditions. Adsorption of TGF-beta1 (0.05 mug/mL) on coral particles (<80 <mu>m or 300-450 mum) after 24 h of incubation was high, regardless of conditions. TGF-beta1 release kinetics in an artificial bone fluid followed a specific profile: an initial 1-h protein burst, followed by a decreasing release during the next 24 h at which time the release increased again to reach a constant rate until the end of the 2-week study. The protein release rate appeared mainly to depend upon the diffusion of TGF-beta1. TGF-beta1 release from coral particles was enhanced in the presence of bovine serum albumin (BSA) compared to the release in the presence of gelatin, and was dependent on the pH of adsorption. The highest total TGF-beta1 release was obtained when adsorption occurred with BSA at pH 7.4 (82 +/-3%), while the lowest release was observed when adsorption was done in the presence of gelatin at pH 11 (38 +/-1%). TGF-beta1 release was also found to vary with particle size, higher release being obtained with the smaller particles. These results suggest that coral particles could be used as a delivery system for growth factors, and that the release rate may be modulated through modification of the adsorption conditions and coral particle size. (C) 2001 John Wiley & Sons, Inc. J Biomed Mater Res 59: 403-410,2002.
C1 Ecole Polytech, Dept Mech Engn, BBRG, Montreal, PQ H3C 3A7, Canada.
   McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada.
   McGill Univ, Lady Davis Inst Med Res, Div Orthopaed Surg, Montreal, PQ H3T 1E2, Canada.
   McGill Univ, Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada.
   McGill Univ, Montreal Childrens Hosp, Res Inst, Montreal, PQ H3G 1A6, Canada.
   McGill Univ, Dept Orthopaed, Montreal, PQ H3G 1A6, Canada.
RP Demers, CN (reprint author), Ecole Polytech, Dept Mech Engn, BBRG, POB 6079,Stn Ctr-ville, Montreal, PQ H3C 3A7, Canada.
CR Arnaud E, 1999, BIOMATERIALS, V20, P1909, DOI 10.1016/S0142-9612(99)00090-3
   Arnaud E, 1998, Ann Chir Plast Esthet, V43, P40
   BEGLEY CT, 1995, BIOMATERIALS, V16, P1181, DOI 10.1016/0142-9612(95)93584-Z
   Boden SD, 1995, SPINE, V20, P2633, DOI 10.1097/00007632-199512150-00004
   BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312
   Bostrom M P, 1998, Clin Orthop Relat Res, pS124, DOI 10.1097/00003086-199810001-00014
   CHAMBERLAIN JA, 1978, PALEOBIOLOGY, V4, P419
   Chinn J. A., 1995, BIOMEDICAL ENG HDB, P1597
   DANIELPOUR D, 1989, J CELL PHYSIOL, V138, P79, DOI 10.1002/jcp.1041380112
   de Visser KE, 1999, LEUKEMIA, V13, P1188, DOI 10.1038/sj.leu.2401477
   DEMERS C, 2001, IN PRESS BIOMED MAT
   Eliaz RE, 2000, J BIOMED MATER RES, V50, P388, DOI 10.1002/(SICI)1097-4636(20000605)50:3<388::AID-JBM13>3.0.CO;2-F
   Fricain JC, 1998, J BIOMED MATER RES, V42, P96, DOI 10.1002/(SICI)1097-4636(199810)42:1<96::AID-JBM12>3.0.CO;2-M
   GAUTAM J, 1994, J PHARM SCI, V83, P316, DOI 10.1002/jps.2600830310
   GOMBOTZ WR, 1994, J APPL BIOMATER, V5, P141, DOI 10.1002/jab.770050207
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Jameela SR, 1998, J CONTROL RELEASE, V52, P17, DOI 10.1016/S0168-3659(97)00187-9
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   KomsaPenkova R, 1996, J BIOCHEM BIOPH METH, V32, P33, DOI 10.1016/0165-022X(95)00046-T
   Krewson CE, 1996, J BIOMAT SCI-POLYM E, V8, P103
   Laffargue P, 2000, J BIOMED MATER RES, V49, P415, DOI 10.1002/(SICI)1097-4636(20000305)49:3<415::AID-JBM15>3.3.CO;2-Q
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   MASSON M, 1988, NORME FRANCAISE, P9
   Ongpipattanakul B, 1997, J BIOMED MATER RES, V36, P295, DOI 10.1002/(SICI)1097-4636(19970905)36:3<295::AID-JBM4>3.0.CO;2-9
   OREFFO ROC, 1989, BIOCHEM BIOPH RES CO, V158, P817, DOI 10.1016/0006-291X(89)92795-2
   Patat J L, 1992, Acta Orthop Belg, V58 Suppl 1, P115
   PATAT JL, 1989, ANN CHIR PLAST ESTH, V34, P221
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   SOUYRIS F, 1985, J MAXILLOFAC SURG, V13, P64, DOI 10.1016/S0301-0503(85)80018-7
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Volpi N, 1999, BIOMATERIALS, V20, P1359, DOI 10.1016/S0142-9612(99)00031-9
   WASSELL DTH, 1995, BIOMATERIALS, V16, P697, DOI 10.1016/0142-9612(95)99697-K
   Wassell DTH, 1997, BIOMATERIALS, V18, P1001, DOI 10.1016/S0142-9612(97)00028-8
   Yamamoto M, 2000, J CONTROL RELEASE, V64, P133, DOI 10.1016/S0168-3659(99)00129-7
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P711, DOI 10.1016/S0142-9612(98)00199-9
NR 38
TC 14
Z9 15
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 2002
VL 59
IS 3
BP 403
EP 410
DI 10.1002/jbm.1256
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 507GX
UT WOS:000173019600001
PM 11774297
DA 2018-10-19
ER

PT J
AU Welch, JA
   Montgomery, RD
   Lenz, SD
   Plouhar, P
   Shelton, WR
AF Welch, JA
   Montgomery, RD
   Lenz, SD
   Plouhar, P
   Shelton, WR
TI Evaluation of small-intestinal submucosa implants for repair of meniscal
   defects in dogs
SO AMERICAN JOURNAL OF VETERINARY RESEARCH
LA English
DT Article
ID AUGMENTATION CYSTOPLASTY; MECHANICAL-PROPERTIES; VASCULAR GRAFT;
   GROWTH-FACTOR; MODEL; REGENERATION; BIOMATERIAL; TRANSPLANTATION;
   BIOSCAFFOLD; REPLACEMENT
AB Objective-To assess the effects of porcine small intestinal submucosa (SIS) implants on the healing of meniscal lesions in dogs.
   Animals-16 adult Greyhounds of both sexes.
   Procedure-Unilateral osteotomy was performed at time 0 to disrupt the medial collateral ligament attachment, and two (1 cranial and 1 caudal) 4-mm circular defects were created in the avascular portion of the medial meniscus. One defect was filled with an SIS graft, and the other defect remained empty (control). Three months later, the identical procedure was performed on the contralateral limb. Three months after the second surgery, dogs were euthanatized, and meniscal tissue specimens from both stifle joints were collected for gross, histologic, biomechanical, and biochemical evaluations.
   Results-Regenerative tissue was evident in 4 (2 SIS-implanted and 2 control) of 16 defects examined histologically. In 3 defects, this thin bridge of tissue was composed of immature haphazardly arranged fibrous connective tissue with a relatively uniform distribution of fibroblasts. Aggregate modulus, Poisson ratio, permeability, and shear modulus were not significantly different between control and SIS-implanted defects either 3 or 6 months after surgery. Hydroxyproline content also did not differ between SIS-implanted and control defects at 3 or 6 months.
   Conclusions and Clinical Relevance-implantation of porcine SIS into experimentally induced meniscal lesions in dogs did not promote tissue regeneration.
C1 Auburn Univ, Coll Vet Med, Dept Clin Sci, Auburn, AL 36832 USA.
   Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36832 USA.
   DePuy Inc, Warsaw, IN 46581 USA.
   Mississippi Sports Med, Jackson, MS 39202 USA.
RP Welch, JA (reprint author), Auburn Univ, Coll Vet Med, Dept Clin Sci, Auburn, AL 36832 USA.
CR AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   Arnoczky S. P, 1993, DIS MECH SMALL ANIMA, P764
   ARNOCZKY SP, 1983, AM J SPORT MED, V11, P131, DOI 10.1177/036354658301100305
   ARNOCZKY SP, 1988, J BONE JOINT SURG AM, V70A, P1209, DOI 10.2106/00004623-198870080-00012
   ATHANASIOU KA, 1994, J ORTHOPAED RES, V12, P340, DOI 10.1002/jor.1100120306
   ATHANASIOU KA, 1995, CLIN ORTHOP RELAT R, P254
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   Calvano CJ, 2000, J ENDOUROL, V14, P213, DOI 10.1089/end.2000.14.213
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   Collier S, 1996, VET COMP ORTHOPAED, V9, P60
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   COX JS, 1975, CLIN ORTHOP RELAT R, P178
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   DOWDY PA, 1995, AM J SPORT MED, V23, P721, DOI 10.1177/036354659502300615
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   HOSGOOD G, 1993, VET SURG, V22, P490, DOI 10.1111/j.1532-950X.1993.tb00426.x
   Kim SS, 1999, J PEDIATR SURG, V34, P124, DOI 10.1016/S0022-3468(99)90241-5
   King D, 1936, J BONE JOINT SURG, V18, P333
   Koski JA, 2000, ORTHOP CLIN N AM, V31, P419, DOI 10.1016/S0030-5898(05)70161-9
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   Lewin GA, 1999, J SMALL ANIM PRACT, V40, P340, DOI 10.1111/j.1748-5827.1999.tb03094.x
   MILACHOWSKI KA, 1989, INT ORTHOP, V13, P1
   Pearson P T, 1971, Vet Clin North Am, V1, P489
   Portis AJ, 2000, J ENDOUROL, V14, P203, DOI 10.1089/end.2000.14.203
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Robotin-Johnson MC, 1998, J THORAC CARDIOV SUR, V116, P805, DOI 10.1016/S0022-5223(98)00436-X
   Shalhav AL, 1999, J ENDOUROL, V13, P241, DOI 10.1089/end.1999.13.241
   SPINDLER KP, 1995, J ORTHOP RES, V13, P201, DOI 10.1002/jor.1100130208
   STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2
   Suckow MA, 1999, J INVEST SURG, V12, P277, DOI 10.1080/089419399272395
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
NR 38
TC 29
Z9 40
U1 2
U2 10
PU AMER VETERINARY MEDICAL ASSOC
PI SCHAUMBURG
PA 1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 USA
SN 0002-9645
J9 AM J VET RES
JI Am. J. Vet. Res.
PD MAR
PY 2002
VL 63
IS 3
BP 427
EP 431
DI 10.2460/ajvr.2002.63.427
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA 526ML
UT WOS:000174134200020
PM 11911579
DA 2018-10-19
ER

PT J
AU Gottenbos, B
   van der Mei, HC
   Klatter, F
   Nieuwenhuis, P
   Busscher, HJ
AF Gottenbos, B
   van der Mei, HC
   Klatter, F
   Nieuwenhuis, P
   Busscher, HJ
TI In vitro and in vivo antimicrobial activity of covalently coupled
   quaternary ammonium silane coatings on silicone rubber
SO BIOMATERIALS
LA English
DT Article
DE 3-(trimethoxysilyl)-propyldimethyloctadecylammonium chloride;
   poly(dimethylsiloxane); antimicrobial agents; biomaterial-centered
   infection; parallel plate flow chamber; rat model
ID BIOFILM FORMATION; BETAINE ESTERS; CHAIN-LENGTH; INFECTIONS; ADHESION;
   SURFACES; GROWTH
AB Biomaterial-centered infection is a dreaded complication associated with the use of biomedical implants. In this paper, the antimicrobial activity of silicone rubber with a covalently coupled 3-(trimethoxysilyl)-propyldimethyloctadecylammonium chloride (QAS) coating was studied in vitro and in vivo. Gram-positive Staphylococcus aureus ATCC 12600, Staphylococcus epidermidis HBH2 102, and Gram-negative Escherichia coli O2K2 and Pseudomonas aeruginosa AK1 were seeded on silicone rubber with and without QAS-coating, in the absence or presence of adsorbed human plasma proteins. The viability of the adherent bacteria was determined using a live/dead fluorescent stain and a confocal laser scanning microscope. The coating reduced the viability of adherent staphylococci from 90% to 0%, and of Gram-negative bacteria from 90% to 25%, while the presence of adsorbed plasma proteins had little influence. The biomaterials were also subcutaneously implanted in rats for 3 or 7 days, while pre- or postoperatively seeded with S. aureus ATCC 12600. Preoperative seeding resulted in infection of 7 out of 8 silicone rubber implants against 1 out of 8 QAS-coated silicone rubber implants. Postoperative seeding resulted in similar infection incidences on both implant types, but the numbers of adhering bacteria were 70% lower on QAS-coated silicone rubber. In conclusion, QAS-coated silicone rubber shows antimicrobial properties against adhering bacteria, both in vitro and in vivo. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Groningen, Fac Med Sci, Dept Cell Biol, Immunol Sect, NL-9713 AV Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR Ahlstrom B, 1999, APMIS, V107, P318, DOI 10.1111/j.1699-0463.1999.tb01560.x
   AHLSTROM B, 1995, ANTIMICROB AGENTS CH, V39, P50, DOI 10.1128/AAC.39.1.50
   Calas M, 1997, J MED CHEM, V40, P3557, DOI 10.1021/jm9701886
   Chen CZ, 1999, CHEM COMMUN, P1585
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Everaert EPJM, 1999, ARCH OTOLARYNGOL, V125, P1329, DOI 10.1001/archotol.125.12.1329
   Flemming RG, 2000, BIOMATERIALS, V21, P273, DOI 10.1016/S0142-9612(99)00176-3
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   Gottenbos B, 1999, METHODS ENZYMOL, V310, P523
   Gould IM, 1999, J ANTIMICROB CHEMOTH, V43, P459, DOI 10.1093/jac/43.4.459
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HARKES G, 1992, J BIOMAT SCI-POLYM E, V3, P403, DOI 10.1163/156856292X00213
   Hugo WB, 1992, PRINCIPLES PRACTICE, P7
   ISQUITH AJ, 1972, APPL MICROBIOL, V24, P859
   Kenawy ER, 1998, J CONTROL RELEASE, V50, P145, DOI 10.1016/S0168-3659(97)00126-0
   LINDSTEDT M, 1990, ANTIMICROB AGENTS CH, V34, P1949, DOI 10.1128/AAC.34.10.1949
   MERRIANOS JJ, 1991, DISINFECTION STERILI, P225
   MURRAY PR, 1988, J CLIN MICROBIOL, V26, P1884
   Printzen G, 1996, INJURY, V27, P9
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   VANWAGENEN RA, 1980, J COLLOID INTERF SCI, V76, P305, DOI 10.1016/0021-9797(80)90374-4
   Verkerke GJ, 1997, ARTIF ORGANS, V21, P413
NR 23
TC 293
Z9 304
U1 6
U2 112
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2002
VL 23
IS 6
BP 1417
EP 1423
DI 10.1016/S0142-9612(01)00263-0
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 515EC
UT WOS:000173481600003
PM 11829437
DA 2018-10-19
ER

PT J
AU Ziegelaar, BW
   Aigner, J
   Staudenmaier, R
   Lempart, K
   Mack, B
   Happ, T
   Sittinger, M
   Endres, M
   Naumann, A
   Kastenbauer, E
   Rotter, N
AF Ziegelaar, BW
   Aigner, J
   Staudenmaier, R
   Lempart, K
   Mack, B
   Happ, T
   Sittinger, M
   Endres, M
   Naumann, A
   Kastenbauer, E
   Rotter, N
TI The characterisation of human respiratory epithelial cells cultured on
   resorbable scaffolds: first steps towards a tissue engineered tracheal
   replacement
SO BIOMATERIALS
LA English
DT Article
DE tissue engineering; respiratory epithelium; lectins; biodegradable
   scaffolds
ID CILIOGENESIS; EXPRESSION; TOPOGRAPHY; CARTILAGE; MATRIX
AB In this study we have used lectin histochemistry and scanning electron microscopy (SEM) to assess the growth and characterise the differentiation of human respiratory epithelial cells (REC) cultured on two biomaterial scaffolds. The first scaffold, based on a hyaluronic acid derivative, was observed to be non-adhesive for REC. This lack of adhesion was found to be unrelated to the presence of the hyaluronic acid binding domain on the surface of isolated REC. The other scaffold, consisting of equine collagen, was observed to encourage REC spreading and adhesion. Positive Ulex Europaeus agglutinin (UEA) lectin staining of this preparation indicated the presence of ciliated REC on the scaffold surface. However, the marked decrease in peanut agglutinin (PNA) positive staining, relative to that of control cultures and native tissue, indicates a dedifferentiation of the secretory cells of the REC monolayer. SEM analysis of REC cultured on the collagen scaffold confirmed the presence of ciliated cells thereby validating the UEA positive staining. The presence of both established and developing cilia was also verified. This study indicates that collagen biomaterials are appropriate for the tissue engineering of REC. Furthermore, that UEA and PNA staining is a useful tool in the characterisation of cells cultured on biomaterials, therefore helpful in identifying biomaterials that are suitable for specific tissue engineering purposes. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, D-81377 Munich, Germany.
   Tech Univ Munich, Cent Inst Med Engn, D-85748 Munich, Germany.
   German Rheumatism Res Ctr, Lab Tissue Engn, D-10117 Berlin, Germany.
RP Ziegelaar, BW (reprint author), Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Marchioninistr 15, D-81377 Munich, Germany.
OI Rotter, Nicole/0000-0003-1537-8340
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   BELITSOS PC, 1990, J IMMUNOL, V144, P1661
   BOTTEMA JR, 1986, J SURG RES, V41, P16, DOI 10.1016/0022-4804(86)90003-X
   Bucheler M, 2000, LARYNGO RHINO OTOL, V79, P160
   Carbognani P, 1999, EUR SURG RES, V31, P210, DOI 10.1159/000008641
   COLOMBATTI A, 1982, P NATL ACAD SCI-BIOL, V79, P1926, DOI 10.1073/pnas.79.6.1926
   CULL DL, 1990, ANN THORAC SURG, V50, P889
   DEJONG PM, 1994, AM J RESP CELL MOL, V10, P271, DOI 10.1165/ajrcmb.10.3.8117445
   Evans MDM, 1999, J BIOMED MATER RES, V46, P485, DOI 10.1002/(SICI)1097-4636(19990915)46:4<485::AID-JBM6>3.0.CO;2-F
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   Galassi G, 2000, BIOMATERIALS, V21, P2183, DOI 10.1016/S0142-9612(00)00147-2
   HANAMURE Y, 1994, ANN OTO RHINOL LARYN, V103, P889, DOI 10.1177/000348949410301111
   Hassid S, 1997, EUR J MORPHOL, V35, P79, DOI 10.1076/ejom.35.2.79.13066
   HE YG, 1991, CURR EYE RES, V10, P851, DOI 10.3109/02713689109013881
   Horch RE, 2000, TISSUE ENG, V6, P53, DOI 10.1089/107632700320892
   JORISSEN M, 1990, ORL J OTO-RHINO-LARY, V52, P368, DOI 10.1159/000276166
   KEENAN KP, 1983, VIRCHOWS ARCH B, V43, P213, DOI 10.1007/BF02932958
   Messineo A, 1992, J PEDIATR SURG, V27, P1134
   MORISSEN M, 1991, EUR RESPIR J, V2, P210
   OKAMURA N, 1991, ASAIO T, V37, P317
   Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038
   Otori N, 1998, ORL J OTO-RHINO-LARY, V60, P339, DOI 10.1159/000027621
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   SUEMASU K, 1975, GANN, V66, P109
   TOURNIER JM, 1992, ARCH INT PHYSIOL BIO, V100, pA47, DOI 10.3109/13813459209000713
   VACANTI CA, 1994, J PEDIATR SURG, V29, P201, DOI 10.1016/0022-3468(94)90318-2
   WATT FM, 1986, TRENDS BIOCHEM SCI, V11, P482, DOI 10.1016/0968-0004(86)90252-5
NR 27
TC 22
Z9 30
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2002
VL 23
IS 6
BP 1425
EP 1438
DI 10.1016/S0142-9612(01)00264-2
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 515EC
UT WOS:000173481600004
PM 11829438
DA 2018-10-19
ER

PT J
AU Hillmann, G
   Steinkamp-Zucht, A
   Geurtsen, W
   Gross, G
   Hoffmann, A
AF Hillmann, G
   Steinkamp-Zucht, A
   Geurtsen, W
   Gross, G
   Hoffmann, A
TI Culture of primary human gingival fibroblasts on biodegradable membranes
SO BIOMATERIALS
LA English
DT Article
DE gingiva; fibroblasts; biodegradable membranes; tissue engineering; bone
   morphogenetic proteins
ID ARTIFICIAL TISSUES; POLYMER SCAFFOLDS; BONE-FORMATION; BIO-OSS;
   CARTILAGE; CHONDROCYTES; REGENERATION; EXPRESSION; TRANSPLANTATION;
   MATRICES
AB Repair and regeneration of periodontal tissues by tissue engineering is dependent on the use of biodegradable polymer scaffolds which serve as a carrier for cells or bioactive substances. There is a need to understand how a specific biomaterial may influence gene expression. The aim of this investigation was to develop and to optimize an in vitro technique for the adhearance and proliferation of primary human gingiva cells on implantable and biodegradable matrices. Square pieces of Bio-GIDE(R) matrix (BG) and slices of ETHISORB(R) tamponade (ET) were coated with poly-L-lactide. The stability of coated and uncoated scaffolds was investigated by incubation in standard culture medium. Various concentrations of the cells were seeded onto coated and uncoated polymer matrices in tissue culture dishes without shaking ("static seeding") or continuous shaking ("agitated seeding"). Cultures were grown for 4 week and were then evaluated by light and scanning electron microscopy. After a culture period of 10 d, BG-carriers showed a delicate consistency which made histological processing difficult. Cells were grown only sparsely in coated and non-coated BG-scaffolds. Contrary, ET-specimens were stable during a 4 week culture period. After "static seeding" a significantly higher number of cells resulted in comparison to those in "agitated" cultures. The cells were evenly distributed throughout the ET-carriers and produced extracellular matrix compounds as well. Furthermore, the examination with RT-PCR (reverse transcription-polymerase chain reaction) revealed that the cells synthesized and secreted type I collagen, and expressed genes implicated in transducing bone morphogenetic protein (BMP) signals. Messenger RNAs for BMP-2, -4, -7, the BMP type I receptors Act R-I (alk 2, activin-like kinase receptor), BMPR-IA (alk 3), -IB (alk 6), and the type II receptor BMPR-II were detected. These data reveal that static seeding favors the adherence and proliferation of primary gingival cells on polyglactin matrices. This system may serve as a valuable tool for periodontal tissue engineering. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Hannover Med Sch, Sch Dent, Dept Conservat Dent & Periodontol, D-30623 Hannover, Germany.
   GBF, D-38124 Braunschweig, Germany.
RP Hillmann, G (reprint author), Hannover Med Sch, Sch Dent, Dept Conservat Dent & Periodontol, Carl Neuberg Str 1, D-30623 Hannover, Germany.
CR Alpaslan C, 1996, BRIT J ORAL MAX SURG, V34, P414, DOI 10.1016/S0266-4356(96)90098-4
   Buurma B, 1999, EUR J ORAL SCI, V107, P282, DOI 10.1046/j.0909-8836.1999.eos107408.x
   Camelo M, 1998, INT J PERIODONT REST, V18, P321
   GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P667
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   Hillmann G, 1999, J CELL SCI, V112, P2823
   Hoerstrup S P, 1998, Swiss Surg, VSuppl 2, P23
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KIM WS, 1994, PLAST RECONSTR SURG, V94, P233, DOI 10.1097/00006534-199408000-00001
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Kuboki Y, 1998, EUR J ORAL SCI, V106, P197, DOI 10.1111/j.1600-0722.1998.tb02176.x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Minuth WW, 1998, CELL TISSUE RES, V291, P1
   PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Saldanha V, 2000, BIOMATERIALS, V21, P2427, DOI 10.1016/S0142-9612(00)00110-1
   SASANO Y, 1993, ANAT REC, V236, P373, DOI 10.1002/ar.1092360211
   Sittinger M, 1997, INT J ARTIF ORGANS, V20, P57
   Tatakis DN, 1999, PERIODONTOL 2000, V19, P59, DOI 10.1111/j.1600-0757.1999.tb00147.x
   Unsal B, 1999, J Oral Sci, V41, P57
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Zitzmann NU, 1997, INT J ORAL MAX IMPL, V12, P844
   Zund G, 1998, EUR J CARDIO-THORAC, V13, P160, DOI 10.1016/S1010-7940(97)00309-6
NR 25
TC 43
Z9 53
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2002
VL 23
IS 6
BP 1461
EP 1469
DI 10.1016/S0142-9612(01)00270-8
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 515EC
UT WOS:000173481600008
PM 11829442
DA 2018-10-19
ER

PT J
AU Arciola, CR
   Campoccia, D
   Montanaro, L
AF Arciola, CR
   Campoccia, D
   Montanaro, L
TI Effects on antibiotic resistance of Staphylococcus epidermidis following
   adhesion to polymethylmethacrylate and to silicone surfaces
SO BIOMATERIALS
LA English
DT Article
DE bacterial adhesion; antibiotic resistance; Staphylococcus epidermidis;
   biomaterials; polymethylmethacrylate (PMMA); silicone
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; IN-VITRO; METHICILLIN RESISTANCE;
   PROSTHESIS INFECTIONS; SLIME PRODUCTION; AUREUS; ADHERENCE; BACTERIA;
   INVITRO; STRAINS
AB A number of studies appears to give emphasis to the role of prosthetic materials in determining microbial adherence and resistance to host defence and drug therapy. Aim of this study was to explore whether the direct contact with biomaterial substrata of different chemical nature could influence bacterial behaviour, determining possible changes in the bacteria population as far as antibiotic resistance is concerned. To this end, susceptibility to penicillin, erythromycin, clindamycin, cefamandole, imipenem, vancomycin, ciprofloxacin, ampicillin, cefazolin, trimethoprim-sulfamethoxazole, chloramphenicol, amikacin and netilmicin was evaluated in a methicillin-, gentamicin- and tobramycin-resistant Staphylococcus epidermidis strain, after in vitro adhesion to polymethylmethacrylate (PMMA) and to silicone elastomer. The susceptibility to antibiotics of both adherent bacteria and bacteria which, although exposed to the materials, had not undergone adhesion was measured as bacterial growth inhibition area onto a plate antibiogram, according to Kirby-Bauer and using an image analyser system. The results obtained suggest that the two test materials considered in this study were capable to condition bacterial behaviour. In particular, the adhesion onto PMMA surfaces induced a marked and significant decrease in susceptibility to the following beta-lactam antibiotics: cefamandole (32%), cefazolin (23%), imipenem (27%), ampicillin (31%). Moreover, PMMA caused a lower but significant reduction in resistance to vancomycin (15%), chloramphenicol (16%), amikacin (13%), netilmicin (13%), erythromycin (11%), trimethoprim-sulfamethoxazole (13%). In contrast, the adhesion onto silicone elastomer appeared to influence bacterial changes to a lesser extent and elicited a significant decrease in susceptibility only to cefazolin (10%) and amikacin (11%). Further studies are required to thoroughly investigate the mechanisms of these variations, even though, also according to other authors, one of the best conceivable conclusions is that some material substrata can lead to selection of variant adhesive bacteria with increased antibiotic resistance. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Rizzoli Orthopaed Inst, Res Lab Biocompatibil Implant Mat, I-40136 Bologna, Italy.
   Univ Bologna, Dept Expt Pathol, Bologna, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthopaed Inst, Res Lab Biocompatibil Implant Mat, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM carlarenata.arciola@ior.it
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   An YH, 2000, HDB BACTERIAL ADHESI, P609
   ARCIOLA CR, 1995, BIOMATERIALS, V16, P681, DOI 10.1016/0142-9612(95)99694-H
   Arciola CR, 1998, J BIOMED MATER RES, V42, P1
   ARCIOLA CR, 1993, BIOMATERIALS, V14, P1161, DOI 10.1016/0142-9612(93)90161-T
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   ARIZONO T, 1992, ACTA ORTHOP SCAND, V63, P661
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781
   CRISTHENSEN GD, 1982, INFECT IMMUN S, V2, P2870
   Foster T. J., 1994, P31
   Francois P, 1996, INFECT CONT HOSP EP, V17, P514
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872
   Frere JM, 1999, NAT BIOTECHNOL, V17, pBV17, DOI 10.1038/7158
   GRISTINA AG, 1989, ANTIMICROB AGENTS CH, V33, P813, DOI 10.1128/AAC.33.6.813
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Huebner J, 1999, ANNU REV MED, V50, P223
   Kelly CG, 1999, NAT BIOTECHNOL, V17, P42, DOI 10.1038/5213
   MEMPEL M, 1994, ANTIMICROB AGENTS CH, V38, P1251, DOI 10.1128/AAC.38.6.1251
   MEMPEL M, 1995, MED MICROBIOL IMMUN, V184, P109
   Montanaro L, 1999, BIOMATERIALS, V20, P1945, DOI 10.1016/S0142-9612(99)00099-X
   Montanaro L, 1999, MICROBIOLOGICA, V22, P331
   Montanaro L, 2001, MICROBIOLOGICA, V24, P57
   Montanaro L., 2000, HDB BACTERIAL ADHESI, P331
   *NAT COMM CLIN LAB, 1998, M2T4 NAT COMM CLIN L
   Oga M, 1992, J Long Term Eff Med Implants, V1, P321
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PRATT W B, 1990, P565
   Vaudaux PE, 1998, ANTIMICROB AGENTS CH, V42, P564, DOI 10.1128/AAC.42.3.564
   WEBB LX, 1994, J ORTHOP TRAUMA, V8, P28, DOI 10.1097/00005131-199402000-00007
   Williams I, 1997, MICROBIOL-UK, V143, P2407, DOI 10.1099/00221287-143-7-2407
NR 31
TC 50
Z9 51
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2002
VL 23
IS 6
BP 1495
EP 1502
DI 10.1016/S0142-9612(01)00275-7
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 515EC
UT WOS:000173481600012
PM 11829446
DA 2018-10-19
ER

PT J
AU Heath, DJ
   Christian, P
   Griffin, M
AF Heath, DJ
   Christian, P
   Griffin, M
TI Involvement of tissue trans glutaminase in the stabilisation of
   biomaterial/tissue interfaces important in medical devices
SO BIOMATERIALS
LA English
DT Article
DE human osteoblasts; tissue transglutaminase; ECM stabilisation;
   poly(epsilon-caprolactone); bioactive biomaterial
ID CROSS-LINKING ENZYMES; CELL-ADHESION; 3T3 FIBROBLASTS; BINDING SITE;
   TRANSGLUTAMINASE; FIBRONECTIN; EXPRESSION; POLYMERS; SURFACE;
   IDENTIFICATION
AB Tissue transglutaminase (tTG) has recently been established as a novel cell surface adhesion protein that binds with high affinity to fibronectin in the pericellular matrix. In this study, we have made use of this property to enhance the biocompatibility of poly(epsilon-caprolactone) (PCL), a biomaterial currently used in bone repair. Poly(epsilon-caprolactone) discs were first coated with fibronectin and then tTG. The surface localisation of the two proteins was confirmed using ELISA and the tTG shown to be active on the surface by incorporation of biotin cadaverine into the fibronectin coating. When human osteoblasts (HOBs) were seeded onto the coated polymer surfaces in serum free medium, the surface coated with fibronectin and then tTG showed an increase in the spreading of the cells as compared to the surface coated with fibronectin alone, when analysed using environmental scanning electron microscopy. The presence of tTG had no effect on HOB cell differentiation when analysed by determining alkaline phosphatase activity. The use of tTG as a novel adhesion protein in this way may therefore have considerable potential in forming a stable tissue/bio material interface for application in medical devices. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Nottingham Trent Univ, Dept Life Sci, Nottingham NG11 8NS, England.
   Univ Nottingham, Sch Med, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England.
   Univ Nottingham, Sch Mech Mat Mfg Engn & Management, Nottingham NG7 2RD, England.
RP Griffin, M (reprint author), Nottingham Trent Univ, Dept Life Sci, Clifton Lane, Nottingham NG11 8NS, England.
CR ACHYUTHAN KE, 1995, J IMMUNOL METHODS, V180, P69, DOI 10.1016/0022-1759(94)00300-L
   ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901
   AESCHLIMANN D, 1995, J CELL BIOL, V129, P881, DOI 10.1083/jcb.129.3.881
   AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402
   AESCHLIMANN D, 1993, J CELL BOIL, V120, P1462
   Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825
   ALI SAM, 1992, BIOMATER TISSUE INTE, V10, P399
   Blitterswijk CAv, 1991, BIOMATERIALS, V12, P187
   Borge L, 1996, BBA-MOL CELL RES, V1312, P117, DOI 10.1016/0167-4889(96)00028-6
   Coombes A. G. A., 1994, Clinical Materials, V17, P35, DOI 10.1016/0267-6605(94)90046-9
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   DISILVIO L, 1995, THESIS U LONDON UK
   FENG XD, 1983, J POLYM SCI POL LETT, V21, P593, DOI 10.1002/pol.1983.130210802
   FESUS L, 1986, EUR J BIOCHEM, V154, P371, DOI 10.1111/j.1432-1033.1986.tb09407.x
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707
   Gaudry CA, 1999, EXP CELL RES, V252, P104, DOI 10.1006/excr.1999.4633
   GAUDRY CA, 1998, THESIS NOTTINGHAM TR
   GENTILE V, 1992, J CELL BIOL, V119, P463, DOI 10.1083/jcb.119.2.463
   GREENBERG CS, 1991, FASEB J, V5, P3071
   Heath DJ, 2001, J BONE MINER RES, V16, P1477, DOI 10.1359/jbmr.2001.16.8.1477
   HOHENADL C, 1995, J BIOL CHEM, V270, P23415, DOI 10.1074/jbc.270.40.23415
   Isobe T, 1999, EUR J CELL BIOL, V78, P876, DOI 10.1016/S0171-9335(99)80089-2
   JEONG JM, 1995, J BIOL CHEM, V270, P5654, DOI 10.1074/jbc.270.10.5654
   Jones RA, 1997, J CELL SCI, V110, P2461
   Kaartinen MT, 1997, J BIOL CHEM, V272, P22736, DOI 10.1074/jbc.272.36.22736
   Lemmouchi Y, 1998, BIOMATERIALS, V19, P1827, DOI 10.1016/S0142-9612(98)00074-X
   LEMOSY EK, 1992, J BIOL CHEM, V267, P7880
   Lowry KJ, 1997, J BIOMED MATER RES, V36, P536
   PELUSO G, 1996, J MATER SCI-MATER M, V7, P701
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   PITT CG, 1979, J BIOMED MATER RES, V13, P479
   POTTS JR, 1994, CURR OPIN CELL BIOL, V6, P648, DOI 10.1016/0955-0674(94)90090-6
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Smethurst PA, 1996, BIOCHEM J, V313, P803, DOI 10.1042/bj3130803
   SMITH K L, 1990, Advanced Drug Delivery Reviews, V4, P343, DOI 10.1016/0169-409X(90)90026-O
   Ueki S, 1996, J CELL SCI, V109, P2727
   UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304
   Verderio E, 1999, J HISTOCHEM CYTOCHEM, V47, P1417, DOI 10.1177/002215549904701108
   Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874
NR 42
TC 33
Z9 33
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2002
VL 23
IS 6
BP 1519
EP 1526
DI 10.1016/S0142-9612(01)00282-4
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 515EC
UT WOS:000173481600015
PM 11829448
DA 2018-10-19
ER

PT J
AU Levy, I
   Nussinovitch, A
   Shpigel, E
   Shoseyov, O
AF Levy, I
   Nussinovitch, A
   Shpigel, E
   Shoseyov, O
TI Recombinant cellulose crosslinking protein: a novel paper-modification
   biomaterial
SO CELLULOSE
LA English
DT Article
DE cellulose crosslinking protein; cellulose fibers; cellulose-binding
   domain; mechanical properties; paper
ID BINDING DOMAIN; CRYSTALLINE CELLULOSE; FIMI; PURIFICATION; COMPOSITES;
   ADSORPTION; RESIDUES; DRY
AB Cellulose-binding domains have been isolated from various cellulases, and proteins, which lack hydrolytic activity. The hypothesis that a cellulose-binding domain can be used to alter surface and mechanical properties of paper was tested. Two cellulose-binding domains from Clostriium cellulovorans were fused to form a cellulose crosslinking protein (CCP). The recombinant bifunctional cellulose-binding protein was expressed in E. coli, applied by immersion onto Whatman cellulose filter paper, and its mechanical properties were tested. The purified protein improved the treated paper's mechanical properties (tensile strength, brittleness, Young's modulus and energy to break). In addition, cellulose crosslinking protein treatment was shown to transform filter paper into a more water-repellent paper. The binding of cellulose-binding domains to cellulose under a wide range of envi-ronmental conditions, without the need for chemical reactions, and its biodegradability make them attractive moieties for the design of a new class of paper-modification materials.
C1 Hebrew Univ Jerusalem, Kennedy Leigh Ctr Hort Res, IL-76100 Rehovot, Israel.
   Hebrew Univ Jerusalem, Otto Warburg Ctr Agr Biotechnol, IL-76100 Rehovot, Israel.
   Hebrew Univ Jerusalem, Inst Biochem Food Sci & Human Nutr, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel.
   CBD Technol Ltd, IL-76100 Rehovot, Israel.
CR Askling C, 1998, J MATER SCI, V33, P1997, DOI 10.1023/A:1004390313084
   Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065
   Bledzki AK, 1996, J APPL POLYM SCI, V59, P1329, DOI 10.1002/(SICI)1097-4628(19960222)59:8<1329::AID-APP17>3.3.CO;2-5
   DIN N, 1994, MOL MICROBIOL, V11, P747, DOI 10.1111/j.1365-2958.1994.tb00352.x
   DOI RH, 1994, CRIT REV MICROBIOL, V20, P87, DOI 10.3109/10408419409113548
   Dourado F, 1999, CELLULOSE, V6, P265, DOI 10.1023/A:1009251722598
   Dufresne A, 1997, J APPL POLYM SCI, V64, P1185
   Gassan J, 1999, J APPL POLYM SCI, V71, P623, DOI 10.1002/(SICI)1097-4628(19990124)71:4<623::AID-APP14>3.3.CO;2-B
   GILKES NR, 1992, J BIOL CHEM, V267, P6743
   GILKES NR, 1991, MICROBIOL REV, V55, P303
   Glasser WG, 1999, J APPL POLYM SCI, V73, P1329, DOI 10.1002/(SICI)1097-4628(19990815)73:7<1329::AID-APP26>3.0.CO;2-Q
   GOLDSTEIN MA, 1993, J BACTERIOL, V175, P5762
   HARSH DC, 1991, J CONTROL RELEASE, V17, P175, DOI 10.1016/0168-3659(91)90057-K
   HAYDEN W, 1956, MECH BEHAV, P1
   HENRISSAT B, 1994, CELLULOSE, V1, P169, DOI 10.1007/BF00813506
   Kauffmann C, 2000, ENVIRON SCI TECHNOL, V34, P1292, DOI 10.1021/es990754h
   Linder M, 1996, P NATL ACAD SCI USA, V93, P12251, DOI 10.1073/pnas.93.22.12251
   Linder M, 1996, J BIOL CHEM, V271, P21268, DOI 10.1074/jbc.271.35.21268
   McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801
   Rechter M, 1999, BIOCHEM BIOPH RES CO, V255, P657, DOI 10.1006/bbrc.1999.0181
   Roberts JC, 1996, CHEM PAPER ROYAL SOC
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sellen D. B., 1980, The mechanical properties of biological materials., P315
   SHOSEYOV O, 1990, BIOCHEM BIOPH RES CO, V169, P667, DOI 10.1016/0006-291X(90)90382-W
   SHOSEYOV O, 1990, P NATL ACAD SCI USA, V87, P2192, DOI 10.1073/pnas.87.6.2192
   SHOSEYOV O, 1992, P NATL ACAD SCI USA, V89, P3483, DOI 10.1073/pnas.89.8.3483
   Shpigel E, 1998, PROTEIN EXPRES PURIF, V14, P185, DOI 10.1006/prep.1998.0929
   Shpigel E, 2000, BIOTECHNOL APPL BIOC, V31, P197, DOI 10.1042/BA20000002
   Shpigel E, 1999, BIOTECHNOL BIOENG, V65, P17, DOI 10.1002/(SICI)1097-0290(19991005)65:1<17::AID-BIT3>3.0.CO;2-Y
   SPENCE EE, 1987, ENCY POLYM SCI TECHN, V10, P761
   Teeri T T, 1992, Biotechnology, V21, P417
   TESORO GC, 1961, CELLULOSE CELLULOS 5, P835
   Tomme P, 1998, J CHROMATOGR B, V715, P283, DOI 10.1016/S0378-4347(98)00053-X
   Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5
   Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x
   VILLALOBOS JA, 1981, J TAPPI, V64, P129
   WHITE A, 1994, BIOCHEMISTRY-US, V33, P12546, DOI 10.1021/bi00208a003
   Xu GG, 1999, J APPL POLYM SCI, V74, P907, DOI 10.1002/(SICI)1097-4628(19991024)74:4<907::AID-APP17>3.0.CO;2-9
   XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011
NR 39
TC 38
Z9 39
U1 0
U2 15
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
J9 CELLULOSE
JI Cellulose
PD MAR
PY 2002
VL 9
IS 1
BP 91
EP 98
DI 10.1023/A:1015848701029
PG 8
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA 562YU
UT WOS:000176227200010
DA 2018-10-19
ER

PT J
AU Hubbard, SC
   Burns, JW
AF Hubbard, SC
   Burns, JW
TI Effects of a hyaluronan-based membrane (Seprafilm (R)) on
   intraperitoneally disseminated human colon cancer cell growth in a nude
   mouse model
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article
DE Seprafilm (R) adhesion prevention; human xenograft model; nude mouse;
   colon cancer
ID REGENERATED CELLULOSE INTERCEED; TEX SURGICAL MEMBRANE; ADHESIONS;
   REDUCTION; MULTICENTER; LOCOMOTION; RECEPTORS; SELECTION; VARIANTS;
   BARRIER
AB PURPOSE: The purpose of this study was to examine whether a hyaluronan-based membrane (Seprafilm(R) Adhesion Barrier) could affect growth and metastasis of colon cancer in a human xenograft/nude mouse model. METHODS: Male athymic (nude) mice underwent a midline abdominal incision followed by an intraperitoneal inoculation of KM12-L4 human colon cancer cells. Seprafilm(R) membrane was placed under the incision or on the right lateral abdominal wall control groups received no Seprafilm(R) membrane. In another group, Vicryl(TM) mesh was placed on the right lateral abdominal wall and removed after I minute to control for surgical trauma associated with biomaterial placement. RESULTS: Intraperitoneal Seprafilm did not affect human colon cancer tumor metastasis, including the liver, spleen, and mesenteric lymph nodes. The application of a biomaterial such as Seprafilm(R) or Vicryl(TM) mesh to the peritoneal sidewall away from the midline wound was associated with in increased rate of local tumor growth. This was Likely because of the local trauma of biomaterial placement in the nude mouse model and not because of the presence of a foreign material. CONCLUSIONS: Our study suggests that Seprafilm(R) does not affect tumor metastasis. Additionally, placement of biomaterials may cause local trauma that stimulates the formation of localized sidewall tumors in the nude mouse model. Further studies in other animal models and ultimately, in humans are required to unambiguously understand the safety of Seprafilm(R) and other biomaterials in cancer patients.
C1 Genzyme Corp, Biomat & Surg Prod Res Lab, Cambridge, MA 02139 USA.
RP Burns, JW (reprint author), Genzyme Corp, Biomat & Surg Prod Res Lab, 1 Kendall Sq, Cambridge, MA 02139 USA.
CR ANTILTILA MA, 2000, CANCER RES, V60, P15
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   Burns JW, 1997, EUR J SURG, V163, P40
   Diamond MP, 1996, FERTIL STERIL, V66, P904, DOI 10.1016/S0015-0282(16)58716-0
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   GROW DR, 1994, FERTIL STERIL, V61, P1141
   HANEY AF, 1992, AM J OBSTET GYNECOL, V166, P1137, DOI 10.1016/S0002-9378(11)90600-0
   HANEY AF, 1992, FERTIL STERIL, V57, P202
   KIMATA K, 1983, CANCER RES, V43, P1347
   KNUDSON W, 1989, CIBA F SYMP, V143, P150
   LINSKY CB, 1987, J REPROD MED, V32, P17
   LINSKY CB, 1989, FERTIL STERIL, V51, P933
   MCBRIDE WH, 1979, J EXP MED, V149, P507, DOI 10.1084/jem.149.2.507
   MORIKAWA K, 1988, CANCER RES, V48, P1943
   MORIKAWA K, 1988, CANCER RES, V48, P6863
   Tan B, 2001, BRIT J SURG, V88, P246, DOI 10.1046/j.1365-2168.2001.01664.x
   Toole B, 1982, CELL BIOL EXTRACELLU, P259
   TURLEY EA, 1993, EXP CELL RES, V207, P277, DOI 10.1006/excr.1993.1194
   TURLEY EA, 1985, CANCER RES, V45, P5098
   TURLEY EA, 1992, CANCER METAST REV, V11, P21, DOI 10.1007/BF00047600
   Underwood RA, 1999, DIS COLON RECTUM, V42, P614, DOI 10.1007/BF02234137
   YANG BH, 1993, J BIOL CHEM, V268, P8617
   ZENG C, 1998, INT J CANCER, V77, P936
   ZHANG LR, 1995, CANCER RES, V55, P428
NR 24
TC 18
Z9 20
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0012-3706
EI 1530-0358
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD MAR
PY 2002
VL 45
IS 3
BP 334
EP 341
PG 8
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 539VA
UT WOS:000174891300008
PM 12068190
DA 2018-10-19
ER

PT J
AU Schuster, M
   Kocher, A
   John, R
   Hoffman, M
   Ankersmit, J
   Lietz, K
   Edwards, O
   Oz, M
   Itescu, S
AF Schuster, M
   Kocher, A
   John, R
   Hoffman, M
   Ankersmit, J
   Lietz, K
   Edwards, O
   Oz, M
   Itescu, S
TI B-cell activation and allosensitization after left ventricular assist
   device implantation is due to T-cell activation and CD40 ligand
   expression
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE LVAD; CD40L; allosensitization
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; DECREASED PRODUCTION; APOPTOTIC CELLS;
   LVAD RECIPIENTS; NUCLEAR FACTOR; ANTIBODIES; DEATH; INTERLEUKIN-2;
   TRANSFUSIONS; DYSFUNCTION
AB Left ventricular assist device (LVAD) implantation is frequently complicated by B-cell activation and allosensitization, posing a significant risk to successful transplant outcome. This study investigated whether B-cell hyperreactivity and alloantibody production in LVAD recipients involves T-cell dependent pathways. T-cell calcium flux and nuclear translocation of NFATc were used to determine states of T-cell activation. Flow cytometry was used to assess human T- and B-cell activation after culture with LVAD-derived biomattrial particles. Sera from LVAD recipients and controls were tested for the presence of anti-HLA antibodies, and for soluble CD40 ligand. LVAD-derived biomaterial induced rapid and sustained calcium flux into normal T cells, resulting in calcineurin-dependent nuclear translocation of NFATc. This resulted in increased T-cell expression of CD40 ligand and subsequent B-cell activation, which was reduced by inhibitors of T-cell activation (CsA or anti-CD25 mAb) or by anti-CD40 ligand mAb. LVAD recipients demonstrated higher frequencies of anti-FILA antibodies and serum levels of soluble CD40 ligand compared with heart failure controls. The results indicate that exposure of human mononuclear cells to LVAD-derived biomaterial leads to T-cell dependent B-cell activation via CD40-CD40 ligand interaction, and suggest that treatment with calcineurin inhibitors or monoclonal antibodies against either CD25 or CD-40 ligand could be effective at preventing B-cell hyperreactivity and allosensitization after LVAD implantation. (C) American Society for Histocompatibility and Immunogenetics, 2002. Published by Elsevier Science Inc.
C1 Columbia Univ, Coll Phys & Surg, Dept Surg, New York, NY 10032 USA.
RP Itescu, S (reprint author), Columbia Univ, Coll Phys & Surg, Dept Surg, 630 W 168th St,P&S 14-402, New York, NY 10032 USA.
CR Al-Maini MH, 2000, LUPUS, V9, P132, DOI 10.1191/096120300678828145
   ALCOCERVARELA J, 1982, J CLIN INVEST, V69, P1388, DOI 10.1172/JCI110579
   AMEISEN JC, 1991, IMMUNOL TODAY, V12, P102
   Ankersmit HJ, 1999, LANCET, V354, P550, DOI 10.1016/S0140-6736(98)10359-8
   Ankersmit HJ, 1999, CIRCULATION, V100, P211
   BACH FH, 1997, NAT MED, V3, P1
   BERNARD C, 1990, J ACQ IMMUN DEF SYND, V3, P536
   Bijl M, 2001, CLIN EXP IMMUNOL, V123, P127, DOI 10.1046/j.1365-2249.2001.01418.x
   CasciolaRosen L, 1996, P NATL ACAD SCI USA, V93, P1624, DOI 10.1073/pnas.93.4.1624
   Casiano CA, 1996, J EXP MED, V184, P765, DOI 10.1084/jem.184.2.765
   DASSE KA, 1987, T AM SOC ART INT ORG, V33, P418
   Datta SK, 1998, LUPUS, V7, P591, DOI 10.1191/096120398678920703
   Funauchi M, 1998, SCAND J RHEUMATOL, V27, P219
   Goldstein D J, 1995, ASAIO J, V41, P873, DOI 10.1097/00002480-199510000-00010
   GROUX H, 1992, J EXP MED, V175, P331, DOI 10.1084/jem.175.2.331
   Hermann M, 1997, CIRCULATION, V95, P814
   HOGNES JR, 1991, ARTIFICIAL HEART PRO
   Horwitz DA, 1998, ARTHRITIS RHEUM, V41, P838, DOI 10.1002/1529-0131(199805)41:5<838::AID-ART10>3.0.CO;2-S
   HUANG YP, 1986, J IMMUNOL, V137, P3515
   Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657
   Itescu S, 1998, CIRCULATION, V98, P786, DOI 10.1161/01.CIR.98.8.786
   ITESCU S, 1998, J HEART LUNG TRANSPL, V17, P105
   Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005
   Kanakaraj P, 2001, CYTOKINE, V13, P25, DOI 10.1006/cyto.2000.0793
   Kato K, 1999, J CLIN INVEST, V104, P947, DOI 10.1172/JCI7014
   Khan WN, 1997, INT IMMUNOL, V9, P395, DOI 10.1093/intimm/9.3.395
   KLINMAN DM, 1991, ARTHRITIS RHEUM, V34, P11
   Ma J, 1996, J IMMUNOL, V157, P417
   MACCHIA D, 1993, NATURE, V363, P464, DOI 10.1038/363464a0
   Massad MG, 1997, ANN THORAC SURG, V64, P1120, DOI 10.1016/S0003-4975(97)00807-2
   MATSUDA T, 1994, BIOMATERIALS, V15, P417, DOI 10.1016/0142-9612(94)90219-4
   Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387
   Moazami N, 1998, J HEART LUNG TRANSPL, V17, P876
   Niimi M, 1998, J IMMUNOL, V161, P5331
   Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X
   ROBINS JP, 1997, CURRENT PROTOCOLS CY, V1
   ROSE EA, 1994, CIRCULATION, V50, P1187
   SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4
   Shapiro VS, 1998, J IMMUNOL, V161, P6455
   SOLLINGER AM, 1991, RHEUM DIS CLIN N AM, V17, P157
   Stringham JC, 1999, J HEART LUNG TRANSPL, V18, P160, DOI 10.1016/S1053-2498(98)00006-0
   Tsytsykova AV, 1996, J BIOL CHEM, V271, P3763
   *US DEP HHS, 1990, ANN REP US SCI REG O
   Vakkalanka RK, 1999, ARTHRITIS RHEUM, V42, P871, DOI 10.1002/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J
   Waples LM, 1996, J BIOMED MATER RES, V32, P65, DOI 10.1002/(SICI)1097-4636(199609)32:1<65::AID-JBM8>3.0.CO;2-N
NR 45
TC 44
Z9 46
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0198-8859
J9 HUM IMMUNOL
JI Hum. Immunol.
PD MAR
PY 2002
VL 63
IS 3
BP 211
EP 220
AR PII S0198-8859(01)00380-9
DI 10.1016/S0198-8859(01)00380-9
PG 10
WC Immunology
SC Immunology
GA 532VJ
UT WOS:000174495500007
PM 11872239
DA 2018-10-19
ER

PT J
AU Whang, K
   Satsangi, N
   Norling, BK
   Kadapakkam, S
   Furman, BR
   Glover, R
   Cardenas, HL
   Liska, B
   Emmons, J
   Vo, J
AF Whang, K
   Satsangi, N
   Norling, BK
   Kadapakkam, S
   Furman, BR
   Glover, R
   Cardenas, HL
   Liska, B
   Emmons, J
   Vo, J
TI The development of a novel osteotropic biomaterial: OG-PLG.
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 Univ Texas, Hlth Sci Ctr, San Antonio, TX USA.
RI Norling, Barry/I-4119-2013
OI Norling, Barry/0000-0001-6655-8750
NR 0
TC 0
Z9 0
U1 0
U2 1
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD MAR
PY 2002
VL 81
SI SI
MA 2138
BP A274
EP A274
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 559KE
UT WOS:000176024702118
DA 2018-10-19
ER

PT J
AU Dayi, E
   Aslan, M
   Simsek, G
   Yilmaz, AB
AF Dayi, E
   Aslan, M
   Simsek, G
   Yilmaz, AB
TI The effects of bone chips dehydrated with solvent on healing bone
   defects
SO JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
LA English
DT Article
DE biomaterial; bone chips dehydrated with solvent; graft; bone healing
ID POROUS HYDROXYLAPATITE; DEMINERALIZED BONE; TISSUE-RESPONSE;
   RHESUS-MONKEYS; AUGMENTATION; ALLOGRAFT; PARTICLES
AB The effect of bone chips dehydrated with solvent on the healing of bone defects was evaluated. Solvent-dehydrated spongiose bone chips were placed in experimentally formed cavities in the right back tibia of rabbits. After 10, 20 and 30 days, histopathological cross-sections from the bone grafts were examined microscopically for bone healing and formation of spongiose bone, cortex and bone marrow. Spongiose bone chips had a positive and accelerating influence on the healing of bone defects in the 10-day period after transplantation, but no significant differences were observed between the treated and control groups 20 and 30 days after transplantation.
C1 Ataturk Univ, Dishekimligi Fak, Erzurum, Turkey.
   Ataturk Univ, Dept Oral & Maxillofacial Surg, Erzurum, Turkey.
   Ataturk Univ, Dept Oral Diagnosis & Maxillofacial Radiol, Erzurum, Turkey.
RP Dayi, E (reprint author), Ataturk Univ, Dishekimligi Fak, Erzurum, Turkey.
CR AKAL U, 1995, J DENT ANKARA U, V22, P103
   BELL R, 1988, J ORAL MAXIL SURG, V46, P589, DOI 10.1016/0278-2391(88)90150-4
   BLOCK MS, 1986, J ORAL MAXIL SURG, V44, P89, DOI 10.1016/0278-2391(86)90187-4
   Boyce T, 1999, ORTHOP CLIN N AM, V30, P571, DOI 10.1016/S0030-5898(05)70110-3
   CHAO SY, 1987, J ORAL MAXIL SURG, V45, P359, DOI 10.1016/0278-2391(87)90361-2
   Davy DT, 1999, ORTHOP CLIN N AM, V30, P553, DOI 10.1016/S0030-5898(05)70108-5
   Dayi E, 1997, AUST DENT J, V42, P315, DOI 10.1111/j.1834-7819.1997.tb00136.x
   ELDEEB M, 1989, J ORAL MAXIL SURG, V47, P1282, DOI 10.1016/0278-2391(89)90725-8
   FRAME JW, 1987, J ORAL MAXIL SURG, V45, P771, DOI 10.1016/0278-2391(87)90200-X
   HOSNY M, 1985, J ORAL MAXIL SURG, V43, P837, DOI 10.1016/0278-2391(85)90219-8
   KUTLU H, 2001, TUTOPLAST
   LEHTINEN R, 1990, J ORAL MAXIL SURG, V48, P1075, DOI 10.1016/0278-2391(90)90292-A
   MARX RE, 1981, J ORAL SURG, V39, P264
   OZCAN A, 2000, TURKIYE KLIN J DENT, V6, P138
   PETRI WH, 1991, J ORAL MAXIL SURG, V49, P392, DOI 10.1016/0278-2391(91)90377-X
   PINHOLT EM, 1992, J ORAL MAXIL SURG, V50, P1300, DOI 10.1016/0278-2391(92)90231-N
   Shors EC, 1999, ORTHOP CLIN N AM, V30, P599, DOI 10.1016/S0030-5898(05)70113-9
   Stevenson S, 1999, ORTHOP CLIN N AM, V30, P543, DOI 10.1016/S0030-5898(05)70107-3
NR 18
TC 3
Z9 3
U1 0
U2 0
PU CAMBRIDGE MED PUBL
PI WORTHING
PA WICKER HOUSE, HIGH ST, WORTHING BN11 1DJ, W SUSSEX, ENGLAND
SN 0300-0605
J9 J INT MED RES
JI J. Int. Med. Res.
PD MAR-APR
PY 2002
VL 30
IS 2
BP 168
EP 173
DI 10.1177/147323000203000209
PG 6
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 548RU
UT WOS:000175403900009
PM 12025524
OA Bronze
DA 2018-10-19
ER

PT J
AU Broberg, M
   Eriksson, C
   Nygren, H
AF Broberg, M
   Eriksson, C
   Nygren, H
TI GPIIb/IIIa is the main receptor for initial platelet adhesion to glass
   and titanium surfaces in contact with whole blood
SO JOURNAL OF LABORATORY AND CLINICAL MEDICINE
LA English
DT Article
ID GLYCOPROTEIN-IIB-IIIA; VON-WILLEBRAND-FACTOR; DIFFERENT OXIDE
   THICKNESSES; ADSORBED PLASMA-PROTEINS; HUMAN-MELANOMA CELLS;
   MONOCLONAL-ANTIBODY; FC-RECEPTOR; ELECTROPOLISHED IMPLANTS; FIBRINOGEN
   ADSORPTION; VITRONECTIN RECEPTOR
AB Platelets are the first cells to adhere to a surface in contact with blood and are capable of mediating several different responses after contact with different protein-coated surfaces. They are the main source of growth factors such as platelet-derived growth factor and are therefore important in the healing process. In this study, initial platelet adhesion to and spread on hydrophilic and hydrophobic (methylized) glass and titanium with similar wettability were investigated. Whole coagulating blood was used to simulate the in vivo situation shortly after implantation, in which bleeding precedes inflammation and wound healing. Several different antibodies directed against platelet integrins and receptors (CD9, FcgammaRII, GPIIb/IIIa, vitronectin receptor, GPIb/V/IX) were used in an attempt to block platelet adhesion to the surfaces. Immunofluorescence results show that initial platelet adhesion to all the surfaces we investigated can be almost completely inhibited (approximately 95%) by clone M148, an antibody against the GPIIb/IIIa complex (integrin alpha(IIbbeta)3; CD41/CD61), but not with other antibodies to the separate parts of the integrin. Antibodies known to inhibit fibrinogen binding to GPIIb/IIIa after adenosine diphosphate- and collagen-induced aggregation had very little effect on initial platelet adhesion. None of the other integrins were found to have such an effect on initial platelet adhesion. Antibody clone M148 was furthermore found to inhibit platelet spreading. This study shows that regardless of wettability and the biomaterial used, initial adhesion of platelets appears to be mediated by GPIIb/IIIa binding to surface adsorbed fibrinogen.
C1 Gothenburg Univ, Dept Anat & Cell Biol, SE-40530 Gothenburg, Sweden.
RP Broberg, M (reprint author), Gothenburg Univ, Dept Anat & Cell Biol, Box 420, SE-40530 Gothenburg, Sweden.
CR ALBREKTSSON T, 1985, Critical Reviews in Biocompatibility, V1, P53
   ANDERSON GP, 1991, BRIT J HAEMATOL, V79, P75, DOI 10.1111/j.1365-2141.1991.tb08010.x
   ANDREWS RK, 1991, J BIOL CHEM, V266, P7144
   BERNDT MC, 1993, PLATELETS, V4, P190, DOI 10.3109/09537109309013216
   BEUMER S, 1994, BLOOD, V84, P3724
   Brisson C, 1997, HISTOCHEM J, V29, P153, DOI 10.1023/A:1026437522882
   Broberg M, 1998, COLLOID SURFACE B, V11, P67, DOI 10.1016/S0927-7765(98)00026-5
   CHINN JA, 1991, THROMB HAEMOSTASIS, V65, P608
   Clemetson KJ, 1997, THROMB HAEMOSTASIS, V78, P266
   CRAMER EM, 1990, BLOOD, V75, P1220
   DAHLGREN C, 1981, J IMMUNOL METHODS, V40, P171, DOI 10.1016/0022-1759(81)90064-8
   DEVRIES JE, 1986, INT J CANCER, V38, P465, DOI 10.1002/ijc.2910380403
   DiazRicart M, 1996, ARTERIOSCL THROM VAS, V16, P883, DOI 10.1161/01.ATV.16.7.883
   DSOUZA SE, 1990, J BIOL CHEM, V265, P3440
   Eriksson C, 2001, J LAB CLIN MED, V137, P296, DOI 10.1067/mlc.2001.114066
   Eriksson C, 1997, J BIOMED MATER RES, V37, P130, DOI 10.1002/(SICI)1097-4636(199710)37:1<130::AID-JBM16>3.0.CO;2-K
   Falati S, 1999, BLOOD, V94, P1648
   FITZGERALD LA, 1985, ANAL BIOCHEM, V151, P169, DOI 10.1016/0003-2697(85)90067-3
   FUJIMURA K, 1983, J BIOL CHEM, V258, P247
   GINSBERG MH, 1993, THROMB HAEMOSTASIS, V70, P87
   GOODMAN SL, 1993, J BIOMED MATER RES, V27, P683, DOI 10.1002/jbm.820270516
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   Grunkemeier JM, 2000, J BIOMED MATER RES, V51, P669, DOI 10.1002/1097-4636(20000915)51:4<669::AID-JBM15>3.0.CO;2-#
   HECKER M, 1989, BIOCHEM BIOPH RES CO, V159, P961, DOI 10.1016/0006-291X(89)92202-X
   HORNBY EJ, 1991, BRIT J HAEMATOL, V79, P277, DOI 10.1111/j.1365-2141.1991.tb04533.x
   IKEDA Y, 1991, J CLIN INVEST, V87, P1234, DOI 10.1172/JCI115124
   Inngjerdingen M, 1999, THROMB RES, V95, P215, DOI 10.1016/S0049-3848(99)00035-3
   Jamieson GA, 1997, THROMB HAEMOSTASIS, V78, P242
   Ji P, 1999, BBA-MOL CELL RES, V1448, P543, DOI 10.1016/S0167-4889(98)00160-8
   JONES D, 1984, BRIT J HAEMATOL, V57, P621, DOI 10.1111/j.1365-2141.1984.tb02939.x
   KARAS SP, 1982, BLOOD, V60, P1277
   KIEFFER N, 1991, J CELL BIOL, V113, P451, DOI 10.1083/jcb.113.2.451
   KUNICKI TJ, 1981, BLOOD, V58, P268
   KURODA K, 1995, J IMMUNOL, V155, P4427
   LAM SCT, 1989, J BIOL CHEM, V264, P3742
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   LINDON JN, 1986, BLOOD, V68, P355
   MASON RG, 1971, P SOC EXP BIOL MED, V137, P680
   MCEVER RP, 1983, J BIOL CHEM, V258, P5269
   McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8
   MILLER JL, 1986, BLOOD, V68, P743
   MODDERMAN PW, 1988, THROMB HAEMOSTASIS, V60, P68
   Nygren H, 1998, J BIOMAT SCI-POLYM E, V9, P817, DOI 10.1163/156856298X00172
   Nygren H, 1996, COLLOID SURFACE B, V6, P329, DOI 10.1016/0927-7765(96)01270-2
   NYGREN H, 1988, ACTA PHYSIOL SCAND, V133, P573, DOI 10.1111/j.1748-1716.1988.tb08443.x
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   RUAN C, 1987, THROMB HAEMOSTASIS, V58, P243
   RUBINSTEIN E, 1991, BRIT J HAEMATOL, V78, P80, DOI 10.1111/j.1365-2141.1991.tb04386.x
   SAVAGE B, 1991, J BIOL CHEM, V266, P11227
   Slupsky JR, 1997, EUR J BIOCHEM, V244, P168, DOI 10.1111/j.1432-1033.1997.00168.x
   STEL HV, 1985, BLOOD, V65, P85
   STIBBE J, 1977, THROMB HAEMOSTASIS, V38, P1042
   TETTEROO PAT, 1983, BRIT J HAEMATOL, V55, P509, DOI 10.1111/j.1365-2141.1983.tb02166.x
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   VROMAN L, 1980, BLOOD, V55, P156
   VRZHESHCH PV, 1992, THROMB RES, V67, P505, DOI 10.1016/0049-3848(92)90012-Y
   ZUCKER MB, 1969, P SOC EXP BIOL MED, V131, P318
NR 58
TC 39
Z9 40
U1 1
U2 9
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-2143
J9 J LAB CLIN MED
JI J. Lab. Clin. Med.
PD MAR
PY 2002
VL 139
IS 3
BP 163
EP 172
DI 10.1067/mlc.2002.121604
PG 10
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA 544NK
UT WOS:000175166500006
PM 11944027
DA 2018-10-19
ER

PT J
AU Manso-Silvan, M
   Martinez-Duart, JM
   Ogueta, S
   Garcia-Ruiz, P
   Perez-Rigueiro, J
AF Manso-Silvan, M
   Martinez-Duart, JM
   Ogueta, S
   Garcia-Ruiz, P
   Perez-Rigueiro, J
TI Development of human mesenchymal stem cells on DC sputtered titanium
   nitride thin films
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID DIFFUSION BARRIER; TIN; NANOINDENTATION; ADHESION; BEHAVIOR; MODULUS; CU
AB The biocompatible properties of titanium nitride (TiN) have opened a new field of applications for this material. In the present work, TiN coatings with thicknesses around 1 mum have been prepared by DC magnetron sputtering. The aim has been to evaluate the adherence, growth and proliferation of human pluripotent mesenchymal stem cells (hMSCs) on the surface of TiN films with contrasted structural, electrical, and mechanical properties. For this purpose, the films were characterized by X-ray diffraction, scanning electron microscopy, sheet resistance measurements, and nanoindentation. Biological tests show that hMSCs adhere and proliferate onto TiN surfaces. The combination of the mechanical, electrical, and biological responses suggest that TiN coatings present appropriate properties to induce the in vitro stimulated differentiation of hMSCs. This possibility gives an added value to TiN based biomaterial coatings. (C) 2002 Academic Publishers.
C1 Univ Autonoma Madrid, Dept Fis Aplicada, E-28049 Madrid, Spain.
   Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain.
   Univ Politecn Madrid, ETSI Caminos Canales & Puertos, Dept Ciencia Mat, E-28040 Madrid, Spain.
RP Manso-Silvan, M (reprint author), Univ Autonoma Madrid, Dept Fis Aplicada, E-28049 Madrid, Spain.
RI Manso Silvan, Miguel/B-4947-2010
OI Manso Silvan, Miguel/0000-0002-5063-1607
CR ALJAROUDI MY, 1991, THIN SOLID FILMS, V195, P63, DOI 10.1016/0040-6090(91)90259-Z
   AMIGLIATO A, 1985, THIN SOLID FILMS, V129, P55
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Chun JS, 1999, J APPL PHYS, V86, P3633, DOI 10.1063/1.371271
   DION I, 1993, BIOMATERIALS, V14, P712, DOI 10.1016/0142-9612(93)90070-I
   HARAKI Y, 1987, BIOCHIM BIOPHYS ACTA, V931, P94
   Hayashi T, 1999, THIN SOLID FILMS, V349, P199, DOI 10.1016/S0040-6090(99)00241-2
   HUBLER R, 1993, J VAC SCI TECHNOL A, V11, P451
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Lennon DP, 1996, IN VITRO CELL DEV-AN, V32, P602
   Ljungcrantz H, 1996, J APPL PHYS, V80, P6725, DOI 10.1063/1.363799
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Ogueta S, 2000, J ENDOCRINOL, V165, P321, DOI 10.1677/joe.0.1650321
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PARK KC, 1995, J ELECTROCHEM SOC, V142, P3109, DOI 10.1149/1.2048697
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   Rie KT, 1995, SURF COAT TECH, V74-75, P973, DOI 10.1016/0257-8972(95)08316-2
   Samuels L. E., 1986, MICROINDENTATION TEC, P5
   SCHLALDACH M, 1995, MED PROG TECHNOL, V21, P1
   Schmidt H, 1998, MATER SCI TECH-LOND, V14, P592, DOI 10.1179/mst.1998.14.6.592
   TOROK E, 1987, THIN SOLID FILMS, V153, P37, DOI 10.1016/0040-6090(87)90167-2
   TORREGROSA F, 1995, THIN SOLID FILMS, V266, P245, DOI 10.1016/0040-6090(96)80028-9
   WANG SQ, 1990, J APPL PHYS, V68, P5176, DOI 10.1063/1.347059
NR 25
TC 12
Z9 12
U1 0
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2002
VL 13
IS 3
BP 289
EP 293
DI 10.1023/A:1014062918261
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 519BR
UT WOS:000173705200007
PM 15348626
DA 2018-10-19
ER

PT J
AU Boeck-Neto, R
   Gabrielli, MFR
   Lia, RCC
   Marcantonio, E
   Shibli, JA
   Marcantonio, E
AF Boeck-Neto, R
   Gabrielli, MFR
   Lia, RCC
   Marcantonio, E
   Shibli, JA
   Marcantonio, E
TI Histomorphometrical analysis of bone formed after maxillary sinus floor
   augmentation by grafting with a combination of autogenous bone and
   demineralized freeze-dried bone allograft or hydroxyapatite
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE dental implants; hydroxyapatite/therapeutic use; regeneration grafts,
   bone; maxillary sinus augmentation; comparison studies
ID ANIONIC COLLAGEN MEMBRANES; DENTAL IMPLANTS; CLINICAL REPORT; ENDOSSEOUS
   IMPLANTS; ELEVATION; PLACEMENT; DEVICE; SITES
AB Background: Maxillary sinus floor augmentation procedures are currently the treatment of choice when the alveolar crest of the posterior maxilla is insufficient for dental implant anchorage. This procedure aims to obtain enough bone with biomaterial association with the autogenous bone graft to create volume and allow osteo conduction. The objective of this study was to histologically and histometrically evaluate the bone formed after maxillary sinus floor augmentation by grafting with a combination of autogenous bone, from the symphyseal area mixed with DFDBA or hydroxyapatite.
   Methods: Ten biopsies were taken from 10 patients 10 months after sinus floor augmentation using a combination of 50% autogenous bone plus 50% dernineralized freeze-dried bone allograft (DFDBA group) or 50% autogenous bone plus 50% hydroxyapatite (HA group). Routine histological processing and staining with hernatoxylin and eosin and Masson's trichrome were performed.
   Results: The histomorphometrical analysis indicated good regenerative results in both groups for the bone tissue mean in the grafted area (50.46 +/- 16.29% for the DFDBA group and 46.79 +/- 8.56% for the HA group). Histological evaluation revealed the presence of mature bone with compact and cancellous areas in both groups. The inflammatory infiltrate was on average nonsignificant and of mononuclear prevalence. Some biopsies showed blocks of the biomaterial in the medullary spaces close to the bone wall, with absence of osteogenic activity.
   Conclusions: The results indicated that both DFDBA and HA associated with an autogenous bone graft were biocompatible and promoted osteoconduction, acting as a matrix for bone formation. However, both materials were still present after 10 months.
C1 State Univ Sao Paulo, Araraquara Dent Sch, Dept Periodontol, Araraquara, SP, Brazil.
   State Univ Sao Paulo, Araraquara Dent Sch, Dept Oral & Maxillofacial Surg, Araraquara, SP, Brazil.
   State Univ Sao Paulo, Araraquara Dent Sch, Dept Pathol & Physiol, Araraquara, SP, Brazil.
RP Marcantonio, E (reprint author), UNESP, Fac Odontol Araraquara, Rua Humaita 1680, BR-14801903 Araraquara, SP, Brazil.
RI Marcantonio, Elcio/A-4784-2008; Shibli, Jamil/A-1361-2014
OI Marcantonio, Elcio/0000-0003-1294-2305; Shibli,
   Jamil/0000-0003-1971-0195
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P233
   Anitua E, 1999, INT J ORAL MAX IMPL, V14, P529
   Block MS, 1997, J ORAL MAXIL SURG, V55, P1281, DOI 10.1016/S0278-2391(97)90185-3
   BLOCK MS, 1993, J AM DENT ASSOC, V124, P139, DOI 10.14219/jada.archive.1993.0127
   Blomqvist JE, 1998, INT J ORAL MAX IMPL, V13, P758
   BLOMQVIST JE, 1998, ORAL SURG ORAL MED O, V85, P268
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Cancian DCJ, 1999, INT J ORAL MAX IMPL, V14, P859
   Chavanaz M, 1990, J ORAL IMPLANTOL, V16, P199
   Cirelli JA, 1997, BIOMATERIALS, V18, P1227, DOI 10.1016/S0142-9612(97)00053-7
   Cordioli G, 2001, CLIN ORAL IMPLAN RES, V12, P270, DOI 10.1034/j.1600-0501.2001.012003270.x
   De Leonardis D, 1999, INT J ORAL MAX IMPL, V14, P869
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   Furusawa T, 1997, Implant Dent, V6, P93, DOI 10.1097/00008505-199700620-00003
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   Groeneveld EHJ, 1999, CLIN ORAL IMPLAN RES, V10, P499, DOI 10.1034/j.1600-0501.1999.100608.x
   Groenveld HHJ, 1999, J CLIN PERIODONTOL, V26, P841, DOI 10.1034/j.1600-051X.1997.00841.x
   Hanisch O, 1999, INT J ORAL MAX IMPL, V14, P329
   Hanisch O, 1997, INT J ORAL MAX IMPL, V12, P785
   Lundgren S, 1997, INT J ORAL MAX SURG, V26, P428, DOI 10.1016/S0901-5027(97)80007-0
   Mazor Z, 1999, INT J ORAL MAX IMPL, V14, P55
   MOY PK, 1993, J ORAL MAXIL SURG, V51, P857, DOI 10.1016/S0278-2391(10)80103-X
   Peleg M, 1998, J PERIODONTOL, V69, P1397, DOI 10.1902/jop.1998.69.12.1397
   Quinones CR, 1997, CLIN ORAL IMPLAN RES, V8, P497, DOI 10.1034/j.1600-0501.1997.080608.x
   Rosetti EP, 2000, J PERIODONTOL, V71, P1441, DOI 10.1902/jop.2000.71.9.1441
   ten Bruggenkate CM, 1998, PERIODONTOL 2000, V17, P176
   WAGNER J R, 1991, Journal of Oral Implantology, V17, P152
   Wallace SS, 1996, INT J PERIODONT REST, V16, P47
   WATZEK G, 1998, INT J ORAL MAXILLOF, V26, P841
   Wheeler S L, 1996, Int J Oral Maxillofac Implants, V11, P26
   Wheeler SL, 1997, J ORAL MAXIL SURG, V55, P1287, DOI 10.1016/S0278-2391(97)90186-5
NR 31
TC 28
Z9 28
U1 0
U2 3
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD MAR
PY 2002
VL 73
IS 3
BP 266
EP 270
DI 10.1902/jop.2002.73.3.266
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 532CK
UT WOS:000174453900003
PM 11922255
DA 2018-10-19
ER

PT J
AU Yang, MC
   Lin, WC
AF Yang, MC
   Lin, WC
TI Ultrafiltration of myoglobin using surface-sulfonated polysulfone hollow
   fiber
SO JOURNAL OF POLYMER RESEARCH-TAIWAN
LA English
DT Article
DE blanc reaction; hollow fiber; membrane; polysulfone; sulfonation;
   ultrafiltration
ID POLYDIMETHYLSILOXANE GRAFT COPOLYMER; CHEMICAL MODIFICATION; MEMBRANES;
   POLYETHERSULFONE; PROTEINS
AB The usage of ionic polysulfone (PSF) hollow fiber for the ultrafiltration of protein was investigated. The surface of polysulfone hollow fiber was sulfonated through the Blanc chloromethylation reaction to become anionic. Characterization of the modified hollow fiber was performed including ion exchange titration, pure water permeation, and molecular sieving measurement. The performance of ultrafiltration of protein was evaluated using myoglobin at various pH values. The results show that the water contact angles and hydraulic resistance are markedly decreased, indicating that the surface-modified PSF hollow fibers are more hydrophilic. In addition, the retention of myoglobin depends on the pH of the solution. At a pH higher than the isoelectric point of myoglobin, both hollow fiber and the protein have the same charge sign, and both the flux of the solution and the retention are the highest. The sulfonated PSF hollow fiber may be used as a biomaterial for protein separation and purification.
C1 Natl Taiwan Univ Sci & Technol, Dept Fiber & Polymer Engn, Taipei 106, Taiwan.
RP Yang, MC (reprint author), Natl Taiwan Univ Sci & Technol, Dept Fiber & Polymer Engn, Taipei 106, Taiwan.
CR *AM PERF PROD INC, UDEL POL DES ENG DAT
   CABASSO I, 1977, J APPL POLYM SCI, V21, P165, DOI 10.1002/app.1977.070210115
   CABASSO I, 1976, J APPL POLYM SCI, V20, P2377, DOI 10.1002/app.1976.070200908
   CABASSO I, 1977, J APPL POLYM SCI, V21, P1883, DOI 10.1002/app.1977.070210715
   DALY WH, 1985, J MACROMOL SCI CHEM, V A22, P713, DOI 10.1080/00222338508056632
   HAMEL JFP, 1990, ACS S SERIES, V419
   HIGUCHI A, 1991, J MEMBRANE SCI, V57, P175, DOI 10.1016/S0376-7388(00)80677-8
   HIGUCHI A, 1988, J APPL POLYM SCI, V36, P1753, DOI 10.1002/app.1988.070360804
   HIGUCHI A, 1990, J APPL POLYM SCI, V40, P709, DOI 10.1002/app.1990.070400508
   HIGUCHI A, 1988, J APPL POLYM SCI, V36, P1973
   HINKE E, 1991, J APPL POLYM SCI, V42, P2951, DOI 10.1002/app.1991.070421112
   HOWELL JA, 1993, MEMBRANES BIOPROCESS, pCH6
   KIM KJ, 1994, J MEMBRANE SCI, V87, P35, DOI 10.1016/0376-7388(93)E0044-E
   LEROUX JD, 1992, J MEMBRANE SCI, V74, P233, DOI 10.1016/0376-7388(92)80064-Q
   LIU TH, 1992, SEPAR SCI TECHNOL, V27, P161, DOI 10.1080/01496399208018871
   LUCA C, 1980, J POLYM SCI POL CHEM, V18, P449, DOI 10.1002/pol.1980.170180205
   MIYAMA H, 1988, J APPL POLYM SCI, V36, P925, DOI 10.1002/app.1988.070360415
   MIYAMA H, 1977, J BIOMED MATER RES, V11, P251, DOI 10.1002/jbm.820110210
   NAGASE Y, 1989, POLYMER, V30, P1931, DOI 10.1016/0032-3861(89)90368-6
   NAGASE Y, 1990, POLYMER, V31, P121, DOI 10.1016/0032-3861(90)90361-2
   NAKAO S, 1988, DESALINATION, V70, P191, DOI 10.1016/0011-9164(88)85054-9
   SHELDON JM, 1991, J MEMBRANE SCI, V62, P87, DOI 10.1016/0376-7388(91)85006-Q
   SHELDON JM, 1991, J MEMBRANE SCI, V62, P75, DOI 10.1016/0376-7388(91)85005-P
   SUKI A, 1984, J MEMBRANE SCI, V21, P269, DOI 10.1016/S0376-7388(00)80218-5
   VOGEL AI, 1978, VOGELS TXB PRACTICAL, P636
   ZSCHOCKE P, 1985, J MEMBRANE SCI, V22, P325, DOI 10.1016/S0376-7388(00)81290-9
NR 26
TC 11
Z9 12
U1 0
U2 8
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1022-9760
J9 J POLYM RES-TAIWAN
JI J. Polym. Res.-Taiwan
PD MAR
PY 2002
VL 9
IS 1
BP 61
EP 67
DI 10.1023/A:1020610919593
PG 7
WC Polymer Science
SC Polymer Science
GA 619DH
UT WOS:000179458400009
DA 2018-10-19
ER

PT J
AU Chertin, B
   Colhoun, E
   Velayudham, M
   Puri, P
AF Chertin, B
   Colhoun, E
   Velayudham, M
   Puri, P
TI Endoscopic treatment of vesicoureteral reflux: 11 to 17 years of
   followup
SO JOURNAL OF UROLOGY
LA English
DT Article
DE polytetrafluoroethylene; vesico-ureteral reflux; endoscopy
ID POLYTETRAFLUOROETHYLENE INJECTION; INTRAVESICAL INJECTION; SUBURETERIC
   INJECTION; TEFLON INJECTION; MIGRATION; BRAIN; PASTE; INCONTINENCE;
   EXPERIENCE; URETERS
AB Purpose: We review our 17-experience with endoscopic subureteral polytetrafluoroethylene, injection for the treatment of primary vesicoureteral reflux in children.
   Materials and Methods: We retrospectively reviewed the charts of 258 patients with primary vesicoureteral reflux who were treated with subureteral polytetrafluoroethylene injection from 1984 to 1990.
   Results: The study included 205 girls and 53 boys between 3 months and 14 years old (median age 6 years). Of the patients 92 had unilateral vesicoureteral reflux, 129 had bilateral reflux and 37 had a refluxing duplex system including 6 with bilateral duplex systems. Endoscopic treatment by subureteral polytetrafluoroethylene injection was performed in 393 ureters. Reflux was corrected in 302 ureters (76.8%) after a single injection. Injection failed to stop reflux in 7 ureters (7 patients) and reimplantation was required. Patients were followed from 11 to 17 years with a mean followup plus or minus standard deviation of 13.5 +/- 3.4 years. Four patients were either lost to followup or parents refused to let them undergo voiding cystourethrography. Voiding cystourethrography in 247 patients with 379 ureters revealed that 360 ureters (95%) remain free of reflux whereas reflux recurred in 19 ureters (5%). Of these 19 ureters reflux was grade I or II in 13 for which no treatment was given and reflux was grade III or IV in 6, which required repeat injection. No untoward effects were seen in any of these patients with use of polytetrafluoroethylene as an injectable biomaterial.
   Conclusions: Endoscopic subureteral polytetrafluoroethylene injection is a simple and effective outpatient procedure for in the treatment of vesicoureteral reflux. No long-term morbidity was observed in our patients with small amounts of injectable polytetrafluoroethylene.
C1 Natl Childrens Hosp, Dublin, Ireland.
   Our Ladys Hosp Sick Children, Childrens Res Ctr, Dublin 12, Ireland.
RP Chertin, B (reprint author), Natl Childrens Hosp, Dublin, Ireland.
CR AARONSON IA, 1993, EUR UROL, V23, P394, DOI 10.1159/000474637
   Aragona F, 1997, J UROLOGY, V158, P1539, DOI 10.1016/S0022-5347(01)64275-7
   ARNOLD GE, 1963, ANN OTO RHINOL LARYN, V72, P384, DOI 10.1177/000348946307200209
   BAILEY RR, 1993, DIS KIDNEY, P68
   BECMEUR F, 1990, EUR UROL, V17, P299
   BISCHOFF F, 1972, CLIN CHEM, V18, P869
   Caldamone AA, 2001, J UROLOGY, V165, P2224, DOI 10.1016/S0022-5347(05)66170-8
   DEMOURIGUAND P, 1995, ROB SMITHS OPERATIVE, P638
   FARKAS A, 1990, J UROLOGY, V144, P534, DOI 10.1016/S0022-5347(17)39515-0
   Joyner BD, 1997, UROLOGY, V50, P489, DOI 10.1016/S0090-4295(97)00261-6
   Kershen RT, 1999, UROL CLIN N AM, V26, P81, DOI 10.1016/S0094-0143(99)80008-1
   LEVITT SB, 1981, PEDIATRICS, V67, P392
   MALIZIA AA, 1984, JAMA-J AM MED ASSOC, V251, P3277, DOI 10.1001/jama.251.24.3277
   Misra D, 1996, J PEDIATR SURG, V31, P1262, DOI 10.1016/S0022-3468(96)90246-8
   Miyakita H, 1998, EUR UROL, V34, P233, DOI 10.1159/000019720
   MIYAKITA H, 1994, J UROLOGY, V152, P636, DOI 10.1016/S0022-5347(17)32670-8
   MONTGOMERY R, 1982, PATTYS IND HYGIENE C, V2, P4308
   ODONNELL B, 1988, J UROLOGY, V140, P1101, DOI 10.1016/S0022-5347(17)41971-9
   ODONNELL B, 1984, BRIT MED J, V289, P7, DOI 10.1136/bmj.289.6436.7
   PETERS CA, 1991, DIAL PED UROL, V14, P4
   POLITANO VA, 1974, J UROLOGY, V111, P180, DOI 10.1016/S0022-5347(17)59921-8
   Puri P, 1998, J UROLOGY, V160, P1007, DOI 10.1016/S0022-5347(01)62683-1
   PURI P, 1984, BRIT MED J, V289, P5, DOI 10.1136/bmj.289.6436.5
   Puri P, 2000, Curr Opin Urol, V10, P593, DOI 10.1097/00042307-200011000-00010
   PURI P, 1987, J PEDIATR SURG, V22, P1087, DOI 10.1016/S0022-3468(87)80714-5
   PURI P, 1995, EUR UROL, V27, P67
   PURI P, 1990, LANCET, V335, P1320, DOI 10.1016/0140-6736(90)91197-I
   PURI P, 1995, BRIT J UROL, V75, P126, DOI 10.1111/j.1464-410X.1995.tb07296.x
   PURI P, 1986, BRIT J UROL, V58, P504, DOI 10.1111/j.1464-410X.1986.tb05455.x
   PURI P, 1995, EUR UROL, V27, P71
   Puri Prem, 1995, P638
   RAMES RA, 1991, PEDIATR SURG INT, V6, P239
   SCHULMAN CC, 1987, J UROLOGY, V138, P953
   SILVER F, 1989, BIOCOMPTIBILITY, V1, P129
   1991, PEDIATRICS, V88, P410
NR 35
TC 53
Z9 60
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD MAR
PY 2002
VL 167
IS 3
BP 1443
EP 1445
DI 10.1016/S0022-5347(05)65340-2
PG 3
WC Urology & Nephrology
SC Urology & Nephrology
GA 519YK
UT WOS:000173752900083
PM 11832767
DA 2018-10-19
ER

PT J
AU Keeley, FW
   Bellingham, CM
   Woodhouse, KA
AF Keeley, FW
   Bellingham, CM
   Woodhouse, KA
TI Elastin as a self-organizing biomaterial: use of recombinantly expressed
   human elastin polypeptides as a model for investigations of structure
   and self-assembly of elastin
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article
DE elastin; self-assembly; recombinant elastin polypeptide; coacervation;
   cross-linking
ID BINDING PROTEIN; TROPOELASTIN; COACERVATION; PENTAPEPTIDE; OXIDATION;
   DESMOSINE; AORTA
AB Elastin is the major extracellular matrix protein of large arteries such as the aorta, imparting characteristics of extensibility and elastic recoil. Once laid down in tissues, polymeric elastin is not subject to turnover, but is able to sustain its mechanical resilience through thousands of millions of cycles of extension and recoil. Elastin consists of ca. 36 domains with alternating hydrophobic and cross-linking characteristics. It has been suggested that these hydrophobic domains, predominantly containing glycine, proline, leucine and valine, often occurring in tandemly repeated sequences, are responsible for the ability of elastin to align monomeric chains for covalent cross-linking. We have shown that small, recombinantly expressed polypeptides based on sequences of human elastin contain sufficient information to self-organize into fibrillar structures and promote the formation of lysine-derived cross-links. These cross-linked polypeptides can also be fabricated into membrane structures that have solubility and mechanical properties reminiscent of native insoluble elastin. Understanding the basis of the self-organizational ability of elastin-based polypeptides may provide important clues for the general design of self-assembling biomaterials.
C1 Hosp Sick Children, Res Inst, Cardiovasc Res Program, Toronto, ON M5G 1X8, Canada.
   Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada.
   Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada.
   Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 1A1, Canada.
RP Keeley, FW (reprint author), Hosp Sick Children, Res Inst, Cardiovasc Res Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM fwk@sickkids.ca
CR Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045
   BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345
   Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X
   BRESSAN GM, 1986, J ULTRA MOL STRUCT R, V94, P209, DOI 10.1016/0889-1605(86)90068-6
   COX BA, 1973, BIOCHIM BIOPHYS ACTA, V317, P209, DOI 10.1016/0005-2795(73)90215-8
   DAVIS EC, 1993, HISTOCHEMISTRY, V100, P17, DOI 10.1007/BF00268874
   Debelle L, 1998, EUR J BIOCHEM, V258, P533, DOI 10.1046/j.1432-1327.1998.2580533.x
   GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0
   HINEK A, 1994, J CELL BIOL, V126, P563, DOI 10.1083/jcb.126.2.563
   HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941
   JAMIESON AM, 1972, BIOCHIM BIOPHYS ACTA, V271, P34, DOI 10.1016/0005-2795(72)90130-4
   KING GS, 1980, CONNECT TISSUE RES, V7, P263, DOI 10.3109/03008208009152362
   McConnell CJ, 1996, EXPERIENTIA, V52, P918, DOI 10.1007/BF01938880
   Mecham R. P., 1994, EXTRACELLULAR MATRIX, P281
   Mecham R. P, 1991, CELL BIOL EXTRACELLU, P79
   MORELLI MAC, 1993, J BIOMOL STRUCT DYN, V11, P181
   PARTRIDGE SM, 1955, BIOCHEM J, V61, P11, DOI 10.1042/bj0610011
   PARTRIDGE SM, 1966, FED PROC, V25, P1023
   PASQUALIRONCHET.I, 1979, MICRON, V10, P89
   Reiersen H, 1998, J MOL BIOL, V283, P255, DOI 10.1006/jmbi.1998.2067
   ROSS R, 1969, J CELL BIOL, V40, P366, DOI 10.1083/jcb.40.2.366
   Ross R, 1977, Adv Exp Med Biol, V79, P7
   SHAH MA, 1992, BIOCHIM BIOPHYS ACTA, V1159, P311, DOI 10.1016/0167-4838(92)90061-H
   STAHMANN MA, 1977, BIOPOLYMERS, V16, P1307, DOI 10.1002/bip.1977.360160611
   STARCHER B, 1995, RESPIRATION, V62, P252
   STARCHER B, 1985, CONNECT TISSUE RES, V13, P207, DOI 10.3109/03008208509152400
   TAMBURRO AM, 1992, J BIOMOL STRUCT DYN, V10, P441, DOI 10.1080/07391102.1992.10508661
   URRY DW, 1969, NATURE, V222, P795, DOI 10.1038/222795a0
   URRY DW, 1974, BIOCHIM BIOPHYS ACTA, V371, P597, DOI 10.1016/0005-2795(74)90057-9
   URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x
NR 32
TC 94
Z9 96
U1 0
U2 21
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
EI 1471-2970
J9 PHILOS T R SOC B
JI Philos. Trans. R. Soc. B-Biol. Sci.
PD FEB 28
PY 2002
VL 357
IS 1418
BP 185
EP 189
DI 10.1098/rstb.2001.1027
PG 5
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 535NJ
UT WOS:000174650300008
PM 11911775
OA Green Published
DA 2018-10-19
ER

PT J
AU Valluzzi, R
   Winkler, S
   Wilson, D
   Kaplan, DL
AF Valluzzi, R
   Winkler, S
   Wilson, D
   Kaplan, DL
TI Silk: molecular organization and control of assembly
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES
   B-BIOLOGICAL SCIENCES
LA English
DT Article
DE silk; redox; copolymers
ID CRYSTALLIZATION
AB The interface between the science and engineering of biology and materials is an area of growing interest. One of the goals of this field is to utilize biological synthesis and processing of polymers as a route to gain insight into topics such as molecular recognition, self-assembly and the formation of materials with well-defined architectures. The biological processes involved in polymer synthesis and assembly can offer important information on fundamental interactions involved in the formation of complex material architectures, as well as practical knowledge into new and important materials related to biomaterial uses and tissue engineering needs. Classic approaches in biology, including genetic engineering, controlled microbial physiology and enzymatic synthesis, are prototypical methods used to control polymer structure and chemistry, including stereoselectivity and regioselectivity, to degrees unattainable using traditional synthetic chemistry. This type of control can lead to detailed and systematic studies of the formation of the structural hierarchy in materials and the subsequent biological responses to these materials.
C1 Tufts Univ, Dept Chem & Biol Engn, Biotechnol & Bioengn Ctr, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Chem & Biol Engn, Biotechnol & Bioengn Ctr, Medford, MA 02155 USA.
CR McGrath K. P., 1997, PROTEIN BASED MAT
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   Valluzzi R, 1999, INT J BIOL MACROMOL, V24, P227, DOI 10.1016/S0141-8130(99)00005-7
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   WINKLER S, 2000, MOL BIOTECHNOL, V74, P85
NR 7
TC 42
Z9 46
U1 3
U2 13
PU ROYAL SOC LONDON
PI LONDON
PA 6 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
J9 PHILOS T ROY SOC B
JI Philos. Trans. R. Soc. Lond. Ser. B-Biol. Sci.
PD FEB 28
PY 2002
VL 357
IS 1418
BP 165
EP 167
DI 10.1098/rstb.2001.1032
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 535NJ
UT WOS:000174650300006
PM 11911773
OA Green Published
DA 2018-10-19
ER

PT J
AU Hiromoto, S
   Hanawa, T
AF Hiromoto, S
   Hanawa, T
TI Re-passivation current of amorphous Zr65Al7.5Ni10Cu17.5 alloy in a
   Hanks' balanced solution
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE amorphous Zr-Al-Ni-Cu alloy; biomaterial; chronoamperometry
   re-passivation
ID PHOSPHATE-BUFFERED SOLUTION; CR-P ALLOYS; POLARIZATION BEHAVIOR;
   REPASSIVATION; ELECTRODE; APPLICABILITY; RESISTANCE; PASSIVITY;
   SURFACES; FRACTURE
AB To evaluate the repassivation behavior of amorphous phase with chemical and structural homogeneity, time transient of re-passivation current density was measured on amorphous Zr65Al7.5Ni10Cu17.5 alloy and crystalline pure Zr with a momentary fracture of a ribbon shaped specimen in an artificial body fluid. Current density abruptly increased to a peak, J(peak), and exponentially decreased to the constant value, J(infinity), J(peak) and J(infinity) on the amorphous specimen were smaller than those on the crystalline specimen, indicating that the amorphous phase would show the smaller dissolution rate from bare metal surface and from a re-passive film than the crystalline specimen, respectively. On the other hand, decrease rate of the current density on the amorphous specimen was smaller than that on the crystalline specimen, indicating the regeneration of passive film on the amorphous specimen was delayed probably because the amount of metal ions dissolved at the initial stage, i.e. the source of re-passive film, was smaller on the amorphous specimen. Consequently, the total charge for the re-passivation of the amorphous specimen was smaller than that of the crystalline specimen, supposing that the amount of dissolved metal ions during re-passivation was smaller on the amorphous specimen than the crystalline specimen. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Natl Inst Mat Sci, Ctr Biomat, Reconstruct Mat Res Grp, Tsukuba, Ibaraki 3050047, Japan.
RP Hiromoto, S (reprint author), Natl Inst Mat Sci, Ctr Biomat, Reconstruct Mat Res Grp, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.
RI HIROMOTO, Sachiko/H-2686-2011; BAI, JIE/D-7448-2016
CR BASTEK PD, 1993, J ELECTROCHEM SOC, V140, P1884, DOI 10.1149/1.2220733
   BURSTEIN GT, 1983, CORROS SCI, V23, P125, DOI 10.1016/0010-938X(83)90111-7
   BURSTEIN GT, 1991, CORROS SCI, V32, P1195, DOI 10.1016/0010-938X(91)90132-9
   Goldberg JR, 1997, J BIOMED MATER RES, V37, P421, DOI 10.1002/(SICI)1097-4636(19971205)37:3<421::AID-JBM13>3.0.CO;2-E
   HANAWA T, 2000, ZAIRYO TO KANKYO, V49, P463
   HASHIMOTO K, 1976, CORROS SCI, V16, P71, DOI 10.1016/0010-938X(76)90031-7
   HASHIMOTO K, 1978, BOSHOKU GIJUTSU, V27, P279
   Hiromoto S, 2000, CORROS SCI, V42, P1651, DOI 10.1016/S0010-938X(00)00022-6
   Hiromoto S, 2000, CORROS SCI, V42, P2193, DOI 10.1016/S0010-938X(00)00056-1
   Hiromoto S, 2000, CORROS SCI, V42, P2167, DOI 10.1016/S0010-938X(00)00043-3
   HIROMOTO S, UNPUB J ELECTROCHEM
   HIROMOTO S, UNPUB MAT T
   Itagaki M, 1997, J ELECTROCHEM SOC, V144, P64, DOI 10.1149/1.1837366
   Kolman DG, 1996, J ELECTROCHEM SOC, V143, P1847, DOI 10.1149/1.1836914
   KOLMAN DG, 1995, J ELECTROCHEM SOC, V142, P2179, DOI 10.1149/1.2044272
   LEAMY HJ, 1972, METALL TRANS, V3, P699, DOI 10.1007/BF02642754
   PEARSON HJ, 1981, J ELECTROCHEM SOC, V128, P2297, DOI 10.1149/1.2127238
   POURBAIX M, 1974, ATLAS ELECTROCHEMICA, P226
   VIRTANEN S, 1990, CORROS SCI, V31, P333, DOI 10.1016/0010-938X(90)90128-R
   VIRTANEN S, 1991, ISIJ INT, V31, P229, DOI 10.2355/isijinternational.31.229
   WATSON SW, 1992, CORROSION, V48, P727, DOI 10.5006/1.3315993
NR 21
TC 29
Z9 31
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD FEB 15
PY 2002
VL 47
IS 9
BP 1343
EP 1349
AR PII S0013-4686(01)00876-3
DI 10.1016/S0013-4686(01)00876-3
PG 7
WC Electrochemistry
SC Electrochemistry
GA 536WD
UT WOS:000174724100001
DA 2018-10-19
ER

PT J
AU Lopez, MF
   Gutierrez, A
   Jimenez, JA
AF Lopez, MF
   Gutierrez, A
   Jimenez, JA
TI In vitro corrosion behaviour of titanium alloys without vanadium
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE electrochemical techniques; corrosion Biomaterials; Ti alloys; surfaces
ID PHYSIOLOGICAL SOLUTION; COATINGS
AB The corrosion behaviour of three new non-toxic titanium alloys for use as biomaterials has been investigated. The corrosion current densities of these Ti alloys have low values, indicating a passive state that is stable with time. These values were calculated by using both direct and alternate current methods. The comparison with Ti-6Al-4V, widely used as biomaterial, shows slightly lower corrosion rates for the non V-containing alloys. To determine the pitting corrosion resistance, anodic polarisation curves were performed. Those alloys containing Zr, with very low passivation current densities, show the best behaviour. This indicates a low susceptibility to localised corrosion in these alloys. The chemical surface analysis performed on the samples suggests an influence of the passive layer composition on the passivation current density. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 CSIC, Inst Ciencia Mat, E-28049 Madrid, Spain.
   Univ Miguel Hernandez, Dept Fis & Ciencia Mat, E-03202 Elche, Spain.
   CSIC, Ctr Nacl Invest Met, E-28040 Madrid, Spain.
RP Lopez, MF (reprint author), CSIC, Inst Ciencia Mat, E-28049 Madrid, Spain.
RI Lopez, Maria/C-4571-2011; Gutierrez, Alejandro/A-9092-2011; Jimenez,
   Jose/H-2644-2015
OI Lopez, Maria/0000-0001-7894-566X; Gutierrez,
   Alejandro/0000-0002-1150-0719; Jimenez, Jose/0000-0003-4272-6873
CR Bathias C, 1997, ENG FRACT MECH, V56, P255, DOI 10.1016/0013-7944(95)00256-1
   Boyer R., 1994, MAT PROPERTIES HDB T
   BREME HJ, 1998, METALS BIOMATERIALS, pCH2
   Cabrini M, 1997, BIOMATERIALS, V18, P783, DOI 10.1016/S0142-9612(96)00205-0
   CORDERO J, 1994, J BONE JOINT SURG BR, V76B, P717
   Escudero ML, 1996, J BIOMED MATER RES, V31, P313
   FRAKER AC, 1977, J MET, V5, P22
   Jones D., 1996, PRINCIPLES PREVENTIO
   KOHN DH, 1992, SERIE MAT SCI TECHNO, V14, pCH2
   Lopez MF, 2001, SURF SCI, V482, P300, DOI 10.1016/S0039-6028(00)01005-0
   LYTH C, 1970, AUST CORR ENG, V25, P34
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   PARK JB, 1995, BIOMEDICAL ENG HDB, pCH40
   SHIRKHANZADEH M, 1995, J MATER SCI-MATER M, V6, P206, DOI 10.1007/BF00146857
   SIBUM H, 1998, ALLOYS PREPARATION P, pCH11
   Steinemann S., 1980, EVALUATION BIOMATERI
   STERN M, 1957, J ELECTROCHEM SOC, V104, P56, DOI 10.1149/1.2428496
   Talbot D. E. J, 1998, CORROSION SCI TECHNO
NR 19
TC 105
Z9 106
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD FEB 15
PY 2002
VL 47
IS 9
BP 1359
EP 1364
AR PII S0013-4686(01)00860-X
DI 10.1016/S0013-4686(01)00860-X
PG 6
WC Electrochemistry
SC Electrochemistry
GA 536WD
UT WOS:000174724100003
DA 2018-10-19
ER

PT J
AU Fricain, JC
   Alouf, J
   Bareille, R
   Rouais, F
   Rouvillain, JL
AF Fricain, JC
   Alouf, J
   Bareille, R
   Rouais, F
   Rouvillain, JL
TI Cytocompatibility study of organic matrix extracted from Caribbean coral
   porites astroides
SO BIOMATERIALS
LA English
DT Article
DE coral; bone substitute; organic matrix; biomaterial cells
ID BONE-GRAFT SUBSTITUTE; RAT BONE; PROLIFERATION; STERILIZATION;
   RESORPTION; INVITRO
AB Since 1980, natural coral exoskeleton has been widely used as bone graft substitute. Despite numerous in vitro and in vivo studies, there is still a lack of knowledge concerning the organic matrix associated with coral exoskeleton (COM). In fact, some surgical interventions have failed and this has sometimes been attributed to the exoskeleton organic matrix. For others, only amino acids are present in the matrix after coral preparation for clinical use. The objective of this study was to extract the exoskeleton organic matrix to carry out biochemical analysis and study its specific cytocompatibility. Demineralized bone powder (DBP) was used as control. A decalcification process was used to extract CONI and DBP. Protein, carbohydrate and glycosaminoglycan analysis was carried out in DBP and CONI using classical staining methods. Human bone marrow cells were cultured in the presence of 20, 40, 80, 160 mug Of COM or DBP for 24, 48 and 72 h. The methods used to analyze COM and DBP effects were scanning electron microscopy, immunocytochemistry. manual cell count, and cyto-compatibility assay (Neutral red and MTT tests). Results showed that in spite of treating coral before clinical use, a COM was present in which GAG, protein and carbohydrate were found. The in vitro cytocompatibility of COM was confirmed for 20 and 40 mug values but was less pronounced for 80 and 160 mug levels. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Bordeaux 2, INSERM, U443, F-33076 Bordeaux, France.
   CHR Ft de France, Serv Chirurg Orthoped & Traumatol, F-97261 Ft de, France.
RP Fricain, JC (reprint author), Univ Bordeaux 2, INSERM, U443, Bat 4A,146 Rue Leo Saignat, F-33076 Bordeaux, France.
OI ROUVILLAIN, JEAN LOUIS/0000-0002-9076-9096
CR *AFNOR NF, 1994, 309935 AFNORNF EN
   ALLEMAND D, 1994, B I OCEANOGR MONACO, V14, P1
   [Anonymous], 1992, ISO109935
   *ASTM, 1991, F748 ASTM
   BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3
   CHIROFF RT, 1975, J BIOMED MATER RES S, V6, P29
   DEPERETTI F, 1995, COMMUNICATION GR NOV
   Fricain JC, 1998, J BIOMED MATER RES, V42, P96, DOI 10.1002/(SICI)1097-4636(199810)42:1<96::AID-JBM12>3.0.CO;2-M
   FRICAIN JC, 1997, BIOCERAMICS, V10, P383
   GOLD EW, 1979, ANAL BIOCHEM, V99, P183, DOI 10.1016/0003-2697(79)90061-7
   GRASSE P, 1987, TRAITE ZOOLOGIE, V3
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HEINEGARD D, 1989, FASEB J, V3, P2042
   HUANG DST, 1988, J ORAL MAXIL SURG, V46, P460, DOI 10.1016/0278-2391(88)90411-9
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Lopez E., 1995, B I OCEANOGR MONACO, V143, P49
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Marchac D, 1994, J Craniofac Surg, V5, P213, DOI 10.1097/00001665-199409000-00003
   MORA F, 1995, J CLIN PERIODONTOL, V22, P877, DOI 10.1111/j.1600-051X.1995.tb01787.x
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MUNTING E, 1988, ACTA ORTHOP SCAND, V59, P34, DOI 10.3109/17453678809149340
   PARACHARALAMBOU.SK, 1993, ORAL MAXILLOFAC SURG, V22, P260
   ROUDIER M, 1995, J BIOMED MATER RES, V29, P909, DOI 10.1002/jbm.820290802
   ROUVILLAIN J., 1995, J BONE JOINT SURG BR, V77B, P226
   ROUX FX, 1988, J NEUROSURG, V69, P510, DOI 10.3171/jns.1988.69.4.0510
   SCHWARZ N, 1988, ACTA ORTHOP SCAND, V59, P165
   SWIFT DM, 1986, J EXP ZOOL, V240, P65, DOI 10.1002/jez.1402400109
   Weiner S, 1983, BIOMINERALIZATION BI, P205
NR 29
TC 9
Z9 10
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 3
BP 673
EP 679
DI 10.1016/S0142-9612(01)00155-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 500RF
UT WOS:000172640000006
PM 11771687
DA 2018-10-19
ER

PT J
AU Dalby, MJ
   Kayser, MV
   Bonfield, W
   Di Silvio, L
AF Dalby, MJ
   Kayser, MV
   Bonfield, W
   Di Silvio, L
TI Initial attachment of osteoblasts to an optimised HAPEX (TM) topography
SO BIOMATERIALS
LA English
DT Article
DE osteoblasts; HAPEX; topography
ID IN-VITRO; MECHANICAL-PROPERTIES; SIGNAL-TRANSDUCTION; FOCAL ADHESIONS;
   BIOACTIVE GLASS; BONE-FORMATION; CELL BEHAVIOR; SURFACE; HYDROXYAPATITE;
   POLYETHYLENE
AB The interactions between an implant material and the Surrounding tissue are of a complicated nature, and the initial attachment of Cells to the surface is important in determining the implant success. HAPEX(TM) has been developed as a second-generation orthopaedic biomaterial. with both mechanical and biological characteristics that make it suitable for bone augmentation. Further optimisation of the material is being continued to increase the attachment of osteoblasts coupled with improving mechanical characteristics. so it may be used in load bearing applications, It has been previously observed that polishing followed by roughening the Surface of HAPEX(TM) enhances osteoblast proliferation and phenotype. This article discusses the recruitment of primary human osteoblast cells onto the optimised Surface, by examining morphology and cytoskeletal changes using scanning electron microscopy and confocal laser scanning microscopy. The results show that the cells attach in greater numbers to the optimised surface. and develop notably faster. than cells on machined HAPEX(TM). (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 IRC Biomed Mat, Inst Orthopaed, Stanmore HA7 4LP, Middx, England.
RP Dalby, MJ (reprint author), Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
RI Dalby, Matthew/G-2426-2012
OI Di Silvio, Lucy/0000-0003-2554-2052
CR ABRAM J, 1984, PLAST RUB PROC APPL, V4, P261
   ALI SY, 1992, BONE BIOL SKELETAL D, P19
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   CARY LA, 1999, FRONT BIOSCI, V4, P102
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLOVER J, 1992, J CELL SCI, V103, P267
   COOPER GM, 1997, CELL MOL APPROACH
   Cowles EA, 1998, CALCIFIED TISSUE INT, V62, P74, DOI 10.1007/s002239900397
   CURTIS A, 1999, BIOCH SOC S, V65, P15
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   Dalby MJ, 1999, J MATER SCI-MATER M, V10, P793, DOI 10.1023/A:1008907218330
   Dalby MJ, 2001, BIOMATERIALS, V22, P1739, DOI 10.1016/S0142-9612(00)00334-3
   DALBY MJ, OPTIMISING HAPEX TOP
   Dalton BA, 1999, J BIOMED MATER RES, V45, P384, DOI 10.1002/(SICI)1097-4636(19990615)45:4<384::AID-JBM14>3.0.CO;2-O
   DALTON BA, 2000, S26 TISS ENG
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   DISILVIO L, 1995, THESIS U LONDON
   DOWNES S, 1991, CELL MATER, V1, P171
   Gray C, 1996, BONE, V18, P115, DOI 10.1016/8756-3282(95)00456-4
   HARRIS SA, 1995, J BONE MINER RES, V10, P178
   HEMACHANDRA K, 1992, THESIS U LONDON
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   LARSSON C, 1994, BIOMATERIALS, V15, P1061
   MARIE PJ, 1995, CALCIF TISSUE INT S, V56
   OCONNOR TP, 1993, J CELL BIOL, V123, P935, DOI 10.1083/jcb.123.4.935
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T
   POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003
   PULEO DA, 1992, BONE MINER, V18, P215, DOI 10.1016/0169-6009(92)90808-Q
   Rajnicek AM, 1997, J CELL SCI, V110, P2915
   RIEHLE M, 2000, S28 TISS ENG
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Stein Gary S., 1993, P47
   Stephenson P K, 1991, J Arthroplasty, V6, P51, DOI 10.1016/S0883-5403(06)80157-9
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   Vuori K, 1998, J MEMBRANE BIOL, V165, P191, DOI 10.1007/s002329900433
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wang M, 2000, J MATER SCI, V35, P1023, DOI 10.1023/A:1004731315328
   WEISS MJ, 1986, P NATL ACAD SCI USA, V83, P7182, DOI 10.1073/pnas.83.19.7182
NR 43
TC 45
Z9 46
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 3
BP 681
EP 690
DI 10.1016/S0142-9612(01)00156-9
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 500RF
UT WOS:000172640000007
PM 11771688
DA 2018-10-19
ER

PT J
AU Schumacher, K
   Strehl, R
   de Vries, U
   Minuth, WW
AF Schumacher, K
   Strehl, R
   de Vries, U
   Minuth, WW
TI Advanced technique for long term culture of epithelia in a continuous
   luminal-basal medium gradient
SO BIOMATERIALS
LA English
DT Article
DE epithelia; biomaterial testing; tissue engineering; gradient perfusion
   culture
ID NEONATAL RABBIT KIDNEY; COLLECTING DUCT; IN-VITRO; CELL-DIFFERENTIATION;
   INTERCALATED CELLS; PERFUSION CULTURE; RAT-KIDNEY; REPLACEMENT;
   CYCLOOXYGENASE-2; CONTAINER
AB The majority of epithelia in Our organism perform barrier functions on being exposed to different fluids at the luminal and basal sides. To simulate this natural situation under in vitro conditions for biomaterial testing and tissue engineering the epithelia have to withstand mechanical and fluid stress over a prolonged period of time. Leakage. edge damage and pressure differences in the Culture system have to be avoided so that the epithelial barrier function is maintained. Besides, the environmental influences on important cell biological features Such as, sealing or transport functions, have to remain upregulated and a loss of characteristics by dedifferentiation is prevented.
   Our aim is to expose embryonic renal collecting duct (CD) epithelia as model tissue for 14 days to fluid gradients and to monitor the development of tissue-specific features, For these experiments, Cultured embryonic epithelia are placed in tissue carriers and in gradient containers, where different media are superfused at the luminal and as basal sides. Epithelia growing on the tissue carriers act as a physiological barrier during the whole Culture period. To avoid mechanical damage of the tissue and to suppress fluid pressure differences between the luminal and basal compartments improved transport of the medium and an elimination of unilaterally accumulated gas bubbles in the gradient container compartments by newly developed gas expander modules is introduced. By the application of these tools the yield of embryonic renal collecting duct epithelia with intact barrier function on a fragile natural support material Could be increased significantly as compared to earlier experiments. Epithelia treated with a luminal NaCl load ranging from 3 to 24 mmol/l were analyzed by immunohistochemical methods to determine the degree of differentiation. The tissue showed an upregulation of individual CD cell features as compared to embryonic epithelia in the neonatal kidney. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Regensburg, Dept Anat, D-93053 Regensburg, Germany.
RP Minuth, WW (reprint author), Univ Regensburg, Dept Anat, Univ Str 31, D-93053 Regensburg, Germany.
CR Bader A, 1999, EXP CELL RES, V246, P221, DOI 10.1006/excr.1998.4295
   Coppelli A, 1996, ACTA DIABETOL, V33, P166, DOI 10.1007/BF00569429
   EMMONS C, 1994, J CLIN INVEST, V93, P417, DOI 10.1172/JCI116976
   Fey-Lamprecht F, 1998, J MATER SCI-MATER M, V9, P711, DOI 10.1023/A:1008994601138
   Goto Y, 1999, AM J RESP CELL MOL, V20, P312, DOI 10.1165/ajrcmb.20.2.3062
   GROSS P, 1988, PFLUG ARCH EUR J PHY, V412, P434, DOI 10.1007/BF01907564
   Gstraunthaler G, 2000, AM J PHYSIOL-RENAL, V278, pF227
   Gustafson CJ, 1999, BURNS, V25, P331, DOI 10.1016/S0305-4179(99)00004-2
   HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620
   Humes HD, 1999, NAT BIOTECHNOL, V17, P451, DOI 10.1038/8626
   ISCOVE NN, 1978, J EXP MED, V147, P923, DOI 10.1084/jem.147.3.923
   KIM J, 1994, AM J PHYSIOL, V266, pF977
   Ludwikowski B, 1999, BJU INT, V84, P507
   Miki H, 1999, ASAIO J, V45, P502, DOI 10.1097/00002480-199909000-00025
   MINUTH WW, 1987, DIFFERENTIATION, V36, P12, DOI 10.1111/j.1432-0436.1987.tb00177.x
   Minuth WW, 1997, PEDIATR NEPHROL, V11, P140, DOI 10.1007/s004670050245
   MINUTH WW, 1994, IN VITRO CELL DEV-AN, V30A, P12
   Minuth WW, 1999, EXP NEPHROL, V7, P394
   MINUTH WW, 1993, KIDNEY INT, V44, P337
   Negrete HO, 1996, AM J PHYSIOL-RENAL, V271, pF886
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Ohshima N, 1997, J CHIN INST CHEM ENG, V28, P441
   Papas KK, 1999, BIOTECHNOL BIOENG, V66, P231, DOI 10.1002/(SICI)1097-0290(1999)66:4<231::AID-BIT4>3.3.CO;2-L
   Schumacher K, 1999, IN VITRO CELL DEV-AN, V35, P465
   Steiner P, 1997, DIFFERENTIATION, V62, P193
   Stockmann M, 1999, PFLUG ARCH EUR J PHY, V438, P107, DOI 10.1007/s004240050886
   Strehl R, 1999, CELL TISSUE RES, V298, P539, DOI 10.1007/s004410050076
   Strehl R, 1997, KIDNEY INT, V52, P1469, DOI 10.1038/ki.1997.477
   Surowiec SM, 2000, J SURG RES, V88, P34, DOI 10.1006/jsre.1999.5759
   Takimoto Y, 1998, J THORAC CARDIOV SUR, V116, P98, DOI 10.1016/S0022-5223(98)70247-8
   TAUC M, 1992, BIOL CELL, V76, P55, DOI 10.1016/0248-4900(92)90195-7
   Van Dorp AGM, 1999, WOUND REPAIR REGEN, V7, P214
   Waybill PN, 1999, J VASC INTERV RADIOL, V10, P1051, DOI 10.1016/S1051-0443(99)70191-0
   Williams CS, 1999, ONCOGENE, V18, P7908
   WILLIAMS CS, 1996, AM J PHYSIOL, V270, P873
   Yang TX, 1998, AM J PHYSIOL-RENAL, V274, pF481, DOI 10.1152/ajprenal.1998.274.3.F481
   Zhang MZ, 1999, P NATL ACAD SCI USA, V96, P15280, DOI 10.1073/pnas.96.26.15280
NR 37
TC 23
Z9 23
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 3
BP 805
EP 815
DI 10.1016/S0142-9612(01)00186-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 500RF
UT WOS:000172640000021
PM 11771700
DA 2018-10-19
ER

PT J
AU Ishihara, M
   Nakanishi, K
   Ono, K
   Sato, M
   Kikuchi, M
   Saito, Y
   Yura, H
   Matsui, T
   Hattori, H
   Uenoyama, M
   Kurita, A
AF Ishihara, M
   Nakanishi, K
   Ono, K
   Sato, M
   Kikuchi, M
   Saito, Y
   Yura, H
   Matsui, T
   Hattori, H
   Uenoyama, M
   Kurita, A
TI Photocrosslinkable chitosan as a dressing for wound occlusion and
   accelerator in healing process
SO BIOMATERIALS
LA English
DT Article
DE chitosan; chitin; photocrosslinking; wound occlusion; wound healing
ID FIBROBLAST-GROWTH-FACTOR; DEACETYLATED CHITIN; CYTOKINE PRODUCTION;
   BIOMATERIAL; STIMULATION; MIGRATION; MICE; DOGS
AB Application of ultraviolet light (UV-) irradiation to a photocrosslinkable chitosan (Az-CH-LA) aqueous solution resulted in an insoluble. flexible hydrogel like soft rubber within 60 s. The chitosan hydrogel could completely stop bleeding from a cut Mouse tail within 30 s of UV-irradiation and could firmly adhere two pieces of sliced skins of mouse to each other. In order to evaluate its accelerating effect on wound healing, full thickness-skin incisions were made on the back of mice and subsequently an Az-CH-LA aqueous solution was added into the wound and irradiated with UV light for 90 s. Application of the chitosan hydrogel significantly induced wound contraction and accelerated wound closure and healing. Histological examinations also have demonstrated an advanced granulation tissue formation and epithelialization in the chitosan hydrogel treated wounds. The chitosan hydrogel due to its accelerating healing ability is considered to become an excellent dressing for wound occlusion and tissue adhesive in urgent hemostasis Situations, (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Natl Def Med Coll, Res Inst, Dept Surg 2, Saitama 3598513, Japan.
   Natl Def Med Coll, Res Inst, Dept Orthopaed Surg, Saitama 3598513, Japan.
   Natl Def Med Coll, Dept Med Engn, Saitama 3598513, Japan.
   NeTech Inc, Kanagawa 2130012, Japan.
RP Ishihara, M (reprint author), Natl Def Med Coll, Res Inst, Dept Surg 2, 3-2 Namiki Tokorozawa, Saitama 3598513, Japan.
OI Sato, Masato/0000-0003-4049-7325
CR ALLAN GG, 1995, CARBOHYD RES, V277, P257, DOI 10.1016/0008-6215(95)00207-A
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   FUKASAWA M, 1992, SURG TODAY, V22, P333, DOI 10.1007/BF00308742
   GUO Y, 1989, ANAL BIOCHEM, V176, P96, DOI 10.1016/0003-2697(89)90278-9
   KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Ono I, 1999, J BIOMED MATER RES, V48, P621, DOI 10.1002/(SICI)1097-4636(1999)48:5<621::AID-JBM5>3.0.CO;2-1
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   PRUDDEN JF, 1970, AM J SURG, V119, P560, DOI 10.1016/0002-9610(70)90175-3
   Purna S K, 2000, Burns, V26, P54
   Radhakrishnan VV, 1991, BIOMEDICINE, V2, P3
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   USAMI Y, 1994, J VET MED SCI, V56, P761, DOI 10.1292/jvms.56.761
   USAMI Y, 1994, J VET MED SCI, V56, P1215, DOI 10.1292/jvms.56.1215
   WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0
NR 23
TC 289
Z9 325
U1 20
U2 175
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 3
BP 833
EP 840
DI 10.1016/S0142-9612(01)00189-2
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 500RF
UT WOS:000172640000024
PM 11771703
DA 2018-10-19
ER

PT J
AU Amaral, M
   Lopes, MA
   Silva, RF
   Santos, JD
AF Amaral, M
   Lopes, MA
   Silva, RF
   Santos, JD
TI Densification route and mechanical properties of Si3N4-bioglass
   biocomposites
SO BIOMATERIALS
LA English
DT Article
DE Si3N4-bioglass composites; hot-pressing; densification behaviour;
   mechanical properties
ID SILICON-NITRIDE; BRITTLE SOLIDS
AB The processing route and the final microstructural and mechanical characteristics of a Nobel biomaterial composite are described, This new material is composed of 70 wt% Si3N4 ceramic phase and 30 wt% bioglass, the later performing as a liquid sintering aid system and simultaneously providing bioactivity characteristics to the composite. The conditions for fabrication of an almost fully dense material (similar to 98% of relative density) were pursued. Optimised parameters were 1350 degreesC-40 min-30 MPa by hot-pressing technique, The very fast densification rate of the process avoided the crystallisation of the bioglass intergranular phase and therefore its intrinsic properties were maintained. Also, the large amount of glassy phase assured the densification by liquid phase assisted grain rearrangement Without Si3N4 Phase transformation. The final mechanical properties of the Si3N4-bioglass were as follows: fracture toughness. K-IC = 4.4 MPa m(1/2). Vickers hardness. H-V = 10.3 GPa, Young's modulus, E = 197 GPa; bending strength, sigma (R) = 383 MPa, Weibull modulus, m = 8.3. These values provide an attractive set of properties among other bioactive materials, namely by upgrading the main drawback of bioceramics and bioglasses for high-load medical applications, which is the lack of satisfactory fracture toughness. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Porto, Seccao Mat, Fac Engn, DEMM, P-4200465 Oporto, Portugal.
   Inst Biomed Engn, Lab Biomat, P-4150 Oporto, Portugal.
   Univ Aveiro, Dept Ceram & Glass Engn, UIMC, P-3810193 Aveiro, Portugal.
RP Santos, JD (reprint author), Univ Porto, Seccao Mat, Fac Engn, DEMM, Rua Roberto Frias, P-4200465 Oporto, Portugal.
RI Amaral, Margarida/B-7393-2008; Lopes, Maria A./P-4442-2014; Silva,
   Rui/B-8208-2008; Lopes, Cristina/A-4241-2010
OI Amaral, Margarida/0000-0003-4966-2614; Lopes, Maria
   A./0000-0003-4105-8148; Silva, Rui/0000-0002-2584-1792; Santos, Jose
   Domingos/0000-0002-6871-9850
CR *ASTM, C125995 ASTM
   DUCHEYNE P, 1993, ADV SERIES CERAMICS, V1, P281
   EVANS AG, 1976, ACTA METALL MATER, V24, P939, DOI 10.1016/0001-6160(76)90042-0
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   GAZZARA CP, 1977, AM CERAM SOC BULL, V56, P777
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Howlett C., 1989, CLIN ORTHOP RELAT R, V244, P296
   KINGERY WD, 1959, J APPL PHYS, V30, P301, DOI 10.1063/1.1735155
   KONG YM, 1999, J AM CERAM SOC, V82, P963
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   NIIHARA K, 1982, J MATER SCI LETT, V1, P13, DOI 10.1007/BF00724706
   Radin S, 2000, J BIOMED MATER RES, V49, P264, DOI 10.1002/(SICI)1097-4636(200002)49:2<264::AID-JBM16>3.0.CO;2-2
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   Santos J. D., 2001, KEY ENG MATER, V192-195, P589
   YAMAMURO T, 1990, HDB BIOACTIVE CERAMI, V1, P335
   ZIEGLER G, 1987, J MATER SCI, V22, P3041, DOI 10.1007/BF01161167
NR 17
TC 48
Z9 48
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 3
BP 857
EP 862
DI 10.1016/S0142-9612(01)00194-6
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 500RF
UT WOS:000172640000027
PM 11771704
DA 2018-10-19
ER

PT J
AU Wettero, J
   Askendal, A
   Bengtsson, T
   Tengvall, P
AF Wettero, J
   Askendal, A
   Bengtsson, T
   Tengvall, P
TI On the binding of complement to solid artificial surfaces in vitro
SO BIOMATERIALS
LA English
DT Article
DE biomaterial; complement activation; protein adsorption; IgG;
   hemodialysis
ID NEUTROPHIL RESPIRATORY BURST; ALTERNATIVE PATHWAY; HEMODIALYSIS
   MEMBRANES; METHYLATED SILICON; ESTER LINKAGE; GOLD SURFACES;
   HUMAN-SERUM; BOUND C-3; ACTIVATION; IGG
AB Since the realization of a complement activation capacity by artificial surfaces upon contact with blood. a common belief has evolved that charged nucleophilic surface groups such as amine (-NH2) and hydroxyl (-OH) react with and eventually bind to the internal thioester in complement factor 3 (C3). A covalent amide or ester linkage is thereby supposed to form between Ob and the surface itself. In this report, we present complement surface binding data by null-ellipsometry for two nucleophilic Surfaces (-NH2 and -OH), for surfaces with immunoglobulin G (IgG) covalently bound, and for IgG spontaneously pre-adsorbed to hydrophobic silicon. The results reveal that the plasma proteins that were deposited during complement activation became eluted by sodium dodecyl sulfate. Hence the direct covalent binding between C3 and solid nucleophilic surfaces seems to be only of moderate importance. at least during shorter serum incubations. This strongly suggests that the prevalent covalent linkage model between solid artificial Surfaces and C3b is not accurate. Instead we suggest a more pronounced role for C3 associations to other adsorbed proteins and/or electrostatic and hydrophobic protein-surface interactions. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Linkoping Univ, Div Appl Phys, Dept Phys & Measurement Technol, SE-58183 Linkoping, Sweden.
   Linkoping Univ, Fac Hlth Sci, Dept Hlth & Environm, Div Med Microbiol, SE-58185 Linkoping, Sweden.
RP Wettero, J (reprint author), Linkoping Univ, Div Appl Phys, Dept Phys & Measurement Technol, SE-58183 Linkoping, Sweden.
EM jonwe@ifm.liu.se
RI Wettero, Jonas/C-9578-2009
OI Wettero, Jonas/0000-0002-6916-5490
CR BENESCH J, 2001, IN PRESS J BIOMATER
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   CHENOWETH DE, 1987, ANN NY ACAD SCI, V516, P306, DOI 10.1111/j.1749-6632.1987.tb33051.x
   CHEUNG AK, 1989, KIDNEY INT, V35, P576, DOI 10.1038/ki.1989.26
   CHEUNG AK, 1989, KIDNEY INT, V36, P257, DOI 10.1038/ki.1989.188
   COOPER NR, 1999, INFLAMMATION BASIC P, P281
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   ELWING H, 1987, J COLLOID INTERF SCI, V119, P203, DOI 10.1016/0021-9797(87)90260-8
   GACHON A M F, 1991, Journal of Biomaterials Science Polymer Edition, V2, P263, DOI 10.1163/156856291X00160
   GADD KJ, 1981, BIOCHEM J, V195, P471, DOI 10.1042/bj1950471
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P474
   GOODMAN EB, 1995, J LEUKOCYTE BIOL, V58, P168
   HERMANSON GT, 1992, IMMOBILIZED AFFINITY, P51
   Hirata I, 2000, COLLOID SURFACE B, V18, P285, DOI 10.1016/S0927-7765(99)00154-X
   IKEDA K, 1987, J BIOL CHEM, V262, P7451
   JANATOVA J, 1991, COMPLEMENT INFLAMMAT, V8, P61, DOI 10.1159/000463181
   JOHNSON U, 1982, ACTA PATH MICRO IM C, V90, P321
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   KERN W, 1970, RCA REV, V31, P187
   LAW SK, 1977, P NATL ACAD SCI USA, V74, P2701, DOI 10.1073/pnas.74.7.2701
   LAW SK, 1979, J IMMUNOL, V123, P1388
   Law SKA, 1997, PROTEIN SCI, V6, P263
   Lhotta K, 1998, KIDNEY INT, V53, P1044
   Liu L, 1997, CLIN EXP IMMUNOL, V109, P204, DOI 10.1046/j.1365-2249.1997.4311329.x
   LIU L, 1994, J BIOMED MATER RES, V28, P767, DOI 10.1002/jbm.820280703
   Liu L, 1996, J BIOMED MATER RES, V30, P535, DOI 10.1002/(SICI)1097-4636(199604)30:4<535::AID-JBM12>3.0.CO;2-G
   Loos M., 1998, COMPLEMENT SYSTEM, P1
   McCrackin F. L., 1969, 479 NBS
   NILSSON B, 1986, IMMUNOL LETT, V13, P11, DOI 10.1016/0165-2478(86)90118-5
   NILSSON B, 1989, MOL IMMUNOL, V26, P383, DOI 10.1016/0161-5890(89)90127-2
   NILSSON B, 1985, SCAND J IMMUNOL, V22, P703, DOI 10.1111/j.1365-3083.1985.tb01933.x
   NILSSON B, 1998, COMPLEMENT SYSTEM, P23
   Pangburn M. K., 1998, COMPLEMENT SYSTEM, P93
   PANGBURN MK, 1989, J IMMUNOL, V142, P2766
   PANGBURN MK, 1989, J IMMUNOL, V142, P2759
   PETERS DA, 1979, J ELECTROCHEM SOC, V126, P883, DOI 10.1149/1.2129162
   REID KBM, 1998, COMPLEMENT SYSTEM, P86
   SAHU A, 1994, J BIOL CHEM, V269, P28997
   SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115
   STOSSEL TP, 1975, J EXP MED, V141, P1329, DOI 10.1084/jem.141.6.1329
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   Tengvall P, 1997, J BIOMED MATER RES, V35, P81, DOI 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I
   Tengvall P, 1996, BIOMATERIALS, V17, P1001, DOI 10.1016/0142-9612(96)84675-8
   Tengvall P, 1996, J BIOMED MATER RES, V31, P305, DOI 10.1002/(SICI)1097-4636(199607)31:3<305::AID-JBM3>3.0.CO;2-Q
   VENKATESH YP, 1983, ANN NY ACAD SCI, V421, P313, DOI 10.1111/j.1749-6632.1983.tb18119.x
   VENKATESH YP, 1988, MOL IMMUNOL, V25, P821, DOI 10.1016/0161-5890(88)90118-6
   VENKATESH YP, 1984, J IMMUNOL, V132, P1435
   Walivaara B, 1996, J BIOMAT SCI-POLYM E, V8, P41, DOI 10.1163/156856297X00560
   WEETALL HH, 1993, APPL BIOCHEM BIOTECH, V41, P157, DOI 10.1007/BF02916421
   Wettero J, 2001, J BIOMED MATER RES, V57, P550, DOI 10.1002/1097-4636(20011215)57:4<550::AID-JBM1201>3.0.CO;2-T
   Wettero J, 2000, J BIOMED MATER RES, V51, P742, DOI 10.1002/1097-4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D
   ZHANG W, 1994, IMMUNOLOGY, V81, P137
   ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407
NR 54
TC 40
Z9 40
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 4
BP 981
EP 991
DI 10.1016/S0142-9612(01)00203-4
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 502HR
UT WOS:000172738500002
PM 11791932
DA 2018-10-19
ER

PT J
AU Grigolo, B
   Lisignoli, G
   Piacentini, A
   Fiorini, M
   Gobbi, P
   Mazzotti, G
   Duca, M
   Pavesio, A
   Facchini, A
AF Grigolo, B
   Lisignoli, G
   Piacentini, A
   Fiorini, M
   Gobbi, P
   Mazzotti, G
   Duca, M
   Pavesio, A
   Facchini, A
TI Evidence for redifferentiation of human chondrocytes grown on a
   hyaluronan-based biomaterial (HYAFF (R) 11): molecular,
   immunohistochemical and ultrastructural analysis
SO BIOMATERIALS
LA English
DT Article
DE hyaluronan; tissue engineering; chondrocytes; collagen; proteoglycans
ID ARTICULAR-CARTILAGE; CELL-SHAPE; DEFECTS; REPAIR; TRANSPLANTATION;
   EXPRESSION; PHENOTYPE; ALGINATE; CULTURES; INVITRO
AB Association of biomaterials with autologous cells can provide a new generation of implantable devices for cartilage repair. Such scaffolds should provide a preformed three-dimensional shape and prevent cells from escaping into the articular cavity. Furthermore, these constructs should have sufficient mechanical strength to facilitate handling in a clinical setting and stimulate the uniform spreading of cells and their phenotype redifferentiation. The aim of this study was to verify the ability of HYAFF (R) 11, a recently developed hyaluronic-acid-based biodegradable polymer, to support the growth of human chondrocytes and to maintain their original phenotype. This capability was assessed by the evaluation of collagen types I, II and aggrecan mRNA expression. Immunohistochemical analyses were also performed to evaluate collagen types I, II and proteoglycans synthesis. A field emission in lens scanning microscopy was utilized to verify the interactions between the cells and the biomaterial.
   Our data indicate that human chondrocytes seeded on HYAFF (R) 11 express and produce collagen type II and aggrecan and downregulate the production of collagen type I. These results provide an in vitro demonstration for the therapeutic potential of HYAFF (R) 11 as a delivery vehicle in a tissue-engineered approach towards the repair of articular cartilage defects. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Ist Ortoped Rizzoli, Ist Ric Codivilla Putti, Lab Immunol & Genet, I-40136 Bologna, Italy.
   Univ Bologna, Unita Complessa Sci Anat Umane & Fisiopatol Appar, I-40126 Bologna, Italy.
   Fidia Adv Biopolymers, I-35031 Abano Terme, Padova, Italy.
   Univ Bologna, Dipartimento Med Interna & Gastroenterol, I-40138 Bologna, Italy.
RP Facchini, A (reprint author), Ist Ortoped Rizzoli, Ist Ric Codivilla Putti, Lab Immunol & Genet, Via di Barbiano 1-10, I-40136 Bologna, Italy.
EM labimge@alma.unibo.it
RI Grigolo, Brunella/J-5417-2016; Gobbi, Pietro/J-2566-2012
OI Grigolo, Brunella/0000-0002-3990-6745; Gobbi, Pietro/0000-0003-4705-0833
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   ARCHER CW, 1990, J CELL SCI, V97, P361
   AULTHOUSE AL, 1989, IN VITRO CELL DEV B, V25, P659
   BASSLEER C, 1986, IN VITRO CELL DEV B, V22, P113
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brun P, 1999, J BIOMED MATER RES, V46, P337, DOI 10.1002/(SICI)1097-4636(19990905)46:3<337::AID-JBM5>3.3.CO;2-H
   BUCKWALTER JA, 1990, BRIS MYER Z, P19
   BUCKWALTER JA, 1994, J BONE JOINT SURG AM, V76A, P1405, DOI 10.2106/00004623-199409000-00019
   COLETTI JM, 1972, J BONE JOINT SURG AM, VA 54, P147, DOI 10.2106/00004623-197254010-00014
   CORTIVO R, 1990, CELL BIOL INT REP, V14, P111
   DELBRUCK A, 1986, CONNECT TISSUE RES, V15, P115
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   HENDRICKSON DA, 1994, J ORTHOP RES, V12, P484
   HOMMINGA GN, 1989, ACTA ORTHOP SCAND, V60, P326, DOI 10.3109/17453678909149287
   HORTON W, 1986, DEV BIOL, V115, P392, DOI 10.1016/0012-1606(86)90258-7
   KIMURA T, 1984, CLIN ORTHOP RELAT R, P231
   KUETTNER KE, 1992, CLIN BIOCHEM, V25, P155, DOI 10.1016/0009-9120(92)90224-G
   KUETTNER KE, 1998, RHEUMATOLOGY, V2
   LEFREED, 1993, J BIOMED MATER RES, V27, P11
   MALLEINGERIN F, 1990, DIFFERENTIATION, V43, P204, DOI 10.1111/j.1432-0436.1990.tb00447.x
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   O'Driscoll SW, 1998, J BONE JOINT SURG AM, V80A, P1795, DOI 10.2106/00004623-199812000-00011
   RASTRELLI A, 1990, CLIN IMPLANT MAT, V9, P199
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Stanton JS, 1995, J MATER SCI-MATER M, V6, P739
   TRIPPEL SB, 1995, NEW ENGL J MED, V332, P539
   VACHON AM, 1991, AM J VET RES, V52, P317
   vanSusante JLC, 1995, ACTA ORTHOP SCAND, V66, P549, DOI 10.3109/17453679509002314
   WRIGHT JG, 1995, NEW ENGL J MED, V332, P540
NR 32
TC 189
Z9 195
U1 1
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 4
BP 1187
EP 1195
DI 10.1016/S0142-9612(01)00236-8
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 502HR
UT WOS:000172738500024
PM 11791922
DA 2018-10-19
ER

PT J
AU Bruining, MJ
   Pijpers, AP
   Kingshott, P
   Koole, LH
AF Bruining, MJ
   Pijpers, AP
   Kingshott, P
   Koole, LH
TI Studies on new polymeric biomaterials with tunable hydrophilicity, and
   their possible utility in corneal repair surgery
SO BIOMATERIALS
LA English
DT Article
DE polymeric biomaterials; tunable hydrophilicity; corneal repair surgery
ID PERFORATION; KERATOPROSTHESIS
AB A well-known complication in corneal repair surgery is (recurrent) rejection of donor corneal tissue, particularly in patients suffering from an auto-immune disease such as rheumatoid arthritis. Down-regulation of their immune system, by means of drugs, is necessary in order to perform an allograft implantation afterwards. The patient may need a temporary prosthetic cornea while the immune system is inactivated. Recently, NeuroPatch (R), a mesh-type polyurethane, was used for this purpose. The material exhibits excellent biocompatibility and allows ingrowth of stromal fibroblasts which deposit matrix material into the pores. A serious drawback of NeuroPatch (R) is its non-transparency, which impairs vision. In this work we attempted to develop an improved biomaterial that combines the advantages of NeuroPatch (R) with optical transparency. Based on previous findings that copolymers of hexaethyleneglycolmethacrylate (HEGMA) and butylmethacrylate (BMA), are transparent and well accepted by human corneal epithelial cells, we studied these materials further in detail. (Bruining et al., Bio-Macromolecules 1 (2000) 418) Copolymerizations were studied by means of H-1 NMR. The influence of the HEGMA content on hydrophilicity, flexibility and resistance to protein adsorption was studied. The results indicate that materials with a HEGMA content of approximately 20 mol% are potentially useful in corneal repair surgery. These biomaterials meet most of the stringent physical and biological requirements. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Maastricht, Ctr Biomat Res, NL-6200 MD Maastricht, Netherlands.
   DSM Res & Patents, Geleen, Netherlands.
   Aachen Ctr Competence, Dept Text Chem & Macromol Chem, Aachen, Germany.
RP Koole, LH (reprint author), Univ Maastricht, Ctr Biomat Res, POB 616, NL-6200 MD Maastricht, Netherlands.
OI Kingshott, Peter/0000-0001-5882-5804
CR Adachi W, 1998, BRIT J OPHTHALMOL, V82, P1445
   Beamson G., 1992, HIGH RESOLUTION XPS
   Bruining MJ, 2000, BIOMATERIALS, V21, P595, DOI 10.1016/S0142-9612(99)00223-9
   Bruining MJ, 2000, BIOMACROMOLECULES, V1, P418, DOI 10.1021/bm000009t
   Cheng CL, 1999, AUST NZ J OPHTHALMOL, V27, P437
   Hicks C, 2000, PROG RETIN EYE RES, V19, P149, DOI 10.1016/S1350-9462(99)00013-0
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Kompa S, 2000, INT J ARTIF ORGANS, V23, P345
   Kruft MAB, 1996, MACROMOLECULES, V29, P5513, DOI 10.1021/ma951399s
   Lekskul M, 2000, CORNEA, V19, P313, DOI 10.1097/00003226-200005000-00011
   NOLLER HG, 1974, J ELECTRON SPECTROSC, V5, P705, DOI 10.1016/0368-2048(74)85047-4
   Nuyts RMMA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1427
   Sandeman SR, 2000, BRIT J OPHTHALMOL, V84, P640, DOI 10.1136/bjo.84.6.640
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
NR 15
TC 16
Z9 16
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 4
BP 1213
EP 1219
DI 10.1016/S0142-9612(01)00237-X
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 502HR
UT WOS:000172738500027
PM 11791925
DA 2018-10-19
ER

PT J
AU Rosengren, A
   Pavlovic, E
   Oscarsson, S
   Krajewski, A
   Ravaglioli, A
   Piancastelli, A
AF Rosengren, A
   Pavlovic, E
   Oscarsson, S
   Krajewski, A
   Ravaglioli, A
   Piancastelli, A
TI Plasma protein adsorption pattern on characterized ceramic biomaterials
SO BIOMATERIALS
LA English
DT Article
DE biomaterials; ceramics; protein adsorption; plasma proteins
ID HUMAN CORTICAL BONE; OSTEOBLAST ADHESION; CALCIUM-PHOSPHATE;
   HYDROXYAPATITE; SURFACES; SERUM; ELECTROPHORESIS; REACTIVITY; ALBUMIN
AB The protein/biomaterial interactions of three biomaterials used in hard tissue surgery were studied in vitro. A dynamic flow system and two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) were used to investigate the adsorption of proteins from diluted human plasma on hydroxyapatite, alumina and zirconia, with regard to total protein binding capacity, relative binding capacity for specific proteins and flow-through and desorption patterns. The ceramics were characterized regarding physicochemical properties, namely, chemical composition by elementary analyses and specific surface, pore volume and pore size distribution using the BET-method and Hg-porosimetry.
   The materials were found to adsorb a surprisingly low amount of plasma proteins, leaving more than 70% of the surface free. The cellular response will therefore be highly affected by the physico-chemical properties of the material, in contrast to a surface fully covered with proteins. Regarding the adsorption of proteins, most proteins exhibited similar flow-through patterns on the three adsorbents. The exceptions with different flow-through patterns were apolipoprotein D (Apo D), apolipoprotein J (Apo J), complement factor C1s (C1s). complement factor C3 (C3), ceruloplasmin, fibrinogen, alpha (1) B glycoprotein and alpha (2) HS glycoprotein a nd serum retinal-binding protein (SRBP). The role of these proteins on acceptance or rejection of implants has to be investigated. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Uppsala, Ctr Surface Biotechnol, S-75123 Uppsala, Sweden.
   Malardalen Univ, Dept Biol & Chem Engn, S-63105 Eskilstuna, Sweden.
   Italian Natl Res Council, Inst Technol Res Ceram, I-48018 Faenza, Italy.
RP Rosengren, A (reprint author), Univ Uppsala, Ctr Surface Biotechnol, Box 577, S-75123 Uppsala, Sweden.
CR Allen T., 1997, PARTICLE SIZE MEASUR, V2
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ASHTON BA, 1976, CALC TISS RES, V22, P27
   Bergkvist M, 1998, J COLLOID INTERF SCI, V206, P475, DOI 10.1006/jcis.1998.5630
   Brash J. L., 1995, ACS SYM SER, V602, P1
   BROADLEY C, 1989, AM J PATHOL, V135, P647
   CHRISTEL PS, 1992, CLIN ORTHOP RELAT R, P10
   CLARKE IC, 1992, CLIN ORTHOP RELAT R, P19
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   FAIR BD, 1980, J COLLOID INTERF SCI, V77, P525, DOI 10.1016/0021-9797(80)90325-2
   FENG L, 1995, COLLOID SURFACE B, V4, P313, DOI 10.1016/0927-7765(95)01190-T
   FLOWER DR, 1994, FEBS LETT, V354, P7, DOI 10.1016/0014-5793(94)01078-1
   GARNETT J, 1990, BIOCHEM J, V266, P863
   GOLAZ O, 1993, ELECTROPHORESIS, V14, P1223, DOI 10.1002/elps.11501401183
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   Hanson S. R., 1996, BIOMATERIALS SCI INT, P193
   HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HO CH, 1991, J BIOMED MATER RES, V25, P423, DOI 10.1002/jbm.820250402
   Hoffman A. S., 1982, BIOMATERIALS INTERFA, P3
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   HORBETT TA, 1989, BIOMATERIALS INTERFA, P233
   Hulbert SF, 1993, INTRO BIOCERAMICS, P25
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Johnson R. J., 1996, BIOMATERIALS SCI, P173
   KARLSSON E, 1997, PROTEIN PURIFICATION, P145
   KLEIN CPAT, 1983, BIOMATERIALS, V4, P181, DOI 10.1016/0142-9612(83)90007-8
   Krajewski A, 1996, BIOMATERIALS, V17, P53, DOI 10.1016/0142-9612(96)80755-1
   Lemons JE, 1996, BONE, V19, pS121, DOI 10.1016/S8756-3282(96)00128-7
   NORDE W, 1986, J COLLOID INTERF SCI, V112, P447, DOI 10.1016/0021-9797(86)90113-X
   Okazaki J, 1999, BIOMATERIALS, V20, P309, DOI 10.1016/S0142-9612(98)00162-8
   Pankhurst GJ, 1998, BIOCHEMISTRY-US, V37, P4823, DOI 10.1021/bi972367v
   Peracchia MT, 1999, BIOMATERIALS, V20, P1269, DOI 10.1016/S0142-9612(99)00021-6
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   RAVAGLIOLI A, 1992, MAT SURG USE BIOCERA, P101
   ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V7, P669
   SCHADEL A, 1993, ORL J OTO-RHINO-LARY, V55, P216, DOI 10.1159/000276426
   Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789
   SILVER F, 1989, BIOCOMPATIBILITY INT, V1, P97
   Slack SM, 1995, ACS SYM SER, V602, P112
   SMITH AJ, 1985, CALCIFIED TISSUE INT, V37, P208, DOI 10.1007/BF02554843
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Takami Y, 1998, J BIOMED MATER RES, V40, P24, DOI 10.1002/(SICI)1097-4636(199804)40:1<24::AID-JBM3>3.3.CO;2-U
   TUNG PS, 1992, J CELL PHYSIOL, V152, P410, DOI 10.1002/jcp.1041520224
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   VEERMAN ECI, 1988, IMPLANT MATERIALS BI, V8, P331
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   WESTERMEIER R, 1997, PROTEIN PURIFICATION, P557
   YOUNG BR, 1982, BIOMATERIALS INTERFA, P317
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
   Zreiqat H., 1996, Cells and Materials, V6, P45
NR 55
TC 90
Z9 91
U1 2
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 4
BP 1237
EP 1247
DI 10.1016/S0142-9612(01)00244-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 502HR
UT WOS:000172738500030
PM 11791928
DA 2018-10-19
ER

PT J
AU LeGeros, RZ
AF LeGeros, RZ
TI Properties of osteoconductive biomaterials: Calcium phosphates
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID IN-VITRO; BONE-FORMATION; OSTEOCLASTIC RESORPTION; ELECTRON-MICROSCOPY;
   HA/BETA-TCP; HYDROXYAPATITE; INTERFACE; IMPLANTS; CERAMICS; CELLS
AB Bone is formed by a series of complex events involving the mineralization of extracellular matrix proteins rigidly orchestrated by cells with specific functions of maintaining the integrity of the bone. Bone, similar to other calcified tissues, is an intimate composite of the organic (collagen and non-collagenous proteins) and inorganic or mineral phases. The bone mineral idealized as calcium hydroxyapatite, Ca-10(PO4)(6)(OH)(2), is a carbonate-hydroxyapatite, approximated by the formula: (Ca,X)(10)(PO4,HPO4,CO3)(6)(OH,Y)(2), where X are cations (magnesium, sodium, strontium ions) that can substitute for the calcium ions, and Y are anions (chloride or fluoride ions) that can substitute for the hydroxyl group. The current author presents a brief review of CaP biomaterials that now are used as grafts for bone repair, augmentation, or substitution. Commercially-available CaP biomaterials differ in origin (natural or synthetic), composition (hydroxyapatite, beta-tricalcium phosphate, and biphasic CaP), or physical forms (particulates, blocks, cements, coatings on metal implants, composites with polymers), and in physicochemical properties. CaP biomaterials have outstanding properties: similarity in composition to bone mineral; bioactivity (ability to form bone apatitelike material or carbonate hydroxyapatite on their surfaces), ability to promote cellular function and expression leading to formation of a uniquely strong bone-CaP biomaterial interface; and osteoconductivity (ability to provide the appropriate scaffold or template for bone formation). In addition, CaP biomaterials with appropriate three-dimensional geometry are able to bind and concentrate endogenous bone morphogenetic proteins in circulation, and may become osteoinductive (capable of osteogenesis), and can be effective carriers of bone cell seeds. Therefore, CaP biomaterials potentially are useful in tissue engineering for regeneration of hard tissues.
C1 NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10010 USA.
RP LeGeros, RZ (reprint author), NYU, Coll Dent, Dept Biomat, 345 E 24th St, New York, NY 10010 USA.
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
FU NCRR NIH HHS [S07RR076226]; NIDCR NIH HHS [DE 04123, DE 12388, DE07223]
CR Acil Y, 2000, J BIOMED MATER RES, V51, P703, DOI 10.1002/1097-4636(20000915)51:4<703::AID-JBM19>3.0.CO;2-A
   Albee FH, 1920, ANN SURG, V71, P32
   AlliotLicht B, 1997, J PERIODONTOL, V68, P158, DOI 10.1902/jop.1997.68.2.158
   AOKI H, 1991, SCI MED APPL HYDROXY
   AOKI H, 1977, J DENT ENG, V18, P86
   BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210
   BAUER TW, 1995, ORTHOPEDICS, V18, P885
   BECKHAM CA, 1971, CALC TISS RES, V8, P165, DOI 10.1007/BF02010133
   BEEVERS CA, 1946, MINERAL MAG, V27, P254, DOI DOI 10.1180/MINMAG.1946.027.194.05
   BLOEBAUM RD, 1994, CLIN ORTHOP RELAT R, P19
   Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6
   BROWN WE, 1976, ANNU REV MATER SCI, V6, P213, DOI 10.1146/annurev.ms.06.080176.001241
   BROWN WE, 1962, NATURE, V196, P1048, DOI 10.1038/1961048b0
   Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1
   CHOW LC, 1991, MATER RES SOC SYMP P, V179, P3
   CHOW LC, 1998, BIOCERAMICS, V11, P45
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   Craig RG, 1999, J BIOMED MATER RES, V47, P585, DOI 10.1002/(SICI)1097-4636(19991215)47:4<585::AID-JBM16>3.0.CO;2-O
   Cranin A N, 1987, Compendium, V8, P334
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DAVIES HML, 1995, ADV NITROG HETERCYC, V1, P1
   Davies JE, 1996, ANAT REC, V245, P426
   de Jong WF, 1926, RECL TRAV CHIM PAY-B, V45, P445
   DEBRUIJN JD, 1994, J BIOMED MATER RES, V28, P105, DOI 10.1002/jbm.820280114
   DEGROOT K, 1983, BIOCERAMICS CAP
   DENISSEN HW, 1989, J PROSTHET DENT, V61, P706, DOI 10.1016/S0022-3913(89)80047-2
   DENISSEN HW, 1979, THESIS VRIJE U
   Doyle C, 1990, HDB BIOACTIVE CERAMI, V2, P195
   Driessens F. C. M., 1995, P855
   DRIESSENS FCM, 1985, CALCIFIED TISSUE INT, V37, P376, DOI 10.1007/BF02553705
   ELLIOTT JC, 1974, CLIN ORTHOP RELAT R, V93, P313
   FRONDOZA CG, 1998, BIOCERAMICS, V11, P289
   GANELES J, 1986, J PERIODONTOL, V57, P133, DOI 10.1902/jop.1986.57.3.133
   Gatti AM, 1998, BIOCERAMICS, V11, P399
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   GEESINK RGT, 1995, J BONE JOINT SURG BR, V77B, P534
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   HAYEK E, 1963, INORG SYN, V7, P63, DOI 10.1002/9780470132388.ch17
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HEUGHEBAERT M, 1988, J BIOMED MATER RES-A, V22, P257, DOI 10.1002/jbm.820221406
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   Hubbard W, 1974, THESIS MARQUETTE U M
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   Kamakura S, 1999, J DENT RES, V78, P1682, DOI 10.1177/00220345990780110401
   Kawai N, 1997, J BIOMED MATER RES, V37, P1
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   KAZIMIROFF J, 1996, BIOCERAMICS, V9, P169
   Khairoun I, 2002, J BIOMED MATER RES, V60, P633, DOI 10.1002/jbm.10132
   KLAWITTER JJ, 1979, THESIS CLEMSON U CLE
   Koerten HK, 1999, J BIOMED MATER RES, V44, P78, DOI 10.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-6
   Kokubo T, 1996, THERMOCHIM ACTA, V280, P479, DOI 10.1016/0040-6031(95)02784-X
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003
   LAURIE SWS, 1984, PLAST RECONSTR SURG, V73, P933, DOI 10.1097/00006534-198406000-00014
   Lee D D, 1999, Clin Orthop Relat Res, pS396, DOI 10.1097/00003086-199910001-00038
   LEGEROS JP, 1994, AM SOC TEST MATER, V1196, P33, DOI 10.1520/STP25181S
   LeGeros JP, 2000, J DENT RES, V79, P560
   LEGEROS R Z, 1982, Journal of Dental Research, V61, P343
   LeGeros R Z, 1996, Adv Dent Res, V10, P225
   LeGeros R Z, 1995, Connect Tissue Res, V33, P203, DOI 10.3109/03008209509017003
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LeGeros R. Z., 1970, DEV APPL SPEC      B, V7B, P3
   LeGeros R.Z, 1983, HDB EXPT ASPECTS ORA, P159
   LeGeros R. Z., 1995, ENCY HDB BIOMATERI A, V2, P1429
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   LEGEROS RZ, 1973, CALC TISS RES, V13, P173, DOI 10.1007/BF02015408
   LEGEROS RZ, 1991, BONE-BIOMATERIAL INTERFACE, P76
   LeGeros RZ, 1999, AM J DENT, V12, P65
   LEGEROS RZ, 1983, CARIES RES, V17, P419, DOI 10.1159/000260696
   LEGEROS RZ, 1986, J DENT RES, V65, P292
   LEGEROS RZ, 1967, SCIENCE, V155, P1409, DOI 10.1126/science.155.3768.1409
   LEGEROS RZ, BIOCERAMICS, V9, P796
   Legeros RZ, 1988, J DENT RES, V67, P177
   LEGEROS RZ, 1989, MAGNESIUM HLTH DIS, P11
   LEGEROS RZ, 1992, P INT SEM ORTH RES N, P147
   LEGEROS RZ, 1993, BONE BONDING BIOMATE, P201
   LEGEROS RZ, 1995, CERAMIC T, V48, P173
   LeGeros RZ, 1971, ADV XRAY ANALYSIS, V14, P57
   LEGEROS RZ, 1995, BIOCERAMICS, V8, P81
   LEGEROS RZ, 1998, BIOCERAMIC, V11, P181
   LeGeros RZ, 1967, THESIS NEW YORK U NE
   LEGEROS RZ, 1990, HDB BIOACTIVE CERAMI, V2, P17
   LEGEROS RZ, 1993, INTRO BIOCERAMICS, P139
   LEGEROS RZ, 1988, 3 WORLD BIOM C JAP, P35
   Levitt S R, 1969, J Biomed Mater Res, V3, P683, DOI 10.1002/jbm.820030413
   LINKOW L, 1984, J ORAL IMPLANTOL, V11, P211
   Liu DM, 1997, MATER SCI FORUM, V250, P183, DOI 10.4028/www.scientific.net/MSF.250.183
   MCCONNELL D, 1952, J DENT RES, V31, P53, DOI 10.1177/00220345520310012301
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   MONROE EA, 1971, J DENT RES, V50, P860, DOI 10.1177/00220345710500041201
   MORENO EC, 1977, CARIES RES, V11, P142, DOI 10.1159/000260299
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Nery EB, 1978, PROSTHET DENT, V43, P338
   NIKI M, 1991, BONE-BIOMATERIAL INTERFACE, P350
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Ohgushi H, 1997, MATER SCI FORUM, V250, P209, DOI 10.4028/www.scientific.net/MSF.250.209
   Okazaki M, 1992, Magnes Res, V5, P103
   Okazaki M., 1998, BIOCERAMICS, V11, P85
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   POSNER AS, 1954, EXPERIENTIA, V10, P424, DOI 10.1007/BF02318507
   RAY RD, 1951, SURG FORUM, V2, P429
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   REY C, 1991, CALCIFIED TISSUE INT, V49, P251, DOI 10.1007/BF02556214
   RING ME, 1985, DENT ILLUSTRATED HIS, P15
   RIPAMONTI U, 1992, MATRIX, V12, P202, DOI 10.1016/S0934-8832(11)80063-6
   ROBEY PG, 1992, DISORDERS BONE MINER, P241
   ROUFOSSE AH, 1979, J ULTRA MOL STRUCT R, V68, P235, DOI 10.1016/S0022-5320(79)90157-6
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   Ryan LM, 1999, CALCIFIED TISSUE INT, V65, P374, DOI 10.1007/s002239900716
   SAKAE T, 2000, BIOCERAMICS, V13, P347
   SCHEVILL WE, 1965, NATURE, V205, P373, DOI 10.1038/205373a0
   Schroeder H. E., 1969, FORMATION INHIBITION
   SHIRKAHANZADEH M, 1994, J MATER SCI LETT, V10, P1415
   Shors C, 1993, INTRO BIOCERAMICS, P181
   TAKATA T, 1995, J PERIODONTOL, V66, P125, DOI 10.1902/jop.1995.66.2.125
   TERMINE JD, 1966, SCIENCE, V153, P1523, DOI 10.1126/science.153.3743.1523
   Toquet J, 1999, J BIOMED MATER RES, V44, P98, DOI 10.1002/(SICI)1097-4636(199901)44:1<98::AID-JBM11>3.0.CO;2-P
   TOTH JM, 1993, BIOCERAMICS, V6, P9
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1984, CLIN ORTHOP RELAT R, V187, P277
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   VIJAYARAGHAVAN TV, 1994, J MATER SCI LETT, V13, P1782, DOI 10.1007/BF00776358
   WAGNER J R, 1989, Journal of Oral Implantology, V15, P186
   WEINER S, 1989, CONNECT TISSUE RES, V21, P589, DOI 10.3109/03008208909050015
   WINTER J, 1989, Journal of Dental Research, V68, P353
   WYKROTA LL, 1998, BIOCERAMICS, V11, P641
   Yamada S, 1997, J BIOMED MATER RES, V37, P346, DOI 10.1002/(SICI)1097-4636(19971205)37:3<346::AID-JBM5>3.0.CO;2-L
   Zambonin G, 2000, J BIOMED MATER RES, V49, P120, DOI 10.1002/(SICI)1097-4636(200001)49:1<120::AID-JBM15>3.0.CO;2-Q
NR 139
TC 915
Z9 945
U1 20
U2 415
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-921X
EI 1528-1132
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD FEB
PY 2002
IS 395
BP 81
EP 98
PG 18
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 522XE
UT WOS:000173921600010
PM 11937868
DA 2018-10-19
ER

PT J
AU Chotard-Ghodsnia, R
   Drochon, A
   Faucheux, N
   Nagel, MD
   Grebe, R
AF Chotard-Ghodsnia, R
   Drochon, A
   Faucheux, N
   Nagel, MD
   Grebe, R
TI Effect of shear stress and of transmural pressure on cAMP-dependent
   responses of cells adhering to a biomaterial
SO EUROPEAN PHYSICAL JOURNAL-APPLIED PHYSICS
LA English
DT Article
ID CULTURED ENDOTHELIAL-CELLS; HYDROSTATIC-PRESSURE; CYCLIC-AMP;
   VISCOELASTIC PROPERTIES; HYDRAULIC CONDUCTIVITY; ADHESION; ACTIVATION;
   MEMBRANE; SURFACES; PROTEIN
AB Biomaterials used in some bioreactors are porous and exposed to normal and tangential flow of physiological fluid. Flow-induced forces may influence the morphological and biochemical responses of cells adhering to these materials. The objective of this work is to examine the capacity of mechanical stress to cause changes in cell morphology via the cAMP pathway (cyclic adenosine monophosphate). This second messenger is known to modulate cell morphology in static conditions. In classical flow devices, cells are submitted to only tangential stresses. We designed a new flow system, a Hele-Shaw cell with a porous bottom wall, in order to take into account the influence of a transmural pressure. This flow chamber allows to follow up continuously the shape changes of cells that are adherent to a porous biomaterial (polyacrylonitrile) and are exposed to controlled levels of shear stress or transmural pressure. Mouse Swiss 3T3 fibroblasts exposed to a 1.1-Pa shear stress, as well as those exposed to a 84-mm Hg transmural pressure, round up (up to 50%) in a few minutes. If the cAMP pathway is inhibited when a mechanical stress is applied, cell rounding is significantly prevented. These observations suggest that flow-induced cell shape changes are cAMP-dependent. This conclusion is supported by an increased cAMP accumulation measured in cells under mechanical stress when compared to static experiments. Our in vitro flow system is thus useful to study the influence of transmural pressure or shear stress on the early morphological and biochemical responses of cells in contact with a biomaterial.
C1 Univ Technol Compiegne, CNRS, UMR 6600, F-60205 Compiegne, France.
RP Chotard-Ghodsnia, R (reprint author), Univ Technol Compiegne, CNRS, UMR 6600, BP 20529, F-60205 Compiegne, France.
CR ACEVEDO AD, 1993, J CELL PHYSIOL, V157, P603, DOI 10.1002/jcp.1041570321
   BIAGINI G, 1994, INT J ARTIF ORGANS, V17, P620
   BOURNS B, 1988, CELL MOTIL CYTOSKEL, V10, P380, DOI 10.1002/cm.970100305
   CAILLA HL, 1973, ANAL BIOCHEM, V56, P394, DOI 10.1016/0003-2697(73)90205-4
   CHOTARDGHODSNIA R, IN PRESS ASME
   CHOTARDGHODSNIA R, 2000, THESIS U TECHNOLOGY
   CHOTARDGHODSNIA R, IN PRESS BIORHEOLOGY
   Cohen CR, 1997, EXP CELL RES, V231, P184, DOI 10.1006/excr.1996.3450
   DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276
   Faucheux N, 1999, BIOMATERIALS, V20, P159, DOI 10.1016/S0142-9612(98)00156-2
   Faucheux N, 2000, BIOMATERIALS, V21, P1031, DOI 10.1016/S0142-9612(99)00277-X
   Faucheux N, 2001, BIOMATERIALS, V22, P2993, DOI 10.1016/S0142-9612(01)00045-X
   FRANGOS JA, 1988, BIOTECHNOL BIOENG, V32, P1053, DOI 10.1002/bit.260320812
   GLASS WF, 1993, J CELL PHYSIOL, V157, P296
   Groth T, 1995, ATLA-ALTERN LAB ANIM, V23, P790
   HALL AC, 1991, J ORTHOPAED RES, V9, P1, DOI 10.1002/jor.1100090102
   HASKIN C, 1993, BIOCHEM CELL BIOL, V71, P27, DOI 10.1139/o93-005
   HONIGER J, 1994, INT J ARTIF ORGANS, V17, P46
   HSIUNG CC, 1984, BIORHEOLOGY, V21, P207
   JAFFRIN MY, 1988, J BIOMECH ENG-T ASME, V110, P1, DOI 10.1115/1.3108400
   Kessler L, 1997, J BIOMED MATER RES, V34, P235, DOI 10.1002/(SICI)1097-4636(199702)34:2<235::AID-JBM13>3.0.CO;2-H
   LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567
   LEW HS, 1969, J APPL MATH PHYS, V20, P750
   LUNDBERG L, 1994, INT J ARTIF ORGANS, V17, P131
   MALEK AM, 1993, P NATL ACAD SCI USA, V90, P5999, DOI 10.1073/pnas.90.13.5999
   MANOLOPOULOS VG, 1993, BIOCHEM BIOPH RES CO, V191, P1379, DOI 10.1006/bbrc.1993.1370
   MARTINY L, 1991, FEBS LETT, V286, P105, DOI 10.1016/0014-5793(91)80951-X
   MCNAMEE CJ, 1995, CELL BIOL INT, V19, P769, DOI 10.1006/cbir.1995.1128
   MULVIHILL J, 1992, BIOMATERIALS, V13, P527, DOI 10.1016/0142-9612(92)90104-V
   Nerem R.E., 1992, ASME, V114, P274, DOI DOI 10.1115/1.2891384
   RAMIREZ OT, 1990, BIOTECHNOL BIOENG, V36, P911, DOI 10.1002/bit.260360906
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   REICH KM, 1990, J CELL PHYSIOL, V143, P100, DOI 10.1002/jcp.1041430113
   Sato M, 1996, J BIOMECH, V29, P461, DOI 10.1016/0021-9290(95)00069-0
   SATO M, 1990, J BIOMECH ENG-T ASME, V112, P263, DOI 10.1115/1.2891183
   SILL HW, 1995, AM J PHYSIOL-HEART C, V268, pH535
   SMAJE LH, 1984, BIORHEOLOGY, V21, P171
   SMIRNOV VN, 1989, J MOL CELL CARDIOL, V21, P3, DOI 10.1016/0022-2828(89)90832-8
   Tarbell JM, 1999, J APPL PHYSIOL, V87, P261
   THOUMINE O, 1995, IN VITRO CELL DEV-AN, V31, P45
   Thoumine O, 1997, BIORHEOLOGY, V34, P309, DOI 10.1016/S0006-355X(98)00007-9
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
   VANKOOTEN TG, 1992, J BIOMED MATER RES, V26, P725, DOI 10.1002/jbm.820260604
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   VIGGERS RF, 1986, J BIOMECH ENG-T ASME, V108, P332, DOI 10.1115/1.3138624
   WATSON PA, 1991, FASEB J, V5, P2013
NR 47
TC 2
Z9 2
U1 0
U2 2
PU E D P SCIENCES
PI LES ULIS CEDEXA
PA 7, AVE DU HOGGAR, PARC D ACTIVITES COURTABOEUF, BP 112, F-91944 LES ULIS
   CEDEXA, FRANCE
SN 1286-0042
J9 EUR PHYS J-APPL PHYS
JI Eur. Phys. J.-Appl. Phys
PD FEB
PY 2002
VL 17
IS 2
BP 155
EP 162
DI 10.1051/epjap:2002007
PG 8
WC Physics, Applied
SC Physics
GA 522CX
UT WOS:000173879100007
DA 2018-10-19
ER

PT J
AU Mantero, S
   Piuri, D
   Montevecchi, FM
   Vesentini, S
   Ganazzoli, F
   Raffaini, G
AF Mantero, S
   Piuri, D
   Montevecchi, FM
   Vesentini, S
   Ganazzoli, F
   Raffaini, G
TI Albumin adsorption onto pyrolytic carbon: A molecular mechanics approach
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE molecular modeling; protein adsorption; albumin; pyrolytic carbon;
   molecular mechanics
ID TEMPERATURE ISOTROPIC CARBON; PROTEIN ADSORPTION; FIBRINOGEN
AB A number of implants of cardiac valve prosthesis, vascular prosthesis, and coronary stents present a pyrolytic carbon interface to blood. Plasma protein adsorption is essential for the hemocompatibility of the implanted devices. This work quantitatively evaluates the molecular interaction force between a biomaterial surface (pyrolytic carbon) and plasma protein (albumin) binding sites through a simplified molecular model of the interface consisting of (i) multioriented graphite micro crystallites; (ii) selected fragments of albumin; and (iii) a water environment. A number of simplifying assumptions were made in the calculation: the albumin molecule was divided into hydrophobic and hydrophilic subunits (helices); an idealized clean, nonoxidized polycrystalline graphite surface was assumed to approximate the surface of pyrolytic carbon. The interaction forces between albumin helices and pyrolytic carbon surfaces are evaluated from potential energy data. These forces are decomposed into a normal and a tangential component. The first one is calculated using a docking procedure (F-perpendicular to tot MAX = 4.16 x 10(-20) N). The second one (F-parallel to), calculated by mean of geometric models estimating the energy variation associated with the protein sliding on the material surface, varies within the range +/-9.62 x 10(-21) N. The molecular simulations were performed using the commercial soft-ware package Hyperchem 5.0 (Hyperchem, Hypercube, Canada). (C) 2001 John Wiley & Sons, Inc.
C1 Politecn Milan, Dipartimento Bioingn, I-20133 Milan, Italy.
   Politecn Milan, Dipartimento Chim, I-20131 Milan, Italy.
RP Mantero, S (reprint author), Politecn Milan, Dipartimento Bioingn, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.
RI Ganazzoli, Fabio/F-9543-2013; Raffaini, Giuseppina/N-1578-2014; Mantero,
   Sara/F-6587-2013
OI Ganazzoli, Fabio/0000-0002-9762-4535; Raffaini,
   Giuseppina/0000-0003-3462-6514; MANTERO, SARA/0000-0002-1264-0465
CR BALE MD, 1988, J COLLOID INTERF SCI, V125, P516, DOI 10.1016/0021-9797(88)90017-3
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   CHUN FL, 1994, J COLLOID INTERF SCI, V168, P152
   FENG L, 1994, J BIOMED MATER RES, V28, P735, DOI 10.1002/jbm.820280611
   FENG L, 1995, J BIOMAT SCI-POLYM E, V7, P439, DOI 10.1163/156856295X00445
   FENG L, 1993, J BIOMED MATER RES, V27, P177, DOI 10.1002/jbm.820270206
   FENG L, 1994, BIOMATERIALS, V15, P323
   Frenkel D., 1996, UNDERSTANDING MOL SI
   Hentschke R, 1997, MACROMOL THEOR SIMUL, V6, P287, DOI 10.1002/mats.1997.040060201
   Israelachvili J. N., 1991, INTERMOLECULAR SURFA
   Jo S, 2000, BIOMATERIALS, V21, P605, DOI 10.1016/S0142-9612(99)00224-0
   KIRAKI N, 1989, J MICROSS, V156, P267
   Lu D R, 1990, J Biomater Sci Polym Ed, V1, P243
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   MIN X, 1992, NATURE, V358, P209
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   Pitt W G, 1991, J Biomater Sci Polym Ed, V2, P317, DOI 10.1163/156856291X00205
   PUSINERI C, 1986, BLOOD SURFACE INTERA, P45
   Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399
NR 19
TC 12
Z9 13
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2002
VL 59
IS 2
BP 329
EP 339
DI 10.1002/jbm.1249
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 497JT
UT WOS:000172452300017
PM 11745570
DA 2018-10-19
ER

PT J
AU Sigurdson, L
   Carney, DE
   Hou, YX
   Hall, L
   Hard, R
   Hicks, W
   Bright, FV
   Gardella, JA
AF Sigurdson, L
   Carney, DE
   Hou, YX
   Hall, L
   Hard, R
   Hicks, W
   Bright, FV
   Gardella, JA
TI A comparative study of primary and immortalized cell adhesion
   characteristics to modified polymer surfaces: Toward the goal of
   effective re-epithelialization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE tissue engineering; cell adhesion; primary cells; fluoropolymer; PVA
ID ETHYLENE-PROPYLENE FILMS; RESPIRATORY EPITHELIUM; TRACHEAL REPLACEMENT;
   IN-VITRO; COLLAGEN; POPULATION; ATTACHMENT; SEQUENCES; CANCER; GROWTH
AB Facilitating tissue regeneration or replacement requires development of synthetic surfaces that promote cell adhesion, migration, and proliferation. Two successful approaches have been to incorporate minimal cell adhesion recognition sequences at the biomaterial surface and to integrate the entire adhesion molecule into a compatible synthetic matrix. While adhesion assays using immortalized cell lines are important in evaluating synthetic materials, cell type and source play a significant role in the ability of such models to mimic real tissues. Models that utilize multiple cell types or primary cells are more representative of native tissues than models that use single cell types or primary cells. In this study we investigated primary respiratory epithelial cell (REC) adhesion to modified fluoropolymers incorporating simple functional groups and minimal peptide recognition sequences, and we evaluated the potential of hybrid biopolymer materials to support adhesion and proliferation. X-ray photoelectron spectroscopy (XPS) was used to verify substrate surface composition. Significant differences were found in the adhesion characteristics of primary REC and in the A549 lung carcinoma cell line. Model Systems composed of multiple cell types and/or primary cells necessarily represent increased levels of complexity for an investigation of cellular responses to synthetic surfaces. When evaluating biomaterials, adhesion studies using immortalized cell lines cannot necessarily be extrapolated to normal cell behavior. (C) 2001 John Wiley & Sons, Inc.
C1 SUNY Buffalo, Dept Chem, Buffalo, NY 14214 USA.
   Roswell Pk Canc Inst, Dept Head & Neck Surg, Buffalo, NY 14263 USA.
   SUNY Buffalo, Dept Anat Sci, Buffalo, NY 14214 USA.
RP Gardella, JA (reprint author), SUNY Buffalo, Dept Chem, Buffalo, NY 14214 USA.
CR AKIYAMA SK, 1993, SEMIN CANCER BIOL, V4, P215
   BEKOS EJ, 1996, THESIS STATE U NEW Y
   BREEZE RG, 1977, AM REV RESPIR DIS, V116, P705, DOI 10.1164/arrd.1977.116.4.705
   Cascone MG, 1996, J MATER SCI-MATER M, V7, P297, DOI 10.1007/BF00058570
   Cascone MG, 1998, POLYMER, V39, P6357, DOI 10.1016/S0032-3861(98)00148-7
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   CHOPRA DP, 1992, LARYNGOSCOPE, V102, P528, DOI 10.1288/00005537-199205000-00011
   GRILLO HC, 1990, ANN THORAC SURG, V49, P864, DOI 10.1016/0003-4975(90)90857-3
   Hicks W, 1997, EXP CELL RES, V237, P357, DOI 10.1006/excr.1997.3796
   Hicks W. L. Jr., 1994, Molecular Biology of the Cell, V5, p118A
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0
   ITOH S, 1999, BIOMATERIALS, V15, P1229
   JOLINO VG, 1982, BIOTECHNOL BIOENG, V24, P1069
   Juliano Rudy, 1996, Bioessays, V18, P911, DOI 10.1002/bies.950181110
   Kim HA, 1998, CLIN EXP RHEUMATOL, V16, P9
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lelievre S, 1996, RECENT PROG HORM RES, V51, P417
   Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   METTE SA, 1993, AM J RESP CELL MOL, V8, P562, DOI 10.1165/ajrcmb/8.5.562
   Okumura N, 1991, ASAIO Trans, V37, pM317
   PLOPPER CG, 1983, EXP LUNG RES, V5, P281, DOI 10.3109/01902148309061521
   RANDELL SH, 1992, CHEST, V101, pS11
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   SCHWARTZ MA, 1994, MOL BIOL CELL, V5, P389
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   SEPNICK D, 1997, OTOLARYNGOL J CLUB J, V4, P258
   Sigurdson SL, 1998, EXP LUNG RES, V24, P307, DOI 10.3109/01902149809041537
   STAATZ WD, 1991, J BIOL CHEM, V266, P7363
   VACANTI CA, 1994, J PEDIATR SURG, V29, P201, DOI 10.1016/0022-3468(94)90318-2
   VARGO TG, 1992, LANGMUIR, V8, P130, DOI 10.1021/la00037a025
   VARGO TG, 1995, J BIOMED MATER RES, V29, P767, DOI 10.1002/jbm.820290613
   VARGO TG, 1991, J POLYM SCI POL CHEM, V29, P555, DOI 10.1002/pola.1991.080290412
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
NR 37
TC 12
Z9 12
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2002
VL 59
IS 2
BP 357
EP 365
DI 10.1002/jbm.1252
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 497JT
UT WOS:000172452300020
PM 11745573
DA 2018-10-19
ER

PT J
AU Kidd, KR
   Nagle, RB
   Williams, SK
AF Kidd, KR
   Nagle, RB
   Williams, SK
TI Angiogenesis and neovascularization associated with extracellular
   matrix-modified porous implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE angiogenesis; ePTFE; endothelium; extracellular matrix
ID TISSUE-RESPONSE; ENDOTHELIUM; MACROPHAGES; PROSTHESES; POROSITY; GRAFTS
AB Therapies directed toward stimulation of angiogenesis seek to accelerate the development of new blood vessels in tissues rendered dysfunctional because of an insufficient microvascular supply. The goal of the current study was the stimulation of an angiogenic response around and within porous biomedical implants, such as vascular grafts, constructed from a base polymer composed of expanded polytetrafluoroethylene (ePTFE). Similar to many biomaterial, ePTFE does not elicit a significant angiogenic response and the porous interstices of this material remain avascular after implantation. Studies were performed to evaluate the ability of a tumorigenic cell line, the 804-G rat kidney cell to secrete an angiogenic extracellular matrix on and within the porous structures of ePTFE. A rat model was used to evaluate and compare implant-associated healing responses between nonmodified materials and extracellular matrix-modified ePTFE. Results demonstrated that, in contrast to untreated ePTFE, the matrix-modified ePTFE stimulated both angiogenesis in implant-associated tissue and neovascularization of the pores within the ePTFE interstices. Deposition of an insoluble matrix stimulates an angiogenic response and has a potential application for the improvement of medical device function. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Arizona, Biomed Engn Program, Tucson, AZ 85724 USA.
   Univ Arizona, Physiol Sci Grad Program, Tucson, AZ 85724 USA.
   Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA.
RP Williams, SK (reprint author), Univ Arizona, Biomed Engn Program, 1501 N Campbell Ave, Tucson, AZ 85724 USA.
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Bellon JM, 1996, J BIOMED MATER RES, V31, P1, DOI 10.1002/(SICI)1097-4636(199605)31:1<1::AID-JBM1>3.0.CO;2-S
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   DIDISHEIM P, 1993, CARDIOVASC PATHOL, V2, pS1
   Didisheim P, 1994, ASAIO J, V40, P230, DOI 10.1097/00002480-199404000-00020
   Gerritsen M, 2000, DIABETES CARE, V23, P143, DOI 10.2337/diacare.23.2.143
   GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   POLVERINI PJ, 1984, LAB INVEST, V51, P635
   Polverini PJ, 1996, EUR J CANCER, V32A, P2430, DOI 10.1016/S0959-8049(96)00386-3
   Salzmann DL, 1999, CARDIOVASC PATHOL, V8, P63, DOI 10.1016/S1054-8807(98)00003-9
   Salzmann DL, 1997, J BIOMED MATER RES, V34, P463, DOI 10.1002/(SICI)1097-4636(19970315)34:4<463::AID-JBM7>3.0.CO;2-I
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   SCHREUDERS PD, 1988, J BIOMED MATER RES, V22, P121, DOI 10.1002/jbm.820220205
   Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
   Updike SJ, 2000, DIABETES CARE, V23, P208, DOI 10.2337/diacare.23.2.208
   WILLIAMS SK, 1991, J ELECTRON MICR TECH, V19, P439, DOI 10.1002/jemt.1060190406
NR 19
TC 36
Z9 40
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2002
VL 59
IS 2
BP 366
EP 377
DI 10.1002/jbm.1253
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 497JT
UT WOS:000172452300021
PM 11745574
DA 2018-10-19
ER

PT J
AU Brodbeck, WG
   Shive, MS
   Colton, E
   Ziats, NP
   Anderson, JM
AF Brodbeck, WG
   Shive, MS
   Colton, E
   Ziats, NP
   Anderson, JM
TI Interleukin-4 inhibits tumor necrosis factor-alpha-induced and
   spontaneous apoptosis of biomaterial-adherent macrophages
SO JOURNAL OF LABORATORY AND CLINICAL MEDICINE
LA English
DT Article
ID MULTINUCLEATED GIANT-CELLS; HUMAN-MONOCYTES; FACTOR CACHECTIN;
   EXPRESSION; TNF; DEATH; ADHESION; CRACKING; INVITRO; FUSION
AB Biocompatibility of implanted materials is determined by the host foreign-body response, which is comprised of cellular (adherent monocytes and macrophages) and soluble (secreted cytokines) components. Modulating the presence, activity or both of adherent macrophages may increase or decrease the biocompatibility of implants because these cells remain adherent to the implant surface and fuse to form foreign-body giant cells (FBGCs), leading to failure of the implant. An attractive mechanism of eliminating these cells is through the induction of apoptosis; therefore ways of Inducing or inhibiting apoptosis of biomaterial-adherent inflammatory cells are being investigated. We hypothesized that interleukin-4 (IL-4) promotes macrophage survival by inhibiting tumor necrosis factor-alpha (TNF-alpha)-induced apoptosis. We found that TNF-alpha induces apoptosis in a time- and dose-dependent manner, whereas IL-4 inhibits TNF-alpha-induced and spontaneous apoptosis of biomaterial-adherent macrophages. Blocking experiments and evaluation of shedding of soluble TNF receptor type I (TNF-RI) demonstrated that endogenous TNF-alpha production Is responsible for spontaneous apoptosis of biomaterial-adherent cells and that IL-4 inhibits this opoptosis by increasing levels of shedding of soluble TNF-RI. These findings suggest that TNF-alpha and IL-4 play key roles in determining the fate of biomaterial-adherent cells and that fusion of macrophages Into FBGCs is a mechanism for promoting inflammatory-cell survival on implanted materials.
C1 Case Western Reserve Univ, Sch Med, Inst Pathol, Dept Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Sch Med, Inst Pathol, Dept Pathol, Room 306, Cleveland, OH 44106 USA.
FU NIGMS NIH HHS [GM-20380]; NHLBI NIH HHS [HL-55714]
CR AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   ANDERSON JM, 1996, BIOMATERIALS SCI, P451
   BELLOMO G, 1992, CANCER RES, V52, P1342
   BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   COLLIER TO, 1999, J BIOMED MATER RES, P141
   COTTER TG, 1990, ANTICANCER RES, V10, P1153
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433
   EIRMAN DF, 1989, J IMMUNOL, V142, P1970
   ESSNER R, 1989, J IMMUNOL, V142, P3857
   Estaquier J, 1997, BLOOD, V90, P1618
   FADY C, 1995, J INTERF CYTOK RES, V15, P71, DOI 10.1089/jir.1995.15.71
   FESUS L, 1993, FEBS LETT, V328, P1, DOI 10.1016/0014-5793(93)80952-Q
   Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3
   GORCZEYOA W, 1993, LEUKEMIA, V14, P659
   HASKILL S, 1988, J IMMUNOL, V140, P1690
   HASSAN NF, 1989, J IMMUNOL, V143, P2179
   HERNANDEZCASELLES T, 1993, J IMMUNOL, V151, P3999
   Huppertz B, 1999, ANAT EMBRYOL, V200, P1, DOI 10.1007/s004290050254
   Igleslas J, 1999, AM J PHYSIOL-RENAL, V277, pF711, DOI 10.1152/ajprenal.1999.277.5.F711
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Joyce DA, 1996, CYTOKINE, V8, P49, DOI 10.1006/cyto.1996.0007
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   Kidd VJ, 1998, ANNU REV PHYSIOL, V60, P533, DOI 10.1146/annurev.physiol.60.1.533
   KLEBANOFF SJ, 1986, J IMMUNOL, V136, P4220
   KREIPE H, 1988, AM J PATHOL, V130, P232
   LARRICK JW, 1990, FASEB J, V4, P3215
   Lieberthal W, 1998, AM J PHYSIOL-RENAL, V275, pF691, DOI 10.1152/ajprenal.1998.275.5.F691
   MAJNO G, 1995, AM J PATHOL, V146, P3
   MANAGAN DF, 1991, J IMMUNOL, V147, P3408
   MANAGAN DF, 1991, J IMMUNOL, V146, P1541
   MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545
   MARTINET Y, 1988, AM REV RESPIR DIS, V138, P659, DOI 10.1164/ajrccm/138.3.659
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MOHLER KM, 1993, J IMMUNOL, V151, P1548
   MUNKER R, 1992, ANN HEMATOL, V65, P50, DOI 10.1007/BF01715127
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0
   Perera LP, 1998, P NATL ACAD SCI USA, V95, P14308, DOI 10.1073/pnas.95.24.14308
   SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303
   TAKEDA Y, 1993, INT IMMUNOL, V5, P691, DOI 10.1093/intimm/5.6.691
   WEINRAUCH LA, 1984, UREMIA INVEST, V8, P1
   WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 54
TC 37
Z9 37
U1 1
U2 6
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-2143
J9 J LAB CLIN MED
JI J. Lab. Clin. Med.
PD FEB
PY 2002
VL 139
IS 2
BP 90
EP 100
DI 10.1067/mlc.2002.121260
PG 11
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA 535XE
UT WOS:000174671000004
PM 11919547
DA 2018-10-19
ER

PT J
AU Hiromoto, S
   Asami, K
   Tsai, AP
   Hanawa, T
AF Hiromoto, S
   Asami, K
   Tsai, AP
   Hanawa, T
TI Surface characterization of amorphous Zr-Al-(Ni, Cu) alloys immersed in
   cell-culture medium
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE zirconium-base amorphous alloy; surface composition; cell-culture
   medium; biomaterial
ID PHOSPHATE-BUFFERED SOLUTION; POLARIZATION BEHAVIOR; CORROSION; XPS;
   ADSORPTION; CHROMIUM; PROTEINS; OXIDES; OXYGEN; IRON
AB For the evaluation of zirconium-base amorphous alloys as biomaterials, the surface compositions of amorphous Zr-Al-Ni-Cu and Zr-Al-Cu alloys were characterized using X-ray photoelectron spectroscopy. The alloys were polished, autoclaved, and immersed in Hanks' solution or Eagle's minimum essential medium containing fetal bovine serum, MEM + FBS, Aluminum was enriched in the surface oxide film and the substrate just under the film of the alloys polished in water, After autoclaving, aluminum and copper were enriched in the substrate while zirconium was preferentially oxidized and incorporated into the surface oxide film. In Hanks' solution, copper and nickel decreased in the substrate and surface oxide film, resulting in the enrichment of aluminum in the substrate. In MEM + FBS, zirconium preferentially decreased by the effects of amino acids and proteins while copper was enriched in the substrate, The surface composition of zirconium-base amorphous alloys was much influenced by amino acids and proteins in MEM + FBS.
C1 Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
   Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Hiromoto, S (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
RI HIROMOTO, Sachiko/H-2686-2011; BAI, JIE/D-7448-2016
CR ASAMI K, 1984, CORROS SCI, V24, P83, DOI 10.1016/0010-938X(84)90039-8
   ASAMI K, 1976, J ELECTRON SPECTROSC, V9, P469, DOI 10.1016/0368-2048(76)80065-5
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   ASAMI K, 1977, CORROS SCI, V17, P713, DOI 10.1016/0010-938X(77)90067-1
   CLARK GCF, 1982, J BIOMED MATER RES, V16, P125, DOI 10.1002/jbm.820160205
   do Serro APVA, 1999, J BIOMED MATER RES, V46, P376, DOI 10.1002/(SICI)1097-4636(19990905)46:3<376::AID-JBM10>3.3.CO;2-K
   EAGLE H, 1959, SCIENCE, V130, P432, DOI 10.1126/science.130.3373.432
   Gebert A, 1999, MAT SCI ENG A-STRUCT, V267, P294, DOI 10.1016/S0921-5093(99)00105-7
   HANAWA T, 1992, J JPN I MET, V56, P1168, DOI 10.2320/jinstmet1952.56.10_1168
   HANKS JH, 1949, P SOC EXP BIOL MED, V71, P196
   HASHIMOTO K, 1979, CORROS SCI, V19, P3, DOI 10.1016/0010-938X(79)90003-9
   HASHIMOTO K, 1977, BOSHOKU GIJUTSU, V26, P445
   HILL D, 1998, DESIGN ENG BIOMATERI, P157
   Hiromoto S, 2000, CORROS SCI, V42, P1651, DOI 10.1016/S0010-938X(00)00022-6
   Hiromoto S, 2000, CORROS SCI, V42, P2193, DOI 10.1016/S0010-938X(00)00056-1
   Hiromoto S, 2000, CORROS SCI, V42, P2167, DOI 10.1016/S0010-938X(00)00043-3
   HIROMOTO S, IN PRESS J ELECTROCH
   HIROMOTO S, IN PRESS ELECTROCHIM
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   IVARSSON BA, 1985, COLLOID SURFACE, V13, P169
   Mu Y, 2000, J BIOMED MATER RES, V49, P238, DOI 10.1002/(SICI)1097-4636(200002)49:2<238::AID-JBM12>3.0.CO;2-J
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   TERAMOTO K, 1978, BOSHOKU GIJUTSU, V27, P57
   UENO K, 1964, CHELETMETRIC TITRATI, P31
   Wagner C., 1979, HDB XRAY PHOTOELECTR, P54
   WAGNER CD, 1990, APP, V5, P595
   YOSHIOKA H, 1991, CORROS SCI, V32, P313, DOI 10.1016/0010-938X(91)90076-2
NR 27
TC 23
Z9 24
U1 0
U2 8
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD FEB
PY 2002
VL 43
IS 2
BP 261
EP 266
DI 10.2320/matertrans.43.261
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 540MA
UT WOS:000174931700030
OA Bronze
DA 2018-10-19
ER

PT J
AU Hitchcock, AP
   Morin, C
   Tyliszczak, T
   Koprinarov, IN
   Ikeura-Sekiguchi, H
   Lawrence, JR
   Leppard, GG
AF Hitchcock, AP
   Morin, C
   Tyliszczak, T
   Koprinarov, IN
   Ikeura-Sekiguchi, H
   Lawrence, JR
   Leppard, GG
TI Soft X-ray microscopy of soft matter - Hard information from two softs
SO SURFACE REVIEW AND LETTERS
LA English
DT Article; Proceedings Paper
CT 13th International Conference on Vacuum Ultraviolet Radiation Physics
   (VUV-13)
CY JUL 23-27, 2001
CL TRIESTE, ITALY
ID POLYURETHANE POLYMERS; SPECTROMICROSCOPY; SPECTROSCOPY; ABSORPTION;
   FOAMS
AB Scanning transmission X-ray microscopy (STXM) and X-ray photoelectron emission microscopy (X-PEEM) provide quantitative chemical analysis at a spatial resolution well below 100 nm. Soft X-ray absorption or near edge X-ray absorption (NEXAFS) contrast provides sensitive differentiation of species which have similar elemental composition but are chemically distinct. Due to the ability of soft X-rays at wavelengths below the O K-edge to penetrate water, and on account of lower radiation damage, soft X-ray microscopy is an ideal tool for providing quantitative information about soft matter in the context of biological, polymer and environmental studies. Examples are given from recent studies of: phase segregation in polyurethanes and polymer blends, protein adsorption on polymers relating to biomaterial optimization, and metal mapping in biofilms. These examples show that it is indeed possible to get quantitative (hard) information by combining soft X-rays and soft materials.
C1 McMaster Univ, Brockhouse Inst Mat Res, Hamilton, ON L8S 4M1, Canada.
   Natl Water Res Inst Branch, Saskatoon, SK S7N 3H5, Canada.
   NWRI, Burlington, ON L7R 4A6, Canada.
   AIST, Tsukuba, Ibaraki 3058568, Japan.
RP Hitchcock, AP (reprint author), McMaster Univ, Brockhouse Inst Mat Res, Hamilton, ON L8S 4M1, Canada.
RI Ikeura-Sekiguchi, Hiromi/M-4150-2018; Lawrence, John/D-5758-2011
OI Ikeura-Sekiguchi, Hiromi/0000-0002-8593-0332; Lawrence,
   John/0000-0001-5872-1212
CR ADE H, 1998, EXPT METHODS PHYSICA, V32, P255
   ADE H, 2001, CHEM APPL SYNCHROTRO
   ADE H, 1992, SCIENCE, V258, P971
   ARMISTEAD JP, 1988, J APPL POLYM SCI, V35, P601, DOI 10.1002/app.1988.070350305
   Bauer E, 2001, J ELECTRON SPECTROSC, V114, P975, DOI 10.1016/S0368-2048(00)00261-9
   BAUER E, 1991, ULTRAMICROSCOPY, V36, P52, DOI 10.1016/0304-3991(91)90137-U
   Chapman HN, 1996, ULTRAMICROSCOPY, V62, P191, DOI 10.1016/0304-3991(96)00003-4
   Cornelius RM, 1999, BIOMATERIALS, V20, P341, DOI 10.1016/S0142-9612(98)00174-4
   Dawes K., 1996, EFFECTS ELECT BEAM G
   De Stasio G, 2001, J ELECTRON SPECTROSC, V114, P997, DOI 10.1016/S0368-2048(00)00369-8
   do Rego AMB, 2000, LANGMUIR, V16, P2385, DOI 10.1021/1a981657p
   Herrington R. M., 1997, FLEXIBLE POLYURETHAN
   Hitchcock AP, 2001, J SYNCHROTRON RADIAT, V8, P66, DOI 10.1107/S0909049500016447
   Hitchcock AP, 2001, ULTRAMICROSCOPY, V88, P33, DOI 10.1016/S0304-3991(00)00113-3
   HITCHCOCK AP, UNPUB
   KILCOYNE ALD, 2001, SYNCHROTRON RAD INST
   KIRZ J, 1995, Q REV BIOPHYS, V28, P33, DOI 10.1017/S0033583500003139
   Koprinarov I, 2001, MACROMOLECULES, V34, P4424, DOI 10.1021/ma001626c
   KOPRINAROV IN, UNPUB J PHYS CHEM B
   Maser J, 2000, J MICROSC-OXFORD, V197, P68
   MORELAND JC, 1994, J APPL POLYM SCI, V52, P1459, DOI 10.1002/app.1994.070521011
   MORIN C, 2001, IN PRESS J ELECT SPE
   Neuhausler U, 1999, COLLOID POLYM SCI, V277, P719, DOI 10.1007/s003960050445
   Rightor EG, 1997, J PHYS CHEM B, V101, P1950, DOI 10.1021/jp9622748
   RIGHTOR EG, UNPUB
   Rothe J, 1999, J SYNCHROTRON RADIAT, V6, P359, DOI 10.1107/S0909049599001715
   Smith AP, 1996, APPL PHYS LETT, V69, P3833, DOI 10.1063/1.117120
   TONNER BP, 1988, REV SCI INSTRUM, V59, P853, DOI 10.1063/1.1139792
   Tonner BP, 1999, SURF INTERFACE ANAL, V27, P247, DOI 10.1002/(SICI)1096-9918(199904)27:4<247::AID-SIA553>3.0.CO;2-M
   Urquhart SG, 1999, J PHYS CHEM B, V103, P4603, DOI 10.1021/jp990059w
   URQUHART SG, 1995, J POLYM SCI POL PHYS, V33, P1593, DOI 10.1002/polb.1995.090331104
   Urquhart SG, 1999, J ELECTRON SPECTROSC, V100, P119, DOI 10.1016/S0368-2048(99)00043-2
   Vermette P., 2001, BIOMEDICAL APPL POLY
   YOUNG AT, UNPUB PHYS REV B
NR 34
TC 16
Z9 16
U1 0
U2 6
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA JOURNAL DEPT PO BOX 128 FARRER ROAD, SINGAPORE 912805, SINGAPORE
SN 0218-625X
J9 SURF REV LETT
JI Surf. Rev. Lett.
PD FEB
PY 2002
VL 9
IS 1
BP 193
EP 201
DI 10.1142/S0218625X02001781
PG 9
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 589JE
UT WOS:000177754500031
DA 2018-10-19
ER

PT J
AU Zimehl, R
   Drews, J
   Fischer-Brandies, H
AF Zimehl, R
   Drews, J
   Fischer-Brandies, H
TI Thermometric monitoring of setting biomaterials
SO THERMOCHIMICA ACTA
LA English
DT Article; Proceedings Paper
CT 14th Ulm-Freiberg Calorimetry Conference
CY MAR 21-23, 2001
CL TECHN UNIV BERGAKAD FREIBERG, FREIBERG, GERMANY
SP Inst Phys Chem, German Soc Thermal Anal
HO TECHN UNIV BERGAKAD FREIBERG
DE micro-calorimetry; biomaterials; glassionomer cements; water adsorption;
   dental enamel
ID GLASS-IONOMER CEMENTS; PELLICLE FORMATION; RESTORATIVE MATERIALS;
   HYDROXYAPATITE
AB The setting reaction of different dental glues, i.e. conventional glassionomer cement (GIC), resin modified glassionomer cement (RMGIC) and composite adhesive were investigated with the thermal activity monitor (TAM). The water content of the materials and the water activity in the specimens were determined with isopiestic measurements after different setting periods. The information extracted from the thermochemical analysis for the setting reaction at different time intervals were further correlated with the material balance of the setting biomaterial. In respect to the practical application of the materials in dentistry we discussed the formation and the mechanical strength of the interfacial layer formed between enamel and orthodontic attachments. The study clearly revealed that the use of the aforementioned techniques, namely calorimetric, adsorption measurements, and the combination with microscopy and spectroscopic techniques is a suitable tool in examining the setting process of dental material. The study further elucidate information on several aspects of bonding orthodontic attachments with GIC to enamel surfaces, evaluation of material properties, future developments of biomaterials and related dental materials for orthodontic, conservative and restoring strategies. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Kiel, Inst Inorgan Chem, D-24098 Kiel, Germany.
   Univ Kiel, Clin Orthodont, D-24105 Kiel, Germany.
RP Zimehl, R (reprint author), Univ Kiel, Inst Inorgan Chem, Olshausenstr 40, D-24098 Kiel, Germany.
EM r.zimehl@email.uni-kiel.de
CR Buonocore MG., 1955, J DENT RES, V34, P849, DOI DOI 10.1177/00220345550340060801
   Craig RG, 1997, RESTORATIVE DENT MAT
   DIEDRICH P, 1992, PRAXIS ZAHNHEILKUNDE, V12, P291
   EMBERY G, 1986, ARCH ORAL BIOL, V31, P623, DOI 10.1016/0003-9969(86)90087-7
   Es-Souni M, 1999, COLLOID POLYM SCI, V277, P382, DOI 10.1007/s003960050396
   FISCHER-BRANDIES H, 1991, Deutsche Zahn- Mund- und Kieferheilkunde, V79, P349
   Fischer-Brandies H, 1992, Fortschr Kieferorthop, V53, P131, DOI 10.1007/BF02341447
   Hannig M, 2001, COLLOID POLYM SCI, V279, P479, DOI 10.1007/s003960000478
   Hannig M, 1997, EUR J ORAL SCI, V105, P422, DOI 10.1111/j.1600-0722.1997.tb02139.x
   LIE T, 1975, ARCH ORAL BIOL, V20, P739, DOI 10.1016/0003-9969(75)90045-X
   NEWMAN GV, 1965, AMER J ORTHODONTICS, V51, P901, DOI 10.1016/0002-9416(65)90203-4
   Smith AMV, 2000, ARCH ORAL BIOL, V45, P277, DOI 10.1016/S0003-9969(99)00141-7
   SMITH DC, 1990, J AM DENT ASSOC, V120, P20, DOI 10.14219/jada.archive.1990.0002
   *THERM AB, THERM DIGITAM 2 SOFT
   *THERM AB, INSTR MAN 2277 THERM
   Thylstrup A, 1994, TXB CLIN CARIOLOGY
   TSANIDIS V, 1992, J DENT RES, V71, P7, DOI 10.1177/00220345920710011201
   WILSON AD, 1971, J APPL CHEM BIOTECHN, V21, P313
   WILSON AD, 1983, J DENT RES, V62, P590, DOI 10.1177/00220345830620051801
   WILSON AD, 1970, J DENT RES, V49, P21, DOI 10.1177/00220345700490012501
   WILSON AD, 1970, J DENT RES, V49, P7, DOI 10.1177/00220345700490013301
   WILSON AD, 1988, GLASS IONOMER CEMENT
   Yoshida Y, 2000, J DENT RES, V79, P709, DOI 10.1177/00220345000790020301
   Zimehl R, 2000, COLLOID SURFACE A, V163, P55, DOI 10.1016/S0927-7757(99)00430-6
   ZIMEHL R, 2001, PROGR COLL POLYM SCI, V117
   1974, CRC HDB CHEM PHYSICS
NR 26
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0040-6031
EI 1872-762X
J9 THERMOCHIM ACTA
JI Thermochim. Acta
PD JAN 31
PY 2002
VL 382
IS 1-2
BP 161
EP 168
DI 10.1016/S0040-6031(01)00726-2
PG 8
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA 521CB
UT WOS:000173820200017
DA 2018-10-19
ER

PT J
AU Klok, HA
   Hwang, JJ
   Iyer, SN
   Stupp, SI
AF Klok, HA
   Hwang, JJ
   Iyer, SN
   Stupp, SI
TI Cholesteryl-(L-lactic acid)((n)over-bar) building blocks for
   self-assembling biomaterials
SO MACROMOLECULES
LA English
DT Article
ID LIQUID-CRYSTALS; POLYMER; POLYLACTONES; CHOLESTEROL; SURFACES; LACTIDE;
   FUNCTIONALIZATION; TRANSPLANTATION; INITIATORS; MEMBRANE
AB The synthesis and properties of a novel set of building blocks for the preparation of self-assembling biomaterials are described. These molecules consist of a relatively short oligo(L-lactic acid)((n) over bar) segment ((n) over bar = 10-40) that is substituted with a cholesterol moiety as an end group and in some cases has a second biofunctional substituent at its other terminus. The cholesterol moiety not only serves to induce liquid crystalline properties and drive the self-assembly of these oligomers, but also is expected to have an effect on the interaction of cells with these materials. The cholesteryl-(L-lactic acid)((n) over bar) (CLA((n) over bar)) oligomers form thermotropic liquid crystals and self-assemble into lamellar structures consisting of interdigitated bilayers. In addition, the CLA((n) over bar) oligomers can be homogeneously blended with poly(L-lactic acid), thereby offering the possibility to improve the cell interaction properties of this common surgical biomaterial. Furthermore, the secondary alcohol terminus of the CLA((n) over bar) oligomers allows the opportunity to introduce additional bioactive substituents such as cholesterol, indomethacin (an antiinflammatory drug), and pyrene and rhodamine B (which can act as fluorescent labels for bioimaging purposes) and various alpha-amino acids. These biofunctional CLA((n) over bar) oligomers can also be homogeneously mixed with the unsubstituted CLA((n) over bar) oligomers and thus could enable a further noncovalent functionalization of self-assembling biomaterials.
C1 Northwestern Univ, Sch Med, Dept Chem, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
RP Stupp, SI (reprint author), Northwestern Univ, Sch Med, Dept Chem, Dept Mat Sci & Engn, 2225 N Campus Dr, Evanston, IL 60208 USA.
RI Stupp, Samuel/B-6737-2009
CR AKASHI M, 1990, ADV POLYM SCI, V97, P107
   ALBERTS B, 1989, MOL BIOL CELL
   BARAKAT I, 1993, J POLYM SCI POL CHEM, V31, P505, DOI 10.1002/pola.1993.080310222
   BEDNAREK MA, 1983, INT J PEPT PROT RES, V21, P196
   BERO M, 1990, MAKROMOL CHEM, V191, P2287
   BOLIN DR, 1989, ORG PREP PROCED INT, V21, P67, DOI 10.1080/00304948909356348
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   CIFERRI A, 2000, SUPRAMOLECULAR POLYM
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   de Jong SJ, 1998, MACROMOLECULES, V31, P6397, DOI 10.1021/ma980553i
   DESANTIS P, 1968, BIOPOLYMERS, V6, P299, DOI 10.1002/bip.1968.360060305
   DUBOIS P, 1991, MAKROMOL CHEM-M SYMP, V42-3, P103, DOI 10.1002/masy.19910420108
   Emrick T, 1999, CURR OPIN COLLOID IN, V4, P15, DOI 10.1016/S1359-0294(99)00008-4
   Goodby JW, 1998, LIQ CRYST, V24, P25, DOI 10.1080/026782998207550
   Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797
   Hench LL, 1999, MATER SCI FORUM, V293, P37, DOI 10.4028/www.scientific.net/MSF.293.37
   Hubbell JA, 1998, CURR OPIN SOLID ST M, V3, P246, DOI 10.1016/S1359-0286(98)80098-3
   JAMSHIDI K, 1988, POLYMER, V29, P2229, DOI 10.1016/0032-3861(88)90116-4
   KESSLER H, 1983, TETRAHEDRON LETT, V24, P281, DOI 10.1016/S0040-4039(00)81385-4
   KLOK HA, 1998, POLYM PREPR DIV POLY, V39, P166
   KLOK HA, UNPUB
   Knoll W, 1996, ISRAEL J CHEM, V36, P357
   KRICHELDORF HR, 1995, POLYMER, V36, P1253, DOI 10.1016/0032-3861(95)93928-F
   KRICHELDORF HR, 1994, POLYMER, V35, P4175, DOI 10.1016/0032-3861(94)90593-2
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   Li LS, 1996, LIQ CRYST, V21, P469, DOI 10.1080/02678299608032856
   Lowe CR, 2000, CURR OPIN STRUC BIOL, V10, P428, DOI 10.1016/S0959-440X(00)00110-X
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Montaudo G, 1996, MACROMOLECULES, V29, P6461, DOI 10.1021/ma960538i
   MOORE JS, 1990, MACROMOLECULES, V23, P65, DOI 10.1021/ma00203a013
   Olabisi O., 1979, POLYM POLYM MISCIBIL
   Radler J, 1997, CURR OPIN SOLID ST M, V2, P330, DOI 10.1016/S1359-0286(97)80124-6
   Reinitzer F., 1888, MONATSH CHEM, V9, P421, DOI DOI 10.1007/BF01516710
   Ringsdorf H., 1975, J POLYM SCI POLYM S, V51, P135
   Sasaki S., 1985, HDB PROTON NMR SPECT, V5
   SCRIVEN EFV, 1983, CHEM SOC REV, V12, P129, DOI 10.1039/cs9831200129
   SHEEHAN JC, 1961, J ORG CHEM, V26, P2525, DOI 10.1021/jo01351a600
   Sijbesma RP, 1999, CURR OPIN COLLOID IN, V4, P24, DOI 10.1016/S1359-0294(99)00011-4
   Stupp SI, 2000, MRS BULL, V25, P42, DOI 10.1557/mrs2000.28
   TARBELL DS, 1972, P NATL ACAD SCI USA, V69, P730, DOI 10.1073/pnas.69.3.730
   vanDijkWolthuis WNE, 1997, POLYMER, V38, P6235, DOI 10.1016/S0032-3861(97)00189-4
   WEISS RG, 1988, TETRAHEDRON, V44, P3413, DOI 10.1016/S0040-4020(01)85977-9
   YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G
   YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5
NR 45
TC 84
Z9 94
U1 1
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JAN 29
PY 2002
VL 35
IS 3
BP 746
EP 759
DI 10.1021/ma010907x
PG 14
WC Polymer Science
SC Polymer Science
GA 515CQ
UT WOS:000173478200026
DA 2018-10-19
ER

PT J
AU Vago, R
   Plotquin, D
   Bunin, A
   Sinelnikov, I
   Atar, D
   Itzhak, D
AF Vago, R
   Plotquin, D
   Bunin, A
   Sinelnikov, I
   Atar, D
   Itzhak, D
TI Hard tissue remodeling using biofabricated coralline biomaterials
SO JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
LA English
DT Article; Proceedings Paper
CT Era of Biotechnology Internatiuonal Conference
CY OCT, 2000
CL BEN-GURION UNIV NEGEV, BEER SHEVA, ISRAEL
HO BEN-GURION UNIV NEGEV
DE bone; cartilage; biomaterial; remodeling; calcium carbonate; hydrocoral
AB Biotechnical and biomedical approaches were combined in an attempt to identify potential uses of biofabricated marine carbonate materials in biomedical applications. particularly as biomatrices for remodeling bone and cartilage tissue. After grafting, it is desirable for bone ingrowth to proceed as quickly as possible because the strength of the implanted region depends on a good mechanical bond forming between the implant and surrounding regions in the body. Ingrowth can take place as a result of growth of tissue and cells into the implanted porous material. or it may be promoted by transplanting cells seeded onto such a material. The rate at which ingrowth occurs is dependent on many factors, including pore size and the interconnectivity of the implanted structure. In vivo graftings into osteochondral defects demonstrated that our biofabricated porous material is highly biocompatible with cartilage and bone tissue. The biofabricated matrix was well incorporated into the biphasic osteochondral area. Resorption was followed by bone and cartilage formation, and after 4 months, the biomaterial had been replaced by new tissue. Ossification was induced and enhanced without introduction of additional factors. We believe that this is the first time that such biofabricated materials have been used for biomedical purposes. In face of the obvious environmental disadvantages of harvesting from limited natural resources, we propose the use of bioengineered coralline and other materials such as those cultured by our group under field and laboratory conditions as a possible biomatrix for hard tissue remodeling. (C) 2002 Elsevier Science B.V, All rights reserved.
C1 Ben Gurion Univ Negev, Inst Appl Biosci, IL-84105 Beer Sheva, Israel.
   Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
   Ben Gurion Univ Negev, Dept Orthoped Surg, IL-84105 Beer Sheva, Israel.
   Soroka Med Ctr, Dept Pathol, IL-84105 Beer Sheva, Israel.
   Ben Gurion Univ Negev, Dept Mat Engn, IL-84105 Beer Sheva, Israel.
RP Vago, R (reprint author), Ben Gurion Univ Negev, Inst Appl Biosci, IL-84105 Beer Sheva, Israel.
CR ABRAMOVITCHGOTT.L, 2001, J BIOCH BIOPHYS METH
   BENNISSAN B, 2000, BIOCERAMICS KEY ENG, V191, P959
   BRIAN K, 1993, BONE, V14, P225
   BRONZINO J, 1995, BIOMEDICAL ENG HDB
   Dee KC, 1996, BIOTECHNOL BIOENG, V50, P438, DOI 10.1002/(SICI)1097-0290(19960520)50:4<438::AID-BIT11>3.0.CO;2-F
   DUNN MG, 1994, IMPLANTATION BIOL HO, P230
   Hench L. L., 1993, INTRO BIOCERAMICS, P1
   Hu J, 2000, J MATER SCI TECHNOL, V16, P591
   LACEFIELD R, 1993, INTRO BIOCERAMICS, P223
   Shahgaldi BF, 1998, BIOMATERIALS, V19, P205, DOI 10.1016/S0142-9612(98)80002-1
   Vago R, 1997, NATURE, V386, P30, DOI 10.1038/386030a0
   Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j
NR 12
TC 40
Z9 40
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-022X
J9 J BIOCHEM BIOPH METH
JI J. Biochem. Biophys. Methods
PD JAN 4
PY 2002
VL 50
IS 2-3
BP 253
EP 259
DI 10.1016/S0165-022X(01)00235-4
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 510CE
UT WOS:000173190500014
PM 11741712
DA 2018-10-19
ER

PT B
AU Ringeisen, BR
   Chrisey, DB
   Krizman, DB
   Kim, H
   Young, HD
   Wu, PK
   Spargo, B
AF Ringeisen, BR
   Chrisey, DB
   Krizman, DB
   Kim, H
   Young, HD
   Wu, PK
   Spargo, B
BE Dittmar, A
   Beebe, D
TI Cell-by-cefl construction of living tissue by ambient laser transfer
SO 2ND ANNUAL INTERNATIONAL IEEE-EMBS SPECIAL TOPIC CONFERENCE ON
   MICROTECHNOLOGIES IN MEDICINE & BIOLOGY, PROCEEDINGS
SE IEEE Engineering in Medicine and Biology Society Annual Conference
   (EMBS)
LA English
DT Proceedings Paper
CT 2nd Annual International IEEE/EMBS Conference on Microtechnologies in
   Medicine and Biology
CY MAY 02-04, 2002
CL MADISON, WI
SP IEEE/Engn Med & Biol Soc, Natl Inst Hlth, Defense Adv Res Project Agcy, Motorola, NimbleGen Syst Inc, PanVera Corp, Dow Chem Co, GWC Instruments, Venture Invest LLC, Univ Wisconsin-Madison, Dept Biomed Engn, IEEE/Robot & Automat Soc, Promega
DE MAPLE DW; tissue engineering; laser processing; biomaterial patteming;
   biosensing; protein microarray; rapid prototyping
ID OXIDE STRUCTURES; SURFACE; KERATINOCYTES; RECONSTITUTE; MONOLAYERS;
   EPIDERMIS; CARTILAGE; POLYMERS; MODEL; LIVER
AB In order to fabricate and interface biological systems for next generation applications such as biosensors, protein recognition microarrays, and engineered tissues, it is imperative to have a method of accurately and rapidly depositing different active biomaterials in patterns or layered structures. Ideally, the biomaterial structures would also be compatible with many different substrates including technologically relevant platforms such as electronic circuits, microfluidic devices, or even living tissue. We have developed a technique termed matrix assisted pulsed laser evaporation direct write (MAPLE DW), that is able to form patterns and three-dimensional structures of numerous biologically active species ranging from protein solutions to living cells. Specifically, we have shown that MAPLE DW is capable of forming inesoscopic pattems of many components needed to construct complex 3D tissue such as living mammalian cells (mouse pluripotent, human ostcoblast, rat cardiac), nurnerous active proteins, extracellular matrix materials, and semi-rigid scaffold materials. This manuscript presents experimental results on our stepwise efforts to fabricate living tissue constructs. We first demonstrate the ability to form 2D microarrays from active proteins and living cells. We then discuss our efforts to begin 3D printing of both living cells and scaffold materials.
C1 USN, Res Lab, Washington, DC 20375 USA.
RP Ringeisen, BR (reprint author), USN, Res Lab, 4555 Overlook Ave SW,Codes 6372 & 6115, Washington, DC 20375 USA.
CR ASONUMA K, 1992, J PEDIATR SURG, V27, P298, DOI 10.1016/0022-3468(92)90850-7
   Athanasiou K, 1997, TISSUE ENG, V3, P363, DOI 10.1089/ten.1997.3.363
   CAPLAN AI, 1996, PRINCIPLES TISSUE EN, P599
   Caplan AI, 1998, FRONTIERS TISSUE ENG, P471
   Chrisey D, 2000, LASER FOCUS WORLD, V36, P113
   Chrisey DB, 2000, SCIENCE, V289, P879, DOI 10.1126/science.289.5481.879
   CHRISEY DB, 2000, APPL SURF SCI, V6683, P1
   DeBoer C, 1998, J IMAGING SCI TECHN, V42, P63
   FEINBERG SE, 2000, SHANGHAI J STOMATOL, V9, P36
   Fishman HA, 1996, ANAL CHEM, V68, P1181, DOI 10.1021/ac950904g
   Fitz-Gerald JM, 2000, APPL PHYS LETT, V76, P1386, DOI 10.1063/1.126040
   Folch A, 2000, J BIOMED MATER RES, V52, P346, DOI 10.1002/1097-4636(200011)52:2<346::AID-JBM14>3.0.CO;2-H
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0
   Hollister SJ, 2000, INT J ORAL MAX SURG, V29, P67, DOI 10.1034/j.1399-0020.2000.290115.x
   Horch RE, 2000, TISSUE ENG, V6, P53, DOI 10.1089/107632700320892
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   KANTOR Z, 1992, APPL PHYS A-MATER, V54, P170, DOI 10.1007/BF00323905
   Kapur R, 1996, J BIOMED MATER RES, V33, P205, DOI 10.1002/(SICI)1097-4636(199624)33:4<205::AID-JBM1>3.0.CO;2-T
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lysaght MJ, 2001, TISSUE ENG, V7, P485, DOI 10.1089/107632701753213110
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.0.CO;2-F
   Pique A, 1999, APPL PHYS A-MATER, V69, pS279, DOI 10.1007/s003390051400
   RENN MJ, 1999, TIBTECH, V17, P383
   Rennekampff HO, 1996, J SURG RES, V62, P288, DOI 10.1006/jsre.1996.0210
   RINGEISEN, UNPUB BIOTECHNOLOGY
   Ringeisen BR, 2002, BIOMATERIALS, V23, P161, DOI 10.1016/S0142-9612(01)00091-6
   RINGEISEN BR, 2001, P 4 INT C MOD SIM MI
   RINGEISEN BR, 2001, AM BIOTECHNOLOGY LAB
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   SPARGO BJ, 1994, P NATL ACAD SCI USA, V91, P11070, DOI 10.1073/pnas.91.23.11070
   Takayama S, 1999, P NATL ACAD SCI USA, V96, P5545, DOI 10.1073/pnas.96.10.5545
   Takezawa T, 2000, TISSUE ENG, V6, P641, DOI 10.1089/10763270050199587
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   VACANTI JP, 1993, CELL TRANSPLANT, V2, P409, DOI 10.1177/096368979300200508
   Voigt M, 1999, TISSUE ENG, V5, P563, DOI 10.1089/ten.1999.5.563
   Wilbur JL, 1996, NANOTECHNOLOGY, V7, P452, DOI 10.1088/0957-4484/7/4/028
   Young D, 2001, J MATER RES, V16, P1720, DOI 10.1557/JMR.2001.0237
   Zeltinger J, 2001, TISSUE ENG, V7, P9, DOI 10.1089/107632701300003250
   Zergioti I, 1998, APPL PHYS A-MATER, V66, P579, DOI 10.1007/s003390050717
NR 43
TC 2
Z9 2
U1 0
U2 6
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7480-0
J9 ENG MED BIOL SOC ANN
PY 2002
BP 120
EP 125
DI 10.1109/MMB.2002.1002277
PG 6
WC Biochemical Research Methods; Engineering, Biomedical; Engineering,
   Electrical & Electronic; Instruments & Instrumentation
SC Biochemistry & Molecular Biology; Engineering; Instruments &
   Instrumentation
GA BU48A
UT WOS:000176123400024
DA 2018-10-19
ER

PT J
AU Dost, P
   ten Cate, WJF
   Wiemann, M
AF Dost, P
   ten Cate, WJF
   Wiemann, M
TI Osteoblast-like cell cultures from human stapes
SO ACTA OTO-LARYNGOLOGICA
LA English
DT Article
DE alkaline phosphatase; biomaterials; osteoblast-like cells; osteocalcine;
   stapes
ID HUMAN-BONE; BIOCOMPATIBILITY; EXPRESSION; MARROW; GROWTH
AB Objective-In order to develop new middle ear prostheses for ossicular reconstruction it is important to study how the recipient middle ear tissues, especially the stapes footplate and superstructure, react to the implanted biomaterial. In this respect, animal studies and cell cultures using non-specific cells are of limited value.
   Material and methods-The morphology and growth pattern of cells cultured from human stapes were studied. Cultured cells were examined for the presence of alkaline phosphatase and were processed for immunocytochemistry in order to detect the presence of osteocalcine. Fibroblast cultures served as controls.
   Results-Cultured stapes cells proliferated in a polygonal-cubic shape and without any regular pattern in the culture. These cells were shown to contain alkaline phosphatase and osteocalcine. Cultured fascia fibroblasts proliferated in a spindle-shaped form and in a pattern resembling a shoal of fish. Cultured fibroblasts did not contain alkaline phosphatase or osteocalcine.
   Conclusions-It is possible to culture osteoblasts from human stapes. These cells can be characterized as osteoblast-like cells by means of their external shape and the presence of alkaline phosphatase and osteocalcine. Using these cultures, specific in vitro investigations concerning the interaction of biomaterials and middle ear ossicles could be performed.
C1 Univ Essen Gesamthsch, Dept Otorhinolaryngol, Essen, Germany.
   Univ Essen Gesamthsch, Inst Physiol, Essen, Germany.
RP Dost, P (reprint author), Univ HNO Klin, DE-45122 Essen, Germany.
CR ASHTON BA, 1985, BONE, V6, P313, DOI 10.1016/8756-3282(85)90321-7
   ATTAWIA MA, 1995, J BIOMED MATER RES, V29, P843, DOI 10.1002/jbm.820290709
   BELEITES E, 1985, LARYNG RHINOL OTOL V, V64, P217, DOI 10.1055/s-2007-1008123
   BODO M, 1991, CELL MOL BIOL, V37, P597
   BUDDECKE E, 1980, GRUNDRISS BIOCH
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   DOST P, 2002, IN PRESS ORL J OTORH
   EAGLE H, 1959, SCIENCE, V130, P432, DOI 10.1126/science.130.3373.432
   ERIKSEN EF, 1988, SCIENCE, V241, P84, DOI 10.1126/science.3388021
   HARRIS SA, 1995, J BONE MINER RES, V10, P178
   HENDRICH C, 1996, BIOMED TECH, V41, P276
   JAHNKE K, 1987, HNO, V35, P1
   LANGEFELD S, 1997, 10 C BIOM 13 14 FEBR
   LIND M, 1995, CYTOKINE, V7, P78, DOI 10.1006/cyto.1995.1010
   Liu F, 1997, EXP CELL RES, V232, P97, DOI 10.1006/excr.1997.3501
   LIU F, 1994, DEV BIOL, V166, P220, DOI 10.1006/dbio.1994.1309
   LUBBEN B, 1996, CHIRURGIE, V1, P155
   MAURIZI M, 1988, AM J OTOLARYNG, V9, P68, DOI 10.1016/S0196-0709(88)80010-3
   MAURIZI M, 1983, CELL TISSUE RES, V229, P505
   Moschinsky E, 1991, Dtsch Zahn Mund Kieferheilkd Zentralbl, V79, P269
   Park Yong-Koo, 1995, Journal of Korean Medical Science, V10, P263
   WILKE A, 1993, BIOMED TECH, V38, P126, DOI 10.1515/bmte.1993.38.6.126
   1994, BIOL BEURTEILUNG MED, V5
NR 23
TC 3
Z9 8
U1 0
U2 2
PU TAYLOR & FRANCIS AS
PI OSLO
PA CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY
SN 0001-6489
J9 ACTA OTO-LARYNGOL
JI Acta Oto-Laryngol.
PY 2002
VL 122
IS 8
BP 836
EP 840
DI 10.1080/000164802321040964
PG 5
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 635GG
UT WOS:000180390400007
PM 12542202
DA 2018-10-19
ER

PT S
AU Gibson, AL
   Wilson, LH
   Wilkerson, WR
   Feinberg, AW
   Seegert, CA
   Baney, RH
   Brennan, AB
AF Gibson, AL
   Wilson, LH
   Wilkerson, WR
   Feinberg, AW
   Seegert, CA
   Baney, RH
   Brennan, AB
BE Moss, SC
TI Characterization of chemically and topographically modified siloxane
   elastomer for controlled cell growth
SO ADVANCED BIOMATERIALS-CHARACTERIZATION, TISSUE ENGINEERING AND
   COMPLEXITY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposia on Physical Characterization of Biological Materials and
   Systems/Polymeric Biomaterials for Tissue Engineering/BioInspired
   Materials-Moving Toward Complexity
CY NOV 26-29, 2001
CL BOSTON, MA
SP Mat Res Soc
ID SILICONE; COATINGS; SURFACES; BEHAVIOR; RELEASE
AB A main limitation of biomedical devices is the inability to start, stop, and control cell growth making it crucial to develop biomaterial surfaces that induce a desired cellular response. Micropatterns of ridges and pillars were created in a siloxane elastomer (Dow Corning) by casting against epoxy replicates of a micromachined silicon wafer. Silicone oils were incorporated to determine the change in modulus and surface energy caused by these additives. SEM and white light interference profilometry verified that the micropatterning process produced high fidelity, low defect micropatterns. Mechanical analysis indicated that varying the viscosity, weight percent and functionality of the added silicone oil could change the elastic modulus by over an order of magnitude (0.1-2.3 MPa). As a self-wetting resin, silicone oils migrate to the surface, hence changing the surface properties from the bulk. Both topographical and chemical features define the surface energy, which in combination with elastic modulus, dictate biological activity. The results imply that the morphology, mechanical properties and surface energy of the siloxane elastomer can be modified to elicit a specific cell response as a function of engineered topographical and chemical functionalization.
C1 Univ Florida, Dept Mat Sci & Engn, Biomed Engn Program, Gainesville, FL 32611 USA.
RP Gibson, AL (reprint author), Univ Florida, Dept Mat Sci & Engn, Biomed Engn Program, Gainesville, FL 32611 USA.
CR Berglin M, 1999, J ADHES SCI TECHNOL, V13, P713, DOI 10.1163/156856199X00956
   Brady RF, 2000, BIOFOULING, V15, P73, DOI 10.1080/08927010009386299
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Kohl JG, 1999, PROG ORG COAT, V36, P15, DOI 10.1016/S0300-9440(98)00074-5
   Oner D, 2000, LANGMUIR, V16, P7777, DOI 10.1021/la000598o
   SAFRIN EG, LANGMUIR, V64, P519
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P675
   Tan J, 2000, J BIOMED MATER RES, V51, P694, DOI 10.1002/1097-4636(20000915)51:4<694::AID-JBM18>3.3.CO;2-E
NR 10
TC 1
Z9 1
U1 0
U2 0
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-647-8
J9 MATER RES SOC SYMP P
PY 2002
VL 711
BP 169
EP 174
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BU92B
UT WOS:000177402200023
DA 2018-10-19
ER

PT S
AU Miller, DC
   Thapa, A
   Haberstroh, KM
   Webster, TJ
AF Miller, DC
   Thapa, A
   Haberstroh, KM
   Webster, TJ
BE Moss, SC
TI An in vitro study of nano-fiber polymers for guided vascular
   regeneration
SO ADVANCED BIOMATERIALS-CHARACTERIZATION, TISSUE ENGINEERING AND
   COMPLEXITY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposia on Physical Characterization of Biological Materials and
   Systems/Polymeric Biomaterials for Tissue Engineering/BioInspired
   Materials-Moving Toward Complexity
CY NOV 26-29, 2001
CL BOSTON, MA
SP Mat Res Soc
AB Biomaterials that successfully integrate into surrounding tissue should match not only the tissue's mechanical properties, but also the dimensions of the associated nano-structured extracellular matrix (ECM) components. The goal of this research was to use these ideals to develop a synthetic, nano-structured, polymeric biomaterial that has cytocompatible and mechanical behaviors similar to that of natural vascular tissue. In a novel manner, poly-lactic acid/polyglycolic acid (PLGA) (50/50 wt.% mix) and polyurethane were separately synthesized to possess a range of fiber dimensions in the micron and nanometer regime. Preliminary results indicated that decreasing fiber diameter on both PLGA and PU enhanced arterial smooth muscle cell adhesion; specifically, arterial smooth muscle cell adhesion increased 23% when PLGA fiber dimensions decreased from 500 to 50 nm and increased 76% on nano-structured, compared to conventional structured, polyurethane. However, nano-structured PLGA decreased endothelial cell adhesion by 52%, whereas adhesion of these same cells was increased by 50% on polyurethane. For these reasons, the present in vitro study provides the first evidence that polymer fiber dimensions can be used to selectively control cell functions for vascular prosthesis.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP Miller, DC (reprint author), Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
CR Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
NR 3
TC 1
Z9 1
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-647-8
J9 MATER RES SOC SYMP P
PY 2002
VL 711
BP 201
EP 204
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BU92B
UT WOS:000177402200028
DA 2018-10-19
ER

PT J
AU Rivers, TJ
   Hudson, TW
   Schmidt, CE
AF Rivers, TJ
   Hudson, TW
   Schmidt, CE
TI Synthesis of a novel, biodegradable electrically conducting polymer for
   biomedical applications
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID NERVE REGENERATION; ELECTROMAGNETIC-FIELDS; GUIDANCE CHANNELS;
   BONE-FORMATION; STIMULATION; POLYPYRROLE; ROUTE
AB We report the synthesis and characterization of a novel biomaterial that possesses the unique properties of being both electrically conducting and biodegradable; and thus capable of electronic interfacing with tissue. This polymer was synthesized from conducting oligomers of pyrrole and thiophene that are connected together via degradable ester linkages. We demonstrate that this polymer is conductive, degradable, and biocompatible.
C1 Univ Texas, Texas Mat Inst & Biomed Engn, Dept Chem Engn, Austin, TX 78712 USA.
RP Rivers, TJ (reprint author), Univ Texas, Texas Mat Inst & Biomed Engn, Dept Chem Engn, 26th & Speedway,MC C0400, Austin, TX 78712 USA.
RI Schmidt, Christine/P-1613-2016
CR AARON RK, 1993, J CELL BIOCHEM, V52, P42, DOI 10.1002/jcb.240520107
   BISWAS M, 1994, J APPL POLYM SCI, V51, P1574
   CIOMBOR DM, 1993, J CELL BIOCHEM, V52, P37, DOI 10.1002/jcb.240520106
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I
   Donat-Bouillud A, 1997, CHEM MATER, V9, P2815, DOI 10.1021/cm9701926
   FINE EG, 1991, BIOMATERIALS, V12, P775, DOI 10.1016/0142-9612(91)90029-A
   Goldman R, 1996, BIOELECTROMAGNETICS, V17, P450, DOI 10.1002/(SICI)1521-186X(1996)17:6<450::AID-BEM4>3.0.CO;2-2
   Green TR, 2000, J BIOMED MATER RES, V53, P490, DOI 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7
   GROENENDAAL L, 1995, MACROMOLECULES, V28, P116, DOI 10.1021/ma00105a015
   HONG YL, 1995, CHEM MATER, V7, P1999, DOI 10.1021/cm00059a003
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Ikada Y, 1996, J BIOMED MATER RES, V30, P553
   KANAZAWA KK, 1980, SYNTHETIC MET, V1, P329, DOI 10.1016/0379-6779(80)90022-3
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MERRILL BA, 1990, J ORG CHEM, V55, P2904, DOI 10.1021/jo00296a062
   PFLUGER P, 1984, J CHEM PHYS, V80, P544, DOI 10.1063/1.446428
   POLITIS MJ, 1989, NEUROSURGERY, V25, P71, DOI 10.1227/00006123-198907000-00012
   POMERANZ B, 1993, BRAIN RES, V603, P271, DOI 10.1016/0006-8993(93)91247-P
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SISKEN BF, 1993, J CELL BIOCHEM, V51, P404, DOI 10.1002/jcb.2400510404
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   VALENTINI RF, 1989, BRAIN RES, V480, P300, DOI 10.1016/0006-8993(89)90196-0
   WALLACE DM, 1993, J ORG CHEM, V58, P7245, DOI 10.1021/jo00077a056
   ZANAKIS MF, 1990, ACUPUNCTURE ELECTRO, V15, P185, DOI 10.3727/036012990816358199
NR 27
TC 215
Z9 218
U1 3
U2 114
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD JAN
PY 2002
VL 12
IS 1
BP 33
EP 37
DI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 515YQ
UT WOS:000173524600005
DA 2018-10-19
ER

PT S
AU Mazzobre, MF
   Longinotti, MP
   Corti, HR
   Buera, MP
AF Mazzobre, MF
   Longinotti, MP
   Corti, HR
   Buera, MP
BE Levine, H
TI Thermophysical properties of amorphous dehydrated and frozen sugar
   systems, as affected by salts
SO AMORPHOUS FOOD AND PHARMACEUTICAL SYSTEMS
SE Royal Society of Chemistry Special Publications
LA English
DT Proceedings Paper
CT Conference on the Amorphous State - A Critical Review
CY MAY 15-17, 2001
CL CHURCHILL COLL, CAMBRIDGE, ENGLAND
SP BioUpdate Fdn, Royal Soc Chem, Biotechnol Grp
HO CHURCHILL COLL
ID DIFFERENTIAL SCANNING CALORIMETRY; AQUEOUS-SOLUTIONS; BIOMATERIAL
   STABILIZATION; ELECTRICAL-CONDUCTIVITY; SUPERCOOLED LIQUIDS;
   GLASS-TRANSITION; WATER ACTIVITY; ICE FORMATION; TREHALOSE; STATE
C1 Univ Buenos Aires, Fac Ciencias Exactas & Nat, INQUIMAE, Dpto Ind, RA-1428 Buenos Aires, DF, Argentina.
RP Mazzobre, MF (reprint author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, INQUIMAE, Dpto Ind, RA-1428 Buenos Aires, DF, Argentina.
EM florm@di.fcem.uba.ar; pilar@di.fcen.uba.ar
CR ANGELL CA, 1994, J FOOD ENG, V22, P115, DOI 10.1016/0260-8774(94)90028-0
   Angyal S., 1973, PURE APPL CHEM, V35, P131, DOI DOI 10.1351/PAC197335020131
   Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380
   BARTHEL J, 1983, J SOLUTION CHEM, V12, P449, DOI 10.1007/BF00651698
   BARTHEL J, 1980, J SOLUTION CHEM, V9, P209, DOI 10.1007/BF00648327
   Cardona S, 1997, J FOOD SCI, V62, P105, DOI 10.1111/j.1365-2621.1997.tb04378.x
   CARPENTER JF, 1988, CRYOBIOLOGY, V25, P459, DOI 10.1016/0011-2240(88)90054-5
   CHVOJ Z, 1991, KINETIC PHASE DIAGRA, P169
   COOK WJ, 1973, CARBOHYD RES, V31, P265, DOI 10.1016/S0008-6215(00)86191-1
   DOREMUS RH, 1985, RATES PHASE TRANSFOR, V24
   Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99
   FLINK J M, 1983, P473
   GOETZE W, 1991, LIQUIDS FREEZING GLA
   GOLDBERG RN, 1978, J PHYS CHEM REF DATA, V7, P263, DOI 10.1063/1.555569
   GRAYDON JW, 1994, J NON-CRYST SOLIDS, V175, P31, DOI 10.1016/0022-3093(94)90312-3
   HEMMINGA MA, 1993, GLASSY STATE IN FOODS, P157
   HER LM, 1995, PHARMACEUT RES, V12, P768, DOI 10.1023/A:1016280113800
   Iglesias HA, 1997, J SCI FOOD AGR, V75, P183, DOI 10.1002/(SICI)1097-0010(199710)75:2<183::AID-JSFA860>3.0.CO;2-T
   Johnson WA, 1939, T AM I MIN MET ENG, V135, P416
   KAREL M, 1981, WATER RELATIONS FOOD, P639
   Kedward CJ, 2000, J FOOD SCI, V65, P324, DOI 10.1111/j.1365-2621.2000.tb16001.x
   KOLMOGOROV AN, 1937, VESTN USSR ACAD SCI, V3, P3551
   Longinotti MP, 2002, PHYS CHEM CHEM PHYS, V4, P533, DOI 10.1039/b107746e
   Mazzobre MF, 2001, CRYOBIOLOGY, V43, P199, DOI 10.1006/cryo.2001.2345
   Mazzobre MF, 1999, BBA-GEN SUBJECTS, V1473, P337, DOI 10.1016/S0304-4165(99)00207-X
   Miller DP, 2000, J PHYS CHEM B, V104, P10419, DOI 10.1021/jp000730t
   Miller DP, 1997, PHARMACEUT RES, V14, P578, DOI 10.1023/A:1012192725996
   MORELDESROSIERS N, 1991, J CHEM SOC FARADAY T, V87, P2173, DOI 10.1039/ft9918702173
   Noel TR, 1996, J CHEM SOC FARADAY T, V92, P1921, DOI 10.1039/ft9969201921
   PETRIELLA C, 1985, J FOOD SCI, V50, P622, DOI 10.1111/j.1365-2621.1985.tb13759.x
   ROBINSON RA, 1955, ELECTROLYTE SOLUTION
   RONGERE P, 1995, J CHEM SOC FARADAY T, V91, P2771, DOI 10.1039/ft9959102771
   ROOS YH, 1991, CRYO-LETT, V12, P367
   ROOS YH, 1991, INT J FOOD SCI TECH, V26, P553
   ROOS YH, 1991, FOOD TECHNOL-CHICAGO, V45, P66
   ROSSLER E, 1990, PHYS REV LETT, V65, P1595, DOI 10.1103/PhysRevLett.65.1595
   SIMATOS D, 1991, ADV EXP MED BIOL, P139
   SLADE L, 1991, CRIT REV FOOD SCI, V30, P115, DOI 10.1080/10408399109527543
   SPIRO M, 1973, ORGANIC SOLVENT SYST, pCH6
   Stokes R. H., 1959, STRUCTURE ELECTROLYT, P298
   SUN WQ, 1993, PHYSIOL PLANTARUM, V89, P767
   Suzuki T, 1997, J CHEM ENG JPN, V30, P609, DOI 10.1252/jcej.30.609
NR 42
TC 1
Z9 1
U1 0
U2 1
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, CAMBRIDGE CB4 4WF, CAMBS, ENGLAND
SN 0260-6291
BN 0-85404-866-9
J9 ROY SOC CH
PY 2002
IS 281
BP 231
EP 243
DI 10.1039/9781847550118-00231
PG 13
WC Chemistry, Applied; Food Science & Technology; Pharmacology & Pharmacy
SC Chemistry; Food Science & Technology; Pharmacology & Pharmacy
GA BW12L
UT WOS:000180940400020
DA 2018-10-19
ER

PT J
AU Zhang, LH
   Ma, DR
   Wang, FJ
   Zhang, QQ
AF Zhang, LH
   Ma, DR
   Wang, FJ
   Zhang, QQ
TI The modification of scaffold material in building artificial dermis
SO ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY
LA English
DT Article
DE dermis; collagen; chondroitin sulfate; tissue engineering
ID HUMAN-FIBROBLASTS; CROSS-LINKING; SKIN; REGENERATION; DESIGN
AB Type X collagen is principal extracellular matrix (ECM) in natural dermis. To prepare artificial dermis, collagen is traditional, and most superior biomaterial. But beside collagen, the dermis also contains many other ECM. Among them, glycosaminoglycan (GAG) is another important substance. To imitate the natural dermis, and modificate the scaffold, materials, two types of scaffolds were prepared: one is traditional type X collagen spongy scaffold, the other is collagen-chondroitin sulfate (CS) spongy scaffold. Collagen was blended with CS, one kind of GAG, and cross-linked by 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC). Dermis fibroblast was isolated from neonate prepuce, and dermis fibroblasts were cultured on the scaffolds. The physical and chemical properties of the scaffolds were tested, including SEM, DSC, H&E staining, immunohistochemical staining and cs content analysis and so on. The results indicated that EDC is an effective and non-cytotoxic cross-link reagent, and attaching CS into collagen scaffold could improve the stability and histocompatibility of scaffold.
C1 Chinese Acad Med Sci, Inst Biomed Engn, Tianjin 300192, Peoples R China.
   Chinese Acad Med Sci, Peking Union Med Coll, Tianjin 300192, Peoples R China.
RP Zhang, LH (reprint author), Chinese Acad Med Sci, Inst Biomed Engn, POB 25-204, Tianjin 300192, Peoples R China.
RI Zhang, QQ/G-3361-2010
CR BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Black AF, 1998, FASEB J, V12, P1331
   BOYCE ST, 1988, J BIOMED MATER RES, V22, P935
   Dermarchez M., 1992, TRANSPLANTATION, V54, P317
   DEVIRE HJC, 1993, WOUND REPAIR REGEN, V1, P244
   Gratzer PF, 1996, J BIOMED MATER RES, V31, P533, DOI 10.1002/(SICI)1097-4636(199608)31:4<533::AID-JBM14>3.0.CO;2-H
   HANSBROUGH JF, 1994, SURGERY, V115, P633
   MIDDELKOOP E, 1995, CELL TISSUE RES, V280, P447, DOI 10.1007/BF00307818
   Osborne CS, 1998, MED BIOL ENG COMPUT, V36, P129, DOI 10.1007/BF02522870
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   SHUUICHI I, 1991, J JAN PRS, V11, P515
   Valle CAL, 1996, TRANSPLANTATION, V62, P317, DOI 10.1097/00007890-199608150-00003
   Yang HY, 2001, J MATER SCI TECHNOL, V17, P495
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zhang QQ, 1997, J APPL POLYM SCI, V64, P2127
   Zhang QQ, 1999, ARTIF CELL BLOOD SUB, V27, P245, DOI 10.3109/10731199909117697
NR 18
TC 13
Z9 15
U1 2
U2 4
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 1073-1199
J9 ARTIF CELL BLOOD SUB
JI Artif. Cells Blood Substit. Immobil. Biotechnol.
PY 2002
VL 30
IS 4
BP 319
EP 332
DI 10.1081/BIO-120006122
PG 14
WC Biotechnology & Applied Microbiology; Engineering, Biomedical; Materials
   Science, Biomaterials
SC Biotechnology & Applied Microbiology; Engineering; Materials Science
GA 594TL
UT WOS:000178067000006
PM 12227650
DA 2018-10-19
ER

PT J
AU Gourlay, T
   Stefanou, D
   Taylor, KM
AF Gourlay, T
   Stefanou, D
   Taylor, KM
TI The effect of methanol washing of plasticized polyvinyl chloride on
   biomaterial-contact-mediated CD11b (mac-1) expression in a rat
   recirculation model
SO ARTIFICIAL ORGANS
LA English
DT Article
DE CD11b expression; inflammatory response; methanol-washing technique;
   neutrophils
ID CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; IN-VITRO; LEUKOCYTE;
   BLOOD; COMPLEMENT; ACTIVATION; ADHESION; HEPARIN; PVC
AB Our objective was to assess whether using a methanol wash to reduce the level of plasticizer present on the surface of medical-grade polyvinyl chloride (PVC) has a moderating effect on the expression of CD11b (mac-1) on neutrophils in rats undergoing recirculation. The study was carried out on 3 groups of 10 adult male Sprague-Dawley rats weighing between 350 and 450 g. In the 2 test groups, the animals were exposed to 48 cm(2) of di-(2-ethyl-hexyl)-phthalate (DEHP)-plasticized PVC in a parallel plate recirculating test cell through which blood was recirculated at 1.5 ml/min. In the first test group, the PVC was untreated; in the second test group, the PVC was washed in methanol to reduce the level of plasticizer on the surface. The test cell was connected to the right femoral circulation, and recirculation was established for a period of 60 min. Blood samples were taken at 0, 30, and 60 min for assessment of CD11b expression on neutrophils using flow cytometric analysis. In a third group of 10 control experiments, rats underwent the entire surgical procedure, but without recirculation through the test cell. There was statistically significant (p < 0.001) lower Cd11b expression on neutrophils in the blood of rats perfused through the cell containing methanol-washed PVC after 30 min and at 60 min. CD11b expression was significantly (p < 0.001) lower in the control group than in both test groups at both the 30 and 60 min time points and at the 60 min time point on comparison with the group where blood was perfused through methanol-washed PVC. These results demonstrate that the biomaterial-contact-mediated upregulation of CD11b may be significantly reduced by employing a methanol-washing technique on the plasticized PVC. Although this technique does not entirely eliminate the expression of CD11b on neutrophils, the difference is significant and suggests the role of the plasticizer in the development of this inappropriate inflammatory response.
C1 Hammersmith Hosp, Imperial Coll Sch Med, Natl Heart & Lung Inst, Dept Cardiac Surg, London W12 0NN, England.
RP Gourlay, T (reprint author), Hammersmith Hosp, Imperial Coll Sch Med, Natl Heart & Lung Inst, Dept Cardiac Surg, 2nd Floor B Block,DuCane Rd, London W12 0NN, England.
CR Asimakopoulos G, 1998, ANN THORAC SURG, V66, P2135, DOI 10.1016/S0003-4975(98)00727-9
   Asimakopoulos G, 2000, ANN THORAC SURG, V69, P1192, DOI 10.1016/S0003-4975(99)01553-2
   Asimakopoulos G, 1999, PERFUSION-UK, V14, P269, DOI 10.1177/026765919901400406
   BONE RC, 1992, CRIT CARE MED, V20, P864
   BUTLER J, 1993, ANN THORAC SURG, V55, P552, DOI 10.1016/0003-4975(93)91048-R
   GAKINANES M, 1996, CIRCULATION, V94, P364
   Gourlay T, 2001, ARTIF ORGANS, V25, P475, DOI 10.1046/j.1525-1594.2001.025006475.x
   HILL GE, 1994, ANAESTH ANALG, V79, P1201
   Lamba NMK, 2000, BIOMATERIALS, V21, P89, DOI 10.1016/S0142-9612(99)00145-3
   Landis NT, 1999, AM J HEALTH-SYST PH, V56, P937
   Latini G, 1999, ACTA PAEDIATR, V88, P1174, DOI 10.1080/08035259950168333
   LEDEIST F, 1995, CIRCULATION, V92, P354, DOI 10.1161/01.CIR.92.9.354
   MATHEW JP, 1995, J THORAC CARDIOV SUR, V109, P448, DOI 10.1016/S0022-5223(95)70275-X
   Mettang T, 2000, PERITON DIALYSIS INT, V20, P80
   Moen O, 1997, ANN THORAC SURG, V63, P105
   TAGGART DP, 1994, ANN THORAC SURG, V57, P376, DOI 10.1016/0003-4975(94)91000-6
   Zhao XB, 1999, ARTIF ORGANS, V23, P104, DOI 10.1046/j.1525-1594.1999.06267.x
NR 17
TC 7
Z9 7
U1 0
U2 1
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD JAN
PY 2002
VL 26
IS 1
BP 5
EP 9
DI 10.1046/j.1525-1594.2002.06730.x
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 520AG
UT WOS:000173757200003
PM 11872005
DA 2018-10-19
ER

PT J
AU Demers, C
   Hamdy, CR
   Corsi, K
   Chellat, F
   Tabrizian, M
   Yahia, L
AF Demers, C
   Hamdy, CR
   Corsi, K
   Chellat, F
   Tabrizian, M
   Yahia, L
TI Natural coral exoskeleton as a bone graft substitute: A review
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Symposium on Advanced Biomaterials
CY JUN   28, 2000
CL MONTREAL, CANADA
SP Biomech Biomat Res Grp, Lab Innovat & Bioperformance Anal Med Devices, Minis Res, Sci & Technol, Digital Instruments, CAMECA, Syst Res Corp, Inotevb, CERAVER, Memoflex
DE coral; biomaterial; bone graft substitute; bioresorbable;
   osteoconductive
ID MARROW-INDUCED OSTEOGENESIS; LUMBAR SPINAL-FUSION; CALCIUM-CARBONATE;
   IN-VIVO; MORPHOGENETIC PROTEIN-2; MADREPORIC CORAL; GROWTH-FACTOR;
   COMPRESSIVE STRENGTH; DIFFERENT POROSITIES; RESORPTION KINETICS
AB Natural coral graft substitutes are derived from the exoskeleton of marine madreporic corals. Researchers first started evaluating corals as potential bone graft substitutes in the early 1970s in animals and in 1979 in humans. The structure of the commonly used coral, Porites, is similar to that of cancellous bone and its initial mechanical properties resemble those of bone. The exoskeleton of these high content calcium carbonate scaffolds has since been shown to be biocompatible, osteoconductive, and biodegradable at variable rates depending on the exoskeleton porosity, the implantation site and the species. Although not osteoinductive or osteogenic, coral grafts act as an adequate carrier for growth factors and allow cell attachment, growth, spreading and differentiation. When applied appropriately and when selected to match the resorption rate with the bone formation rate of the implantation site, natural coral exoskeletons have been found to be impressive bone graft substitutes. The purpose of this article is to review and summarize all the pertinent work that has been published on natural coral as a bone graft including in vitro, animal and clinical human studies. Preliminary report of our own experiments as well as our recommendations on the use of coral are also included.
C1 Ecole Polytech, Dept Mech Engn, Biomech & Biomat Res Grp, Montreal, PQ H3C 3A7, Canada.
   McGill Univ, Montreal Childrens Hosp, Res Inst, Shriners Hosp Children, Montreal, PQ H3H 1P3, Canada.
   McGill Univ, Dept Orthopaed, Montreal, PQ H3H 1P3, Canada.
   Ecole Polytech, Notre Dame Hosp CHUM, Montreal, PQ H3C 3A7, Canada.
   McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada.
RP Yahia, L (reprint author), Ecole Polytech, Dept Mech Engn, Biomech & Biomat Res Grp, POB 6079,Stn Ctr Ville, Montreal, PQ H3C 3A7, Canada.
CR ALPASLAN C, 1994, ORAL SURG ORAL MED O, V77, P335, DOI 10.1016/0030-4220(94)90193-7
   ARNAUD E, 1994, CALCIFIED TISSUE INT, V54, P493, DOI 10.1007/BF00334331
   Arnaud E, 1999, BIOMATERIALS, V20, P1909, DOI 10.1016/S0142-9612(99)00090-3
   Arnaud E, 1998, Ann Chir Plast Esthet, V43, P40
   ATLAN G, 1991, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V92, P199
   BEGLEY CT, 1995, BIOMATERIALS, V16, P1181, DOI 10.1016/0142-9612(95)93584-Z
   BEGLEY CT, 1993, BONE, V14, P661, DOI 10.1016/8756-3282(93)90089-S
   Bizette C, 1999, NEUROCHIRURGIE, V45, P4
   Boden SD, 1997, J SPINAL DISORD, V10, P1
   Boden SD, 1995, SPINE, V20, P2633, DOI 10.1097/00007632-199512150-00004
   Boiteux J P, 1988, Rev Odontostomatol (Paris), V17, P291
   BOUABBOUD NN, 1994, BIOMATERIALS, V15, P201, DOI 10.1016/0142-9612(94)90068-X
   BOUABBOUD NN, 1998, INT J ORAL MAXILLOF, V13, P115
   Boutault F, 1997, Ann Chir Plast Esthet, V42, P216
   Bravetti P, 1998, J ORAL MAXIL SURG, V56, P1170, DOI 10.1016/S0278-2391(98)90765-0
   Braye F, 1996, BIOMATERIALS, V17, P1345, DOI 10.1016/0142-9612(96)88682-0
   BUCKWALTER JA, 1995, J BONE JOINT SURG AM, V77A, P1256, DOI 10.2106/00004623-199508000-00019
   CHAMBERLAIN JA, 1978, PALEOBIOLOGY, V4, P419
   CHEN L, 1996, CHIN MED J, V76, P527
   CHIROFF RT, 1975, J BIOMED MATER RES S, V6, P29
   Collangettes-Peyrat D, 1989, INNOV TECH BIOL MED, V10, P679
   Cunin G, 2000, SPINE, V25, P1070, DOI 10.1097/00007632-200005010-00006
   DAMIEN CJ, 1993, ANN CHIR GYNAECOL FE, V82, P117
   DAMIEN CJ, 1994, CALCIFIED TISSUE INT, V55, P151, DOI 10.1007/BF00297191
   DAMIEN CJ, 1998, ACTUALITES BIOMATERI, V4, P181
   Davy DT, 1999, ORTHOP CLIN N AM, V30, P553, DOI 10.1016/S0030-5898(05)70108-5
   de la Caffiniere JY, 1998, REV CHIR ORTHOP, V84, P501
   DEMERS C, 2000, SIROT CSOS 2000 MAY
   DEMERS C, 2000, IN VITRO KINETICS RE
   dePeretti F, 1996, REV CHIR ORTHOP, V82, P234
   DOHERTY MJ, 1994, BIOMATERIALS, V15, P601, DOI 10.1016/0142-9612(94)90210-0
   Fricain JC, 1995, J MATER SCI-MATER M, V6, P680, DOI 10.1007/BF00134300
   Fricain JC, 1998, J DENT RES, V77, P406, DOI 10.1177/00220345980770020901
   Fricain JC, 1998, J BIOMED MATER RES, V42, P96, DOI 10.1002/(SICI)1097-4636(199810)42:1<96::AID-JBM12>3.0.CO;2-M
   Fricain JC, 1996, J PERIODONTAL RES, V31, P463, DOI 10.1111/j.1600-0765.1996.tb01410.x
   Fuller DA, 1996, SPINE, V21, P2131, DOI 10.1097/00007632-199609150-00015
   Furla P, 2000, M S-MED SCI, V16, P1139, DOI 10.4267/10608/1543
   Gao T, 1996, INT ORTHOP, V20, P321, DOI 10.1007/s002640050086
   Gao TJ, 1997, INT ORTHOP, V21, P194, DOI 10.1007/s002640050149
   Gao TJ, 1997, BIOMATERIALS, V18, P219, DOI 10.1016/S0142-9612(96)00133-0
   Ghiamphy K, 1999, EUROPEAN J ORTHOP SU, V9, P209
   GUIGUI P, 1994, SPINE, V19, P2798, DOI 10.1097/00007632-199412150-00012
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1981, CR ACAD SCI III-VIE, V293, P371
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   GUILLEMIN G, 1993, J MATER SCI-MATER M, V4, P575, DOI 10.1007/BF00125596
   Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505
   Hippolyte M P, 1991, J Parodontol, V10, P279
   HOTT M, 1989, C INSERM, V177, P311
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   IRIGARAY JL, 1993, J RADIOAN NUCL CH AR, V174, P93, DOI 10.1007/BF02040337
   IRIGARAY JL, 1993, J RADIOAN NUCL CH AR, V169, P339, DOI 10.1007/BF02042992
   IRIGARAY JL, 1990, BIOMATERIALS, V11, P73
   IRIGARAY JL, 1993, J THERM ANAL CALORIM, V39, P3, DOI 10.1007/BF02235441
   Issahakian S, 1989, J Parodontol, V8, P251
   ISSAHAKIAN S, 1987, INFORMATION DENTAIRE, V24, P2123
   Jammet P, 1993, Chirurgie, V119, P273
   JAMMET P, 1994, J CRANIO MAXILL SURG, V22, P103, DOI 10.1016/S1010-5182(05)80019-8
   Kajiwara S, 1990, Fukuoka Shika Daigaku Gakkai Zasshi, V17, P358
   KANATANI M, 1995, J BONE MINER RES, V10, P1681, DOI 10.1002/jbmr.5650101110
   Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6
   Kania RE, 1998, J BIOMED MATER RES, V43, P38, DOI 10.1002/(SICI)1097-4636(199821)43:1<38::AID-JBM4>3.0.CO;2-N
   KEHR P, 1998, ACTUALITES BIOMATERI, V4, P147
   Kenesi C, 1997, Chirurgie, V122, P379
   Koide M, 1999, BIOCHEM BIOPH RES CO, V259, P97, DOI 10.1006/bbrc.1999.0715
   Kreklau B, 1999, BIOMATERIALS, V20, P1743, DOI 10.1016/S0142-9612(99)00061-7
   LEVET Y, 1983, ANN CHIR PLAST ESTH, V28, P180
   LOTY B, 1990, INT ORTHOP, V14, P255
   Louisia S, 1999, J BONE JOINT SURG BR, V81B, P719, DOI 10.1302/0301-620X.81B4.9358
   Ma Q, 2000, BRIT J ORAL MAX SURG, V38, P561, DOI 10.1054/bjom.2000.0458
   Marchac D, 1994, J Craniofac Surg, V5, P213, DOI 10.1097/00001665-199409000-00003
   Mercier J., 1996, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V97, P324
   MIAO L, 1997, CHUNG KUO HSIU FU CH, V11, P132
   MIAO L, 1997, CHUNG HUA KOU CHIANG, V32, P221
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   Ongpipattanakul Boonsri, 1994, Pharmaceutical Research (New York), V11, pS82
   Ouhayoun J P, 1991, J Parodontol, V10, P61
   OUHAYOUN JP, 1992, J MATER SCI-MATER M, V3, P222, DOI 10.1007/BF00713454
   PAPACHARALAMBOUS SK, 1993, INT J ORAL MAX SURG, V22, P260, DOI 10.1016/S0901-5027(05)80511-9
   Patat J L, 1992, Acta Orthop Belg, V58 Suppl 1, P115
   PATAT JL, 1989, ANN CHIR PLAST ESTH, V34, P221
   PATEL A, 1980, CHIRURGIE, V106, P199
   Petite H, 1996, J MATER SCI-MATER M, V7, P665, DOI 10.1007/BF00123405
   Piattelli A, 1997, BIOMATERIALS, V18, P623, DOI 10.1016/S0142-9612(96)00158-5
   POULIQUEN JC, 1989, REV CHIR ORTHOP, V75, P360
   POULIQUEN JC, 1990, ANN PEDIATR-PARIS, V37, P59
   RAE T, 1986, CRIT REV BIOCOMPAT, V2, P97
   Reis SA, 1996, CLIN ORAL IMPLAN RES, V7, P253, DOI 10.1034/j.1600-0501.1996.070307.x
   Richard M, 1998, CALCIFIED TISSUE INT, V62, P437, DOI 10.1007/s002239900456
   Robier A, 1987, Ann Otolaryngol Chir Cervicofac, V104, P303
   ROUDIER M, 1995, J BIOMED MATER RES, V29, P909, DOI 10.1002/jbm.820290802
   Roux F X, 1996, Ann Otolaryngol Chir Cervicofac, V113, P29
   ROUX FX, 1995, ACTA NEUROCHIR, V133, P201, DOI 10.1007/BF01420075
   ROUX FX, 1988, J NEUROSURG, V69, P510, DOI 10.3171/jns.1988.69.4.0510
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   Santanche P, 1997, PLAST RECONSTR SURG, V99, P266, DOI 10.1097/00006534-199701000-00058
   SAUTIER JM, 1990, IN VITRO CELL DEV B, V26, P1079
   SAUTIER JM, 1992, BIOMATERIALS, V13, P400, DOI 10.1016/0142-9612(92)90046-Q
   Sciadini MF, 1997, J ORTHOPAED RES, V15, P844, DOI 10.1002/jor.1100150609
   SERVERA C, 1987, REV STOMATOL CHIR, V88, P326
   Shahgaldi BF, 1998, BIOMATERIALS, V19, P205, DOI 10.1016/S0142-9612(98)80002-1
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   Shors EC, 1999, ORTHOP CLIN N AM, V30, P599, DOI 10.1016/S0030-5898(05)70113-9
   SOUYRIS F, 1985, J MAXILLOFAC SURG, V13, P64, DOI 10.1016/S0301-0503(85)80018-7
   Tho K. S., 1996, Annals Academy of Medicine Singapore, V25, P824
   Turunen T, 1997, CLIN ORAL IMPLAN RES, V8, P96, DOI 10.1034/j.1600-0501.1997.080204.x
   Volpi N, 1999, BIOMATERIALS, V20, P1359, DOI 10.1016/S0142-9612(99)00031-9
   Vuola J, 1996, BIOMATERIALS, V17, P1761, DOI 10.1016/0142-9612(95)00351-7
   Vuola J, 1998, BIOMATERIALS, V19, P223, DOI 10.1016/S0142-9612(97)00211-1
   Vuola J, 2000, J BIOMED MATER RES, V51, P117, DOI 10.1002/(SICI)1097-4636(200007)51:1<117::AID-JBM15>3.0.CO;2-9
   WEBER JN, 1973, MINER SCI ENGNG, V5, P151
   WHITE RA, 1972, SCIENCE, V176, P922, DOI 10.1126/science.176.4037.922
   Wikesjo UME, 1998, J CLIN PERIODONTOL, V25, P475, DOI 10.1111/j.1600-051X.1998.tb02476.x
   Yamashiro H, 2000, DIS AQUAT ORGAN, V41, P211, DOI 10.3354/dao041211
   Yukna RA, 1998, J CLIN PERIODONTOL, V25, P1036, DOI 10.1111/j.1600-051X.1998.tb02410.x
   ZAFFE D, 1995, MAT CLIN APPL, P431
   ZANER DJ, 1984, J PERIODONTOL, V55, P406, DOI 10.1902/jop.1984.55.7.406
   Zellin G, 1998, BONE, V22, P613, DOI 10.1016/S8756-3282(98)00059-3
   ZENG R, 1997, CHUNG HUA KOU CHIANG, V32, P16
   ZENG RS, 1991, CHUNG HUA KOU CHIANG, V26, P389
NR 122
TC 81
Z9 90
U1 1
U2 17
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2002
VL 12
IS 1
BP 15
EP 35
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 521XL
UT WOS:000173866600003
PM 11847406
DA 2018-10-19
ER

PT J
AU Assad, M
   Chernyshov, A
   Leroux, MA
   Rivard, CH
AF Assad, M
   Chernyshov, A
   Leroux, MA
   Rivard, CH
TI A new porous titanium-nickel alloy: Part 2. Sensitization, irritation
   and acute systemic toxicity evaluation
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE porous; titanium-nickel; biocompatibility; sensitization testing;
   irritation testing
ID SHAPE-MEMORY ALLOY; IN-VITRO; ORTHODONTIC APPLIANCES;
   CORROSION-RESISTANCE; METAL-IONS; TI-NI; BEHAVIOR; BIOCOMPATIBILITY;
   BIODEGRADATION; MONOCYTES
AB Porous titanium-nickel (PTN) represents a new biomaterial with orthopedic applications as a long-term implant. Because of its nickel content, PTN was tested for its potential to stimulate sensitization, irritation, and systemic toxicity reactions after semi-physiological extraction. In order to do so, an in vivo biocompatibility evaluation was performed following three ISO-standardized methods using accepted animal models for immunity testing: the classical skin sensitization assay (Buehler patch test) in guinea pigs, the rabbit intracutaneous test, and the systemic injection test in mice. The Buehler patch test in guinea pigs revealed no significant change in skin-reactions such as erythema or swelling between the induction and the challenge period. In the rabbit intracutaneous irritation test, no irritation or sensitization reactions were observed in saline-extracted PTN samples. Negligible to slight irritation was observed at some of the sites involving PTN samples extracted in cottonseed oil, however the resulting primary irritation index was similar to the one elicited by the blank solution itself. Finally, no toxic symptoms were observed-with any of the mice injected with porous titanium-nickel extracts during the acute systemic toxicity test. Based on the above results, porous titanium-nickel is considered to be a non-sensitizing, non-irritant, and non-toxic biomaterial for medical applications.
C1 Biorthex Inc, R&D, Biomat Dept, Montreal, PQ H4N 3H5, Canada.
   Natl Res Council Canada, IMI, Boucherville, PQ J4B 6Y4, Canada.
   Hop St Justine, Ctr Rech Pediat, Montreal, PQ H3T 1C5, Canada.
RP Assad, M (reprint author), Biorthex Inc, R&D, Biomat Dept, 9001 Blvd Lacadie,Suite 802, Montreal, PQ H4N 3H5, Canada.
EM massad@biorthex.com
OI Assad, Michel/0000-0001-8734-0267
CR Al-Waheidi E M, 1995, Quintessence Int, V26, P385
   Assad M, 1999, BIO-MED MATER ENG, V9, P1
   ASSAD M, 2002, IN PRESS BIOMED MAT, V12
   Barber FA, 1996, ARTHROSCOPY, V12, P32, DOI 10.1016/S0749-8063(96)90216-9
   Barras CDJ, 2000, EUR J VASC ENDOVASC, V19, P564, DOI 10.1053/ejvs.2000.1111
   BARRETT RD, 1993, AM J ORTHOD DENTOFAC, V103, P8, DOI 10.1016/0889-5406(93)70098-9
   BASS JK, 1993, AM J ORTHOD DENTOFAC, V103, P280, DOI 10.1016/0889-5406(93)70009-D
   BISHARA SE, 1993, AM J ORTHOD DENTOFAC, V103, P115, DOI 10.1016/S0889-5406(05)81760-3
   BOUR H, 1994, CLIN IMMUNOL IMMUNOP, V73, P142, DOI 10.1006/clin.1994.1180
   de Silva BD, 2000, CONTACT DERMATITIS, V42, P102
   DUNLAP CL, 1989, J AM DENT ASSOC, V118, P449, DOI 10.14219/jada.archive.1989.0174
   Gil FJ, 1998, BIO-MED MATER ENG, V8, P335
   GUNTHER VE, 1999, Patent No. 5986169
   Gunther VE, 2000, DELAY LAW NEW CLASS
   *INT LAB OFF, 1993, 1993 WORLD LAB REP, P1
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   Jia WY, 1999, J BIOMED MATER RES, V48, P488, DOI 10.1002/(SICI)1097-4636(1999)48:4<488::AID-JBM14>3.3.CO;2-4
   MAYOR MB, 1980, AM J SURG, V139, P477, DOI 10.1016/0002-9610(80)90323-2
   MERRITT K, 1981, SYSTEMIC ASPECTS BIO, V2, P33
   PAPANASTASOULIS GS, 2000, P 2 INT S ADV BIOM M, P78
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   Rondelli G, 1996, BIOMATERIALS, V17, P2003, DOI 10.1016/0142-9612(95)00352-5
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   RYHANEN J, 1999, THESIS U OULU FINLAN, P39
   Savarino L, 1999, J BIOMED MATER RES, V47, P543, DOI 10.1002/(SICI)1097-4636(19991215)47:4<543::AID-JBM11>3.0.CO;2-G
   SIMON M, 1977, RADIOLOGY, V125, P89, DOI 10.1148/125.1.89
   SPECK KM, 1980, J DENT RES, V59, P1590, DOI 10.1177/00220345800590100601
   Thierry B, 2000, J BIOMED MATER RES, V51, P685, DOI 10.1002/1097-4636(20000915)51:4<685::AID-JBM17>3.0.CO;2-S
   Trepanier C, 1998, J BIOMED MATER RES, V43, P433, DOI 10.1002/(SICI)1097-4636(199824)43:4<433::AID-JBM11>3.0.CO;2-#
   Trepanier C, 1999, J BIOMED MATER RES, V48, P165, DOI 10.1002/(SICI)1097-4636(1999)48:2<165::AID-JBM11>3.0.CO;2-#
   *US PHARM, 2000, BIOL REACT TEST LESS, P1832
   Wataha JC, 1996, DENT MATER, V12, P322, DOI 10.1016/S0109-5641(96)80041-8
   Wataha JC, 1999, J BIOMED MATER RES, V45, P251, DOI 10.1002/(SICI)1097-4636(19990605)45:3<251::AID-JBM13>3.0.CO;2-5
   Watarai M, 1999, BIO-MED MATER ENG, V9, P73
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   WEVER DJ, 2000, SHAPE MEMORY IMPLANT, P129
NR 37
TC 19
Z9 19
U1 0
U2 7
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2002
VL 12
IS 4
BP 339
EP 346
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 642PC
UT WOS:000180811900002
PM 12652028
DA 2018-10-19
ER

PT S
AU Kim, SR
   Riu, DH
   Lee, YJ
   Kim, YH
AF Kim, SR
   Riu, DH
   Lee, YJ
   Kim, YH
BE Brown, S
   Clarke, I
   Williams, P
TI Synthesis and characterization of silicon substituted hydroxyapatite
SO BIOCERAMICS 14
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 14th International Symposium on Ceramics in Medicine (BIOCERAMICS-14)
CY NOV 14-17, 2001
CL PALM SPRINGS, CA
SP Int Soc Ceram Med
AB A silicon-substituted hydroxyapatite has been prepared using tetraethylorthosilicate as a silicon source to obtain a biomaterial having an improved biocompatibility. From the XRD analysis, it was confirmed that the single-phase hydroxyapatite containing silicon has formed without revealing the presence of extra phases related to silicon oxide or other calcium phosphate species. Silicon content was up to 3.32% by weight. (29)Si MAS NMR investigation elucidated the presence of tetrahedral silicate in the framework of hydroxyapatite structure. Substitution of silicon into the hydroxyapatite framework (Ca(10)(PO(4))(6-x)(SiO(4))(x)(OH)(2-x)) reduced the amount of hydroxyl group to compensate for the extra negative charge of the silicate group, which is confirmed by FT-IR.
C1 Korea Inst Ceram Engn & Technol, Seoul, South Korea.
RP Kim, SR (reprint author), Korea Inst Ceram Engn & Technol, Seoul, South Korea.
EM yhkokim@kicet.re.kr
CR CARLISLE EM, 1970, SCIENCE, V167, P179
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Layrolle P, 1998, J AM CERAM SOC, V81, P1421
   Marques PAAP, 2000, KEY ENG MAT, V192-1, P247
   Wakamura M, 2000, COLLOID SURFACE A, V164, P297, DOI 10.1016/S0927-7757(99)00384-2
NR 5
TC 22
Z9 23
U1 1
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-889-3
J9 KEY ENG MATER
PY 2002
VL 218-2
BP 85
EP 88
DI 10.4028/www.scientific.net/KEM.218-220.85
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BU17P
UT WOS:000175229300018
DA 2018-10-19
ER

PT S
AU de Campos, M
   Bressiani, AH
AF de Campos, M
   Bressiani, AH
BE Brown, S
   Clarke, I
   Williams, P
TI Comparative study of the synthesis and processing of hydroxyapatite
SO BIOCERAMICS 14
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 14th International Symposium on Ceramics in Medicine (BIOCERAMICS-14)
CY NOV 14-17, 2001
CL PALM SPRINGS, CA
SP Int Soc Ceram Med
DE hydroxyapatite; synthesis; processing; and plasma spraying
AB The HAp is a biomaterial applied as dense, porous or coating bioceramics, in the medical and odontological areas. The aim of this work was obtain hydroxyapatite with characteristics that allow its application as dense or porous bodies, and coating studying three methods of syntheses: precipitation, neutralization and sol-gel in alcoholic media. Precipitation and neutralization showed the best results for thermal spraying stability, being thereafter reproduced in a pilot scale, in an open and closed system. Nitrogen atmosphere was used to avoid the formation of hydroxyapatite carbonate. The powders obtained by neutralization were used for coating titanium alloy substrate. Plasma spraying technique was used for deposition. On coating layer HAp was the main phase detected, showing a good adherence to the substrate. Porous ceramic bodies were obtained by gel casting foam with the HAp from the neutralization method in an inert atmosphere. The main techniques used on the characterization of powder, metallic substrates, coatings, porous and dense ceramic bodies were: particle size distribution (D), scanning electron microscopy (SEM) and X-ray diffractometry (XRD). The HAp phase was detected as the majority in all conditions and results are no cytotoxicity.
C1 Univ Mogi Das Cruzes, Technol Res Ctr, BR-08780911 Mogi Das Cruzes, SP, Brazil.
   IPEN CNEN SP, DMC, Dept Mat Engn, BR-05508900 Sao Paulo, Brazil.
RP de Campos, M (reprint author), Univ Mogi Das Cruzes, Technol Res Ctr, Av Dr Candido Xavier De Almeida Souza 200, BR-08780911 Mogi Das Cruzes, SP, Brazil.
EM magali@umc.br
RI Bressiani, Ana/I-1402-2012
CR Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   Sepulveda P, 2000, J AM CERAM SOC, V83, P3021, DOI 10.1111/j.1151-2916.2000.tb01677.x
   Valente MDC, 2001, KEY ENG MAT, V189-1, P623
NR 3
TC 3
Z9 3
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-889-3
J9 KEY ENG MATER
PY 2002
VL 218-2
BP 171
EP 174
DI 10.4028/www.scientific.net/KEM.218-220.171
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BU17P
UT WOS:000175229300037
DA 2018-10-19
ER

PT S
AU Mendes, SC
   Sleijster, M
   van den Muysenberg, A
   van Blitterswijk, CA
   de Bruijn, JD
AF Mendes, SC
   Sleijster, M
   van den Muysenberg, A
   van Blitterswijk, CA
   de Bruijn, JD
BE Brown, S
   Clarke, I
   Williams, P
TI Cultured living bone equivalents enhance bone formation when compared to
   a cell seeding approach
SO BIOCERAMICS 14
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 14th International Symposium on Ceramics in Medicine (BIOCERAMICS-14)
CY NOV 14-17, 2001
CL PALM SPRINGS, CALIFORNIA
SP Int Soc Ceram Med
DE tissue engineering; bone; calcium phosphates; bone marrow stromal cells;
   osteogenesis
ID HUMAN MARROW-CELLS; POROUS CERAMICS; IN-VIVO
AB At present, two different approaches use patient own cultured osteogenic cells in combination with a scaffold material to engineer autologous osteoinductive grafts. One of the approaches consists of seeding cells on a suitable biomaterial, after which the construct is ready for implantation. In another approach, the seeded cells are further cultured on the scaffold to obtain in vitro formed bone, prior to implantation. We investigated the in vivo osteogenic potential of both methods through the implantation of porous HA scaffolds coated with a layer of in vitro formed bone and porous HA scaffolds seeded with osteogenic cells. As early as 2 days after implantation, bone was formed on scaffolds in which a bone-like tissue was cultured, while it was only detected on the cell seeded implants from 4 days onwards. After 4 days of implantation there was a significantly higher amount of bone in the bone-like tissue containing scaffolds as compared to cell-seeded ones.
C1 IsoTis BV, NL-3723 MB Bilthoven, Netherlands.
   Univ Twente, IBME, Enschede, Netherlands.
RP Mendes, SC (reprint author), IsoTis BV, Prof Bronkhorstlaan 10, NL-3723 MB Bilthoven, Netherlands.
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   de Bruijn J D, 1999, Adv Dent Res, V13, P74
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   MENDES SC, UNPUB TISSIE ENG
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   OHGUSHI H, 1990, ACTA ORTHOP SCAND, V61, P431, DOI 10.3109/17453679008993556
   Yoshikawa T, 2000, TRANSPLANTATION, V69, P128, DOI 10.1097/00007890-200001150-00022
   Yoshikawa T, 1998, BIO-MED MATER ENG, V8, P311
NR 8
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-889-3
J9 KEY ENG MAT
PY 2002
VL 218-2
BP 227
EP 231
DI 10.4028/www.scientific.net/KEM.218-220.227
PG 5
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BU17P
UT WOS:000175229300051
DA 2018-10-19
ER

PT S
AU Vandenbulcke, L
   De Barros, MI
   Met, C
   Farges, G
AF Vandenbulcke, L
   De Barros, MI
   Met, C
   Farges, G
BE Brown, S
   Clarke, I
   Williams, P
TI Nano-smooth diamond surfaces of duplex coatings on titanium alloy for
   low friction and low wear of biomaterial counterfaces
SO BIOCERAMICS 14
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 14th International Symposium on Ceramics in Medicine (BIOCERAMICS-14)
CY NOV 14-17, 2001
CL PALM SPRINGS, CALIFORNIA
SP Int Soc Ceram Med
ID COATED TI-6AL-4V ALLOY; DEPOSITION
C1 CNRS, Lab Combust & Syst Reactifs, F-45071 Orleans 2, France.
   DGA, CTA, F-94114 Arcueil, France.
RP Vandenbulcke, L (reprint author), CNRS, Lab Combust & Syst Reactifs, F-45071 Orleans 2, France.
CR De Barros MI, 2000, DIAM RELAT MATER, V9, P1862, DOI 10.1016/S0925-9635(00)00335-6
   De Barros MI, 2000, SURF COAT TECH, V127, P193, DOI 10.1016/S0257-8972(00)00668-X
   De Barros MI, 1999, DIAM RELAT MATER, V8, P1022, DOI 10.1016/S0925-9635(98)00439-7
   De Barros MI, 2001, DIAM RELAT MATER, V10, P337, DOI 10.1016/S0925-9635(00)00433-7
   De Barros MI, 2001, WEAR, V249, P68
   DEBARROS MI, 2001, SURF COATINGS TECHNO
   DJEMIA P, 2001, J APPL PHYS, V90, pR30
   DJEMIA P, 2001, SURF COATING TECHNOL
NR 8
TC 1
Z9 1
U1 1
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-889-3
J9 KEY ENG MAT
PY 2002
VL 218-2
BP 595
EP 600
DI 10.4028/www.scientific.net/KEM.218-220.595
PG 6
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BU17P
UT WOS:000175229300139
DA 2018-10-19
ER

PT S
AU Matsunaga, T
   Okamura, Y
AF Matsunaga, T
   Okamura, Y
BE Aizenberg, J
   McKittrick, JM
   Orme, CA
TI Molecular mechanism of bacterial magnetite formation and its application
SO BIOLOGICAL BIOMIMETIC MATERIALS-PROPERTIES TO FUNCTION
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Biological and Biomimetic Materials - Properties to
   Function held at the 2002 MRS Spring Meeting
CY APR 01-05, 2002
CL SAN FRANCISCO, CA
SP Mat Res Soc
ID SP STRAIN AMB-1; MAGNETOTACTIC BACTERIA; PARTICLES; IMMUNOASSAY;
   PROTEIN; MAGNETOSOME; GENE; BIOMINERALIZATION; MICROBIOLOGY; SEDIMENTS
AB Nano-technology has been identified as an area which will bring about new evolutions in materials, devices and processes. ne challenges of nano-biotechnology entail manufacturing more sophisticated and highly efficient biosensors and biomaterials at the nano-scale level for use in interdisciplinary fields. Here, we introduce a biomaterial produced by magnetic bacteria, bacterial magnetic particles (BMPs), and the molecular architecture technique we have used for its application.
   Magnetic bacteria synthesize intracellular magnets which are encapsulated by lipid bilayer membranes. Sizes of BMPs vary from 50 - 100 nm in diameter, and number over 10 per cell. BMPs are composed of magnetite (Fe3O4) with a single magnetic domain. Easy aqueous dispersion of BMPs enable development of highly sensitive chemiluminescence enzyme immunoassays by the chemical coupling of antibodies on BMP surfaces. BMPs can likewise be used as drug delivery systems employing magnetoliposomes with high capture volumes. We previously reported a technique for preparing recombinant BMPs on which proteins were displayed by gene-fusion. We furthermore applied such recombinant BMPs to biotechnologically-important issues, including novel bioassay platforms for medicine and environmental management. We envisage the production of more refined chemicals and agents through expression on BMPs by gene-fusion followed by simple purification using magnet.
C1 Tokyo Univ Agr & Technol, Dept Biotechnol, Tokyo 1848588, Japan.
RP Matsunaga, T (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol, Naka Cho, Tokyo 1848588, Japan.
CR BALKWILL DL, 1980, J BACTERIOL, V141, P1399
   BAZYLINSKI DA, 1995, ASM NEWS, V61, P337
   BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679
   BLAKEMORE RP, 1982, ANNU REV MICROBIOL, V36, P217, DOI 10.1146/annurev.mi.36.100182.001245
   BLAKEMORE RP, 1991, IRON BIOMINERALS, P51
   BLAKEMORE RP, 1989, BERGEYS MANUAL SYSTE, V3, P1882
   ESOUIVEL DMS, 1986, J EXP BIOL, V121, P153
   FASSBINDER JWE, 1990, NATURE, V343, P161, DOI 10.1038/343161a0
   GORBY YA, 1988, J BACTERIOL, V170, P834, DOI 10.1128/jb.170.2.834-841.1988
   MANN S, 1990, ADV MICROB PHYSIOL, V31, P125
   MATSUNAGA T, 1987, APPL MICROBIOL BIOT, V26, P328
   Matsunaga T, 1999, J MAGN MAGN MATER, V194, P126, DOI 10.1016/S0304-8853(98)00575-7
   MATSUNAGA T, 1990, IEEE T MAGN, V26, P1557, DOI 10.1109/20.104444
   MATSUNAGA T, 1992, J BACTERIOL, V174, P2748
   MATSUNAGA T, 1991, APPL MICROBIOL BIOT, V35, P651
   Matsunaga T, 2000, BIOCHEM BIOPH RES CO, V268, P932, DOI 10.1006/bbrc.2000.2236
   MATSUNAGA T, 1993, P 3 IUMRS INT C ADV, P449
   NAKAMURA C, 1995, J BIOCHEM-TOKYO, V118, P23, DOI 10.1093/oxfordjournals.jbchem.a124884
   NAKAMURA C, 1995, J BIOL CHEM, V270, P28392
   NAKAMURA N, 1993, ANAL CHEM, V65, P2036, DOI 10.1021/ac00063a018
   NAKAMURA N, 1993, ANAL CHIM ACTA, V281, P585, DOI 10.1016/0003-2670(93)85018-F
   NAKAMURA N, 1991, ANAL CHEM, V63, P268, DOI 10.1021/ac00003a015
   OBERHACK M, 1987, Z NATURFORSCH C, V42, P300
   Okamura Y, 2001, J BIOL CHEM, V276, P48183, DOI 10.1074/jbc.M106408200
   Okamura Y, 2000, APPL BIOCHEM BIOTECH, V84-6, P441, DOI 10.1385/ABAB:84-86:1-9:441
   SAKAGUCHI T, 1993, NATURE, V365, P47, DOI 10.1038/365047a0
   Schuler D, 1999, APPL MICROBIOL BIOT, V52, P464, DOI 10.1007/s002530051547
   SCHULER D, 1997, TRANSITION METALS MI
   SODE K, 1993, BIOTECHNOL TECH, V7, P688, DOI 10.1007/BF00151871
   SPARKS NHC, 1986, FEMS MICROBIOL LETT, V37, P305, DOI 10.1016/0378-1097(86)90424-6
   STOLZ JF, 1993, J GEN MICROBIOL, V139, P1663, DOI 10.1099/00221287-139-8-1663
   STOLZ JF, 1986, NATURE, V321, P849, DOI 10.1038/321849a0
   TAKEYAMA H, 1995, BIOTECHNOL TECH, V9, P355, DOI 10.1007/BF00638870
   Tanaka T, 2000, ANAL CHEM, V72, P3518, DOI 10.1021/ac9912505
   Tanaka T, 2001, BIOSENS BIOELECTRON, V16, P1089, DOI 10.1016/S0956-5663(01)00187-7
   THORNHILL RH, 1994, FEMS MICROBIOL LETT, V115, P169
   Yang CD, 2001, ENZYME MICROB TECH, V29, P13, DOI 10.1016/S0141-0229(01)00343-X
NR 37
TC 1
Z9 1
U1 0
U2 6
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-660-5
J9 MATER RES SOC SYMP P
PY 2002
VL 724
BP 11
EP 24
DI 10.1017/CBO9780511606397.003
PG 14
WC Materials Science, Biomaterials; Materials Science, Characterization &
   Testing; Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA BV76S
UT WOS:000179970700002
DA 2018-10-19
ER

PT J
AU Tanaka, M
   Mochizuki, A
   Ishii, N
   Motomura, T
   Hatakeyama, T
AF Tanaka, M
   Mochizuki, A
   Ishii, N
   Motomura, T
   Hatakeyama, T
TI Study of blood compatibility with poly(2-methoxyethyl acrylate).
   Relationship between water structure and platelet compatibility in
   poly(2-methoxyethylacrylate-co-2-hydroxyethylmethacrylate)
SO BIOMACROMOLECULES
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; DIFFERENTIAL SCANNING CALORIMETRY; PROTEIN
   ADSORPTION; MOLECULAR-CONFORMATION; METHACRYLATE HYDROGELS; SURFACES;
   ADHESION; POLYMER; RESISTANCE; BIOMATERIAL
AB Previously, we reported that poly(2-methoxyethylacrylate) (PMEA) showed excellent blood compatibility and implied that the water structure in PMEA contributed to the blood compatibility. In this study, the relationship between the water structure and the blood compatibility is clarified by studying the influence of the monomer composition of poly(MEA-co-HEMA) on the water structure and the blood compatibility of the copolymers. The water in the polymer was classified into three types: free water, freezing bound water, and nonfreezing water. The polymers with 0-30 mol % of HEMA content had a significant amount of freezing bound water, and the amount decreases greatly when the composition of HEMA exceeded 30 mol %. On the other hand. the amount of other water increased simply with an increase of HEMA content. The evaluation of the platelet compatibility of poly(MEA-co-HEMA) revealed that the adhesion number and the morphological change of platelet on the copolymer surface were least when the HEMA content was 0-20 mol %. These two results strongly suggest that the freezing bound water relates to the platelet compatibility of the polymers.
C1 Terumo Co Ltd, Ctr Res & Dev, Nakai, Kanagawa 2590151, Japan.
   Otsuma Womens Univ, Chiyoda Ku, Tokyo 1028357, Japan.
RP Tanaka, M (reprint author), Hokkaido Univ, Res Inst Elect Sci, Mol Device Lab, Kita Ku, N12W6, Sapporo, Hokkaido 0600812, Japan.
OI Tanaka, Masaru/0000-0002-1115-2080; Mochizuki, Akira/0000-0001-8104-7764
CR AIZAWA M, 1971, B CHEM SOC JPN, V44, P2967, DOI 10.1246/bcsj.44.2967
   ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   Anzai T., 2000, JPN J ARTIF ORGANS, V29, P73
   CORKHILL PH, 1987, POLYMER, V28, P1758, DOI 10.1016/0032-3861(87)90021-8
   DEQUEIROZ AAA, 1997, THEOCHEM-J MOL STRUC, V394, P271
   Feldman K, 1999, J AM CHEM SOC, V121, P10134, DOI 10.1021/ja991049b
   GRAHAM NB, 1989, POLYMER, V30, P528, DOI 10.1016/0032-3861(89)90026-8
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   HATAKEYAMA H, 1995, THERMOCHIM ACTA, V308, P3
   HAZLEWOO.CF, 1969, NATURE, V222, P747, DOI 10.1038/222747a0
   Horbett Thomas A., 1996, P133
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Iwasaki Y, 1996, J BIOMAT SCI-POLYM E, V8, P91, DOI 10.1163/156856296X00174
   Iwasaki Y, 2000, J BIOMED MATER RES, V52, P701, DOI 10.1002/1097-4636(20001215)52:4<701::AID-JBM15>3.3.CO;2-Y
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   Kataoka K, 1998, J BIOMAT SCI-POLYM E, V9, P111, DOI 10.1163/156856298X00460
   KIKUCHI A, 1993, J COLLOID INTERF SCI, V158, P10, DOI 10.1006/jcis.1993.1222
   Kulik E, 1996, J BIOMED MATER RES, V30, P295, DOI 10.1002/(SICI)1097-4636(199603)30:3<295::AID-JBM4>3.0.CO;2-L
   LING GN, 1983, PHYSIOL CHEM PHYS M, V15, P407
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   NAGAOKA S, 1987, ASAIO, V10, P76
   Nishinari K, 1997, COLLOID POLYM SCI, V275, P1078, DOI 10.1007/s003960050186
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   PEPPAS NA, 1987, HYDROGEL MED PHARM, V2
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI DOI 10.1021/SYMPOSIUM
   RATNER BD, 1975, J BIOMED MATER RES, V9, P407, DOI 10.1002/jbm.820090505
   RATTO J, 1995, POLYMER, V36, P2915, DOI 10.1016/0032-3861(95)94340-Y
   ROWLAND SP, 1980, ACS S SERIES, V127
   Saito N, 2000, ARTIF ORGANS, V24, P547, DOI 10.1046/j.1525-1594.2000.06520.x
   Suhara H, 2001, ANN THORAC SURG, V71, P1603, DOI 10.1016/S0003-4975(01)02466-3
   Tanaka M, 2000, POLYM INT, V49, P1709, DOI 10.1002/1097-0126(200012)49:12<1709::AID-PI601>3.0.CO;2-L
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tanaka M, 2001, COLLOID SURFACE A, V193, P145, DOI 10.1016/S0927-7757(01)00682-3
   TANAKA M, IN PRESS COLLOIDS A
   TANAKA M, 2000, JPN J ARTIF ORGANS, V9, P209
   TANAKA M, IN PRESS RECENT ADV
   TANZAWA H, 1986, JPN J ARTIF ORGANS, V15, P16
   Tsuruta T, 1996, ADV POLYM SCI, V126, P1
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   UEDAIRA H, 1980, WATER METAL CATIONS, P47
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
   Wolfgang G. G., 1992, ACS S SERIES, V489
   YAMADANOSAKA A, 1990, J APPL POLYM SCI, V39, P2443, DOI 10.1002/app.1990.070391117
   YAMADANOSAKA A, 1991, J APPL POLYM SCI, V43, P1165, DOI 10.1002/app.1991.070430617
   YUI N, 1986, J BIOMED MATER RES, V20, P929, DOI 10.1002/jbm.820200708
NR 49
TC 165
Z9 170
U1 5
U2 60
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN-FEB
PY 2002
VL 3
IS 1
BP 36
EP 41
DI 10.1021/bm010072y
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 528RJ
UT WOS:000174256500006
PM 11866553
DA 2018-10-19
ER

PT J
AU Rapoport, HS
   Shadwick, RE
AF Rapoport, HS
   Shadwick, RE
TI Mechanical characterization of an unusual elastic biomaterial from the
   egg capsules of marine snails (Busycon spp.)
SO BIOMACROMOLECULES
LA English
DT Article
ID ENCAPSULATION; MURICIDAE; GASTROPOD; MOLLUSKS; ENERGY
AB Egg capsule material serves as a putative protection mechanism for developing snail embryos facing the perils of the marine environment. We conducted the first quantitative study of this acellular structural protein with the goals of characterizing its chemical and mechanical properties and the relationship of these properties to its biological protective function. We have found that this protein polymer exhibits long-range elasticity with an interesting recoverable yield evidenced by an order of magnitude decrease in elastic modulus (apparent failure) that begins at 3%-5% strain. This material differs significantly from other common structural proteins such as collagen and elastin in mechanical response to strain. Qualitative similarities in stress/strain behavior to keratin, another common structural protein, are more than coincidental when composition and detailed mechanical quantification are considered. This suggests the possibility of a-helical structure and matrix organization that might be similar in these two proteins. Indeed, the egg capsule protein may be closely related to vertebrate keratins such as intermediate filaments. We conclude that while this material's bimodal tensile properties may serve as useful protection against the impact loading egg capsules encounter in the intertidal zone, the full biological importance of these capsules is not known.
C1 Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.
RP Rapoport, HS (reprint author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.
CR CASTILLA JC, 1976, MAR BIOL, V37, P255, DOI 10.1007/BF00387611
   COWAN PM, 1955, S SOC EXP BIOL, V9
   CUNNINGHAM JT, 1899, NATURE, V59, P557
   DASARO CN, 1993, OPHELIA, V38, P149, DOI 10.1080/00785326.1993.10429896
   DASARO CN, 1991, OPHELIA, V35, P1
   DASARO CN, 1993, OPHELIA, V46, P83
   Denny MW, 1988, BIOL MECH WAVE SWEPT
   Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163
   FLOWER NE, 1973, J ULTRA MOL STRUCT R, V44, P134, DOI 10.1016/S0022-5320(73)90046-4
   FLOWER NE, 1969, J ULTRA MOL STRUCT R, V26, P262, DOI 10.1016/S0022-5320(69)80006-7
   FRETTER VERA, 1941, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V25, P173
   Fung YC, 1993, BIOMECHANICS MECH PR
   Garrido Orlando, 1993, Revista de Biologia Marina, V28, P191
   GATHERCOLE L, 1969, THESIS U LEEDS
   GOLDSMITH LA, 1978, COMP BIOCHEM PHYS B, V59, P133, DOI 10.1016/0305-0491(78)90193-1
   GRUBER GL, 1982, THESIS U DELAWARE
   Hearle JWS, 2000, INT J BIOL MACROMOL, V27, P123, DOI 10.1016/S0141-8130(00)00116-1
   HEPWORTH DG, 1994, J STRUCT BIOL, V112, P231, DOI 10.1006/jsbi.1994.1023
   HOLLAND ND, 1990, ACTA ZOOL-STOCKHOLM, V71, P225, DOI 10.1111/j.1463-6395.1990.tb01081.x
   Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9
   HUNT S, 1971, COMP BIOCHEM PHYSIOL, V40, P37, DOI 10.1016/0305-0491(71)90059-9
   HUNT S, 1978, PHILOS T R SOC B, V283, P417, DOI 10.1098/rstb.1978.0048
   HUNT S, 1990, TISSUE CELL, V22, P191, DOI 10.1016/0040-8166(90)90021-Z
   KALYANI R, 1985, INT J INVER REP DEV, V8, P73, DOI 10.1080/01688170.1985.10510129
   Kasapi MA, 1996, J EXP BIOL, V199, P1133
   Knight D.P., 1992, Biomimetics, V1, P151
   MAGALHAES H, 1948, ECOL MONOGR, V18, P377, DOI 10.2307/1948577
   Martin KLM, 1999, AM ZOOL, V39, P215
   MATOLTSY A, 1965, BIOL SKIN HAIR GROWT
   Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516
   PECHENIK JA, 1986, AM MALACOL BULL, V4, P165
   PECHENIK JA, 1979, AM NAT, V114, P859, DOI 10.1086/283533
   PERRON FE, 1981, AM NAT, V118, P110, DOI 10.1086/283805
   PETROVIC ZS, 1991, J APPL POLYM SCI, V42, P391, DOI 10.1002/app.1991.070420211
   PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1
   PRICE N R, 1973, Biochemical Society Transactions, V1, P158
   PRICE NR, 1976, TISSUE CELL, V8, P217, DOI 10.1016/0040-8166(76)90048-3
   RAWLINGS TA, 1990, BIOL BULL, V179, P312, DOI 10.2307/1542323
   Rawlings TA, 1999, AM ZOOL, V39, P230
   RUDALL KM, 1968, COMPREHENSIVE BIOC B, V26, P559
   SHADWICK RE, 1992, PHILOS T ROY SOC B, V337, P419, DOI 10.1098/rstb.1992.0118
   SHADWICK RE, 1990, J APPL PHYSIOL, V68, P1033
   SHADWICK RE, 1983, MOLLUSCA, V1, P399
   SKERTCHLY ARB, 1964, NATURE, V202, P161, DOI 10.1038/202161a0
   SULLIVAN CH, 1984, BIOL BULL-US, V167, P378, DOI 10.2307/1541284
   TAMARIN A, 1967, J ULTRA MOL STRUCT R, V21, P26, DOI 10.1016/S0022-5320(67)80004-2
   Vincent JFV., 1990, STRUCTURAL BIOMATERI
NR 47
TC 25
Z9 25
U1 3
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN-FEB
PY 2002
VL 3
IS 1
BP 42
EP 50
DI 10.1021/bm0155470
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 528RJ
UT WOS:000174256500007
PM 11866554
DA 2018-10-19
ER

PT J
AU Gorbunov, V
   Fuchigami, N
   Stone, M
   Grace, M
   Tsukruk, VV
AF Gorbunov, V
   Fuchigami, N
   Stone, M
   Grace, M
   Tsukruk, VV
TI Biological thermal detection: Micromechanical and microthermal
   properties of biological infrared receptors
SO BIOMACROMOLECULES
LA English
DT Article
ID POLYMERIC MATERIALS; SCANNING PROBE; MICROSCOPY; FILMS; ULTRASTRUCTURE
AB Bioinspired design of biomimetic sensors relies upon the complete understanding of properties and functioning of biological analogues in conjunction with an understanding of their microstructural organization at various length scales, In the spirit of this approach, the microscopic properties of infrared (IR) receptors of snakes with "infrared vision" were studied with scanning thermal microscopy and micromechanical analysis. Low surface thermal conductivity of 0.11 W/(m K) was measured for the IR receptor surfaces as compared to the nonspecific skin areas. This difference in surface thermal conductivity should result in a significant local temperature gradient around the receptor areas. Micromechanical analysis showed that pit organs were more compliant than surrounding skin areas with an elastic modulus close to 40 MPa. In addition, the maximum elastic modulus was detected for the outermost layer with gradually reduced elastic resistance for the interior. The porous microstructure of the underlying tissue combined with the highly branched microfibrillar network (Biomacromolecules 2001, 2, 757) is thought to be responsible for such a combination of biomaterial properties. Considering these biomaterials features, we postulated a possible design of an artificial photothermal detector inspired by the microstructure of natural receptors. This bioinspired design would include a microfabricated cavity filled with an ordered lattice of microspheres with a gradient periodicity from the surface to the interior. Such a "photonic cavity" could provide an opportunity for multiple scattering at wavelength tuned to 8-12 mum as a range of highest sensitivity.
C1 Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
   TM Microscopes, Sunnyvale, CA 94089 USA.
   USAF, Res Lab, MLPJ, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA.
   Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA.
RP Tsukruk, VV (reprint author), Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
CR Amemiya F, 1996, ANAT RECORD, V246, P135
   Amemiya F, 1995, BIOMED RES-TOKYO, V16, P411, DOI 10.2220/biomedres.16.411
   AMEMIYA F., 1996, ANIMAL EYE RES, V15, P13
   Bliznyuk VN, 1998, ACS SYM SER, V695, P220
   Campbell AL, 1999, J STRUCT BIOL, V126, P105, DOI 10.1006/jsbi.1999.4121
   Chizhik SA, 1998, LANGMUIR, V14, P2606, DOI 10.1021/la980042p
   Gorbunov VV, 1999, LANGMUIR, V15, P8340, DOI 10.1021/la990913a
   GORBUNOV VV, 2000, PROBE MICROSC, V2, P65
   GORBUNOV VV, 2000, PROBE MICROSC, V2, P53
   Grace MS, 2001, BEHAV BRAIN RES, V119, P23, DOI 10.1016/S0166-4328(00)00336-3
   Hammiche A, 1996, REV SCI INSTRUM, V67, P4268, DOI 10.1063/1.1147525
   Hazel J, 1999, J BIOMECH, V32, P477, DOI 10.1016/S0021-9290(99)00013-5
   Hazel J, 2001, BIOMACROMOLECULES, V2, P304, DOI 10.1021/bm005648i
   HUES SM, 1993, MRS BULL, V18, P41
   Jiang H, 2000, THIN SOLID FILMS, V372, P85, DOI 10.1016/S0040-6090(00)01033-6
   Jones BS, 2001, J THEOR BIOL, V209, P201, DOI 10.1006/jtbi.2000.2256
   LIDE D, 27 HDB CHEM PHYSICS
   Lvov Y. M., 1994, Crystallography Reports, V39, P628
   POLLOCK H, 2001, J PHYS D, V34, P23
   Pollock HM, 1998, J ADHESION, V67, P217, DOI 10.1080/00218469808011109
   Ratner B. D., 1998, ACS S SERIES, V694
   Sarid D., 1991, SCANNING FORCE MICRO
   Terashima S, 1997, CELL MOL NEUROBIOL, V17, P195, DOI 10.1023/A:1026313828426
   TERASHIMA S, 1998, INFRARED RECEPTORS T
   Tsukruk VV, 1997, PROG POLYM SCI, V22, P247, DOI 10.1016/S0079-6700(96)00005-6
   Tsukruk VV, 2000, POLYMER, V41, P5541, DOI 10.1016/S0032-3861(00)00004-5
   Tsukruk VV, 1998, J MATER SCI, V33, P4905, DOI 10.1023/A:1004457532183
   Tsukruk VV, 1997, RUBBER CHEM TECHNOL, V70, P430, DOI 10.5254/1.3538437
   TSUKRUK VV, UNPUB PROBE MICROSC
   TSUKRUK VV, 2001, MICROSC TODAY, V1, P8
NR 30
TC 26
Z9 26
U1 0
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN-FEB
PY 2002
VL 3
IS 1
BP 106
EP 115
DI 10.1021/bm015591f
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 528RJ
UT WOS:000174256500015
PM 11866562
DA 2018-10-19
ER

PT J
AU Flynn, JM
   Shelton, RM
   Landini, G
AF Flynn, JM
   Shelton, RM
   Landini, G
TI Investigation of primary cell-biomaterial interactions using silver
   nitrate staining of nucleolar organising regions
SO BIOMATERIALS
LA English
DT Article
DE osteoblast; biomaterial; nucleolar organiser; surface; BrdU
ID ORGANIZER REGION; POLYMER SURFACES; IN-VITRO; ADHESION; PROTEINS;
   SUBSTRATUM; RESPONSES; LYMPHOMAS; CULTURE; INVITRO
AB The quantification of silver nitrate staining of nucleolar organising regions (AgNORs) within the nucleus of the cell has been shown to give a relative measure of the metabolic activity of the cell. In the present study, silver nitrate staining was utilised to identify metabolic variations in cells cultured on different surfaces and compared with proliferative activity assessed using bromodeoxyuridine (BrdU) uptake. Primary osteoblast and periosteal cells, isolated from the calvaria of neonate rats, were cultured on tissue culture-grade (TCPS) and bacteriological-grade (BACPS) polystyrene petri dishes for 3, 5, 7 and 9 days (silver nitrate) or 14 days (BrdU). The phenotype of the cells was examined using RT-PCR of the mRNA for osteocalcin, collagen la, alkaline phosphatase and osteopontin. The number and area of AgNORs and the proportion of BrdU positive cells were statistically different in cells cultured on TCPS compared with BACPS at each culture period tested. The results suggest that the metabolic activity and proliferation of cells were affected by the substrate which they colonise. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Birmingham, Biomat Unit, Sch Dent, Birmingham B4 6NN, W Midlands, England.
   Univ Birmingham, Oral Pathol Unit, Sch Dent, Birmingham B4 6NN, W Midlands, England.
RP Shelton, RM (reprint author), Univ Birmingham, Biomat Unit, Sch Dent, Birmingham B4 6NN, W Midlands, England.
CR Alberts B, 1994, MOL BIOL CELL
   AMSTEIN CF, 1975, J CLIN MICROBIOL, V2, P46
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   CROCKER J, 1988, J PATHOL, V154, P151, DOI 10.1002/path.1711540207
   CROCKER J, 1987, J PATHOL, V151, P111, DOI 10.1002/path.1711510203
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   DERENZINI M, 1990, LAB INVEST, V63, P137
   Dewez JL, 1996, J BIOMED MATER RES, V30, P373
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   HALL PA, 1988, HISTOPATHOLOGY, V12, P373, DOI 10.1111/j.1365-2559.1988.tb01952.x
   HUGHES FJ, 1995, ENDOCRINOLOGY, V136, P2671, DOI 10.1210/en.136.6.2671
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Josset Y, 1998, BIOMATERIALS, V19, P1791, DOI 10.1016/S0142-9612(98)00090-8
   Klemperer H.G., 1977, LAB PRACT, V26, P179
   KNAPP PE, 1992, J HISTOCHEM CYTOCHEM, V40, P1405, DOI 10.1177/40.9.1506676
   LANDINI G, 1990, J ORAL PATHOL MED, V19, P257, DOI 10.1111/j.1600-0714.1990.tb00837.x
   LISCHWE MA, 1979, LIFE SCI, V25, P701, DOI 10.1016/0024-3205(79)90512-5
   MAROUDAS NG, 1975, J THEOR BIOL, V49, P417, DOI 10.1016/0022-5193(75)90182-4
   PLOTON D, 1986, HISTOCHEM J, V18, P5, DOI 10.1007/BF01676192
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   REVEL JP, 1974, EXP CELL RES, V84, P207, DOI 10.1016/0014-4827(74)90398-X
   Shelton R. M., 1997, Cells and Materials, V7, P147
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   TANAKA T, 1989, JPN J CANCER RES, V80, P1047, DOI 10.1111/j.1349-7006.1989.tb02257.x
   VANDERVALK P, 1983, J BIOMED MATER RES, V17, P807, DOI 10.1002/jbm.820170508
   WILLIAMS MA, 1982, EXP CELL RES, V137, P341, DOI 10.1016/0014-4827(82)90035-0
   Yonemori K, 1996, BONE, V19, P173, DOI 10.1016/8756-3282(96)00169-X
NR 27
TC 1
Z9 2
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 1
BP 19
EP 26
DI 10.1016/S0142-9612(01)00074-6
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 496YF
UT WOS:000172425400003
PM 11762838
DA 2018-10-19
ER

PT J
AU Mottu, F
   Rufenacht, DA
   Laurent, A
   Doelker, E
AF Mottu, F
   Rufenacht, DA
   Laurent, A
   Doelker, E
TI Iodine-containing cellulose mixed esters as radiopaque polymers for
   direct embolization of cerebral aneurysms and arteriovenous
   malformations
SO BIOMATERIALS
LA English
DT Article
DE embolization; embolic liquids; aneurysms; arteriovenous malformations;
   cellulose esters; iodine-containing cellulose mixed esters; cellulose
   acetate iodobenzoates; radiopacity
ID VINYL ALCOHOL COPOLYMER; ACETATE POLYMER; DIRECT THROMBOSIS;
   LITHIUM-CHLORIDE; BIOMEDICAL APPLICATIONS; CLINICAL-EXPERIENCE;
   IN-VITRO; N,N-DIMETHYLACETAMIDE; BIOMATERIAL; COMBINATION
AB The present study deals with the synthesis and characterization of radiopaque polymers which could, when solubilized in an appropriate water-miscible solvent, be useful embolic materials for the treatment of cerebral aneurysms and arteriovenous malformations. For this purpose cellulose (both microcrystalline and powdered) and partially substituted cellulose acetate (two different viscosity grades) were selected as starting materials to prepare iodine-containing polymers through various synthetic routes. The materials obtained were characterized by IR and NMR spectroscopy, molecular weight, iodine content, radiopacity and solubility in selected injectable organic solvents. The embolic liquids were evaluated for their precipitation behavior in a phosphate buffer solution (pH 7.4) mimicking physiological conditions using an in vitro aneurysm model. A sheep model was also used to assess in vivo the radiopacity and precipitation properties of a highly concentrated solution of a cellulose acetate 2,3,4-triiodobenzoate mixed ester. AH materials with 4-iodo- and 2,3,5-triiodobenzoyl groups gave sufficient radiopacity to be regarded as possible embolization materials, whereas iododeoxycellulose and iododeoxycellulose acetate were not radiopaque because of their low iodine content. Esters synthesized using cellulose as starting material were not soluble in the selected organic solvents due to the presence of many residual hydroxyl groups, but could be used for other biomedical applications where insoluble radiopaque materials are used. In contrast, solubility of the materials as well as satisfactory precipitation properties were ensured using cellulose acetate as the starting material. In conclusion, cellulose acetate iodobenzoate mixed esters dissolved in diglyme or dimethyl isosorbide (dimethyl sulfoxide is probably less appropriate because of its toxicity and hemolytic properties) could be useful embolic liquids for the treatment of cerebral aneurysms or arteriovenous malformations. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Geneva, Sch Pharm, CH-1211 Geneva 4, Switzerland.
   Univ Hosp Geneva, Div Diagnost & Intervent Radiol, Geneva, Switzerland.
   INRA, APHP, Ctr Res Intenvent Radiol, Jouy En Josas, France.
RP Doelker, E (reprint author), Univ Geneva, Sch Pharm, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.
CR BENZINA A, 1994, BIOMATERIALS, V15, P1122, DOI 10.1016/0142-9612(94)90232-1
   CHALOUPKA JC, 1993, J NEUROSURG, V78, P1006
   CHALOUPKA JC, 1994, AM J NEURORADIOL, V15, P1107
   Davy KWM, 1997, POLYM INT, V43, P143, DOI 10.1002/(SICI)1097-0126(199706)43:2<143::AID-PI717>3.0.CO;2-M
   DOELKER E, 1987, POWDER TECHNOL, V52, P207, DOI 10.1016/0032-5910(87)80106-7
   DOTTER CT, 1975, RADIOLOGY, V114, P227, DOI 10.1148/114.1.227
   Gailloud P, 1997, SURG RADIOL ANAT, V19, P119
   Gardner TS, 1942, J AM CHEM SOC, V64, P1539, DOI 10.1021/ja01259a014
   Hassner A., 1978, TETRAHEDRON LETT, V19, P4475
   Heinze T, 1998, MACROMOL CHEM PHYSIC, V199, P2341, DOI 10.1002/macp.1998.021991101
   HEUSER E, 1950, J AM CHEM SOC, V72, P670, DOI 10.1021/ja01158a007
   HIROTSUNE N, 1996, ADV INTERVENTIONAL N, P149
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   KINUGASA K, 1993, J NEUROSURG, V78, P1007
   KINUGASA K, 1994, NEUROSURGERY, V34, P694, DOI 10.1227/00006123-199404000-00019
   KINUGASA K, 1994, NEUROSURGERY, V35, P755, DOI 10.1227/00006123-199410000-00027
   KINUGASA K, 1992, J NEUROSURG, V77, P501, DOI 10.3171/jns.1992.77.4.0501
   KINUGASA K, 1995, J NEUROSURG, V83, P34, DOI 10.3171/jns.1995.83.1.0034
   LAURENT A, 1997, J NEURORADIOLOGY, V24, P314
   LAURENT A, 2001, UNPUB PDA J PHARM SC
   MALM CJ, 1954, ANAL CHEM, V26, P188, DOI 10.1021/ac60085a029
   MALM CJ, 1948, J AM CHEM SOC, V70, P2740, DOI 10.1021/ja01188a031
   Mandai S, 1998, INTERV NEURORADIOL, V4, P173, DOI 10.1177/15910199980040S135
   MANDAI S, 1992, J NEUROSURG, V77, P497, DOI 10.3171/jns.1992.77.4.0497
   MCCORMICK CL, 1990, CARBOHYD RES, V208, P183, DOI 10.1016/0008-6215(90)80098-N
   MCCORMICK CL, 1987, POLYMER, V28, P2317, DOI 10.1016/0032-3861(87)90393-4
   MCCORMICK CL, 1985, MACROMOLECULES, V18, P2394, DOI 10.1021/ma00154a010
   MOSZNER N, 1995, ANGEW MAKROMOL CHEM, V224, P115, DOI 10.1002/apmc.1995.052240112
   Mottu F, 2000, PDA J PHARM SCI TECH, V54, P456
   Mottu F, 1999, INVEST RADIOL, V34, P323, DOI 10.1097/00004424-199905000-00001
   Mottu F, 2001, PDA J PHARM SCI TECH, V55, P16
   MOTTU F, 1999, BIOMATERIALS, V21, P803
   MOTTU F, 2000, Patent No. 0003814
   SAMARANAYAKE G, 1993, CARBOHYD POLYM, V22, P1, DOI 10.1016/0144-8617(93)90159-2
   SAMPEI K, 1996, ADV INTERVENTIONAL N, P293
   Schoniger W., 1955, MIKROCHIM ACTA, V1, P123
   SUGIU K, 1995, J NEUROSURG, V83, P531, DOI 10.3171/jns.1995.83.3.0531
   TAKI W, 1992, J NEUROSURG, V77, P37, DOI 10.3171/jns.1992.77.1.0037
   TAKI W, 1990, AM J NEURORADIOL, V11, P163
   TERADA T, 1991, J NEUROSURG, V75, P655, DOI 10.3171/jns.1991.75.4.0655
   Tipson RS, 1944, J ORG CHEM, V9, P235, DOI 10.1021/jo01185a005
   TIPSON RS, 1947, J ORG CHEM, V12, P133, DOI 10.1021/jo01165a017
   TIPSON RS, 1953, ADV CARBOHYD CHEM, P107
   Tokunaga K, 1998, NEUROSURGERY, V42, P1135, DOI 10.1097/00006123-199805000-00108
   TOKUNAGA K, 1996, ADV INTERVENTIONAL N, P15
   Williamson SL, 1998, J MACROMOL SCI PURE, VA35, P1915, DOI 10.1080/10601329808000987
   WOLFROM ML, 1941, J AM CHEM SOC, V63, P1688
   YAMASHITA K, 1994, AM J NEURORADIOL, V15, P1103
NR 48
TC 61
Z9 63
U1 3
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 1
BP 121
EP 131
DI 10.1016/S0142-9612(01)00087-4
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 496YF
UT WOS:000172425400015
PM 11762830
DA 2018-10-19
ER

PT J
AU Koob, TJ
   Hernandez, DJ
AF Koob, TJ
   Hernandez, DJ
TI Material properties of polymerized NDGA-collagen composite fibers:
   development of biologically based tendon constructs
SO BIOMATERIALS
LA English
DT Article
DE collagen; tendon; ligament; biomaterial; NDGA; polymerization; fibrous
   tissues
ID CONTROLLED PASSIVE MOBILIZATION; NORDIHYDROGUAIARETIC ACID; FLEXOR
   TENDONS; FL5.12 CELLS; REPAIR; DOGS; RECONSTRUCTION; EXPRESSION;
   APOPTOSIS; LIGAMENT
AB Methods for stabilizing collagen-based materials with catechol containing monomers were developed in order to produce fibers with mechanical properties in tension comparable to those of normal tendon. Fibers produced from pepsin solubilized, bovine tendon type I collagen were polymerized with the di-catechol nordihydroguaiaretic acid (NDGA). Polymerization was based on the chemical oxidation of the constituent o-catechols to reactive o-quinone functionalities. NDGA caused a dose dependent increase in the tensile strength and stiffness of the type I collagen fibers. A second treatment with NDGA improved the tensile properties significantly. Comparison of the effects of NDGA with those of biologically relevant mono-catechols indicated that the bi-catechol functionality of NDGA was responsible for generation of the superior tensile properties. Elimination of unreacted intermediates from the treated fibers with ethanol increased the effectiveness of the cross-linking process while simultaneously sterilizing the material. Catalyzing oxidation by saturating the reaction buffer with oxygen increased the effectiveness of polymerization and the resulting tensile properties of the treated fibers. The ultimate tensile strength of the optimized NDGA-treated fibers averaged 90 MPa the elastic modulus of these fibers averaged 580 Wa. Both values are comparable to native tendon. The material properties of the NDGA cross-linked fibers exceed the properties of collagen fibers treated with other cross-linking strategies such as glutaraldehyde and carbodiimide, These results indicate that NDGA cross-linking may provide a viable approach to stabilizing collagenous materials for use in repair of ruptured, lacerated or surgically transected tendons, as well as other biomaterial constructs for surgical repair of musculoskeletal injuries and disease. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Shriners Hosp Children, Skeletal Biol Sect, Ctr Res Skeletal Dev & Pediat Orthopaed, Tampa, FL 33612 USA.
RP Koob, TJ (reprint author), Shriners Hosp Children, Skeletal Biol Sect, Ctr Res Skeletal Dev & Pediat Orthopaed, 12502 N Pine Dr, Tampa, FL 33612 USA.
CR ABRAHAMSSON SO, 1995, J ORTHOPAED RES, V13, P58, DOI 10.1002/jor.1100130110
   ABRAHAMSSON SO, 1994, J HAND SURG-AM, V19A, P259, DOI 10.1016/0363-5023(94)90016-7
   AMIEL D, 1995, J ORTHOPAED RES, V13, P459, DOI 10.1002/jor.1100130321
   AOKI M, 1994, J HAND SURG-AM, V19A, P984, DOI 10.1016/0363-5023(94)90102-3
   ARK JW, 1994, J HAND SURG-AM, V19A, P249, DOI 10.1016/0363-5023(94)90015-9
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   BAINBRIDGE LC, 1994, J HAND SURG-BRIT EUR, V19B, P517, DOI 10.1016/0266-7681(94)90219-4
   Becker H, 1979, J Hand Surg Am, V4, P454
   BENEDICT CV, 1989, ACS SYM SER, V385, P465, DOI 10.1021/bk-1989-0385.ch033
   Biswal SS, 2000, TOXICOL SCI, V53, P77, DOI 10.1093/toxsci/53.1.77
   BRUNELLI G, 1983, HAND, V15, P352
   Datta K, 1998, J BIOL CHEM, V273, P28163, DOI 10.1074/jbc.273.43.28163
   DOCKERY G L, 1986, Journal of Foot Surgery, V25, P469
   DUNN MG, 1993, J BIOMED MATER RES, V27, P1545, DOI 10.1002/jbm.820271211
   ELLIOT D, 1994, J HAND SURG-BRIT EUR, V19B, P607, DOI 10.1016/0266-7681(94)90126-0
   Esa AH, 1996, SCAND J IMMUNOL, V43, P127, DOI 10.1046/j.1365-3083.1996.d01-20.x
   GELBERMAN RH, 1992, J BONE JOINT SURG AM, V74A, P1207, DOI 10.2106/00004623-199274080-00011
   GELBERMAN RH, 1981, HAND, V13, P120, DOI 10.1016/S0072-968X(81)80051-4
   GELBERMAN RH, 1990, J HAND SURG-AM, V15A, P69, DOI 10.1016/S0363-5023(09)91108-X
   GELBERMAN RH, 1986, J HAND SURG-AM, V11A, P106, DOI 10.1016/S0363-5023(86)80115-0
   GELBERMAN RH, 1982, J HAND SURG-AM, V7, P170, DOI 10.1016/S0363-5023(82)80083-X
   GELBERMAN RH, 1991, CLIN ORTHOP RELAT R, P189
   GELBERMAN RH, 1983, J BONE JOINT SURG AM, V65, P70, DOI 10.2106/00004623-198365010-00010
   GOLDSTEIN JD, 1989, J BONE JOINT SURG AM, V71A, P1183, DOI 10.2106/00004623-198971080-00010
   GREEN K, 1997, SURG ADHESIVES SEALA
   HUNTER JM, 1988, J HAND SURG-AM, V13A, P849, DOI 10.1016/0363-5023(88)90259-6
   IANNACE S, 1995, BIOMATERIALS, V16, P675, DOI 10.1016/0142-9612(95)99693-G
   KAIN CC, 1988, J ORTHOPAED RES, V6, P871, DOI 10.1002/jor.1100060611
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   KATO YP, 1991, J BONE JOINT SURG AM, V73A, P561, DOI 10.2106/00004623-199173040-00013
   Koob TJ, 2001, J BIOMED MATER RES, V56, P31, DOI 10.1002/1097-4636(200107)56:1<31::AID-JBM1065>3.0.CO;2-N
   Koob TJ, 2001, J BIOMED MATER RES, V56, P40, DOI 10.1002/1097-4636(200107)56:1<40::AID-JBM1066>3.3.CO;2-9
   LEE H, 1990, J HAND SURG-AM, V15A, P953, DOI 10.1016/0363-5023(90)90022-J
   LEE H, 1990, J HAND SURG-AM, V15A, P945, DOI 10.1016/0363-5023(90)90021-I
   MAY EJ, 1992, J HAND SURG-AM, V17A, P1133, DOI 10.1016/S0363-5023(09)91080-2
   MAY EJ, 1992, J HAND SURG-AM, V17A, P942, DOI 10.1016/0363-5023(92)90475-5
   MCMASTER WC, 1986, B HOSP JOINT DIS ORT, V46, P174
   MENDES DG, 1986, J BIOMED MATER RES, V20, P699, DOI 10.1002/jbm.820200604
   MESSINA A, 1992, J HAND SURG-AM, V17A, P137, DOI 10.1016/0363-5023(92)90129-D
   Messinger PR, 1997, MARKET SCI, V16, P1, DOI 10.1287/mksc.16.1.1
   MILTHORPE BK, 1994, BIOMATERIALS, V15, P745, DOI 10.1016/0142-9612(94)90027-2
   Noguchi M, 1997, J HAND SURG-AM, V22A, P457, DOI 10.1016/S0363-5023(97)80013-5
   ROBISON TW, 1990, TOXICOL APPL PHARM, V105, P113, DOI 10.1016/0041-008X(90)90363-Y
   ROE S C, 1992, Clinical Materials, V9, P149, DOI 10.1016/0267-6605(92)90094-A
   ROGERS GT, 1995, BIOMATERIALS, V16, P803, DOI 10.1016/0142-9612(95)99643-Z
   SALERNO AJ, 1993, APPL MICROBIOL BIOT, V39, P221
   SAVAGE R, 1989, J HAND SURG-BRIT EUR, V14B, P396, DOI 10.1016/0266-7681(89)90154-X
   SEILER JG, 1995, J HAND SURG-AM, V20A, P492, DOI 10.1016/S0363-5023(05)80115-7
   SEILER JG, 1993, J BONE JOINT SURG AM, V75A, P1004, DOI 10.2106/00004623-199307000-00006
   SILFVERSKIOLD KL, 1993, J HAND SURG-AM, V18A, P654, DOI 10.1016/0363-5023(93)90312-Q
   SILFVERSKIOLD KL, 1994, J HAND SURG-AM, V19A, P53, DOI 10.1016/0363-5023(94)90224-0
   SMITH DJ, 1986, J HAND SURG-AM, V11A, P97, DOI 10.1016/S0363-5023(86)80114-9
   STRICKLAND JW, 1980, J HAND SURG-AM, V5, P537, DOI 10.1016/S0363-5023(80)80101-8
   Strickland JW, 2000, J HAND SURG-AM, V25A, P214
   STROM H, 1990, J VET PHARMACOL THER, V13, P186, DOI 10.1111/j.1365-2885.1990.tb00767.x
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   TAKAI S, 1991, J ORTHOP RES, V9, P705, DOI 10.1002/jor.1100090510
   Tang DG, 1997, J CELL PHYSIOL, V172, P155, DOI 10.1002/(SICI)1097-4652(199708)172:2<155::AID-JCP3>3.0.CO;2-N
   WAITE JH, 1990, COMP BIOCHEM PHYS B, V97, P19, DOI 10.1016/0305-0491(90)90172-P
   WAITE JH, 1995, METHOD ENZYMOL, V258, P1
   WOO SLY, 1981, ACTA ORTHOP SCAND, V52, P615, DOI 10.3109/17453678108992156
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
NR 63
TC 51
Z9 57
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 1
BP 203
EP 212
DI 10.1016/S0142-9612(01)00096-5
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 496YF
UT WOS:000172425400024
PM 11762839
DA 2018-10-19
ER

PT J
AU Caplan, MR
   Schwartzfarb, EM
   Zhang, SG
   Kamm, RD
   Lauffenburger, DA
AF Caplan, MR
   Schwartzfarb, EM
   Zhang, SG
   Kamm, RD
   Lauffenburger, DA
TI Control of self-assembling oligopeptide matrix formation through
   systematic variation of amino acid sequence
SO BIOMATERIALS
LA English
DT Article
DE oligopeptide; biomaterial; self-assembly; amino acid sequence
ID HYDROPHOBICITY SCALE; COMPLEMENTARY OLIGOPEPTIDE; PROTEINS
AB In order to elucidate design principles for biocompatible materials that can be created by in situ transformation from self assembling oligopeptides, we investigate a class of oligopeptides that can self-assemble in salt solutions to form three-dimensional matrices. This class of peptides. possesses a repeated sequence of amino acid residues with the type: hydrophobic/negatively-charged/hydrophobic/positively-charged. We systematically vary three chief aspects of this sequence type: (1) the hydrophobic side chains: (2) the charged side-chains, and (3) the number of repeats. Employing a rheometric assay to judge matrix formation, we determine the critical concentration of NaCl salt solution required to drive transformation from viscous state to gel state. We find that increasing side-chain hydrophobicity decreases the critical salt concentration in accord with our previous validation of DLVO theory for explaining this self-assembly phenomenon Caplan et al. (Biomacromolecules 1 (2000) 627). Further, we find that increasing the number of repeats yields a biphasic dependence-first decreasing, then increasing, the critical salt concentration. We believe that this result is likely due to an unequal competition between a greater hydrophobic (favorable) effect and a greater entropic (unfavorable) effect as the peptide length is increased. Finally, we find that we can use this understanding to rationally alter the charged side-chains to create a self-assembling oligopeptide sequence that at pH 7 remains viscous in the absence of salt but gels in the presence of physiological salt concentrations, a highly useful property for technological applications. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
   MIT, Div Bioengn & Environm Hlth, Cambridge, MA 02139 USA.
RP Lauffenburger, DA (reprint author), MIT, Dept Chem Engn, Bldg 56,Room 341 B, Cambridge, MA 02139 USA.
FU NIGMS NIH HHS [GM55781]
CR Anderson J. P., 1997, PROTEIN BASED MAT, P371
   BRANDEN C, 1991, INTRO PROTEIN FOLDIN
   BULL HB, 1974, ARCH BIOCHEM BIOPHYS, V161, P665, DOI 10.1016/0003-9861(74)90352-X
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   CLARK AH, 1987, ADV POLYM SCI, V83, P58
   Creighton T, 1993, PROTEINS STRUCTURE M
   Hiemenz P.C., 1997, PRINCIPLES COLLOID S
   Hubbell JA, 1996, MRS BULL, V21, P33
   Leon EJ, 1998, J BIOMAT SCI-POLYM E, V9, P297, DOI 10.1163/156856298X00668
   NOZAKI Y, 1971, J BIOL CHEM, V246, P2211
   Overbeek J. T. G, 1952, COLLOID SCI, VI, P302
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Tanford C, 1973, HYDROPHOBIC EFFECT F
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   VERWEY EJW, 1948, THEORY STABILITY LYO
   Vorobev MM, 1997, Z NATURFORSCH C, V52, P227
   WELLINGS DA, 1997, METHOD ENZYMOL, P61
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 20
TC 169
Z9 177
U1 2
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 1
BP 219
EP 227
DI 10.1016/S0142-9612(01)00099-0
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 496YF
UT WOS:000172425400026
PM 11762841
DA 2018-10-19
ER

PT J
AU Rocha, LB
   Goissis, G
   Rossi, MA
AF Rocha, LB
   Goissis, G
   Rossi, MA
TI Biocompatibility of anionic collagen matrix as scaffold for bone healing
SO BIOMATERIALS
LA English
DT Article
DE collagen/therapeutic use; bone substitutes; bone regeneration;
   osteogenesis; biocompatible materials
ID CALCIFIC DEGENERATION; INJECTABLE COLLAGEN; CLINICAL USE; REPLACEMENT;
   BIOMATERIAL; GRAFTS; REPAIR
AB The basic approach to the treatment of bone defects involves the use of scaffolds to favor tissue growth. Although several bioscaffolds have been proposed for this purpose, the search for new and enhanced materials continues in an attempt to address the drawbacks of the present ones. Modifying current materials can be a fast and cheap way to develop new ones. Among them, type I collagen allows its structure to be modified using relatively simple techniques. By means of an alkaline treatment, anionic collagen with enhanced piezoelectric properties can be obtained through hydrolysis of carboxyamides groups of asparagine and glutamine residues from collagen in carboxylic. The process applied to a raw source of collagen, bovine pericardium, provided a sponge-like structure, with heterogeneous pore size, and, moreover, the complete removal of interstitial cells. For the evaluation of the biocompatibility of such matrices, they were implanted in surgically created bone defects in rat tibias. Empty defects served as controls. This experimental model allowed a preliminary evaluation of the osteoconductiveness of the matrices. The histological results presented a low inflammatory response and bone formation within a short period of Lime, similar to that of controls. The low cost of production associated to the biocompatibility and osteoconductivity performance make the anionic collagen matrices promising alternatives for bone defects treatment. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, BR-14049900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Dept Mol Chem & Phys, Inst Chem Sao Carlos, BR-13560250 Sao Carlos, SP, Brazil.
RP Rocha, LB (reprint author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
RI Rocha, Lenaldo/D-2382-2011
OI Rocha, Lenaldo/0000-0002-4345-6994
CR Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Chiang TM, 1999, HISTOL HISTOPATHOL, V14, P579, DOI 10.14670/HH-14.579
   CITARDI MJ, 1994, OTOLARYNG CLIN N AM, V27, P891
   Constantino PD, 1994, OTOLARYNGOL CLIN N A, V27, P1037
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   DELACURE MD, 1994, OTOLARYNG CLIN N AM, V27, P859
   DELBALSO AM, 1976, ORAL SURG ORAL MED O, V42, P562, DOI 10.1016/0030-4220(76)90205-X
   DELUSTRO F, 1987, PLAST RECONSTR SURG, V79, P581, DOI 10.1097/00006534-198704000-00012
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Goissis G, 1998, ARTIF ORGANS, V22, P203, DOI 10.1046/j.1525-1594.1998.06109.x
   Horton M. A., 1996, P217
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   KAMER FM, 1984, ARCH OTOLARYNGOL, V110, P93
   Lacerda C, 1998, QUIM NOVA, V21, P267, DOI 10.1590/S0100-40421998000300006
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706
   MITCHELL R, 1992, BRIT J ORAL MAX SURG, V30, P180, DOI 10.1016/0266-4356(92)90153-A
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Plepis AMD, 1996, POLYM ENG SCI, V36, P2932
   Pohunkova H, 1996, BIOMATERIALS, V17, P1567, DOI 10.1016/0142-9612(95)00310-X
   Radhika M, 1999, COMP BIOCHEM PHYS C, V124, P131, DOI 10.1016/S0742-8413(99)00042-0
   Radhika M, 1997, J BIOMED MATER RES, V35, P497
   RAPPAPORT C, 1960, EXP CELL RES, V20, P465, DOI 10.1016/0014-4827(60)90117-8
   ROSSI MA, 1986, INT J CARDIOL, V12, P331, DOI 10.1016/0167-5273(86)90269-X
   ROSSI MA, 1990, J EXP PATHOL, V71, P187
   Toung JS, 1999, LARYNGOSCOPE, V109, P1580, DOI 10.1097/00005537-199910000-00006
   Van Heest Ann, 1999, Lancet (North American Edition), V353, P28
   Watson SP, 1999, THROMB HAEMOSTASIS, V82, P365
   Wight Thomas N., 1992, Current Opinion in Cell Biology, V4, P793, DOI 10.1016/0955-0674(92)90102-I
NR 31
TC 93
Z9 105
U1 1
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 2
BP 449
EP 456
DI 10.1016/S0142-9612(01)00126-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 498FC
UT WOS:000172498300015
PM 11761165
DA 2018-10-19
ER

PT J
AU Wooley, PH
   Morren, R
   Andary, J
   Sud, SA
   Yang, SY
   Mayton, L
   Markel, D
   Sieving, A
   Nasser, S
AF Wooley, PH
   Morren, R
   Andary, J
   Sud, SA
   Yang, SY
   Mayton, L
   Markel, D
   Sieving, A
   Nasser, S
TI Inflammatory responses to orthopaedic biomaterials in the murine air
   pouch
SO BIOMATERIALS
LA English
DT Article
DE orthopaedic biomaterials; particulates; inflammation; polymers; alloys
ID TOTAL HIP-ARTHROPLASTY; TISSUE; MODEL; IMPLANTATION; PARTICLES;
   SYNOVITIS; CYTOKINE; DEBRIS; WEAR
AB An in vivo model of the inflammatory response to orthopaedic biomaterials was used to examine cellular and cytokine responses to polymer particles of ultra high molecular weight polyethylene (UHMWPE) and polymethylmethacrylate (PMMA), and metal particles of cobalt-chrome (Co Cr) and titanium alloy (Ti-6Al-4V). Responses were determined separately and in combinations, to examine interactions between different forms of biomaterials. Murine air pouches were injected with particle suspensions, and reactions evaluated using histological, immunological, and molecular techniques. All particulate biomaterials caused significant increases in membrane thickness compared with control (saline) air pouches, with the highest reaction seen in response to Ti-6Al-4V particles. A synergistic increase in membrane thickness was observed when PMMA was combined with UHMWPE, suggesting that multiple biomaterial stimuli markedly increase the inflammatory reaction. Cellular analysis indicated that all particles increased the absolute number and the percentage of macrophages in the membrane over the control level, with the most pronounced increase due to individual biomaterial occurring with UHMWPE particles. Cytokine analysis revealed that biomaterials provoked a strong IL-I response. Ti-6Al-4V stimulated the highest IL-6 gene transcription and the lowest IL-I gene transcription. The data suggest that synergism in the inflammatory response to biomaterials may be important in adverse responses to orthopaedic wear debris. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Wayne State Univ, Hutzel Hosp, Sch Med, Dept Orthopaed Surg, Detroit, MI 48201 USA.
   Vet Adm Med Ctr, Detroit, MI 48201 USA.
RP Wooley, PH (reprint author), Wayne State Univ, Hutzel Hosp, Sch Med, Dept Orthopaed Surg, 1 South,4707 St Antoine Blvd, Detroit, MI 48201 USA.
OI Yang, Shang-You/0000-0002-8835-5302
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   AKAGAWA Y, 1985, J PROSTHET DENT, V53, P681, DOI 10.1016/0022-3913(85)90023-X
   ALSAFFAR N, 1994, BRIT J RHEUMATOL, V33, P309
   Bi Y, 1999, T ORTHOP RES SOC, V45, P5
   BOS I, 1995, ACTA ORTHOP SCAND, V66, P1, DOI 10.3109/17453679508994628
   BOSS JH, 1990, INT ORTHOP, V14, P399
   Buly R L, 1992, J Arthroplasty, V7, P315, DOI 10.1016/0883-5403(92)90056-V
   CHADHA HS, 1995, INFLAMM RES, V44, P145, DOI 10.1007/BF01782811
   DAWSON J, 1989, AGENTS ACTIONS, V27, P461, DOI 10.1007/BF01972853
   EFTEKHAR NS, 1985, PROSTHETIC SYNOVITIS, P169
   GELB H, 1994, J ORTHOP RES, V12, P83, DOI 10.1002/jor.1100120111
   Gonzales JB, 1996, CLIN ORTHOP RELAT R, P244
   GOODMAN SB, 1990, J BIOMED MATER RES, V24, P517, DOI 10.1002/jbm.820240408
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   Haynes DR, 1996, CLIN ORTHOP RELAT R, P316
   ISAJI M, 1989, BRIT J EXP PATHOL, V70, P705
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   KAUFMAN RL, 1985, J RHEUMATOL, V12, P1066
   KOROVESSIS P, 1994, CLIN ORTHOP RELAT R, P155
   Liu HC, 1999, ARTIF ORGANS, V23, P1099, DOI 10.1111/j.1525-1594.1999.06343.x
   LOMBARDI AV, 1989, J BONE JOINT SURG AM, V71A, P1337, DOI 10.2106/00004623-198971090-00009
   MORRIS CJ, 1987, ANN RHEUM DIS, V46, P334, DOI 10.1136/ard.46.4.334
   NAGASE M, 1988, J RHEUMATOL, V15, P1334
   Nagase M, 1990, Nihon Seikeigeka Gakkai Zasshi, V64, P602
   Perry MJ, 1995, BRIT J RHEUMATOL, V34, P1127
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   Schaefer CJ, 1997, ARTHRITIS RHEUM-US, V40, P1064, DOI 10.1002/art.1780400611
   SEDGWICK AD, 1983, J PATHOL, V141, P483, DOI 10.1002/path.1711410406
   SHANBHAG AS, 1995, J ARTHROPLASTY, V10, P498, DOI 10.1016/S0883-5403(05)80152-4
   WITT JD, 1991, J BONE JOINT SURG BR, V73, P559
   Wooley PH, 1998, AUTOIMMUNITY, V27, P91, DOI 10.3109/08916939809008039
   Wooley PH, 1996, CLIN ORTHOP RELAT R, P63
   WOOLEY PH, 1996, ORTHOP T, V21, P500
   WOOLEY PH, 1996, ARTHRITIS RHEUM, V39, P175
NR 34
TC 139
Z9 154
U1 1
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 2
BP 517
EP 526
DI 10.1016/S0142-9612(01)00134-X
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 498FC
UT WOS:000172498300023
PM 11761173
DA 2018-10-19
ER

PT J
AU Lobler, M
   Sass, M
   Kunze, C
   Schmitz, KP
   Hopt, UT
AF Lobler, M
   Sass, M
   Kunze, C
   Schmitz, KP
   Hopt, UT
TI Biomaterial patches sutured onto the rat stomach induce a set of genes
   encoding pancreatic enzymes
SO BIOMATERIALS
LA English
DT Article
DE biomaterial; gastrointestine; differential display; polyhydroxybutyric
   acid; mRNA; hydrolases
ID MESSENGER-RNA EXPRESSION; DIFFERENTIAL DISPLAY; BIODEGRADABLE PATCH; PCR
   ANALYSIS; POLY(3-HYDROXYBUTYRATE); ANASTOMOSES; SURGERY; TISSUE
AB Asymmetric patches of polyhydroxybutyric acid with one smooth and one rough surface were produced by a dipping procedure. These patches were implanted into the rat gastrointestine and tissue samples were generated at distinct time intervals after surgery. The host's response towards the foreign material was analyzed by Differential Display and RNA profiles were compared to each other. One to two weeks after surgery a group of mRNAs encoding pancreatic enzymes was transiently present after biomaterial implantation. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Rostock, Chirurg Klin & Poliklin, Forschungslab, D-18057 Rostock, Germany.
   Univ Rostock, Inst Biomed Tech, Kompetenzzentrum Biomat, D-18057 Rostock, Germany.
RP Lobler, M (reprint author), Univ Freiburg, Chirurg Klin, Abt Allg & Visceralchirurg, Hugstetter Str 55, D-79106 Freiburg, Germany.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   AMID PK, 1994, J BIOMED MATER RES, V28, P373, DOI 10.1002/jbm.820280312
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   DINARELLO CA, 1990, BLOOD PURIFICAT, V8, P208, DOI 10.1159/000169968
   DUVERNOY O, 1995, THORAC CARDIOV SURG, V43, P271, DOI 10.1055/s-2007-1013226
   FREIER T, IN VITRO IN VIVO DEG
   GOLDBERG RB, 1981, DEV BIOL, V83, P201, DOI 10.1016/0012-1606(81)90467-X
   Hazari A, 1999, J HAND SURG-BRIT EUR, V24B, P291, DOI 10.1054/jhsb.1998.0001
   HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640
   Kishida A, 1996, BIOMATERIALS, V17, P1301, DOI 10.1016/0142-9612(96)88675-3
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   LIANG P, 1993, NUCLEIC ACIDS RES, V21, P3269, DOI 10.1093/nar/21.14.3269
   Ljungberg C, 1999, MICROSURG, V19, P259, DOI 10.1002/(SICI)1098-2752(1999)19:6<259::AID-MICR1>3.0.CO;2-Q
   MALM T, 1992, SCAND J THORAC CARD, V26, P15, DOI 10.3109/14017439209099048
   MALM T, 1992, SCAND J THORAC CARD, V26, P9, DOI 10.3109/14017439209099047
   Miguel O, 1999, J APPL POLYM SCI, V73, P455, DOI 10.1002/(SICI)1097-4628(19990725)73:4<455::AID-APP1>3.0.CO;2-Y
   MOREHEAD JM, 1994, OTOLARYNG CLIN N AM, V27, P195
   Mutter D, 1997, EUR J SURG, V163, P287
   Nkere UU, 1998, THORAC CARDIOV SURG, V46, P77, DOI 10.1055/s-2007-1010194
   Park YK, 1998, NEUROSURGERY, V42, P813, DOI 10.1097/00006123-199804000-00076
   Shinohe T, 1996, FEMS MICROBIOL LETT, V141, P103
   SIEGLING A, 1994, J IMMUNOL METHODS, V177, P23, DOI 10.1016/0022-1759(94)90139-2
   WINKELTAU GJ, 1993, DIS COLON RECTUM, V36, P154, DOI 10.1007/BF02051171
NR 23
TC 16
Z9 17
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 2
BP 577
EP 583
DI 10.1016/S0142-9612(01)00144-2
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 498FC
UT WOS:000172498300029
PM 11761178
DA 2018-10-19
ER

PT S
AU Te, CC
   Ferguson, B
   Abbott, D
AF Te, CC
   Ferguson, B
   Abbott, D
BE Nicolau, DV
   Lee, AP
TI Investigation of biomaterial classification using T-rays
SO BIOMEDICAL APPLICATIONS OF MICRO- AND NANOENGINEERING
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT International Symposium on Smart Materials, Nano-, and Micro-Smart
   Systems
CY DEC 16-18, 2002
CL RMIT UNIV, MELBOURNE, AUSTRALIA
SP SPIE, Univ Arkansas, Natl Inst Adv Ind Sci & Technol, Cooperat Res Ctr Microtechnol, Dept Def, Australia, Swinburne Univ Technol, Adelaide Univ, Japanese Soc Electr Packaging, New Energy & Ind Technol Dev Org
HO RMIT UNIV
DE terahertz detection; T-rays; statistical pattern classification
AB The use of terahertz pulses (T-rays) for imaging has created a wide range of new applications. This paper investigates a number of techniques for optimally classifying terahertz data. Specifically we consider statistical pattern classification methods.
   A goal of this research is to implement a classifier as for classifying biomaterials. The objective is to train a classifier using THz images of known materials and then to use the classifier to identify the materials present in unknown images. Potential applications in security systems for airports, customs, and post offices are significant, because we can actually identify the material inside the package without opening it, based on a material's broadband frequency signature.
C1 Univ Adelaide, Ctr Biomed Engn, Adelaide, SA 5005, Australia.
RP Te, CC (reprint author), Univ Adelaide, Ctr Biomed Engn, Adelaide, SA 5005, Australia.
RI Abbott, Derek/E-8352-2011
OI Abbott, Derek/0000-0002-0945-2674
CR BACHMAN G, 1999, FOURIER WAVELET ANAL
   Balakrishnama S., 1998, LINEAR DISCRIMINANT
   Chen C, 1988, SIGNAL PROCESSING HD
   CHERKASSKY V, 1998, LEARNING DATA
   Duda R. O., 1973, PATTERN CLASSIFICATI
   Duda RO, 2001, PATTERN CLASSIFICATI
   Ferguson B, 2001, FLUCT NOISE LETT, V1, pL65, DOI 10.1142/S0219477501000226
   FERGUSON B, IN PRESS MICROELECTR
   HAIR JF, 1995, MULTIVARIATE DATA AN
   JAIN AK, 2000, IEEE PATTERN ANAL MA, V22
   Ljung L, 2000, SYSTEM IDENTIFICATIO
   *MATHWORKS INC, 2000, STAT TOOLB US GUID V
   Misiti M, 2000, WAVELET TOOLBOX USER
   Mittleman DM, 1996, IEEE J SEL TOP QUANT, V2, P679, DOI 10.1109/2944.571768
   Prasad L., 1997, WAVELET ANAL APPL IM
   SUTER BW, 1998, MULTIRATE WAVELET SI
NR 16
TC 5
Z9 5
U1 1
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4732-3
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4937
BP 294
EP 306
DI 10.1117/12.476426
PG 13
WC Engineering, Biomedical; Engineering, Electrical & Electronic;
   Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BW27F
UT WOS:000181394800033
OA Green Published
DA 2018-10-19
ER

PT S
AU Maitland, DJ
   Wilson, T
   Metzger, M
   Schumann, DL
AF Maitland, DJ
   Wilson, T
   Metzger, M
   Schumann, DL
BE Bornhop, DJ
   Dunn, DA
   Mariella, RP
   Murphy, CJ
   Nicolau, DV
   Nie, S
   Palmer, M
   Raghavachari, R
TI Laser-activated shape memory polymer microactuators for treating stroke
SO BIOMEDICAL NANOTECHNOLOGY ARCHITECTURES AND APPLICATIONS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Nanotechnology Architectures and Applications
CY JAN 20-24, 2002
CL SAN JOSE, CA
SP SPIE
DE diode laser; hemorrhagic stroke; ischemic stroke; biomaterial
ID RHEOLYTIC CATHETER; THROMBECTOMY
AB In this paper the photothermal engineering issues of novel shape memory polymer (SMP) microactuators for treating stroke are presented. The engineering issues for using lasers to heat and subsequently actuate these SMP devices are presented in order to provide design criteria and guidelines for intravascular, laser activated SMP devices. The optical properties of SMP, methods for coupling laser light into SMP, heating distributions in the SMP devices and the impact of operating the thermally activated material in a blood vessel (with and without flow) are presented. A total of three devices will be presented: two interventional ischemic stroke devices and one device for releasing embolic coils. The optical properties of SMP, methods for coupling laser light into SMP, heating distributions in the SNP devices and the impact of operating the thermally activated material in a blood vessel are presented. Actuating the devices requires device temperatures in the range of 65 degreesC - 85 degreesC. Attaining these temperatures under flow conditions requires critical engineering of the SMP optical properties, optical coupling into the SMP, and device geometries. Laser-activated SMP devices are a unique combination of laser-tissue and biomaterial technologies. Successful deployment of the microactuator requires well-engineered coupling of the light from the diffusing fiber through the blood into the SMP.
C1 Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
RP Maitland, DJ (reprint author), Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
CR BENDERSON JB, 2000, STROKE, V31, P2742
   BENETT WJ, 1998, Patent No. 5783130
   Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415
   CONNORS JJ, 1999, INTERV NEURORADIOL, P650
   CONNORS JJ, 1999, INTERV NEURORADIOL, P276
   FITCH JP, 1998, Patent No. 5722989
   Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112
   Hayashi S., 1991, U. S. Patent, Patent No. [5,049,591, 5049591]
   HAYASHI S, 1988, MITSUBHISHI TECHNICA, V184
   Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151
   KUSY RP, 1994, THERMOCHIM ACTA, V243, P253, DOI 10.1016/0040-6031(94)85060-7
   LAFONTAINE D, 1996, Patent No. 5662621
   Maitland DJ, 2002, LASER SURG MED, V30, P1
   MAITLAND DJ, 1998, Patent No. 6102917
   METZGER MF, 2002, IN PRESS J BIOMEDICA
   National Institute of Neurological Disorders and Stroke rt-PA Study Group, 1995, NEW ENGL J MED, V333, P1581, DOI DOI 10.1056/NEJM199512143332401
   Opatowsky MJ, 1999, AM J NEURORADIOL, V20, P414
   OTA S, 1981, RADIAT PHYS CHEM, V18, P81, DOI 10.1016/0146-5724(81)90066-2
   Otsuka K., 1998, SHAPE MEMORY MAT
   Ratner BD, 1996, INTRO MAT MED
   Takahashi T, 1996, J APPL POLYM SCI, V60, P1061
   Vesely TM, 1999, J VASC INTERV RADIOL, V10, P1195, DOI 10.1016/S1051-0443(99)70220-4
   Wang MT, 1999, J POLYM SCI POL PHYS, V37, P101, DOI 10.1002/(SICI)1099-0488(19990115)37:2<101::AID-POLB1>3.0.CO;2-X
   Wiebers D, 1998, NEW ENGL J MED, V339, P1725
NR 24
TC 9
Z9 9
U1 3
U2 12
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4365-4
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4626
BP 394
EP 402
DI 10.1117/12.472105
PG 9
WC Biotechnology & Applied Microbiology; Optics; Imaging Science &
   Photographic Technology
SC Biotechnology & Applied Microbiology; Optics; Imaging Science &
   Photographic Technology
GA BU92U
UT WOS:000177419500047
DA 2018-10-19
ER

PT J
AU Scholler, M
   Hauck, A
   Thull, R
   Steinmeyer, R
   Hedrich, R
   Schneider, FW
   Kiefer, W
   Popp, J
AF Scholler, M
   Hauck, A
   Thull, R
   Steinmeyer, R
   Hedrich, R
   Schneider, FW
   Kiefer, W
   Popp, J
TI Laser scanning microscopy study on adsorption of biologically relevant
   proteins on implant materials
SO BIOPOLYMERS
LA English
DT Article; Proceedings Paper
CT 9th European Conference on the Spectroscopy of Biological Molecules
CY SEP 08-13, 2001
CL PRAGUE, CZECH REPUBLIC
DE laser scanning microscopy; protein; adsorption; implant
ID FLUORESCENCE CORRELATION SPECTROSCOPY; TITANIUM
AB The adsorption of proteins at implant surfaces plays a key role in osscointegration and is therefore of great importance in biomaterial science. Laser scanning microscopy (LSM) is described, a method that is used here for the first study of the adsorption of proteins on implant surfaces. These LSM measurements provide information on the surface morphology, and the spatial distribution of adsorbed proteins can be deduced. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Wurzburg, Inst Phys Chem, D-97074 Wurzburg, Germany.
   Abt Funkt Werkostoffe Med & Zahnheilkunde, D-97072 Wurzburg, Germany.
   Julius Von Sachs Inst Biowissensch, D-97082 Wurzburg, Germany.
RP Popp, J (reprint author), Univ Wurzburg, Inst Phys Chem, Hubland, D-97074 Wurzburg, Germany.
RI Popp, Juergen/E-6471-2012; Hedrich, Rainer/G-8771-2011
OI Hedrich, Rainer/0000-0003-3224-1362
CR Benes M, 2001, COLLECT CZECH CHEM C, V66, P855, DOI 10.1135/cccc20010855
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102
   Francois P, 1997, CLIN ORAL IMPLAN RES, V8, P217, DOI 10.1034/j.1600-0501.1997.080308.x
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   MADGE D, 1974, BIOPOLYMERS, V13, P29
   Olbrich KC, 1996, BIOMATERIALS, V17, P759, DOI 10.1016/0142-9612(96)81412-8
   Ramsden J. J., 1993, Q REV BIOPHYS, V27, P41
   RAMSDEN JJ, 1993, J STAT PHYS, V73, P853, DOI 10.1007/BF01052813
   STRYER L, 1999, BIOCHIMIE, P266
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   WILLIAMS RL, 1995, J BIOMED MATER RES, V29, P1545, DOI 10.1002/jbm.820291211
NR 14
TC 0
Z9 0
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PY 2002
VL 67
IS 4-5
BP 344
EP 348
DI 10.1002/bip.10100
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 548PH
UT WOS:000175397200033
PM 12012463
DA 2018-10-19
ER

PT J
AU Filmon, R
   Basle, MF
   Atmani, H
   Chappard, D
AF Filmon, R
   Basle, MF
   Atmani, H
   Chappard, D
TI Adherence of osteoblast-like cells on calcospherites developed on a
   biomaterial combining poly(2-hydroxyethyl) methacrylate and alkaline
   phosphatase
SO BONE
LA English
DT Article
DE mineralization; osteoblast; polymer; 2-hydroxyethylmethacrylate; hybrid
   material; confocal microscopy; immunogold technique; cytomorphometry;
   cellular adhesion; bone sialoprotein; fibronectin
ID BIOMIMETIC PEPTIDE SURFACES; BONE SIALOPROTEIN; FIBRONECTIN; ATTACHMENT;
   ADHESION; MINERALIZATION; ORGANIZATION; ADSORPTION; MORPHOLOGY;
   SUBSTRATE
AB The polymer poly (2-hydroxyethyl) methacrylate (pHEMA) can copolymerize with alkaline phosphatase (AlkP) to form a hybrid material. The enzyme retains its biological activity and forms hydroxyapatite nodules (calcospherites) when polymer pellets are incubated with a synthetic body fluid. Osteoblast-like cells (ROS 17/2.8) were seeded on pellets of pHEMA and pHEMA-AlkP on which calcospherites were grown. They were examined by scanning electron microscopy, (SEM) with backscattered electron imaging. Cell surface and shape were measured by image analysis combining the SEM images. Cells grown on pHEMA-AlkP had an increased surface area (449 +/- 216 mum(2) vs. 204 +/- 80 mum(2)). The number of filopodia anchoring the cells on the free polymer surface was reduced on pHEMA-AlkP, but numerous thick pseudopodia permitted a direct anchorage on the calcospherites. Pseudopodia were-wider and longer than the filopodia. The backscattered images revealed that each cell was seated on 7.1 +/- 1.5 calcospherites and partially covered 10.3 +/- 1.9 others. Antifibronectin and anti-bone sialoprotein antibodies were used to investigate cell attachment. With confocal microscopy, both molecules were located at the interface between the cells and the mineral, inside the cells, and as free molecules on the calcospherites. Immunogold labeling was done with the same antibodies and examined with transmission electron microscopy (TEM). Adsorption of fibronectin and bone sialoprotein was noticeable at the cell/calcospherite interface and on the surface of the hydroxyapatite crystals. Immunogold studies revealed adhesion proteins (bone sialoprotein, fibronectin) to be present at the surface of crystals and at focal points of cell contact. (C) 2002 by Elsevier Science Inc. All rights reserved.
C1 Fac Med, Lab Histol Embryol, LHEA, GEROM, F-49045 Angers, France.
   Fac Med, Serv Commun Imagerie & Anal Microscop, Angers, France.
RP Chappard, D (reprint author), Fac Med, Lab Histol Embryol, LHEA, GEROM, F-49045 Angers, France.
CR ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   CHEN JK, 1992, J BONE MINER RES, V7, P987
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   DENIZLI A, 1995, INT J ARTIF ORGANS, V18, P90
   Filmon R, 1997, J HISTOTECHNOL, V20, P343
   Filmon R., 1996, Cells and Materials, V6, P11
   Filmon R, 2000, J BIOMAT SCI-POLYM E, V11, P849, DOI 10.1163/156856200744057
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Garrett Q, 1998, BIOMATERIALS, V19, P2175, DOI 10.1016/S0142-9612(98)00125-2
   Gehron-Robey P, 1996, OSTEOPOROSIS, P95
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Harris J G, 1995, J Int Neuropsychol Soc, V1, P10
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HUBBELL JA, 1992, ANN NY ACAD SCI, V665, P253, DOI 10.1111/j.1749-6632.1992.tb42589.x
   LAI CS, 1993, J MOL BIOL, V230, P625, DOI 10.1006/jmbi.1993.1174
   Lombello CB, 2000, CYTOBIOS, V101, P115
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MONTHEARD JP, 1997, REFERENCE FUNCTIONAL, P699
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   OKANO T, 1993, J BIOMED MATER RES, V27, P1519, DOI 10.1002/jbm.820271208
   REGINATO AM, 1994, ARTHRITIS RHEUM, V37, P1338, DOI 10.1002/art.1780370912
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   WATTS KC, 1984, ANAL QUANT CYTOL, V6, P272
   WENNERBERG A, 1992, J BIOMED ENG, V14, P412, DOI 10.1016/0141-5425(92)90087-2
   WHYTE MP, 1995, J CLIN INVEST, V95, P1440, DOI 10.1172/JCI117814
   WUTHIER RE, 1982, CLIN ORTHOP RELAT R, P219
NR 30
TC 40
Z9 40
U1 2
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD JAN
PY 2002
VL 30
IS 1
BP 152
EP 158
DI 10.1016/S8756-3282(01)00634-2
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 516DP
UT WOS:000173536900023
PM 11792578
DA 2018-10-19
ER

PT J
AU del Real, RP
   Arcos, D
   Vallet-Regi, M
AF del Real, RP
   Arcos, D
   Vallet-Regi, M
TI Implantable magnetic glass-ceramic based on (Fe,Ca)SiO3 solid solutions
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID INTRACELLULAR HYPERTHERMIA; SYSTEM FEO-FE2O3-CAO-SIO2; FERROMAGNETIC
   IMPLANTS; IN-VITRO; SURFACE; CELLS; CANCER; CRYSTALLIZATION;
   DISTRIBUTIONS; INDUCTION
AB A magnetic glass-ceramic suitable to be used as biomaterial has been synthesized. After the NaO-Fe2O3-CaO-SiO2 starting glass is annealed, a glass-ceramic based on ferroan wollastonite-like and is an element of-(Fe,Ca)SiO3-like phases is obtained. Both phases contain Fe 21 ions, leading to two magnetic phases with different coercive forces. Because of the magnetic properties, this material could be used as a thermoseed for cancer treatment by hyperthermia. This glass-ceramic is coated by an amorphous layer when it is soaked in simulated body fluid (SBF). This new layer, formed with the incorporation of phosphorus over the surface, would lead to a good integration with the bone tissue after being implanted.
C1 Univ Complutense, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
RP Vallet-Regi, M (reprint author), Univ Complutense, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
RI Arcos, Daniel/L-6167-2014; Vallet-Regi, Maria/M-3378-2014; perez del
   real, rafael/C-2178-2013
OI Arcos, Daniel/0000-0002-5367-7272; Vallet-Regi,
   Maria/0000-0002-6104-4889; PEREZ DEL REAL, RAFAEL/0000-0003-1374-8037
CR Andra W, 1999, J MAGN MAGN MATER, V194, P197, DOI 10.1016/S0304-8853(98)00552-6
   BREZOVICH IA, 1989, RADIOL CLIN N AM, V27, P589
   BREZOVICH IA, 1984, MED PHYS, V11, P145, DOI 10.1118/1.595490
   Burgman P., 1995, THERMORADIOTHERAPY T, V1
   Case JA, 2000, J BIOMED MATER RES, V53, P791, DOI 10.1002/1097-4636(2000)53:6<791::AID-JBM21>3.0.CO;2-A
   CHAN DCF, 1993, J MAGN MAGN MATER, V122, P374
   EBISAWA Y, 1991, NIPPON SERAM KYO GAK, V99, P7
   Ebisawa Y, 1997, BIOMATERIALS, V18, P1277, DOI 10.1016/S0142-9612(97)00067-7
   Ebisawa Y, 1997, J CERAM SOC JPN, V105, P947, DOI 10.2109/jcersj.105.947
   FAIRBAIRN JJ, 1995, CANCER LETT, V89, P183, DOI 10.1016/0304-3835(94)03668-9
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hiergeist R, 1999, J MAGN MAGN MATER, V201, P420, DOI 10.1016/S0304-8853(99)00145-6
   HULBERT SF, 1982, CERAM INT, V8, P121
   IKENAGA I, 1991, BIOCERAMICS, V4, P255
   IKENAGA M, 1993, J ORTHOP RES, V11, P849, DOI 10.1002/jor.1100110611
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   KIMURA I, 1986, IEEE T MAGN, V22, P1897, DOI 10.1109/TMAG.1986.1064667
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Konaka H, 1997, J CERAM SOC JPN, V105, P833, DOI 10.2109/jcersj.105.833
   Kurkjian C. R., 1970, Journal of Non-Crystalline Solids, V3, P157, DOI 10.1016/0022-3093(70)90174-2
   Lee YK, 2000, J MATER SCI-MATER M, V11, P511, DOI 10.1023/A:1008913909247
   LURDERER AA, 1983, RADIAT RES, V94, P190
   MATSUKI H, 1990, IEEE T MAGN, V26, P1551, DOI 10.1109/20.104442
   MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222
   OHASHI Y, 1978, AM MINERAL, V63, P274
   OHURA K, 1991, J APPL BIOMATER, V2, P153, DOI 10.1002/jab.770020303
   OVERGAARD J, 1977, CANCER-AM CANCER SOC, V39, P2637, DOI 10.1002/1097-0142(197706)39:6<2637::AID-CNCR2820390650>3.0.CO;2-S
   Shinkai M, 1999, J MAGN MAGN MATER, V194, P176, DOI 10.1016/S0304-8853(98)00586-1
   Singh K, 1999, J MATER SCI-MATER M, V10, P481, DOI 10.1023/A:1008949025635
   SONG CW, 1995, THERMORADIOTHERAPY T, V1
   STAUFFER PR, 1984, IEEE T BIO-MED ENG, V31, P76, DOI 10.1109/TBME.1984.325373
   Takahashi H, 2000, EXP ONCOL, V22, P186
   Tucker RD, 2000, J ENDOUROL, V14, P511, DOI 10.1089/end.2000.14.511
   Uzuka T, 2001, INT J HYPERTHER, V17, P114
   Vallet-Regi M, 1999, J BIOMED MATER RES, V46, P560
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Wiersma J, 2001, INT J HYPERTHER, V17, P63, DOI 10.1080/02656730150201606
NR 37
TC 16
Z9 16
U1 2
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
EI 1520-5002
J9 CHEM MATER
JI Chem. Mat.
PD JAN
PY 2002
VL 14
IS 1
BP 64
EP 70
DI 10.1021/cm011020i
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 514UK
UT WOS:000173459300016
DA 2018-10-19
ER

PT B
AU Li, MQ
   Shang, DS
   Chen, HT
   Ma, C
AF Li, MQ
   Shang, DS
   Chen, HT
   Ma, C
BE Zhang, S
   Zhou, ZR
   Liu, JJ
   Zhu, MH
TI Study on the subsonically thermal sprayed coating of hydroxyapatite
SO CONTRIBUTIONS OF SURFACE ENGINEERING TO MODERN MANUFACTURING AND
   REMANUFACTURING
LA English
DT Proceedings Paper
CT 3rd International Conference on Surface Engineering
CY OCT 10-13, 2002
CL CHENGDU, PEOPLES R CHINA
SP Chinese Mech Engn Soc, SW Jiaotong Univ
DE subsonic thermal spraying; hydroxyapatite; coating; biomaterial; tensile
   strength
AB A new method of preparation of biomaterial composite coating by the technique of subsonic thermal spraying was discussed in this paper. Ti6Al4V and pure Ti were chosen as substrate and sublayer material respectively and the working layer was sprayed with biomaterial hydroxyapatite(HAP), forming the composite coating. The experiments of heat shock and tensile strength show that the bonding strength between coating and substrate is almost the same as that of specimen in which Ni/Al powder was adopted as sublayer. The phases of TiN, TiO2, Ti2O3 were formed in the sublayer, which are free of toxic and have no side effects. The powder of working layer HAP was decomposed partly during spraying, but it can be solved by the later treatment.
C1 Jiamusi Univ, Key Lab Biomat, Jiamusi, Heilongjiang Pr, Peoples R China.
RP Li, MQ (reprint author), Jiamusi Univ, Key Lab Biomat, Jiamusi, Heilongjiang Pr, Peoples R China.
CR GAO JC, 1998, CHINESE J MAT RES, V12, P95
   Gledhill HC, 2001, BIOMATERIALS, V22, P695, DOI 10.1016/S0142-9612(00)00232-5
   Huang L Y, 1999, J CHINESE CERAMIC SO, V27, P351
   Kim HM, 2000, BIOMATERIALS, V21, P353, DOI 10.1016/S0142-9612(99)00190-8
   XI YX, 1999, DEV APPL MAT, V14, P41
   YUAN RZ, 1994, RES DEV TECHNIQUE SE
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
NR 7
TC 0
Z9 0
U1 0
U2 0
PU SOUTHWEST JIAOTONG UNIV PRESS
PI CHENGDU
PA ERHUAN RD, CHENGDU 610031, SICHUAN, PEOPLES R CHINA
BN 7-81057-661-5
PY 2002
BP 478
EP 480
PG 3
WC Engineering, Mechanical; Materials Science, Coatings & Films
SC Engineering; Materials Science
GA BV99R
UT WOS:000180624600099
DA 2018-10-19
ER

PT J
AU Garcia, AJ
   Keselowsky, BG
AF Garcia, AJ
   Keselowsky, BG
TI Biomimetic surfaces for control of cell adhesion to facilitate bone
   formation
SO CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
LA English
DT Article
DE biomaterial; integrin; fibronectin; collagen; RGD
ID OSTEOBLAST-LIKE CELLS; COLLAGEN-ALPHA-2-BETA-1 INTEGRIN INTERACTION;
   MURINE MC3T3-E1 CELLS; AMINO-ACID-SEQUENCE; BIOACTIVE GLASS; IN-VITRO;
   EXTRACELLULAR-MATRIX; GENE-EXPRESSION; CHEMICAL MODIFICATION;
   BIOLOGICAL-ACTIVITY
AB Cell adhesion to extracellular matrix ligands through integrin receptors plays a central role in bone formation and maintenance by anchoring cells and triggering signals that direct osteoblast proliferation and differentiation. Moreover, osteoblast adhesion to adsorbed, synthesized, or engineered extracellular ligands on synthetic surfaces is critical to numerous biomedical and biotechnological applications. Considerable research efforts have concentrated on the development of surfaces that promote osteoblast differentiation and bone formation. Emerging surface engineering approaches have focused on creating biomimetic substrates that target integrins to activate signaling pathways directing the osteoblast differentiation program. These initiatives generally rely on controlling the adsorption of extracellular matrix ligands or engineering synthetic supports presenting bioadhesive motifs from extracellular matrix proteins. These biomolecular approaches provide promising strategies for the engineering of robust biofunctional matrices that control cell adhesion and signaling and promote osteoblast proliferation, differentiation, and matrix mineralization.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 315 Ferst Dr,Room 2314 IBB, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Keselowsky, Benjamin/A-8000-2009
CR ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E
   AKIYAMA SK, 1995, CELL ADHES COMMUN, V3, P13, DOI 10.3109/15419069509081275
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Aubin JE, 1996, PRINCIPLES BONE BIOL
   Bearinger JP, 1998, J BIOMAT SCI-POLYM E, V9, P629, DOI 10.1163/156856298X00064
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   COOK SD, 1988, CLIN ORTHOP RELAT R, V230, P303
   CRANE GM, 1995, NAT MED, V1, P1322, DOI 10.1038/nm1295-1322
   CUTLER SM, 2002, IN PRESS BIOMATERIAL
   Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4
   De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   DUCHEYNE P, 1981, J BIOMED MATER RES, V15, P441, DOI 10.1002/jbm.820150315
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   Ducheyne P, 1992, Clin Orthop Relat Res, P102
   DUCHEYNE P, 1993, BONE BIOACTIVE BIOMA
   Einhorn TA, 1999, CLIN ORTHOP RELAT R, pS59, DOI 10.1097/00003086-199910001-00007
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   ElGhannam A, 1997, J BIOMED MATER RES, V36, P167, DOI 10.1002/(SICI)1097-4636(199708)36:2<167::AID-JBM5>3.0.CO;2-I
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   ELGHANNAM A, 1995, J BIOMED MATER RES, V29, P359, DOI 10.1002/jbm.820290311
   Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4
   FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155
   FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Globus RK, 1998, J CELL SCI, V111, P1385
   Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GRONOWICZ GA, 1994, J BONE MINER RES, V9, P193, DOI 10.1002/jbmr.5650090208
   HENCH L L, 1972, Journal of Biomedical Materials Research Biomedical Materials Symposium, V2, P117
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075
   Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Kao WYJ, 2001, BIOMATERIALS, V22, P2901, DOI 10.1016/S0142-9612(01)00037-0
   KESELOWSKY BG, 2002, IN PRESS J BIOMED MA
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200
   Martin P, 1995, CELEST MECH DYN ASTR, V63, P29, DOI 10.1007/BF00691913
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   MENKO AS, 1987, CELL, V51, P51, DOI 10.1016/0092-8674(87)90009-2
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Moursi AM, 1996, J CELL SCI, V109, P1369
   Moursi AM, 2002, BIOMATERIALS, V23, P133, DOI 10.1016/S0142-9612(01)00088-6
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   PETTIT DK, 1992, J BIOMED MATER RES, V26, P1259, DOI 10.1002/jbm.820261002
   PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224
   Plenk H, 1998, J BIOMED MATER RES, V43, P350
   PRAEMER A, 1992, MUSCULOSKELETAL COND
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   REYES CD, 2002, IN PRESS J BIOMED MA
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SAUTIER JM, 1994, CALCIFIED TISSUE INT, V55, P458, DOI 10.1007/BF00298560
   SCHEPERS E, 1991, J ORAL REHABIL, V18, P439, DOI 10.1111/j.1365-2842.1991.tb01689.x
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772
   ULMAN A, 1989, LANGMUIR, V5, P1147, DOI 10.1021/la00089a003
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   WEISS RE, 1981, EXP CELL RES, V133, P247, DOI 10.1016/0014-4827(81)90316-5
   WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391
   Zimmerman D, 2000, DEV BIOL, V220, P2, DOI 10.1006/dbio.2000.9633
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
NR 93
TC 43
Z9 46
U1 1
U2 16
PU BEGELL HOUSE INC
PI DANBURY
PA 50 NORTH ST, DANBURY, CT 06810 USA
SN 1045-4403
EI 2162-6502
J9 CRIT REV EUKAR GENE
JI Crit. Rev. Eukaryot. Gene Expr.
PY 2002
VL 12
IS 2
BP 151
EP 162
DI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
PG 12
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 610WH
UT WOS:000178984300005
PM 12434928
DA 2018-10-19
ER

PT J
AU Pelled, G
   Turgeman, G
   Aslan, H
   Gazit, Z
   Gazit, D
AF Pelled, G
   Turgeman, G
   Aslan, H
   Gazit, Z
   Gazit, D
TI Mesenchymal Stem Cells for bone gene therapy and tissue engineering
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Review
DE Mesenchymal Stem Cells; bone marrow; osteoprogenitors; bone;
   osteoporosis; gene therapy; tissue engineering
ID MARROW STROMAL CELLS; IN-VIVO; POSTMENOPAUSAL OSTEOPOROSIS;
   APLASTIC-ANEMIA; MICE; DIFFERENTIATION; CYTOKINES; ESTROGEN; CULTURE;
   PROGENITORS
AB Mesenchymal Stem Cells (MSCs) are adult stem cells that constitute a variety of adult tissues. MSCs maintain self-renewal ability with the ability to give rise to different mesenchymal cells, and are therefore responsible in part, for the regenerative capacity of mesenchymal tissues. MSCs throughout a variety of species were found to be able to differentiate to several mesenchymal tissues including: bone, cartilage, stroma, adipose, connective tissue, muscle and tendon. MSCs are relatively easily isolated from the bone marrow and expanded in vitro. It was found that MSCs play an important role in bone physiology and hematopiesis, and in part participate in the pathophysiology related to bone diseases, mainly osteoporosis. MSCs were widely used in experimental studies in vivo, and were shown to form mesenchymal tissues. These discovered features have made MSCs good candidate's for the development of various therapeutic modalities aimed to regenerate mesenchymal tissues, mainly bone. The more important approaches currently utilizing MSCs are gene therapy and tissue engineering. Both exploit the current knowledge in molecular biology and biomaterial science in order to direct MSCs to differentiate in vivo to desired lineages and tissues. Better understanding of the molecular mechanism directing the differentiation of MSCs, will eventually allow us to properly manipulate MSCs both in vivo and ex vivo to allow the regeneration of complex tissues and organs.
C1 Hebrew Univ Jerusalem, Hadassah Med & Gene Therapy Ctr, Skeletal Biotech Lab, Jerusalem, Israel.
RP Gazit, D (reprint author), Hebrew Univ Jerusalem, Hadassah Med & Gene Therapy Ctr, Skeletal Biotech Lab, POB 12272, Jerusalem, Israel.
CR Allay JA, 1997, HUM GENE THER, V8, P1417, DOI 10.1089/hum.1997.8.12-1417
   Anderson WF, 1998, NATURE, V392, P25
   AZIZI SA, 1998, P NATL ACAD SCI USA, V95, P7
   Bardies M, 2000, CURR PHARM DESIGN, V6, P1469, DOI 10.2174/1381612003399176
   Bartholomew A, 2001, HUM GENE THER, V12, P1527, DOI 10.1089/10430340152480258
   Bergman RJ, 1996, J BONE MINER RES, V11, P568
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Byers RJ, 2001, J ENDOCRINOL, V168, P353, DOI 10.1677/joe.0.1680353
   CAMPAGNOLI C, 2001, BLOOD, V98, P8
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3
   Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700
   Devine SM, 2001, EXP HEMATOL, V29, P244, DOI 10.1016/S0301-472X(00)00635-4
   Engstrand T, 2000, HUM GENE THER, V11, P205, DOI 10.1089/10430340050016274
   ERICES A, 2000, BRIT J HAEMATOL, V109, P1
   FERNANDEZ M, 1997, J BONE MARROW TRANSP, V20, P4
   FRIEDENSTEIN AIA, 1982, ARKH PATOL, V44, P10
   Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   Gazit D, 1999, J GENE MED, V1, P121, DOI 10.1002/(SICI)1521-2254(199903/04)1:2<121::AID-JGM26>3.0.CO;2-J
   Gazit D, 1998, J CELL BIOCHEM, V70, P478, DOI 10.1002/(SICI)1097-4644(19980915)70:4<478::AID-JCB5>3.0.CO;2-G
   Gerson SL, 1999, NAT MED, V5, P262, DOI 10.1038/6470
   Gharaee-Kermani M, 2001, CURR PHARM DESIGN, V7, P1083, DOI 10.2174/1381612013397573
   GRONTHOS S, 1995, BLOOD, V85, P4
   HAYNESWORTH SE, 1992, BONE, V13, P1
   Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529
   Hou Z, 1999, P NATL ACAD SCI USA, V96, P7294, DOI 10.1073/pnas.96.13.7294
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   KAHN A, 1995, CLIN ORTHOP RELAT R, P69
   Kassem Moustapha, 1996, P691
   KELEMENT BJ, 1993, J CELL BIOCHEM, V51, P252
   Kostenuik PJ, 2001, CURR PHARM DESIGN, V7, P613, DOI 10.2174/1381612013397807
   Krebsbach PH, 1998, TRANSPLANTATION, V66, P1272, DOI 10.1097/00007890-199811270-00002
   KUZNETSOV SA, 2001, J CELL BIOL, V153, P5
   Labat ML, 2001, BIOMED PHARMACOTHER, V55, P179, DOI 10.1016/S0753-3322(01)00057-9
   Lieberman JR, 1998, J ORTHOP RES, V16, P330, DOI 10.1002/jor.1100160309
   Liechty KW, 2000, NAT MED, V6, P1282
   LOU J, 1999, ORTHOP RES, V17, P43
   MACKAY AM, 1998, TISSUE ENG, V4, P4
   MACKENZIE TC, 2001, BLOOD CELL MOL DIS, V27, P3
   MAJUMDAR MK, 2000, J CELL PHYSL, V185, P1
   MAJUMDAR MK, 2000, J HEMATOTH STEM CELL, V9, P6
   MANKANI MH, 2001, BIOTECHNOL BIOENG, V72, P1
   MARESCHI K, 2001, HAEMATOLOGICA, V86, P10
   MARSH JCW, 1991, BRIT J HAEMATOL, V78, P258, DOI 10.1111/j.1365-2141.1991.tb04426.x
   MARSH JCW, 1990, BLOOD, V76, P1748
   Martin I, 1998, J ORTHOPAED RES, V16, P181, DOI 10.1002/jor.1100160205
   MARTIN I, 2001, J BIOMED MATER RES, V21, P231
   MOSCA DJ, 2000, CLIN ORTHOP S, V379, P71
   Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291
   MURRAY JF, 1999, PRIMER METABOLIC BON, V4
   Nishida S, 1999, J BONE MINER METAB, V17, P171, DOI 10.1007/s007740050081
   NOLTA JA, 1994, BLOOD, V83, P3041
   Notelovitz M, 1997, AM J MED SCI, V313, P2, DOI 10.1097/00000441-199701000-00002
   Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193
   Pacifici R, 1998, ENDOCRINOLOGY, V139, P2659, DOI 10.1210/en.139.6.2659
   Pacifici R, 1996, J BONE MINER RES, V11, P1043
   PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857
   Pittenger M. F., 1996, Molecular Biology of the Cell, V7, p305A
   Pittenger Mark F., 1999, SCIENCE, V284, P5411
   QUARTO R, 1995, CALCIFIED TISSUE INT, V56, P123, DOI 10.1007/BF00296343
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   REYES M, 2001, BLOOD, V98, P9
   Scopes J, 2001, BRIT J HAEMATOL, V115, P642, DOI 10.1046/j.1365-2141.2001.03134.x
   Stenderup K, 2001, J BONE MINER RES, V16, P1120, DOI 10.1359/jbmr.2001.16.6.1120
   Thalmeier K, 2001, ACTA HAEMATOL-BASEL, V105, P159, DOI 10.1159/000046559
   TREMAIN N, 2001, STEM CELLS, V19, P5
   Turgeman G, 2001, J GENE MED, V3, P240
   YOO JU, 1998, J BONE JOINT SURG AM, V80, P12
   YOUNG RG, 1998, J ORTHOPAED RES, V16, P4
   ZHOU S, 2001, J CELL BIOCHEM, V8, P144
   ZILBERMAN Y, 2002, IN PRESS PAT
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   ZVAIFLER NJ, 2000, ARTHRITIS RES, V2, P6
NR 77
TC 48
Z9 58
U1 0
U2 11
PU BENTHAM SCIENCE PUBL LTD
PI HILVERSUM
PA PO BOX 1673, 1200 BR HILVERSUM, NETHERLANDS
SN 1381-6128
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2002
VL 8
IS 21
BP 1917
EP 1928
DI 10.2174/1381612023393666
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 582PB
UT WOS:000177359400005
PM 12171527
DA 2018-10-19
ER

PT J
AU Ichikawa, A
   Tsuchiya, T
AF Ichikawa, A
   Tsuchiya, T
TI A strategy for the suppression of tumorigenesis induced by biomaterials:
   Restoration of transformed phenotype of polyetherurethane-induced tumor
   cells by Cx43 transfection
SO CYTOTECHNOLOGY
LA English
DT Article
DE biomaterial; connexin 43; gap junctional intercellular communication;
   malignant fibrous histiocytoma; polyetherurethane; subcutaneous
   implantation
ID GAP-JUNCTIONAL COMMUNICATION; C6 GLIOMA-CELLS; INTERCELLULAR
   COMMUNICATION; METABOLIC COOPERATION; PROMOTING ACTIVITY; SUBCUTANEOUS
   IMPLANTATION; CARCINOMA-CELLS; GROWTH-CONTROL; CANCER-CELLS; EXPRESSION
AB Biomaterials such as polyetherurethans (PEUs) are the scaffolding, which is indispensable for the development of the bio-artificial organs. However, PEUs can induce tumors in subcutaneous implantation sites in rat. We have shown that the different inhibitory potential of gap junctional intercellular communication (GJIC) on the surface of the biomaterials, including PEUs, is a key step in determining the tumorigenic potential. Here we show that suppression of a gap junctional protein connexin 43 (Cx43) plays an important role in in vivo tumorigenesis induced by PEUs for the first time and that Cx43 transfection may be an effective strategy for preventing tumorigenesis induced by biomaterials. Rat tumor cell line U41 is derived from tumors in the subcutaneous implantation of PEU films. The GJIC and the expression of Cx43 were suppressed in U41. The restoration of normal phenotype, such as reduction of growth rate, recovery of contact inhibition and loss of colony formation ability in soft agar, was achieved by Cx43 transfection. These results strongly suggest that suppression of Cx43 expression plays an important role in the development of rat malignant fibrous histiocytoma (MFHC) caused by PEUs and that Cx43 transfection is effective for prevention of tumorigenesis induced by PEUs.
C1 Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo 1588501, Japan.
   Japan Sci & Technol Corp, Kawaguchi 3320012, Japan.
RP Tsuchiya, T (reprint author), Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.
CR Asamoto M, 1998, JPN J CANCER RES, V89, P481, DOI 10.1111/j.1349-7006.1998.tb03287.x
   BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q
   EGHBALI B, 1991, P NATL ACAD SCI USA, V88, P10701, DOI 10.1073/pnas.88.23.10701
   ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0
   GROSSMAN HB, 1994, CANCER RES, V54, P3062
   GUTHRIE SC, 1989, TRENDS NEUROSCI, V12, P12, DOI 10.1016/0166-2236(89)90150-1
   Huang RP, 1998, CANCER RES, V58, P5089
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   KLAUNIG JE, 1990, LAB INVEST, V62, P135
   Klugherz BD, 2000, NAT BIOTECHNOL, V18, P1181
   LEE SW, 1992, J CELL BIOL, V118, P1213, DOI 10.1083/jcb.118.5.1213
   LO CW, 1979, CELL, V18, P411, DOI 10.1016/0092-8674(79)90060-6
   LOEWENSTEIN WR, 1979, BIOCHIM BIOPHYS ACTA, V560, P1, DOI 10.1016/0304-419X(79)90002-7
   MESNIL M, 1993, MOL CARCINOGEN, V7, P14, DOI 10.1002/mc.2940070103
   MESNIL M, 1995, CANCER RES, V55, P629
   NAKAMURA A, 1992, J BIOMED MATER RES, V26, P631, DOI 10.1002/jbm.820260506
   Nakaoka R, 1997, J BIOMED MATER RES, V35, P391, DOI 10.1002/(SICI)1097-4636(19970605)35:3<391::AID-JBM13>3.0.CO;2-I
   NAUS CCG, 1992, CANCER RES, V52, P4208
   Schoen F.J., 1987, T AM SOC ART INT ORG, V33, P8
   STEWART WW, 1978, CELL, V14, P741, DOI 10.1016/0092-8674(78)90256-8
   STEWART WW, 1981, NATURE, V292, P17, DOI 10.1038/292017a0
   TOMASETTO C, 1993, J CELL BIOL, V122, P157, DOI 10.1083/jcb.122.1.157
   Tsai H, 1996, BIOCHEM BIOPH RES CO, V227, P64, DOI 10.1006/bbrc.1996.1468
   TSUCHIYA T, 1995, J BIOMED MATER RES, V29, P835, DOI 10.1002/jbm.820290708
   Tsuchiya T., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P200
   Tsuchiya T, 1995, J LONG-TERM EFF MED, V5, P233
   Tsuchiya T, 1996, J BIOMED MATER RES, V31, P299
   TSUCHIYA T, 1995, J BIOMED MATER RES, V29, P113, DOI 10.1002/jbm.820290116
   Tsuchiya T, 2000, J BIOMAT SCI-POLYM E, V11, P947, DOI 10.1163/156856200744129
   TSUCHIYA T, 1999, SURG IMPLANTS OTHER, V74, P290
   TSUCHIYA T, 1999, SURG IMPLANTS OTHER, V74, P293
   TSUDA H, 1995, CARCINOGENESIS, V16, P101, DOI 10.1093/carcin/16.1.101
   UPHAM BL, 1995, ENVIRON SCI TECHNOL, V29, P2923, DOI 10.1021/es00012a006
   WILGENBUS KK, 1992, INT J CANCER, V51, P522, DOI 10.1002/ijc.2910510404
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
   XI TF, 1994, J BIOMED MATER RES, V28, P483, DOI 10.1002/jbm.820280411
   Zhang ZQ, 1998, CARCINOGENESIS, V19, P1889, DOI 10.1093/carcin/19.11.1889
   ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883
NR 38
TC 2
Z9 2
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-9069
J9 CYTOTECHNOLOGY
JI Cytotechnology
PY 2002
VL 39
IS 1
BP 1
EP 8
DI 10.1023/A:1022430021868
PG 8
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA 646MN
UT WOS:000181039000001
PM 19003298
DA 2018-10-19
ER

PT J
AU Burillon, C
   Kodjikian, L
   Pellon, G
   Martra, A
   Freney, J
   Renaud, FNR
AF Burillon, C
   Kodjikian, L
   Pellon, G
   Martra, A
   Freney, J
   Renaud, FNR
TI In-vitro study of bacterial adherence to different types of intraocular
   lenses
SO DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; ADHESION; EPIDERMIDIS; HYDROPHOBICITY;
   HEPARIN; METHACRYLATE; PREVENTION; CATHETERS; SURFACES; ORIGIN
AB The aim of this study was to determine the adherence of Staphylococcus epidermidis to intraocular lenses made of five different biomaterials: polymethylmethacrylate (PMMA), heparinized PMMA, silicone, hydrophilic acrylic, and hydrogel. The extent of bacterial binding was measured by counting. The results were compared using a one-factor variance analysis. Adherence was weakest on hydrogel and strongest on the silicone polymer. Bacterial adherence to the implant surface must therefore depend on the hydrophobicity or hydrophilicity of the biomaterial.
C1 Inst Sci Pharmaceut & Biol, Microbiol Lab, F-69379 Lyon 08, France.
RP Renaud, FNR (reprint author), Inst Sci Pharmaceut & Biol, Microbiol Lab, Pavillon Netien,8 Av Rockefeller, F-69379 Lyon 08, France.
RI burillon, carole/C-5989-2014
OI burillon, carole/0000-0002-1850-9038
CR AbuElAsrar AM, 1997, INT OPHTHALMOL, V21, P71, DOI 10.1023/A:1005835013581
   ALFONSO EC, 1995, ARCH OPHTHALMOL-CHIC, V113, P1369, DOI 10.1001/archopht.1995.01100110029018
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   BOOS A, 1999, FEMS MICROBIOL REV, V23, P179
   CARRUTHERS MM, 1983, INFECT IMMUN, V40, P444
   CUSUMANO A, 1991, OPHTHALMOLOGY, V98, P1703
   DANKERT J, 1986, CRITICAL REV BIOCOMP, V2, P263
   DILLY PN, 1989, J CATARACT REFR SURG, V15, P317, DOI 10.1016/S0886-3350(89)80092-6
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   JANSEN B, 1991, J HOSP INFECT, V19, P83, DOI 10.1016/0195-6701(91)90100-M
   Kenne L, 1983, POLYSACCHARIDES, P287
   KRISTINSSON KG, 1989, J MED MICROBIOL, V28, P249, DOI 10.1099/00222615-28-4-249
   LUDWICKA A, 1985, J MICROBIOL METH, V4, P169, DOI 10.1016/0167-7012(85)90033-8
   Magnusson KE, 1982, SCAND J INFECT DIS S, V33, P32
   MULLER E, 1993, J INFECT DIS, V168, P1211, DOI 10.1093/infdis/168.5.1211
   MULLER E, 1993, INFECT IMMUN, V61, P55
   Ng EWM, 1996, J CATARACT REFR SURG, V22, P1331, DOI 10.1016/S0886-3350(96)80093-9
   NODA Y, 1986, J BACTERIOL, V167, P1016, DOI 10.1128/jb.167.3.1016-1019.1986
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   Pinna A, 2000, OPHTHALMOLOGY, V107, P1042, DOI 10.1016/S0161-6420(00)00080-4
   PORTOLES M, 1993, J CATARACT REFR SURG, V19, P755, DOI 10.1016/S0886-3350(13)80345-8
   RASKIN EM, 1993, ARCH OPHTHALMOL-CHIC, V111, P250, DOI 10.1001/archopht.1993.01090020104032
   REES D. A., 1982, POLYSACCHARIDES, V1, P195
   Rutter PR, 1980, MICROBIAL ADHESION S
   Schloricke E, 1997, OPHTHALMOLOGE, V94, P785, DOI 10.1007/s003470050204
   Schmidt H, 1998, ZBL BAKT-INT J MED M, V287, P135, DOI 10.1016/S0934-8840(98)80159-X
   TETZ MR, 1996, ASCRS S CAT IOL REFR
   VANDERMEI HC, 1992, J DISPER SCI TECHNOL, V13, P447, DOI 10.1080/01932699208943327
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
NR 29
TC 23
Z9 28
U1 1
U2 4
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0363-9045
J9 DRUG DEV IND PHARM
JI Drug Dev. Ind. Pharm.
PY 2002
VL 28
IS 1
BP 95
EP 99
DI 10.1081/DDC-120001490
PG 5
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 521WX
UT WOS:000173865300011
PM 11859867
DA 2018-10-19
ER

PT S
AU Yamada, K
   Nakamura, S
   Tsuchiya, T
   Yamashita, K
AF Yamada, K
   Nakamura, S
   Tsuchiya, T
   Yamashita, K
BE Murata, M
   Kimura, T
   Fujitsu, S
   Shinozaki, K
TI Electrical properties of polarized partially stabilized zirconia for
   biomaterials
SO ELECTROCERAMICS IN JAPAN IV
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 20th Electronics Division Meeting of the Ceramic-Society-of-Japan
CY OCT, 2000
CL KAWASAKI, JAPAN
SP Ceram Soc Japan
DE biomaterial; grain and grain boundary; Partially Stabilized Zirconia;
   polarization; thermally stimulated depolarization current
AB Partially Stabilized Zirconia. (PSZ) ceramics for biomaterials were electrically polarized. The depolarization process of PSZ was investigated by thermally stabilized depolarized current (TSDC) measurement. The biocompatibility of polarized PSZ was examined using osteoblastic cell cultivation. The PSZ (containing 3 mol% Y2O3) pellets sintered at 1400 degreesC for Ih were polarized at 800 degreesC for 1h in a d.c. field of 50Vcm(-1). The proliferation of adhesive cells were accelerated on the negative charge surface and decelerated on the positive charge surface.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   Sci Univ Tokyo, Fac Ind Sci & Technol, Chiba 2788510, Japan.
RP Yamada, K (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
CR KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   NAKAMURA S, IN PRESS J APP PHYS
   OHGAKI M, 1999, P 12 INT S CERM MED, P187
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
NR 5
TC 3
Z9 3
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-883-4
J9 KEY ENG MAT
PY 2002
VL 216
BP 149
EP 152
DI 10.4028/www.scientific.net/KEM.216.149
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BT31S
UT WOS:000172619400035
DA 2018-10-19
ER

PT J
AU Schweiger, M
   Rheinberger, V
   Holand, W
AF Schweiger, M
   Rheinberger, V
   Holand, W
TI Sintered apatite glass-ceramic and nanophase formation in glass-ceramics
SO GLASS SCIENCE AND TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Otto Schott Colloquium
CY JUL 07-11, 2002
CL FRIEDRICH SCHILLER UNIV, JENA, GERMANY
HO FRIEDRICH SCHILLER UNIV
AB The formation of fluorapatite in translucent glass-ceramics was studied in the SiO2-Li2O-K2O-ZnO-CaO-P2O5-F system by SEM and thermal analysis. Needle-like apatite represented the main crystal phase of the glass-ceramic. By means of the precipitation of fluorapatite crystals, optical properties similar to those of natural teeth were achieved. Therefore, the glass-ceramic was proposed as a biomaterial for restorative dental treatment. The apatite glass-ceramic is characterized by a flexural strength of 106 +/- 17 MPa (requirement according to dental ISO standards: 50 MPa), good chemical durability in 4% acetic acid, and a thermal expansion coefficient (100-400 degreesC) of 9.75 +/- 0.25 . 10(-6) K-1. Additionally, the material can be homogeneously sintered at 750 degreesC with low residual porosity. Nanophase formation was studied in apatite-containing glass-ceramics. The main goal of the investigation was to control the nucleation processes. Glassy nanophases and crystalline nanophases were developed in glass-ceramics for dental applications.
C1 Ivoclar Vivadent AG, FL-9494 Schaan, Liechtenstein.
RP Schweiger, M (reprint author), Ivoclar Vivadent AG, Bendererstr 2, FL-9494 Schaan, Liechtenstein.
CR BEALL GH, 1971, SPECIAL PUBLICATION, V5, P251
   *BRIT STAND I, 1978, 56121978 BSI
   Chan JCC, 2001, CHEM MATER, V13, P4198, DOI 10.1021/cm0101834
   Clifford A, 1996, J NON-CRYST SOLIDS, V196, P346, DOI 10.1016/0022-3093(95)00611-7
   Frank M., 1994, GLASTECH BER GLASS C, V67, P117
   Holand W, 2002, GLASS CERAMIC TECHNO
   International Organization for Standardization, 1995, 68721995E ISO
   Moisescu C, 1999, PHOSPHORUS RES B, V10, P515
   Muller R, 1999, J MATER SCI, V34, P65, DOI 10.1023/A:1004457305970
   PANNHORST W, 1993, CERAM TRANS, V30, P267
   SCHWEIGER M, 2002, IN PRESS P 104 AM CE
NR 11
TC 0
Z9 0
U1 0
U2 0
PU VERLAG DEUTSCHEN GLASTECHNISCHEN
PI FRANKFURT
PA MENDELSSOHNSTR 75-77, D-60325 FRANKFURT, GERMANY
SN 0946-7475
J9 GLASS SCI TECHNOL
JI Glass Sci. Technol.
PY 2002
VL 75
SU S
BP 103
EP 108
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 667UP
UT WOS:000182252600019
DA 2018-10-19
ER

PT J
AU Fini, M
   Giavaresi, G
   Rimondini, L
   Giardino, R
AF Fini, M
   Giavaresi, G
   Rimondini, L
   Giardino, R
TI Titanium alloy osseointegration in cancellous and cortical bone of
   ovariectomized animals: Histomorphometric and bone hardness measurements
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE bone-biomaterial interface; implant; microhardness; osseointegration;
   osteoporosis; titanium alloy
ID RAT MODEL; POSTMENOPAUSAL WOMEN; IMPLANTS; OSTEOPOROSIS; INTERFACE;
   HYDROXYAPATITE; MICROHARDNESS; BIOMATERIALS; FRACTURES; TIBIA
AB Purpose: Histomorphometry and microhardness measurements were performed after Ti6Al4V implantation in cancellous and cortical bone of healthy and ovariectomized animals to determine characterization of the bone-biomaterial interface in osteopenic bone. Materials and Methods: Nine ovariectomized and 9 sham-aged rats were used. Four months later, nails were implanted in the distal femurs, and the animals were sacrificed after 8 weeks. Moreover, 3 ovariectomized and 3 sham-aged sheep were used. Twenty-four months later, screws were implanted in the tibial diaphyses and the animals were sacrificed after 12 weeks. Results: Histomorphometry showed the development of osteopenia in both trabecular and cortical bone, and revealed a significant decrease in the osseointegration rate in osteopenic versus sham-aged animals for both trabecular (Affinity Index: -18.6%, P < .001) and cortical bone (Affinity Index: -23.5%, P < .005; Bone Ingrowth: -9%, P < .05). At the interfaces of the sham-aged animals in both trabecular and cortical bone, a decrease of bone microhardness was observed in comparison with preexisting bone (trabecular: -9.8%, P < .0005; cortical: -19.3%, P < .0005). In case of osteopenia, this decrease was even more extensive (trabecular: -15.5%, P < .0005; cortical: -24.7%, P < .0005). Discussion: The present data suggest that bone formation around Ti6Al4V was not associated with complete bone maturation, even in healthy animals. In case of osteopenia, both bone formation and maturation were delayed. Conclusion: These results apparently demonstrate the utility of investigating biomaterials in osteopenic bone and the importance of careful evaluation of the healing rate and bone maturation degree around implanted biomaterials.
C1 Rizzoli Orthopaed Inst, Res Inst Codivilla Putti, Dept Expt Surg, I-40136 Bologna, Italy.
   Univ Milan, Dept Oral Med & Pathol, Milan, Italy.
   Univ Bologna, Fac Med, Bologna, Italy.
RP Fini, M (reprint author), Rizzoli Orthopaed Inst, Res Inst Codivilla Putti, Dept Expt Surg, Via Barbiano 1-10, I-40136 Bologna, Italy.
RI Fini, Milena/J-4808-2016
OI Fini, Milena/0000-0002-3732-3570; Giavaresi,
   Gianluca/0000-0001-7843-5969
CR BARRIOS C, 1993, J ORTHOP TRAUMA, V7, P438, DOI 10.1097/00005131-199310000-00006
   Becker W, 2000, J PERIODONTOL, V71, P625, DOI 10.1902/jop.2000.71.4.625
   Bellino FL, 2000, MENOPAUSE, V7, P14, DOI 10.1097/00042192-200007010-00004
   Blomqvist JE, 1996, INT J ORAL MAX SURG, V25, P63, DOI 10.1016/S0901-5027(96)80015-4
   Bollen AM, 2000, ORAL SURG ORAL MED O, V90, P518, DOI 10.1067/moe.2000.107802
   Buser D, 1999, PROCEEDINGS OF THE 3RD EUROPEAN WORKSHOP ON PERIODONTOLOGY: IMPLANT DENTISTRY, P88
   Celiker R, 2000, RHEUMATOL INT, V19, P205, DOI 10.1007/s002960000058
   Chappard D, 1999, INT J ORAL MAX IMPL, V14, P189
   CHENG SL, 1995, J BONE MINER RES, V10, P139
   Dao T T, 1993, Int J Oral Maxillofac Implants, V8, P137
   Fini M, 2000, INT J ARTIF ORGANS, V23, P275
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   Fini M, 2001, J BONE JOINT SURG BR, V83B, P139, DOI 10.1302/0301-620X.83B1.10162
   Fini M, 2000, J MATER SCI-MATER M, V11, P579, DOI 10.1023/A:1008932303913
   FROST HM, 1992, BONE MINER, V18, P227, DOI 10.1016/0169-6009(92)90809-R
   Fujimoto T, 1998, INT J ORAL MAX IMPL, V13, P183
   Fujimoto T, 1996, Int J Oral Maxillofac Implants, V11, P539
   Giavaresi G, 2000, BONE, V26, P297, DOI 10.1016/S8756-3282(99)00267-7
   GLOWACKI J, 1991, BONE-BIOMATERIAL INTERFACE, P265
   HAMMERLE CHF, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P297
   Hara T, 1999, J BONE JOINT SURG BR, V81B, P705, DOI 10.1302/0301-620X.81B4.9138
   HAYASHI K, 1994, BIOMATERIALS, V15, P11, DOI 10.1016/0142-9612(94)90189-9
   Huja SS, 1998, J ORTHOPAED RES, V16, P54, DOI 10.1002/jor.1100160110
   HUJA SS, 1999, MECH TESTING BONE BO, P247
   *ISO, 1994, 10993 ISO
   Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5
   Kannus P, 2000, ARCH INTERN MED, V160, P2145, DOI 10.1001/archinte.160.14.2145
   KLEEREKOPER M, 1998, METABOLIC BONE DIS, P387
   Krall EA, 1996, CALCIFIED TISSUE INT, V59, P433, DOI 10.1007/BF00369206
   KRIBBS PJ, 1990, J PROSTHET DENT, V63, P218, DOI 10.1016/0022-3913(90)90108-O
   Kubo T, 1999, J STEROID BIOCHEM, V68, P197, DOI 10.1016/S0960-0760(99)00032-1
   Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X
   Marie PJ, 1999, HISTOL HISTOPATHOL, V14, P525, DOI 10.14670/HH-14.525
   MARTIN RB, 1988, J BONE JOINT SURG AM, V70A, P540, DOI 10.2106/00004623-198870040-00010
   Miller SC, 1997, J DENT RES, V76, P1471, DOI 10.1177/00220345970760080901
   MILLER SC, 1991, BONE, V12, P439, DOI 10.1016/8756-3282(91)90033-F
   Mori H, 1997, J ORAL MAXIL SURG, V55, P351, DOI 10.1016/S0278-2391(97)90124-5
   Moroni A, 1997, J ORTHOP TRAUMA, V11, P154, DOI 10.1097/00005131-199704000-00003
   Muschler G.F., 1992, BONE GRAFTS BONE SUB, P375
   Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2
   NEWMAN E, 1995, BONE, V16, pS277, DOI 10.1016/8756-3282(95)00026-A
   NISHIMURA I, 1992, J PROSTHET DENT, V67, P820, DOI 10.1016/0022-3913(92)90592-X
   Oleksik A, 2000, J BONE MINER RES, V15, P1384, DOI 10.1359/jbmr.2000.15.7.1384
   Pan JL, 2000, J ORAL MAXIL SURG, V58, P877, DOI 10.1053/joms.2000.8212
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   RALTSON SH, 1992, CYTOKINE BONE METABO, P362
   Roberts W E, 1992, Implant Dent, V1, P11, DOI 10.1097/00008505-199200110-00002
   RUFF CB, 1988, J ORTHOPAED RES, V6, P886, DOI 10.1002/jor.1100060613
   SAVARINO L, 1995, J BIOMED MATER RES, V29, P701, DOI 10.1002/jbm.820290605
   Soballe K, 1993, Acta Orthop Scand Suppl, V255, P1
   STEA S, 1995, J BIOMED MATER RES, V29, P695, DOI 10.1002/jbm.820290604
   Takeshita F, 1997, J PERIODONTOL, V68, P180, DOI 10.1902/jop.1997.68.2.180
   Thomas John G., 1995, Clinical Microbiology Newsletter, V17, P125, DOI 10.1016/S0196-4399(00)80022-7
   Thorndike E. A., 1998, FRONT BIOSCI, V3, P17
   VONWOWERN N, 1994, J PERIODONTOL, V65, P1134, DOI 10.1902/jop.1994.65.12.1134
   Walsh WR, 1997, CLIN ORTHOP RELAT R, P218
   Weber R L, 1997, Periodontal Clin Investig, V19, P5
   WHEELER DL, 2000, J ORTHOP TRAUMA, V2, P86
   Wiktorowicz ME, 2001, OSTEOPOROSIS INT, V12, P271, DOI 10.1007/s001980170116
   YAMAZAKI I, 1989, J BONE MINER RES, V4, P13
   Yamazaki M, 1999, ORAL SURG ORAL MED O, V87, P411, DOI 10.1016/S1079-2104(99)70239-8
NR 61
TC 33
Z9 36
U1 0
U2 5
PU QUINTESSENCE PUBL CO INC
PI CAROL STREAM
PA 551 NORTH KIMBERLY DR, CAROL STREAM, IL 60188-1881 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD JAN-FEB
PY 2002
VL 17
IS 1
BP 28
EP 37
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 521DY
UT WOS:000173824700004
PM 11858572
DA 2018-10-19
ER

PT J
AU Saikumar, C
AF Saikumar, C
TI Adhesives in the leather industry - perspectives for changing needs
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE leather surface; adhesive formulations; joint design; footwear adhesives
ID SURFACE; STRENGTH; FAILURE; ENERGY
AB Adhesion is a surface physico-chemical phenomenon. The nature of the adhesive joint and its mechanical proper-ties depend strongly on the nature of the substrate and the interaction of adhesive with the substrate. The adhesives are used in a wide array of applications ranging from packaging to aircraft and spacecraft. Leather is a unique biomaterial. It has a three-dimensional fibrillar textured surface. The use of adhesives in the leather industry has been mostly confined to the production of footwear and, to some extent, in leather goods and garments. Leather articles and footwear are made using synthetic dissimilar materials. where the adhesion between the leather and other materials such as cotton fiber, nylon, polyester, and other synthetics is important. The use of adhesives in such instances requires a careful selection and application of adhesives depending on the end-use of the leather product. The present overview discusses, at length, the various aspects of usage of adhesives in the leather industry, keeping in view the perspectives for the changing needs that are emerging in the third millennium. The description of adhesives widely in use and the improvements required to meet the environmental aspects and on-line production are discussed in terms of their formulations, physical properties. cure, and substrate preparations.
C1 Cent Leather Res Inst, Ind Chem Div, Chennai 600020, Tamil Nadu, India.
RP Saikumar, C (reprint author), Cent Leather Res Inst, Ind Chem Div, Chennai 600020, Tamil Nadu, India.
CR AHMED SU, 1999, ADHESIVES AGE, V34
   Almela M, 1999, J SOC LEATH TECH CH, V83, P32
   Arrowsmith D. J., 1970, T I MET FINISH, V48, P88, DOI 10.1080/00202967.1970.11870136
   *ASTM, 1955, TERMS REL ADH D907
   ATTENBURROW GE, 1994, J AM LEATHER CHEM AS, V89, P391
   Bikerman J. J., 1961, SCI ADHESIVE JOINTS
   BOLGER JC, 1973, TREATISE ADHESION AD, V6, pCH3
   BOLLARD I, 1995, WORLD LEATHER    JUN, P31
   Bosch T, 1999, J SOC LEATH TECH CH, V83, P243
   BRENNAN WJ, 1991, POLYMER, V32, P527
   CAGLE CV, 1968, ADHESIVE BONDING, pCH2
   DEMPSEY M, 1948, PROGR LEATHER SCI
   DERJAGUIN BV, 1960, P 3 INT C SURF ACT B, V2, P349
   DICKINSON JT, 1994, J ADHES SCI TECHNOL, V8, P1285, DOI 10.1163/156856194X00618
   FAFARD M, 1994, J ADHES SCI TECHNOL, V8, P1383, DOI 10.1163/156856194X00681
   FERRANDIZGOMEZ TP, 1994, J ADHES SCI TECHNOL, V8, P1043, DOI 10.1163/156856194X00915
   FOX HW, 1952, J COLL SCI IMP U TOK, V7, P428, DOI 10.1016/0095-8522(52)90008-1
   GLEDHILL RA, 1974, J ADHESION, V6, P315, DOI 10.1080/00218467408075035
   HOMES CM, 1971, J SOC LEATHER TECHNO, V55, P242
   HUNSTON DL, 1989, J ADHESION, V28, P103, DOI 10.1080/00218468908030877
   IYENGAR Y, 1967, J APPL POLYM SCI, V11, P2311, DOI 10.1002/app.1967.070111118
   KAELBLE DH, 1962, ADHESION COHESION, P75
   KAZUTAMI W, 1998, HIKAKU KAGAKU SCI, V44, P159
   Kinloch A. J., 1975, AM CHEM SOC DIV ORG, V35, P546
   KRONICK PL, 1995, JALCA, V91, P39
   Landrock AK, 1985, ADHESIVE TECHNOLOGY
   Lange S, 1999, J SOC LEATH TECH CH, V83, P1
   LEVINE M, 1964, POLYM LETT, V2, P915
   Liu CK, 1997, J AM LEATHER CHEM AS, V92, P157
   Long AJ, 1999, J SOC LEATH TECH CH, V83, P167
   Maeser M., 1960, JALCA, V55, P501
   MANGIPUDI V, 1994, J ADHES SCI TECHNOL, V8, P1251, DOI 10.1163/156856194X00591
   MANSFIELD KF, 1991, MACROMOLECULES, V24, P6283, DOI 10.1021/ma00023a034
   McBain JW, 1927, IND ENG CHEM, V19, P1005, DOI 10.1021/ie50213a016
   MCBAIN JW, 1925, J PHYS CHEM-US, V29, P88
   MCLAUGHLIN GD, 1945, CHEM LEATHER MANUFAC
   Mittal K. L., 2000, ACID BASE INTERACTIO, V2
   Mittal K. L., 1991, ACID BASE INTERACTIO
   MITTAL KL, 1977, POLYM ENG SCI, V17, P467, DOI 10.1002/pen.760170709
   MITTAL KL, 1975, ADHESION SCI TECHNOL, P129
   MITTAL KL, 1992, METALLIZED PLASTICS, V3
   MOORE JS, 1998, Patent No. 5807409
   NEEDLES HL, 1980, J APPL POLYM SCI, V25, P1745, DOI 10.1002/app.1980.070250821
   NEGRU D, 1998, PIEL BLANURI INLOCUI, V7, P29
   OFLAHERTY F, 1958, CHEM TECHNOL LEATHER, V1, P5
   QIAN AU, 1997, HENAN HUAGONG, V4, P18
   RAHMAN MA, 1993, BANGLADESH J SCI RES, V28, P142
   SAMMS JB, 1998, ADHESIVES AGE, V18
   *SATRA, 1990, SATRA B          MAR, P5
   SKLYAR TA, 1993, Patent No. 1792845
   STIRTZ T, 1975, DAS LEDER, V26, P156
   Strobel M., 1994, PLASMA SURFACE MODIF
   TAME R, 1996, WORLD LEATHER    JAN, P69
   THIAGARAJAN M, 1992, ADHESIVES AGE, V34
   VACULIC J, 1992, DAS LEDER, V43, P104
   VACULIK J, 1995, LEDER, V46, P28
   VOSS PA, 1998, ADHESIVES AGE, V26
   Wake W C, 1973, J COATED FABRICS, V3, P84
   WHITTAKER RE, 1975, J SOC LEATHER TECHNO, V59, P172
   WILSON JA, 1944, MODERN PRACTICE LEAT
   WU SH, 1987, POLYM ENG SCI, V27, P335, DOI 10.1002/pen.760270506
   ZISMAN WA, 1963, IND ENG CHEM, V55, P19
   ZISMAN WA, 1962, ADHESION COHESION, P176
NR 63
TC 3
Z9 3
U1 0
U2 4
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 2002
VL 16
IS 5
BP 543
EP 563
DI 10.1163/156856102760070367
PG 21
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 560TE
UT WOS:000176096800004
DA 2018-10-19
ER

PT J
AU Spijker, HT
   Bos, R
   Busscher, HJ
   Graaff, R
   van Oeveren, W
AF Spijker, HT
   Bos, R
   Busscher, HJ
   Graaff, R
   van Oeveren, W
TI Adhesion of blood platelets under flow to wettability gradient
   polyethylene surfaces made in a shielded gas plasma
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE platelets; wettability gradients; adhesion; flow; detachment
ID PROTEIN ADSORPTION; FIBROBLASTS; FIBRINOGEN; ABSORPTION; ACTIVATION
AB Adhesion and activation of platelets are important steps in the thrombosis of blood after contact with a biomaterial surface and are governed, in part, by the wettability of the surface. Since most implanted devices are in contact with blood under flow conditions, it is important to study the effect of wettability of device surfaces on the behavior of platelets also under flow. To this end, wettability gradient polyethylene surfaces were prepared through glow discharge with partial shielding over a length of 5 cm, with advancing water contact angles varying from 95 to 45 degrees and a contact angle hysteresis of 30 degrees. The role of blood flow on the adhesion of platelets was examined by incubating these gradient surfaces in anticoagulated, whole human blood under static conditions or in blood under a flow of 10 or 40 ml/min through a 3 mm diameter circuit or for 5 or 15 min with either the hydrophobic or hydrophilic end upstream. Generally, more platelets adhered on the hydrophilic end of the wettability gradient than on the hydrophobic end, although the increment along the wettability gradient was dependent on both the flow conditions and direction. More platelets adhered under a flow of 10 ml/min than under static conditions, due to higher mass transport. Especially when the hydrophilic end was upstream, there was a more pronounced adhesion. This can be explained in terms of immediate platelet activation by shear stress imposed at the upstream end. During flow of 40 ml/min, platelet adhesion on an upstream hydrophilic end was less than on a downstream hydrophilic end. We conclude that platelets detach from the hydrophilic end at high shear stress due to the spherical form of adhered platelets. Platelets on the hydrophobic end could withstand detachment by strong, flat shaped platelet-material contact.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
RI Graaff, Reindert/G-8941-2011
CR Andrade JD, 1985, SURFACE INTERFACIAL, VI, P15
   Dintenfass L., 1976, RHEOLOGY BLOOD DIAGN
   ELWING H, 1987, J COLLOID INTERF SCI, V119, P203, DOI 10.1016/0021-9797(87)90260-8
   ELWING H, 1990, ADV COLLOID INTERFAC, V32, P317, DOI 10.1016/0001-8686(90)80022-R
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   FREDRICKSON BJ, 1987, HEMOSTASIS THOMBOSIS, P625
   Jen CJ, 1996, AM J PHYSIOL-HEART C, V270, pH160
   LEE JH, 1992, J COLLOID INTERF SCI, V151, P563, DOI 10.1016/0021-9797(92)90504-F
   Lee JH, 1999, J BIOMAT SCI-POLYM E, V10, P283
   OBRIEN JR, 1990, LANCET, V335, P711, DOI 10.1016/0140-6736(90)90815-M
   Otto K, 1999, COLLOID SURFACE B, V15, P99, DOI 10.1016/S0927-7765(99)00050-8
   OWEN MJ, 1988, POLYM SURFACE DYNAMI, P101
   Petibois C, 2001, CLIN CHEM, V47, P730
   POLANOWSKAGRABOWSKA R, 1992, P NATL ACAD SCI USA, V89, P5754, DOI 10.1073/pnas.89.13.5754
   Ruardy TG, 1997, J COLLOID INTERF SCI, V188, P209, DOI 10.1006/jcis.1997.4769
   RUARDY TG, 1995, J BIOMED MATER RES, V29, P1415, DOI 10.1002/jbm.820291113
   RUARDY TG, 1997, SURF SCI REP, V27, P1
   Spijker H. T., 1997, Cells and Materials, V7, P201
   Spijker HT, 1999, COLLOID SURFACE B, V15, P89, DOI 10.1016/S0927-7765(99)00056-9
   Spijker HT, 2002, BIOMATERIALS, V23, P757, DOI 10.1016/S0142-9612(01)00181-8
   Suzuki H, 1996, PROG HISTOCHEM CYTOC, V30, P1
   VANDERMEI HC, 1991, J ADHES SCI TECHNOL, V5, P757, DOI 10.1163/156856191X00684
   VENNART JK, 1982, ELEMENTARY FLUID MEC
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   VROMAN L, 1980, BLOOD, V55, P156
   WAHLGREN M, 1995, COLLOID SURFACE B, V4, P23
   WARKENTIN P, 1994, BIOMATERIALS, V15, P786, DOI 10.1016/0142-9612(94)90033-7
   Welle A, 1998, J COLLOID INTERF SCI, V197, P263, DOI 10.1006/jcis.1997.5238
   Yayapour N, 1999, COLLOID SURFACE B, V15, P127, DOI 10.1016/S0927-7765(99)00049-1
NR 29
TC 10
Z9 10
U1 2
U2 9
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 2002
VL 16
IS 13
BP 1703
EP 1713
DI 10.1163/156856102320396094
PG 11
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 607WW
UT WOS:000178814600001
DA 2018-10-19
ER

PT J
AU Motta, A
   Migliaresi, C
   Lloyd, AW
   Denyer, SP
   Santin, M
AF Motta, A
   Migliaresi, C
   Lloyd, AW
   Denyer, SP
   Santin, M
TI Serum protein absorption on silk fibroin fibers and films: Surface
   opsonization and binding strength
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
ID COMPLEMENT ACTIVATION; POLYMER SURFACES; SOLID-SURFACES; ADSORPTION;
   ALPHA-1-MICROGLOBULIN
AB Fibroin, the core of the silk filament protein, has been proposed as a biomaterial for different biomedical applications since it can be engineered as a thread, fabric or film. Infrared spectroscopy suggests that the dissolution of the fibroin filaments and subsequent casting of the fibroin solution into films followed by treatment with methanol alters the protein structure leading to an increase in amorphous domains. The adsorption of serum proteins on fabrics and films showed different hydrophobic binding strengths for the two materials with the protein binding being greatest for the more hydrophobic fibroin fibers. Differences between the materials were also observed in the adsorption of key immunoproteins. Although the C3 fragment of the complement system was adsorbed on both the surfaces, it appeared to be activated preferentially on the fibroin films and not on the fibroin fibers, whereas the Bb and C1q factors were only significantly present on the fibroin fabric. IgG appeared to be adsorbed, although to different extents, on both types of fibroin substrates. These results suggest that the biocompatibility of the silk fibroin may be affected by changes in protein structure induced by processing the material.
C1 Univ Trent, Dipartimento Ingn Mat, I-38050 Trent, Italy.
   Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
RP Motta, A (reprint author), Univ Trent, Dipartimento Ingn Mat, Via Mesiano 77, I-38050 Trent, Italy.
RI Lloyd, Andrew/D-1369-2011
OI Lloyd, Andrew/0000-0003-2778-8195
CR AMBROSE EJ, 1951, NATURE, V167, P264, DOI 10.1038/167264a0
   ANDERSON JM, 1988, AM SOC ARTIF INTERN, V28, P767
   BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   ELWING H, 1988, J COLLOID INTERF SCI, V125, P139, DOI 10.1016/0021-9797(88)90062-8
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P474
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   HIRABAYASHI K, 1968, SEN-I GAKKAISHI, V24, P392
   IIZUKA E, 1968, BIOCHEMISTRY-US, V7, P2218, DOI 10.1021/bi00846a026
   KATAOKA K, 1976, KOBUNSHI RONBUNSHU, V33, P453, DOI 10.1295/koron.33.453
   KREJCHI MT, 1994, SCIENCE, V265, P1427, DOI 10.1126/science.8073284
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOTZ B, 1979, BIOCHIMIE, V61, P205, DOI 10.1016/S0300-9084(79)80067-X
   MAGOSHI J, 1975, J APPL POLYM SCI, V19, P1013, DOI 10.1002/app.1975.070190410
   MAGOSHI J, 1985, J APPL POLYM SCI APP, V41, P187
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MONTI P, IN PRESS J RAMAN SPE
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   Santin M, 1998, J MATER SCI-MATER M, V9, P135, DOI 10.1023/A:1008863518572
   Santin M, 1997, BIOMATERIALS, V18, P823, DOI 10.1016/S0142-9612(97)00004-5
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
NR 26
TC 29
Z9 29
U1 1
U2 16
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 6 BONHILL STREET, LONDON EC2A 4PU, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JAN
PY 2002
VL 17
IS 1
BP 23
EP 35
DI 10.1106/088391102023195
PG 13
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 551KF
UT WOS:000175559600002
DA 2018-10-19
ER

PT J
AU Karakecili, AG
   Gumusderelioglu, M
AF Karakecili, AG
   Gumusderelioglu, M
TI Comparison of bacterial and tissue cell initial adhesion on
   hydrophilic/hydrophobic biomaterials
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE bacterial adhesion; tissue integration; biomaterials;
   biomaterial-centered infection
ID STAPHYLOCOCCUS-EPIDERMIDIS; PSEUDOMONAS-AERUGINOSA; MICROBIAL ADHESION;
   SURFACES; POLYMERS; INVITRO; GROWTH; ENERGY; PHEMA; PU
AB In this study, interactions of widely-used polymeric biomaterials, i.e. poly(hydroxyethyl methacrylate) (PHEMA) and its copolymer with dimethylaminoethyl methacrylate (PHEMA-20% DMAEMA), polyurethane (PU), polypropylene (PP), poly(vinyl chloride) (PVC), and poly(lactide-glycolide) (PLGA), with three pathogenic bacteria and one nonpathogen were investigated comparatively with the adhesion of two tissue cells in different morphologies, i.e. fibroblast-like baby hamster kidney (BHK 21) cells and epithelia] Madine Darby kidney (MDBK) cells. Biomaterials were prepared in the membrane form by bulk polymerization or solvent casting. Surface characterization studies showed that these polymers have different surface free energies in the range of 26.9-63.1 erg cm(-2) and they have smooth surfaces. The bacteria used were; Escherichia coli ATCC 25922, Staphylococcus epidermidis ATCC 12228, Staphylococcus aureus, and Lactobacillus acidophilus B-13. Initial adhesion of bacteria to the polymeric surfaces was examined under static conditions and in a laminar flow cell. The adhesion behaviour of S. aureus and S. epidermidis was found independent of the polymeric surface hydrophobicity. However, the percentage of attached E. coli decreased when increasing the surface free energy of the polymer, while L. acidophilus showed just the opposite behaviour. The comparative results indicated that the adhesion of BHK and MDBK cell was lowest on the most hydrophilic PHEMA surface and highest oil the most hydrophobic PP surface. In contrast to the case of bacterial adhesion, no relationship was found between polymer hydrophobicity and mammalian cell adherence.
C1 Hacettepe Univ, Dept Chem Engn, TR-06532 Ankara, Turkey.
RP Gumusderelioglu, M (reprint author), Hacettepe Univ, Dept Chem Engn, TR-06532 Ankara, Turkey.
CR ANDRADE JD, 1979, J COLLOID INTERF SCI, V72, P488, DOI 10.1016/0021-9797(79)90350-3
   Anwar H., 1992, ASM NEWS, V58, P665
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BROKKE P, 1992, J MATER SCI-MATER M, V3, P101, DOI 10.1007/BF00705276
   Busscher H J, 1997, Adv Dent Res, V11, P24
   BUTRUS SI, 1990, CURR EYE RES, V9, P717, DOI 10.3109/02713689008999566
   COOK AD, 1993, J BIOMED MATER RES, V27, P119, DOI 10.1002/jbm.820270115
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1991, INTERFACIAL PHENOMEN, P106
   GRISTINA AG, 1996, BIOMATERIALS SCI INT, P205
   Gumusderelioglu M, 2000, J BIOMAT SCI-POLYM E, V11, P1039, DOI 10.1163/156856200743562
   HOEDEMAKER HOT, 1997, BIOMEDICAL MAT RES G, P109
   KIREMITCI M, 1991, Clinical Materials, V8, P9, DOI 10.1016/0267-6605(91)90004-Y
   KIREMITCI M, 1994, J BIOMAT SCI-POLYM E, V6, P425
   Kiremitci M, 1993, J Biomater Appl, V7, P250, DOI 10.1177/088532829300700304
   KiremitciGumusderelioglu M, 1996, BIOMATERIALS, V17, P443, DOI 10.1016/0142-9612(96)89662-1
   KUNIN CM, 1985, J CLIN MICROBIOL, V21, P902
   REID G, 1988, MICROBIAL ECOL, V16, P241, DOI 10.1007/BF02011698
   REID G, 1991, BIOFOULING, V4, P171, DOI DOI 10.1080/08927019109378207
   Schakenraad J.M., 1996, BIOMATERIALS SCI INT, P141
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   Vacheethasanee K, 2000, J BIOMED MATER RES, V50, P302, DOI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
   VANLOOSDRECHT MCM, 1989, MICROBIAL ECOL, V17, P1, DOI 10.1007/BF02025589
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P775, DOI 10.1002/jbm.820270610
   VERHEYEN CCPM, 1993, BIOMATERIALS, V14, P383, DOI 10.1016/0142-9612(93)90059-B
   VISSER SA, 1996, BIOMATERIALS SCI INT, P50
NR 30
TC 34
Z9 35
U1 3
U2 30
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 2
BP 185
EP 196
DI 10.1163/156856202317414366
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 553WA
UT WOS:000175698300006
PM 12022749
DA 2018-10-19
ER

PT J
AU Caplan, MR
   Schwartzfarb, EM
   Zhang, SG
   Kamm, RD
   Lauffenburger, DA
AF Caplan, MR
   Schwartzfarb, EM
   Zhang, SG
   Kamm, RD
   Lauffenburger, DA
TI Effects of systematic variation of amino acid sequence on the mechanical
   properties of a self-assembling, oligopeptide biomaterial
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE shear modulus; protein engineering; rational design
ID COMPLEMENTARY OLIGOPEPTIDE; HYDROPHOBICITY SCALE; RESIDUES; POLYMERS;
   MATRIX
AB In order to elucidate design principles for biocompatible materials that can be created by in situ transformation from self-assembling oligopeptides, we investigate a class of oligopeptides that can self-assemble in salt solutions to form three-dimensional matrices. This class of peptides possesses a repeated sequence of amino acid residues with the type: hydrophobic/negativelycharged/hydrophobic/positively-charged. We systematically vary three chief aspects of this sequence type: (1) the hydrophobic side chains; (2) the charged side chains; and (3) the number of repeats. Each of these has been previously shown to influence the self-assembly properties of these materials. Employing a rheometric assay we measure the shear modulus of gels created from variants of each of these aspects. First, we observe order-of-magnitude changes in shear moduli when we vary oligopeptide length, with biphasic dependence on length. This result may be due to competition between, in short oligopeptides, additional repeats either increasing the diameter of the filaments or increasing the area of interaction between individual molecules and, in large oligopeptides, additional repeats allowing the oligopeptides to fold back upon themselves and decrease their effective length. Second, no statistically significant difference is observed among the hydrophobic variants, suggesting that hydrophobicity and steric overlap are unlikely to play a significant role in filament mechanical properties. Finally, in variation of the charged side chains we observe a small difference in the shear moduli that, if significant, may mean that decreasing the energetic penalty for dehydrating the charged side chains can lead to a stiffer matrix. Overall, we demonstrate that it is possible to achieve order-of-magnitude changes in shear modulus by simple variations of oligopeptide length, while the residue substitutions affect only self-assembly properties. Thus. diverse aspects of these molecules can be designed rationally to yield desirable materials properties of different type.
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
   MIT, Biol Engn Div, Cambridge, MA 02139 USA.
RP Lauffenburger, DA (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
OI /0000-0002-7232-304X
FU NIGMS NIH HHS [GM55781]
CR Bostman OM, 2000, CLIN ORTHOP RELAT R, P216
   BULL HB, 1974, ARCH BIOCHEM BIOPHYS, V161, P665, DOI 10.1016/0003-9861(74)90352-X
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0
   CLARK AH, 1987, ADV POLYM SCI, V83, P58
   CREIGHTON TE, 1993, PROTEINS STRUCTURE M, P142
   Gibson L. J., 1988, CELLULAR SOLIDS
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Leon EJ, 1998, J BIOMAT SCI-POLYM E, V9, P297, DOI 10.1163/156856298X00668
   Prockop D. J., 1994, EXTRACELLULAR MATRIX, P47
   ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714
   Urry DW, 1998, BIOPOLYMERS, V47, P167, DOI 10.1002/(SICI)1097-0282(1998)47:2<167::AID-BIP6>3.0.CO;2-S
   Vorobev MM, 1997, Z NATURFORSCH C, V52, P227
   WELLINGS DA, 1997, METHOD ENZYMOL, V289, P61
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 17
TC 63
Z9 64
U1 0
U2 17
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 3
BP 225
EP 236
DI 10.1163/156856202320176493
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 576ET
UT WOS:000176990400001
PM 12102591
DA 2018-10-19
ER

PT J
AU Ma, N
   Petit, A
   Yahia, L
   Huk, OL
   Tabrizian, M
AF Ma, N
   Petit, A
   Yahia, L
   Huk, OL
   Tabrizian, M
TI Cytotoxic reaction and TNF-alpha response of macrophages to polyurethane
   particles
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polyurethane particles; inflammatory response; macrophage; cytotoxicity
ID TUMOR NECROSIS FACTOR; POLYETHYLENE PARTICLES; INFLAMMATORY RESPONSE;
   IN-VITRO; DEGRADATION; INVIVO; BIOCOMPATIBILITY; BIODEGRADATION;
   BIOMATERIALS; SIZE
AB Their unique mechanical and biological properties make polyurethanes (PUs) ideal materials for many implantable devices. However, uncertain long-term biostability in the human physiological environment limits their extensive clinical applications. Chronic inflammatory response associated with macrophage activation has been suggested as a prime factor; although the mechanism of macrophage activation in response to biomaterial surfaces and debris is still unknown. The overall objective of this work was to study the response of macrophages to PU materials in vitro by measuring cell viability and activity. The studies were carried out using phagocytozable-size PU particles from three types of commercially-available PUs: Pellethane(R) 2363 80ABA (PL); Tecothane(R) TT2065 (TC65); and Tecothane(R) TT2085 (TC85). These polymers posess the same generic composition but differ in the length of hard and soft segments, as revealed by the FTIR and NMR studies. The results showed that PU particles affected both viability and activity of J774 macrophages. The percentage of mortality ranged front 1 to 15% with 10-100 mugml(-1) of particles after 24 and 48 h incubation. These three types of particles induced different mortality on the macrophages. Specifically, the mortality with PL particles was 1-4% (p > 0.05), while the mortality with TC85 particles was 2-10% (p < 0.05) and 4-15% with TC65 (p < 0.05). Conversely, these particles also affected cell proliferation. Cell numbers increased by 132 and 167% after 24 and 48 h incubation, respectively, without particles, whereas the cell numbers increased only 46 and 78% with TC65, 66 and 105% with TC85, and 67 and 110% with PL in the presence of 100 mug ml(-1) of particles for the respective incubation times. PU particles also increased TNF-alpha release from macrophage. After having been incubated for 24 h with 100 mug ml(-1) particles of TC65, TC85, and PL, macrophages release TNF-alpha 7.4, 5.2, and 4.1 times more than the control. In conclusion, PU particles had cytotoxic effects on J774 macrophage at high concentrations. The order of macrophage response for three types of particles was TC65 > TC85 > PL. PU particles' effect on macrophage viability and activity depends on the concentration of particles and their chemical composition, especially on the ratio of hard to soft segments.
C1 McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada.
   Ecole Polytech, GRBB, Inst Biomed Engn, Montreal, PQ H3C 3A7, Canada.
   McGill Univ, Lady Davis Inst Med Res, Div Orthoped Surg, Montreal, PQ H3T 1E2, Canada.
RP Tabrizian, M (reprint author), McGill Univ, Dept Biomed Engn, 3775 Univ St, Montreal, PQ H3A 2B4, Canada.
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   AZIZSOLTANI E, 1995, J BIOMED MATER RES, V29, P101, DOI 10.1002/jbm.820290114
   Bellingan GJ, 1996, J IMMUNOL, V157, P2577
   BENOIT FM, 1993, J BIOMED MATER RES, V27, P1341, DOI 10.1002/jbm.820271014
   BOUVIER M, 1991, J BIOMED MATER RES, V25, P773, DOI 10.1002/jbm.820250607
   BRUNSTEDT MR, 1990, BIOMATERIALS, V11, P370, DOI 10.1016/0142-9612(90)90089-9
   CASAS J, 1999, J BIOMED MATER RES, V15, P475
   Catelas I, 1998, J BIOMED MATER RES, V41, P600, DOI 10.1002/(SICI)1097-4636(19980915)41:4<600::AID-JBM12>3.3.CO;2-7
   Chen JH, 1998, J BIOMED MATER RES, V41, P633, DOI 10.1002/(SICI)1097-4636(19980915)41:4<633::AID-JBM16>3.0.CO;2-F
   Clark R.A.F., 1988, MOL CELLULAR BIOL WO
   Collier T, 1998, J BIOMED MATER RES, V41, P192, DOI 10.1002/(SICI)1097-4636(199808)41:2<192::AID-JBM3>3.0.CO;2-D
   DARBY TD, 1978, TOXICOL APPL PHARM, V46, P449, DOI 10.1016/0041-008X(78)90090-X
   DEVOR DE, 1993, TOXICOL PATHOL, V21, P261, DOI 10.1177/019262339302100301
   FERRANTE A, 1988, INT ARCH ALLER A IMM, V86, P82, DOI 10.1159/000234610
   GRASEL TG, 1986, BIOMATERIALS, V7, P315, DOI 10.1016/0142-9612(86)90002-5
   Green TR, 2000, J BIOMED MATER RES, V53, P490, DOI 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7
   GUIDOIN R, 1992, ANN PLAS SURG, V28, P342, DOI 10.1097/00000637-199204000-00009
   Holevinsky KO, 1998, BIOPHYS J, V75, P2577, DOI 10.1016/S0006-3495(98)77703-3
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   Jayabalan M, 1993, J Biomater Appl, V8, P64, DOI 10.1177/088532829300800104
   Johnston CJ, 1996, TOXICOL APPL PHARM, V140, P154, DOI 10.1006/taap.1996.0208
   LABOW RS, 1995, BIOMATERIALS, V16, P51, DOI 10.1016/0142-9612(95)91096-H
   Labow RS, 1999, J BIOMATER APPL, V13, P187, DOI 10.1177/088532829901300302
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   LUU HMD, 1994, J APPL BIOMATER, V5, P1, DOI 10.1002/jab.770050102
   MCGRATH MH, 1990, CLIN PLAST SURG, V17, P421
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MOONEY DP, 1990, ANN SURG, V211, P124, DOI 10.1097/00000658-199002000-00002
   Pauluhn J, 2000, ARCH TOXICOL, V74, P257, DOI 10.1007/s002040000114
   PHILLIPS R, 1988, PACING CLIN ELECTROP, V9, P1166
   Rice JM, 1998, J BIOMAT SCI-POLYM E, V9, P833, DOI 10.1163/156856298X00181
   Saad B, 1997, J BIOMED MATER RES, V36, P65, DOI 10.1002/(SICI)1097-4636(199707)36:1<65::AID-JBM8>3.3.CO;2-#
   SATO M, 1995, J BIOMED MATER RES, V29, P1201, DOI 10.1002/jbm.820291007
   SINCLAIR TM, 1995, PLAST RECONSTR SURG, V96, P1326, DOI 10.1097/00006534-199511000-00014
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Szycher M, 1991, J Biomater Appl, V6, P110, DOI 10.1177/088532829100600202
   Szycher M., 1985, CORROSION DEGRADATIO, P308
   SZYCHER M, 1991, HIGH PERFORMANCE BIO, P223
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tsuchiya T, 1996, J BIOMED MATER RES, V31, P299
   Vermette P, 1999, J BIOMAT SCI-POLYM E, V10, P729, DOI 10.1163/156856299X00612
   Wang GB, 1997, J CHROMATOGR B, V698, P69, DOI 10.1016/S0378-4347(97)00282-X
   WILLIAMS DF, 1991, CONCISE ENCY MED DEN
   WU Y, 1991, J BIOMED MATER RES, V25, P1415, DOI 10.1002/jbm.820251109
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   Zhang Z, 1997, BIOMATERIALS, V18, P113, DOI 10.1016/S0142-9612(96)00054-3
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO QH, 1992, J BIOMED MATER RES, V26, P1019, DOI 10.1002/jbm.820260805
NR 50
TC 13
Z9 13
U1 1
U2 4
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 3
BP 257
EP 272
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 576ET
UT WOS:000176990400003
PM 12102593
DA 2018-10-19
ER

PT J
AU Wagner, MS
   McArthur, SL
   Shen, MC
   Horbett, TA
   Castner, DG
AF Wagner, MS
   McArthur, SL
   Shen, MC
   Horbett, TA
   Castner, DG
TI Limits of detection for time of flight secondary ion mass spectrometry
   (ToF-SIMS) and X-ray photoelectron spectroscopy (XPS): detection of low
   amounts of adsorbed protein
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE ToF-SIMS; XPS; protein adsorption; quantitation; limit of detection
ID PRINCIPAL COMPONENT ANALYSIS; SURFACE-PLASMON RESONANCE; BIOMATERIAL
   SURFACES; S-SIMS; ADSORPTION; FILMS; POLYMERS; ALBUMIN
AB Characterization of biomaterial surfaces requires analytical techniques that are capable of detecting a wide concentration range of adsorbed protein. This range includes detection of low amounts of adsorbed protein (<10 ng/cm(2)) that may be present on non-fouling biomaterials. X-ray Photoelectron Spectroscopy (XPS) and Time of Flight Secondary Ion Mass Spectrometry (ToF-SIMS) are surface sensitive techniques capable of detecting adsorbed proteins. We have investigated the lower limits of detection of both XPS and ToF-SIMS on four model substrates each presenting unique challenges for analysis by XPS and ToF-SIMS: mica, poly(tetrafluoroethylene), allyl amine plasma polymer and heptyl amine plasma polymer. The detection limit for XPS ranged from 10 ng/cm(2) of fibrinogen (on mica) to 200 ng/cm(2) (on allyl amine plasma polymers). The detection limit for ToF-SIMS ranged from 0.1 ng/cm(2) of fibrinogen to 100 ng/cm(2), depending on the substrate and data analysis. Optimal conditions provided detection limits between 0.1 ng/cm(2) and 15 ng/cm(2) on all of the substrates used in this study. While both techniques were shown to be effective in detecting protein, the sensitivity of both XPS and ToF-SIMS was, shown to be dependent on substrate surface chemistry and the organization of the adsorbed protein film. This study specifically highlights the applicability of ToF-SIMS in the characterization of low level protein adsorption.
C1 Univ Washington, Dept Chem Engn, Natl ESCA & Surface Anal Ctr Biomed Problems, Seattle, WA 98195 USA.
   Univ Washington, Dept Bioengn, Natl ESCA & Surface Anal Ctr Biomed Problems, Seattle, WA 98195 USA.
RP Castner, DG (reprint author), Univ Washington, Dept Chem Engn, Natl ESCA & Surface Anal Ctr Biomed Problems, Box 351750, Seattle, WA 98195 USA.
RI McArthur, Sally/B-6848-2008
OI McArthur, Sally/0000-0002-4914-6989
FU NCRR NIH HHS [RR-01296]; NHLBI NIH HHS [HL19419]
CR Adriaens A, 1999, MASS SPECTROM REV, V18, P48, DOI 10.1002/(SICI)1098-2787(1999)18:1<48::AID-MAS2>3.3.CO;2-9
   Balcells M, 1999, J COLLOID INTERF SCI, V220, P198, DOI 10.1006/jcis.1999.6527
   BARBUCCI R, 1992, Clinical Materials, V11, P37, DOI 10.1016/0267-6605(92)90028-R
   Briggs D, 1996, SURF INTERFACE ANAL, V24, P419, DOI 10.1002/(SICI)1096-9918(199606)24:6<419::AID-SIA132>3.3.CO;2-P
   Burlingame AL, 1998, ANAL CHEM, V70, p647R
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Douglas MA, 1998, SURF INTERFACE ANAL, V26, P984, DOI 10.1002/(SICI)1096-9918(199812)26:13<984::AID-SIA446>3.0.CO;2-K
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   FADLEY CS, 1984, PROG SURF SCI, V16, P275, DOI 10.1016/0079-6816(84)90001-7
   Ferrari S, 2000, SURF INTERFACE ANAL, V29, P837, DOI 10.1002/1096-9918(200012)29:12<837::AID-SIA937>3.0.CO;2-O
   FITZPATRICK H, 1992, J COLLOID INTERF SCI, V149, P1, DOI 10.1016/0021-9797(92)90384-X
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   HAGENHOFF B, 1995, BIOSENS BIOELECTRON, V10, P885, DOI 10.1016/0956-5663(95)99226-B
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   HORBETT TA, 1986, TECHNIQUES BIOCOMPAT, P183
   Jackson J. E., 1991, USERS GUIDE PRINCIPA
   John CM, 1997, INT J MASS SPECTROM, V161, P47, DOI 10.1016/S0168-1176(96)04505-3
   Kingshott P, 2000, J BIOMED MATER RES, V49, P36, DOI 10.1002/(SICI)1097-4636(200001)49:1<36::AID-JBM5>3.0.CO;2-B
   Leonard D, 1999, FRESEN J ANAL CHEM, V365, P3, DOI 10.1007/s002160051437
   Leonard D., 1999, Plasmas and Polymers, V4, P97, DOI 10.1023/A:1021892707963
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   LHOEST JB, 1999, 12 INT C SEC ION MAS, P935
   LOPEZ GP, 1991, LANGMUIR, V7, P766, DOI 10.1021/la00052a027
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   MARLETTA G, 1990, SURF INTERFACE ANAL, V16, P407, DOI 10.1002/sia.740160185
   MULZER S R, 1990, Journal of Biomaterials Science Polymer Edition, V1, P173
   PAYNTER RW, 1984, J COLLOID INTERF SCI, V101, P233, DOI 10.1016/0021-9797(84)90023-7
   PAYNTER RW, 1985, SURFACE INTERFACIAL, V2, P189
   Ratner BD, 1997, SURFACE ANALYSIS - THE PRINCIPAL TECHNIQUES, P43
   RATNER BD, 1981, J COLLOID INTERF SCI, V83, P630, DOI 10.1016/0021-9797(81)90358-1
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V113, P530, DOI 10.1016/S0021-9797(86)90446-7
   Tidwell CD, 2001, SURF INTERFACE ANAL, V31, P724, DOI 10.1002/sia.1101
   Turner NH, 1998, ANAL CHEM, V70, p229R
   Van Vaeck L, 1999, MASS SPECTROM REV, V18, P1
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
   WELLE A, 1998, J COLLOID INTERF SCI, V197, P262
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
NR 40
TC 95
Z9 97
U1 2
U2 57
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 4
BP 407
EP 428
DI 10.1163/156856202320253938
PG 22
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 586HE
UT WOS:000177577900006
PM 12160301
DA 2018-10-19
ER

PT J
AU Tang, YW
   Labow, RS
   Revenko, I
   Santerre, JP
AF Tang, YW
   Labow, RS
   Revenko, I
   Santerre, JP
TI Influence of surface morphology and chemistry on the enzyme catalyzed
   biodegradation of polycarbonate-urethanes
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE AFM; XPS; polyurethanes; enzymes; hard segment; biodegradation; esterase
ID ATOMIC-FORCE MICROSCOPY; SEGMENTED POLYURETHANES; PHASE-DETECTION;
   POLYMER BLENDS; DEGRADATION; BIOMATERIAL; POLYETHER; CHOLESTEROL;
   HYDROLYSIS; POLY(ETHER
AB Polycarbonate based polyurethanes were synthesized with varying hard segment content as well as hard segment chemistry based on three different diisocyanates,1,6-hexane diisocyanate (HDI), 4,4'-methylene bisphenyl diisocyanate (MDI) and 4,4-methylene biscyclohexyl diisocyanate (HMDI). The surface chemistry and morphology were characterized using X-ray photoelectron spectroscopy (XPS) and atomic force microscopy (AFM). The polymers were incubated with cholesterol esterase (CE) in a phosphate buffer solution at 37degreesC over 10 weeks. XPS results showed that the surface chemistry changed as the size and chemistry of the hard segment varied within the materials. AFM images exhibited distinctive surface morphologies for all polymers, and this was particularly apparent with changes in the hard segment chemistry. The results showed that the surface of HDI polymers consisted of relatively stiff rod-like structures, which corresponded to the soft segment domains. Polymers with a higher HDI content exhibited a dense top layer containing a relatively higher hard segment component, covering the sub-surface matrix of rod like structures. The MDI based polyurethane had large aggregates on its top surface, which corresponded to the aggregation of harder components. The HMDI based polycarbonate-urethane presented a relatively homogeneous surface where no phase separation could be detected. The relative differences in hard and soft segment content in their surface structure was supported by XPS findings. The analysis of the biodegradation results, concluded that enzyme catalyzed biodegradation within these materials was initiated in amorphous soft segment regions located in the region of the interface between hard and soft segments. A higher hard segment content at the surface contributed significantly to an increase in biostability. The findings provided an enhanced understanding for the role of surface molecular structure in the enzyme catalyzed biodegradation of polyurethanes.
C1 Univ Toronto, Fac Dent, Dept Biol & Diagnost Sci, Toronto, ON M5G 1G6, Canada.
   Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada.
   Digital Instruments, Goleta, CA 93117 USA.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Dept Biol & Diagnost Sci, 124 Edward St, Toronto, ON M5G 1G6, Canada.
CR ABE H, 1995, MACROMOLECULES, V28, P844, DOI 10.1021/ma00108a007
   Bar G, 1997, LANGMUIR, V13, P3807, DOI 10.1021/la970091m
   Bourauel C, 1998, EUR J ORTHODONT, V20, P79, DOI 10.1093/ejo/20.1.79
   CHAPMAN TM, 1989, J POLYM SCI POL CHEM, V27, P1993, DOI 10.1002/pola.1989.080270620
   Chen X, 1998, MACROMOLECULES, V31, P2278, DOI 10.1021/ma9704525
   Focarete ML, 1998, MACROMOLECULES, V31, P8485, DOI 10.1021/ma981115e
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   Grobe GL, 1996, J BIOMED MATER RES, V32, P45, DOI 10.1002/(SICI)1097-4636(199609)32:1<45::AID-JBM6>3.0.CO;2-P
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P667
   HEARN MJ, 1988, MACROMOLECULES, V21, P2950, DOI 10.1021/ma00188a011
   Iwata T, 1998, MACROMOLECULES, V31, P2461, DOI 10.1021/ma980008h
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   LABOW RS, 1995, BIOMATERIALS, V16, P51, DOI 10.1016/0142-9612(95)91096-H
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Magonov SN, 1997, ANNU REV MATER SCI, V27, P175, DOI 10.1146/annurev.matsci.27.1.175
   Magonov SN, 1997, SURF SCI, V375, P385
   McLean RS, 1997, MACROMOLECULES, V30, P8314, DOI 10.1021/ma970350e
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   RATNER BD, 1993, CARDIOVASC PATHOL, V2, pS87, DOI 10.1016/1054-8807(93)90049-8
   RATNER BD, 1987, POLYM SURFACES INTER, P231
   Revenko I, 2001, SURF SCI, V491, P346, DOI 10.1016/S0039-6028(01)01298-5
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   SERRY FM, 1998, BIOMATERIALS FORUM, V20, P11
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   Suyama T, 1997, ENZYME MICROB TECH, V20, P122, DOI 10.1016/S0141-0229(96)00084-1
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   TABAK A, 1994, J PHARM PHARMACOL, V46, P789, DOI 10.1111/j.2042-7158.1994.tb03731.x
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Tanzi MC, 1997, J BIOMED MATER RES, V36, P550, DOI 10.1002/(SICI)1097-4636(19970915)36:4<550::AID-JBM14>3.0.CO;2-E
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   TINGEY KG, 1995, SER ACS S, V602, P66
   VANBOGART JWC, 1980, J MACROMOL SCI PHYS, VB17, P267, DOI 10.1080/00222348008213125
NR 38
TC 48
Z9 49
U1 2
U2 14
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 4
BP 463
EP 483
DI 10.1163/156856202320253965
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 586HE
UT WOS:000177577900009
PM 12160304
DA 2018-10-19
ER

PT J
AU Rubens, FD
AF Rubens, FD
TI Cardiopulmonary bypass technology transfer: musings of a cardiac surgeon
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biocompatibility; heparin-coated circuits; SMA; PMEA; biomembrane
   mimicry; thrombosis; inflammation; cardiopulmonary bypass; review
ID REDUCED COMPLEMENT ACTIVATION; MOLECULAR-WEIGHT KININOGEN;
   HEPARIN-COATED CIRCUITS; HUMAN-PLATELETS; PROCOAGULANT ACTIVITY; PLASMA
   KALLIKREIN; EXTRACORPOREAL-CIRCULATION; PLASMINOGEN-ACTIVATOR;
   IMMOBILIZED HEPARIN; ARTIFICIAL SURFACES
AB The development of cardiopulmonary bypass (CPB) has been one of the greatest technical advancements in cardiovascular medicine. With heparin anticoagulation, this device can safely replace the circulatory and gas-exchanging functions of the heart and lung, facilitating complex cardiac operations. Limitations still exist however, related to blood reactions at the biomaterial surface, such as cell activation, inflammation and low-grade thrombosis. In this brief review, the thought processes which paralleled the development of CPB biocompatible surfaces such as heparin-coating, will be explored, as well as current theories on the suspected mechanisms by which heparin-coated surfaces act as an anti-inflammatory device during CPB. Results with new surfaces for CPB designed to capitalize on superior protein adsorption properties, such as surface modifying additive (SMA) and poly (2-methoxyethylacrylate) (PMEA), will also be described. Finally, the significance of biomaterial-independent blood activation will be discussed, emphasizing the current need to develop strategies utilizing optimal biomaterials, modified surgical technique and pharmacologic therapy to minimize the systemic complications of CPB.
C1 Ottawa Heart Inst, Ottawa, ON K1Y 4W7, Canada.
RP Rubens, FD (reprint author), Ottawa Heart Inst, Room H211,40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.
CR Aldea GS, 1996, ANN THORAC SURG, V62, P410, DOI 10.1016/0003-4975(96)00249-4
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   BAKHLE YS, 1977, BRIT J PHARMACOL, V59, P123, DOI 10.1111/j.1476-5381.1977.tb06985.x
   Bannan S, 1998, BRIT J HAEMATOL, V101, P455, DOI 10.1046/j.1365-2141.1998.00723.x
   Barstad RM, 1996, BRIT J HAEMATOL, V94, P517, DOI 10.1111/j.1365-2141.1996.tb08989.x
   Baufreton C, 1997, ANN THORAC SURG, V63, P50
   BOISCLAIR MD, 1993, BLOOD, V82, P3350
   BORDET J, 1901, ANN I PASTEUR PARIS, V15, P129
   BRACE LD, 1985, SEMIN THROMB HEMOST, V11, P190, DOI 10.1055/s-2007-1004374
   BRAMSON ML, 1965, J THORAC CARDIOV SUR, V50, P391
   CAMPBELL EJ, 1994, ASAIO J, V40, P853
   CAVAROCCHI NC, 1986, J THORAC CARDIOV SUR, V91, P252
   Chung JH, 1996, CIRCULATION, V93, P2014, DOI 10.1161/01.CIR.93.11.2014
   COLMAN RW, 1990, HEMATOL ONCOL CLIN N, V4, P27
   COLMAN RW, 1984, J CLIN INVEST, V73, P1249, DOI 10.1172/JCI111326
   Davies MG, 1996, J VASC SURG, V23, P410, DOI 10.1016/S0741-5214(96)80005-X
   De Somer F, 2000, EUR J CARDIO-THORAC, V18, P602, DOI 10.1016/S1010-7940(00)00508-X
   Defraigne JO, 2000, ANN THORAC SURG, V70, P2075, DOI 10.1016/S0003-4975(00)01838-5
   DEHAAN J, 1995, ANN THORAC SURG, V59, P901, DOI 10.1016/0003-4975(95)00012-A
   DEHAAN J, 1993, J THORAC CARDIOV SUR, V106, P1017
   deHaan J, 1996, J THORAC CARDIOV SUR, V111, P272, DOI 10.1016/S0022-5223(96)70427-0
   DEWALL RA, 1961, SURGERY, V50, P931
   DEWALL RA, 1962, SURGERY, V51, P251
   DEWALL RA, 1956, SURG CLIN N AM, V36, P1025
   EDMUNDS LH, 1978, ANN THORAC SURG, V25, P306, DOI 10.1016/S0003-4975(10)63546-1
   EDMUNDS LH, 1994, ANN THORAC SURG, V58, P285, DOI 10.1016/0003-4975(94)92193-8
   ELGUE G, 1993, THROMB HAEMOSTASIS, V70, P289
   ELLISON N, 1978, ANESTHESIOLOGY, V48, P65, DOI 10.1097/00000542-197801000-00008
   Ernofsson M, 1997, J THORAC CARDIOV SUR, V113, P576, DOI 10.1016/S0022-5223(97)70373-8
   FEARON DT, 1980, J EXP MED, V152, P20, DOI 10.1084/jem.152.1.20
   Ferraris VA, 1998, ANN THORAC SURG, V65, P352, DOI 10.1016/S0003-4975(97)01348-9
   FUHRER G, 1992, BLOOD COAGUL FIBRIN, V3, P99, DOI 10.1097/00001721-199202000-00014
   GIBBON J H Jr, 1954, Minn Med, V37, P171
   Gorman RC, 1996, J THORAC CARDIOV SUR, V111, P1, DOI 10.1016/S0022-5223(96)70395-1
   Gott VL, 1999, ANN THORAC SURG, V68, pS19, DOI 10.1016/S0003-4975(99)00817-6
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   Heller W, 1989, Adv Exp Med Biol, V247B, P43
   Hufnagel C A, 1968, Ann N Y Acad Sci, V146, P262, DOI 10.1111/j.1749-6632.1968.tb20287.x
   Jansen PGM, 1996, ANN THORAC SURG, V61, P1363, DOI 10.1016/0003-4975(96)00056-2
   JUNOD AF, 1977, AM REV RESPIR DIS, V115, P51
   KAZATCHKINE MD, 1979, J EXP MED, V150, P1202, DOI 10.1084/jem.150.5.1202
   KHURI SF, 1995, ANN THORAC SURG, V60, P1008, DOI 10.1016/0003-4975(95)00668-B
   KINLOUGHRATHBONE RL, 1995, THROMB HAEMOSTASIS, V74, P958
   KITAGUCHI H, 1979, THROMB RES, V16, P407, DOI 10.1016/0049-3848(79)90088-4
   LANDE AJ, 1970, T AM SOC ART INT ORG, V16, P352
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   LISTER J, 1863, P ROY SOC, V12, P580
   LOVINGER AJ, 1993, J POLYM SCI POL PHYS, V31, P115, DOI 10.1002/polb.1993.090310201
   Mahoney CB, 1998, PERFUSION-UK, V13, P192, DOI 10.1177/026765919801300307
   Moen O, 1997, ANN THORAC SURG, V63, P105
   MOLLNES TE, 1995, ARTIF ORGANS, V19, P909, DOI 10.1111/j.1525-1594.1995.tb02450.x
   Mombouli JV, 1999, J MOL CELL CARDIOL, V31, P61, DOI 10.1006/jmcc.1998.0844
   Muriithi EW, 2000, ANN THORAC SURG, V69, P1827, DOI 10.1016/S0003-4975(00)01299-6
   NILSSON T, 1983, THROMB HAEMOSTASIS, V49, P193
   OKANO T, 1986, J BIOMED MATER RES, V20, P919, DOI 10.1002/jbm.820200707
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   OLSON ST, 1993, BIOCHEMISTRY-US, V32, P12136, DOI 10.1021/bi00096a026
   Ovrum E, 1995, ANN THORAC SURG, V60, P1755, DOI 10.1016/0003-4975(95)00763-6
   OVRUM E, 1995, ANN THORAC SURG, V60, P365, DOI 10.1016/0003-4975(95)00366-S
   Ovrum E, 1996, ANN THORAC SURG, V62, P1128, DOI 10.1016/0003-4975(96)00490-0
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   Parratt R, 1998, BRIT J HAEMATOL, V101, P40, DOI 10.1046/j.1365-2141.1998.00674.x
   PEKNA M, 1994, ANN THORAC SURG, V58, P421, DOI 10.1016/0003-4975(94)92219-5
   RABHISABILE S, 1995, THROMB HAEMOSTASIS, V73, P693
   Ranucci M, 1999, ANN THORAC SURG, V67, P994, DOI 10.1016/S0003-4975(99)00062-4
   RATNOFF OD, 1955, J CLIN INVEST, V34, P602, DOI 10.1172/JCI103109
   RINDER CS, 1992, BLOOD, V79, P1201
   RINDER CS, 1995, J CLIN INVEST, V96, P1564, DOI 10.1172/JCI118195
   Rubens FD, 1999, ANN THORAC SURG, V67, P689, DOI 10.1016/S0003-4975(99)00068-5
   RUBENS FD, 1995, THROMB HAEMOSTASIS, V73, P850
   RUCINSKI B, 1979, BLOOD, V53, P47
   RYGG IH, 1956, ACTA CHIR SCAND, V112, P443
   Saito N, 2000, ARTIF ORGANS, V24, P547, DOI 10.1046/j.1525-1594.2000.06520.x
   SALZMAN EW, 1971, BLOOD-J HEMATOL, V38, P509
   Shapira OM, 1996, J CARDIAC SURG, V11, P307, DOI 10.1111/j.1540-8191.1996.tb00055.x
   SHUMACKER HB, 2000, CARDIOPULMONARY BYPA, P22
   SIMS PJ, 1995, SEMIN CELL BIOL, V6, P275, DOI 10.1006/scel.1995.0037
   STEINBERG BM, 1995, ANN THORAC SURG, V60, P525, DOI 10.1016/0003-4975(95)00482-Z
   STEINBERG JB, 1993, J THORAC CARDIOV SUR, V106, P1008
   Suhara H, 2001, ANN THORAC SURG, V71, P1603, DOI 10.1016/S0003-4975(01)02466-3
   TABUCHI N, 1993, J THORAC CARDIOV SUR, V106, P828
   Te Velthuis Henk, 1997, Journal of Thoracic and Cardiovascular Surgery, V114, P117, DOI 10.1016/S0022-5223(97)70124-7
   Tengvall P, 1997, J BIOMED MATER RES, V35, P81, DOI 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I
   TRACY PB, 1988, SEMIN THROMB HEMOST, V14, P227, DOI 10.1055/s-2007-1002782
   *TRILL, 2000, PROD MON TRILL
   Tsai C C, 1994, ASAIO J, V40, pM619, DOI 10.1097/00002480-199407000-00073
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P803, DOI 10.1016/S0022-5223(99)70302-8
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P794, DOI 10.1016/S0022-5223(99)70301-6
   VONSEGESSER LK, 1994, ANN THORAC SURG, V58, P391
   Voorhees ME, 1996, INT ANESTHESIOL CLIN, V34, P29, DOI 10.1097/00004311-199603420-00005
   WARD PA, 1967, J EXP MED, V126, P189, DOI 10.1084/jem.126.2.189
   WARD RS, 1987, Patent No. 4663413
   WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723
   Wendel HP, 1999, IMMUNOPHARMACOLOGY, V43, P149, DOI 10.1016/S0162-3109(99)00073-9
   WIEDMER T, 1993, BLOOD, V82, P1192
   WIGGINS RC, 1981, J EXP MED, V153, P1391, DOI 10.1084/jem.153.6.1391
   Wildevuur CRH, 1997, EUR J CARDIO-THORAC, V11, P616, DOI 10.1016/S1010-7940(96)01122-0
   Williams D., 1990, CONCISE ENCY MED DEN
NR 99
TC 16
Z9 17
U1 2
U2 5
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 4
BP 485
EP 499
DI 10.1163/156856202320253974
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 586HE
UT WOS:000177577900010
PM 12160305
DA 2018-10-19
ER

PT J
AU Merrett, K
   Cornelius, RM
   McClung, WG
   Unsworth, LD
   Sheardown, H
AF Merrett, K
   Cornelius, RM
   McClung, WG
   Unsworth, LD
   Sheardown, H
TI Surface analysis methods for characterizing polymeric biomaterials
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE surface characterization; SEM; AFM; XPS; SIMS; contact angle;
   ellipsometry
ID ATOMIC-FORCE MICROSCOPY; SELF-ASSEMBLED MONOLAYERS; AIR-WATER-INTERFACE;
   ION MASS-SPECTROMETRY; ORGANIZED MOLECULAR ASSEMBLIES; SOLID-LIQUID
   INTERFACE; NEUTRON REFLECTION; X-RAY; PROTEIN ADSORPTION; IN-VITRO
AB Surface properties have an enormous effect on the success or failure of a biomaterial device, thus signifying the considerable importance of and the need for adequate characterization of the biomaterial surface. Microscopy techniques used in the analysis of biomaterial surfaces include scanning electron microscopy, transmission electron microscopy, atomic force microscopy, and confocal microscopy. Spectroscopic techniques include X-ray photoelectron spectroscopy, Fourier Transform infrared attenuated total reflection and secondary ion mass spectrometry. The measurement of contact angles, although one of the earlier techniques developed remains a very useful tool in the evaluation of surface hydrophobicity/ hydrophilicity. This paper provides a brief, easy to understand synopsis of these and other techniques including emerging techniques, which are proving useful in the analysis of the surface properties of polymeric biomaterials. Cautionary statements have been made, numerous authors referenced and examples used to show the specific type of information that can be acquired from the different techniques used in the characterization of polymeric biomaterials surfaces.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Dept Pathol, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Dept Mol Med, Hamilton, ON L8S 4L7, Canada.
   Univ Ottawa, Dept Chem Engn, Ottawa, ON K1N 6N5, Canada.
RP Sheardown, H (reprint author), McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
RI Unsworth, Larry/A-7231-2011
CR AKINYEMI O, 1992, SCANNING, V14, P136, DOI 10.1002/sca.4950140303
   ALLARA DL, 1985, LANGMUIR, V1, P45, DOI 10.1021/la00061a007
   Amato I, 1997, SCIENCE, V276, P1982, DOI 10.1126/science.276.5321.1982
   Andrade J.D., 1985, SURFACE INTERFACIAL, V1, P1985
   Appenzeller T, 1997, SCIENCE, V276, P1981, DOI 10.1126/science.276.5321.1981
   Azzam R. M. A., 1977, ELLIPSOMETRY POLARIZ
   BARBUCCI R, 1992, Clinical Materials, V11, P37, DOI 10.1016/0267-6605(92)90028-R
   BATICH CD, 1988, APPL SURF SCI, V32, P57, DOI 10.1016/0169-4332(88)90073-6
   Battistoni C, 2000, SURF INTERFACE ANAL, V29, P773, DOI 10.1002/1096-9918(200011)29:11<773::AID-SIA928>3.3.CO;2-U
   Benesch J, 2001, J BIOMAT SCI-POLYM E, V12, P581, DOI 10.1163/156856201316883421
   BENNINGHOVEN A, 1984, ORG MASS SPECTROM, V19, P346, DOI 10.1002/oms.1210190713
   Bianco-Peled H, 2001, LANGMUIR, V17, P6931, DOI 10.1021/la990383i
   Born R, 1998, FRESEN J ANAL CHEM, V361, P697, DOI 10.1007/s002160050997
   BRANDRUP J, 1975, POLYM HDB
   BROWNE MA, 1992, SCANNING, V14, P145, DOI 10.1002/sca.4950140304
   Brunner H, 1999, J COLLOID INTERF SCI, V212, P545, DOI 10.1006/jcis.1998.6062
   Burns NL, 1998, BIOMATERIALS, V19, P423, DOI 10.1016/S0142-9612(97)00225-1
   CHEN J, 2000, MACROMOLECULES, V33, P4276
   Chen JX, 1999, MACROMOLECULES, V32, P7380, DOI 10.1021/ma990205w
   CHILKOTI A, 1991, CHEM MATER, V3, P51, DOI 10.1021/cm00013a016
   Chittur KK, 1998, BIOMATERIALS, V19, P301, DOI 10.1016/S0142-9612(97)00107-5
   Clifton BJ, 1998, PHYSICA B, V248, P289, DOI 10.1016/S0921-4526(98)00252-X
   Conrad KA, 1996, REV SCI INSTRUM, V67, P3954, DOI 10.1063/1.1147273
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Cullander C, 1998, J Investig Dermatol Symp Proc, V3, P166
   CUMPSON PJ, 1995, J ELECTRON SPECTROSC, V73, P25, DOI 10.1016/0368-2048(94)02270-4
   Cunningham T, 2000, SURF ENG, V16, P295, DOI 10.1179/026708400101517260
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   Daw R, 1998, BIOMATERIALS, V19, P1717, DOI 10.1016/S0142-9612(98)00080-5
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   DELANEY PM, 1994, J ANAT, V184, P157
   DEQUEIROZ AAA, 1997, THEOCHEM-J MOL STRUC, V394, P271
   DILKS A, 1981, ELECT SPECTROSCOPY T, V4
   Drude P, 1889, ANN PHYS CHEM, V272, P865
   EGBERS G, 1981, SECONDARY ION MASS S
   Fergg F, 2001, COLLOID POLYM SCI, V279, P61, DOI 10.1007/s003960000398
   FERNANDEZ ML, 1988, POLYMER, V29, P1923, DOI 10.1016/0032-3861(88)90162-0
   Gad M, 1997, CELL BIOL INT, V21, P697, DOI 10.1006/cbir.1997.0214
   GENTLE IR, 1993, LANGMUIR, V9, P646, DOI 10.1021/la00027a005
   Gilchrist VA, 1999, LANGMUIR, V15, P250, DOI 10.1021/la9810758
   Goedel WA, 1999, MACROMOLECULES, V32, P7599, DOI 10.1021/ma981900r
   GROBE GL, 1982, RES SOC S P, V55, P401
   GROSS ML, 1992, MASS SPECTROMETRY C, V353
   HAGENHOFF B, 1992, J PHYS D APPL PHYS, V25, P818, DOI 10.1088/0022-3727/25/5/012
   HAGENHOFF B, 1995, BIOSENS BIOELECTRON, V10, P885, DOI 10.1016/0956-5663(95)99226-B
   Harzallah B, 1998, INT J BIOL MACROMOL, V23, P73, DOI 10.1016/S0141-8130(98)00035-X
   Heavens O. S., 1965, OPTICAL PROPERTIES T
   HOEVE CAJ, 1970, J POLYM SCI POL SYM, P361
   Hoeve CAJ, 1971, J POLYMER SCI      C, V34, P1
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   HOPKINSON I, 1995, MACROMOLECULES, V28, P627, DOI 10.1021/ma00106a031
   Howse JR, 1999, PHYS REV E, V59, P5577, DOI 10.1103/PhysRevE.59.5577
   HWANG J, 1995, SCIENCE, V270, P610, DOI 10.1126/science.270.5236.610
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Irvine DJ, 1998, J BIOMED MATER RES, V40, P498, DOI 10.1002/(SICI)1097-4636(19980605)40:3<498::AID-JBM21>3.0.CO;2-E
   Iucci G, 2000, SURF INTERFACE ANAL, V30, P40, DOI 10.1002/1096-9918(200008)30:1<40::AID-SIA812>3.0.CO;2-B
   Jablonski A, 2000, POL J CHEM, V74, P1533
   Jeppesen C, 2001, SCIENCE, V293, P465, DOI 10.1126/science.293.5529.465
   JESPERSEN S, 1994, RAPID COMMUN MASS SP, V8, P581, DOI 10.1002/rcm.1290080802
   JESTER JV, 1991, J ELECTRON MICR TECH, V18, P50, DOI 10.1002/jemt.1060180108
   JOANNY JF, 1984, J CHEM PHYS, V81, P552, DOI 10.1063/1.447337
   Johnston EE, 1996, J ELECTRON SPECTROSC, V81, P303, DOI 10.1016/0368-2048(95)02666-5
   Karlsson CAC, 2001, COLLOID SURFACE B, V20, P9, DOI 10.1016/S0927-7765(99)00134-4
   KASEMO B, 1997, SURFACE CHARACTERIZA
   Kingshott P, 2000, J BIOMED MATER RES, V49, P36, DOI 10.1002/(SICI)1097-4636(200001)49:1<36::AID-JBM5>3.0.CO;2-B
   KINGSHOTT P, 1997, POLYM MAT SCI ENG, V76, P81
   Kinumi T, 2000, J MASS SPECTROM, V35, P417, DOI 10.1002/(SICI)1096-9888(200003)35:3<417::AID-JMS952>3.0.CO;2-#
   KLEE D, 2000, ADV POLYM SCI, V149, P1
   LEE EM, 1990, EUROPHYS LETT, V13, P135, DOI 10.1209/0295-5075/13/2/007
   Lee JW, 2001, MACROMOLECULES, V34, P3928, DOI 10.1021/ma0022351
   Lee LT, 1999, J PHYS CHEM B, V103, P7489, DOI 10.1021/jp991032f
   Leonard D, 1999, FRESEN J ANAL CHEM, V365, P3, DOI 10.1007/s002160051437
   Leonard D, 1998, SURF INTERFACE ANAL, V26, P783, DOI 10.1002/(SICI)1096-9918(199810)26:11<783::AID-SIA420>3.0.CO;2-O
   LI D, 1992, J COLLOID INTERF SCI, V148, P190, DOI 10.1016/0021-9797(92)90127-8
   Lin JC, 1999, BIOMATERIALS, V20, P1613, DOI 10.1016/S0142-9612(99)00068-X
   Liu JS, 1999, MACROMOLECULES, V32, P5777, DOI 10.1021/ma9905324
   Lu JR, 1998, J CHEM SOC FARADAY T, V94, P3279, DOI 10.1039/a805731a
   Lu JR, 1999, LANGMUIR, V15, P6975, DOI 10.1021/la990131h
   LU JR, 1995, J PHYS CHEM-US, V99, P8233, DOI 10.1021/j100020a055
   Maierhofer AP, 1999, BIOPHYS J, V76, pA211
   Malmsten M, 1998, J COLLOID INTERF SCI, V202, P507, DOI 10.1006/jcis.1998.5513
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   MATSUNAGA T, 1981, J COLLOID INTERF SCI, V84, P8, DOI 10.1016/0021-9797(81)90253-8
   McLean KM, 2000, COLLOID SURFACE B, V17, P23, DOI 10.1016/S0927-7765(99)00055-7
   MEYER E, 1992, ULTRAMICROSCOPY, V274, P42
   MILLER DR, 1986, J MACROMOL SCI R M C, VC26, P33
   MISSIRLIS Y, 1991, MODERN ASPECTS PROTE
   OLESCHUK RD, 2001, BIOMATERIALS, V21, P1701
   Olivieri MP, 1999, J BIOMED MATER RES, V46, P355, DOI 10.1002/(SICI)1097-4636(19990905)46:3<355::AID-JBM7>3.0.CO;2-O
   Paynter RW, 2000, SURF INTERFACE ANAL, V29, P56, DOI 10.1002/(SICI)1096-9918(200001)29:1<56::AID-SIA693>3.0.CO;2-2
   PENFOLD J, 1991, PHYSICA B, V173, P1, DOI 10.1016/0921-4526(91)90028-D
   PENFOLD J, 1990, J PHYS-CONDENS MAT, V2, P1369, DOI 10.1088/0953-8984/2/6/001
   PerezLuna VH, 1997, J APPL POLYM SCI, V63, P1467, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1467::AID-APP9>3.0.CO;2-K
   Petroll WM, 1996, INT REV EXP PATHOL, V36, P93
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   Poste G, 1972, PROGR SURFACE SCI
   RABE JP, 1988, THIN SOLID FILMS, V159, P359, DOI 10.1016/0040-6090(88)90649-9
   RATNER B D, 1992, Clinical Materials, V11, P25, DOI 10.1016/0267-6605(92)90027-Q
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   RATNER BD, 1995, SURF INTERFACE ANAL, V23, P521, DOI 10.1002/sia.740230712
   RATNER BD, 1993, CLIN MATER, V13, P71, DOI 10.1016/0267-6605(93)90093-M
   RATNER BD, 1986, SPECTROSCOPY BIOMEDI
   REVENKO I, 2000, INT LAB          JUL, P32
   Russell T. P., 1990, Material Science Reports, V5, P171, DOI 10.1016/S0920-2307(05)80002-7
   Sabbatini L, 1996, J ELECTRON SPECTROSC, V81, P285, DOI 10.1016/0368-2048(95)02528-6
   Schneider SW, 1999, P NATL ACAD SCI USA, V96, P12180, DOI 10.1073/pnas.96.21.12180
   SHOTTON DM, 1995, HISTOCHEM CELL BIOL, V104, P97, DOI 10.1007/BF01451571
   SILBERBERG A, 1962, J PHYS CHEM-US, V66, P1884, DOI 10.1021/j100816a024
   SILBERBERG A, 1971, PURE APPL CHEM, V26, P583
   Sodhi RNS, 1996, J ELECTRON SPECTROSC, V81, P269, DOI 10.1016/0368-2048(95)02665-7
   SPENGLER B, 1991, RAPID COMMUN MASS SP, V5, P198, DOI 10.1002/rcm.1290050412
   STJOHN HAW, 1997, POLYM MAT SCI ENG, V76, P83
   STOCKER W, 1993, MACROMOLECULES, V26, P5915, DOI 10.1021/ma00074a013
   Strutwolf J, 2000, J ELECTROANAL CHEM, V483, P163, DOI 10.1016/S0022-0728(00)00027-9
   Su TJ, 1998, LANGMUIR, V14, P438, DOI 10.1021/la970623z
   Tadrous PJ, 2000, J PATHOL, V191, P345, DOI 10.1002/1096-9896(200008)191:4<345::AID-PATH696>3.0.CO;2-R
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   Tengvall P, 2001, COLLOID SURFACE B, V20, P51, DOI 10.1016/S0927-7765(00)00174-0
   TILLMAN N, 1988, J AM CHEM SOC, V110, P6136, DOI 10.1021/ja00226a031
   Ulman A., 1991, INTRO ULTRATHIN ORGA
   Uyama Y, 1998, ADV POLYM SCI, V137, P1
   Vansteenkiste SO, 1998, PROG SURF SCI, V57, P95, DOI 10.1016/S0079-6816(98)00014-8
   Vickerman J. C., 1989, SECONDARY ION MASS S
   VROMAN L, 1964, NBS MISCELLANEOUS PU, V256, P335
   Vroman L, 1969, P S REC DEV ELL
   WASSERMAN SR, 1989, J AM CHEM SOC, V111, P5852, DOI 10.1021/ja00197a054
   Werner C, 1999, INT J ARTIF ORGANS, V22, P160
   WERNER C, 1995, J BIOMAT SCI-POLYM E, V7, P61, DOI 10.1163/156856295X00832
   WEST RH, 1995, J MATER SCI-MATER M, V6, P63, DOI 10.1007/BF00120408
   WHITESIDES GM, 1990, LANGMUIR, V6, P87, DOI 10.1021/la00091a013
   Wold DJ, 2001, J AM CHEM SOC, V123, P5549, DOI 10.1021/ja0101532
   Wong JY, 1997, SCIENCE, V275, P820, DOI 10.1126/science.275.5301.820
   ZHOU XL, 1995, PHYS REP, V257, P223, DOI 10.1016/0370-1573(94)00110-O
NR 133
TC 64
Z9 65
U1 1
U2 49
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 6
BP 593
EP 621
DI 10.1163/156856202320269111
PG 29
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 587NT
UT WOS:000177648500001
PM 12182547
DA 2018-10-19
ER

PT J
AU Poshusta, AK
   Bowman, CN
   Anseth, KS
AF Poshusta, AK
   Bowman, CN
   Anseth, KS
TI Application of a kinetic gelation simulation to the characterization of
   in situ cross-linking biomaterials
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE cross-linking simulation; kinetic gelation model; in situ forming
   polymers
ID FREE-RADICAL POLYMERIZATION; DENTAL COMPOSITES; REACTION BEHAVIOR;
   NETWORK FORMATION; PREDICTIONS; CARTILAGE
AB Multifunctional monomers that are polymerized in situ to form highly cross-linked biomaterials have been an area of recent interest for medical applications. From a biomaterial application standpoint, the relationship between the reaction conditions, polymer structure. and final physical properties is important, particularly for in situ formed materials, as they must have optimum network properties immediately after formation. However, multifunctional monomer reaction mechanisms are complicated by mobility restrictions on the reacting species, cyclization of pendant groups, unequal reactivity of functional groups, and structural heterogeneities. Also. experimental characterization of these complexities is difficult and limited by the insolubility of the resulting cross-linked structure. Thus, in this contribution, a kinetic gelation simulation was used to understand and characterize the evolution of in situ forming, three-dimensional polymer structures. Specifically. the reaction of tetrafunctional monomers (i,e. divinyl monomers) to form high strength networks with degradable cross-links was modeled. This work focuses on using a lattice-based model to characterize network properties important for biomaterial applications and compare them with an experimental system (i.e. cross-linked polvanhydrides) where appropriate. Simulated results for pendant group reactivity. kinetic chain lengths. and radical concentrations (trapped and free) are presented herein.
C1 Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA.
RI Bowman, Christopher/B-1490-2008
OI Bowman, Christopher/0000-0001-8458-7723
FU NIAMS NIH HHS [AR44375]
CR ANSETH KS, 1995, J POLYM SCI POL PHYS, V33, P1769, DOI 10.1002/polb.1995.090331207
   ANSETH KS, 1994, CHEM ENG SCI, V49, P2207, DOI 10.1016/0009-2509(94)E0055-U
   ANSETH KS, 1994, POLYMER, V35, P3243, DOI 10.1016/0032-3861(94)90129-5
   Anseth KS, 1995, ADV POLYM SCI, V122, P177
   Anseth KS, 1996, J DENT RES, V75, P1607, DOI 10.1177/00220345960750081301
   Ashiku SK, 1997, MATER SCI FORUM, V250, P129, DOI 10.4028/www.scientific.net/MSF.250.129
   BANSIL R, 1984, MACROMOLECULES, V17, P998, DOI 10.1021/ma00135a004
   BOWMAN CN, 1992, CHEM ENG SCI, V47, P1411, DOI 10.1016/0009-2509(92)80286-L
   Burkoth AK, 1999, MACROMOLECULES, V32, P1438, DOI 10.1021/ma9814651
   Burkoth AK, 2000, BIOMATERIALS, V21, P2395, DOI 10.1016/S0142-9612(00)00107-1
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Elliott JE, 1999, MACROMOLECULES, V32, P8621, DOI 10.1021/ma990797i
   ENGELBRECHT J, 1989, Patent No. 4872936
   GARRETT RW, 1989, POLYM BULL, V22, P611
   HERRMANN HJ, 1982, PHYS REV LETT, V49, P412, DOI 10.1103/PhysRevLett.49.412
   KINNEY AB, 1994, ACS SYM SER, V273, P2
   KLOOSTERBOER JG, 1988, ADV POLYM SCI, V84, P1
   KUHN KD, 2000, BONE CEMENTS DATE CO, P272
   MANNEVILLE P, 1981, PERCOLATION GELATION, P116
   MIYAZAKI K, 1988, J BIOMED MATER RES, V22, P1011, DOI 10.1002/jbm.820221105
   ODIAN G, 1991, PRINCIPLES POLYM, P768
   Svaldi-Muggli D., 1999, J BIOMED MATER RES, V46, P271
   SVALDIMUGGLI D, 1998, MACROMOLECULES, V31, P4120
   ZHU S, 1990, MACROMOLECULES, V23, P1144, DOI 10.1021/ma00206a037
   Zilling TL, 1999, EUR J SURG, V165, P61, DOI 10.1080/110241599750007522
NR 25
TC 7
Z9 7
U1 0
U2 7
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 7
BP 797
EP 815
DI 10.1163/156856202760197429
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 611KP
UT WOS:000179016500005
PM 12296445
DA 2018-10-19
ER

PT J
AU Yuan, YL
   Al, F
   Zhang, J
   Zang, XB
   Shen, J
   Lin, SC
AF Yuan, YL
   Al, F
   Zhang, J
   Zang, XB
   Shen, J
   Lin, SC
TI Grafting sulfobetaine monomer onto the segmented poly(ether-urethane)
   surface to improve hemocompatibility
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE ozonization; SPEU-g-DNIAPS; platelet adhesion
ID PLATELET-ADHESION; POLYMERIZATION; ACRYLAMIDE
AB Polyurethanes are widely used as blood-contacting biomaterials, due to their good biocompatibility and mechanical properties. Nevertheless, their blood compatibility is still not adequate for more demanding applications. Surface modification is an effective way to improve the hemocompatibility for biomaterials. The purpose of the present study was to synthesize a novel nonthrombogenic biomaterial by modifying the surface of polyurethane. Ozonization was used to introduce active peroxide groups onto the segmented poly (ether-urethane) (SPEU) film surface and graft polymerization of N,N'-dimethyl (methacryloyloxyethyl) ammonium propanesulfonate (DMAPS), a sulfobetaine structure. onto the ozone-activated SPEU surface was conducted. The SPEU-g-PDMAPS film was characterized by ATR-FTIR. XPS, and contact angle measurements. ATR-FTIR and XPS confirmed the graft polymerization, The grafted film possessed a relatively hydrophilic surface. as revealed by contact angle measurement. The blood compatibility of the grafted films was evaluated by a platelet-rich plasma (PRP) adhesion study and scanning electron microscopy, using SPEU film as the reference. No platelet adhesion was observed for the grafted films incubated with PRP at 37degreesC for 60 and 180 min. This new sulfobetaine structure grafted biomaterial might have potential for biomedical applications.
C1 Nanjing Univ, Ctr Res Surface & Interface Chem Engn & Technol, Nanjing 210093, Peoples R China.
RP Shen, J (reprint author), Nanjing Univ, Ctr Res Surface & Interface Chem Engn & Technol, Nanjing 210093, Peoples R China.
CR Andrade J. D., 1987, ASAIO J, V33, P75
   BRASH JL, 1985, MAKROMOL CHEM S, V9, P69
   Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J
   FOUGNOT C, 1984, MACROMOLECULAR BIOMA
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P442, DOI 10.1016/0142-9612(93)90147-T
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   HOESCHELE GK, 1977, ANGEW MAKROMOL CHEM, V58, P299, DOI 10.1002/apmc.1977.050580113
   HORNING EC, 1955, ORGANIC SYNTHESIS CO, V3, P415
   IKADA Y, 1983, POLYM PREPR JPN, V32, P314
   Ishihara K, 1997, TRENDS POLYM SCI, V5, P401
   Kokatnur V. R., 1941, J AM CHEM SOC, V63, P1432
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   Lelah M. D., 1986, POLYURETHANES MED
   LELAH MD, 1985, J COLLOID INTERF SCI, V104, P422, DOI 10.1016/0021-9797(85)90051-7
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   Lin JC, 2000, J BIOMAT SCI-POLYM E, V11, P701, DOI 10.1163/156856200743968
   LIN SC, 1991, J BIOMED MATER RES, V25, P791, DOI 10.1002/jbm.820250608
   Lin SC, 1998, POLYM B, V1, P1
   Nakaya T, 1999, PROG POLYM SCI, V24, P143, DOI 10.1016/S0079-6700(98)00015-X
   NEILL TO, 1972, J POLYM SCI POL CHEM, V10, P569
   NVSTROM M, 1991, J MEMBRANE SCI, V60, P275
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   TANIGUCHI M, 1982, ACS SYM SER, V187, P217
   THOMPSON AR, 1983, MANUAL HEMOSTASIS TH
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   WANG CH, 1997, ACTA POLYM SIN, V1, P114
NR 27
TC 56
Z9 59
U1 3
U2 33
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 10
BP 1081
EP 1092
DI 10.1163/156856202320813800
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 630MV
UT WOS:000180112600002
PM 12484485
DA 2018-10-19
ER

PT J
AU Sen Gupta, A
   Lopina, ST
AF Sen Gupta, A
   Lopina, ST
TI L-Tyrosine-based backbone-modified poly(amino acids)
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE pseudo-peptide; L-tyrosine; cyanogen bromide; polyiminocarbonate;
   triphosgene polycarbonate
ID HYDROLYTIC DEGRADATION; BIOMATERIALS; POLYCARBONATES; POLYMERIZATION
AB Tyrosine-based pseudo-peptide polymers, first introduced in 1987 by Kohn and Langer, have been identified for potential biomaterial applications. These materials combine the desired polypeptide proper-ties of biocompatibility. biodegradability, non-toxicity, and non-immunogenicity with good processing properties including solubility, thermal stability. and moldability which a-rise from alternating non-amide bonds along the polymer backbone. This paper focuses on the analysis of two such polymers based on the natural amino acid L-tyrosine. Starting from L-tyrosine and its deaminated analogue, 3-(4-para-hydroxy)-phenylpropionic acid. a diphenolic structure containing an amide linkage, was synthesized following standard procedures of peptide synthesis. This diphenolic structure was then used as a monomer to synthesize a polyiminocarbonate using a cyanogen bromide-initiated reaction and a polycarbonate using a triphosgene-initiated reaction. The polyiminocarbonate has iminocarbonate linkages and the polycarbonate has carbonate linkages alternating with amide linkages in the respective polymer backbone. Analytical studies were performed regarding the feasibility of the reaction procedures. the physical proper-ties of the polymers. and their degradation processes, to gain insight into the potential biomaterial applications of these polymers. These results independently reaffirm the studies published by Kohn et tit. working on similar polymeric systems.
C1 Univ Akron, Dept Chem Engn, Akron, OH 44325 USA.
   Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
RP Lopina, ST (reprint author), Univ Akron, Dept Chem Engn, Olson,Rm 301K, Akron, OH 44325 USA.
CR BODZANSKY M, 1984, PRACTICE PEPTIDE SYN
   Borda J, 2000, J POLYM SCI POL CHEM, V38, P2925, DOI 10.1002/1099-0518(20000815)38:16<2925::AID-POLA100>3.0.CO;2-E
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.0.CO;2-E
   ECKERT H, 1987, ANGEW CHEM INT EDIT, V26, P894, DOI 10.1002/anie.198708941
   ERTEL SI, 1995, J BIOMED MATER RES, V29, P1337, DOI 10.1002/jbm.820291105
   GELBIN ME, 1992, J AM CHEM SOC, V114, P3962, DOI 10.1021/ja00036a051
   James K, 1996, TRENDS POLYM SCI, V4, P394
   KOHN J, 1986, BIOMATERIALS, V7, P176, DOI 10.1016/0142-9612(86)90098-0
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   KOHN J, 1993, Patent No. 5198507
   KOHN J, 1992, Patent No. 5099060
   KOHN J, 1991, Patent No. 4980449
   KOHN J, 1996, Patent No. 5587507
   Lunt J, 1998, POLYM DEGRAD STABIL, V59, P145, DOI 10.1016/S0141-3910(97)00148-1
   PULAPURA S, 1990, BIOMATERIALS, V11, P666, DOI 10.1016/0142-9612(90)90025-L
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   Tangpasuthadol V, 2000, BIOMATERIALS, V21, P2371, DOI 10.1016/S0142-9612(00)00104-6
   Tangpasuthadol V, 2000, BIOMATERIALS, V21, P2379, DOI 10.1016/S0142-9612(00)00105-8
NR 18
TC 7
Z9 7
U1 1
U2 9
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 10
BP 1093
EP 1104
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 630MV
UT WOS:000180112600003
DA 2018-10-19
ER

PT J
AU Woo, GLY
   Yang, ML
   Yin, HQ
   Jaffer, F
   Mittleman, MW
   Santerre, JP
AF Woo, GLY
   Yang, ML
   Yin, HQ
   Jaffer, F
   Mittleman, MW
   Santerre, JP
TI Biological characterization of a novel biodegradable antimicrobial
   polymer synthesized with fluoroquinolones
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE ciprofloxacin; antimicrobial; polyurethane; biodegradation; enzyme;
   bacteria; cytotoxicity; drug polymer
ID RAPID COLORIMETRIC ASSAY; BACTERIAL-COLONIZATION; CHOLESTEROL ESTERASE;
   DELIVERY SYSTEM; INFECTION; CATHETERS; POLYURETHANE; HYDROLYSIS;
   RELEASE; RESISTANCE
AB Biomaterial-related infections continue to represent a significant challenge to the medical community. Several approaches have been utilized to incorporate antimicrobial agents at the surface of implant devices in attempts to delay or eliminate the formation of biofilms. To date, most of these strategies have focused on drug conjugation or diffusion-limited systems for the delivery of such pharmaceutical agents. More recently, work has been presented on the feasibility of incorporating drugs into the backbone of polymers as a main-chain monomer. When sequenced into the backbone of the polymer with other monomers that are hydrolytically sensitive to enzyme-catalyzed breakdown, it is thought that drugs may be able to be selectively released. Specifically, degradable polyurethanes have been synthesized with fluoroquinolone antibiotics and have shown an ability to kill bacteria when released following degradation of the polymer chains by the macrophage-derived enzyme cholesterol esterase. However, specificity of the cleavage sites in the polymer was difficult to control. Since cholesterol esterase has specificity for hydrophobic moieties, it is desirable to alter the formulation of the polyurethanes to incorporate long hydrophobic monomers immediately adjacent to the ciprofloxacin molecule. Hence, the current study focuses on evaluating the enzyme-catalyzed degradation of a degradable polyurethane synthesized with 1,12 diisocyanatododecane as a substitute for 1,6 diisocyanatohexane, which was used in previous work. Validation of specific ciprofloxacin release and the generation of antimicrobial are shown. A preliminary cell study to assess the cytotoxicity of this biodegradable antibiotic polymer shows that the material has no observable effects on cell proliferation or cell membrane structure. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Toronto, Fac Engn, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
   Univ Toronto, Fac Dent, Dept Biomat, Toronto, ON M5G 1G6, Canada.
   Westaim Corp, Ft Saskatchewan, AB, Canada.
   Altran Corp, Boston, MA USA.
RP Santerre, JP (reprint author), Univ Toronto, Fac Engn, Dept Chem Engn & Appl Chem, 100 Coll St, Toronto, ON, Canada.
CR ACAR JF, 1985, REV INFECT DIS S4, V7, P545
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   ANWAR H, 1989, ANTIMICROB AGENTS CH, V33, P1824, DOI 10.1128/AAC.33.10.1824
   Anwar H, 1990, ANTIMICROB AGENTS CH, V71, P101
   ARIZONO T, 1992, ACTA ORTHOP SCAND, V63, P661
   *ASTM, ASTM PUB E, V442
   Bach A, 1996, J ANTIMICROB CHEMOTH, V37, P315, DOI 10.1093/jac/37.2.315
   BACH A, 1994, J ANTIMICROB CHEMOTH, V33, P969
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   Brockerhoff H., 1974, LIPOLYTIC ENZYMES, P176
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   Ciresi DL, 1996, AM SURGEON, V62, P641
   Costerton J. W., 1985, BACTERIAL ADHESION M, P3
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Dasgupta MK, 1997, PERITON DIALYSIS INT, V17, pS142
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   Erfle DJ, 1997, CARDIOVASC PATHOL, V6, P333, DOI 10.1016/S1054-8807(97)00031-8
   ERLANSON CH, 1970, SCAND J GASTROENTERO, V5, P333
   Gold HS, 1996, NEW ENGL J MED, V335, P1445, DOI 10.1056/NEJM199611073351907
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   Hasaniya NWMA, 1996, CHEST, V109, P1030, DOI 10.1378/chest.109.4.1030
   HSIEH DST, 1981, P NATL ACAD SCI-BIOL, V78, P1863, DOI 10.1073/pnas.78.3.1863
   Isaacson D. M., 1986, MANUAL IND MICROBIOL, P410
   JANSEN B, 1990, CLIN IMPLANT MAT ADV, V9, P117
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   LABOW RS, 1983, BIOCHIM BIOPHYS ACTA, V749, P32, DOI 10.1016/0167-4838(83)90147-4
   LABOW RS, 1995, BIOMATERIALS, V16, P51, DOI 10.1016/0142-9612(95)91096-H
   LY Y, 1993, J MEMBRANE SCI, V77, P99, DOI 10.1016/0376-7388(93)85238-R
   LYNN KR, 1982, BIOORG CHEM, V11, P19, DOI 10.1016/0045-2068(82)90044-X
   MITTELMAN MW, 1997, MOL ECOLOGICAL DIVER, P89
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   *NCCLS, 1990, M7A2 NCCLS, V10
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   ROSKOS KV, 1993, CLIN MATER, V13, P109, DOI 10.1016/0267-6605(93)90097-Q
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SHERERTZ RJ, 1989, ANTIMICROB AGENTS CH, V33, P1174, DOI 10.1128/AAC.33.8.1174
   SUTTON LD, 1986, BIOCHEM BIOPH RES CO, V134, P386, DOI 10.1016/0006-291X(86)90575-9
   SUTTON LD, 1990, BIOCHIM BIOPHYS ACTA, V1041, P79, DOI 10.1016/0167-4838(90)90125-Y
   Suzuki Y, 1998, J BIOMED MATER RES, V42, P112, DOI 10.1002/(SICI)1097-4636(199810)42:1<112::AID-JBM14>3.0.CO;2-N
   TROOSKIN SZ, 1985, SURGERY, V97, P547
   Wang GB, 1997, J CHROMATOGR B, V698, P69, DOI 10.1016/S0378-4347(97)00282-X
   Woo GLY, 2000, BIOMATERIALS, V21, P1235, DOI 10.1016/S0142-9612(00)00003-X
   ZAHALKA HA, 1987, BIOCHIM BIOPHYS ACTA, V921, P481, DOI 10.1016/0005-2760(87)90075-0
NR 45
TC 55
Z9 61
U1 1
U2 23
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 2002
VL 59
IS 1
BP 35
EP 45
DI 10.1002/jbm.1214
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 493DP
UT WOS:000172207000005
PM 11745535
DA 2018-10-19
ER

PT J
AU Basoli, A
   Bordi, F
   Cametti, C
   Gili, T
AF Basoli, A
   Bordi, F
   Cametti, C
   Gili, T
TI Structural alteration of erythrocyte cell membrane in presence of
   artificial prostheses: a radiowave dielectric spectroscopy study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE cardiovascular biomaterials; erythrocyte membrane; electrical impedance;
   erythrocyte surface charge
ID ELECTRICAL-PROPERTIES; ADHESION; BLOOD; SUSPENSIONS
AB The exposure of a biomaterial to blood gives rise to complex reactions playing an important role in many biological phenomena, such as the problem of biocompatibility and the mechanism of cardiovascular and thromboembolic diseases. In the present work, we use a frequency-domain dielectric spectroscopy approach to evaluate possible changes in the passive electrical parameters of the erythrocyte membrane, i.e., the membrane conductivity sigma (s) and the membrane permittivity epsilon (s), after the insertion of a prosthesis (mean implantation time 8 days) in the circulatory system of patients treated for aortic aneurysm and the consequent interactions of erythrocyte cells with the biomaterial surface. We observe an increase of both the membrane conductivity and membrane permittivity, indicating changes at molecular level in the structural organization of the membrane. These membrane alterations can be viewed as precursory events for the initiation of the complex sequence of enzymatic reactions that take place on the material surface. Our results, although preliminary imply that a direct interaction between erythrocyte cell membrane and vascular prostheses may occur, causing a marked alteration in the electrical properties of the cell membrane. These findings might have relevant clinical implications and might offer possibilities to predict biocompatibility of biomaterials and give some further suggestions to resolve the problem of biomaterial-associated thrombogenicity. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy.
   Univ Roma La Sapienza, Clin Chirurg 2, I-00185 Rome, Italy.
   Ist Nazl Fis Mat, Unita Roma, Rome, Italy.
RP Cametti, C (reprint author), Univ Roma La Sapienza, Dipartimento Fis, Piazzale A Morro 2, I-00185 Rome, Italy.
RI Bordi, Federico/H-1862-2011
OI Bordi, Federico/0000-0001-6373-5176; Gili, Tommaso/0000-0001-9154-1758;
   Cametti, Cesare/0000-0003-2077-3660
CR ASAMI K, 1989, BIOCHIM BIOPHYS ACTA, V1010, P49, DOI 10.1016/0167-4889(89)90183-3
   ASAMI K, 1980, JPN J APPL PHYS, V19, P359, DOI 10.1143/JJAP.19.359
   Asami K, 1995, BBA-GEN SUBJECTS, V1245, P317, DOI 10.1016/0304-4165(95)00116-6
   ASAMI K, 1980, BIOPHYS J, V31, P215, DOI 10.1016/S0006-3495(80)85052-1
   BALLARIO C, 1984, Z NATURFORSCH C, V39, P1163
   BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6
   BONGRAND P, 1988, PHYSICAL BASIS CELL
   Bordi F, 1996, BIOPOLYMERS, V40, P485, DOI 10.1002/(SICI)1097-0282(1996)40:5<485::AID-BIP6>3.0.CO;2-S
   Bordi F, 1997, EUR BIOPHYS J BIOPHY, V26, P215, DOI 10.1007/s002490050074
   CORRY WD, 1981, J BIOCHEM BIOPH METH, V4, P29, DOI 10.1016/0165-022X(81)90003-8
   DIOCIAIUTI M, 1991, BIOELECTROCH BIOENER, V26, P177, DOI 10.1016/0302-4598(91)80022-U
   EYLAR EH, 1962, J BIOL CHEM, V237, P1992
   Godin C, 1997, EUR BIOPHYS J BIOPHY, V26, P175, DOI 10.1007/s002490050069
   GODIN C, 1996, EUR BIOPHYS J, V25, P35
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   HANAI T, 1960, KOLLOID Z, V171, P23, DOI DOI 10.1007/BF01520320
   HASTED JB, 1973, AQUEOUS DIELECTRICS
   Havriliak S.J, 1997, DIELECTRIC MECH RELA
   HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O
   Karlsson C, 2000, COLLOID SURFACE B, V17, P95, DOI 10.1016/S0927-7765(99)00018-1
   LOOYENGA H, 1965, PHYSICA, V31, P401, DOI 10.1016/0031-8914(65)90045-5
   Santini MT, 1997, J BIOMED MATER RES, V35, P165
   SEAMAN GVF, 1963, ARCH BIOCHEM BIOPHYS, V100, P463
   SINGER JS, 1976, SURFACE MEMBRANE REC, P1
   STORYGIN A, 1971, IEEE T MICR THEORY T, V19, P733
   Stratton J. A., 1941, ELECTROMAGNETIC THEO
   Swartbol P, 1996, J BIOMED MATER RES, V32, P669, DOI 10.1002/(SICI)1097-4636(199612)32:4<669::AID-JBM21>3.0.CO;2-7
   Takashima S., 1989, ELECT PROPERTIES BIO
NR 28
TC 5
Z9 12
U1 2
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 2002
VL 59
IS 1
BP 100
EP 109
DI 10.1002/jbm.1221
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 493DP
UT WOS:000172207000012
PM 11745542
DA 2018-10-19
ER

PT J
AU Musgrave, DS
   Pruchnic, R
   Bosch, P
   Ziran, BH
   Whalen, J
   Huard, J
AF Musgrave, DS
   Pruchnic, R
   Bosch, P
   Ziran, BH
   Whalen, J
   Huard, J
TI Human skeletal muscle cells in ex vivo gene therapy to deliver bone
   morphogenetic protein-2
SO JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
LA English
DT Article
ID RAT ECTOPIC MODEL; BIOMATERIAL CARRIERS; DIFFERENTIATION;
   PHARMACOKINETICS; IMPLANTATION; LINEAGE; REPAIR
AB We have examined whether primary human muscle-derived cells can he used in ex vivo gene therapy to deliver BMP-2 and to produce bone in vivo. Two in vitro experiments and one in vivo experiment were used to determine the osteocompetence and BMP-2 secretion capacity of cells isolated from human skeletal muscle.
   We isolated five different populations of primary muscle cells from human skeletal muscle in three patients. In the first in vitro experiment, production of alkaline phosphatase by the cells in response to stimulation by rhBMP-2 was measured and used as an indicator of cellular osteocompetence. In the second, secretion of BMP-2 was measured after the cell populations had been transduced by an adenovirus encoding for BMP-2. In the in vivo experiment, the cells were cotransduced with a retrovirus encoding for a nuclear, localised beta-galactosidase gene and an adenovirus encoding for BMP-2. The cotransduced cells,were then injected into the hind limbs of severe combined immune-deficient (SCID) mice and analysed radiographically and histologically. The nuclear localised beta-galactosidase gene allowed identification of the injected cells in histological specimens. In the first in vitro experiment, the five different cell populations all responded to in vitro stimulation of rhBMP-2 by producing higher levels of alkaline phosphatase when compared with non-stimulated cells. In the second, the five different cell populations were all successfully transduced by an adenovirus to express and secrete BMP-2. The cells secreted between 444 and 2551 ng of BMP-2 over three days. In the in vivo experiment, injection of the transduced cells into the hind-limb musculature of SCID mice resulted in the formation of ectopic bone at 1, 2, 3 and 4 weeks after injection. Retroviral labelling of the cell nuclei showed labelled human muscle-derived cells occupying locations of osteoblasts in the ectopic bone, further supporting their osteocompetence.
   Cells from human skeletal muscle, because of their availability to orthopaedic surgeons, their osteocompetence, and their ability to express BMP-2 after genetic engineering, are an attractive cell population for use in BMP-2 gene therapy approaches.
C1 Univ Pittsburgh, Pittsburgh, PA 15260 USA.
RP Huard, J (reprint author), Childrens Hosp Pittsburgh, Dept Orthopaed Surg, 4151 Rangos Res Ctr,3705 5th Ave, Pittsburgh, PA 15213 USA.
FU NIAMS NIH HHS [1P60 AR44811-01]; NIDCR NIH HHS [IR01 DE13420-01A2]
CR Alden TD, 1999, J NEUROSURG, V90, P109, DOI 10.3171/spi.1999.90.1.0109
   Bosch P, 2000, CELL TRANSPLANT, V9, P463, DOI 10.1177/096368970000900403
   Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Hardy S, 1997, J VIROL, V71, P1842
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Kawasaki K, 1998, BONE, V23, P223, DOI 10.1016/S8756-3282(98)00105-7
   Khouri RK, 1996, PLAST RECONSTR SURG, V98, P103, DOI 10.1097/00006534-199607000-00017
   Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085
   Lieberman JR, 1998, J ORTHOP RES, V16, P330, DOI 10.1002/jor.1100160309
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Lou JR, 1999, J ORTHOPAED RES, V17, P43, DOI 10.1002/jor.1100170108
   Mason JM, 1998, GENE THER, V5, P1098, DOI 10.1038/sj.gt.3300703
   Musgrave DS, 1999, BONE, V24, P541, DOI 10.1016/S8756-3282(99)00086-1
   Musgrave DS, 2000, CLIN ORTHOP RELAT R, P290
   Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1969, CLIN ORTHOP RELAT R, P194
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
NR 25
TC 75
Z9 92
U1 0
U2 0
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 0301-620X
J9 J BONE JOINT SURG BR
JI J. Bone Joint Surg.-Br. Vol.
PY 2002
VL 84B
BP 120
EP 127
DI 10.1302/0301-620X.84B1.11708
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 520YN
UT WOS:000173811500027
PM 11837817
OA Bronze
DA 2018-10-19
ER

PT J
AU Trombelli, L
   Heitz-Mayfield, LJA
   Needleman, I
   Moles, D
   Scabbia, A
AF Trombelli, L
   Heitz-Mayfield, LJA
   Needleman, I
   Moles, D
   Scabbia, A
TI A systematic review of graft materials and biological agents for
   periodontal intraosseous defects
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article; Proceedings Paper
CT 4th European Workshop on Periodontology
CY FEB 02-06, 2002
CL ITTINGEN, SWITZERLAND
DE periodontal diseases/therapy; periodontal regeneration; intrabony
   defects; grafts/bone substitutes; systematic review; meta-analysis
ID GUIDED TISSUE REGENERATION; MATRIX DERIVATIVE EMDOGAIN(R); CANCELLOUS
   BONE ALLOGRAFT; OPEN FLAP DEBRIDEMENT; OSSEOUS DEFECTS; INTRABONY
   DEFECTS; CLINICAL-EVALUATION; ALLOPLASTIC IMPLANT; HYDROXYLAPATITE
   IMPLANT; HISTOLOGIC EVALUATION
AB Objectives: To determine the adjunctive effect of grafting biomaterials/biological agents with open flap debridement (OFD) in the treatment of deep intraosseous defects.
   Background: No systematic review of treatment outcomes in patients who received graft biomaterials or biological agents have been published.
   Methods: A rigorous systematic review of randomized controlled trials of at least 6-month duration was conducted comparing grafting biomaterials/biological agents (alone or in combination) + OFD (test group) to OFD alone or in combination with a placebo (control group).
   Results: The difference in CAL change between test and control groups varied from -1.45 mm to 1.40 mm with respect to different biomaterials/biological agents. Meta-analysis showed that CAL change significantly improved after treatment for coralline calcium carbonate (weighted mean difference 0.90 mm; 95% CI: 0.53-1.27), bioactive glass (weighted mean difference 1.04 mm; 95% CI: 0.31-1.76), hydroxyapatite (weighted mean difference 1.40 mm, 95% Cl 0.64-2.16), and enamel matrix proteins (weighted mean difference 1.33 mm, 95% CI 0.78-1.88). However, heterogeneity in results between studies was highly statistically significant for most of biomaterials/biologicals and could not be fully explained.
   Conclusions: Overall, the use of specific biomaterials/biologicals was more effective than OFD in improving attachment levels in intraosseous defects. Difference in CAL gain varied greatly with respect to different biomaterial/biological agent. Due to a significant heterogeneity in results between studies in most treatment groups, general conclusions about the expected clinical benefit of graft biomaterials/biologicals need to be interpreted with caution. Further research should focus on understanding this variability.
C1 Univ Ferrara, Res Ctr Study Periodontal Dis, I-44100 Ferrara, Italy.
   Univ Bern, Dept Periodontol & Fixed Prosthodont, CH-3012 Bern, Switzerland.
   UCL, Eastman Dent Inst, Dept Periodontol, London WC1E 6BT, England.
   UCL, Eastman Dent Inst, Dept Oral Pathol, London WC1E 6BT, England.
RP Trombelli, L (reprint author), Univ Ferrara, Res Ctr Study Periodontal Dis, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM l.trombelli@unife.it
RI Trombelli, Leonardo/I-4671-2015
OI Trombelli, Leonardo/0000-0002-1147-2199; Moles,
   David/0000-0001-9797-6226
CR ALTIERE ET, 1979, J PERIODONTOL, V50, P510, DOI 10.1902/jop.1979.50.10.510
   BLUMENTHAL N, 1990, J PERIODONTOL, V61, P319, DOI 10.1902/jop.1990.61.6.319
   BORGHETTI A, 1993, J PERIODONTOL, V64, P128, DOI 10.1902/jop.1993.64.2.128
   BOWERS GM, 1989, J PERIODONTOL, V60, P675, DOI 10.1902/jop.1989.60.12.675
   Brown GD, 1998, J PERIODONTOL, V69, P146, DOI 10.1902/jop.1998.69.2.146
   CARRARO J J, 1976, Journal of Clinical Periodontology, V3, P104, DOI 10.1111/j.1600-051X.1976.tb01856.x
   DRAGOO MR, 1973, J PERIODONTOL, V44, P599, DOI 10.1902/jop.1973.44.10.599
   ELLEGAARD B, 1971, J PERIODONTOL, V42, P648, DOI 10.1902/jop.1971.42.10.648
   Flemmig TF, 1998, J PERIODONTOL, V69, P47, DOI 10.1902/jop.1998.69.1.47
   FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q
   Froum SJ, 2001, J PERIODONTOL, V72, P25, DOI 10.1902/jop.2001.72.1.25
   FROUM SJ, 1976, J PERIODONTOL, V47, P287, DOI 10.1902/jop.1976.47.5.287
   Froum SJ, 1998, J PERIODONTOL, V69, P698, DOI 10.1902/jop.1998.69.6.698
   GALGUT P N, 1990, Journal of Oral Implantology, V16, P173
   GALGUT PN, 1991, J PERIODONTOL, V62, P44, DOI 10.1902/jop.1991.62.1.44
   GALGUT PN, 1992, J CLIN PERIODONTOL, V19, P570, DOI 10.1111/j.1600-051X.1992.tb00685.x
   Garrett S, 1996, Ann Periodontol, V1, P621, DOI 10.1902/annals.1996.1.1.621
   Hancock EB, 1989, P WORLD WORKSH CLIN, pVI1
   Heijl L, 1997, J CLIN PERIODONTOL, V24, P705, DOI 10.1111/j.1600-051X.1997.tb00253.x
   Hiatt W H, 1986, Int J Periodontics Restorative Dent, V6, P8
   HIATT WH, 1973, J PERIODONTOL, V44, P194, DOI 10.1902/jop.1973.44.4.194
   Howell TH, 1997, J PERIODONTOL, V68, P1186, DOI 10.1902/jop.1997.68.12.1186
   KENNEY EB, 1985, J PERIODONTOL, V56, P82, DOI 10.1902/jop.1985.56.2.82
   Kilic AR, 1997, J CLIN PERIODONTOL, V24, P372, DOI 10.1111/j.1600-051X.1997.tb00200.x
   Kim CK, 1996, J PERIODONTOL, V67, P1301, DOI 10.1902/jop.1996.67.12.1301
   Kornman KS, 2000, PERIODONTOL 2000, V22, P22, DOI 10.1034/j.1600-0757.2000.2220103.x
   KREJCI CB, 1987, J PERIODONTOL, V58, P521, DOI 10.1902/jop.1987.58.8.521
   Levin M P, 1974, J Clin Periodontol, V1, P197
   LEVIN MP, 1974, ORAL SURG ORAL MED O, V38, P344, DOI 10.1016/0030-4220(74)90359-4
   Louise F, 1987, J Parodontol, V6, P203
   MABRY TW, 1985, J PERIODONTOL, V56, P74, DOI 10.1902/jop.1985.56.2.74
   Masters LB, 1996, J PERIODONTOL, V67, P770, DOI 10.1902/jop.1996.67.8.770
   MEADOWS CL, 1993, J PERIODONTOL, V64, P103, DOI 10.1902/jop.1993.64.2.103
   MEFFERT RM, 1985, J PERIODONTOL, V56, P63, DOI 10.1902/jop.1985.56.2.63
   MELLONIG JT, 1984, INT J PERIODONT REST, V4, P41
   Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X
   MORA F, 1995, J CLIN PERIODONTOL, V22, P877, DOI 10.1111/j.1600-051X.1995.tb01787.x
   MOVIN S, 1982, J CLIN PERIODONTOL, V9, P141, DOI 10.1111/j.1600-051X.1982.tb01230.x
   NEEDLEMAN IG, 2001, COCHRANE LIB
   NERY EB, 1990, J PERIODONTOL, V61, P737, DOI 10.1902/jop.1990.61.12.737
   Okuda K, 2000, J PERIODONTOL, V71, P1821, DOI 10.1902/jop.2000.71.12.1821
   Ong MMA, 1998, J PERIODONTOL, V69, P1346, DOI 10.1902/jop.1998.69.12.1346
   PAPAPANOU PN, 1991, J CLIN PERIODONTOL, V18, P317, DOI 10.1111/j.1600-051X.1991.tb00435.x
   Park JS, 2001, J PERIODONTOL, V72, P730, DOI 10.1902/jop.2001.72.6.730
   PEARSON GE, 1981, J PERIODONTOL, V52, P55, DOI 10.1902/jop.1981.52.2.55
   Pontoriero R, 1999, J CLIN PERIODONTOL, V26, P833
   RABALAIS ML, 1981, J PERIODONTOL, V52, P680, DOI 10.1902/jop.1981.52.11.680
   Rosen PS, 2000, PERIODONTOL 2000, V22, P88, DOI 10.1034/j.1600-0757.2000.2220107.x
   SCHALLHORN RG, 1972, J PERIODONTOL, V43, P67, DOI 10.1902/jop.1972.43.2.67
   SCHALLHORN RG, 1980, INT DENT J, V30, P101
   SCHRAD SC, 1986, J PERIODONTOL, V57, P205, DOI 10.1902/jop.1986.57.4.205
   Schulz A, 2000, Clin Oral Investig, V4, P98, DOI 10.1007/s007840050123
   SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408
   SHAFFER CD, 1971, J PERIODONTOL, V42, P685, DOI 10.1902/jop.1971.42.11.685
   SHAHMIRI S, 1992, INT J PERIODONT REST, V12, P295
   Silvestri M, 2000, J CLIN PERIODONTOL, V27, P603, DOI 10.1034/j.1600-051x.2000.027008603.x
   STAHL SS, 1983, J PERIODONTOL, V54, P325, DOI 10.1902/jop.1983.54.6.325
   Tonetti MS, 2002, J CLIN PERIODONTOL, V29, P317, DOI 10.1034/j.1600-051X.2002.290407.x
   TROMBELLI L, 2002, IN PRESS J CLIN PERI
   YUKNA RA, 1994, J PERIODONTOL, V65, P177, DOI 10.1902/jop.1994.65.2.177
   Yukna RA, 1998, J PERIODONTOL, V69, P655, DOI 10.1902/jop.1998.69.6.655
   Yukna RA, 2000, J PERIODONTOL, V71, P752, DOI 10.1902/jop.2000.71.5.752
   YUKNA RA, 1989, J CLIN PERIODONTOL, V16, P398, DOI 10.1111/j.1600-051X.1989.tb01667.x
   YUKNA RA, 1985, J PERIODONTOL, V56, P540, DOI 10.1902/jop.1985.56.9.540
   YUKNA RA, 1984, J PERIODONTOL, V55, P633, DOI 10.1902/jop.1984.55.11.633
   YUKNA RA, 1989, J PERIODONTOL, V60, P544, DOI 10.1902/jop.1989.60.10.544
   YUKNA RA, 1990, J PERIODONTOL, V61, P633, DOI 10.1902/jop.1990.61.10.633
   YUKNA RA, 1986, INT J PERIODONT REST, V6, P35
   Zamet JS, 1997, J CLIN PERIODONTOL, V24, P410, DOI 10.1111/j.1600-051X.1997.tb00205.x
   Zetterstrom O, 1997, J CLIN PERIODONTOL, V24, P697, DOI 10.1111/j.1600-051X.1997.tb00252.x
NR 70
TC 137
Z9 139
U1 1
U2 15
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PY 2002
VL 29
SU 3
BP 117
EP 135
DI 10.1034/j.1600-051X.29.s3.7.x
PG 19
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 662UU
UT WOS:000181967900013
PM 12787213
DA 2018-10-19
ER

PT J
AU Sabino, MA
   Feijoo, JL
   Nunez, O
   Ajami, D
AF Sabino, MA
   Feijoo, JL
   Nunez, O
   Ajami, D
TI Interaction of fibroblast with poly(p-dioxanone) and its degradation
   products
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID IN-VITRO; POLYMERS; ADHESION
AB In vitro techniques were used to evaluate the interactions between Fibroblastic cells and Poly(p-Dioxanone) PPDX and compared its performance with that of other polymeric substrates. In vitro biocompatibility was assessed by studying cell adhesion and cell growth of cells on the polymer films themselves as well as in media enriched with the degradation products of PPDX and Poly(glycolic)/Poly(L-lactide 90:10 copolymer (PGLA-910). Our results show that althought all polymers tested were suitable for initial attachment, PPDX proved to be the most favorable surface for cell growth; as cell density after 48 h of culture was similar to that obtained on tissue culture Polystyrene TCPS (control). No signs of cell damage were detected using scanning electron microscopy (SEM) where after 48 h. of cell seeding on PPDX, fibroblast exhibited a confluent cell multilayer similar to TCPS. In addition, the products of the hydrolytic degradation of PPDX had no citotoxic effect on the adherence and proliferation of fibroblastic cell on TCPS. The hydrolytic degradation starts in the amorphous regions, as the tie-chain segments in these regions degrade into fragments causing the pH decrease in buffer solution and weight loss of degradable polymers. The in vitro evaluation suggests that PPDX may be candidate biomaterial for the construction a cell-polymer matrix. (C) 2002 Kluwer Academic Publishers.
C1 Univ Simon Bolivar, Dept Biol Celular, Caracas 1080A, Venezuela.
   Univ Simon Bolivar, Dept Proc & Sistemas, Caracas 1080A, Venezuela.
   Univ Simon Bolivar, Dept Ciencias Mat, Grp Polimeros USB, Caracas 1080A, Venezuela.
RP Ajami, D (reprint author), Univ Simon Bolivar, Dept Biol Celular, Apartado 89000, Caracas 1080A, Venezuela.
RI Ajami, Dariush/A-1312-2014
CR ATTAWIA MA, 1995, J BIOMED MATER RES, V29, P1233, DOI 10.1002/jbm.820291010
   Behravesh E, 1999, CLIN ORTHOP RELAT R, pS118
   Burmeister JS, 1999, J BIOMED MATER RES, V47, P577, DOI 10.1002/(SICI)1097-4636(19991215)47:4<577::AID-JBM15>3.0.CO;2-S
   Elvira C, 1999, REV PLAST MOD, V77, P49
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   HORBETT TA, 1999, J BIOMAT SCI-POLYM E, V10, P2
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   KARLSSON S, 1995, J MACROMOL SCI PURE, VA32, P599, DOI 10.1080/10601329508010273
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   MACFARLAND CD, 1999, J BIOMED MATER RES, V44, P1
   Minuth WW, 1998, CELL TISSUE RES, V291, P1
   MORRISON C, 1995, BIOMATERIALS, V16, P987, DOI 10.1016/0142-9612(95)94906-2
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Saad B, 1997, J BIOMED MATER RES, V36, P65, DOI 10.1002/(SICI)1097-4636(199707)36:1<65::AID-JBM8>3.3.CO;2-#
   SABINO MA, IN PRESS POLYM DEG S
   Sung HW, 1996, J BIOMED MATER RES, V31, P511, DOI 10.1002/(SICI)1097-4636(199608)31:4<511::AID-JBM11>3.0.CO;2-J
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   TORMALA P, 1991, J BIOMED MATER RES, V21, P1
   VERT M, 1992, BIOMATERIALS HARD TI, P223
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
NR 22
TC 13
Z9 14
U1 0
U2 12
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD JAN
PY 2002
VL 37
IS 1
BP 35
EP 40
DI 10.1023/A:1013129421038
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 500XT
UT WOS:000172654500003
DA 2018-10-19
ER

PT J
AU Zhao, XB
   Fraser, JE
   Alexander, C
   Lockett, C
   White, BJ
AF Zhao, XB
   Fraser, JE
   Alexander, C
   Lockett, C
   White, BJ
TI Synthesis and characterization of a novel double crosslinked hyaluronan
   hydrogel
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CROSS-LINKING; ACID; DERIVATIVES
AB Hyaluronan has great potential in medicine as a biomaterial. However, in its native form, hyaluronan is rapidly metabolized in vivo by free radicals and enzymes such as hyaluronidase, and it is highly soluble. Various methods have been adopted therefore, to modify the physicochemical properties of hyaluronan, while maintaining biocompatibility, and thereby widen its spectrum of therapeutic applications.
   Hyaluronan has four reactive groups (acetamido, carboxyl, hydroxyl and the reducing end) available for crosslinking to itself or other polymers. Using a variety of crosslinking agents, researchers have developed a host of crosslinked hyaluronan derivatives with an increased in vivo residence time. This chemical modification has enabled the production of gels and films, which can be used in applications such as the prevention of post-surgical adhesions, wound healing and dermal augmentation.
   We have found that if hyaluronan is crosslinked to itself, or to other polymers (either synthetic or biopolymer), in two stages, then a high degree of crosslinking is achieved, conferring improved biostability. In each of the two stages, the same crosslinking agent is used, but different functional groups are bound by altering the reaction conditions. The novel process can be tailored to yield water insoluble gels and films with a broad range of physical and chemical characteristics, and greater resistance to degradation by hyaluronidase and free radicals. These derivatives are currently undergoing biocompatibility testing, and should ultimately lead to a series of innovative second-generation medical products. (C) 2002 Kluwer Academic Publishers.
C1 Vitrolife UK Ltd, Edinburgh EH14 4AP, Midlothian, Scotland.
RP Zhao, XB (reprint author), Vitrolife UK Ltd, Heriot Watt Res Pk, Edinburgh EH14 4AP, Midlothian, Scotland.
CR Balazs E A, 1986, US patent, Patent No. [4582865, 4,582,865]
   Bell E, 1995, Tissue Eng, V1, P163, DOI 10.1089/ten.1995.1.163
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   De Belder A. N., 1989, U.S. patent, Patent No. [4886787, 4,886,787]
   Dickerson K.T., 1997, US Patent, Patent No. [5,677,276, 5677276]
   DURANTI F, 1998, DERMATOL SURG, V24, P1314
   JOHNS DB, 1997, FERTIL STERIL, V68, P137
   LAURENT TC, 1964, ACTA CHEM SCAND, V18, P274, DOI 10.3891/acta.chem.scand.18-0274
   LONGAKER M T, 1991, Clinical Materials, V8, P223, DOI 10.1016/0267-6605(91)90035-E
   Meyer K, 1934, J BIOL CHEM, V107, P629
   RASTRELLI A, 1990, CLIN IMPLANT MAT, V9, P199
   RHEE W, 1996, Patent No. 5510121
   Tomihata K, 1997, BIOMATERIALS, V18, P189, DOI 10.1016/S0142-9612(96)00116-0
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Tomihata K, 1997, J POLYM SCI POL CHEM, V35, P3553, DOI 10.1002/(SICI)1099-0518(19971130)35:16<3553::AID-POLA22>3.0.CO;2-D
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   YUI N, 1992, J CONTROL RELEASE, V22, P105
   ZHAO X, 2000, Patent No. 0046253
   ZHAO X, 2000, Patent No. 0046254
NR 21
TC 35
Z9 35
U1 4
U2 21
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2002
VL 13
IS 1
BP 11
EP 16
DI 10.1023/A:1013618115163
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 509JH
UT WOS:000173144300004
PM 15348198
DA 2018-10-19
ER

PT J
AU Giannoulis, CS
   Desai, TA
AF Giannoulis, CS
   Desai, TA
TI Characterization of proteins and fibroblasts on thin inorganic films
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SILICON SURFACES; ELLIPSOMETRY; CELLS
AB The ability of biomaterial surfaces to regulate cell behavior requires control over surface chemistry and material microstructure. One of the goals in the development of silicon-based biomedical devices such as biosensors or drug delivery systems is improved biocompatibility which may be achieved through the deposition or adsorption of thin films. In this study, films of single crystal silicon, stoichiometric and low stress silicon nitride, doped and undoped polysilicon, as well as Arg-Gly-Asp (RGD) peptide adsorbed surfaces characterized in terms of protein adsorption or cellular adhesion for a period of four days. Protein adsorption studies using fibrinogen and albumin, two proteins implicated in cellular adhesion and surface activity, reveal that low stress silicon nitride surfaces have a 223%+/-2.50% greater protein adsorption compared to undoped polysilicon surfaces, followed by silicon nitride, unmodified silicon, and doped polysilicon surfaces, respectively. The thickness of the adsorbed albumin and fibrinogen layer on various thin films was measured by ellipsometry and compared to contact angle measurements. The greatest cellular adhesion was observed on undoped polysilicon, followed by unmodified (control) silicon, low stress silicon nitride, silicon nitride, and doped polysilicon surfaces. Cellular binding supports the differential protein adsorption found on modified and unmodified silicon surfaces. Understanding the biological response to thin films will allow us to design more appropriate interfaces for implantable diagnostic and therapeutic silicon-based microdevices. (C) 2002 Kluwer Academic Publishers.
C1 Univ Illinois, Dept Bioengn MC 063, Chicago, IL 60607 USA.
RP Desai, TA (reprint author), Univ Illinois, Dept Bioengn MC 063, 851 S Morgan St, Chicago, IL 60607 USA.
CR ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   HANSFORD DJ, 1999, THESIS U CALIFORNIA
   Henry S, 1999, J PHARM SCI, V88, P948
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   JAEGER RC, 1998, INTRO MICROELECTRONI, V5
   MALMSTEN M, 1995, PROTEINS INTERFACES, V2, P228
   MANDENIUS CF, 1984, ANAL BIOCHEM, V137, P106, DOI 10.1016/0003-2697(84)90354-3
   MARGEL S, 1993, J BIOMED MATER RES, V27, P1463, DOI 10.1002/jbm.820271202
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Ratner B. D., 1997, SURFACE MODIFICATION
   STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766
   TUNER JN, 1999, EXP NEUROL, V156, P33
   Ulman A., 1991, INTRO ULTRATHIN ORGA
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 19
TC 16
Z9 16
U1 0
U2 1
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2002
VL 13
IS 1
BP 75
EP 80
DI 10.1023/A:1013646805593
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 509JH
UT WOS:000173144300015
PM 15348209
DA 2018-10-19
ER

PT J
AU White, JF
   Werkmeister, JA
   Darby, IA
   Bisucci, T
   Birk, DE
   Ramshaw, JAM
AF White, JF
   Werkmeister, JA
   Darby, IA
   Bisucci, T
   Birk, DE
   Ramshaw, JAM
TI Collagen fibril formation in a wound healing model
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article; Proceedings Paper
CT Workshop on Coiled-Coils, Collagen, and Co-Proteins
CY SEP 16-21, 2001
CL ALPBACH, AUSTRIA
DE collagen; fibril formation; gentamicin; heterotypic fibrils; histology;
   in situ hybridization; immunoelectron microscopy; immunofluorescence;
   wound healing
ID FIBRILLOGENESIS IN-SITU; EXTRACELLULAR COMPARTMENTS; III COLLAGEN;
   POINTED TIPS; TENDON; SEGMENTS; MATRIX; GROWTH; MORPHOGENESIS; LIGAMENT
AB Control of tissue composition and organization will be a key feature in the development of successful products through tissue engineering. However, the mechanism of collagen fibril formation, growth, and organization is not yet fully understood. In this study we have examined collagen fibril formation in a wound healing model in which the newly formed fibrils were kept distinct from preexisting tissue through use of a porous tubular biomaterial implant. Samples were examined after 4, 6, 14, and 28 days by light microscopy, in situ hybridization, and immunofluorescence microscopy. These showed a normal wound healing response, with significant collagen formation at 14 and 28 days. Individual collagen fibrils were isolated from these samples by gentle extraction in a gentamicin-containing buffer which allowed extraction of a large proportion of intact fibrils. Examination by transmission electron microscopy showed that similar to80% of the intact fibrils showed a single polarity reversal, with both ends of each fibril comprising collagen amino-terminal domains; the remaining fibrils had no polarity reversal. All fibrils had similar diameters at both time points. Immunoelectron microscopy showed that all labeled fibrils contained both type I and III collagens. These data indicate that this wound healing model provides a system in which collagen fibril formation can be readily followed. (C) 2002 Elsevier Science (USA).
C1 CSIRO Mol Sci, Parkville, Vic, Australia.
   RMIT Univ, Dept Human Biol & Movement Sci, Bundoora, Vic, Australia.
   Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.
RP Ramshaw, JAM (reprint author), CSIRO Mol Sci, 343 Royal Parade, Parkville, Vic, Australia.
RI Birk, David/I-4072-2012; Ramshaw, John/A-9411-2011
OI Birk, David/0000-0002-4865-9088; Darby, Ian/0000-0002-0990-1986
CR BAILEY AJ, 1975, BIOCHIM BIOPHYS ACTA, V405, P412, DOI 10.1016/0005-2795(75)90106-3
   BARNES MJ, 1976, BIOCHEM J, V157, P263, DOI 10.1042/bj1570263
   BIRK DE, 1995, DEV DYNAM, V202, P229, DOI 10.1002/aja.1002020303
   BIRK DE, 1994, J ANAT, V184, P457
   Birk DE, 1997, DEV DYNAM, V208, P291
   Birk DE, 1996, MATRIX BIOL, V15, P111, DOI 10.1016/S0945-053X(96)90152-3
   BIRK DE, 1984, J CELL BIOL, V99, P2024, DOI 10.1083/jcb.99.6.2024
   BIRK DE, 1989, P NATL ACAD SCI USA, V86, P4549, DOI 10.1073/pnas.86.12.4549
   BIRK DE, 1990, ANN NY ACAD SCI, V580, P176, DOI 10.1111/j.1749-6632.1990.tb17928.x
   Bisucci T, 2000, METH MOL B, V123, P291
   BRUNS RR, 1979, P NATL ACAD SCI USA, V76, P313, DOI 10.1073/pnas.76.1.313
   Clark R.A.F., 1988, MOL CELLULAR BIOL WO
   CRAIG AS, 1989, CONNECT TISSUE RES, V19, P51, DOI 10.3109/03008208909016814
   DeVente JE, 1997, J ELECTRON MICROSC, V46, P353, DOI 10.1093/oxfordjournals.jmicro.a023530
   FLEISCHMAJER R, 1983, P NATL ACAD SCI-BIOL, V80, P3354, DOI 10.1073/pnas.80.11.3354
   FLEISCHMAJER R, 1990, J STRUCT BIOL, V105, P162, DOI 10.1016/1047-8477(90)90110-X
   Graham HK, 2000, J MOL BIOL, V295, P891, DOI 10.1006/jmbi.1999.3384
   HOLMES DF, 1994, J MOL BIOL, V235, P80, DOI 10.1016/S0022-2836(05)80016-6
   Kadler KE, 1996, BIOCHEM J, V316, P1
   KADLER KE, 1990, BIOCHEM J, V268, P339, DOI 10.1042/bj2680339
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   MIYAHARA M, 1984, J BIOL CHEM, V259, P9891
   MULLERMAI CM, 1991, J APPL BIOMATER, V2, P29, DOI 10.1002/jab.770020105
   NAKATSUKASA H, 1990, J CLIN INVEST, V85, P1833, DOI 10.1172/JCI114643
   Neame PJ, 2000, CELL MOL LIFE SCI, V57, P859, DOI 10.1007/s000180050048
   PARKINSON J, 1994, PHYS REV E, V50, P2963, DOI 10.1103/PhysRevE.50.2963
   Parry D A D, 1988, COLLAGEN, V2, P1
   SCOTT JE, 1992, INT J BIOL MACROMOL, V14, P292, DOI 10.1016/S0141-8130(05)80043-1
   SILVER D, 1992, P NATL ACAD SCI USA, V89, P9860, DOI 10.1073/pnas.89.20.9860
   THURMOND FA, 1994, J MOL BIOL, V235, P73, DOI 10.1016/S0022-2836(05)80015-4
   Trotter JA, 1998, J MOL BIOL, V284, P1417, DOI 10.1006/jmbi.1998.2230
   VEIS A, 1988, COLLAGEN, V1, P113
   WERKMEISTER JA, 1990, EUR J BIOCHEM, V187, P439, DOI 10.1111/j.1432-1033.1990.tb15323.x
   WERKMEISTER JA, 1991, BIOCHEM J, V274, P895, DOI 10.1042/bj2740895
NR 34
TC 23
Z9 23
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JAN-FEB
PY 2002
VL 137
IS 1-2
BP 23
EP 30
DI 10.1006/jsbi.2002.4460
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 566XL
UT WOS:000176453500005
PM 12064930
DA 2018-10-19
ER

PT S
AU De Ford, D
   Higgins, A
   Gregory, KW
AF De Ford, D
   Higgins, A
   Gregory, KW
BE Bartels, KE
   Bass, LS
   DeRiese, WTW
   Gregory, KW
   Katzir, A
   Kollias, N
   Lucroy, MD
   Malek, RS
   Peavy, GM
   Reidenbach, HD
   Robinson, DS
   Shah, UK
   Tate, LP
   Trowers, EA
   Wong, BJF
   Woodward, TA
TI Vascular anastomosis using a pulsed diode laser
SO LASERS IN SURGERY: ADVANCED CHARACTERIZATION, THERAPEUTICS, AND SYSTEMS
   XII
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Lasers in Surgery - Advanced Characterization,
   Therapeutics, and Systems XII
CY JAN 19-22, 2002
CL SAN JOSE, CA
SP SPIE
DE laser welding; vascular anastomosis; elastin patch; albumin films; organ
   repair; tissue repair
ID INDOCYANINE GREEN
AB The objective of this research is to provide a novel approach to the problem of vascular anastomosis. The work subscribes to the idea that if we use a human protein that has adhesive properties, denatures by heat in an irreversible way and forms a semi-hard but flexible matter. Also belongs to the circulatory system, is liquid in its native state, and after denaturing it is not soluble in water, blood plasma or any other related fluids anymore. Therefore, a pulsed diode laser beam can be used on this protein in order to have a strong welding for vascular anastomosis.
   It was established in the Oregon Medical Laser Center that the best proteins to be used, as a welding biomaterial, is human albumin. Indocyanine Green was added to provide a compound that absorbs light and transforms it in heat to the denaturing and welding process.
   Tests with liquid albumin were performed, the results obtained were unreliable due to the following facts: the variation in the liquid film thickness produced pockets of native (non-denatured albumin) underneath the denatured welded crust and bubbles produced by water evaporation. This phenomenon led to a weak welding.
   After testing different options, it was decided that the manufacturing of a solid thin film of albumin/ICG with a content of water between 37-40% was the best option. It reduces the number of bubbles, and provides a constant thickness between 200-250 mum. This thin film can be used alone on the vascular surface to be welded, or in combination with an elastin strip to increase strength.
   To avoid collapsing of the blood vessel while welding, and also keep both edges of the vessel together, an albumin/ICG stent was designed so the configuration of the stent does not allow the vessel to slip away or collapse. The stent is made out of native human albumin with water content between 37-40%. When the weld is completed and the forceps are released, it is expected that the natural flow of blood will dissolve the stent in less than 12 minutes (according with experiments already performed with lukewarm water).
C1 Oregon State Univ, Oregon Med Laser Ctr, Corvallis, OR 97331 USA.
RP De Ford, D (reprint author), Oregon State Univ, Oregon Med Laser Ctr, Corvallis, OR 97331 USA.
CR GOLNIK G, 1993, IR EO SYSTEMS HDB, V8, P403
   LaJoie EN, 1997, LASER MED SCI, V12, P49, DOI 10.1007/BF02763921
   PETERS TJ, 1996, ALL ABOUT ALBUMIN
   POSEY J A JR, 1973, Cardiovascular Research Center Bulletin (Houston), V11, P83
   ROSENBLOOM J, 1987, METHOD ENZYMOL, V144, P172
   SAWYER P, 1987, MODERN VASCULAR GRAF, P326
   ZHOU JF, 1994, P SOC PHOTO-OPT INS, V2128, P495, DOI 10.1117/12.184936
NR 7
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4348-4
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4609
BP 449
EP 455
DI 10.1117/12.444382
PG 7
WC Engineering, Biomedical; Optics; Surgery
SC Engineering; Optics; Surgery
GA BU92L
UT WOS:000177417100061
DA 2018-10-19
ER

PT J
AU Simpson, KH
   Bowden, MG
   Hook, M
   Anvari, B
AF Simpson, KH
   Bowden, MG
   Hook, M
   Anvari, B
TI Measurement of adhesive forces between S-epidermidis and
   fibronectin-coated surfaces using optical tweezers
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Article
DE bacterial adhesion; biofilm; extracellular matrix; infection
ID FIBRINOGEN; PROTEIN
AB Background and Objectives: Biomaterial-mediated infection, a common cause of medical device failure, is initiated by bacterial adhesion to an adsorbed protein layer on the implant surface. This adhesion is thought to be mediated by specific molecules present on the bacterial cell surface. Optical tweezers can be used to measure the adhesive force between a single bacterium and a protein-coated surface.
   Study Design/Materials and Methods: Using optical tweezers, a bacterium was trapped and brought in contact with a 10-mum diameter polystyrene microsphere coated with fibronectin. The minimum force required to detach the cell from the bead was determined over a range of fibronectin concentrations and contact times.
   Results: The detachment forces were integer multiples of an 18-pN base value that was independent of contact time and coating concentration; we propose that the variation in force is related to the number of bonds formed.
   Conclusions: These experiments demonstrate that optical tweezers can be used to investigate the adhesion of individual bacteria to surfaces. The results suggest that S. epidermidis has surface proteins capable of binding fibronectin. (C) 2002 Wiley-Liss, Inc.
C1 Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   Texas A&M Univ, Syst Hlth Sci Ctr, Albert B Alkek Inst Biosci & Technol, Ctr Extracellular Matrix Biol, Houston, TX 77030 USA.
RP Anvari, B (reprint author), Rice Univ, Dept Bioengn, POB 1892,MS 142, Houston, TX 77251 USA.
CR Boland T, 2000, CRIT REV BIOMED ENG, V28, P195, DOI 10.1615/CritRevBiomedEng.v28.i12.330
   DICKINSON RB, 2000, HDB BACTERIAL ADHESI, P297
   Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7
   FELGNER H, 1995, APPL OPTICS, V34, P977, DOI 10.1364/AO.34.000977
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   Hook M, 2000, GRAM-POSITIVE PATHOGENS, P386
   KUUSELA P, 1985, INFECT IMMUN, V50, P77
   Liang H, 1996, BIOPHYS J, V70, P1529, DOI 10.1016/S0006-3495(96)79716-3
   Mohamed N, 2000, BIOTECHNOL BIOENG, V68, P628, DOI 10.1002/(SICI)1097-0290(20000620)68:6<628::AID-BIT5>3.3.CO;2-4
   Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1
   Nilsson M, 1998, INFECT IMMUN, V66, P2666
   Razatos A, 1998, J BIOMAT SCI-POLYM E, V9, P1361, DOI 10.1163/156856298X00442
   Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972
   Stout AL, 2001, BIOPHYS J, V80, P2976, DOI 10.1016/S0006-3495(01)76263-7
   SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335
   Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863
   WRIGHT WH, 1994, APPL OPTICS, V33, P1735, DOI 10.1364/AO.33.001735
NR 18
TC 24
Z9 24
U1 1
U2 8
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0196-8092
J9 LASER SURG MED
JI Lasers Surg. Med.
PY 2002
VL 31
IS 1
BP 45
EP 52
DI 10.1002/lsm.10070
PG 8
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 581UL
UT WOS:000177311900008
PM 12124715
DA 2018-10-19
ER

PT J
AU Maitland, DJ
   Metzger, MF
   Schumann, D
   Lee, A
   Wilson, TS
AF Maitland, DJ
   Metzger, MF
   Schumann, D
   Lee, A
   Wilson, TS
TI Photothermal properties of shape memory polymer micro-actuators for
   treating stroke
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Article
DE diode laser; hemorrhagic stroke; ischemic stroke; biomaterial
ID RHEOLYTIC CATHETER; THROMBECTOMY
AB Background and Objectives: In this paper the photothermal engineering issues of novel shape memory polymer (SMP) microactuators for treating stroke are presented. The engineering issues for using lasers to heat and subsequently actuate these SMP devices are presented in order to provide design criteria and guidelines for intravascular, laser activated SMP devices.
   Materials and Methods: A total of three devices will be presented: two interventional ischemic stroke devices (coil and umbrella) and one device for releasing embolic coils (microgripper). The optical properties of SMP, methods for coupling laser light into SMP, heating distributions in the SMP devices, and the impact of operating the thermally activated material in a blood vessel are presented.
   Results: Actuating the devices requires device temperatures in the range of 65-85degreesC. Attaining these temperatures under flow conditions requires critical engineering of the SMP optical properties, optical coupling into the SMP, and device geometries.
   Conclusion: Laser-activated SMP devices are a unique combination of laser-tissue and biomaterial technologies. Successful deployment of the microactuator requires well-engineered coupling of the light from the diffusing fiber through the blood into the SMP. (C) 2002 Wiley-Liss, Inc.
C1 Lawrence Livermore Natl Lab, Med Technol Program, Livermore, CA 94550 USA.
RP Maitland, DJ (reprint author), Lawrence Livermore Natl Lab, Med Technol Program, 7000 E Ave,Mail Stop L-174, Livermore, CA 94550 USA.
CR BENDERSON JB, 2000, STROKE, V31, P2742
   BENETT WJ, 1998, Patent No. 5788130
   Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415
   CONNORS JJ, 1999, INTERV NEURORADIOL, P650
   CONNORS JJ, 1999, INTERV NEURORADIOL, P276
   FITCH JP, 1998, Patent No. 5722989
   Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112
   Hayashi S., 1988, MITSUBISHI TECHNICAL, V184
   Hayashi S., 1991, U. S. Patent, Patent No. [5,049,591, 5049591]
   Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151
   KUSY RP, 1994, THERMOCHIM ACTA, V243, P253, DOI 10.1016/0040-6031(94)85060-7
   LAFONTAINE D, 1996, Patent No. 5662621
   Maitland DJ, 1997, LASER SURG MED, V20, P310, DOI 10.1002/(SICI)1096-9101(1997)20:3<310::AID-LSM10>3.0.CO;2-H
   MAITLAND DJ, 1998, Patent No. 6102917
   MARLER JR, 1995, NEW ENGL J MED, V333, P1581
   Opatowsky MJ, 1999, AM J NEURORADIOL, V20, P414
   OTA S, 1981, RADIAT PHYS CHEM, V18, P81, DOI 10.1016/0146-5724(81)90066-2
   Otsuka K., 1998, SHAPE MEMORY MAT
   Pearce JA, 1995, OPTICAL THERMAL RESP, P561
   Ratner BD, 1996, INTRO MAT MED
   Takahashi T, 1996, J APPL POLYM SCI, V60, P1061
   Vesely TM, 1999, J VASC INTERV RADIOL, V10, P1195, DOI 10.1016/S1051-0443(99)70220-4
   Wang MT, 1999, J POLYM SCI POL PHYS, V37, P101, DOI 10.1002/(SICI)1099-0488(19990115)37:2<101::AID-POLB1>3.0.CO;2-X
   Wiebers D, 1998, NEW ENGL J MED, V339, P1725
NR 24
TC 200
Z9 202
U1 4
U2 79
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0196-8092
J9 LASER SURG MED
JI Lasers Surg. Med.
PY 2002
VL 30
IS 1
BP 1
EP 11
PG 11
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 514DT
UT WOS:000173423500001
PM 11857597
DA 2018-10-19
ER

PT J
AU Vena, P
   Contro, R
AF Vena, P
   Contro, R
TI Micromechanical analysis of the trabecular bone stress state at the
   interface with metallic biomedical devices
SO MECCANICA
LA English
DT Article; Proceedings Paper
CT 15th Congress of AIMETA
CY SEP 26-29, 2001
CL SICILY, ITALY
DE microstructures; interface behaviour; finite elements; multi-scale
   computing; iterative techniques
ID FINITE-ELEMENT MODELS; ACCURACY
AB An iterative procedure for the stress analysis at interfaces between dissimilar materials is presented. The problem is specialised to the case of biomaterial interfaces with particular reference to materials which are characterised by tiny microstructures. The procedure is based on a recursive analysis of small size problems defined upon subdomains obtained by partitioning the whole structural domain. The kinematic boundary conditions are iteratively adjusted by using appropriate preconditioners. The numerical example reported in this paper shows that the procedure is effective regardless of the degree of material heterogeneity, in contrast with the results obtained by using a coarse mesh for the whole domain. The procedure seems to be a promising one for determining the structural strength of interfaces between trabecular bone and metal implants requiring accurate evaluation of stress at the scale level of the single microstructure exhibited by the bone.
C1 Politecn Milan, Dept Struct Engn, Lab Biol Struct Mech, I-20133 Milan, Italy.
RP Vena, P (reprint author), Politecn Milan, Dept Struct Engn, Lab Biol Struct Mech, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.
RI Vena, Pasquale/F-6684-2013
OI Vena, Pasquale/0000-0003-2229-5156
CR Charras GT, 2000, J BIOMECH, V33, P255, DOI 10.1016/S0021-9290(99)00141-4
   Guldberg RE, 1998, J BIOMECH ENG-T ASME, V120, P289, DOI 10.1115/1.2798314
   Jacobs CR, 1999, J BIOMECH, V32, P1159, DOI 10.1016/S0021-9290(99)00115-3
   Le Tallec P, 1994, COMPUT MECH ADV, V1, P121
   Niebur GL, 2000, J BIOMECH, V33, P1575, DOI 10.1016/S0021-9290(00)00149-4
   Pistoia W, 2001, J BIOMECH ENG-T ASME, V123, P176, DOI 10.1115/1.1352734
   Terada K, 2000, INT J SOLIDS STRUCT, V37, P2285, DOI 10.1016/S0020-7683(98)00341-2
   Wentorf R, 1999, COMPUT METHOD APPL M, V172, P273, DOI 10.1016/S0045-7825(98)00232-1
   ZOHDI TI, 1999, COMPUT METHODS APPL, V172, P3
NR 9
TC 2
Z9 2
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0025-6455
J9 MECCANICA
JI Meccanica
PY 2002
VL 37
IS 4-5
BP 431
EP 439
DI 10.1023/A:1020852108109
PG 9
WC Mechanics
SC Mechanics
GA 606DG
UT WOS:000178717800012
DA 2018-10-19
ER

PT S
AU Gonsalves, KE
   He, W
   Poker, DB
   Batina, N
   Merhari, L
AF Gonsalves, KE
   He, W
   Poker, DB
   Batina, N
   Merhari, L
BE Merhari, L
   Gonsalves, KE
   Dobisz, EA
   Angelopoulos, M
   Herr, D
TI A versatile approach for biomaterial patterning: Masked ion beam
   lithography
SO NANOPATTERNING-FROM ULTRALARGE-SCALE INTERGRATION TO BIOTECHNOLOGY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanopatterning - From Ultralarge-Scale Integration to
   Biotechnology held at the 2001 MRS Fall Meeting
CY NOV 25-29, 2001
CL BOSTON, MA
SP CERAMEC France, Motorola France, Res Ctr, Nanoresist Technologies Inc, Natl Sci Fdn, Whitaker Fdn, Mat Res Soc
ID IMPLANTATION
AB We describe a new approach for biomaterial patterning, viz, masked ion beam lithography. Poly (methyl methacrylate) (PMMA) film was used as a model system and subjected to Ca+ and P+ ion implantations through masks. Ca+ ion implantation was performed at an energy of 85 keV with a fluence of 1x10(14) ions/cm(2). P+ ion implantation was done at an energy of 85 keV with fluences of 1x10(15) and 1x10(16) ions/cm(2). Arrays of holes were generated during these processes. AFM showed that the depth of the holes is in the nanoscale region. The surface hydrophobicity of the exposed PMMA films was investigated by contact angle measurement. The results indicated that ion implantation changed the surface hydrophobicity.
C1 Univ N Carolina, Dept Chem, Charlotte, NC 28223 USA.
RP Gonsalves, KE (reprint author), Univ N Carolina, Dept Chem, Charlotte, NC 28223 USA.
RI Batina, Nikola/J-6871-2017; He, Wei/K-7218-2013
OI Batina, Nikola/0000-0001-8217-8563; He, Wei/0000-0002-6638-9691
CR Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   Hyun J, 2001, J AM CHEM SOC, V123, P6943, DOI 10.1021/ja015798g
   IWAKI M, 1989, CRIT REV SOLID STATE, V15, P473, DOI 10.1080/10408438908243743
   Li DJ, 1999, NUCL INSTRUM METH B, V152, P80, DOI 10.1016/S0168-583X(98)00915-X
   MAGANOV SN, 1994, SURFACE ANAL STM AFM, P31
   TANDON US, 1993, PATTERNING MAT LAYER, P39
NR 6
TC 0
Z9 0
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-641-9
J9 MATER RES SOC SYMP P
PY 2002
VL 705
BP 247
EP 251
PG 5
WC Biotechnology & Applied Microbiology; Engineering, Multidisciplinary;
   Materials Science, Multidisciplinary; Physics, Applied
SC Biotechnology & Applied Microbiology; Engineering; Materials Science;
   Physics
GA BU87A
UT WOS:000177252400031
DA 2018-10-19
ER

PT S
AU Orth, RN
   Hafez, I
   Wu, M
   Ilic, B
   Baird, B
   Clark, TG
   Craighead, HG
AF Orth, RN
   Hafez, I
   Wu, M
   Ilic, B
   Baird, B
   Clark, TG
   Craighead, HG
BE Merhari, L
   Gonsalves, KE
   Dobisz, EA
   Angelopoulos, M
   Herr, D
TI Micro- and nanofabricating lipid patterns using a polymer-based wet
   lift-off
SO NANOPATTERNING-FROM ULTRALARGE-SCALE INTERGRATION TO BIOTECHNOLOGY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanopatterning - From Ultralarge-Scale Integration to
   Biotechnology held at the 2001 MRS Fall Meeting
CY NOV 25-29, 2001
CL BOSTON, MA
SP CERAMEC France, Motorola France, Res Ctr, Nanoresist Technologies Inc, Natl Sci Fdn, Whitaker Fdn, Mat Res Soc
ID RESONANCE; BILAYERS; BIOTIN
AB Accurate placement of biomaterials at nanoscale resolution opens new capabilities for biological sensing, cell manipulation, and control of cellular transduction cascades. We demonstrate that lipid molecules can be patterned on silicon using a polymer lift-off technique. Patterned lipid bilayers serve as biomaterial patterning platforms useful for studies of cellular function. Submicron feature sizes were achieved using this templating technique which is suitable for delicate biomaterials(1). Projection lithography and reactive ion etching were used to pattern a Parylene-coated surface. The patterned surface was subsequently exposed to 100 nm unilamellar lipid vesicles that bound to the native oxide surfaces of silicon and spread to form supported lipid bilayers. The nanoscale pattern is realized as the polymer is peeled away in deionized water. The versatility of this method is demonstrated by the successful preparation of functionalized lipid bilayer surfaces. Specific intermolecular interactions were demonstrated between supported membranes: DPPE-PE (2000) biotin/avidin, dinitrophenol (DNP)-conjugated lipids/anti-DNP IgE, and cationic lipid and M13 dsDNA:YOYO-1.
C1 Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.
RP Orth, RN (reprint author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.
RI Wu, Min/H-8048-2012; Ilic, Rob/N-1359-2014
OI Wu, Min/0000-0002-9161-7940; 
CR *AV POL LIP INC, 2001, AV POL LIP CAT
   BAYER EA, 1990, METHOD ENZYMOL, V184, P174
   BAYERL TM, 1990, BIOPHYS J, V58, P357, DOI 10.1016/S0006-3495(90)82382-1
   Biebuyck HA, 1997, IBM J RES DEV, V41, P159, DOI 10.1147/rd.411.0159
   FUCCILLO D A, 1985, Biotechniques, V3, P494
   GORHAM WF, 1966, J POLYM SCI A1, V4, P3027, DOI 10.1002/pol.1966.150041209
   Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8
   Hengsakul M, 1996, BIOCONJUGATE CHEM, V7, P249, DOI 10.1021/bc960007z
   Ilic B, 2000, BIOMED MICRODEVICES, V2, P317, DOI 10.1023/A:1009911407093
   JOHNSON SJ, 1991, BIOPHYS J, V59, P289, DOI 10.1016/S0006-3495(91)82222-6
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0
   Nikolelis DP, 1996, ANAL CHEM, V68, P1735, DOI 10.1021/ac950403v
   ORTH R, 2001, UNPUB LANMUIR
   ORTH R, 2001, IN PRESS BIOMEDICAL
   Roda A, 2000, BIOTECHNIQUES, V28, P492, DOI 10.2144/00283st07
   SALAMON Z, 1994, BBA-BIOMEMBRANES, V1195, P267, DOI 10.1016/0005-2736(94)90266-6
   SAVAGE D, 1994, AVIDINBIOTIN CHEM HD
   WILCHEK M, 1988, ANAL BIOCHEM, V171, P1, DOI 10.1016/0003-2697(88)90120-0
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Yang PD, 1998, SCIENCE, V282, P2244, DOI 10.1126/science.282.5397.2244
NR 21
TC 0
Z9 0
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-641-9
J9 MATER RES SOC SYMP P
PY 2002
VL 705
BP 259
EP 264
PG 6
WC Biotechnology & Applied Microbiology; Engineering, Multidisciplinary;
   Materials Science, Multidisciplinary; Physics, Applied
SC Biotechnology & Applied Microbiology; Engineering; Materials Science;
   Physics
GA BU87A
UT WOS:000177252400033
DA 2018-10-19
ER

PT S
AU Perry, CC
   Eglin, D
   Ali, SAM
   Downes, S
AF Perry, CC
   Eglin, D
   Ali, SAM
   Downes, S
BE Sanchez, C
   Laine, RM
   Yang, S
   Brinker, CJ
TI A statistical approach to the effect of sol-gel process variables on the
   physical properties of polymer [PLLA]-Silica hybrid materials for use as
   Biomaterials
SO ORGANIC/INORGANIC HYBRID MATERIALS-2002
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Hybrid Organic-Inorganic Materials held at the 2002 MRS
   Spring Meeting
CY APR 01-05, 2002
CL SAN FRANCISCO, CA
SP Mat Res Soc
ID BIODEGRADABLE POLYMERS; MECHANICAL-PROPERTIES; MORPHOLOGY; BEHAVIOR;
   SCREWS; SILICA
AB Hybrid poly(L-lactic acid)-silica materials for potential use in orthopaedic applications have been prepared by a sol-gel method using an experimental design approach to investigate the effect of synthesis variables separately and together on the physical form of the organic polymer. The five factors investigated were the molar ratios of tetraethyl orthosilicate (TEOS)/Poly(L-lactic acid) (PLLA), Toluene/PLLA, EtOH/TEOS, Water/TEOS and HCl (catalyst)/TEOS. All other synthesis conditions were kept constant. X-Ray powder diffraction (Statton's graphical method) and differential scanning calorimetry were used to assess the extent of polymer crystallinity in the hybrid materials. In accordance with other studies, increasing the molar ratio of TEOS/PLLA lead to increasing incorporation of the organic polymer into the silica network. Increase of the toluene/PLLA molar ratio lead to an increase in the crystallinity of the polymer phase. As our studies investigated the effect of synthesis variables simultaneously it was possible to identify, for the first time, that interactions between specific reactants are important in the development of the two structural components of this hybrid system. The most important of these was the TEOS/PLLA*H2O/TEOS interaction that may indicate that silica species from hydrolysed TEOS interact with the PLLA phase possibly via hydrogen bonding and leads to the lowering of the crystalline order of the polymer The results from this study give useful information on the ability of the organic polymer and the silica phase to form interpenetrating networks, an important requirement for the generation of a potential hybrid polyester-silica biomaterial for orthopaedic applications.
C1 Nottingham Trent Univ, Dept Phys & Chem, Nottingham NG11 8FU, England.
RP Perry, CC (reprint author), Nottingham Trent Univ, Dept Phys & Chem, Nottingham NG11 8FU, England.
OI Perry, Professor Carole/0000-0003-1517-468X; Eglin,
   David/0000-0002-8500-6887
CR Ahola M., 1999, International Journal of Pharmaceutics (Amsterdam), V181, P181, DOI 10.1016/S0378-5173(99)00022-8
   ANDRIANO KP, 1994, J APPL BIOMATER, V5, P133, DOI 10.1002/jab.770050206
   AUBONNET S, 1999, THESIS NOTTINGHAM TR
   Brizzolara D, 1996, MACROMOLECULES, V29, P191, DOI 10.1021/ma951144e
   Chirila TV, 2002, BIOMATERIALS, V23, P321, DOI 10.1016/S0142-9612(01)00125-9
   CHRISTENSEN RR, 1996, ANAL VARIANCE DESIGN
   Cox D. R., 2000, THEORY DESIGN EXPT
   Dell'Erba R, 2001, POLYMER, V42, P7831, DOI 10.1016/S0032-3861(01)00269-5
   DOMB AJ, 1997, HDB BIODEGRADABLE PO
   EGLIN D, UNPUB POLYMER
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Hatakeyama T, 1999, THERMAL ANAL FUNDAME
   HUANG HH, 1987, POLYM BULL, V18, P455
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Jiang SC, 2001, POLYMER, V42, P3901, DOI 10.1016/S0032-3861(00)00565-6
   Kasuga T, 1999, J MATER SCI LETT, V18, P2021, DOI 10.1023/A:1006602404232
   KLUG HP, 1952, XRAY DIFFRACTION PRO
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Moukwa M, 1997, JOM-J MIN MET MAT S, V49, P46, DOI 10.1007/BF02915480
   Oye G, 2000, MICROPOR MESOPOR MAT, V34, P291, DOI 10.1016/S1387-1811(99)00181-X
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Rueda N, 2001, APPL CATAL A-GEN, V215, P81, DOI 10.1016/S0926-860X(01)00509-9
   Schliephake H, 2001, J BIOMED MATER RES, V56, P128, DOI 10.1002/1097-4636(200107)56:1<128::AID-JBM1077>3.0.CO;2-L
   Schwach G, 1999, INT J BIOL MACROMOL, V25, P283, DOI 10.1016/S0141-8130(99)00043-4
   Statton W.O., 1963, J APPL POLYM SCI, V7, P803, DOI 10.1002/app.1963.070070302
   Statton WO, 1967, J POLYM SCI C, V18, P33
   Tian D, 1997, CHEM MATER, V9, P871, DOI 10.1021/cm960514q
   Tian D, 1998, POLYMER, V39, P855, DOI 10.1016/S0032-3861(97)00343-1
   Tian D, 1997, J POLYM SCI POL CHEM, V35, P2295, DOI 10.1002/(SICI)1099-0518(199708)35:11<2295::AID-POLA21>3.0.CO;2-8
   Tian D, 1999, POLYMER, V40, P951, DOI 10.1016/S0032-3861(98)00353-X
   Vert M, 1998, J CONTROL RELEASE, V53, P85, DOI 10.1016/S0168-3659(97)00240-X
NR 33
TC 5
Z9 6
U1 0
U2 0
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-662-1
J9 MATER RES SOC SYMP P
PY 2002
VL 726
BP 67
EP 78
PG 12
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA BV44F
UT WOS:000178977700009
DA 2018-10-19
ER

PT J
AU Longinotti, MP
   Mazzobre, MF
   Buera, MP
   Corti, HR
AF Longinotti, MP
   Mazzobre, MF
   Buera, MP
   Corti, HR
TI Effect of salts on the properties of aqueous sugar systems in relation
   to biomaterial stabilization - Part 2. Sugar crystallization rate and
   electrical conductivity behavior
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID GLASS-TRANSITION; SUPERCOOLED LIQUIDS; TREHALOSE; STABILITY; PROTEIN;
   MIXTURES; SUCROSE; CONDUCTANCE; TEMPERATURE; DESICCATION
AB Two of the sugars involved in the protection of living organisms, trehalose and sucrose, were employed to analyze the effect of different salts (MgCl2, CaCl2, KCl, NaCl) on sugar crystallization kinetics. The conductivity behavior in supercooled aqueous sugar salt systems was also studied to evaluate the extent of water salt interactions. Trehalose and sucrose crystallization, evaluated by differential scanning calorimetry (DSC), was delayed by the presence of salt without affecting the glass transition temperature, T-g, of the system. Sugar crystallization rates increased as the temperature increased above T-g. The crystallization kinetics was analyzed using the Johnson-Mehl-Avrami-Kolmogorov equation (JMAK), and it was found that the index n varied from 4 for pure sugars to less than 2 for sugar MgCl2 mixtures, suggesting that the presence of salts constrained the number of configurations for crystal growth.
   The electrical conductivity of NaCl and MgCl2 was measured in liquid and supercooled trehalose and sucrose aqueous solutions over a wide range of viscosity to find evidence of preferential solvation in the sugar water solutions. The results indicated that large positive deviations from the Walden rule occur in these systems, due to the higher tendency of the ions to move in water-rich regions. The observed delayed crystallization of sugar in aqueous solutions containing salt could be attributed to effects on the nucleation mechanism of ion-induced microheterogeneities in the supercooled solutions.
C1 Comis Nacl Energia Atom, Unidad Activdad Quim, RA-1650 San Martin, Buenos Aires, Argentina.
   Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ind, RA-1428 Buenos Aires, DF, Argentina.
   Univ Buenos Aires, Fac Ciencias Exactas & Nat, INQUIMAE, RA-1428 Buenos Aires, DF, Argentina.
RP Longinotti, MP (reprint author), Comis Nacl Energia Atom, Unidad Activdad Quim, Avda Gen Paz 1499, RA-1650 San Martin, Buenos Aires, Argentina.
OI Buera, Pilar/0000-0001-9290-7299
CR ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6536, DOI 10.1021/bi00268a033
   ARVANITOYANNIS I, 1994, J FOOD SCI, V59, P197, DOI 10.1111/j.1365-2621.1994.tb06931.x
   Avrami M., 1940, Journal of Chemical Physics, V8, P212, DOI 10.1063/1.1750631
   Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380
   BARTHEL J, 1983, J SOLUTION CHEM, V12, P449, DOI 10.1007/BF00651698
   BARTHEL J, 1980, J SOLUTION CHEM, V9, P209, DOI 10.1007/BF00648327
   Buitink J, 2000, BIOPHYS J, V79, P1119, DOI 10.1016/S0006-3495(00)76365-X
   Cardona S, 1997, J FOOD SCI, V62, P105, DOI 10.1111/j.1365-2621.1997.tb04378.x
   CARPENTER JF, 1988, CRYOBIOLOGY, V25, P459, DOI 10.1016/0011-2240(88)90054-5
   Chang BS, 1996, ARCH BIOCHEM BIOPHYS, V331, P249, DOI 10.1006/abbi.1996.0305
   CHVOJ Z, 1991, KINETIC PHASE DIAGRA, P169
   COLACO C, 1992, BIO-TECHNOL, V10, P1007, DOI 10.1038/nbt0992-1007
   Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73
   Crowe LM, 1996, BIOPHYS J, V71, P2087, DOI 10.1016/S0006-3495(96)79407-9
   DOREMUS RH, 1985, RATES PHASE TRANSFOR, P24
   Duddu SP, 1997, PHARMACEUT RES, V14, P591, DOI 10.1023/A:1012144810067
   Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99
   EHLICH D, 1990, MACROMOLECULES, V23, P1600, DOI 10.1021/ma00208a008
   GRAYDON JW, 1994, J NON-CRYST SOLIDS, V175, P31, DOI 10.1016/0022-3093(94)90312-3
   Johnson WA, 1939, T AM I MIN MET ENG, V135, P416
   KEDWARD CJ, 2000, J FOOD SCI, V2, P324
   KOLMOGOROV AN, 1937, VESTN USSR ACAD SCI, V3, P3551
   KOSTER KL, 1988, PLANT PHYSIOL, V88, P829, DOI 10.1104/pp.88.3.829
   Kreilgaard L, 1999, J PHARM SCI, V88, P281, DOI 10.1021/js980399d
   LESLIE SB, 1995, APPL ENVIRON MICROB, V61, P3592
   Mazzobre MF, 1999, BBA-GEN SUBJECTS, V1473, P337, DOI 10.1016/S0304-4165(99)00207-X
   MAZZOBRE MF, 2001, IN PRESS CRYOBIOLOGY
   Miller DP, 2000, J PHYS CHEM B, V104, P10419, DOI 10.1021/jp000730t
   Miller DP, 1997, PHARMACEUT RES, V14, P578, DOI 10.1023/A:1012192725996
   Miller DP, 1998, PHARM RES-DORDR, V15, P1215, DOI 10.1023/A:1011987707515
   Noel TR, 1996, J CHEM SOC FARADAY T, V92, P1921, DOI 10.1039/ft9969201921
   PANCOAST HM, 1980, HDB SUGARS, P46
   PETRIELLA C, 1985, J FOOD SCI, V50, P622, DOI 10.1111/j.1365-2621.1985.tb13759.x
   Ross Y., 1991, J FOOD SCI, V56, P1676
   ROSSLER E, 1990, PHYS REV LETT, V65, P1595, DOI 10.1103/PhysRevLett.65.1595
   Shneidman VA, 1998, J CHEM PHYS, V109, P186, DOI 10.1063/1.476548
   SPIRO M, 1973, ORGANIC SOLVENT SYST, pCH6
   Stokes R. H., 1959, STRUCTURE ELECTROLYT, P298
   Storey BT, 1998, CRYOBIOLOGY, V37, P46, DOI 10.1006/cryo.1998.2097
   SUN WQ, 1993, PHYSIOL PLANTARUM, V89, P767
   Suzuki T, 1997, J CHEM ENG JPN, V30, P609, DOI 10.1252/jcej.30.609
   TREINER C, 1965, J PHYS CHEM-US, V69, P2576, DOI 10.1021/j100892a016
   Tzannis ST, 1999, J PHARM SCI-US, V88, P360, DOI 10.1021/js9800127
   URITANI M, 1995, J BIOCHEM-TOKYO, V117, P774, DOI 10.1093/oxfordjournals.jbchem.a124775
NR 44
TC 36
Z9 36
U1 1
U2 12
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD,, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2002
VL 4
IS 3
BP 533
EP 540
DI 10.1039/b107746e
PG 8
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 514MY
UT WOS:000173445200020
DA 2018-10-19
ER

PT B
AU Mendes, SC
   De Bruijn, JD
   Van Blitterswijk, CA
AF Mendes, SC
   De Bruijn, JD
   Van Blitterswijk, CA
BE Reis, RL
   Cohn, D
TI Cultured bone on biomaterial substrates - A tissue engineering approach
   to treat bone defects
SO POLYMER BASED SYSTEMS ON TISSUE ENGINEERING, REPLACEMENT AND
   REGENERATION
SE NATO SCIENCE SERIES, SERIES II: MATHEMATICS, PHYSICS AND CHEMISTRY
LA English
DT Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on Polymer Based Systems
   on Tissue Engineering, Replacement and Regeneration
CY OCT 15-25, 2001
CL ALVOR, PORTUGAL
SP NATO, Adv Study Inst
ID MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS; CALCIUM-PHOSPHATE
   CERAMICS; FIBROBLAST-GROWTH-FACTOR; ADULT HUMAN BONE; HUMAN
   OSTEOPROGENITOR CELLS; IN-VITRO; MORPHOGENETIC PROTEIN-2; POROUS
   HYDROXYAPATITE; OSTEOGENIC DIFFERENTIATION
AB In the present work, a tissue engineering approach to treat bone defects was investigated. Such strategy was based on the use of patient own cultured bone marrow stromal cells (BMSCs) in association with biomaterials to produce autologous living bone equivalents. When engineering such implants, three main factors had to be taken into account: (i) the cells, (ii) the culture technology and (iii) the biomaterial scaffolds. The capacity of BMSCs to proliferate, differentiate along the osteogenic lineage and form a bone like tissue was demonstrated in various in vitro assays making use of biochemical, immunological, microscopic and gene expression techniques. The ability of the cells to produce bone in vivo was established using an ectopic (extra osseous) implantation model. Results indicated that BMSC cultures were composed of a heterogeneous population containing a subpopulation of cells with high proliferative capacity and with potential to differentiate into bone forming cells. Both the growth and the differentiation pattern of these cells could be manipulated, to a certain degree, through the use of bioactive factors during culture. After implantation, the bone forming capacity of the cultures proved to be related to the amount of early osteoprogenitors and precursors cells that could be induced into starting the osteogenic differentiation process. In bone marrow aspirates, this subpopulation appeared to decrease with donor age and to be strongly dependent on the donor, indicating that the aspiration procedure plays an important role in the obtained bone marrow cell population. In order to evaluate the in vivo bone formation capacity of BMSC cultures prior to implantation, an experimental method was developed in which the amount of early osteoprogenitors and precursors cells could be quantified. With regard to the technology design, data indicated that the culture of cells on the biomaterial scaffolds prior to implantation resulted in implants with faster in vivo bone forming ability as compared to scaffolds implanted shortly after cell seeding. In addition, two biodegradable polymeric systems were proposed as scaffolds to be used in the described bone engineering approach after evaluating their ability to support bone marrow cell growth, differentiation and in vivo bone, formation. In summary, although the complete knowledge of the, factors controlling BMSC growth and osteogenic differentiation still needs to be further expanded, the obtained results suggest that the bone tissue engineering approach described in this work presents a great potential for the repair of bone defects and will become an advantageous alternative to the traditional autologous bone grafting.
C1 IsoTis NV, NL-3723 MB Bilthoven, Netherlands.
RP Mendes, SC (reprint author), IsoTis NV, Prof Bronkhorstlaan 10, NL-3723 MB Bilthoven, Netherlands.
RI Group, 3Bs/E-4374-2012
OI Group, 3Bs/0000-0002-5195-3456
CR Anderson MLC, 1999, CLIN ORTHOP RELAT R, P231
   Anselme K, 1999, BONE, V25, p51S, DOI 10.1016/S8756-3282(99)00133-7
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Aspenberg P, 1996, BONE, V19, P499, DOI 10.1016/S8756-3282(96)90257-4
   Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Aubin Jane E., 1996, P51
   Aubin JE, 2000, BONE ENG, P19
   BAB I, 1988, BONE MINER, V4, P373
   Balk ML, 1997, BONE, V21, P7, DOI 10.1016/S8756-3282(97)00075-6
   BENNETT JH, 1991, J CELL SCI, V99, P131
   BERESFORD JN, 1989, CLIN ORTHOP RELAT R, P270
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Boden SD, 1999, SPINE, V24, P320, DOI 10.1097/00007632-199902150-00003
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   BROWN KLB, 1982, J BONE JOINT SURG AM, V64, P270, DOI 10.2106/00004623-198264020-00020
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Bruder SP, 1997, BONE, V21, P225, DOI 10.1016/S8756-3282(97)00127-0
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   BUCKWATER JA, 1987, INSTR COURSE LECT, V16, P27
   Bulstra SK, 1996, J BONE JOINT SURG BR, V78B, P892, DOI 10.1302/0301-620X78B6.6806
   Calvert JW, 2000, J BIOMED MATER RES, V52, P279, DOI 10.1002/1097-4636(200011)52:2<279::AID-JBM6>3.0.CO;2-8
   CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277
   Cook S D, 1987, Int J Oral Maxillofac Implants, V2, P15
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   Coombes A. G. A., 1994, Clinical Materials, V17, P35, DOI 10.1016/0267-6605(94)90046-9
   Cooper LF, 2001, J DENT RES, V80, P314, DOI 10.1177/00220345010800010401
   CORNELL CN, 1998, CLIN ORTHOP RELAT R, V355, pS67
   Cortes F, 1999, BLOOD, V93, P826
   COVENTRY MB, 1972, J BONE JOINT SURG AM, VA 54, P83, DOI 10.2106/00004623-197254010-00008
   COWLEY SP, 1983, J BONE JOINT SURG AM, V65, P1023, DOI 10.2106/00004623-198365070-00022
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DAVIES JE, 1991, CELL MATER, V1, P3
   De Bruijin J. D., 2000, BONE ENG, P421
   de Bruijn J D, 1999, Adv Dent Res, V13, P74
   DEBOER HH, 1988, CLIN ORTH OP, P226
   DEBRUIJN JD, 1992, RES SOC SP P, V251, P63
   Dennis JE, 1998, BIOMATERIALS, V19, P1323, DOI 10.1016/S0142-9612(97)00170-1
   Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700
   Derkx P, 1998, BONE, V22, P367, DOI 10.1016/S8756-3282(97)00299-8
   DESCHAMPS AA, UNPUB J CONTROLLED R
   Dieudonne Suzanne C., 1999, Journal of Cellular Biochemistry, V76, P231
   Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828
   DRUDER SP, 1999, CLIN ORTHOP RELAT R, V167, pS68
   EVANS CE, 1990, J ORTHOPAED RES, V8, P234, DOI 10.1002/jor.1100080212
   Filshie RJA, 1998, LEUKEMIA, V12, P414, DOI 10.1038/sj.leu.2400922
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   Fromigue O, 1997, CYTOKINE, V9, P613, DOI 10.1006/cyto.1997.0209
   Fromigue O, 1998, J CELL BIOCHEM, V68, P411, DOI 10.1002/(SICI)1097-4644(19980315)68:4<411::AID-JCB2>3.0.CO;2-T
   FURLONG RJ, 1991, J BONE JOINT SURG BR, V73, P741
   GALOTTO M, 1994, J BONE MINER RES, V9, P1239
   Geesink RGT, 1999, J BONE JOINT SURG BR, V81B, P710, DOI 10.1302/0301-620X.81B4.9311
   Goldstein AS, 1999, TISSUE ENG, V5, P421, DOI 10.1089/ten.1999.5.421
   GRONTHOS S, 1994, BLOOD, V84, P4164
   GRONTHOS S, 1995, BLOOD, V85, P929
   Gronthos S, 1998, MARROW STROMAL CELL, P26
   Gundle R, 1997, J MATER SCI-MATER M, V8, P519, DOI 10.1023/A:1018538529108
   Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2
   HERBERTSON A, 1995, J BONE MINER RES, V10, P285
   Hing KA, 1998, P I MECH ENG H, V212, P437, DOI 10.1243/0954411981534204
   Inui K, 1997, CELL BIOL INT, V21, P419, DOI 10.1006/cbir.1997.0165
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Joyner CJ, 1997, BONE, V21, P1, DOI 10.1016/S8756-3282(97)00074-4
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Kim CH, 1999, J ENDOCRINOL, V162, P371, DOI 10.1677/joe.0.1620371
   Kim KJ, 1997, J BIOMED MATER RES, V35, P279, DOI 10.1002/(SICI)1097-4636(19970605)35:3<279::AID-JBM2>3.3.CO;2-S
   King GN, 1997, J DENT RES, V76, P1460, DOI 10.1177/00220345970760080801
   KLEIN CPAT, 1989, BIOMATERIALS, V10, P59
   KNIGHT S M, 1992, Calcified Tissue International, V50, pA12
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   Lane JM, 1999, CLIN ORTHOP RELAT R, pS107
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurencin C. T., 1999, CURR OPIN ORTHOP, V10, P445, DOI DOI 10.1097/00001433-199912000-00005
   LEBOY PS, 1991, J CELL PHYSIOL, V146, P370, DOI 10.1002/jcp.1041460306
   Lecoeur L, 1997, BIOMATERIALS, V18, P989, DOI 10.1016/S0142-9612(97)00025-2
   Lemons JE, 1996, BONE, V19, pS121, DOI 10.1016/S8756-3282(96)00128-7
   Lennon DP, 1996, IN VITRO CELL DEV-AN, V32, P602
   Lennon DP, 2000, DEV DYNAM, V219, P50, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1037>3.0.CO;2-7
   LI Y, 1998, T SOC BIOMATERIALS 1, P428
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P407, DOI 10.3109/17453679609002342
   Liu P, 1999, CALCIFIED TISSUE INT, V65, P173, DOI 10.1007/s002239900678
   Louisia S, 1999, J BONE JOINT SURG BR, V81B, P719, DOI 10.1302/0301-620X.81B4.9358
   MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marcacci M, 1999, CALCIFIED TISSUE INT, V64, P83, DOI 10.1007/s002239900583
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456
   Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H
   Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Miura Y, 1998, CELL TRANSPLANT, V7, P453, DOI 10.1016/S0963-6897(98)00033-5
   Muraglia A, 2000, J CELL SCI, V113, P1161
   Muschler GF, 1997, J BONE JOINT SURG AM, V79A, P1699, DOI 10.2106/00004623-199711000-00012
   Muschler GF, 2001, J ORTHOPAED RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3
   Nefussi JR, 1997, J HISTOCHEM CYTOCHEM, V45, P493, DOI 10.1177/002215549704500402
   Nichter L S, 1992, J Craniofac Surg, V3, P63, DOI 10.1097/00001665-199209000-00003
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   OHGUSHI H, 1990, ACTA ORTHOP SCAND, V61, P431, DOI 10.3109/17453679008993556
   OIKARINEN J, 1979, CLIN ORTHOP RELAT R, P208
   OKLUND SA, 1986, CLIN ORTHOP RELAT R, P269
   Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6
   Oreffo ROC, 1999, J CELL BIOCHEM, V75, P382, DOI 10.1002/(SICI)1097-4644(19991201)75:3<382::AID-JCB4>3.0.CO;2-N
   Owen M, 1988, J Cell Sci Suppl, V10, P63
   Owen ME, 1998, MARROW STROMAL CELL, P1
   Oyajobi BO, 1999, J BONE MINER RES, V14, P351, DOI 10.1359/jbmr.1999.14.3.351
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   Peter SJ, 2000, BIOMATERIALS, V21, P1207, DOI 10.1016/S0142-9612(99)00254-9
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.3.CO;2-#
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pri-Chen S, 1998, BONE, V23, P111, DOI 10.1016/S8756-3282(98)00087-8
   PROLO DJ, 1985, CLIN ORTHOP RELAT R, P322
   Puleo DA, 1997, J CELL PHYSIOL, V173, P93, DOI 10.1002/(SICI)1097-4652(199710)173:1<93::AID-JCP11>3.0.CO;2-O
   RADDER AM, 1994, J BIOMED MATER RES, V28, P141, DOI 10.1002/jbm.820280202
   Reid IR, 1997, EUR J ENDOCRINOL, V137, P209, DOI 10.1530/eje.0.1370209
   Rickard DJ, 1996, J BONE MINER RES, V11, P312
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Ripamonti U, 2001, J BONE JOINT SURG AM, V83A, pS116
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   RODAN GA, 1992, BONE, V13, pS3, DOI 10.1016/S8756-3282(09)80003-3
   Saad B, 1998, J BIOMED MATER RES, V39, P594, DOI 10.1002/(SICI)1097-4636(19980315)39:4<594::AID-JBM14>3.0.CO;2-7
   SALYER KE, 1989, PLAST RECONSTR SURG, V84, P236, DOI 10.1097/00006534-198908000-00008
   SIMMONS PJ, 1991, BLOOD, V78, P55
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   SPECTOR M, 1992, ORTHOP CLIN N AM, V23, P211
   Stewart K, 1999, J BONE MINER RES, V14, P1345, DOI 10.1359/jbmr.1999.14.8.1345
   Strong DM, 1996, CLIN ORTHOP RELAT R, P107
   SUMNER DR, 1995, J BONE JOINT SURG AM, V77A, P1135, DOI 10.2106/00004623-199508000-00001
   Takiguchi T, 1998, J PERIODONTAL RES, V33, P476
   Takushima A, 1998, J SURG RES, V78, P68, DOI 10.1006/jsre.1998.5378
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VANBLITTERSWIJK CA, 1990, J BIOMED MATER RES, V24, P433, DOI 10.1002/jbm.820240403
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
   Wada Y, 1998, BONE, V22, P479, DOI 10.1016/S8756-3282(98)00039-8
   Walsh S, 2000, BONE, V27, P185, DOI 10.1016/S8756-3282(00)00319-7
   Weng YL, 2001, J ORAL MAXIL SURG, V59, P185, DOI 10.1053/joms.2001.20491
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   Wikesjo UME, 2001, J BONE JOINT SURG AM, V83A, pS136
   WINTER GD, 1969, NATURE, V223, P88, DOI 10.1038/223088a0
   WYKROTA L. L., 2000, BONE ENG, P516
   Yang ZJ, 1997, J MATER SCI-MATER M, V8, P697, DOI 10.1023/A:1018540024082
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   YAO KL, 1994, J BONE MINER RES, V9, P231
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yoshikawa T, 2000, TRANSPLANTATION, V69, P128, DOI 10.1097/00007890-200001150-00022
   Yoshikawa T, 1998, BIO-MED MATER ENG, V8, P311
   Yoshikawa T, 1997, BIO-MED MATER ENG, V7, P49
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zellin G, 2000, BONE, V26, P161, DOI 10.1016/S8756-3282(99)00252-5
NR 168
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 1-4020-1000-1
J9 NATO SCI SER II MATH
PY 2002
VL 86
BP 265
EP 298
PG 34
WC Engineering, Biomedical; Engineering, Chemical
SC Engineering
GA BV99N
UT WOS:000180622900015
DA 2018-10-19
ER

PT B
AU Hunkeler, D
   Wandrey, C
   Ceausoglu, I
   Vidal, DS
   Espinosa, D
AF Hunkeler, D
   Wandrey, C
   Ceausoglu, I
   Vidal, DS
   Espinosa, D
BE Prusse, U
   Vorlop, KD
TI Downstream processing of microcapsules: Quality control of capsule
   morphology, permeability and mechanical properties as a function of raw
   material endotoxin levels
SO PRACTICAL ASPECTS OF ENCAPSULATION TECHNOLOGIES
LA English
DT Proceedings Paper
CT Workshop on Practical Aspects of Encapsulation Technologies
CY OCT 12-14, 2001
CL BRAUNSCHWEIG, GERMANY
SP FAL, Inst Technol & Biosyst Engn
DE alginate; bioartificial pancreas; cellulose sulfate; endotoxin;
   microencapsulation
ID ISLETS
AB The large-scale production of microcapsules with defined membrane thickness and permeabilities, both decoupled from the mechanical resistance, is demonstrated. Specifically, a novel apparatus, which controls the downstream part of the microencapsulation process has been developed. The oscillating reactor system permits the formation of capsules with controlled membranes based on pre-cast microbeads. The precise manipulation of the reaction time, and its distribution, between polyanion beads and the cationic receiving bath has been found to be critical. Given this, microcapsule diameters can be produced within 10%, both within and between batches. The membrane thickness can also be controlled to a tolerance of 5 micrometers. The Automatic Reaction Control has been tested on polysaccharide blends of alginate and cellulose sulfate, and found to produce identical capsules, independent of the endotoxin level of the biomaterial. When this is combined with the demonstration that alginate and cellulose sulfate can be depyrogenated to fractions of the limit imposed by the FDA, the novel technology enables, for the first time, the production of clinical quantities of sterile microcapsules suitable for transplantation. The downstream control of microcapsule reaction parameters can be coupled with any front-end system for bead generation, based on air-stripping, electrostatics or jet cutting. It is demonstrated on the former, using calcium and poly(methylene-co-guanidine) hydrochloride as the cations.
C1 AQUA TECH Specialties, CH-117 Geneva, Switzerland.
RP Hunkeler, D (reprint author), AQUA TECH Specialties, 4 Chemin Chalet Bac, CH-117 Geneva, Switzerland.
CR CEAUSOGLU I, IN PRESS MICROENCAPU
   *FDA, 1987, GUID USP BACT END TE
   *FDA, 1991, GUID USP BACT END TE
   Hunkeler D, 1997, TRENDS POLYM SCI, V5, P286
   KLOCK G, 1994, APPL MICROBIOL BIOT, V40, P638
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Rehor A, 2001, J BIOMAT SCI-POLYM E, V12, P157, DOI 10.1163/156856201750180898
   Schuldt U, 2000, MINERVA BIOTECNOL, V12, P249
   STEGEMANN JP, 1996, CAN J CHEM ENG, V4, P518
   Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358
NR 10
TC 0
Z9 0
U1 1
U2 6
PU BUNDESFORSCHUNGSANSTALT LANDWIRTSCHAFT (FAL)
PI BRAUNSCHWEIG
PA BUNDESALLEE 50, 38116 BRAUNSCHWEIG, GERMANY
BN 3-933140-63-3
PY 2002
BP 59
EP 62
PG 4
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA BW59K
UT WOS:000182532400010
DA 2018-10-19
ER

PT B
AU Agnihotri, A
   Siedlecki, CA
AF Agnihotri, A
   Siedlecki, CA
BE Moxon, K
   ElSherif, D
   Kanakasabai, S
TI AFM investigation of molecular level events at biomaterial-biological
   interface
SO PROCEEDINGS OF THE IEEE 28TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT IEEE 28th Annual Northeast Bioengineering Conference
CY APR 20-21, 2002
CL DREXEL UNIV, PHILADELPHIA, PA
SP IEEE EMBS, Exponent, GE Global Res Ctr, Johnson & Johnson, Merck Res Labs, Orthovita, Pfizer
HO DREXEL UNIV
ID FIBRINOGEN
AB Interaction of water and proteins with biomateriaIs constitutes the first events occurring at the biomaterial/biological interface, and these events are believed to guide further responses. In this study we report two aspects of these initial events as studied by atomic force microscopy (AFM). First the time dependent conformational changes in fibrinogen adsorbed on a model hydrophobic biomaterial (graphite) and second, the morphological changes in poly(urethane urea) associated with hydration.
C1 Penn State Univ, Dept Bioengn, Hershey, PA 17033 USA.
RP Agnihotri, A (reprint author), Penn State Univ, Dept Bioengn, Hershey, PA 17033 USA.
CR Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   Garrett JT, 2000, MACROMOLECULES, V33, P6353, DOI 10.1021/ma000600i
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   TINGEY KG, 2000, LANGMUIR, V16, P2744
NR 5
TC 0
Z9 0
U1 2
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7419-3
PY 2002
BP 125
EP 126
DI 10.1109/NEBC.2002.999497
PG 2
WC Engineering, Biomedical
SC Engineering
GA BU42Z
UT WOS:000175970000063
DA 2018-10-19
ER

PT B
AU Bussard, KM
   Vogler, EA
   Siedlecki, CA
AF Bussard, KM
   Vogler, EA
   Siedlecki, CA
BE Moxon, K
   ElSherif, D
   Kanakasabai, S
TI Effective production of FXIIa and thrombin by model biomaterials
SO PROCEEDINGS OF THE IEEE 28TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT IEEE 28th Annual Northeast Bioengineering Conference
CY APR 20-21, 2002
CL DREXEL UNIV, PHILADELPHIA, PA
SP IEEE EMBS, Exponent, GE Global Res Ctr, Johnson & Johnson, Merck Res Labs, Orthovita, Pfizer
HO DREXEL UNIV
AB The initiation of contact activation of the coagulation cascade takes place when Factor XII interacts with a procoagulant surface. Subsequent events include FXII autoactivation to the enzyme FXIIa and formation of a contact activation complex. Additional conversions result in the generation of thrombin and formation of an insoluble fibrin clot. This study examines the ability of a biomaterial to generate FXIIa and thrombin by comparing the procoagulant efficiency of glass beads to soluble aliquots of enzymes. FXIIa induced activation of coagulation saturates at surprisingly dilute concentrations (similar to0.5 mug/ml), and this effect is also seen in surface and thrombin induced contact activation. Preliminary analysis of data suggests that 50 turn 2 glass surface area generates the equivalent of 5 ng of FXIIa, or only similar to0.0125% conversion of physiologic concentration, as well as producing the equivalent of similar to2.65 units/ml of thrombin. Addition of procoagulant (glass) surface was also found to modulate a local minimum observed in FXIIa titration curves. The results observed with FXIIa and biomaterials suggest that an investigation of the mechanisms behind FXIIa and thrombin production by biomaterials, as well as a clearer understanding of how signals propagate down the pathway, are necessary for assembling a detailed mechanism for surface activation.
C1 Penn State Univ, Dept Bioengn, Hershey, PA 17033 USA.
RP Bussard, KM (reprint author), Penn State Univ, Dept Bioengn, Hershey, PA 17033 USA.
OI Bussard, Karen/0000-0002-6519-9300
CR FUHRER G, 1990, BLUT, V61, P258, DOI 10.1007/BF01732874
   Marder V., 1994, HEMOSTASIS THROMBOSI, P3
   WACHTFOGEL YT, 1993, THROMB RES, V72, P1, DOI 10.1016/0049-3848(93)90168-N
NR 3
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7419-3
PY 2002
BP 129
EP 130
DI 10.1109/NEBC.2002.999499
PG 2
WC Engineering, Biomedical
SC Engineering
GA BU42Z
UT WOS:000175970000065
DA 2018-10-19
ER

PT B
AU Longsworth, J
   Eppell, S
AF Longsworth, J
   Eppell, S
BE Moxon, K
   ElSherif, D
   Kanakasabai, S
TI Design and assembly of a sterile nanoscale orthopedic biomaterial
SO PROCEEDINGS OF THE IEEE 28TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT IEEE 28th Annual Northeast Bioengineering Conference
CY APR 20-21, 2002
CL DREXEL UNIV, PHILADELPHIA, PA
SP IEEE EMBS, Exponent, GE Global Res Ctr, Johnson & Johnson, Merck Res Labs, Orthovita, Pfizer
HO DREXEL UNIV
AB This paper details the design and manufacture of a synthetic biomemtic bone biomaterial. The material is a composite of collagen fibrils and nanometer sized mineral apatites to enhance its resorbability over previous hydroxyapatite ceramics and bone cements. An aseptic protocol for producing a sterile composite has been developed and tested It is no;v possible to use this biomaterial in cell experiments.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Longsworth, J (reprint author), Case Western Reserve Univ, Dept Biomed Engn, 10900 Euclid Ave, Cleveland, OH 44106 USA.
OI Eppell, Steven/0000-0002-0302-1910
CR BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9
   Hodge A J, 1989, Connect Tissue Res, V21, P137, DOI 10.3109/03008208909050004
   HOLMES DF, 1986, INT J BIOL MACROMOL, V8, P161, DOI 10.1016/0141-8130(86)90020-6
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Yuasa T, 2001, J BIOMED MATER RES, V54, P344
NR 5
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7419-3
PY 2002
BP 173
EP 174
DI 10.1109/NEBC.2002.999521
PG 2
WC Engineering, Biomedical
SC Engineering
GA BU42Z
UT WOS:000175970000087
DA 2018-10-19
ER

PT S
AU Li, YH
   Rong, LJ
   Li, YY
AF Li, YH
   Rong, LJ
   Li, YY
BE Ge, CC
   Rogachev, AS
TI Porous NiTi alloy prepared from combustion synthesis
SO PROGRESS IN SELF-PROPAGATING HIGH-TEMPERATURE SYNTHESIS
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 1st Sino-Russian Workshop on Self-Propagating High-Temperature Synthesis
CY SEP 21-24, 2000
CL BEIJING, PEOPLES R CHINA
SP Univ Sci & Technol Bijing, Russian Acad Sci, Inst Struct Macrokinet & Mat Sci
DE combustion synthesis; compressive properties; porous NiTi alloy
ID SHAPE-MEMORY; APPOSITION; INGROWTH; IMPLANT
AB Porous NiTi shape memory alloy (SMA) is a promising biomaterial which can be used as replacement of hard tissue implant It was prepared from elemental titanium and nickel powders by method of combustion synthesis. The phase composition, pore and fracture morphology were investigated by X-ray diffraction (XRD) and scanning electron microscopy (SEM) respectively. Meanwhile the compressive mechanical property was also studied. The preliminary data indicated that porous NiTi SMA prepared from combustion synthesis had homogeneous pore distribution and proper mean pore size. The mechanical property of pure product depended strongly on preheating temperature during synthesis process. It has also good superelasticity.
C1 Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
RP Li, YH (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
OI Li, Yong-Hua/0000-0003-0005-3789
CR Ayers RA, 1999, J BIOMED MATER RES, V45, P42
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   GIBSON LJ, 1997, CELLULAR SOLID STRUC, P431
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   Munir Z. A., 1989, Material Science Reports, V3, P277, DOI 10.1016/0920-2307(89)90001-7
   Otsuka K, 1999, INTERMETALLICS, V7, P511, DOI 10.1016/S0966-9795(98)00070-3
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
NR 7
TC 6
Z9 6
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-885-0
J9 KEY ENG MAT
PY 2002
VL 217
BP 137
EP 141
DI 10.4028/www.scientific.net/KEM.217.137
PG 5
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BU11H
UT WOS:000175042000023
DA 2018-10-19
ER

PT B
AU Tsiridis, V
   Persoone, G
AF Tsiridis, V
   Persoone, G
BE Kungolos, AG
   Liakopoulos, AB
   Korfiatis, GP
   Koutsospyros, AD
   Katsifarakis, KL
   Demetracopoulos, AD
TI Toxkit microbiotests: New low cost tools for hazard detection/monitoring
   in environmental toxicology
SO PROTECTION AND RESTORATION OF THE ENVIRONMENT VI, VOLS I - III,
   PROCEEDINGS
LA English
DT Proceedings Paper
CT 6th International Conference on Protection and Restoration of the
   Environment
CY JUL 01-05, 2002
CL SKIATHOS ISL, GREECE
SP Minist Environm, Phys Planning & Public Works, Municipal Skiathos, USA Res, Dev & Standardizat Grp, Magnesia Prefecture, Volos & Nea Ionia Municipal Assoc Solid Waste Disposal, Univ Thessaly, Res Comm, Univ Thessaly, Civil Engn, Univ Thessaly, Dept Planning & Reg Dev, Stevens Inst Technol, HERACLES G C Co S A, SOVEL S A BIOCHALCO Grp, Coca-Cola 3E Hellen Bottling Co, Themeliodomi S A, SCIETACT S A, AIAS RESEARCH Ltd, AIR METAL Ltd, AQUACHEM Ltd, ARVIS Environm Enterprise Greece, Bio Eco Sol S A, Eurotrans Consulting Ltd, ENVITEC S A, INTERGEO EnvironmTechnol Ltd, BAKAKOS S A, APOSTOLAKIS S A ARGO WINE, EPSA S A, Karkanias Environm Technol SA
ID TOXICITY
AB In recent years, attention has gradually focussed on the use of toxicity tests as a useful tool to estimate chemical contamination and its potential impact on terrestrial and aquatic environments. New microbiotests, called Toxkits, have been developed in the Laboratory for Environmental Toxicology and Aquatic Ecology at the Ghent University in Belgium. The new approach is based on the use of "dormant, inactive or immobilized" stages of selected aquatic biota as the biomaterial from which life test organism can easily be obtained on demand to perform the toxicity tests. Several highly standardized "culture/maintenance free" toxicity tests are now commercially available, with selected species of micro-algae, protozoans, rotifers and crustaceans. A brief review of Toxkit microbiotests and their applications is given in this study.
C1 Air Met Ltd, Thessaloniki 55133, Greece.
RP Tsiridis, V (reprint author), Air Met Ltd, Aegeou 75, Thessaloniki 55133, Greece.
EM airmetal@the.forthnet.gr
CR Artoxkit M, 1990, ARTEMIA TOXICITY SCR
   *ASTM, 1991, E1440 ASTM, P1210
   Clement B, 1996, CHEMOSPHERE, V33, P2303
   *EPA, 1993, EPA600490027F
   Hadjispyrou S, 2001, ECOTOX ENVIRON SAFE, V49, P179, DOI 10.1006/eesa.2001.2059
   Kungolos A, 1999, WATER SCI TECHNOL, V40, P357, DOI 10.1016/S0273-1223(99)00384-4
   MARSALEK B, 2000, MICROBIOTESTS ROUTIN, P519
   OECD, 1984, GUID TEST CHEM DAPHN, P1
   *OECD, 1985, GUID TEST CHEM DAPHN, P1
   PERSOONE G, 1991, Zeitschrift fuer Angewandte Zoologie, V78, P235
   Persoone G, 1998, MICROSCALE TESTING IN AQUATIC TOXICOLOGY, P311
   PERSOONE G, 1989, AQUAT TOXICOL, V14, P149, DOI 10.1016/0166-445X(89)90025-8
   Persoone G, 1998, MICROSCALE TESTING IN AQUATIC TOXICOLOGY, P437
   Persoone G, 2000, NEW MICROBIOTESTS RO
   PERSOONE G, 1993, COST EFFECTIVE ACUTE
   Samaras P, 1998, FRESEN ENVIRON BULL, V7, P623
   Thamnotoxkit FTM, 1995, CRUSTACEAN TOXICITY
   VANHAECKE P, 1981, ECOTOX ENVIRON SAFE, V5, P382, DOI 10.1016/0147-6513(81)90012-9
   VANSTEERTEGEM M, 1993, SETAC SP P, P81
NR 19
TC 0
Z9 0
U1 0
U2 3
PU GRAFIMA LOANNIS TSAROUCHIDIS
PI THESSALONIKI
PA 62-68, D GOUNARI, THESSALONIKI 54635, GREECE
BN 960-86574-5-8
PY 2002
BP 809
EP 816
PG 8
WC Engineering, Environmental; Environmental Sciences; Water Resources
SC Engineering; Environmental Sciences & Ecology; Water Resources
GA BV61E
UT WOS:000179504900098
DA 2018-10-19
ER

PT S
AU Nikolovski, J
   Simmons, CA
   Mooney, DJ
AF Nikolovski, J
   Simmons, CA
   Mooney, DJ
GP IEEE
   IEEE
   IEEE
TI Regulation of bone-associated genes in smooth muscle with mechanical
   strain
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE smooth muscle; mechanical strain; calcification
ID CELL
AB Calcification is a common problem associated with cardiovascular disease, injury, aging, and as a result of biomaterial implantation. Osteopontin (OPN) and matrix gla protein (MGP) are key bone-associated molecules in the calcification process, and we hypothesize that mechanical strain is an important signal mediating their expression in the cardiovasculature. To address this, we studied the effects of cyclic mechanical strain (7% strain, 1 Hz) on bone-associated gene expression in rat aortic smooth muscle cells grown in a three-dimensional tissue model. Mechanical strain was found to modulate the expression of OPN, MGP, and CBFA-1, a transcription factor normally found in osteoblasts. Significant increases in their expression were noted without chronic cyclic strain exposure. Long-term strain of these tissues appeared to play a protective role in regards to calcification, as strained tissues exhibited decreased amounts of total calcium with respect to controls. These studies suggest that mechanical strain is an important signal in maintaining the smooth muscle phenotype, and its' absence leads cells to switch to a phenotype that is more bone-like.
C1 Univ Michigan, Ann Arbor, MI 48109 USA.
RP Nikolovski, J (reprint author), Univ Michigan, Ann Arbor, MI 48109 USA.
CR Giachelli C M, 2001, Z Kardiol, V90 Suppl 3, P31
   Hungerford JE, 1999, J VASC RES, V36, P2, DOI 10.1159/000025622
   Kim BS, 2000, J BIOMECH ENG-T ASME, V122, P210, DOI 10.1115/1.429651
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Wada T, 1999, CIRC RES, V84, P166, DOI 10.1161/01.RES.84.2.166
   Wozniak M, 2000, J BONE MINER RES, V15, P1731, DOI 10.1359/jbmr.2000.15.9.1731
NR 6
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 314
EP 315
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800148
DA 2018-10-19
ER

PT S
AU Sorensen, EN
   Burgreen, GW
   Wagner, WR
   Antaki, JF
AF Sorensen, EN
   Burgreen, GW
   Wagner, WR
   Antaki, JF
GP IEEE
   IEEE
   IEEE
TI Simulation of platelet deposition in disturbed flow
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE platelets; thrombosis; computational fluid dynamics; mathematical
   modeling
ID COMPUTATIONAL SIMULATION; ACTIVATION; COLLAGEN
AB We have developed a two-dimensional computational model of platelet-mediated biomaterial thrombosis. When applied to plane Poiseuille flow over collagen, it showed very good agreement with experimental results. Here, we attempt to simulate platelet deposition onto collagen in the presence of disturbed flow in a tubular expansion. At 0% hematocrit, good agreement with experiments is obtained for the recirculation zone, but not for the fully-developed downstream zone. At 20% hematocrit, poor agreement is observed unless the platelet-surface reaction coefficients are altered. In both cases, it appears the deficiencies are due to incomplete modeling of platelet transport mechanisms.
C1 Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
RP Sorensen, EN (reprint author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
CR AARTS PAMM, 1988, ARTERIOSCLEROSIS, V8, P819, DOI 10.1161/01.ATV.8.6.819
   KARINO T, 1979, MICROVASC RES, V17, P238, DOI 10.1016/S0026-2862(79)80002-3
   Sorensen EN, 1999, ANN BIOMED ENG, V27, P436, DOI 10.1114/1.200
   Sorensen EN, 1999, ANN BIOMED ENG, V27, P449, DOI 10.1114/1.201
   ZYDNEY A, 1988, PHYSICO CHEM HYDRODY, V10, P79
NR 5
TC 2
Z9 2
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 390
EP 391
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800186
DA 2018-10-19
ER

PT S
AU Janis, AD
   Lagerquist, KA
   Hinds, MT
AF Janis, AD
   Lagerquist, KA
   Hinds, MT
GP IEEE
   IEEE
   IEEE
TI Directional permeability in a porcine carotid elastin biomaterial
   vascular conduit - 2(nd) Joint Conference of the IEEE Engineering in
   Medicine and Biology Society and the Biomedical Engineering Society
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE elastin; vascular; permeability
AB Purified porcine carotid elastin is under development as a substrate for a vascular conduit. The permeability of the graft may have implications in recellularlization. Light and scanning electron microscopy indicate that the lumen and adventitial surfaces have unique extracellular matrix morphology. This study investigates the permeability of the material, with consideration of the direction of the flow. The permeability of the adventitial surface was found to be approximately twice that of the lumenal surface. The mean permeability was 0.0123 +/- 0.005 mL/min*cm(2) for flow through from lumen surface to the adventitial surface and 0.0310 +/- 0.007 mL/min*cm(2) for flow through the adventitial surface to the lumen surface. The difference in elastin architecture can be taken advantage of to optimize recellularization in vitro and in vivo This is only the second biomaterial to have this described behavior.
C1 Providence St Vincent Hosp, Oregon Med Laser Ctr, Portland, OR USA.
RP Janis, AD (reprint author), Providence St Vincent Hosp, Oregon Med Laser Ctr, Portland, OR USA.
CR FERRAND BK, 1993, J BIOMED MATER RES, V27, P1235, DOI 10.1002/jbm.820271004
   WESOLOWSKI SA, 1962, EVALUATION TISSUE PR
NR 2
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 413
EP 414
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800197
DA 2018-10-19
ER

PT S
AU Shea, LD
   Whittlesey, KJ
   Segura, T
   Jang, J
   Yang, Y
AF Shea, LD
   Whittlesey, KJ
   Segura, T
   Jang, J
   Yang, Y
GP IEEE
   IEEE
   IEEE
TI Tissue engineering scaffolds for controlled protein and plasmid delivery
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE tissue engineering; gene therapy; drug delivery
ID MATRICES
AB Tissue engineering approaches employ polymer scaffolds to supports, promote, and direct tissue formation by progenitor cells, which are either present in the surrounding tissue or transplanted with the polymer. We hypothesize that scaffolds capable of delivering tissue-inductive factors, or genes encoding for these factors, at the correct time and location, and in the appropriate concentration could enhance the effectiveness of current regenerative approaches. Scaffolds have been developed that provide a controlled, sustained delivery of protein and non-viral DNA. Polymeric scaffolds capable of sustained drug release can be fabricated by the assembly of drug-loaded microspheres and subsequent fusion of the microspheres using a gas foaming process. This process has been developed to regulate the amount released and the release rates for protein, naked DNA, and DNA complexed with cationic lipid and polymers. Alternatively, we have developed a controlled DNA delivery system based on the tethering of DNA complexes to a biomaterial surfaces. Complexes can be immobilized at high densities and cells cultured on the substrates can internalize and express the DNA. These systems for the controlled delivery of proteins, or DNA-encoding for these proteins, are versatile and can be readily applied to the regeneration of various tissues.
C1 Northwestern Univ, Dept Chem Engn, Evanston, IL 60208 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem Engn, Evanston, IL 60208 USA.
RI Shea, Lonnie/B-7615-2009
CR Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
NR 2
TC 1
Z9 1
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 474
EP 474
PG 1
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800227
DA 2018-10-19
ER

PT S
AU Ghosh, K
   Chen, WL
   Rafailovich, M
   Ge, SR
AF Ghosh, K
   Chen, WL
   Rafailovich, M
   Ge, SR
GP IEEE
   IEEE
   IEEE
TI Formulation and characterization of biodegrdable hyaluronan (HA) gene
   delivery films
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE crosslinking; hydrophobicity; HA films
AB Hyaluronan is a naturally occurring polysaccharide found in the human body. Its unique physical/chemical properties make HA a prospective biomaterial for clinical applications. Gene Delivery coronary stent coating can be formulated using HA. 1 % HA (a gel) was used to make the HA and HA-DNA-Protamine films. The films were cross-linked with Adipic dihydrazide. Atomic Force Microscopy (AFM) on the dried films was done to determine a) surface topography at nm- and mum- resolution and b) relative Young's Modulus. Results indicated the overnight crosslinked films to have a relatively higher Young's modulus as compared to the 4-hour crosslinked ones. Comparison of the surface topography of the HA-DNA films (with 2.5% and 5% DNA loading) revealed the DNA-Protamine on the film sample. Results of Contact angle measurements indicate that the films with 4-hour crosslinking have smaller contact angles, indicating lesser hydophobicity than the overnight crosslinked samples. The results obtained from the AFM and contact angle assays thereby suggest that crosslinking of HA and HA-DNA Protamine films renders them more hydrophobic, and thereby more suitable for gene delivery applications.
C1 SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
RP Ghosh, K (reprint author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
CR Adam N, 2001, INFLAMM RES, V50, P294, DOI 10.1007/PL00000247
   Engstrom PE, 2001, J PERIODONTOL, V72, P1192, DOI 10.1902/jop.2000.72.9.1192
   Ge S, 2000, PHYS REV LETT, V85, P2340, DOI 10.1103/PhysRevLett.85.2340
   LARSEN NE, 1993, J BIOMED MATER RES, V27, P1129, DOI 10.1002/jbm.820270903
   POUYANI T, 1994, BIOCONJUGATE CHEM, V5, P339, DOI 10.1021/bc00028a010
   POUYANI T, 1997, Patent No. 5616568
   PRESTWICH GD, CONTROLLED CHEM MODI, P93
NR 7
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 541
EP 542
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800261
DA 2018-10-19
ER

PT S
AU Ai, H
   Lvov, YM
   Mills, DK
   Meng, HD
   Qiao, XX
   Alexander, JS
   Jones, SA
AF Ai, H
   Lvov, YM
   Mills, DK
   Meng, HD
   Qiao, XX
   Alexander, JS
   Jones, SA
GP IEEE
   IEEE
   IEEE
TI Coating bio-nanofilm on PDMS through layer-by-layer self-assembly
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE PDMS; bio-nanofilm; layer-by-layer; cell adhesion; self-assembly
ID FILMS
AB PDMS is a popular biomaterial, and its surface modification with biocompatible ultrathin films may have potential applications in many biomedical areas. The technique of electrostatic Layer-by-Layer (LbL) assembly of polyions has been widely used in recent years to form ultrathin films. In this study, cationic Poly(ethyleneimine) (PEI) and anionic poly(styrene sulfonate) (PSS) were alternately adsorbed onto PDMS through LbL self-assembly. Then poly-D-lysine, gelatin, collagen, fibronectin, laminin, hyaluronic acid, and heparin were coated on PDMS through LbL assembly by alternate adsorption with oppositely charged polyelectrolytes. The film coated on PDMS was hydrophilic compared to the PDMS substrate, as verified through contact angle measurement. The film thickness could be controlled precisely with an accuracy of nanometers by varying the number of layers. The protein nanofilm was biocompatible, enabling endothelial cells, nerve cells, hepatocytes, or smooth muscle cells to adhere and grow. No cell growth was found on the unmodified PDMS substrate.
C1 Louisiana Tech Univ, Dept Biomed Engn, Ruston, LA 71272 USA.
RP Ai, H (reprint author), Louisiana Tech Univ, Dept Biomed Engn, Ruston, LA 71272 USA.
CR Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   KELLER SW, 1994, J AM CHEM SOC, V116, P8817, DOI 10.1021/ja00098a055
   LVOV Y, 1993, LANGMUIR, V9, P481, DOI 10.1021/la00026a020
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
NR 5
TC 5
Z9 5
U1 0
U2 10
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 608
EP 609
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800294
DA 2018-10-19
ER

PT S
AU Brown, CT
   Weng, ZP
   Zhang, H
   Wong, JY
AF Brown, CT
   Weng, ZP
   Zhang, H
   Wong, JY
GP IEEE
   IEEE
   IEEE
TI Mutational analysis verifies that "kneed" sequence of fibronectin
   participates in cell-substrate interactions
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE adhesion; bioadhesion; tissue engineering
ID RECOGNITION; DOMAINS; RGD
AB Interactions between cell-surface integrins and extracellular matrix (ECM) proteins underlie a versatile recognition system providing cells with anchorage and traction for migration or matrix remodeling. Short peptide sequences of fibronectin (FN), most notably RGD found on a loop in the tenth type III domain, are effective in promoting cell adhesion when immobilized to a biomaterial scaffold. Using bioinformatics, we identified a candidate cell-binding peptide sequence, KNEED, located on the loop region of the 8(th) domain of fibronectin that from in vitro studies appears to participate in cell attachment and spreading. To demonstrate its importance, the KNEED sequence of Fibronectin type III domains 7-10 (FN7-10) was mutated to AAAAA or SNSSS (FN7-10 AAAAA and FN7-10 SNSSS respectively). Wildtype and mutant proteins were expressed in E. omegali, purified by conventional chromatography and tested in cell adhesion assays. Results indicate that the extent of cell spreading on surfaces coated with either FN7-10 AAAAA or FN7-10 SNSSS was measurably less than on surfaces coated with wildtype FN7-10. Mutational analysis may aid in the characterization of new targets for applications where biorecognition plays a key role.
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Brown, CT (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
RI Wong, Joyce/F-3732-2011
OI Wong, Joyce/0000-0002-3526-6381
CR AUKHIL I, 1993, J BIOL CHEM, V268, P2542
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   KIMIZUKA F, 1991, J BIOCHEM-TOKYO, V110, P284, DOI 10.1093/oxfordjournals.jbchem.a123572
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   WONG JY, IN PRESS BIOMATERIAL
NR 6
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 614
EP 615
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800297
DA 2018-10-19
ER

PT S
AU Yoshida, M
   Babensee, JE
AF Yoshida, M
   Babensee, JE
GP IEEE
   IEEE
   IEEE
TI Assessment of monocyte derived dendritic cell phenotype upon biomaterial
   contact in vitro
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE biomaterial; dendritic cells
AB Immune response remains a concern associated with the successful integration of tissue engineered device into living systems. Upon implantation, both living and non-living device components elicit a specific immune and a nonspecific inflammatory response, respectively. We hypothesize that biomaterial contact is a maturation stimulus for dendritic cells (DC), the antigen presenting cells that activate T cells and initiate adaptive immunity. Maturation of DC was reconstituted by culturing human blood monocytes with GM-CSF and IL-4 to induce differentiation into immature DC (iDC). iDC were then treated with 4 mum poly(lactic-co-glycolic) acid microparticles (PLGA MP), or with LPS to yield mature DC (mDC) as positive control. Cell morphology and surface phenotype were monitored as a function of time. On day 10, biomaterial- treated cells morphologically most closely resembled mDC with dendritic processes. In contrast and as expected, monocytes/ macrophages did not exhibit processes and expressed high levels of CD14. mDC expressed high levels of costimulatory and MHC molecules compared to iDC. Our preliminary, results show that biomaterial microparticles were phagocytosed, and the level of costimulatory and MHC molecules expression by biomaterial- treated cells was between that expressed by iDC and mDC.
C1 Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
RP Yoshida, M (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
CR Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
NR 1
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 619
EP 620
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800299
DA 2018-10-19
ER

PT S
AU Leach, JB
   Patrick, CW
   Schmidt, CE
AF Leach, JB
   Patrick, CW
   Schmidt, CE
GP IEEE
   IEEE
   IEEE
TI Directing tissue regeneration via hyaluronic acid hydrogel scaffolds
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE biomaterial; hyaluronic acid; biodegradable; polymer;
   photopolymerization; tissue engineering
AB Comprehensive regeneration therapies should provide a bioactive, degradable support structure as well as promote the ingrowth of new blood vessels and nerves. The ultimate goal of our research is to synthesize a biomimetic tissue engineering hydrogel that will promote rapid incorporation of the scaffold with the host's vascular and nervous systems. Hyaluronic acid (HA), a naturally occurring non-immunogenic polymer, is inherently angiogenic and involved with neural development and regeneration. HA presents unique advantages due to its ease of production and modification, hydrophilic and non-adhesive character, natural biodegradation and prominent role in scar-free wound healing. Therefore, the aim of the research presented here is to utilize HA's distinctive advantages to create a novel scaffold suitable for supporting angiogenesis and neurite outgrowth. We have chemically modified HA with methacrylate groups and used photo-initiated polymerization to synthesize cross-linked HA hydrogels, resulting in a selection of materials that span a range of physiochemical and biochemical properties. In vitro and in vivo studies have been used to assess the hydrogels' potential to support angiogenesis and nerve repair. Finally, we seek to modify HA's non-adhesiveness through the addition of bioactive sequences to tune the specific cellular responses to the material.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
RP Leach, JB (reprint author), Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
CR Anseth KS, 2002, MRS BULL, V27, P130, DOI 10.1557/mrs2002.49
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   KING TW, IN PRESS INTERNET J
   LEACH JB, UNPUB HYALURONIC ACI
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Stocum David L., 1998, Wound Repair and Regeneration, V6, P276, DOI 10.1046/j.1524-475X.1998.60404.x
NR 6
TC 1
Z9 1
U1 1
U2 6
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 753
EP 754
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800361
DA 2018-10-19
ER

PT S
AU Brieva, TA
   Moghe, PV
AF Brieva, TA
   Moghe, PV
GP IEEE
   IEEE
   IEEE
TI Hepatocellular engineering via acellular cadherin-derived
   microinterfaces
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE cadherin; biomaterial; hepatocyte; differentiation
ID DIFFERENTIATION; HEPATOCYTES
AB The development of cell-based therapies for liver failure relies on the availability of scaffolds that support high levels of cellular function. In this work, we functionalize biomaterial surfaces using a novel cell-based ligand as an alternative to traditional extracellular matrix-derived ligands. Initial studies in a model coculture system indicate that E-cadherin, a key cell-cell adhesion molecule present on hepatocytes, enhances liver-specific function when presented by chaperone cells. We then investigate the behavior of hepatocytes on acellular cadherin-presenting immobilized microparticle-based biomaterials. Biologically activity of acellular cadherins is ensured by appending to the extracellular domain of E-cadherin to an immunoglobulin Fc region, which induces dimerization and specifically adheres to a Protein A coating on the microbeads. Hepatocellular function was elevated on these surfaces as compared to control, Fc presenting surfaces. Both surfaces exhibited similar cell adhesion and morphogenesis, suggesting that induction of hepatocyte function by cadherins was due to signaling activities rather than adhesive activities. Overall, we have demonstrated that functionalization of biomaterials with acellular cadherins is a powerful way to induce hepatocyte function.
C1 Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08855 USA.
RP Brieva, TA (reprint author), Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08855 USA.
CR Brieva TA, 2001, BIOTECHNOL BIOENG, V76, P295, DOI 10.1002/bit.10041
   Goichberg P, 1998, MOL BIOL CELL, V9, P3119, DOI 10.1091/mbc.9.11.3119
   Jayaraman A, 2000, METAB ENG, V2, P239, DOI 10.1006/mben.2000.0153
   Knudsen K A, 1998, J Cell Biochem Suppl, V30-31, P168
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mariadason JM, 2001, CANCER RES, V61, P3465
   MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308
   Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738
NR 8
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 778
EP 779
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800373
DA 2018-10-19
ER

PT S
AU Fisher, JP
   Lalani, Z
   Demian, N
   Wong, MEK
   Mikos, AG
AF Fisher, JP
   Lalani, Z
   Demian, N
   Wong, MEK
   Mikos, AG
GP IEEE
   IEEE
   IEEE
TI Immunohistochemical characterization of guided bone formation by a
   biodegradable-tissue engineering scaffold in a healing tooth socket of a
   rabbit model
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE tissue engineering; scaffold; bone formation; immunohistochemistry
ID FUMARATE)
AB We have developed a novel, biocompatible, biodegradable tissue engineering scaffold that has been shown to facilitate bone formation in vivo. The process of bone formation within this scaffold, however, is unknown at a molecular level. To study this process, a rabbit's four healing incisor sockets (two mandibular and two maxillar) that remain after tooth extraction were used as a bone defect model. One socket was left empty, while the remaining three were filled with crosslinked polymer networks formed from either the hydrophobic polymer poly(propylene fumarate) (PPF), the hydrophilic oligomer oligo(poly(ethylene glycol) fumarate) (OPF), or PPF with adsorbed transforming growth factor - beta1 (PPF+TGF-beta1). At 4 days, 1 week, 2 weeks, 4 weeks, 8 weeks, and 16 weeks both the mandible and maxilla were removed and prepared for histological analysis. Using immunohistochemical techniques, frozen sections were stained for the presence of TGF-beta1, platelet derived growth factor (PDGF), fibroblast growth factor - 2 (FGF-2), vascular endothelial growth factor (VEGF), and bone morphogenetic protein - 2 (BMP-2). Results indicate the effect of differing biomaterial properties upon bone formation as described by the spatial and temporal development of those growth factors. thought to be intimately involved in the process.
C1 Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
RP Fisher, JP (reprint author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
CR BUCKWALTER JA, 1995, J BONE JOINT SURG AM, V77A, P1276, DOI 10.2106/00004623-199508000-00020
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Jo S, 2001, MACROMOLECULES, V34, P2839, DOI 10.1021/ma001563y
   SHUNG AK, IN PRESS J BIOMATER
NR 4
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 827
EP 828
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800398
DA 2018-10-19
ER

PT S
AU McKenzie, JL
   Cardona, BE
   Shi, R
   Webster, TJ
AF McKenzie, JL
   Cardona, BE
   Shi, R
   Webster, TJ
GP IEEE
   IEEE
   IEEE
TI Cytocompatibility of carbon nanofibers for use as a neural biomaterial
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE carbon nanofibers; neural biomaterial; cytocompatibility; astrocytes;
   neurons
ID NANOPHASE CERAMICS; OSTEOBLAST
AB Carbon nanoribers possess excellent conductivity properties, which may be beneficial in the design of more effective neural prostheses. The objective of the present in vitro study was to determine cytocompatibility properties of carbon nanofibers pertinent for neuronal prosthetic applications. Carbon fibers were compacted in a manual hydraulic press via a uniaxial loading cycle. The substrates were prepared from four different types of carbon fibers, two with nanoscale diameters and two with microscale diameters. In these two categories, both a high and a low surface energy fiber were investigated. Astrocytes (glial scar tissue-forming cells) were seeded onto the substrates for adhesion, proliferation, and long-term function studies. Astrocytes preferentially adhered, proliferated, and showed the greatest alkaline phosphatase activity on the carbon fiber that had the largest diameter and the lowest surface energy. For this reason, carbon fibers in the nanometer regime with high surface energies may limit astrocyte interactions. Positive interactions with neurons, and, at the same time, limited astrocyte functions leading to scar tissue formation are essential for increased neuronal implant efficacy.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP McKenzie, JL (reprint author), Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
CR Kam L, 1999, BIOMATERIALS, V20, P2343, DOI 10.1016/S0142-9612(99)00163-5
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   XINYAN C, 2001, J BIOMED MATER RES, V56, P261
NR 5
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 2119
EP 2120
DI 10.1109/IEMBS.2002.1053197
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194801039
DA 2018-10-19
ER

PT S
AU Simpson, KH
   Bowden, MG
   Hook, M
   Anvari, B
AF Simpson, KH
   Bowden, MG
   Hook, M
   Anvari, B
GP IEEE
   IEEE
   IEEE
TI Quantification of S-aureus adhesion to fibronectin using optical
   tweezers
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE bacterial adhesion; biofilm; extracellular matrix; infection
ID FORCES
AB Biomaterial infection, a common cause of medical device failure, is initiated by bacterial adhesion to an adsorbed protein layer on the implant surface. This adhesion is thought to be mediated by specific molecules present on the bacterial cell surface. We have used optical tweezers to measure the adhesive force between a single bacterium and a protein-coated surface. A bacterium was optically trapped and brought in contact with a 10-mum diameter polystyrene microsphere coated with fibronectin. The minimum force required to detach the cell from the bead was determined over a range of fibronectin concentrations. The detachment forces were integer multiples of a 25-pN base value that was independent of coating concentration; we propose that the variation in force is related to the number of bonds formed.
C1 Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
RP Simpson, KH (reprint author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
CR FELGNER H, 1995, APPL OPTICS, V34, P977, DOI 10.1364/AO.34.000977
   Fischetti VA, 2000, GRAM-POSITIVE PATHOGENS, P11
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1
   SMELTZER MS, 2000, HDB BACTERIAL ADHESI, P411
   SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335
   WRIGHT WH, 1994, APPL OPTICS, V33, P1735, DOI 10.1364/AO.33.001735
NR 7
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 2277
EP 2278
DI 10.1109/IEMBS.2002.1053280
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194801116
DA 2018-10-19
ER

PT S
AU Yi, YB
   Wang, H
   Sastry, AM
   Lamberson, L
AF Yi, YB
   Wang, H
   Sastry, AM
   Lamberson, L
BE McGowan, AMR
TI Network formation and percolation: biomaterial-inspired probabilistic
   modeling
SO SMART STRUCTURES AND MATERIALS 2002: INDUSTRIAL AND COMMERCIAL
   APPLICATIONS OF SMART STRUCTURES TECHNOLOGIES
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2002 Conference
CY MAR 18-21, 2002
CL SAN DIEGO, CA
SP SPIE, Amer Soc Mech Engineers, Soc Exptl Mech, Boeing Co, Rhombus Consultants Grp, CSA Engn, ISIS Canada, USAF Off Sci Res, Def Adv Res Projects Agcy, Intelligent Mat Forum, USA Res OFf, Jet Propuls Lab, Natl Sci Fdn, Ceram Soc Japan, USN Off Naval Res, Nav Res Lab
DE percolation; network; fiber; ellipse; conduction; optimization; sea
   urchin; battery
ID EGG EXTRACELLULAR LAYERS; SHEAR-STRESS
AB The extracellular layers ("jelly coat,,) of the sea urchin egg are used as a model system for understanding the role of stochastically-placed fibers in providing reinforcement. We present preliminary results of deformation of the egg, and at a smaller scale, some results on percolation modeling of fibrous materials to determine percolation points in closed-form. We suggest some general methodologies for analysis of extracellular matrices based on this work, with implications for design in engineered structures.
C1 Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.
RP Yi, YB (reprint author), 2250 GG Brown Bldg,2350 Hayward St, Ann Arbor, MI 48109 USA.
CR BONNELL BS, 1994, DEV BIOL, V162, P313, DOI 10.1006/dbio.1994.1088
   CONIGLIO A, 1977, J PHYS A-MATH GEN, V10, P219, DOI 10.1088/0305-4470/10/2/011
   CONIGLIO A, 1977, J PHYS A-MATH GEN, V10, P1123, DOI 10.1088/0305-4470/10/7/011
   Drory A, 1997, PHYS REV E, V55, P3878, DOI 10.1103/PhysRevE.55.3878
   Gartner L. P., 1997, COLOR TXB HISTOLOGY
   MEAD KS, 1995, BIOL BULL-US, V188, P46, DOI 10.2307/1542066
   PIKE GE, 1974, PHYS REV B, V10, P1421, DOI 10.1103/PhysRevB.10.1421
   SYKES MF, 1963, PHYS REV LETT, V10, P3, DOI 10.1103/PhysRevLett.10.3
   Thomas FIM, 1999, BIOL BULL, V197, P7, DOI 10.2307/1542991
   Thomas FIM, 2001, J EXP BIOL, V204, P815
   Thomas FIM, 1999, J EXP BIOL, V202, P3111
NR 11
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4446-4
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4698
BP 212
EP 219
DI 10.1117/12.475067
PG 8
WC Engineering, Aerospace; Engineering, Electrical & Electronic;
   Instruments & Instrumentation; Materials Science, Composites
SC Engineering; Instruments & Instrumentation; Materials Science
GA BV06K
UT WOS:000177732700021
DA 2018-10-19
ER

PT B
AU Gupta, N
   Mallik, H
   Sarkar, A
AF Gupta, N
   Mallik, H
   Sarkar, A
BE Chowdari, BVR
   Prabaharan, SRS
   Yahaya, M
   Talib, IA
TI An experimental syudy of electrical character of proteins
SO SOLID STATE IONICS: TRENDS IN THE NEW MILLENNIUM, PROCEEDINGS
LA English
DT Proceedings Paper
CT 8th Asian Conference on Solid State Ionics
CY DEC 15-19, 2002
CL LANGKAWI, MALAYSIA
SP Asian Soc Solid State Ion
AB Various experimental studies on biomaterials are carried so far. The electrical and thermodynamic studies show that many biomaterial or biopolymers in solid state like a class of plant gum, animal glue, membranes, natural silk, bird feathers etc are solid ionic conductors. Their total electrical conductivity are comparable to that of synthetic polymers doped with inorganic salts. This present work is carried over various protenous biomaterials namely natural silk, animal gum, membranes, bird feathers and powdered enzyme and bacteria. The results of electrical measurements thus obtained exhibit special characteristics in its electrical conductivity sigma(omega) namely some anomalous behavior in their frequency dispersion. Each of the mentioned element exhibit a common discontinuity of sigma(omega), which have been identified as characteristics of conduction through structural protein. A possible theoretical explanation of the observed phenomenon has also been attempted here.
C1 BK Girls Coll, Dept Phys, Howrah 711101, India.
RP Sarkar, A (reprint author), BK Girls Coll, Dept Phys, Howrah 711101, India.
EM alokesarkar@vsnl.net
CR COLOMBAN P, 1992, PROTON CONDUCTORS, P389
   FANCKHON E, 2000, STRUCTURE DYNAMICS B, pCH1
   HODGE IM, 1977, J CHEM PHYS, V67, P1647, DOI 10.1063/1.434997
   Ichiye T, 1999, AIP CONF PROC, V492, P431, DOI 10.1063/1.1301541
   Jonscher A.K., 1983, DIELECTRICS RELAXATI
   KRISHNASWAMY S, 1996, SERICULTURE MANUAL, V3
   LOFTLER G, 1997, J MOL BIOL, V270, P520
   PENNINGTON SR, 2001, PROTEOMICS, pCH3
   POHORILLE A, 1999, SIMULATION THEORY EL, P49492
   SMITH PE, 1993, J PHYS CHEM-US, V97, P2009, DOI 10.1021/j100111a046
   WAGNER JB, 1957, J CHEM PHYS, V26, P1597, DOI 10.1063/1.1743590
   Zhang LY, 1999, AIP CONF PROC, V492, P451, DOI 10.1063/1.1301542
   1998, BIO ELECT HDB MOSFET, P101
NR 13
TC 1
Z9 1
U1 1
U2 1
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
BN 981-238-248-8
PY 2002
BP 823
EP 829
DI 10.1142/9789812776259_0098
PG 7
WC Electrochemistry; Materials Science, Multidisciplinary; Physics,
   Condensed Matter
SC Electrochemistry; Materials Science; Physics
GA BX43Z
UT WOS:000185284700098
DA 2018-10-19
ER

PT J
AU Pudney, PDA
   Hancewicz, TM
   Cunningham, DG
AF Pudney, PDA
   Hancewicz, TM
   Cunningham, DG
TI The use of confocal Raman spectroscopy to characterise the
   microstructure of complex biomaterials: foods
SO SPECTROSCOPY-AN INTERNATIONAL JOURNAL
LA English
DT Article; Proceedings Paper
CT 1st International Conference on Biomedical Spectroscopy
CY JUL 07-10, 2002
CL CARDIFF, WALES
ID DEPTH RESOLUTION; MICROSCOPY
AB The properties and behaviour of many biomaterials often depends crucially on their microstructure. This is especially true of the largest class of biomaterials in use, foods. They include general properties, e.g., food texture, and others, such as spreadability of margarine/butter, pourablity of ketchup, scoopablity of ice cream, and also flavour release (a problem that has much in common with drug delivery), to name but a few. Thus, most food laboratories do a large amount of work in rheology and microscopy to relate structure and properties. However, a knowledge gap exists, i.e., what is the location and quantity of ingredients/molecules within a structure? Both of these questions need to be answered if a complete understanding is to be obtained. The "what is where" question can sometimes be answered by using various microscopic labelling techniques, although there can be many problems with these methods. Bulk separation is often attempted, followed by some kind of more classical analysis, but this is often either not possible or may cause some kind of uncontrolled perturbation. Thus, the ability to obtain quantitative information in situ within a microstructure has been an unobtained goal in much of food science research. These types of questions are, of course, also asked in many related fields of research.
   This paper will illustrate how the advances in confocal Raman spectroscopy have allowed this problem to be tackled, in a non-invasive way. It will show how careful development of experimental procedures and advances in data analysis methods, allow even quantitative maps of microstructures to be obtained. The details of this approach will be described including a discussion of the limitations of current methods, especially depth resolution, and how these were overcome. The use of these methods will be illustrated with a gelled mixture of two carbohydrate polymers, kappa-carageenan and gellan. Despite being similar polymers, and hence having highly overlapping spectra, the pure spectral components can be separated using a chemometrics based method, multivariate curve resolution (MCR). The principles of this method will be described. Under certain concentration regimes these two biopolymers phase separate. This property can be used to produce different microstructures. Two different microstructures were produced and mapped using Raman spectroscopy. This data was analysed using the MCR method to show the relative locations of the two polymers within the microstructure. Furthermore, by augmenting the data from these maps with calibration data for the two bioploymers, quantitative maps were produced. The resultant concentrations can then be used to produce tie lines for the kappa-carageenan/gellan phase diagram, which is essential for understanding and manipulating the structure and properties in a systematic way. This methodology can be readily extended to much more complex multicomponent systems, such as complete food products.
   This paper shows that the combination of the confocal Raman spectroscopy and MCR data analysis methodology is very powerful and is readily applicable in many areas of research, especially the biomaterial/biomedical fields.
C1 Unilever Bestfoods R&D, Colworth Lab, Sharnbrook MK44 1LQ, Beds, England.
   Unilever R&D US Edgewater Lab, Edgewater, NJ USA.
CR Andrew JJ, 1998, APPL SPECTROSC, V52, P797, DOI 10.1366/0003702981944526
   Baldwin KJ, 2001, APPL SPECTROSC, V55, P517, DOI 10.1366/0003702011952190
   Durrani CM, 1995, CARBOHYD POLYM, V28, P297, DOI 10.1016/0144-8617(95)00107-7
   Everall NJ, 2000, APPL SPECTROSC, V54, P1515, DOI 10.1366/0003702001948439
   Everall NJ, 2000, APPL SPECTROSC, V54, P773, DOI 10.1366/0003702001950382
   HANCEWICZ TM, UNPUB
   Malinowski E. R., 1987, J CHEMOMETR, V1, P33
   MALINOWSKI ER, 1977, ANAL CHEM, V49, P612, DOI 10.1021/ac50012a027
   MALINOWSKI ER, 1977, ACS S SER, V52, pCH3
   Normand V, 2000, J APPL POLYM SCI, V77, P1465, DOI 10.1002/1097-4628(20000815)77:7<1465::AID-APP8>3.0.CO;2-F
   Otto C, 1997, J RAMAN SPECTROSC, V28, P143
   PUDNEY PDA, UNPUB FOOD HYDROCOLL
   PUDNEY PDA, 2000, P 17 C RAM SPECTR
   WILLIAMS KPJ, 1995, J RAMAN SPECTROSC, V26, P427, DOI 10.1002/jrs.1250260606
NR 14
TC 22
Z9 22
U1 0
U2 11
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0712-4813
J9 SPECTROSC-INT J
JI Spectr.-Int. J.
PY 2002
VL 16
IS 3-4
SI SI
BP 217
EP 225
DI 10.1155/2002/726874
PG 9
WC Biochemical Research Methods; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 618WA
UT WOS:000179439200014
OA Other Gold, Bronze
DA 2018-10-19
ER

PT J
AU Mansur, H
   Orefice, R
   Pereira, M
   Lobato, Z
   Vasconcelos, W
   Machado, L
AF Mansur, H
   Orefice, R
   Pereira, M
   Lobato, Z
   Vasconcelos, W
   Machado, L
TI FTIR and UV-vis study of chemically engineered biomaterial surfaces for
   protein immobilization
SO SPECTROSCOPY-AN INTERNATIONAL JOURNAL
LA English
DT Article; Proceedings Paper
CT 1st International Conference on Biomedical Spectroscopy
CY JUL 07-10, 2002
CL CARDIFF, WALES
ID BOVINE SERUM-ALBUMIN; PORCINE INSULIN; GEL; ENCAPSULATION; ADSORPTION;
   SILICATE; NETWORKS; GLASS
AB The biomaterials research field has broadened in the last 3 decades, including replacement of diseased or damaged parts, assist in healing, correct and improve functional abnormality, drug delivery systems, immunological kits and biosensors. Proteins play crucial role in almost every biological system. They are involved in enzymatic catalysis, transport and storage, coordinated motion, mechanical support, immune protection, control of growth and cell differentiation among many others. The immobilization of proteins onto surface functionalized substrates has been one of the most promising areas in bioengineering field. It is important to note that the term immobilization can refer either to a temporary or to a permanent localization of the biomolecule on or within a support. Proteins have very particular chain configurations and conformations that promote high levels of specificity during chemical interactions. In the present work, we aimed to study the phenomenon of protein immobilization onto biomaterial with chemically engineered surface. We have tailored the surface of the porous gels of SiO2 with 5 different silane surface modifying agents: tetraethoxysilane (TEOS), 3-mercaptopropyltrimethoxysilane (MPTMS) and 3-aminopropyltriethoxysilane (APTES), 3-glycidoxypropyltrimethoxysilane (GPTMS) and 3-isocyanatopropyltriethoxysilane (ICPES). Fourier Transform Infrared Spectroscopy (FTIR) was used to characterize the presence of all specific chemical groups in the materials. The surface functionalized gels were then immersed in porcine insulin (PI) solutions for protein immobilization. The incorporation of protein within the gels was also monitored by FTIR spectroscopy. The kinetics of protein adsorption and desorption from the gel matrix in vitro tests were monitored by UV-visible spectroscopy. We could not observe any evidence of denaturation of insulin after its desorption from gel matrices using UV-visible spectroscopy technique. In vivo tests with adult male rats were used to verify the immobilized insulin bioactivity after implantation of different biomaterial with functionalized surfaces. Plasma glucose levels were obtained by using the Glucose GOD-ANA Colorimetric Assay. All surface modified materials have presented acute hypoglycemic peak response associated with the insulin bioactivity.
C1 Univ Fed Minas Gerais, Dept Met & Mat Engn, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Vet Med, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Sch Med, Dept Internal Med, Belo Horizonte, MG, Brazil.
RI Orefice, Rodrigo/N-8055-2018
OI Orefice, Rodrigo/0000-0002-6046-4056; Mansur,
   Herman/0000-0002-3032-495X; Lobato, Zelia/0000-0002-9399-3691
CR Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Copeland R. A., 1994, METHODS PROTEIN ANAL
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X
   LIVAGE J, 1994, P SOC PHOTO-OPT INS, V2288, P493, DOI 10.1117/12.188984
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LU CF, 1994, J COLLOID INTERF SCI, V168, P152, DOI 10.1006/jcis.1994.1404
   MALMSTEN M, 1998, BIOPOLYMERS INTERFAC, P143
   Mansur HS, 2001, ADSORPTION, V7, P105, DOI 10.1023/A:1011687706161
   Mansur HS, 2000, BIOMACROMOLECULES, V1, P789, DOI 10.1021/bm0056198
   McDonagh C, 1998, ANAL CHEM, V70, P45, DOI 10.1021/ac970461b
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   YAMAGUCHI N, 1992, CAN J PHYSIOL PHARM, V70, P167, DOI 10.1139/y92-024
   ZUSMAN R, 1992, ANAL BIOCHEM, V201, P103, DOI 10.1016/0003-2697(92)90180-F
NR 17
TC 36
Z9 37
U1 1
U2 16
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0712-4813
J9 SPECTROSC-INT J
JI Spectr.-Int. J.
PY 2002
VL 16
IS 3-4
SI SI
BP 351
EP 360
DI 10.1155/2002/183053
PG 10
WC Biochemical Research Methods; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 618WA
UT WOS:000179439200029
OA Bronze, Other Gold
DA 2018-10-19
ER

PT S
AU Xu, LY
   Hou, ZD
   Qin, YW
AF Xu, LY
   Hou, ZD
   Qin, YW
BE Wu, X
   Qin, YW
   Fang, J
   Ke, JT
TI The measurement of the Young's modulus of thin or flexible specimen with
   digital image correlation method
SO THIRD INTERNATIONAL CONFERENCE ON EXPERIMENTAL MECHANICS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 3rd International Conference on Experimental Mechanics
CY OCT 15-17, 2001
CL BEIJING, PEOPLES R CHINA
SP Chinese Soc Theoret & Appl Mech, Soc Exptl Mech, Japan Soc Mech Engineers, Mat & Mech Div, British Soc Strain Measurement, SPIE, Int Measurement Confederat, Chinese Soc Theoret & Appl Mech, Comm Exptl Stress Anal
DE dgital image; correlation; Young's modulus; flexible materials;
   bi-image; thin film; composite material
ID FILMS
AB Because some composite material, thin film material, and biomaterial, are very thin and some of them are flexible, the classical methods for measuring their Young's moduli, by mounting extensometers on specimens, are not available. A bi-image (two vision field) method based on image correlation for measuring Young's moduli is developed in this paper. The measuring precision achieved is one order enhanced with general digital image (single vision field) correlation or called single image method. By this way, the Young's modulus of a SS301 stainless steel thin tape, with thickness 0.067mm,is measured, and the moduli of polyester fiber films, a kind of flexible sheet with thickness 0.25mm, are also measured.
C1 Tianjin Univ, Dept Mech, Tianjin 300072, Peoples R China.
RP Xu, LY (reprint author), Tianjin Univ, Dept Mech, Tianjin 300072, Peoples R China.
CR HOU ZD, 2000, P SOC PHOTO-OPT INS, V4317, P32
   Huber N, 2000, INT J SOLIDS STRUCT, V37, P6499, DOI 10.1016/S0020-7683(99)00270-X
   Jin G C, 1997, COMPUTER AIDED OPTIC, P143
   Schneider D, 2000, SURF COAT TECH, V126, P136, DOI 10.1016/S0257-8972(99)00672-6
NR 4
TC 0
Z9 0
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4261-5
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4537
BP 406
EP 409
DI 10.1117/12.468877
PG 4
WC Instruments & Instrumentation; Mechanics; Materials Science,
   Characterization & Testing; Optics
SC Instruments & Instrumentation; Mechanics; Materials Science; Optics
GA BU73C
UT WOS:000176853900097
DA 2018-10-19
ER

PT J
AU Holmes, TC
AF Holmes, TC
TI Novel peptide-based biomaterial scaffolds for tissue engineering
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID NONPOLAR AMINO-ACIDS; CELL ATTACHMENT; BONE; CARTILAGE; POLAR; VIVO
AB Biomaterial scaffolds are components of cell-laden artificial tissues and transplantable biosensors. Some of the most promising new synthetic biomaterial scaffolds are composed of self-assembling peptides that can be modified to contain biologically active motifs. Peptide-based biomaterials can be fabricated to form two- and three-dimensional structures. Recent studies show that biomaterial promotion of multi-dimensional cell-cell interactions and cell density are crucial for proper cellular differentiation and for subsequent tissue formation. Other refinements in tissue engineering include the use of stem cells, cell pre-selection and growth factor pre-treatment of cells that are used for seeding scaffolds. These cell-culture technologies, combined with improved processes for defining the dimensions of peptide-based scaffolds, might lead to further improvements in tissue engineering. Novel peptide-based biomaterial scaffolds seeded with cells show promise for tissue repair and for other medical applications.
C1 NYU, Dept Biol, New York, NY 10003 USA.
RP Holmes, TC (reprint author), NYU, Dept Biol, New York, NY 10003 USA.
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Atala A, 2000, J ENDOUROL, V14, P49, DOI 10.1089/end.2000.14.49
   BANKER G, 1991, CULTURING NERVE CELL, P41
   Broome BM, 2000, J MOL BIOL, V296, P961, DOI 10.1006/jmbi.2000.3514
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Dan N, 2000, TRENDS BIOTECHNOL, V18, P370, DOI 10.1016/S0167-7799(00)01482-7
   Ellis DL, 1996, BIOMATERIALS, V17, P291, DOI 10.1016/0142-9612(96)85567-0
   Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O
   HYNES RO, 1999, TRENDS CELL BIOL, V9, P33
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Lanza R. P., 1997, PRINCIPLES TISSUE EN
   Lashuel HA, 2000, J AM CHEM SOC, V122, P5262, DOI 10.1021/ja9937831
   Liszewski K, 2000, GENET ENG NEWS, V20, P1
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Nitabach MN, 2001, P NATL ACAD SCI USA, V98, P705, DOI 10.1073/pnas.031446198
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   PRIETO AL, 1993, P NATL ACAD SCI USA, V90, P10154, DOI 10.1073/pnas.90.21.10154
   Schachner M, 2000, NATURE, V405, P747, DOI 10.1038/35015648
   Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211
   XIONG HY, 1995, P NATL ACAD SCI USA, V92, P6349, DOI 10.1073/pnas.92.14.6349
   Xu GF, 2001, P NATL ACAD SCI USA, V98, P3652, DOI 10.1073/pnas.071400098
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 30
TC 214
Z9 235
U1 1
U2 59
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD JAN
PY 2002
VL 20
IS 1
BP 16
EP 21
DI 10.1016/S0167-7799(01)01840-6
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 505AU
UT WOS:000172889400009
PM 11742673
DA 2018-10-19
ER

PT J
AU Crigel, MH
   Balligand, M
AF Crigel, MH
   Balligand, M
TI Critical size defect model on the femur in rabbits
SO VETERINARY AND COMPARATIVE ORTHOPAEDICS AND TRAUMATOLOGY
LA English
DT Article
DE rabbit; bone; segmental; critical size defect
ID SEGMENTAL BONE DEFECTS; MORPHOGENETIC PROTEIN-2; INTRAMEDULLARY PIN;
   PLATE STRAIN; MARROW; NONUNION; REPAIR
AB The study purposed to elaborate a model of non-union to test a now biomaterial enhancing bone healing in large segmental defects. The authors' concern was to develop a model of osteosynthesis capable of maintaining the stability of a femur that sustained a segmental defect. Also, they intended to determine the length of a defect that would create a nonunion. The model was a 20-mm segmental bone defect coupled with an appropriate osteosynthesis in the rabbit femur. Two groups of rabbits underwent a mid-shaft ostectomy. Osteosynthesis was mode by two superposed 15 holes 2-mm cuttable plates with cordage wires. In one group, an additional intramedullary pin was inserted. The experiment lasted 16 weeks. The rabbits of the control group suffered fracture of the plates before the end of the experiment. The rabbits of the test group showed stability of the implants and nonunion of the defect. It was concluded that a mid-shaft segmental defect of 20 mm, coupled with an osteosynthesis combining plates, wires and intramedullary pin, is a valid critical size defect model in the rabbit femur.
C1 Univ Liege, Fac Vet, Dept Small Anim Clin Sci, B-4000 Liege, Belgium.
RP Crigel, MH (reprint author), Ecole Natl Vet, 7 Av Gen De Gaulle, F-94704 Maisons Alfort, France.
CR Baltzer AWA, 1999, KNEE SURG SPORT TR A, V7, P197, DOI 10.1007/s001670050147
   Beck LS, 1998, J PHARM SCI, V87, P1379, DOI 10.1021/js9800883
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Bruder SP, 1998, CLIN ORTHOP RELAT R, V355, P247
   Chakkalakal DA, 1999, BONE, V25, P321, DOI 10.1016/S8756-3282(99)00167-2
   Concannon MJ, 1997, PLAST RECONSTR SURG, V99, P1983, DOI 10.1097/00006534-199706000-00025
   Cook SD, 1999, ORTHOPEDICS, V22, P669
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   Cook SD, 1998, J ORTHOP TRAUMA, V12, P407, DOI 10.1097/00005131-199808000-00007
   Gugala Z, 1999, J ORTHOP TRAUMA, V13, P187, DOI 10.1097/00005131-199903000-00006
   Hietaniemi K, 1995, INJURY, V26, P681, DOI 10.1016/0020-1383(95)00135-2
   Hulse D, 2000, VET COMP ORTHOPAED, V13, P185
   Hulse D, 1997, VET SURG, V26, P451, DOI 10.1111/j.1532-950X.1997.tb00516.x
   Inui K, 1998, CALCIFIED TISSUE INT, V63, P490, DOI 10.1007/s002239900563
   Itoh T, 1998, J VET MED SCI, V60, P451, DOI 10.1292/jvms.60.451
   Johnson KD, 1996, J ORTHOP TRAUMA, V10, P28, DOI 10.1097/00005131-199601000-00005
   Kaderly RE, 1993, TXB SMALL ANIMAL SUR, P1676
   Kato T, 1998, J ORTHOP RES, V16, P654, DOI 10.1002/jor.1100160605
   Key JA, 1934, J BONE JOINT SURG, V16, P176
   KIKERHEAD CA, 1998, CLIN ORTHOP RELAT R, V349, P205
   KITSUGI T, 1989, J BONE JOINT SURG AM, V71A, P264, DOI 10.2106/00004623-198971020-00014
   Kraus KH, 1999, J INVEST SURG, V12, P115
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   MATHEWS F, 1998, J CHILD YOUTH CARE, V11, P1
   Moxham JP, 1996, J OTOLARYNGOL, V25, P388
   NIYIBIZI C, 1998, CLIN ORTHOP RELAT R, V355, P148
   NUNAMAKER DM, 1998, CLIN ORTHOP S, V355, pS56
   OKADA Y, 1999, J BIOMED MATER RES, V48, P689
   PARDO AD, 1993, TXB SMALL ANIMAL SUR, P1634
   Rhinelander F.W., 1982, BONE CLIN ORTHOPAEDI, P81
   Sciadini MF, 1997, J ORTHOPAED RES, V15, P844, DOI 10.1002/jor.1100150609
   Sebecic B, 1999, BONE, V24, P195, DOI 10.1016/S8756-3282(98)00180-X
   TEIXEIRA JO, 1998, ARCH ORTHOP TRAUMA S, V117, P103
   TOOMBS JP, 1985, AM J VET RES, V46, P513
   TOOMBS JP, 1985, AM J VET RES, V46, P519
   VOLPON JB, 1997, ARCH TRAUMA SURG, V113, P312
   Wheeler DI, 1998, J BIOMED MATER RES, V43, P365, DOI 10.1002/(SICI)1097-4636(199824)43:4<365::AID-JBM4>3.0.CO;2-6
   Wippermann B, 1999, ANN CHIR GYNAECOL FE, V88, P194
   YUEHUEI H, 1999, P ORTH AN MOD DES EF, P28
   Zegzula HD, 1997, J BONE JOINT SURG AM, V79A, P1778, DOI 10.2106/00004623-199712000-00003
NR 40
TC 7
Z9 9
U1 1
U2 4
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0932-0814
J9 VET COMP ORTHOPAED
JI Vet. Comp. Orthop. Traumatol.
PY 2002
VL 15
IS 3
BP 158
EP 163
PG 6
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA 589VM
UT WOS:000177781600006
DA 2018-10-19
ER

PT J
AU Favia, P
   d'Agostino, R
AF Favia, P
   d'Agostino, R
TI Plasma processed surfaces for biomedical devices: PEO-like, Ag/PEO-like,
   -COOH functional and micro-patterned coatings
SO VIDE-SCIENCE TECHNIQUE ET APPLICATIONS
LA English
DT Article
DE plasma processes; biomaterials; non fouling; antibacterial coatings;
   micro-patterning
ID POLYMERIZATION; GROWTH; CELLS
AB Plasma deposition and treatment processes, of interest for different applications in the,field of biomaterial surfaces, are briefly reviewed in this paper. In particular details are given on processes developed in our laboratory, namely : the deposition of non fouling (PEO-like) and bacterial resistant (Ag/PEO-like) coatings. that of -COOH functional coatings. and combined processes utilized for obtaining micro-patterned polymer surfaces.
C1 Univ Bari, Dept Chem, Ctr Studio Chim Plasmi, CNR, I-70126 Bari, Italy.
RP Favia, P (reprint author), Univ Bari, Dept Chem, Ctr Studio Chim Plasmi, CNR, Via Orabona 4, I-70126 Bari, Italy.
CR BIEDERMAN H, 1990, PLASMA DEPOSITION TR
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0
   CHAWLA AS, 1975, ART ORG, V3, P92
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   DAGOSTINO R, 1991, PLASMA CHEM PLASMA P, V11, P1, DOI 10.1007/BF01447031
   DAI L, 1996, SURFACE MODIFICATION
   Daw R., 1999, PLASMAS POLYM, V4, P113
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   *EUR COMM, 2000, BRPRCT970415 EUR COM
   FAVIA P, 2001, IN PRESS SURF COAT T
   Favia P., 2000, PLASMAS POLYM, DOI [10.1023/A:1009517408368, DOI 10.1023/A:1009517408368]
   Favia P, 1996, PLASMAS POLYM, V1, P91, DOI DOI 10.1007/BF02532821
   FAVIA P, 1998, PLASMAS POLYM, V3, P77, DOI DOI 10.1023/B:PAPO.0000005940.30092.58
   GOMBOTZ WR, 1987, CRC CRITICAL REV BIO, V4
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   HOLLAHAN JR, 1969, J APPL POLYM SCI, V13, P807, DOI 10.1002/app.1969.070130419
   Johnston E.E., 1997, NATO ASI SERIES E, V346
   Kratzmuller T, 1999, ADV MATER, V11, P555, DOI 10.1002/(SICI)1521-4095(199905)11:7<555::AID-ADMA555>3.0.CO;2-E
   LAROUGE S, 2001, IN PRESS PLASMAS POL
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Muller M, 1999, SURF COAT TECH, V116, P802, DOI 10.1016/S0257-8972(99)00268-6
   Ohl A, 1999, J MATER SCI-MATER M, V10, P747, DOI 10.1023/A:1008943625715
   OHL K, 1999, SURF COAT TECH, V116, P820
   PALUMBO F, 1999, PLASMAS POLYM, V4, P133
   PALUMBO F, 2001, IN PRESS PLASMAS POL
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Ratner BD, 1990, PLASMA DEPOSITION TR
   RATNER BD, 1997, NATO ASI SERIES E, V346
   Smith L, 1975, ACS POLYM PREP, V16, P187
   WU YJ, 2001, IN PRESS PLASMAS POL
   Wu YLJ, 2000, COLLOID SURFACE B, V18, P235, DOI 10.1016/S0927-7765(99)00150-2
   Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q
   YASUDA H, 1975, J BIOMED MATER RES, V9, P629, DOI 10.1002/jbm.820090609
   YASUDA H, 1974, PREMEABILITY PLASTIC
NR 37
TC 9
Z9 9
U1 1
U2 6
PU SOC FRANCAISE DU VID
PI PARIS
PA 19 RUE DU RENARD, 75004 PARIS, FRANCE
SN 1266-0167
J9 VIDE
JI Vide-Sci. Techn. Appl.
PY 2002
VL 57
IS 303
BP 40
EP 48
PG 9
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 535PF
UT WOS:000174652300005
DA 2018-10-19
ER

PT J
AU Elifantz, H
   Tel-Or, E
AF Elifantz, H
   Tel-Or, E
TI Heavy metal biosorption by plant biomass of the macrophyte Ludwigia
   stolonifera
SO WATER AIR AND SOIL POLLUTION
LA English
DT Article
DE biofilter; biosorption; cadmium; Ludwigia stolonifera; metal binding
   capacity; nickel; pectin
ID PECTIC SUBSTANCES; IONS; CADMIUM; WATER; BINDING
AB Ludwigia stolonifera biomass of roots, floating roots and leaves were tested for their performance as heavy metal biofilters. Cadmium (Cd) and nickel (Ni) (50 ppm) solutions were filtered through 0.5-1.5 g packed columns with each biomaterial, to determine their metal removal efficiency. Root column was more efficient in removing Ni (as low as 6 ppb in the effluent) than of Cd (as low as to 22 ppb in the effluent). This tendency was also observed upon treatment of a mixed solution of both metals. Floating roots column reduced Cd content to the same level as the root column, but its metal binding capacity was higher; 93 mg Cd g(-1) DW in floating roots in comparison to 43 mg Cd g(-1) DW in the roots biofilter. Leaf biomass column demonstrated the best metal binding capacity; 128 mg Cd g(-1) DW, and Cd concentration in the effluent was 17 ppb. Pectin content was 5, 8 and 10% W/W in roots, leaves and floating roots biofilters, respectively. It seems that ion exchange is the major mechanism by which the metal is biosorbed. Evidence for the exchange of the bound heavy metal ions against the discharge of light metal ions such as calcium (Ca), magnesium (Mg), potassium (K) and sodium (Na) was provided.
C1 Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Dept Agr Bot, IL-76100 Rehovot, Israel.
RP Elifantz, H (reprint author), Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Dept Agr Bot, IL-76100 Rehovot, Israel.
CR Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   BENARIE R, 1979, J AM SOC HORTIC SCI, V104, P500
   BREWSTER MD, 1994, ENVIRON PROG, V13, P143
   Dronnet VM, 1996, CARBOHYD POLYM, V30, P253, DOI 10.1016/S0144-8617(96)00107-5
   ELLMORE GS, 1981, AM J BOT, V68, P227
   GARG P, 1997, ENVIRON MONIT ASSESS, V47, P163
   HOCH PC, 1993, SYST BOT, V18, P31, DOI 10.2307/2419786
   Kahkonen MA, 1998, CHEMOSPHERE, V36, P1381, DOI 10.1016/S0045-6535(97)10022-4
   Kamnev AA, 1998, FOOD HYDROCOLLOID, V12, P263, DOI 10.1016/S0268-005X(98)00014-9
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P782, DOI 10.1021/es00028a018
   Kratochvil D, 1998, TRENDS BIOTECHNOL, V16, P291, DOI 10.1016/S0167-7799(98)01218-9
   Kurt G.E., 1996, ENVIRON SCI TECHNOL, V29, P2496
   Lee HS, 1997, WATER RES, V31, P3082, DOI 10.1016/S0043-1354(97)00022-5
   Maine MA, 2001, WATER RES, V35, P2629, DOI 10.1016/S0043-1354(00)00557-1
   MARCUS Y, 1969, ION EXCHANGE SOLVENT, P321
   RAI UN, 1995, ECOL ENG, V5, P5, DOI 10.1016/0925-8574(95)00011-7
   RAMELOW GJ, 1992, MICROBIOS, V72, P81
   REBHUN M, 1990, MANAGEMENT OF HAZARDOUS SUBSTANCES IN THE ENVIRONMENT, P85
   REJMANKOVA E, 1992, AQUAT BOT, V43, P283, DOI 10.1016/0304-3770(92)90073-R
   Schneider IAH, 1999, ENVIRON SCI TECHNOL, V33, P2213, DOI 10.1021/es981090z
   Spinti M, 1995, WATER ENVIRON RES, V67, P943, DOI 10.2175/106143095X133176
   THIBAULT JF, 1979, LEBENSM WISS TECHNOL, V12, P247
   Thompson ES, 1997, ARCH ENVIRON CON TOX, V32, P161, DOI 10.1007/s002449900169
   TOBIN JM, 1984, APPL ENVIRON MICROB, V47, P821
   Webster EA, 1997, BIOMETALS, V10, P105, DOI 10.1023/A:1018379106700
NR 25
TC 27
Z9 29
U1 0
U2 9
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0049-6979
J9 WATER AIR SOIL POLL
JI Water Air Soil Pollut.
PY 2002
VL 141
IS 1-4
BP 207
EP 218
DI 10.1023/A:1021343804220
PG 12
WC Environmental Sciences; Meteorology & Atmospheric Sciences; Water
   Resources
SC Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences;
   Water Resources
GA 621YT
UT WOS:000179619300013
DA 2018-10-19
ER

PT J
AU Yourtee, DM
   Smith, RE
   Russo, KA
   Burmaster, S
   Cannon, JM
   Eick, JD
   Kostoryz, EL
AF Yourtee, DM
   Smith, RE
   Russo, KA
   Burmaster, S
   Cannon, JM
   Eick, JD
   Kostoryz, EL
TI The stability of methacrylate biomaterials when enzyme challenged:
   Kinetic and systematic evaluations
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterial hydrolysis; monomer leaching; esterases; dental resins;
   methacrylates; biocompatibility; biodurability
ID POLYMERS; DEGRADATION; COMPONENTS; INVITRO; RESINS
AB This study addressed whether methacrylate monomers and polymers used in dentistry might degrade from enzymolysis by acetylcholinesterase (ACHE), cholesterol esterase (CHE), porcine liver esterase (PRLE), and a pancreatic lipase (PNL). Short (hour) and long-term (day) exposures were performed. Product ratios were used to determine surface hydrolysis of the polymeric materials. Enzyme kinetics were studied for the monomers when challenged by ACHE, CHE, and PRLE. In the case of PRLE, the V-max for the dimethacrylate substrates varied slightly, but amounted to as much as 10% of that of p-nitrophenylacetate. The K-m for triethylene glycol dimethacrylate (TEGDMA) was 197 muM for ACHE and 1107 muM for CHE. The V-max was 2.7 nmol/min for ACHE and 3.5 nmol/min for CHE. TEGDMA was converted by CHE at 2% the rate of cholesteryl oleate. Long-term incubations of monomers with CHE and ACHE produced degrees of hydrolysis that evidenced structure dependency in the ability of the enzymes to effect hydrolysis. Particularly resistant were aromativ derivatives and those with branching in methacrylate linkages. Overall, the study confirms the ability of physiologically important esterases to catalyze the hydrolysis of biomaterial methacrylates. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Missouri, Sch Pharm, Div Pharmacol, Toxicore Lab, Kansas City, MO 64108 USA.
   Aventis Pharma, Kansas City, MO 64134 USA.
   US FDA, Kansas City Dist Off, Off Regulatory Affairs, Lenexa, KS 66061 USA.
   Univ Missouri, Sch Dent, Div Oral Biol, Kansas City, MO 64108 USA.
RP Yourtee, DM (reprint author), Univ Missouri, Sch Pharm, Div Pharmacol, Toxicore Lab, Med Sch Bldg M5-C04,2411 Holmes St, Kansas City, MO 64108 USA.
FU NIDCR NIH HHS [P01-DE09696]
CR BEAN TA, 1994, J BIOMED MATER RES, V28, P59, DOI 10.1002/jbm.820280108
   DIXON M, 1979, ENZYMES, P251
   FERRACANE JL, 1985, J DENT RES, V64, P1332, DOI 10.1177/00220345850640111701
   FERRACANE JL, 1984, J DENT RES, V63, P1093, DOI 10.1177/00220345840630081901
   FREUND M, 1990, SCAND J DENT RES, V98, P351
   Gerzina TM, 1996, J DENT, V24, P125, DOI 10.1016/0300-5712(95)00036-4
   HALLSTROM U, 1993, J DENT CHILD, V60, P143
   HANKS CT, 1991, J DENT RES, V70, P1450, DOI 10.1177/00220345910700111201
   Heymann E., 1980, ENZYMATIC BASIS DETO, P291
   HORSTED PB, 1986, SCAND J DENT RES, V94, P154
   Hume WR, 1996, CRIT REV ORAL BIOL M, V7, P172, DOI 10.1177/10454411960070020501
   MUNKSGAARD EC, 1990, SCAND J DENT RES, V98, P261
   ROULET JF, 1987, DEGRADATION DENT BAS, P193
   SIEBERT S, 1988, ENZYMATIC ATTACK MET
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   Tong PY, 1996, J DENT RES, V75, P315
   VANGROENINGEN G, 1986, DENT MATER, V2, P225, DOI 10.1016/S0109-5641(86)80018-5
   VANKERCKHOVEN H, 1982, J DENT RES, V61, P791, DOI 10.1177/00220345820610062801
   Yourtee DM, 1997, IN VITRO TOXICOL, V10, P245
NR 19
TC 55
Z9 55
U1 1
U2 17
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2001
VL 57
IS 4
BP 522
EP 531
DI 10.1002/1097-4636(20011215)57:4<522::AID-JBM1198>3.0.CO;2-9
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 478YQ
UT WOS:000171376800006
PM 11553882
DA 2018-10-19
ER

PT J
AU Loebsack, A
   Greene, K
   Wyatt, S
   Culberson, C
   Austin, C
   Beiler, R
   Roland, W
   Eiselt, P
   Rowley, J
   Burg, K
   Mooney, D
   Holder, W
   Halberstadt, C
AF Loebsack, A
   Greene, K
   Wyatt, S
   Culberson, C
   Austin, C
   Beiler, R
   Roland, W
   Eiselt, P
   Rowley, J
   Burg, K
   Mooney, D
   Holder, W
   Halberstadt, C
TI In vivo characterization of a porous hydrogel material for use as a
   tissue bulking agent
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE soft-tissue engineering; hydrogel; RGD peptides; alginate; surgical
   implantation; animal model; rodent; confocal microscopy
ID ALGINATE HYDROGELS; GORE-TEX; IMPLANTS; AUGMENTATION; WRINKLES; ZYPLAST;
   SMOOTH; FACE
AB Tissue engineered biomaterial constructs are needed for plastic and reconstructive applications. To successfully form a space-filling tissue, the construct should induce a minimal inflammatory response, create minimal or no fibrotic capsule, and establish a vascular bed within the first few days after implantation to ensure survival of the implanted cells. In addition, the biomaterial should support cellular adhesion and induce tissue ingrowth. A macroporous hydrogel bead using sodium alginate covalently coupled with an arginine, glycine, and aspartic acid-containing peptide was created. A 6-month subcutaneous rat model study was performed to determine if the implanted material induced tissue ingrowth throughout the implantation area and maintained a three-dimensional vascular bed. The implanted materials produced a vascular bed, minimal inflammation and capsule formation, and good tissue ingrowth throughout the experiment. The material retained its bulking capacity by demonstration of no significant change of the cross-sectional area as measured from the center of the implants after the 2-week time point. In addition, the granulation tissue formed around the implant was loosely organized, and the surrounding tissue had integrated well with the implant. These results indicate that this material has the desired properties for the development of soft-tissue-engineering constructs. (C) 2001 John Wiley & Sons, Inc.
C1 Carolinas Med Ctr, Cannon Res Ctr, Dept Gen Surg, Charlotte, NC 28232 USA.
   Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Clemson Univ, Dept Bioengn, Clemson, SC USA.
RP Halberstadt, C (reprint author), Carolinas Med Ctr, Cannon Res Ctr, Dept Gen Surg, Cannon Res Bldg,POB 32861, Charlotte, NC 28232 USA.
CR Basse P, 1992, Acta Chir Plast, V34, P92
   Brown AN, 2000, TISSUE ENG, V6, P297, DOI 10.1089/107632700418029
   BURG KJL, 2000, P 6 WORLD BIOM C
   CISNEROS JL, 1993, J DERMATOL SURG ONC, V19, P539, DOI 10.1111/j.1524-4725.1993.tb00387.x
   DeVos P, 1997, BIOMATERIALS, V18, P273, DOI 10.1016/S0142-9612(96)00135-4
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   EPPLEY BL, 1994, ANN PLAS SURG, V32, P463, DOI 10.1097/00000637-199405000-00004
   GREENE KG, 1999, P 3 N CAR TISS ENG G
   GREENE KG, 2000, P 6 WORLD BIOM C
   Lemperle G, 1998, AESTHET PLAST SURG, V22, P356, DOI 10.1007/s002669900217
   MATTI BA, 1990, AESTHET PLAST SURG, V14, P227, DOI 10.1007/BF01578354
   MOLE B, 1992, PLAST RECONSTR SURG, V90, P200, DOI 10.1097/00006534-199290020-00007
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sayag J, 1996, J Wound Care, V5, P357
   STEGMAN SJ, 1987, ARCH DERMATOL, V123, P1644, DOI 10.1001/archderm.123.12.1644
   Wyatt LE, 1998, PLAST RECONSTR SURG, V102, P1922, DOI 10.1097/00006534-199811000-00017
NR 16
TC 54
Z9 56
U1 4
U2 19
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2001
VL 57
IS 4
BP 575
EP 581
DI 10.1002/1097-4636(20011215)57:4<575::AID-JBM1204>3.0.CO;2-9
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 478YQ
UT WOS:000171376800012
PM 11553888
DA 2018-10-19
ER

PT J
AU Lee, WF
   Chen, YJ
AF Lee, WF
   Chen, YJ
TI Graft copolymerization of N-isopropylacrylamide on
   styrene-butadiene-styrene block copolymer
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE styrene-butadiene-styrene; N-isopropylacrylamide; grafting
   copolymerization; thermosensitivity
ID SBS-G-VP; OXYGEN PERMEATION; POLY(ETHYLENE-TEREPHTHALATE) FIBERS;
   POLY(VINYL CHLORIDE); METHYL-METHACRYLATE; BENZOYL-PEROXIDE;
   ACRYLIC-ACID; POLYETHYLENE SURFACE; TRIBLOCK COPOLYMER; BIOMATERIAL
   USAGE
AB Graft polymerization of N-isopropylacrylamide (NIPA-Am) onto styrene-butadiene-styrene (SBS) block copolymer using benzoyl peroxide was studied to improve the water absorptivity and thermosensitivity of SBS. The influence of various grafting reaction factors on the conversion of NIPAAm and the grafting percentage of SBS-g-NIPAAm were also investigated in the study. The experimental results showed that the conversion of SBS-g-NIPAAm was enhanced as the monomers of NIPAAm were increased. The maximum conversion of SBS-g-NIPAAm was observed when the molar ratio of NIPAAm to butadiene was 1.25. In addition, increasing the reaction time enhanced the conversion of SBS-g-NIPAAm; the maximum grafting percentage was obtained with a 4-h reaction. The optimal concentration of the initiator was 3 X 10(-4) mol/20 mL of toluene, and the grafting reaction occurred at over 65 degreesC. The test results of the hydrophilicity of the grafted membranes showed that the hydrophilicity and thermosensitivity were significantly enhanced by grafting NIPAAm onto SBS. (C) 2001 John Wiley & Sons, Inc.
C1 Tatung Univ, Dept Chem Engn, Taipei 10451, Taiwan.
RP Lee, WF (reprint author), Tatung Univ, Dept Chem Engn, Taipei 10451, Taiwan.
CR COHN D, 1988, J MACROMOL SCI CHEM, VA25, P373, DOI 10.1080/00222338808053375
   DONG L C, 1986, Journal of Controlled Release, V4, P223, DOI 10.1016/0168-3659(86)90006-4
   FRELTAS RFS, 1987, SEPAR SCI TECHNOL, V22, P911
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P441
   HEIEH Y, 1984, J APPL POLYM SCI, V29, P2547
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   HIROTSU S, 1987, J PHYS SOC JPN, V56, P233, DOI 10.1143/JPSJ.56.233
   HOIDEN G, 1969, J POLYM SCI C, V26, P37
   HSIUE GH, 1991, MAKROMOL CHEM, V192, P2687
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   ISHIGAKI I, 1982, J APPL POLYM SCI, V27, P1033, DOI 10.1002/app.1982.070270322
   KOCHWA S, 1977, ANN NY ACAD SCI, V283, P37, DOI 10.1111/j.1749-6632.1977.tb41751.x
   KOSTOV GK, 1993, J APPL POLYM SCI, V47, P361, DOI 10.1002/app.1993.070470216
   KULIK EA, 1993, BIOMATERIALS, V14, P763, DOI 10.1016/0142-9612(93)90041-Y
   Lee HS, 1997, POLYMER, V38, P4505, DOI 10.1016/S0032-3861(96)01050-6
   LEE WF, 1995, J APPL POLYM SCI, V55, P1197, DOI 10.1002/app.1995.070550807
   Lee WF, 1999, J APPL POLYM SCI, V74, P1234
   LEE WF, 1994, J APPL POLYM SCI, V51, P2175, DOI 10.1002/app.1994.070511309
   MEMETEA T, 1979, POLYMER, V20, P465, DOI 10.1016/0032-3861(79)90072-7
   MINGHONG W, 1999, RADIAT PHYS CHEM, V56, P341
   MINGHONG W, 1996, RADIAT PHYS CHEM, V48, P525
   NEEDLES HL, 1978, J APPL POLYM SCI, V22, P3405, DOI 10.1002/app.1978.070221206
   OKADA T, 1992, J BIOMED MATER RES, V26, P2569
   ONEILL T, 1972, J POLYM SCI A1, V10, P569, DOI 10.1002/pol.1972.150100221
   PRADHAN AK, 1982, J APPL POLYM SCI, V27, P1873, DOI 10.1002/app.1982.070270602
   SACAK M, 1989, J APPL POLYM SCI, V38, P539, DOI 10.1002/app.1989.070380313
   SACAK M, 1992, J APPL POLYM SCI, V44, P1737, DOI 10.1002/app.1992.070441006
   SANLI O, 1993, J APPL POLYM SCI, V47, P1, DOI 10.1002/app.1993.070470101
   SAROOP UK, 1988, EUR POLYM J, V24, P689, DOI 10.1016/0014-3057(88)90035-3
   SCHAMBER.E, 1970, J POLYM SCI A1, V8, P693, DOI 10.1002/pol.1970.150080312
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   TOMITA N, 1994, J APPL BIOMATER, V5, P175, DOI 10.1002/jab.770050211
   TSENG YC, 1992, J BIOMED MATER RES, V26, P373, DOI 10.1002/jbm.820260308
   TSUBOKAWA N, 1992, J POLYM SCI POL CHEM, V30, P2241, DOI 10.1002/pola.1992.080301020
   TSUBOKAWA N, 1993, J POLYM SCI POL CHEM, V31, P563, DOI 10.1002/pola.1993.080310229
   UCHIDA E, 1990, J APPL POLYM SCI, V41, P677, DOI 10.1002/app.1990.070410317
   UCHIDA E, 1993, J APPL POLYM SCI, V47, P417, DOI 10.1002/app.1993.070470305
   UYAMA Y, 1990, J APPL POLYM SCI, V39, P489, DOI 10.1002/app.1990.070390301
   WANG CC, 1993, J POLYM SCI POL CHEM, V31, P1307, DOI 10.1002/pola.1993.080310526
   YANG JM, 1990, ANGEW MAKROMOL CHEM, V179, P99, DOI 10.1002/apmc.1990.051790108
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   YANG JM, 1995, ANGEW MAKROMOL CHEM, V231, P1, DOI 10.1002/apmc.1995.052310101
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 1999, J MEMBRANE SCI, V153, P175, DOI 10.1016/S0376-7388(98)00261-0
   YANG JM, 1990, J APPL POLYM SCI, V41, P1141, DOI 10.1002/app.1990.070410523
   Yasuda H., 1985, PLASMA POLYM
   Yuan GX, 1997, POLYMER, V38, P119, DOI 10.1016/S0032-3861(96)00491-0
NR 55
TC 9
Z9 10
U1 0
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD DEC 9
PY 2001
VL 82
IS 11
BP 2641
EP 2650
DI 10.1002/app.2117
PG 10
WC Polymer Science
SC Polymer Science
GA 483CK
UT WOS:000171616000006
DA 2018-10-19
ER

PT J
AU Shen, MC
   Horbett, TA
AF Shen, MC
   Horbett, TA
TI The effects of surface chemistry and adsorbed proteins on
   monocyte/macrophage adhesion to chemically modified polystyrene surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE monocyte adhesion; protein adsorption; fibrinogen; polystyrene; surface
   analysis
ID HUMAN-MONOCYTES; MESSENGER-RNA; INFLAMMATORY RESPONSES; FIBRINOGEN
   ADSORPTION; CYTOKINE PRODUCTION; ADHERENCE; CELLS; MACROPHAGES;
   EXPRESSION; BIOMATERIALS
AB Monocytes and macrophages play critical roles in inflammatory responses to implanted biomaterials. Monocyte adhesion may lead to macrophage activation and the foreign body response. We report that surface chemistry, preadsorbed proteins, and adhesion time all play important roles during monocyte adhesion bi vitro. The surface chemistry of tissue culture polystyrene (TCPS), polystyrene, Primaria, and ultra low attachment (ULA) used for adhesion studies was characterized by electron spectroscopy for chemical analysis. Fibrinogen adsorption measured by I-125-labeled fibrinogen was the lowest on ULA, higher on TCPS, and the highest on polystyrene or Primaria. Monocyte adhesion on protein preadsorbed surfaces for 2 h or 1 day was measured with a lactate-dehydrogenase method. Monocyte adhesion decreased over time. The ability of preadsorbed proteins to modulate monocyte adhesion was surface dependent. Adhesion was the lowest on ULA, higher and similar on TCPS or polystyrene, and the highest on Primaria. Monocyte adhesion on plasma or fibrinogen adsorbed surfaces correlated positively and linearly to the amount of adsorbed fibrinogen. Preadsorbed fibronectin, immunoglobulin G, plasma, or serum also promoted adhesion compared with albumin preadsorbed or uncoated surfaces. Overall, biomaterial surface chemistry, the type and amount of adsorbed proteins, and adhesion time all affected monocyte adhesion in vitro. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Horbett, TA (reprint author), Univ Washington, Dept Bioengn, Box 351750, Seattle, WA 98195 USA.
EM horbett@cheme.washington.edu
CR ALTIERI DC, 1986, J CLIN INVEST, V78, P968, DOI 10.1172/JCI112687
   ALTIERI DC, 1991, J IMMUNOL, V147, P1891
   ALTIERI DC, 1988, J BIOL CHEM, V263, P7007
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   BROWN DL, 1989, J CLIN INVEST, V84, P366, DOI 10.1172/JCI114166
   DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   EIERMAN DF, 1989, J IMMUNOL, V142, P1970
   FRIEDMAN A, 1987, IMMUNOLOGY, V61, P469
   Gordon S, 1988, J Cell Sci Suppl, V9, P1
   GRABBE J, 1994, J INVEST DERMATOL, V103, P504, DOI 10.1111/1523-1747.ep12395649
   HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559
   HASKILL S, 1988, J IMMUNOL, V140, P1690
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   HORSBURGH CR, 1987, J LEUKOCYTE BIOL, V41, P14
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   KRUSKAL BA, 1987, J CELL BIOL, V105, P2685, DOI 10.1083/jcb.105.6.2685
   Mattana J, 1997, KIDNEY INT, V52, P1478, DOI 10.1038/ki.1997.478
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MELLMAN I, 1988, J CELL SCI, P45
   MONTESANO R, 1985, J CELL PHYSIOL, V122, P424, DOI 10.1002/jcp.1041220313
   NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815
   PEREZ RL, 1995, J IMMUNOL, V154, P1879
   RABINOVITCH M, 1973, EXP CELL RES, V77, P323, DOI 10.1016/0014-4827(73)90584-3
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   SCHMIDT JA, 1982, J IMMUNOL, V128, P2177
   SCHMIERER AS, 1998, THESIS U WASHINGTON
   SHAW RJ, 1990, J CELL BIOL, V111, P2139, DOI 10.1083/jcb.111.5.2139
   SHEN M, IN PRESS J BIOMED MA
   SHEN M, IN PRESS J BIOMATER
   SLACK SM, 1987, ANN NY ACAD SCI, V516, P223, DOI 10.1111/j.1749-6632.1987.tb33044.x
   SPORN SA, 1990, J IMMUNOL, V144, P4434
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   THORENS B, 1987, CELL, V48, P671, DOI 10.1016/0092-8674(87)90245-5
   TOBIAS JW, 1987, BLOOD, V69, P1265
   TRIGLIA T, 1985, BLOOD, V65, P921
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680
   WEBB DSA, 1990, SCIENCE, V249, P1295, DOI 10.1126/science.1697984
   WRIGHT SD, 1988, J CELL SCI, P99
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 50
TC 147
Z9 150
U1 2
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2001
VL 57
IS 3
BP 336
EP 345
DI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472AE
UT WOS:000170960200003
PM 11523028
DA 2018-10-19
ER

PT J
AU Ohgaki, M
   Kizuki, T
   Katsura, M
   Yamashita, K
AF Ohgaki, M
   Kizuki, T
   Katsura, M
   Yamashita, K
TI Manipulation of selective cell adhesion and growth by surface charges of
   electrically polarized hydroxyapatite
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hydroxyapatite; surface charge; manipulation; cell adhesion;
   polarization; tissue engineering
ID CRYSTAL-GROWTH; BINDING; BIOMATERIALS; SUBUNIT
AB Adherence of cells to a surface, such as a biomaterial surface, can be significantly influenced by the surface charge on that material. The applicability of electrically charged hydroxyapatite ceramics to selective cell adhesion was examined, and we show that polarized hydroxyapatite has significant effects on cell growth and adhesion. The surface charge applied to polarized hydroxyapatite promotes (i) enhanced colon), formation of osteoblast-like cells, (ii) activation of gap junctions, and (iii) specific orienting of neuroblastoma cells. These findings will be of great utility and have significance in applications of tissue engineering, for example, in potential treatments for osteoporosis. (C) 2001 John Wiley & Sons, Inc.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
   Chiba Inst Technol, Chiba 2750016, Japan.
RP Ohgaki, M (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM ohgaki.bcr@tmd.ac.jp
CR ABBOTT A, 1983, J GEN MICROBIOL, V129, P439
   Aizawa M, 1999, ELECTROCHEMISTRY, V67, P118
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BASSETT CAL, 1974, SCIENCE, V184, P575
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Calvert P, 1997, NATURE, V386, P127, DOI 10.1038/386127a0
   DOILLON CJ, 1987, BIOMATERIALS, V8, P195, DOI 10.1016/0142-9612(87)90063-9
   DSOUZA SE, 1994, CELL, V79, P659, DOI 10.1016/0092-8674(94)90551-7
   EDWARDS JG, 1988, J CELL SCI, V89, P507
   Hamann CS, 1998, PROTEIN ENG, V11, P219, DOI 10.1093/protein/11.3.219
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   LAVINE LS, 1972, SCIENCE, V175, P1118, DOI 10.1126/science.175.4026.1118
   OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937
   PASQUALINI R, 1995, J CELL BIOL, V130, P1189, DOI 10.1083/jcb.130.5.1189
   PERSON BS, 1988, J DENT RES, V67, P515
   Ruoslahti E, 1996, EXP CELL RES, V227, P1, DOI 10.1006/excr.1996.0243
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0
   SHIMABAYASHI S, 1981, CHEM PHARM BULL, V29, P3090
   WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
   Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
NR 25
TC 136
Z9 138
U1 0
U2 57
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2001
VL 57
IS 3
BP 366
EP 373
DI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472AE
UT WOS:000170960200006
PM 11523031
DA 2018-10-19
ER

PT J
AU Kraft, CN
   Burian, B
   Perlick, L
   Wimmer, MA
   Wallny, T
   Schmitt, O
   Diedrich, O
AF Kraft, CN
   Burian, B
   Perlick, L
   Wimmer, MA
   Wallny, T
   Schmitt, O
   Diedrich, O
TI Impact of a nickel-reduced stainless steel implant on striated muscle
   microcirculation: A comparative in vivo study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE nickel; stainless steel; osteosynthesis materials; microcirculation;
   biocompatibility
ID MICROVASCULAR RESPONSE; ORTHOPEDIC IMPLANTS; METAL-IONS; TOXICITY;
   TISSUE; MICROSCOPY; LEUKOCYTES; PRODUCTS; TITANIUM; ADHESION
AB The impairment of skeletal muscle microcirculation by a biomaterial may have profound consequences. With moderately good physical and corrosion characteristics, implant-quality stainless steel is particularly popular in orthopedic surgery. However, due to the presence of a considerable amount of nickel in the alloy, concern has been voiced in respect to local tissue responses. More recently a stainless steel alloy with a significant reduction of nickel has become commercially available. We, therefore, studied bi vivo nutritive perfusion and leukocytic response of striated muscle to this nickel-reduced alloy, and compared these results with those of the materials conventional stainless steel and titanium. Using the hamster dorsal skinfold chamber preparation and intravital microscopy, we could demonstrate that reduction of the nickel quantity in a stainless steel implant has a positive effect on local microvascular parameters. Although the implantation of a conventional stainless steel sample led to a distinct and persistent activation of leukocytes combined with disruption of the microvascular endothelial integrity, marked leukocyte extravasation, and considerable venular dilation, animals with a nickel-reduced stainless steel implant showed only a moderate increase of these parameters, with a clear tendency of recuperation. Titanium implants merely caused a transient increase of leukocyte-endothelial cell interaction within the first 120 min, and no significant change in macromolecular leakage, leukocyte extravasation, or venular diameter. Pending biomechanical and corrosion testing, nickel-reduced stainless steel may be a viable alternative to conventional implant-quality stainless steel for biomedical applications. Concerning tolerance by the local vascular system, titanium currently remains unsurpassed, (C) 2001 John Wiley & Sons, Inc.
C1 Univ Bonn, Dept Orthopaed Surg, D-53105 Bonn, Germany.
   Univ Regensburg, Dept Orthopaed Surg, D-93077 Bad Abbach, Germany.
   AO Res Inst, CH-7270 Davos, Switzerland.
RP Kraft, CN (reprint author), Univ Bonn, Dept Orthopaed Surg, D-53105 Bonn, Germany.
CR Abreu A. M., 1995, Biomedical Letters, V52, P133
   Arens S, 1996, J BONE JOINT SURG BR, V78B, P647
   BergerGorbet M, 1996, J BIOMED MATER RES, V32, P243, DOI 10.1002/(SICI)1097-4636(199610)32:2<243::AID-JBM14>3.0.CO;2-K
   BLACK J, 1988, J BONE JOINT SURG BR, V70, P517
   Brunner J, 2000, MICROCIRCULATION, V7, P103, DOI 10.1038/sj.mn.7300094
   Chen FS, 1999, J BIOMED MATER RES, V48, P904, DOI 10.1002/(SICI)1097-4636(1999)48:6<904::AID-JBM21>3.0.CO;2-5
   CIGADA A, 1994, COMPATIBILITY BIOMED, P185
   COTRAN RS, 1989, ROBBINS PATHOLOGIC B, P39
   DISEGI JA, 2000, P SOC BIOMATER, V6, P816
   Doran A, 1998, BIOMATERIALS, V19, P751, DOI 10.1016/S0142-9612(97)00209-3
   ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841
   FANTONE JC, 1982, AM J PATHOL, V107, P397
   GALANTE JO, 1991, J ORTHOPAED RES, V9, P760, DOI 10.1002/jor.1100090516
   GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662
   HENNIG FF, 1992, J TRACE ELEM ELECT H, V6, P239
   HIERHOLZER S, 1992, INTERNAL FIXATION ME
   Hosokawa Y, 1997, X-RAY SPECTROM, V26, P380
   Intergovernmental Oceanographic Commission, 1997, IARC HDB CANC PREV N, P1
   International Agency for Research on Cancer, 1995, IARC MON EV CARC RIS, P1
   JACOBS JJ, 1996, CLIN ORTHOP S, V329, P256
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   McKay GC, 1996, BIOMATERIALS, V17, P1339, DOI 10.1016/0142-9612(96)88681-9
   MENGER MD, 1993, IMMUNOL TODAY, V14, P519, DOI 10.1016/0167-5699(93)90179-O
   Menger MD, 1996, BRIT J SURG, V83, P588, DOI 10.1002/bjs.1800830506
   MERRITT K, 1993, BRIS MYER Z, P147
   MERRITT K, 1993, TECHN ORTHOP, V8, P228
   MERRITT K, 1996, CLIN ORTHOP RELAT R, V329, P233
   NIEBOER E, 1980, NICKEL TOXICOLOGY, P359
   Pereira MC, 1998, J BIOMED MATER RES, V40, P40, DOI 10.1002/(SICI)1097-4636(199804)40:1<40::AID-JBM5>3.0.CO;2-R
   PRIES AR, 1988, INT J MICROCIRC, V7, P327
   Schaser KD, 1999, J ORTHOPAED RES, V17, P678, DOI 10.1002/jor.1100170509
   Shettlemore MG, 1999, J BIOMED MATER RES, V45, P395
   Sun ZL, 1997, J BIOMED MATER RES, V34, P29, DOI 10.1002/(SICI)1097-4636(199701)34:1<29::AID-JBM5>3.0.CO;2-P
   TAKAMURA K, 1994, J BIOMED MATER RES, V28, P583, DOI 10.1002/jbm.820280508
   Takeshita F, 1997, BIOMATERIALS, V18, P21, DOI 10.1016/S0142-9612(96)00051-8
   Uo M, 1999, BIOMATERIALS, V20, P747, DOI 10.1016/S0142-9612(98)00224-5
   VOLLMAR B, 1993, ZBL CHIR, V118, P691
   WATAHA JC, 1993, J BIOMED MATER RES, V27, P227, DOI 10.1002/jbm.820270212
   WILLIAMS D, 1990, ENCY MED DENT MAT
   WILLIAMS DF, 1981, SYSTEMIC ASPECTS BIO, V2
   WILLIAMS DF, 1981, SYSTEMIC ASPECTS BIO, V1
NR 42
TC 30
Z9 30
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2001
VL 57
IS 3
BP 404
EP 412
DI 10.1002/1097-4636(20011205)57:3<404::AID-JBM1183>3.0.CO;2-W
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472AE
UT WOS:000170960200010
PM 11523035
DA 2018-10-19
ER

PT J
AU Kumar, N
   Ravikumar, MNV
   Domb, AJ
AF Kumar, N
   Ravikumar, MNV
   Domb, AJ
TI Biodegradable block copolymers
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE biodegradable; block copolymer; star-block copolymer; poly(esters);
   poly(ether-b-ester); poly(ether ester amide); surface modification;
   micelles; hydrogels; nanoparticles; microparticles; drug-targeting
ID ABA TRIBLOCK COPOLYMERS; POLYMERIC ANTICANCER DRUG; IN-VITRO
   DEGRADATION; POLY(ETHYLENE GLYCOL); POLY(L-LACTIC ACID); POLYETHYLENE
   OXIDE; L-LACTIDE; POLY(LACTIC-GLYCOLIC ACID); COMPRISING
   POLY(L-LACTIDE); THERMOREVERSIBLE GELATION
AB Recently, block copolymers have got tremendous impetus on the ongoing research in the area of drug delivery technology, due to their capability to provide a biomaterial having a broad range of amphiphilic characteristics, as well as targeting the drugs to specific site. This article is an attempt to review applications of block copolymers in surface modification, drug targeting, nano and microparticles, hydrogels, micelles etc. The physicochemical properties of block copolymers and various synthetic routes for block copolymers are also discussed. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel.
   Univ Kentucky, Med Ctr, Dept Prevent Med & Environm Hlth, Lexington, KY 40536 USA.
RP Domb, AJ (reprint author), Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel.
RI Xu, Qingguo/C-1962-2014; Kumar, M N V R/D-6286-2011
OI Xu, Qingguo/0000-0003-3191-0771; Kumar, M N V R/0000-0001-5606-401X
CR ABADIE MSM, 1980, INFORMATIONS CHIMIE, V208, P135
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   ANDRADE J D, 1992, Clinical Materials, V11, P67, DOI 10.1016/0267-6605(92)90031-N
   BADER H, 1984, ANGEW CHEM, V123
   BAZEMER JM, 2000, J CONTROL RELEASE, V64, P179
   BAZILE D, 1995, J PHARM SCI, V84, P493, DOI 10.1002/jps.2600840420
   BEDELLS AD, 1993, J CHEM SOC FARADAY T, V89, P1243, DOI 10.1039/ft9938901243
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   Bezemer JM, 2000, J BIOMED MATER RES, V52, P8, DOI 10.1002/1097-4636(200010)52:1<8::AID-JBM2>3.0.CO;2-3
   Black FE, 1999, LANGMUIR, V15, P3157, DOI 10.1021/la9803575
   Bouillot P, 1998, J APPL POLYM SCI, V68, P1695, DOI 10.1002/(SICI)1097-4628(19980606)68:10<1695::AID-APP19>3.0.CO;2-W
   Bronich TK, 1997, MACROMOLECULES, V30, P3519, DOI 10.1021/ma970197o
   Cammas S, 1997, J CONTROL RELEASE, V48, P157, DOI 10.1016/S0168-3659(97)00040-0
   Cammas S, 1996, NATO ADV SCI INST SE, V327, P83
   Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0
   Cha Y., 1997, US Patent, Patent No. 5702717
   Cho CS, 2000, POLYMER, V41, P5185, DOI 10.1016/S0032-3861(99)00746-6
   Choi SW, 1999, J POLYM SCI POL CHEM, V37, P2207, DOI 10.1002/(SICI)1099-0518(19990701)37:13<2207::AID-POLA35>3.0.CO;2-0
   Choi YK, 1996, P INT S CONTR REL BI, V23, P349
   Choi YR, 1998, MACROMOLECULES, V31, P8766, DOI 10.1021/ma981069i
   Chung JE, 1999, J CONTROL RELEASE, V62, P115, DOI 10.1016/S0168-3659(99)00029-2
   COHEN D, 1988, J BIOMED METER RES, V22, P992
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   DENG XM, 1990, J POLYM SCI POL LETT, V28, P411, DOI 10.1002/pol.1990.140281303
   DENG XM, 1995, J APPL POLYM SCI, V55, P1193, DOI 10.1002/app.1995.070550806
   DESIMONE V, 1992, J APPL POLYM SCI, V46, P1813, DOI 10.1002/app.1992.070461013
   Feast W.J, 1987, POLYM SURFACES INTER
   FERRUTI P, 1995, BIOMATERIALS, V16, P1423, DOI 10.1016/0142-9612(95)96879-5
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Guerra GD, 2001, J MATER SCI-MATER M, V12, P313, DOI 10.1023/A:1011243003712
   HAGAN SA, 1995, LANGMUIR, V11, P1482, DOI 10.1021/la00005a013
   Harada A, 1999, SCIENCE, V283, P65, DOI 10.1126/science.283.5398.65
   Hiki S, 2000, POLYMER, V41, P7369, DOI 10.1016/S0032-3861(00)00086-0
   HOES C J T, 1985, Journal of Controlled Release, V2, P205, DOI 10.1016/0168-3659(85)90046-X
   HU DSG, 1993, J APPL POLYM SCI, V50, P1391, DOI 10.1002/app.1993.070500810
   Hubbell JA, 1996, J CONTROL RELEASE, V39, P305, DOI 10.1016/0168-3659(95)00162-X
   HVIDT S, 1994, J PHYS CHEM-US, V98, P12320, DOI 10.1021/j100098a030
   ILLUM L, 1984, FEBS LETT, V167, P79, DOI 10.1016/0014-5793(84)80836-4
   ILLUM L, 1987, LIFE SCI, V40, P367, DOI 10.1016/0024-3205(87)90138-X
   Izhar U, 2001, J SURG RES, V95, P152, DOI 10.1006/jsre.2000.6042
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   JURGENS CH, 1998, GHIM WALENKAMP BIOMA, P112
   Kabanov AV, 1996, MACROMOLECULES, V29, P6797, DOI 10.1021/ma960120k
   Kataoka K, 1998, MACROMOLECULES, V31, P6071, DOI 10.1021/ma971838i
   KATAOKA K, 1993, J CONTROL RELEASE, V24, P119
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   KENNEDY JP, 1992, ACS SYM SER, V496, P258
   Kim DK, 1996, POLYM-KOREA, V20, P431
   KIMURA Y, 1989, POLYMER, V30, P1342, DOI 10.1016/0032-3861(89)90058-X
   Kissel T, 1996, J CONTROL RELEASE, V39, P315, DOI 10.1016/0168-3659(95)00163-8
   KITAYAMA T, 1991, POLYM BULL, V26, P513, DOI 10.1007/BF01032676
   Kreuter J., 1994, COLLOIDAL DRUG DELIV, P219
   KRICHELDORF HR, 1993, MAKROMOL CHEM, V194, P715
   KRICHELDORF HR, 1993, MAKROMOL CHEM-M SYMP, V73, P47, DOI 10.1002/masy.19930730107
   KWON G, 1993, LANGMUIR, V9, P945, DOI 10.1021/la00028a012
   Kwon GS, 1996, ADV DRUG DELIVER REV, V21, P107, DOI 10.1016/S0169-409X(96)00401-2
   KWON GS, 1995, ADV DRUG DELIVER REV, V16, P295, DOI 10.1016/0169-409X(95)00031-2
   KWON GS, 1993, PHARMACEUT RES, V10, P970, DOI 10.1023/A:1018998203127
   LAM KH, 1995, J APPL BIOMATER, V6, P191, DOI 10.1002/jab.770060308
   Lee CW, 1996, B CHEM SOC JPN, V69, P1787, DOI 10.1246/bcsj.69.1787
   Lee CW, 1996, SEN-I GAKKAISHI, V52, P405, DOI 10.2115/fiber.52.8_405
   LEE CW, 1995, KOBUNSHI RONBUNSHU, V52, P692, DOI 10.1295/koron.52.692
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   Li H, 1997, MACROMOLECULES, V30, P1347, DOI 10.1021/ma961520a
   Li XH, 1999, INT J PHARM, V178, P245, DOI 10.1016/S0378-5173(98)00379-2
   Li XW, 1997, J APPL POLYM SCI, V66, P583, DOI 10.1002/(SICI)1097-4628(19971017)66:3<583::AID-APP20>3.0.CO;2-V
   Li YX, 1998, POLYMER, V39, P4421, DOI 10.1016/S0032-3861(97)10362-7
   LI YX, 1993, J CONTROL RELEASE, V27, P247
   LI YX, 1994, J CONTROL RELEASE, V32, P121
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   Lucke A, 2000, BIOMATERIALS, V21, P2361, DOI 10.1016/S0142-9612(00)00103-4
   Lysenko EA, 1998, MACROMOLECULES, V31, P4511, DOI 10.1021/ma980366k
   Ma J, 2001, COLLOID POLYM SCI, V279, P387, DOI 10.1007/s003960000467
   Mader K, 1998, PHARMACEUT RES, V15, P787, DOI 10.1023/A:1011939607573
   MALSTOM M, 1992, MACROMOLECULES, V25, P5440
   Martinez MB, 1997, MACROMOLECULES, V30, P3197
   Moghimi S. Moein, 1993, Biochemical Society Transactions, V21, p128S
   MOGHIMI SM, 1988, FEBS LETT, V233, P143, DOI 10.1016/0014-5793(88)81372-3
   Morlock M, 1998, J CONTROL RELEASE, V56, P105, DOI 10.1016/S0168-3659(98)00070-4
   NATHAN A, 1994, J BIOACT COMPAT POL, V9, P239, DOI 10.1177/088391159400900301
   Nawata M, 2001, NAT BIOTECHNOL, V19, P332
   NICOLAS CV, 1993, POLYMER, V34, P138
   Nishiyama N, 1999, LANGMUIR, V15, P377, DOI 10.1021/la980572l
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Otsuka H, 2001, CURR OPIN COLLOID IN, V6, P3, DOI 10.1016/S1359-0294(00)00082-0
   Otsuka H, 2000, BIOMACROMOLECULES, V1, P39, DOI 10.1021/bm990005s
   Park YH, 1999, POLYM-KOREA, V23, P163
   Park YH, 1998, POLYM-KOREA, V22, P559
   PATEL HM, 1992, CRIT REV THER DRUG, V9, P39
   Pechar M, 1997, MACROMOL CHEM PHYSIC, V198, P1009, DOI 10.1002/macp.1997.021980408
   Pechar M, 1995, COLLECT CZECH CHEM C, V60, P1765, DOI 10.1135/cccc19951765
   Pechar M, 2000, BIOCONJUGATE CHEM, V11, P131, DOI 10.1021/bc990092l
   Penco M, 1996, BIOMATERIALS, V17, P1583, DOI 10.1016/0142-9612(95)00323-1
   Peppas N. A., 1986, HYDROGELS MED PHARM, VI, P1
   PEPPAS NA, 1976, J POLYM SCI POL CHEM, V14, P441, DOI 10.1002/pol.1976.170140215
   PEPPAS NA, 1976, J APPL POLYM SCI, V20, P1457, DOI 10.1002/app.1976.070200604
   POZNANSKY MJ, 1984, PHARMACOL REV, V36, P277
   PRATTEN MK, 1985, MAKROMOL CHEM, V186, P725
   Quellec P, 1999, J BIOMED MATER RES, V47, P388, DOI 10.1002/(SICI)1097-4636(19991205)47:3<388::AID-JBM14>3.0.CO;2-V
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI DOI 10.1021/SYMPOSIUM
   RAVIKUMAR MNV, 2001, DRUG DEV IND PHARM, V27, P1
   Richards R. W., 1993, POLYM SURFACES INTER
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Scholes P. D., 1997, CONTROLLED DRUG DELI, P73
   Serres A, 1996, PHARMACEUT RES, V13, P196, DOI 10.1023/A:1016026711364
   Shi FY, 1996, MACROMOLECULES, V29, P10, DOI 10.1021/ma950707j
   Shi FY, 1996, MACROMOLECULES, V29, P7753, DOI 10.1021/ma960805k
   SHIELDS R, 1968, GASTROENTEROLOGY, V54, P331
   STOLNIK S, 1995, ADV DRUG DELIVER REV, V16, P195, DOI 10.1016/0169-409X(95)00025-3
   STOLNIK S, 1994, PHARMACEUT RES, V11, P1800, DOI 10.1023/A:1018931820564
   TOMLINSON E, 1986, SITE SPECIFIC DRUG D, pCH6
   Trollsas M, 1998, MACROMOLECULES, V31, P3439, DOI 10.1021/ma980241f
   Trollsas M, 1997, MACROMOLECULES, V30, P8508, DOI 10.1021/ma970798f
   Trollsas M, 1998, J AM CHEM SOC, V120, P4644, DOI 10.1021/ja973678w
   Trollsas M, 1999, MACROMOLECULES, V32, P4917, DOI 10.1021/ma990054x
   TSUKADA Y, 1984, JNCI-J NATL CANCER I, V73, P721
   UCHIDA T, 1995, CHEM PHARM BULL, V43, P1569
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Vakkalanka SK, 1996, J BIOMAT SCI-POLYM E, V8, P119, DOI 10.1163/156856296X00192
   XIONG CD, 1995, J APPL POLYM SCI, V55, P865, DOI 10.1002/app.1995.070550604
   Yamaoka T, 1999, J POLYM SCI POL CHEM, V37, P1513, DOI 10.1002/(SICI)1099-0518(19990515)37:10<1513::AID-POLA13>3.0.CO;2-9
   Yasugi K, 1999, J CONTROL RELEASE, V62, P89, DOI 10.1016/S0168-3659(99)00028-0
   YOKOYAMA M, 1992, CRIT REV THER DRUG, V9, P213
   YOKOYAMA M, 1987, MAKROMOL CHEM-RAPID, V8, P431
   YOKOYAMA M, 1991, CANCER RES, V51, P3229
   YOKOYAMA M, 1990, J CONTROL RELEASE, V11, P269
   YOKOYAMA M, 1994, J CONTROL RELEASE, V32, P269, DOI 10.1016/0168-3659(94)90237-2
   YOKOYAMA M, 1990, CANCER RES, V50, P1693
   YOKOYAMA M, 1993, DRUG DELIV, V1, P11
   YOUNES H, 1987, J BIOMED MATER RES, V21, P1301, DOI 10.1002/jbm.820211103
   Youxin L., 1994, J CONTROL RELEASE, V32, P121
   Zambaux MF, 2001, INT J PHARM, V212, P1, DOI 10.1016/S0378-5173(00)00548-2
   Zhang XC, 1996, INT J PHARM, V132, P195, DOI 10.1016/0378-5173(95)04386-1
   Zhu ZX, 1999, EUR POLYM J, V35, P1821, DOI 10.1016/S0014-3057(98)00265-1
NR 137
TC 215
Z9 232
U1 4
U2 67
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD DEC 3
PY 2001
VL 53
IS 1
BP 23
EP 44
DI 10.1016/S0169-409X(01)00219-8
PG 22
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 501XZ
UT WOS:000172712500003
PM 11733116
DA 2018-10-19
ER

PT J
AU Luyten, FP
   Dell'Accio, F
   De Bari, C
AF Luyten, FP
   Dell'Accio, F
   De Bari, C
TI Skeletal tissue engineering: opportunities and challenges
SO BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
LA English
DT Article
DE joint resurfacing; skeletal engineering; stem cells; morphogens;
   biomaterials
ID MESENCHYMAL STEM-CELLS; ARTICULAR CHONDROCYTES; MORPHOGENETIC PROTEINS;
   EXTRACELLULAR-MATRIX; BONE DIFFERENTIATION; GROWTH-FACTOR; CARTILAGE;
   REGENERATION; OSTEOGENIN; REGULATORS
AB Tissue engineering is a field of biomedicine that is growing rapidly and is critically driven by scientific advances in the areas of developmental and cell biology and biomaterial sciences. Regeneration of skeletal tissues is among the most promising areas of biological tissue repair and is providing a broad spectrum of potential clinical applications, including joint resurfacing. The availability of novel tools such as pluripotent stem cells, morphogens, smart biomaterials and gene transfer technologies, makes us dream of many exciting novel therapeutic approaches. Despite these opportunities in regenerative medicine, good clinical practice requires the clinician to question the consistency, reproducibility, validation and appropriate regulation of these new biological treatments.
C1 KU, Univ Hosp, Lab Skeletal Dev & Joint Disorders, Onderwijs & Navorsin,Dept Rheumatol, Louvain, Belgium.
RP Luyten, FP (reprint author), KU, Univ Hosp, Lab Skeletal Dev & Joint Disorders, Onderwijs & Navorsin,Dept Rheumatol, Herestr 49, Louvain, Belgium.
RI Dell'Accio, Francesco/A-2923-2013
CR BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Caplan AI, 2000, TISSUE ENG, V6, P1, DOI 10.1089/107632700320838
   CAPLAN AI, 2000, CLIN ORTHOP S, V379, pS67
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P85, DOI 10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dell'Accio F, 2001, ARTHRITIS RHEUM, V44, P1608, DOI 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T
   Dell'Accio F, 1999, JPN J RHEUMATOL, V9, P17
   DOMINICE J, 1986, Mechanisms of Ageing and Development, V37, P231
   Evans CH, 2001, ARTHRITIS RES, V3, P142, DOI 10.1186/ar291
   FROGERGAILLARD B, 1989, EXP CELL RES, V183, P388, DOI 10.1016/0014-4827(89)90399-6
   Gilbert J E, 1998, Am J Knee Surg, V11, P42
   Goossens PH, 2001, ARTHRITIS RHEUM, V44, P48, DOI 10.1002/1529-0131(200101)44:1<48::AID-ANR7>3.0.CO;2-D
   HARRISON ET, 1991, EXP CELL RES, V192, P340, DOI 10.1016/0014-4827(91)90050-5
   Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580
   HOMMINGA GN, 1990, J BONE JOINT SURG BR, V72, P1003
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   Hynes M, 2000, NEURON, V28, P11, DOI 10.1016/S0896-6273(00)00079-9
   Jorgensen C, 2001, ANN RHEUM DIS, V60, P305, DOI 10.1136/ard.60.4.305
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Liechty KW, 2000, NAT MED, V6, P1282
   Lind M, 2000, J ARTHROPLASTY, V15, P339, DOI 10.1016/S0883-5403(00)90693-4
   LUYTEN FP, 1989, J BIOL CHEM, V264, P13377
   Luyten FP, 1997, ORAL SURG ORAL MED O, V83, P167, DOI 10.1016/S1079-2104(97)90109-8
   LUYTEN FP, 2001, IN PRESS BONE MORPHO
   Marinova-Mutafchieva L, 2000, ARTHRITIS RHEUM-US, V43, P2046, DOI 10.1002/1529-0131(200009)43:9<2046::AID-ANR16>3.0.CO;2-8
   Minas T, 1997, ORTHOPEDICS, V20, P525
   Nakagawa S, 1996, J RHEUMATOL, V23, P2098
   NAKAHARA H, 1991, J ORTHOP RES, V9, P465, DOI 10.1002/jor.1100090402
   Nehrer S, 1999, CLIN ORTHOP RELAT R, P149
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   SAMPATH TK, 1984, J CELL BIOL, V98, P2192, DOI 10.1083/jcb.98.6.2192
   SAMPATH TK, 1990, J BIOL CHEM, V265, P13198
   Schultz O, 2000, ARTHRITIS RES, V2, P433, DOI 10.1186/ar123
   Shortkroff S, 1996, BIOMATERIALS, V17, P147, DOI 10.1016/0142-9612(96)85759-0
   SPIRO RC, 2000, INT C BON MORPH PROT
   Tsumaki N, 1999, J CELL BIOL, V144, P161, DOI 10.1083/jcb.144.1.161
   van den Bergh JPA, 2000, J CLIN PERIODONTOL, V27, P627, DOI 10.1034/j.1600-051x.2000.027009627.x
   VONDERMARK K, 1977, NATURE, V267, P431
   Wang H L, 2000, Compend Contin Educ Dent, V21, P399
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130
NR 45
TC 31
Z9 37
U1 0
U2 1
PU BAILLIERE TINDALL
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1521-6942
J9 BEST PRACT RES CL RH
JI Best Pract. Res. Clin. Rheumatol.
PD DEC
PY 2001
VL 15
IS 5
BP 759
EP 769
DI 10.1053/berh.2001.0192
PG 11
WC Rheumatology
SC Rheumatology
GA 515AD
UT WOS:000173472500008
PM 11812020
DA 2018-10-19
ER

PT J
AU Bet, MR
   Goissis, G
   Lacerda, CA
AF Bet, MR
   Goissis, G
   Lacerda, CA
TI Characterization of polyanionic collagen prepared by selective
   hydrolysis of asparagine and glutamine carboxyamide side chains
SO BIOMACROMOLECULES
LA English
DT Article
ID ANIONIC COLLAGEN; BIOCOMPATIBILITY; COMPOSITES; MATRICES; RELEASE; WATER
AB Acellular polyanionic collagen materials intended for biomaterial and tissue engineering uses were prepared by the selective and controlled hydrolysis of carboxyamides from asparagine and glutamine residues of type I collagen present in pericardium, tendon, and intestinal submucosa, all from bovine origin. The increase in carboxyl groups was from 26 +/- 14 (12 h of hydrolysis) to 134 12 (144 h of hydrolysis). Although collagen triple helix structure of polyanionic materials was preserved in all cases, a decrease in thermal stability and a gradual loss in the ability of collagen molecules to form fibrils were detected with increasing carboxyl content, probably as a result of changes in the pattern of electrostatic interaction, The resulting materials were basically acellular polyanionic collagen matrixes associated with an elastin content dependent on the time of hydrolysis. The results showed that the procedure described in this work may be a useful process for preparation of collagen biomaterials with variable physicochemical properties and macromolecular arrangement with respect to fibril formation and with potential use in tissue engineering.
C1 Univ Sao Paulo, Inst Quim, Dept Quim & Fis Mol, BR-13560970 Sao Paulo, Brazil.
RP Goissis, G (reprint author), Univ Sao Paulo, Inst Quim, Dept Quim & Fis Mol, Av Trabalhador Saocarlense 400,CP 780, BR-13560970 Sao Paulo, Brazil.
CR Bouaziz A, 1997, BIOMATERIALS, V18, P107, DOI 10.1016/S0142-9612(96)00114-7
   CHAPMAN JA, 1990, ELECTRON MICROSC REV, V3, P143, DOI 10.1016/0892-0354(90)90018-N
   Chen YS, 2000, BIOMATERIALS, V21, P1541, DOI 10.1016/S0142-9612(00)00028-4
   Chevallay B, 2000, J BIOMED MATER RES, V49, P448, DOI 10.1002/(SICI)1097-4636(20000315)49:4<448::AID-JBM3>3.0.CO;2-L
   Chvapil M, 1980, BIOL COLLAGEN, P313
   CROSS HR, 1973, J AGR FOOD CHEM, V21, P716, DOI 10.1021/jf60188a033
   Eastoe JE, 1967, TREATISE COLLAGEN, V1, P1
   FLANDIN F, 1984, BIOCHIM BIOPHYS ACTA, V791, P205, DOI 10.1016/0167-4838(84)90010-4
   GIUSTI P, 1994, MACROMOL SYMP, V78, P285, DOI 10.1002/masy.19940780124
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   Goissis G, 1998, ARTIF ORGANS, V22, P203, DOI 10.1046/j.1525-1594.1998.06109.x
   GOISSIS G, 1994, PROCESS EXTRACTION C
   GRIMM M, 1992, SURGERY, V111, P74
   Hu XW, 1996, TISSUE CELL, V28, P215
   MAHLLER HR, 1996, BIOL CHEM, P87
   Martins VCA, 1998, ARTIF ORGANS, V22, P215, DOI 10.1046/j.1525-1594.1998.06004.x
   Nezu T, 2000, BIOMATERIALS, V21, P415, DOI 10.1016/S0142-9612(99)00204-5
   Plepis AMD, 1996, POLYM ENG SCI, V36, P2932
   Radhika M, 1999, COMP BIOCHEM PHYS C, V124, P131, DOI 10.1016/S0742-8413(99)00042-0
   RAMIREZ F, 1988, COLLAGEN, V4, P21
   RAO KP, 1988, COLLAGEN, V3, P63
   REID JRW, 1993, KOWARI, V4, P1
   RENUGOPALAKRISHNAN V, 1989, MACROMOLECULES, V22, P4121, DOI 10.1021/ma00200a054
   Sai P, 2000, BURNS, V26, P54
   SCHERRER SA, 1986, Patent No. 0214853
   Shenoy V, 1995, MACROMOLECULES, V28, P8751, DOI 10.1021/ma00130a007
   SILVESTER MF, 1989, THROMB RES, V55, P135
   SINGH MP, 1995, PHARMACEUT RES, V12, P1205, DOI 10.1023/A:1016272212833
   STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2
NR 29
TC 34
Z9 35
U1 1
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD WIN
PY 2001
VL 2
IS 4
BP 1074
EP 1079
DI 10.1021/bm0001188
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 528RH
UT WOS:000174256400003
PM 11777376
DA 2018-10-19
ER

PT J
AU Yamada, M
   Kato, K
   Shindo, K
   Nomizu, M
   Haruki, M
   Sakairi, N
   Ohkawa, K
   Yamamoto, H
   Nishi, N
AF Yamada, M
   Kato, K
   Shindo, K
   Nomizu, M
   Haruki, M
   Sakairi, N
   Ohkawa, K
   Yamamoto, H
   Nishi, N
TI UV-irradiation-induced DNA immobilization and functional utilization of
   DNA on nonwoven cellulose fabric
SO BIOMATERIALS
LA English
DT Article
DE immobilized DNA; intercalation; UV irradiation; antibacterial activity;
   endocrine disruptor; functional biomaterial
ID SILVER SULFADIAZINE; LIPID COMPLEX; BIOSENSORS; BURNS
AB Immobilization of double-stranded DNA onto nonwoven cellulose fabric by UV irradiation and utilization of DNA-immobilized cloth were examined. The immobilized DNA was found to be stable in water, with the maximum amount of fabric-immobilized DNA being approximately 20 mg/g of nonwoven fabric. The DNA-immobilized cloth could effectively accumulate endocrine disruptors and harmful DNA intercalating pollutants, such as dibenzo-p-dioxin, dibenzofuran, biphenyl, benzo[a]pyrene and ethidium bromide. Additionally, DNA-immobilized cloth was found to bind metal ions, such as Ag+, Cu2+, and Zn2+. The maximum amounts of bound Ag+, Cu2+, and Zn2+ onto DNA-immobilized cloth (1 g) were approximately 5, 2, and 1 mg, respectively. DNA-immobilized cloth containing Ag+ showed antibacterial activity against Escherichia coli and Staphylococcus aureus. DNA-immobilized cloth without metal ion and with Cu2+ or Zn2+ did not show antibacterial activity. These results suggest that immobilized DNA imparts useful functionality to cloth. DNA-immobilized cloth prepared by UV irradiation has potential to serve as a useful biomaterial for medical, engineering, and environmental application. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Lab Biomat Chem,Kita Ku, Sapporo, Hokkaido 0600810, Japan.
   Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan.
RP Nishi, N (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Lab Biomat Chem,Kita Ku, Sapporo, Hokkaido 0600810, Japan.
RI Ohkawa, Kousaku/E-1497-2014
OI Ohkawa, Kousaku/0000-0001-5199-092X
CR BEUKERS R, 1960, BIOCHIM BIOPHYS ACTA, V41, P550, DOI 10.1016/0006-3002(60)90063-9
   BEUKERS R, 1958, RECL TRAV CHIM PAY B, V77, P729
   BOECKX W, 1992, BURNS, V18, P456, DOI 10.1016/0305-4179(92)90177-V
   BUK KFS, 1975, J AM CHEM SOC, V97, P1241
   CAVALIERI LF, 1970, P NATL ACAD SCI USA, V67, P807, DOI 10.1073/pnas.67.2.807
   EICHHORN GL, 1968, J AM CHEM SOC, V90, P7323, DOI 10.1021/ja01028a024
   FULLER W, 1964, BERICH BUNSEN GESELL, V68, P805, DOI 10.1002/bbpc.19640680830
   GEACINTOV NE, 1976, J AM CHEM SOC, V98, P6444, DOI 10.1021/ja00437a002
   GLISIN VR, 1967, BIOCHIM BIOPHYS ACTA, V142, P314, DOI 10.1016/0005-2787(67)90614-4
   HOFFMANN S, 1984, SCAND J PLAST RECONS, V18, P119, DOI 10.3109/02844318409057413
   IJIRO K, 1992, J CHEM SOC CHEM COMM, P1339, DOI 10.1039/c39920001339
   Iwata K, 1996, INT J BIOL MACROMOL, V18, P149, DOI 10.1016/0141-8130(95)01073-4
   Kitamura H, 1997, INT J BIOL MACROMOL, V20, P75, DOI 10.1016/S0141-8130(97)01146-X
   Kitamura H, 1997, INT J BIOL MACROMOL, V20, P241, DOI 10.1016/S0141-8130(97)00021-4
   KITAMURA H, 1997, NUCL ACIDS S SER, V37, P273
   LITMAN RM, 1968, J BIOL CHEM, V243, P6222
   MIZUTANI T, 1983, J BIOCHEM-TOKYO, V94, P163
   NAGATA C, 1967, B CHEM SOC JPN, V40, P2564, DOI 10.1246/bcsj.40.2564
   RICKWOOD D, 1972, BIOCHIM BIOPHYS ACTA, V269, P47, DOI 10.1016/0005-2787(72)90072-X
   Skuridin SG, 1996, BIOSENS BIOELECTRON, V11, P903, DOI 10.1016/0956-5663(96)89439-5
   Tanaka K, 1996, J AM CHEM SOC, V118, P10679, DOI 10.1021/ja9617855
   TSO POP, 1964, P NATL ACAD SCI USA, V51, P17, DOI 10.1073/pnas.51.1.17
   Wang J, 1997, ANAL CHIM ACTA, V347, P1, DOI 10.1016/S0003-2670(96)00598-3
   YAMAGUCHI S, 1993, ANAL CHEM, V65, P1925, DOI 10.1021/ac00062a019
   ZIMMER C, 1974, BIOPOLYMERS, V13, P425, DOI 10.1002/bip.1974.360130302
NR 25
TC 57
Z9 62
U1 2
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2001
VL 22
IS 23
BP 3121
EP 3126
DI 10.1016/S0142-9612(01)00061-8
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 476UE
UT WOS:000171246500006
PM 11603583
DA 2018-10-19
ER

PT J
AU Manwaring, ME
   Biran, R
   Tresco, PA
AF Manwaring, ME
   Biran, R
   Tresco, PA
TI Characterization of rat meningeal cultures on materials of differing
   surface chemistry
SO BIOMATERIALS
LA English
DT Article
DE meningeal cells; synthetic materials; cell adhesion; cell surface area;
   DNA synthesis
ID CENTRAL NERVOUS-SYSTEM; ENDOTHELIAL-CELLS; ASTROCYTES; LEPTOMENINGEAL;
   REGENERATION; INVITRO; PROTEIN; FIBRONECTIN; ANTIBODIES; MOLECULES
AB To better understand the interactions of cells derived from meningeal tissues with the surfaces of devices used for the treatment of central nervous system disorders, the behavior of primary postnatal day 1 rat meningeal cultures was evaluated on biomaterials of differing surface chemistry. Meningeal cultures in serum containing media were analyzed for attachment, spread cell area, proliferation, the production of extracellular matrix (ECM), and neuronal outgrowth. In general, both cell attachment as well as cell spread area decreased with increasing substrate hydrophobicity, whereas cell division as indicated by BrdU incorporation and time to confluence, was lower on the most hydrophobic materials. We suggest that such differences immediately after cell seeding were most likely mediated by differences in surface adsorption of proteins. In longer-term experiments, most of the materials were colonized by meningeal cultures irrespective of surface chemistry, and all cultures were equally inhibitory to neuronal outgrowth suggesting that over time, cells can modify the substrate perhaps by secretion of extracellular matrix molecule proteins. Our data suggests that cell type-specific differences in response to different biomaterials may play an important role in determining the Ultimate nature and composition of the CNS at the host-biomaterial interface. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, Salt Lake City, UT 84112 USA.
RP Tresco, PA (reprint author), Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, 20 S 2030 E Bldg 570,Room 108D, Salt Lake City, UT 84112 USA.
EM patrick.tresco@m.cc.utah.edu
CR ABNET K, 1991, DEV BRAIN RES, V59, P187, DOI 10.1016/0165-3806(91)90099-5
   ALCOLADO R, 1988, NEUROPATH APPL NEURO, V14, P1, DOI 10.1111/j.1365-2990.1988.tb00862.x
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Biran R, 1999, J BIOMED MATER RES, V46, P150, DOI 10.1002/(SICI)1097-4636(199908)46:2<150::AID-JBM3>3.3.CO;2-K
   BROWN WJ, 1977, J NEUROSURG, V47, P366, DOI 10.3171/jns.1977.47.3.0366
   CARBONELL AL, 1988, BRAIN RES, V439, P337, DOI 10.1016/0006-8993(88)91491-6
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CRUL BJP, 1991, REGION ANESTH, V16, P209
   DEBUS E, 1983, EMBO J, V2, P2305, DOI 10.1002/j.1460-2075.1983.tb01738.x
   DELBIGIO MR, 1992, J BIOMED MATER RES, V26, P979, DOI 10.1002/jbm.820260802
   DUIJVESTIJN AM, 1992, LAB INVEST, V66, P459
   FEURER DJ, 1991, NEUROPATH APPL NEURO, V17, P391, DOI 10.1111/j.1365-2990.1991.tb00739.x
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   Hirsch S, 1999, GLIA, V26, P36, DOI 10.1002/(SICI)1098-1136(199903)26:1<36::AID-GLIA4>3.0.CO;2-C
   Hoke A, 1996, PROG BRAIN RES, V108, P149, DOI 10.1016/S0079-6123(08)62538-8
   HORBETT TA, 1985, J COLLOID INTERF SCI, V104, P28, DOI 10.1016/0021-9797(85)90006-2
   KNOX P, 1980, J CELL SCI, V46, P97
   KRUGER S, 1986, J COMP NEUROL, V249, P103, DOI 10.1002/cne.902490108
   LEWANDOWSKA K, 1992, J BIOMED MATER RES, V26, P1343, DOI 10.1002/jbm.820261007
   Li MS, 1996, GLIA, V18, P306, DOI 10.1002/(SICI)1098-1136(199612)18:4<306::AID-GLIA5>3.0.CO;2-V
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MATTHIESSEN HP, 1991, J NEUROCHEM, V56, P759, DOI 10.1111/j.1471-4159.1991.tb01989.x
   MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   McMenamin PG, 1999, J COMP NEUROL, V405, P553, DOI 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6
   MURPHY M, 1991, J NEUROSCI RES, V30, P475, DOI 10.1002/jnr.490300304
   NABESHIMA S, 1975, J COMP NEUROL, V164, P127, DOI 10.1002/cne.901640202
   Ness R, 1997, GLIA, V19, P47, DOI 10.1002/(SICI)1098-1136(199701)19:1<47::AID-GLIA5>3.0.CO;2-7
   REIER PJ, 1983, SPINAL CORD RECONSTR, P163
   REYNOLDS AF, 1983, NEUROSURGERY, V13, P63, DOI 10.1227/00006123-198307000-00013
   RODRIGUEZPERALTA LA, 1957, J COMP NEUROL, V107, P455, DOI 10.1002/cne.901070308
   ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0
   RUDGE JS, 1989, EXP NEUROL, V103, P1, DOI 10.1016/0014-4886(89)90180-5
   RUTKA JT, 1986, J NEUROPATH EXP NEUR, V45, P285, DOI 10.1097/00005072-198605000-00012
   Schwab ME, 1996, PHYSIOL REV, V76, P319
   SEKHAR LN, 1982, J NEUROSURG, V56, P411, DOI 10.3171/jns.1982.56.3.0411
   SIEVERS J, 1994, J NEUROCYTOL, V23, P135, DOI 10.1007/BF01183867
   Takamiya Y, 1988, Brain Res, V466, P201
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   Vandenabeele F, 1996, J ANAT, V189, P417
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   WAGGENER JD, 1967, J NEUROPATH EXP NEUR, V26, P412, DOI 10.1097/00005072-196707000-00005
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   WEBB K, 2001, UNPUB BIOMATERIALS
   WILLIAMS RL, 1995, J BIOMED MATER RES, V29, P1545, DOI 10.1002/jbm.820291211
NR 45
TC 19
Z9 19
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2001
VL 22
IS 23
BP 3155
EP 3168
DI 10.1016/S0142-9612(01)00068-0
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 476UE
UT WOS:000171246500011
PM 11603588
DA 2018-10-19
ER

PT J
AU Bruce, AS
   Mainstone, JC
   Golding, TR
AF Bruce, AS
   Mainstone, JC
   Golding, TR
TI Analysis of tear film breakup on Etafilcon A hydrogel lenses
SO BIOMATERIALS
LA English
DT Article
DE tear film breakup; tear film stability; tear film meniscus; hydrogel
   lens; Acuvue
ID STABILITY; WEAR; RUPTURE; TIME
AB Purpose: There is a need to understand better the biomaterial characteristics responsible for tear film stability during hydrogel lens wear. The underlying cause of pre-lens tear film instability may be indicated by the distribution of sites of breakup. The purpose of this study was to compare the distribution of rupture sites during wear of a common biomaterial to that without lenses. Methods: A videokeratography unit, the Topographic Modeling System(TM), was used to capture an image of the tear film at the moment of breakup. Forty measurements were made for each of ten subjects, and the resultant rupture site distributions evaluated. The pre-lens tear film breakup locations were studied for Acuvue (Etafilcon A) disposable contact lenses using the same technique. Results: There was a statistically significant trend for pre-corneal tear film breaks to occur more commonly in parameniscal zones than in areas overlying the central cornea (ANOVA, p = 0.002). With the Etafilcon A lenses, a significant difference in breakup frequency between the two regions was not observed. Conclusions: The pre-corneal tear film findings are consistent with the meniscus model of tear film stability; however, the biomaterial surface characteristics of Etafilcon A give other factors a more dominant role in tear film rupture. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Melbourne, Victorian Coll Optometry, Melbourne, Vic 3053, Australia.
   Univ Melbourne, Dept Optometry & Vis Sci, Carlton, Vic 3053, Australia.
   Queensland Univ Technol, Sch Optometry, Ctr Eye Res, Kelvin Grove, Qld 4059, Australia.
RP Bruce, AS (reprint author), Univ Melbourne, Victorian Coll Optometry, Cnr Keppel & Cardigan St, Melbourne, Vic 3053, Australia.
CR Bitton E, 1998, ADV EXP MED BIOL, V438, P381
   CHO P, 1992, OPTOMETRY VISION SCI, V69, P879, DOI 10.1097/00006324-199211000-00007
   Creech JL, 1998, CURR EYE RES, V17, P1058, DOI 10.1076/ceyr.17.11.1058.5233
   Dillehay S. M., 2000, CLIN MANUAL CONTACT, P239
   DOANE MG, 1988, T BRIT CONT LENS ASS, P110
   FABER E, 1991, OPTOMETRY VISION SCI, V68, P380, DOI 10.1097/00006324-199105000-00010
   FATT I, 1991, CLAO Journal, V17, P267
   Golding TR, 1997, CORNEA, V16, P649
   Guillon J, 1994, CONTACT LENS PRACTIC, P453
   GUILLON JP, 1990, OPHTHAL PHYSL OPT, V10, P343, DOI 10.1111/j.1475-1313.1990.tb00880.x
   Guillon JP, 1998, ADV EXP MED BIOL, V438, P859
   Guillon JP, 1986, PREOCULAR TEAR FILM, P914
   Guillon M, 1992, ICLC, V19, P104
   HOLLY FJ, 1973, EXP EYE RES, V15, P515, DOI 10.1016/0014-4835(73)90064-X
   KORB DR, 1994, ADV EXP MED BIOL, V350, P403
   LEMP MA, 1973, ARCH OPHTHALMOL-CHIC, V89, P103
   MCDONALD JE, 1971, AM J OPHTHALMOL, V72, P139, DOI 10.1016/0002-9394(71)91604-7
   McMonnies C W, 1986, J Am Optom Assoc, V57, P512
   MENGHER LS, 1985, CURR EYE RES, V4, P1, DOI 10.3109/02713688508999960
   NORN MS, 1969, ACTA OPHTHALMOL, V47, P865
   PATEL S, 1987, AM J OPTOM PHYS OPT, V64, P167
   PATEL S, 1985, AM J OPTOM PHYS OPT, V62, P188
   RENGSTORFF RH, 1974, AM J OPTOM PHYS OPT, V51, P765
   Sharma A, 1998, ADV EXP MED BIOL, V438, P425
   Tomlinson A, 1992, COMPLICATIONS CONTAC, P159
   Vajdic C, 1999, OPTOMETRY VISION SCI, V76, P705, DOI 10.1097/00006324-199910000-00022
   YOUNG G, 1991, OPHTHAL PHYSL OPT, V11, P53, DOI 10.1016/0275-5408(91)90011-7
NR 27
TC 16
Z9 16
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2001
VL 22
IS 24
SI SI
BP 3249
EP 3256
DI 10.1016/S0142-9612(01)00162-4
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 485NB
UT WOS:000171759500005
PM 11700796
DA 2018-10-19
ER

PT J
AU Singh, S
   Woerly, S
   Mclaughlin, BJ
AF Singh, S
   Woerly, S
   Mclaughlin, BJ
TI Natural and artificial substrates for retinal pigment epithelial
   monolayer transplantation
SO BIOMATERIALS
LA English
DT Article
DE retinal pigment epithelium; transplantation; lens capsule; hydrogel
ID HUMAN BRUCHS MEMBRANE; MACULAR DEGENERATION; LENS CAPSULE; CELLS;
   REATTACHMENT; CULTURE; LAYERS; RPE
AB The aim of this study was to culture retinal pigment epithelial (RPE) cells on natural and synthetic substrates for future use in RPE monolayer transplantation in the eye. The extracellular capsules surrounding the human lens and a hydrogel biomaterial were used as substrates for monolayer culture. All materials were seeded with either pig or human retinal pigment epithelial cells and were maintained in tissue culture conditions. Upon confluency, the cell density was calculated and cell viability determined. All monolayers were stained with phalloidin-rhodamine for F-actin and antibodies to tight junction-associated protein, ZO(1). The final cell density of human RPE monolayers on the hydrogel and lens capsule was 3200 +/- 187 and 3350 +/- 120 cells/mm(2) respectively. Pig RPE cells had a final cell density of 3740 +/- 205 cells/mm(2) on the lens capsule and 3025 +/- + cells/mm(2) on the hydrogel. F-actin staining revealed a circumferential ring of actin filaments in all the cells grown on substrates. ZO(1) immunohistochemistry demonstrated staining along the lateral cell borders of all cell types. The successful culture of RPE cells on these substrates may have the potential for transplanting cell monolayers in the eye to improve outcomes for degenerative diseases in the retina. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Louisville, Sch Med, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA.
   Organogel Canada Ltec, Quebec City, PQ G1P 4R70, Canada.
RP Mclaughlin, BJ (reprint author), Univ Louisville, Sch Med, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA.
FU NEI NIH HHS [EY02853]
CR Algvere PV, 1999, EUR J OPHTHALMOL, V9, P217
   BHATT NS, 1994, AM J OPHTHALMOL, V117, P214, DOI 10.1016/S0002-9394(14)73079-X
   BINDER PS, 1984, OPHTHALMOLOGY, V91, P806
   CAMMARATA PR, 1986, TISSUE CELL, V18, P83, DOI 10.1016/0040-8166(86)90009-1
   CHANG CW, 1990, INVEST OPHTHALMOL SC, V5, P879
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   Del Priore LV, 1998, ARCH OPHTHALMOL-CHIC, V116, P335, DOI 10.1001/archopht.116.3.335
   DelPriore LV, 1997, INVEST OPHTH VIS SCI, V38, P1207
   DELPRIORE LV, RESURFACING INNER LA, V41, P4562
   Farrokh-Siar L, 1999, CURR EYE RES, V19, P89, DOI 10.1076/ceyr.19.2.89.5331
   FERRIS FL, 1983, AM J EPIDEMIOL, V118, P132, DOI 10.1093/oxfordjournals.aje.a113624
   GLASER BM, 1985, ARCH OPHTHALMOL-CHIC, V103, P1870
   Green W R, 1977, Trans Am Ophthalmol Soc, V75, P180
   Hadlock T, 1999, TISSUE ENG, V5, P187, DOI 10.1089/ten.1999.5.187
   Hartmann U, 1999, GRAEF ARCH CLIN EXP, V237, P940, DOI 10.1007/s004170050390
   Ho TC, 1997, INVEST OPHTH VIS SCI, V38, P1110
   Kiilgaard J. F., 1998, IOVS, V39, pS100
   LIU Y, 1992, INVEST OPHTH VIS SCI, V33, P2180
   MARMOR MF, 1998, RETINAL PIGMENT EPIT, P672
   MCKEEHAN WL, 1976, J CELL BIOL, V71, P727, DOI 10.1083/jcb.71.3.727
   MOHAY J, 1994, CORNEA, V13, P173, DOI 10.1097/00003226-199403000-00011
   Oganesian A, 1997, INVEST OPHTH VIS SCI, V38, P1568
   PEYMAN GA, 1991, OPHTHALMIC SURG LAS, V22, P102
   REZAI KA, 1999, INVEST OPHTH VIS SCI, V40, P3137
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   SAMPLES JR, 1984, INVEST OPHTH VIS SCI, V25, P843
   SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324
   Tezel TH, 1997, GRAEF ARCH CLIN EXP, V235, P41, DOI 10.1007/BF01007836
   Tezel TH, 1999, INVEST OPHTH VIS SCI, V40, P467
   Weisz JM, 1999, RETINA-J RET VIT DIS, V19, P540, DOI 10.1097/00006982-199911000-00011
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   WOERLY S, 1993, BRAIN RES BULL, V30, P423, DOI 10.1016/0361-9230(93)90274-F
   YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540
NR 33
TC 33
Z9 35
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2001
VL 22
IS 24
SI SI
BP 3337
EP 3343
DI 10.1016/S0142-9612(01)00171-5
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 485NB
UT WOS:000171759500015
PM 11700806
DA 2018-10-19
ER

PT J
AU Grant, GGS
   Koktysh, DS
   Yun, BG
   Matts, RL
   Kotov, NA
AF Grant, Gregory G. S.
   Koktysh, Dmitry S.
   Yun, BoGeon
   Matts, Robert L.
   Kotov, Nicholas A.
TI Layer-By-Layer Assembly of Collagen Thin Films: Controlled Thickness and
   Biocompatibility
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE layer-by-layer assembly; thin films; polyelectrolytes; collagen;
   biocompatibility
AB The extracellular matrix molecular collagen is the one of the most widely utilized scaffolding materials in tissue engineering. However, obtaining uniform bioactive collagen films in the nanoscale range and precisely controlling the physical and chemical properties of these biological films is still a challenge for biomedical engineering. Layer-by-layer assembly, i.e., sequential adsorption of oppositely charged macromolecular species, is a powerful new film preparation technique that can be applied to the design of versatile biomaterials, with well-controlled interfacial, mechanical and biological functions. To demonstrate the feasibility of biomaterial design by means of layer-by-layer assembly, type-I collagen thin films were prepared by using this technique with poly(styrene) sulfonate as a partner polyelectrolyte. The gradual build-up of the collagen films was confirmed by UV-vis spectroscopy and ellipsometry, while their surface morphology was assessed by atomic force microscopy. The thickness of the collagen layers can be changed by increasing the number of bilayers adsorbed with an increment of 13 nm. It was found that the layer-by-layer assembled collagen scaffolds can support the attachment and growth of C2C12 myoblast cells and PC12 pheochromocytoma cells. Accurate thickness control and compatibility with nerve cell precursors indicate the utility of layer-by-layer assembled films in neuroprosthesis.
C1 [Grant, Gregory G. S.; Koktysh, Dmitry S.; Kotov, Nicholas A.] Oklahoma State Univ, Dept Chem, Stillwater, OK 74078 USA.
   [Yun, BoGeon; Matts, Robert L.] Oklahoma State Univ, Noble Res Ctr, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.
RP Kotov, NA (reprint author), Oklahoma State Univ, Dept Chem, 107 PS I, Stillwater, OK 74078 USA.
OI Kotov, Nicholas/0000-0002-6864-5804
FU NSF [CHE-9876265]; AFOSR [F49620-99-C-0072]; OCAST, NSF/NATO (NSF-NATO)
   OSU Sensor Center [DGE-9902637]; NSF/NATO (NSF-NATO) [DGE-9902637]
FX N.A.K. thanks NSF CAREER (CHE-9876265), AFOSR (F49620-99-C-0072), and
   OCAST, NSF/NATO (NSF-NATO Grant # DGE-9902637) OSU Sensor Center, for
   partial financial support of this research. D.S.K. acknowledges support
   from the NSF/NATO (NSF-NATO Grant # DGE-9902637) for the postdoctoral
   fellowship.
CR Aliev FG, 1999, ADV MATER, V11, P1006, DOI 10.1002/(SICI)1521-4095(199908)11:12<1006::AID-ADMA1006>3.0.CO;2-2
   Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Carrino DA, 1996, CONNECT TISSUE RES, V35, P325, DOI 10.3109/03008209609029207
   Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 1991, MAKROMOL CHEM-M SYMP, V46, P321, DOI 10.1002/masy.19910460145
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Falini G, 1998, CHEM-EUR J, V4, P1048, DOI 10.1002/(SICI)1521-3765(19980615)4:6<1048::AID-CHEM1048>3.0.CO;2-U
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Koktysh D.S., 2001, UNPUB
   Mamedov A, 2000, LANGMUIR, V16, P3941, DOI 10.1021/la990957j
   Nakamura O., 1994, J BONE MINER METAB, V12, P17
   Ngankam PA, 2000, J AM CHEM SOC, V122, P8998, DOI 10.1021/ja000783o
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Pachence JM, 1987, MED DEVICE DIAGN IND, V9, P49
   Pins GD, 1995, MAT SCI ENG C-BIOMIM, V3, P101, DOI 10.1016/0928-4931(95)00109-3
   Silver F.H., 1997, HDB BIODEGRADABLE PO, V7, P319
   Uemura T, 1997, MAT SCI ENG C-BIO S, V4, P303, DOI 10.1016/S0928-4931(97)00015-5
NR 18
TC 51
Z9 53
U1 1
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD DEC
PY 2001
VL 3
IS 4
BP 301
EP 306
DI 10.1023/A:1012456714628
PG 6
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA V33KX
UT WOS:000209018800006
DA 2018-10-19
ER

PT J
AU Zanchetta, P
   Guezennec, J
AF Zanchetta, P
   Guezennec, J
TI Surface thermodynamics of osteoblasts: relation between hydrophobicity
   and bone active biomaterials
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE thermodynamics; biomaterial; surface tension
ID IN-VITRO; BACTERIAL ADHESION; CELL-CULTURE; FIBRONECTIN; ATTACHMENT
AB Surface tensions of rat calvaria osteoblasts were determined by measuring the cell-liquid-vapor contact angle with sessile drops of water on the cell monolayer. The results indicated the hydrophobic character of osteoblastic cells with a contact angle of 26.89 degrees (0.29 degrees). This value could explain the ability of osteoblasts to specifically attach onto hydrophobic surfaces like titanium or hydroxyapatite. The first cellular step of bone healing requires the presence of osteoblasts and their adhesion to biomaterial surfaces is the crucial phase of the osteointegration process. The presence of a monolayer of a newly discovered hydrophobic bacterial exopolysaccharide on coverglass slides appeared to strongly encourage adhesion of osteoblastic cells. In that, providing surfaces with this hydrophobic material induced a selective adsorption of osteoblast cells and might enhance osteo integration. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Dent Univ, F-29200 Brest, France.
   IFREMER, Dept DRV, VP, BMM, Plouzane, France.
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   ABSOLOM DR, 1980, CELL BIOPHYS, V2, P113, DOI 10.1007/BF02795838
   ABSOLOM DR, 1982, J COLLOID INTERF SCI, V85, P168, DOI 10.1016/0021-9797(82)90245-4
   ABSOLOM DR, 1979, T AM SOC ART INT ORG, V25, P152
   AMARA M, 1991, EUROPHYS LETT, V16, P153, DOI 10.1209/0295-5075/16/2/006
   Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Bartee B K, 1995, J Oral Implantol, V21, P88
   Blanquaert F, 1999, J BIOMED MATER RES, V44, P63, DOI 10.1002/(SICI)1097-4636(199901)44:1<63::AID-JBM7>3.0.CO;2-S
   BOSCH C, 1995, CLEFT PALATE-CRAN J, V32, P311, DOI 10.1597/1545-1569(1995)032<0311:GBRICB>2.3.CO;2
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   CUISINIER F, 1996, SOLID STATE MATER SI, V1, P10
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   DEXTER SC, 1979, J COLLOID INTERF SCI, V70, P346, DOI 10.1016/0021-9797(79)90038-9
   DUBOIS JC, 1996, J BIOMATER DENTAIRES, V11, P85
   EICK JD, 1975, J COLLOID INTERF SCI, V53, P235, DOI 10.1016/0021-9797(75)90010-7
   Fletcher M, 1996, BACTERIAL ADHESION M, P1
   FROST HM, 1989, CLIN ORTHOP RELAT R, P283
   Globus RK, 1998, J CELL SCI, V111, P1385
   Good R. J., 1993, CONTACT ANGLE WETTAB
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   GUEZENNEC JG, 1994, CARBOHYD POLYM, V24, P287, DOI 10.1016/0144-8617(94)90073-6
   HILL PA, 1994, J CELL SCI, V107, P3055
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   ISAKSSON S, 1993, INT J ORAL MAX SURG, V22, P375, DOI 10.1016/S0901-5027(05)80673-3
   Israelachvili JN, 1992, INTERMOLECULAR SURFA
   IVESARO J, 1999, J BONE MINER RES, V14, P1338
   KASEMO B, 1988, IMPLANTS OSTEOINTEGR, P99
   KLEIN G, 1994, MATRIX BIOL, V14, P457
   MACK D, 1992, AM J PHYSIOL, V25, pG171
   MACK DR, 1994, PEDIATR RES, V35, P209, DOI 10.1203/00006450-199402000-00017
   Mackie EJ, 1996, J CELL SCI, V109, P1597
   Moursi AM, 1997, J CELL SCI, V110, P2187
   NEFUSSI JR, 1993, CR SOC BIOL, V187, P620
   Quinquis P., 1993, J BIOM DENT, V8, P31
   Raguenes G, 1996, APPL ENVIRON MICROB, V62, P67
   STUBLEY GD, 1987, HYDRODYNAMICS, V8, P221
   THASVEERI J, 1995, APPL ENVIRON MICROB, V61, P3681
   ZINGG W, 1991, BIOFOULING, V4, P293
NR 39
TC 35
Z9 36
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD DEC
PY 2001
VL 22
IS 4
BP 301
EP 307
DI 10.1016/S0927-7765(01)00200-4
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 479NE
UT WOS:000171409800004
DA 2018-10-19
ER

PT J
AU Dalton, BA
   Steele, JG
AF Dalton, BA
   Steele, JG
TI Migration mechanisms: Corneal epithelial tissue and dissociated cells
SO EXPERIMENTAL EYE RESEARCH
LA English
DT Article
DE corneal epithelium; tissue migration; cell migration
ID SURFACE-TOPOGRAPHY; LEADING-EDGE; MICROTUBULES; MOVEMENT; COLCHICINE;
   FILAMENTS; ADHESION; POLYMER; MODULATION; LOCOMOTION
AB The migratory mechanism of intact bovine corneal epithelial tissue and individual corneal epithelial cells over synthetic surfaces in vitro were compared. In migrating tissue, adhesion between component cells was demonstrated by immunostaining for desmoplakin and identification of desmosomes by electron microscopy. The apparent intermeshing of microtubules within the tissue and interdigitation of cytoplasmic membranes showed the close association of cells. Portions of the advancing edge of the tissue contained actin filaments that were orientated parallel to the leading tissue front. These filaments appeared to span adjacent cells suggesting that migration partially involved the contraction of the actin cable, similar to the 'purse-string' mechanism originally identified in the closure of fetal skin wounds. Intact actin filaments and microtubules were necessary to maintain optimum migration rates for tissue and cells. However, tissue morphology was not dependent on microtubule integrity. During the migration of individual epithelial cells, no staining for desmoplakin was observed and there were clear divisions between the microtubules of adjacent cells. Actin filaments tended to be arranged parallel to the direction of cell movement.
   Therefore, migration of epithelial tissue sheets over synthetic surfaces occurs by mechanisms that differ from the migration of individual epithelial cells, Model systems based on the migration of intact tissue would give a more realistic assessment of the suitability of a material for biomaterial applications than the use of separate epithelial cells.
C1 CSIRO, Mol Sci & Cooperat Res Ctr Eye Res & Technol, N Ryde, NSW 1670, Australia.
RP Dalton, BA (reprint author), CSIRO, Mol Sci & Cooperat Res Ctr Eye Res & Technol, Riverside Corp Pk,POB 184, N Ryde, NSW 1670, Australia.
CR BEMENT WM, 1993, J CELL BIOL, V121, P565, DOI 10.1083/jcb.121.3.565
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Chung JH, 1998, OPHTHALMOLOGICA, V212, P46, DOI 10.1159/000027259
   Dalton BA, 1999, J BIOMED MATER RES, V45, P384, DOI 10.1002/(SICI)1097-4636(19990615)45:4<384::AID-JBM14>3.0.CO;2-O
   Dalton BA, 2001, J BIOMED MATER RES, V56, P83, DOI 10.1002/1097-4636(200107)56:1<83::AID-JBM1071>3.0.CO;2-H
   Danjo Y, 1998, J CELL SCI, V111, P3323
   DIPASQUALE A, 1975, EXP CELL RES, V94, P191, DOI 10.1016/0014-4827(75)90545-5
   DIPASQUALE A, 1975, EXP CELL RES, V95, P425, DOI 10.1016/0014-4827(75)90568-6
   DUA HS, 1994, BRIT J OPHTHALMOL, V78, P401, DOI 10.1136/bjo.78.5.401
   EUTENEUER U, 1986, ANN NY ACAD SCI, V466, P867, DOI 10.1111/j.1749-6632.1986.tb38473.x
   Evans MDM, 2000, INVEST OPHTH VIS SCI, V41, P1674
   Evans MDM, 1997, EXP CELL RES, V233, P88, DOI 10.1006/excr.1997.3523
   FISHER EG, 1990, J IMMUNOL METHODS, V128, P235
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   GIPSON IK, 1982, INVEST OPHTH VIS SCI, V22, P643
   GIPSON IK, 1982, INVEST OPHTH VIS SCI, V22, P633
   GIPSON IK, 1977, INVEST OPHTH VIS SCI, V16, P161
   GIPSON IK, 1994, PRINCIPLES PRACTICE, P3
   GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752
   GOTLIEB AI, 1983, J CELL BIOL, V96, P1266, DOI 10.1083/jcb.96.5.1266
   GUNDERSEN GG, 1987, J CELL BIOL, V105, P251, DOI 10.1083/jcb.105.1.251
   GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946
   HOGAN MJ, 1971, HIST HUMAN EYE
   HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Krendel MF, 1999, CELL MOTIL CYTOSKEL, V43, P296, DOI 10.1002/(SICI)1097-0169(1999)43:4<296::AID-CM3>3.0.CO;2-U
   Latkany R, 1997, J BIOMED MATER RES, V36, P29, DOI 10.1002/(SICI)1097-4636(199707)36:1<29::AID-JBM4>3.3.CO;2-3
   Lee Juliet, 1993, Trends in Cell Biology, V3, P366, DOI 10.1016/0962-8924(93)90084-E
   LIAO GJ, 1995, J CELL SCI, V108, P3473
   MAHAN JT, 1986, J EXP ZOOL, V237, P35, DOI 10.1002/jez.1402370107
   MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0
   Mikhailov A, 1998, CELL MOTIL CYTOSKEL, V41, P325, DOI 10.1002/(SICI)1097-0169(1998)41:4<325::AID-CM5>3.0.CO;2-D
   Nodder S, 1997, ANAT EMBRYOL, V195, P215, DOI 10.1007/s004290050041
   SANDVIG KU, 1994, ACTA OPHTHALMOL, V72, P43
   Schliwa Manfred, 1993, Trends in Cell Biology, V3, P377
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   VAUGHAN RB, 1966, J CELL SCI, V1, P407
NR 37
TC 7
Z9 7
U1 0
U2 2
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0014-4835
J9 EXP EYE RES
JI Exp. Eye Res.
PD DEC
PY 2001
VL 73
IS 6
BP 797
EP 814
DI 10.1006/exer.2001.1090
PG 18
WC Ophthalmology
SC Ophthalmology
GA 517HK
UT WOS:000173604900006
PM 11846511
DA 2018-10-19
ER

PT J
AU Guzzardella, GA
   Torricelli, P
   Aldini, NN
   Giardino, R
AF Guzzardella, GA
   Torricelli, P
   Aldini, NN
   Giardino, R
TI Laser technology in orthopedics: preliminary study on low power laser
   therapy to improve the bone-biomaterial interface
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE diode laser; biomaterial; bone-biomaterial interface; low-power laser
ID HYDROXYAPATITE; IRRADIATION; RATS; BIOSTIMULATION; CO2-LASER; SURGERY;
   TISSUE; REPAIR
AB Low Power Laser (LPL) seems to enhance the healing of bone defects and fractures, The effect of LPL in other orthopedic areas such as osteointegration of implanted prosthetic bone devices is still unclear. In the present study, 12 rabbits were used to evaluate whether Ga-Al-As (780 nm) LPL stimulation has positive effects on osteointegration. Hydroxyapatite (HA) cylindrical nails were drilled into both distal femurs of rabbits. From postoperative day I and for 5 consecutive days, the left femura of all rabbits were given LPL treatment (Laser Group-LG) with the following parameters: 300 Joule/cm(2), 1 Watt, 300 Hertz, pulsating emission, 10 minutes, The right femura were sham-treated (Control Group-CG), At 4 and 8 weeks after implantation, histologic and histomorphometric investigations evaluated bone-biomaterial-con tact. Histomorphometry showed a higher degree of osteointegration at the HA-bone interface in the LG Group at 4 (p<0.0005) and 8 weeks (p<0.001), These preliminary positive results seem to support the hypothesis that LPL treatment can be considered a good tool to enhance the bone-implant interface in orthopedic surgery.
C1 Rizzoli Orthoped Inst, Res Inst Codivilla Putti, Expt & Surg Dept, Serv Chirurg Sperimentale, I-40136 Bologna, Italy.
   Univ Bologna, Sch Med, Chair Surg Pathophysiol, Bologna, Italy.
RP Guzzardella, GA (reprint author), Rizzoli Orthoped Inst, Res Inst Codivilla Putti, Expt & Surg Dept, Serv Chirurg Sperimentale, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM gaetanoantonio.guzzardella@ior.it
RI TORRICELLI, PAOLA/J-5298-2016
OI TORRICELLI, PAOLA/0000-0001-7494-9970
CR ALFAROADRIAN J, 1998, HIP INT, V8, P62
   Capello WN, 1998, CLIN ORTHOP RELAT R, P200, DOI 10.1097/00003086-199810000-00021
   CEDER L, 1998, HIP INT, V8, P99
   DEW DK, 1993, ORTHOPEDICS, V16, P581
   Dorr LD, 1998, J ARTHROPLASTY, V13, P729, DOI 10.1016/S0883-5403(98)90023-7
   Dortbudak O, 2000, CLIN ORAL IMPLAN RES, V11, P540, DOI 10.1034/j.1600-0501.2000.011006540.x
   el-Montaser M, 1999, Implant Dent, V8, P79, DOI 10.1097/00008505-199901000-00010
   ENWEMEKA C S, 1991, Journal of Orthopaedic and Sports Physical Therapy, V14, P198
   Fini M, 2000, INT J ARTIF ORGANS, V23, P275
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   GUILLEMIN F, 2000, HIP INT, V10, P108
   Guzzardella G A, 1996, Acta Biomed Ateneo Parmense, V67, P55
   GUZZARDELLA GA, 2001, BLOOD SUBS IMMOB BIO, V29, P235
   HALL RR, 1971, NATURE, V232, P131, DOI 10.1038/232131a0
   Kawasaki K, 2000, LASER SURG MED, V26, P282, DOI 10.1002/(SICI)1096-9101(2000)26:3<282::AID-LSM6>3.3.CO;2-O
   Lee JJ, 2000, J ORAL MAXIL SURG, V58, P1372, DOI 10.1053/joms.2000.18269
   LEGEROS RZ, 1993, J BONE MINER RES, V8, pS583
   Lewandrowski KU, 1996, LASER SURG MED, V19, P40, DOI 10.1002/(SICI)1096-9101(1996)19:1<40::AID-LSM6>3.3.CO;2-3
   Luger EJ, 1998, LASER SURG MED, V22, P97, DOI 10.1002/(SICI)1096-9101(1998)22:2<97::AID-LSM5>3.0.CO;2-R
   Meffert R M, 1999, Adv Dent Res, V13, P170
   Morrone G, 2000, ARTIF CELL BLOOD SUB, V28, P321, DOI 10.3109/10731190009119362
   Ong JL, 2000, CRIT REV BIOMED ENG, V28, p667A
   Parker M J, 1998, HIP INT, V8, P10
   Rocca M, 1998, INT J ARTIF ORGANS, V21, P553
   Rocca M, 2000, INT J ARTIF ORGANS, V23, P824
   Rokkum M, 1999, J ARTHROPLASTY, V14, P689, DOI 10.1016/S0883-5403(99)90224-3
   Romanos GE, 2000, J PERIODONTOL, V71, P810, DOI 10.1902/jop.2000.71.5.810
   SHEWALE SB, 2001, HIP INT, V11, P158
   SOBALLE K, 2000, HIP INT, V10, P181
   TANG XM, 1986, LASER SURG MED, V6, P346, DOI 10.1002/lsm.1900060309
   Toni A., 2001, HIP INT, V11, P1
   TORIYAMA M, 1995, J MATER SCI, V30, P3216, DOI 10.1007/BF01209240
   TRELLES MA, 1987, LASER SURG MED, V7, P36, DOI 10.1002/lsm.1900070107
   Tsai CL, 1997, LASER SURG MED, V20, P172
   TUNER J, 1999, LEVEL LASER THERAPY, P169
   WILLMANN G, 2000, HIP INT, V10, P193
NR 36
TC 14
Z9 17
U1 0
U2 3
PU WICHTIG PUBLISHING
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD DEC
PY 2001
VL 24
IS 12
BP 898
EP 902
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 510YC
UT WOS:000173234300010
PM 11831596
DA 2018-10-19
ER

PT J
AU Lamghari, M
   Antonietti, P
   Berland, S
   Laurent, A
   Lopez, E
AF Lamghari, M
   Antonietti, P
   Berland, S
   Laurent, A
   Lopez, E
TI Arthrodesis of lumbar spine transverse processes using nacre in rabbit
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Article
DE biomaterial; nacre; osteogenesis; orthopaedic surgery; axial correction
ID OSTEOBLASTS MAINTAINED INVITRO; NONHUMAN PRIMATE; BONE-DEVELOPMENT;
   PROTEIN; MATRIX; FUSION; PROTEOGLYCAN; INTERFACE; INDUCTION; CARTILAGE
AB This study compares the osteogenic effects of nacre and autogenous bone grafts in a rabbit model of lumbar spine transverse process arthrodesis. A total of 15 rabbits were processed for arthrodesis between the fifth and sixth lumbar vertebrae using nacre powder mixed with autologous blood or autogenous iliac crest bone. Control rabbits were sham operated. Sample vertebrae were removed from the nacre-implanted rabbits at 2, 5, and 11 weeks postsurgery. The autogenous bone graft and sham-operated groups were processed for histological study 11 weeks postsurgery. The results for the three groups were compared at 11 weeks. The nacre-implanted samples taken at 2 weeks showed that the nacre was well tolerated by the host tissue. Endochondral bone formation was seen in the region of the dissolving nacre particles by 5 weeks. The newly formed bone formed a solid fusion between the transverse processes in one-third of the rabbits. There was still new bone formation at 11 weeks at the nacre implant site. Two-thirds of the rabbits had formed a solid fusion. Light microscopy also showed new bone formation 11 weeks after the autologous bone graft. All rabbits had a solid fusion. This initial study indicates that nacre can induce spinal fusion in an acceptable percentage of cases.
C1 Museum Natl Hist Nat, Lab Physiol Gen & Comparee, CNRS, UMR 8572, F-75231 Paris 05, France.
   Clin Jouvenet, Dept Chirurg Orthoped, Paris, France.
   Hop Lariboisiere, Serv Neuroradiol Diagnost & Intervent, Paris, France.
RP Lopez, E (reprint author), Museum Natl Hist Nat, Lab Physiol Gen & Comparee, CNRS, UMR 8572, 7 Rue Cuvier, F-75231 Paris 05, France.
RI Lamghari, Meriem/K-2159-2013
OI Lamghari, Meriem/0000-0002-2500-4548
CR Almeida MJ, 2000, J EXP ZOOL, V288, P327, DOI 10.1002/1097-010X(20001215)288:4<327::AID-JEZ5>3.0.CO;2-#
   Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Boden SD, 1999, SPINE, V24, P320, DOI 10.1097/00007632-199902150-00003
   BODEN SD, 1995, J BONE JOINT SURG AM, V77, P1404, DOI 10.2106/00004623-199509000-00017
   FRENKEL SR, 1993, SPINE, V18, P1634, DOI 10.1097/00007632-199309000-00011
   Guicheux J, 1998, J BONE MINER RES, V13, P793
   HAGEN JW, 1992, J BIOMED MATER RES, V26, P897, DOI 10.1002/jbm.820260706
   Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6
   LEFAOU A, 1995, CALCIF TISSUE INT S, V56, pA461
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   LOPEZ E, Patent No. 9724133
   MALININ TI, 1981, CLIN ORTHOP RELAT R, P68
   Martin GJ, 1999, J SPINAL DISORD, V12, P179, DOI 10.1097/00002517-199906000-00001
   MUTAHIR F, 2001, J MATER SCI-MATER M, V12, P1
   POOLE AR, 1982, DEV BIOL, V89, P532, DOI 10.1016/0012-1606(82)90343-8
   REDDI AH, 1978, J BIOL CHEM, V253, P2429
   SCHIMANDLE JH, 1995, SPINE, V20, P1326, DOI 10.1097/00007632-199506000-00002
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243
   URIST MR, 1994, BONE GRAFTS, DERIVATIVES AND SUBSTITUTES, P315
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Villas C, 1996, Rev Med Univ Navarra, V40, P15
   WANG JS, 1993, ACTA ORTHOP SCAND, V64, P557, DOI 10.3109/17453679308993692
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
   WOLFINBARGER L, 1993, IN VITRO CELL DEV-AN, V29A, P914
NR 27
TC 21
Z9 24
U1 0
U2 3
PU AMER SOC BONE & MINERAL RES
PI WASHINGTON
PA 2025 M ST, N W, STE 800, WASHINGTON, DC 20036-3309 USA
SN 0884-0431
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD DEC
PY 2001
VL 16
IS 12
BP 2232
EP 2237
DI 10.1359/jbmr.2001.16.12.2232
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 495BP
UT WOS:000172320600008
PM 11760836
OA Bronze
DA 2018-10-19
ER

PT J
AU Voggenreiter, G
   Hartl, K
   Assenmacher, S
   Chatzinikolaidou, M
   Rumpf, HM
   Jennissen, HP
AF Voggenreiter, G
   Hartl, K
   Assenmacher, S
   Chatzinikolaidou, M
   Rumpf, HM
   Jennissen, HP
TI Assesment of the biological activity of chemically immobilized rhBMP-2
   on titanium surfaces in vivo
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article
ID IMPLANTS
AB Previously it has been shown that recombinant human bone morphogenetic protein (rhBMP-2) can be chemically immobilized by anchor molecules" on titanium surfaces for serving as a drug delivery device. This opened the question of whether the insoluble immobilized rhBMP-2 retained its activity in comparison to the same amount of soluble rhBMP-2 included with the implant samples. Electropolished titanium miniplates (10 x 6 X 0.8 mm) were 11 surface -enhanced" by a novel treatment with chromosulfuric acid and then coated with a total amount of 150 - 200 ng rhBMP-2 prepared by recombinant technology. Periosteal flaps (7 x 20 mm) were detached and isolated front the anterior surface of the tibiac of adult rabbit,, and scrapped around the titanium sample plates which were then implanted in the M. gastrocnemius. In the first experimental group various controls without rhBMP-2 were combined (n - 12). In the second experimental group implants with chemically immobilized rhBMP-2 ( n = 8) were compared with implants to which non-immobilized soluble rhBMP-2 was added (n = 8). Animals were sacrificed after 28 days and a quantitative evaluation vas carried out by means of serial sections. Untreated control plates showed bone formation in 2/12 implants. rhBMP-2 coated implants in 6/8 and implants,kith free rhBMP-2 administered subperiostally in 8/8 cases. In the case of rhBMP-2 coated implants the induced bone had direct contact to the implant in all cases while in the group with free administered rhBMP-2 the bone had no contact to the implant in two cases, but was separated by a fibrous capsule. Bone volume. bone surface area, and trabecular number displayed no difference between the two rhBMP-2-groups. However, in the biocoated group a tendency to an increase in the bone-implant contact area was evident, No differences in osteoid area, osteoid perimeter and eroded perimeter were detected. We conclude that in the case of non-immobilized rhBMP-2 there is the danger for formation of fibrous tissue between the implant and the newly formed bone and in addition the generation of ectopic bone at inappropriate places. In contrast chemically immobilized rhBMP-2 does not have these drawbacks and at the same time displays a biological activity on surfaces similar to that of soluble rhBMP-2 demonstrating that biomaterial surface,, can be tailored for a,elective and specific interaction with the target tissue.
C1 Univ Heidelberg, Klinikum Mannheim, Dept Trauma Surg, D-68165 Mannheim, Germany.
   Bethesda Hosp, Dept Trauma Surg, Duisburg, Germany.
   Univ Essen Gesamthsch Klinikum, Inst Physiol Chem, D-4300 Essen, Germany.
RP Voggenreiter, G (reprint author), Univ Heidelberg, Klinikum Mannheim, Dept Trauma Surg, Theodor Kutzer Ufer 1-3, D-68165 Mannheim, Germany.
RI Chatzinikolaidou, Maria/H-1061-2014
OI Chatzinikolaidou, Maria/0000-0002-2749-2506
CR ASSENMACHER S, 2000, CHIRUG FORUM, V29, P433
   Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Bessho K, 1999, CLIN ORAL IMPLAN RES, V10, P212, DOI 10.1034/j.1600-0501.1999.100304.x
   Heckman JD, 1999, J BONE JOINT SURG AM, V81A, P1717, DOI 10.2106/00004623-199912000-00009
   Jennissen H. P., 2000, DVM BERICHT, V313, P127
   Jennissen HP, 1999, MATERIALWISS WERKST, V30, P838, DOI 10.1002/(SICI)1521-4052(199912)30:12<838::AID-MAWE838>3.0.CO;2-W
   JENNISSEN HP, 2001, BIOMATERIALIEN, V2, P45
   JENNISSEN HP, 2000, Patent No. 10037852
   Lian J, 1999, PRIMER METABOLIC BON, P14
   Lind M, 2000, J ARTHROPLASTY, V15, P339, DOI 10.1016/S0883-5403(00)90693-4
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   WIEMANN M, 2001, WERKSTOFFTECH, V32, P931
   Zegzula HD, 1997, J BONE JOINT SURG AM, V79A, P1778, DOI 10.2106/00004623-199712000-00003
NR 16
TC 20
Z9 20
U1 0
U2 2
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD DEC
PY 2001
VL 32
IS 12
BP 942
EP 948
DI 10.1002/1521-4052(200112)32:12<942::AID-MAWE942>3.0.CO;2-9
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 510YD
UT WOS:000173234400009
DA 2018-10-19
ER

PT J
AU Wissler, JH
AF Wissler, JH
TI Engineering of blood vessel patterns by angio-morphogens [angiotropins]:
   Non-mitogenic copper-ribonucleoprotein cytokines [CuRNP ribokines] with
   their metalloregulated constituents of RAGE-binding S100-EF-hand
   proteins and extracellular RNA bioaptamers in vascular remodeling of
   tissue and angiogenesis in vitro
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Review
ID CAPILLARY ENDOTHELIAL-CELLS; INDUCED CORNEAL VASCULARIZATION;
   LOW-DENSITY LIPOPROTEIN; TUMOR ANGIOGENESIS; IN-VITRO; THERAPEUTIC
   IMPLICATIONS; COLLAGEN SUBSTRATUM; NUCLEASE ACTIVITY; GENETIC ALPHABET;
   GROWTH-FACTORS
AB Tissue vascularization is requisite to successful cell-based therapies, biomaterial design and implant integration. Thus, known problems in ossointegration of avascular implants in connection with the generation of bone tissue reflect arrays of general problem,. of socio-economic relevance existing in reparative medicine still waiting for to be solved. For this purpose. morphogenesis and remodeling of endothelial angio-architectures in tissue and in vitro by isolated non-mitogenic angio-morphogens [angiotropins] are considered in terms of their structure, function and action mechanisms. Extracellular angiotropins are secreted by activated leukocytes/monocytes/macrophages. They are a family of cytokines with morphogen bioactivity selectively directed to endothelial cells. Their Structure as deciphered as metalloregulated copper-ribonucleoproteins [CuRNP ribokines]. The) are built up of angiotropin-related S100-EF-hand protein [ARP] and highly modified and edited 5'end-phosphorylated RNA [ARNA]. complexed together by copper ions. Oxidant-sensitive ARNA and their precursors represent novel tapes in a RNA world: The are the first isolated and sequenced forms of extracellular RNA [eRNA], may act as cytokine and bioaptamer. contain isoguanosine [crotonoside] as modified nucleoside and show up copper as RNA-structuring transition metal ion. By metalloregulated bioaptamer functions, ARNA impart novel biofunctions to RAGE-binding S100-EF-hand proteins. Angiotropin morphogens were shown suitable for neointiation and remodeling of blood vessel patterns in different. adult, embryonal and artificial tissues. These neovascular patterns manifest regulated hemodynamics for preventing tissue necrosis, supporting tissue functions and promoting wound healing, As evaluatcd in skin and muscle vascularization, the neovascular patterns are integrated into homeostatic control mechanisms of tissue, Thus, the morphogens show up beneficial perspectives and are suggested Useful tools for further investigations in angiotherapy engineering of blood vessel patterns in tissues and biocompatible artificial organs as well as in the preparation of novel implants with morphogen-coated surfaces.
C1 ARCONS Appl Res, D-61231 Bad Nauheim, Germany.
RP Wissler, JH (reprint author), ARCONS Appl Res, Postfach 1327, D-61231 Bad Nauheim, Germany.
CR ACKERS GK, 1962, ACTA, V69, P137
   ALPERNELRAN H, 1989, J NEUROSURG, V70, P942, DOI 10.3171/jns.1989.70.6.0942
   ALTMAN S, 1989, ENZYMOL RELAT AREAS, V62, P1
   ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222
   Auerbach R, 2000, CANCER METAST REV, V19, P167, DOI 10.1023/A:1026574416001
   AUERBACH W, 1994, PHARMACOL THERAPEUT, V63, P265, DOI 10.1016/0163-7258(94)90027-2
   BANDA MJ, 1982, P NATL ACAD SCI-BIOL, V79, P7773, DOI 10.1073/pnas.79.24.7773
   BANDA MJ, 1985, J CELL BIOCHEM, V29, P183, DOI 10.1002/jcb.240290303
   BENNER SA, 1989, TRENDS BIOCHEM SCI, V14, P396, DOI 10.1016/0968-0004(89)90282-X
   BENNER SA, 1988, FEBS LETT, V233, P225, DOI 10.1016/0014-5793(88)80431-9
   BERNAUER W, 1972, INT ARCH ALLER A IMM, V42, P136, DOI 10.1159/000230599
   BILLROTH T, 1986, ED UNTERSUCHUNGEN EN
   Brem S, 1999, CANC CONTROL, V6, P436
   BRILLOUIN L, 1962, SCI INFORMATION THEO
   BURDACH SE, 1984, PROTIDES BIOL FLUIDS, V32, P1181
   BURDACH SEG, 1984, RES CLIN LAB, V14, P565
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   CARMICHAEL PL, 1992, CARCINOGENESIS, V13, P1127, DOI 10.1093/carcin/13.7.1127
   Carreira CM, 1998, J BIOL CHEM, V273, P22224, DOI 10.1074/jbc.273.35.22224
   Carreira CM, 2001, GROWTH FACTORS, V18, P277, DOI 10.3109/08977190109029116
   Cavallaro U, 2001, J CELL BIOCHEM, V82, P619, DOI 10.1002/jcb.1190
   CECH TR, 1989, BIOCHEM INT, V18, P7
   CHEN CHB, 1993, P NATL ACAD SCI USA, V90, P4206, DOI 10.1073/pnas.90.9.4206
   CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0
   Crick F. H C., 1971, Symp Soc Exp Biol, V25, P429
   DAMORE PA, 1987, ANNU REV PHYSIOL, V49, P453
   Darland DC, 2001, CURR TOP DEV BIOL, V52, P107, DOI 10.1016/S0070-2153(01)52010-4
   DAVIS JT, 1995, J ORG CHEM, V60, P4167, DOI 10.1021/jo00118a038
   Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7
   DELLANGELICA EC, 1994, J BIOL CHEM, V269, P28929
   DESHPANDE R G, 1989, Indian Journal of Medical Research Section B, V90, P241
   DODD NJF, 1984, J CELL SCI, V68, P153
   Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0
   EDMAN P, 1956, ACTA CHEM SCAND, V10, P761, DOI 10.3891/acta.chem.scand.10-0761
   EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283
   EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x
   Edman P, 1970, Mol Biol Biochem Biophys, V8, P211
   ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0
   ERROI AL, 1986, ANTICANCER RES, V6, P1045
   Fabbrizzi L, 1999, ACCOUNTS CHEM RES, V32, P846, DOI 10.1021/ar990013l
   FAVARD C, 1991, BIOL CELL, V73, P1, DOI 10.1016/0248-4900(91)90002-5
   FENSELAU A, 1981, J BIOL CHEM, V256, P9605
   FENSELAU A, 1981, J MICROVASC RES, V22, P58
   FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8
   FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030
   FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275
   FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0
   FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
   Folkman J, 1997, EXS, V79, P1
   Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3
   FROMER CH, 1976, AM J PATHOL, V82, P157
   FROMER CH, 1975, AM J PATHOL, V81, P531
   FROMER CH, 1975, AM J PATHOL, V79, P537
   FULTON GEORGE P., 1960, PHYSIOL REVS, V40, P57
   Garrett KL, 2001, J GENE MED, V3, P373, DOI 10.1002/jgm.197
   Gesteland R.F., 1999, RNA WORLD
   Giordano FJ, 2001, CURR OPIN GENET DEV, V11, P35, DOI 10.1016/S0959-437X(00)00153-2
   Gospodarowicz D, 1976, Prog Clin Biol Res, V9, P1
   GOTTWIK M, 1982, H-S Z PHYSIOL CHEM, V363, P938
   GROSJEAN H, 1998, MODIFICATION EDITON
   GULLINO PM, 1990, CANCER METAST REV, V9, P239, DOI 10.1007/BF00046363
   HOCKEL M, 1985, FED PROC, V44, P1880
   HOCKEL M, 1984, INT J TISSUE REACT, V6, P323
   HOCKEL M, 1987, J CELL PHYSIOL, V133, P1, DOI 10.1002/jcp.1041330102
   HOCKEL M, 1989, ARCH SURG-CHICAGO, V124, P693
   HOCKEL M, 1988, J CLIN INVEST, V82, P1075, DOI 10.1172/JCI113664
   HOCKEL M, 1985, KLIN FORSCH GYN GEBU, V10, P122
   HOCKEL M, 1986, PROTIDES BIOL FLUIDS, V34, P517
   HOCKEL M, 1984, PROTIDES BIOL FLUIDS, V31, P1161
   Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6
   Ilan N, 1999, CURR OPIN BIOTECH, V10, P536, DOI 10.1016/S0958-1669(99)00026-9
   IRUELAARISPE ML, 1993, J CELL BIOCHEM, V52, P414, DOI 10.1002/jcb.240520406
   IRUELAARISPE ML, 1997, THROMB HAEMOSTASIS, V78, P6272
   KAMINSKI M, 1988, P SOC EXP BIOL MED, V188, P440
   KASTNER M, 1984, Z NATURFORSCH C, V39, P639
   KEEGAN A, 1982, J CELL SCI, V55, P261
   KELLER H, 1980, J IMMUNOL METHODS, V36, P41, DOI 10.1016/0022-1759(80)90092-7
   KELLER HU, 1979, EXPERIENTIA, V35, P1669, DOI 10.1007/BF01953261
   KELLER HU, 1977, EXPERIENTIA, V33, P534, DOI 10.1007/BF01922257
   KELLER HU, 1981, IMMUNOLOGY, V42, P379
   Kersten JR, 1999, CARDIOVASC RES, V43, P44, DOI 10.1016/S0008-6363(99)00077-2
   Kiesewetter S., 1995, Biological Chemistry Hoppe-Seyler, V376, pS115
   KIESEWETTER S, 1995, FASEB J, V9, pA1369
   KOLODNY G M, 1974, P97
   KOLODNY GM, 1971, EXP CELL RES, V65, P313, DOI 10.1016/0014-4827(71)90007-3
   KOLODNY GM, 1972, EXP CELL RES, V73, P65, DOI 10.1016/0014-4827(72)90102-4
   KOLODNY GM, 1972, J CELL PHYSL, V79, P177
   KUHN E, 1996, BIOL CHEM, V377, pS195
   KUMAR S, 1980, JNCI-J NATL CANCER I, V64, P683
   KUMAR S, 1987, DIFFERENTIATION, V36, P57, DOI 10.1111/j.1432-0436.1987.tb00181.x
   KUWABARA M, 1986, BIOCHEMISTRY-US, V25, P7401, DOI 10.1021/bi00371a023
   Kuwano M, 2001, INTERNAL MED, V40, P565, DOI 10.2169/internalmedicine.40.565
   Landriscina M, 2001, J BIOL CHEM, V276, P22544, DOI 10.1074/jbc.M100546200
   LANDRISCINA M, 1981, J BIOL CHEM, V276, P25549
   LANE TF, 1994, J CELL BIOL, V125, P929, DOI 10.1083/jcb.125.4.929
   Lanza R. P., 1997, PRINCIPLES TISSUE EN
   Leenders WPJ, 1997, MECH DEVELOP, V67, P193, DOI 10.1016/S0925-4773(97)00121-4
   LIEBOW AA, 1963, HANDB PHYSIOL, V2, P1251
   Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4
   Liss C, 2001, INT J CANCER, V93, P781, DOI 10.1002/ijc.1407
   LOEWENSTEIN WR, 1971, HDB SENSORY PHYSL, V1, P226
   Long EC, 1999, ACCOUNTS CHEM RES, V32, P827, DOI 10.1021/ar980072j
   LUCCHESI BR, 1986, ANNU REV PHARMACOL, V26, P201, DOI 10.1146/annurev.pa.26.040186.001221
   Malonne H, 1999, CLIN EXP METASTAS, V17, P1, DOI 10.1023/A:1026443925807
   Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700
   MAURER HR, 1981, Z PHYSL CHEM, V362, P221
   Mauro A, 1979, MUSCLE REGENERATION
   MEINHARDT H, MODELS BIOL PATTERNS, P82
   MENEGHINI R, 1995, CANCER J, V8, P109
   MIDY V, 1994, BIOCHEM BIOPH RES CO, V199, P380, DOI 10.1006/bbrc.1994.1240
   Milkiewicz M, 2001, MICROCIRCULATION, V8, P229, DOI 10.1038/sj.mn.7800074
   MODAK AS, 1991, J AM CHEM SOC, V113, P283, DOI 10.1021/ja00001a041
   MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297
   MOROWITZ HJ, 1971, ENTROPY BIOL
   MOYON D, 2001, MECH DEVELOP, V103, P133
   MULVIHILL DA, 1931, NEW ENGL J MED, V104, P1032
   NEUMEIER R, 1982, H-S Z PHYSIOL CHEM, V363, P193
   OREILLY MS, 1994, COLD SPRING HARB SYM, V59, P471, DOI 10.1101/SQB.1994.059.01.052
   OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3
   OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6
   ORGEL LE, 1990, NATURE, V343, P18, DOI 10.1038/343018a0
   ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455
   OSHEA PS, 1988, EXPERIENTIA, V44, P631, DOI 10.1007/BF01941022
   PAPPENHEIMER JR, 1951, AM J PHYSIOL, V167, P13
   Patan S, 2000, J NEURO-ONCOL, V50, P1, DOI 10.1023/A:1006493130855
   Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274
   PETERSON HI, 1979, TUMOR BLOOD CIRCULAT
   PICCIRILLI JA, 1990, NATURE, V343, P33, DOI 10.1038/343033a0
   POLAKOWSKI IJ, 1993, AM J PATHOL, V143, P507
   Polverini P J, 1997, EXS, V79, P11
   POLVERINI PJ, 1984, LAB INVEST, V51, P635
   POLVERINI PJ, 1977, NATURE, V269, P804, DOI 10.1038/269804a0
   Potter JD, 2001, CANCER EPIDEM BIOMAR, V10, P161
   PRIGOGINE I, 1978, ANGEW CHEM, V90, P704
   RAINES RT, 1995, J BIOL CHEM, V270, P17180, DOI 10.1074/jbc.270.29.17180
   RAJU KS, 1982, J NATL CANCER I, V69, P1183
   Ramirez-Bergeron DL, 2001, STEM CELLS, V19, P279, DOI 10.1634/stemcells.19-4-279
   Reilly W, 1988, Adv Exp Med Biol, V242, P221
   RENKIN EM, 1954, J GEN PHYSIOL, V38, P225
   Rich A, 1962, HORIZONS BIOCH, P103
   ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511
   Rosenthal AM, 1990, CELL CULTURE TECHNIQ, P117
   Rudman SM, 1997, J INVEST DERMATOL, V109, P770, DOI 10.1111/1523-1747.ep12340934
   RUSSMANN E, 1985, IMMUNOBIOLOGY, V169, P389, DOI 10.1016/S0171-2985(85)80019-X
   RUSSMANN E, 1986, CELL IMMUNOL, V100, P167
   RUSSMANN E, 1984, VERH DTSCH KREBSGESE, V5, P146
   RUSSMANN E, 1985, TREATMENT METASTASIS, P161
   RUTT GT, 1989, ONKOL, V165, P508
   Sambrook J., 2001, MOL CLONING
   SAUER E, 1980, MYOCARD VENTRIKELSZI
   SCHOR AM, 1979, INT J CANCER, V24, P225, DOI 10.1002/ijc.2910240215
   SIGMAN DS, 1993, CHEM REV, V93, P2295, DOI 10.1021/cr00022a011
   SIMORREPINATEL V, 1994, INVEST OPHTH VIS SCI, V35, P3393
   Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133
   STEIN O, 1980, BIOCHIM BIOPHYS ACTA, V620, P631, DOI 10.1016/0005-2760(80)90155-1
   STEINER R, 1992, ANGIJOGENESIS
   STOKES RH, 1950, J AM CHEM SOC, V72, P763, DOI 10.1021/ja01158a032
   STOKES RH, 1950, J AM CHEM SOC, V72, P2243, DOI 10.1021/ja01161a101
   Tabata T, 2001, NAT REV GENET, V2, P620, DOI 10.1038/35084577
   TARR GE, 1978, ANAL BIOCHEM, V84, P622, DOI 10.1016/0003-2697(78)90086-6
   TARR GE, 1981, ANAL BIOCHEM, V111, P27, DOI 10.1016/0003-2697(81)90223-2
   THESLEFF I, 1983, CANCER RES, V43, P5902
   TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121
   Vallee BL, 1997, CELL MOL LIFE SCI, V53, P803, DOI 10.1007/s000180050101
   VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034
   WAKELEY C, 1955, Ann R Coll Surg Engl, V16, P69
   Wang ZB, 2001, BIOCHEM BIOPH RES CO, V285, P669, DOI 10.1006/bbrc.2001.5232
   WEISSMAN SM, 1983, METHODS DNA RNA SEQU
   Wissler J. H., 1997, Molecular Biology of the Cell, V8, p231A
   Wissler JH, 2000, FASEB J, V14, pA1420
   Wissler JH, 2000, FASEB J, V14, pA20
   WISSLER JH, 1991, BIOL CHEM H-S, V372, P780
   WISSLER JH, 1989, BIOL CHEM H-S, V370, P975
   Wissler JH, 1999, MOL BIOL CELL, V10, p449A
   Wissler JH, 1998, MOL BIOL CELL, V9, p71A
   WISSLER JH, 1990, BIOL CHEM H-S, V371, P827
   WISSLER JH, 1972, INT ARCH ALLER A IMM, V42, P722, DOI 10.1159/000230652
   Wissler JH, 1998, FASEB J, V12, pA1463
   WISSLER JH, 1981, IMMUNOBIOLOGY, V160, P131
   WISSLER JH, 1981, Z PHYSL CHEM, V362, P244
   WISSLER JH, 1982, ENTZUNDUNGSMEDIATORE, P1
   WISSLER JH, 1989, MODERN TRENDS IMMUNO, P174
   WISSLER JH, 1984, PROTIDES BIOL FLUIDS, V32, P1167
   WISSLER JH, 1985, PROTIDES BIOL FLUIDS, V33, P643
   WISSLER JH, 1980, J PHYSL CHEM, V361, P351
   WISSLER JH, 2000, BIOL CHEM, V381, pS246
   WISSLER JH, 1982, Z PHYSL CHEM, V363, P941
   WISSLER JH, 2001, MOL BIOL CELL S, V12, P2304
   WISSLER JH, 1984, BLOOD CELLS NUCL M 2, P41
   WISSLER JH, 1980, INFLAMMATION MECH TR, P591
   WISSLER JH, 1982, KFA, P293
   WISSLER JH, 1986, PROTIDES BIOL FLUIDS, V34, P525
   WISSLER JH, 1982, BIOCH DIFFERENTIATIO, P257
   WISSLER JH, 1984, BLOOD CELLS NUCL 2, P393
   WISSLER JH, 1993, ERKRANKUNGEN IMMUNOP, P1
   WISSLER JH, 2001, BIOL CHEM, V382, pS99
   WISSLER JH, 1984, PROTIDES BIOL FLUIDS, V32, P1165
   WISSLER JH, 1975, GRAM NEGATIVE BACTER, P91
   WISSLER JH, 2000, FASEB J, V14, pS1392
   WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0
   Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9
   Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407
   Zhao Hui, 1999, Journal of Cellular Biochemistry, V76, P109
   Zimrin AB, 1996, J BIOL CHEM, V271, P32499, DOI 10.1074/jbc.271.51.32499
   Zuker M., 1999, V70, P11
NR 205
TC 4
Z9 4
U1 0
U2 9
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD DEC
PY 2001
VL 32
IS 12
BP 984
EP 1008
DI 10.1002/1521-4052(200112)32:12<984::AID-MAWE984>3.0.CO;2-M
PG 25
WC Materials Science, Multidisciplinary
SC Materials Science
GA 510YD
UT WOS:000173234400015
DA 2018-10-19
ER

PT J
AU Song, F
   Bai, YL
AF Song, F
   Bai, YL
TI Analysis of the strengthening and toughening of a biomaterial interface
SO SCIENCE IN CHINA SERIES A-MATHEMATICS PHYSICS ASTRONOMY
LA English
DT Article
DE organic matrix interface; mineral bridge; nacre; microstructure;
   fracture toughness
ID CERAMICS; NACRE
AB Based on the transmission electron micrographs of nacre, the existence of mineral bridges in the organic matrix interface is confirmed. It is proposed that the microarchitecture of nacre should be considered as a "brick-bridge-mortar" (BBM) arrangement rather than traditional "brick and mortar" (BM) one. Experiments and analyses indicate that the mineral bridges effectively affect the strength and toughness of the interfaces in nacre. Comparison with a laminated composite with BM structure, SiC/BN, shows that the pattern of the crack extension and the toughening mechanism of the two materials are different. This reveals that the mineral bridges play a key role in the toughening mechanisms of nacre, which gives a conceptual guidance in material synthesis.
C1 Chinese Acad Sci, Inst Mech, LNM, Beijing 100080, Peoples R China.
RP Song, F (reprint author), Chinese Acad Sci, Inst Mech, LNM, Beijing 100080, Peoples R China.
RI Bai, Yilong/B-7781-2013
CR Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010
   CLEGG WJ, 1990, NATURE, V347, P455, DOI 10.1038/347455a0
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   Feng Q. L., 1995, Biomimetics, V3, P159
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   JACKSON AP, 1986, J MATER SCI LETT, V5, P975, DOI 10.1007/BF01730253
   Schaffer TE, 1997, CHEM MATER, V9, P1731, DOI 10.1021/cm960429i
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   SONG F, 2000, ACTA MECH SOLIDI SIN, V21, P171
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   Szuromi P, 1997, SCIENCE, V277, P1183, DOI 10.1126/science.277.5330.1183
   Vincent JFV., 1982, STRUCTURAL BIOMATERI
   WANG RZ, 1995, J MATER SCI, V30, P2299, DOI 10.1007/BF01184577
   WATABE N, 1981, PROG CRYST GROWTH CH, V4, P99, DOI 10.1016/0146-3535(81)90050-2
NR 15
TC 3
Z9 4
U1 1
U2 7
PU SCIENCE CHINA PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1006-9283
J9 SCI CHINA SER A
JI Sci. China Ser. A-Math. Phys. Astron.
PD DEC
PY 2001
VL 44
IS 12
BP 1596
EP 1601
DI 10.1007/BF02880799
PG 6
WC Mathematics, Applied; Mathematics
SC Mathematics
GA 542DX
UT WOS:000175029200012
DA 2018-10-19
ER

PT J
AU Gruessner, U
   Clemens, M
   Pahlplatz, PV
   Sperling, P
   Witte, E
   Rosen, HR
AF Gruessner, U
   Clemens, M
   Pahlplatz, PV
   Sperling, P
   Witte, E
   Rosen, HR
CA Septocoll Study Grp
TI Improvement of perineal wound healing by local administration of
   gentamicin-impregnated collagen fleeces after abdominoperineal excision
   of rectal cancer
SO AMERICAN JOURNAL OF SURGERY
LA English
DT Article
DE rectal cancers; abdominoperineal excision; sacral cavity; wound
   infection; gentamycin; collagen fleece
ID SURGERY; INFECTION
AB Background: Despite significant advancements in rectal surgery, poor perineal wound healing after abdominoperineal resection (APR) of the anorectum continues to be a potential complication of the procedure. The aim of this prospective randomized multicenter study was to investigate the efficacy of a new mode of local antibiotic administration.
   Patients and methods: Ninety-seven patients who had to undergo APR for low rectal carcinoma either received sacral drainage plus primary wound closure (control group, n = 48) or the same treatment and supplementary application of three resorbable gentamicin-impregnated collagen fleeces (Septocoll; Merck Biomaterial GmbH, Darmstadt, Germany; Genta group, 49). The following target criteria were investigated: bacteriologic efficacy with respect to the eradication of Enterobacteriaceae, Staphlylococcus, and Pseudomonas organisms, and clinical efficacy with respect to perineal wound healing.
   Results: The Genta group showed a marked reduction in the investigated pathogens from the secretion obtained by sacral drainage on da 1 and 3, as well as high gentamicin concentrations (day 1, median 126.2 mug/mL; day 3, median 97.6 mug/mL). In total, bacteriologic efficacy amounted to 83.7% in the Genta group (41 of 49 patients) versus 60.4% (29 of 48 patients) in controls (P = 0.013). In concurrence with these bacteriologic results, the postoperative infection rate was significantly higher in controls: 10 patients (20.83%) in the control a cup versus 3 (6.1%) in the Genta group developed perineal or sacral infection (P <0.05). Postoperative complications in the recruited patients revealed no indication of gentamicin-induced adverse reactions.
   Conclusions: The results of the study show that the specified dose of 3 Septocoll fleeces in patients with APR is liable to significantly eliminate enterobacteria, staphylococci, and pseudomonads. The clinical course is improved as a result of the bactericidal effect exerted by the gentamicin fleece. The use of Septocoll reduced the incidence of postoperative perineal and sacral infections. Local antibiotic carriers seem to be of great advantage in poorly perfused areas such as the sacral cavity or anatomically problematic regions as the rima ani. In locally contaminated or infected areas, local antibiotic carriers achieve greater concentrations of the active substance than those achieved with systemic antibiotics, even if the latter are administered by the parenteral route. (C) 2001 Excerpta Medica, Inc. All rights reserved.
C1 Danube Hosp SMZ Ost, Ludwig Boltzmann Res Inst Surg Oncol, Vienna Med Sch, A-1220 Vienna, Austria.
   Merck Biomat GmbH, Abt Forsch & Entwicklung, D-64271 Darmstadt, Germany.
   Stadt Kliniken Osnabruck, D-49076 Osnabruck, Germany.
   Ziekenhuis Leyenburg, Chirurg Abt, NL-2545 CH The Hague, Netherlands.
   St Marien Krankenhaus Berlin Lankwitz, Chirurg Klin, D-12249 Berlin, Germany.
   Zent Klinikum, Chirurg Klin 2, D-86156 Augsburg, Germany.
RP Rosen, HR (reprint author), Danube Hosp SMZ Ost, Ludwig Boltzmann Res Inst Surg Oncol, Vienna Med Sch, Langobardenstr 122, A-1220 Vienna, Austria.
CR ALTEMEIER WA, 1974, AM J SURG, V127, P215, DOI 10.1016/0002-9610(74)90160-3
   ANDERSEN B, 1972, ANN SURG, V176, P129, DOI 10.1097/00000658-197208000-00001
   AUBREY DA, 1986, PHARMATHERAPEUTICA, V4, P536
   BERRY AR, 1980, CLIN ONCOL, V6, P231
   DAVIES OVL, 1957, P ROY SOC MED, V50, P1047
   DINGELDEIN E, 1990, 1190 ZPD
   ECKERT P, 1993, ENTWICKLUNGEN UNFALL, P214
   HARSHAW DH, 1974, SURG GYNECOL OBSTET, V139, P756
   HOFFMANN CEJ, 1981, ANN SURG, V193, P353, DOI 10.1097/00000658-198103000-00018
   IRVIN TT, 1975, BRIT J SURG, V62, P287, DOI 10.1002/bjs.1800620409
   KAYSER H, 1988, RECONST SURG TRAUMA, V20, P1
   Lutje H C, 1988, Reconstr Surg Traumatol, V20, P112
   MARTI MC, 1983, SURGERY, V93, P190
   MCDONALD PJ, 1983, DIS COLON RECTUM, V6, P661
   MCLACHLIN AD, 1970, CAN J SURG, V13, P350
   Miles WE, 1908, LANCET, V2, P1812
   Muhleder H, 1988, Reconstr Surg Traumatol, V20, P105
   *NAT COMM CLIN LAB, 1988, PERF STAND ANT DISK, V4, P16
   PETRELLI N, 1986, J SURG ONCOL, V32, P138, DOI 10.1002/jso.2930320303
   Renner K, 1999, DIS COLON RECTUM, V42, P1160, DOI 10.1007/BF02238568
   Robson MC, 1999, AM J SURG, V178, P399, DOI 10.1016/S0002-9610(99)00208-1
   ROSEN HR, 1991, AM J SURG, V162, P438, DOI 10.1016/0002-9610(91)90256-D
   Sachweh D, 1988, Reconstr Surg Traumatol, V20, P63
NR 23
TC 56
Z9 59
U1 0
U2 1
PU EXCERPTA MEDICA INC
PI NEW YORK
PA 650 AVENUE OF THE AMERICAS, NEW YORK, NY 10011 USA
SN 0002-9610
J9 AM J SURG
JI Am. J. Surg.
PD NOV
PY 2001
VL 182
IS 5
BP 502
EP 509
DI 10.1016/S0002-9610(01)00762-0
PG 8
WC Surgery
SC Surgery
GA 506YL
UT WOS:000172999300013
PM 11754859
DA 2018-10-19
ER

PT J
AU Phaneuf, MD
   Bide, MJ
   Szycher, M
   Gale, MB
   Huang, HX
   Yang, CQ
   LoGerfo, FW
   Quist, WC
AF Phaneuf, MD
   Bide, MJ
   Szycher, M
   Gale, MB
   Huang, HX
   Yang, CQ
   LoGerfo, FW
   Quist, WC
TI Development of infection resistant polyurethane biomaterials using
   textile dyeing technology
SO ASAIO JOURNAL
LA English
DT Article
ID VASCULAR PROSTHETIC INFECTION; GRAFT INFECTION; DRUG DELIVERY; DACRON
   GRAFT; PREVENTION; PROTECTION; SURFACE; POLYTETRAFLUOROETHYLENE;
   PROPHYLAXIS; ADHESION
AB Infection is a major complication when using biomaterials such as polyurethane in the clinical setting. The purpose of this study was to develop a novel infection resistant polyurethane biomaterial using textile dyeing technology. This procedure results in incorporation of the antibiotic into the polymer, resulting in a slow, sustained release of antibiotic from the material over time, without the use of exogenous binder agents. Polycarbonate based urethanes were synthesized that contained either a non-ionic (bdPU) or anionic (cPU) chain extender within the polymer backbone and cast into films. The fluoroquinolone antibiotic ciprofloxacin (Cipro) was applied to bdPU and cPU using textile dyeing technology, with Cipro uptake determined by absorbance reduction of the "dyebath." These dyed bdPU/cPU samples were then evaluated for prolonged Cipro release and antimicrobial activity by means of spectrophotometric and zone of inhibition assays, respectively. Cipro release and antimicrobial activity by dyed cPU segments that were aggressively washed persisted over 9 days, compared with dyed bdPU and dipped cPU control segments that lasted < 24 hours. Dyed cPU segments, which remained in a static wash solution, maintained antimicrobial activity for 11 days (length of study), whereas controls again lost antimicrobial activity within 24 hours. Thus, application of Cipro to the cPU polymer by means of dyeing technology results in a slow sustained release of antibiotic with persistent bacteriocidal properties over extended periods of time.
C1 Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
   Univ Rhode Isl, Dept Text, Kingston, RI USA.
   Cardiotech Int Inc, Woburn, MA USA.
RP Phaneuf, MD (reprint author), Beth Israel Deaconess Med Ctr, 4 Blackfan Circle,Room 131, Boston, MA 02115 USA.
FU NHLBI NIH HHS [R41 HL62764]
CR BANDYK DF, 1991, J VASC SURG, V13, P575
   BENVENISTY AI, 1988, J SURG RES, V44, P1, DOI 10.1016/0022-4804(88)90116-3
   BIDE M, 1993, TEXT CHEM COLOR, V25, P15
   BUDE MJ, 1999, P AM ASS TEXT CHEM C
   CHERVU A, 1991, J VASC SURG, V14, P521, DOI 10.1016/0741-5214(91)90246-Q
   EDWARDS LD, 1976, ANN SURG, V184, P758, DOI 10.1097/00000658-197612000-00017
   Fujimoto K, 1995, JPN J PHARMACOL, V69, P443, DOI 10.1254/jjp.69.443
   GoeauBrissonniere O, 1996, J MAL VASCUL, V21, P146
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P937, DOI 10.1002/jbm.820250803
   GRECO F, 1991, J BIOMED MATER RES, V25, P39, DOI 10.1002/jbm.820250104
   GRECO RS, 1985, ARCH SURG-CHICAGO, V120, P71
   GRECO RS, 1991, J VASC SURG, V13, P753
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HARVEY RA, 1981, ANN SURG, V194, P642, DOI 10.1097/00000658-198111000-00015
   HARVEY RA, 1984, AM J SURG, V147, P205, DOI 10.1016/0002-9610(84)90089-8
   HARVEY RA, 1982, SURGERY, V92, P504
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   Johnson A, 1989, THEORY COLORATION TE
   KAISER AB, 1978, ANN SURG, V188, P283, DOI 10.1097/00000658-197809000-00003
   KRAJICEK M, 1969, J CARDIOVASC SURG, V10, P453
   McDougal E G, 1986, J Vasc Surg, V4, P5
   MODAK SM, 1987, SURG GYNECOL OBSTET, V164, P143
   MOORE WS, 1977, INFECT PROSTHETIC HE
   Muhl E, 1996, ANN VASC SURG, V10, P244, DOI 10.1007/BF02001890
   Nunn D. M., 1979, DYEING SYNTHETIC POL
   OKAHARA K, 1995, EUR J VASC ENDOVASC, V9, P408, DOI 10.1016/S1078-5884(05)80008-5
   Phaneuf MD, 1997, J BIOMATER APPL, V12, P100, DOI 10.1177/088532829701200202
   POWELL TW, 1983, SURGERY, V94, P765
   Sardelic F, 1996, Cardiovasc Surg, V4, P389, DOI 10.1016/0967-2109(95)00075-5
   SHENK JS, 1989, J SURG RES, V47, P487, DOI 10.1016/0022-4804(89)90125-X
   Shore J., 1990, COLORANTS AUXILIARIE
   SHUE WB, 1988, J VASC SURG, V8, P600, DOI 10.1067/mva.1988.avs0080600
   Strachan C J, 1991, Eur J Vasc Surg, V5, P627, DOI 10.1016/S0950-821X(05)80896-5
   TOLLEFSON DF, 1987, ARCH SURG-CHICAGO, V122, P38
   Tweden KS, 1997, ASAIO J, V43, pM475
   *US DHHS, 1995, INF CONTR S INFL MED
   WEBB LX, 1986, J VASC SURG, V4, P16
   Whalen RL, 1997, ASAIO J, V43, pM842
   WHITE JV, 1984, J VASC SURG, V1, P372, DOI 10.1067/mva.1984.avs0010372
NR 39
TC 11
Z9 13
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD NOV-DEC
PY 2001
VL 47
IS 6
BP 634
EP 640
DI 10.1097/00002480-200111000-00013
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 493TZ
UT WOS:000172240700012
PM 11730202
OA Bronze
DA 2018-10-19
ER

PT J
AU Charriere, E
   Terrazzoni, S
   Pittet, C
   Mordasini, P
   Dutoit, M
   Lemaitre, J
   Zysset, P
AF Charriere, E
   Terrazzoni, S
   Pittet, C
   Mordasini, P
   Dutoit, M
   Lemaitre, J
   Zysset, P
TI Mechanical characterization of brushite and hydroxyapatite cements
SO BIOMATERIALS
LA English
DT Article
DE brushite; calcium phosphate cement; elasticity; hydroxyapatite;
   mechanical properties; strength criterion
ID CALCIUM-PHOSPHATE CEMENTS; COMPRESSIVE PROPERTIES; ANISOTROPIC
   MATERIALS; BONE; STRENGTH; TISSUE; REINFORCEMENT; BEHAVIOR; TENSILE;
   MODULI
AB Compression, tension and torsion tests were designed and completed successfully on a brushite and a precipitated hydroxyapatite cement in moist condition. Elastic and strength properties were measured for these three loading cases. For each cement, the full set of strength data was fitted to an isotropic Tsai-Wu criterion and the associated coefficients identified. Since the compressive Young's moduli were about 10% larger than the tensile moduli, the full set of elastic data of each cement was fitted to a conewise linear elastic model. Hysteresis of the stress-strain curves was also observed, indicating dissipation mechanisms within these cement microstructures. A comparison of the measured mechanical properties with human cancellous bone confirmed the indication of brushite as a bone filling material and the potential of the hydroxyapatite cement as a structural biomaterial. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Swiss Fed Inst Technol, Lab Appl Mech & Reliabil Anal, Dept Mech Engn, EPFL, CH-1015 Lausanne, Switzerland.
   Swiss Fed Inst Technol, Powder Technol Lab, Dept Mat Sci, EPFL, CH-1015 Lausanne, Switzerland.
   Hop Orthoped Suisse Romande, CH-1005 Lausanne, Switzerland.
RP Charriere, E (reprint author), Swiss Fed Inst Technol, Lab Appl Mech & Reliabil Anal, Dept Mech Engn, EPFL, CH-1015 Lausanne, Switzerland.
EM eric.charriere@epfl.ch
RI Zysset, Philippe/B-2997-2018
OI Zysset, Philippe/0000-0002-4712-7047
CR Bednar N, 1999, COMPOS PART A-APPL S, V30, P147, DOI 10.1016/S1359-835X(98)00101-8
   BENZEGGAGH ML, 1995, COMPOS SCI TECHNOL, V55, P145, DOI 10.1016/0266-3538(95)00098-4
   BERMUDEZ O, 1994, J MATER SCI-MATER M, V5, P67, DOI 10.1007/BF00121693
   BERMUDEZ O, 1993, J MATER SCI-MATER M, V4, P389, DOI 10.1007/BF00122197
   BRUYEREGARNIER K, 2000, THESIS INSA LYON
   Chaboche J.L., 1990, DAMAGE MECH ENG MAT, P153
   COWIN S, 1991, BONE MECH
   CURNIER A, 1995, J ELASTICITY, V37, P1, DOI 10.1007/BF00043417
   DRIESSENS FCM, 1992, ADV BIOMAT, V10, P123
   GOULET RW, 1994, J BIOMECH, V27, P375, DOI 10.1016/0021-9290(94)90014-0
   Hill R., 1950, MATH THEORY PLASTICI
   Hoffman O., 1967, J COMPOS MATER, V1, P200, DOI DOI 10.1177/002199836700100210
   HORII H, 1983, J MECH PHYS SOLIDS, V31, P155, DOI 10.1016/0022-5096(83)90048-0
   Hou FJ, 1998, J BIOMECH, V31, P1009, DOI 10.1016/S0021-9290(98)00110-9
   JIANG ZQ, 1989, J COMPOS MATER, V23, P208
   KUHN JL, 1989, J ORTHOPAED RES, V7, P876, DOI 10.1002/jor.1100070614
   MARTIN RI, 1995, J MATER SCI-MATER M, V6, P138, DOI 10.1007/BF00120289
   MATTOS HC, 1992, INT J SOLIDS STRUCT, V29, P3185, DOI 10.1016/0020-7683(92)90035-R
   MAZARS J, 1990, ENG FRACT MECH, V35, P629, DOI 10.1016/0013-7944(90)90145-7
   Mente PL, 1987, T 33 ANN M ORTH RES, P49
   MIRTCHI AA, 1991, BIOMATERIALS, V12, P505, DOI 10.1016/0142-9612(91)90150-9
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P634, DOI 10.1016/0142-9612(89)90120-8
   NAHLA K, 1996, COMPOS B, V27, P339
   Pittet C, 2000, J BIOMED MATER RES, V53, P769, DOI 10.1002/1097-4636(2000)53:6<769::AID-JBM19>3.0.CO;2-P
   PRIDDY TG, 1974, J ENG MATER-T ASME, V96, P91, DOI 10.1115/1.3443201
   REILLY DT, 1975, J BIOMECH, V8, P393, DOI 10.1016/0021-9290(75)90075-5
   RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D
   ROHL L, 1991, J BIOMECH, V24, P1143, DOI 10.1016/0021-9290(91)90006-9
   Roschke P, 1996, J ENG MATER-T ASME, V118, P207, DOI 10.1115/1.2804888
   Runkle J C, 1975, Bull Hosp Joint Dis, V36, P2
   TENNYSON RC, 1983, 72192 NASA CR
   TOWNSEND PR, 1975, J BIOMECH, V8, P199, DOI 10.1016/0021-9290(75)90025-1
   TSAI SW, 1971, J COMPOS MATER, V5, P58, DOI 10.1177/002199837100500106
   Van Landuyt P, 1999, BONE, V25, p95S, DOI 10.1016/S8756-3282(99)00142-8
   Van Landuyt P, 1997, BIOCERAMICS, V10, P477
NR 35
TC 102
Z9 105
U1 1
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2001
VL 22
IS 21
BP 2937
EP 2945
DI 10.1016/S0142-9612(01)00041-2
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 469MT
UT WOS:000170820000014
PM 11561900
DA 2018-10-19
ER

PT J
AU Faucheux, N
   Correze, C
   Haye, B
   Nagel, MD
AF Faucheux, N
   Correze, C
   Haye, B
   Nagel, MD
TI Accumulation of cyclic AMP in Swiss 3T3 cells adhering to a cellulose
   biomaterial substratum through interaction with adenylyl cyclase
SO BIOMATERIALS
LA English
DT Article
DE Cuprophan; cAMP-dependent aggregation; cell shape
ID G-PROTEIN; GEOMETRIC CONTROL; CAMP; ACTIVATION; ALPHA; RECEPTOR;
   CYTOSKELETON; ORGANIZATION; FIBROBLASTS; FORSKOLIN
AB Controlling cell shape induced by cell-substrata interaction appears of prime importance to influence subsequent biological processes such as cell migration, proliferation, differentiation or apoptosis. Studies on Swiss 3T3 fibroblasts have recently provided evidence that cell spreading is mediated by integrins and RhoA. Our previous studies showed that on Cuprophan, a cellulose membrane (CU) to which vitronectin adhesive protein is poorly adsorbed, Swiss 3T3 cells are rounded and undergo cAMP-dependent aggregation. In contrast, on a polyacrylonitrile membrane (AN69) that favours the adsorption of vitronectin and fibronectin, cells spread out and contain low concentrations of cAMP. We have now examined the parts played by the three components in the cAMP pathway (receptors, G-proteins and adenylyl cyclase itself) in cAMP-dependent cell aggregation on CU. Experiments with intact cells showed no interaction between the CU and receptors, or between the CU and G-proteins. Assays on membrane preparations plus the Mn-ATP substrate, which uncouples G-proteins and adenylyl cyclase, demonstrated that activation of the cAMP pathway by CU depends primarily on the catalytic activity of the adenylyl cyclase. These investigations provide essential data for the development of biomaterials that favour cell functionality. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Technol Compiegne, CNRS, UMR 6600, F-60205 Compiegne, France.
   Fac Pharm Chatenay Malabry, INSERM, U486, Unite Rech Transduct Hormonale & Regulat Cellulai, Malabry, France.
   UFR Sci Exactas & Nat, Biochim Lab, IFR Biomol 53, CNRS,UPRES A 6021, Reims, France.
RP Nagel, MD (reprint author), Univ Technol Compiegne, CNRS, UMR 6600, BP 20529,Domaine Biomat Biocompatibil, F-60205 Compiegne, France.
CR CASSEL D, 1977, P NATL ACAD SCI USA, V74, P3307, DOI 10.1073/pnas.74.8.3307
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554
   Faucheux N, 2000, BIOMATERIALS, V21, P1031, DOI 10.1016/S0142-9612(99)00277-X
   FAUCHEUX N, 1999, BIOMATERIALS, V20, P150
   Han JD, 1996, J BIOL CHEM, V271, P29211, DOI 10.1074/jbc.271.46.29211
   Holm I, 1999, EUR J CELL BIOL, V78, P856, DOI 10.1016/S0171-9335(99)80087-9
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   LAMPUGNANI MG, 1990, LAB INVEST, V63, P521
   LAURENZA A, 1989, TRENDS PHARMACOL SCI, V10, P442, DOI 10.1016/S0165-6147(89)80008-2
   LeVine H, 1999, MOL NEUROBIOL, V19, P111, DOI 10.1007/BF02743657
   LIMBIRD LE, 1979, J BIOL CHEM, V254, P2677
   MARTINY L, 1991, FEBS LETT, V286, P105, DOI 10.1016/0014-5793(91)80951-X
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   McClary KB, 1999, BIOMATERIALS, V20, P2435, DOI 10.1016/S0142-9612(99)00171-4
   MURAYAMA T, 1989, J BIOL CHEM, V264, P15186
   ODONNELL JK, 1991, MOL PHARMACOL, V39, P702
   Patel N, 1998, FASEB J, V12, P1447
   SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X
   Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4
   Schonbrunn A, 1999, ANN ONCOL, V10, pS17, DOI 10.1093/annonc/10.suppl_2.S17
   SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363
   Simonds WF, 1999, TRENDS PHARMACOL SCI, V20, P66, DOI 10.1016/S0165-6147(99)01307-3
   SIMONDS WF, 1989, FEBS LETT, V249, P189, DOI 10.1016/0014-5793(89)80622-2
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   WANG YJ, 1995, J CELL SCI, V108, P3501
   WATSON PA, 1990, J BIOL CHEM, V265, P6569
   Watson PA, 1995, BIOCHEM CELL BIOL, V73, P367, DOI 10.1139/o95-044
   ZACHARY I, 1990, BIOCHEM BIOPH RES CO, V168, P1184, DOI 10.1016/0006-291X(90)91154-K
   Zeiders JL, 1997, J MOL CELL CARDIOL, V29, P603, DOI 10.1006/jmcc.1996.0303
NR 32
TC 9
Z9 10
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2001
VL 22
IS 22
BP 2993
EP 2998
DI 10.1016/S0142-9612(01)00045-X
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 474FD
UT WOS:000171094900005
PM 11575473
DA 2018-10-19
ER

PT J
AU Mazzobre, MF
   Longinotti, MP
   Corti, HR
   Buera, MP
AF Mazzobre, MF
   Longinotti, MP
   Corti, HR
   Buera, MP
TI Effect of salts on the properties of aqueous sugar systems, in relation
   to biomaterial stabilization. 1. Water sorption behavior and ice
   crystallization/melting
SO CRYOBIOLOGY
LA English
DT Article
ID GLASS-TRANSITION; TREHALOSE; CRYOPRESERVATION; VITRIFICATION;
   TEMPERATURES; STABILITY; GLYCEROL; SUCROSE; CATIONS; FROZEN
AB Trehalose and sucrose, two sugars that are involved in the protection of living organisms under extreme conditions, and their mixtures with salts were employed to prepare supercooled or freeze-dried glassy systems. The objective of the present work was to explore the effects of different salts on water sorption, glass transition temperature (T,), and formation and melting of ice in aqueous sugar systems. In the sugar-salt mixtures, water adsorption was higher than expected on the basis of the water uptake by each pure component. In systems with a reduced mass fraction of water (w less than or equal to 0.4), salts delayed water crystallization, probably due to ion-water interactions. In systems where w > 0.6, water crystallization could be explained by the known colligative properties of the solutes, The glass transition temperature of the maximally concentrated matrix (T(g)') was decreased by the presence of salts. However, the actual T, values of the systems were not modified. Thus, the effect of salts on sorption behavior and formation of ice may reflect dynamic water-salt-sugar interactions which take place at a molecular level and are related to the charge/mass ratio of the cation present without affecting supramolecular or macroscopic properties. (C) 2001 Elsevier Science (USA).
C1 Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ind, RA-1428 Buenos Aires, DF, Argentina.
   Comis Nacl Energia Atom, Unidad Actividad Quim, RA-1650 San Martin, Buenos Aires, Argentina.
   Univ Nacl Gen San Martin, Escuela Ciencia & Tecnol, RA-1650 San Martin, Buenos Aires, Argentina.
RP Mazzobre, MF (reprint author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ind, RA-1428 Buenos Aires, DF, Argentina.
OI Buera, Pilar/0000-0001-9290-7299
CR ABLETT S, 1992, J CHEM SOC FARADAY T, V88, P789, DOI 10.1039/ft9928800789
   ANGELL CA, 1994, J FOOD ENG, V22, P115, DOI 10.1016/0260-8774(94)90028-0
   ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6536, DOI 10.1021/bi00268a033
   CARPENTER JF, 1990, J DAIRY SCI, V73, P3627, DOI 10.3168/jds.S0022-0302(90)79065-0
   Cerrutti P, 2000, APPL MICROBIOL BIOT, V54, P575, DOI 10.1007/s002530000428
   CHANG BS, 1992, CRYOBIOLOGY, V29, P632, DOI 10.1016/0011-2240(92)90067-C
   Chen TN, 2000, CRYOBIOLOGY, V40, P277, DOI 10.1006/cryo.2000.2244
   COHEN MD, 1987, J PHYS CHEM-US, V91, P4563, DOI 10.1021/j100301a029
   COOK WJ, 1973, CARBOHYD RES, V31, P265, DOI 10.1016/S0008-6215(00)86191-1
   Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73
   FLINK J M, 1983, P473
   GOETZE W, 1999, J PHYS CONDENS MATT, V11, pA1
   GOLDBERG RN, 1978, J PHYS CHEM REF DATA, V7, P263, DOI 10.1063/1.555569
   HEMMINGA MA, 1993, GLASSY STATE IN FOODS, P157
   HER LM, 1995, PHARMACEUT RES, V12, P768, DOI 10.1023/A:1016280113800
   Iglesias HA, 1997, J SCI FOOD AGR, V75, P183, DOI 10.1002/(SICI)1097-0010(199710)75:2<183::AID-JSFA860>3.0.CO;2-T
   KAREL M, 1981, WATER RELATIONS FOOD, P639
   Lammert AM, 1998, FOOD CHEM, V61, P139, DOI 10.1016/S0308-8146(97)00132-5
   LEVINE H, 1988, J CHEM SOC FARAD T 1, V84, P2619, DOI 10.1039/f19888402619
   Mazzobre MF, 1999, BBA-GEN SUBJECTS, V1473, P337, DOI 10.1016/S0304-4165(99)00207-X
   Miller DP, 1997, PHARMACEUT RES, V14, P578, DOI 10.1023/A:1012192725996
   Miller DP, 1998, PHARM RES-DORDR, V15, P1215, DOI 10.1023/A:1011987707515
   MORELDESROSIERS N, 1991, J CHEM SOC FARADAY T, V87, P2173, DOI 10.1039/ft9918702173
   Obendorf RL, 1997, SEED SCI RES, V7, P63
   PITZER KS, 1973, J PHYS CHEM-US, V77, P268, DOI 10.1021/j100621a026
   RASMUSSEN D, 1969, BIODYNAMICA, V10, P319
   ROBINSON RA, 1955, ELECTROLYTE SOLUTION, P23
   ROOS YH, 1991, CRYO-LETT, V12, P367
   ROOS YH, 1991, INT J FOOD SCI TECH, V26, P553
   ROOS YH, 1991, FOOD TECHNOL-CHICAGO, V45, P66
   ROOS YH, 1993, CARBOHYD RES, V238, P39, DOI 10.1016/0008-6215(93)87004-C
   SIMATOS D, 1993, GLASSY STATE IN FOODS, P395
   SIMATOS D, 1991, ADV EXP MED BIOL, P139
   SLADE L, 1991, CRIT REV FOOD SCI, V30, P115, DOI 10.1080/10408399109527543
   STOKES RH, 1948, J AM CHEM SOC, V70, P1870, DOI 10.1021/ja01185a065
   Storey BT, 1998, CRYOBIOLOGY, V37, P46, DOI 10.1006/cryo.1998.2097
   Sun WQ, 1997, COMP BIOCHEM PHYS A, V117, P327, DOI 10.1016/S0300-9629(96)00271-X
   Suzuki T, 1997, J CHEM ENG JPN, V30, P609, DOI 10.1252/jcej.30.609
   Turner S, 2001, PLANT SCI, V160, P489, DOI 10.1016/S0168-9452(00)00420-9
NR 39
TC 39
Z9 40
U1 0
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0011-2240
J9 CRYOBIOLOGY
JI Cryobiology
PD NOV
PY 2001
VL 43
IS 3
BP 199
EP 210
DI 10.1006/cryo.2001.2345
PG 12
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA 533AQ
UT WOS:000174507600002
PM 11888214
DA 2018-10-19
ER

PT J
AU Nuttelman, CR
   Mortisen, DJ
   Henry, SM
   Anseth, KS
AF Nuttelman, CR
   Mortisen, DJ
   Henry, SM
   Anseth, KS
TI Attachment of fibronectin to poly(vinyl alcohol) hydrogels promotes
   NIH3T3 cell adhesion, proliferation, and migration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE tissue engineering; hydrogel; poly(vinyl alcohol); polymer scaffold;
   fibronectin
ID BIOMATERIALS; INTEGRINS; SURFACES; BINDING
AB Hydrogels have been used in biology and medicine for many years, and they possess many properties that make them advantageous for tissue engineering applications. Their high water content and tissue-like elasticity are similar to the native extracellular matrix of many tissues. In this work, we investigated the potential of a modified poly(vinyl alcohol) (PVA) hydrogel as a biomaterial for tissue engineering applications. First, the ability of NIH3T3 fibroblast cells to attach to PVA hydro-els was evaluated. Because of PVA's extremely hydrophilic nature, important cell adhesion proteins do not adsorb to PVA hydrogels, and consequently, cells are unable to adhere to the hydrogel. By covalently attaching the important cell adhesion protein fibronectin onto the PVA hydrogel surface, the rate of fibroblast attachment and proliferation was dramatically improved, and promoted two-dimensional cell migration. These studies illustrate that a fibronectin-modified PVA hydrogel is a potential biomaterial for tissue engineering applications. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA.
FU NIDCR NIH HHS [DE12998]
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   AYAD S, 1994, EXTRACELLULAR MATRIX, P104
   Biran R, 2001, J BIOMED MATER RES, V55, P1
   Chinn J. A., 1995, BIOMEDICAL ENG HDB, P1597
   Faucheux N, 2000, BIOMATERIALS, V21, P1031, DOI 10.1016/S0142-9612(99)00277-X
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   JULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103
   Maury F, 1997, J MATER SCI-MATER M, V8, P571, DOI 10.1023/A:1018502915904
   OXLEY HR, 1993, BIOMATERIALS, V14, P1064, DOI 10.1016/0142-9612(93)90207-I
   Peppas N. A., 1986, HYDROGELS MED PHARM, P1
   PETTIT DK, 1992, J BIOMED MATER RES, V26, P1259, DOI 10.1002/jbm.820261002
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   Tabata Y, 1999, J BIOMAT SCI-POLYM E, V10, P79, DOI 10.1163/156856299X00298
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P1513, DOI 10.1016/S0142-9612(99)00062-9
NR 23
TC 185
Z9 189
U1 6
U2 60
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 2001
VL 57
IS 2
BP 217
EP 223
DI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 466QP
UT WOS:000170656500008
PM 11484184
DA 2018-10-19
ER

PT J
AU Radin, S
   Ducheyne, P
   Kamplain, T
   Tan, BH
AF Radin, S
   Ducheyne, P
   Kamplain, T
   Tan, BH
TI Silica sol-gel for the controlled release of antibiotics. I. Synthesis,
   characterization, and in vitro release
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE drug delivery; controlled release; sol-gels; antibiotics; in vitro
ID DRUG-DELIVERY SYSTEM; CALCIUM-PHOSPHATE; TRANSFORMING
   GROWTH-FACTOR-BETA-1; BONE-CEMENT; GLASS; OSTEOMYELITIS; VANCOMYCIN;
   CARRIER; BIOMATERIAL; GENTAMICIN
AB Room temperature processed silica sol-gel (xerogel) was investigated as a novel controlled release carrier of antibiotics (vancomycin). Xerogel characteristics, in vitro release properties, and bactericidal efficacy of the released antibiotic were determined. The xerogel/vancomycin composite showed a long-term sustained release (up to 6 weeks). In addition, bactericidal efficacy of released vancomycin was retained. The kinetics of release and the amount released were dose dependent. The initial, first-order release was followed by a near-zero-order release. The time to transition from the first- to zero-order release increased with vancomycin load (from 2 to 3 weeks with load increase from 2.2 to 11.1 mg/g). Regardless of the load, about 70% of the original vancomycin content was released by the transitional point, and the cumulative release after 6 weeks of immersion was about 90%. This study, combined with other reports documenting biocompatibility and controlled resorbability of the xerogel/drug, composite in vivo, suggests that silica xerogel is a promising controlled release material for the treatment of bone infections. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Penn, Dept Bioengn, Ctr Biomat & Tissue Engn, Philadelphia, PA 19104 USA.
RP Radin, S (reprint author), Univ Penn, Dept Bioengn, Ctr Biomat & Tissue Engn, 3320 Smith Walk, Philadelphia, PA 19104 USA.
CR ACAR JF, 1991, ANTIBIOTICS LAB MED, P17
   AGRAWAL CM, 1994, J BIOMED MATER RES, V28, P851, DOI 10.1002/jbm.820280803
   AUGHENBAUGH W, 2001, IN PRESS J BIOMED MA
   Benoit MA, 1997, INT ORTHOP, V21, P403
   BRAUN S, 1992, J NON-CRYST SOLIDS, V147, P739, DOI 10.1016/S0022-3093(05)80708-2
   BRINKER CJ, 1990, SOL GEL SCI PHYSICS
   Brunauer S, 1940, J AM CHEM SOC, V62, P1723, DOI 10.1021/ja01864a025
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   BUCHHOLZ HW, 1984, CLIN ORTHOP RELAT R, V190, P96
   Chohfi M, 1998, INT ORTHOP, V22, P171, DOI 10.1007/s002640050235
   CORNELL CN, 1993, J ORTHOPAED RES, V11, P619, DOI 10.1002/jor.1100110502
   DANHERS LE, 1987, CLIN ORTHOP RELAT R, V219, P278
   Debeaumont D., 1982, CLIN ORTHOPAEDICS, V167, P263
   Ducheyne P, 1992, Clin Orthop Relat Res, P102
   Falaize S, 1999, J AM CERAM SOC, V82, P969, DOI 10.1111/j.1151-2916.1999.tb01861.x
   GARVIN KL, 1988, ORTHOP CLIN N AM, V19, P605
   Gautier H, 2000, BIOMATERIALS, V21, P243, DOI 10.1016/S0142-9612(99)00139-8
   GERACI JE, 1983, MAYO CLIN PROC, V58, P88
   GOMBOTZ WR, 1994, J APPL BIOMATER, V5, P141, DOI 10.1002/jab.770050207
   Heller J., 1987, CONTROLLED DRUG DELI, P139
   Henry S L, 1991, Orthop Rev, V20, P242
   HOFF SF, 1981, J BONE JOINT SURG AM, V63, P798, DOI 10.2106/00004623-198163050-00015
   ITOKAZU M, 1995, J APPL BIOMATER, V6, P167, DOI 10.1002/jab.770060304
   Kimakhe S, 1999, J BIOMED MATER RES, V47, P18, DOI 10.1002/(SICI)1097-4636(199910)47:1<18::AID-JBM3>3.0.CO;2-T
   Kokubo T., 1993, BONE BONDING BIOMATE, P31
   KORKUSUZ F, 1993, J BONE JOINT SURG BR, V75, P111
   LANGLAIS F, 1988, J ORTHOP SURG, V2, P300
   LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806
   MAJID SA, 1985, ACTA ORTHOP SCAND, V56, P265, DOI 10.3109/17453678508993010
   Nicoll SB, 1997, BIOMATERIALS, V18, P853, DOI 10.1016/S0142-9612(97)00008-2
   OTSUKA M, 1995, J BIOMED MATER RES, V29, P33, DOI 10.1002/jbm.820290106
   Radin S, 1997, BIOMATERIALS, V18, P777, DOI 10.1016/S0142-9612(96)00190-1
   RADIN S, 1998, BIOCERAMICS, V2, P529
   RADIN S, UNPUB BIOMATERIALS
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   Santos EM, 1999, BIOMATERIALS, V20, P1695, DOI 10.1016/S0142-9612(99)00066-6
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   TAN BH, 1996, P 5 WORLD BIOM C 29, P161
   WU SG, 1993, CHEM MATER, V5, P115, DOI 10.1021/cm00025a022
   YAMAMURA K, 1992, J BIOMED MATER RES, V26, P1053, DOI 10.1002/jbm.820260807
   YING JY, 1993, J AM CERAM SOC, V76, P2571, DOI 10.1111/j.1151-2916.1993.tb03983.x
NR 41
TC 125
Z9 128
U1 3
U2 31
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 2001
VL 57
IS 2
BP 313
EP 320
DI 10.1002/1097-4636(200111)57:2<313::AID-JBM1173>3.0.CO;2-E
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 466QP
UT WOS:000170656500020
PM 11484196
DA 2018-10-19
ER

PT J
AU Nemcova, S
   Noel, AA
   Jost, CJ
   Gloviczki, P
   Miller, VM
   Brockbank, KGM
AF Nemcova, S
   Noel, AA
   Jost, CJ
   Gloviczki, P
   Miller, VM
   Brockbank, KGM
TI Evaluation of a xenogeneic acellular collagen matrix as a small-diameter
   vascular graft in dogs - Preliminary observations
SO JOURNAL OF INVESTIGATIVE SURGERY
LA English
DT Article
DE arterial reconstruction; biomaterial; blood flow; graft patency
ID ENDOTHELIAL GROWTH-FACTOR; AUTOLOGOUS SAPHENOUS-VEIN; RAT
   CAROTID-ARTERY; AUTOGENOUS VEIN; INTIMAL HYPERPLASIA; BLOOD-FLOW;
   ACCELERATES REENDOTHELIALIZATION; POLYTETRAFLUOROETHYLENE GRAFTS;
   INTESTINAL SUBMUCOSA; CELL-PROLIFERATION
AB Autogenous veins are the materials of choice for arterial reconstruction. In the absence of autogenous material, prosthetic materials are used. However, vascular prostheses of less than 0.4 cm in diameter have low long-term patency. This study was designed to determine if cells would infiltrate an engineered xenogeneic biomaterial used as a small-diameter arterial graft in dogs and, if so, to determine the phenotype of the infiltrating cells. Nine acellular xenogeneic grafts (0.4 cm in diameter, 5 cm long), composed of porcine collagen derived from the submucosa of the small intestine and type I bovine collagen, were implanted as end-to-end interposition grafts in femoral arteries of five male mongrel dogs (total of nine grafts). All dogs received daily aspirin (325 mg). Patency of implanted grafts was monitored weekly by Duplex ultrasonography. After 9 weeks, or earlier in case of blood flow reduction by at least 75%, grafts were explanted and prepared for light or electron microscopy to evaluate cellularization. Eight of nine grafts remained patent up to 9 weeks. At explant, diameters were 0.31+/-0.02 cm at the midgraft, and 0.14+/-0.01 and 0.19+/-0.01 cm at the proximal and distal anastomoses. At explant, cells of mesenchymal origin (endothelial cells, smooth muscle cells, myofibroblasts) were embedded in the extracellular matrix of the graft scaffold. Minimal evidence of cellular inflammatory reaction and no aneurysmal dilatation or thrombus formation was detected. Variable degrees of hyperplasia were present at proximal and distal anastomoses. This preliminary study demonstrates that a collagen-based xenogeneic biomaterial provides a scaffold for cellularization when used for arterial reconstruction in dogs.
C1 Mayo Clin & Mayo Fdn, Dept Surg, Rochester, MN 55905 USA.
   KGB Associates Inc, Charleston, SC USA.
RP Miller, VM (reprint author), Mayo Clin & Mayo Fdn, Dept Surg, 200 1St St SW, Rochester, MN 55905 USA.
CR Abbott WM, 1997, J VASC SURG, V25, P19, DOI 10.1016/S0741-5214(97)70317-3
   Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   ANDERSON JS, 1987, SURGERY, V101, P577
   ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793
   BAUTERS C, 1995, CIRCULATION, V91, P2802, DOI 10.1161/01.CIR.91.11.2802
   BERGAN JJ, 1982, SURGERY, V92, P921
   Bilder G, 1999, CIRCULATION, V99, P3292, DOI 10.1161/01.CIR.99.25.3292
   CAMBRIA RA, 1994, J VASC SURG, V20, P765, DOI 10.1016/S0741-5214(94)70164-4
   CASSCELLS W, 1995, CIRCULATION, V91, P2699, DOI 10.1161/01.CIR.91.11.2699
   Chen DH, 1999, CIRCULATION, V100, P849, DOI 10.1161/01.CIR.100.8.849
   Conte MS, 1998, FASEB J, V12, P43
   Dalsing M C, 1989, Ann Vasc Surg, V3, P127, DOI 10.1016/S0890-5096(06)62005-0
   DAVIDS L, 1999, TISSUE ENG PROSTHETI, P3
   FOGLE MA, 1987, J VASC SURG, V5, P46, DOI 10.1067/mva.1987.avs0050046
   Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589
   GRAHAM LM, 1991, J BIOMED MATER RES, V25, P525, DOI 10.1002/jbm.820250409
   Halayko AJ, 2001, J APPL PHYSIOL, V90, P358
   Hart CE, 1999, CIRCULATION, V99, P564, DOI 10.1161/01.CIR.99.4.564
   HERRING MB, 1991, SURG ANN, V2, P157
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Hu YH, 1999, CIRCULATION, V100, P861, DOI 10.1161/01.CIR.100.8.861
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   ISHIKAWA T, 1988, AM J PHYSIOL, V255, P970
   JOHNSON WC, 1988, ARCH SURG-CHICAGO, V123, P434
   Kalra M, 2000, J VASC RES, V37, P576, DOI 10.1159/000054091
   KESLER KA, 1986, J VASC SURG, V3, P58
   KOHLER TR, 1991, CIRC RES, V69, P1557, DOI 10.1161/01.RES.69.6.1557
   L'Heureux N, 1998, FASEB J, V12, P47
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   LAWLER MR, 1971, AM J SURG, V122, P517, DOI 10.1016/0002-9610(71)90478-8
   LEWIS DA, 1997, J VASC SURG, V1, P187
   LONDREY GL, 1991, J VASC SURG, V13, P631
   Mensink A, 1996, EUR J PHARMACOL, V310, P73, DOI 10.1016/0014-2999(96)00368-8
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Noishiki Y, 1993, J Invest Surg, V6, P231, DOI 10.3109/08941939309141614
   OBrien JE, 1997, J THORAC CARDIOV SUR, V114, P38, DOI 10.1016/S0022-5223(97)70115-6
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   Scott NA, 1996, CIRCULATION, V93, P2178, DOI 10.1161/01.CIR.93.12.2178
   Seifalian A. M., 1999, TISSUE ENG VASCULAR, P45
   Shi Y, 1997, CIRCULATION, V95, P2684, DOI 10.1161/01.CIR.95.12.2684
   Teebken O E, 1998, Langenbecks Arch Chir Suppl Kongressbd, V115, P1256
   VEITH FJ, 1986, J VASC SURG, V3, P104
   Weatherford DA, 1996, SURGERY, V120, P433, DOI 10.1016/S0039-6060(96)80320-5
   Williams S K, 1989, Ann Vasc Surg, V3, P146, DOI 10.1016/S0890-5096(06)62008-6
   WILLIAMS SK, 1994, J BIOMED MATER RES, V28, P203, DOI 10.1002/jbm.820280210
   WILLIAMS SK, 1995, CELL TRANSPLANT, V4, P401, DOI 10.1016/0963-6897(95)00023-Q
   YAMAMURA S, 1994, J SURG RES, V56, P155, DOI 10.1006/jsre.1994.1026
NR 48
TC 26
Z9 26
U1 0
U2 8
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0894-1939
J9 J INVEST SURG
JI J. Invest. Surg.
PD NOV-DEC
PY 2001
VL 14
IS 6
BP 321
EP 330
DI 10.1080/089419301753435693
PG 10
WC Surgery
SC Surgery
GA 521ZR
UT WOS:000173871700005
PM 11905500
DA 2018-10-19
ER

PT J
AU Chow, LC
   Takagi, S
AF Chow, LC
   Takagi, S
TI A natural bone cement - A laboratory novelty led to the development of
   revolutionary new biomaterials
SO JOURNAL OF RESEARCH OF THE NATIONAL INSTITUTE OF STANDARDS AND
   TECHNOLOGY
LA English
DT Article
DE biomaterial; bone graft; bone repair; dicalcium phosphate anhydrous;
   hydroxyapatite; self-setting calcium phosphate cement; tetracalcium
   phosphate
ID CALCIUM-PHOSPHATE CEMENT; HYDROXYAPATITE CEMENT; RECONSTRUCTION;
   DEFECTS; SURGERY; REPAIR
AB Research on calcium phosphate chemistry at NIST led to the discovery of the worlds first self-hardening calcium phosphate cements (CPC) in 1987. Laboratory, animal, and clinical studies were conducted to develop CPC into clinically useful biomaterials. The combination of self-hardening capability and high biocompatibility makes CPC a unique material for repairing bone defects. Near perfect adaptation of the cement to the tissue surfaces in a defect, and a gradual resorption followed by new bone formation are some of the other distinctive advantages of this biomaterial. In 1996 a CPC, consisting of tetracalcium phosphate and dicalcium phosphate anhydrous, was approved by the Food and Drug Administration ( FDA) for repairing cranial defects in humans, thus becoming the first material of its kind available for clinical use. This paper will review the course of the development, the physical and chemical properties, and clinical applications of CPC.
C1 NIST, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Dent Chem Div, Gaithersburg, MD 20899 USA.
   NIST, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Cariol Div,Polymer Div,Mat Sci & Engn Lab, Gaithersburg, MD 20899 USA.
RP Chow, LC (reprint author), NIST, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Dent Chem Div, Gaithersburg, MD 20899 USA.
EM laurence.chow@nist.gov; shozo.takagi@nist.gov
FU NIDCR NIH HHS [R01 DE011789]
CR BAUER G, 1985, BIOAKTIVE WERKSTOFFE, V6, P103
   BROWN WE, 1965, J RES NBS A PHYS CH, VA 69, P547, DOI 10.6028/jres.069A.059
   Brown WE, 1987, CEMENTS RES PROGR 19, P352
   Cherng A, 1997, J BIOMED MATER RES, V35, P273, DOI 10.1002/(SICI)1097-4636(19970605)35:3<273::AID-JBM1>3.0.CO;2-E
   Chow LC, 1998, CEMENTS RESEARCH PROGRESS 1996, P215
   Chow LC, 2000, J BIOMED MATER RES, V53, P511, DOI 10.1002/1097-4636(200009)53:5<511::AID-JBM10>3.3.CO;2-5
   CHOW LC, 1991, MATER RES SOC SYMP P, V179, P3
   CHOW LC, 1996, CEMENTS RES PROGR 19, P189
   COSTANTINO PD, 1991, ARCH OTOLARYNGOL, V117, P379
   COSTANTINO PD, 1992, PLAST RECONSTR SURG, V90, P174, DOI 10.1097/00006534-199290020-00003
   Friedman C D, 2000, Arch Facial Plast Surg, V2, P124, DOI 10.1001/archfaci.2.2.124
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   Fujikawa K, 1995, Dent Mater J, V14, P45
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   HONG YC, 1991, J BIOMED MATER RES, V25, P485, DOI 10.1002/jbm.820250406
   ISHIKAWA K, 1995, J MATER SCI-MATER M, V6, P528, DOI 10.1007/BF00151034
   KAMERER DB, 1994, AM J OTOL, V15, P47
   KVETON JF, 1995, LARYNGOSCOPE, V105, P156, DOI 10.1288/00005537-199502000-00008
   KVETON JF, 1995, AM J OTOL, V16, P465
   LEGEROS RZ, 1994, ORAL BIOL MED, P162
   Lew D, 1997, J ORAL MAXIL SURG, V55, P1441, DOI 10.1016/S0278-2391(97)90647-9
   SHINDO ML, 1993, ARCH OTOLARYNGOL, V119, P185
   SUGAWARA A, 1990, J ENDODONT, V16, P162, DOI 10.1016/S0099-2399(06)81963-1
   Sugawara A, 1992, Dent Mater J, V11, P11
   Sugawara A., 1995, J HARD TISSUE BIOL, V4, P1
   Sugawara A, 1993, J SOC MAT DEVICES, V12, P691
   Sugawara A, 1990, TOKYO SHIKA ISHIKAI, V38, P348
   TAKAGI S, 2000, T 6 WORLD BIOM C, P19
   TAKAGI S, 1999, J DENT RES, V78, P152
   Weissman JL, 1996, AM J NEURORADIOL, V17, P1569
   XU HHK, 2002, IN PRESS J DENT RES
NR 31
TC 40
Z9 42
U1 0
U2 18
PU US GOVERNMENT PRINTING OFFICE
PI WASHINGTON
PA SUPERINTENDENT DOCUMENTS,, WASHINGTON, DC 20402-9325 USA
SN 1044-677X
J9 J RES NATL INST STAN
JI J. Res. Natl. Inst. Stand. Technol.
PD NOV-DEC
PY 2001
VL 106
IS 6
BP 1029
EP 1033
DI 10.6028/jres.106.053
PG 5
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA 527WM
UT WOS:000174211000009
PM 27500062
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Yasuda, HY
   Mahara, S
   Umakoshi, Y
AF Yasuda, HY
   Mahara, S
   Umakoshi, Y
TI Microstructure and mechanical property of
   hydroxyapatite/calcium-deficient hydroxyapatite composites prepared by a
   colloidal process
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE hydroxyapatite; calcium-deficient hydroxyapatite; biomaterial; colloidal
   process; bone; mechanical property; microstructure
ID TRICALCIUM PHOSPHATE; BONE; CERAMICS
AB Calcium-deficient hydroxyapatite (DAp) having a rod-like or thin-blade-like shape was produced by hydrolysis of alpha -tricalcium phosphate (alpha -TCP) at different pH values. Mixed powder composed of 40 mass%DAp and 60 mass% stoichiometric hydroxyapatite (HAp) was suspended in an aqueous solution containing a small amount of dispersant by colloidal process, After dehydration, HAp-40 mass%, DAp consolidated samples were sintered at 1473 K for 2 h. Rheological behaviour of the slurry, microstructure and bending strength of HAp-40 mass%DAp prepared by this process depended strongly on quantity of the dispersant. Good dispersion of HAp and DAp powders at an optimum quantity of the dispersant resulted in high relative density of HAp/DAp composites with homogeneous microstructure, DAp starting powder readily decomposed to alpha -TCP and HAp at 1473 K. while the formation of alpha -TCP phase took place less intensively in HAp-40 mass%DAp composites sintered at that temperature. In contrast to HAp/alpha -TCP composites, an interdiffusion of ions between HAp and DAp during sintering may result in the increase in the thermal stability of DAp. HAp-40 mass%DAp composites prepared by a suitable colloidal process exhibited higher bending strength than HAp-40 mass%alpha -TCP composites and stoichiometric HAp alone.
C1 Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, Suita, Osaka 5650871, Japan.
RP Yasuda, HY (reprint author), Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
CR AKSAY IA, 1983, J AM CERAM SOC C, V66, P190
   CESARANO J, 1988, J AM CERAM SOC, V71, P250, DOI 10.1111/j.1151-2916.1988.tb05855.x
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DEWITH G, 1981, J MATER SCI, V16, P1592
   Elliott JC, 1994, STRUCTURE CHEM APATI, V18, P1
   FAYSSINET P, 1993, BIOMATERIALS, V14, P423
   HARADA Y, 1989, J TOKYO DENT COLL SO, V89, P263
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   MONMA H, 1981, J CHEM TECHNOL BIOT, V31, P15, DOI 10.1002/jctb.280310105
   Monma H., 1978, Yogyo-Kyokai-Shi, V86, P73
   MONMA H, 1987, NIPPON SERAM KYO GAK, V95, P814
   MONMA H, 1978, YOGYO-KYOKAI-SHI, V86, P209
   MONMA H, 1978, YOGYO-KYOKAI-SHI, V86, P590
   PREMACHANDRAN RS, 1994, POWDER TECHNOL, V79, P53, DOI 10.1016/0032-5910(93)02793-A
   UMAKOSHI Y, 2000, EUROMAT 99, V2, P46
   YASUDA H, IN PRESS SCI TECH AD
   Yasuda HY, 2000, BIOMATERIALS, V21, P2045, DOI 10.1016/S0142-9612(00)00090-9
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 20
TC 4
Z9 5
U1 0
U2 4
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD NOV
PY 2001
VL 42
IS 11
SI SI
BP 2392
EP 2397
DI 10.2320/matertrans.42.2392
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 504EM
UT WOS:000172844400042
OA Bronze
DA 2018-10-19
ER

PT J
AU Dick, HB
   Frohn, A
   Augustin, AJ
   Wolters, B
   Pakula, T
   Pfeiffer, N
AF Dick, HB
   Frohn, A
   Augustin, AJ
   Wolters, B
   Pakula, T
   Pfeiffer, N
TI Physicochemical surface properties of various intraocular lenses
SO OPHTHALMIC RESEARCH
LA English
DT Article
DE intraocular lenses; surface characteristics; contact angle;
   biocompatibility
ID IN-VITRO ADHERENCE; STAPHYLOCOCCUS-EPIDERMIDIS; CELL ADHESION;
   CONTACT-ANGLE; HEPARIN
AB Purpose: It is of major interest to understand how intraocular lens (IOL) surfaces interact with aqueous humor or tissues after implantation. Important parameters to describe the physicochemical surface properties are the contact angle and critical surface tension. Therefore, we performed measurements of the contact angle and critical surface tension of several commercially available IOLs. Setting: Department of Ophthalmology, Johannes Gutenberg University, Mainz, University Eye Hospital, Tubingen, and Max Planck Institute for Polymer Research, Mainz, Germany. Methods: A total of 17 commercially available standard quality IOL types (6 of each) of different materials from several manufacturers were studied. Scanning electron microscopy and contact angle measurements using the sessile drop method were made. Results: The sessile drop method differentiated all materials based on their surface forces. The contact angle (mean SD) ranged from 56.5 +/- 3.8 degrees (CeeOn 811C, Pharmacia) to 119.0 +/- 3 degrees (Silens 6, Bausch & Lomb). Conclusion: Contact angles differed between the IOLs depending on the IOL material with the lowest contact angle in the heparin-surface-modified IOL. The contact angle measurement method generates useful information about the material surface and its potential biomaterial interactions. Copyright (C) 2001 S. Karger AG, Basel.
C1 Johannes Gutenberg Univ Mainz, Dept Ophthalmol, D-55131 Mainz, Germany.
   Univ Tubingen, Hosp Eye, Tubingen, Germany.
   Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
RP Dick, HB (reprint author), Johannes Gutenberg Univ Mainz, Dept Ophthalmol, Langenbeckstr 1, D-55131 Mainz, Germany.
EM bdick@mail.uni-mainz.de
CR Andrade J D, 1973, Med Instrum, V7, P110
   ANDRADE JD, 1979, J POLYM SCI POL SYM, P313
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BAIER RE, 1970, ADHESION BIOLOGICAL, pCH2
   Chan A W, 1999, Cloning, V1, P25, DOI 10.1089/15204559950020076
   CHRIST FR, 1992, J BIOMED MATER RES, V26, P607
   Cunanan CM, 1998, J CATARACT REFR SURG, V24, P341, DOI 10.1016/S0886-3350(98)80322-2
   CUNANAN CM, 1991, J CATARACT REFR SURG, V17, P767
   Dick B, 1997, KLIN MONATSBL AUGENH, V211, P192, DOI 10.1055/s-2008-1035121
   Dick B, 1997, OPHTHALMOLOGICA, V211, P75, DOI 10.1159/000310762
   EISENBERGER P, 1996, J BIOMED MATER RES, V32, P143
   Gabriel MM, 1998, J CATARACT REFR SURG, V24, P124, DOI 10.1016/S0886-3350(98)80085-0
   GRIFFITHS PG, 1989, BRIT J OPHTHALMOL, V73, P402, DOI 10.1136/bjo.73.6.402
   HORBETT TA, 1985, J COLLOID INTERF SCI, V104, P28, DOI 10.1016/0021-9797(85)90006-2
   JANSEN JA, 1983, ADV BIOMATER, P259
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   KINLOCH AJ, 1980, J MATER SCI, V15, P2141, DOI 10.1007/BF00552302
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MATEO NB, 1989, INVEST OPHTH VIS SCI, V30, P853
   NAVASCUES G, 1981, CHEM PHYS LETT, V82, P586, DOI 10.1016/0009-2614(81)85446-2
   Pinna A, 2000, OPHTHALMOLOGY, V107, P1042, DOI 10.1016/S0161-6420(00)00080-4
   Prosdocimo G, 1997, Eur J Ophthalmol, V7, P241
   RUCKENSTEIN E, 1987, J COLLOID INTERF SCI, V120, P153, DOI 10.1016/0021-9797(87)90334-1
   SCHURCH S, 1981, BIOCHIM BIOPHYS ACTA, V640, P557, DOI 10.1016/0005-2736(81)90480-6
   TABOR D, 1977, J COLLOID INTERF SCI, V58, P2, DOI 10.1016/0021-9797(77)90366-6
   Trocme SD, 2000, OPHTHALMOLOGY, V107, P1031, DOI 10.1016/S0161-6420(00)00098-1
   WEAST RC, 1984, CRC HDB CHEM PHYSICS, pF33
   Wise D. L., 1995, ENCY HDB BIOMATERI A, V1
   Young T, 1805, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
   Zisman WA, 1972, J PAINT TECH, V44, P42
NR 30
TC 12
Z9 14
U1 1
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0030-3747
J9 OPHTHALMIC RES
JI Ophthalmic Res.
PD NOV-DEC
PY 2001
VL 33
IS 6
BP 303
EP 309
DI 10.1159/000055685
PG 7
WC Ophthalmology
SC Ophthalmology
GA 498MV
UT WOS:000172515800001
PM 11721181
DA 2018-10-19
ER

PT J
AU Leatherman, BD
   Dornhoffer, JL
   Fan, CY
   Mukunyadzi, P
AF Leatherman, BD
   Dornhoffer, JL
   Fan, CY
   Mukunyadzi, P
TI Demineralized bone matrix as an alternative for mastoid obliteration and
   posterior canal wall reconstruction: Results in an animal model
SO OTOLOGY & NEUROTOLOGY
LA English
DT Article
DE biomaterial; cholesteatoma; canal wall reconstruction; mastoid cavity
   obliteration; human demineralized bone matrix; implant
ID AUDITORY-EVOKED-POTENTIALS; DEFECTS; RAT; PATE
AB Hypothesis: This study was conducted to evaluate the use of Grafton human demineralized bone matrix as a graft material for mastoid cavity obliteration and canal wall reconstruction in an animal model.
   Background: Canal wall down procedures in the treatment of cholesteatoma may result in a problematic mastoid cavity. Elimination of the mastoid cavity by obliteration or canal wall reconstruction can prevent or correct this problem. Many techniques and implant materials have been used for this application, yet no single material has proven to be ideal.
   Methods: Athymic rats received tympanic bulla obliteration and lateral bulla wall reconstruction utilizing the Grafton Putty and Flex formulations, respectively. Wound healing was monitored twice a week. Auditory brainstem evoked responses were obtained 8 weeks after implantation. Nine weeks after implantation, the animals were killed, and histologic sections were prepared. A histologic bone formation score (range 0-4) was determined for each implant.
   Results: Wound healing occurred without complication. Auditory brainstem response thresholds (average 23.5) fell within the normal range for all ears tested. The average histologic bone formation score for all implants was 3.7 The average scores for obliteration implants and wall reconstruction implants were 3.5 and 3.9, respectively. All wall reconstruction implants underwent partial or total collapse into the bulla.
   Conclusions: The high level of bone formation obtained by the use of Grafton implants in this study makes this material a promising resource for use in mastoid obliteration. The use of the material for canal wall reconstruction will likely require a sturdier preparation to prevent collapse into the mastoid cavity.
C1 Univ Arkansas Med Sci, Dept Otolaryngol Head & Neck Surg, Little Rock, AR 72205 USA.
   Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA.
RP Leatherman, BD (reprint author), Univ Arkansas Med Sci, Dept Otolaryngol Head & Neck Surg, 4301 W Markham,Slot 543, Little Rock, AR 72205 USA.
CR AN HS, 1995, SPINE, V20, P2211, DOI 10.1097/00007632-199510001-00006
   Black B, 1995, LARYNGOSCOPE, V105, P1, DOI 10.1288/00005537-199512000-00023
   BURKARD R, 1990, AUDIOLOGY, V29, P146
   CHEN TJ, 1990, ACTA PHYSIOL SCAND, V138, P529, DOI 10.1111/j.1748-1716.1990.tb08881.x
   Chesmel KD, 1998, J ORAL MAXIL SURG, V56, P857, DOI 10.1016/S0278-2391(98)90015-5
   Dornhoffer JL, 1999, OTOLARYNG HEAD NECK, V120, P361, DOI 10.1016/S0194-5998(99)70276-7
   Edwards JT, 1998, CLIN ORTHOP RELAT R, P219
   Estrem SA, 1999, OTOLARYNG HEAD NECK, V120, P345, DOI 10.1016/S0194-5998(99)70273-1
   Groeneveld EHJ, 1999, CLIN ORAL IMPLAN RES, V10, P499, DOI 10.1034/j.1600-0501.1999.100608.x
   Groeneveld EHJ, 1999, J BIOMED MATER RES, V48, P393, DOI 10.1002/(SICI)1097-4636(1999)48:4<393::AID-JBM1>3.3.CO;2-3
   GUILFORD F, 1958, T AM ACAD OPHTHALMOL, P455
   HOHMANN A, 1969, LARYNGOSCOPE, V79, P1618, DOI 10.1288/00005537-196909000-00007
   IRVING RM, 1994, CLIN OTOLARYNGOL, V19, P158, DOI 10.1111/j.1365-2273.1994.tb01202.x
   Jackson CG, 1996, AM J OTOL, V17, P7
   KABAN LB, 1982, J ORAL MAXIL SURG, V40, P623, DOI 10.1016/0278-2391(82)90109-4
   Killian JT, 1998, J PEDIATR ORTHOPED, V18, P621, DOI 10.1097/00004694-199809000-00013
   Ladd A L, 1999, J Am Acad Orthop Surg, V7, P279
   Martin GJ, 1999, SPINE, V24, P637, DOI 10.1097/00007632-199904010-00005
   MINATOGAWA T, 1995, AM J OTOL, V16, P99
   MOFFAT DA, 1994, CLIN OTOLARYNGOL, V19, P149, DOI 10.1111/j.1365-2273.1994.tb01201.x
   MULLIKEN JB, 1981, ANN SURG, V194, P366, DOI 10.1097/00000658-198109000-00015
   PALVA T, 1979, ACTA OTO-LARYNGOL, P152
   POU JW, 1977, LARYNGOSCOPE, V87, P1826
   SADE J, 1982, J LARYNGOL OTOL, V96, P869, DOI 10.1017/S0022215100093221
   SHAPIRO SM, 1984, ELECTROEN CLIN NEURO, V58, P266, DOI 10.1016/0013-4694(84)90112-3
   Shea M C Jr, 1972, Otolaryngol Clin North Am, V5, P161
   SHEA M C JR, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P160
   SHEA MC, 1970, ARCHIV OTOLARYNGOL, V92, P358
   Tiedeman JJ, 1995, ORTHOPEDICS, V18, P1153
NR 29
TC 10
Z9 12
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1531-7129
EI 1537-4505
J9 OTOL NEUROTOL
JI Otol. Neurotol.
PD NOV
PY 2001
VL 22
IS 6
BP 731
EP 736
DI 10.1097/00129492-200111000-00004
PG 6
WC Clinical Neurology; Otorhinolaryngology
SC Neurosciences & Neurology; Otorhinolaryngology
GA 494CG
UT WOS:000172260700004
PM 11698788
DA 2018-10-19
ER

PT J
AU Huang, L
   Apkarian, RP
   Chaikof, EL
AF Huang, L
   Apkarian, RP
   Chaikof, EL
TI High-resolution analysis of engineered type I collagen nanofibers by
   electron microscopy
SO SCANNING
LA English
DT Article
DE collagen; polyethylene oxide; nanofiber; biomimetic; biomaterial
ID DIAMETER FIBERS
AB Collagen nanofibers were generated at ambient temperature and pressure by electrospinning a 1 wt% solution of type 1 collagen and polyethylene oxide. Products were imaged with high-resolution scanning electron microscopy (HRSEM) at medium (similar to 30,000 x) and high magnifications (similar to 100,000 x) and with transmission electron microscopy (TEM). The capacity to produce collagen nanofibers may lead to the generation of extracellular matrix-based fabrics with applications in the fields of wound healing and tissue engineering.
C1 Emory Univ, Dept Surg, Atlanta, GA 30322 USA.
   Emory Univ, Integrated Microscopy & Microanalyt Facil Chem, Atlanta, GA 30322 USA.
   Georgia Inst Technol, Sch Chem Engn, Atlanta, GA 30332 USA.
RP Chaikof, EL (reprint author), Emory Univ, Dept Surg, 1639 Pierce Dr,Room 5105, Atlanta, GA 30322 USA.
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
CR Apkarian RP, 1999, MICROSC MICROANAL, V5, P197, DOI 10.1017/S1431927699000148
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Entov V. M., 1997, Fluid Dynamics, V32, P696
   Fang X, 1997, J MACROMOL SCI PHYS, VB36, P169, DOI 10.1080/00222349708220422
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   JOY DC, 1994, PROC ANN MEET MSA, P1032
   PETERS KR, 1985, SCANNING ELECTRON MI, V4, P1519
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   SILVER FH, 1980, J BIOL CHEM, V255, P9427
   YARIN AL, 1993, HYDRODYNAMICS RHEOLO
   ZHU KJ, 1990, J APPL POLYM SCI, V39, P1, DOI 10.1002/app.1990.070390101
NR 12
TC 52
Z9 57
U1 0
U2 13
PU FAMS INC
PI MAHWAH
PA BOX 832, MAHWAH, NJ 07430-0832 USA
SN 0161-0457
J9 SCANNING
JI Scanning
PD NOV-DEC
PY 2001
VL 23
IS 6
BP 372
EP 375
PG 4
WC Instruments & Instrumentation; Microscopy
SC Instruments & Instrumentation; Microscopy
GA 499WT
UT WOS:000172594100003
PM 11770932
DA 2018-10-19
ER

PT J
AU Ono, K
   Ishihara, M
   Ozeki, Y
   Deguchi, H
   Sato, M
   Saito, Y
   Yura, H
   Sato, M
   Kikuchi, M
   Kurita, A
   Maehara, T
AF Ono, K
   Ishihara, M
   Ozeki, Y
   Deguchi, H
   Sato, M
   Saito, Y
   Yura, H
   Sato, M
   Kikuchi, M
   Kurita, A
   Maehara, T
TI Experimental evaluation of photocrosslinkable chitosan as a biologic
   adhesive with surgical applications
SO SURGERY
LA English
DT Article
ID FIBRIN GLUE; POLY(L-GLUTAMIC ACID); CYTOKINE PRODUCTION; CHITIN;
   BIOMATERIAL; STIMULATION; OPERATIONS; SURGERY; GELATIN; DOGS
AB Background. In various surgical cases, effective tissue adhesives are required for both hemostasis (eg, intraoperative bleeding) and air sealing (eg, thoracic surgery). We have designed a chitosan molecule (Az-CH-LA) that can be photocrosslinked by ultraviolet (UV) light irradiation, thereby forming a hydrogel. The purpose of this work was to evaluate the effectiveness and safely of the photocrosslinkable chitosan hydrogel as an adhesive with surgical applications.
   Methods. The sealing ability of the chitosan hydrogel, determined as a bursting pressure, was assessed with removed thoracic aorta, trachea, and lung of farm pigs and in a rabbit model. The carotid artery and lung of rabbits were punctured with a needle, and the chitosan hydrogel was applied to, respectively, stop the bleeding and the air leakage. In vivo chitosan degradability and biologic responses were histologically assessed in animal models.
   Results. The bursting pressure of chitosan hydrogel (30 mg/mL) and fibrin glue, respectively, was 225 +/- 25 mm Hg (mean +/- SD) and 80 +/- 20 mm fg in the thoracic aorta; 77 +/- 29 mm Hg and 48 +/- 21 mm Hg in the trachea; and in the lung, 51 +/- 11 mm Hg (chitosan hydrogel), 62 +/- 4 min Hg (fibrin glue, rubbing method), and 12 +/- 2 mm Hg (fibrin glue, laver method). The sealing ability of the chitosan hydrogel was stronger than that of fibrin glue. All rabbits with a carotid artery (n = 8) or lung (n = 8) that was punctured with a needle and then sealed with chitosan hydrogel survived the 1-month observation period without any bleeding or air leakage from the puncture sites. Histologic examinations demonstrated that 30 days after application, a fraction of the chitosan hydrogel was phagocytosed by macrophages, had partially degraded, and had induced the formation of fibrous tissues around the hydrogel.
   Conclusions. A newly developed photocrosslinkable chitosan has demonstrated strong sealing ability and a great potential for use as an adhesive in surgical operations.
C1 Natl Def Med Coll, Res Inst, Div Biomed Engn, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Dept Med Engn, Dept Orthoped Surg, Dept Surg 2, Tokorozawa, Saitama 3598513, Japan.
   NeTech Inc, Kanagawa, Japan.
RP Ishihara, M (reprint author), Natl Def Med Coll, Res Inst, Div Biomed Engn, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.
OI Sato, Masato/0000-0003-4049-7325
CR BORST HG, 1982, J THORAC CARDIOV SUR, V84, P548
   BRAUNWALD NS, 1966, SURGERY, V59, P1024
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   JESSEN C, 1985, ANN THORAC SURG, V39, P521, DOI 10.1016/S0003-4975(10)61991-1
   KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554
   KOEHNLEIN HE, 1969, SURGERY, V66, P377
   MINAMI S, 1992, ADVANCES IN CHITIN AND CHITOSAN, P61
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Morikawa T, 1999, EUR SURG RES, V31, P180, DOI 10.1159/000008637
   MOY OJ, 1988, J HAND SURG-AM, V13A, P273, DOI 10.1016/S0363-5023(88)80063-7
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Otani Y, 1996, J BIOMED MATER RES, V31, P157
   Otani Y, 1996, BIOMATERIALS, V17, P1387, DOI 10.1016/0142-9612(96)87279-6
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   PRUDDEN JF, 1970, AM J SURG, V119, P560, DOI 10.1016/0002-9610(70)90175-3
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   ROUSOU JA, 1984, ANN THORAC SURG, V38, P409, DOI 10.1016/S0003-4975(10)62297-7
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   STARK J, 1984, ANN THORAC SURG, V38, P411, DOI 10.1016/S0003-4975(10)62298-9
   THETTER O, 1981, THORAC CARDIOV SURG, V29, P290, DOI 10.1055/s-2007-1023498
   TSENG YC, 1990, BIOMATERIALS, V11, P73, DOI 10.1016/0142-9612(90)90055-U
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   VANHOLDER R, 1993, BIOMATERIALS, V14, P737, DOI 10.1016/0142-9612(93)90037-3
NR 27
TC 77
Z9 83
U1 1
U2 30
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0039-6060
J9 SURGERY
JI Surgery
PD NOV
PY 2001
VL 130
IS 5
BP 844
EP 850
DI 10.1067/msy.2001.117197
PG 7
WC Surgery
SC Surgery
GA 490AL
UT WOS:000172026000011
PM 11685194
DA 2018-10-19
ER

PT J
AU Wu, PK
   Ringeisen, BR
   Callahan, J
   Brooks, M
   Bubb, DM
   Wu, HD
   Pique, A
   Spargo, B
   McGill, RA
   Chrisey, DB
AF Wu, PK
   Ringeisen, BR
   Callahan, J
   Brooks, M
   Bubb, DM
   Wu, HD
   Pique, A
   Spargo, B
   McGill, RA
   Chrisey, DB
TI The deposition, structure, pattern deposition, and activity of
   biomaterial thin-films by matrix-assisted pulsed-laser evaporation
   (MAPLE) and MAPLE direct write
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 28th International Conference on Metallurgical Coatings and Thin Films
CY APR 30-MAY 05, 2001
CL SAN DIEGO, CA
SP AVS Sci & Technol Soc, Adv Surface Engn Div
DE biomaterials; biosensors; cells; polymers; direct-write; laser ablation;
   physical vapor deposition (PVD); pulsed-laser; matrix-assisted
   pulsed-laser evaporation (MAPLE)
ID ELECTROCHEMICAL BIOSENSOR; MEMBRANE; GLUCOSE
AB Two techniques, Matrix-Assisted Pulsed-Laser Evaporation (MAPLE) and MAPLE Direct Write (MDW) were developed to deposit biomaterial thin-films. MAPLE involves dissolving or suspending the biomaterial in a volatile solvent, freezing the mixture to create a solid target, and using a low fluence pulsed laser to evaporate the target for deposition of the solute inside a vacuum system. Using simple shadow masks, i.e. lines, dots and arrays, pattern features with length scales as small as 20 mum can be deposited using multiple materials on different types of substrates. MDW uses pulsed laser to directly transfer material from a ribbon to a substrate. Patterns with a spatial resolution of similar to 10 mum can be written directly. Biomaterials ranging from polyethylene glycol to eukaryotic cells, i.e. Chinese hamster ovaries, were deposited with no measurable damage to their structures or genotype. Deposits of immobilized horseradish peroxidase, an enzyme, in the form of a polymer composite with a protective coating, i.e. polyurethane, retained their enzymatic functions. A dopamine electrochemical sensor was fabricated by MDW using a natural tissues/graphite composite. These examples and the unique features of MAPLE and MDW for biosensor fabrication have been discussed. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 USN, Res Lab, Washington, DC 20375 USA.
   So Oregon Univ, Dept Phys, Ashland, OR 97520 USA.
RP Wu, PK (reprint author), USN, Res Lab, Code 6372,Bldg 74,4555 Overlook Ave SW, Washington, DC 20375 USA.
EM wup@ccf.nrl.navy.mil
CR ADAMS RN, 1976, ANAL CHEM, V48, P1126
   ANTONISSE MMG, 1996, CHEMOSENSORS ION MOL, P23
   Ballantine D., 1997, ACOUSTIC WAVE SENSOR
   BELLI SL, 1986, ANAL LETT, V19, P403
   BUBB DM, 2001, IN PRESS APPL PHYS L
   Chen Q, 1998, ELECTROANAL, V10, P94, DOI 10.1002/(SICI)1521-4109(199802)10:2<94::AID-ELAN94>3.0.CO;2-A
   CLARK C, 1987, BIOSENSORS FUNDAMENT, pCH1
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   DANIELSSON B, 1987, BIOSENSORS FUNDAMENT, pCH29
   DIAMOND D, 1996, CHEMOSENSORS ION MOL, P91
   Eggins B., 1996, BIOSENSORS INTRO
   ElRhazi M, 1997, QUIM ANAL, V16, P49
   Fitz-Gerald JM, 2000, INTEGR FERROELECTR, V29, P13
   HALL EAH, 1990, BIOSENSORS, pCH2
   Harmer A., 1996, CHEM BIOCH SENSING O
   HARRIS JM, 1991, ACS SYM SER, V467, P418
   HAWKESWORTH K, 1993, ANALYST, V118, P395, DOI 10.1039/an9931800395
   Henry CM, 2000, CHEM ENG NEWS, V78, P49, DOI 10.1021/cen-v078n028.p049
   KARUBE I, 1987, BIOSENSORS FUNDAMENT, pCH2
   LEECH D, 1994, CHEM SOC REV, V23, P205, DOI 10.1039/cs9942300205
   Mar MN, 1999, SENSOR ACTUAT B-CHEM, V54, P125, DOI 10.1016/S0925-4005(98)00330-X
   Nakaya T, 1999, PROG POLYM SCI, V24, P143, DOI 10.1016/S0079-6700(98)00015-X
   NEWMAN JD, 1992, ANAL CHIM ACTA, V262, P13, DOI 10.1016/0003-2670(92)80002-O
   PALMER JK, 1963, PLANT PHYSIOL, V38, P508, DOI 10.1104/pp.38.5.508
   Pique A, 2000, P SOC PHOTO-OPT INS, V3933, P105, DOI 10.1117/12.387545
   Pique A, 1999, THIN SOLID FILMS, V355, P536, DOI 10.1016/S0257-8972(99)00376-X
   PONCHON JL, 1979, ANAL CHEM, V51, P1483, DOI 10.1021/ac50045a030
   Rechnitz GA, 1978, CHEM ENG NEWS, V56, P16
   RINGEISEN BR, 2001, IN PRESS BIOMATERIAL
   RINGEISEN BR, 2001, MODELLING SIMULATION
   Roda A, 2000, BIOTECHNIQUES, V28, P492, DOI 10.2144/00283st07
   SIDWELL JS, 1985, BIOTECHNOL LETT, V7, P419, DOI 10.1007/BF01166215
   Sirkar K, 2000, ANAL CHEM, V72, P2930, DOI 10.1021/ac991041k
   Stamford JA, 1996, ANAL CHEM, V68, pA359, DOI 10.1021/ac961943a
   Suggs L.J., 1998, POLYM TISSUE ENG, P99
   Tortora GJ, 1995, MICROBIOLOGY INTRO
   TSIEN RY, 1996, CHEMOSENSORS ION MOL, P17
   TURNER AFP, 1997, ANN CHIM, V87, P244
   VADGAMA P, 1992, ANALYST, V117, P1657, DOI 10.1039/an9921701657
   Vaidya R, 1998, BIOTECHNOL PROGR, V14, P371, DOI 10.1021/bp980039w
   WANG J, 1988, ANAL CHEM, V60, P1545, DOI 10.1021/ac00166a014
   WANG J, 2000, ANAL ELECTROCHEMISTY
   WARNER PG, 1987, BIOSENSORS FUNDAMENT, pCH7
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
   WU PK, 2000, MAT RES SOC S P, V617
   Zhang S, 2000, BIOSENS BIOELECTRON, V15, P273, DOI 10.1016/S0956-5663(00)00076-2
NR 46
TC 98
Z9 102
U1 1
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD NOV 1
PY 2001
VL 398
BP 607
EP 614
DI 10.1016/S0040-6090(01)01347-5
PG 8
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 505GZ
UT WOS:000172906200105
DA 2018-10-19
ER

PT J
AU Ishihara, M
   Ono, K
   Sato, M
   Nakanishi, K
   Saito, Y
   Yura, H
   Matsui, T
   Hattori, H
   Fujita, M
   Kikuchi, M
   Kurita, A
AF Ishihara, M
   Ono, K
   Sato, M
   Nakanishi, K
   Saito, Y
   Yura, H
   Matsui, T
   Hattori, H
   Fujita, M
   Kikuchi, M
   Kurita, A
TI Acceleration of wound contraction and healing with a photocrosslinkable
   chitosan hydrogel
SO WOUND REPAIR AND REGENERATION
LA English
DT Article
ID FIBROBLAST-GROWTH-FACTOR; DEACETYLATED CHITIN; CYTOKINE PRODUCTION;
   BIOMATERIAL; STIMULATION; MIGRATION; CELLS; MICE; DOGS
AB Application of ultraviolet light irradiation to a photocrosslinkable chitosan aqueous solution resulted in an insoluble, flexible hydrogel like soft rubber within 60 seconds. In order to evaluate its accelerating effect on wound healing, full-thickness skin incisions were made on the backs of mice and subsequently a photocrosslinkable chitosan aqueous solution was added into the wound and irradiated with UV light for 90 seconds. Application of the chitosan hydrogel significantly induced wound contraction and accelerated wound closure and healing compared with the untreated controls. Histological examination also showed an advanced contraction rate on the first 2 days and tissue fill rate on days 2 to 4 in the chitosan hydrogel-treated wounds. Furthermore, in cell culture studies, chitosan hydrogel culture medium supplemented with 5% fetal-bovine serum was found to be chemoattractant for human dermal fibroblasts in an invasion chamber assay using filters coated with Matrigel and in a cell migration assay. Due to its ability to accelerate wound contraction and healing, chitosan hydrogel may become accepted as an occlusive dressing for wound management.
C1 Natl Def Med Coll, Res Inst, Div Biomed Engn, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Res Inst, Dept Surg 2, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Res Inst, Dept Orthoped Surg, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Res Inst, Dept Med Engn, Tokorozawa, Saitama 3598513, Japan.
   NeTech Inc, Tokorozawa, Saitama, Japan.
RP Ishihara, M (reprint author), Natl Def Med Coll, Res Inst, Div Biomed Engn, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.
OI Sato, Masato/0000-0003-4049-7325
CR ALBINI A, 1987, CANCER RES, V47, P3239
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   FUKASAWA M, 1992, SURG TODAY, V22, P333, DOI 10.1007/BF00308742
   GILMAN TH, 1994, OSTOMY WOUND MANAGE, V41, P6
   KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Ono I, 1999, J BIOMED MATER RES, V48, P621, DOI 10.1002/(SICI)1097-4636(1999)48:5<621::AID-JBM5>3.0.CO;2-1
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   ONO K, IN PRESS SURGERY
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   PRUDDEN JF, 1970, AM J SURG, V119, P560, DOI 10.1016/0002-9610(70)90175-3
   Radhakrishnan VV, 1991, BIOMEDICINE, V2, P3
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   USAMI Y, 1994, J VET MED SCI, V56, P761, DOI 10.1292/jvms.56.761
   USAMI Y, 1994, J VET MED SCI, V56, P1215, DOI 10.1292/jvms.56.1215
NR 22
TC 86
Z9 94
U1 4
U2 26
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 1067-1927
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD NOV-DEC
PY 2001
VL 9
IS 6
BP 513
EP 521
DI 10.1046/j.1524-475x.2001.00513.x
PG 9
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA 536NT
UT WOS:000174709400011
PM 11896994
DA 2018-10-19
ER

PT J
AU Ozawa, T
   Weisel, RD
   Mickle, DAG
   Ohno, N
   Matsubayashi, K
   Kitagawa, A
   Li, GM
   Tumiati, L
   Ozawa, S
   Morita, S
   Ikada, Y
   Li, RK
AF Ozawa, T
   Weisel, RD
   Mickle, DAG
   Ohno, N
   Matsubayashi, K
   Kitagawa, A
   Li, GM
   Tumiati, L
   Ozawa, S
   Morita, S
   Ikada, Y
   Li, RK
TI The optimal biomaterial for autologous cardiac grafts to repair
   congenital heart defects
SO CIRCULATION
LA English
DT Meeting Abstract
C1 Toronto Gen Hosp, Toronto, ON, Canada.
   GUNZE Ltd, Kyoto, Japan.
   Suzuka Univ, Sch Med, Suzuka, Mie, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD OCT 23
PY 2001
VL 104
IS 17
SU S
MA 2053
BP 433
EP 433
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 487UW
UT WOS:000171895002035
DA 2018-10-19
ER

PT J
AU Chu, CL
   Zhu, JC
   Yin, ZD
   Lin, PH
AF Chu, CL
   Zhu, JC
   Yin, ZD
   Lin, PH
TI Structure optimization and properties of hydroxyapatite-Ti symmetrical
   functionally graded biomaterial
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE functionally graded biomaterial; structure optimization; titanium;
   hydroxyapatite
AB The hydroxyapatite(HA)-Ti/Ti/HA-Ti symmetrical functionally graded biomaterial (FGM) combining the excellent biocompatible properties of hydroxyapatite ceramic and the good mechanical properties of titanium component is a very promising biomaterial for hard tissue replacement implant. The optimized distribution function of components of this FGM has been obtained based on the classical lamination theory and thermo-elastic mechanics to overcome the tendency toward microcracking in earlier samples firstly. The perfect FGM sample without any microcracks on the surfaces was fabricated by hot pressing successfully whose actual distributions of compositions and thermal residual stress have been analyzed by electron probe microanalyser (EPMA) and X-ray diffraction method, which are consistent with those designed theoretically. Its integral apparent bending strength can reach to 158.9 MPa, which is higher than that of human bone. HA-Ti/Ti/Ti-HA symmetrical FGM behaved integral-fracture without falling apart or delaminating under two different loading modes. As a result, the pure titanium layer could provide an effective support of mechanical properties for the whole functionally graded biomaterial. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 SE Univ, Dept Mech Engn, Nanjing 210018, Peoples R China.
   Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
RP Chu, CL (reprint author), SE Univ, Dept Mech Engn, Nanjing 210018, Peoples R China.
RI Zhu, Jingchuan/B-3573-2018
OI Zhu, Jingchuan/0000-0002-6075-2373
CR BISHOP A, 1993, J MATER SCI LETT, V12, P1516
   Chu CL, 1999, J INORG MATER, V14, P775
   Chu CL, 1999, MAT SCI ENG A-STRUCT, V271, P95, DOI 10.1016/S0921-5093(99)00152-5
   Chu CL, 2000, T NONFERR METAL SOC, V10, P505
   CHU CL, 2000, THESIS HARBIN I TECH
   CHU CL, 1999, T NONFERROUS METALS, V9, P57
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Neubrand A, 1997, Z METALLKD, V88, P358
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Suresh S, 1997, INT MATER REV, V42, P85, DOI 10.1179/imr.1997.42.3.85
   Tang X.F., 1994, J CHINESE CERAMIC SO, V22, P44
   Watari F, 1998, J JPN I MET, V62, P1095, DOI 10.2320/jinstmet1952.62.11_1095
NR 12
TC 25
Z9 33
U1 0
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD OCT 15
PY 2001
VL 316
IS 1-2
BP 205
EP 210
DI 10.1016/S0921-5093(01)01239-4
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 477EB
UT WOS:000171269200026
DA 2018-10-19
ER

PT J
AU Hayashi, M
   Tomita, M
   Yoshizato, K
AF Hayashi, M
   Tomita, M
   Yoshizato, K
TI Production of EGF-collagen chimeric protein which shows the mitogenic
   activity
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE recombinant protein; fusion protein; type III collagen; biomaterial;
   growth factor
ID EPIDERMAL GROWTH-FACTOR; BACULOVIRUS EXPRESSION SYSTEM; HUMAN
   PROCOLLAGEN-I; DELIVERY SYSTEM; EXTRACELLULAR-MATRIX; HUMAN-FIBROBLASTS;
   CARRIER MATERIAL; ARTIFICIAL SKIN; FUSION PROTEIN; BINDING DOMAIN
AB Collagen has been utilized as a natural biomaterial because of its high biocompatibility, adhesiveness to cells and tissues, and biodegradability. The present study developed a recombinant technology to confer a mitogenic activity on type III collagen by fusing it to epidermal growth factor (EGF) at the collagen's N-terminus. The chimeric protein of EGF-collagen was synthesized in insect cells by the baculovirus-insect cell expression system. The fusion protein was shown to hold the triple helical conformation of collagen and the mitogenic activity of EGF. It was also demonstrated that the chimeric protein can be immobilized on tissue culture dishes as a fibrous form and in collagen fibrils without abolishing the original mitogenic, activity of EGF. This fusion protein can be utilized as a biocompatible, biodegradable, and adhesive fibrous mitogen for a variety of purposes in the area of tissue engineering. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Hiroshima Univ, Dev Biol Lab, Dept Biol Sci, Grad Sch Sci, Hiroshima 7398526, Japan.
   Japan Sci & Technol Corp, Hiroshima Tissue Regenerat Project, Hiroshima Prefecture Collaborat Reg Ent Advanceme, Hiroshima Prefecture Inst Ind Sci & Technol, Hiroshima 7390046, Japan.
   Terumo Co Ltd, Ctr Res & Dev, Nakai, Kanagawa 2590151, Japan.
RP Yoshizato, K (reprint author), Hiroshima Univ, Dev Biol Lab, Dept Biol Sci, Grad Sch Sci, 1-3-1 Kagamiyama, Hiroshima 7398526, Japan.
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   ALAKOKKO L, 1989, BIOCHEM J, V260, P509, DOI 10.1042/bj2600509
   Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342
   ARTURSON G, 1984, SCAND J PLAST RECONS, V18, P33, DOI 10.3109/02844318409057400
   Asahina K, 1999, DEV DYNAM, V216, P59, DOI 10.1002/(SICI)1097-0177(199909)216:1<59::AID-DVDY8>3.0.CO;2-B
   Bailey AJ, 2000, WOUND REPAIR REGEN, V8, P5, DOI 10.1046/j.1524-475x.2000.00005.x
   BENNETT NT, 1993, AM J SURG, V166, P74, DOI 10.1016/S0002-9610(05)80589-6
   BROWN GL, 1991, PLAST RECONSTR SURG, V88, P189, DOI 10.1097/00006534-199108000-00001
   BROWN GL, 1986, J EXP MED, V163, P1319
   BROWN GL, 1989, NEW ENGL J MED, V321, P76, DOI 10.1056/NEJM198907133210203
   BUCKLEY A, 1985, P NATL ACAD SCI USA, V82, P7340, DOI 10.1073/pnas.82.21.7340
   BURKE KE, 1985, ANN PLAS SURG, V14, P515, DOI 10.1097/00000637-198506000-00004
   Chen GP, 1997, BBA-MOL CELL RES, V1358, P200, DOI 10.1016/S0167-4889(97)00065-7
   FUJIOKA K, 1995, J CONTROL RELEASE, V33, P307, DOI 10.1016/0168-3659(94)00107-6
   GRAY A, 1983, NATURE, V303, P722, DOI 10.1038/303722a0
   GREAVES MW, 1980, CLIN EXP DERMATOL, V5, P101, DOI 10.1111/j.1365-2230.1980.tb01675.x
   Hall FL, 2000, INT J MOL MED, V6, P635
   Ishikawa T, 2001, J BIOCHEM-TOKYO, V129, P627, DOI 10.1093/oxfordjournals.jbchem.a002900
   Ishino K, 1998, JPN J CANCER RES, V89, P1126, DOI 10.1111/j.1349-7006.1998.tb00507.x
   ISHIYAMA M, 1993, CHEM PHARM BULL, V41, P1118
   Ito Y, 1997, J BIOCHEM-TOKYO, V121, P514
   Kadler KE, 1996, BIOCHEM J, V316, P1
   KAWASE Y, 1992, FEBS LETT, V298, P126, DOI 10.1016/0014-5793(92)80037-H
   Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Lamberg A, 1996, J BIOL CHEM, V271, P11988, DOI 10.1074/jbc.271.20.11988
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8
   MIDDELKOOP E, 1995, CELL TISSUE RES, V280, P447, DOI 10.1007/BF00307818
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018
   NISHIKAWA A, 1987, EXP CELL RES, V171, P164, DOI 10.1016/0014-4827(87)90259-X
   Ochiya T, 1999, NAT MED, V5, P707
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Prockop DJ, 1998, MATRIX BIOL, V16, P399, DOI 10.1016/S0945-053X(98)90013-0
   RAMSHAW JAM, 1995, BIOTECHNOL GENET ENG, V13, P335
   ROMANIC AM, 1991, J BIOL CHEM, V266, P12703
   Scopes RK, 1999, NAT BIOTECHNOL, V17, P21, DOI 10.1038/5190
   SCOTT J, 1983, SCIENCE, V221, P236, DOI 10.1126/science.6602382
   SODEK J, 1988, COLLAGEN REL RES, V1, P11
   Taipale J, 1997, FASEB J, V11, P51
   Tanaka Y, 1998, P ASSOC AM PHYSICIAN, V110, P118
   TESSIER DC, 1991, GENE, V98, P177, DOI 10.1016/0378-1119(91)90171-7
   Tomita M, 1995, BIOCHEM J, V312, P847, DOI 10.1042/bj3120847
   Tomita M, 1997, J BIOCHEM-TOKYO, V121, P1061
   Tomita M, 1999, J BIOCHEM, V126, P1118, DOI 10.1093/oxfordjournals.jbchem.a022557
   WEISSMAN BE, 1983, CELL, V32, P599, DOI 10.1016/0092-8674(83)90479-8
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YOSHIZATO K, 1988, BIOMED RES-TOKYO, V9, P33, DOI 10.2220/biomedres.9.33
   YOSHIZATO K, 1985, BIOMED RES-TOKYO, V6, P61
   YOSHIZATO K, 1984, ANN PLAS SURG, V13, P9, DOI 10.1097/00000637-198407000-00002
NR 52
TC 18
Z9 20
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD OCT 3
PY 2001
VL 1528
IS 2-3
BP 187
EP 195
DI 10.1016/S0304-4165(01)00187-8
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 490DM
UT WOS:000172035200016
PM 11687306
DA 2018-10-19
ER

PT J
AU Szyk, L
   Schaaf, P
   Gergely, C
   Voegel, JC
   Tinland, B
AF Szyk, L
   Schaaf, P
   Gergely, C
   Voegel, JC
   Tinland, B
TI Lateral mobility of proteins adsorbed on or embedded in polyelectrolyte
   multilayers
SO LANGMUIR
LA English
DT Article
ID SURFACE-DIFFUSION; SERUM-ALBUMIN; ADSORPTION; FILMS; INTERFACES; NEUTRON
AB We present the first results relative to the diffusion process of proteins (human serum albumin) adsorbed on or embedded in poly(sodium 4-styrenesulfonate)/poly(allylamine hydrochloride) polyelectrolyte multilayer films by using fluorescence recovery after photobleaching. At least two populations of adsorbed proteins exist on the top or within the multilayer architectures. One population, which typically represents 50-70% of the adsorbed proteins, corresponds to proteins that are able to diffuse laterally along the surface or in the multilayers, whereas the others diffuse more slowly or seem almost immobile over the experimental time scale. This constitutes a key result for the practical applications of the polyelectrolyte multilayers as targeted biomaterial coatings. Surprisingly, the diffusion coefficients of the mobile proteins that are embedded in the multilayers are comparable with the diffusion coefficients of the mobile proteins adsorbed on top of the multilayers. The diffusion coefficients, which are 1 order of magnitude smaller than on rigid substrates such as silica or poly(methyl methacrylate), are of the order of 10(-10) and 10(-11) cm(2)/s.
C1 Inst Charles Sadron, CNRS ULP, F-67083 Strasbourg, France.
   Univ Strasbourg 1, INSERM Unite 4245, UFR Odontol, F-67085 Strasbourg, France.
RP Schaaf, P (reprint author), Inst Charles Sadron, CNRS ULP, 6 Rue Boussingault, F-67083 Strasbourg, France.
RI SCHAAF, Pierre/J-2751-2016
OI SCHAAF, Pierre/0000-0001-7423-5492
CR Chan V, 1997, LANGMUIR, V13, P320, DOI 10.1021/la960670b
   COHN EJ, 1947, J AM CHEM SOC, V69, P1753, DOI 10.1021/ja01199a051
   DAVOUST J, 1982, EMBO J, V1, P1233, DOI 10.1002/j.1460-2075.1982.tb00018.x
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 1991, MAKROMOL CHEM-M SYMP, V46, P321, DOI 10.1002/masy.19910460145
   HAMMOND PT, 2000, CURR OPIN COLLOID IN, V4, P430
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Kusumi A, 1999, CURR OPIN CELL BIOL, V11, P582, DOI 10.1016/S0955-0674(99)00020-4
   Ladam G, 2000, BIOMACROMOLECULES, V1, P674, DOI 10.1021/bm005572q
   Ladam G, 2001, LANGMUIR, V17, P878, DOI 10.1021/la0013087
   Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k
   Losche M, 1998, MACROMOLECULES, V31, P8893, DOI 10.1021/ma980910p
   Onda M, 1997, JPN J APPL PHYS 2, V36, pL1608, DOI 10.1143/JJAP.36.L1608
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   Picart C, 2001, J CHEM PHYS, V115, P1086, DOI 10.1063/1.1375156
   RAMSDEN JJ, 1995, THIN SOLID FILMS, V254, P246, DOI 10.1016/0040-6090(94)06262-J
   RAMSDEN JJ, 1994, J PHYS CHEM-US, V98, P5376, DOI 10.1021/j100071a031
   SCHMITT J, 1993, MACROMOLECULES, V26, P7058, DOI 10.1021/ma00077a052
   SCHWINTE P, IN PRESS J PHYS CHEM
   Serizawa T, 1998, LANGMUIR, V14, P4088, DOI 10.1021/la9713661
   TILTON RD, 1990, BIOPHYS J, V58, P1321, DOI 10.1016/S0006-3495(90)82473-5
   TILTON RD, 1998, BIOPOLYMERS INTERFAC, pCH11
   VANBLAADEREN A, 1992, J CHEM PHYS, V96, P4591, DOI 10.1063/1.462795
NR 24
TC 40
Z9 40
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 2
PY 2001
VL 17
IS 20
BP 6248
EP 6253
DI 10.1021/la0104469
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 477VV
UT WOS:000171305700037
DA 2018-10-19
ER

PT J
AU D'Souza, SF
AF D'Souza, SF
TI Immobilization and stabilization of biomaterials for biosensor
   applications
SO APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT National Symposium on Biomolecular Electronics-Interfacing Physics and
   Chemistry with Biology (BEIPCB)
CY SEP 16-17, 1999
CL NATL PHYS LAB, NEW DELHI, INDIA
SP Council Sci & Ind Res, Indian Natl Sci Acad
HO NATL PHYS LAB
DE biosensors; immobilization; stabilization; permeabilized cells;
   microbial sensors
ID RADIATION POLYMERIZED POLYACRYLAMIDE; OXIDASE ENZYME ELECTRODE; WHITE
   FOAM MATRIX; YEAST-CELLS; GLUCOSE-OXIDASE; CROSS-LINKING; COTTON CLOTH;
   HORSERADISH-PEROXIDASE; PERMEABILIZED CELLS; ESCHERICHIA-COLI
AB Biosensors are finding applications in a variety of analytical fields. A biosensor basically consists of a transducer in conjunction with a biologically active molecule that converts a biochemical signal into a quantifiable electric response. The specificity of the biosensor depends on the selection of the biomaterial. Enzymes, antibodies, DNA, receptors, organelles, microorganisms as well as animal and plant cells or tissues have been used as biologic sensing materials. Advances in biochemistry, molecular biology, and immunochemistry are expected to lead to a rapid expansion in the range of biologic recognition elements to be used in the field of biosensors. Biomaterials that are stable and function even in highly acidic, alkaline, hydrophobic, or oxidizing environments as well as stable to high temperature and immune to toxic substrates in the processing stream will play an important role. Techniques for immobilization of the biomaterials have played a significant role in the biosensor field. Immobilization not only brings about the intimate contact of the biologic catalysts with the transducer, but also helps in the stabilization of the biologic system, thus enhancing its operational and storage stability. A number of techniques have been developed in our laboratory for the immobilization of enzymes, multienzyme systems, cells, and enzyme-cell conjugates. Some of these aspects that are of significance in biosensor applications have been highlighted.
C1 Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Trombay 400085, Mumbai, India.
RP D'Souza, SF (reprint author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Trombay 400085, Mumbai, India.
CR AHLUWALIA A, 1992, THIN SOLID FILMS, V210, P726, DOI 10.1016/0040-6090(92)90386-P
   Araujo AM, 1997, BIOTECHNOL TECH, V11, P67, DOI 10.1023/A:1018404103626
   Arnold FH, 1998, P NATL ACAD SCI USA, V95, P2035, DOI 10.1073/pnas.95.5.2035
   Bart JC, 1997, ENVIRON SCI TECHNOL, V31, P1505, DOI 10.1021/es960777l
   BENKOVIC SJ, 1992, ANNU REV BIOCHEM, V61, P29
   BICKERSTAFF GF, 1997, IMMOBILIZATION ENYME
   BLANCO RM, 1989, ENZYME MICROB TECH, V11, P353, DOI 10.1016/0141-0229(89)90019-7
   Blum L. J., 1991, BIOSENSOR PRINCIPLES
   BONNINGTON LS, 1995, ENZYME MICROB TECH, V17, P746, DOI 10.1016/0141-0229(95)00001-L
   Brenchley JE, 1996, J IND MICROBIOL BIOT, V17, P432, DOI 10.1007/BF01574774
   Chen JY, 2000, ACTA MATH SIN, V16, P541
   Corbisier P, 1996, ENVIRON TOXIC WATER, V11, P171, DOI 10.1002/(SICI)1098-2256(1996)11:3<171::AID-TOX1>3.0.CO;2-6
   D'souza S. F., 1989, INDIAN J MICROBIOL, V29, P83
   D'Souza SF, 1999, CURR SCI INDIA, V77, P69
   D'Souza SF, 1999, BIOTECHNOL TECH, V13, P375, DOI 10.1023/A:1008979709047
   Daniel RM, 1996, ENZYME MICROB TECH, V19, P74, DOI 10.1016/0141-0229(95)00174-3
   DANIEL RM, 1990, BIOCATALYSIS, P243
   Das N, 1997, BIOTECHNOL BIOENG, V54, P329, DOI 10.1002/(SICI)1097-0290(19970520)54:4<329::AID-BIT5>3.0.CO;2-M
   DESHPANDE A, 1987, Biotechnology Techniques, V1, P55, DOI 10.1007/BF00156288
   DESHPANDE A, 1986, INDIAN J BIOCHEM BIO, V23, P353
   DESHPANDE A, 1987, J BIOSCIENCE, V11, P137, DOI 10.1007/BF02704664
   DOMINGUEZ E, 1993, BIOSENS BIOELECTRON, V8, P229, DOI 10.1016/0956-5663(93)85038-P
   DORDICK JS, 1989, ENZYME MICROB TECH, V11, P194, DOI 10.1016/0141-0229(89)90094-X
   DSouza SE, 1997, WORLD J MICROB BIOT, V13, P561, DOI 10.1023/A:1018521510665
   DSOUZA SE, 1992, J BIOCHEM BIOPH METH, V24, P239, DOI 10.1016/0165-022X(94)90076-0
   DSOUZA SF, 1981, BIOTECHNOL BIOENG, V23, P431, DOI 10.1002/bit.260230217
   DSOUZA SF, 1980, BIOTECHNOL BIOENG, V22, P2191, DOI 10.1002/bit.260221015
   DSOUZA SF, 1989, BIOTECHNOL LETT, V11, P211, DOI 10.1007/BF01026061
   DSOUZA SF, 1983, BIOTECHNOL BIOENG, V25, P1661, DOI 10.1002/bit.260250619
   DSOUZA SF, 1991, ENZYME MICROB TECH, V13, P508, DOI 10.1016/0141-0229(91)90011-X
   DSOUZA SF, 1985, BIOTECHNOL LETT, V7, P589, DOI 10.1007/BF01026454
   DSOUZA SF, 1988, APPL MICROBIOL BIOT, V29, P136
   DSOUZA SF, 1986, BIOTECHNOL LETT, V8, P643, DOI 10.1007/BF01025974
   DSOUZA SF, 1980, ENZYME MICROB TECH, V2, P217, DOI 10.1016/0141-0229(80)90050-2
   DSOUZA SF, 1990, FOOD BIOTECHNOL, V4, P373
   DSOUZA SF, 1999, ADV BIOPROCESSING R, P107
   DSOUZA SF, 2000, IN PRESS APPL BIOCH
   DUrso EM, 1996, ENZYME MICROB TECH, V18, P482, DOI 10.1016/0141-0229(95)00153-0
   FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438
   Fojta M, 1997, ANAL CHIM ACTA, V342, P1, DOI 10.1016/S0003-2670(96)00551-X
   Gerlach CL, 1996, ENVIRON SCI TECHNOL, V30, P486
   GODBOLE SS, 1990, ENZYME MICROB TECH, V12, P214, DOI 10.1016/0141-0229(90)90041-N
   GODBOLE SS, 1983, ENZYME MICROB TECH, V5, P125, DOI 10.1016/0141-0229(83)90046-7
   GODBOLE SS, 1980, ENZYME MICROB TECH, V2, P223, DOI 10.1016/0141-0229(80)90051-4
   GODBOLE SS, 1983, BIOTECHNOL BIOENG, V25, P217, DOI 10.1002/bit.260250117
   Gu MB, 1996, BIOTECHNOL PROGR, V12, P393, DOI 10.1021/bp9600142
   GUILBAULT GG, 1989, BIO-TECHNOL, V7, P349, DOI 10.1038/nbt0489-349
   Gupte A, 1999, J BIOCHEM BIOPH METH, V40, P39, DOI 10.1016/S0165-022X(99)00015-9
   Hatti-Kaul R., 2000, AQUEOUS 2 PHASE SYST
   Huang XL, 1996, ENZYME MICROB TECH, V19, P378, DOI 10.1016/S0141-0229(96)00015-4
   Husain S, 1995, BIOCHEM MOL BIOL INT, V36, P669
   Janson JC, 1998, PROTEIN PURIFICATION
   Joshi NT, 1999, J ENVIRON SCI HEAL A, V34, P1689, DOI 10.1080/10934529909376921
   KAMATH N, 1988, APPL BIOCHEM BIOTECH, V19, P251, DOI 10.1007/BF02921497
   Kamath N, 1992, ENZYME MICROB TECHNO, V13, P935
   KAMATH N, 1991, TRENDS BIOMATER ARTI, V54, P67
   Katrlik J, 1996, ANAL CHIM ACTA, V331, P225, DOI 10.1016/0003-2670(96)00209-7
   KAUL R, 1983, BIOTECHNOL BIOENG, V25, P887, DOI 10.1002/bit.260250325
   KAUL R, 1986, J MICROBIOL BIOTECHN, V1, P12
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   Koyano T, 1996, BIOTECHNOL PROGR, V12, P141, DOI 10.1021/bp9500573
   KUMAR SD, 1992, BIOELECTROCH BIOENER, V27, P153, DOI 10.1016/0302-4598(92)87039-W
   KUMAR SD, 1994, BIOELECTROCH BIOENER, V34, P195, DOI 10.1016/0302-4598(94)80036-7
   MAROLIA KZ, 1994, J FOOD SCI TECH MYS, V31, P153
   Marolia KZ, 1999, J BIOCHEM BIOPH METH, V39, P115, DOI 10.1016/S0165-022X(98)00021-9
   MARSHALL RC, 1984, MICROBIAL ADHESION A
   Marty JL, 1997, ENVIRON TECHNOL, V18, P333, DOI 10.1080/09593331808616544
   MATTIASSON B, 1982, APPL BIOCHEM BIOTECH, V7, P121, DOI 10.1007/BF02798633
   MAZZEI F, 1995, ANAL CHIM ACTA, V316, P79, DOI 10.1016/0003-2670(95)00343-X
   MELO JS, 1992, FOOD BIOTECHNOL, V6, P175, DOI 10.1080/08905439209549830
   MELO JS, 1992, APPL BIOCHEM BIOTECH, V32, P159, DOI 10.1007/BF02922156
   MELO JS, 1999, WORLD J MICROB BIOT, V15, P25
   Miland E, 1996, ENZYME MICROB TECH, V19, P63, DOI 10.1016/0141-0229(95)00169-7
   Mulchandani A, 1998, ANAL CHEM, V70, P4140, DOI 10.1021/ac9805201
   Mulchandani A, 1998, ENZYME MICROBIAL BIO
   Murai T, 1997, APPL MICROBIOL BIOT, V48, P499, DOI 10.1007/s002530051086
   Nandakumar R, 1999, ANAL LETT, V32, P2379, DOI 10.1080/00032719908542976
   Nandakumar R, 1999, BIOTECHNOL TECH, V13, P689, DOI 10.1023/A:1008963730069
   NIKOLELIS D, 1998, BIOSENSORS DIRECT MO
   Patil AR, 1997, J GEN APPL MICROBIOL, V43, P163, DOI 10.2323/jgam.43.163
   RAMSAY G, 1998, COMMERICAL BIOSENSOR
   RAO BYK, 1988, BIOTECHNOL LETT, V10, P427, DOI 10.1007/BF01087444
   Rella R, 1996, BIOTECHNOL APPL BIOC, V24, P83
   Rogers K. R., 1998, AFFINITY BIOSENSORS
   RYAN O, 1994, ENZYME MICROB TECH, V16, P501, DOI 10.1016/0141-0229(94)90021-3
   SANKARAN K, 1989, ENZYME MICROB TECH, V11, P617, DOI 10.1016/0141-0229(89)90091-4
   SCHOMBURG D, 1990, FOOD BIOTECHNOL, V4, P329, DOI 10.1080/08905439009549745
   Simkus RA, 1996, ANAL LETT, V29, P1907
   SIVARAMAN H, 1982, BIOTECHNOL LETT, V4, P359, DOI 10.1007/BF00135422
   Skladal P, 1997, ELECTROANAL, V9, P737, DOI 10.1002/elan.1140091002
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   SRINIVASAN MC, 1994, CURR SCI INDIA, V66, P137
   STCLAIR NL, 1992, J AM CHEM SOC, V114, P7314, DOI 10.1021/ja00044a064
   Sung WJ, 2000, ANAL CHEM, V72, P2177, DOI 10.1021/ac9908041
   Svitel J, 1998, BIOTECHNOL APPL BIOC, V27, P153
   TANAKA A, 1991, PROTEIN IMMOBILIZATI, P183
   Tomalia D, 1985, ENCY POLYM SCI ENG, V1, P680
   Trojanowicz M, 1996, TRAC-TREND ANAL CHEM, V15, P38, DOI 10.1016/0165-9936(96)88036-8
   Tyagi R, 1999, ENZYME MICROB TECH, V24, P348, DOI 10.1016/S0141-0229(98)00131-8
   Uhlich Thhomas, 1996, Enzyme and Microbial Technology, V19, P124, DOI 10.1016/0141-0229(95)00190-5
   Ulbricht M, 1997, ENZYME MICROB TECH, V20, P61, DOI 10.1016/S0141-0229(96)00085-3
   Walcerz I, 1996, ANAL LETT, V29, P1939
NR 102
TC 59
Z9 59
U1 1
U2 29
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0273-2289
J9 APPL BIOCHEM BIOTECH
JI Appl. Biochem. Biotechnol.
PD OCT-DEC
PY 2001
VL 96
IS 1-3
BP 225
EP 238
DI 10.1385/ABAB:96:1-3:225
PG 14
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 503UW
UT WOS:000172820600023
PM 11783889
DA 2018-10-19
ER

PT J
AU Sikavitsas, VI
   Temenoff, JS
   Mikos, AG
AF Sikavitsas, VI
   Temenoff, JS
   Mikos, AG
TI Biomaterials and bone mechanotransduction
SO BIOMATERIALS
LA English
DT Review
DE adhesion; biomaterial; bone biology; bone mechanotransduction;
   cell-surface interaction; cytoskeleton; fluid flow; gap junction;
   mechanosensory cell; microgravity; osteoblast; osteocyte; shear stress;
   tissue engineering
ID MESSENGER-RNA EXPRESSION; BIODEGRADABLE POLYMER MICROPARTICLES;
   STRAIN-RELATED CHANGES; OSTEOBLAST-LIKE CELLS; GROWTH-FACTOR BETA-1;
   FLUID SHEAR-STRESS; C-FOS EXPRESSION; IN-VITRO; MECHANICAL STIMULATION;
   GENE-EXPRESSION
AB Bone is an extremely complex tissue that provides many essential functions in the body. Bone tissue engineering holds great promise in providing strategies that will result in complete regeneration of bone and restoration of its function. Currently, such strategies include the transplantation of highly porous scaffolds seeded with cells. Prior to transplantation the seeded cells are cultured in vitro in order for the cells to proliferate, differentiate and generate extracellular matrix. Factors that can affect cellular function include the cell-biomaterial interaction, as well as the biochemical and the mechanical environment. To optimize culture conditions, good understanding of these parameters is necessary. The new developments in bone biology, bone cell mechanotransduction, and cell-surface interactions are reviewed here to demonstrate that bone mechanotransduction is strongly influenced by the biomaterial properties. (C) 2001 Published by Elsevier Science Ltd.
C1 Rice Univ, Dept Bioengn, Inst Biosci & Bioengn, Houston, TX 77005 USA.
RP Mikos, AG (reprint author), Rice Univ, Dept Bioengn, Inst Biosci & Bioengn, 6100 Main,MS-142, Houston, TX 77005 USA.
EM mikos@rice.edu
FU NIAMS NIH HHS [R29-AR42639]
CR Ajubi NE, 1996, BIOCHEM BIOPH RES CO, V225, P62, DOI 10.1006/bbrc.1996.1131
   Akhouayri O, 2000, J CELL BIOCHEM, V76, P217, DOI 10.1002/(SICI)1097-4644(20000201)76:2<217::AID-JCB6>3.3.CO;2-B
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Baron Roland, 1993, P3
   Bronckers ALJJ, 1996, J BONE MINER RES, V11, P1281
   BUCKWALTER JA, 1995, J BONE JOINT SURG AM, V77A, P1256, DOI 10.2106/00004623-199508000-00019
   Burger EH, 1999, FASEB J, V13, pS101
   Caplan A.I.B.B., 1994, BONE, V8, P1
   Caplan AI, 1997, PRINCIPLES TISSUE EN, P603
   Carmeliet G, 1999, FASEB J, V13, pS129
   Carvalho RS, 1998, J CELL BIOCHEM, V70, P376, DOI 10.1002/(SICI)1097-4644(19980901)70:3<376::AID-JCB11>3.0.CO;2-J
   CHAMBERS TJ, 1993, BONE MINER, V20, P167, DOI 10.1016/S0169-6009(08)80025-6
   Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163
   Cowin SC, 1999, J BIOMECH, V32, P217, DOI 10.1016/S0021-9290(98)00161-4
   COWIN SC, 1995, J BIOMECH, V28, P1281, DOI 10.1016/0021-9290(95)00058-P
   Cowin SC, 1998, AM J MED SCI, V316, P184, DOI 10.1097/00000441-199809000-00006
   CRANE GM, 1995, NAT MED, V1, P1322, DOI 10.1038/nm1295-1322
   Currey J. D., 1984, MECH ADAPTATION BONE, P3
   DALLAS SL, 1993, J BONE MINER RES, V8, P251
   Damsky CH, 1997, KIDNEY INT, V51, P1427, DOI 10.1038/ki.1997.195
   Dodd JS, 1999, AM J PHYSIOL-CELL PH, V277, pC598, DOI 10.1152/ajpcell.1999.277.3.C598
   Donahue HJ, 2000, BONE, V26, P417, DOI 10.1016/S8756-3282(00)00245-3
   EANES E, 1992, CALCIFICATION BIOL S, P2
   Fitzgerald J, 1996, EXP CELL RES, V228, P168, DOI 10.1006/excr.1996.0313
   Fitzgerald J, 1999, FASEB J, V13, P553
   Globus RK, 1998, J CELL SCI, V111, P1385
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Harris SA, 2000, BONE, V26, P325, DOI 10.1016/S8756-3282(00)00234-9
   HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706
   HUBBELL JA, 2000, PRINCIPLES TISSUE EN, P237
   Hughes-Fulford M, 1999, FASEB J, V13, pS121
   INAOKA T, 1995, BIOCHEM BIOPH RES CO, V217, P264, DOI 10.1006/bbrc.1995.2773
   Ingber D, 1999, FASEB J, V13, pS3
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6
   Jo S, 2000, POLYMER, V41, P7595, DOI 10.1016/S0032-3861(00)00117-8
   JOHNSON DL, 1996, AM J PHYSIOL, V271, P205
   Klein-Nulend J, 1998, BIOCHEM BIOPH RES CO, V250, P108, DOI 10.1006/bbrc.1998.9270
   KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822
   KLEINNULEND J, 1995, FASEB J, V9, P441
   Kostenuik PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE1133
   KUFAHL RH, 1990, J BIOMECH, V23, P171, DOI 10.1016/0021-9290(90)90350-C
   Kumei Y, 1996, J BIOTECHNOL, V47, P313, DOI 10.1016/0168-1656(96)01412-5
   KUMEI Y, 1998, J APPL PHYSIOL, V45, P139
   Langer R, 2000, AICHE J, V46, P1286, DOI 10.1002/aic.690460702
   LEAN JM, 1995, AM J PHYSIOL-ENDOC M, V268, pE318
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Mason DJ, 1996, J BONE MINER RES, V11, P350
   McAllister TN, 1999, J BONE MINER RES, V14, P930, DOI 10.1359/jbmr.1999.14.6.930
   Mueller SM, 1999, J BONE MINER RES, V14, P2118, DOI 10.1359/jbmr.1999.14.12.2118
   MURRAY D, 1990, CALCIFIED TISSUE INT, V37, P411
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Ogata T, 2000, J CELL BIOCHEM, V76, P529, DOI 10.1002/(SICI)1097-4644(20000315)76:4<529::AID-JCB1>3.0.CO;2-5
   Owan I, 1997, AM J PHYSIOL-CELL PH, V273, pC810
   Parfitt AM, 1984, CALCIF TISSUE INT S, V36, P37
   Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591, DOI 10.1152/ajpcell.1998.275.6.C1591
   Peter SJ, 2000, J BIOMED MATER RES, V50, P452, DOI 10.1002/(SICI)1097-4636(20000605)50:3<452::AID-JBM20>3.3.CO;2-S
   Puleo DA, 1998, J BIOMED MATER RES, V41, P104, DOI 10.1002/(SICI)1097-4636(199807)41:1<104::AID-JBM13>3.0.CO;2-N
   REICH KM, 1990, J CELL PHYSIOL, V143, P100, DOI 10.1002/jcp.1041430113
   REICH KM, 1991, AM J PHYSIOL, V261, pC429
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Richards M, 1999, J BIOMECH ENG-T ASME, V121, P348, DOI 10.1115/1.2798331
   Richards M, 1999, J ORTHOP RES, V17, P900, DOI 10.1002/jor.1100170615
   ROBEY PG, 1989, ENDOCRIN METAB CLIN, V18, P859, DOI 10.1016/S0889-8529(18)30347-5
   Rosen V., 1995, CELLULAR MOL BASIS B, P97
   Salter DM, 1997, J BONE MINER RES, V12, P1133, DOI 10.1359/jbmr.1997.12.7.1133
   SALZSTEIN RA, 1987, J BIOMECH, V20, P261, DOI 10.1016/0021-9290(87)90293-4
   Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217
   Shah AK, 1999, BIOL CELL, V91, P131, DOI 10.1016/S0248-4900(99)80037-9
   SKERRY TM, 1989, J BONE MINER RES, V4, P783, DOI 10.1002/jbmr.5650040519
   Smalt R, 1997, AM J PHYSIOL-ENDOC M, V273, pE751, DOI 10.1152/ajpendo.1997.273.4.E751
   TANAKA K, 1995, MINER ELECTROL METAB, V21, P189
   Tate MLK, 1998, AM J MED SCI, V316, P189, DOI 10.1097/00000441-199809000-00007
   Toma CD, 1997, J BONE MINER RES, V12, P1626, DOI 10.1359/jbmr.1997.12.10.1626
   Turner CH, 1996, AM J PHYSIOL-ENDOC M, V270, pE634
   VANDERPLAS A, 1994, J BONE MINER RES, V9, P1697
   Vico L, 1998, BONE, V22, p95S, DOI 10.1016/S8756-3282(98)00017-9
   WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8
   Wolff J, 1892, GASETZ TRANSFORMATIO
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yellowley CE, 2000, J BONE MINER RES, V15, P209, DOI 10.1359/jbmr.2000.15.2.209
   Ziambaras K, 1998, J BONE MINER RES, V13, P218, DOI 10.1359/jbmr.1998.13.2.218
NR 84
TC 277
Z9 290
U1 2
U2 97
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2001
VL 22
IS 19
BP 2581
EP 2593
DI 10.1016/S0142-9612(01)00002-3
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 463HE
UT WOS:000170470400001
PM 11519777
DA 2018-10-19
ER

PT J
AU Mueller, HJ
   Hirthe, RW
AF Mueller, HJ
   Hirthe, RW
TI Electrochemical characterization and immersion corrosion of a
   consolidated silver dental biomaterial
SO BIOMATERIALS
LA English
DT Article
DE silver particle consolidation; artificial saliva; corrosion;
   electrochemical polarization; impedance spectroscopy
ID IMPEDANCE; SPECTROSCOPY; AMALGAMS; MODEL
AB A consolidated silver (CS) material, an alternative to dental amalgam, was studied for corrosion. Chemically precipitated silver particles were acid activated and pressure consolidated to a volume porosity of 25%. In selected tests comparisons were made between CS and melted and cast silver particles (MS), silver with a known mass fraction purity of 99.998% (FS), a silver-palladium alloy (SP), and a dispersed-phase amalgam (DA). Fusayama artificial saliva was used with controlled variations in pH, sulfide content, mucin content, and absorbed oxygen content. Electrochemical polarization, electrochemical impedance spectroscopy, and immersion methods were used. Results revealed differences in the zero current potentials E(I = 0) from forward polarization between CS and MS (or FS) in deaerated solution, By superposition of the cathodic polarization curves, the area for CS was increased by 7.3 times and was enclosed within an outer shell of material 5.5 mum thick. Polarization resistance was significantly the highest for SP, followed in order by MS (or FS) and CS or DA. With scanning electron microscopy, CS was shown to be significantly more susceptible than MS to long-term immersion corrosion. The modeled equivalent electrical circuits for CS and DA involved a double layer capacitance, a charge transfer resistance, and an element attributed to adsorption. The active pore depth for CS from the transmission line model for porous solids revealed satisfactory agreement with polarization results. It is concluded that the corrosion susceptibility of CS in Fusayama solution, while similar to that for DA, is greater than it is for MS. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Natl Inst Stand & Technol, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Gaithersburg, MD 20899 USA.
   Marquette Univ, Coll Engn, Milwaukee, WI 53233 USA.
RP Mueller, HJ (reprint author), Natl Inst Stand & Technol, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Gaithersburg, MD 20899 USA.
FU NIDCR NIH HHS [P50 DE 09322]
CR Annergren I, 1997, J ELECTROCHEM SOC, V144, P1208, DOI 10.1149/1.1837574
   BOUKAMP BA, 1988, EQUIVALENT CIRCUIT E
   Brady J M, 1975, J Endod, V1, P205, DOI 10.1016/S0099-2399(75)80198-1
   CHANA MS, 1984, J DENT, V12, P319
   DELEVIE R, 1967, ADV ELECTROCHEMISTRY, V6, P321
   Goon W W, 1995, Quintessence Int, V26, P629
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Johnson C. E., 1998, U.S. Patent, Patent No. [5,711,866, 5711866]
   LEMAITRE L, 1989, J BIOMED MATER RES, V23, P241, DOI 10.1002/jbm.820230208
   LEMAITRE L, 1989, J ORAL REHABIL, V16, P543, DOI 10.1111/j.1365-2842.1989.tb01376.x
   LIDE DR, 1997, CRC HDB CHEM PHYSICS
   MARGELOS J, 1991, J ENDODONT, V17, P282, DOI 10.1016/S0099-2399(06)81868-6
   Mcdonald J R, 1987, IMPEDANCE SPECTROSCO
   Mueller HJ, 2001, DENT MATER, V17, P60, DOI 10.1016/S0109-5641(00)00061-0
   Nakamoto K., 1996, INFRARED RAMAN SPECT
   Olsson S, 1997, J DENT RES, V76, P1869, DOI 10.1177/00220345970760121001
   OLSSON S, 1994, J DENT RES, V73, P33, DOI 10.1177/00220345940730010501
   PALAGHIAS G, 1985, Dental Materials, V1, P139, DOI 10.1016/S0109-5641(85)80006-3
   Seitz MA, 1996, MATER RES SOC SYMP P, V411, P57
   SELTZER S, 1972, ORAL SURG ORAL MED O, V33, P589, DOI 10.1016/0030-4220(72)90373-8
   Shoesmith D.W., 1987, METALS HDB, V13, P29
   Sridhar N, 1997, J ELECTROCHEM SOC, V144, P4243, DOI 10.1149/1.1838173
   Tomashov N.D., 1966, THEORY CORROSION PRO, P133
   VAIDYANATHAN TK, 1981, J DENT RES, V60, P707, DOI 10.1177/00220345810600030601
NR 24
TC 8
Z9 9
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2001
VL 22
IS 19
BP 2635
EP 2646
DI 10.1016/S0142-9612(01)00004-7
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 463HE
UT WOS:000170470400007
PM 11519783
DA 2018-10-19
ER

PT J
AU Record, RD
   Hillegonds, D
   Simmons, C
   Tullius, R
   Rickey, FA
   Elmore, D
   Badylak, SF
AF Record, RD
   Hillegonds, D
   Simmons, C
   Tullius, R
   Rickey, FA
   Elmore, D
   Badylak, SF
TI In vivo degradation of C-14-labeled small intestinal submucosa (SIS)
   when used for urinary bladder repair
SO BIOMATERIALS
LA English
DT Article
DE small intestinal submucosa; SIS; AMS; extracellular matrices;
   augmentation cystoplasty
ID ACELLULAR MATRIX GRAFT; DOG-MODEL; BIOSCAFFOLD; RAT
AB The rate of in vivo degradation was determined for a naturally occurring biomaterial derived from the extracellular matrix of the small intestinal submucosa (SIS). The SIS was labeled by giving weekly intravenous injections of 10 mu Ci of C-14-proline to piglets from 3 weeks of age until the time of sacrifice at 26 weeks. The resultant SIS prepared from these pigs contained approximately 10(3) fold more C-14 than unlabeled tissues. The labeled SIS was used to repair experimental defects in the urinary bladder of 10 dogs. The animals were sacrificed at post-operative times ranging from 3 days to I year and the remodeled urinary bladder tissue was harvested for evaluation of C-14 by a combination of liquid scintillation counting and accelerator mass spectrometry. The remodeled tissue contained less than 10% of the C-14 (disintegrations per minute/gram tissue wet weight) at 3 months post-surgery compared to the SIS biomaterial that was originally implanted. The SIS scaffold was replaced by host tissue that resembled normal bladder both in structure and function. After implantation, C-14 was detected in highest concentrations in the blood and the urine. The SIS bioscaffold provides a temporary scaffold for tissue remodeling with rapid host tissue remodeling, degradation, and elimination via the urine when used as a urinary bladder repair device. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Purdue Univ, Dept Biol Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Phys, PRIME Lab, W Lafayette, IN 47907 USA.
RP Record, RD (reprint author), Purdue Univ, Dept Biol Engn, 1296 Potter Ctr, W Lafayette, IN 47907 USA.
EM rrecord@ecn.purdue.edu
OI Badylak, Stephen/0000-0003-3555-0689; Ritchie, Rae/0000-0002-0693-0693
CR ALLMAN AJ, IN PRESS TRANSPLANTA
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Dahms SE, 1998, BRIT J UROL, V82, P411
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Horrocks D., 1974, APPL LIQUID SCINTILL
   JACKSON GS, 2000, CURR SEP, V19, P3
   KLEIN L, 1972, SURG GYNECOL OBSTETR, V135, P49
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Piechota HJ, 1999, UROL RES, V27, P206, DOI 10.1007/s002400050111
   Rickey FA, 2000, NUCL INSTRUM METH B, V172, P904, DOI 10.1016/S0168-583X(00)00344-X
   STETTEN MR, 1949, J BIOL CHEM, V181, P31
NR 15
TC 146
Z9 163
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2001
VL 22
IS 19
BP 2653
EP 2659
DI 10.1016/S0142-9612(01)00007-2
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 463HE
UT WOS:000170470400009
PM 11519785
DA 2018-10-19
ER

PT J
AU Alferiev, I
   Vyavahare, N
   Song, CX
   Connolly, J
   Hinson, JT
   Lu, ZB
   Tallapragada, S
   Bianco, R
   Levy, R
AF Alferiev, I
   Vyavahare, N
   Song, CX
   Connolly, J
   Hinson, JT
   Lu, ZB
   Tallapragada, S
   Bianco, R
   Levy, R
TI Bisphosphonate derivatized polyurethanes resist calcification
SO BIOMATERIALS
LA English
DT Article
DE heart valves; prostheses; mineralization; biomaterials
ID BIOPROSTHETIC HEART-VALVES; DIPHOSPHONATES; ALENDRONATE; PROSTHESES;
   INHIBITION
AB Calcification of polyurethane cardiovascular implants is an important disease process that has the potential to compromise the long-term function of devices such as polymer heart valves and ventricular assist systems In this study we report the successful formulation and characterization of bisphosphonate-derivatized polyurethanes, hypothesized to resist implant calcification based on the pharmacologic activity of the immobilized bisphosphonate. Fully polymerized polyurethanes (a polyurea-polyurethane and a polycarbonate polyurethane) were modified (post-polymerization) with bromoalkylation of the hard segments followed by attachment of a bisphosphonate group at the bromine site. These bisphosphonate-polyurethanes resisted calcification in rat 60 day subdermal implants compared to nonmodified control polyurethane implants, that calcify. Bisphosphonates-modified polyurethanes were also studied in circulatory implants using a pulmonary valve cusp replacement model in sheep. Polyurethane cusps modified with bisphosphonate did not calcify in 90 day implants, compared to control polyurethane cusps implants, that demonstrated nodular surface oriented calcific deposits. It is concluded that bisphosphonate modified polyurethanes resist calcification both in subdermal implants and in the circulation. This novel biomaterial approach offers great promise for long-term blood stream implantation with calcification resistance. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA 19104 USA.
   Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA.
RP Levy, R (reprint author), Childrens Hosp Philadelphia, Div Cardiol, Abramson Res Bldg,3516 Civ Ctr Blvd, Philadelphia, PA 19104 USA.
OI Bianco, Richard/0000-0003-1294-1599
FU NHLBI NIH HHS [HL59730]
CR Alferiev IS, 2001, J POLYM SCI POL CHEM, V39, P105, DOI 10.1002/1099-0518(20010101)39:1<105::AID-POLA120>3.3.CO;2-#
   Bernacca GM, 1997, J BIOMED MATER RES, V34, P371
   Bernacca GM, 1998, INT J ARTIF ORGANS, V21, P814
   BILLY GG, 1995, ARTIF ORGANS, V19, P339, DOI 10.1111/j.1525-1594.1995.tb02338.x
   Bone HG, 2000, CLIN THER, V22, P15, DOI 10.1016/S0149-2918(00)87974-6
   BOSKEY AL, 1992, CELL MATER, V2, P209
   BRAUNWALD NS, 1972, B NEW YORK ACAD MED, V48, P357
   BRAUNWALD NS, 1989, ANN THORAC SURG, V48, pS1, DOI 10.1016/0003-4975(89)90615-2
   CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033
   Clift S E, 1996, Proc Inst Mech Eng H, V210, P267, DOI 10.1243/PIME_PROC_1996_210_423_02
   Downs RW, 2000, J CLIN ENDOCR METAB, V85, P1783, DOI 10.1210/jc.85.5.1783
   FISHBEIN MC, 1975, AM HEART J, V89, P443, DOI 10.1016/0002-8703(75)90149-0
   FLEISCH H, 1987, CLIN ORTHOP RELAT R, P72
   Fleisch H, 1989, Recent Results Cancer Res, V116, P1
   Fleisch H, 1987, BONE S, V8, P23
   GOLOMB G, 1986, Journal of Controlled Release, V4, P181, DOI 10.1016/0168-3659(86)90002-7
   GOLOMB G, 1987, J PHARM SCI-US, V76, P271, DOI 10.1002/jps.2600760402
   HIRSCH D, 1993, BIOMATERIALS, V14, P371, DOI 10.1016/0142-9612(93)90057-9
   Joshi RR, 1996, J BIOMED MATER RES, V31, P201
   JOSHI RR, 1994, J APPL BIOMATER, V5, P65, DOI 10.1002/jab.770050109
   KAY EB, 1989, ANN THORAC SURG, V48, pS24, DOI 10.1016/0003-4975(89)90625-5
   LEVY RJ, 1987, J THORAC CARDIOV SUR, V94, P551
   LEVY RJ, 1985, SCIENCE, V228, P190, DOI 10.1126/science.3919445
   Park Y, 1999, ARTIF ORGANS, V23, P210, DOI 10.1046/j.1525-1594.1999.06013.x
   Robin J, 1998, J THORAC CARDIOV SUR, V115, P898, DOI 10.1016/S0022-5223(98)70372-1
   Wheatley DJ, 2000, EUR J CARDIO-THORAC, V17, P440, DOI 10.1016/S1010-7940(00)00381-X
NR 26
TC 21
Z9 22
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2001
VL 22
IS 19
BP 2683
EP 2693
DI 10.1016/S0142-9612(01)00010-2
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 463HE
UT WOS:000170470400012
PM 11519788
DA 2018-10-19
ER

PT J
AU Paez, JMG
   Jorge-Herrero, E
   Carrera, A
   Millan, I
   Rocha, A
   Calero, P
   Cordon, A
   Sainz, N
   Castillo-Olivares, JL
AF Paez, JMG
   Jorge-Herrero, E
   Carrera, A
   Millan, I
   Rocha, A
   Calero, P
   Cordon, A
   Sainz, N
   Castillo-Olivares, JL
TI Ostrich pericardium, a biomaterial for the construction of valve
   leaflets for cardiac bioprostheses: mechanical behaviour, selection and
   interaction with suture materials
SO BIOMATERIALS
LA English
DT Article
DE ostrich pericardium; cardiac bioprostheses; biaxial testing;
   biomaterials; mechanical properties; sutures
ID PHOTOOXIDIZED BOVINE PERICARDIUM; HEART-VALVES; SUPRAANNULAR PORCINE;
   FIBER ARCHITECTURE; CALF PERICARDIUM; TISSUE; CALCIFICATION;
   POLYURETHANE; PROSTHESES; DURABILITY
AB The mechanical behavior of ostrich pericardium was studied for the purpose of assessing its utility in the construction of bioprosthetic cardiac valve leaflets. The tissue was tested biaxially using a hydraulic simulator that subjected it to increasing stress until rupture. One hundred eighty trials were performed, 36 with unsutured pericardium and four series of 36 trials each with pericardium sutured with silk, Prolene, nylon or Gore-Tex. The samples were tested in pairs from three different pericardial regions. One sample from each pair (the predictive specimen) was assessed according to morphological and mechanical criteria, while the other (the predicted or selectable specimen) was subjected only to morphological analysis. The findings show that ostrich pericardium treated with glutaraldehyde according to standard methods has an excellent resistance to rupture in biaxial testing, withstanding stresses of up to 100 M Pa, and never lower than 30 M Pa. Its resistance to rupture is lowered by suturing, a loss that is less pronounced when silk sutures are used. The results with Gore-Tex are very homogeneous and the elastic behavior of the pericardium/suture unit appears to be similar to that of unsutured tissue, suggesting that the interaction between the two biomaterials is minor. Similar results were observed in the series sutured with Prolene and nylon. The use of paired samples makes it possible to closely estimate the mechanical behavior of the tissue in a given zone by determining that of its mate. The statistical study shows that this estimation is not conditioned by the suture employed, thus validating this approach and providing more precise criteria for tissue selection. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Clin Puerta Hierro, Serv Med Prevent, Madrid 28035, Spain.
   Escuela Tecn Super Ingn Ind, Madrid, Spain.
RP Paez, JMG (reprint author), Clin Puerta Hierro, Serv Med Prevent, C San Martin de Porres 4, Madrid 28035, Spain.
RI Jorge Herrero, EDUARDO/F-7240-2010
CR Bernacca GM, 1998, INT J ARTIF ORGANS, V21, P814
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   Butany J, 1999, Semin Thorac Cardiovasc Surg, V11, P157
   Butterfield M, 2000, J HEART VALVE DIS, V9, P161
   DATO GMA, 1999, MINERVA CARDIOANGIOL, V47, P275
   Ellsmere JC, 1999, BIOMATERIALS, V20, P1143, DOI 10.1016/S0142-9612(99)00013-7
   GARCIAPAEZ JM, 1996, J BIOMED MATER RES, V30, P47
   GLOWER DD, 1994, J THORAC CARDIOV SUR, V107, P381
   GUERRA F, 1990, J THORAC CARDIOV SUR, V99, P838
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   Hyde JAJ, 1999, J HEART VALVE DIS, V8, P331
   Jamieson WRE, 1999, ANN THORAC SURG, V67, P10, DOI 10.1016/S0003-4975(98)01056-X
   Jamieson WRE, 1999, J THORAC CARDIOV SUR, V118, P297
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   Kent PD, 1998, CARDIOVASC PATHOL, V7, P9, DOI 10.1016/S1054-8807(97)00040-9
   Moore MA, 1998, ANN THORAC SURG, V66, pS245, DOI 10.1016/S0003-4975(98)01118-7
   Munro AI, 1995, ANN THORAC SURG S2, V60, P470
   Paez JMG, 2000, J BIOMATER APPL, V15, P47
   PAEZ JMG, 1990, J THORAC CARDIOV SUR, V100, P580
   PAEZ JMG, 1994, BIOMATERIALS, V15, P172, DOI 10.1016/0142-9612(94)90063-9
   Paez JMG, 1999, J BIOMATER APPL, V13, P351, DOI 10.1177/088532829901300404
   Paez JMG, 1996, BIOMATERIALS, V17, P1677, DOI 10.1016/0142-9612(96)87647-2
   PAEZ JMG, 1994, BIOMATERIALS, V15, P981, DOI 10.1016/0142-9612(94)90078-7
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   San Martin AC, 1998, J BIOMED MATER RES, V39, P568, DOI 10.1002/(SICI)1097-4636(19980315)39:4<568::AID-JBM10>3.0.CO;2-3
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schoen FJ, 1998, J HEART VALVE DIS, V7, P174
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   SESTAFE JVG, 1994, J BIOMED MATER RES, V28, P755, DOI 10.1002/jbm.820280613
   Talman EA, 1996, J HEART VALVE DIS, V5, P152
   TROWBRIDGE EA, 1989, CRIT REV BIOCOMPAT, V5, P105
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   Wheatley DJ, 2000, EUR J CARDIO-THORAC, V17, P440, DOI 10.1016/S1010-7940(00)00381-X
NR 35
TC 14
Z9 14
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2001
VL 22
IS 20
BP 2731
EP 2740
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 466CR
UT WOS:000170627200004
PM 11545307
DA 2018-10-19
ER

PT J
AU Gorman, SP
   McGovern, JG
   Woolfson, AD
   Adair, CG
   Jones, DS
AF Gorman, SP
   McGovern, JG
   Woolfson, AD
   Adair, CG
   Jones, DS
TI The concomitant development of poly(vinyl chloride)-related biofilm and
   antimicrobial resistance in relation to ventilator-associated pneumonia
SO BIOMATERIALS
LA English
DT Article
DE biomaterial; medical device; AFM; pneumonia; biofilm; antibiotic
ID ATOMIC-FORCE MICROSCOPY; ENDOTRACHEAL-TUBES; BACTERIAL; ELECTRON;
   SURFACE
AB Ventilator-associated pneumonia is a major cause of death in intensive care patients and the endotracheal tube, commonly fabricated from poly(vinyl chloride) (PVC), is acknowledged as a significant factor in this. Bacteria colonise the biomaterial, thereby adopting a sessile mode of growth that progresses to the establishment of an antibiotic-resistant biofilm by the accretion of a protective glycocalyx. This study examined the sequential steps involved in the formation of biofilm on PVC by atomic force microscopy and the concomitant development of resistance to an antibiotic (ceftazidime) and to a non-antibiotic antimicrobial agent (hexetidine). Staphylococcus aureus and Pseudomonas aeruginosa isolated from ET tube biofilm were employed. The surface microrugosity of bacteria growing in sessile mode on PVC decreased significantly (p < 0.05) over the period 4, 24 48 h and 5 d. The progressive accretion of bacterial glycocalyx was readily visualised in micrographs leading to a smoother surface topography with time. The minimum inhibitory concentrations (MIC) and minimum bactericidal concentrations (MBC) for ceftazidime and hexetidine against planktonic (suspension) S. aureus were lower than for Ps. aeruginosa. Furthermore, sessile populations of S. aureus and Ps. aeruginosa on PVC exhibited greater resistance to both ceftazidime and hexetidine when compared to planktonic bacterial growth. The efficacy of the agents, determined by kill kinetics, against sessile bacteria was dependent on age, with established biofilms (greater than or equal to 24 h) significantly more resistant (p < 0.05) than early sessile populations (less than or equal to 4 h). Importantly, for practice, even newly colonised bacteria (1 h) were significantly more resistant to antibiotic than planktonic bacteria. Hexetidine was significantly more active (p < 0.05) than ceftazidime on biofilms of both isolates, irrespective of age, with total kill within 24 h treatment. Hexetidine may offer promise in the resolution of infection associated with PVC endotracheal tubes. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Queens Univ Belfast, Ctr Med Biol, Sch Pharm, Med Devices Grp, Belfast BT9 7BL, Antrim, North Ireland.
RP Gorman, SP (reprint author), Queens Univ Belfast, Ctr Med Biol, Sch Pharm, Med Devices Grp, Belfast BT9 7BL, Antrim, North Ireland.
CR Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014
   Adair CG, 2000, HDB BACTERIAL ADHESI, P249
   Bradshaw DJ, 1996, J APPL BACTERIOL, V80, P124, DOI 10.1111/j.1365-2672.1996.tb03199.x
   BREMER PJ, 1992, CURR MICROBIOL, V24, P223, DOI 10.1007/BF01579285
   BROWN MRW, 1993, J APPL BACTERIOL, V74, pS87, DOI 10.1111/j.1365-2672.1993.tb04345.x
   DeRiso A, 1996, CHEST, V109, P1556, DOI 10.1378/chest.109.6.1556
   GORMAN S, 1993, EUR J CLIN MICROBIOL, V12, P9, DOI 10.1007/BF01997050
   GORMAN SP, 1987, J CLIN PHARM THER, V12, P393, DOI 10.1111/j.1365-2710.1987.tb00552.x
   GORMAN SP, 1994, EPIDEMIOL INFECT, V112, P551, DOI 10.1017/S0950268800051256
   Gorman SP, 1991, MECH ACTION CHEM BIO, P271
   GRISTINA AG, 1993, INT J ARTIF ORGANS, V16, P755
   Gunning PA, 1996, J APPL BACTERIOL, V81, P276, DOI 10.1111/j.1365-2672.1996.tb04329.x
   INGLIS TJJ, 1995, J HOSP INFECT, V30, P409, DOI 10.1016/0195-6701(95)90045-4
   Jones DS, 1997, BIOMATERIALS, V18, P503, DOI 10.1016/S0142-9612(96)00170-6
   LAWRENCE JR, 1991, J BACTERIOL, V173, P6558, DOI 10.1128/jb.173.20.6558-6567.1991
   LEVINE SA, 1991, CLIN CHEST MED, V12, P523
   MAWHINNEY WM, 1993, INT J PHARM PRACT, V1, P136
   McGovern JG, 1997, INT J PHARM, V149, P251, DOI 10.1016/S0378-5173(97)04883-7
   Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X
   NAYLOR PT, 1990, CLIN ORTHOP RELAT R, P126
   RUBENSTEIN JS, 1992, CRIT CARE MED, V20, P1544, DOI 10.1097/00003246-199211000-00011
   SOTTILE FD, 1986, CRIT CARE MED, V14, P265, DOI 10.1097/00003246-198604000-00001
   TUNNEY MM, 1996, REV MED MICROBIOL, V7, P195
   WILE DB, 1986, CURR MED RES OPIN, V10, P82, DOI 10.1185/03007998609110423
   WILLIAMS MJR, 1987, BRIT DENT J, V163, P300, DOI 10.1038/sj.bdj.4806275
NR 25
TC 39
Z9 39
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2001
VL 22
IS 20
BP 2741
EP 2747
DI 10.1016/S0142-9612(01)00017-5
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 466CR
UT WOS:000170627200005
PM 11545308
DA 2018-10-19
ER

PT J
AU Iooss, P
   Le Ray, AM
   Grimandi, G
   Daculsi, G
   Merle, C
AF Iooss, P
   Le Ray, AM
   Grimandi, G
   Daculsi, G
   Merle, C
TI A new injectable bone substitute combining poly(epsilon-caprolactone)
   microparticles with biphasic calcium phosphate granules
SO BIOMATERIALS
LA English
DT Article
DE microparticles; solvent evaporation process; poly(epsilon-caprolactone);
   texture analysis; biphasic calcium phosphate; injectability
ID DRUG-DELIVERY SYSTEM; IN-VITRO; GROWTH-HORMONE; EPSILON-CAPROLACTONE;
   VACUUM METHOD; RELEASE; HYDROXYAPATITE; MICROSPHERES; CERAMICS;
   BIOMATERIALS
AB Previous studies have shown the effectiveness of an injectable bone substitute (IBS) composed of biphasic calcium phosphate in 2% hydroxypropyl methylcellulose gel (50/50 w/w). A therapeutic agent in the form of a drug can be added to the biomaterial by encapsulation into microparticles to protect the active agent, control its release and preserve the material rheological properties. Poly(epsilon -caprolactone) was used in this study because of its biocompatibility and resorbability, as tested in orthopaedic implants and surgical sutures. Particles (80-200 mum) were manufactured by a solvent evaporation-extraction process (1 g of polymer, 11-15 ml methylene chloride, with a stirring speed of 400-600 rpm) and introduced into the IBS in a 5-50% (V/V) range. Injectability was evaluated by texture analysis. With less than 45% of particles, the material had rheological properties similar to those of the reference IBS, whereas injectability decreased markedly with more than 45% of particles. A preliminary in vitro release study showed that this type of triphasic IBS could be efficient for drug delivery systems with osteoconduction properties. (C) 2001 Published by Elsevier Science Ltd.
C1 Fac Pharm, Pharm Galen Lab, F-44035 Nantes, France.
   Fac Chirurg Dent, Equipe INSERM 99 03, Ctr Rech Mat Interet Biol, F-44042 Nantes, France.
RP Le Ray, AM (reprint author), Fac Pharm, Pharm Galen Lab, BP 53508,1 Rue Gaston Veil, F-44035 Nantes, France.
RI Xu, Qingguo/C-1962-2014; Daculsi, Guy/P-1320-2014
OI Xu, Qingguo/0000-0003-3191-0771; Daculsi, Guy/0000-0003-1030-3446
CR Aftabrouchard D., 1992, STP PHARMA SCI, V2, P365
   ARSHADY R, 1991, J CONTROL RELEASE, V17, P1, DOI 10.1016/0168-3659(91)90126-X
   Bai B, 1999, SPINE, V24, P1521, DOI 10.1097/00007632-199908010-00004
   BAJPAI PK, 1988, J BIOMED MATER RES, V22, P1245, DOI 10.1002/jbm.820221212
   Benoit MA, 1997, INT ORTHOP, V21, P403
   BENOIT MA, 1995, P 1 WORLD M APGI APV, P431
   BEZWADA RS, 1995, BIOMATERIALS, V16, P1141, DOI 10.1016/0142-9612(95)93577-Z
   Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   BREWER E, 1995, J PHARM SCI, V84, P499, DOI 10.1002/jps.2600840421
   Calvo P, 1996, J PHARM PHARMACOL, V48, P1147, DOI 10.1111/j.2042-7158.1996.tb03911.x
   Chang CM, 1996, INT J PHARM, V130, P187, DOI 10.1016/0378-5173(95)04287-3
   CHANG RK, 1986, DRUG DEV IND PHARM, V12, P2355, DOI 10.3109/03639048609063187
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   DACULSI G, 1995, CAHIER ENSEIGNEMENT, P5
   Daculsi G, 1995, CNRS patent, Patent No. [9521634, WO 95/21634]
   DOWNES S, 1991, CELL MATER, V1, P171
   DOWNES S, 1991, J MATER SCI-MATER M, V2, P176, DOI 10.1007/BF00692977
   DOWNES S, 1995, J BIOMED MATER RES, V29, P1053, DOI 10.1002/jbm.820290905
   DOWNES S, 1992, BONE BONDING, P101
   DUBERNET C, 1987, INT J PHARM, V35, P145, DOI 10.1016/0378-5173(87)90083-4
   DUBERNETPRUDHON C, 1986, INT TECHNOL PHARM, V11, P173
   Dupraz A, 1996, J MATER SCI-MATER M, V7, P52, DOI 10.1007/BF00121190
   Ekholm M, 1999, J MATER SCI-MATER M, V10, P69, DOI 10.1023/A:1008912802263
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   ESPUELAS MS, 1995, 10 J SCI GTRV ANG DE
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P169, DOI 10.1023/A:1008937507714
   Gautier H, 2000, BIOMATERIALS, V21, P243, DOI 10.1016/S0142-9612(99)00139-8
   Gautier H, 1998, J BIOMED MATER RES, V40, P606, DOI 10.1002/(SICI)1097-4636(19980615)40:4<606::AID-JBM12>3.0.CO;2-D
   GILLARD J, 1998, P 2 WORLD M APGI APV, P359
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   GRIMANDI G, 1996, THESIS U NANTES FRAN
   Guicheux J, 1997, J BIOMED MATER RES, V34, P165, DOI 10.1002/(SICI)1097-4636(199702)34:2<165::AID-JBM4>3.0.CO;2-O
   Guzman M, 1996, J MICROENCAPSUL, V13, P25, DOI 10.3109/02652049609006801
   HUATAN H, 1995, J MICROENCAPSUL, V12, P557, DOI 10.3109/02652049509006786
   Itokazu M, 1998, BIOMATERIALS, V19, P817, DOI 10.1016/S0142-9612(97)00237-8
   Itokazu M, 1999, J MATER SCI-MATER M, V10, P249, DOI 10.1023/A:1008966314075
   Itokazu M, 1998, J BIOMED MATER RES, V39, P536, DOI 10.1002/(SICI)1097-4636(19980315)39:4<536::AID-JBM5>3.0.CO;2-K
   ITOKAZU M, 1994, J ORTHOP SURG, V2, P47
   Jameela SR, 1997, J BIOMAT SCI-POLYM E, V8, P457, DOI 10.1163/156856297X00380
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   LEGEROS RZ, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P3
   LEGEROS RZ, 1991, CALCIUM PHOSPHATES O, P3
   Lowry KJ, 1997, J BIOMED MATER RES, V36, P536
   MCDOUGALL KE, 1998, 14 EUR C BIOM THE HA
   Menei P, 1997, STP PHARMA SCI, V7, P53
   MENEI P, 1994, J BIOMED MATER RES, V28, P1079, DOI 10.1002/jbm.820280913
   MICLAU T, 1993, J ORTHOPAED RES, V11, P627, DOI 10.1002/jor.1100110503
   MOUSSET B, 1995, INT ORTHOP, V19, P157
   OTSUKA M, 1992, CHEM PHARM BULL, V40, P3346, DOI 10.1248/cpb.40.3346
   Pasquier G, 1996, J MATER SCI-MATER M, V7, P683, DOI 10.1007/BF00123407
   Radin S, 1997, BIOMATERIALS, V18, P777, DOI 10.1016/S0142-9612(96)00190-1
   REY C, 1990, Biomaterials, V11, P13
   RIPAMONTI U, 1992, MATRIX, V12, P202, DOI 10.1016/S0934-8832(11)80063-6
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   THIES C, 1952, MICROCAPSULES NANOPA, P48
   THIES C, 1981, INT J PHARM TECH PRO, V2, P25
   TOTH JM, 1991, J APPL BIOMATER, V2, P37, DOI 10.1002/jab.770020106
   UCHIDA A, 1992, J ORTHOPAED RES, V10, P440, DOI 10.1002/jor.1100100317
   Weiss P, 1999, BONE, V25, p67S, DOI 10.1016/S8756-3282(99)00146-5
   WEISS P, 1997, THESIS U NANTES FRAN
   Youan B. B. C., 1997, Journal of Controlled Release, V48, P339
   YU D, 1992, J PHARM SCI, V81, P529, DOI 10.1002/jps.2600810611
   1993, MAT CHIRURG DETERMIN
NR 66
TC 50
Z9 53
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2001
VL 22
IS 20
BP 2785
EP 2794
DI 10.1016/S0142-9612(01)00022-9
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 466CR
UT WOS:000170627200010
PM 11545313
DA 2018-10-19
ER

PT J
AU Solchaga, LA
   Goldberg, VM
   Caplan, AI
AF Solchaga, LA
   Goldberg, VM
   Caplan, AI
TI Cartilage regeneration using principles of tissue engineering
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID ARTICULAR-CARTILAGE; HYALURONIC-ACID; REPAIR; DEFECTS; CELLS; BONE;
   CHONDROGENESIS; CULTURE; TRANSPLANTATION; DIFFERENTIATION
AB It is well known that articular cartilage in adults has a limited ability for self-repair. Numerous methods have been devised to augment its natural heating response, but these methods generally lead to filling of the defect with fibrous tissue or fibrocartilage, which lacks the mechanical characteristics of articular cartilage and fails with time. Recently, tissue engineering has emerged as a new discipline that amalgamates aspects from biology, engineering, materials science, and surgery and that has as a goal the fabrication of functional new tissues to replace damaged tissues. The emergence of tissue engineering has facilitated the generation of new concepts and the revival of old ideas all of which has allowed a fresh approach to the repair or regeneration of tissues such as cartilage. The collaborations between scientists with different backgrounds and expertise has allowed the identification of some key principles that serve as the basis for the development of therapeutic approaches that now are less empiric and more hypothesis-driven than ever before. The current authors review some of the considerations regarding the various models used to test and validate the above repair methods and to address different aspects of the cartilage repair paradigm. Also, some key principles identified from past and current research, the need for the development of new biomaterials, and considerations in scale-up of cell-biomaterial constructs are summarized.
C1 Case Western Reserve Univ, Dept Orthopaed, Sch Med, Cleveland, OH 44106 USA.
   Univ Hosp Cleveland, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biol, Skeletal Res Ctr, Cleveland, OH 44106 USA.
RP Goldberg, VM (reprint author), Case Western Reserve Univ, Dept Orthopaed, Sch Med, 11100 Euclid Ave, Cleveland, OH 44106 USA.
OI Caplan, Arnold/0000-0002-8677-6621
CR AMIEL D, 1985, J BONE JOINT SURG AM, V67A, P911, DOI 10.2106/00004623-198567060-00013
   Buckwalter J A, 1997, Iowa Orthop J, V17, P1
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Caplan A I, 1999, Clin Orthop Relat Res, pS12, DOI 10.1097/00003086-199910001-00003
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429
   CAPLAN AI, 1983, SCIENCE, V221, P921, DOI 10.1126/science.6348946
   Caplan AI, 2000, TISSUE ENG, V6, P1, DOI 10.1089/107632700320838
   CAPLAN AI, 1986, BIOESSAYS, V5, P129, DOI 10.1002/bies.950050309
   Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7
   Dennis J E, 1992, Cell Transplant, V1, P23
   FEINBERG RN, 1983, SCIENCE, V220, P1177, DOI 10.1126/science.6857242
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Goldberg VM, 1998, J SPORT TRAUMATOL, V20, P81
   GOLDBERG VM, 1999, SEMIN ARTHROPLASTY, V10, P30
   GRANDE DA, 1987, ANAT REC, V218, P142, DOI 10.1002/ar.1092180208
   HUIBREGTSE BA, 1998, T ORTHOP RES SOC, V23, P796
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   KUJAWA MJ, 1986, DEV BIOL, V114, P504, DOI 10.1016/0012-1606(86)90214-9
   KUJAWA MJ, 1986, DEV BIOL, V114, P519, DOI 10.1016/0012-1606(86)90215-0
   LINSENMA.TF, 1973, DEV BIOL, V35, P232, DOI 10.1016/0012-1606(73)90020-1
   Mankin HJ, 1996, J BONE JOINT SURG AM, V78A, P1
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   MAOR G, 1989, ENDOCRINOLOGY, V125, P1239, DOI 10.1210/endo-125-3-1239
   MITCHELL N, 1976, J BONE JOINT SURG AM, V58, P230, DOI 10.2106/00004623-197658020-00012
   O'Driscoll SW, 1998, J BONE JOINT SURG AM, V80A, P1795, DOI 10.2106/00004623-199812000-00011
   ROBINSON D, 1990, CALCIFIED TISSUE INT, V46, P246, DOI 10.1007/BF02555003
   Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Solchaga LA, 2000, J ORTHOP RES, V18, P773, DOI 10.1002/jor.1100180515
   Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x
   VACANTI JP, 1999, LANCET S1, V354, pS132
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Walsh CJ, 1999, TISSUE ENG, V5, P327, DOI 10.1089/ten.1999.5.327
   WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582
   Wei XC, 1997, J BIOMED MATER RES, V34, P63, DOI 10.1002/(SICI)1097-4636(199701)34:1<63::AID-JBM9>3.0.CO;2-L
   Wennberg JE, 1996, DARTMOUTH ATLAS HLTH, P113
   WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
NR 45
TC 68
Z9 70
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD OCT
PY 2001
IS 391
SU S
BP S161
EP S170
PG 10
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 483GD
UT WOS:000171624500016
PM 11603701
DA 2018-10-19
ER

PT J
AU Nygren, H
   Broberg, M
   Eriksson, C
   Sahlin, H
   Yahyapour, N
AF Nygren, H
   Broberg, M
   Eriksson, C
   Sahlin, H
   Yahyapour, N
TI The respiratory burst response of surface-adhering leukocytes. A key to
   tissue engineering
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Review
DE biomaterials; cellular signalling pathways; extra/intracellular redox
   states; respiratory burst response; surface-adhering leukocytes
ID CELL-FREE SYSTEM; FC-GAMMA-RIIIB; HUMAN POLYMORPHONUCLEAR LEUKOCYTES;
   DEPENDENT SUPEROXIDE PRODUCTION; RECEPTOR-MEDIATED PHAGOCYTOSIS;
   TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; HUMAN-NEUTROPHILS; NADPH-OXIDASE;
   TYROSINE PHOSPHORYLATION
AB Biomaterials implanted into tissue will participate in the complex signalling between cells during wound healing. Recent studies have revealed that crucial cellular signalling pathways are regulated by the extra- and intracellular redox states and that reactive oxygen species function as intercellular signal molecules. Biomaterials have been shown to affect the respiratory burst response of surface-adhering leukocytes, thus interfering with major regulatory functions of cells also in surrounding tissues. The respiratory burst of surface-adhering leukocytes may thus be a key event in the understanding of biomaterial interaction with tissues, and the aim of this review is to highlight this field of research. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Gothenburg, Inst Anat & Cell Biol, Dept Appl Cell Biol, SE-40530 Gothenburg, Sweden.
EM hakan.nygren@anatcell.gu.se
CR AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   Babior BM, 1999, BLOOD, V93, P1464
   BACUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141
   BAIER RE, 1982, J BIOMECH ENG-T ASME, V104, P257, DOI 10.1115/1.3138358
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   BEUTH J, 1990, INFECTION, V18, P36, DOI 10.1007/BF01644181
   Blouin E, 1999, EUR J IMMUNOL, V29, P3419, DOI 10.1002/(SICI)1521-4141(199911)29:11<3419::AID-IMMU3419>3.3.CO;2-T
   BRASH JL, 1987, ANN NY ACAD SCI, V516, P206, DOI 10.1111/j.1749-6632.1987.tb33043.x
   BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2
   BROMBERG Y, 1985, J BIOL CHEM, V260, P3539
   Bulkley GB, 1997, BIOCHEM SOC T, V25, P804, DOI 10.1042/bst0250804
   Cario E, 1999, SCAND J GASTROENTERO, V34, P485, DOI 10.1080/003655299750026218
   Chambers RC, 1998, BIOCHEM J, V333, P121, DOI 10.1042/bj3330121
   Coffer PJ, 1998, BIOCHEM J, V329, P121
   DAHINDEN CA, 1983, J CLIN INVEST, V72, P113, DOI 10.1172/JCI110948
   De La Cruz C, 1998, J SURG RES, V80, P28, DOI 10.1006/jsre.1998.5262
   DELLABIANCA V, 1993, J LEUKOCYTE BIOL, V53, P427
   Demaurex N, 1996, J CELL BIOL, V133, P1391, DOI 10.1083/jcb.133.6.1391
   Edwards SW, 1997, ANN NY ACAD SCI, V832, P341, DOI 10.1111/j.1749-6632.1997.tb46262.x
   ElBenna J, 1996, ARCH BIOCHEM BIOPHYS, V334, P395
   English D, 1996, CELL SIGNAL, V8, P341, DOI 10.1016/0898-6568(95)00076-3
   Eriksson C, 2001, J LAB CLIN MED, V137, P56, DOI 10.1067/mlc.2001.111470
   ERIKSSON C, IN PRESS J LAB CLIN
   Exton JH, 1997, PHYSIOL REV, V77, P303
   Fernandez R, 1998, J IMMUNOL, V160, P5154
   FUORTES M, 1993, J CELL BIOL, V120, P777, DOI 10.1083/jcb.120.3.777
   GARNOTEL R, 1995, J BIOL CHEM, V270, P27495, DOI 10.1074/jbc.270.46.27495
   Glaser K B, 1990, Adv Exp Med Biol, V275, P1
   GOLDSTEIN IM, 1975, J CLIN INVEST, V56, P1155, DOI 10.1172/JCI108191
   Gorodetsky R, 1998, J LAB CLIN MED, V131, P269, DOI 10.1016/S0022-2143(98)90100-7
   GRESHAM HD, 1990, J BIOL CHEM, V265, P7819
   GRETZER C, 2000, THESIS GOTEBORG U
   HIDAKA H, 1996, ADV PHARM, V36
   Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891
   HORBETT TA, 1982, ADV CHEM SER, P233
   HYSLOP PA, 1995, FREE RADICAL BIO MED, V19, P31, DOI 10.1016/0891-5849(95)00005-I
   Inanami O, 1998, J BIOL CHEM, V273, P9539, DOI 10.1074/jbc.273.16.9539
   INDIK ZK, 1995, BLOOD, V86, P4389
   JabrilCuenod B, 1996, J BIOL CHEM, V271, P16268, DOI 10.1074/jbc.271.27.16268
   JESAITIS AJ, 1990, J CLIN INVEST, V85, P821, DOI 10.1172/JCI114509
   JOHANSSON A, 1995, CELL IMMUNOL, V161, P61, DOI 10.1006/cimm.1995.1009
   JOHNSTON RB, 1976, J CLIN INVEST, V57, P836, DOI 10.1172/JCI108359
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   KASAMA T, 1989, CLIN IMMUNOL IMMUNOP, V53, P439, DOI 10.1016/0090-1229(89)90006-8
   Kaul N, 1998, FREE RADICAL BIO MED, V24, P202, DOI 10.1016/S0891-5849(97)00209-8
   LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7
   Lofgren R, 1999, BBA-MOL CELL RES, V1452, P46, DOI 10.1016/S0167-4889(99)00112-3
   MACKENZIE SJ, 1995, BIOCHEM J, V306, P519, DOI 10.1042/bj3060519
   Madesh M, 1997, ARCH BIOCHEM BIOPHYS, V346, P187, DOI 10.1006/abbi.1997.0288
   Matsuo T, 1996, BIOCHEM J, V315, P505, DOI 10.1042/bj3150505
   MCPHAIL LC, 1983, J CLIN INVEST, V72, P192, DOI 10.1172/JCI110957
   METINKO AP, 1992, J CLIN INVEST, V90, P791, DOI 10.1172/JCI115953
   MILLER RA, 1995, J INVEST MED, V43, P39
   Model MA, 1998, IMMUNOBIOLOGY, V199, P39, DOI 10.1016/S0171-2985(98)80062-4
   MOLLINEDO F, 1993, FEBS LETT, V326, P209, DOI 10.1016/0014-5793(93)81792-X
   Movitz C, 1997, INFLAMMATION, V21, P531, DOI 10.1023/A:1027363730746
   Muller M, 1997, PROSTAGLANDINS, V54, P493, DOI 10.1016/S0090-6980(97)00060-9
   Muszbek L, 1999, THROMB RES, V94, P271, DOI 10.1016/S0049-3848(99)00023-7
   Nakamura R, 1998, EUR J BIOCHEM, V251, P583, DOI 10.1046/j.1432-1327.1998.2510583.x
   NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341
   Nick JA, 1997, J CLIN INVEST, V99, P975, DOI 10.1172/JCI119263
   Nisimoto Y, 1997, J BIOL CHEM, V272, P18834, DOI 10.1074/jbc.272.30.18834
   Nygren H, 1998, J BIOMAT SCI-POLYM E, V9, P817, DOI 10.1163/156856298X00172
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   NYGREN H, 1982, ACTA PHYSIOL SCAND, V116, P201, DOI 10.1111/j.1748-1716.1982.tb07130.x
   Nygren H, 1999, J BIOMED MATER RES, V45, P117
   OCLURA M, 1998, AM SOC NEPHR 31 ANN, pA429
   Park JW, 1998, EXP HEMATOL, V26, P37
   Rane MJ, 1997, J IMMUNOL, V159, P5070
   RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325
   Reilly TJ, 1996, J BIOL CHEM, V271, P10973, DOI 10.1074/jbc.271.18.10973
   Sakane F, 1997, INT J BIOCHEM CELL B, V29, P1139, DOI 10.1016/S1357-2725(97)00037-X
   SALMON JE, 1995, J CLIN INVEST, V95, P2877, DOI 10.1172/JCI117994
   Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2
   STOCKL J, 1995, J IMMUNOL, V154, P5452
   Stocum DL, 1999, CURR BIOL, V9, pR644, DOI 10.1016/S0960-9822(99)80413-8
   Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522
   Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4
   Thelen M, 1997, ANN NY ACAD SCI, V832, P368, DOI 10.1111/j.1749-6632.1997.tb46265.x
   Tilton B, 1997, J BIOL CHEM, V272, P28096, DOI 10.1074/jbc.272.44.28096
   TURNER NC, 1994, EUR RESPIR J, V7, P934
   VROMAN L, 1980, BLOOD, V55, P156
   Williams MA, 1999, J LEUKOCYTE BIOL, V65, P725
   Wymann MP, 2000, IMMUNOL TODAY, V21, P260, DOI 10.1016/S0167-5699(00)01649-2
   YAN SR, 1995, J LEUKOCYTE BIOL, V58, P595
   ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407
   Zu YL, 1998, J IMMUNOL, V160, P1982
NR 90
TC 10
Z9 11
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT
PY 2001
VL 22
IS 2
BP 87
EP 97
DI 10.1016/S0927-7765(00)00216-2
PG 11
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 509TB
UT WOS:000173164800001
DA 2018-10-19
ER

PT J
AU Minamide, A
   Tamaki, T
   Yoshida, M
   Hashizume, H
   Nakagawa, Y
AF Minamide, A
   Tamaki, T
   Yoshida, M
   Hashizume, H
   Nakagawa, Y
TI The use of sintered bone in spinal surgery
SO EUROPEAN SPINE JOURNAL
LA English
DT Article
DE animal model; biomaterials; biomechanics; sintered bone; spinal fusion
ID BOVINE BONE; OSTEOPOROSIS
AB The sintered bovine bone True Bone Ceramics (TBC) is one of the biomaterials based on calcium phosphate, an organized crystal of bone mineral and a biomaterial possessing a natural trabecular structure. We examined whether the sintered bovine bone can integrate with recipient bone and adjust to the strength of recipient bone for anterior spinal fusion in an animal model. Based on radiographic evaluation, manual palpation, biomechanical testing, and histological examination, spinal fusion with TBC resulted in a composition and structure similar to that of autograft (and to no implantation). TBC, with its moderate strength, tended to adjust to the bone stiffness of the host bone in the respective specimens as new bone growth developed. Our observations warrant further clinical investigation of the use of sintered bone as an effective spinal arthrodesis, especially in patients who have fragile vertebrae, as in osteoporosis.
C1 Wakayama Med Coll, Dept Orthopaed Surg, Wakayama 6418157, Japan.
RP Minamide, A (reprint author), Wakayama Med Coll, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6418157, Japan.
CR ABUMI K, 1998, RINSHO SEIKEIGEKA, V33, P495
   Hashizume H, 1998, J Orthop Sci, V3, P42, DOI 10.1007/s007760050020
   KANEDA K, 1992, SPINE S, V17, P295
   KATOH T, 1993, CLIN ORTHOP RELAT R, P266
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   LEONG JCY, 1994, CLIN ORTHOP RELAT R, P52
   Matsumoto T, 1999, J ORTHOP RES, V17, P586, DOI 10.1002/jor.1100170419
   Minamide A, 2000, J SPINAL DISORD, V13, P156, DOI 10.1097/00002517-200004000-00011
   Myers ER, 1997, SPINE, V22, p25S, DOI 10.1097/00007632-199712151-00005
   Nibu K, 1997, J SPINAL DISORD, V10, P357
   SHIKATA J, 1990, SPINE, V15, P485, DOI 10.1097/00007632-199006000-00010
   TAMAKI T, 1994, BONE GRAFTS, DERIVATIVES AND SUBSTITUTES, P235
   UENO Y, 1985, BESSATSU SEIKEIGEKA, V8, P85
NR 13
TC 6
Z9 7
U1 0
U2 2
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0940-6719
J9 EUR SPINE J
JI Eur. Spine J.
PD OCT
PY 2001
VL 10
SU 2
BP S185
EP S188
DI 10.1007/s005860100274
PG 4
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 488MA
UT WOS:000171937900015
PM 11716017
OA Green Published
DA 2018-10-19
ER

PT J
AU Granados, DL
   Jimenez, A
   Cuadrado, TR
AF Granados, DL
   Jimenez, A
   Cuadrado, TR
TI Assessment of parameters associated to the risk of PVC catheter reuse
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE catheter; catheter reprocessing; poly(vinyl chloride); reuse risk
   factors
ID SUPERCRITICAL-FLUID EXTRACTION; POLY(VINYL CHLORIDE); PLASTICIZER;
   INFECTION
AB The practice of single use devices (SUD) recycling raises public health concerns, primarily with regard to the potential risks of infection and device malfunction. These concerns have led to a Food and Drug Administration (FDA) revision of the present regulations. The purpose of our work is to identify different material parameters that could contribute to the health risks associated with the practice of reprocessing PVC catheters for use in other patients. Ethylene oxide hospital-reprocessed central venous Catheter samples were obtained from the stock of a health-care institution. One device trademark was selected, and samples that had been used 8 and 24 times were compared with new ones. In order to determine the total percentage of extractables, supercritical fluid extraction (SFE) was used, and off-line gas-chromatography-flame-ionization detection (GC-FID) was employed for identification and quantitation of bis-(2-ethyl hexil)phthalate (DEHP). Storage modulus (E ') and dissipation factor (tan delta curves were obtained by dynamic mechanical analysis (DMA). Successive catheter recycles produced increased plasticizer loss, increased glass transition temperature (T-g) and E ', widening of tan delta curve with a simultaneous shift to higher temperature, small decrease of weight average molecular weight (M-w), increased surface roughness, and increased appearance of surface grooves (severe damage). The magnitude of biomaterial parameter changes measured suggests that reuse could alter the original device performance. Examples of possible adverse clinical events include leaching of toxic agents, device rigidization or breakage, increased catheter protein retention, or the promotion of bacterial adhesion by device topography modification. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Mar del Plata, Natl Res Council, Inst Mat Sci & Technol, RA-7600 Mar Del Plata, Argentina.
   Natl Univ San Juan, Inst Chem Engn, RA-5400 Oeste, San Juan, Argentina.
   Univ Alicante, Dept Analyt Chem, E-03080 Alicante, Spain.
RP Cuadrado, TR (reprint author), Univ Mar del Plata, Natl Res Council, Inst Mat Sci & Technol, Juan B Justo 4302, RA-7600 Mar Del Plata, Argentina.
RI Jimenez, Alfonso/L-2211-2014
OI Jimenez, Alfonso/0000-0003-1043-6759
CR Abraham GA, 1997, J APPL POLYM SCI, V65, P1193, DOI 10.1002/(SICI)1097-4628(19970808)65:6<1193::AID-APP15>3.0.CO;2-V
   ALAVA JI, 2000, P BIOAV 2000 FIRST C, P75
   Collins J L, 1991, Oncol Nurs Forum, V18, P819
   DUMITRIU S, 1994, POLYM BIOMATERIALS, pCH1
   Goetz AM, 1998, INFECT CONT HOSP EP, V19, P842
   HEINRICH J, 2000, SINGLE USE MED DEVIC, P1
   HERMANSON N, 1991, SOC PLAST ENG MED RE
   HERMANSON NJ, 1997, MED DEVICE DIAGN AUG, P1
   Jayakrishnan K, 1998, NATURE, V396, P638
   Lakshmi S, 1998, POLYMER, V39, P151, DOI 10.1016/S0032-3861(97)00244-9
   LEROUGE S, 1999, 25 ANN M T SOC BIOM, P195
   MA N, 2000, T 6 WORLD BIOM C, P37
   Maki DG, 1997, ANN INTERN MED, V127, P257, DOI 10.7326/0003-4819-127-4-199708150-00001
   Marin ML, 1998, J SUPERCRIT FLUID, V12, P271, DOI 10.1016/S0896-8446(98)00086-2
   Marin ML, 1996, J CHROMATOGR A, V750, P183, DOI 10.1016/0021-9673(96)00393-7
   MCALLISTER EW, 1993, GASTROINTEST ENDOSC, V39, P422, DOI 10.1016/S0016-5107(93)70120-0
   Raad II, 1997, INFECT CONT HOSP EP, V18, P227
   RAAD II, 1996, INFECT MED, V13, P807
   STOERMER WB, 1999, MED DEVICE DIAGN IND, V21, P38
   STUDERVANT M, 1990, SOC PLAST ENG ANN C
   Szycher M., 1991, BLOOD COMPATIBLE MAT
   Wickham R, 1992, Semin Oncol Nurs, V8, P133, DOI 10.1016/0749-2081(92)90029-3
   Yin HQ, 1999, J MATER SCI-MATER M, V10, P527, DOI 10.1023/A:1008912213420
NR 23
TC 10
Z9 11
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2001
VL 58
IS 5
BP 505
EP 510
DI 10.1002/jbm.1047
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472VR
UT WOS:000171006100005
PM 11505424
DA 2018-10-19
ER

PT J
AU Verdonschot, N
   van Hal, CTH
   Schreurs, BW
   Buma, P
   Huiskes, R
   Slooff, TJJH
AF Verdonschot, N
   van Hal, CTH
   Schreurs, BW
   Buma, P
   Huiskes, R
   Slooff, TJJH
TI Time-dependent mechanical properties of HA/TCP particles in relation to
   morsellized bone grafts for use in impaction grafting
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE total hip replacement; revision; biomaterials; mechanical testing
ID ALLOGRAFTS
AB In reconstructive surgery human bone defects are sometimes filled with the use of the impaction bone grafting technique. Currently different types of biomaterial particles are being developed as bone-substitute materials. Before these biomaterials can be applied their mechanical and biological behavior should be characterized. In this study the time-dependent mechanical behavior of biomaterial particles with different tri-calcium-phosphate/hydroxy-apatite (TCP:HA) ratios, particle sizes, and porosities is determined and compared to the behavior of human bone grafts, the latter being the standard material currently used to augment bone defects. The mechanical properties were assessed with the use of dynamic confined compression creep tests with a loading and unloading phase. Different graft material groups were tested, consisting of 100% human bone grafts, 100% biomaterial particles, and 50:50 weight mixtures of human grafts and biomaterial particles. No damage to the particles was observed by the impaction in the test chamber or by the dynamic load. Relative to the human graft material, the biomaterial particles hardly deformed under loading, were much stiffer, and showed almost no viscoelastic behavior. The mixtures showed intermediate results. Particle size and porosity influenced the behavior of the biomaterial particles. TCP:HA ratio did not have a great effect. The conclusion is that the application of these particles should be done with great care, as their mechanical behavior is drastically different than that of the human graft material. Mixing it with human bone grafts gave the material some biphasic, viscoelastic behavior that may be important for its biological response. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Nijmegen, Orthopaed Res Lab, Ctr Med, NL-6500 HB Nijmegen, Netherlands.
RP Verdonschot, N (reprint author), Univ Nijmegen, Orthopaed Res Lab, Ctr Med, POB 9101, NL-6500 HB Nijmegen, Netherlands.
RI Verdonschot, N.J.J./H-8104-2014; Schreurs, B.W./L-4639-2015; Buma,
   P./H-8019-2014; Buma, Pieter/C-9828-2013
CR DALSTRA M, 1995, J BIOMECH, V28, P715, DOI 10.1016/0021-9290(94)00125-N
   DUNLOP DG, 2000, J BONE JOINT SU B S1, V82, P78
   Eldridge JDJ, 1997, J BONE JOINT SURG BR, V79, P364
   GIE GA, 1993, J BONE JOINT SURG BR, V75, P14
   Giesen EBW, 1999, J BONE JOINT SURG BR, V81B, P1052, DOI 10.1302/0301-620X.81B6.8742
   KANG JD, 1991, J BONE JOINT SURG AM, V73A, P93, DOI 10.2106/00004623-199173010-00012
   KUIPER JH, 1998, T EORS, V8, P60
   MOORE DC, 1987, J ORTHOP RES, V5, P356, DOI 10.1002/jor.1100050307
   OHASHI H, 1999, T ORS
   Schreurs BW, 1998, J BONE JOINT SURG BR, V80B, P391, DOI 10.1302/0301-620X.80B3.8534
   Ullmark G, 1999, J ARTHROPLASTY, V14, P1019, DOI 10.1016/S0883-5403(99)90019-0
   VERDONSCHOT N, 1999, T ORS, V24, P867
   Voor MJ, 2000, J BIOMECH, V33, P1683, DOI 10.1016/S0021-9290(00)00156-1
   Wallace IW, 1997, J BONE JOINT SURG BR, V79, P366
   WEINANS H, 1992, J ORTHOPAED RES, V10, P845, DOI 10.1002/jor.1100100614
NR 15
TC 51
Z9 53
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2001
VL 58
IS 5
BP 599
EP 604
DI 10.1002/jbm.1058
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472VR
UT WOS:000171006100016
PM 11505435
DA 2018-10-19
ER

PT J
AU Branda, F
   Costantini, A
   Luciani, G
   Ambrosio, L
AF Branda, F
   Costantini, A
   Luciani, G
   Ambrosio, L
TI Improvement of swelling properties of poly(2-hydroxyethyl methacrylate)
   hydrogel by means of biomimetic method
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE poly(2-hydroxyethyl methacrylate); swelling; biomimetic method;
   thermogravimetric analysis
ID HYDROXYAPATITE
AB Poly(2-hydroxyethyl methacrylates) (PHEMAs) structurally modified by means of polymer blends and ran dom copolymers are intensively studied in order to improve mechanical properties. It was recently shown that a hydroxyapatite coating, which should improve the bonding of this biomaterial to the bone, can be obtained by means of the biomimetic method. When PHEMA is submitted to the biomimetic method, its swelling ratio is improved. This can be ascribed to the deposition of a silicatic layer, which improves the hydrophilicity, on the surface of the internal pores during the first stage of the method. This appears to be a valuable result for producing modified PHEMAs with improved mechanical properties and good swelling. The experimental results indicate the following: stronger interactions with the water molecules are set up, an induction period is observed that is linked to the rate of the reactions occurring at the surface of the glass and the establishment of a convenient concentration of the silicate ions at the external surface of the polymer, and the diffusion of simulated body fluid into the pores is the limiting stage of the process. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Naples Federico II, Dipartimento Ingn Mat & Prod, I-80125 Naples, Italy.
   Univ Naples Federico II, Ist Tecnol Mat Compositi, CNR, I-80125 Naples, Italy.
   Univ Naples Federico II, Ctr Interdipartimentale Ric Biomat, I-80125 Naples, Italy.
RP Branda, F (reprint author), Univ Naples Federico II, Dipartimento Ingn Mat & Prod, Piazzale Tecchio 80, I-80125 Naples, Italy.
OI AMBROSIO, LUIGI/0000-0002-8367-2405
CR Branda F, 1999, J MATER SCI, V34, P1319, DOI 10.1023/A:1004550131705
   DAVIS PA, 1991, HIGH PERFORMANCE BIO, P343
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   KOKUBO T, P 16 INT C GLASS MAD, V1, P113
   Kokubo T, 1991, BIOCERAMICS, V4, P113
   NETTI PA, 1993, BIOMATERIALS, V14, P14
   Paul A., 1990, CHEM GLASSES
   Peppas N. A., 1987, HYDROGELS MED PHARM, V1-3
   Rawson H., 1980, PROPERTIES APPL GLAS
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P19, DOI 10.1163/156856299X00252
   TANAHASHI M, 1995, J MATER SCI-MATER M, V6, P319, DOI 10.1007/BF00120299
   Tanahashi M., 1992, BIOCERAMICS, P57
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
NR 13
TC 12
Z9 12
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2001
VL 57
IS 1
BP 79
EP 83
DI 10.1002/1097-4636(200110)57:1<79::AID-JBM1144>3.0.CO;2-6
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 452DY
UT WOS:000169842900011
PM 11416852
DA 2018-10-19
ER

PT J
AU Clarke, SA
   Revell, PA
AF Clarke, SA
   Revell, PA
TI Integrin expression at the bone/biomaterial interface
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE integrins; interface; wear debris; aseptic loosening; transmigration
ID CELL-ADHESION MOLECULES; HUMAN ENDOTHELIAL-CELLS; ORTHOPEDIC IMPLANTS;
   RHEUMATOID-ARTHRITIS; ALPHA-V; EXTRACELLULAR-MATRIX; IN-VITRO; RECEPTOR;
   LIGANDS; LAYER
AB The aim of this study was to visualize integrin expression by cells in interface tissue in relation to their ligands. Tissue samples were obtained from 25 patients undergoing revision of aseptically loose total joint replacements. Serial sections were immunolabeled for the integrins alpha (2)beta (1) alpha (v)beta (3), alpha (4)beta (1) alpha (L)beta (2) (CD11a), alpha (M)beta (2) (CD11b), and alpha (x)beta (2) (CD11c), and the ligands fibronectin, laminin, vitronectin, intercellular adhesion molecule-1, and vascular adhesion molecule-1. Most cells were found to express alpha (2)beta (1) most macrophages and giant cells expressed CD11b, and the majority of CD11a was found on perivascular T lymphocytes. From the small amount of alpha (4)beta (1) and vascular adhesion molecule-1 expression in the interface tissue and the combination of CD11a, CD11b, and intercellular adhesion molecule-1 expression, it would seem that macrophages use beta (2) integrins to transmigrate. (C) 2001 John Wiley & Sons, Inc.
C1 Addenbrookes Hosp, Orthopaed Res Unit, Cambridge CB2 2QQ, England.
   UCL Royal Free & Univ Coll Med Sch, Interdisciplinary Res Ctr Biomed Mat, London NW3 2PF, England.
RP Clarke, SA (reprint author), Addenbrookes Hosp, Orthopaed Res Unit, Box 180,Hills Rd, Cambridge CB2 2QQ, England.
EM sac42@cam.ac.uk
CR AlSaffar N, 1996, AM J CLIN PATHOL, V105, P628
   ALSAFFAR N, 1994, J MATER SCI-MATER M, V5, P813, DOI 10.1007/BF00213140
   AlSaffar N, 1997, J MATER SCI-MATER M, V8, P641, DOI 10.1023/A:1018575504518
   ALSAFFAR N, 1995, ANN RHEUM DIS, V54, P201, DOI 10.1136/ard.54.3.201
   ARNAOUT MA, 1990, BLOOD, V75, P1037
   Aspenberg P, 1996, J BONE JOINT SURG BR, V78B, P641
   BARBADILLO C, 1995, SPRINGER SEMIN IMMUN, V16, P427
   BENTON LD, 1993, SURG GYNECOL OBSTET, V177, P311
   BROWN EJ, 1995, BIOESSAYS, V17, P109, DOI 10.1002/bies.950170206
   CARLOS T, 1991, BLOOD, V77, P2266
   CHEN D, 1992, J BIOL CHEM, V267, P23502
   DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D
   ElGabalawy H, 1996, ARTHRITIS RHEUM-US, V39, P1913, DOI 10.1002/art.1780391119
   ELICES MJ, 1995, CIBA F SYMP, V189, P79
   Featherstone C, 1996, LANCET, V347, P1106, DOI 10.1016/S0140-6736(96)90297-4
   HAAS TA, 1994, CURR OPIN CELL BIOL, V6, P656, DOI 10.1016/0955-0674(94)90091-4
   Hammes HP, 1996, NAT MED, V2, P529, DOI 10.1038/nm0596-529
   HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053
   HENCH L, 1994, BONE BIOMATERIAL INT, P33
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   IWAKI H, 1999, T 45 ANN M ORTH RES
   JASTY M, 1984, T ORTHOP RES SOC, V9, P125
   KIM KJ, 1993, CLIN ORTHOP RELAT R, P142
   Kubota Y, 1996, J DERMATOL SCI, V12, P36, DOI 10.1016/0923-1811(95)00462-9
   LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x
   LUSCINSKAS FW, 1994, FASEB J, V8, P929
   MALCHAU H, 1998, 65 AADS M 1998 FEB 1, P595
   Mohanty M, 1996, BIO-MED MATER ENG, V6, P165
   MONDAL K, 1995, BIOCHEM SOC T, V23, P460, DOI 10.1042/bst0230460
   MullerLadner U, 1997, J RHEUMATOL, V24, P1873
   MYONES BL, 1988, J CLIN INVEST, V82, P640, DOI 10.1172/JCI113643
   Newham P, 1996, MOL MED TODAY, V2, P304, DOI 10.1016/1357-4310(96)10021-6
   NIKKARI L, 1995, J RHEUMATOL, V22, P16
   PACIFICI R, 1994, J IMMUNOL, V153, P2222
   Polak JM, 1986, IMMUNOCYTOCHEMISTRY
   POLLOCK LE, 1990, RHEUMATOL INT, V9, P277, DOI 10.1007/BF00541324
   QUINN JMW, 1991, HISTOCHEMISTRY, V96, P169, DOI 10.1007/BF00315989
   Rankin SM, 2000, MOL MED TODAY, V6, P20, DOI 10.1016/S1357-4310(99)01635-4
   REVELL P, 1994, BONE BIOMATERIAL INT, P438
   Revell PA, 1997, P I MECH ENG H, V211, P187, DOI 10.1243/0954411971534304
   REVELL PA, 1995, ANN RHEUM DIS, V54, P404, DOI 10.1136/ard.54.5.404
   REVELL PA, 1995, BIOCERAMICS, V8, P11
   Rinaldi N, 1997, ANN RHEUM DIS, V56, P729, DOI 10.1136/ard.56.12.729
   RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957
   RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   RYAN US, 1992, CURR OPIN IMMUNOL, V4, P33, DOI 10.1016/0952-7915(92)90120-4
   Samanen J, 1997, CURR PHARM DESIGN, V3, P545
   Sjaastad MD, 1997, BIOESSAYS, V19, P47, DOI 10.1002/bies.950190109
   SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9
   VanderVieren M, 1995, IMMUNITY, V3, P683, DOI 10.1016/1074-7613(95)90058-6
   WEBER C, 1995, BIOCHEM BIOPH RES CO, V206, P621, DOI 10.1006/bbrc.1995.1088
   Xu JW, 1996, CLIN EXP RHEUMATOL, V14, P643
NR 54
TC 13
Z9 13
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2001
VL 57
IS 1
BP 84
EP 91
DI 10.1002/1097-4636(200110)57:1<84::AID-JBM1145>3.0.CO;2-5
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 452DY
UT WOS:000169842900012
PM 11416853
DA 2018-10-19
ER

PT J
AU Gao, TJ
   Uludag, H
AF Gao, TJ
   Uludag, H
TI Effect of molecular weight of thermoreversible polymer on in vivo
   retention of rhBMP-2
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE thermoreversible polymers; recombinant human bone morphogenetic
   protein-2; molecular weight; in vivo retention; gel microstructure
ID RAT ECTOPIC MODEL; N-ISOPROPYLACRYLAMIDE; BIOMATERIAL CARRIERS;
   IN-VITRO; PHARMACOKINETICS; PROTEINS; RELEASE
AB To investigate the effect of polymer molecular weight (MW) on rhBMP-2 delivery by thermoreversible polymers, four polymers with similar lower critical solution temperatures (20 degrees -22 degreesC) but different MWs were studied. Thermoreversible polymers were based on N-isopropyl-acrylamide (NiPAM), ethyl methacrylate (EMA), and N-acryloxvsuccinimide (NASI), and had MWs of either similar to 49 kDa or similar to 400 kDa. The NASI content was either 0 or 1-1.6%. High MW polymers, irrespective of their NASI content, formed a stable gel with significantly lower water uptake and exhibited a dense micelle with average pore size smaller than the low MW polymers. NiPAM/EMA polymers without NASI did not conjugate with recombinant human bone morphogenetic protein-2 (rhBMP-2). NiPAM/EMA polymers containing NASI, however, gave conjugation with rh-BMP-2. For polymers without NASI, a high MW was essential for rhBMP-2 retention when injected intramuscularly in Sprague-Dawley rats. For NASI-containing polymers, the MW of the polymer did not make a significant difference because rhBMP-2 retention was equivalent for different size polymers. We conclude that polymer MW affects rhBMP-2 retention in vivo in polymers designed for physical entrapment of rhBMP-2, but not in polymers designed for chemical conjugation with rhBMP-2. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Alberta, Fac Med, Dept Biomed Engn, Edmonton, AB T6G 2V2, Canada.
RP Gao, TJ (reprint author), Univ Alberta, Fac Med, Dept Biomed Engn, 1098 RTF Bldg, Edmonton, AB T6G 2V2, Canada.
CR Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   GAO TJ, IN PRESS BIOMATERIAL
   GAO TJ, 1996, BONE MORPHOGENETIC P, P121
   GAO TJ, IN PRESS MAT SCI ENG
   GRAESSLEY WW, 1986, POLYM SOLUTION, P145
   GUTOWSKA A, 1995, J BIOMED MATER RES, V29, P811, DOI 10.1002/jbm.820290705
   MIRON T, 1982, ANAL BIOCHEM, V126, P433, DOI 10.1016/0003-2697(82)90540-1
   PITT CG, 1995, J CONTROL RELEASE, V33, P397, DOI 10.1016/0168-3659(94)00098-F
   Ramkissoon-Ganorkar C, 1999, PHARMACEUT RES, V16, P819, DOI 10.1023/A:1018813700535
   Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Shah SS, 1997, J CONTROL RELEASE, V45, P95, DOI 10.1016/S0168-3659(96)01550-7
   Shimizu S, 1996, ARTIF ORGANS, V20, P1232
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2000, J APPL POLYM SCI, V75, P583, DOI 10.1002/(SICI)1097-4628(20000124)75:4<583::AID-APP15>3.0.CO;2-L
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   ULUDAG H, IN PRESS BIOTECHNOL
   ULUDAG H, 2000, DRUG DELIVERY 21ST C, P253
   Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   WOZNEY J, 1988, SCIENCE, V241, P1528
NR 24
TC 21
Z9 22
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2001
VL 57
IS 1
BP 92
EP 100
DI 10.1002/1097-4636(200110)57:1<92::AID-JBM1146>3.0.CO;2-1
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 452DY
UT WOS:000169842900013
PM 11416854
DA 2018-10-19
ER

PT J
AU Schierholz, JM
   Beuth, J
AF Schierholz, JM
   Beuth, J
TI Implant infections: a haven for opportunistic bacteria
SO JOURNAL OF HOSPITAL INFECTION
LA English
DT Review
DE implant infection; prevention; drug-delivery system; host defence
   mechanism
ID CENTRAL VENOUS CATHETER; FOREIGN-BODY INFECTION;
   STAPHYLOCOCCUS-EPIDERMIDIS; BIOMATERIAL INFECTION; NOSOCOMIAL
   INFECTIONS; ANTIBIOTICS; SURFACES; GROWTH; PATHOGENESIS; ADHESION
AB The insertion of implants and medical devices has emerged as a common and often life-saving procedure. A current estimate of the rate of total hip replacement in the world is approximately one million a year, and knee replacements more than 250 000. More than 30% of hospitalized patients have one or more vascular catheters in place. More than 10% of hospitalized patients have an indwelling urinary catheter. Some patients require multiple joint replacements. In the United States, approximately 2 million nosocomial infections cost nearly $11 billion annually. Exposure to invasive medical devices is one of the most important risk factors.' Devices predispose to infection by damaging or invading epithelial or mucosal barriers and by supporting growth of micro-organisms, thus serving as reservoirs. Invasive medical devices impair host defence mechanisms and, when contaminated, can result in resistant chronic infection or tissue necrosis, the major objections to extended use of implant devices. Implant devices today account for approximately 45% of all nosocomial infections.(2) Implant infections are extremely resistant to antibiotics and host defences and frequently persist until the implant is removed, which is the standard therapy. Tissue damage caused by surgery and foreign body implantation further increases the susceptibility to infections, activates host defences and stimulates the generation of inflammatory mediators; these are enhanced by bacterial activity and toxins.(3) The ability of bacteria such as Staphylococcus epidermidis, which are otherwise virtually avirulent, to escape from host defences and antibiotic therapy, has led to the development of alternative methods of control such as infection-resistant materials acting as antimicrobial drug-delivery systems. By these methods, there is a sustained delivery of antimicrobial drugs into the local micro-environment of implants, which avoids systemic side-effects and exceeds usual systemic concentrations by several orders of magnitude. Bioengineering of hybrid implant materials in order to achieve optimal performance and to prevent inflammatory reactions and interface cellular disorganization is a field undergoing rapid development. Biomimetic hybrid materials that slowly deliver antimicrobial drugs may reduce implant infections in the future. (C) 2001 The Hospital Infection Society.
C1 Caesar Ctr Adv European Studies & Res, D-53111 Bonn, Germany.
   Univ Cologne, Inst Sci Evaluat Naturopathy, D-50931 Cologne, Germany.
RP Schierholz, JM (reprint author), Caesar Ctr Adv European Studies & Res, Friedenspl 16, D-53111 Bonn, Germany.
CR AHN SS, 1994, J VASC SURG, V20, P202, DOI 10.1016/0741-5214(94)90007-8
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BAIER RE, 1982, J BIOMECH ENG-T ASME, V104, P257, DOI 10.1115/1.3138358
   BAMBERGER DM, 1990, J INFECT DIS, V162, P186, DOI 10.1093/infdis/162.1.186
   BERGAMINI TM, 1995, ARCH SURG-CHICAGO, V130, P1345
   BERGAMINI TM, 1988, J VASC SURG, V7, P21, DOI 10.1067/mva.1988.avs0070021
   Bouhadir KH, 1998, ANN NY ACAD SCI, V842, P188, DOI 10.1111/j.1749-6632.1998.tb09647.x
   CHRISTENSEN GD, 1990, J INFECT DIS, V161, P1153, DOI 10.1093/infdis/161.6.1153
   COOPER M, 1995, LIFE DEATH BIOFILM, P93
   Craven D E, 1996, Semin Respir Infect, V11, P32
   Eiselt P, 1998, BIOTECHNOL PROGR, V14, P134, DOI 10.1021/bp970135h
   Feldman C, 1999, EUR RESPIR J, V13, P546, DOI 10.1183/09031936.99.13354699
   Fridkin SK, 1996, INFECT CONT HOSP EP, V17, P150
   GARRISON JR, SOC U SURG 1995 37 A
   GOMER R, 1982, SCI AM, V247, P98, DOI 10.1038/scientificamerican0882-98
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   Haxhe JJ, 1998, J HOSP INFECT, V40, P166, DOI 10.1016/S0195-6701(98)90101-3
   Henke PK, 1997, J SURG RES, V69, P372, DOI 10.1006/jsre.1997.5088
   Henke PK, 1998, J SURG RES, V74, P17, DOI 10.1006/jsre.1997.5210
   Henke PK, 1997, ARCH SURG-CHICAGO, V132, P894
   Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552
   JOHNSON GM, 1986, INFECT IMMUN, V54, P13
   Kaplan S S, 1990, ASAIO Trans, V36, pM172
   KASCHKE O, 1995, HNO, V43, P80
   KLOCK JC, 1976, BLOOD, V48, P149
   Livermore D M, 1990, Scand J Infect Dis Suppl, V74, P15
   Loh J H, 1999, Med Device Technol, V10, P24
   MODUN B, 1992, INFECT IMMUN, V60, P2551
   Myrvik Q N, 1989, J Invest Surg, V2, P381, DOI 10.3109/08941938909018263
   NELSON CL, 1979, ARCH SURG-CHICAGO, V114, P778
   NOBLE MA, 1990, J INFECT DIS, V162, P909, DOI 10.1093/infdis/162.4.909
   NOONAN JR, 1986, SCIENCE, V234, P310, DOI 10.1126/science.234.4774.310
   OAKES JA, 1986, N ENGL J, V315, P1129
   RAAD I, 1997, ANN INTERN MED, V15, P1
   Sapatnekar S, 1997, J BIOMED MATER RES, V35, P409, DOI 10.1002/(SICI)1097-4636(19970615)35:4<409::AID-JBM1>3.0.CO;2-L
   Schierholz JM, 1999, J ANTIMICROB CHEMOTH, V43, P158, DOI 10.1093/jac/43.1.158
   Schierholz JM, 1998, ANTICANCER RES, V18, P3629
   Schierholz JM, 2000, J ANTIMICROB CHEMOTH, V46, P45, DOI 10.1093/jac/46.1.45
   Schierholz JM, 1997, BIOMATERIALS, V18, P839, DOI 10.1016/S0142-9612(96)00199-8
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   SIPEHIA R, 1993, BIOMAT ARTIF CELL IM, V21, P455, DOI 10.3109/10731199309117651
   STAMM WE, 1978, ANN INTERN MED, V89, P764, DOI 10.7326/0003-4819-89-5-764
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   WAGMAN GH, 1975, J ANTIMICROBIAL AGEN, V7, P316
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 47
TC 234
Z9 248
U1 6
U2 78
PU W B SAUNDERS CO LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0195-6701
J9 J HOSP INFECT
JI J. Hosp. Infect.
PD OCT
PY 2001
VL 49
IS 2
BP 87
EP 93
DI 10.1053/jhin.2001.1052
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 481TF
UT WOS:000171535600001
PM 11567552
DA 2018-10-19
ER

PT J
AU Jandt, KD
AF Jandt, KD
TI Atomic force microscopy of biomaterials surfaces and interfaces
SO SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 2nd Internatinal Conference on Scanning Probe Microscopy in Biomaterials
   Science
CY JUN   23, 2000
CL BRISTOL, ENGLAND
DE surface structure, morphology, roughness. and topography; biological
   molecules - proteins; titanium; etching; surface chemical reaction;
   physical adsorption; solid-liquid interfaces
ID SCANNING PROBE MICROSCOPY; SELF-ASSEMBLED MONOLAYERS;
   VON-WILLEBRAND-FACTOR; AQUEOUS CONDITIONS; HUMAN DENTIN; IN-SITU;
   NANOMECHANICAL PROPERTIES; 3-DIMENSIONAL STRUCTURE; COLLAGEN
   CONFORMATION; MOLECULAR COMPOSITION
AB The use of atomic force microscopy (AFM) in biomaterials science and engineering applications has increased rapidly over the last few years. Beyond being merely a tool for measuring surface topography, AFM has made significant contributions to various biomaterials research areas dealing with the structure, properties, dynamics and manipulation of biomaterials surfaces and interfaces. This paper critically reviews methodological approaches and presents aspects of this research. Selected examples presented include micro and nanostructure and properties of biomaterials surfaces, molecular level interactions at biomaterial-biomolecule interfaces, interfaces between biomaterials and mineralised tissues as well as advances of mineralised tissue research. In these areas, AFM is shown to be a useful and versatile tool to study micro and nanostructure, to probe mechanical properties or to investigate dynamic process at biomaterials surfaces and interfaces. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Bristol, Biomed Engn & Biomat Sci Sect, Dept Oral & Dent Sci, Bristol BS1 2LY, Avon, England.
RP Jandt, KD (reprint author), Univ Bristol, Biomed Engn & Biomat Sci Sect, Dept Oral & Dent Sci, Lower Maudling St, Bristol BS1 2LY, Avon, England.
RI Jandt, Klaus/C-8077-2016
OI Jandt, Klaus/0000-0002-7537-5603
CR ALBRECHT TR, 1990, J VAC SCI TECHNOL A, V8, P3386, DOI 10.1116/1.576520
   Balooch M, 1998, J BIOMED MATER RES, V40, P539, DOI 10.1002/(SICI)1097-4636(19980615)40:4<539::AID-JBM4>3.3.CO;2-O
   Baretzky B, 1996, Z METALLKD, V87, P332
   BASELT DR, 1994, J APPL PHYS, V76, P33, DOI 10.1063/1.357150
   BHUSHAN B, 1994, APPL PHYS LETT, V64, P1653, DOI 10.1063/1.111949
   Bhushan B, 1996, PHILOS MAG A, V74, P1117, DOI 10.1080/01418619608239712
   BINNIG G, 1986, IBM J RES DEV, V30, P355
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BINNIG G, 1986, REV SCI INSTRUM, V57, P1688, DOI 10.1063/1.1139196
   BOLAND T, 1995, P NATL ACAD SCI USA, V92, P5297, DOI 10.1073/pnas.92.12.5297
   Bonnell D., 2000, SCANNING PROBE MICRO
   Braem MJA, 1997, J DENT RES, V76, P493
   Browne M, 1996, J MATER SCI-MATER M, V7, P323, DOI 10.1007/BF00154543
   BURNHAM NA, 1989, J VAC SCI TECHNOL A, V7, P2906, DOI 10.1116/1.576168
   BUSHAN B, 1998, HDB MICRONANOTRIBOLO
   Cacciafesta P, 2001, SURF SCI, V491, P405, DOI 10.1016/S0039-6028(01)01303-6
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   CASSINELLI C, 1994, J MATER SCI-MATER M, V5, P606, DOI 10.1007/BF00120339
   CASSINELLI C, 1994, J BIOMED MATER RES, V28, P1427, DOI 10.1002/jbm.820281207
   Chen C. J., 1993, INTRO SCANNING TUNNE
   Chen X, 1998, MACROMOLECULES, V31, P2278, DOI 10.1021/ma9704525
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   Colton RJ, 1997, CURR OPIN CHEM BIOL, V1, P370, DOI 10.1016/S1367-5931(97)80076-2
   Corneillie S, 1998, POLYM INT, V46, P251, DOI 10.1002/(SICI)1097-0126(199807)46:3<251::AID-PI6>3.0.CO;2-Z
   Costa KD, 1999, J BIOMECH ENG-T ASME, V121, P462, DOI 10.1115/1.2835074
   Denhardt D T, 1998, J Cell Biochem Suppl, V30-31, P92
   DeRose JA, 1998, THIN SOLID FILMS, V331, P194, DOI 10.1016/S0040-6090(98)00919-5
   *DIG INSTR, 1996, MULT SCANN PROB MICR
   *DIG INSTR, 1997, NAN HARDN TEST NAN S
   *DIG INSTR, 1995, PHAS IM BEYOND TOP D
   Disley DM, 1998, BIOSENS BIOELECTRON, V13, P1213, DOI 10.1016/S0956-5663(98)00059-1
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   Eckert R, 1997, CELL BIOL INT, V21, P707, DOI 10.1006/cbir.1997.0215
   Eick JD, 1997, CRIT REV ORAL BIOL M, V8, P306, DOI 10.1177/10454411970080030501
   El Feninat F, 1998, J BIOMED MATER RES, V42, P549, DOI 10.1002/(SICI)1097-4636(19981215)42:4<549::AID-JBM10>3.0.CO;2-L
   Eliades G, 1997, DENT MATER, V13, P24, DOI 10.1016/S0109-5641(97)80005-X
   Eliades G, 1999, DENT MATER, V15, P310, DOI 10.1016/S0109-5641(99)00050-0
   EMCH R, 1992, ULTRAMICROSCOPY, V42, P1155, DOI 10.1016/0304-3991(92)90417-I
   Engel A, 1997, J STRUCT BIOL, V119, P83, DOI 10.1006/jsbi.1997.3894
   Farina M, 1999, J STRUCT BIOL, V125, P39, DOI 10.1006/jsbi.1998.4069
   Finke M, 2000, J COLLOID INTERF SCI, V232, P156, DOI 10.1006/jcis.2000.7200
   Finke M, 2001, SURF SCI, V491, P456, DOI 10.1016/S0039-6028(01)01311-5
   FINKE M, 2000, J DENT RES, V79, P3687
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   Fong H, 2000, MAT SCI ENG C-BIO S, V7, P119, DOI 10.1016/S0928-4931(99)00133-2
   FRISBIE CD, 1994, SCIENCE, V265, P2071, DOI 10.1126/science.265.5181.2071
   FRITZ M, 1995, P SOC PHOTO-OPT INS, V2384, P150, DOI 10.1117/12.205923
   FRITZ M, 1995, LANGMUIR, V11, P3529, DOI 10.1021/la00009a040
   Garrison MD, 2000, ULTRAMICROSCOPY, V82, P193, DOI 10.1016/S0304-3991(99)00150-3
   Giancarlo LC, 1998, ANNU REV PHYS CHEM, V49, P297, DOI 10.1146/annurev.physchem.49.1.297
   GIRARD C, 1989, PHYS REV B, V40, P12133, DOI 10.1103/PhysRevB.40.12133
   GRUTTER P, 1992, ULTRAMICROSCOPY, V47, P393, DOI 10.1016/0304-3991(92)90170-O
   Hans D, 1993, Eur J Med, V2, P157
   Harada Y, 2000, LANGMUIR, V16, P708, DOI 10.1021/la990236k
   HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4
   HEINZELMANN H, 1990, NATO ASI SER, V184, P449
   Hemmerle J, 1999, P NATL ACAD SCI USA, V96, P6705, DOI 10.1073/pnas.96.12.6705
   HLADY V, 1998, BIOPOLYMERS INTERFAC, P181
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Holland NB, 1998, NATURE, V392, P799
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   HORBETT TA, 1996, BIOMATERIALS SCI INT, pCH3
   HORBETT TA, 1982, ADV CHEM SER, V199, P233
   Hosoi H, 2000, APPL SURF SCI, V157, P218, DOI 10.1016/S0169-4332(99)00529-2
   Hostetler MJ, 1997, CURR OPIN COLLOID IN, V2, P42, DOI 10.1016/S1359-0294(97)80007-6
   HUES SM, 1994, J VAC SCI TECHNOL B, V12, P2211, DOI 10.1116/1.587743
   HUES SM, 1994, REV SCI ISNTR, V65
   Humphris ADL, 2000, LANGMUIR, V16, P7891, DOI 10.1021/la000766c
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   ISHIDA H, 1985, MOL CHARACTERIZATION, P25
   ISRAELACHVILI J, 1991, INTERMOLECULAR SURFA, pCH16
   Jandt KD, 1996, ADV MATER, V8, P660, DOI 10.1002/adma.19960080813
   JANDT KD, 1994, POLYMER, V35, P2458, DOI 10.1016/0032-3861(94)90789-7
   Jandt KD, 2000, COLLOID SURFACE B, V19, P301, DOI 10.1016/S0927-7765(00)00139-9
   JANDT KD, 1993, MACROMOLECULES, V26, P6552, DOI 10.1021/ma00076a037
   JANDT KD, 1999, PROBE MICROSCOPY, V1, P323
   JANDT KD, 1989, MAT SCI ENG, V21
   Johannson O. K., 1967, J COMPOS MATER, V1, P278
   KAAS S, 1997, INT J IMAG SYST TECH, V8, P151
   Kanno T, 2000, JPN J APPL PHYS 2, V39, pL269, DOI 10.1143/JJAP.39.L269
   KASAS S, 1993, P SOC PHOTO-OPT INS, V1855, P17, DOI 10.1117/12.146381
   KIKUKAWA A, 1995, REV SCI INSTRUM, V66, P101, DOI 10.1063/1.1145274
   Kilpadi DV, 1998, COLLOID SURFACE A, V135, P89, DOI 10.1016/S0927-7757(97)00237-9
   Kinney JH, 1996, J BIOMECH ENG-T ASME, V118, P133, DOI 10.1115/1.2795939
   Kirkham J, 1997, J DENT RES, V76, P1029
   KIRKHAM J, 1998, CONNECT TISSUE RES, V39, P91
   Klinov DV, 1998, NUCLEIC ACIDS RES, V26, P4603, DOI 10.1093/nar/26.20.4603
   KULKARNI AV, 1996, THIN SOLID FILMS, V291, P206
   LACHMANN PJ, 1985, COMPLEMENT, P147
   LATOUR RA, 1999, HDB BIOMATERIALS EVA, pCH3
   Li HB, 2000, MACROMOLECULES, V33, P465, DOI 10.1021/ma990878e
   Liu L, 2000, PHYS REV LETT, V84, P4950, DOI 10.1103/PhysRevLett.84.4950
   LYUBCHENKO Y, 1993, P NATL ACAD SCI USA, V90, P2137, DOI 10.1073/pnas.90.6.2137
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   MAIWALD P, 1991, NANOTECHNOLOGY, V2, P103
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   MARSHALL GW, 1993, DENT MATER, V9, P265, DOI 10.1016/0109-5641(93)90072-X
   Marshall GW, 1997, DENT MATER, V13, P338, DOI 10.1016/S0109-5641(97)80104-2
   MARSHALL GW, 1995, J BIOMED MATER RES, V29, P1381, DOI 10.1002/jbm.820291109
   Marshall GW, 1999, AM J DENT, V12, P271
   Martin FE, 1996, J DENT RES, V75, P2197
   MARTIN Y, 1987, J APPL PHYS, V61, P4723, DOI 10.1063/1.338807
   MATE CM, 1987, PHYS REV LETT, V59, P1942, DOI 10.1103/PhysRevLett.59.1942
   MCKNEE MD, 1996, CONNECT TISSUE RES, V35, P197
   MECHOLSKY JJ, 1995, DENT MATER, V11, P113, DOI 10.1016/0109-5641(95)80045-X
   MEYER D, 1993, THROMB HAEMOSTASIS, V70, P99
   MOKOTOFF GF, 1990, ELECT MICROSCOPY LAB
   Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025
   Ohnesorge FM, 1999, SURF INTERFACE ANAL, V27, P379, DOI 10.1002/(SICI)1096-9918(199905/06)27:5/6<379::AID-SIA506>3.0.CO;2-D
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Orisaka S, 1999, APPL SURF SCI, V140, P243, DOI 10.1016/S0169-4332(98)00534-0
   Ortega-Vinuesa JL, 1998, J COLLOID INTERF SCI, V207, P228, DOI 10.1006/jcis.1998.5624
   Parbhu AN, 1999, BIOCHEMISTRY-US, V38, P11755, DOI 10.1021/bi990746d
   PARKER DM, 1998, J DENT RES, V77, P1708
   Perdigao J, 1999, AM J DENT, V12, P250
   Phrukkanon S, 2000, DENT MATER, V16, P255, DOI 10.1016/S0109-5641(00)00015-4
   Placko HE, 2000, INT J ORAL MAX IMPL, V15, P355
   Porte-Durrieu MC, 2000, J BIOMED MATER RES, V52, P119, DOI 10.1002/1097-4636(200010)52:1<119::AID-JBM15>3.0.CO;2-Q
   QUATE CF, 1994, SURF SCI, V300, P980
   QUIST AP, 1995, SURF SCI, V325, pL406, DOI 10.1016/0039-6028(94)00809-4
   RADMACHER M, 1994, LANGMUIR, V10, P3809, DOI 10.1021/la00022a068
   Raghavachari M, 2000, THROMB RES, V98, P351, DOI 10.1016/S0049-3848(00)00185-7
   Raghavan D, 2000, MACROMOLECULES, V33, P2573, DOI 10.1021/ma991206r
   RASMUSSON JR, 1994, SCANNING MICROSCOPY, V8, P481
   RATNER BD, 1996, BIOMATERIALS SCI, P445
   Resch R, 2000, ULTRAMICROSCOPY, V82, P135, DOI 10.1016/S0304-3991(99)00152-7
   Rief M, 1999, NAT STRUCT BIOL, V6, P346
   Rosales JI, 1999, J DENT RES, V78, P1554, DOI 10.1177/00220345990780091001
   RUGAR D, 1994, SCIENCE, V264, P1560, DOI 10.1126/science.264.5165.1560
   SADER JE, 1995, REV SCI INSTRUM, V66, P3789, DOI 10.1063/1.1145439
   SARID D, 1991, J VAC SCI TECHNOL B, V9, P431, DOI 10.1116/1.585585
   SAWYERS LC, 1996, POLYM MICROSCOPY
   SCHAAD P, 1993, SCANNING MICROSCOPY, V7, P1149
   SENDEN TJ, 1994, LANGMUIR, V10, P1003, DOI 10.1021/la00016a600
   SHAKESHEFF KM, 1995, LANGMUIR, V11, P2447
   Shi HQ, 1999, NATURE, V398, P593
   Siedlecki CA, 1996, BLOOD, V88, P2939
   Silikas N, 1999, J DENT, V27, P137, DOI 10.1016/S0300-5712(98)00032-3
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   *SOC BIOM US, 2000, 6 WORLD BIOM C 15 20, V1
   SODERHOLM KJM, 1993, J DENT RES, V72, P1050, DOI 10.1177/00220345930720061001
   SOLLBOHMER O, 1995, THIN SOLID FILMS, V264, P176, DOI 10.1016/0040-6090(95)05847-8
   Ta TC, 1998, LANGMUIR, V14, P2435, DOI 10.1021/la9712348
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   UHLMAN A, 1998, THIN FILMS SELF ASSE, V24
   VONRECUM AF, 1999, HDB BIOMATERIALS EVA, pCH13
   WAGNER P, 1995, LANGMUIR, V11, P3867, DOI 10.1021/la00010a043
   WAGNER P, 1994, FEBS LETT, V356, P267, DOI 10.1016/0014-5793(94)01296-2
   Walivaara B, 1997, J COLLOID INTERF SCI, V187, P121, DOI 10.1006/jcis.1996.4673
   Watari F, 1999, J ELECTRON MICROSC, V48, P537, DOI 10.1093/oxfordjournals.jmicro.a023713
   WEISENHORN AL, 1991, LANGMUIR, V7, P8, DOI 10.1021/la00049a003
   WEISS HJ, 1989, J CLIN INVEST, V83, P288, DOI 10.1172/JCI113871
   West NX, 2000, TOOTH WEAR SENSITIVI, P105
   WICKRAMASINGHE HK, 1992, AIP CONF PROC, V241, P9
   Wiesendanger R, 1995, SCANNING PROBE MICRO
   WIGREN R, 1991, FEBS LETT, V280, P225, DOI 10.1016/0014-5793(91)80298-H
   Williams D., 1990, CONCISE ENCY MED DEN
   Yang YZ, 2000, J BIOMED MATER RES, V52, P333, DOI 10.1002/1097-4636(200011)52:2<333::AID-JBM12>3.3.CO;2-K
   Yoshida Y, 1999, J BIOMED MATER RES, V47, P85, DOI 10.1002/(SICI)1097-4636(199910)47:1<85::AID-JBM12>3.0.CO;2-H
   YU J, 1994, BIOMATERIALS, V15, P805, DOI 10.1016/0142-9612(94)90035-3
   ZENHAUSERN F, 1993, J ELECTRON MICROSC, V42, P378
   Zhang WK, 2000, LANGMUIR, V16, P4305, DOI 10.1021/la991230y
   Zhong Q, 1993, SURF SCI LETT, V290, P688
NR 163
TC 150
Z9 152
U1 2
U2 64
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD OCT 1
PY 2001
VL 491
IS 3
BP 303
EP 332
DI 10.1016/S0039-6028(01)01296-1
PG 30
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 482DQ
UT WOS:000171559900002
DA 2018-10-19
ER

PT J
AU Fischbach, C
   Tessmar, J
   Lucke, A
   Schnell, E
   Schmeer, G
   Blunk, T
   Gopferich, A
AF Fischbach, C
   Tessmar, J
   Lucke, A
   Schnell, E
   Schmeer, G
   Blunk, T
   Gopferich, A
TI Does UV irradiation affect polymer properties relevant to tissue
   engineering?
SO SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 2nd Internatinal Conference on Scanning Probe Microscopy in Biomaterials
   Science
CY JUN   23, 2000
CL BRISTOL, ENGLAND
DE photoelectron spectroscopy; atomic force microscopy; surface structure,
   morphology, roughness, and topography; biological molecules - proteins;
   adhesion
ID CELL-ADHESION; BIOMATERIALS; SURFACES; PEG; DEGRADATION; MIGRATION;
   OXIDE
AB For most tissue engineering approaches aiming at the repair or generation of living tissues the interaction of cells and polymeric biomaterials is of paramount importance. Prior to contact with cells or tissues, biomaterials have to be sterilized. However, many sterilization procedures such as steam autoclave or heat sterilization are known to strongly affect polymer properties. UV irradiation is used as an alternative sterilization method in many tissue engineering laboratories on a routine basis, however, potential alterations of polymer properties have not been extensively considered,
   In this study we investigated the effects of UV irradiation on spin-cast films made from biodegradable poly(D,L-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers (Me.PEG-PLA) which have recently been developed for controlled cell-biomaterial interaction. After 2 h of UV irradiation, which is sufficient for sterilization, no alterations in cell adhesion to polymer films were detected, as demonstrated with 3T3-L1 preadipocytes. This correlated with unchanged film topography and molecular weight distribution. However, extended UV irradiation for 5-24 h elicited drastic responses regarding Me.PEG-PLA polymer properties and interactions with biological elements: Large increases in unspecific protein adsorption and subsequent cell adhesion were observed, Changes in polymer surface properties could be correlated with the observed alterations in cell/protein-polymer interactions. Atomic force microscopy analysis of polymer films revealed a marked "smoothing" of the polymer surface after UV irradiation. Investigations using GPC, H-1-NMR, mass spectrometry, and a PEG-specific colorimetric assay demonstrated that polymer film composition was time-dependently affected by exposure to UV irradiation, i.e., that large amounts of PEG were lost from the copolymer surface.
   The data indicate that sterilization using UV irradiation for 2 h is an appropriate technique for the recently synthesized Me.PEG-PLA diblock copolymers. However, the study also serves as an example that it is indispensable to control the duration of exposure to UV irradiation for a given biomaterial in order not to compromise polymer properties relevant to tissue engineering purposes. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Regensburg, Dept Pharmaceut Technol, D-93040 Regensburg, Germany.
   Univ Regensburg, Dept Phys & Theoret Chem, D-93040 Regensburg, Germany.
RP Gopferich, A (reprint author), Univ Regensburg, Dept Pharmaceut Technol, D-93040 Regensburg, Germany.
RI Tessmar, Joerg/H-3606-2012; Fischbach, Claudia/C-8550-2009
OI Tessmar, Joerg/0000-0001-7057-5369; Fischbach,
   Claudia/0000-0002-9368-0150
CR ABSHIRE RL, 1981, APPL ENVIRON MICROB, V41, P1419
   BALEUX B, 1972, CR ACAD SCI C CHIM, V274, P1617
   Bittner B, 1999, J CONTROL RELEASE, V59, P23, DOI 10.1016/S0168-3659(98)00170-9
   BOUSQUET J, 1991, CLIN REV ALLERG, V9, P357
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   Fu K, 2000, NAT BIOTECHNOL, V18, P24, DOI 10.1038/71875
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   Holy CE, 2001, BIOMATERIALS, V22, P25, DOI 10.1016/S0142-9612(00)00136-8
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lucke A, 2000, BIOMATERIALS, V21, P2361, DOI 10.1016/S0142-9612(00)00103-4
   MCKELLAR JF, 1979, PHOTOCHEMISTRY MAN M
   Praschak D, 1998, APPL PHYS A-MATER, V66, P69, DOI 10.1007/s003390050639
   Schwendeman S.P., 1996, MICROPARTICULATE SYS, P1
   Staiger H, 1998, EUR J CELL BIOL, V77, P220, DOI 10.1016/S0171-9335(98)80110-6
   TESSMAR J, 2000, 6 WORLD BIOM C T, P595
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   *UV TECHN SPEZ GMB, 1999, DES UV STRAHL STRAHL
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 24
TC 55
Z9 57
U1 4
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD OCT 1
PY 2001
VL 491
IS 3
BP 333
EP 345
DI 10.1016/S0039-6028(01)01297-3
PG 13
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 482DQ
UT WOS:000171559900003
DA 2018-10-19
ER

PT J
AU Cacciafesta, P
   Hallam, KR
   Watkinson, AC
   Allen, GC
   Miles, MJ
   Jandt, KD
AF Cacciafesta, P
   Hallam, KR
   Watkinson, AC
   Allen, GC
   Miles, MJ
   Jandt, KD
TI Visualisation of human plasma fibrinogen adsorbed on titanium implant
   surfaces with different roughness
SO SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 2nd Internatinal Conference on Scanning Probe Microscopy in Biomaterials
   Science
CY JUN   23, 2000
CL BRISTOL, ENGLAND
DE atomic force microscopy; X-ray photoelectron spectroscopy; secondary ion
   mass spectroscopy; physical adsorption; surface structure, morphology,
   roughness, and topography; titanium; titanium oxide; biological
   molecules - proteins
ID ATOMIC-FORCE MICROSCOPY; DIFFERENT OXIDE THICKNESSES; ELECTROPOLISHED
   IMPLANTS; BONE RESPONSE; BIOLOGICAL PROPERTIES; ENERGY-DISSIPATION;
   PROTEIN ADSORPTION; TISSUE-RESPONSE; PHASE-CONTRAST; ORAL IMPLANTS
AB Direct visualisation of adsorbed human plasma proteins on biomaterial surfaces may help the understanding of the performance of implants, The aim of this study was the visualisation of human plasma fibrinogen (HPF) adsorbed on different titanium implants with characterised surface properties. Seven types of titanium samples were used: mechanically polished (P); mechanically ground (G); sand blasted with alumina (B); sand blasted with alumina and etched in HF/HNO3 (BN); sand blasted with alumina and etched in HCl/H2SO4 (SLA); mechanically polished and etched in HCl/H2SO4 (PSLA); and plasma sprayed (TPS). The surface morphology and roughness of these surfaces were analysed by atomic force microscopy (AFM), The surface chemical composition of the implants was analysed by X-ray photoelectron spectroscopy (XPS) and time of flight secondary ion mass spectrometry (ToF-SIMS). The seven processing methods influenced the roughness and produced distinct morphologies of the implant surfaces, The main chemical constituent of all surfaces was TiO2, with some samples showing the presence of other elements. HPF adsorbed on the titanium surfaces was visualised by AFM phase imaging. Visualisation of the adsorbed HPF was successfully achieved on samples P and G, but not on the other five samples. Differences in the dimensions and in the phase contrast of HPF molecules adsorbed on P and G surfaces were observed and discussed. No correlation between surface topography and morphology of the adsorbed proteins was observed on surfaces P and G. Possible reasons for not detecting HPF with AFM on five of the seven sample types were attributed to the surface physico-chemical properties of these samples. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Bristol, Biomed Engn & Biomat Sci Sect, Dept Oral & Dent Sci, Bristol BS1 2LY, Avon, England.
   Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England.
   Univ Bristol, Interface Anal Ctr, Bristol BS2 8BS, Avon, England.
RP Jandt, KD (reprint author), Univ Bristol, Biomed Engn & Biomat Sci Sect, Dept Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England.
RI Jandt, Klaus/C-8077-2016
OI Jandt, Klaus/0000-0002-7537-5603; Miles, Mervyn/0000-0001-7762-6827
CR Ahariz M, 2000, J BIOMED MATER RES, V52, P567, DOI 10.1002/1097-4636(20001205)52:3<567::AID-JBM16>3.0.CO;2-K
   ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   Andrade J. D., 1985, SURFACE INTERFACIAL, V2
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Briggs D, 1977, HDB XRAY ULTRAVIOLET
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   Chen YL, 1999, J COLLOID INTERF SCI, V214, P38
   Cleveland JP, 1998, APPL PHYS LETT, V72, P2613, DOI 10.1063/1.121434
   Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523
   Cooper LF, 1999, INT J ORAL MAX IMPL, V14, P37
   *DIG INSTR INC, 1997, NAN COMM REF MAN, P68
   *DIG INSTR INC, 1997, NAN COMM REF MAN, P41
   Francois P, 1997, CLIN ORAL IMPLAN RES, V8, P217, DOI 10.1034/j.1600-0501.1997.080308.x
   Garcia R, 1999, SURF INTERFACE ANAL, V27, P312, DOI 10.1002/(SICI)1096-9918(199905/06)27:5/6<312::AID-SIA496>3.0.CO;2-Y
   Giacomelli CE, 1999, J COLLOID INTERF SCI, V218, P404, DOI 10.1006/jcis.1999.6434
   HANTGAN RR, 1994, HEMOSTASIS THROMBOSI, pCH14
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Horbett Thomas A., 1996, P133
   Jackson DR, 2000, LANGMUIR, V16, P5449, DOI 10.1021/la991497x
   Jandt KD, 1998, MAT SCI ENG R, V21, P221, DOI 10.1016/S0927-796X(97)00012-0
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   Kasemo B, 1985, TISSUE INTEGRATED PR, P99
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Klinger A, 1997, J BIOMED MATER RES, V36, P387, DOI 10.1002/(SICI)1097-4636(19970905)36:3<387::AID-JBM13>3.0.CO;2-B
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Larsson C, 1997, J MATER SCI-MATER M, V8, P721, DOI 10.1023/A:1018548225899
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LI J, 1994, J MATER SCI-MATER M, V5, P760, DOI 10.1007/BF00120372
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   MacDonald DE, 1998, COLLOID SURFACE B, V11, P131, DOI 10.1016/S0927-7765(98)00030-7
   Magonov SN, 1997, SURF SCI, V375, P385
   Nagao E, 1999, BIOPHYS J, V76, P3289, DOI 10.1016/S0006-3495(99)77481-3
   NEWCOMBE JR, UNPUB
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   Roddick-Lanzilotta AD, 1998, LANGMUIR, V14, P6479, DOI 10.1021/la980425n
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   SIPEHIA R, 1993, BIOMAT ARTIF CELL IM, V21, P647, DOI 10.3109/10731199309117389
   SIPEHIA R, 1989, ACS SYM SER, V392, pCH12
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   SODHI RNS, 1991, J VAC SCI TECHNOL A, V9, P1329, DOI 10.1116/1.577621
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   Tamayo J, 1998, APPL PHYS LETT, V73, P2926, DOI 10.1063/1.122632
   Tamayo J, 1996, LANGMUIR, V12, P4430, DOI 10.1021/la960189l
   Trisi P, 1999, INT J ORAL MAX IMPL, V14, P689
   WAHLBECK PG, 1966, J AM CERAM SOC, V49, P180, DOI 10.1111/j.1151-2916.1966.tb13229.x
   Walivaara B, 1996, J BIOMAT SCI-POLYM E, V8, P41, DOI 10.1163/156856297X00560
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   ZENHAUSERN F, 1993, J ELECTRON MICROSC, V42, P378
NR 59
TC 69
Z9 69
U1 2
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD OCT 1
PY 2001
VL 491
IS 3
BP 405
EP 420
DI 10.1016/S0039-6028(01)01303-6
PG 16
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 482DQ
UT WOS:000171559900009
DA 2018-10-19
ER

PT J
AU Denes, AR
   Somers, EB
   Wong, ACL
   Denes, F
AF Denes, AR
   Somers, EB
   Wong, ACL
   Denes, F
TI 12-crown-4-ether and tri(ethylene glycol) dimethyl-ether plasma-coated
   stainless steel surfaces and their ability to reduce bacterial biofilm
   deposition
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE bacterial attachment; biofilm formation; cold-plasma-induced surface
   modification; PEG-like structures; surface chemistry
ID ADHESION; POLYMERIZATION; BIOMATERIAL; PEG
AB It has been demonstrated that surfaces coated with poly(ethylene glycol) (PEG) are capable of reducing protein adsorption, bacterial attachment, and biofilm formation. In this communication cold-plasma-enhanced processes were employed for the deposition of PEG-like structures onto stainless steel surfaces. Stainless steel samples were coated under 1,4,7,10-tetraoxacyclododecane (12-crown-4)-ether and tri(ethylene glycol) dimethyl ether (triglyme)-radio frequency (RF)-plasma conditions. The chemistry and characteristics of plasma-coated samples and biofilms were investigated using electron spectroscopy for chemical analysis (ESCA), atomic force microscopy (AFM), and water contact angle analysis. ESCA analysis indicated that the plasma modification resulted in the deposition of PEG-like structures, built up mainly of -CH2-CH2-O- linkages. Plasma-coated stainless steel surfaces were more hydrophilic and had lower surface roughness values compared to those of unmodified substrates. Compared to the unmodified surfaces, they not only significantly reduced bacterial attachment and biofilm formation in the presence of a mixed culture of Salmonella typhimurium, Staphylococcus epidermidis, and Pseudomonas fluorescens but also influenced the chemical characteristics of the biofilm. Thus, plasma deposition of PEG-like structures will be of use to the food-processing and medical industries searching for new technologies to reduce bacterial contamination. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Wisconsin, Food Res Inst, Madison, WI 53706 USA.
   Univ Wisconsin, Ctr Plasma Aided Mfg, Madison, WI 53706 USA.
RP Wong, ACL (reprint author), Univ Wisconsin, Food Res Inst, 1925 Willow Dr, Madison, WI 53706 USA.
CR AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   Characklis W. G., 1990, BIOFILMS, P195
   Chen XL, 1996, CHEM MATER, V8, P1067, DOI 10.1021/cm9504854
   Denes F, 1997, TRENDS POLYM SCI, V5, P23
   Denes F, 1999, J APPL POLYM SCI, V71, P1627, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1627::AID-APP10>3.0.CO;2-D
   *DIG INSTR, DIG INSTR NAN 3 SCAN
   Flint SH, 2000, J FOOD ENG, V43, P235, DOI 10.1016/S0260-8774(99)00157-0
   GOMBOTZ WR, 1992, POLYETHYLENE GLYCOL, P47
   Han LM, 1998, CHEM MATER, V10, P1422, DOI 10.1021/cm970779k
   Harris JM, 1997, ACS S SERIES, V680
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   HOLMBREG K, 1993, CONTACT ANGLE WETTAB, P813
   Hsiue GH, 1998, J BIOMED MATER RES, V42, P134, DOI 10.1002/(SICI)1097-4636(199810)42:1<134::AID-JBM17>3.0.CO;2-L
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   JOHNSTON EE, 1996, SURFACE MODIFICATION, P35
   LECHEVALLIER MW, 1988, APPL ENVIRON MICROB, V54, P649
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MAGNUSSON KE, 1977, STUD BIOPHYS, V66, P145
   Morra M, 1996, J BIOMED MATER RES, V31, P149
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   PANCHALINGAM V, 1993, ASAIO J, V30, P305
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Rad AY, 1998, J BIOMED MATER RES, V41, P349, DOI 10.1002/(SICI)1097-4636(19980905)41:3<349::AID-JBM2>3.0.CO;2-C
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   Rinsch CL, 1996, LANGMUIR, V12, P2995, DOI 10.1021/la950685u
   Sarmadi M, 1996, TEXT CHEM COLOR, V28, P17
   SHAMAMIAN V, IN PRESS J APPL PHYS
   Shi FF, 1996, SURF COAT TECH, V82, P1, DOI 10.1016/0257-8972(95)02621-5
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Taylor RL, 1998, J MATER SCI-MATER M, V9, P17, DOI 10.1023/A:1008874326324
   VANDERMEI HC, 2000, J SURF SCI REP, V39, P1
   WEST RC, 1976, HDB CHEM PHYSICS, pF156
NR 34
TC 37
Z9 40
U1 1
U2 12
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 29
PY 2001
VL 81
IS 14
BP 3425
EP 3438
DI 10.1002/app.1799
PG 14
WC Polymer Science
SC Polymer Science
GA 454RC
UT WOS:000169984700009
DA 2018-10-19
ER

PT J
AU Dixit, P
   Hern-Anderson, D
   Ranieri, J
   Schmidt, CE
AF Dixit, P
   Hern-Anderson, D
   Ranieri, J
   Schmidt, CE
TI Vascular graft endothelialization: Comparative analysis of canine and
   human endothelial cell migration on natural biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE endothelial cell migration; natural biomaterials; growth factors;
   adhesion proteins
ID FIBROBLAST GROWTH-FACTOR; DYE-MEDIATED PHOTOOXIDATION;
   POLYTETRAFLUOROETHYLENE GRAFTS; ARTERIAL PROSTHESES; PERICARDIAL TISSUE;
   DACRON GRAFTS; HEPARIN; PROLIFERATION; MOTILITY; INVIVO
AB Canines are typically used as the standard preclinical model to gauge the success of vascular graft materials. However, canines spontaneously re-endothelialize vascular grafts, whereas humans do not, even after years. This raises questions of why there are differences in vascular healing between humans and other species and whether the canine is the appropriate preclinical model. In the present study we evaluated human and canine endothelial cell (EC) migration on the novel cross-linked collagen biomaterial PhotoFix (TM) pericardium. We compared in vitro migration of these cells on PhotoFix alone and on PhotoFix adsorbed with various growth factors (aFGF and bFGF) and adhesion proteins (fibronectin, collagen IV, vitronectin, and laminin). We also compared human and canine ECs in terms of their morphologies and prostacyclin production. We found that human umbilical vein ECs (HUVECs) and canine ECs (CECs) migrated well on PhotoFix, suggesting that this biomaterial may be a good vascular graft candidate. Both cell types responded similarly to different growth factors and adhesive proteins, but HUVEC migration was consistently higher than that for CECs. This suggested that human in vivo graft re-endothelialization is likely not hindered by poor endothelial migration but is hindered by other cellular or graft properties. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
   Sulzer Biol, Austin, TX 78752 USA.
RP Schmidt, CE (reprint author), Univ Texas, Dept Chem Engn, 26th & Speedway,MC C0400, Austin, TX 78712 USA.
RI Schmidt, Christine/P-1613-2016
CR ASHTON AW, 1995, GROWTH FACTORS, V12, P111, DOI 10.3109/08977199509028957
   AUGUSTINVOSS HG, 1993, J CELL PHYSIOL, V157, P279, DOI 10.1002/jcp.1041570210
   BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018
   BULL DA, 1995, J SURG RES, V58, P58, DOI 10.1006/jsre.1995.1010
   CASSCELLS W, 1992, CIRCULATION, V86, P723, DOI 10.1161/01.CIR.86.3.723
   Consigny PM, 2000, J LONG-TERM EFF MED, V10, P79
   FASOL R, 1989, J VASC SURG, V9, P432, DOI 10.1067/mva.1989.vs0090432
   Gillis C, 1995, CELL MOL BIOL, V41, P1131
   GILLISHAEGERSTR.C, 1995, THESIS LAROLINSKA I
   GREISLER HP, 1992, SURGERY, V112, P244
   HESS F, 1988, J CARDIOVASC SURG, V29, P458
   KENT KC, 1989, J VASC SURG, V9, P271, DOI 10.1067/mva.1989.vs0090271
   KLAGSBRUN M, 1985, P NATL ACAD SCI USA, V82, P805, DOI 10.1073/pnas.82.3.805
   LEE Y, 1994, BIOTECHNOL BIOENG, V43, P622, DOI 10.1002/bit.260430712
   MACIAG T, 1984, SCIENCE, V225, P932, DOI 10.1126/science.6382607
   MADRI JA, 1991, J CELL BIOCHEM, V45, P123, DOI 10.1002/jcb.240450202
   MCNEIL PL, 1989, GASTROENTEROLOGY, V96, P1238, DOI 10.1016/S0016-5085(89)80010-1
   MOORE MA, 1994, J BIOMED MATER RES, V28, P611, DOI 10.1002/jbm.820280511
   Moore MA, 1997, J HEART VALVE DIS, V6, P307
   Ohtake S, 1997, Hokkaido Igaku Zasshi, V72, P43
   Onuki Y, 1997, ANN VASC SURG, V11, P141, DOI 10.1007/s100169900024
   ORTENWALL P, 1990, J VASC SURG, V11, P403
   RAMALANJAONA G, 1986, J VASC SURG, V3, P264, DOI 10.1067/mva.1986.avs0030264
   ROSEN EM, 1989, IN VITRO CELL DEV B, V25, P1079
   SAUVAGE LR, 1974, ARCH SURG-CHICAGO, V109, P698
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SCOTT SM, 1994, J VASC SURG, V19, P585, DOI 10.1016/S0741-5214(94)70030-3
   SHAREFKIN JB, 1983, J SURG RES, V34, P33, DOI 10.1016/0022-4804(83)90019-7
   SHI Q, 1994, J VASC SURG, V20, P546, DOI 10.1016/0741-5214(94)90279-8
   Tomizawa Y, 1996, ASAIO J, V42, pM698, DOI 10.1097/00002480-199609000-00077
   TRACHTENBERG JD, 1994, IMPLANTATION BIOL HO
   WESOLOW A, 1982, THORAC CARDIOV SURG, V30, P196, DOI 10.1055/s-2007-1022388
   ZILLA P, 1993, J CARDIAC SURG, V8, P32, DOI 10.1111/j.1540-8191.1993.tb00574.x
NR 33
TC 34
Z9 34
U1 0
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 2001
VL 56
IS 4
BP 545
EP 555
DI 10.1002/1097-4636(20010915)56:4<545::AID-JBM1126>3.0.CO;2-V
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 447EZ
UT WOS:000169559500010
PM 11400132
DA 2018-10-19
ER

PT J
AU Ferrari, A
   Hannouche, D
   Oudina, K
   Bourguignon, M
   Meunier, A
   Sedel, L
   Petite, H
AF Ferrari, A
   Hannouche, D
   Oudina, K
   Bourguignon, M
   Meunier, A
   Sedel, L
   Petite, H
TI In vivo tracking of bone marrow fibroblasts with fluorescent
   carbocyanine dye
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE carbocyanines; fluorescent dyes; transplantation; tissue engineering;
   mesenchymal stem cells
ID STROMAL CELLS; IN-VIVO; EXPRESSION; GROWTH; CORAL
AB Recent advances in the field of tissue engineering have culminated in new tissue substitutes that combine a biomaterial and precursor cells. The effectiveness of these materials is generally assessed in animals, but few studies explore the fate of the transplanted cells in vivo, despite its paramount importance for understanding the function of the engineered tissues. Current methods that use reporter genes or chimeric animals are not always well suited to solving tissue-engineering problems. We therefore developed a new method for irreversible labeling of cells to track their fate in oho. We used a fluorescent lipophilic probe, CM-Dil, that avidly binds to the cell membrane. Human bone marrow stromal fibroblasts could be labeled with 20 muM CM-Dil in 30 min. The CM-Dil was nor cytotoxic and did not affect cell proliferation in vitro. Cells could be monitored for up to 30 days when placed in a coral scaffold and implanted intramuscularly or in a bony site. However, the fluorescence intensity decreased roughly in parallel with the number of cell divisions. This fact needs to be taken into account during the design and interpretation of experiments. We believe that this technique is also of interest for other cell types. (C) 2001 John Wiley & Sons, inc.
C1 Univ D Diderot, Fac Med Lariboisiere, Lab Rech Orthoped, CNRS UPRESA 7052, F-75010 Paris, France.
RP Petite, H (reprint author), Univ D Diderot, Fac Med Lariboisiere, Lab Rech Orthoped, CNRS UPRESA 7052, 10 Ave de Verdun, F-75010 Paris, France.
RI Bourguignon, Marianne/O-5854-2017; Petite, Herve/E-3478-2016
OI Bourguignon, Marianne/0000-0001-9824-1248; Petite,
   Herve/0000-0003-1694-5060
CR Allay JA, 1997, HUM GENE THER, V8, P1417, DOI 10.1089/hum.1997.8.12-1417
   Andrade W, 1996, J IMMUNOL METHODS, V194, P181, DOI 10.1016/0022-1759(96)00083-X
   ASHTON BA, 1985, BONE, V6, P313, DOI 10.1016/8756-3282(85)90321-7
   ButnariuEphrat M, 1996, CLIN ORTHOP RELAT R, P234
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P274
   GUILLEMIN G, 1993, J MATER SCI-MATER M, V4, P575, DOI 10.1007/BF00125596
   Hebda PA, 1999, OTOLARYNG HEAD NECK, V121, P245, DOI 10.1016/S0194-5998(99)70179-8
   HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171
   HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0
   IRIGARAY JL, 1993, J THERM ANAL CALORIM, V39, P3, DOI 10.1007/BF02235441
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Louisia S, 1999, J BONE JOINT SURG BR, V81B, P719, DOI 10.1302/0301-620X.81B4.9358
   NAUGHTON BA, 1992, SOMAT CELL MOLEC GEN, V18, P451, DOI 10.1007/BF01233085
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   Owen M, 1988, J Cell Sci Suppl, V10, P63
   Petite H, 1996, J MATER SCI-MATER M, V7, P665, DOI 10.1007/BF00123405
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Triffitt James T., 1996, P39
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
NR 21
TC 46
Z9 47
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 2001
VL 56
IS 3
BP 361
EP 367
DI 10.1002/1097-4636(20010905)56:3<361::AID-JBM1104>3.0.CO;2-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 442DV
UT WOS:000169270700006
PM 11372053
DA 2018-10-19
ER

PT J
AU Massia, SP
   Stark, J
AF Massia, SP
   Stark, J
TI Immobilized RGD peptides on surface-grafted dextran promote biospecific
   cell attachment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE surface modification; immobilized dextran; biospecific cell adhesion;
   engineered biomaterials
ID PLASMA-PROTEINS; ADHESION; POLYSACCHARIDE; ADSORPTION; COATINGS;
   RECEPTOR
AB Dextran has recently been investigated as an alternative to poly(ethylene glycol) (PEG) for low protein-binding, cell-resistant coatings on biomaterial surfaces. Although antifouling properties of surface-grafted dextran and PEG are quite similar, surface-bound dextran has multiple reactive sites for high-density surface immobilization of biologically active molecules. We recently reported nontoxic aqueous methods to covalently immobilize dextran on material surfaces. These dextran coatings effectively limited cell adhesion and spreading in the presence of serum-borne cell adhesion proteins. In this study we utilized the same nontoxic aqueous methods to graft cell adhesion peptides on low protein-binding dextran monolayer surfaces. Chemical composition of all modified surfaces was verified by X-ray photoelectron spectroscopy (XPS). Surface-grafted cell adhesion peptides stimulated endothelial cell, fibroblast, and smooth muscle cell attachment and spreading in vitro. In contrast, surface-grafted inactive peptide sequences did not promote high levels of cell interaction. Surface-grafted high affinity cyclic RGD peptides promoted cell type-dependent interactions. With dextran-based surface coatings, it will be possible to develop well-defined surface modifications that promote specific cell interactions and perhaps better performance in long-term biomaterial implants. (C) 2001 John Wiley & Sons, Inc.
C1 Arizona State Univ, Dept Bioengn, Tempe, AZ 85287 USA.
RP Massia, SP (reprint author), Arizona State Univ, Dept Bioengn, POB 879709, Tempe, AZ 85287 USA.
RI Zhou, Feng/E-9510-2011
FU NHLBI NIH HHS [HL60450]
CR BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   BRANDLEY BK, 1989, DEV BIOL, V135, P74, DOI 10.1016/0012-1606(89)90159-0
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hirtenstein M, 1980, Dev Biol Stand, V46, P109
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Kao WYJ, 1998, BIOTECHNOL BIOENG, V59, P2, DOI 10.1002/(SICI)1097-0290(19980705)59:1<2::AID-BIT2>3.0.CO;2-G
   KONDOH A, 1993, J APPL POLYM SCI, V47, P1983, DOI 10.1002/app.1993.070471108
   MARCHANT RE, 1994, J BIOMAT SCI-POLYM E, V6, P549, DOI 10.1163/156856294X00509
   MASSIA SP, 2000, IN PRESS BIOMATERIAL
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   NAKAJIMA K, 1990, POLYM J, V22, P985, DOI 10.1295/polymj.22.985
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   OLBRICH KC, 1996, BIOMATERIALS, V17, P144
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   ROWLAND SA, 1995, J APPL BIOMATER, V6, P1, DOI 10.1002/jab.770060102
   SOSA JM, 1980, ANAL CHEM, V52, P910, DOI 10.1021/ac50056a031
   WEETALL HH, 1993, APPL BIOCHEM BIOTECH, V41, P157, DOI 10.1007/BF02916421
   WILSON MB, 1976, J IMMUNOL METHODS, V12, P171
   Xiao Y, 1996, BIOPHYS J, V71, P2869, DOI 10.1016/S0006-3495(96)79484-5
NR 25
TC 141
Z9 147
U1 3
U2 38
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 2001
VL 56
IS 3
BP 390
EP 399
DI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 442DV
UT WOS:000169270700010
PM 11372057
DA 2018-10-19
ER

PT J
AU Ramage, G
   vande Walle, K
   Wickes, BL
   Lopez-Ribot, JL
AF Ramage, G
   vande Walle, K
   Wickes, BL
   Lopez-Ribot, JL
TI Standardized method for in vitro antifungal susceptibility testing of
   Candida albicans biofilms
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID CLINICAL-LABORATORY-STANDARDS; IN-VITRO; BACTERIAL BIOFILMS;
   GROWTH-RATE; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS;
   ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL AGENTS; NATIONAL-COMMITTEE;
   ESCHERICHIA-COLI
AB Candida albicans is implicated in many biomaterial-related infections. Typically, these infections are associated with biofilm formation. Cells in biofilms display phenotypic traits that are dramatically different from those of their free-floating planktonic counterparts and are notoriously resistant to antimicrobial agents. Consequently, biofilm-related infections are inherently difficult to treat and to fully eradicate with normal treatment regimens. Here, we report a rapid and highly reproducible microtiter-based colorimetric assay for the susceptibility testing of fungal biofilms, based on the measurement of metabolic activities of the sessile cells by using a formazan salt reduction assay. The assay was used for in vitro antifungal susceptibility testing of several C. albicans strains grown as biofilms against amphotericin B and fluconazole and the increased resistance of C albicans biofilms against these antifungal agents was demonstrated. Because of its simplicity, compatibility with a widely available 96-well microplate platform, high throughput, and automation potential, we believe this assay represents a promising tool for the standardization of in vitro antifungal susceptibility testing of fungal biofilms.
C1 Univ Texas, Hlth Sci Ctr, Dept Med, Div Infect Dis,S Texas Ctr Biol Med, San Antonio, TX 78245 USA.
   Univ Texas, Hlth Sci Ctr, Dept Microbiol, San Antonio, TX 78245 USA.
RP Lopez-Ribot, JL (reprint author), Univ Texas, Hlth Sci Ctr, Dept Med, Div Infect Dis,S Texas Ctr Biol Med, Texas Res Pk,15355 Lambda Dr, San Antonio, TX 78245 USA.
RI Lopez-Ribot, Jose/D-2048-2010
CR Amorena B, 1999, J ANTIMICROB CHEMOTH, V44, P43, DOI 10.1093/jac/44.1.43
   Baillie GS, 1999, METHOD ENZYMOL, V310, P644
   Baillie GS, 1998, ANTIMICROB AGENTS CH, V42, P1900, DOI 10.1128/AAC.42.8.1900
   Baillie GS, 1998, ANTIMICROB AGENTS CH, V42, P2146, DOI 10.1128/AAC.42.8.2146
   BROWN R, 1989, PRACTICAL MED MICROB, P240
   Cannon RD, 1999, CRIT REV ORAL BIOL M, V10, P359, DOI 10.1177/10454411990100030701
   Ceri H, 1999, J CLIN MICROBIOL, V37, P1771
   Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130
   CHALLACOMBE SJ, 1994, ORAL SURG ORAL MED O, V78, P202, DOI 10.1016/0030-4220(94)90148-1
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Crump JA, 2000, EUR J CLIN MICROBIOL, V19, P1, DOI 10.1007/s100960050001
   DOMINGUE G, 1994, J CLIN MICROBIOL, V32, P2564
   Ell SR, 1996, J LARYNGOL OTOL, V110, P240
   Espinel-Ingroff A, 1998, MED MYCOL, V36, P68
   EVANS DJ, 1991, J ANTIMICROB CHEMOTH, V27, P177, DOI 10.1093/jac/27.2.177
   EVANS DJ, 1990, J ANTIMICROB CHEMOTH, V25, P585, DOI 10.1093/jac/25.4.585
   Gander S, 1997, J ANTIMICROB CHEMOTH, V40, P329, DOI 10.1093/jac/40.3.329
   Gander S, 1996, J ANTIMICROB CHEMOTH, V37, P1047, DOI 10.1093/jac/37.6.1047
   Ghannoum MA, 1997, J CHEMOTHERAPY, V9, P19
   Ghannoum MA, 1996, J CLIN MICROBIOL, V34, P489
   Gilbert P, 1997, Adv Dent Res, V11, P160
   GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865
   Gracia E, 1999, LUMINESCENCE, V14, P23, DOI 10.1002/(SICI)1522-7243(199901/02)14:1<23::AID-BIO513>3.0.CO;2-M
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Hawser S, 1996, J MED VET MYCOL, V34, P407
   Hawser S, 1996, J MED VET MYCOL, V34, P149
   HAWSER SP, 1995, ANTIMICROB AGENTS CH, V39, P2128, DOI 10.1128/AAC.39.9.2128
   Hawser SP, 1998, J CLIN MICROBIOL, V36, P1450
   Hoyle B D, 1991, Prog Drug Res, V37, P91
   HOYLE BD, 1990, J ANTIMICROB CHEMOTH, V26, P1, DOI 10.1093/jac/26.1.1
   HOYLE BD, 1993, INFECT IMMUN, V61, P777
   HOYLE BD, 1992, ANTIMICROB AGENTS CH, V36, P2054, DOI 10.1128/AAC.36.9.2054
   Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001
   Maira-Litran T, 2000, J APPL MICROBIOL, V88, P243, DOI 10.1046/j.1365-2672.2000.00963.x
   *NAT COMM CLIN LAB, 1997, M27A NCCLS
   Rex JH, 1997, CLIN INFECT DIS, V24, P235, DOI 10.1093/clinids/24.2.235
   Schierholz JM, 1999, ZBL BAKT-INT J MED M, V289, P165
   Stickler D, 1999, CURR OPIN MICROBIOL, V2, P270, DOI 10.1016/S1369-5274(99)80047-2
   TELLIER R, 1992, ANTIMICROB AGENTS CH, V36, P1619, DOI 10.1128/AAC.36.8.1619
NR 39
TC 408
Z9 464
U1 4
U2 33
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD SEP
PY 2001
VL 45
IS 9
BP 2475
EP 2479
DI 10.1128/AAC.45.9.2475-2479.2001
PG 5
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 465KQ
UT WOS:000170588500012
PM 11502517
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Praetorius, M
   Limberger, A
   Muller, M
   Lehner, R
   Schick, B
   Zenner, HP
   Plinkert, P
   Knipper, M
AF Praetorius, M
   Limberger, A
   Muller, M
   Lehner, R
   Schick, B
   Zenner, HP
   Plinkert, P
   Knipper, M
TI A novel microperfusion system for the long-term local supply of drugs to
   the inner ear: Implantation and function in the rat model
SO AUDIOLOGY AND NEURO-OTOLOGY
LA English
DT Article
DE cochlea; microperfusion system; inner ear therapy; drug delivery
ID ROUND WINDOW MEMBRANE; GUINEA-PIG; COCHLEA; PERMEABILITY; INFUSION
AB Local therapy is practiced for middle and inner ear diseases but is usually restricted to cases of ear drum perforation or repeated invasive intratympanic drug application. Perfusion of drugs on the round window or through the scalae of animals using a pump system suggests that the chronic local drug treatment might also be feasible in humans. However, drug delivery systems that are currently on the market involve repeated reimplantation if they are to be used for long-term drug supply. A bone-anchored, totally implantable micro-drug delivery system (MDS) for patient-controlled drug supply has been developed [Lehner et al., 1997]. In this study, we show the first successful long-term in vivo test of the MDS micro-pump in rats. The process of implantation and first functional tests will be described. The biomaterial used to manufacture the delivery system did not cause any inflammation reaction in any of the 9 animals successfully implanted. After activation of the micro-pump, the drug reservoir and port was found to be fluid-tight. Bolus applications of tetrodotoxin (TTX) to the round window induced a transient decrease of evoked brainstem responses. In 2 animals which carried the MDS for more than 8 months the proper functioning of the pumping device was examined in a 2-3 week interval over a 3 month period. The MDS can be autoclaved even after long-term implantation and can then be reused for subsequent implantations. Designed for life-long implantation in humans, the demonstration of an effective longterm drug supply to the inner ear using the MDS provides an encouraging first step towards future long-term drug treatment of the inner ear in humans. Copyright (C) 2001 S. Karger AG, Basel.
C1 Univ Tubingen, THRC, D-72076 Tubingen, Germany.
   Univ Homburg, Hosp Saarland, Dept Otorhinolaryngol, Homburg, Germany.
RP Knipper, M (reprint author), Univ Tubingen, THRC, Rontgenweg 11, D-72076 Tubingen, Germany.
RI Muller, Marcus/B-3877-2016
OI Muller, Marcus/0000-0001-5881-7708
CR BROWN JN, 1993, HEARING RES, V70, P167, DOI 10.1016/0378-5955(93)90155-T
   Ernfors P, 1996, NAT MED, V2, P463, DOI 10.1038/nm0496-463
   Goycoolea MV, 1997, MICROSC RES TECHNIQ, V36, P201, DOI 10.1002/(SICI)1097-0029(19970201)36:3<201::AID-JEMT8>3.3.CO;2-F
   HONRUBIA V, 1965, Acta Otolaryngol, V60, P105, DOI 10.3109/00016486509126993
   IGARASHI Y, 1985, ARCH OTO-RHINO-LARYN, V242, P167, DOI 10.1007/BF00454417
   Iguchi H, 1998, ORL J OTO-RHINO-LARY, V60, P181, DOI 10.1159/000027591
   Juhn SK, 1989, ACTA OTO-LARYNGOL, V457, P43
   JUNG W, 1971, ARCH KLIN EXP OHR, V199, P473
   Keithley EM, 1998, NEUROREPORT, V9, P2183, DOI 10.1097/00001756-199807130-00007
   KINGMA GG, 1992, J NEUROSCI METH, V45, P127, DOI 10.1016/0165-0270(92)90050-N
   Knipper M, 1997, NEUROCHEM INT, V31, P659, DOI 10.1016/S0197-0186(97)00009-0
   Knipper M, 1997, HNO, V45, P181
   Konishi T, 1966, Acta Otolaryngol, V62, P393, DOI 10.3109/00016486609119584
   KUIJPERS W, 1969, ACTA OTOLARYNGOL STO, V67, P202
   Lehner R, 1997, Ear Nose Throat J, V76, P567
   LUNDMAN LA, 1987, ACTA OTO-LARYNGOL, V104, P472, DOI 10.3109/00016488709128277
   MORI N, 1986, ACTA OTO-LARYNGOL, V101, P217, DOI 10.3109/00016488609132830
   MORIZONO T, 1987, REC ADV OT MED P 4 I, P1
   NUTTALL AL, 1977, ACTA OTO-LARYNGOL, V83, P393, DOI 10.3109/00016487709128863
   Oestreicher E, 2000, EUR J NEUROSCI, V12, P1584, DOI 10.1046/j.1460-9568.2000.00049.x
   PASIC TR, 1989, J COMP NEUROL, V283, P474, DOI 10.1002/cne.902830403
   RYAN AF, 1987, J COMP NEUROL, V255, P606, DOI 10.1002/cne.902550411
   SCHACHERN PA, 1987, ARCH OTOLARYNGOL, V113, P625
   SCHNIEDER EA, 1974, ANN OTO RHINOL LARYN, V83, P76, DOI 10.1177/000348947408300113
   STAECKER H, 1997, OTOLARYNGOL HEAD NEC, V119, P7
   TASAKI I, 1952, J NEUROPHYSIOL, V15, P497
   THEEUWES F, 1976, ANN BIOMED ENG, V4, P343, DOI 10.1007/BF02584524
NR 27
TC 20
Z9 21
U1 0
U2 5
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1420-3030
J9 AUDIOL NEURO-OTOL
JI Audiol. Neuro-Otol.
PD SEP-OCT
PY 2001
VL 6
IS 5
BP 250
EP 258
DI 10.1159/000046130
PG 9
WC Audiology & Speech-Language Pathology; Neurosciences;
   Otorhinolaryngology
SC Audiology & Speech-Language Pathology; Neurosciences & Neurology;
   Otorhinolaryngology
GA 503EJ
UT WOS:000172785400002
PM 11729327
DA 2018-10-19
ER

PT J
AU Chluba, J
   Voegel, JC
   Decher, G
   Erbacher, P
   Schaaf, P
   Ogier, J
AF Chluba, J
   Voegel, JC
   Decher, G
   Erbacher, P
   Schaaf, P
   Ogier, J
TI Peptide hormone covalently bound to polyelectrolytes and embedded into
   multilayer architectures conserving full biological activity
SO BIOMACROMOLECULES
LA English
DT Article
ID GROWTH-FACTOR; MELANOMA-CELLS; ADSORPTION; RECEPTORS; SURFACES; SYSTEMS;
   HEPARIN; FILMS; MODEL
AB We report the development of new bioactive coatings of biomaterials based on the alternate deposition of oppositely charged polyelectrolytes. We selected polylysine (PLL) and poly(glutamic acid) (PGA) for the polyelectrolytes and murine melanoma cells as a biological test model system. These cells respond specifically to a small peptide hormone, alpha-melanocortin, which is a potent stimulator of melanogenesis. We show that a synthetic alpha-melanocortin derivative, covalently coupled to PLL forming the outer layer of a multilayer film remains as biologically active as the free hormone. Furthermore, the long time activity of the hormone is maintained when embedded in multilayer architectures whereas its short time activity depends on integration depth. The embedding of bioactive molecules not only anchors them irreversibly on the biomaterial, but opens also the possibility to control their activity. In comparison to conventional coating methods, polyelectrolyte multilayers are easy to prepare and retain their biological activity after storage as dry material. These very flexible systems allow broad medical applications for implant and tissue engineering.
C1 INSERM U424, Ctr Rech Odontol, F-67085 Strasbourg, France.
   ULP, CNRS, Inst Charles Sadron, F-67083 Strasbourg, France.
   Fac Pharm, UMR 7514 CNRS, F-67400 Illkirch Graffenstaden, France.
RP Chluba, J (reprint author), INSERM U424, Ctr Rech Odontol, 11 Rue Humann, F-67085 Strasbourg, France.
RI SCHAAF, Pierre/J-2751-2016; Decher, Gero/E-7665-2011
OI SCHAAF, Pierre/0000-0001-7423-5492; Decher, Gero/0000-0002-7976-8818;
   Chluba, Johanna/0000-0001-8779-8016
CR Caruso F, 1997, LANGMUIR, V13, P3427, DOI 10.1021/la9608223
   Chluba-de Tapia J, 1996, J CELL SCI, V109, P2023
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   EBERLE AN, 1993, ANN NY ACAD SCI, V680, P320, DOI 10.1111/j.1749-6632.1993.tb19693.x
   EBERLE AN, 1988, MELANOTROPINS CHEM P, P128
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148
   FORTIER G, 1990, BIOSENS BIOELECTRON, V5, P473, DOI 10.1016/0956-5663(90)80036-D
   Haller MF, 1998, J CONTROL RELEASE, V53, P1, DOI 10.1016/S0168-3659(97)00232-0
   Ito Y, 1996, P NATL ACAD SCI USA, V93, P3598, DOI 10.1073/pnas.93.8.3598
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   LUKOSZ W, 1991, BIOSENS BIOELECTRON, V6, P215, DOI 10.1016/0956-5663(91)80006-J
   MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   RAMSDEN JJ, 1994, J PHYS CHEM-US, V98, P5376, DOI 10.1021/j100071a031
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   SOLCA FF, 1993, FEBS LETT, V322, P177, DOI 10.1016/0014-5793(93)81563-F
   WAGNER E, 1990, P NATL ACAD SCI USA, V87, P3410, DOI 10.1073/pnas.87.9.3410
   Zarge JI, 1997, J VASC SURG, V25, P840, DOI 10.1016/S0741-5214(97)70213-1
   ZASADZINSKI JA, 1994, SCIENCE, V263, P1726, DOI 10.1126/science.8134836
NR 21
TC 200
Z9 202
U1 0
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FAL
PY 2001
VL 2
IS 3
BP 800
EP 805
DI 10.1021/bm015529i
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 528RG
UT WOS:000174256300023
PM 11710034
DA 2018-10-19
ER

PT J
AU Broberg, M
   Nygren, H
AF Broberg, M
   Nygren, H
TI Von Willebrand factor, a key protein in the exposure of CD62P on
   platelets
SO BIOMATERIALS
LA English
DT Article
DE platelets; vWF; CD62P; granule release
ID PLATELET/POLYMORPHONUCLEAR LEUKOCYTE INTERACTION; VIII-VONWILLEBRAND
   FACTOR; P-SELECTIN; ACTIVATED PLATELETS; ENDOTHELIAL-CELLS; GLYCOPROTEIN
   LIGAND; ALPHA-GRANULE; SHEAR-STRESS; GPIIB-IIIA; ADHESION
AB When a biomaterial is introduced into the body water, electrolytes, and proteins adsorb to the surface. Platelets are then the first cells to interact with the surface adsorbed protein layer. We have studied the role of von Willebrand factor (vWF) for platelet-protein interaction by measuring different platelet responses to protein- and plasma-coated hydrophobic glass surfaces. A high exposure of CD62P on the platelet surface was seen after 10 min of incubation on platelets interacting with vWF and normal plasma-coated surfaces (79 and 67%, respectively). On the surfaces coated with albumin and factor VIII deficient plasma, the exposure was low (11 and 27%, respectively). A higher formation of filipodial extensions on the platelets was seen on the surfaces coated with vWF and normal plasma than on the surfaces coated with albumin or factor VIII deficient plasma. No significant differences were seen between the surfaces regarding the platelet release of PF4, ATP, or phospholipids. As shown by these results, vWF is a specific regulator of the exposure of CD62P by platelets and hence important for the interaction between platelets and later arriving neutrophils at biomaterial surfaces. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Gothenburg, Dept Anat & Cell Biol, S-40530 Gothenburg, Sweden.
RP Broberg, M (reprint author), Univ Gothenburg, Dept Anat & Cell Biol, Box 420, S-40530 Gothenburg, Sweden.
CR AZIZ KA, 1995, BRIT J HAEMATOL, V91, P846, DOI 10.1111/j.1365-2141.1995.tb05399.x
   BROBERG M, UNPUB PLATELET RELEA
   BUSCH C, 1980, THROMB RES, V19, P129, DOI 10.1016/0049-3848(80)90412-0
   BUTTRUM SM, 1993, BLOOD, V82, P1165
   CAPITANIO AM, 1985, BIOCHIM BIOPHYS ACTA, V839, P161, DOI 10.1016/0304-4165(85)90033-9
   CRAMER EM, 1994, BLOOD, V84, P1722
   Cunningham JG, 1996, J BIOL CHEM, V271, P11581, DOI 10.1074/jbc.271.19.11581
   DAHLGREN C, 1981, J IMMUNOL METHODS, V40, P171, DOI 10.1016/0022-1759(81)90064-8
   Du X, 1997, THROMB HAEMOSTASIS, V78, P96
   EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677
   Eriksson C, 1997, J BIOMED MATER RES, V37, P130, DOI 10.1002/(SICI)1097-4636(199710)37:1<130::AID-JBM16>3.0.CO;2-K
   ERIKSSON C, 2000, THESIS
   Evangelista V, 1999, BLOOD, V93, P876
   Evangelista V, 1996, BLOOD, V88, P4183
   Falati S, 1999, BLOOD, V94, P1648
   Frojmovic MM, 1997, THROMB HAEMOSTASIS, V77, P568
   FURIE B, 1995, THROMB HAEMOSTASIS, V74, P224
   Furlan M, 1996, ANN HEMATOL, V72, P341, DOI 10.1007/s002770050184
   FURLAN M, 1987, BIOCHIM BIOPHYS ACTA, V924, P27, DOI 10.1016/0304-4165(87)90067-5
   GEORGE JN, 1982, BLOOD, V59, P194
   HORNE MK, 1993, THROMB RES, V70, P91
   HOUDIJK WPM, 1986, ARTERIOSCLEROSIS, V6, P24, DOI 10.1161/01.ATV.6.1.24
   IKEDA Y, 1991, J CLIN INVEST, V87, P1234, DOI 10.1172/JCI115124
   JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906
   KAPLAN KL, 1979, BLOOD, V53, P604
   KLINGER MHF, 1995, INT ARCH ALLERGY IMM, V107, P541, DOI 10.1159/000237097
   KORTH R, 1993, LIPIDS, V28, P193, DOI 10.1007/BF02536639
   MOORE KL, 1994, J BIOL CHEM, V269, P23318
   NAGATA K, 1993, J IMMUNOL, V151, P3267
   Nygren H, 1998, J BIOMAT SCI-POLYM E, V9, P817, DOI 10.1163/156856298X00172
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   OSTERMAN DG, 1982, BIOCHEM BIOPH RES CO, V107, P130, DOI 10.1016/0006-291X(82)91679-5
   PEERSCHKE EIB, 1993, J EXP MED, V178, P579, DOI 10.1084/jem.178.2.579
   RIKSSON C, 2001, J LAB CLIN MED, V137, P56
   SAKARIASSEN KS, 1979, NATURE, V279, P636, DOI 10.1038/279636a0
   SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M
   Savage B, 1998, CELL, V94, P657, DOI 10.1016/S0092-8674(00)81607-4
   SAVAGE B, 1992, J BIOL CHEM, V267, P11300
   STEL HV, 1985, BLOOD, V65, P85
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   Wu YP, 1996, ARTERIOSCL THROM VAS, V16, P611, DOI 10.1161/01.ATV.16.5.611
   YEO EL, 1994, BLOOD, V83, P2498
   Yuan YP, 1999, J BIOL CHEM, V274, P36241, DOI 10.1074/jbc.274.51.36241
NR 43
TC 14
Z9 17
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2001
VL 22
IS 17
BP 2403
EP 2409
DI 10.1016/S0142-9612(00)00427-0
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 460GT
UT WOS:000170300400010
PM 11511037
DA 2018-10-19
ER

PT J
AU Grigolo, B
   Roseti, L
   Fiorini, M
   Fini, M
   Giavaresi, G
   Aldini, NN
   Giardino, R
   Facchini, A
AF Grigolo, B
   Roseti, L
   Fiorini, M
   Fini, M
   Giavaresi, G
   Aldini, NN
   Giardino, R
   Facchini, A
TI Transplantation of chondrocytes seeded on a hyaluronan derivative (Hyaff
   (R)-11) into cartilage defects in rabbits
SO BIOMATERIALS
LA English
DT Article
DE chondrocytes; transplantation; articular cartilage; Hyaff (R)-11
ID ARTICULAR-CARTILAGE; OSTEOCHONDRAL DEFECTS; ALLOGRAFT CHONDROCYTES;
   PERIOSTEAL GRAFTS; COLLAGEN GEL; CANINE MODEL; KNEE-JOINT; REPAIR;
   RECONSTRUCTION; ALGINATE
AB Different methods have been used to improve chondrocyte transplantation for the repair of articular cartilage defects. Several groups of biomaterials have been proposed as support for in vitro cell growth and for in vivo implantation. Here, we describe a new approach investigating the healing of rabbit cartilage by means of autologous chondrocytes seeded on a hyaluronan derivative referred to as Hyaff(R)-11. Full thickness defects were created bilaterally in the weight-bearing Surface of the medial femoral condyle of both femora of New Zealand male rabbits. The wounds were then repaired using both chondrocytes seeded on the biomaterial and biomaterial alone. Controls were similarly treated but received either no treatment or implants of the delivery substance. Histologic samples from in and around the defect sites were examined 1, 3 and 6 months after surgery and were scored from 0 to 16. Statistically significant differences in the quality of the regenerated tissue were found between the grafts carried out with biomaterial carrying chondrocyte cells compared to the biomaterial alone or controls. This study demonstrates the efficacy of this hyaluronan-based scaffold for autologous chondrocytes transplantation. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Ist Ortoped Rizzoil, Ist Ric Codivilla Putti, Lab Immunol & Genet, I-40136 Bologna, Italy.
   Ist Ortoped Rizzoil, Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, I-40136 Bologna, Italy.
   Univ Bologna, Dipartimento Med Interna & Gastroenterol, I-40138 Bologna, Italy.
RP Facchini, A (reprint author), Ist Ortoped Rizzoil, Ist Ric Codivilla Putti, Lab Immunol & Genet, Via Barbiano 1-10, I-40136 Bologna, Italy.
RI Grigolo, Brunella/J-5417-2016
OI Grigolo, Brunella/0000-0002-3990-6745; Giavaresi,
   Gianluca/0000-0001-7843-5969; Fini, Milena/0000-0002-3732-3570
CR BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Breinan HA, 1997, J BONE JOINT SURG AM, V79A, P1439, DOI 10.2106/00004623-199710000-00001
   Brittberg M, 1997, BIOMATERIALS, V18, P235, DOI 10.1016/S0142-9612(96)00117-2
   Brittberg M, 1996, CLIN ORTHOP RELAT R, P270
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BUCKWALTER JA, 1994, J BONE JOINT SURG AM, V76A, P1405, DOI 10.2106/00004623-199409000-00019
   CAMPOCCIA D, 1993, BIOMATERIALS, V14, P1135, DOI 10.1016/0142-9612(93)90156-V
   Carranza-Bencano A, 1999, CALCIFIED TISSUE INT, V65, P402, DOI 10.1007/s002239900721
   Chu CR, 1997, CLIN ORTHOP RELAT R, P220
   COLETTI JM, 1972, J BONE JOINT SURG AM, VA 54, P147, DOI 10.2106/00004623-197254010-00014
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   Fujimoto E, 1999, ARCH ORTHOP TRAUM SU, V119, P139, DOI 10.1007/s004020050377
   GOMARSANCHO F, 1987, INT ORTHOP, V11, P65, DOI 10.1007/BF00266060
   GRANDE DA, 1987, ANAT REC, V218, P142, DOI 10.1002/ar.1092180208
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Guzzardella GA, 2000, J APPL ANIM RES, V17, P217, DOI 10.1080/09712119.2000.9706305
   HENDRICKSON DA, 1994, J ORTHOP RES, V12, P484
   HOMMINGA GN, 1989, ACTA ORTHOP SCAND, V60, P326, DOI 10.3109/17453678909149287
   Kawamura S, 1998, ACTA ORTHOP SCAND, V69, P56, DOI 10.3109/17453679809002358
   KIM HKW, 1991, J BONE JOINT SURG AM, V73A, P1301, DOI 10.2106/00004623-199173090-00004
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   MILLER D V, 1989, Arthroscopy, V5, P245, DOI 10.1016/0749-8063(89)90137-0
   Morrone G, 2000, ARTIF CELL BLOOD SUB, V28, P321, DOI 10.3109/10731190009119362
   Nehrer S, 1998, BIOMATERIALS, V19, P2313, DOI 10.1016/S0142-9612(98)00143-4
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   RASTRELLI A, 1990, CLIN IMPLANT MAT, V9, P199
   RUBAK JM, 1982, ACTA ORTHOP SCAND, V53, P175, DOI 10.3109/17453678208992197
   Shortkroff S, 1996, BIOMATERIALS, V17, P147, DOI 10.1016/0142-9612(96)85759-0
   Stanton JS, 1995, J MATER SCI-MATER M, V6, P739
   TRIPPEL SB, 1995, NEW ENGL J MED, V332, P539
   VACHON AM, 1991, AM J VET RES, V52, P317
   vanSusante JLC, 1995, ACTA ORTHOP SCAND, V66, P549, DOI 10.3109/17453679509002314
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   Wei XC, 1999, J BIOMED MATER RES, V46, P539, DOI 10.1002/(SICI)1097-4636(19990915)46:4<539::AID-JBM12>3.0.CO;2-S
   Wei XC, 1997, J BIOMED MATER RES, V34, P63, DOI 10.1002/(SICI)1097-4636(199701)34:1<63::AID-JBM9>3.0.CO;2-L
   WRIGHT JG, 1995, NEW ENGL J MED, V332, P540
NR 38
TC 179
Z9 190
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2001
VL 22
IS 17
BP 2417
EP 2424
DI 10.1016/S0142-9612(00)00429-4
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 460GT
UT WOS:000170300400012
PM 11511039
DA 2018-10-19
ER

PT J
AU Andersson, J
   Larsson, R
   Richter, R
   Ekdahl, KN
   Nilsson, B
AF Andersson, J
   Larsson, R
   Richter, R
   Ekdahl, KN
   Nilsson, B
TI Binding of a model regulator of complement activation (RCA) to a
   biomaterial surface: surface-bound factor H inhibits complement
   activation
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; blood; complement activation; factor H
ID IN-VITRO MODEL; CARDIOPULMONARY BYPASS; EXTRACORPOREAL-CIRCULATION;
   PROTEIN BETA-1H; WHOLE-BLOOD; PURIFICATION; ADSORPTION; INTERFACES;
   GENERATION; PLATELET
AB The complement system is an important inflammatory mediator during procedures such as cardiopulmonary bypass and hemodialysis when blood is exposed to large areas of biomaterial surface. This contact between blood and the biomaterials of implants and extracorporeal circuits leads to an inflammatory response mediated by the complement system. The aim of this study was to assess the ability of a complement regulator (factor H) immobilised on a biomaterial surface to inhibit complement cascade mediated inflammatory responses. The cross-linker-N-succinimidyl 3-(2-pyridyldithio) propionate was used to immobilise factor H on a model biomaterial surface without affecting the biological activity of the inhibitor. Binding of factor H was then characterised using quartz crystal micro balance-dissipation (QCM-D) and enzyme immunoassays for products of complement activation: bound C3 fragments and soluble C3a, sC5b-9, and C1s-C1INA. Immobilised factor H reduced the amount C3 fragments deposited on the biomaterial surface after incubation with serum, plasma, or whole blood. In addition, lower levels of soluble C3a, and sC5b-9 were generated after incubation with whole blood. In summary, we have demonstrated that complement activation on a highly activating model surface can be inhibited by immobilised factor H and have defined prerequisites for the preparation of future biomaterial surfaces with immobilised regulators of complement activation. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Hosp, Clin Immunol Sect, S-75185 Uppsala, Sweden.
   Q Sense AB, S-41292 Gothenburg, Sweden.
   Univ Kalmar, Dept Chem & Biomed Sci, S-39182 Kalmar, Sweden.
RP Nilsson, B (reprint author), Univ Hosp, Clin Immunol Sect, S-75185 Uppsala, Sweden.
RI Nilsson Ekdahl, Kristina/B-5301-2012; Richter, Ralf Peter/B-3343-2013;
   Nilsson, Bo/B-3102-2012
OI Richter, Ralf Peter/0000-0003-3071-2837; Nilsson, Bo/0000-0003-0057-2730
CR Caruso F, 1997, J COLLOID INTERF SCI, V186, P129, DOI 10.1006/jcis.1996.4625
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   DECORDOBA SR, 1987, IMMUNOGENETICS, V25, P267
   DISCIPIO RG, 1992, J IMMUNOL, V149, P2592
   EASTERBROOKSMITH SB, 1992, MOL IMMUNOL, V29, P1203, DOI 10.1016/0161-5890(92)90056-4
   Efendic E, 1999, Lakartidningen, V96, P4538
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   GREELEY WJ, 1991, ANN THORAC SURG, V52, P417, DOI 10.1016/0003-4975(91)90900-B
   HAMMER CH, 1981, J BIOL CHEM, V256, P3995
   HIMMELFARB J, 1995, J LAB CLIN MED, V126, P392
   HOLERS VM, 1992, IMMUNOL TODAY, V13, P231
   HOLME ER, 1992, MOL IMMUNOL, V29, P957, DOI 10.1016/0161-5890(92)90134-J
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271
   Hook F, 1998, J COLLOID INTERF SCI, V208, P63, DOI 10.1006/jcis.1998.5774
   HOOK F, 2001, UNPUB J AM CHEM SOC
   KIRKLIN JK, 1989, CARDIOPULMONARY BYPA, P3026
   Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7
   MCALEER MA, 1988, GENOME S, V30, P136
   Mollnes TE, 1998, VOX SANG, V74, P303, DOI 10.1111/j.1423-0410.1998.tb05435.x
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x
   Nangaku M, 1998, KIDNEY INT, V54, P1419, DOI 10.1046/j.1523-1755.1998.00130.x
   Nilsson B, 1998, BLOOD, V92, P1661
   NILSSON UR, 1965, J EXP MED, V122, P277, DOI 10.1084/jem.122.2.277
   NILSSON UR, 1993, SCAND J IMMUNOL, V37, P349, DOI 10.1111/j.1365-3083.1993.tb02564.x
   PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257
   PEKNA M, 1993, CLIN EXP IMMUNOL, V91, P404
   RATNER BD, 1996, BIOMATERIALS SCI INT, P484
   Rauterberg E W, 1988, Adv Exp Med Biol, V240, P365
   RINDER CS, 1995, J CLIN INVEST, V96, P1564, DOI 10.1172/JCI118195
   RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   Sahu A, 1996, J IMMUNOL, V157, P884
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   SEYA T, 1995, MICROBIOL IMMUNOL, V39, P295, DOI 10.1111/j.1348-0421.1995.tb02205.x
   STORM KE, 1992, VET IMMUNOL IMMUNOP, V34, P47, DOI 10.1016/0165-2427(92)90151-F
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Wanner C, 1997, Kidney Int Suppl, V62, pS53
   WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268
   WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147
NR 42
TC 34
Z9 37
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2001
VL 22
IS 17
BP 2435
EP 2443
DI 10.1016/S0142-9612(00)00431-2
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 460GT
UT WOS:000170300400014
PM 11511041
DA 2018-10-19
ER

PT J
AU Alferiev, IS
   Hinson, JT
   Ogle, M
   Breuer, E
   Levy, RJ
AF Alferiev, IS
   Hinson, JT
   Ogle, M
   Breuer, E
   Levy, RJ
TI High reactivity of alkyl sulfides towards epoxides under conditions of
   collagen fixation - a convenient approach to 2-amino-4-butyrolactones
SO BIOMATERIALS
LA English
DT Article
DE alkylations; oxiranes; tissue fixation; bioorganic chemistry;
   2-amino-4-butyrolactones
ID ACID
AB Epoxy crosslinking agents have been investigated for use in the fabrication of bioprosthetic devices, such as heterograft heart valve prostheses. It has been generally assumed that epoxy crosslinking takes place via amino-epoxy reactions. The present study investigated the hypothesis that the reactions of methionine residues with epoxides also can occur in biomaterial crosslinking. A series of model reactions were studied in which a mono-epoxide was combined with individual alkyl sulfides. In the present studies epoxides rapidly alkylate aliphatic sulfides, including methionine derivatives, in buffered aqueous solutions at room temperature and pH close to neutral, forming sulfonium compounds, which are stable at pH 5-7 at temperatures up to 50 degreesC, except for cases in which methionine derivatives with non-protected carboxy groups are used. The rate of reaction remains practically unchanged within the range of pH from 5 to 12, whereas in strongly alkaline media the reverse reaction occurs. This discovery can provide a better understanding of processes occurring in the fixation of bioprosthetic tissues with polyepoxides. It can also develop into a site-specific method to label methionine residues in proteins. The carboxy group-containing sulfonium betaines derived from N-protected methionines undergo cyclization in unexpectedly mild conditions, which can be used as an efficient method for preparation of N-protected 2-amino-4-butyrolactones with sensitive protective groups. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Childrens Hosp Philadelphia, Div Cardiol, Abramson Res Ctr, Philadelphia, PA 19104 USA.
   St Jude Med Inc, St Paul, MN 55117 USA.
   Hebrew Univ Jerusalem, Dept Med Chem, IL-91120 Jerusalem, Israel.
RP Levy, RJ (reprint author), Childrens Hosp Philadelphia, Div Cardiol, Abramson Res Ctr, Suite 702,3516 Civic Ctr Blvd, Philadelphia, PA 19104 USA.
RI Breuer, Eli/E-8382-2011
FU NHLBI NIH HHS [HL59730]
CR Alferiev IS, 2001, J POLYM SCI POL CHEM, V39, P105, DOI 10.1002/1099-0518(20010101)39:1<105::AID-POLA120>3.3.CO;2-#
   Berkowitz DB, 1996, SYNTHESIS-STUTTGART, P39, DOI 10.1055/s-1996-4177
   Karnbrock W, 1996, J AM CHEM SOC, V118, P913, DOI 10.1021/ja953222j
   KRIEF A, 1989, SYNTHETIC COMMUN, V19, P1203, DOI 10.1080/00397918908054524
   MATSUURA F, 1994, TETRAHEDRON, V50, P265, DOI 10.1016/S0040-4020(01)80749-3
   Moore MA, 1996, J BIOMED MATER RES, V32, P209, DOI 10.1002/(SICI)1097-4636(199610)32:2<209::AID-JBM9>3.0.CO;2-X
   OKUMA K, 1987, HETEROCYCLES, V26, P2343, DOI 10.3987/R-1987-09-2343
   OZINSKAS AJ, 1986, J ORG CHEM, V51, P5047, DOI 10.1021/jo00376a001
   PATTENDEN G, 1991, TETRAHEDRON LETT, V32, P259, DOI 10.1016/0040-4039(91)80870-C
   Snyder HR, 1942, J AM CHEM SOC, V64, P2082, DOI 10.1021/ja01261a022
   Tang Z, 1995, ASAIO J, V41, P72, DOI 10.1097/00002480-199501000-00012
   TU R, 1994, J BIOMED MATER RES, V28, P677, DOI 10.1002/jbm.820280604
   TU R, 1993, INT J ARTIF ORGANS, V16, P537
   WANG E, 1993, INT J ARTIF ORGANS, V16, P530
   Weitz IS, 1997, J ORG CHEM, V62, P2527, DOI 10.1021/jo962257e
NR 15
TC 10
Z9 10
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2001
VL 22
IS 18
BP 2501
EP 2506
DI 10.1016/S0142-9612(00)00440-3
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 460GV
UT WOS:000170300600009
PM 11516082
DA 2018-10-19
ER

PT J
AU Gottenbos, B
   Klatter, F
   Van Der Mei, HC
   Busscher, HJ
   Nieuwenhuis, P
AF Gottenbos, B
   Klatter, F
   Van Der Mei, HC
   Busscher, HJ
   Nieuwenhuis, P
TI Late hematogenous infection of subcutaneous implants in rats
SO CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
LA English
DT Article
ID BACTERIAL TRANSLOCATION; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS;
   BIOMEDICAL POLYMERS; ADHESION; COLONIZATION
AB Late biomaterial-centered infection is a major complication associated with the use of biomaterial implants. In this study biomaterials that had been implanted subcutaneously in rats were hematogenously challenged with bacteria 4 weeks after implantation. Bacteria were spread either by intravenous injection or by stimulation of bacterial translocation. It was found that none of the biomaterials was infected by hematogenous spread, whereas 5% of the implants were infected by perioperative contamination. We conclude that late hematogenous infection of subcutaneous biomaterials does not occur in the rat. For humans as well, there are growing doubts whether implants actually become infected through hematogenous routes; it is thought that late infections may be caused by delayed appearance of perioperatively introduced bacteria.
C1 Univ Groningen, Fac Med Sci, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Groningen, Fac Med Sci, Dept Cell Biol, Immunol Sect, NL-9713 AV Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Fac Med Sci, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR AHLBERG A, 1978, CLIN ORTHOP RELAT R, P69
   BENGTSON S, 1987, ACTA ORTHOP SCAND, V58, P529, DOI 10.3109/17453678709146393
   BERG RD, 1975, INFECT IMMUN, V11, P320
   BLACKBURN WD, 1991, ARTHRITIS RHEUM, V34, P110, DOI 10.1002/art.1780340118
   BLOMGREN G, 1980, CLIN ORTHOP RELAT R, P308
   BLOMGREN G, 1981, CLIN ORTHOP RELAT R, P244
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Deitch EA, 1994, GUT               S1, V35, pS23
   Duchmann R, 1996, EUR J IMMUNOL, V26, P934, DOI 10.1002/eji.1830260432
   EDMISTON CE, 1991, SURG GYNECOL OBSTET, V173, P73
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GUO W, 1993, SCAND J GASTROENTERO, V28, P393, DOI 10.3109/00365529309098238
   LaPorte DM, 1999, J BONE JOINT SURG BR, V81B, P56, DOI 10.1302/0301-620X.81B1.8608
   MANILOFF G, 1987, CLIN ORTHOP RELAT R, P194
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   MOORE WS, 1980, ARCH SURG-CHICAGO, V115, P1379
   MORA EM, 1991, ARCH SURG-CHICAGO, V126, P157
   *NIH, 1985, NIH PUBL, V8623
   O'Boyle CJ, 1998, GUT, V42, P29, DOI 10.1136/gut.42.1.29
   POSS R, 1984, CLIN ORTHOP RELAT R, P117
   Printzen G, 1996, INJURY, V27, P9
   Smith RP, 2000, J ANTIMICROB CHEMOTH, V45, P483, DOI 10.1093/jac/45.4.483
   SOUTHWOOD RT, 1985, J BONE JOINT SURG BR, V67, P229
   VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28
   WIEDERMANN U, 1995, INFECT IMMUN, V63, P3062
   ZDANOWSKI Z, 1994, ARTIF ORGANS, V18, P448, DOI 10.1111/j.1525-1594.1994.tb02231.x
NR 27
TC 5
Z9 5
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1071-412X
J9 CLIN DIAGN LAB IMMUN
JI Clin. Diagn. Lab. Immunol.
PD SEP
PY 2001
VL 8
IS 5
BP 980
EP 983
DI 10.1128/CDLI.8.5.980-983.2001
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 471ZR
UT WOS:000170959000024
PM 11527814
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Luo, Y
   Prestwich, GD
AF Luo, Y
   Prestwich, GD
TI Novel biomaterials for drug delivery
SO EXPERT OPINION ON THERAPEUTIC PATENTS
LA English
DT Review
DE biodegradable; biomaterials; drug delivery; hybrid; inorganic; natural;
   polymer; synthetic
ID HUMAN GROWTH-HORMONE; CALCIUM-PHOSPHATE BIOMATERIAL;
   LACTIDE-CO-GLYCOLIDE; CONTROLLED-RELEASE; IN-VITRO; BIODEGRADABLE
   MICROSPHERES; HYDROLYTIC DEGRADATION; POLY(ETHYLENE GLYCOL);
   BLOCK-COPOLYMERS; POLYMERIC DRUGS
AB Safety and efficacy of pharmaceutical agents can be greatly improved by encapsulation within, or covalent attachment to, a biomaterial carrier. Such drug delivery systems differ from conventional drug dosage forms (pills, tablets, ointments, creams, injectables and 'tiny time capsules') in that a localised depot of drug provides patterned release of the active agent with a predetermined time course. The pattern of drug release may be constant, oscillating, declining continuously, or even pulsatile. The need to engineer different release patterns for drugs of different molecular sizes, potency, stability and hydrophobicity provides the impetus for active study of the design of new biomaterials, intelligent delivery systems and approaches for delivery through different portals in the body. The field of controlled drug delivery provides a driving force for current innovations in biomaterials. For most drug delivery systems, polymers function simply as inert, biocompatible carriers. In other systems, polymers can be designed with targeting or pathology-responsive functions. This review summarises some of the recently developed intellectual property in the field of biomaterials applied to drug delivery systems. Included are implantable ceramics and other inorganic materials, nondegradable and degradable synthetic polymers, natural polymers and hybrid biomaterials derived from synthetic and natural polymers.
C1 Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA.
RP Prestwich, GD (reprint author), Univ Utah, Dept Med Chem, 30 South 2000 East,Room 201, Salt Lake City, UT 84112 USA.
CR ALLCOCK HR, 1983, MACROMOLECULES, V16, P1401, DOI 10.1021/ma00243a001
   ANDARIS LTD, 1997, Patent No. 9710850
   Bell CL, 1996, J BIOMAT SCI-POLYM E, V7, P671, DOI 10.1163/156856296X00444
   Bellini D., 2000, [No title captured], Patent No. [W00001733 (Al), 0001733, WO0001733A1]
   BEMOIT MA, 1997, INT ORTHOP, V21, P403
   BOARD TRUSTEES U ILL, 1997, Patent No. 9737680
   BOUHADIR KH, 1999, 217 ACS NAT M AN CAL
   BOUHADIR KH, 1998, 216 ACS NAT M BOST A
   Bruining MJ, 1999, J BIOMED MATER RES, V47, P189, DOI 10.1002/(SICI)1097-4636(199911)47:2<189::AID-JBM8>3.0.CO;2-M
   CAMPBELL P, 1980, ARCH BIOCHEM BIOPHYS, V203, P676, DOI 10.1016/0003-9861(80)90225-8
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Chaput C, 1995, MATER RES SOC SYMP P, V385, P49, DOI 10.1557/PROC-385-49
   Cleland JL, 1997, PHARMACEUT RES, V14, P420, DOI 10.1023/A:1012031012367
   Cleland JL, 1996, PHARMACEUT RES, V13, P1464, DOI 10.1023/A:1016063109373
   DAHIYAT BI, 1995, J CONTROL RELEASE, V33, P13, DOI 10.1016/0168-3659(94)00039-W
   DANBIOSYST UK LTD, 1997, Patent No. 9735562
   DROHAN WN, 1996, Patent No. 9641818
   DUCHEYNE P, 1997, Patent No. 5591453
   DV TECH INC, 1997, Patent No. 9721441
   E KARLS U TUBINGEN, 1997, Patent No. 9707204
   Egilmez NK, 2000, CANCER RES, V60, P3832
   Eligio T, 1999, ANGEW MAKROMOL CHEM, V270, P69
   ELSAYED M, 2000, POLYM PREPR, V41, P1726
   EMISPHERE TECH INC, 1997, Patent No. 5601846
   ENGELBERG J, 1991, BIOMATERIALS, V12, P290
   FEIJEN J, 1994, EUR J PHARM SCI, V2, P7, DOI 10.1016/0928-0987(94)90050-7
   Feng Y, 1999, MATERIALWISS WERKST, V30, P862, DOI 10.1002/(SICI)1521-4052(199912)30:12<862::AID-MAWE862>3.3.CO;2-Z
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gaspar MM, 1998, J CONTROL RELEASE, V52, P53
   Gautier H, 1998, J BIOMED MATER RES, V40, P606, DOI 10.1002/(SICI)1097-4636(19980615)40:4<606::AID-JBM12>3.0.CO;2-D
   Gautier H, 2000, J BIOMED MATER RES, V52, P308, DOI 10.1002/1097-4636(200011)52:2<308::AID-JBM9>3.0.CO;2-6
   Goodwin CJ, 1998, J BIOMED MATER RES, V40, P204
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Guicheux J, 1998, J BIOMED MATER RES, V40, P79, DOI 10.1002/(SICI)1097-4636(199804)40:1<79::AID-JBM9>3.0.CO;2-O
   Guicheux J, 1998, J BONE MINER RES, V13, P739, DOI 10.1359/jbmr.1998.13.4.739
   GURSEL I, 1997, P INT S CONTR REL BI, P1045
   Hanes J, 1998, BIOMATERIALS, V19, P163, DOI 10.1016/S0142-9612(97)00221-4
   Hassan CM, 2000, EUR J PHARM BIOPHARM, V49, P161, DOI 10.1016/S0939-6411(99)00056-9
   HELLER J, 1987, Journal of Controlled Release, V6, P217, DOI 10.1016/0168-3659(87)90078-2
   HELLER J, 1990, BIOMATERIALS, V11, P659, DOI 10.1016/0142-9612(90)90024-K
   HELLER J, 2001, 10 INT S REC ADV DRU, P49
   HOFFMAN AS, 1984, POLYM MAT ARTIFICIAL, P13
   Inukai M, 2000, CHEM PHARM BULL, V48, P850
   JALIL RU, 1990, DRUG DEV IND PHARM, V16, P2353, DOI 10.3109/03639049009058535
   Jeong B, 1999, J CONTROL RELEASE, V62, P109, DOI 10.1016/S0168-3659(99)00061-9
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   JEONG S Y, 1986, Archives of Pharmacal Research (Seoul), V9, P63, DOI 10.1007/BF02857213
   Jo S, 1999, J BIOACT COMPAT POL, V14, P457, DOI 10.1177/088391159901400602
   John G, 1999, MACROMOLECULES, V32, P1853, DOI 10.1021/ma981729j
   Kim DD, 1998, PHARMACEUT RES, V15, P783
   Kim Y, 1999, CHEM-EUR J, V5, P2133, DOI 10.1002/(SICI)1521-3765(19990702)5:7<2133::AID-CHEM2133>3.0.CO;2-J
   Kimakhe S, 1999, J BIOMED MATER RES, V47, P18, DOI 10.1002/(SICI)1097-4636(199910)47:1<18::AID-JBM3>3.0.CO;2-T
   Kishida A, 1998, J BIOACT COMPAT POL, V13, P270, DOI 10.1177/088391159801300403
   Kishida A, 1998, J BIOACT COMPAT POL, V13, P222, DOI 10.1177/088391159801300305
   KOBAYASHI H, 1992, J BIOMED MATER RES, V26, P1463, DOI 10.1002/jbm.820261106
   KOHN J, 1986, BIOMATERIALS, V7, P176, DOI 10.1016/0142-9612(86)90098-0
   KOHN J, 1991, POLYM PREPR, V32, P223
   Kreitz MR, 1997, BIOMATERIALS, V18, P1645, DOI 10.1016/S0142-9612(97)00106-3
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Kurisawa M, 1997, J BIOMAT SCI-POLYM E, V8, P691, DOI 10.1163/156856297X00506
   Lambotte J C, 1998, Chirurgie, V123, P572, DOI 10.1016/S0001-4001(99)80006-3
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Langer R, 1995, CHEM ENG SCI, V50, P4109, DOI 10.1016/0009-2509(95)00226-X
   LANGER R, 1995, MRS BULL, V20, P18
   Langer R, 1998, NATURE, V392, P5
   Lee KY, 2000, NATURE, V408, P998
   Lemons JE, 1996, BONE, V19, pS121, DOI 10.1016/S8756-3282(96)00128-7
   Li C, 1998, CANCER RES, V58, P2404
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Li SM, 2000, J MATER SCI-MATER M, V11, P227, DOI 10.1023/A:1008920326988
   LMOLINA I, 2001, BIOMATERIALS, V22, P363
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   LUCKE A, 2000, BIOMATERIALS, V21, P2371
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Luo Y, 1999, BIOCONJUGATE CHEM, V10, P755, DOI 10.1021/bc9900338
   Luo Y, 2000, BIOMACROMOLECULES, V1, P208, DOI 10.1021/bm000283n
   MACROMED INC, 1999, Patent No. 9918142
   MASSACHUSETTS I TECH, 1999, Patent No. 5955343
   Mathiowitz E, 1997, NATURE, V386, P410, DOI 10.1038/386410a0
   MAXIM PHARM, 1997, Patent No. 9705267
   MERKLI A, 1995, EUR J PHARM BIOPHARM, V41, P271
   Meyer DE, 2001, CANCER RES, V61, P1548
   Morita T, 2000, J CONTROL RELEASE, V69, P435, DOI 10.1016/S0168-3659(00)00326-6
   MULLER HM, 1993, ANGEW CHEM INT EDIT, V32, P477, DOI 10.1002/anie.199304771
   NAGARSEKAR A, 2000, AM CHEM SOC 220
   NOBES GAR, 1998, DRUG DELIV, V5, P161
   NUTTELMAN CR, 2000, POLYM PREPR, V41, P1685
   Ooya T., 2000, ACS SYM SER, V752, P375
   Pean JM, 1999, PHARMACEUT RES, V16, P1294, DOI 10.1023/A:1014818118224
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Pettit DK, 1997, PHARMACEUT RES, V14, P1422, DOI 10.1023/A:1012176823155
   POINT BIOMEDICAL COR, 1999, Patent No. 9911196
   POUYANI T, 1997, Patent No. 5616568
   Prestwich GD, 2000, INT CONGR SER, V1196, P181
   PRESTWICH GD, 2001, GLCOFORUM
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   Ramchandani M, 1998, J CONTROL RELEASE, V54, P167, DOI 10.1016/S0168-3659(97)00113-2
   Ramchandani M, 1997, J CONTROL RELEASE, V43, P161, DOI 10.1016/S0168-3659(96)01481-2
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   Remunan-Lopez C, 1998, EUR J PHARM BIOPHARM, V45, P49, DOI 10.1016/S0939-6411(97)00122-7
   RodriguezLorenzo LM, 1996, J BIOMED MATER RES, V30, P515, DOI 10.1002/(SICI)1097-4636(199604)30:4<515::AID-JBM10>3.0.CO;2-G
   Rosa G D, 2000, J Control Release, V69, P283, DOI 10.1016/S0168-3659(00)00315-1
   Saito N, 1999, J BIOMED MATER RES, V47, P104, DOI 10.1002/(SICI)1097-4636(199910)47:1<104::AID-JBM15>3.0.CO;2-7
   Sanchez A, 1996, J PHARM SCI, V85, P547, DOI 10.1021/js960069y
   Sastry TP, 1997, J MACROMOL SCI PURE, VA34, P915, DOI 10.1080/10601329708014341
   SCHWARTE LM, 1998, ACS SYM SER, V709, P56
   Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569
   Serizawa T, 1999, J BIOMAT SCI-POLYM E, V10, P391, DOI 10.1163/156856299X00441
   SMITHKLINE BEECHAM P, 1997, Patent No. 9720579
   Suh HR, 1998, J BIOMED MATER RES, V42, P331, DOI 10.1002/(SICI)1097-4636(199811)42:2<331::AID-JBM19>3.0.CO;2-L
   SUPRATEK PHARM INC, 1999, Patent No. 9943343
   TAGAI T, 1997, KOBUTSUGAKU ZASSHI, V26, P59
   U GUELPH, 1997, Patent No. 9705899
   U UTAH RES FDN, 1999, Patent No. 9915151
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   VOURNAKIS JN, 1997, Patent No. 5624679
   WADE CWR, 1977, J TEST EVAL, V5, P397
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang GJ, 1999, J ORG CHEM, V64, P4140, DOI 10.1021/jo9902852
   Won CY, 1996, MACROMOL RAPID COMM, V17, P653, DOI 10.1002/marc.1996.030170907
   YOSHIDA M, 1993, HOSHASEN, V19, P27
   Yu C, 1999, BIOMATERIALS, V20, P253, DOI 10.1016/S0142-9612(98)00169-0
   Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z
   Zhang S., 1997, [No title captured], Patent No. [US5670483 A, 5670483]
   Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52
   1997, Patent No. 9720575
   1997, Patent No. 9738731
   2000, Patent No. 0004924
   2000, Patent No. 0019976
NR 129
TC 23
Z9 23
U1 1
U2 30
PU ASHLEY PUBLICATIONS LTD
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1354-3776
J9 EXPERT OPIN THER PAT
JI Expert Opin. Ther. Patents
PD SEP
PY 2001
VL 11
IS 9
BP 1395
EP 1410
PG 16
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 468WU
UT WOS:000170781800003
DA 2018-10-19
ER

PT J
AU von Stechow, D
   Gaulthier, O
   Bouler, J
   Daculsi, G
   Aguado, E
   Muller, R
AF von Stechow, D
   Gaulthier, O
   Bouler, J
   Daculsi, G
   Aguado, E
   Muller, R
TI 3D micro-computed tomography assessment of injectable calcium phosphate
   biomaterial in vivo.
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Meeting Abstract
C1 Beth Israel Deaconess Med Ctr, Orthoped Biomech Lab, Boston, MA 02215 USA.
   Harvard Univ, Sch Med, Boston, MA USA.
   Ecole Natl Vet, Lab Chirurg, Nantes, France.
   Fac Chirurg Dent, Lab Rech Mat Interet Biol, Nantes, France.
   Inst Biomed Engn, Zurich, Switzerland.
   ETH Zurich, Zurich, Switzerland.
   Univ Zurich, CH-8006 Zurich, Switzerland.
RI Daculsi, Guy/P-1320-2014
OI Daculsi, Guy/0000-0003-1030-3446
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC BONE & MINERAL RES
PI WASHINGTON
PA 2025 M ST, N W, STE 800, WASHINGTON, DC 20036-3309 USA
SN 0884-0431
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD SEP
PY 2001
VL 16
SU 1
BP S343
EP S343
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 467MU
UT WOS:000170709000848
DA 2018-10-19
ER

PT J
AU Ruan, JM
   Grant, MH
AF Ruan, JM
   Grant, MH
TI Biocompatibility evaluation in vitro. Part III: Cytotoxicity expression
   of human and animal osteoblasts on the biomaterials
SO JOURNAL OF CENTRAL SOUTH UNIVERSITY OF TECHNOLOGY
LA English
DT Article
DE biomaterial; cytotoxicity; biological molecular technique
ID CELLS; GROWTH
AB Exclusion and inflammation in the clinic are observed for various reasons including material chemical composition, physical properties as well as macro- and micro-structure of the implants, surface condition of the implants, and also patient dependent factors. Cytotoxicity expression of cells is a central issue in current biocompatibility to screen the potential implant materials and drugs. This study was aimed at investigation reaction between the potential implant materials and surround tissue. Cytotoxicity of human and rat osteoblast in the material extracts was determinated by testing standards such as GHS assay, MIT assay, alkaline phosphatase activity assay, LDH assay, and Lowry assay. Research results demonstrated that compared with the control condition polystyrene culture plate both human and rat osteoblast cells have normal phenotypic expression in hydroxyapatite extract, and this expression was statistically restricted in hydroxyapatite-spinel extract. However, this restrict, e. g. cytotoxicity could be partially eliminated by immersion treatment of the materials in culture medium.
C1 Cent S Univ, State Key Lab Powder Met, Changsha 410083, Peoples R China.
   Univ Strathclyde, Bioengn Unit, Glasgow G4 0NW, Lanark, Scotland.
RP Ruan, JM (reprint author), Cent S Univ, State Key Lab Powder Met, Changsha 410083, Peoples R China.
CR ANGERER J, 1999, ANAL HAZARDOUS SUBST, V6, P1
   ANUFORO DC, 1978, IN VITRO CELL DEV B, V14, P981
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   JEFFERY EH, 1995, TOXICOLOGY METALS C, P138
   Letzel S, 1996, OCCUP HYG, V3, P271
   Macnab G, 1996, SIGHT SOUND, V6, P71
   MACNAIR RA, 1997, J MATER SCI-MATER M, V47, P105
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   Rodgers EH, 1998, CHEM-BIOL INTERACT, V116, P213, DOI 10.1016/S0009-2797(98)00092-1
   RUAN J, 1993, FOUNCTIONAL MATES, V24, P561
   RUAN J, 1992, J CSUT, V23, P60
   RUAN J, 1993, J CSUT, V24, P509
   Ruan JM, 2001, J CENT SOUTH UNIV T, V8, P1, DOI 10.1007/s11771-001-0015-6
   Shi Q, 1998, ARTIF ORGANS, V22, P1023
   WILLIAMS DF, 1981, SYSTEMIC ASPECTS BIO, V1, P49
NR 16
TC 3
Z9 4
U1 0
U2 2
PU JOURNAL OF CENTRAL SOUTH UNIV TECHNOLOGY
PI HUNAN
PA EDITORIAL OFFICE, CHANGSHA, HUNAN 410083, PEOPLES R CHINA
SN 1005-9784
J9 J CENT SOUTH UNIV T
JI J. Cent. South Univ. Technol.
PD SEP
PY 2001
VL 8
IS 3
BP 147
EP 155
DI 10.1007/s11771-001-0044-1
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 477UB
UT WOS:000171301700001
DA 2018-10-19
ER

PT J
AU Yuan, HP
   De Bruijn, JD
   Zhang, XD
   Van Blitterswijk, CA
   De Groot, K
AF Yuan, HP
   De Bruijn, JD
   Zhang, XD
   Van Blitterswijk, CA
   De Groot, K
TI Use of an osteoinductive biomaterial as a bone morphogenetic protein
   carrier
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; INDUCED OSTEOGENESIS; IN-VIVO;
   HYDROXYAPATITE; INDUCTION; LAMINECTOMY; IMPLANTS; KINDS; RATS; DOGS
AB A porous calcium phosphate ceramic, which induced bone formation in soft tissues of dogs, was termed as osteoinductive biomaterial and studied as a carrier of bone morphogenetic protein (rhBMP-2). Cylinder implants (empty set 4x5 mm) impregnated with 0, 1, 10 and 40 mug rhBMP-2 were implanted in dorsal muscles of rabbits for five weeks. Histological observation and histomorphometric analysis were performed on thin un-decalcified sections. No bone formation was detected in the implants without rhBMP-2, while mature lamellar bone was found inside the implants with 1 mug rhBMP-2, both on the outer surface and inside the implants with 10 mug and 40 mug rhBMP-2. Little difference in formed bone was found between 1 mug and 10 mug rhBMP-2, but no difference was found between 10 mug and 40 mug rhBMP-2. A significant difference in bone marrow formation was found among 1, 10 and 40 mug rhBMP-2. The more rhBMP-2, the more bone marrow formed. The present results indicate that osteoinductive biomaterial is a good carrier of BMP and high dose of BMP is not necessary for bone formation in clinic. (C) 2001 Kluwer Academic Publishers.
C1 Leiden Univ, Biomat Res Grp, NL-2300 RA Leiden, Netherlands.
   IsoTis BV, NL-3723 MB Bilthoven, Netherlands.
   Sichuan Univ, Inst Mat Sci & Technol, Chengdu 610064, Peoples R China.
RP Yuan, HP (reprint author), Leiden Univ, Biomat Res Grp, NL-2300 RA Leiden, Netherlands.
EM huipin.yuan@isotis.com
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR Aspenberg P, 1996, ACTA ORTHOP SCAND, V67, P3, DOI 10.3109/17453679608995598
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   BODEN SD, 1999, CLIN ORTHOP S, V367, P84
   Bruder SP, 1999, CLIN ORTHOP RELAT R, pS68
   Cook SD, 1996, CLIN ORTHOP RELAT R, P29
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   de Bruijn J.D., 1999, T 25 ANN M SOC BIOM, P235
   de Groot K, 1998, TISSUE ENG, V4, P337
   GREEN JP, 1995, AM J OPHTHALMOL, V120, P681, DOI 10.1016/S0002-9394(14)72222-6
   Herr G, 1996, ACTA ORTHOP SCAND, V67, P606, DOI 10.3109/17453679608997765
   HOTZ G, 1994, INT J ORAL MAX SURG, V23, P413, DOI 10.1016/S0901-5027(05)80033-5
   Ijiri S, 1997, J BIOMED MATER RES, V35, P421
   Isobe M, 1996, J BIOMED MATER RES, V32, P433
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KAWAI T, 1993, CLIN ORTHOP RELAT R, V290, P296
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6
   Meyer RA, 1999, SPINE, V24, P747, DOI 10.1097/00007632-199904150-00004
   MIZUTANI H, 1982, CLIN ORTHOP RELAT R, P213
   OHGUSHI H, 1995, BIOCERAMICS, V8, P61
   ONO I, 1992, PLAST RECONSTR SURG, V90, P870, DOI 10.1097/00006534-199211000-00023
   REDDI AH, 1995, CLIN ORTHOP RELAT R, P115
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, V234, P250
   Takita H, 1997, EUR J ORAL SCI, V105, P588, DOI 10.1111/j.1600-0722.1997.tb00222.x
   TOTH JM, 1993, BIOCERAMICS, V6, P9
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1984, CLIN ORTHOP RELAT R, V187, P277
   Vargervik K., 1992, BONE GRAFTS BONE SUB, P112
   VolekSmith H, 1996, P SOC EXP BIOL MED, V211, P265
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   Winn SR, 1999, CLIN ORTHOP RELAT R, pS95
   WONZEY JM, 1988, SCIENCE, V242, P1528
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   Yamamoto M, 1996, Tissue Eng, V2, P315, DOI 10.1089/ten.1996.2.315
   YAMASAKI H, 1992, BIOMATERIALS, V13, P308, DOI 10.1016/0142-9612(92)90054-R
   Yamasaki H., 1990, JPN J ORAL BIOL, V32, P190, DOI DOI 10.2330/JORALBIOSCI1965.32.190
   Yang ZJ, 1997, J MATER SCI-MATER M, V8, P697, DOI 10.1023/A:1018540024082
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   YUAN H, 1997, BIOMEDICAL MAT RES F, P228
   YUAN H, 2000, T 6 WBC HAW US, P114
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zhang XD, 1991, BIOCERAMICS HUMAN BO, P408
NR 50
TC 42
Z9 44
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2001
VL 12
IS 9
BP 761
EP 766
DI 10.1023/A:1013957431372
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 471XV
UT WOS:000170954700002
PM 15348221
DA 2018-10-19
ER

PT J
AU Yaszay, B
   Trindade, MCD
   Lind, M
   Goodman, SB
   Smith, RL
AF Yaszay, B
   Trindade, MCD
   Lind, M
   Goodman, SB
   Smith, RL
TI Fibroblast expression of C-C chemokines in response to orthopaedic
   biomaterial particle challenge in vitro
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
ID MONOCYTE CHEMOATTRACTANT PROTEIN-1; MACROPHAGE INFLAMMATORY
   PROTEIN-1-ALPHA; TOTAL HIP-ARTHROPLASTY; IN-VITRO;
   POLYMETHYLMETHACRYLATE PARTICLES; PERIPROSTHETIC OSTEOLYSIS; ENZYMATIC
   AMPLIFICATION; CHEMOTACTIC CYTOKINES; TITANIUM PARTICLES;
   GENE-EXPRESSION
AB C-C chemokines are soluble mediators that occur in a periprosthetic granuloma and influence recruitment, localization and activation of inflammatory cells. This studs, tested effects of titanium and polymethylmethacrylate (PMMA) particles on expression of selected C-C chemokines in cultured human fibroblasts. The C-C chemokines analyzed included monocyte chemoattractant protein-1. 2 (MCP-1. 2). monocyte inflammatory protein-1 alpha (MIP-1 alpha), and regulated on activation, normal T-cell expressed and secreted protein (RANTES). Interleukin-1 beta (IL-1 beta) served Lis a known stimulator of chemokine release while interleukin-6 (IL-6) expression served as a marker for fibroblast activation. Protein and mRNA signal levels were determined by ELISA and RT-PCR. respectively. The results demonstrated that exposure of fibroblasts to titanium and PMMA particles resulted in increased release of MCP-1 in a dose- and time-dependent manner. After 24 h. titanium particles maximally upregulated MCP-1 release 7-fold while PMMA particles increased MCP-1 levels 2-fold. when compared to unchallenged fibroblasts. MCP-2, MIP-1 alpha and RANTES levels remained unchanged Following exposure of fibroblasts to titanium or PMMA particles at any concentration or time point tested. However. IL-1 beta stimulated release of MCP-1, MCP-2. and RANTES. but not MIP-1 alpha from the fibroblasts. IL-1 beta, not particles, exhibited the most prominent effect on MCP-1 mRNA levels. Increased release of MCP-1 front fibroblasts exposed to titanium and PMMA particles coincided with increased release of IL-6. This study suggests that release of chemoattractant factors from fibroblasts localized in periprosthetic membranes enhances the chronic inflammatory process leading to bone resorption and implant loosening. (C) 2001 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.
C1 Stanford Univ, Sch Med, Orthopaed Res Lab, Stanford, CA 94305 USA.
RP Smith, RL (reprint author), Stanford Univ, Sch Med, Orthopaed Res Lab, 300 Pasteur Dr,R-144, Stanford, CA 94305 USA.
CR AKAHOSHI T, 1993, ARTHRITIS RHEUM-US, V36, P762, DOI 10.1002/art.1780360605
   BEDARD PA, 1993, J CELL PHYSIOL, V154, P433, DOI 10.1002/jcp.1041540227
   FROKJAER J, 1995, ACTA ORTHOP SCAND, V66, P303, DOI 10.3109/17453679508995549
   FRONDOZA CG, 1993, J BIOMED MATER RES, V27, P611, DOI 10.1002/jbm.820270508
   GharaeeKermani M, 1996, J BIOL CHEM, V271, P17779, DOI 10.1074/jbc.271.30.17779
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   Gonzalez O, 1996, J BIOMED MATER RES, V30, P463, DOI 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.3.CO;2-I
   Goodman SB, 1996, J BIOMED MATER RES, V31, P421, DOI 10.1002/(SICI)1097-4636(199607)31:3<421::AID-JBM17>3.0.CO;2-L
   Hogaboam C M, 1999, J Immunol, V163, P2193
   Hogaboam CM, 1998, KIDNEY INT, V54, P2152, DOI 10.1046/j.1523-1755.1998.00176.x
   Horowitz SM, 1997, J ORTHOP RES, V15, P50, DOI 10.1002/jor.1100150108
   Ishiguro N, 1997, J BIOMED MATER RES, V35, P399, DOI 10.1002/(SICI)1097-4636(19970605)35:3<399::AID-JBM14>3.0.CO;2-A
   JIANG YL, 1992, J IMMUNOL, V148, P2423
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   JOHNSTON RF, 1990, ELECTROPHORESIS, V11, P355, DOI 10.1002/elps.1150110503
   Lee SH, 1997, J ORTHOP RES, V15, P40, DOI 10.1002/jor.1100150107
   Lind M, 1999, J BIOMED MATER RES, V48, P246, DOI 10.1002/(SICI)1097-4636(1999)48:3<246::AID-JBM7>3.0.CO;2-X
   Lind M, 1998, J BONE JOINT SURG BR, V80B, P924, DOI 10.1302/0301-620X.80B5.8710
   LUKACS NW, 1993, J EXP MED, V177, P1551, DOI 10.1084/jem.177.6.1551
   LUKACS NW, 1994, AM J PATHOL, V144, P711
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1448, DOI 10.2106/00004623-199509000-00022
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   MALONEY WJ, 1993, J BONE JOINT SURG AM, V75A, P835, DOI 10.2106/00004623-199306000-00005
   Manlapaz M, 1996, J ORTHOP RES, V14, P465, DOI 10.1002/jor.1100140317
   Meyer JE, 1998, INT ARCH ALLERGY IMM, V117, P60, DOI 10.1159/000023991
   MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17
   Nakashima Y, 1999, J BONE JOINT SURG AM, V81A, P603, DOI 10.2106/00004623-199905000-00002
   Nakashima Y, 1999, J BONE JOINT SURG BR, V81B, P155, DOI 10.1302/0301-620X.81B1.8884
   NELSON PJ, 1993, J IMMUNOL, V151, P2601
   NIWA M, 1969, J BACTERIOL, V97, P1069
   NOONAN KE, 1988, NUCLEIC ACIDS RES, V16, P10366, DOI 10.1093/nar/16.21.10366
   RAGAB AA, 1998, T ORTHOP RES SOC, V23, P355
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SMITH RE, 1995, J LEUKOCYTE BIOL, V57, P782
   TAUB DD, 1993, CYTOKINE, V5, P175, DOI 10.1016/1043-4666(93)90001-L
   UGUCCIONI M, 1995, EUR J IMMUNOL, V25, P64, DOI 10.1002/eji.1830250113
   VANDAMME J, 1994, J IMMUNOL, V152, P5495
   VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0
   WOLPE SD, 1989, FASEB J, V3, P2565
   YAO JL, 1995, J BONE MINER RES, V10, P1417
   YOSHIMURA T, 1990, J IMMUNOL, V144, P2377
   ZHOU LJ, 1995, BLOOD, V86, P3295
   Zickus C, 1998, MEDIAT INFLAMM, V7, P269, DOI 10.1080/09629359890956
NR 45
TC 32
Z9 32
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0736-0266
J9 J ORTHOPAED RES
JI J. Orthop. Res.
PD SEP
PY 2001
VL 19
IS 5
BP 970
EP 976
DI 10.1016/S0736-0266(01)00003-1
PG 7
WC Orthopedics
SC Orthopedics
GA 468RC
UT WOS:000170771100032
PM 11562149
OA Bronze
DA 2018-10-19
ER

PT J
AU Takenaka, K
   Kawamoto, Y
AF Takenaka, K
   Kawamoto, Y
TI Fabrication of hybrid material by coating of bioactive glass-ceramic on
   alumina substrate through porcelain enamel process
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE bioactive glass-ceramics; biomaterial; adhesion-glass; porcelain enamel
   technique
AB In artificial bones, a steady bioactivity over long-term service, no dissolution of harmful ions and a sufficient mechanical strength are required, though the relative importance of the above factors depends upon the implantation place. In general, bioactive materials have no sufficient mechanical strength and, on the other hand, materials with high mechanical strength are not bioactive. In the present study, a porcelain enamel technique was applied to produce a hybrid material whose both bioactivity and high mechanical strength, which merely consists of inorganic materials. High-strength alumina and bioactive glass-ceramics were used as substrate and coating material, respectively, and an adhesion-glass was employed to achieve a tight bond between alumina and the bioactive glass-ceramic. Appropriate heat-treatments of the alumina, adhesion-glass and bioactive glass-ceramic composite resulted in the successful production of a hybrid material that has about 2.5 times stronger in bending-strength than that of an apatite precipitation-type glass-ceramic. This technique gives a useful process on production of ceramic-ceramic hybrid materials with high mechanical strength and bioactivity for bone substitution.
C1 Kobe Univ, Grad Sch Sci & Technol, Div Mol Sci, Nada Ku, Kobe, Hyogo 6578501, Japan.
   Minolta Co Ltd, R&D Headquarters, Opt Technol Div, Takatsuki, Osaka 5698503, Japan.
RP Takenaka, K (reprint author), Kobe Univ, Grad Sch Sci & Technol, Div Mol Sci, Nada Ku, 1-1,Rokkodai Cho, Kobe, Hyogo 6578501, Japan.
CR ANDERSSON OH, 1991, J NON-CRYST SOLIDS, V129, P145, DOI 10.1016/0022-3093(91)90090-S
   BROMER H, Patent No. 5021015
   Han Y, 1999, J BIOMED MATER RES, V45, P198, DOI 10.1002/(SICI)1097-4636(19990605)45:3<198::AID-JBM6>3.0.CO;2-Q
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1999, MRS BULL, P13
   Jiang GW, 1999, J BIOMED MATER RES, V48, P117, DOI 10.1002/(SICI)1097-4636(1999)48:2<117::AID-JBM4>3.0.CO;2-B
   KOKUBO T, 1991, NIPPON SERAM KYO GAK, V99, P965
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   OHTSUKI C, 1992, J MATER SCI-MATER M, V3, P119, DOI 10.1007/BF00705279
   Schrooten J, 1999, J BIOMED MATER RES, V44, P243, DOI 10.1002/(SICI)1097-4636(19990305)44:3<243::AID-JBM2>3.0.CO;2-O
   URATSUJI M, 1983, THESIS KOBE U, P1
   URATSUJI M, 1983, P 3 ORTH CER IMPL ST, P17
NR 12
TC 0
Z9 1
U1 1
U2 2
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD SEP
PY 2001
VL 109
IS 9
BP 733
EP 737
DI 10.2109/jcersj.109.1273_733
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 475AY
UT WOS:000171140500003
OA Bronze
DA 2018-10-19
ER

PT J
AU Zhang, SM
   Li, SP
   Yan, YH
   Wan, T
   Jiang, X
   Han, CR
   Song, XP
AF Zhang, SM
   Li, SP
   Yan, YH
   Wan, T
   Jiang, X
   Han, CR
   Song, XP
TI Surface modification of hydroxyapatite by using gamma-aminopropyl silane
SO JOURNAL OF WUHAN UNIVERSITY OF TECHNOLOGY-MATERIALS SCIENCE EDITION
LA English
DT Article
DE biomaterial; hydroxyapatite; surface modification; r-aminopropyl silane;
   characterization
ID MECHANICAL-PROPERTIES
AB Surface modification of hydroxyapatite ( IR) powder was performed with r-aminopropyl silane in toluent solvent. The modification effects were characterized by using XPS and FT-IR methods. The results indicated that the P2p electron binding energy of the modified HA decreases 0.4eV compared to that of HA. Furthermore, a new peak, 998 cm(-1) absorption appeared in IR differential spectra of modified HA and HA, which is due to a stretching vibration of structure P-O-Si, meaning that a direct covalent bonding between hydroxyl group on HA surface and the organic silane molecule was realized after modification, and the chemical bonding type was P-O-Si. The formation of the above structure suggested that the more effective interfacial adhesion between the modified HA and polymer matrix could be carried out.
C1 Wuhan Univ Technol, Sch Mat Sci & Engn, Wuhan 430070, Peoples R China.
   Hainan Normal Univ, Hainan, Peoples R China.
CR ANDRIANO KP, 1992, J APPL BIOMATER, V3, P197, DOI 10.1002/jab.770030306
   BO YH, 1999, ACTA SCIANTIARUM NAT, V38, P36
   OGISO M, 1992, J LONG-TERM EFF MED, V2, P137
   Shikinami Y, 1996, BIOCERAMICS, V9, P391
   Suchanek W, 1997, J AM CERAM SOC, V80, P2805, DOI 10.1111/j.1151-2916.1997.tb03197.x
   VERHEYEN CCP, 1993, THESIS U LEIDEN LEID
NR 6
TC 3
Z9 4
U1 0
U2 1
PU JOURNAL WUHAN UNIV TECHNOLOGY
PI WUHAN
PA WUHAN UNIV TECHNOLOGY, WUHAN 430070, PEOPLES R CHINA
SN 1000-2413
J9 J WUHAN UNIV TECHNOL
JI J. Wuhan Univ. Technol.-Mat. Sci. Edit.
PD SEP
PY 2001
VL 16
IS 3
BP 37
EP 38
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA 576PC
UT WOS:000177012800010
DA 2018-10-19
ER

PT J
AU Nyman, R
   Sennerby, L
   Nyman, S
   Lundgren, D
AF Nyman, R
   Sennerby, L
   Nyman, S
   Lundgren, D
TI Influence of bone marrow on membrane-guided bone regeneration of
   segmental long-bone defects in rabbits
SO SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND
   SURGERY
LA English
DT Article
DE biomaterial; e-PTFE membrane; guided bone regeneration; guided tissue
   regeneration; histology; long-bone defects; radiography; radius
AB Defects 10 mm long were created in long bone in the diaphysis of both radii of 18 rabbits (test and control side). On the test side, ingrowth of bone marrow into the defects was hindered or delayed by: plugging the opening of the cut bone ends with gutta-percha points (n = 7); plugging with Gelfoam (n = 6); or by removing the bone marrow by flushing with saline (n = 5). The defects on both test and control side were covered with an expanded polytetrafluoroethylene membrane, shaped as a tube. Healing was followed with radiographs for four to five months, after which the animals were killed and ground sections of the areas of the defects were prepared for histological examination. On the control side, nine of 18 animals had complete osseous bridging of the defect, and a small transverse non-mineralised zone remained in the centre of the healed defect in the other animals. This zone consisted of loose connective and cartilagenous tissue as well as connective tissue obviously derived from the outside of the membrane. By preventing-or delaying the ingrowth of bone marrow we retarded the regeneration of mineralised bone, particularly in the gutta-percha and flushed bone marrow groups. The principle of guided tissue regeneration may be used to achieve regeneration of extensive long-bone defects. Any attempts to delay or prevent bone marrow ingrowth into the defects did retard regeneration of segmental long-bone defects.
C1 Univ Hosp, Dept Radiol, SE-75185 Uppsala, Sweden.
   Univ Gothenburg, Dept Biomat Handicap Res, Gothenburg, Sweden.
RP Nyman, R (reprint author), Univ Hosp, Dept Diagnost Radiol, SE-75185 Uppsala, Sweden.
CR BLUHM AE, 1995, J ORAL MAXIL SURG, V53, P163, DOI 10.1016/0278-2391(95)90395-X
   Karring T, 1993, Periodontol 2000, V1, P26, DOI 10.1111/j.1600-0757.1993.tb00204.x
   NIELSEN FF, 1992, THESIS ROYAL DENT CO
   NYMAN R, 1995, ACTA ORTHOP SCAND, V66, P169, DOI 10.3109/17453679508995515
   Nyman S R, 1994, Periodontol 2000, V4, P109, DOI 10.1111/j.1600-0757.1994.tb00011.x
   Owen M, 1988, J Cell Sci Suppl, V10, P63
   REDDI AH, 1987, ORTHOP CLIN N AM, V18, P207
   Zellin G, 1997, SCAND J PLAST RECONS, V31, P97, DOI 10.3109/02844319709085475
NR 8
TC 8
Z9 9
U1 0
U2 2
PU TAYLOR & FRANCIS AS
PI OSLO
PA CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY
SN 0284-4311
J9 SCAND J PLAST RECONS
JI Scand. J. Plast. Reconstr. Surg. Hand Surg.
PD SEP
PY 2001
VL 35
IS 3
BP 239
EP 246
PG 8
WC Surgery
SC Surgery
GA 479VX
UT WOS:000171425200003
PM 11680392
DA 2018-10-19
ER

PT J
AU Aizenberg, J
   Tkachenko, A
   Weiner, S
   Addadi, L
   Hendler, G
AF Aizenberg, J
   Tkachenko, A
   Weiner, S
   Addadi, L
   Hendler, G
TI Calcitic microlenses as part of the photoreceptor system in brittlestars
SO NATURE
LA English
DT Article
ID OPHIUROIDEA; ECHINODERMATA; BIOMINERALIZATION; LOCALIZATION
AB Photosensitivity in most echinoderms has been attributed to 'diffuse' dermal receptors(1-3). Here we report that certain single calcite crystals used by brittlestars for skeletal construction(4,5) are also a component of specialized photosensory organs, conceivably with the function of a compound eye. The analysis of arm ossicles in Ophiocoma(6) showed that in light-sensitive species, the periphery of the labyrinthic calcitic skeleton extends into a regular array of spherical microstructures that have a characteristic double-lens design. These structures are absent in light-indifferent species. Photolithographic experiments in which a photoresist film was illuminated through the lens array showed selective exposure of the photoresist under the lens centres. These results provide experimental evidence that the microlenses are optical elements that guide and focus the light inside the tissue. The estimated focal distance (4-7 mum below the lenses) coincides with the location of nerve bundles-the presumed primary photoreceptors. The lens array is designed to minimize spherical aberration and birefringence and to detect light from a particular direction. The optical performance is further optimized by phototropic chromatophores that regulate the dose of illumination reaching the receptors. These structures represent an example of a multifunctional biomaterial that fulfills both mechanical and optical functions.
C1 Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA.
   Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.
   Natl Hist Museum Los Angeles Cty, Los Angeles, CA 90007 USA.
RP Aizenberg, J (reprint author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.
RI Tkachenko, Alexei/I-9040-2012
OI Tkachenko, Alexei/0000-0003-1291-243X
CR Aizenberg J, 1997, APPL PHYS LETT, V71, P3773, DOI 10.1063/1.120502
   Ameye L, 1999, J HISTOCHEM CYTOCHEM, V47, P1189, DOI 10.1177/002215549904700911
   Belcher AM, 1998, ACTA MATER, V46, P733, DOI 10.1016/S1359-6454(97)00253-X
   CLARKSON ENK, 1975, NATURE, V254, P663, DOI 10.1038/254663a0
   COBB JLS, 1990, COMP BIOCHEM PHYS A, V97, P329, DOI 10.1016/0300-9629(90)90619-4
   COBB JLS, 1986, J NEUROCYTOL, V15, P97, DOI 10.1007/BF02057908
   Cowles RP, 1910, J EXP ZOOL, V9, P387, DOI 10.1002/jez.1400090209
   Doderlein L., 1898, DENKSCHR MED NAT GES, V8, P491
   DONNAY G, 1969, SCIENCE, V166, P1147, DOI 10.1126/science.166.3909.1147
   FLINT HT, 1936, GEOMETRICAL OPTICS
   Gal J, 2000, VISION RES, V40, P843, DOI 10.1016/S0042-6989(99)00216-3
   HENDLER G, 1984, PSZNI MAR ECOL, V5, P379, DOI 10.1111/j.1439-0485.1984.tb00131.x
   HENDLER G, 1987, ZOOMORPHOLOGY, V107, P261, DOI 10.1007/BF00312172
   Hyman LH, 1955, INVERTEBRATES, V4
   Johnsen S, 1997, BIOL BULL, V193, P97, DOI 10.2307/1542739
   LAND MF, 1981, COMP PHYSL EVOLUTI B, V1, P471
   Lowenstam H. A., 1989, BIOMINERALISATION, P123
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   MILLOTT N, 1975, ADV MAR BIOL, V13, P1, DOI 10.1016/S0065-2881(08)60279-5
   Smith A, 1980, SPEC PAP PALAEONTOL, V25, P1
   Stubbs T.R., 1982, Echinoderms, P403
   TOWE KM, 1973, SCIENCE, V179, P1007, DOI 10.1126/science.179.4077.1007
   Wainwright S. A., 1976, MECH DESIGN ORGANISM
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Yoshida M., 1984, PHOTORECEPTION VISIO, P743
NR 25
TC 376
Z9 385
U1 11
U2 154
PU MACMILLAN PUBLISHERS LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD AUG 23
PY 2001
VL 412
IS 6849
BP 819
EP 822
DI 10.1038/35090573
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 465ET
UT WOS:000170577200037
PM 11518966
DA 2018-10-19
ER

PT J
AU Kowalski, ZW
AF Kowalski, ZW
TI Ion sputter induced surface morphology - biomedical implications
SO VACUUM
LA English
DT Article; Proceedings Paper
CT International Symposium on Ion Implantation and Other Applications of
   IOns and Electrons (ION 2000)
CY JUN 12-15, 2000
CL KAZIMIERS DOLNY, POLAND
SP Inst Phys, Maria Curie Sklodowska Univ, Tech Univ Lublin, Tech Univ Wroclaw
DE ion sputtering; ion etching; surface morphology; surface topography;
   surface roughness; biocompatible materials; biomaterials; implants;
   biological response
ID LINE-EDGE ROUGHNESS; CELL-ADHESION; BOMBARDMENT; BIOMATERIALS; IMPLANTS;
   PROTEIN; BONE; SI
AB This is a short review of surface morphological changes induced by ion sputtering of solids (mainly biocompatible materials) as well as potential and practical biomedical applications of the sputtering process. Usually changes of two aspects of surface morphology are studied, i.e. surface topography and roughness. It can be generally accepted that, among other factors which affect the so-called biological response to biomaterial, surface morphology is one of the more important. Depending on surface topography and/or roughness various biological responses could be expected, generally, changes in: (a) attachment of the surrounding tissue or thrombus to the material in question and (b) cell attachment kinetics that can influence the heating process resulting from the presence of the sputtered implant and/or tissue inflammatory in the tissue surrounding the implanted material. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Wroclaw Univ Technol, Inst Microsyst Technol, PL-50372 Wroclaw, Poland.
RP Kowalski, ZW (reprint author), Wroclaw Univ Technol, Inst Microsyst Technol, Z Janiszewskiego 11-17, PL-50372 Wroclaw, Poland.
EM zwkoval@wtm.ite.pwr.wroc.pl
CR Auciello O., 1984, ION BOMBARDMENT MODI
   BEHRISCH R, 1983, TOPICS APPL PHYSICS, V52
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Carter G, 1996, VACUUM, V47, P409, DOI 10.1016/0042-207X(95)00239-1
   CHASON E, 1994, PHYS REV LETT, V72, P3040, DOI 10.1103/PhysRevLett.72.3040
   EKLUND EA, 1991, PHYS REV LETT, V67, P1759, DOI 10.1103/PhysRevLett.67.1759
   EKLUND EA, 1993, SURF SCI, V285, P157, DOI 10.1016/0039-6028(93)90427-L
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   HAUFFE W, 1991, TOP APPL PHYS, V64, P305
   Henry S, 1998, MICRO ELECTRO MECHANICAL SYSTEMS - IEEE ELEVENTH ANNUAL INTERNATIONAL WORKSHOP PROCEEDINGS, P494, DOI 10.1109/MEMSYS.1998.659807
   Henry S, 1998, J PHARM SCI, V87, P922, DOI 10.1021/js980042+
   Ivanova OP, 1996, VACUUM, V47, P67, DOI 10.1016/0042-207X(95)00180-8
   Iwaki M, 1995, NUCL INSTRUM METH B, V106, P618, DOI 10.1016/0168-583X(96)80035-8
   Kowalski Z. W., 1998, Electron Technology, V31, P477
   KOWALSKI ZW, 1985, J MATER SCI, V20, P1521, DOI 10.1007/BF00555259
   KOWALSKI ZW, 1989, MONOGRAPHS TU WOCL, V13
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   Leitao E, 1998, J MATER SCI-MATER M, V9, P543, DOI 10.1023/A:1008896106994
   Lhoest JB, 1995, NUCL INSTRUM METH B, V105, P322, DOI 10.1016/0168-583X(95)00524-2
   Loesing R, 2000, J VAC SCI TECHNOL B, V18, P509, DOI 10.1116/1.591222
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MAZOLDI P, 1987, ION BEAM MODIFICATIO
   Namatsu H, 1998, J VAC SCI TECHNOL B, V16, P3315, DOI 10.1116/1.590375
   Nelson C, 1999, J VAC SCI TECHNOL B, V17, P2488, DOI 10.1116/1.591117
   NOWICKI B, 1991, STRUKTURA GEOMETRYCZ
   Otte K, 1999, J VAC SCI TECHNOL A, V17, P19, DOI 10.1116/1.581548
   Reynolds GW, 1999, J VAC SCI TECHNOL B, V17, P2723, DOI 10.1116/1.591053
   Saitoh H, 1996, J MATER SCI, V31, P603, DOI 10.1007/BF00367874
   SIGMUND P, 1995, APPL PHYS LETT, V66, P433, DOI 10.1063/1.114047
   Verdonschot N, 1998, J BIOMED MATER RES, V42, P554, DOI 10.1002/(SICI)1097-4636(19981215)42:4<554::AID-JBM11>3.3.CO;2-B
   VISHNYAKOV V, 1995, VACUUM, V46, P637, DOI 10.1016/0042-207X(95)00003-8
   WILK J, 1997, 27 ITE TUW
   Wittmaack K, 2000, J VAC SCI TECHNOL B, V18, P524, DOI 10.1116/1.591225
NR 33
TC 11
Z9 11
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0042-207X
J9 VACUUM
JI Vacuum
PD AUG 16
PY 2001
VL 63
IS 4
BP 603
EP 608
DI 10.1016/S0042-207X(01)00247-0
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 470TH
UT WOS:000170886900028
DA 2018-10-19
ER

PT J
AU Hu, WJ
   Eaton, JW
   Tang, LP
AF Hu, WJ
   Eaton, JW
   Tang, LP
TI Molecular basis of biomaterial-mediated foreign body reactions
SO BLOOD
LA English
DT Article
ID GLYCOPROTEIN-GPIIB-IIIA; ADSORBED FIBRINOGEN; PROTEIN ADSORPTION;
   CELL-ADHESION; POLYMERIC BIOMATERIALS; INFLAMMATORY RESPONSES;
   CONFORMATIONAL-CHANGES; ARTERIAL PROSTHESES; PLATELET-ADHESION;
   ANTIBODY-BINDING
AB Despite being inert and nontoxic, implanted biomaterials often trigger adverse foreign body reactions such as inflammation, fibrosis, infection, and thrombosis. With regard to the inflammatory responses to biomaterial implants, it was previously found that a crucial precedent event was the spontaneous adsorption and denaturation of fibrinogen on implant surfaces. It was further found that interactions between the phagocyte integrin Mac-1 (CD11b/CD18) and one short sequence within the fibrinogen D domain (gamma 190-202; P1) at least partially explained phagocyte accumulation on implant surfaces. However, the reason that adsorbed fibrinogen is proinflammatory-while soluble fibrinogen clearly is not-remained obscure. In this study, therefore, the question of how fibrinogen is converted to a proinflammatory state when adsorbed to biomaterial surfaces is investigated. In soluble fibrinogen, the 13 amino acid P1 sequence was found to be hidden. However, the adsorption and denaturation of fibrinogen on the surfaces of commonly used biomaterials lead to the exposure of P1 and a second neo-epitope, gamma 377-395 (P2), which also interacts with Mac-1 and is similarly occult in the soluble protein. The extent of biomaterial-mediated PI and P2 exposure appears directly related to the severity of inflammatory responses to a test panel of biomaterials. Finally, thrombin-mediated conversion of fibrinogen to fibrin also exposes both P1 and P2 epitopes. These observations may help explain both the inflammation caused by many types of implanted biomaterials and that which occurs naturally following thrombotic events.
C1 Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
RP Tang, LP (reprint author), Univ Texas, Biomed Engn Program, Box 19138, Arlington, TX 76019 USA.
FU NHLBI NIH HHS [R01-HL60787, R01-HL63199, R01-HL56187]
CR ALTIERI DC, 1993, J BIOL CHEM, V268, P1847
   ANDRADE JD, 1984, PURE APPL CHEM, V56, P1345, DOI 10.1351/pac198456101345
   Bailly AL, 1996, J BIOMED MATER RES, V30, P101, DOI 10.1002/(SICI)1097-4636(199601)30:1<101::AID-JBM13>3.0.CO;2-R
   BASSET F, 1986, AM J PATHOL, V122, P443
   BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   Bennett JS, 1999, J BIOL CHEM, V274, P25301, DOI 10.1074/jbc.274.36.25301
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   BRANDSTEDT S, 1980, ACTA CHIR SCAND, V146, P483
   BUDZYNSKI AZ, 1986, CRIT REV ONCOL HEMAT, V6, P97, DOI 10.1016/S1040-8428(86)80019-1
   CHAN SC, 1991, CLIN CHEM, V37, P756
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   COLMAN RW, 1984, J CLIN INVEST, V73, P1249, DOI 10.1172/JCI111326
   DOBKE MK, 1995, ANN PLAS SURG, V34, P563, DOI 10.1097/00000637-199506000-00001
   DOMANSKIS EJ, 1976, PLAST RECONSTR SURG, V58, P689, DOI 10.1097/00006534-197612000-00006
   DONOVAN JW, 1974, P NATL ACAD SCI USA, V71, P4125, DOI 10.1073/pnas.71.10.4125
   DOOLITTLE RF, 1967, ARCH BIOCHEM BIOPHYS, V118, P456, DOI 10.1016/0003-9861(67)90374-8
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   FAIR DS, 1981, J BIOL CHEM, V256, P8018
   FENG L, 1994, J BIOMED MATER RES, V28, P735, DOI 10.1002/jbm.820280611
   GORDON M, 1982, J BONE JOINT SURG AM, V64, P574, DOI 10.2106/00004623-198264040-00013
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   GRISTINA A G, 1988, Medical Progress Through Technology, V14, P205
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   HAUGEN PK, 1990, J CELL BIOL, V111, P2733, DOI 10.1083/jcb.111.6.2733
   HIMMELHOCH SR, 1969, BIOCHEMISTRY-US, V8, P914, DOI 10.1021/bi00831a022
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   HORBETT TA, 1994, J BIOMAT SCI-POLYM E, V6, P15, DOI 10.1163/156856295X00724
   HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886
   Jansen B, 1988, J Biomater Appl, V2, P520
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   KOSSOVSKY N, 1991, J BIOMED MATER RES, V25, P1287, DOI 10.1002/jbm.820251009
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   KOTTKEMARCHANT K, 1986, BIOMATERIALS, V7, P441, DOI 10.1016/0142-9612(86)90032-3
   LEE RG, 1974, J BIOMED MATER RES, V8, P251, DOI 10.1002/jbm.820080507
   LENK TJ, 1991, LANGMUIR, V7, P1755, DOI 10.1021/la00056a030
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MCCARTHY JB, 1990, J CELL BIOL, V110, P777, DOI 10.1083/jcb.110.3.777
   MORRISSEY BW, 1976, T AM SOC ART INT ORG, V22, P278
   NELSON GD, 1981, PLAST RECONSTR SURG, V68, P969, DOI 10.1097/00006534-198112000-00027
   NIEWIAROWSKI S, 1983, ANN NY ACAD SCI, V408, P536, DOI 10.1111/j.1749-6632.1983.tb23271.x
   Parise LV, 1999, CURR OPIN CELL BIOL, V11, P597, DOI 10.1016/S0955-0674(99)00018-6
   PICHA GJ, 1990, PLAST RECONSTR SURG, V85, P903, DOI 10.1097/00006534-199006000-00011
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   PLOW EF, 1992, J LAB CLIN MED, V120, P198
   REINER E, 1989, ENZYMES HYDROLYSING, P266
   SCHIELEN WJG, 1991, BLOOD, V77, P2169
   SHIBA E, 1991, AM J PHYSIOL, V260, pC965
   SLACK SM, 1989, J COLLOID INTERF SCI, V133, P148, DOI 10.1016/0021-9797(89)90288-9
   SLAUSON DO, 1982, ADV VET SCI COMP MED, V26, P99
   SMAHEL J, 1979, BRIT J PLAST SURG, V32, P35, DOI 10.1016/0007-1226(79)90058-4
   SPENCER H, 1975, PROGR RESPIR RES, V8, P34
   STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   TANG L, 1997, T SOC BIOMATER, V23, pA261
   Tang LP, 1998, J BIOMAT SCI-POLYM E, V9, P1257
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   TORRES JL, 1988, ARCH BIOCHEM BIOPHYS, V267, P271, DOI 10.1016/0003-9861(88)90032-X
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Ugarova TP, 1998, J BIOL CHEM, V273, P22519, DOI 10.1074/jbc.273.35.22519
   UGAROVA TP, 1993, J BIOL CHEM, V268, P21080
   VISTNES LM, 1978, PLAST RECONSTR SURG, V62, P580, DOI 10.1097/00006534-197810000-00015
   VROMAN L, 1977, ANN NY ACAD SCI, V283, P65, DOI 10.1111/j.1749-6632.1977.tb41753.x
   Ward CM, 2000, BLOOD, V96, P161
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
   YATES SG, 1973, SURG GYNECOL OBSTET, V136, P12
   Yung LYL, 1999, BLOOD, V94, P2716
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 73
TC 244
Z9 245
U1 2
U2 59
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD AUG 15
PY 2001
VL 98
IS 4
BP 1231
EP 1238
DI 10.1182/blood.V98.4.1231
PG 8
WC Hematology
SC Hematology
GA 461KU
UT WOS:000170364100047
PM 11493475
DA 2018-10-19
ER

PT J
AU Hughes, TC
   Meijs, GF
   Chaouk, H
   Steele, JG
   Johnson, G
AF Hughes, TC
   Meijs, GF
   Chaouk, H
   Steele, JG
   Johnson, G
TI Porous perfluoroalkyl acrylates: A potential ophthalmic biomaterial.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 CSIRO, Clayton, Vic 3169, Australia.
RI Hughes, Timothy/A-9319-2011
OI Hughes, Timothy/0000-0002-7990-4509
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG
PY 2001
VL 222
MA 417-POLY
BP U318
EP U318
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 467EU
UT WOS:000170690101747
DA 2018-10-19
ER

PT J
AU Sanborn, TJ
   Messersmith, PB
   Barron, AE
AF Sanborn, TJ
   Messersmith, PB
   Barron, AE
TI Enzymatically crosslinked PEG-peptide hydrogel for biomaterial
   applications.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Northwestern Univ, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RI Barron, Annelise/B-7639-2009; Messersmith, Phil/B-6695-2009
NR 0
TC 0
Z9 0
U1 1
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG
PY 2001
VL 222
MA 22-MACR
BP U421
EP U421
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 467EU
UT WOS:000170690102366
DA 2018-10-19
ER

PT J
AU Stayton, PS
AF Stayton, PS
TI Biomaterial interfaces that instruct cell behavior.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RI Stayton, Patrick/C-1975-2018
OI Stayton, Patrick/0000-0001-6939-6371
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG
PY 2001
VL 222
MA 282-COLL
BP U374
EP U374
PN 1
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 467ET
UT WOS:000170690001869
DA 2018-10-19
ER

PT J
AU Zhu, XL
   Kim, KH
   Jeong, YS
AF Zhu, XL
   Kim, KH
   Jeong, YS
TI Anodic oxide films containing Ca and P of titanium biomaterial
SO BIOMATERIALS
LA English
DT Article
DE titanium; anodic oxide film; surface composition; structure and
   roughness; calcium glycerophosphate; calcium acetate
ID SURFACE; BONE; BEHAVIOR; LAYERS; METAL; IMPLANTS; INVITRO; TI6AL4V;
   GROWTH; ALLOY
AB Anodic oxidation and oxide films of titanium in the new electrolyte of calcium glycerophosphate (Ca-GP) and calcium acetate (CA) were investigated by galvanostatic mode, SEM, XRD and EPMA. The anodic oxide film displayed porosity, intermediate roughness, and high crystallinity. Also, the oxide film is enriched with Ca and P and high in thickness without microcracks. According to the surface properties of the oxide film, the optimum condition was that the concentration of the electrolyte was 0.02 M Ca-GP and 0.15 M CA, and current density and final voltage were 70 A/m(2) and ca. 350 V. The oxide film formed in the condition is 0.98 mum (R-a) rough, 5-7 mum thick, adhesive to the underlying substrate, and near 1.67 Ca/P ratio in the oxide film. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Kyungpook Natl Univ, Coll Dent, Inst Biomat Res, Taegu 700422, South Korea.
   Kyungpook Natl Univ, Coll Dent, Dept Dent Biomat, Taegu 700422, South Korea.
   Korea Inst Machinery & Mat, Dept Surface Engn, Changwon, South Korea.
RP Kim, KH (reprint author), Kyungpook Natl Univ, Coll Dent, Inst Biomat Res, 2-101 Dongin Dong, Taegu 700422, South Korea.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1987, J PROSTHET DENT, V57, P597, DOI 10.1016/0022-3913(87)90344-1
   Blendeau G., 1977, J LESS-COMMON MET, V56, P215
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   CAMARA OR, 1984, ELECTROCHIM ACTA, V29, P1111, DOI 10.1016/0013-4686(84)87163-7
   CAMERON HU, 1973, J BIOMED MATER RES, V7, P301, DOI 10.1002/jbm.820070404
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   CIGADA A, 1992, J MATER SCI-MATER M, V3, P408, DOI 10.1007/BF00701236
   EFFAH EAB, 1995, J BIOMED MATER RES, V29, P73, DOI 10.1002/jbm.820290111
   FELSKE A, 1989, ELECTROCHIM ACTA, V34, P75, DOI 10.1016/0013-4686(89)80012-X
   Fini M, 1999, BIOMATERIALS, V20, P1587, DOI 10.1016/S0142-9612(99)00060-5
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   HAZAN R, 1993, BIOMATERIALS, V14, P570, DOI 10.1016/0142-9612(93)90172-X
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   KURZE P, 1986, CRYST RES TECHNOL, V21, P1603, DOI 10.1002/crat.2170211224
   Lausmaa J, 1986, MATER RES SOC S P, V55, P351
   Lee TM, 2000, J BIOMED MATER RES, V50, P499, DOI 10.1002/(SICI)1097-4636(20000615)50:4<499::AID-JBM5>3.0.CO;2-U
   Lemons J E, 1988, J Dent Educ, V52, P748
   Letic-Gavrilovic A, 2000, Dent Mater J, V19, P99
   McAlarney M E, 1996, Int J Oral Maxillofac Implants, V11, P73
   Ohtsuka T, 1998, CORROS SCI, V40, P951, DOI 10.1016/S0010-938X(98)00032-8
   Ong J L, 1996, Implant Dent, V5, P83, DOI 10.1097/00008505-199600520-00002
   ONG JL, 1995, J MATER SCI-MATER M, V6, P113, DOI 10.1007/BF00120418
   Pouilleau J, 1997, MAT SCI ENG B-SOLID, V47, P235, DOI 10.1016/S0921-5107(97)00043-3
   RICCI JL, 1991, BONE-BIOMATERIAL INTERFACE, P334
   Shackelford JF, 1999, MATER SCI FORUM, V293, P1, DOI 10.4028/www.scientific.net/MSF.293.1
   Sviridov VV, 1998, RUSS J APPL CHEM+, V71, P2026
   Van N. R., 1987, J MATER RES, V22, P3801
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   WILLIAMS DF, 1990, INTERDISCIPL SCI REV, V15, P20
   Zwilling V, 1999, SURF INTERFACE ANAL, V27, P629, DOI 10.1002/(SICI)1096-9918(199907)27:7<629::AID-SIA551>3.0.CO;2-0
NR 33
TC 171
Z9 179
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2001
VL 22
IS 16
BP 2199
EP 2206
DI 10.1016/S0142-9612(00)00394-X
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 448TQ
UT WOS:000169646400003
PM 11456059
DA 2018-10-19
ER

PT J
AU Yamada, K
   Imamura, K
   Itoh, H
   Iwata, H
   Maruno, S
AF Yamada, K
   Imamura, K
   Itoh, H
   Iwata, H
   Maruno, S
TI Bone bonding behavior of the hydroxyapatite containing glass-titanium
   composite prepared by the Cullet method
SO BIOMATERIALS
LA English
DT Article
DE implant; hydroxyapatite-containing glass; biomaterial; bone bonding;
   artificial joint
ID FUNCTIONALLY GRADIENT COMPOSITE; COATED TITANIUM; IMPLANTS; PHOSPHATE;
   SURFACE
AB Bioactive composites composed of hydroxyapatite containing glass (HA-G) as a coating and titanium (Ti) or titanium alloy implants as a substrate were prepared by the Cullet method. This method results in the HA-G coating layer on the substrate with a compositional gradient in HA concentration. The results of in vitro and in vivo experiments investigating the characteristics of the composite materials are reported and discussed in this article. In vitro evaluations confirmed that the Cullet method was suitable for the preparation of the functionally gradient composite implants with higher reliable quality. In vivo experiments permitted evaluation of bonding strength of these composite implants to living bone tissue. Mechanical pull-out tests indicated that the implants bonded to living bone at least as firmly as those by the conventional method, and that the adhesion between the HA-G coating layer and metal substrate was well integrated and strongly maintained in vivo. SEM observations with EDX and a histological study of the interface between the HA-G-Ti composite implants and bone tissue revealed not only that the implants bonded to bone directly without any intervening tissue but that bone ingrowth into the HA-G layer occurred. The HA-G-Ti composite implants demonstrate both biocompatible and osteoconductive characteristics, and may be expected to obtain good and lasting results when applied clinically. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Nagoya Univ, Sch Med, Dept Orthoped Surg, Showa Ku, Nagoya, Aichi 4668550, Japan.
   Nagoya Inst Technol, Dept Elect & Comp Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.
   Tokyo Kouseinenkin Hosp, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1620821, Japan.
RP Yamada, K (reprint author), Aichi Canc Ctr Hosp, Dept Orthopaed Surg, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.
CR BAN S, 1994, J BIOMED MATER RES, V28, P65, DOI 10.1002/jbm.820280109
   BAN S, 1991, BIOMATERIALS, V12, P205, DOI 10.1016/0142-9612(91)90201-K
   BAN SJ, 1991, JPN J APPL PHYS 2, V30, pL1333, DOI 10.1143/JJAP.30.L1333
   BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   BLOEBAUM RD, 1993, J ARTHROPLASTY, V8, P195
   COOK SD, 1988, CLIN ORTHOP RELAT R, P225
   DELANGE GL, 1989, BIOMATERIALS, V10, P121, DOI 10.1016/0142-9612(89)90044-6
   FRAYSSINET P, 1992, BIOMATERIALS, V13, P668, DOI 10.1016/0142-9612(92)90126-9
   GEESINK RGT, 1995, J BONE JOINT SURG BR, V77B, P534
   Ishikawa Tomoji, 1993, Clinical Materials, V14, P277, DOI 10.1016/0267-6605(93)90014-X
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P973, DOI 10.1002/jbm.820250805
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   Maruno S., 1999, Materials Science Forum, V308-311, P344
   MARUNO S, 1991, BIOMATERIALS, V12, P225, DOI 10.1016/0142-9612(91)90204-N
   MARUNO S, 1992, NIPPON SERAM KYO GAK, V100, P362
   PASCHALIS EP, 1995, J BIOMED MATER RES, V29, P1499, DOI 10.1002/jbm.820291206
   Shen W J, 1992, J Arthroplasty, V7, P43, DOI 10.1016/0883-5403(92)90031-K
   Soballe K, 1993, Acta Orthop Scand Suppl, V255, P1
   SOBALLE K, 1991, CLIN ORTHOP RELAT R, P300
   YAMADA K, 1996, BIOCERAMICS, V9, P285
NR 20
TC 13
Z9 15
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2001
VL 22
IS 16
BP 2207
EP 2214
DI 10.1016/S0142-9612(00)00402-6
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 448TQ
UT WOS:000169646400004
PM 11456060
DA 2018-10-19
ER

PT J
AU Elizabeth, A
   Joseph, C
   Ittyachen, MA
AF Elizabeth, A
   Joseph, C
   Ittyachen, MA
TI Growth and micro-topographical studies of gel grown cholesterol crystals
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE cholesterol; gel method; organic solvents; micro-topographical studies;
   layered growth
AB Cholesterol (C27H46O) is the most abundant and best-known steroid in the animal kingdom. The in vitro crystallization of this important biomaterial has been attempted by few researchers. Here we are reporting crystallization of pure cholesterol monohydrate crystals in gel medium. It is found that the morphology of the crystals depends on various parameters. The effect of solvent has been studied in detail. The different morphologies observed are fibrous, needle, platelet, dendrite etc. Micro topographical studies have been made and it is found that the crystals grow, at least in the last stage, by spreading of layers. However, at initial stage microcrystals formed and developed into dendrite or needle forms. These one-dimensional crystals developed into platelets and finally thickened. Further studies reveal that micro impurities play a vital role in the development of these crystals as seen by dissolution figures on the crystals. These crystals are characterized by using the XRD and IR spectroscopic methods.
C1 Mahatma Gandhi Univ, Sch Pure & Appl Phys, Kottayam 686560, India.
RP Ittyachen, MA (reprint author), Mahatma Gandhi Univ, Sch Pure & Appl Phys, Kottayam 686560, India.
CR ADMIRAND WH, 1968, J CLIN INVEST, V4, P1045
   BAR LK, 1984, J CHEM ENG DATA, V29, P440, DOI 10.1021/je00038a023
   GARTI N, 1981, J LIPID RES, V22, P785
   GARTI N, 1980, THERMOCHIM ACTA, V35, P343, DOI 10.1016/0040-6031(80)87134-6
   Henisch H. K., 1988, CRYSTAL GROWTH GELS
   KALKURA SN, 1986, J MATER SCI LETT, V5, P741, DOI 10.1007/BF01730234
   KALKURA SN, 1987, J CRYST GROWTH, V83, P446, DOI 10.1016/0022-0248(87)90308-3
   LABOWITZ LC, 1972, THERMOCHIM ACTA, V3, P419
   PAL S, 1987, INDIAN J BIOCHEM BIO, V24, P24
NR 9
TC 16
Z9 17
U1 0
U2 3
PU INDIAN ACADEMY SCIENCES
PI BANGALORE
PA P B 8005 C V RAMAN AVENUE, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD AUG
PY 2001
VL 24
IS 4
BP 431
EP 434
DI 10.1007/BF02708643
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 461KL
UT WOS:000170363400014
DA 2018-10-19
ER

PT J
AU Tong, HH
   Monteiro, OR
   MacGill, RA
   Brown, IG
   Yin, GF
   Luo, JM
AF Tong, H. H.
   Monteiro, O. R.
   MacGill, R. A.
   Brown, I. G.
   Yin, G. F.
   Luo, J. M.
TI Fabrication and characteristics of ta-C biomaterial coatings on
   Ti-6Al-4V using metal plasma immersion ion implantation and deposition
SO CURRENT APPLIED PHYSICS
LA English
DT Article
DE ta-C; Biomaterials; Metal plasma immersion ion implantation and
   deposition; Diamond-like carbon; Hard coatings
AB We have formed amorphous diamond (ta-C) coatings on Ti-6Al-4V substrates using a metal plasma immersion ion implantation and deposition (MEPIIID) technique, and characterized the mechanical properties and biological compatibility of the coating material. The hemocompatibility of the coating compared favorably with that of low temperature isotropic (LTI) carbon, with kinetic clotting time and hemolysis rate approximately the same as for LTI carbon, and platelet consumption about twice that of the latter. The mechanical properties were good, with a microhardness greater than that of the uncoated metal substrates, and high adhesion of >0.75 GPa (interface shear stress) as estimated from a thermal quench method. Glancing-angle X-ray diffraction measurements indicated the presence of a TiC transition layer, suggesting the formation of a Ti/TiC/ta-C multilayer structure, leading in turn to good film-substrate adhesion. We conclude that this kind of amorphous diamond coating could provide benefit as a biocompatible hard coating for Ti-6Al-4V substrate material. (c) 2001 Elsevier Science B.V. All rights reserved.
C1 [Tong, H. H.] SW Inst Phys, Chengdu 610041, Sichuan, Peoples R China.
   [Monteiro, O. R.; MacGill, R. A.; Brown, I. G.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
   [Yin, G. F.; Luo, J. M.] Sichuan Univ, Dept Inorgan Mat, Chengdu 610065, Peoples R China.
RP Tong, HH (reprint author), SW Inst Phys, Chengdu 610041, Sichuan, Peoples R China.
EM thonghui@hotmail.com
FU IAEA; US Department of Energy, Office of Energy Research
   [DE-AC03-76SF00098]
FX One of us (H.H. Tong) was supported at LBNL by an IAEA Fellowship, for
   which he would like to express his appreciation. This work was supported
   in part by the US Department of Energy, Office of Energy Research, under
   Contract Number DE-AC03-76SF00098.
CR Alonso F, 1996, SURF COAT TECH, V83, P301, DOI 10.1016/0257-8972(96)02767-3
   ANDERS A, 1995, PLASMA SOURCES SCI T, V4, P1, DOI 10.1088/0963-0252/4/1/001
   Anders A, 1997, SURF COAT TECH, V93, P158, DOI 10.1016/S0257-8972(97)00037-6
   ANDERS S, 1997, DATA STORAGE, V4, P31
   Andreazza P, 1998, THIN SOLID FILMS, V319, P62, DOI 10.1016/S0040-6090(97)01086-9
   Baba K, 1998, SURF COAT TECH, V104, P235, DOI 10.1016/S0257-8972(98)00401-0
   BIERSACK JP, 1991, NUCL INSTRUM METH B, V59, P21, DOI 10.1016/0168-583X(91)95167-C
   BLECH IA, 1993, J VAC SCI TECHNOL A, V11, P728, DOI 10.1116/1.578800
   Brown IG, 1998, ANNU REV MATER SCI, V28, P243, DOI 10.1146/annurev.matsci.28.1.243
   BROWN IG, 1993, NUCL INSTRUM METH B, V80-1, P1281, DOI 10.1016/0168-583X(93)90782-2
   De Barros MI, 1999, DIAM RELAT MATER, V8, P1022, DOI 10.1016/S0925-9635(98)00439-7
   de Souza TM, 1997, THIN SOLID FILMS, V308, P254, DOI 10.1016/S0040-6090(97)00378-7
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   Fan QH, 1998, J APPL PHYS, V83, P5588, DOI 10.1063/1.367399
   Grill A, 1999, DIAM RELAT MATER, V8, P428, DOI 10.1016/S0925-9635(98)00262-3
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Lifshitz Y., 1999, DIAM RELAT MATER, V8, P779
   Lin CR, 1997, THIN SOLID FILMS, V308, P273, DOI 10.1016/S0040-6090(97)00392-1
   Littmark U., 1985, STOPPING RANGE IONS, V1
   Loinaz A, 1998, SURF COAT TECH, V104, P262, DOI 10.1016/S0257-8972(98)00411-3
   MacGill RA, 1998, REV SCI INSTRUM, V69, P801, DOI 10.1063/1.1148718
   Miji M., 1992, BIOMATERIALS, V13, P682
   Monteiro OR, 1999, NUCL INSTRUM METH B, V148, P12, DOI 10.1016/S0168-583X(98)00685-5
   Pharr GM, 1996, APPL PHYS LETT, V68, P779, DOI 10.1063/1.116530
   Ran J.G., 1992, 1 AS PAC C PLASM SCI, V1, P179
   Rinner M, 1998, SURF COAT TECH, V100, P366, DOI 10.1016/S0257-8972(97)00650-6
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   Sonoda T, 1998, SURF SCI, V402, P241, DOI 10.1016/S0039-6028(98)00032-6
   TOULOUKIAN YS, 1975, THERMALOPHYSICAL PRO, V12, P1272
   Viviente JL, 1999, APPL SURF SCI, V144-45, P249, DOI 10.1016/S0169-4332(98)00806-X
   Voevodin AA, 1997, THIN SOLID FILMS, V298, P107, DOI 10.1016/S0040-6090(96)09145-6
   Wilson AD, 1999, SURF COAT TECH, V114, P70, DOI 10.1016/S0257-8972(99)00024-9
   Yin GF, 1999, THIN SOLID FILMS, V345, P67, DOI 10.1016/S0040-6090(99)00076-0
   Zhang F, 1998, SURF COAT TECH, V104, P146, DOI 10.1016/S0257-8972(98)00434-4
NR 35
TC 5
Z9 6
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
EI 1878-1675
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD AUG
PY 2001
VL 1
IS 2-3
BP 197
EP 201
AR PII S1567-1739(01)00016-5
DI 10.1016/S1567-1739(01)00016-5
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA V23BZ
UT WOS:000208319600015
DA 2018-10-19
ER

PT J
AU Schoof, H
   Apel, J
   Heschel, I
   Rau, G
AF Schoof, H
   Apel, J
   Heschel, I
   Rau, G
TI Control of pore structure and size in freeze-dried collagen sponges
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE collagen sponge; pore structure; unidirectional solidification;
   freeze-drying; tissue engineering
ID ARTIFICIAL SKIN; MORPHOLOGY; MATRICES; TISSUE
AB Because of many suitable properties, collagen sponges are used as an acellular implant or a biomaterial in the field of tissue engineering. Generally, the inner three-dimensional structure of the sponges influences the behavior of cells. To investigate this influeuce, it is necessary to develop a process to produce sponges with a defined, adjustable, and homogeneous pore structure, Collagen sponges can be produced by freeze-drying of collagen suspensions. The pore structure of the freeze-dried sponges mirrors the ice-crystal morphology after freezing. In industrial production, the collagen suspensions are solidified under time- and space-dependent freezing conditions, resulting in an inhomogeneous pore structure. In this investigation, unidirectional solidification was applied during the freezing process to produce collagen sponges with a homogeneous pore structure. Using this technique the entire sample can be solidified under thermally constant freezing conditions, The ice-crystal morphology and size can be adjusted by varying the solute concentration in the collagen suspension, Collagen sponges with a very uniform and defined pore structure can be produced. Furthermore, the pore size can be adjusted between 20-40 mum. The thickness of the sponges prepared during this research was 10 mm, (C) 2001 John Wiley & Sons. Inc.
C1 Aachen Univ Technol, Rhein Westfal TH Aachen, Helmholtz Inst Biomed engn, D-52074 Aachen, Germany.
RP Heschel, I (reprint author), Aachen Univ Technol, Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Pauwelsstr 20, D-52074 Aachen, Germany.
CR AUBOURG P, 1978, THESIS MIT CAMBRIDGE
   BECKMANN J, 1990, CRYOBIOLOGY, V27, P279, DOI 10.1016/0011-2240(90)90027-2
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P721, DOI 10.1002/jbm.820110508
   CHVAPIL M, 1982, J BIOMED MATER RES, V16, P245, DOI 10.1002/jbm.820160306
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Ehlers EM, 1999, ANN ANAT, V181, P513, DOI 10.1016/S0940-9602(99)80055-7
   Ellis DL, 1996, BIOMATERIALS, V17, P291, DOI 10.1016/0142-9612(96)85567-0
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   HESCHEL I, 1996, ADV CRYOGEN ENG, P13
   HOBBS PV, 1974, ICE PHYSICS
   KURZ W, 1989, FUNDAMENTALS SOLIDIF, P7
   MARKS MG, 1991, J BIOMED MATER RES, V25, P683, DOI 10.1002/jbm.820250510
   MATSUDA K, 1990, BIOMATERIALS, V11, P351, DOI 10.1016/0142-9612(90)90113-5
   Mueller SM, 1999, BIOMATERIALS, V20, P701, DOI 10.1016/S0142-9612(98)00189-6
   MULLINS WW, 1964, J APPL PHYS, V35, P444, DOI 10.1063/1.1713333
   Nachf O. S., 1990, German Pat., Patent No. [DE 40 28 622 C2, 4028622]
   OLIVER RF, 1985, BIOCOMPATIBILITY TIS
   RODKEY WG, 1999, CLIN ORTHOP S, V367, P281
   RUTTER JW, 1953, CAN J PHYS, V31, P15, DOI 10.1139/p53-003
   Schlegel AK, 1997, BIOMATERIALS, V18, P535, DOI 10.1016/S0142-9612(96)00175-5
   Schoof H, 2000, J CRYST GROWTH, V209, P122, DOI 10.1016/S0022-0248(99)00519-9
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   WINTER G, 1973, BIOL FIBROBLAST, P104
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   YANNAS IV, 1989, Patent No. 8910728
   YANNAS IV, 1988, COLLAGEN BIOTECHNOLO, P87
   YAYALAOGLU MB, 1999, BIOMATER, V20, P1513
NR 28
TC 217
Z9 221
U1 5
U2 87
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 2001
VL 58
IS 4
BP 352
EP 357
DI 10.1002/jbm.1028
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 452CL
UT WOS:000169839500003
PM 11410892
DA 2018-10-19
ER

PT J
AU Dexter, SJ
   Pearson, RG
   Davies, MC
   Camara, M
   Shakesheff, KM
AF Dexter, SJ
   Pearson, RG
   Davies, MC
   Camara, M
   Shakesheff, KM
TI A comparison of the adhesion of mammalian cells and Staphylococcus
   epidermidis on fibronectin-modified polymer surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE cell adhesion; fibronectin; bacteria; fibroblast; tissue engineering
   scaffold
ID AUREUS; BINDING; TISSUE; ADHERENCE; BIOMATERIALS; INFECTIONS; RECEPTOR;
   BIOFILMS; PROTEINS; MATRICES
AB The modification of polymer surfaces to mimic the extracellular matrix, and therefore, stimulate cell growth via receptor-mediated interactions, is one approach used to promote the integration of tissue-engineering scaffolds and biomaterials into the body. However, by optimizing surfaces for tissue integration it is likely that bacterial adhesion may also be affected, resulting in a greater risk of biomaterial-related infection. This could be detrimental to both the implant and the patient because biomaterial related infections are particularly resistant to host defenses and antibiotics. In this study, we analyzed the adhesion of a Staphylococcus epidermidis clinical isolate and 3T3 rat fibroblasts to tissue culture plastic coated with varying concentrations of fibronectin (Fn). Bacterial adhesion was always lower than tissue culture plastic and appeared to decrease with increasing Fn concentrations. Mammalian cell adhesion to Fn Exceeded adhesion to tissue culture plastic but did not differ significantly over the range of protein concentrations or between 1 and 4 h of incubation. In most casts, the total surface coverage did not vary with time or Fn concentration, indicating that maximal cell adhesion and spreading occurred rapidly and at low protein concentrations. This study suggests that, by controlling the density of proteins or ligands on a surface, we can potentially optimize mammalian cell adhesion without stimulating bacterial adhesion, hence reducing the likelihood of infection. (C) 2001 John Wiley Sons, Inc. J Biomed Mater Res 56: 222-227, 2001.
C1 Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England.
RP Shakesheff, KM (reprint author), Univ Nottingham, Sch Pharmaceut Sci, Univ Pk, Nottingham NG7 2RD, England.
RI Shakesheff, Kevin/O-6371-2018
OI Shakesheff, Kevin/0000-0003-3236-2439; Davies,
   Martyn/0000-0001-7695-0596; Pearson, Richard/0000-0002-5241-9810
CR BOZZINI S, 1992, EUR J BIOCHEM, V207, P327, DOI 10.1111/j.1432-1033.1992.tb17054.x
   CIMA LG, 1993, CHEM ENG PROG, V89, P46
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   DRUMHELLER PD, 1995, BIOMEDICAL ENG HDB, pCH106
   DUNNE WM, 1993, J APPL BACTERIOL, V74, P411, DOI 10.1111/j.1365-2672.1993.tb05147.x
   ESPERSEN F, 1982, INFECT IMMUN, V37, P526
   FROMAN G, 1987, J BIOL CHEM, V262, P6564
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Habash M, 1999, J CLIN PHARMACOL, V39, P887, DOI 10.1177/00912709922008506
   HEALY KE, 1999, BIOARTIFICIAL ORGANS, V2, P24
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Marler JJ, 1998, ADV DRUG DELIVER REV, V33, P165, DOI 10.1016/S0169-409X(98)00025-8
   MOSHER DF, 1980, SCIENCE, V209, P927, DOI 10.1126/science.7403857
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   SOTTILE J, 1991, J BIOL CHEM, V266, P12840
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   VERCELLOTTI GM, 1985, AM J PATHOL, V120, P13
NR 23
TC 25
Z9 25
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 2001
VL 56
IS 2
BP 222
EP 227
DI 10.1002/1097-4636(200108)56:2<222::AID-JBM1087>3.0.CO;2-L
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 438BJ
UT WOS:000169033600008
PM 11340592
DA 2018-10-19
ER

PT J
AU Itala, A
   Nordstrom, EG
   Ylanen, H
   Aro, HT
   Hupa, M
AF Itala, A
   Nordstrom, EG
   Ylanen, H
   Aro, HT
   Hupa, M
TI Creation of microrough surface on sintered bioactive glass microspheres
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bioactive glass; microspheres; microroughness; atomic force microscopy;
   scanning electron microscopy
ID TITANIUM IMPLANTS; ELECTRON-MICROSCOPY; MINIATURE PIGS; BONE CELL;
   BIOMATERIALS; ROUGHNESS; CERAMICS; BEHAVIOR; COATINGS; ALLOY
AB Bioactive glasses are surface-active, generally silica-based, synthetic materials that form a firm chemical bond to bone. The aim of this study was to further enhance the bioactivity of glasses by creating a microroughness on their surface. Microroughness increases potential surface area for cell attachment and biomaterial-cell interactions. Three bioactive glasses of different composition were studied. Each material was flame-sprayed into microspheres, and a selected fraction of the spheres (250-300 mum) was sintered to form porous bioactive glass specimens. To create microrough surfaces, different acid etching techniques were tested. Atomic force microscopy (AFM) and back-scattered electron imaging of scanning electron microscopy (BEI-SEM) were used to characterize surface roughness. The degree of roughness was measured by AFM. A novel chemical-etching method, developed through intensive screening of different options, was found consistently to create the desired microroughness, with an average roughness value (R-a) of 0.35-0.52 mum and a root mean-square roughness value (R-rms) of 0.42-0.64 mum. Microroughening of the glass surface was obtained even in the internal parts of the porous glass matrices. Measured by BEI-SEM, the etching of a bioactive glass surface did not interfere with the formation of the characteristic surface reactions of bioactive glasses. This was confirmed by immersing the etched and control glass bodies in a simulated body fluid and tris(hydroxymethyl) aminomethane/HCl. The etching process did not significantly affect the mechanical strength of the sintered bioactive glass structures. Based on these experiments, it stems possible to create a reproducible microroughness of appropriate size on the surface of porous bioactive glass. The biologic benefits of such a surface treatment need to be validated with in vivo experiments. (C) 2001 John Wiley & Sons, Inc. J Biomed Mater Res 56: 282-288, 2001.
C1 Univ Turku, Dept Surg, FIN-20520 Turku, Finland.
   Abo Akad Univ, Proc Chem Grp, SF-20500 Turku, Finland.
RP Aro, HT (reprint author), Univ Turku, Dept Surg, FIN-20520 Turku, Finland.
OI Aro, Hannu/0000-0003-3118-9144
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   BARO AM, 1986, BIOMATERIALS, V7, P463, DOI 10.1016/0142-9612(86)90036-0
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Brink M, 1996, BIOCERAMICS, V9, P127
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Carlsson L, 1988, Int J Oral Maxillofac Implants, V3, P21
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5
   GAPPI C, 1995, BIOMATERIALS, V16, P515
   Gomez-Vega JM, 1999, J BIOMED MATER RES, V46, P549, DOI 10.1002/(SICI)1097-4636(19990915)46:4<549::AID-JBM13>3.0.CO;2-M
   Grossner-Schreiber B, 1991, Dtsch Zahnarztl Z, V46, P691
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   JONES SJ, 1985, SCANNING, V7, P5, DOI 10.1002/sca.4950070101
   KARLSSON KH, 1999, ANN CHIR GYNAECOL, V88, P237
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   Kitsugi T, 1996, J BIOMED MATER RES, V30, P261, DOI 10.1002/(SICI)1097-4636(199602)30:2<261::AID-JBM17>3.0.CO;2-P
   LACEFIELD WR, 1986, BIOMATERIALS, V7, P104, DOI 10.1016/0142-9612(86)90064-5
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   MICHAELS C M, 1989, Journal of Dental Research, V68, P276
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S
   Oliva A, 1998, BIOMATERIALS, V19, P1019, DOI 10.1016/S0142-9612(97)00249-4
   PAJAMAKI J, 1995, ARCH ORTHOP TRAUM SU, V114, P119, DOI 10.1007/BF00422839
   PITKANEN V, 1995, J AEROSOL SCI, V26, P831
   RATNER BD, 1983, ANN BIOMED ENG, V11, P313, DOI 10.1007/BF02363290
   Schrooten J, 1999, J BIOMED MATER RES, V44, P243, DOI 10.1002/(SICI)1097-4636(19990305)44:3<243::AID-JBM2>3.0.CO;2-O
   TAKADAMA H, 1999, BIOCERAMICS, V12, P109
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   Virolainen P, 1997, J BIOMED MATER RES, V35, P9, DOI 10.1002/(SICI)1097-4636(199704)35:1<9::AID-JBM2>3.3.CO;2-H
   Wen XJ, 1996, BIO-MED MATER ENG, V6, P173
   Ylanen H, 2000, J NON-CRYST SOLIDS, V275, P107, DOI 10.1016/S0022-3093(00)00245-3
   Ylanen HO, 1999, ANN CHIR GYNAECOL FE, V88, P237
NR 35
TC 24
Z9 24
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 2001
VL 56
IS 2
BP 282
EP 288
DI 10.1002/1097-4636(200108)56:2<282::AID-JBM1096>3.0.CO;2-5
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 438BJ
UT WOS:000169033600016
PM 11340600
DA 2018-10-19
ER

PT J
AU Hong, J
   Larsson, A
   Ekdahl, KN
   Elgue, G
   Larsson, R
   Nilsson, B
AF Hong, J
   Larsson, A
   Ekdahl, KN
   Elgue, G
   Larsson, R
   Nilsson, B
TI Contact between a polymer and whole blood: Sequence of events leading to
   thrombin generation
SO JOURNAL OF LABORATORY AND CLINICAL MEDICINE
LA English
DT Article
ID IN-VITRO MODEL; PLATELET ACTIVATION; FACTOR-XII; IMMOBILIZED HEPARIN;
   ARTIFICIAL SURFACES; FLOWING BLOOD; P-SELECTIN; COAGULATION;
   ERYTHROCYTES; PHOSPHORYLATION
AB The mechanism by which thrombin is generated on a polymer surface in an extracorporeal circuit is not yet fully understood. To address this question we have developed an in vitro chamber model in which whole blood containing heparin (I IU/mL) comes in contact with a commonly used biomaterial, polyvinyl chloride (PVC). Incubation of blood in the chamber for 60 minutes at 37 degreesC resulted in the binding of platelets to the material surface and the generation of thrombin-antithrombin complexes. Corn trypsin inhibitor, a specific inhibitor of factor XIIa, inhibited this thrombin-antithrombin complex generation in blood in contact with PVC, which is not considered an efficient activator of factor XII. The addition of the glycoprotein IIb/IIIa inhibitor Ro44-9883 abrogated platelet binding and aggregation and resulted in decreased generation of thrombin-antithrombin complexes. Thrombin-antithrombin generation was also negligible in platelet-rich plasma but could be partially restored in the presence of erythrocytes. Taken together, these data are compatible with a model in which thrombin generation is triggered by factor XII. The response to contact with PVC appears to begin with a low-grade generation of thrombin that involves both erythrocytes and leukocytes and that activates platelets, followed by the activation of a platelet-dependent amplification loop that produces most of the thrombin.
C1 Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden.
   Univ Hosp, Dept Med Sci, Uppsala, Sweden.
   Univ Kalmar, Dept Chem & Nat Sci, Kalmar, Sweden.
RP Nilsson, B (reprint author), Univ Uppsala Hosp, Dept Clin Immunol & Transfus Med, S-75185 Uppsala, Sweden.
RI Nilsson Ekdahl, Kristina/B-5301-2012; Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
CR AARTS PAMM, 1988, ARTERIOSCLEROSIS, V8, P819, DOI 10.1161/01.ATV.8.6.819
   Amirkhosravi A, 1996, THROMB HAEMOSTASIS, V75, P87
   Baglia FA, 2000, J BIOL CHEM, V275, P20514, DOI 10.1074/jbc.M000464200
   Basmadjian D, 1997, BIOMATERIALS, V18, P1511, DOI 10.1016/S0142-9612(97)00101-4
   Carroll RC, 1997, THROMB RES, V88, P109, DOI 10.1016/S0049-3848(97)00223-5
   Colman RW, 1997, BLOOD, V90, P3819
   Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429
   EGBERG N, 1983, THROMB RES, V31, P875, DOI 10.1016/0049-3848(83)90118-4
   Ekdahl KN, 1999, THROMB HAEMOSTASIS, V82, P1283
   ELAM JH, 1992, BIOMATERIALS, V13, P3, DOI 10.1016/0142-9612(92)90086-4
   ELGUE G, 1993, ARTIF ORGANS, V17, P721
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Helley D, 1996, THROMB HAEMOSTASIS, V76, P322
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Hunt BJ, 1997, BLOOD COAGUL FIBRIN, V8, P223, DOI 10.1097/00001721-199706000-00003
   Kirchhofer D, 1997, BLOOD, V89, P1270
   Koenig A, 1998, J CLIN INVEST, V101, P877, DOI 10.1172/JCI1509
   Lamba NMK, 2000, BIOMATERIALS, V21, P89, DOI 10.1016/S0142-9612(99)00145-3
   Li N, 1998, BLOOD COAGUL FIBRIN, V9, P507, DOI 10.1097/00001721-199809000-00008
   Li NL, 2000, ARTERIOSCL THROM VAS, V20, P2702, DOI 10.1161/01.ATV.20.12.2702
   Lindmark E, 2000, ARTERIOSCL THROM VAS, V20, P2322, DOI 10.1161/01.ATV.20.10.2322
   MATSUDA T, 1997, INT J ORAL MAXILLIFA, V12, P472
   Matsumoto Y, 1999, THROMB RES, V95, P19, DOI 10.1016/S0049-3848(98)00189-3
   NELSON RM, 1993, BLOOD, V82, P3253
   Nilsson B, 1998, BLOOD, V92, P1661
   Ostrovsky L, 1998, BLOOD, V91, P3028
   Peyrou V, 1999, THROMB HAEMOSTASIS, V81, P400
   SALZMAN EW, 1987, ANN NY ACAD SCI, V516, P184, DOI 10.1111/j.1749-6632.1987.tb33040.x
   Sanchez J, 1998, THROMB RES, V89, P41, DOI 10.1016/S0049-3848(97)00310-1
   SANTOS MT, 1991, J CLIN INVEST, V87, P571, DOI 10.1172/JCI115032
   VALLES J, 1991, BLOOD, V78, P154
   Walsh PN, 1999, THROMB HAEMOSTASIS, V82, P234
   WICKI AN, 1985, EUR J BIOCHEM, V153, P1, DOI 10.1111/j.1432-1033.1985.tb09259.x
NR 34
TC 39
Z9 39
U1 0
U2 5
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-2143
J9 J LAB CLIN MED
JI J. Lab. Clin. Med.
PD AUG
PY 2001
VL 138
IS 2
BP 139
EP 145
DI 10.1067/mlc.2001.116486
PG 7
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA 459YT
UT WOS:000170279600008
PM 11477381
DA 2018-10-19
ER

PT J
AU Sabokbar, A
   Pandey, R
   Diaz, J
   Quinn, JMW
   Murray, DW
   Athanasou, NA
AF Sabokbar, A
   Pandey, R
   Diaz, J
   Quinn, JMW
   Murray, DW
   Athanasou, NA
TI Hydroxyapatite particles are capable of inducing osteoclast formation
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BONE-RESORBING CELLS; MACROPHAGES DIFFERENTIATE; IN-VITRO; RESORPTION;
   IMPLANTS
AB Hydroxyapatite (HA) coatings have been used to improve implant fixation by promoting bone formation around the prosthesis. A macrophage response to HA particulates has been noted around loosened HA-coated prostheses. As biomaterial wear particle-associated macrophages are known to be capable of differentiating into osteoclasts that are capable of bone resorption, we examined whether particulate HA could similarly induce macrophage-osteoclast differentiation. HA-associated macrophages were isolated from granulomas, formed by subcutaneous implantation of HA, and co-cultured with UMR 106 osteoblast-like cells in the presence of 1,25-dihydroxyvitamin D-3 for up to 14 days on glass coverslips and bone slices. HA-associated macrophage-osteoclast differentiation was evidenced by the formation of numerous multinucleated tartrate resistant acid phosphatase (TRAP)-positive cells which formed lacunar resorption pits on bone slices. Polymethylmethacrylate (PMMA) particle-associated macrophages, isolated from subcutaneous PMMA-containing granulomas, caused significantly more osteoclast formation and bone resorption than HA-associated macrophages. These results indicate that macrophages responding to HA particles are capable of osteoclast differntiation. They also suggest that particles derived from uncemented (HA-coated) implants are likely to induce less osteoclast formation and osteolysis than cemented implants. (C) 2001 Kluwer Academic Publishers.
C1 Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Surg, Dept Pathol, Oxford OX3 7LD, England.
RP Athanasou, NA (reprint author), Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Surg, Dept Pathol, Oxford OX3 7LD, England.
RI Murray, David/D-7117-2011
CR ATHANASOU NA, 1992, J BONE JOINT SURG BR, V74, P57
   Athanasou NA, 1996, J BONE JOINT SURG AM, V78A, P1096, DOI 10.2106/00004623-199607000-00016
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   BAUER TW, 1994, CLIN ORTHOP RELAT R, P11
   BLOEBAUM RD, 1993, J ARTHROPLASTY, V8, P195
   BLOEBAUM RD, 1994, CLIN ORTHOP RELAT R, P19
   BULLOUGH PG, 1988, ORTHOP CLIN N AM, V19, P611
   EVANS JJ, 1991, CLIN MATER, V7, P241
   GLOWACKI J, 1986, CALCIFIED TISSUE INT, V39, P97, DOI 10.1007/BF02553297
   Harada Y, 1996, J BIOMED MATER RES, V31, P19, DOI 10.1002/(SICI)1097-4636(199605)31:1<19::AID-JBM3>3.3.CO;2-L
   Jaffe WL, 1996, J BONE JOINT SURG AM, V78A, P1918, DOI 10.2106/00004623-199612000-00018
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   KIM KJ, 1993, CLIN ORTHOP RELAT R, P142
   Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X
   LENNOX DW, 1987, CLIN ORTHOP RELAT R, P171
   MARKS SC, 1991, J BONE MINER RES, V6, P395
   MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   NAGASE M, 1988, J RHEUMATOL, V15, P1334
   Neale SD, 2000, J ARTHROPLASTY, V15, P654, DOI 10.1054/arth.2000.6622
   Pandey R, 1996, ANN RHEUM DIS, V55, P388, DOI 10.1136/ard.55.6.388
   QUINN J, 1992, J BONE JOINT SURG BR, V74, P652
   Quinn JMW, 1997, CALCIFIED TISSUE INT, V60, P63, DOI 10.1007/s002239900187
   REVELL PA, 1982, CURRENT TRENDS PATHO, P137
   Sabokbar A, 1997, ANN RHEUM DIS, V56, P414, DOI 10.1136/ard.56.7.414
   SABOKBAR A, 1998, ARCH ORTHOP TRAUMA S, V184, P31
   SOBALLE K, 1991, CLIN ORTHOP RELAT R, P255
   Sun JS, 1999, J BIOMED MATER RES, V45, P311
   WANG W, 1999, HIP INT, V9, P178
NR 29
TC 29
Z9 31
U1 1
U2 6
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2001
VL 12
IS 8
BP 659
EP 664
DI 10.1023/A:1011267005465
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 459AG
UT WOS:000170227200001
PM 15348234
DA 2018-10-19
ER

PT J
AU Garcia Paez, JM
   Jorge-Herrero, E
   Carrera, A
   Millan, I
   Rocha, A
   Cordon, A
   Salvador, J
   Sainz, N
   Mendez, J
   Castillo-Olivares, JL
AF Garcia Paez, JM
   Jorge-Herrero, E
   Carrera, A
   Millan, I
   Rocha, A
   Cordon, A
   Salvador, J
   Sainz, N
   Mendez, J
   Castillo-Olivares, JL
TI A new method for selecting calf pericardium for use in cardiac
   bioprostheses on the basis of morphological and mechanical criteria
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PROSTHETIC HEART-VALVES; BOVINE PERICARDIUM; TISSUE SELECTION; PORCINE
   BIOPROSTHESES; FIBER ARCHITECTURE; FAILURE; INVIVO; SITES
AB The durability of existing calf pericardium bioprostheses is limited by phenomena such as mechanical stress and calcification, the factors most frequently implicated in valve failure. Varying the preferred direction of the collagen fibers influences the mechanical behavior of the pericardial membrane. Given this possible variation, a strict control of the selection of the biomaterial employed in the construction of valve leaflets is essential, but a reliable method of selection has yet to be established.
   This study describes the development of a new system of in vitro selection involving a hydraulic simulator that reproduces the mechanical behavior of pericardial membranes subjected to the stress of continuous flow.
   By combining morphological criteria such as thickness and homogeneity with those of mechanical behavior, and by selecting paired samples from different parts of the pericardium, we obtained excellent mathematical fits. Linear regression analysis provided the mode of predicting the tensile strength in a given sample when this value had been determined in its twin. The upper zones of calf pericardium, corresponding to either right or left ventricle but at a distance from ligamentous structures, showed the best mean results at rupture (60 MPa) and permitted the most reliable prediction. The expected stress for an elongation of 30% was 1.12 MPa, as was previously observed, with a 95% confidence interval of between 1.11 and 1.14 MPa.
   These trials, together with the careful selection of the pairs, should help to establish definitive selection criteria. (C) 2001 Kluwer Academic Publishers.
C1 Clin Puerta Hierro, Serv Med Prevent, Madrid 28035, Spain.
   Clin Puerta Hierro, Serv Expt Surg, Madrid 28035, Spain.
   Clin Puerta Hierro, Serv Biostat, Madrid 28035, Spain.
   Super Tech Sch Ind Engn, Madrid, Spain.
RP Garcia Paez, JM (reprint author), Clin Puerta Hierro, Serv Med Prevent, San Martin Porres 4, Madrid 28035, Spain.
RI Jorge Herrero, EDUARDO/F-7240-2010; Sainz, Nekane/G-3136-2016
OI Sainz, Nekane/0000-0002-8438-6929
CR BLOOMFIELD P, 1991, NEW ENGL J MED, V324, P573, DOI 10.1056/NEJM199102283240901
   Bortolotti U, 1988, Eur J Cardiothorac Surg, V2, P458, DOI 10.1016/1010-7940(88)90052-8
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   Bustamante John, 1996, Archivos del Instituto de Cardiologia de Mexico, V66, P229
   Carrera San Martin A., 1993, Biomaterials, V14, P76, DOI 10.1016/0142-9612(93)90079-H
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   GABBAY S, 1984, J THORAC CARDIOV SUR, V87, P836
   GRUNKEMEIER GL, 1994, J THORAC CARDIOV SUR, V108, P709
   Haziza F, 1996, J HEART VALVE DIS, V5, P35
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   Kent PD, 1998, CARDIOVASC PATHOL, V7, P9, DOI 10.1016/S1054-8807(97)00040-9
   Levy R J, 1994, J Heart Valve Dis, V3, P101
   MUNRO AI, 1995, ANN THORAC SURG, V60, pS470
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   Sacks MS, 1997, ANN BIOMED ENG, V25, P678, DOI 10.1007/BF02684845
   SCHOEN FJ, 1985, HUM PATHOL, V16, P549, DOI 10.1016/S0046-8177(85)80103-9
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P697, DOI 10.1002/jbm.820270602
   THUBRIKAR M, 1982, J THORAC CARDIOV SUR, V84, P282
   TIMOSHENKO S, 1970, RESISTENCIA MAT, V1, P163
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   VONFRAUNHOFER JA, 1988, BIOMATERIALS, V9, P324, DOI 10.1016/0142-9612(88)90027-0
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
NR 24
TC 0
Z9 0
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2001
VL 12
IS 8
BP 665
EP 671
DI 10.1023/A:1011252022303
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 459AG
UT WOS:000170227200002
PM 15348235
DA 2018-10-19
ER

PT J
AU Yanagisawa, N
   Li, DQ
   Ljungh, A
AF Yanagisawa, N
   Li, DQ
   Ljungh, A
TI The N-terminal of thrombospondin-1 is essential for coagulase-negative
   staphylococcal binding
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
ID EXTRACELLULAR-MATRIX PROTEINS; VON-WILLEBRAND-FACTOR; HEPARIN-BINDING;
   AFFINITY-CHROMATOGRAPHY; CELL-SURFACE; HUMAN-PLASMA; AUREUS; DOMAIN;
   VITRONECTIN; INFECTIONS
AB Bacterial binding was studied to determine whether thrombospondin-l (TSP) acts as a ligand in attachment of coagulase-negative staphylococci (CNS), Twenty-five of 27 CNS strains bound soluble TSP, Staphylococcus epidermidis J9P bound I-125-labelled TSP in a dose-dependent manner. Scatchard plot analysis of the binding of TSP by strain J9P revealed two Kd values of 6.4 x 10(-9) h4 and 2.9 x 10(-8)M. The binding structures of strain J9P were sensitive to protease and were resistant to heat treatment. Unlabelled TSP and recombinant von Willebrand factor inhibited binding of TSP by strain J9P, but other proteins or monosaccharides did not. Heparin inhibited binding of TSP to strain J9P and two other S. epidermidis strains, BD5703 and BD969, Fusion proteins of the type 1 repeats, type 2 repeats, type 3 repeats and C-terminal domain of TSP or the synthetic Arg-Gly-Asp peptide did not inhibit binding of TSP to bacteria. TSP promoted adhesion of S. epidermidis strains when it was immobilised on polymer surfaces. These results indicate that the specific interaction between CNS and TSP may contribute to bacterial adhesion on biomaterial surfaces. The N-terminal heparin-binding domain of TSP appears to be the major region for recognition by CNS.
C1 Univ Lund, Dept Med Microbiol Dermatol & Infect, Lund, Sweden.
RP Ljungh, A (reprint author), Univ Lund, Dept Med Microbiol Dermatol & Infect, Lund, Sweden.
CR Allignet J, 1999, MICROBIOL-UK, V145, P2033, DOI 10.1099/13500872-145-8-2033
   BANDYK DF, 1992, INFECT DIS CLIN N AM, V6, P719
   Barabino GA, 1997, BLOOD, V89, P2560
   BORNSTEIN P, 1994, METHOD ENZYMOL, V245, P62
   Clezardin P, 1997, BIOCHEM J, V321, P819, DOI 10.1042/bj3210819
   GUO NH, 1992, P NATL ACAD SCI USA, V89, P3040, DOI 10.1073/pnas.89.7.3040
   HERRMANN M, 1991, INFECT IMMUN, V59, P279
   Hotchkiss KA, 1998, BBA-PROTEIN STRUCT M, V1388, P478, DOI 10.1016/S0167-4838(98)00211-8
   Incardona F, 1996, J CELL BIOCHEM, V62, P431, DOI 10.1002/(SICI)1097-4644(19960915)62:4<431::AID-JCB1>3.0.CO;2-N
   Kang JK, 1999, CHILD NERV SYST, V15, P711, DOI 10.1007/s003810050460
   LAWLER J, 1992, BIOCHEMISTRY-US, V31, P1173, DOI 10.1021/bi00119a029
   Li DQ, 2000, J MED MICROBIOL, V49, P217, DOI 10.1099/0022-1317-49-3-217
   LIANG OD, 1992, INFECT IMMUN, V60, P899
   Ljungh A, 1996, ADV EXP MED BIOL, V408, P129
   Lundberg F, 1997, ACTA NEUROCHIR, V139, P734, DOI 10.1007/BF01420046
   MAMO W, 1988, VET MICROBIOL, V18, P163, DOI 10.1016/0378-1135(88)90062-4
   MCGAVIN MH, 1993, INFECT IMMUN, V61, P2479
   Mikhailenko I, 1997, J BIOL CHEM, V272, P6784, DOI 10.1074/jbc.272.10.6784
   Modun B, 1999, INFECT IMMUN, V67, P1086
   Nakamura T, 1999, FEMS MICROBIOL LETT, V175, P267, DOI 10.1016/S0378-1097(99)00205-0
   PARRODI F, 1990, INT J PARASITOL, V20, P899, DOI 10.1016/0020-7519(90)90028-L
   Partridge SR, 1996, INFECT IMMUN, V64, P4324
   PAULSSON M, 1993, J MED MICROBIOL, V38, P96, DOI 10.1099/00222615-38-2-96
   REED MJ, 1993, J HISTOCHEM CYTOCHEM, V41, P1467, DOI 10.1177/41.10.8245406
   Riessen R, 1998, AM HEART J, V135, P357, DOI 10.1016/S0002-8703(98)70105-X
   Rubin B G, 1993, Ann Vasc Surg, V7, P200, DOI 10.1007/BF02001017
   SHEN W, 1995, GUT, V36, P401, DOI 10.1136/gut.36.3.401
   Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900
   von Eiff C, 1999, EUR J CLIN MICROBIOL, V18, P843, DOI 10.1007/s100960050417
   VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331
   Vuong C, 2000, INFECT IMMUN, V68, P1048, DOI 10.1128/IAI.68.3.1048-1053.2000
   WISNIOWSKI P, 1995, J LAB CLIN MED, V125, P38
   YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281
   Yu HN, 2000, ARCH BIOCHEM BIOPHYS, V374, P13, DOI 10.1006/abbi.1999.1597
   ZARDI L, 1980, J IMMUNOL METHODS, V34, P155, DOI 10.1016/0022-1759(80)90169-6
   Zareba TW, 1997, CURR MICROBIOL, V34, P6, DOI 10.1007/s002849900135
NR 36
TC 7
Z9 7
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-2615
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD AUG
PY 2001
VL 50
IS 8
BP 712
EP 719
DI 10.1099/0022-1317-50-8-712
PG 8
WC Microbiology
SC Microbiology
GA 454UE
UT WOS:000169989500010
PM 11478675
OA Bronze
DA 2018-10-19
ER

PT J
AU Badylak, S
   Kokini, M
   Tullius, B
   Whitson, B
AF Badylak, S
   Kokini, M
   Tullius, B
   Whitson, B
TI Strength over time of a resorbable bioscaffold for body wall repair in a
   dog model
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE tissue engineering; extracellular matrix; resorbable bioscaffold;
   scaffold; body wall repair; mechanical properties
ID SMALL-INTESTINAL SUBMUCOSA; ACHILLES-TENDON REPAIR; DERMAL SHEEP
   COLLAGEN; ABDOMINAL-WALL; AUGMENTATION CYSTOPLASTY; MESH; BIOMATERIAL;
   DEFECTS; GRAFT; HERNIA
AB The change in strength over time of a biomaterial derived from the small intestinal submucosa (SIS) was determined in a dog model of body wall repair. Full-thickness body wall defects measuring 8 x 12 cm were surgically created and then repaired with a multilaminate eight-layer form of SIS in 40 dogs. Five dogs were sacrificed at each of the following time points: 1 day, 4 days, 7 days, 10 days, and 1, 3, 6, and 24 months. Ball burst tests that measured biaxial ultimate load-bearing capability were performed on the device prior to implantation and on the device/implant site at the time of sacrifice. The strength of the device at the time of implant was approximately 73 +/- 12 pounds. The strength of the implant site diminished to 40 +/- 18 pounds at 10 days, and then progressively increased to a value of 156 +/- 26 pounds at 24 months (P < 0.05). The clinical utility of a degradable biomaterial such as SIS depends on a balance between the rate of degradation and the rate of host remodeling. Naturally occuring extracellular matrix scaffolds such as SIS show rapid degradation with associated and subsequent remodeling to a tissue with strength that exceeds that of the native tissue when used as a body wall repair device. (C) 2001 Academic Press.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Mech Engn, W Lafayette, IN 47907 USA.
RP Badylak, S (reprint author), Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
OI Badylak, Stephen/0000-0003-3555-0689
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   DEJARDIN LM, IN PRESS AM J SPORTS
   Gloeckner DC, 2000, J BIOMED MATER RES, V52, P365, DOI 10.1002/1097-4636(200011)52:2<365::AID-JBM17>3.0.CO;2-3
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Hodde JP, 1997, TISSUE ENG, V3, P27, DOI 10.1089/ten.1997.3.27
   JAMES NL, 1991, BIOMATERIALS, V12, P801, DOI 10.1016/0142-9612(91)90065-I
   JENKINS SD, 1983, SURGERY, V94, P392
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   LAMB JP, 1983, SURGERY, V93, P643
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   LEWIS RT, 1984, CAN J SURG, V27, P155
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   RECORD RD, IN PRESS BIOMATERILS
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   TYRELL J, 1989, SURG GYNECOL OBSTET, V168, P227
   VANDERLAAN JS, 1991, INT J ARTIF ORGANS, V14, P661
   VANWACHEM PB, 1994, INT J ARTIF ORGANS, V17, P230
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
NR 30
TC 150
Z9 158
U1 3
U2 19
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD AUG
PY 2001
VL 99
IS 2
BP 282
EP 287
DI 10.1006/jsre.2001.6176
PG 6
WC Surgery
SC Surgery
GA 460GE
UT WOS:000170299200017
PM 11469898
DA 2018-10-19
ER

PT J
AU Konig, DP
   Schierholz, JM
   Hilgers, RD
   Bertram, C
   Perdreau-Remington, F
   Rutt, A
AF Konig, DP
   Schierholz, JM
   Hilgers, RD
   Bertram, C
   Perdreau-Remington, F
   Rutt, A
TI In vitro adherence and accumulation of Staphylococcus epidermidis RP 62
   A and Staphylococcus epidermidis M7 on four different bone cements
SO LANGENBECKS ARCHIVES OF SURGERY
LA English
DT Article
DE bone cement; Staphylococcus epidermidis; biomaterials; exopolysaccharide
   slime production
ID BACTERIAL ADHERENCE; INVITRO; SURFACES; ADHESION; SURGERY; AUREUS;
   STRAIN
AB Bacterial resistance of Staphylococcus epidermidis, a serious pathogen of implant-related infections, to antibiotics is related to the production of a glycocalyx slime that impairs antibiotic access and the killing by host defense mechanisms. In vitro studies of different bone cements containing antibiotics, developed for the prevention of biomaterial-associated infection, could not always demonstrate complete eradication of biomaterial-adherent bacteria. We have investigated four different bone cements in regard to bacterial accumulation of a slime-producing strain RP 62 A and its isogenic mutant M7 lacking the ability to produce exopolysaccharide slime using a bacterial adhesion assay and modified Kirby-Bauer technique. A significant effect of exopolysaccharide production for the accumulation on bone cement could be demonstrated. The gentamicin/clindamycin bone cement was the only tested biomaterial that produced a large zone of bacterial inhibition in the inoculated area adjacent to the biomaterial. The bacterial adhesion was not reduced significantly and there was no correlation between zones of inhibition on blood agar plates and the quantitative adhesion assay. The clinical efficacy of the gentamicin/clindamycin bone cement must be proven in vivo.
C1 Univ Cologne, Dept Orthopaed Surg, D-50924 Cologne, Germany.
   Univ Calif San Francisco, San Francisco, CA 94143 USA.
   Univ Cologne, Dept Med Stat, D-5000 Cologne, Germany.
   Ctr Adv European Studies & Res, Bonn, Germany.
RP Konig, DP (reprint author), Univ Cologne, Dept Orthopaed Surg, Joseph Stelzmann Str 9, D-50924 Cologne, Germany.
RI Hilgers, Ralf-Dieter/C-7090-2013
OI Hilgers, Ralf-Dieter/0000-0002-5945-1119
CR ARIZONO T, 1992, ACTA ORTHOP SCAND, V63, P661
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   CHANG CC, 1992, J BIOMED MATER RES, V26, P197, DOI 10.1002/jbm.820260206
   Chohfi M, 1998, INT ORTHOP, V22, P171, DOI 10.1007/s002640050235
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   Espehaug B, 1997, J BONE JOINT SURG BR, V79B, P590, DOI 10.1302/0301-620X.79B4.7420
   GARVIN KL, 1994, CLIN ORTHOP RELAT R, P97
   Gracia E, 1997, INT ORTHOP, V21, P46, DOI 10.1007/s002640050116
   Gristina A. G., 1987, ZENTRALBL BAKTERIO S, V16, P143
   Hanssen AD, 1998, J BONE JOINT SURG AM, V80A, P910, DOI 10.2106/00004623-199806000-00016
   Konig DP, 1998, ACTA ORTHOP SCAND, V69, P523, DOI 10.3109/17453679808997791
   Masri BA, 1998, J ARTHROPLASTY, V13, P331, DOI 10.1016/S0883-5403(98)90179-6
   NAYLOR P, 1988, ORTHOP T, V12, P524
   OGA M, 1992, ACTA ORTHOP SCAND, V63, P301, DOI 10.3109/17453679209154787
   OGA M, 1993, ACTA ORTHOP SCAND, V64, P273, DOI 10.3109/17453679308993623
   Ozaki T, 1998, J Orthop Sci, V3, P163, DOI 10.1007/s007760050037
   RUCKELSHAUSEN MC, 1987, VERWENDUNG POLYMETHY, P15
   Scherertz J, 1990, J CLIN MICROBIOL, V28, P76
   SCHERERTZ RJ, 1996, INFECT CONT HOSP EP, V17, P746
   Schierholz JM, 1999, ZBL BAKT-INT J MED M, V289, P165
   SCHUMACHERPERDREAU F, 1994, FEMS MICROBIOL LETT, V117, P71
   Tunney MM, 1998, ANTIMICROB AGENTS CH, V42, P3002, DOI 10.1128/AAC.42.11.3002
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P775, DOI 10.1002/jbm.820270610
   Voos K, 1999, J ORTHOP TRAUMA, V13, P98, DOI 10.1097/00005131-199902000-00005
   Yaniv M, 1999, CLIN ORTHOP RELAT R, P232
NR 25
TC 20
Z9 21
U1 0
U2 1
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 1435-2443
J9 LANGENBECK ARCH SURG
JI Langenbecks Arch. Surg.
PD AUG
PY 2001
VL 386
IS 5
BP 328
EP 332
DI 10.1007/s004230100229
PG 5
WC Surgery
SC Surgery
GA 477GU
UT WOS:000171275700004
PM 11685562
DA 2018-10-19
ER

PT J
AU Al-Abdullat, Y
   Tsutsumi, S
   Nakajima, N
   Ohta, M
   Kuwahara, H
   Ikeuchi, K
AF Al-Abdullat, Y
   Tsutsumi, S
   Nakajima, N
   Ohta, M
   Kuwahara, H
   Ikeuchi, K
TI Surface modification of magnesium by NaHCO3 and corrosion behavior in
   Hank's solution for new biomaterial applications
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE magnesium; biomaterials; corrosion; surface modification;
   whitlockite-like; sodium hydrogen carbonate; Hank's solution
ID SUPPLEMENTATION
AB The present study was carried out to improve the corrosion resistance of pure magnesium in Hank's Balanced Salt Solution (HBSS) through the surface modification. Three kinds of alkaline compounds, such as sodium hydrogen carbonate, sodium carbonate, and lithium hydroxide, were used for treatment. Only magnesium treated with aqueous sodium hydrogen carbonate solution gave a good corrosion resistance in HBSS solution at 25 degreesC up to 75 days, while almost no effect in sodium carbonate and lithium hydroxide. It was likely that hydrogen carbonate ions were essential for the surface improvement of magnesium. X-ray diffraction patterns of modified magnesium showed now peaks of magnesium carbonate and others on the surface. New surface structure of needle-shaped crystals was observed by scanning electron microscopy (SEM). Both elemental mapping, and energy dispersive (EDX) techniques in SEM showed the precipitation of calcium magnesium phosphate (low crystallinity whitlockite:(Ca,Mg)(3)(PO4)(2)) on the surface of magnesium specimen. It could be concluded that surface modification with sodium hydrogen carbonate made it possible to apply metal magnesium in biomedical, dental, and other industrial usage.
C1 Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan.
   Res Inst Appl Sci, Kyoto 6068203, Japan.
RP Al-Abdullat, Y (reprint author), Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan.
RI Ohta, Makoto/I-7104-2018
OI Ohta, Makoto/0000-0001-8571-6400
CR Al-Abdullat Y, 2000, J DENT RES, V79, P618
   ALABDULLAT Y, 2000, J JAPAN DENT MAT, V19, P95
   Barrere F, 2000, MATER RES SOC SYMP P, V599, P135
   EKTESSABI AM, 1994, INT J PIXE, V4, P81
   GHALI E, 2000, CORROSION PROTECTION, P261
   Haferkamp H, 2000, MATER SCI FORUM, V350-3, P31, DOI 10.4028/www.scientific.net/MSF.350-351.31
   *JCPDS, 1988, JCPDS INT CTR DIFFR, V201
   *JCPDS, 1998, JCPDS INT CTR DIFFR, V201
   Kumar TSS, 2000, BIOMATERIALS, V21, P1623
   Kuwahara H, 2000, MATER SCI FORUM, V350-3, P349, DOI 10.4028/www.scientific.net/MSF.350-351.349
   MAKAR GL, 1993, INT MATER REV, V38, P138, DOI 10.1179/imr.1993.38.3.138
   MARIE PJ, 1983, CALCIFIED TISSUE INT, V35, P755, DOI 10.1007/BF02405119
   MAYER I, 1995, J SOLID STATE CHEM, V56, P230
   POURBAIX M, 1966, ATLAS ELECTROCHEMICA, P139
   SOJKA JE, 1995, NUTR REV, V53, P71
   TAKAYA M, 1998, J JPN I LIGHT METALS, V48, P352
NR 16
TC 59
Z9 70
U1 1
U2 27
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD AUG
PY 2001
VL 42
IS 8
BP 1777
EP 1780
DI 10.2320/matertrans.42.1777
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 474NF
UT WOS:000171112800059
OA Bronze
DA 2018-10-19
ER

PT J
AU Griguer, F
   Raymond, I
   Regnier, A
AF Griguer, F
   Raymond, I
   Regnier, A
TI Preliminary evaluation of the biocompatibility of the small intestinal
   submucosa (SIS) biomaterial with the rabbit cornea
SO REVUE DE MEDECINE VETERINAIRE
LA English
DT Article
DE small intestinal submucosa; corneal tolerance; lamellar keratoplasty;
   rabbit
ID BLADDER AUGMENTATION; DOG-MODEL; LONG-TERM; IN-VIVO; REPAIR;
   NEOVASCULARIZATION; RELEASE; ULCERS; GRAFT; BETA
AB The early stages of the ocular response to porcine small intestinal submucosa (SIS) transplantation were assessed in a model of anterior keratectomy in the rabbit. After surgery, the operated eyes (n = 17) were examined on a regular basis over a 15-day period and animals were sacrified at predetermined times for histopathologic evaluation. In all but one animal, the biomaterial was well tolerated, and the corneal response was restricted to a localized neovascularization. The grafted material was epithelialised within 7 days and incorporated into the corneal tissue without inducing granuloma formation. In one rabbit, the corneal inflammation was severe but the biomaterial was maintained in place. Although further studies with longer follow-up periods are needed, these preliminary observations suggest that porcine SIS can be incorporated into the corneal tissue during healing process and may represent a promising graft material for lamellar keratoplasty.
C1 Ecole Natl Vet Toulouse, Clin Ophthalmol, Dept Sci Biol & Fonctionnelles, F-31076 Toulouse 03, France.
   Ecole Natl Vet Toulouse, Dept Clin Sci, F-31076 Toulouse, France.
RP Regnier, A (reprint author), Ecole Natl Vet Toulouse, Clin Ophthalmol, Dept Sci Biol & Fonctionnelles, 23 Chemin Capelles, F-31076 Toulouse 03, France.
CR Antrade AL, 1999, VET OPHTHALMOL, V2, P79
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   Barros Paulo S. M., 1998, Veterinary Ophthalmology, V1, P119, DOI 10.1046/j.1463-5224.1998.00026.x
   BARROS PSM, 1993, 24 ANN M AM COLL VET, P23
   Benelli U, 1997, INVEST OPHTH VIS SCI, V38, P274
   CAPRIOLI J, 1985, P257
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   DEAN DC, 1988, J CELL BIOL, V106, P2159, DOI 10.1083/jcb.106.6.2159
   Featherstone H, 2000, VET REC, V146, P136, DOI 10.1136/vr.146.5.136
   GELATT KN, 1995, HDB SMALL ANIMAL OPH, V2, P43
   HACKER DV, 1991, J AM ANIM HOSP ASSOC, V27, P387
   HAKANSON NE, 1987, J AM ANIM HOSP ASSOC, V23, P641
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   KOBAYASHI H, 1992, J BIOMED MATER RES, V26, P1463, DOI 10.1002/jbm.820261106
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Kropp BP, 2000, J ENDOUROL, V14, P59, DOI 10.1089/end.2000.14.59
   Kruse FE, 1999, OPHTHALMOLOGY, V106, P1504, DOI 10.1016/S0161-6420(99)90444-X
   Lewin GA, 1999, J SMALL ANIM PRACT, V40, P340, DOI 10.1111/j.1748-5827.1999.tb03094.x
   LI WW, 1991, INVEST OPHTH VIS SCI, V32, P2906
   LIN MT, 1992, INVEST OPHTH VIS SCI, V33, P558
   MELLES GRJ, 1994, ARCH OPHTHALMOL-CHIC, V112, P100, DOI 10.1001/archopht.1994.01090130110027
   POLACK FM, 1962, J EXP MED, V116, P709, DOI 10.1084/jem.116.5.709
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   WAHL SM, 1989, IMMUNOL TODAY, V10, P258, DOI 10.1016/0167-5699(89)90136-9
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
   WICKSTROM K, 1991, CURR EYE RES, V10, P463, DOI 10.3109/02713689109001753
   Wilkie DA, 1997, VET CLIN N AM-SMALL, V27, P1067, DOI 10.1016/S0195-5616(97)50104-5
   Xie RZ, 1997, AUST NZ J OPHTHALMOL, V25, pS46
   ZIESKE JD, 1987, INVEST OPHTH VIS SCI, V28, P1668
NR 37
TC 11
Z9 11
U1 0
U2 0
PU ECOLE NATIONALE VETERINAIRE TOULOUSE
PI TOULOUSE CEDEX 3
PA 23 CHEMIN DES CAPELLES, 31076 TOULOUSE CEDEX 3, FRANCE
SN 0035-1555
J9 REV MED VET-TOULOUSE
JI Rev. Med. Vet.
PD AUG-SEP
PY 2001
VL 152
IS 8-9
BP 597
EP 604
PG 8
WC Veterinary Sciences
SC Veterinary Sciences
GA 489UP
UT WOS:000172011100002
DA 2018-10-19
ER

PT J
AU Bing, S
   Hong, L
AF Bing, S
   Hong, L
TI Tribological applications of biomaterials: an overview
SO SCIENCE IN CHINA SERIES A-MATHEMATICS
LA English
DT Article
DE biomaterials; tribological materials
ID HIP PROSTHESES; DNA; CORROSION; COMPONENTS; MICROSCOPY; MOLECULES;
   FAILURE
AB Tribological research is the study of lubrication, friction, and wear. Tribology of biomaterials is to study how the materials work and fail. This will help us to produce better biomaterials. Tribology plays a very important role in improving the design and making successful biomaterials for medical purposes. Joints of human body, such as hip, knee, jaw, dental parts etc., all need to consider the wear and lubrication problem. In this paper, we give a general introduction of biomaterial research in tribological applications. Materials, the synthetic characterization, and their failure are introduced.
C1 Univ Alaska Fairbanks, Dept Mech Engn, Fairbanks, AK 99775 USA.
RP Bing, S (reprint author), Univ Alaska Fairbanks, Dept Mech Engn, Fairbanks, AK 99775 USA.
CR Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0
   AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, V276, P7
   BACH D, 1966, BIOCHIM BIOPHYS ACTA, V114, P311, DOI 10.1016/0005-2787(66)90312-1
   BOSS JH, 1992, AM SOC TEST MATER, V1144, P90, DOI 10.1520/STP14856S
   BUCKLEY CA, 1992, T SOC BIOMATER IMPLA, V15, P58
   CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0
   CHERYL RB, 1995, TECHNOLOGY TODAY FAL
   COLLIER JP, 1992, J BONE JOINT SURG BR, V74, P511
   COLLIER JP, 1991, CLIN ORTHOP RELAT R, V271, P305
   DICARLO E F, 1992, Clinical Materials, V9, P235, DOI 10.1016/0267-6605(92)90104-2
   DOWSON D, 1997, PRGRESS TRIBOLOGY HI, P3
   ESSNER WA, 1997, NEW DIRECTIONS TRIBO, P443
   FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413
   Gilbert JL, 1997, AM SOC TEST MATER, V1301, P45, DOI 10.1520/STP12020S
   GILBERT JL, 1993, J BIOMED MATER RES, V27, P1357, DOI 10.1002/jbm.820271103
   GILBERT JL, 1994, J BONE JOINT SURG AM, V76A, P110, DOI 10.2106/00004623-199401000-00014
   GILBERT JL, 1995, TOTAL HIP REVISION S
   GILBERT JL, 1992, T 4 WORLD BIOM C BER, P267
   Goldberg JR, 1997, J BIOMED MATER RES, V37, P421, DOI 10.1002/(SICI)1097-4636(19971205)37:3<421::AID-JBM13>3.0.CO;2-E
   KOSSOVSKY N, 1991, HIP ARTHROPLASTY, P571
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lu XC, 2000, SURF COAT TECH, V128, P341, DOI 10.1016/S0257-8972(00)00602-2
   Lu XC, 1996, CHINESE SCI BULL, V41, P1873
   Luo J, 2000, INT J NONLINEAR SCI, V1, P419
   Luo JB, 1999, TRIBOL T, V42, P912, DOI 10.1080/10402009908982301
   MATHIESEN EB, 1991, J BONE JOINT SURG BR, V73, P569
   MCLAUGHLIN J, 1994, ANN M AM AC ORTH SUR
   MILLER IR, 1968, BIOPOLYMERS, V6, P169, DOI 10.1002/bip.1968.360060202
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   Mirra J M, 1976, Clin Orthop Relat Res, P221
   Niemeyer CM, 1997, ANGEW CHEM INT EDIT, V36, P585, DOI 10.1002/anie.199705851
   NIEMEYER CM, 1997, ANGEW CHEM, V109, P603
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   NYQUIST RA, 1971, INFRARED SPECTRA INO, P171
   PIZZOFERRATO A, 1991, Clinical Materials, V7, P51, DOI 10.1016/0267-6605(91)90057-M
   RITTER MA, 1995, CLIN ORTHOP RELAT R, P79
   Sarikaya M, 1999, MATER SCI FORUM, V293, P83, DOI 10.4028/www.scientific.net/MSF.293.83
   Seeman NC, 1997, ACCOUNTS CHEM RES, V30, P357, DOI 10.1021/ar9601407
   SMITH SM, WINTER, V2, P11
   SPANIER S, 1991, HISTOLOGY PAHTOLOGY, P165
   SPECTOR M, 1992, ORTHOP CLIN N AM, V23, P211
   Tour JM, 1996, CHEM REV, V96, P537, DOI 10.1021/cr9500287
   URBAN RM, 1994, J BONE JOINT SURG AM, V76A, P1345, DOI 10.2106/00004623-199409000-00009
   URBAN RM, 1993, T ORTHOP RES SOC, V18, P81
   VOLLENWEIDER HJ, 1975, P NATL ACAD SCI USA, V72, P83, DOI 10.1073/pnas.72.1.83
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WILLERT HG, 1990, FAILURE MODES ARTIFI
   WOODRUFF LL, 1951, FDN BIOL
   WU C, 1996, SCI NEWS, V150
NR 51
TC 1
Z9 1
U1 1
U2 5
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1006-9283
J9 SCI CHINA SER A
JI Sci. China Ser. A-Math.
PD AUG
PY 2001
VL 44
SU S
BP 297
EP 306
PG 10
WC Mathematics, Applied; Mathematics
SC Mathematics
GA 485ZH
UT WOS:000171793000048
DA 2018-10-19
ER

PT J
AU Mathieu, HJ
AF Mathieu, HJ
TI Bioengineered material surfaces for medical applications
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article; Proceedings Paper
CT Asia-Pacific Surface and Interface Analysis Conference (APSIAC 2000)
CY OCT 23-26, 2000
CL BEIJING, PEOPLES R CHINA
SP Natl Nat Sci Fdn China, Chinese Acad Sci
DE biomaterials; XPS; ToF-SIMS; surface functionalization
ID ION MASS-SPECTROMETRY; POLYMERIC BIOMATERIALS; TOF-SIMS; MICROSCOPY; XPS
AB Man-made materials are increasingly being applied as substitutes for defective functions in human hosts. These biomaterials may be non-viable materials used in medical devices interacting with biological systems. Such engineered materials should be biocompatible, i.e. with minimal non-specific protein adsorption. This paper describes the functionalization of soft biomaterial surfaces and diamond-covered silicon wafers controlled by surface spectroscopies such as x-ray photoelectron spectroscopy (XPS) and time-of-flight secondary ion mass spectrometry (ToF-SIMS), as well as contact angle measurements and scanning force microscopy (SFM). Surface functionalization is obtained with molecules such as phosphorylcholine, carbohydrates, dextran or peptides added to various soft and hard materials. Surface analytical tools are able to control the chemistry, energy and topography of surfaces and thin films with high sensitivity down to the femtomole range and nanometer resolution. Copyright (C) 2001 John Wiley & Sons, Ltd.
C1 Ecole Polytech Fed Lausanne, Dept Mat, LMCH, CH-1015 Lausanne, Switzerland.
RP Mathieu, HJ (reprint author), Ecole Polytech Fed Lausanne, Dept Mat, LMCH, CH-1015 Lausanne, Switzerland.
CR AEBISCHER P, 1992, MED SCI TECHNOLOGY, P131
   Aleyamma A. J., 1991, BLOOD COMPATIBLE MAT, P123
   ANDERSON AB, 1994, 20 ANN M SOC BIOMATE
   BAI C, 1995, SCANNING TUNNELING M
   Barthlott W., 1990, APPL SCANNING EM TAX, P69
   Benninghoven A., 1987, SECONDARY ION MASS S
   Bertrand P., 1996, MIKROCHIM ACTA S, V13, P167
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57
   BLETSOS IV, 1985, ANAL CHEM, V57, P2384, DOI 10.1021/ac00289a049
   BRIGGS D, 1992, PRACTICAL SURFACE AN, V2
   BRIGGS D, 1992, PRACTICAL SURFACE AN, V2, P367
   BUSTAMANTE C, 1995, PHYS TODAY, V48, P32, DOI 10.1063/1.881478
   CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012
   CHAPMAN D, 1987, Patent No. 4689386
   Chevolot Y, 1999, BIOCONJUGATE CHEM, V10, P169, DOI 10.1021/bc980050h
   CHEVOLOT Y, 1999, THESIS ECOLE POLYTEC
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   DAVIES MC, 1990, CRIT REV BIOCOMPAT, V5, P297
   GAO H, 1995, BIOSENS BIOELECTRON, V10, P317, DOI 10.1016/0956-5663(95)96850-X
   GARBASSI F, 1994, POLYM SURFACES PHYSI, P161
   GOODE R, 1993, COMMERCIAL AND CONSUMER LAW, P3
   GRISTINA AG, 1991, HIGH PERFORMANCE BIO, P143
   Gunther H., 1996, NMR SPECTROSCOPY BAS
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   HUBBELL JA, 1995, CHEM ENG NEWS, V73, P42, DOI 10.1021/cen-v073n011.p042
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   ISHIHARA K, 1990, J JPN SOC BIOMATER, V8, P231
   Israelachvili JN, 1992, INTERMOLECULAR SURFA
   LARSSON PH, 1987, J IMMUNOL METHODS, V98, P129, DOI 10.1016/0022-1759(87)90446-7
   Lelah M. D., 1986, POLYURETHANES MED
   Leonard D, 1999, FRESEN J ANAL CHEM, V365, P3, DOI 10.1007/s002160051437
   Leonard D, 1998, SURF INTERFACE ANAL, V26, P793, DOI 10.1002/(SICI)1096-9918(199810)26:11<793::AID-SIA421>3.0.CO;2-K
   LEONARD D, 1996, THESIS U CATHOLIQUE
   Magonov S. N., 1996, SURFACE ANAL STM AFM
   Makohliso SA, 1999, LANGMUIR, V15, P2940, DOI 10.1021/la980688h
   MAKOHLISO SA, 1999, THESIS ECOLE POLYTEC
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   Marieb E. N., 1998, HUMAN ANATOMY PHYSL
   RATNER B D, 1992, Clinical Materials, V11, P25, DOI 10.1016/0267-6605(92)90027-Q
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Ruiz L, 1998, BIOMATERIALS, V19, P987, DOI 10.1016/S0142-9612(97)00197-X
   Ruiz L, 1999, J BIOMAT SCI-POLYM E, V10, P931, DOI 10.1163/156856299X00540
   RUIZ L, 1997, THESIS ECOLE POLYTEC
   Sabbatini L, 1996, J ELECTRON SPECTROSC, V81, P285, DOI 10.1016/0368-2048(95)02528-6
   SIDOUNI F, 1999, THESIS U PARIS 8 PAR
   SIGRIST H, 1995, OPT ENG, V34, P2339, DOI 10.1117/12.201815
   SIGRIST H, 2000, Patent No. 9911242232110
   SZYCHER M, 1991, HIGH PERFORMANCE BIO, P3
   VARGO TG, 1991, J POLYM SCI POL CHEM, V29, P555, DOI 10.1002/pola.1991.080290412
   Vickerman J. C., 1997, SURFACE ANAL PRINCIP
   WANG X, 1993, J APPL POLYM SCI, V49, P2179, DOI 10.1002/app.1993.070491214
   WEAST RC, 1973, HDB CHEM PHYSICS
   WIESENDANGER R, 1996, SCANNING TUNNELING M, V29
   WIESENDANGER R, 1992, SCANNING TUNNELING M, V20
   WIESENDANGER R, 1995, SCANNING TUNNELING M, V28
   Williams D. H., 1995, SPECTROSCOPIC METHOD
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG
   WILLIAMS JL, 1984, POLYM BIOMATERIALS, P33
   ZALM PC, 1994, VACUUM, V45, P753, DOI 10.1016/0042-207X(94)90113-9
NR 63
TC 89
Z9 89
U1 1
U2 9
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD AUG
PY 2001
VL 32
IS 1
BP 3
EP 9
DI 10.1002/sia.995
PG 7
WC Chemistry, Physical
SC Chemistry
GA 464VE
UT WOS:000170551800002
DA 2018-10-19
ER

PT J
AU Bennet, W
   Bjorkland, A
   Sundberg, B
   Brandhorst, D
   Brendel, MD
   Richards, A
   White, DJ
   Nilsson, B
   Groth, CG
   Korsgren, O
AF Bennet, W
   Bjorkland, A
   Sundberg, B
   Brandhorst, D
   Brendel, MD
   Richards, A
   White, DJ
   Nilsson, B
   Groth, CG
   Korsgren, O
TI Expression of complement regulatory proteins on islets of langerhans: A
   comparison between human islets and islets isolated from normal and hDAF
   transgenic pigs'
SO TRANSPLANTATION
LA English
DT Article
ID DECAY-ACCELERATING FACTOR; PORCINE ISLETS; HUMAN BLOOD; IN-VITRO;
   TRANSPLANTATION; FETAL; XENOTRANSPLANTATION; PANCREAS; MODEL;
   BIOMATERIAL
AB Background. The expression of regulators of complement activity (RCAs) on islet cells may be of great importance for protecting them against complement-mediated lysis in the immediate posttransplant period after intraportal islet transplantation. We examined porcine and human islet cells for expression of RCA. We also examined to what extent human decay accelerating factor (hDAF) is expressed on adult and fetal islet cells isolated from hDAF transgenic (TG) pigs having a high transgene expression on endothelial cells. Moreover, the susceptibility of the various types of cells to lysis in human serum and blood was investigated.
   Methods. Adult human islets (n = 5), normal adult and fetal porcine islets (n = 9 and n = 8, respectively), and islets from adult and fetal hDAF TG pigs (n = 5 and n = 6, respectively) were examined. With islet single-cell suspensions and flow cytometry, adult human islet cells were examined for expression of hDAF (CD55), hCD59, and human membrane cofactor protein (hMCP; CD46), while porcine islet cells were examined for expression of pCD59 and pMCP. Islet cells from hDAF TG pigs were also examined for hDAF expression. Porcine peripheral blood lymphocytes, normal and hDAF TG porcine endothelial cell lines, a human endothelial cell line, and the human cell line, U937 served as controls. Islet cytotoxicity was assayed after incubation of the islet cells with fresh human serum. Furthermore, adult islets from normal control pigs and hDAF TG pigs were exposed to fresh human blood in vitro for 60 min, and the inflammatory reaction elicited was compared between the different types of islets.
   Results. All human islet cell preparations expressed hCD59, two of five expressed hMCP, but none expressed hDAF. Porcine islet cells expressed both pCD59 and pMCP. Normal adult porcine islet cells exposed to fresh human serum resulted in 74 +/- 5.4% cell lysis (mean +/- SEM, n = 16). In comparison, only 1.3 +/- 2.8% (n = 20, P < 0.001) of human islet cells were lysed in the human serum. One islet cell preparation from an hDAF TG pig expressed small amounts of hDAF. This preparation from hDAF TG pigs bound significantly less C3c than did normal control islets (mean fluorescence ratio 16 +/- 2.2 and 58 +/- 4.3, respectively; P = 0.046) and were partially protected from cell lysis in fresh human serum (47 +/- 10% and 78 +/- 18% cell lysis, respectively; P = 0.046). The other four preparations from hDAF TG pigs were negative for hDAF and were equally susceptible to lysis as normal control islets. All fetal pancreatic islet cells from hDAF TG pigs analyzed were negative for hDAF expression. When exposed to fresh human blood in vitro, adult and fetal islets from hDAF TG pigs elicited equally strong inflammatory changes as did the normal control islets. The inflammatory changes were characterized by activation of the complement and coagulation systems, resulting in islet damage with "dumping" of insulin into the blood.
   Conclusions. Porcine and human islet cells express species-restricted complement regulatory proteins, with the human islet cells expressing mainly hCD59. A low expression of hDAF was detected on islet cells from one of five hDAF TG pigs. These islet cells displayed reduced islet cell cytotoxicity in fresh human serum. We conclude that protection from complement-mediated lysis will be important in the context of intraportal pig-to-human islet transplantation, and expression of a human RCA on islet cells should be beneficial in this context.
C1 Huddinge Hosp, Karolinska Inst, Dept Transplantat Surg, S-14186 Huddinge, Sweden.
   Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden.
   Univ Giessen, Dept Med 3, Giessen, Germany.
   Policlin Univ Giessen, Giessen, Germany.
   Imutran Ltd, Cambridge, England.
RP Bennet, W (reprint author), Huddinge Hosp, Karolinska Inst, Dept Transplantat Surg, S-14186 Huddinge, Sweden.
RI Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
CR ANDERSON SP, 1989, J IND ECON, V38, P1, DOI 10.2307/2098395
   Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907
   Bennet W, 2000, TRANSPLANTATION, V69, P711
   Bennet W, 2000, TRANSPLANTATION, V69, P1711
   BENNET W, 2001, XENOTRANSPLANTATION, V8, P1
   Brandhorst H, 1998, CELL TRANSPLANT, V7, P489, DOI 10.1016/S0963-6897(98)00028-1
   Byrne G, 1997, TRANSPLANTATION, V63, P149, DOI 10.1097/00007890-199701150-00027
   Cozzi E, 1997, TRANSPLANTATION, V64, P1383, DOI 10.1097/00007890-199711270-00002
   COZZI E, 1995, NAT MED, V1, P964, DOI 10.1038/nm0995-964
   DALMASSO AP, 1992, IMMUNOPHARMACOLOGY, V24, P149, DOI 10.1016/0162-3109(92)90020-D
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   FODOR WL, 1994, P NATL ACAD SCI USA, V91, P11153, DOI 10.1073/pnas.91.23.11153
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   GROTH CG, 1994, LANCET, V344, P1402, DOI 10.1016/S0140-6736(94)90570-3
   GROTTING JC, 1978, AM J PATHOL, V92, P653
   KOHNERT KD, 1986, J BIOCHEM BIOPH METH, V12, P81, DOI 10.1016/0165-022X(86)90053-9
   KOOYMAN DL, 1995, SCIENCE, V269, P89, DOI 10.1126/science.7541557
   KORSGREN O, 1988, TRANSPLANTATION, V45, P509, DOI 10.1097/00007890-198803000-00001
   Kuipers HW, 1997, TRANSGENIC RES, V6, P253, DOI 10.1023/A:1018402510471
   LACHMANN PJ, 1991, IMMUNOL TODAY, V12, P312, DOI 10.1016/0167-5699(91)90005-E
   LANGFORD GA, 1994, TRANSPLANT P, V26, P1400
   Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7
   MOLLNES T, 1985, SCAND J IMMUNOL, V22, P703
   RICORDI C, 1986, DIABETES, V35, P649, DOI 10.2337/diabetes.35.6.649
   ROLLINS SA, 1991, J IMMUNOL, V146, P2345
   SANDBERG JO, 1995, TRANSPLANTATION, V59, P1665, DOI 10.1097/00007890-199506270-00004
   Schmoeckel M, 1998, TRANSPLANTATION, V65, P1570, DOI 10.1097/00007890-199806270-00006
   SHIN ML, 1986, J IMMUNOL, V136, P1777
   Zaidi A, 1998, TRANSPLANTATION, V65, P1584, DOI 10.1097/00007890-199806270-00008
NR 29
TC 41
Z9 45
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0041-1337
J9 TRANSPLANTATION
JI Transplantation
PD JUL 27
PY 2001
VL 72
IS 2
BP 312
EP 319
DI 10.1097/00007890-200107270-00026
PG 8
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 461AK
UT WOS:000170342600026
PM 11477359
DA 2018-10-19
ER

PT J
AU Wagner, MS
   Castner, DG
AF Wagner, MS
   Castner, DG
TI Characterization of adsorbed protein films by time-of-flight secondary
   ion mass spectrometry with principal component analysis
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; ABSORPTION FINE-STRUCTURE; ATOMIC-FORCE
   MICROSCOPY; BIOMATERIAL SURFACES; TOF-SIMS; PLASMA DEPOSITION;
   SOLID-SURFACES; CELL-ADHESION; ADSORPTION; POLYMERS
AB Characterization of the adsorbed protein film that forms upon implantation of a biomedical device is a long-standing interest in biomaterials research. Time-of-flight secondary ion mass spectrometry (ToF-SIMS) is a powerful method for the characterization of adsorbed proteins on biomaterial surfaces due to its chemical specificity and surface sensitivity. However, the SIMS fragmentation patterns for proteins are quite complex due to the heterogeneity of the protein sequence; Therefore, the multivariate analysis technique principal components analysis (PCA) was used to obtain a more detailed interpretation of the protein SIMS spectra. This study utilizes single component adsorbed protein films on three model substrates and multivariate analysis of the ToF-SIMS data to determine the identity of protein films. Furthermore, ToF-SIMS and PCA were used to give insight into the composition of a 1% bovine plasma protein film. The single component spectra from 13 different proteins were readily distinguishable using PCA. The major component of the 1% bovine plasma film was found to shift from fibrinogen to gamma -globulins over the course of 2 h, in agreement with the current literature. This study shows how combination of ToF-SIMS and PCA provides new insights into the composition of adsorbed protein films on biomaterial surfaces.
C1 Univ Washington, Natl ESCA & Surface Anal Ctr Biomed Problems, Dept Chem Engn, Seattle, WA 98195 USA.
   Univ Washington, Natl ESCA & Surface Anal Ctr Biomed Problems, Dept Bioengn, Seattle, WA 98195 USA.
RP Castner, DG (reprint author), Univ Washington, Natl ESCA & Surface Anal Ctr Biomed Problems, Dept Chem Engn, Box 351750, Seattle, WA 98195 USA.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   Bartiaux S., 1995, THESIS U CATHOLIQUE
   Benninghoven A, 1993, ANAL CHEM, V65, P630
   Boeckl MS, 1998, BIOPOLYMERS, V47, P185, DOI 10.1002/(SICI)1097-0282(1998)47:2<185::AID-BIP8>3.0.CO;2-Q
   BOHNERT J L, 1990, Journal of Biomaterials Science Polymer Edition, V1, P279
   BOUCHONNET S, 1992, ANAL CHEM, V64, P743, DOI 10.1021/ac00031a009
   BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326
   BRYERS JD, 1994, COLLOID SURFACE B, V2, P9, DOI 10.1016/0927-7765(94)80013-8
   Chittur KK, 1998, BIOMATERIALS, V19, P301, DOI 10.1016/S0142-9612(97)00107-5
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Chowdhury PB, 1998, COLLOID SURFACE A, V143, P53, DOI 10.1016/S0927-7757(98)00408-7
   Clerc J, 1997, CELL BIOL INT, V21, P619, DOI 10.1006/cbir.1998.0205
   Colliver TL, 1997, ANAL CHEM, V69, P2225, DOI 10.1021/ac9701748
   Dannenberger O, 1997, THIN SOLID FILMS, V307, P183, DOI 10.1016/S0040-6090(97)00280-0
   Deng L, 1996, J AM CHEM SOC, V118, P5136, DOI 10.1021/ja960461d
   Derue C, 1999, J TRACE MICROPROBE T, V17, P451
   EASTMENT HT, 1982, TECHNOMETRICS, V24, P73, DOI 10.2307/1267581
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P667, DOI 10.1002/jbm.820280603
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Fischer D, 1997, J VAC SCI TECHNOL A, V15, P2173, DOI 10.1116/1.580529
   Fourre C, 1997, J ANAL ATOM SPECTROM, V12, P1105, DOI 10.1039/a700777i
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   HEALD SM, 1988, XRAY ABSORPTION PRIN
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   HORBETT TA, 1984, THROMB HAEMOSTASIS, V51, P174
   HORBETT TA, 1986, TECHNIQUES BIOCOMPAT
   Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979
   Jackson J. E., 1991, USERS GUIDE PRINCIPA
   John CM, 1997, INT J MASS SPECTROM, V161, P47, DOI 10.1016/S0168-1176(96)04505-3
   Kao WJ, 1999, J MATER SCI-MATER M, V10, P601, DOI 10.1023/A:1008971222932
   KARGACIN ME, 1986, ANAL CHEM, V58, P2300, DOI 10.1021/ac00124a041
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   Leonard D, 1999, FRESEN J ANAL CHEM, V365, P3, DOI 10.1007/s002160051437
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   LHOEST JB, IN PRESS J BIOMED MA
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Lundberg F, 1997, INFECT IMMUN, V65, P897
   Mallet Y, 1996, CHEMOMETR INTELL LAB, V35, P157, DOI 10.1016/S0169-7439(96)00050-0
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   MARLETTA G, 1990, SURF INTERFACE ANAL, V16, P407, DOI 10.1002/sia.740160185
   McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x
   Montanaro L, 1999, BIOMATERIALS, V20, P1945, DOI 10.1016/S0142-9612(99)00099-X
   Morra M., 1993, Clinical Materials, V14, P255, DOI 10.1016/0267-6605(93)90010-5
   Ohrlund A, 1997, SURF INTERFACE ANAL, V25, P105, DOI 10.1002/(SICI)1096-9918(199702)25:2<105::AID-SIA213>3.0.CO;2-R
   Ohta T, 1998, J ELECTRON SPECTROSC, V92, P131, DOI 10.1016/S0368-2048(98)00114-5
   PAYNTER RW, 1984, J COLLOID INTERF SCI, V101, P233, DOI 10.1016/0021-9797(84)90023-7
   PAYNTER RW, 1985, SURFACE INTERFACIAL
   RATNER B D, 1992, Clinical Materials, V11, P25, DOI 10.1016/0267-6605(92)90027-Q
   RATNER BD, 1995, SURF INTERFACE ANAL, V23, P521, DOI 10.1002/sia.740230712
   RATNER BD, 1993, CLIN MATER, V13, P71, DOI 10.1016/0267-6605(93)90093-M
   RATNER BD, 1994, COLLOID SURFACE B, V2, P333, DOI 10.1016/0927-7765(94)80048-0
   RATNER BD, 1996, 5WORLD BIOM C TOR CA, P577
   RATNER BD, 1995, THIN FILMS SURFACES, P195
   RATNER BD, 1996, POLYM PREPR, V37, P843
   Rudnicka W, 1997, FEMS IMMUNOL MED MIC, V19, P7, DOI 10.1016/S0928-8244(97)00045-X
   SHEU MS, 1993, CLIN MATER, V13, P41, DOI 10.1016/0267-6605(93)90088-O
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   Shi HQ, 1999, NATURE, V398, P593
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   THOMPSON PM, 1991, ANAL CHEM, V63, P2447, DOI 10.1021/ac00021a012
   TIDWELL CD, 2001, IN PRESS SURF INTERF
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   Vandeginste B. G. M., 1998, HDB CHEMOMETRICS Q B
   Vanden Eynde X, 1999, APPL SURF SCI, V141, P1, DOI 10.1016/S0169-4332(98)00626-6
   Vanden-Eynde X, 1997, SURF INTERFACE ANAL, V25, P878
   Vasin SL, 1998, J BIOMED MATER RES, V39, P491, DOI 10.1002/(SICI)1097-4636(19980305)39:3<491::AID-JBM21>3.3.CO;2-Z
   Wagner M., UNPUB
   Wise B. M., 1998, PLS TOOLBOX VERSION
   WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639
   WOLD S, 1976, PATTERN RECOGN, V8, P127, DOI 10.1016/0031-3203(76)90014-5
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   Yu JL, 1997, FEMS IMMUNOL MED MIC, V19, P247, DOI 10.1016/S0928-8244(97)00092-8
NR 76
TC 294
Z9 295
U1 3
U2 81
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 24
PY 2001
VL 17
IS 15
BP 4649
EP 4660
DI 10.1021/la001209t
PG 12
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 455LX
UT WOS:000170029300031
DA 2018-10-19
ER

PT J
AU Kaiitani, M
   Wadia, Y
   Hinds, MT
   Teach, J
   Swartz, KR
   Gregory, KW
AF Kaiitani, M
   Wadia, Y
   Hinds, MT
   Teach, J
   Swartz, KR
   Gregory, KW
TI Successful repair of esophageal injury using an elastin based
   biomaterial patch
SO ASAIO JOURNAL
LA English
DT Article
ID GUNSHOT WOUNDS; MANAGEMENT; PERFORATION
AB An esophageal injury with significant tissue loss is very difficult to repair. We conducted an in vivo study to test our elastin based acellular biomaterial patch to repair such defect. The patch was made from porcine aorta, by decellularization and sterilization. Collagen fibers were preserved to retain mechanical strength and enhance cellular in-growth. Ten domestic pigs underwent right thoracotomy. A 2 cm circular defect was made on the distal esophagus, excising half its circumference, and was repaired using the biomaterial patch and sutures. Soon after the procedure, the animals resumed oral feeding. They were followed for clinical status, weight gain, barium studies, and endoscopic studies, and were killed after 6 weeks to 4 months. All ten animals survived long term, with a procedure success rate of 100% (10 of 10). With the exception of one pneumothorax, no complications occurred, and all animals resumed oral feeding and gained weight. Endoscopic studies showed mucosal coverage by 6 weeks, with minimal stricture at the repair site. Excised specimens showed complete mucosal coverage with regeneration of all three layers. Our biomaterial patch can be used safely and reliably for repair of esophageal injury with significant tissue loss when repaired immediately as in our experiment.
C1 Oregon Med Laser Ctr, Portland, OR 97225 USA.
RP Gregory, KW (reprint author), Oregon Med Laser Ctr, 9205 SW Barnes Rd, Portland, OR 97225 USA.
CR BANECKO RM, 1994, GEN THORACIC SURG, P1514
   DEMEESTER TR, 1986, ANN THORAC SURG, V42, P231, DOI 10.1016/S0003-4975(10)62723-3
   GRILLO HG, 1975, ANN THORAC SURG, V29, P387
   Kajitani M, 2000, ASAIO J, V46, P409, DOI 10.1097/00002480-200007000-00007
   PASS LJ, 1987, ANN THORAC SURG, V44, P253, DOI 10.1016/S0003-4975(10)62066-8
   POPOVSKY J, 1976, J THORAC CARDIOV SUR, V72, P609
   POPOVSKY J, 1984, J TRAUMA, V24, P337, DOI 10.1097/00005373-198404000-00010
   THAL AP, 1965, ARCH SURG-CHICAGO, V90, P464
   TRIGGIANI E, 1977, THORAX, V32, P241, DOI 10.1136/thx.32.3.241
   URSCHEL HC, 1974, ANN SURG, V179, P587, DOI 10.1097/00000658-197405000-00010
NR 10
TC 35
Z9 39
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD JUL-AUG
PY 2001
VL 47
IS 4
BP 342
EP 345
DI 10.1097/00002480-200107000-00009
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 451XE
UT WOS:000169827200009
PM 11482483
OA Bronze
DA 2018-10-19
ER

PT J
AU Fowers, KD
   Janatova, J
AF Fowers, KD
   Janatova, J
TI Specific inhibition of C3 to facilitate general complement inhibition on
   endotoxin affinity sorbents for apheresis applications
SO BIOMATERIALS
LA English
DT Article
DE complement activation; apheresis; endotoxin adsorption; C3 inhibition
ID POLYSTYRENE SURFACES; ACTIVATION; MEMBRANES; PLASMA; CIRCULATION;
   PROTEINS; BLOOD; BIOCOMPATIBILITY; ADSORPTION; COPOLYMERS
AB Complement activation, as a result of human blood exposure to biomaterial surfaces, continues to be a concern in medical applications. The purpose of this study was to identify sorbent(s) and surface modification(s) that allow specific removal of endotoxin, while minimizing complement activation. Maleic anhydride (MA) modification of Sepharose CL-4B, cellulose, and Toyopearl HW-65F resulted in reduced generation of C3a, a marker of complement activation, by two orders of magnitude over unmodified surfaces. Surfaces modified with both MA and polymyxin B (PMB), utilized for binding endotoxin, reduced complement activation in a similar manner. Western Blot analysis of the larger C3 cleavage product C3dg showed a similar reduction, for all MA-modified sorbents, as observed for C3a by ELISA. C3 alpha 43 levels (constituent of iC3b and C3c) were also reduced, although only MA-Sepharose CL-4B levels were similar to C3a. Activation of C5, measured as the SC5b-9 complex, was also reduced by two orders of magnitude after MA modification of Sepharose CL-4B; the decrease was similar to all chemical modifications tested. PMB immobilized via CNBr on MA-modified cellulose maintained its endotoxin-binding capacity, while the latter was eliminated when PMB was immobilized via CNBr to MA-modified Sepharose CL-4B and Toyopearl HW-65F. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
   Ctr Biopolymers Interfaces, Salt Lake City, UT 84112 USA.
RP Janatova, J (reprint author), Univ Utah, Dept Bioengn, 50 S Cent Campus Dr,Rm 2480, Salt Lake City, UT 84112 USA.
CR Baufreton C, 1998, ANN THORAC SURG, V66, P1837, DOI 10.1016/S0003-4975(98)00726-7
   Fadul JEM, 1998, J CLIN APHERESIS, V13, P167, DOI 10.1002/(SICI)1098-1101(1998)13:4<167::AID-JCA5>3.0.CO;2-N
   GOLANDER CG, 1992, J BIOMAT SCI-POLYM E, V4, P25
   Hermanson G T, 1992, IMMOBILIZED AFFINITY, P454
   Jaber BL, 1998, BLOOD PURIFICAT, V16, P325, DOI 10.1159/000014352
   JANATOVA J, 2000, ASAIO J, V46, P553
   JOHNSON RJ, 1990, BLOOD PURIFICAT, V8, P318, DOI 10.1159/000169986
   JOHNSON RJ, 1989, MED PROG TECHNOL, V15, P77
   JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147
   KIRKLIN JK, 1983, J THORAC CARDIOV SUR, V86, P845
   KISHIDA A, 1992, BIOMATERIALS, V13, P113, DOI 10.1016/0142-9612(92)90006-A
   KOTTKEMARCHANT K, 1987, J BIOMED MATER RES, V21, P379, DOI 10.1002/jbm.820210310
   Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7
   LIN YS, 1992, BIOMATERIALS, V13, P497
   MONTDARGENT B, 1993, BIOMATERIALS, V14, P203, DOI 10.1016/0142-9612(93)90024-V
   Nilsson B, 1998, BLOOD, V92, P1661
   NILSSON UR, 1993, SCAND J IMMUNOL, V37, P349, DOI 10.1111/j.1365-3083.1993.tb02564.x
   NORMAN ME, 1993, BIOMATERIALS, V14, P193, DOI 10.1016/0142-9612(93)90023-U
   PAUL D, 1990, ARTIF ORGANS, V14, P122
   Rosenkranz AR, 1999, J AM SOC NEPHROL, V10, P128
   SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V
   Shiga Y, 1998, ARTIF ORGANS, V22, P1067, DOI 10.1046/j.1525-1594.1998.06170.x
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Watkins NJ, 1997, IMMUNOPHARMACOLOGY, V38, P111, DOI 10.1016/S0162-3109(97)00068-4
   Yang V C, 1991, ASAIO Trans, V37, pM229
NR 25
TC 1
Z9 2
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2001
VL 22
IS 13
BP 1749
EP 1761
DI 10.1016/S0142-9612(00)00335-5
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 435YE
UT WOS:000168909100007
PM 11396878
DA 2018-10-19
ER

PT J
AU Lauto, A
   Ohebshalom, M
   Esposito, M
   Mingin, J
   Li, PS
   Felsen, D
   Goldstein, M
   Poppas, DP
AF Lauto, A
   Ohebshalom, M
   Esposito, M
   Mingin, J
   Li, PS
   Felsen, D
   Goldstein, M
   Poppas, DP
TI Self-expandable chitosan stent: design and preparation
SO BIOMATERIALS
LA English
DT Article
DE elasticity; cylindrical helix; biopolymers; laser solder
ID DL-LACTIC ACID; URETERAL STENT; METAL STENTS; LASER; BIOMATERIAL;
   OBSTRUCTION; PREVENTION; EXPERIENCE; INSERTION; PROSTATE
AB Stents are largely used in surgical procedures to relieve pathological obstructions. The purpose of the present study was to design and prepare a biocompatible stent with a self-expandable mechanism. Thin films were prepared from deacetylated chitosan (4% w/v) dissolved in acetic acid solution (2% v/v). The chitosan films were tested by a calibrated tensiometer to measure the Young's module (E). The films were used to manufacture stents by pulling and winding them around a cylindrical rod in a helical fashion. Thirteen stents (diameter = 0.5 +/- 0.05 mm, length similar to4 mm) were inserted into the vas deferens of wistar rats. Upon stent insertion, the vasal anastomosis was achieved with a laser-soldering technique. The animals were sacrificied 8 weeks later. The stress test showed that the chitosan film was elastic (maximum strain = 105% +/- 6%, E = 0.7655 +/- 0.0288 Mpa). The stents self-expanded by releasing their elastic energy. All the stents but one remained open inside the vasa despite high incidence of sperm granuloma. A biocompatible and self-expandable stent with a helical design is proposed. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Cornell Univ, New York Presbyterian Hosp, Weill Med Coll,Dept Urol, Ctr Pediat Urol & Minimal Invas Urol Surg, New York, NY 10021 USA.
RP Lauto, A (reprint author), Mem Hosp, Dept Med Phys, Room F1134,1275 York Ave, New York, NY 10021 USA.
CR Benoit G, 1996, J UROLOGY, V156, P881, DOI 10.1016/S0022-5347(01)65647-7
   Braf Z, 1996, J ENDOUROL, V10, P555, DOI 10.1089/end.1996.10.555
   Caldwell J C, 1996, Clin Anat, V9, P302, DOI 10.1002/(SICI)1098-2353(1996)9:5<302::AID-CA3>3.0.CO;2-E
   Costain DJ, 1997, SURGERY, V121, P314, DOI 10.1016/S0039-6060(97)90360-3
   Cozzi G, 1994, Radiol Med, V88, P272
   HOLMES SAV, 1992, BRIT J UROL, V69, P383, DOI 10.1111/j.1464-410X.1992.tb15564.x
   Lauto A, 1998, MICROSURG, V18, P60, DOI 10.1002/(SICI)1098-2752(1998)18:1<60::AID-MICR13>3.0.CO;2-Q
   Lauto A, 1998, LASER SURG MED, V22, P120, DOI 10.1002/(SICI)1096-9101(1998)22:2<120::AID-LSM8>3.0.CO;2-R
   Lauto A, 1999, LASER SURG MED, V25, P250, DOI 10.1002/(SICI)1096-9101(1999)25:3<250::AID-LSM9>3.3.CO;2-M
   LEE BH, 1995, J VASC INTERV RADIOL, V6, P635, DOI 10.1016/S1051-0443(95)71151-4
   Marsman J W, 1996, Australas Radiol, V40, P80
   MUZZARELLI R, 1990, ANTIMICROB AGENTS CH, V34, P2019, DOI 10.1128/AAC.34.10.2019
   OKAMOTO Y, 1995, J VET MED SCI, V57, P765, DOI 10.1292/jvms.57.765
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Okamura Takehiko, 1995, Acta Urologica Japonica, V41, P289
   Petas A, 1997, BRIT J UROL, V80, P439, DOI 10.1046/j.1464-410X.1997.00308.x
   Petas A, 1997, BRIT J UROL, V80, P903, DOI 10.1046/j.1464-410X.1997.00476.x
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SANFORD PA, 1990, AM CHEM SOC DIV POLY, V31, P628
   Sauter ER, 1996, J SURG ONCOL, V62, P10
   Schlick RW, 1997, BRIT J UROL, V80, P908, DOI 10.1046/j.1464-410X.1997.00484.x
   Shigemasa Y, 1996, BIOTECHNOL GENET ENG, V13, P383, DOI 10.1080/02648725.1996.10647935
   SMITS M, 1995, ENDOSCOPY, V27, P505, DOI 10.1055/s-2007-1005756
   SUZUKI K, 1984, MICROBIOL IMMUNOL, V28, P909
   Trickett RI, 1998, MICROSURG, V18, P414, DOI 10.1002/(SICI)1098-2752(1998)18:7<414::AID-MICR5>3.0.CO;2-W
   TSCHADA RK, 1994, J ENDOUROL, V8, P119, DOI 10.1089/end.1994.8.119
   VANSONNENBERG E, 1994, RADIOLOGY, V191, P765, DOI 10.1148/radiology.191.3.8184060
   YOUNG GPH, 1995, SURG MALE INFERTILIT, P297
NR 28
TC 29
Z9 29
U1 3
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2001
VL 22
IS 13
BP 1869
EP 1874
DI 10.1016/S0142-9612(00)00371-9
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 435YE
UT WOS:000168909100021
PM 11396892
DA 2018-10-19
ER

PT J
AU Zoulgami, M
   Lucas, A
   Briard, P
   Gaude, J
AF Zoulgami, M
   Lucas, A
   Briard, P
   Gaude, J
TI A self-setting single-component calcium phosphate cement
SO BIOMATERIALS
LA English
DT Article
DE phosphate cement; self-setting; biomaterial; apatite
ID FIBROBLASTIC CELLS; BONE; HYDROXYAPATITE; CARBONATE; CERAMICS
AB Following an original synthesis route, we have prepared a single-component calcium phosphate apatite-like powder which settles and hardens when mixed with deionized water in an approximative 1.2g : 1ml ratio. This paper describes the first physico-chemical studies and characterizations of the material. Observations of its in vitro behavior show a slight volume contraction and toxicity against fibroblasts bone marrow cells on disks of compacted powder. It is suggested that after an improvement of the powder characters such as grain size, and the choice of another hardening liquid, to name a few, this material should be a potential - or an ingredient of - bone cement. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 LCSIM, UMR 6511, Grp Cristallochim & Biomat, F-35042 Rennes, France.
RP Gaude, J (reprint author), LCSIM, UMR 6511, Grp Cristallochim & Biomat, Batiment 10B,Campus Beaulieu 263,Ave Gen Leclerc,, F-35042 Rennes, France.
CR BOULTIF A, 1991, J APPL CRYSTALLOGR, V24, P987, DOI 10.1107/S0021889891006441
   CONSTANTZ BR, 1994, Patent No. 5336264
   CONSTANTZ BR, 1998, Patent No. 08356681
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DRIESSENS FMC, 1999, 15 EUR C BIOM ESB 99
   ELLIOTT JC, 1994, STUDIES INORGANIC CH, V18, P54
   Frayssinet P, 1997, J BIOMED MATER RES, V35, P337, DOI 10.1002/(SICI)1097-4636(19970605)35:3<337::AID-JBM8>3.3.CO;2-H
   HYAKUNA K, 1989, J BIOMED MATER RES, V23, P1049, DOI 10.1002/jbm.820230906
   HYAKUNA K, 1990, J BIOMED MATER RES, V24, P471, DOI 10.1002/jbm.820240406
   Kawachi EY, 1998, BIOMATERIALS, V19, P2329, DOI 10.1016/S0142-9612(98)00148-3
   Khairoun I, 1997, BIOMATERIALS, V18, P1535, DOI 10.1016/S0142-9612(97)00096-3
   Khairoun I, 1999, BIOMATERIALS, V20, P393, DOI 10.1016/S0142-9612(98)00202-6
   LEE DD, 1996, Patent No. 9636562
   LEE DD, 1998, Patent No. 9816209
   LEMAITRE J, 15 C BIOM ESB 99 SEP
   Malard O, 1999, J BIOMED MATER RES, V46, P103, DOI 10.1002/(SICI)1097-4636(199907)46:1<103::AID-JBM12>3.0.CO;2-Z
   Oreffo ROC, 1998, TISSUE ENG, V4, P293, DOI 10.1089/ten.1998.4.293
   POSNER A S, 1975, Seminars in Arthritis and Rheumatism, V4, P267, DOI 10.1016/0049-0172(75)90013-X
   Redey SA, 1999, J BIOMED MATER RES, V45, P140, DOI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
   REY C, 1990, Biomaterials, V11, P13
   REY C, 1995, MINERAL OSSEUX BIOMA, P41
   RUDIN VN, 1994, Patent No. 06641331
   RUDIN VN, 1998, Patent No. 9818719
   SCHEICHER H, 1990, Patent No. 4917702
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   Wieliczka DM, 1996, J DENT RES, V75, P1865, DOI 10.1177/00220345960750110801
   WIRONEN JF, 1998, Patent No. 9840113
NR 28
TC 14
Z9 15
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2001
VL 22
IS 13
BP 1933
EP 1937
DI 10.1016/S0142-9612(00)00384-7
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 435YE
UT WOS:000168909100029
PM 11396900
DA 2018-10-19
ER

PT J
AU Daamen, WF
   Hafmans, T
   Veerkamp, JH
   van Kuppevelt, TH
AF Daamen, WF
   Hafmans, T
   Veerkamp, JH
   van Kuppevelt, TH
TI Comparison of five procedures for the purification of insoluble elastin
SO BIOMATERIALS
LA English
DT Article
DE insoluble elastin; purification; ligamentum nuchae; calcification
ID VASCULAR BIOPROSTHESES; CALCIFICATION; MICROFIBRILS; FIBRILLIN; TISSUES;
   DOMAINS
AB Elastin is an insoluble. highly cross-linked protein. providing elasticity to organs like lung, aorta, and ligaments. Despite its remarkable mechanical properties, elastin has Found little use as a biomaterial. Purification of intact elastin from elastic fibres presents a major challenge, among others for the intimate interwoveness of elastin and microfibrils. Insoluble elastin preparations tend to calcify, which may be due to calcium-binding microfibrillar (e.g. fibrillin). In this study, elastin was purified from horse ligamentum nuchae using five different procedures. One procedure is based on treatment with 0.1 M NaOH, another on autoclaving and treatment with cyanogen bromide. Three other procedures are based on combinations of extraction steps and enzyme digestions. Purity of preparations was assessed by sodium dodecyl sulphate polyacrylamide gel electrophoresis. amino acid analysis, bright held immunofluorescence and transmission electron microscopy. The procedure involving extracrions/enzymes combined with an early application of 2-mercaptoethanol and cyanogen bromide gives a highly pure elastin preparation. Electron microscopic analysis showed that this preparation is: devoid of microfibrillar components. This procedure is therefore the method of choice for preparation of insoluble elastin as a biomaterial for tissue engineering. (C) 2001 Elsevier Science Ltd. AH rights reserved.
C1 Univ Nijmegen, Ctr Med, Dept Biochem 160, NL-6500 HB Nijmegen, Netherlands.
RP van Kuppevelt, TH (reprint author), Univ Nijmegen, Ctr Med, Dept Biochem 160, POB 9101, NL-6500 HB Nijmegen, Netherlands.
RI Kuppevelt, A.H.M.S.M./L-4463-2015; Daamen, Willeke/D-5854-2015
OI Daamen, Willeke/0000-0003-3155-3030
CR Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171
   Atkinson J, 1999, PATHOL BIOL, V47, P677
   AYAD S, 1994, EXTRACELLULAR MATRIX
   Bisaccia F, 1998, BIOCHEMISTRY-US, V37, P11128, DOI 10.1021/bi9802566
   BOBRYSHEV YV, 1995, ATHEROSCLEROSIS, V118, P9, DOI 10.1016/0021-9150(95)05588-N
   Bradbury P, 1990, THEORY PRACTICE HIST, P119
   BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149
   Cardy CM, 1998, J MOL BIOL, V276, P855, DOI 10.1006/jmbi.1997.1593
   Chanda J, 1999, BIOMATERIALS, V20, P1753, DOI 10.1016/S0142-9612(98)00078-7
   Chanda J, 1998, BIOMATERIALS, V19, P1651, DOI 10.1016/S0142-9612(98)00038-6
   de Chalain T, 1999, J BIOMED MATER RES, V44, P280, DOI 10.1002/(SICI)1097-4636(19990305)44:3<280::AID-JBM6>3.0.CO;2-H
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Fauvel-Lafeve F, 1999, INT REV CYTOL, V188, P1
   JOHN R, 1972, BIOCHEM J, V127, P261, DOI 10.1042/bj1270261
   Knott V, 1996, J MOL BIOL, V255, P22, DOI 10.1006/jmbi.1996.0003
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lamme EN, 1996, J HISTOCHEM CYTOCHEM, V44, P1311, DOI 10.1177/44.11.8918906
   LANSING AI, 1952, ANAT RECORD, V114, P555, DOI 10.1002/ar.1091140404
   Nimni ME, 1997, J BIOMED MATER RES, V35, P531
   PAULE WJ, 1992, J BIOMED MATER RES, V26, P1169, DOI 10.1002/jbm.820260907
   RASMUSSEN BL, 1975, ANAL BIOCHEM, V64, P255, DOI 10.1016/0003-2697(75)90426-1
   Reinhardt DP, 1997, J BIOL CHEM, V272, P7368, DOI 10.1074/jbc.272.11.7368
   RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49
   Robinson PN, 2000, J MED GENET, V37, P9, DOI 10.1136/jmg.37.1.9
   ROSENBLOOM J, 1993, FASEB J, V7, P1208
   SAKAI LY, 1991, J BIOL CHEM, V266, P14763
   Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2
   SOSKEL NT, 1983, EXP LUNG RES, V4, P109, DOI 10.3109/01902148309055008
   STARCHER BC, 1976, ANAL BIOCHEM, V74, P4417
   VACCA LL, 1985, LAB MANUAL HISTOCHEM, P297
   Vyavahare N, 1999, AM J PATHOL, V155, P973, DOI 10.1016/S0002-9440(10)65197-8
NR 31
TC 72
Z9 73
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2001
VL 22
IS 14
BP 1997
EP 2005
DI 10.1016/S0142-9612(00)00383-5
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 439WU
UT WOS:000169141200006
PM 11426877
DA 2018-10-19
ER

PT J
AU Pavcnik, D
   Uchida, B
   Timmermans, H
   Keller, FS
   Rosch, J
AF Pavcnik, D
   Uchida, B
   Timmermans, H
   Keller, FS
   Rosch, J
TI Square stent: A new self-expandable endoluminal device and its
   applications
SO CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
LA English
DT Review
DE stents and prostheses; filters, interventional procedures; embolism,
   pulmonary; embolization; endovascular stent graft; venous valve; aortic
   valve; biomaterial
ID SMALL-INTESTINAL SUBMUCOSA; GRAFT; DOG
AB The square stent is a new, simply constructed, self-expanding device that has recently been described. Compared with other stents, the square stent has a minimal amount of metal and thus requires a smaller-diameter catheter for introduction. Despite the small amount of metal present, the square stent has adequate expansile force. We have been evaluating the square stent for various interventional. applications. In addition to the basic square stent, combinations of square stents and coverings for square stents were developed and evaluated to expand its uses and indications. One of the coverings tested is a new biomaterial: small intestinal submucosa (SIS). This paper will discuss the various applications of the square stent, which include a retrievable inferior vena cava filter, vascular occluder, graft adapter, and venous and aortic valves. In addition, we will review the important properties of SIS as a covering for the square stent.
C1 Oregon Hlth Sci Univ, Dotter Intervent Inst, Portland, OR 97201 USA.
RP Pavcnik, D (reprint author), Oregon Hlth Sci Univ, Dotter Intervent Inst, L342,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.
CR AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   MCGEE P, 1998, ORTHOPEDICS TODAY, V18, P43
   Park JW, 2000, J VASC INTERV RADIOL, V11, P1325, DOI 10.1016/S1051-0443(07)61310-4
   Pavcnik D, 1999, CARDIOVASC INTER RAD, V22, P239, DOI 10.1007/s002709900374
   Pavcnik D, 2000, MINIM INVASIV THER, V9, P287, DOI 10.1080/13645700009169659
   Pavcnik D, 2000, J VASC INTERV RADIOL, V11, P1227, DOI 10.1016/S1051-0443(07)61369-4
   PAVCNIK D, 2001, Patent No. 6200336
   Peel SAF, 1998, TISSUE ENG, V4, P143, DOI 10.1089/ten.1998.4.143
   Pfister ME, 2001, J VASC INTERV RADIOL, V12, P235, DOI 10.1016/S1051-0443(07)61831-4
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   PREVEL CD, 1995, ANN PLAST SURG, V35, P347
   Sakaguchi S, 1999, J VASC INTERV RADIOL, V10, P1092, DOI 10.1016/S1051-0443(99)70197-1
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   YAMADA K, 2001, CARDIOVASC INTERVENT, V2, P99
NR 19
TC 17
Z9 19
U1 0
U2 4
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0174-1551
J9 CARDIOVASC INTER RAD
JI Cardiovasc. Interv. Radiol.
PD JUL-AUG
PY 2001
VL 24
IS 4
BP 207
EP 217
DI 10.1007/s00270-001-0041-7
PG 11
WC Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical
   Imaging
SC Cardiovascular System & Cardiology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 481WE
UT WOS:000171542800001
PM 11779008
DA 2018-10-19
ER

PT J
AU Arkharov, IA
   Navasardyan, ES
   Luk'yanov, PA
AF Arkharov, IA
   Navasardyan, ES
   Luk'yanov, PA
TI Equipment for biomaterial storage systems
SO CHEMICAL AND PETROLEUM ENGINEERING
LA English
DT Article
C1 NE Bauman Moscow State Tech Univ, Moscow, Russia.
RP Arkharov, IA (reprint author), NE Bauman Moscow State Tech Univ, Moscow, Russia.
CR AZAROV AI, 2 INT C EC DEV NW RU, P7
   Piralishvili Sh. A., 2000, VORTEX EFFECT EXPT T
   Suslov A. D., 1985, VORTEX EQUIPMENTS
NR 3
TC 1
Z9 1
U1 0
U2 0
PU CONSULTANTS BUREAU
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-2355
J9 CHEM PETROL ENG+
JI Chem. Pet. Eng.
PD JUL-AUG
PY 2001
VL 37
IS 7-8
BP 428
EP 433
DI 10.1023/A:1012567916724
PG 6
WC Engineering, Chemical
SC Engineering
GA 509JB
UT WOS:000173143700020
DA 2018-10-19
ER

PT J
AU Gottenbos, B
   Grijpma, DW
   van der Mei, HC
   Feijen, J
   Busscher, HJ
AF Gottenbos, B
   Grijpma, DW
   van der Mei, HC
   Feijen, J
   Busscher, HJ
TI Antimicrobial effects of positively charged surfaces on adhering
   Gram-positive and Gram-negative bacteria
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
ID MICROBIAL ADHESION; METHACRYLATE POLYMERS; INITIAL ADHESION;
   IMAGE-ANALYSIS; FLOW CHAMBER; GROWTH; STAPHYLOCOCCI; COPOLYMERS
AB The infection of biomaterials is determined by an interplay of adhesion and surface growth of the infecting organisms. In this study, the antimicrobial effects on adhering bacteria of a positively charged poly(methacrylate) surface ( potential +12 mV) were compared with those of negatively charged poly(methyl methacrylate) (-12 mV) and a highly negatively charged poly(methacrylate) (-18 mV) surface. Initial adhesion of Staphylococcus aureus ATCC 12600, Staphylococcus epidermidis HBH2 102, Escherichia coli O2K2 and Pseudomonas aeruginosa AK1 to these surfaces was measured in a parallel plate flow chamber in phosphate-buffered saline. Adhering bacteria were allowed to multiply by perfusing the flow chamber with growth medium. All bacteria adhered most rapidly to the positively charged surface, but there was no subsequent surface growth of the Gram-negative strains. On the negatively charged surfaces, despite a slower initial adhesion, surface growth of the adhering bacteria was exponential for both Gram-positive and Gram-negative strains. These results suggest that positively charged biomaterial surfaces exert an antimicrobial effect on adhering Gram-negative bacteria, but not on Gram-positive ones.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Twente, Dept Chem Technol, NL-7500 AE Enschede, Netherlands.
   Univ Twente, Inst Biomed Technol, NL-7500 AE Enschede, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
RI Hori, Katsutoshi/K-5289-2012
OI Hori, Katsutoshi/0000-0003-1994-3124
CR Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P455
   BUSSCHER HJ, 1995, FEMS MICROBIOL LETT, V128, P229, DOI 10.1016/0378-1097(95)00103-C
   Domagk G, 1935, DEUT MED WOCHENSCHR, V61, P829, DOI 10.1055/s-0028-1129654
   Everaert EPJM, 1998, J MATER SCI-MATER M, V9, P147, DOI 10.1023/A:1008867619481
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Gottenbos B, 1999, METHODS ENZYMOL, V310, P523
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HARKES G, 1992, J BIOMAT SCI-POLYM E, V3, P403, DOI 10.1163/156856292X00213
   Hiemenz P.C, 1977, PRINCIPLES COLLOID S, P452
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   HOGT AH, 1985, J COLLOID INTERF SCI, V106, P289, DOI 10.1016/S0021-9797(85)80002-3
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   Kenawy ER, 1998, J CONTROL RELEASE, V50, P145, DOI 10.1016/S0168-3659(97)00126-0
   LAWRENCE C A, 1968, DISINFECTION STERILI, P430
   MORTIMER GA, 1965, J ORG CHEM, V30, P1632, DOI 10.1021/jo01016a074
   NOORDMANS J, 1993, J COLLOID INTERF SCI, V156, P394, DOI 10.1006/jcis.1993.1128
   SPEIER JL, 1982, J COLLOID INTERF SCI, V89, P68, DOI 10.1016/0021-9797(82)90121-7
   VANDERMEI HC, 1992, J DISPER SCI TECHNOL, V13, P447, DOI 10.1080/01932699208943327
   VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75
   VANWAGENEN RA, 1980, J COLLOID INTERF SCI, V76, P305, DOI 10.1016/0021-9797(80)90374-4
   Verkerke GJ, 1997, ARTIF ORGANS, V21, P413
NR 22
TC 229
Z9 231
U1 9
U2 76
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD JUL
PY 2001
VL 48
IS 1
BP 7
EP 13
DI 10.1093/jac/48.1.7
PG 7
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 456HW
UT WOS:000170077900002
PM 11418507
OA Bronze
DA 2018-10-19
ER

PT J
AU Morgan, TD
   Wilson, M
AF Morgan, TD
   Wilson, M
TI The effects of surface roughness and type of denture acrylic on biofilm
   formation by Streptococcus oralis in a constant depth film fermentor
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
ID BACTERIAL ADHESION; PLAQUE ACCUMULATION; CANDIDA-ALBICANS; ADHERENCE;
   RETENTION; SUSCEPTIBILITY; BIOMATERIAL; TOPOGRAPHY; FINISHES; GROWTH
AB Aims: To investigate the effects of surface roughness and type of denture acrylic on the early development of a Streptococcus oralis biofilm in a constant depth film fermenter (CDFF).
   Methods and Results: Streptococcus oralis was incubated with acrylic of known surface roughness in the CDFF. Adherent Strep. oralis were enumerated by viable counting. Cold-cure acrylic was rougher (P < 0.01) than heat-cure acrylic after polishing with abrasive paper of any given grit-grade. Heat-cure acrylic was colonized by fewer (P < 0.001) bacteria than cold-cure acrylic at any given surface roughness. The number of bacteria adhering to heat-cure and cold-cure acrylic increased linearly with mean surface roughness after 2 h incubation, the increase being greater (P < 0.001) for the cold-cure compared with the heat-cure acrylic. However, after 4 h incubation, surface roughness appeared to have no effect on the number of adherent bacteria.
   Conclusions: The type of acrylic used, and its roughness, affect the early stages of biofilm formation by Strep. oralis.
   Significance and Impact of the Study: Choosing an appropriate type of smooth acrylic could lead to reduced biofilm formation in vivo.
C1 UCL, Eastman Dent Inst Oral Hlth Care Sci, Dept Microbiol, London WC1X 8LD, England.
RP Wilson, M (reprint author), UCL, Eastman Dent Inst Oral Hlth Care Sci, Dept Microbiol, 256 Grays Inn Rd, London WC1X 8LD, England.
EM M.Wilson@eastman.ucl.ac.uk
RI Wilson, Michael/D-2085-2009
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   An Yuehuei H., 1996, P19
   Bollen CML, 1996, CLIN ORAL IMPLAN RES, V7, P201, DOI 10.1034/j.1600-0501.1996.070302.x
   Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3
   BRECX M, 1983, J PERIODONTAL RES, V18, P177, DOI 10.1111/j.1600-0765.1983.tb00351.x
   BUSSCHER HJ, 1992, FEMS MICROBIOL LETT, V88, P199, DOI 10.1111/j.1574-6968.1992.tb04988.x
   BUSSCHER HJ, 1992, J DENT RES, V71, P491, DOI 10.1177/00220345920710031301
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Embleton JV, 1998, APPL ENVIRON MICROB, V64, P3503
   Fletcher M, 1996, BACTERIAL ADHESION M, P1
   GIBBONS RJ, 1975, ANNU REV MICROBIOL, V29, P19, DOI 10.1146/annurev.mi.29.100175.000315
   Gurgan S, 1997, J ORAL REHABIL, V24, P624, DOI 10.1046/j.1365-2842.1997.00534.x
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   JANSEN B, 1997, CATHETER RELATED INF, P411
   Kerr A, 1999, J MAR BIOL ASSOC UK, V79, P357, DOI 10.1017/S002531549800040X
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LIE T, 1979, ACTA ODONTOL SCAND, V37, P73, DOI 10.3109/00016357909027575
   Merritt K., 2000, HDB BACTERIAL ADHESI, P53
   Mittelman M. W., 1996, BACTERIAL ADHESION M, P89
   Neill D.J., 1968, BRIT DENT J, V124, P107
   OLSSON J, 1982, FEMS MICROBIOL LETT, V15, P319
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   Quirynen M, 2000, HDB BACTERIAL ADHESI, P91
   QUIRYNEN M, 1991, BIOFOULING, V4, P187
   Radford DR, 1998, J DENT, V26, P577, DOI 10.1016/S0300-5712(97)00034-1
   Steinberg D, 1998, CLIN ORAL IMPLAN RES, V9, P67, DOI 10.1034/j.1600-0501.1998.090201.x
   Taylor R, 1998, J PROSTHET DENT, V80, P592, DOI 10.1016/S0022-3913(98)70037-X
   Taylor RL, 1998, J MATER SCI-MATER M, V9, P17, DOI 10.1023/A:1008874326324
   TEBBS SE, 1994, BRIT J ANAESTH, V72, P587, DOI 10.1093/bja/72.5.587
   ULUSOY M, 1986, J PROSTHET DENT, V56, P107, DOI 10.1016/0022-3913(86)90292-1
   Vacheethasanee K., 2000, HDB BACTERIAL ADHESI, P73
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   Verran J., 1991, Biofouling, V3, P183
   Verran J, 1997, J PROSTHET DENT, V77, P535, DOI 10.1016/S0022-3913(97)70148-3
   WEITMAN RT, 1975, J AM DENT ASSOC, V91, P101, DOI 10.14219/jada.archive.1975.0294
   Wilson M, 1996, J MED MICROBIOL, V44, P79, DOI 10.1099/00222615-44-2-79
   Wilson M, 1999, METHOD ENZYMOL, V310, P264
NR 38
TC 80
Z9 83
U1 1
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1364-5072
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD JUL
PY 2001
VL 91
IS 1
BP 47
EP 53
DI 10.1046/j.1365-2672.2001.01338.x
PG 7
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 453AD
UT WOS:000169891300005
PM 11442713
OA Bronze
DA 2018-10-19
ER

PT J
AU Weber, N
   Wendel, HP
   Ziemer, G
AF Weber, N
   Wendel, HP
   Ziemer, G
TI Gene monitoring of surface-activated monocytes in circulating whole
   blood using duplex RT-PCR
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hemocompatibility; heparin coating; Duplex RT-PCR; hsp70; cytokines
ID MESSENGER-RNA EXPRESSION; HEAT-SHOCK PROTEINS; POLYMERIC BIOMATERIALS;
   CARDIOPULMONARY BYPASS; PROCOAGULANT ACTIVITY; BIOLOGICAL RESPONSES;
   CYTOKINE PRODUCTION; HSP70; CELLS; INTERLEUKIN-1
AB Previous studies have shown that blood-contacting materials activate blood monocytes. The aim of this study is to evaluate a highly sensitive technique for detecting changes at the mRNA level in circulating monocytes and to find suitable "gene markers" for assessing the hemocompatibility of biomaterials. Human blood was recirculated in a modified Chandler Loop formed of test tubes. Five groups of biomaterials were compared. Monocytes were separated by using magnetic beads, and gene expression analyses were performed using RT-PCR. We investigated the mRNA expression of stress proteins (hsp70) and inflammatory markers (IL-1 alpha, IL-1 beta, IL-6, TNF-alpha). mRNAs for cytokines were highly upregulated in LPS-stimulated monocytes. Hsp70 transcripts were upregulated after heat shock but were not influenced by treatment with LPS. The gene expression of the cytokines was affected by various biomaterials. The intensity of the inflammatory response increased in the following order: heparin coatings (PVC) < uncoated PVC < silicone, polypeptide-coated PVC. No change was seen in the expression of the hsp70 genes. An inhibitory effect of systemic heparin on surface-activated monocytes was observed for the mRNA expression of the cytokines. The recirculation of human blood in an in vitro model in combination with the immunomagnetic separation of monocytes and the Duplex RT-PCR method is a powerful tool for getting reliable results. Our data demonstrate that hsp70 genes cannot be recommended for short-term, biomaterial-induced mRNA expression studies. Conversely, mRNAs for IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha were expressed in a material-dependent manner. Thus om model provides an effective tool for assessing the hemocompatibility of biomaterials before their clinical application and it also can serve as a safety control during the industrial manufacturing process. This method can be applied to various blood cell populations and numerous gene expression studies and may enable a more fundamental understanding of the biologic processes involved in blood-material interactions. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Tubingen, Dept Surg, Div Thorac Cardiac & Vasc Surg, D-72076 Tubingen, Germany.
RP Wendel, HP (reprint author), Univ Tubingen, Dept Surg, Div Thorac Cardiac & Vasc Surg, Hopper Seyler Str 3, D-72076 Tubingen, Germany.
RI Weber, Norbert/E-8701-2011; Wendel, Hans/C-5687-2009
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   Asea A, 2000, NAT MED, V6, P435
   Attanasio M, 1998, THROMB HAEMOSTASIS, V79, P959
   Balasubramanian V, 1998, J BIOMAT SCI-POLYM E, V9, P1349, DOI 10.1163/156856298X00433
   BLUM GE, 1993, ANAL BIOCHEM, V210, P235
   CHANDLER AB, 1958, LAB INVEST, V7, P110
   CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717
   DAYER JM, 1994, EUR CYTOKINE NETW, V5, P563
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   Dinarello CA, 1996, BLOOD, V87, P2095
   Hill GE, 1998, J CARDIOTHOR VASC AN, V12, P21
   HOMAN DJF, 1991, J BIOMAT SCI-POLYM E, V3, P27
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   Housby JN, 1999, CYTOKINE, V11, P347, DOI 10.1006/cyto.1998.0437
   Hu J, 1997, J CLIN INVEST, V99, P2312, DOI 10.1172/JCI119410
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Kato S, 1998, BIOMATERIALS, V19, P821, DOI 10.1016/S0142-9612(97)00240-8
   Kato S, 1997, J BIOMAT SCI-POLYM E, V8, P809, DOI 10.1163/156856297X00335
   KELLOGG DE, 1994, BIOTECHNIQUES, V16, P1134
   Kirchhofer D, 1996, CURR OPIN BIOTECH, V7, P386, DOI 10.1016/S0958-1669(96)80112-1
   Kruse N, 1997, J IMMUNOL METHODS, V210, P195, DOI 10.1016/S0022-1759(97)00188-9
   Mackman N, 1996, HAEMOSTASIS, V26, P17
   Mangurten AB, 1997, CELL STRESS CHAPERON, V2, P168, DOI 10.1379/1466-1268(1997)002<0168:HAHAPE>2.3.CO;2
   Mayer MP, 1998, BIOL CHEM, V379, P261
   MINOTA S, 1988, J EXP MED, V168, P1475, DOI 10.1084/jem.168.4.1475
   MOLDAWER LL, 1994, CRIT CARE MED, V22, pS3
   NADLER SG, 1992, SCIENCE, V258, P484, DOI 10.1126/science.1411548
   Osnes LTN, 1996, CYTOKINE, V8, P822, DOI 10.1006/cyto.1996.0110
   Parra B, 1997, VIROLOGY, V233, P260, DOI 10.1006/viro.1997.8613
   Rodenburg RJT, 1998, J IMMUNOL METHODS, V221, P169, DOI 10.1016/S0022-1759(98)00183-5
   SCHMIDT JA, 1988, J IMMUNOL, V141, P2027
   Sporri B, 1996, CYTOKINE, V8, P631, DOI 10.1006/cyto.1996.0084
   Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   Zimmermann R, 1996, BIOTECHNIQUES, V21, P824
NR 36
TC 11
Z9 11
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2001
VL 56
IS 1
BP 1
EP 8
DI 10.1002/1097-4636(200107)56:1<1::AID-JBM1024>3.0.CO;2-C
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 431AB
UT WOS:000168608600001
PM 11405188
DA 2018-10-19
ER

PT J
AU Koob, TJ
   Willis, TA
   Qiu, YS
   Hernandez, DJ
AF Koob, TJ
   Willis, TA
   Qiu, YS
   Hernandez, DJ
TI Biocompatibility of NDGA-polymerized collagen fibers. II. Attachment,
   proliferation, and migration of tendon fibroblasts in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterials; tendon; NDGA; fibroblasts; polymerization; bioprosthesis
ID FLEXOR TENDON; REPAIR; RECONSTRUCTION; LIGAMENT; GRAFTS; DOGS
AB The material properties of collagen fibers polymerized with nordihydroguaiaretic acid (NDGA) are equivalent to native tendon, suggesting that NDGA crosslinking may provide a viable approach to stabilizing collagenous materials for use in repairing ruptured, lacerated, or surgically transected fibrous tissues, such as tendons and ligaments (Koob & Hemandez, Biomaterials, in press). The present study evaluated the biocompatibility of these fibers with cultured bovine tendon fibroblasts. Fibroblast attachment, migration, and proliferation on NDGA-crosslinked materials were compared to those on prepolymerized type I tendon collagen constructs as well as on tissue-culture-treated plastic. Fibroblast attachment on NDGA-crosslinked collagen fibrils was equivalent to attachment on plates coated with collagen alone. Over a period of 8 days in culture, attached fibroblasts proliferated on NDGA-crosslinked collagen at a rate identical to that of fibroblasts attached to native collagen, in order for the biomaterial effectively to bridge gaps in fibrous tissues, fibroblasts must be able to migrate and replicate on the bridging fiber. Control and crosslinked fibers were inserted in calf tendon explants, with a portion of the fiber extending out of the sectioned end of the tendon. Explants were cultured for 9 weeks, and the number of cells was measured at weekly intervals. Cells appeared on the fibers after 1 week of culture. By 2 weeks, cells had colonized the entire fiber. The number of cells continued to increase throughout the 9 weeks in culture, forming a layer several cells thick. Histologic analysis indicated that the fibroblasts populating the fibers appeared to originate in the epitenon. There was no difference in the rate of fibroblast migration and replication, nor in the ultimate number of colonizing cells, between control collagen fibers and NDGA-crosslinked fibers. NDGA-crosslinked fibers may provide a means of bridging gaps in ruptured, lacerated, or surgically transected tendons by providing a mechanically competent scaffold on which tendon fibroblasts can migrate, attach, and proliferate. (C) 2001 John Wiley & Sons, Inc.
C1 Shriners Hosp Children, Ctr Res Skeletal Dev & Pediat Orthopaed, Skeletal Biol Sect, Tampa, FL 33612 USA.
RP Koob, TJ (reprint author), Shriners Hosp Children, Ctr Res Skeletal Dev & Pediat Orthopaed, Skeletal Biol Sect, 12502 N Pine Dr, Tampa, FL 33612 USA.
CR ABRAHAMSSON SO, 1995, J ORTHOPAED RES, V13, P58, DOI 10.1002/jor.1100130110
   ABRAHAMSSON SO, 1994, J HAND SURG-AM, V19A, P259, DOI 10.1016/0363-5023(94)90016-7
   AMIEL D, 1995, J ORTHOPAED RES, V13, P459, DOI 10.1002/jor.1100130321
   AOKI M, 1994, J HAND SURG-AM, V19A, P984, DOI 10.1016/0363-5023(94)90102-3
   ARK JW, 1994, J HAND SURG-AM, V19A, P249, DOI 10.1016/0363-5023(94)90015-9
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   BECKER H, 1981, J HAND SURG-AM, V6, P616, DOI 10.1016/S0363-5023(81)80146-3
   Butler DL, 1999, CLIN ORTHOP RELAT R, pS324
   DOCKERY G L, 1986, Journal of Foot Surgery, V25, P469
   DUNN MG, 1993, J BIOMED MATER RES, V27, P1545, DOI 10.1002/jbm.820271211
   GELBERMAN R H, 1984, Journal of Orthopaedic Research, V2, P39, DOI 10.1002/jor.1100020107
   GELBERMAN RH, 1992, J BONE JOINT SURG AM, V74A, P1207, DOI 10.2106/00004623-199274080-00011
   GELBERMAN RH, 1992, J HAND SURG-AM, V17A, P551, DOI 10.1016/0363-5023(92)90370-5
   GOLDSTEIN JD, 1989, J BONE JOINT SURG AM, V71A, P1183, DOI 10.2106/00004623-198971080-00010
   Huang LLH, 1998, J BIOMED MATER RES, V42, P568, DOI 10.1002/(SICI)1097-4636(19981215)42:4<568::AID-JBM13>3.0.CO;2-7
   HUNTER JM, 1988, J HAND SURG-AM, V13A, P849, DOI 10.1016/0363-5023(88)90259-6
   IANNACE S, 1995, BIOMATERIALS, V16, P675, DOI 10.1016/0142-9612(95)99693-G
   KAIN CC, 1988, J ORTHOPAED RES, V6, P871, DOI 10.1002/jor.1100060611
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   KATO YP, 1991, J BONE JOINT SURG AM, V73A, P561, DOI 10.2106/00004623-199173040-00013
   KOOB TJ, IN PRESS BIOCOMPATIB, V1
   KOOB TJ, IN PRESS BIOMATERIAL
   Lundborg G, 1978, J Hand Surg Am, V3, P21
   LUNDBORG G, 1980, HAND, V12, P3, DOI 10.1016/S0072-968X(80)80023-4
   MANSKE PR, 1984, J BONE JOINT SURG AM, V66A, P385, DOI 10.2106/00004623-198466030-00011
   MANSKE PR, 1984, J HAND SURG-BRIT EUR, V9B, P117, DOI 10.1016/S0266-7681(84)80005-4
   MANSKE PR, 1984, CLIN ORTHOP RELAT R, P297
   MCMASTER WC, 1986, B HOSP JOINT DIS ORT, V46, P174
   MENDES DG, 1986, J BIOMED MATER RES, V20, P699, DOI 10.1002/jbm.820200604
   MILTHORPE BK, 1994, BIOMATERIALS, V15, P745, DOI 10.1016/0142-9612(94)90027-2
   Noguchi M, 1997, J HAND SURG-AM, V22A, P457, DOI 10.1016/S0363-5023(97)80013-5
   ROE S C, 1992, Clinical Materials, V9, P149, DOI 10.1016/0267-6605(92)90094-A
   ROGERS GT, 1995, BIOMATERIALS, V16, P803, DOI 10.1016/0142-9612(95)99643-Z
   RUSSELL JE, 1990, J ORTHOPAED RES, V8, P13, DOI 10.1002/jor.1100080103
   SEILER JG, 1995, J HAND SURG-AM, V20A, P492, DOI 10.1016/S0363-5023(05)80115-7
   SEILER JG, 1993, J BONE JOINT SURG AM, V75A, P1004, DOI 10.2106/00004623-199307000-00006
   SMITH DJ, 1986, J HAND SURG-AM, V11A, P97, DOI 10.1016/S0363-5023(86)80114-9
   Strickland JW, 2000, J HAND SURG-AM, V25A, P214
   Sung HW, 2000, BIOMATERIALS, V21, P1353, DOI 10.1016/S0142-9612(00)00017-X
   Woo SLY, 1999, CLIN ORTHOP RELAT R, pS312
   YOUNG RG, 1940, J ORTHOPAED RES, P16
NR 41
TC 37
Z9 37
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2001
VL 56
IS 1
BP 40
EP 48
DI 10.1002/1097-4636(200107)56:1<40::AID-JBM1066>3.3.CO;2-9
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 431AB
UT WOS:000168608600006
PM 11309789
DA 2018-10-19
ER

PT J
AU Hung, WS
   Fang, CL
   Su, CH
   Lai, WFT
   Chang, YC
   Tsai, YH
AF Hung, WS
   Fang, CL
   Su, CH
   Lai, WFT
   Chang, YC
   Tsai, YH
TI Cytotoxicity and immunogenicity of SACCHACHITIN and its mechanism of
   action on skin wound healing
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE SACCHACHITIN; wound healing; inflammatory effect; chemotactic effect;
   angiogenesis; granulation tissue; scar formation
ID FUNGAL MYCELIA; SUBSTITUTES; TISSUE
AB SACCHACHITIN membrane, a weavable skin substitute made from the residual fruiting body of Ganoderma tsugae, has been demonstrated to promote skin wound healing. Prior to its clinical application, it is critical to learn more about any possible cytotoxicity, immunogenicity, or allergy response, and at least some of its mechanism(s) of action(s). In the present studies, it has been found that SACCHACHITIN suspension at less than 0.05% shows no cytotoxicity to the primary culture of rat fibroblasts. However, at higher concentrations (greater than or equal to0.1%), it does reduce the growth of fibroblasts, based on MTT assays. This might be caused by positive charges on chitin molecules that are too strong, and may be harmful to the cell membrane. SACCHACHITIN showed no immunogenicity after it was inoculated into rats three times; however, the unmodified, purified rabbit type I and type II collagens did. Subcutaneous injection of SACCHACHITIN suspension into rats showed no gross allergic responses on skin. Nevertheless, it did cause local acute inflammation, as observed by histological investigation. This is similar to what occurred in the wound site covered with SACCHACHITIN membrane. The chemotactic effect of SACCHACHITIN was exhibited in both intact and wounded skin tissues. This may be one of the initial beneficial effects of SACCHACHITIN membrane to wound healing. The rapid acute inflammatory process was followed by the appearance of angiogenesis and granulation tissue formation, which occurred earlier than it normally would. Coverage of the wound area with SACCHACHITIN membrane also induced an earlier formation of scar tissue to replace the granulation tissue. A 1.5 x 1.5 cm(2) wound area covered by SACCHACHITIN completely healed by 21 days, while that covered with cotton gauze did not. Therefore, SACCHACHITIN is a safe biomaterial for use as a wound dressing for skin healing. Its promoting action for wound healing might be due to its chemotactic effect for inflammatory cells. This, in turn, may facilitate subsequent angiogenesis, granulation tissue formation, and faster new tissue formation, leading to faster wound healing. (C) 2001 John Wiley & Sons, Inc.
C1 Taipei Med Univ, Grad Inst Cell & Mol Biol, Taipei 110, Taiwan.
   Taipei Med Univ, Dept Pathol, Taipei 110, Taiwan.
   Taipei Med Univ, Grad Inst Biomed Mat, Taipei 110, Taiwan.
   Taipei Med Univ, Grad Inst Med Sci, Taipei 110, Taiwan.
RP Tsai, YH (reprint author), Taipei Med Univ, Grad Inst Cell & Mol Biol, 250 Wu Hsing St, Taipei 110, Taiwan.
RI leu, borwen/K-8547-2012
CR ARTURO T, 1976, SURG GYNECOL OBSTET, V142, P537
   BLACK J, 1984, BIOMATERIALS, V5, P11, DOI 10.1016/0142-9612(84)90061-9
   BLACK J, 1981, BIOL PERFORMANCE MAT
   CHUNG LY, 1994, J BIOMED MATER RES, V28, P463, DOI 10.1002/jbm.820280409
   Clark RA., 1995, MOL CELLULAR BIOL WO, P3
   Damsky Caroline H., 1992, Current Opinion in Cell Biology, V4, P772, DOI 10.1016/0955-0674(92)90100-Q
   HUNT TK, 1979, WOUND HEALING WOUND
   KALLUS T, 1983, J BIOMED MATER RES, V17, P741, DOI 10.1002/jbm.820170503
   KURKINEN M, 1980, LAB INVEST, V43, P47
   LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453
   MERRITT K, 1984, BIOMATERIALS, V5, P47, DOI 10.1016/0142-9612(84)90066-8
   NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981
   ROBBIN SL, 1979, PATHOLOGIC BASIC DIS
   Su CH, 1997, BIOMATERIALS, V18, P1169, DOI 10.1016/S0142-9612(97)00048-3
   Su CH, 1999, BIOMATERIALS, V20, P61, DOI 10.1016/S0142-9612(98)00139-2
NR 15
TC 24
Z9 25
U1 1
U2 6
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2001
VL 56
IS 1
BP 93
EP 100
DI 10.1002/1097-4636(200107)56:1<93::AID-JBM1072>3.0.CO;2-B
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 431AB
UT WOS:000168608600012
PM 11309795
DA 2018-10-19
ER

PT J
AU Billiar, K
   Murray, J
   Laude, D
   Abraham, G
   Bachrach, N
AF Billiar, K
   Murray, J
   Laude, D
   Abraham, G
   Bachrach, N
TI Effects of carbodiimide crosslinking conditions on the physical
   properties of laminated intestinal submucosa
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE repair biomaterial; collagen; crosslinking; mechanical properties;
   multilayer composite
ID DERMAL SHEEP COLLAGEN; WATER-SOLUBLE CARBODIIMIDE; ABDOMINAL-WALL;
   CROSS-LINKING; BOVINE PERICARDIUM; DOG-MODEL; REPAIR; GLUTARALDEHYDE;
   BIOPROSTHESES; MESH
AB Functional tissue engineering of load-bearing repair tissues requires the design and production of biomaterials that provide a remodelable scaffold for host infiltration and tissue regeneration while maintaining the repair function throughout the remodeling process. Layered constructs have been fabricated from chemically and mechanically cleaned porcine intestinal collagen using ethyl-3(3dimethylamino) propyl carbodiimide (EDC) and an acetone solvent. By varying the concentration of the crosslinker from 1 to 10 mM and the solvent from 0 to 90% acetone, the strength, stiffness, maximum strain, thermal stability, lamination strength, and suture retention strength can be adjusted. These parameters have either functional importance or the potential to modify the remodeling kinetics, or they have both. This study investigates the interdependence of these parameters, the specific effects that variations in concentration can achieve, and how the two crosslinking variables interact. The results demonstrate that there is substantial latitude in the design of these constructs by these straightforward crosslinking modifications. These data provide the basis for studying the in vivo response to crosslinking conditions that will supply the requisite strength while still allowing host cell infiltration and remodeling. (C) 2001 John Wiley & Sons, Inc.
C1 Organogenesis Inc, Canton, MA 02021 USA.
RP Bachrach, N (reprint author), Organogenesis Inc, 150 Dan Rd, Canton, MA 02021 USA.
CR ABRAHAM G, 1999, SOC BIOMATER, V22, P589
   Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   BADYLAK S, 1998, TISSUE ENG, V42, P379
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   CHEUNG DT, 1985, CONNECT TISSUE RES, V13, P109, DOI 10.3109/03008208509152389
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Damink LHHO, 1996, BIOMATERIALS, V17, P679, DOI 10.1016/0142-9612(96)86737-8
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   FISHER J, 1987, LIFE SUPPORT SYST, V5, P189
   GABELLA G, 1987, CELL TISSUE RES, V248, P491, DOI 10.1007/BF00216474
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Kemp P D, 1995, Tissue Eng, V1, P71, DOI 10.1089/ten.1995.1.71
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Klinge U, 1998, EUR J SURG, V164, P951
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   LAUN A, 1990, ACTA NEUROCHIR, V107, P16, DOI 10.1007/BF01402607
   MATLOUB HS, 1992, ANN PLAS SURG, V29, P508, DOI 10.1097/00000637-199212000-00005
   MATSUMOTO T, 1966, ANN SURG, V164, P845
   ORBERG J, 1983, CONNECT TISSUE RES, V11, P285, DOI 10.3109/03008208309004861
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   QUILICI PJ, 1985, SURG GYNECOL OBSTET, V161, P47
   SCHOEN FJ, 1994, J CARDIAC SURG, V9, P222, DOI 10.1111/j.1540-8191.1994.tb00932.x
   SCHOEN FJ, 1991, SECONDARY CALCIFICAT, P125
   TROWBRIDGE EA, 1989, CRIT REV BIOCOMPAT, V5, P105
   VANWACHEM PB, 1994, INT J ARTIF ORGANS, V17, P230
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
NR 34
TC 73
Z9 77
U1 0
U2 19
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2001
VL 56
IS 1
BP 101
EP 108
DI 10.1002/1097-4636(200107)56:1<101::AID-JBM1074>3.0.CO;2-6
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 431AB
UT WOS:000168608600013
PM 11309796
DA 2018-10-19
ER

PT J
AU Ram, J
   Pandey, SK
   Apple, DJ
   Werner, L
   Brar, GS
   Singh, R
   Chaudhary, KP
   Gupta, A
AF Ram, J
   Pandey, SK
   Apple, DJ
   Werner, L
   Brar, GS
   Singh, R
   Chaudhary, KP
   Gupta, A
TI Effect of in-the-bag intraocular lens fixation on the prevention of
   posterior capsule opacification
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article; Proceedings Paper
CT 56th All India Ophthalmological-Society Conference
CY FEB, 1998
CL GAUHATI, INDIA
SP All India Ophthalmol Soc
ID 75 AUTOPSY EYES; SURGICAL PREVENTION; CATARACT-SURGERY; PART 1;
   POLYMETHYLMETHACRYLATE; SILICONE; SERIES; DECENTRATION; BARRIER; UPDATE
AB Purpose: To compare the incidence of posterior capsule opacification (PCO) after extracapsular cataract extraction (ECCE) and phacoemulsification and to evaluate the role of posterior chamber intraocular lens (PC IOL) haptic fixation and biomaterial/design in reducing the incidence.
   Setting: Postgraduate Institute of Medical Education and Research, Chandigarh, India; Center for Research on Ocular Therapeutics and Biodevices, Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina, USA.
   Methods. This study comprised 278 eyes of 263 patients having ECCE and 318 eyes of 297 patients having phacoemulsification with PC IOL implantation. Posterior capsule opacification leading to a decrease in Snellen visual acuity of 2 or more lines was considered visually significant. The presence of PCO and IOL haptic fixation were evaluated postoperatively using slitlamp biomicroscopy. Haptic position was noted as in-the-bag (B-B), 1 haptic in the bag and 1 in the sulcus (bag-sulcus [B-S]), or both haptics out of the bag (sulcus-sulcus [S-S]). In addition, the rate of visually significant PCO was compared among 3 IOL biomaterials: poly(methyl methacrylate), silicone, and hydrophobic acrylic.
   Results: Visually significant PCO occurred in 42.45% of eyes having ECCE and 19.18% of eyes having phacoemulsification (P < .001, chi-square test) after a mean follow-up of 2.4 years +/- 0.7 (SID). In both groups, visually significant PCO was significantly less in eyes with B-B fixation than in those with B-S or S-S fixation (P < .001). The rate of visually significant PCO in all eyes in the phacoemulsification group with B-B fixation was low (11.90%) and was significantly lower in eyes with a hydrophobic acrylic IOL (2.22%; P < .05, chi-square test).
   Conclusions. In-the-bag PC IOL fixation is required to consistently reduce the incidence of PCO. Thorough removal of lens substance, including hydrodissection-assisted cortical cleanup, and in-the-bag PC IOL fixation seem to be the most important factors in reducing PCO, regardless of surgical procedure or IOL type used. Intraocular lens biomaterial and design also help prevent PCO. (C) 2001 ASCRS and ESCRS.
C1 Postgrad Inst Med Educ & Res, Dept Ophthalmol, Chandigarh 160012, India.
   Indira Gandhi Med Coll Shimla, Shimla, India.
   Med Univ S Carolina, Storm Eye Inst, Ctr Res Ocular Therapeut & Biodevices, Charleston, SC 29425 USA.
RP Ram, J (reprint author), Postgrad Inst Med Educ & Res, Dept Ophthalmol, Chandigarh 160012, India.
OI Gupta, Amod/0000-0001-8427-5738
CR Apple D J, 1985, J Am Intraocul Implant Soc, V11, P44
   Apple D. J., 2000, FOLDABLE INTRAOCULAR
   APPLE DJ, 1992, SURV OPHTHALMOL, V37, P73, DOI 10.1016/0039-6257(92)90073-3
   APPLE DJ, 1984, SURV OPHTHALMOL, V29, P1, DOI 10.1016/0039-6257(84)90113-9
   Apple DJ, 1999, OPHTHALMOLOGY, V106, P1861, DOI 10.1016/S0161-6420(99)90393-7
   Apple DJ, 2001, OPHTHALMOLOGY, V108, P505, DOI 10.1016/S0161-6420(00)00589-3
   APPLE DJ, 1986, J CATARACT REFR SURG, V12, P358, DOI 10.1016/S0886-3350(86)80095-5
   Apple DJ, 2000, J CATARACT REFR SURG, V26, P180, DOI 10.1016/S0886-3350(99)00353-3
   APPLE DJ, 2000, SURV OPHTHALMOL S1, V45, P451
   HANSEN SO, 1988, OPHTHALMOLOGY, V95, P344
   Hayashi H, 1998, ARCH OPHTHALMOL-CHIC, V116, P1579, DOI 10.1001/archopht.116.12.1579
   Hollick EJ, 1999, OPHTHALMOLOGY, V106, P49, DOI 10.1016/S0161-6420(99)90047-7
   Linnola RJ, 2000, J CATARACT REFR SURG, V26, P1792, DOI 10.1016/S0886-3350(00)00748-3
   LINNOLA RJ, 2000, J CATARACT REFR SURG, V26, P1087
   LINNOLA RJ, 1997, J CATARACT REFR SURG, V23, P527
   MIYAKE K, 1984, AM J OPHTHALMOL, V98, P451, DOI 10.1016/0002-9394(84)90130-2
   MIYAKE K, 1984, OPHTHALMIC SURG LAS, V15, P658
   Nagata T, 1998, J CATARACT REFR SURG, V24, P367, DOI 10.1016/S0886-3350(98)80325-8
   Nishi O, 1999, J CATARACT REFR SURG, V25, P106, DOI 10.1016/S0886-3350(99)80020-0
   Oshika T, 1998, BRIT J OPHTHALMOL, V82, P549, DOI 10.1136/bjo.82.5.549
   Oshika T, 1996, J CATARACT REFR SURG, V22, P104, DOI 10.1016/S0886-3350(96)80278-1
   PARK SB, 1986, J CATARACT REFR SURG, V12, P363, DOI 10.1016/S0886-3350(86)80096-7
   Peng Q, 2000, J CATARACT REFR SURG, V26, P198, DOI 10.1016/S0886-3350(99)00352-1
   Peng Q, 2000, J CATARACT REFR SURG, V26, P188, DOI 10.1016/S0886-3350(99)00354-5
   Ram J, 1999, OPHTHALMOLOGY, V106, P883, DOI 10.1016/S0161-6420(99)00505-9
   Ram J, 1999, OPHTHALMOLOGY, V106, P891, DOI 10.1016/S0161-6420(99)00506-0
   Schaumberg DA, 1998, OPHTHALMOLOGY, V105, P1213, DOI 10.1016/S0161-6420(98)97023-3
   Tetz MR, 1999, J CATARACT REFR SURG, V25, P1662, DOI 10.1016/S0886-3350(99)00259-X
   TETZ MR, 1988, J CATARACT REFR SURG, V14, P614, DOI 10.1016/S0886-3350(88)80028-2
   Ursell PG, 1998, J CATARACT REFR SURG, V24, P352, DOI 10.1016/S0886-3350(98)80323-4
   Werner L, 2000, CATARACT SURG COMPLI, P399
NR 31
TC 50
Z9 52
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD JUL
PY 2001
VL 27
IS 7
BP 1039
EP 1046
DI 10.1016/S0886-3350(00)00841-5
PG 8
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 459VK
UT WOS:000170272000025
PM 11489573
DA 2018-10-19
ER

PT J
AU Chiou, SH
   Wu, WT
   Huang, YY
   Chung, TW
AF Chiou, SH
   Wu, WT
   Huang, YY
   Chung, TW
TI Effects of the characteristics of chitosan on controlling drug release
   of chitosan coated PLLA microspheres
SO JOURNAL OF MICROENCAPSULATION
LA English
DT Article
DE chitosan; PLLA; microsphere; controlled drug release
ID WALLED POLYMER MICROSPHERES; IN-VIVO DEGRADATION; CONTROLLED DELIVERY;
   PREPARED CAPSULE; CHITIN; MOLECULES; MEMBRANES; LYSOZYME; INVITRO;
   COMPLEX
AB Chitosan has been shown to be a biomaterial with good biocompatibility, and is highly biodegradable. This study investigated the effect of post-coating PLLA microspheres with different chitosans on the initial burst and controlling the drug release of the microspheres. Without chitosan, 19.2% of encapsulated lidocaine would release from PLLA microspheres within the first hour. (R-1), and the time of 50% release. (T-50) was 25 h. After the microspheres were coated with chitosan of viscosity. (eta) 384 +/- 10 cp, R-1 and T-50 could be reduced and prolonged to 14.6% and 90 h, respectively, for all tested molecular weights (Mw) of chitosan. In the case of the same Mw of chitosan being applied, the efficacy of reducing the initial burst of drug release was higher for a lower degree of deacetylation (D.D.). With chitosan in acetic acid solution, coating the microspheres with high Mw and high viscosity could most effectively reduce the initial burst and control drug release of PLLA microspheres. For example, the microspheres coated with chitosan solution of Mw 800 kDa and eta of 1479 cp, R-1 and T-50 could be reduced and prolonged to 7.4% and 245 h, respectively. The study indicated that manipulating the viscosity of the chitosan solution was the most important factor in contributing to controlling the drug release of chitosan post-coated PLLA microspheres.
C1 Chung Yuan Christian Univ, Dept Biomed Engn, Chungli, Taiwan.
   Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.
   Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan.
RP Chung, TW (reprint author), Chung Yuan Christian Univ, Dept Biomed Engn, Chungli, Taiwan.
CR AKBUGA J, 1994, INT J PHARM, V111, P217, DOI 10.1016/0378-5173(94)90344-1
   CHANDY T, 1992, BIOMATERIALS, V13, P949, DOI 10.1016/0142-9612(92)90119-9
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chang SJ, 1996, PLANT MOL BIOL, V31, P693, DOI 10.1007/BF00042242
   CHEN RH, 1994, CARBOHYD POLYM, V24, P41, DOI 10.1016/0144-8617(94)90115-5
   Chen RH, 1997, J APPL POLYM SCI, V66, P161, DOI 10.1002/(SICI)1097-4628(19971003)66:1<161::AID-APP19>3.0.CO;2-4
   Chen RH, 1996, CARBOHYD POLYM, V31, P141, DOI 10.1016/S0144-8617(96)00047-1
   Chung TW, 1998, DIABETIC MED, V15, P380, DOI 10.1002/(SICI)1096-9136(199805)15:5<380::AID-DIA592>3.3.CO;2-#
   GEOLWSKI S, 1993, J BIOMEDICAL MAT RES, V27, P1135
   Gupta RK, 1997, VACCINE, V15, P1716, DOI 10.1016/S0264-410X(97)00116-3
   HIRANO S, 1989, AGR BIOL CHEM TOKYO, V53, P3065, DOI 10.1080/00021369.1989.10869777
   Huang YY, 1999, INT J PHARM, V182, P93, DOI 10.1016/S0378-5173(99)00060-5
   Jameela SR, 1998, J CONTROL RELEASE, V52, P17, DOI 10.1016/S0168-3659(97)00187-9
   JAMEELA SR, 1995, BIOMATERIALS, V16, P769, DOI 10.1016/0142-9612(95)99639-4
   Kreitz MR, 1997, BIOMATERIALS, V18, P1645, DOI 10.1016/S0142-9612(97)00106-3
   Leach KJP, 1998, BIOMATERIALS, V19, P1981
   LEHR CM, 1992, INT J PHARM, V78, P43, DOI 10.1016/0378-5173(92)90353-4
   Mi FL, 1997, J APPL POLYM SCI, V66, P2495, DOI 10.1002/(SICI)1097-4628(19971226)66:13<2495::AID-APP12>3.0.CO;2-X
   MUZZARELLI R, 1990, ANTIMICROB AGENTS CH, V34, P2019, DOI 10.1128/AAC.34.10.2019
   OKAMOTO Y, 1993, J VET MED SCI, V55, P743, DOI 10.1292/jvms.55.743
   PANGBURN SH, 1982, BIOMATERIALS, V3, P105, DOI 10.1016/0142-9612(82)90043-6
   PEKAREK KJ, 1994, NATURE, V367, P258, DOI 10.1038/367258a0
   POLK AE, 1994, AQUACULT ENG, V13, P311, DOI 10.1016/0144-8609(94)90018-3
   SEZER AD, 1995, INT J PHARM, V121, P113, DOI 10.1016/0378-5173(94)00413-Y
   SHIRAISHI S, 1993, J CONTROL RELEASE, V25, P217, DOI 10.1016/0168-3659(93)90080-O
   Singh DK, 1999, J MEMBRANE SCI, V155, P107, DOI 10.1016/S0376-7388(98)00311-1
   SINGH PC, 1996, CHEM ENG PROCESS, V35, P342
   Yamamoto H, 1997, MACROMOLECULES, V30, P3936, DOI 10.1021/ma961766f
   YAMAMOTO H, 1984, MACROMOLECULAR CHEM, V186, P1613
   Yang YY, 2000, CHEM ENG SCI, V55, P2223, DOI 10.1016/S0009-2509(99)00503-5
   YAO KD, 1995, J MACROMOL SCI R M C, VC35, P155, DOI 10.1080/15321799508014592
NR 31
TC 35
Z9 37
U1 5
U2 21
PU TAYLOR & FRANCIS LTD
PI LONDON
PA 11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND
SN 0265-2048
J9 J MICROENCAPSUL
JI J. Microencapsul.
PD JUL
PY 2001
VL 18
IS 5
BP 613
EP 625
PG 13
WC Chemistry, Applied; Engineering, Chemical; Pharmacology & Pharmacy
SC Chemistry; Engineering; Pharmacology & Pharmacy
GA 459FM
UT WOS:000170240400007
PM 11508767
DA 2018-10-19
ER

PT J
AU Kojima, Y
AF Kojima, Y
TI Project of platform science and technology for advanced magnesium alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE advanced magnesium alloys; platform science; platform technology;
   microstructure control; surface modification; ecomaterial; environmental
   burden; structural space material; new functionality; biomaterial
AB The four year project on "Platform Science and Technology for Advanced Magnesium-Alloys" started in September 1999 with financial support from the Ministry of Education, Science, Sports and Culture of Japan. The project members consisting mainly of Professors in Japanese Universities are going to make various efforts for the advancement of studies on magnesium alloys. The background and concept of the research project is described, and then the contents and practical activities of the group are briefly explained.
C1 Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata 9402188, Japan.
RP Kojima, Y (reprint author), Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata 9402188, Japan.
CR AGHION E, 1998, P 1 ISR INT C MAGN S, P1
   AGHION E, 2000, P 2 ISR INT C MAGN S, P1
   Aizawa T, 1999, J ALLOY COMPD, V291, P248, DOI 10.1016/S0925-8388(99)00263-7
   AIZAWA T, 1999, J JAPAN SOC POWDER P, V46, P1097
   BAKER C, 1987, MAGNESIUM TECHNOLOGY, P1
   EMLEY EF, 1966, PRINCIPLES MAGNESIUM, P25
   KAMADO S, 1999, MAT JAPAN, V38, P285
   KOJIMA Y, 2000, MAGNESIUM ALLOYS 200, V350, P1
   LORIMER GW, 1997, P 3 INT MAGN C, P1
   Mabuchi M, 1997, SCRIPTA MATER, V36, P681, DOI 10.1016/S1359-6462(96)00444-7
   Mabuchi M, 1997, MATER SCI TECH SER, V13, P825, DOI 10.1179/mst.1997.13.10.825
   Mordike B. L., 2000, MAGNESIUM EIGENSCHAF, P1
   MORDIKE BL, 1998, MAGNESIUM ALLOYS THE, P1
   MORDIKE BL, 1992, MAGNESIUM ALLOYS THE, P1
   POLMEAR IJ, 1995, LIGHT ALLOYS, P17
   Yamada Y, 1999, J MATER SCI LETT, V18, P1477, DOI 10.1023/A:1006677930532
   Yamada Y, 1999, MAT SCI ENG A-STRUCT, V272, P455, DOI 10.1016/S0921-5093(99)00484-0
NR 17
TC 95
Z9 123
U1 0
U2 17
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2001
VL 42
IS 7
BP 1154
EP 1159
DI 10.2320/matertrans.42.1154
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 462EW
UT WOS:000170408600002
OA Bronze
DA 2018-10-19
ER

PT J
AU Kuwahara, H
   Al-Abdullat, Y
   Mazaki, N
   Tsutsumi, S
   Aizawa, T
AF Kuwahara, H
   Al-Abdullat, Y
   Mazaki, N
   Tsutsumi, S
   Aizawa, T
TI Precipitation of magnesium apatite on pure magnesium surface during
   immersing in Hank's solution
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE biomaterial; artificial bone design; precipitation; magnesium apatite;
   heat treatment; Hank's solution
AB A new artificial bone concept by magnesium alloys is proposed to think much importance on its homogenization with a surrounding natural hard and soft tissue. Magnesium is an essential element for human body, so that magnesium bone implants can be expected to be toxicity free even though magnesium dissolved into human soft tissue. In addition, magnesium base artificial bone has vivo-adaptively to growing bone cells once vivo-coating is formed on the surface of magnesium in the inside of soft tissue. In the present paper, its chemical behavior in Hank's solution (HBSS (+)) is described to simulate biochemical reactions of magnesium in the human body. An effect of heat treatment of magnesium on its chemical behavior is also investigated. Specimens of 10 x 20 x 2 mm(3) were used for examining chemical behaviors of commercial grade pure magnesium (3N-Mg) in a HBSS (+) for various holding time (25-700h). Specific mass gain of each specimen was measured, the surface microstructure was observed by a scanning electron microscope, identification of reaction products were examined by x-ray diffraction measurements. Chemical compositions of reaction products were also analyzed by an energy dispersion x-ray spectrometry. Mass change of heat-treated 3N-Mg, which was heat-treated at 803 K for 90 ks increased with immersing time in HBSS (+) though that of other heat-treated 3N-Mg unstably decreased in HBSS (+). Magnesium reacted with HBSS (+) and then a magnesium apatite was precipitated on the heat-treated 3N-Mg specimen surface. The magnesium apatite should be described as (Ca0.86Mg0.14)(10)(PO4)(6)(OH)(2).
C1 Res Inst Appl Sci, Kyoto 6068202, Japan.
   Kyoto Univ, Grad Sch Engn, Kyoto 6068507, Japan.
   Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan.
   Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan.
RP Kuwahara, H (reprint author), Res Inst Appl Sci, Kyoto 6068202, Japan.
CR Kawamura Y, 2000, MATER SCI FORUM, V350-3, P111, DOI 10.4028/www.scientific.net/MSF.350-351.111
   KAWAMURA Y, 2000, MATER SCI FORUM, V3500, P117
   Kim HM, 1997, J CERAM SOC JPN, V105, P111, DOI 10.2109/jcersj.105.111
   Koike J, 2000, MATER SCI FORUM, V350-3, P105, DOI 10.4028/www.scientific.net/MSF.350-351.105
   KOKUBO T, 1983, CHEM IND, V36, P533
   KOKUBO T, 1999, MAT INTEGRATION, V12, P39
   KUROKAWA M, 1994, J JPN PLASTIC RECONS, V16, P75
   KUROKAWA M, 1994, J JPN PLASTIC RECONS, V14, P238
   Kuwahara H, 2000, MATER SCI FORUM, V350-3, P349, DOI 10.4028/www.scientific.net/MSF.350-351.349
   OKAZAKI M, 1992, CHEM APATITE CONSTRU, P10
   SUDA T, 1993, SCI BONE, P121
   SUZUKI K, 1999, COMMUNICATION
   WEN CE, 2000, IN PRESS P THERMEC 2
NR 13
TC 126
Z9 154
U1 0
U2 33
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2001
VL 42
IS 7
BP 1317
EP 1321
DI 10.2320/matertrans.42.1317
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 462EW
UT WOS:000170408600028
OA Bronze
DA 2018-10-19
ER

PT J
AU Uludag, H
   Norrie, B
   Kousinioris, N
   Gao, TJ
AF Uludag, H
   Norrie, B
   Kousinioris, N
   Gao, TJ
TI Engineering temperature-sensitive poly(N-isopropylacrylamide) polymers
   as carriers of therapeutic proteins
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE thermosensitive polymers; rhBMP-2; protein conjugation; bone
   regeneration; protein delivery
ID N-HYDROXYSUCCINIMIDE ESTERS; BONE MORPHOGENETIC PROTEIN-2; RAT ECTOPIC
   MODEL; LIGHT-SCATTERING; BIOMATERIAL CARRIERS; AQUEOUS-SOLUTIONS;
   CRYSTAL-STRUCTURE; PHASE-TRANSITION; DRUG-DELIVERY; IN-VITRO
AB This study was carried out to engineer N-isopropylacrylamide (NiPAM) polymers that contain protein-reactive N-acryloxysuccinimide (NASI) and hydrophobic alkylmethacrylates (AMAs). These thermoreversible, protein-conjugating polymers hold potential for retention of therapeutic proteins at an application site where tissue regeneration is desired. The lower critical solution temperatures (LCST) of the polymers were effectively controlled by the AMA mole content. The AMAs with longer side-chains were more effective in lowering the LCST. Polymers without NASI exhibited a stable LCST in phosphate buffer and in serum over a 10-day study period. The LCST of polymers containing NASI was found to increase over time in phosphate buffer, but not in serum-containing medium. The LCST increase in phosphate buffer was proportional to the AMA content. The feasibility of localizing a therapeutic protein, recombinant human bone morphogenetic protein-2 (rhBMP-2), to a site of application was explored in a rat intramuscular injection model. The results indicated that polymers capable of conjugating to rhBMP-2 were most effective in localizing the protein irrespective of the LCST (13-25 degreesC). For polymers with no NASI groups, a lower LCST resulted in a better rhBMP-2 localization. We conclude that thermosensitive polymers can be engineered for delivery of therapeutic proteins to improve their therapeutic efficacy. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB T6G 2V2, Canada.
RP Uludag, H (reprint author), Univ Alberta, Fac Med & Dent, Dept Biomed Engn, 1098 EDC Bldg, Edmonton, AB T6G 2V2, Canada.
CR Brar AS, 1998, POLYM J, V30, P664, DOI 10.1295/polymj.30.664
   BRAZEL CS, 1995, MACROMOLECULES, V28, P8016, DOI 10.1021/ma00128a007
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   CHEN JP, 1990, BIOMATERIALS, V11, P625, DOI 10.1016/0142-9612(90)90019-M
   CLINE GW, 1987, J AM CHEM SOC, V109, P3087, DOI 10.1021/ja00244a035
   CLINE GW, 1988, J ORG CHEM, V53, P3583, DOI 10.1021/jo00250a031
   Davidenko N, 1998, POLYMER, V39, P917, DOI 10.1016/S0032-3861(97)00407-2
   Ding ZL, 1998, J BIOMED MATER RES, V39, P498, DOI 10.1002/(SICI)1097-4636(19980305)39:3<498::AID-JBM22>3.0.CO;2-5
   FEIL H, 1993, MACROMOLECULES, V26, P2496, DOI 10.1021/ma00062a016
   GAO TJ, 2001, UNPUB TISSUE ENG
   GUTOWSKA A, 1995, J BIOMED MATER RES, V29, P811, DOI 10.1002/jbm.820290705
   Hahn M, 1998, MACROMOLECULES, V31, P5616, DOI 10.1021/ma9800010
   HORBETT TA, 1996, BIOMATERIALS SCI, P135
   Idziak I, 1999, MACROMOLECULES, V32, P1260, DOI 10.1021/ma981171f
   Israel D I, 1992, Growth Factors, V7, P139, DOI 10.3109/08977199209046403
   Kawasaki H, 1998, LANGMUIR, V14, P773, DOI 10.1021/la970886t
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   Kirsch T, 2000, NAT STRUCT BIOL, V7, P492
   Kirsch T, 2000, FEBS LETT, V468, P215, DOI 10.1016/S0014-5793(00)01214-X
   KORENBROT JI, 1987, ANAL BIOCHEM, V161, P187, DOI 10.1016/0003-2697(87)90671-3
   Kwon GS, 1999, PHARMACEUT RES, V16, P597, DOI 10.1023/A:1011991617857
   Matsukata M, 1996, BIOCONJUGATE CHEM, V7, P96, DOI 10.1021/bc950082u
   MIRON T, 1982, ANAL BIOCHEM, V126, P433, DOI 10.1016/0003-2697(82)90540-1
   POLLAK A, 1980, J AM CHEM SOC, V102, P6324, DOI 10.1021/ja00540a026
   Qiu X.P., 1998, POLYMER, V39, P1749
   RINGSDORF H, 1991, MACROMOLECULES, V24, P1678, DOI 10.1021/ma00007a034
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590
   Shah SS, 1997, J CONTROL RELEASE, V45, P95, DOI 10.1016/S0168-3659(96)01550-7
   Shimizu S, 1996, ARTIF ORGANS, V20, P1232
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Tong Z, 1999, MACROMOLECULES, V32, P4488, DOI 10.1021/ma990062d
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2000, J APPL POLYM SCI, V75, P583, DOI 10.1002/(SICI)1097-4628(20000124)75:4<583::AID-APP15>3.0.CO;2-L
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   ULUDAG H, 2000, DRUG DELIVERY 21ST C, P253
   Wang XH, 1999, MACROMOLECULES, V32, P4299, DOI 10.1021/ma9902450
   Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345
   Winn SR, 1999, J BONE MINER RES, V14, P1721, DOI 10.1359/jbmr.1999.14.10.1721
   WINNIK FM, 1990, MACROMOLECULES, V23, P233, DOI 10.1021/ma00203a040
   WU C, 1995, MACROMOLECULES, V28, P8381, DOI 10.1021/ma00128a056
NR 41
TC 51
Z9 55
U1 0
U2 14
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JUN 20
PY 2001
VL 73
IS 6
BP 510
EP 521
DI 10.1002/bit.1086
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 436NC
UT WOS:000168941100010
PM 11344456
DA 2018-10-19
ER

PT J
AU Lee, CH
   Singla, A
   Lee, Y
AF Lee, CH
   Singla, A
   Lee, Y
TI Biomedical applications of collagen
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Review
DE collagen; biomaterial; drug/protein/gene delivery; tissue engineering
ID DRUG-DELIVERY SYSTEM; CROSS-LINKED COLLAGEN; BIOPROSTHETIC HEART-VALVES;
   CULTURED SKIN SUBSTITUTES; SOLID LIPID NANOPARTICLES; FIBROBLAST
   GROWTH-FACTOR; RECOMBINANT HUMAN BMP-2; SOFT CONTACT-LENSES; IN-VITRO;
   CORNEAL SHIELDS
AB Collagen is regarded as one of the most useful biomaterials. The excellent biocompatibility and safety due to its biological characteristics. such as biodegradability and weak antigenecity, made collagen the primary resource in medical applications. The main applications of collagen as drug delivery systems are collagen shields in ophthalmology, sponges for burns/wounds, mini-pellets and tablets for protein delivery, gel formulation in combination with liposomes for sustained drug delivery, as controlling material for transdermal delivery, and nanoparticles for gene delivery and basic matrices for cell culture systems. wt was also used for tissue engineering including skin replacement, bone substitutes, and artificial blood vessels and valves. This article reviews biomedical applications of collagen including the collagen film, which we have developed as a matrix system fur evaluation of tissue calcification and for the embedding of a single cell suspension for tumorigenic study. The advantages and disadvantages of each system are also discussed. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Missouri, Coll Pharm, Dept Pharmaceut, Kansas City, MO 64110 USA.
   Univ Missouri, Sch Interdisciplinary Comp & Engn, Kansas City, MO 64110 USA.
RP Lee, CH (reprint author), Univ Missouri, Coll Pharm, Dept Pharmaceut, 5005 Rockhill Rd Katz Bdg 108, Kansas City, MO 64110 USA.
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696
   ALHENDY A, 1995, HUM GENE THER, V6, P165, DOI 10.1089/hum.1995.6.2-165
   Angella GJ, 2000, INVEST OPHTH VIS SCI, V41, P4158
   AQUAVELLA JV, 1988, J CATARACT REFR SURG, V14, P492, DOI 10.1016/S0886-3350(88)80004-X
   ASSIL KK, 1992, AM J OPHTHALMOL, V113, P418, DOI 10.1016/S0002-9394(14)76165-3
   Auger FA, 1998, MED BIOL ENG COMPUT, V36, P801, DOI 10.1007/BF02518887
   Bank RA, 2000, ARTHRITIS RHEUM-US, V43, P2202, DOI 10.1002/1529-0131(200010)43:10<2202::AID-ANR7>3.0.CO;2-E
   BARBANI N, 1995, J BIOMAT SCI-POLYM E, V7, P461
   BARR E, 1991, SCIENCE, V254, P1507, DOI 10.1126/science.1962212
   BAZIUK N, 1992, INT OPHTHALMOL, V16, P101, DOI 10.1007/BF00918940
   BELL E, 1983, J INVEST DERMATOL, V81, P2
   Bender AR, 1996, ANTIMICROB AGENTS CH, V40, P1467, DOI 10.1128/AAC.40.6.1467
   Bergeon M T, 1967, J Okla State Med Assoc, V60, P330
   Berthold A, 1998, EUR J PHARM BIOPHARM, V45, P23, DOI 10.1016/S0939-6411(97)00119-7
   BLOOMFIELD SE, 1978, ARCH OPHTHALMOL-CHIC, V96, P885
   BOYCE ST, 1993, ANTIMICROB AGENTS CH, V37, P1890, DOI 10.1128/AAC.37.9.1890
   BOYCE ST, 1992, J BIOMED MATER RES, V26, P547, DOI 10.1002/jbm.820260410
   BOYCE ST, 1988, J BIOMED MATER RES, V22, P939, DOI 10.1002/jbm.820221008
   BOYCE ST, 1995, ANN SURG, V222, P743, DOI 10.1097/00000658-199512000-00008
   Boyce ST, 1998, MED BIOL ENG COMPUT, V36, P791, DOI 10.1007/BF02518886
   BRADLEY WG, 1977, BIOMATER ARTIF CELL, V5, P159, DOI 10.3109/10731197709118671
   BRAUKER J, 1995, J CELL BIOCH B, V21, pD1
   BROWDER IW, 1986, AM SURGEON, V52, P492
   BURGE RE, 1964, P NATO ADV STUDY GRO, P2
   CAMERON WJ, 1978, OBSTET GYNECOL, V51, P118
   CARROLL RE, 1989, J HAND SURG-BRIT EUR, V14B, P218, DOI 10.1016/0266-7681(89)90131-9
   CASCONE MG, 1995, BIOMATERIALS, V16, P569, DOI 10.1016/0142-9612(95)91131-H
   CHEN JM, 1995, J BIOMOL STRUCT DYN, V12, P1129, DOI 10.1080/07391102.1995.10508804
   CHEN YF, 1990, AM J OPHTHALMOL, V109, P132, DOI 10.1016/S0002-9394(14)75976-8
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   CHVAPIL M, 1993, J BIOMED MATER RES, V27, P313, DOI 10.1002/jbm.820270305
   CHVAPIL M, 1985, AM J OBSTET GYNECOL, V151, P325, DOI 10.1016/0002-9378(85)90296-0
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cochran DI, 2000, J PERIODONTOL, V71, P1241, DOI 10.1902/jop.2000.71.8.1241
   Coester CJ, 2000, J MICROENCAPSUL, V17, P187
   DANIELSEN CC, 1990, BIOCHEM J, V272, P697, DOI 10.1042/bj2720697
   DEATHERAGE JR, 1987, COLLAGEN REL RES, V7, P225
   Desgrandchamps F, 2000, Curr Opin Urol, V10, P201, DOI 10.1097/00042307-200005000-00003
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DORIGO MT, 1995, CHEMOTHERAPY, V41, P1, DOI 10.1159/000239317
   DORR RT, 1982, J BIOMED MATER RES, V16, P839, DOI 10.1002/jbm.820160609
   ELSAMALIGY MS, 1983, J PHARM PHARMACOL, V35, P537, DOI 10.1111/j.2042-7158.1983.tb04831.x
   Farrugia CA, 1999, J PHARM PHARMACOL, V51, P643, DOI 10.1211/0022357991772925
   FELL JT, 1970, J PHARM SCI, V59, P688, DOI 10.1002/jps.2600590523
   FERKOL T, 1993, J CLIN INVEST, V92, P2394, DOI 10.1172/JCI116845
   FINKELSTEIN I, 1991, CAN J OPHTHALMOL, V26, P129
   Fonseca MJ, 1996, BBA-BIOMEMBRANES, V1279, P259
   FRIEDBERG ML, 1991, OPHTHALMOLOGY, V98, P725
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fujioka K, 1998, ADV DRUG DELIVER REV, V31, P247, DOI 10.1016/S0169-409X(97)00119-1
   FUJIOKA K, 1995, J CONTROL RELEASE, V33, P307, DOI 10.1016/0168-3659(94)00107-6
   GEBHARDT BM, 1995, J OCUL PHARMACOL TH, V11, P319, DOI 10.1089/jop.1995.11.319
   Geesin JC, 1996, J BIOMED MATER RES, V33, P1
   Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652
   GLOECKNER DC, 2000, BIOMATERIALS, V52, P365
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   Grammer JB, 1996, CURR EYE RES, V15, P815, DOI 10.3109/02713689609017622
   GROSS J., 1963, COMP BIOCHEM, V5, P307
   GUSSLER JR, 1990, J CATARACT REFR SURG, V16, P719, DOI 10.1016/S0886-3350(13)81013-9
   HARKNESS RD, 1966, SCI PROGRESS-UK, V54, P257
   HARKNESS RD, 1961, BIOL REV, V36, P399, DOI 10.1111/j.1469-185X.1961.tb01596.x
   Harriger MD, 1997, J BIOMED MATER RES, V35, P137, DOI 10.1002/(SICI)1097-4636(199705)35:2<137::AID-JBM1>3.0.CO;2-O
   HARRIS PT, 1989, CORAL REEFS, V8, P97
   HEARTLEIN MW, 1994, P NATL ACAD SCI USA, V91, P10967, DOI 10.1073/pnas.91.23.10967
   HOBDEN JA, 1988, ARCH OPHTHALMOL-CHIC, V106, P1605, DOI 10.1001/archopht.1988.01060140773053
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   HWANG DG, 1989, ARCH OPHTHALMOL-CHIC, V107, P1375, DOI 10.1001/archopht.1989.01070020445052
   Jerome A., 1992, BIOMATERIALS, V9, P137
   JEYANTHI R, 1991, J PHARM PHARMACOL, V43, P60, DOI 10.1111/j.2042-7158.1991.tb05453.x
   JEYANTHI R, 1990, BIOMATERIALS, V11, P238, DOI 10.1016/0142-9612(90)90004-A
   Katsube K, 2000, ARCH ORTHOP TRAUM SU, V120, P121, DOI 10.1007/PL00021232
   KAUFMAN HE, 1994, J OCUL PHARMACOL, V10, P17, DOI 10.1089/jop.1994.10.17
   KAUFMAN HE, 1988, J CATARACT REFR SURG, V14, P487, DOI 10.1016/S0886-3350(88)80002-6
   Kemp PD, 2000, METH MOL B, V139, P287
   KIMURA M, 2000, J PLAST RECONSTR SUR, V34, P289
   Kobayashi Y, 2000, Hinyokika Kiyo, V46, P869
   Kohmura E, 1999, BRAIN RES, V849, P235, DOI 10.1016/S0006-8993(99)02163-0
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Kuwano M, 1997, J OCUL PHARMACOL TH, V13, P31, DOI 10.1089/jop.1997.13.31
   KUZUYA M, 1994, EXP CELL RES, V215, P310, DOI 10.1006/excr.1994.1347
   Lam PK, 1999, ANN PLAS SURG, V43, P523, DOI 10.1097/00000637-199911000-00010
   LEADERS F E, 1973, Annals of Ophthalmology, V5, P513
   Lee CH, 1998, J BIOMED MATER RES, V42, P30, DOI 10.1002/(SICI)1097-4636(199810)42:1<30::AID-JBM5>3.0.CO;2-P
   LEE VHL, 1990, J OCUL PHARMACOL, V6, P157, DOI 10.1089/jop.1990.6.157
   LEFEBVRE F, 1992, BIOMATERIALS, V13, P28, DOI 10.1016/0142-9612(92)90091-2
   Lefebvre F, 1996, BIOMATERIALS, V17, P1813, DOI 10.1016/0142-9612(95)00346-0
   LEIPZIGER LS, 1985, J AM ACAD DERMATOL, V12, P409, DOI 10.1016/S0190-9622(85)80004-9
   LIANG FQ, 1992, INVEST OPHTH VIS SCI, V33, P2194
   LIU HW, 1993, HUM GENE THER, V4, P291, DOI 10.1089/hum.1993.4.3-291
   LUCAS PA, 1989, J BIOMED MATER RES-A, V23, P23, DOI 10.1002/jbm.820231306
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   MARKS MG, 1991, J BIOMED MATER RES, V25, P683, DOI 10.1002/jbm.820250510
   MARMER RH, 1988, J CATARACT REFR SURG, V14, P496, DOI 10.1016/S0886-3350(88)80005-1
   MARTY JJ, 1978, PHARM ACTA HELV, V53, P17
   MATINCHOULY CA, 1999, INVEST RADIOL, V34, P663
   Matsuoka J, 1988, T AM SOC ART INT ORG, V34, P729
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   Meaney D F, 1995, Clin Podiatr Med Surg, V12, P363
   Mendicute Javier, 1995, CLAO Journal, V21, P252
   MILANI JK, 1993, AM J OPHTHALMOL, V116, P622, DOI 10.1016/S0002-9394(14)73206-4
   MILLER JM, 1964, ARCH SURG-CHICAGO, V88, P167, DOI 10.1001/archsurg.1964.01310200005002
   MINABE M, 1989, J PERIODONTOL, V60, P113, DOI 10.1902/jop.1989.60.2.113
   MINABE M, 1989, J PERIODONTOL, V60, P552, DOI 10.1902/jop.1989.60.10.552
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   MIYATA T, 1971, BIOCHIM BIOPHYS ACTA, V229, P672, DOI 10.1016/0005-2795(71)90283-2
   MONDINO BJ, 1991, AM J OPHTHALMOL, V112, P587, DOI 10.1016/S0002-9394(14)76863-1
   MOULLIER P, 1993, NAT GENET, V4, P154, DOI 10.1038/ng0693-154
   MOULLIER P, 1995, NAT MED, V1, P353, DOI 10.1038/nm0495-353
   MOULLIER P, 1993, TRANSPLANTATION, V56, P427, DOI 10.1097/00007890-199308000-00034
   Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4
   Mullins RJ, 1996, AUST NZ J OPHTHALMOL, V24, P257, DOI 10.1111/j.1442-9071.1996.tb01589.x
   Muniruzzaman M, 1998, J BIOMAT SCI-POLYM E, V9, P459, DOI 10.1163/156856298X00569
   Murata M, 1999, INT J ORAL MAX SURG, V28, P232, DOI 10.1034/j.1399-0020.1999.283280316.x
   Murata M, 2000, CLIN ORAL IMPLAN RES, V11, P289, DOI 10.1034/j.1600-0501.2000.011004289.x
   MURRAY TG, 1990, ARCH OPHTHALMOL-CHIC, V108, P104, DOI 10.1001/archopht.1990.01070030110039
   Nakagawa T, 2000, ORAL DIS, V6, P172
   NARAZAKI H, 1994, INT J APPROX REASON, V11, P1, DOI 10.1016/0888-613X(94)90017-5
   NICHOLAS FL, 1997, BIOMATERIALS, V18, P815
   NIMNI ME, 1988, COLLAGEN, V1, P1
   Nimni ME, 1988, COLLAGEN, VIII, P1
   OBRIEN TP, 1988, J CATARACT REFR SURG, V14, P505, DOI 10.1016/S0886-3350(88)80007-5
   Ochiya T, 1999, NAT MED, V5, P707
   Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038
   Pachence JM, 1987, MED DEVICE DIAGN IND, V9, P49
   PAJEAN M, 1993, INT J PHARM, V91, P209, DOI 10.1016/0378-5173(93)90340-L
   PALMER RM, 1995, J CATARACT REFR SURG, V21, P125, DOI 10.1016/S0886-3350(13)80497-X
   Park JC, 2000, J BIOMED MATER RES, V52, P669, DOI 10.1002/1097-4636(20001215)52:4<669::AID-JBM11>3.3.CO;2-L
   PENG YM, 1986, INVEST NEW DRUG, V4, P245
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   PHINNEY RB, 1988, ARCH OPHTHALMOL-CHIC, V106, P1599, DOI 10.1001/archopht.1988.01060140767052
   PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1
   PLEYER U, 1994, CURR EYE RES, V13, P177, DOI 10.3109/02713689408995775
   PODOS SM, 1972, AM J OPHTHALMOL, V73, P336, DOI 10.1016/0002-9394(72)90062-1
   POLAND DE, 1988, J CATARACT REFR SURG, V14, P489, DOI 10.1016/S0886-3350(88)80003-8
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Prajapati RT, 2000, WOUND REPAIR REGEN, V8, P226, DOI 10.1046/j.1524-475x.2000.00226.x
   RAMACHANDRAN GN, 1965, BIOCHIM BIOPHYS ACTA, V109, P314, DOI 10.1016/0926-6585(65)90119-6
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   RAO KP, 1992, J MEMBRANE SCI, V71, P161, DOI 10.1016/0376-7388(92)85015-B
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   REIDY JJ, 1990, CORNEA, V9, P196
   REMACLE M, 1995, ANN OTO RHINOL LARYN, V104, P437, DOI 10.1177/000348949510400604
   ROBIN JB, 1990, INVEST OPHTH VIS SCI, V31, P1294
   Rosenthal FM, 1997, ANTICANCER RES, V17, P1179
   ROSSLER B, 1995, J MICROENCAPSUL, V12, P49, DOI 10.3109/02652049509051126
   ROSSLER B, 1994, PHARMAZIE, V49, P175
   ROYCE PM, 1995, J DERMATOL SCI, V10, P42, DOI 10.1016/0923-1811(95)93713-B
   RUBIN AL, 1973, J CLIN PHARMACOL, V13, P309, DOI 10.1002/j.1552-4604.1973.tb00217.x
   RUDERMAN RJ, 1973, J BIOMED MATER RES, V7, P263, DOI 10.1002/jbm.820070213
   Sahai A., 1995, Pharmaceutical Research (New York), V12, pS227
   Samuel CS, 1998, J ENDOCRINOL, V159, P117, DOI 10.1677/joe.0.1590117
   SASTRY TP, 1991, COMPREHENSIVE GUIDE, P171
   Sato H, 1996, PHARMACEUT RES, V13, P1565, DOI 10.1023/A:1016096016642
   SAWUSCH MR, 1988, AM J OPHTHALMOL, V106, P279, DOI 10.1016/0002-9394(88)90361-3
   SAWUSCH MR, 1988, J CATARACT REFR SURG, V14, P625
   SCHARFMANN R, 1991, P NATL ACAD SCI USA, V88, P4626, DOI 10.1073/pnas.88.11.4626
   SCHOEN FJ, 1992, J THORAC CARDIOV SUR, V104, P1285
   SCHWARTZ SD, 1990, AM J OPHTHALMOL, V109, P701, DOI 10.1016/S0002-9394(14)72439-0
   Sekine T, 2001, J BIOMED MATER RES, V54, P305, DOI 10.1002/1097-4636(200102)54:2<305::AID-JBM18>3.0.CO;2-B
   Sela J, 2000, INFLAMM RES, V49, P679, DOI 10.1007/s000110050646
   SHAKER GJ, 1989, INVEST OPHTH VIS SCI, V30, P1565
   SHANTHA KL, 1993, J BIOACT COMPAT POL, V8, P142, DOI 10.1177/088391159300800204
   SHORTLIFFE LMD, 1989, J UROLOGY, V141, P538
   SOBOLEWSKI K, 1995, ACTA BIOCHIM POL, V42, P301
   Stemberger A, 1997, EUR J SURG, V163, P17
   STENZEL KH, 1969, SCIENCE, V164, P1282, DOI 10.1126/science.164.3885.1282
   STOMPRO BE, 1989, J SURG RES, V46, P413, DOI 10.1016/0022-4804(89)90153-4
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Supp AP, 1999, WOUND REPAIR REGEN, V7, P226, DOI 10.1046/j.1524-475X.1999.00226.x
   Suzuki S, 2000, BRIT J PLAST SURG, V53, P659, DOI 10.1054/bjps.2000.3426
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250
   TAKENAKA H, 1986, PHARM TECH JAPAN, V2, P1083
   TANI K, 1989, BLOOD, V74, P1274
   Taravella MJ, 1999, J CATARACT REFR SURG, V25, P562, DOI 10.1016/S0886-3350(99)80056-X
   Thacharodi D, 1996, BIOMATERIALS, V17, P1307, DOI 10.1016/0142-9612(96)88676-5
   Timpl R, 1984, EXTRACELLULAR MATRIX, P159
   Trasciatti S, 1998, BIOMATERIALS, V19, P897, DOI 10.1016/S0142-9612(97)00175-0
   Traub W, 1971, ADV PROTEIN CHEM, V25, P245
   TU R, 1993, J BIOMED MATER RES, V27, P3, DOI 10.1002/jbm.820270103
   Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K
   Uitterlinden AG, 2001, J BONE MINER RES, V16, P379, DOI 10.1359/jbmr.2001.16.2.379
   Ulrich U, 2001, ARCH GYNECOL OBSTET, V264, P186, DOI 10.1007/s004040000105
   UNTERMAN SR, 1988, J CATARACT REFR SURG, V14, P500, DOI 10.1016/S0886-3350(88)80006-3
   VANDERLAAN JS, 1991, INT J ARTIF ORGANS, V14, P661
   Vaneerdeweg W, 1998, EUR J SURG, V164, P617
   Vaneerdeweg W, 2000, EUR J SURG, V166, P959
   Vardaxis NJ, 1996, BIOMATERIALS, V17, P1489, DOI 10.1016/0142-9612(96)89773-0
   WacholDrewek Z, 1996, BIOMATERIALS, V17, P1733, DOI 10.1016/0142-9612(96)87654-X
   Wada T, 1999, CIRC RES, V84, P166, DOI 10.1161/01.RES.84.2.166
   WALTMAN SR, 1970, INVEST OPHTH VISUAL, V9, P250
   WANG CL, 1978, BIOCHIM BIOPHYS ACTA, V544, P555, DOI 10.1016/0304-4165(78)90330-6
   WEBSTER RC, 1984, ARCH OTOLARYNGOL, V110, P652
   WEDGE CI, 1992, CAN J OPHTHALMOL, V27, P295
   WEINER AL, 1985, J PHARM SCI, V74, P922, DOI 10.1002/jps.2600740903
   WILLEY DE, 1991, CURR EYE RES, V10, P167, DOI 10.3109/02713689109020374
   Woolley D. E., 1984, EXTRACELLULAR MATRIX, P119
   Yamada N, 1999, SCAND J PLAST RECONS, V33, P147
   YAMAHIRA Y, 1991, Patent No. 841123136
   Yang SC, 1999, J CONTROL RELEASE, V59, P299, DOI 10.1016/S0168-3659(99)00007-3
   YANNAS IV, 1990, ANGEW CHEM INT EDIT, V29, P20, DOI 10.1002/anie.199000201
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
NR 202
TC 969
Z9 1045
U1 25
U2 460
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARM
JI Int. J. Pharm.
PD JUN 19
PY 2001
VL 221
IS 1-2
BP 1
EP 22
DI 10.1016/S0378-5173(01)00691-3
PG 22
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 443XJ
UT WOS:000169368300001
PM 11397563
DA 2018-10-19
ER

PT J
AU Rizzi, SC
   Heath, DT
   Coombes, AGA
   Bock, N
   Textor, M
   Downes, S
AF Rizzi, SC
   Heath, DT
   Coombes, AGA
   Bock, N
   Textor, M
   Downes, S
TI Biodegradable polymer/hydroxyapatite composites: Surface analysis and
   initial attachment of human osteoblasts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hydroxyapatite; biodegradable polymers; ESEM; human osteoblasts; bone
ID HUMAN BONE; POLYMERS; BIOCOMPATIBILITY; HYDROXYAPATITE; PROLIFERATION;
   DEGRADATION; CHEMISTRY; MATRICES; INVITRO; CELLS
AB Biodegradable polymer/hydroxyapatite (HA) composites have potential application as bone graft substitutes. Thin films of polymer/HA composites were produced, and the initial attachment of Primary human osteoblasts (HOBs) was assessed to investigate the biocompatibility of the materials. Poly(epsilon -caprolactone) (PCL) and poly(L-lactic acid) (PLA) were used as matrix materials for two types of HA particles, 50-mum sintered and submicron nonsintered. Using ESEM, cell morphology on the surfaces of samples was investigated after 90 min, 4 h, and 24 h of cell culture. Cell activity and viability were assessed after 24 h of cell culture using Alamar blue and DNA assays. Surface morphology of the polymer/HA composites and HA exposure were investigated using ESEM and EDXA, respectively. ESEM enabled investigation of both cell and material surface morphology in the hydrated condition. Combined with EDXA it permitted chemical and visual examination of the composite. Differences in HA exposure were observed on the different composite surfaces that affected the morphology of attached cells. In the first Ih of cell culture, the cells were spread to a higher degree on exposed HA regions of the composites and on PLA than they were on PCL. After 24 h the cells were spread equally on all the samples. The cell activity after 22 h was significantly higher on the polymer/ HA composites than on the polymer films. There was no significant difference in the activity of the cells on the various composite materials. However, cells on PCL showed higher activity compared to those on PLA. A polymer surface exhibiting "point exposure" of HA appeared to provide a novel and favorable substrate for primary cell attachment. The cell morphology and activity results indicate a favorable cell/material interaction and suggest that PLA and PCL and their composites with HA may be candidate materials for the reconstruction of bony tissue. Further investigations regarding long-term biomaterial/cell interactions and the effects of acidic degradation products from the biodegradable polymers are required to confirm their utility. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Zurich, Inst Biomed Engn, CH-8044 Zurich, Switzerland.
   Univ Nottingham Hosp, Sch Biomed Sci, Sch Med, Queens Med Ctr, Nottingham NG7 2UH, England.
   ETH Zurich, Inst Biomed Engn, CH-8044 Zurich, Switzerland.
   Univ Nottingham Hosp, Sch Engn Mat & Manag, Nottingham NG7 2UH, England.
   ETH, Lab Surface Anal& Technol, Zurich, Switzerland.
   Smith & Nephew Grp Res Ctr, York Sci Pk, York YO1 5DD, N Yorkshire, England.
RP Rizzi, SC (reprint author), Univ Zurich, Inst Biomed Engn, Moussonstr 18, CH-8044 Zurich, Switzerland.
RI Textor, Marcus/A-6200-2012
OI Textor, Marcus/0000-0002-0178-1801
CR Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   ATTAWIA MA, 1995, BIOCHEM BIOPH RES CO, V213, P639, DOI 10.1006/bbrc.1995.2179
   BENICEWICZ BC, 1991, J BIOACT COMPAT POL, V6, P64, DOI 10.1177/088391159100600106
   BLOTTIERE HM, 1995, BIOMATERIALS, V16, P497, DOI 10.1016/0142-9612(95)98824-X
   BONFIGLIO M, 1972, CLIN ORTHOP RELAT R, P19
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Coombes A. G. A., 1994, Clinical Materials, V17, P35, DOI 10.1016/0267-6605(94)90046-9
   Coombes AGA, 1998, BIOMATERIALS, V19, P1073, DOI 10.1016/S0142-9612(98)00035-0
   Corden TJ, 2000, BIOMATERIALS, V21, P713, DOI 10.1016/S0142-9612(99)00236-7
   DEBOER HH, 1988, CLIN ORTHOP RELAT R, P292
   DISILVIO L, 1995, THESIS U LONDON UK
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   FEWSTER SD, 1994, NANOBIOLOGY, V3, P201
   GURAV N, 1997, THESIS U LONDON UK
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   HUANG J, 1997, BIOCERAMICS, V10, P519
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Kikuchi M., 1997, BIOCERAMICS, V10, P407
   KIRKPATRICK CJ, 1992, ADV BIOMAT, V10, P31
   LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806
   MALIK MA, 1992, BIOMATERIALS, V13, P123, DOI 10.1016/0142-9612(92)90008-C
   Mayer U., 1993, CELLS MAT, V3, P129
   MUSTER D, 1990, BIOMATERIALS, V11, P57
   Piattelli A, 1997, BIOMATERIALS, V18, P629, DOI 10.1016/S0142-9612(96)00163-9
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   Reis RL, 1997, BIOCERAMICS, V10, P415
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   Wintermantel E, 1996, BIOKOMPATIBLE WERKST
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 34
TC 219
Z9 228
U1 5
U2 55
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2001
VL 55
IS 4
BP 475
EP 486
DI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 423VZ
UT WOS:000168199600005
PM 11288075
DA 2018-10-19
ER

PT J
AU Tomazic-Jezic, VJ
   Merritt, K
   Umbreit, TH
AF Tomazic-Jezic, VJ
   Merritt, K
   Umbreit, TH
TI Significance of the type and the size of biomaterial particles on
   phagocytosis and tissue distribution
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterials; particles; tissue distribution; histology; immune
   responses
ID MACROPHAGES IN-VITRO; BONE-RESORPTION; POLYMETHYLMETHACRYLATE PARTICLES;
   STIMULATED MACROPHAGES; INFLAMMATORY RESPONSE; PARTICULATE DEBRIS;
   SURFACE-AREA; RECRUITMENT; OSTEOBLASTS; EXPOSURE
AB Particulates generated by dissolution or wear of injected or implanted biomaterials may migrate into various tissues and lead to activation of the host's inflammatory and immune responses. The purpose of this study was to evaluate the relevance of size and chemical composition of biomaterial particles on the pattern of particle distribution in host tissues. Adult female B6C3F1 mice were injected intraperitoneally with polymethylmethacrylate (PMMA) particles (size 1.4 and 6.4 mu in diameter) and polystyrene (PS) particles (size 1.2, 5.2, and 12.5 mu in diameter), and euthanized 1, 7 and 28 days later. Peritoneal exudate cells (PECs) were collected and the number of cells and percentage of actively phagocytic cells was determined. Macroscopic examination of the tissues in the peritoneal cavity peritoneum revealed visible accumulations of the colored PS particles in the adipose tissues adjacent to the spleen and pancreas, and caudal to the stomach. Distribution of the FS particles appeared similar regardless of the particle size. The location of PMMA particles, which were not colored, could not be distinguished from host tissue and could not be observed in this manner. Intensive phagocytosis of the small and medium sized particles by peritoneal macrophages was observed on day 1, and was diminishing by day 7 after injection. The largest PS particles (12.5 CL) were not engulfed bp the peritoneal macrophages. Histological examination of the spleen, lymph nodes, and the adjacent adipose tissues revealed a marked difference in the deposition patterns of the two polymers used. PS particles, regardless of size, were accumulated primarily in the white adipose tissues adjacent to the spleen and pancreas gland, but very few particles were observed in the splenic tissue. On the other hand, mice injected with PMMA particles of either size had enlarged and activated spleens with marked deposits of particles in the red pulp. These results indicate that these PS and PMMA particles induce different patterns and intensities of the host response. The chemical makeup of the particle is more important in the distribution pattern than is the size of the particle. (C) 2001 John Wiley & Sons, Inc.
C1 Food & Drug Admin, Ctr Devices & Radiol Hlth, Div Life Sci, Rockville, MD 20852 USA.
RP Tomazic-Jezic, VJ (reprint author), Food & Drug Admin, Ctr Devices & Radiol Hlth, Div Life Sci, HFZ-112,12709 Twinbrook Pkwy, Rockville, MD 20852 USA.
CR Algan SM, 1996, J ORTHOPAED RES, V14, P30, DOI 10.1002/jor.1100140107
   DAVIS RG, 1993, J BIOMED MATER RES, V27, P1039, DOI 10.1002/jbm.820270809
   FRONDOZA CG, 1993, J BIOMED MATER RES, V27, P611, DOI 10.1002/jbm.820270508
   GELB H, 1994, J ORTHOP RES, V12, P83, DOI 10.1002/jor.1100120111
   GLANT TT, 1994, J ORTHOPAED RES, V12, P720, DOI 10.1002/jor.1100120515
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Gonzalez O, 1996, J BIOMED MATER RES, V30, P463, DOI 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.3.CO;2-I
   Hitchins VM, 1999, J BIOMED MATER RES, V46, P434
   HITCHINS VM, 1999, T SOC BIOMATER, V22, P128
   HOROWITZ SM, 1991, J ORTHOPAED RES, V9, P406, DOI 10.1002/jor.1100090313
   HOROWITZ SM, 1995, J BIOMED MATER RES, V29, P477, DOI 10.1002/jbm.820290407
   HOROWITZ SM, 1995, CALCIFIED TISSUE INT, V57, P301, DOI 10.1007/BF00298886
   HOROWITZ SM, 1994, CALCIFIED TISSUE INT, V54, P320, DOI 10.1007/BF00295957
   ISHIMI Y, 1990, J IMMUNOL, V145, P3297
   KLEIN DC, 1970, ENDOCRINOLOGY, V86, P1436, DOI 10.1210/endo-86-6-1436
   LAZARUS MD, 1994, J ORTHOPAED RES, V12, P532, DOI 10.1002/jor.1100120410
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   PAPATHEOFANIS FJ, 1991, J BIOMED MATER RES, V25, P761, DOI 10.1002/jbm.820250606
   POLLICE PF, 1995, J ORTHOPAED RES, V13, P325, DOI 10.1002/jor.1100130305
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   THOMSON BM, 1987, J IMMUNOL, V138, P775
NR 21
TC 55
Z9 57
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2001
VL 55
IS 4
BP 523
EP 529
DI 10.1002/1097-4636(20010615)55:4<523::AID-JBM1045>3.0.CO;2-G
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 423VZ
UT WOS:000168199600010
PM 11288080
DA 2018-10-19
ER

PT J
AU Lee, DH
   Park, JC
   Suh, H
AF Lee, DH
   Park, JC
   Suh, H
TI Synergistic induction of cyclooxygenase-II by bacterial
   lipopolysaccharide in combination with particles of medical device
   materials in a murine macrophage cell medical device line J774A.1
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterials; cyclooxygenase-II; synergistic; inflammation; macrophage;
   J774A1; arachidonic acid; prostaglandin
ID RECEPTOR-MEDIATED PHAGOCYTOSIS; ARACHIDONIC-ACID; PROSTAGLANDIN;
   INHIBITION; RELEASE; GAMMA; DRUGS
AB Corrosion and wear of implanted medical devices may produce particulate debris, leading to acute and chronic inflammatory responses in the host. In the presence of biomaterial wear particles, host monocytes/macrophages are activated to synthesize or secrete mediators of inflammation. In order to understand the mechanisms underlying the host response to particulates and device-associated infections, we have focused on the effects of medical device particles on macrophage function, because these cells play a pivotal role in the body's response to foreign bodies and their interaction with other cellular components of the immune system. In order to evaluate the effects of particles of medical device materials on functional activities of macrophages, we developed a cyclooxygenase-II (COX-II) assay system using J774A.1 macrophages. Constitutive cyclooxygenase (COX-I) is present in cells under physiological conditions, whereas inducible COX-II is induced by some cytokines, mitogens, and endotoxin, presumably in pathological conditions such as inflammation. We have evaluated the inductive effects of implant materials, i.e., particles of poly-methylmethacrylate (PMMA), hydroxyapatite (HA), titanium oxide, and silica, on the activity of COX-II using thin layer chromatography of prostaglandin D, (PGD,) formed from [1-C-14]-labeled arachidonic acid (AA). Also, we have assessed the synergistic effects of these particles on lipopolysaccharide (LPS)-mediated macrophage activation. Addition of LPS to these particles increased PGD, production severalfold greater than the addition of any inducer alone. Our results indicated that device-associated infections could enhance inflammatory responses to the wear particles in subjects with medical implants or in whom particulate biomaterials are used for clinical purposes. The use of this model COX-II assay system may lead to the identification of inflammatory potentials for implant materials more specifically than present in vivo assays. (C) 2001 John Wiley & Sons, Inc. T Biomed Mater Res 55: 547-553, 2001.
C1 Yonsei Univ, Coll Med, Dept Med Engn, Seodaemun Ku, Seoul 120752, South Korea.
RP Suh, H (reprint author), Yonsei Univ, Coll Med, Dept Med Engn, Seodaemun Ku, 134 Shinchon Dong, Seoul 120752, South Korea.
CR Anderson James M., 1996, P165
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANTHONY AG, 1996, BIOMATERIALS SCI, P205
   ARIAS NS, 1995, BIOCHEM BIOPH RES CO, V17, P582
   CHAPEKAR MS, 1996, J BIOMED MATER RES, V31, P151
   CHRISTENSEN GD, 1985, PRINCIPLES PRACTICE, P6
   DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.iy.02.040184.002003
   ESTENSEN RD, 1974, NATURE, V248, P347, DOI 10.1038/248347a0
   FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035
   GOLDSTEIN IM, 1992, INFLAMMATION BASIC P, P1127
   HERSCHMAN HR, 1993, J LIPID MEDIATOR, V6, P89
   HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384
   Hukkanen M, 1997, J BONE JOINT SURG BR, V79B, P467, DOI 10.1302/0301-620X.79B3.7469
   IMAMICHI T, 1991, MOL IMMUNOL, V28, P359
   Lee DH, 1997, NAT PROD SCI, V3, P19
   LEE DH, 1999, BIOMATER RES, V3, P112
   LENNARTZ MR, 1991, J IMMUNOL, V147, P621
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARMOR L, 1978, SURGERY, V83, P291
   MOHR C, 1992, AM J RESP CELL MOL, V6, P390, DOI 10.1165/ajrcmb/6.4.390
   OBAYASHI T, 1985, CLIN CHIM ACTA, V149, P55, DOI 10.1016/0009-8981(85)90273-6
   OSULLIVAN MG, 1992, BIOCHEM BIOPH RES CO, V187, P1123, DOI 10.1016/0006-291X(92)91313-F
   Prabhu A, 1998, J BIOMED MATER RES, V42, P655, DOI 10.1002/(SICI)1097-4636(19981215)42:4<655::AID-JBM23>3.3.CO;2-2
   RAAHAVE D, 1976, ACTA ORTHOP SCAND, V47, P28, DOI 10.3109/17453677608998968
   SCHLONDORFF D, 1993, KIDNEY INT, V44, P643, DOI 10.1038/ki.1993.293
   SCHWACHA MG, 1993, J IMMUNOL, V150, P236
   SHAYNE CG, 1997, SAFETY EVALUATION ME, P117
   SMITH WL, 1994, CURR OPIN INVEST DR, V3, P1
   Song YT, 1999, J MED CHEM, V42, P1151, DOI 10.1021/jm9805081
   VANDEROUDERAA FJ, 1977, BIOCHIM BIOPHYS ACTA, V487, P315, DOI 10.1016/0005-2760(77)90008-X
   VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0
   WHITTLE BJR, 1980, NATURE, V284, P271, DOI 10.1038/284271a0
NR 32
TC 13
Z9 13
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2001
VL 55
IS 4
BP 547
EP 553
DI 10.1002/1097-4636(20010615)55:4<547::AID-JBM1048>3.0.CO;2-Y
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 423VZ
UT WOS:000168199600013
PM 11288083
DA 2018-10-19
ER

PT J
AU Lindfors, NC
   Klockars, M
AF Lindfors, NC
   Klockars, M
TI Immunoglobulin enhances the bioactive-glass-induced chemiluminescence
   response of human polymorphonuclear leukocytes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bioactive glass; polymorphonuclear leukocyte; chemiluminescence;
   immunoglobulin; albumin
ID MONOSODIUM URATE CRYSTALS; IN-VIVO; NEUTROPHILS; SURFACE; GENERATION;
   SERUM
AB Bioactive glasses are bone substitutes that chemically bind to bone. Implanted materials always elicit a response from surrounding tissues and thereby can activate inflammatory cells, with subsequent release of biomaterial and tissue-damaging agents. Bioactive glasses call activate polymorphonuclear leukocytes (PMNL) and induce a release of reactive oxygen metabolites (ROM). Adsorption of proteins on the surface of the implanted material may influence the subsequent inflammatory cell response. The effect of Sandoglobulin (R) (SG) and albumin on the ROM release by PMNLs induced by a bioactive glass M as studied by a chemiluminescence (CL) assay. An enhanced effect for SG and inhibitory effect for albumin on the CL response of PMNLs was observable. The CL response of the PMNLs was dependent on the incubation time of the glass in solution. (C) 2001 John Wiley & Sons, Inc. J Biomed Mater Res 55: 613-617, 2001.
RP Lindfors, NC (reprint author), Missnebacken 9 02, Espoo 02180, Finland.
CR ABRAMSON S, 1982, ARTHRITIS RHEUM, V25, P174, DOI 10.1002/art.1780250210
   ANDERSSON OH, 1990, J NON-CRYST SOLIDS, V119, P290, DOI 10.1016/0022-3093(90)90301-2
   BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205
   BRINK M, BIOCERAMICS, V8, P471
   DENKO CW, 1979, J RHEUMATOL, V6, P117
   DIEPPE PA, 1976, LANCET, V7, P266
   GATTI AM, 1993, CELL MATER, V3, P283
   HASSELBACHER P, 1978, ARTHRITIS RHEUM, V21, P353, DOI 10.1002/art.1780210311
   HEDENBORG M, 1998, INT ARCH OCC ENV HEA, V61, P1
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   Hench L.L., 1973, J BIOMED MATER RES S, V4, P25
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HIGSON FK, 1984, J RHEUMATOL, V11, P735
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   KLOCKARS M, 1992, CLIN EXP IMMUNOL, V90, P68
   KOZIN F, 1979, J RHEUMATOL, V6, P519
   Lindfors NC, 1999, J BIOMED MATER RES, V47, P91, DOI 10.1002/(SICI)1097-4636(199910)47:1<91::AID-JBM13>3.0.CO;2-F
   LINDFORS NC, BIOCERAMICS, V8, P107
   NAGASE M, 1989, J RHEUMATOL, V16, P971
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   PLATT P, 1983, ANN RHEUM DIS, V42, P111, DOI 10.1136/ard.42.Suppl_1.111
   SACHS T, 1978, J CLIN INVEST, P1161
   SCHUMACHER HR, 1977, ANN INTERN MED, V87, P411, DOI 10.7326/0003-4819-87-4-411
   TERKELTAUB R, 1983, ARTHRITIS RHEUM, V26, P775, DOI 10.1002/art.1780260612
   TERKELTAUB RA, 1988, ARTHRITIS RHEUM, V31, P1081, DOI 10.1002/art.1780310901
   VALLYATHAN V, 1988, AM REV RESPIR DIS, V138, P1213, DOI 10.1164/ajrccm/138.5.1213
   WELSS SJ, 1986, ACTA PHYSL SCAND, V548, P9
   WITZMAN SA, 1990, BLOOD, V76, P663
NR 29
TC 1
Z9 1
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2001
VL 55
IS 4
BP 613
EP 617
DI 10.1002/1097-4636(20010615)55:4<613::AID-JBM1055>3.0.CO;2-H
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 423VZ
UT WOS:000168199600020
PM 11288090
DA 2018-10-19
ER

PT J
AU Brodbeck, WG
   Shive, MS
   Colton, E
   Nakayama, Y
   Matsuda, T
   Anderson, JM
AF Brodbeck, WG
   Shive, MS
   Colton, E
   Nakayama, Y
   Matsuda, T
   Anderson, JM
TI Influence of biomaterial surface chemistry on the apoptosis of adherent
   cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE apoptosis; biocompatibility; foreign-body giant cells; IL-4; macrophages
ID MULTINUCLEATED GIANT-CELLS; MACROPHAGES; ADHESION; INVITRO; MONOCYTES;
   CRACKING; INVIVO; DEATH; FORM
AB A common component of the foreign-body response to implanted materials is the presence of adherent macrophages that fuse to form foreign-body giant cells (FBGCs). These multinucleated cells have been shown to concentrate the phagocytic and degradative properties of macrophages at the implant surface and are responsible for the damage and failure of the implant. Therefore, the modulation of the presence or actions of macrophages and FBGCs at the material-tissue interface is an extensive area of recent investigations. A possible mechanism to achieve this is through the induction of the apoptosis of adherent macrophages, which results in no inflammatory consequence. We hypothesize that the induction of the apoptosis of biomaterial adherent cells can be influenced by the chemistry of the surface of adhesion. Herein, we demonstrate that Surfaces displaying hydrophilic and anionic chemistries induce apoytosis of adherent macrophages at a higher magnitude than hydrophobic or cationic surfaces. Additionally, the level of apoptosis for a given surface is inversely related to that surface's ability to promote the fusion of macrophages into FBGCs. This suggests that macrophages fuse into FBGCs to escape apoptosis. (C) 2001 John Wiley & Sons, Inc.
C1 Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   Kyushu Univ, Dept Biomed Engn, Fukuoka 812, Japan.
   Natl Cardiovasc Ctr, Dept Bioengn, Osaka, Japan.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
FU NIGMS NIH HHS [GM-20380]; NHLBI NIH HHS [HL-55714]
CR ANDERSON JM, 1996, IMPLANT RETRIEVAL EV, P451
   Collier TO, 2000, J BIOMED MATER RES, V49, P141, DOI 10.1002/(SICI)1097-4636(200001)49:1<141::AID-JBM18>3.0.CO;2-A
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   ENELOW RI, 1992, J INFECT DIS, V166, P664, DOI 10.1093/infdis/166.3.664
   FESUS L, 1993, FEBS LETT, V328, P1, DOI 10.1016/0014-5793(93)80952-Q
   Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3
   GORCZEYOA W, 1993, LEUKEMIA, V14, P659
   HASSAN NF, 1989, J IMMUNOL, V143, P2179
   Huppertz B, 1999, ANAT EMBRYOL, V200, P1, DOI 10.1007/s004290050254
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   KREIPE H, 1988, AM J PATHOL, V130, P232
   MAJNO G, 1995, AM J PATHOL, V146, P3
   MANAGAN DF, 1991, J IMMUNOL, V147, P3408
   MANAGAN DF, 1991, J IMMUNOL, V146, P1541
   MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0
   SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303
   WEINBERG JB, 1984, P NATL ACAD SCI USA, V81, P454
   WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 25
TC 127
Z9 132
U1 3
U2 26
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2001
VL 55
IS 4
BP 661
EP 668
DI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 423VZ
UT WOS:000168199600026
PM 11288096
DA 2018-10-19
ER

PT J
AU Yang, JM
   Lin, HT
AF Yang, JM
   Lin, HT
TI Wettability and protein adsorption on HTPB-based polyurethane films
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE hydroxyl-terminated polybutadiene; polyurethane; dimethyol propionic
   acid; wettability; protein adsorption
ID SBS-G-VP; DMAEMA COPOLYMER MEMBRANE; BIOMATERIAL USAGE; UV-RADIATION;
   HEPARIN
AB Hydroxyl-terminated polybutadiene-based (HTPB) polyurethane (PU) with different molar ratios of dimethyol propionic acid and 1,4-butane diol as the chain extender was synthesized by solution polymerization. The present PU was then cast into a membrane and subsequently characterized by the Fourier transform infrared spectroscopy. It was found that the participation of carbonyl group in hydrogen bonding increased with the content of dimethyol propionic acid in PU. The properties of the PU films including tensile strength and dynamic mechanical analysis (DMA) were studied. The tensile strength of PU films increased whereas the storage modulus decreased with increasing dimethyol propionic acid content. The glass transition temperature (T-g) Of the PU film with only 1,4-butane diol as the chain extender was 4 degreesC, while that of the films with dimethyol propionic acid as the chain extender was at about -15 degreesC. Wettability and protein adsorption on the films were evaluated from the water content, contact angle, and protein adsorptions of fibrinogen and albumin on the PU films. The diffusion coefficient of water in the membrane was determined in accordance with the Fickian diffusion mechanism. No significant difference in the diffusion coefficient was observed for all the specimens. By using the Kaelble's equation and the contact angle data, the surface tensions of the PU films with different amounts of dimethyol propionic acid were determined. The surface tension of PU film was found to increase with increasing dimethyol propionic acid content, while the opposite trend was observed for the contact angle and the amount of protein adsorption. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
CR Abusafieh A, 1997, J APPL POLYM SCI, V63, P75, DOI 10.1002/(SICI)1097-4628(19970103)63:1<75::AID-APP8>3.0.CO;2-P
   ADAMSON AW, 1990, PHYSICAL CHEM SURFAC
   ANDRADE JD, 1985, SURFACE CHEM PHYSICS, V1
   COLEMAN MM, 1988, MACROMOLECULES, V21, P59, DOI 10.1021/ma00179a014
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   LAI JY, 1991, J APPL POLYM SCI, V43, P1431, DOI 10.1002/app.1991.070430804
   LEE YM, 1994, POLYMER, V35, P1095, DOI 10.1016/0032-3861(94)90958-X
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   MINOURA N, 1993, BIOMEDICAL APPL POLY, P118
   Ratner BD, 1996, BIOMATERIALS SCI, P133
   SEYMOUR RW, 1970, MACROMOLECULES, V3, P579, DOI 10.1021/ma60017a021
   TAKAHARA A, 1990, Artificial Organs, V14, P87
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   Yang JM, 2001, J MEMBRANE SCI, V183, P37, DOI 10.1016/S0376-7388(00)00550-0
NR 21
TC 37
Z9 37
U1 3
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD JUN 15
PY 2001
VL 187
IS 1-2
BP 159
EP 169
DI 10.1016/S0376-7388(01)00340-4
PG 11
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 435JY
UT WOS:000168879400017
DA 2018-10-19
ER

PT J
AU Gourlay, T
   Stefanou, DC
   Asimakopoulos, G
   Taylor, KM
AF Gourlay, T
   Stefanou, DC
   Asimakopoulos, G
   Taylor, KM
TI The effect of circuit surface area on CD11b(mac-1) expression in a rat
   recirculation model
SO ARTIFICIAL ORGANS
LA English
DT Article
DE inflammatory response; cardiopulmonary bypass; miniaturized
   cardiopulmonary bypass circuits
ID CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; LEUKOCYTE; COMPLEMENT;
   ACTIVATION; ADHESION
AB The aim of the study was to assess the effect of exposed surface area of diethylhexylphthalate plasticized polyvinylchloride (PVC) on the expression of the adhesion molecule CD11b(mac-1) on neutrophils and to determine whether there is any apparent advantage in the current trend in reducing circuit surface area in terms of neutrophil activation. The study was carried out using a parallel plate rodent recirculation biomaterial testing model on 4 groups of 10 adult male Sprague Dawley rats weighing between 350 and 450 g. One group comprised the control group in which there was no biomaterial exposure. In the remaining 3 groups, the animals were subjected to either high (48 cm(2)), intermediate (24 cm(2)), or low (12 cm(2)) biomaterial surface area exposure. The parallel plate test cell was connected to the right femoral circulation and recirculation initiated at a flow rate of 1.5 ml/min for a period of 60 min. Blood samples were taken at 0, 30, and 60 min for the assessment of CD11b expression. Cd11b was assessed using flow cytometric analysis on neutrophils. The results demonstrated that there was a surface area related effect in the upregulation of CD11b. The difference at the terminal sample point between the highest surface area group (293.95 +/- 18.57%) and the low surface area group (133.80 +/- 49.31%) was highly statistically significant (p < 0.001). These results demonstrate that there may be some gain in terms of reduced inflammatory response from reducing the exposed surface area of PVC in extracorporeal perfusion circuits.
C1 Natl Heart & Lung Inst, Imperial Coll Med Sch, Hammersmith Hosp, Dept Cardiac Surg, London W12 0NN, England.
RP Gourlay, T (reprint author), Natl Heart & Lung Inst, Imperial Coll Med Sch, Hammersmith Hosp, Dept Cardiac Surg, 2nd Floor B Block,DuCane Rd, London W12 0NN, England.
CR Asimakopoulos G, 1998, ANN THORAC SURG, V66, P2135, DOI 10.1016/S0003-4975(98)00727-9
   Asimakopoulos G, 2000, ANN THORAC SURG, V69, P1192, DOI 10.1016/S0003-4975(99)01553-2
   Asimakopoulos G, 1999, PERFUSION-UK, V14, P269, DOI 10.1177/026765919901400406
   BONE RC, 1992, CRIT CARE MED, V20, P864
   BUTLER J, 1993, ANN THORAC SURG, V55, P552, DOI 10.1016/0003-4975(93)91048-R
   Darling E, 1998, J Extra Corpor Technol, V30, P184
   GAKINANES M, 1996, CIRCULATION, V94, P364
   HILL GE, 1994, ANAESTH ANALG, V79, P1201
   LEDEIST F, 1995, CIRCULATION, V92, P354, DOI 10.1161/01.CIR.92.9.354
   MATHEW JP, 1995, J THORAC CARDIOV SUR, V109, P448, DOI 10.1016/S0022-5223(95)70275-X
   Moen O, 1997, ANN THORAC SURG, V63, P105
   TAGGART DP, 1994, ANN THORAC SURG, V57, P376, DOI 10.1016/0003-4975(94)91000-6
   Taketani S, 1998, ARTIF ORGANS, V22, P337, DOI 10.1046/j.1525-1594.1998.06007.x
NR 13
TC 16
Z9 16
U1 0
U2 0
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD JUN
PY 2001
VL 25
IS 6
BP 475
EP 479
DI 10.1046/j.1525-1594.2001.025006475.x
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 452RT
UT WOS:000169873100009
PM 11453878
DA 2018-10-19
ER

PT J
AU van Luyn, MJA
   Plantinga, JA
   Brouwer, LA
   Khouw, IMSL
   de Leij, LFMH
   van Wachem, PB
AF van Luyn, MJA
   Plantinga, JA
   Brouwer, LA
   Khouw, IMSL
   de Leij, LFMH
   van Wachem, PB
TI Repetitive subcutaneous implantation of different types of
   (biodegradable) biomaterials alters the foreign body reaction
SO BIOMATERIALS
LA English
DT Article
DE biomaterials; repetitive implantation; plasma cells
ID DERMAL SHEEP COLLAGEN; INFLAMMATORY RESPONSES; MACROPHAGE;
   BIOCOMPATIBILITY; HETEROGENEITY; SUBSETS; RATS
AB In the present study two biodegradable materials (cross-linked collagens) and two non-biodegradable materials (polyurethane and silicone) were applied in a repetitive subcutaneous implantation model in rats. In contrast to the first challenge, the second challenge with the same type of material, but at a different subcutaneous site of the same animal, induced an increase of macrophages and giant cells inside the biodegradable materials. Additionally, only after the second challenge clusters and accumulations of plasma cells were present in the surrounding tissue of each type of material. Tn the same areas an increase of MHC II expression was measured by immunocytochemistry. Differences in the numbers of macrophages and T cells were not observed around the explants. Undifferentiated B cells or NK cells were not present at any time point. The results indicate that alterations observed after the second challenge did not depend on biodegradation of the materials. Significance of these Endings should be considered in view of increased and repetitive use of the same type of biomaterial (possibly for different application sites) for implantation in patients. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Groningen, Fac Med Sci, Dept Pathol & Lab Med, NL-9713 GZ Groningen, Netherlands.
RP van Luyn, MJA (reprint author), Univ Groningen, Fac Med Sci, Dept Pathol & Lab Med, Hanzepl 1,Entrance 25, NL-9713 GZ Groningen, Netherlands.
CR ANDERSON JM, 1988, ASAIO, V11, P101
   Bar-Or RL, 1998, J THEOR BIOL, V190, P161
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DIJKSTRA CD, 1993, PROG HISTOCHEM CYTOC, V27, P1
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   HOWIE DW, 1988, J BONE JOINT SURG AM, V70A, P257, DOI 10.2106/00004623-198870020-00015
   HUNIG T, 1989, J EXP MED, V169, P73, DOI 10.1084/jem.169.1.73
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Khouw IMSL, 2000, J BIOMED MATER RES, V49, P297, DOI 10.1002/(SICI)1097-4636(20000305)49:3<297::AID-JBM1>3.0.CO;2-0
   McClelland M, 1997, PLAST RECONSTR SURG, V100, P1466, DOI 10.1097/00006534-199711000-00014
   Moghimi SM, 1997, CLIN SCI, V93, P371, DOI 10.1042/cs0930371
   Naoum C, 1998, DERMATOL SURG, V24, P867, DOI 10.1111/j.1524-4725.1998.tb04264.x
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   VANGULIK TM, 1987, NETH J SURG, V39, P90
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
NR 17
TC 9
Z9 10
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2001
VL 22
IS 11
BP 1385
EP 1391
DI 10.1016/S0142-9612(00)00295-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 425ZU
UT WOS:000168325200022
PM 11336312
DA 2018-10-19
ER

PT J
AU ten Koppel, PGJ
   van Osch, GJVM
   Verwoerd, CDA
   Verwoerd-Verhoef, HL
AF ten Koppel, PGJ
   van Osch, GJVM
   Verwoerd, CDA
   Verwoerd-Verhoef, HL
TI A new in vivo model for testing cartilage grafts and biomaterials: the
   'rabbit pinna punch-hole' model
SO BIOMATERIALS
LA English
DT Article
DE cartilage graft; tissue engineering; demineralized bone matrix;
   perichondrium; animal model
ID TISSUE-ENGINEERED CARTILAGE; TRABECULAR DEMINERALIZED BONE; IN-VIVO;
   PERICHONDRIUM; CHONDROCYTES; SURGERY; RECONSTRUCTION; CYANOACRYLATE;
   REGENERATION; COLLAGEN
AB In this study an animal model was developed for evaluation of the feasibility of cartilage grafts. In the cartilage of the external ear of the rabbit multiple holes, 6 mm in diameter, were punched, leaving the adherent skin intact. Different experimental groups were evaluated. First, the punch-hole model was validated under various conditions to study spontaneous or perichondrial initiated regeneration of the cartilage defect. When both cartilage and perichondrium was excised no spontaneous repair of the cartilage defect was observed. When perichondrium is present, variable patch-like closure of the punch hole was found. As 'golden standard' a punched out piece of cartilage was reimplanted directly. This condition showed adequate closure of the punch hole, however, no perfect integration of graft and surrounding cartilage was observed. Secondly, to evaluate the 'punch-hole model' a biomaterial, trabecular demineralized bovine bone matrix (DBM), was implanted and tested as a scaffold for tissue engineering techniques in vivo and in vitro. Direct implantation of DBM did not lead to any cartilage formation to close the defect. In vivo engineered cartilage, generated by enveloping DBM in perichondrium for 3 weeks, could adequately close the punch hole. When DBM was seeded with isolated chondrocytes in vitro before implantation in the defect, a highly fragmented graft, with some islets of viable cells was seen. To promote an efficient and reliable evaluation of cartilage grafts a semi-quantitative grading system was developed. Items such as quality, quantity and integrity of the cartilage graft were included in a histomorphological grading system to provide information about the properties of a specific cartilage graft. To validate the grading system, all conditions were scored by two independent observers. An excellent reliability (R = 0.96) was seen between the observers. In summary, the rabbit pinna punch-hole model is a reliable and efficient method for first evaluation of cartilage grafts. The results can be easily analyzed using a semi-quantitative grading system. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Erasmus Univ, Ctr Med, Dept Otorhinolaryngol Head & Neck Surg, NL-3000 DR Rotterdam, Netherlands.
RP van Osch, GJVM (reprint author), Erasmus Univ, Ctr Med, Dept Otorhinolaryngol Head & Neck Surg, Room EE1659,POB 1738, NL-3000 DR Rotterdam, Netherlands.
CR AGUADO DL, 1992, ACTA OTO-LARYNGOL, V112, P539, DOI 10.3109/00016489209137437
   Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   BEAN JK, 1993, INT J PEDIATR OTORHI, V25, P163, DOI 10.1016/0165-5876(93)90050-D
   BEAN JK, 1991, CHONDROGENESIS COLLA, P113
   Brown PN, 1996, ARCH OTOLARYNGOL, V122, P873
   BUJIA J, 1994, LARYNGO RHINO OTOL, V73, P577, DOI 10.1055/s-2007-997199
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   DUNCAN MJ, 1984, PLAST RECONSTR SURG, V73, P916, DOI 10.1097/00006534-198406000-00010
   EISEMANN ML, 1983, ARCH OTOLARYNGOL, V109, P469
   ENGKVIST O, 1979, SCAND J PLAST RECONS, V13, P275, DOI 10.3109/02844317909013070
   Haisch A, 1996, HNO, V44, P624, DOI 10.1007/s001060050067
   HARPER MC, 1988, CLIN ORTHOP RELAT R, P272
   HOMMINGA GN, 1989, ACTA ORTHOP SCAND, V60, P326, DOI 10.3109/17453678909149287
   JEFFRIES DJR, 1984, J LARYNGOL OTOL, V98, P577, DOI 10.1017/S0022215100147139
   JOSEPH J, 1966, BRIT J SURG, V53, P372, DOI 10.1002/bjs.1800530415
   Jurgensen K, 1997, J BONE JOINT SURG AM, V79A, P185, DOI 10.2106/00004623-199702000-00004
   MADSEN K, 1983, DEV BIOL, V96, P63, DOI 10.1016/0012-1606(83)90311-1
   MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009
   Marijnissen WJCM, 2000, BIOMATERIALS, V21, P571, DOI 10.1016/S0142-9612(99)00218-5
   MATSUDA K, 1995, J BIOMAT SCI-POLYM E, V7, P221
   MEEUWIS J, 1993, ACTA OTO-LARYNGOL, V113, P379, DOI 10.3109/00016489309135829
   NEHRER S, 1997, BIOMATERIALS, V18, P797
   ODRISCOLL SW, 1986, J BONE JOINT SURG AM, V68A, P1017, DOI 10.2106/00004623-198668070-00008
   Ostergaard K, 1997, ARTHRITIS RHEUM, V40, P1766, DOI 10.1002/art.1780401007
   PETRUSON B, 1986, Rhinology (Utrecht), V24, P147
   PUELACHER WC, 1994, BIOMATERIALS, V15, P774, DOI 10.1016/0142-9612(94)90031-0
   QUATELA VC, 1993, LARYNGOSCOPE, V103, P798
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   SKOOG T, 1972, SCAND J PLAST RECONS, V6, P123, DOI 10.3109/02844317209036711
   STAFFEL G, 1995, OTOLARYNG CLIN N AM, V28, P295
   ten Koppel PGJ, 1998, PLAST RECONSTR SURG, V102, P2012, DOI 10.1097/00006534-199811000-00031
   Urist MR, 1997, PLAST RECONSTR SURG, V99, P1382, DOI 10.1097/00006534-199704001-00028
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VACANTI CA, 1994, J PEDIATR SURG, V29, P201, DOI 10.1016/0022-3468(94)90318-2
   van Osch GJVM, 1999, BIOMATERIALS, V20, P233, DOI 10.1016/S0142-9612(98)00165-3
NR 35
TC 11
Z9 11
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2001
VL 22
IS 11
BP 1407
EP 1414
DI 10.1016/S0142-9612(00)00298-2
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 425ZU
UT WOS:000168325200025
PM 11336315
DA 2018-10-19
ER

PT J
AU Dillow, AK
   Ochsenhirt, SE
   McCarthy, JB
   Fields, GB
   Tirrell, M
AF Dillow, AK
   Ochsenhirt, SE
   McCarthy, JB
   Fields, GB
   Tirrell, M
TI Adhesion of alpha(5)beta(1) receptors to biomimetic substrates
   constructed from peptide amphiphiles
SO BIOMATERIALS
LA English
DT Article
DE biomimetic materials; peptides; surface modification; RGD; adhesion
ID FIBRONECTIN; ACTIVATION; ATTACHMENT; BINDING; CELLS; RGD; RECOGNITION;
   BIOMATERIAL; SEQUENCE; SURFACES
AB Biomimetic membrane surfaces functionalized with Fragments of the extracellular matrix protein, fibronectin, are constructed from mixtures of peptide and polyethylene glycol(PEG) amphiphiles. Peptides from the primary binding loop, GRGDSP, were used in conjunction with the synergy site peptide, PHSRN, in the III9-10 sites of human fibronectin. These peptides were attached to dialkyl lipid tails to form peptide amphiphiles. PEG amphiphiles were mixed in the layer to minimize non-specific adhesion in the background. GRGDSP acid PEG amphiphiles or GRGDSP, PHSRN- and PEG amphiphiles were mixed in various ratios and deposited on solid substrates from the air-water interface using Langmuir-Blodgett techniques. In this method, peptide composition, density, and presentation could be controlled accurately. The effectiveness of these substrates to mimic native fibronectin is evaluated by their ability to generate adhesive forces when they are in contact with purified activated alpha (5)beta (1) integrin receptors that are immobilized on an opposing surface. Adhesion is measured using a contact mechanical approach (JKR experiment). The effects of membrane composition, density, temperature, and peptide conformation on adhesion to activated integrins in this simulated cell adhesion setup were determined. Addition of the synergy site, PHSRN, was found to increase adhesion of alpha (5)beta (1) to biomimetic substrates markedly. Increased peptide mobility (due to increased experimental temperature) increased integrin adhesion markedly at low peptide concentrations. A balance between peptide density and steric accessibility of the receptor binding race to alpha (5)beta (1), integrin was required for highest adhesion. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA.
   Univ Minnesota, Dept Pathol & Lab Med, Minneapolis, MN 55455 USA.
   Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA.
RP Tirrell, M (reprint author), Univ Calif Santa Barbara, Coll Engn, Santa Barbara, CA 93106 USA.
FU NHLBI NIH HHS [HL62427-01]
CR Baneres JL, 1998, J BIOL CHEM, V273, P24744, DOI 10.1074/jbc.273.38.24744
   BARERRA DA, 1993, J AM CHEM SOC, V115, P11010
   BERNDT P, 1995, J AM CHEM SOC, V117, P9515, DOI 10.1021/ja00142a019
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Davison E, 1997, J VIROL, V71, P6204
   DERUELLE M, 1995, MACROMOLECULES, V28, P7419, DOI 10.1021/ma00126a021
   Dillow AK, 1998, CURR OPIN SOLID ST M, V3, P252, DOI 10.1016/S1359-0286(98)80099-5
   DILLOW AK, 2001, UNPUB BIOPHYS J
   Dori Y, 2000, J BIOMED MATER RES, V50, P75, DOI 10.1002/(SICI)1097-4636(200004)50:1<75::AID-JBM11>3.0.CO;2-A
   Faull RJ, 1996, J BIOL CHEM, V271, P25099, DOI 10.1074/jbc.271.41.25099
   FAULL RJ, 1995, STEM CELLS, V13, P38, DOI 10.1002/stem.5530130106
   Garcia AJ, 1998, J BIOL CHEM, V273, P34710, DOI 10.1074/jbc.273.52.34710
   Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988
   Glass JR, 1996, BIOMATERIALS, V17, P1101, DOI 10.1016/0142-9612(96)85911-4
   Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159
   Griffith LG, 1998, BIOMATERIALS, V19, P979, DOI 10.1016/S0142-9612(97)00185-3
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hocking DC, 1998, J CELL BIOL, V141, P241, DOI 10.1083/jcb.141.1.241
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Humphries MJ, 1999, BIOCHEM SOC SYMP, V65, P63
   Johansson Staffan, 1997, Frontiers in Bioscience (online), V2, pD126
   JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141
   KUGO K, 1994, J BIOMAT SCI-POLYM E, V5, P325, DOI 10.1163/156856294X00059
   Lahiri J, 1999, LANGMUIR, V15, P2055, DOI 10.1021/la9811970
   Lasic D. D., 1995, STEALTH LIPOSOMES
   Mangipudi VS, 1998, RUBBER CHEM TECHNOL, V71, P407, DOI 10.5254/1.3538490
   MANNGIPUDI VS, 1996, MACROMOL S, V102, P131
   Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283
   Mould AP, 1998, BIOCHEM J, V331, P821, DOI 10.1042/bj3310821
   OCHSENHIRT SE, 2001, UNPUB
   OCHSENHIRT SE, 1999, UNPUB
   Pakalns T, 1999, BIOMATERIALS, V20, P2265, DOI 10.1016/S0142-9612(99)00157-X
   Porte-Durrieu MC, 1999, J BIOMED MATER RES, V46, P368
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Winger TM, 1996, BIOMATERIALS, V17, P437, DOI 10.1016/0142-9612(96)89661-X
   Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
NR 40
TC 56
Z9 60
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2001
VL 22
IS 12
BP 1493
EP 1505
DI 10.1016/S0142-9612(00)00304-5
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 431MD
UT WOS:000168634300006
PM 11374448
DA 2018-10-19
ER

PT J
AU Peng, Q
   Apple, DJ
   Arthur, SN
   Merritt, JH
   Escobar-Gomez, M
   Hoddinott, DSM
AF Peng, Q
   Apple, DJ
   Arthur, SN
   Merritt, JH
   Escobar-Gomez, M
   Hoddinott, DSM
TI Snowflake opacification of poly(methyl methacrylate) intraocular lens
   optic biomaterial: A newly described syndrome
SO INTERNATIONAL OPHTHALMOLOGY CLINICS
LA English
DT Article
ID GLISTENINGS; SURFACES
C1 Med Univ S Carolina, Dept Ophthalmol, Storm Eye Inst, Ctr Res Ocular Therapeut & Biodevices, Charleston, SC 29425 USA.
RP Peng, Q (reprint author), Med Univ S Carolina, Dept Ophthalmol, Storm Eye Inst, Ctr Res Ocular Therapeut & Biodevices, 171 Ashley Ave, Charleston, SC 29425 USA.
CR Apple DJ, 2000, J CATARACT REFR SURG, V26, P796, DOI 10.1016/S0886-3350(00)00517-4
   APPLE DJ, 1984, SURV OPHTHALMOL, V29, P1, DOI 10.1016/0039-6257(84)90113-9
   APPLE DJ, 2000, FOLDABLE INTRAOCULAR, P103
   APPLE DJ, 2001, IN PRESS AM J OPHTHA
   APPLE DJ, 1995, SURV OPHTHALMOL, V40, P279
   APPLE DJ, 1984, AM INTRA-OCUL IMPL J, V10, P53
   CHRIST FR, 1995, ENCY HDB BIOMATERIAL, P1277
   DAVIS D, 1993, OPHTHALMOLOGY TIMES, V18, P6
   DAVIS D, 1993, OCULAR NEWS, V11, P3
   Dhaliwal DK, 1996, J CATARACT REFR SURG, V22, P452, DOI 10.1016/S0886-3350(96)80041-1
   Omar O, 1998, J CATARACT REFR SURG, V24, P107, DOI 10.1016/S0886-3350(98)80082-5
   PARK JB, 1979, BIOMATERIALS INTRO, P88
   RIDLEY H, 1951, T OPHTHAL SOC UK, V71, P617
   RIDLEY NHL, 1951, ST THOMAS HOSP REPOR, V7, P12
   Sugaya H, 1999, CONTRIB NEPHROL, V125, P1
   Werner L, 2000, OPHTHALMOLOGY, V107, P2179, DOI 10.1016/S0161-6420(00)00416-4
NR 16
TC 7
Z9 8
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0020-8167
J9 INT OPHTHALMOL CLIN
JI Int. Ophthalmol. Clin.
PD SUM
PY 2001
VL 41
IS 3
BP 91
EP 107
DI 10.1097/00004397-200107000-00009
PG 17
WC Ophthalmology
SC Ophthalmology
GA 463WZ
UT WOS:000170501400007
PM 11481542
DA 2018-10-19
ER

PT J
AU Neut, D
   van de Belt, H
   Stokroos, I
   van Horn, JR
   van der Mei, HC
   Busscher, HJ
AF Neut, D
   van de Belt, H
   Stokroos, I
   van Horn, JR
   van der Mei, HC
   Busscher, HJ
TI Biomaterial-associated infection of gentamicin-loaded PMMA beads in
   orthopaedic revision surgery
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
ID HIP; REPLACEMENT
AB In two-stage orthopaedic revision surgery, high local levels of antibiotics are achieved after removal of an infected prosthesis through temporary implantation of gentamicin-loaded beads. However, despite their antibiotic release, these beads act as a biomaterial surface to which bacteria preferentially adhere, grow and potentially develop antibiotic resistance. Gentamicin-loaded beads were retrieved from 20 patients with prosthesis-related infections. Excised tissue samples were taken for routine culture, while beads were analysed in an extensive laboratory procedure. Extensive culture procedures indicated the presence of bacteria on gentamicin-loaded beads in 18 of the 20 patients involved, while 12 of these 18 patients were considered free of infection by routine culture. Nineteen of 28 bacterial strains isolated were gentamicin resistant and cultures from three patients yielded highly gentamicin-resistant sub-populations. It is concluded that routine culture of excised tissues in orthopaedic revision surgery is inadequate to ascertain full eradication of infection, especially as infecting, antibiotic-resistant bacteria preferentially adhere to and grow on gentamicin-loaded beads. Extensive examination of the bead surfaces is proposed as a more reliable indication that infection has been eradicated.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Groningen Hosp, Dept Orthopaed Surg, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen, Dept Cell Biol & Electron Microscopy, NL-9713 EZ Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR ANTTIPOIKA I, 1990, ACTA ORTHOP SCAND, V61, P163, DOI 10.3109/17453679009006513
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   HARRIS WH, 1990, NEW ENGL J MED, V323, P801, DOI 10.1056/NEJM199009203231206
   Kendall RW, 1996, CLIN ORTHOP RELAT R, P273
   LATTIMER GL, 1979, JAMA-J AM MED ASSOC, V242, P2213, DOI 10.1001/jama.242.20.2213
   SPELLER DCE, 1976, LANCET, V1, P464
   Tunney MM, 1998, ANTIMICROB AGENTS CH, V42, P3002, DOI 10.1128/AAC.42.11.3002
   van de Belt H, 1999, NAT MED, V5, P358, DOI 10.1038/7330
   von Eiff C, 1998, Z ORTHOP GRENZGEB, V136, P268, DOI 10.1055/s-2008-1054234
   WAHLIG H, 1978, J BONE JOINT SURG BR, V60, P270
NR 11
TC 135
Z9 139
U1 1
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD JUN
PY 2001
VL 47
IS 6
BP 885
EP 891
DI 10.1093/jac/47.6.885
PG 7
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 442UA
UT WOS:000169302300020
PM 11389124
OA Bronze
DA 2018-10-19
ER

PT J
AU Tsujimoto, K
   Takagi, H
   Takahashi, M
   Yamada, H
   Nakamori, S
AF Tsujimoto, K
   Takagi, H
   Takahashi, M
   Yamada, H
   Nakamori, S
TI Cryoprotective effect of the serine-rich repetitive sequence in silk
   protein sericin
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE Bombyx mori; cryoprotection; freezing tolerance; repetitive sequence;
   sericin
ID CHLORELLA-VULGARIS C-27; SACCHAROMYCES-CEREVISIAE; BOMBYX-MORI; FREEZING
   TOLERANCE; MESSENGER-RNAS; LEA PROTEINS; GENE; PROLINE; DESICCATION;
   EXPRESSION
AB The silk proteins, fibroin and sericin, are produced in the silk gland of Bombyx mori, and hydrophilic sericin envelops fibroin with successive sticky layers in the formation of a cocoon. To study the biological functions of sericin, we focused on the serine-rich sericin peptide consisting of 38 amino acids, which is a highly conserved and internally repetitive sequence of a sericin protein. The corresponding gene was chemically synthesized, and the PCR-amplified gene was ligated to oligomerize sericin peptide and fused at the amino terminus to a His-tagged and proteolytic cleavage sequence in an inducible expression vector, When the dimers of sericin peptides were overexpressed in Escherichia coli, the transformants showed a prominent increase in cell viability after freezing in medium, Further, the purified dimeric sericin peptide from E. coli was found to be effective in protecting lactate dehydrogenase from denaturation caused by freeze-thaw. Both of these protective effects against freezing stress in cells and proteins were also observed with sericin hydrolysate. These results indicate that this unique sericin peptide, like sericin, has a high cryoprotective activity and will be valuable as a new biomaterial for industrial use.
C1 Fukui Prefectural Univ, Dept Biosci, Matsuoka, Fukui 9101195, Japan.
   Seiren Co Ltd, Dept Technol, Fukui 9188560, Japan.
RP Takagi, H (reprint author), Fukui Prefectural Univ, Dept Biosci, 4-1-1 Kenjojima, Matsuoka, Fukui 9101195, Japan.
CR DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962
   DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-19-00999.x
   GALAU GA, 1986, PLANT MOL BIOL, V7, P155, DOI 10.1007/BF00021327
   GAMO T, 1982, BIOCHEM GENET, V20, P165, DOI 10.1007/BF00484944
   GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9
   Garel A, 1997, INSECT BIOCHEM MOLEC, V27, P469, DOI 10.1016/S0965-1748(97)00022-2
   Goller K, 1999, J MOL CATAL B-ENZYM, V7, P37, DOI 10.1016/S1381-1177(99)00043-0
   GRIFFITHS JB, 1978, CRYOBIOLOGY, V15, P517, DOI 10.1016/0011-2240(78)90073-1
   HINSON DL, 1988, BIOTECHNIQUES, V6, P14
   Honjoh K, 1999, J PLANT PHYSIOL, V155, P509, DOI 10.1016/S0176-1617(99)80046-7
   Honjoh K, 2000, BIOSCI BIOTECH BIOCH, V64, P1656, DOI 10.1271/bbb.64.1656
   Imai R, 1996, GENE, V170, P243, DOI 10.1016/0378-1119(95)00868-3
   JOH T, 1995, PLANT CELL PHYSIOL, V36, P85
   Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145
   Komatsu K., 1985, P 7 INT WOOL TEXT RE, V1, P373
   MAKER JC, 1988, PLANT MOL BIOL, V11, P277
   MAZUR P, 1977, CRYOBIOLOGY, V14, P251, DOI 10.1016/0011-2240(77)90175-4
   Meijer PJ, 1996, PROTEIN ENG, V9, P1051, DOI 10.1093/protein/9.11.1051
   MICHAILLE JJ, 1990, GENE, V86, P177, DOI 10.1016/0378-1119(90)90277-X
   MICHAILLE JJ, 1986, BIOCHIMIE, V68, P1165, DOI 10.1016/S0300-9084(86)80060-8
   OKAMOTO H, 1982, J BIOL CHEM, V257, P5192
   Prudhomme J.C., 1985, COMPREHENSIVE INSECT, V10, P571
   RUDOLPH AS, 1985, CRYOBIOLOGY, V22, P367, DOI 10.1016/0011-2240(85)90184-1
   Sambrook J, 1989, MOL CLONING LAB MANU
   Shima J, 1999, APPL ENVIRON MICROB, V65, P2841
   Swire-Clark GA, 1999, PLANT MOL BIOL, V39, P117, DOI 10.1023/A:1006106906345
   Takagi H, 1997, APPL MICROBIOL BIOT, V47, P405, DOI 10.1007/s002530050948
   Takagi H, 2000, FEMS MICROBIOL LETT, V184, P103, DOI 10.1016/S0378-1097(00)00023-9
   TAMIYA T, 1985, CRYOBIOLOGY, V22, P446, DOI 10.1016/0011-2240(85)90156-7
   VANDIJCK P, 1995, APPL ENVIRON MICROB, V61, P109
   Zhang L, 2000, J BIOCHEM, V127, P611, DOI 10.1093/oxfordjournals.jbchem.a022648
NR 31
TC 47
Z9 51
U1 0
U2 15
PU JAPANESE BIOCHEMICAL SOC
PI TOKYO
PA ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN
SN 0021-924X
J9 J BIOCHEM-TOKYO
JI J. Biochem. (Tokyo)
PD JUN
PY 2001
VL 129
IS 6
BP 979
EP 986
DI 10.1093/oxfordjournals.jbchem.a002946
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 440LM
UT WOS:000169176800018
PM 11388915
DA 2018-10-19
ER

PT J
AU Koike, M
   Fujii, H
AF Koike, M
   Fujii, H
TI In vitro assessment of corrosive properties of titanium as a biomaterial
SO JOURNAL OF ORAL REHABILITATION
LA English
DT Article
DE biocompatibility; organic acid; titanium
ID METAL-ION RELEASE; HUMAN TISSUES; SENSITIVITY; DEPOSITION; TI-6A1-4V;
   IMPLANTS; INVITRO
AB Titanium (Ti) is thought to be a highly biocompatible material, and its clinical applications are becoming increasingly frequent. However, there have recently been some clinical papers reporting hypersensitivity and allergic reactions to Ti. The purpose of this study was to assess the corrosive properties of Ti in the intra-oral environment in vitro. Cast pure Ti specimens were immersed in artificial saliva, physiological saline solution, and 128 mmol L-1 of lactic, formic and acetic acids for 3 weeks at 37 degreesC with shaking. The colour, weight, surface morphologies and chemical binding state of specimens were observed before and after immersion. Marked discoloration was recognized on the surface of specimens immersed in formic acid, and a significant difference was found between the immersion solutions. Weight changes also varied with solutions; a tendency to increase in formic acid and to decrease in lactic acid. A slight loss was observed in specimens immersed in lactic acid and artificial saliva. The oxide layer composed mainly of Ti-oxide on the surface of the immersed specimens was thinnest in lactic acid, and thickest in formic acid. The present study indicates that both hydrogen evolution type and oxygen diffusion type corrosion on Ti surfaces are possible in the living body. (Our results also confirm some clinical studies reporting Ti accumulation in surrounding tissues and Ti causing allergic reactions.)
C1 Nagasaki Univ, Sch Dent, Dept Removable Prosthodont, Nagasaki 8528588, Japan.
RP Koike, M (reprint author), Nagasaki Univ, Sch Dent, Dept Removable Prosthodont, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   ARAGON PJ, 1972, J BIOMED MATER RES, V6, P155, DOI 10.1002/jbm.820060304
   ASAMI K, 1993, CORROS SCI, V35, P43, DOI 10.1016/0010-938X(93)90131-Y
   BESSHO K, 1995, J BIOMED MATER RES, V29, P901, DOI 10.1002/jbm.820290716
   Bessho Kazuhisa, 1993, Clinical Materials, V14, P223, DOI 10.1016/0267-6605(93)90006-S
   BREME J, 1988, BIOMATERIALS, V9, P310, DOI 10.1016/0142-9612(88)90024-5
   BROWN SA, 1988, J BIOMED MATER RES, V22, P321, DOI 10.1002/jbm.820220406
   BRUNE D, 1982, SCAND J DENT RES, V90, P168
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   CLARK GCF, 1982, J BIOMED MATER RES, V16, P125, DOI 10.1002/jbm.820160205
   *COMM INT ECL, 1986, TECHN REP COLORIMETR, P74
   CORNELIUS L, 1981, GEIGY SCI TABLES, V1, P111
   CORNELIUS L, 1983, GEIGY SCI TABLES, V3, P107
   DAMEN JJM, 1991, J DENT RES, V70, P1346, DOI 10.1177/00220345910700100601
   DUCHEYNE P, 1984, J BIOMED MATER RES, V18, P293, DOI 10.1002/jbm.820180306
   EASTOE JE, 1968, BIOCH HDB, P907
   ERWIN K, 1970, INTRO MATH STAT PRIN
   FERGUSON AB, 1960, J BONE JOINT SURG AM, V42, P77, DOI 10.2106/00004623-196042010-00007
   GEDDES DA, 1981, FRONTIERS ORAL PHYSL, V3, P78
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   HANSSON HA, 1983, J PROSTHET DENT, V50, P108, DOI 10.1016/0022-3913(83)90175-0
   HEALY KE, 1992, J BIOMED MATER RES, V26, P319, DOI 10.1002/jbm.820260305
   HILLE GH, 1966, J MATER, V1, P373
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P1447, DOI 10.2106/00004623-199810000-00006
   Jorgenson DS, 1997, PLAST RECONSTR SURG, V99, P976, DOI 10.1097/00006534-199704000-00006
   KELLER J C, 1985, Dental Materials, V1, P41, DOI 10.1016/S0109-5641(85)80022-1
   Klinger A, 1997, J BIOMED MATER RES, V36, P387, DOI 10.1002/(SICI)1097-4636(19970905)36:3<387::AID-JBM13>3.0.CO;2-B
   Koike M., 1997, J JPN PROSTHODONT SO, V41, P675
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   LEBUGLE A, 1981, PHYS SCRIPTA, V23, P825, DOI 10.1088/0031-8949/23/5A/013
   MIMURA H, 1996, JPN J DENT MAT DEV, V15, P283
   MITCHELL D L, 1990, International Journal of Oral and Maxillofacial Implants, V5, P79
   Miyakawa O, 1995, J J DENT MAT, V14, P560
   MORAN CA, 1991, HUM PATHOL, V22, P450, DOI 10.1016/0046-8177(91)90130-H
   PETERS MS, 1984, CONTACT DERMATITIS, V11, P214, DOI 10.1111/j.1600-0536.1984.tb00986.x
   PORTE L, 1977, J LESS-COMMON MET, V56, P183, DOI 10.1016/0022-5088(77)90040-6
   QUALE JL, 1992, RADIOLOGY, V182, P855, DOI 10.1148/radiology.182.3.1535907
   RAE T, 1975, J BONE JOINT SURG BR, V57, P444
   RAE T, 1981, J BONE JOINT SURG BR, V63, P435
   RAMQVIST L, 1969, J PHYS CHEM SOLIDS, V30, P1835, DOI 10.1016/0022-3697(69)90252-2
   REDLINE S, 1986, BRIT J IND MED, V43, P652
   REVIE R W, 1969, Journal of Biomedical Materials Research, V3, P465, DOI 10.1002/jbm.820030308
   ROSENBERG A, 1993, INT J ORAL MAX SURG, V22, P185, DOI 10.1016/S0901-5027(05)80249-8
   Solar R. J., 1979, ASTM STP, V684, P161
   SPECK KM, 1980, J DENT RES, V59, P1590, DOI 10.1177/00220345800590100601
   WEINGART D, 1994, INT J ORAL MAX SURG, V23, P450, DOI 10.1016/S0901-5027(05)80045-1
NR 47
TC 25
Z9 25
U1 1
U2 14
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 0305-182X
J9 J ORAL REHABIL
JI J. Oral Rehabil.
PD JUN
PY 2001
VL 28
IS 6
BP 540
EP 548
DI 10.1046/j.1365-2842.2001.00690.x
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 445WM
UT WOS:000169481600007
PM 11422680
DA 2018-10-19
ER

PT J
AU Kyriakides, TR
   Hartzel, T
   Huynh, G
   Bornstein, P
AF Kyriakides, TR
   Hartzel, T
   Huynh, G
   Bornstein, P
TI Regulation of angiogenesis and matrix remodeling by localized,
   matrix-mediated antisense gene delivery
SO MOLECULAR THERAPY
LA English
DT Article
DE local gene therapy; gene-activated matrix; extracellular matrix;
   thrombospondin; foreign body reaction; biomaterial implants;
   angiogenesis; antisense DNA
ID ENDOTHELIAL GROWTH-FACTOR; FOREIGN-BODY REACTION; IN-VIVO; MATRICELLULAR
   PROTEINS; MICE; THROMBOSPONDIN-1; BIOMATERIALS; APOPTOSIS; COLLAGEN;
   INHIBITION
AB Implantation of biomaterials, such as glucose sensors, leads to the formation of a poorly vascularized collagenous capsule that can lead to implant failure. This process, known as the foreign body reaction (FBR), develops in response to almost all biomaterials and consists of overlapping phases similar to those in wound healing. Implantation of porous biomaterials, such as polyvinyl alcohol sponges, also leads to granuloma formation within the interstices of the sponge prior to encapsulation by the FBR. We asked whether delivery of an antisense cDNA for the potent angiogenesis inhibitor thrombospondin (TSP) 2 would enhance blood vessel formation and alter collagen fibrillogenesis in the sponge granuloma and capsule. Collagen solutions were mixed with plasmid to generate gene-activated matrices (GAMs) and applied to biomaterials that were then implanted subcutaneously. Sustained expression of plasmid-encoded proteins was observed at 2 weeks and a month following implantation. In vivo delivery of plasmids, encoding either sense or antisense TSP2 cDNA, altered blood vessel formation and collagen deposition in TSP2-null and wild-type mice, respectively. Untreated implants, implanted next to CAM-treated implants, did not show exogenous gene expression and did not elicit altered responses, suggesting that gene delivery was limited to implant sites. This method of antisense DNA delivery has the potential to improve the performance and life span of implantable delivery devices and biosensors.
C1 Univ Washington, Dept Biochem, Seattle, WA 98195 USA.
   Univ Washington, Dept Med, Seattle, WA 98195 USA.
RP Bornstein, P (reprint author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.
FU NHLBI NIH HHS [HL18645]; NIAMS NIH HHS [AR45418]
CR Andrade SP, 1997, MICROVASC RES, V54, P253, DOI 10.1006/mvre.1997.2047
   ANDRADE SP, 1992, BRIT J CANCER, V66, P821, DOI 10.1038/bjc.1992.367
   Bein K, 2000, J BIOL CHEM, V275, P32167, DOI 10.1074/jbc.M003834200
   Bonadio J, 2000, J MOL MED-JMM, V78, P303, DOI 10.1007/s001090000118
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Bornstein P, 2000, MATRIX BIOL, V19, P557, DOI 10.1016/S0945-053X(00)00104-9
   BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503
   Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Chandler LA, 2000, MOL THER, V2, P153, DOI 10.1006/mthe.2000.0102
   DAVIDSON JM, 1985, J CELL BIOL, V100, P1219, DOI 10.1083/jcb.100.4.1219
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   GOLDSTEIN SA, 1998, CLIN ORTHOPAEDICS, V355, P5154
   Guo NH, 1997, CANCER RES, V57, P1735
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Im SA, 1999, CANCER RES, V59, P895
   Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517
   Khouw IMSL, 2000, J BIOMED MATER RES, V50, P259, DOI 10.1002/(SICI)1097-4636(200005)50:2<259::AID-JBM21>3.0.CO;2-B
   Kyriakides TR, 1999, J INVEST DERMATOL, V113, P782, DOI 10.1046/j.1523-1747.1999.00755.x
   Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   Labhasetwar V, 1998, J PHARM SCI, V87, P1347, DOI 10.1021/js980077+
   Lauffenburger DA, 1999, NAT MED, V5, P733, DOI 10.1038/10451
   Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5
   Maheshwari A, 2000, MOL THER, V2, P121, DOI 10.1006/mthe.2000.0105
   MOREHEAD JM, 1994, OTOLARYNG CLIN N AM, V27, P195
   Nakashima T, 2000, HEAD NECK-J SCI SPEC, V22, P483, DOI 10.1002/1097-0347(200008)22:5<483::AID-HED7>3.3.CO;2-8
   Nor JE, 2000, J VASC RES, V37, P209, DOI 10.1159/000025733
   Ochiya T, 1999, NAT MED, V5, P707
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Werb Z, 1999, APMIS, V107, P11, DOI 10.1111/j.1699-0463.1999.tb01521.x
   WILLIAMS DF, 1989, J BIOMED ENG, V11, P185, DOI 10.1016/0141-5425(89)90138-6
   Yang ZT, 2000, MOL BIOL CELL, V11, P3353, DOI 10.1091/mbc.11.10.3353
NR 35
TC 40
Z9 42
U1 0
U2 3
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1525-0016
J9 MOL THER
JI Mol. Ther.
PD JUN
PY 2001
VL 3
IS 6
BP 842
EP 849
DI 10.1006/mthe.2001.0336
PG 8
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA 444TZ
UT WOS:000169417300005
PM 11407897
OA Other Gold
DA 2018-10-19
ER

PT J
AU Holgers, KM
   Branemark, PI
AF Holgers, KM
   Branemark, PI
TI Immunohistochemical study of clinical skin-penetrating titanium implants
   for orthopaedic prostheses compared with implants in the craniofacial
   area
SO SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND
   SURGERY
LA English
DT Article
DE biomaterial; artificial devices; percutaneous; skin-penetrating;
   titanium; orthopaedic; rehabilitation; prostheses; craniofacial
AB The technique of using osseointrgrated bone-anchored percutaneous titanium implants in the rehabilitation of patients with amputated limbs has recently been introduced at the Branemark Osseointegration Centre in Gotteborg. The new method is based on an implantation technique that is well-established for anchorage of bone-conductive hearing aids and craniofacial prostheses. The soft tissues around skin-penetrating titanium implants used to anchor orthopaedic prostheses were evaluated histochemically using quantitative analyses. The implants had been in clinical use for beta;ren 6 to 24 months. The number of inflammatory cells was higher in the area close to the interface than in the area distant from the skin-penetrating site, and higher than in the corresponding controls. The current data was also compared with corresponding data from tissue around skin-penetrating craniofacial implants. The number of inflammatory cells was lower in the orthopaedic samples than in the craniofacial specimens. We conclude that skin-penetrating of orthopaedic implants is as safe as when titanium implants are used for craniofacial rehabilitation, which is a clinically well-established procedure.
C1 Univ Gothenburg, Sahlgrens Univ Hosp, Dept Audiol, SE-41345 Gothenburg, Sweden.
   Univ Gothenburg, Dept Anat & Cell Biol, Gothenburg, Sweden.
   Carlanderska Hosp, Branemark Osseointegrat Ctr, Gothenburg, Sweden.
RP Holgers, KM (reprint author), Univ Gothenburg, Sahlgrens Univ Hosp, Dept Audiol, SE-41345 Gothenburg, Sweden.
CR Black J., 1992, BIOL PERFORMANCE MAT
   Branemark PI, 1997, OSSEOINTEGRATION IN SKELETAL RECONSTRUCTION AND JOINT REPLACEMENT, P1
   BRANEMARK PI, 1977, SCAND J PLAST RECO S, V16
   GRISTINA AG, 1990, PATHOGENESIS OF WOUND AND BIOMATERIAL-ASSOCIATED INFECTIONS, P193
   Holgers K M, 1987, Int J Oral Maxillofac Implants, V2, P35
   HOLGERS KM, 1992, CONTACT DERMATITIS, V27, P1, DOI 10.1111/j.1600-0536.1992.tb05189.x
   HOLGERS KM, 1988, AM J OTOL, V9, P56
   HOLGERS KM, 1995, BIOMATERIALS, V16, P611, DOI 10.1016/0142-9612(95)93858-B
   HOLGERS KM, 1999, IN PRESS BIOMATERIAL
   HOLGERS KM, 1994, THESIS U GOTEBORG GO
   HOLGERS KM, 1998, CRANIOFACIAL RECONST, P277
   Holgers KM, 1994, INT J ORAL MAXILLOF, V9, P689
   LJUNGH A, 1985, INFECT IMMUN, V47, P522
   Rydevik BL, 1997, OSSEOINTEGRATION IN SKELETAL RECONSTRUCTION AND JOINT REPLACEMENT, P175
   Siegel S, 1956, NONPARAMETRIC STAT, P75
   THOMSEN P, 1991, BONE BIOMATERIAL INT, P153
   TJELLSTROM A, 1981, AM J OTOL, V2, P4
   TWARDOWSKI ZJ, 1991, PERITON DIALYSIS INT, V11, P237
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   WEIBEL ER, 1979, STEREOLOGICAL METHOD, V1
NR 20
TC 5
Z9 5
U1 0
U2 5
PU TAYLOR & FRANCIS AS
PI OSLO
PA CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY
SN 0284-4311
J9 SCAND J PLAST RECONS
JI Scand. J. Plast. Reconstr. Surg. Hand Surg.
PD JUN
PY 2001
VL 35
IS 2
BP 141
EP 148
PG 8
WC Surgery
SC Surgery
GA 449AU
UT WOS:000169662800006
PM 11484523
DA 2018-10-19
ER

PT J
AU De Ruijter, JE
   Ter Brugge, PJ
   Dieudonne, SC
   Van Vliet, SJ
   Torensma, R
   Jansen, JA
AF De Ruijter, JE
   Ter Brugge, PJ
   Dieudonne, SC
   Van Vliet, SJ
   Torensma, R
   Jansen, JA
TI Analysis of integrin expression in U2OS cells cultured on various
   calcium phosphate ceramic substrates
SO TISSUE ENGINEERING
LA English
DT Article
ID ORTHOPEDIC IMPLANT MATERIALS; EXTRACELLULAR-MATRIX; IN-VITRO; HUMAN
   OSTEOBLASTS; ADHESION; BONE; DIFFERENTIATION; MINERALIZATION;
   HYDROXYAPATITE; GLYCOPROTEINS
AB Earlier we observed that calcium phosphate (Ca-P)-coated implant substrates stimulated the differentiation of osteoblast-like cells compared to uncoated substrates. This suggests that this difference in osteogenic induction is due to the chemical composition of the substratum. We hypothesized that Ca-P coatings modulate integrin expression patterns, because those receptors are the sensors of the cell. Therefore, in the present study we quantitatively analyzed integrin expression of osteosarcoma cells and their proliferation behavior on various well-defined Ca-P substrates. For this study we used the osteosarcoma cell line U2OS. Five groups of substrates were used: thermanox (Th), uncoated titanium (Ti), dense sintered hydroxyapatite (HA), and two Ca-P-coated titanium discs (TiHA-O% and TiHA-5%). At day 5, cell numbers were significantly lower (p< 0.05) for both types of Ca-P-coated titanium substrates compared to the other substrates. There were no significant differences between HA and uncoated titanium. From day 5 to 8, accumulated cell number was ranking highest to lowest HA > Th = Ti > TiHA-0% > TiHA-5%. Integrin expression at day 5 and day 8 of incubation was analyzed by flow cytometry for integrin subunits alpha1, alpha3, alpha4, alpha5, alpha6, and alphav. Fluorescence-activated cell sorting (FACS) analysis showed that the cells express high levels of beta1, low levels of alpha4, alpha5, and alpha6, and moderate levels of alpha3 and alphav integrin subunits on the various biomaterial substrates. Minor differences in integrin expression between the various substrates were seen. Therefore, the observed differences in proliferation between the coatings may reside in modulating the functional properties of integrins.
C1 Univ Med Ctr Nijmegen, Coll Dent Sci, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   Univ Med Ctr Nijmegen, Dept Tumor Immunol, Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Univ Med Ctr Nijmegen, Coll Dent Sci, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.kun.nl
RI Torensma, Ruurd/H-3830-2015; Jansen, John/H-8055-2014
OI Torensma, Ruurd/0000-0002-0555-7903; 
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Alberts B, 1994, MOL BIOL CELL
   CAMPANERO MR, 1990, J CELL BIOL, V110, P2157, DOI 10.1083/jcb.110.6.2157
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   CLOVER J, 1992, J CELL SCI, V103, P267
   Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163
   Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4
   DELCOMMENNE M, 1995, J BIOL CHEM, V270, P26794, DOI 10.1074/jbc.270.45.26794
   FRADET Y, 1984, P NATL ACAD SCI-BIOL, V81, P224, DOI 10.1073/pnas.81.1.224
   Garratt AN, 1995, ACTA ANAT, V154, P34
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   HAAS TA, 1994, CURR OPIN CELL BIOL, V6, P656, DOI 10.1016/0955-0674(94)90091-4
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HEMLER ME, 1984, J IMMUNOL, V132, P3011
   HUGHES DE, 1993, J BONE MINER RES, V8, P527
   Hulshoff JEG, 1998, J BIOMED MATER RES, V40, P464, DOI 10.1002/(SICI)1097-4636(19980605)40:3<464::AID-JBM18>3.0.CO;2-J
   HULSHOFF JEG, 1995, J BIOMED MATER RES, V29, P967, DOI 10.1002/jbm.820290808
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   KAWAGUCHI S, 1993, J ORTHOPAED RES, V11, P386, DOI 10.1002/jor.1100110310
   Kostenuik PJ, 1996, CLIN EXP METASTAS, V14, P19, DOI 10.1007/BF00157682
   LIN CQ, 1993, FASEB J, V7, P737
   Lisignoli G, 1995, Boll Soc Ital Biol Sper, V71, P309
   LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005
   MASSAS R, 1993, J DENT RES, V72, P1005, DOI 10.1177/00220345930720060201
   Meredith JE, 1996, ENDOCR REV, V17, P207, DOI 10.1210/er.17.3.207
   Pistone M, 1996, CELL BIOL INT, V20, P471, DOI 10.1006/cbir.1996.0062
   Pommerenke H, 1996, EUR J CELL BIOL, V70, P157
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   RODRIGUEZFERNAN.JL, 1989, DIFFERENTIATION, V42, P65
   SAITO T, 1993, J ORTHOP RES, V11, P386
   SINGER II, 1988, J CELL BIOL, V106, P2171, DOI 10.1083/jcb.106.6.2171
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   Sjaastad MD, 1997, BIOESSAYS, V19, P47, DOI 10.1002/bies.950190109
   STUIVER I, 1995, STEM CELLS, V13, P250, DOI 10.1002/stem.5530130306
   TUAN RS, 1994, SCRIPTA METALL MATER, V31, P971, DOI 10.1016/0956-716X(94)90512-6
   Van Dijk K., 1995, Journal of Biomedical Materials Research, V29, P269
NR 37
TC 27
Z9 27
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2001
VL 7
IS 3
BP 279
EP 289
DI 10.1089/10763270152044143
PG 11
WC Cell & Tissue Engineering
SC Cell Biology
GA 444PB
UT WOS:000169407700003
PM 11429148
DA 2018-10-19
ER

PT J
AU Cook, JL
   Tomlinson, JL
   Arnoczky, SP
   Fox, DB
   Cook, CR
   Kreeger, JM
AF Cook, JL
   Tomlinson, JL
   Arnoczky, SP
   Fox, DB
   Cook, CR
   Kreeger, JM
TI Kinetic study of the replacement of porcine small intestinal submucosa
   grafts and the regeneration of meniscal-like tissue in large avascular
   meniscal defects in dogs
SO TISSUE ENGINEERING
LA English
DT Article; Proceedings Paper
CT 46th Annual Meeting of the Orthopedic-Research-Society
CY MAR 12-15, 2000
CL ORLANDO, FLORIDA
SP Orthoped Res Soc
ID BIOMATERIAL; REPAIR
AB Porcine small intestinal submucosa (SIS) was used to replace large, avascular defects in the medial menisci of dogs. Twelve dogs received SIS grafts and 3 dogs were left untreated as controls. Dogs were evaluated at 4, 8, and 12 weeks by means of lameness scoring and ultrasonography. Dogs were sacrificed at 1, 6, or 12 weeks after implantation, and the tissue at the site of meniscal resection was evaluated for gross and histologic appearance, cross-sectional and surface area, and collagen types I and II. The femoral and tibial condyles were assessed for articular cartilage damage. Control dogs were significantly more lame than grafted dogs 8 and 12 weeks after instrumentation. Grafted dogs' replacement tissue appeared meniscal-like when evaluated grossly and ultrasonographically 12 weeks after instrumentation. The amount of replacement tissue was significantly greater in both cross-sectional and surface area for grafted dogs than for controls at all time points. Histologically, the SIS biomaterial could be identified in all grafted dogs at 1 week post-implantation, but in none at 6 weeks post-implantation. Subjectively, grafted dogs' replacement tissue was histologically superior to that of controls with respect to tissue type, organization, and architecture. Collagen types I and II immunoreactivity in grafted menisci were similar to that of normal menisci. Control dogs had significantly more articular cartilage damage than grafted dogs. SIS appears to induce regeneration of meniscal-like tissue in large, avascular meniscal defects in dogs, resulting in superior clinical function and articular cartilage protection compared to ungrafted controls.
C1 Univ Missouri, Comparat Orthopaed Lab, Columbia, MO 65211 USA.
   Michigan State Univ, Lab Comparat Orthopaed Res, E Lansing, MI 48824 USA.
RP Cook, JL (reprint author), Univ Missouri, Comparat Orthopaed Lab, 379 E Campus Dr, Columbia, MO 65211 USA.
OI Cook, James/0000-0002-0862-995X
CR AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   Arnoczky S P, 1985, Arthroscopy, V1, P247, DOI 10.1016/S0749-8063(85)80092-X
   ARNOCZKY SP, 1988, J BONE JOINT SURG AM, V70A, P1209, DOI 10.2106/00004623-198870080-00012
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1996, 1 SIS S ORL
   Collier S, 1996, VET COMP ORTHOPAED, V9, P60
   COOK CR, 1997, AM COLL VET RAD ANN
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   COOK JL, 1996, 1 SIS S ORL
   DIMENT MT, 1993, ORTHOPEDICS, V16, P973
   GALLOWAY MT, 1994, B RHEUM DIS, V43, P3
   Hardin G T, 1992, Orthop Rev, V21, P1311
   HAZEL WA, 1993, CLIN ORTHOP RELAT R, P232
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   MESSNER K, 1994, BIOMATERIALS, V15, P243, DOI 10.1016/0142-9612(94)90046-9
   METELMAN LA, 1995, VET COMP ORTHOPAED, V8, P118
   NEWMAN AP, 1993, ARTHROSCOPY, V9, P33, DOI 10.1016/S0749-8063(05)80342-1
   O'Meara P M, 1993, Orthop Rev, V22, P681
   STONE KR, 1992, AM J SPORT MED, V20, P104, DOI 10.1177/036354659202000202
   VELTRI DM, 1994, CLIN ORTHOP RELAT R, P44
   WILLIAMS J, 1994, VET MED          JAN, P42
NR 21
TC 39
Z9 45
U1 3
U2 4
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2001
VL 7
IS 3
BP 321
EP 334
DI 10.1089/10763270152044189
PG 14
WC Cell & Tissue Engineering
SC Cell Biology
GA 444PB
UT WOS:000169407700007
PM 11429152
DA 2018-10-19
ER

PT J
AU Willner, I
   Willner, B
AF Willner, I
   Willner, B
TI Biomaterials integrated with electronic elements: en route to
   bioelectronics
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID CHEMICALLY MODIFIED ELECTRODES; OLIGONUCLEOTIDE-DNA INTERACTIONS; DIRECT
   ELECTRICAL COMMUNICATION; REDOX POLYMER-FILMS; GLUCOSE-OXIDASE; ENZYME
   ELECTRODES; AMPEROMETRIC BIOSENSORS; BIOELECTROCATALYZED REDUCTION;
   ELECTROCATALYTIC OXIDATION; IMMUNOSENSOR ELECTRODES
AB Bioelectronics is a progressing interdisciplinary research field that involves the integration of biomaterials with electronic transducers, such as electrodes, field-effect-transistors or piezoelectric crystals. Surface engineering of biomaterials, such as enzymes, antigen-antibodies or DNA on the electronic supports, controls the electrical properties of the biomaterial-transducer interface and enables the electronic transduction of biorecognition events, or biocatalyzed transformation, on the transducers, Bioelectronic sensing devices, biosensors of tailored sensitivities and specificities, are being developed.
C1 Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
RP Willner, I (reprint author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
CR ABRUNA HD, 1988, COORDIN CHEM REV, V86, P135, DOI 10.1016/0010-8545(88)85013-6
   ALBERY WJ, 1982, ANNU REP PROG CHEM C, V78, P377
   Alzari P, 1996, J AM CHEM SOC, V118, P6788, DOI 10.1021/ja960197o
   BADIA A, 1993, J AM CHEM SOC, V115, P7053, DOI 10.1021/ja00069a001
   Bardea A, 1999, CHEM COMMUN, P21, DOI 10.1039/a808319c
   Bardea A, 1998, CHEM COMMUN, P839, DOI 10.1039/a800215k
   Bardea A, 2000, ELECTROANAL, V12, P1097, DOI 10.1002/1521-4109(200010)12:14<1097::AID-ELAN1097>3.3.CO;2-O
   Bardea A, 1997, J AM CHEM SOC, V119, P9114, DOI 10.1021/ja971192+
   BenDov I, 1997, ANAL CHEM, V69, P3506, DOI 10.1021/ac970216s
   Berggren C, 1997, ANAL CHEM, V69, P3651, DOI 10.1021/ac970203e
   BIXON M, 1986, J PHYS CHEM-US, V90, P3795, DOI 10.1021/j100407a055
   Blonder R, 1996, ANAL CHEM, V68, P3151, DOI 10.1021/ac960290v
   Blonder R, 1997, J AM CHEM SOC, V119, P10467, DOI 10.1021/ja971980z
   BUTTRY DA, 1992, CHEM REV, V92, P1355, DOI 10.1021/cr00014a006
   CARUANA DJ, 1999, J AM CHEM SOC, V121, P768
   CASS AEG, 1984, ANAL CHEM, V56, P667, DOI 10.1021/ac00268a018
   Cohen Y, 1996, J ELECTROANAL CHEM, V417, P65, DOI 10.1016/S0022-0728(96)04760-2
   Cosnier S, 1997, ELECTROANAL, V9, P894, DOI 10.1002/elan.1140091206
   DEASY B, 1994, ANAL CHIM ACTA, V294, P291, DOI 10.1016/0003-2670(94)80312-9
   DEGANI Y, 1988, J AM CHEM SOC, V110, P2615, DOI 10.1021/ja00216a040
   DEGANI Y, 1987, J PHYS CHEM-US, V91, P1285, DOI 10.1021/j100290a001
   Ekins R, 1999, TRENDS BIOTECHNOL, V17, P217, DOI 10.1016/S0167-7799(99)01329-3
   Fernandez-Sanchez C, 2000, BIOSENS BIOELECTRON, V14, P917, DOI 10.1016/S0956-5663(99)00065-2
   Finklea HO, 1996, ELECTROANAL CHEM, V19, P109
   GOPEL W, 1995, BIOSENS BIOELECTRON, V10, P853, DOI 10.1016/0956-5663(95)99225-A
   GREGG BA, 1991, J PHYS CHEM-US, V95, P5970, DOI 10.1021/j100168a046
   GREGG BA, 1990, ANAL CHEM, V62, P258, DOI 10.1021/ac00202a007
   GREGG BA, 1991, J PHYS CHEM-US, V95, P5976, DOI 10.1021/j100168a047
   HALE PD, 1989, J AM CHEM SOC, V111, P3482, DOI 10.1021/ja00191a084
   HALE PD, 1991, ANAL CHEM, V63, P677, DOI 10.1021/ac00007a006
   HELLER A, 1990, ACCOUNTS CHEM RES, V23, P128, DOI 10.1021/ar00173a002
   HELLER A, 1992, J PHYS CHEM-US, V96, P3579, DOI 10.1021/j100188a007
   HILL HAO, 1981, PHILOS T R SOC A, V302, P267, DOI 10.1098/rsta.1981.0166
   JESTER CP, 1980, J ELECTROCHEM SOC, V127, P1979, DOI 10.1149/1.2130048
   KAKU T, 1994, ANAL CHEM, V66, P1231, DOI 10.1021/ac00080a006
   KATZ E, 1994, J ELECTROANAL CHEM, V373, P189, DOI 10.1016/0022-0728(94)03328-5
   Katz E, 1999, J ELECTROANAL CHEM, V479, P64, DOI 10.1016/S0022-0728(99)00425-8
   KATZ E, 1993, J ELECTROANAL CHEM, V354, P129, DOI 10.1016/0022-0728(93)80329-G
   Katz E, 1999, ANAL CHIM ACTA, V385, P45, DOI 10.1016/S0003-2670(98)00688-6
   KHARITONOV AB, IN PRESS SENS ACTU B
   KINNEAR KT, 1993, LANGMUIR, V9, P2255, DOI 10.1021/la00033a002
   Kranz C, 1998, ELECTROANAL, V10, P546, DOI 10.1002/(SICI)1521-4109(199807)10:8<546::AID-ELAN546>3.0.CO;2-#
   KULYS JJ, 1983, ANAL LETT PT B, V16, P197, DOI 10.1080/00032718308065162
   MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X
   MARXTIBBON S, 1995, J AM CHEM SOC, V117, P9925, DOI 10.1021/ja00144a025
   Mikkelsen Susan R., 1996, Electroanalysis, V8, P15, DOI 10.1002/elan.1140080104
   MILLAN KM, 1994, ANAL CHEM, V66, P2943, DOI 10.1021/ac00090a023
   MURAMATSU H, 1989, ANAL LETT, V22, P2155
   MURAMATSU H, 1986, ANAL CHIM ACTA, V188, P257, DOI 10.1016/S0003-2670(00)86049-3
   MURRAY RW, 1984, ELECTROANAL CHEM, V13, P191
   MURRAY RW, 1980, ACCOUNTS CHEM RES, V13, P135, DOI 10.1021/ar50149a002
   NIWA O, 1991, ELECTROANAL, V3, P163, DOI 10.1002/elan.1140030305
   Pardo-Yissar V, 2000, FARADAY DISCUSS, V116, P119, DOI 10.1039/b001508n
   Patolsky F, 1999, LANGMUIR, V15, P3703, DOI 10.1021/la981682v
   Patolsky F, 2001, NAT BIOTECHNOL, V19, P253, DOI 10.1038/85704
   Patolsky F, 1998, CHEM-EUR J, V4, P1068, DOI 10.1002/(SICI)1521-3765(19980615)4:6<1068::AID-CHEM1068>3.3.CO;2-H
   PATOLSKY F, IN PRESS ANGEW CHEM
   PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022
   Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524
   PIUNNO PAE, 1994, ANAL CHIM ACTA, V288, P205, DOI 10.1016/0003-2670(93)E0611-A
   RIKLIN A, 1995, ANAL CHEM, V67, P4118, DOI 10.1021/ac00118a014
   Ryabov AD, 1998, CHEM-EUR J, V4, P806, DOI 10.1002/(SICI)1521-3765(19980515)4:5<806::AID-CHEM806>3.0.CO;2-B
   SCHUHMANN W, 1991, J AM CHEM SOC, V113, P1394, DOI 10.1021/ja00004a048
   SCHUHMANN W, 1995, BIOSENS BIOELECTRON, V10, P181, DOI 10.1016/0956-5663(95)96805-9
   SHOHAM B, 1995, BIOSENS BIOELECTRON, V10, P341, DOI 10.1016/0956-5663(95)96852-P
   STUTTS KJ, 1983, ANAL CHEM, V55, P1576, DOI 10.1021/ac00260a029
   Takenaka S, 2000, ANAL CHEM, V72, P1334, DOI 10.1021/ac991031j
   Tiefenauer LX, 1997, BIOSENS BIOELECTRON, V12, P213, DOI 10.1016/S0956-5663(97)85339-0
   TSIONSKY M, 1994, ANAL CHEM, V66, P1747, DOI 10.1021/ac00082a024
   Walcarius A, 1998, ELECTROANAL, V10, P1217, DOI 10.1002/(SICI)1521-4109(199812)10:18<1217::AID-ELAN1217>3.0.CO;2-X
   WANG J, 1994, ELECTROANAL, V6, P571, DOI 10.1002/elan.1140060707
   Warsinke A, 2000, FRESEN J ANAL CHEM, V366, P622, DOI 10.1007/s002160051557
   WILLNER I, 1992, BIOELECTROCH BIOENER, V29, P29, DOI 10.1016/0302-4598(92)80051-H
   Willner I, 1999, J AM CHEM SOC, V121, P6455, DOI 10.1021/ja983182u
   Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611
   WILLNER I, 1993, ADV MATER, V5, P912, DOI 10.1002/adma.19930051206
   WILLNER I, 1994, ANAL CHEM, V66, P1535, DOI 10.1021/ac00081a028
   Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E
   Willner I, 1997, ELECTROANAL, V9, P965, DOI 10.1002/elan.1140091302
   WILLNER I, 1994, J AM CHEM SOC, V116, P1428, DOI 10.1021/ja00083a031
   WRIGHTON MS, 1986, SCIENCE, V231, P32, DOI 10.1126/science.231.4733.32
   Yang MS, 1997, ANAL CHIM ACTA, V346, P259
   ZHONG CJ, 1995, ANAL CHEM, V67, P709
   ZOU CF, 1990, J AM CHEM SOC, V112, P7578, DOI 10.1021/ja00177a020
NR 84
TC 158
Z9 161
U1 1
U2 59
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD JUN
PY 2001
VL 19
IS 6
BP 222
EP 230
DI 10.1016/S0167-7799(01)01634-1
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 432VR
UT WOS:000168716900007
PM 11356284
DA 2018-10-19
ER

PT J
AU Dorner, A
   Schurer, C
   Reisel, G
   Irmer, G
   Seidel, O
   Muller, E
AF Dorner, A
   Schurer, C
   Reisel, G
   Irmer, G
   Seidel, O
   Muller, E
TI Diamond-like carbon-coated Ti6Al4V: influence of the coating thickness
   on the structure and the abrasive wear resistance
SO WEAR
LA English
DT Article
DE diamond-like carbon; abrasive wear; titanium-alloy; biomaterial; Raman
   spectroscopy; atomic force microscopy
ID AMORPHOUS-CARBON; THIN-FILMS; DEPOSITION; BEHAVIOR
AB Diamond-like carbon (DLC) coatings of 0.7, 1.5 and 3.0 mum thickness were deposited on the titanium-alloy Ti6Al4V by a direct current discharge using benzene as gaseous precursor. Scanning electron microscopy, Raman spectroscopy, atomic force microscopy were utilised for gaining information about the micro-structural features and the composition. Hardness measurements, scratch and simple abrasion wear tests (ball-cratering apparatus with an abrasive fluid) were carried out for describing the tribological performance of the DLC.
   The fractures cross-sections of the DLC seems to be featureless and smooth. The universal hardness (HU) amounts to values of between approximately 12.8 and 22.2 GPa and the Young's modulus of between nearly 133 and 213 GPa. Raman spectroscopy points microstructural changes in dependence of the coating thickness. Although, the cohesive failure of the DLC is dependent on the coating thickness, the DLC spallation at the lateral edges of the scratch occurs at approximately 35 N for all coatings. The worn surfaces exhibit a very heterogeneous DLC damage due to the abrasive loading which also points to the micro-structural differences within the DLC film. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Freiberg Univ Min & Technol, Inst Ceram Mat, Freiberg, Germany.
   Inst Phys & Mech Technol, Chemnitz, Germany.
   Tech Univ Chemnitz, Inst Composite Mat & Surface Technol, Chemnitz, Germany.
   Freiberg Univ Min & Technol, Inst Theoret Phys, Freiberg, Germany.
RP Dorner, A (reprint author), Freiberg Univ Min & Technol, Inst Ceram Mat, Freiberg, Germany.
EM dorner@anw.ikw.tu-freiberg.de
CR BLIZNAKOVSKA B, 1994, SCI SERIES INT BUREA, V23
   Collins M, 2000, DIAM RELAT MATER, V9, P781, DOI 10.1016/S0925-9635(99)00325-8
   Deng JG, 1996, DIAM RELAT MATER, V5, P478, DOI 10.1016/0925-9635(96)80063-X
   DORNER A, 1999, THIN SOLID FILMS, V351, P1
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   ENDEMIR A, 1995, SURF COAT TECH, V36, P692
   Fung MK, 2000, DIAM RELAT MATER, V9, P815, DOI 10.1016/S0925-9635(99)00201-0
   Grill A, 1999, DIAM RELAT MATER, V8, P428, DOI 10.1016/S0925-9635(98)00262-3
   JEHN H, 1993, CHARAKTERISIERUNG DU, P210
   Jiu JT, 1999, J MATER SCI, V34, P5205, DOI 10.1023/A:1004711913325
   Li D, 1995, TRIBOL LETT, V1, P87, DOI 10.1007/BF00157978
   Logothetidis S, 2000, NATO SCI S PRT 3 HI, V78, P297
   LUI Y, 1996, SURF COAT TECH, V82, P48
   Maharizi M, 1999, DIAM RELAT MATER, V8, P1050, DOI 10.1016/S0925-9635(99)00003-5
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
   ROBERTSON J, 1992, SURF COAT TECH, V50, P185, DOI 10.1016/0257-8972(92)90001-Q
   ROBERTSON J, 1986, ADV PHYS, V35, P317, DOI 10.1080/00018738600101911
   Ronkainen H, 1998, WEAR, V222, P120, DOI 10.1016/S0043-1648(98)00314-7
   ROTHER B, 1992, PLASMABESCHICHTUNGSV, P36
   Rutherford KL, 1997, J TEST EVAL, V25, P250
   Schroeder A, 2000, BIOMATERIALS, V21, P449, DOI 10.1016/S0142-9612(99)00135-0
   SCHULTRICH BHJ, 1996, P WORKSH ANW MOD OB
   WIELAGE B, 1996, METALLOBERFLACHE, V51, P163
   Yoon ES, 1998, WEAR, V217, P262, DOI 10.1016/S0043-1648(98)00163-X
NR 25
TC 32
Z9 32
U1 0
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
EI 1873-2577
J9 WEAR
JI Wear
PD JUN
PY 2001
VL 249
IS 5-6
BP 489
EP 497
DI 10.1016/S0043-1648(01)00587-7
PG 9
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 445WR
UT WOS:000169482000020
DA 2018-10-19
ER

PT J
AU Elfick, APD
   Smith, SL
   Green, SM
   Unsworth, A
AF Elfick, APD
   Smith, SL
   Green, SM
   Unsworth, A
TI The quantitative assessment of UHMWPE wear debris produced in hip
   simulator testing: the influence of head material and roughness, motion
   and loading
SO WEAR
LA English
DT Article
DE UHMWPE; wear debris; hip simulator
ID MOLECULAR-WEIGHT POLYETHYLENE; TOTAL JOINT REPLACEMENTS;
   SURFACE-ROUGHNESS; ACETABULAR CUPS; FEMORAL HEADS; IN-VITRO; SIZE;
   PARTICLES; TOPOGRAPHY; PROSTHESES
AB Biomaterial wear particles are known to provoke a foreign-body reaction when released from total joint prostheses. Considerable effort is being invested in the search for materials which, by wearing less, will release fewer particles. In this research the role of joint wear simulators is paramount.
   The wear debris from 26 simulator tests of hip prostheses was extracted from the bovine serum lubricant and sized using a laser diffraction technique. The influence on particle size of a broad range of parameters was examined. The parameters considered included the bedding-in phenomenon, the femoral head material and roughness and physiological versus simplified load cycles and wear paths.
   The physiological wear simulators produced a similar size distribution of wear particles to that produced by implanted joints. Head material had no effect on this observation. Simplifying the loading cycle or wear path independently made no impact on this finding. This remained the case when simplified load and wear path were combined in one test.
   The effect of head roughness was pronounced with an increase in minimum particle size with increasing roughness.
   Joint simulators remain the optimal method for assessing new:joint materials and designs. However, their use to characterise joints in terms of wear rate solely should be guarded against. Instead focus should be concentrated on a combination of the size and amount of the wear debris created. In this way the "loosening hazard" of a joint can be distilled. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Durham, Ctr Biomed Engn, Durham DH1 3LE, England.
RP Elfick, APD (reprint author), Univ Durham, Ctr Biomed Engn, South Rd, Durham DH1 3LE, England.
OI green, sarah/0000-0002-8392-8159
CR BARBOUR PSM, 1999, P I MECH ENG H, V213, P445
   Besong AA, 1998, J BONE JOINT SURG BR, V80B, P340, DOI 10.1302/0301-620X.80B2.8234
   BIGGS SA, 1998, T ORTHOP RES SOC, V23, P73
   Bowden F.P., 1973, FRICTION INTRO TRIBO
   Boynton EL, 2000, J BIOMED MATER RES, V52, P239, DOI 10.1002/1097-4636(200011)52:2<239::AID-JBM1>3.0.CO;2-R
   Campbell P, 1996, Proc Inst Mech Eng H, V210, P167, DOI 10.1243/PIME_PROC_1996_210_409_02
   CAMPBELL P, 1995, J BIOMED MATER RES, V29, P127, DOI 10.1002/jbm.820290118
   DOWSON D, 1985, ACS SYM SER, V287, P171
   Elfick AP, 2000, J MATER SCI-MATER M, V11, P267, DOI 10.1023/A:1008992911775
   Elfick AP, 1998, J MATER SCI LETT, V17, P1085, DOI 10.1023/A:1006623830833
   Elfick APD, 1999, J BIOMED MATER RES, V48, P712, DOI 10.1002/(SICI)1097-4636(1999)48:5<712::AID-JBM17>3.0.CO;2-R
   Elfick APD, 2000, J ARTHROPLASTY, V15, P901, DOI 10.1054/arth.2000.9194
   ELFICK APD, 2001, T ORTHOP RES SOC, V26, P1032
   GORE TA, 1980, THESIS U DURHAM DURH
   Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9
   JOHNSTON RC, 1969, J BONE JOINT SURG AM, VA 51, P1083, DOI 10.2106/00004623-196951060-00003
   KLAPPERICH CM, 1999, J TRIB, V12, P394
   Kobayashi A, 1997, P I MECH ENG H, V211, P11, DOI 10.1243/0954411971534638
   MCKELLOP HA, 1995, CLIN ORTHOP RELAT R, P3
   Mie G, 1908, ANN PHYS-BERLIN, V25, P377
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   Paul J. P, 1967, P I MECH ENG, V181, P8
   Pienkowski D, 1996, J BIOMED MATER RES, V33, P65, DOI 10.1002/(SICI)1097-4636(199622)33:2<65::AID-JBM2>3.0.CO;2-J
   Rader CP, 1999, J ARTHROPLASTY, V14, P840, DOI 10.1016/S0883-5403(99)90035-9
   SAIKKO V, 1993, WEAR, V166, P169, DOI 10.1016/0043-1648(93)90259-O
   SCHMALZRIED TP, 1994, J APPL BIOMATER, V5, P185, DOI 10.1002/jab.770050302
   SCHOLES SC, 2000, MED ENG PHYS, V45, P1
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Shanbhag AS, 2000, J BIOMED MATER RES, V53, P100, DOI 10.1002/(SICI)1097-4636(2000)53:1<100::AID-JBM14>3.0.CO;2-4
   SHANBHAG AS, 1997, T ORTHOP RES SOC, V22, P118
   Smith SL, 1999, J MATER SCI, V34, P5159, DOI 10.1023/A:1004737526529
   Smith SL, 1999, P I MECH ENG H, V213, P475, DOI 10.1243/0954411991535086
   SMITH SL, 1999, THESIS U DURHAM DURH
   SMITH SL, IN PRESS P I MECH H
   SMITH SL, 2000, P I MECH ENG H, V214, P238
   SMITH SL, 2000, J BONE JOINT SURG BR, V82, P137
   Streicher RM, 1998, J ARTHROPLASTY, V13, P343, DOI 10.1016/S0883-5403(98)90181-4
   TIPPER JL, 1997, T ORTHOP RES SOC, V22, P355
   Unsworth A, 1995, WEAR, V190, P226, DOI 10.1016/0043-1648(95)06653-5
   Wang A, 1996, Proc Inst Mech Eng H, V210, P141, DOI 10.1243/PIME_PROC_1996_210_407_02
   WANG A, 1995, WEAR, V181, P241, DOI 10.1016/0043-1648(95)90030-6
   Wang A, 1998, J ARTHROPLASTY, V13, P615, DOI 10.1016/S0883-5403(98)80002-8
   Wroblewski BM, 1996, J BONE JOINT SURG BR, V78B, P280
NR 44
TC 30
Z9 33
U1 0
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
J9 WEAR
JI Wear
PD JUN
PY 2001
VL 249
IS 5-6
BP 517
EP 527
DI 10.1016/S0043-1648(01)00589-0
PG 11
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 445WR
UT WOS:000169482000024
DA 2018-10-19
ER

PT J
AU Blazewicz, M
   Paluszkiewicz, C
AF Blazewicz, M
   Paluszkiewicz, C
TI Characterization of biomaterials used for bone regeneration by FTIR
   spectroscopy
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article
DE biomaterial; vibrational spectroscopy; regeneration of bunt; integrated
   area of bands
ID CARBON
AB FTIR spectroscopy has been used to analyse the process of bone regeneration taking place in the presence of surface modified carbon materials. Two types of carbon implant materials differing in their surface properties have been examined: an oxidized carbon fabric and a carbon fabric coated with a pyrolytic carbon layer. Samples of bone tissue have been retrieved at different times after implantation for spectroscopic study. The ratio of bone components has been calculated from the FTIR spectra of the samples. based on the integrated areas of the bands brought about by the vibrations of phosphates and amide groups. Additionally: the analysis of the shape and intensity of these bands provided information on developing and on the rate of bone mineralization. The investigation has shown that healing is faster in the presence of the carbon fabric coated with a pyrolytic carbon layer used as an implant material. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Acad Min & Met, Dept Special Ceram, PL-30059 Krakow, Poland.
   Jagiellonian Univ, Reg Lab, PL-30060 Krakow, Poland.
RP Blazewicz, M (reprint author), Acad Min & Met, Dept Special Ceram, Al Mickiewicza 30, PL-30059 Krakow, Poland.
CR BLAZEWICZ M, 1994, CERAM INT, V20, P99
   BOHEM HP, 1966, ADV CATAL, V16, P179
   BOKROS JC, 1977, CARBON, V15, P355
   BUTTAZZONI B, 1987, BIOMECANIQUE ORTHOPE, P106
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Czajkowska B, 1997, BIOMATERIALS, V18, P69, DOI 10.1016/S0142-9612(96)00103-2
   FORSTER IW, 1978, CLIN ORTHOP RELAT R, P299
   LOUIS JP, 1996, BIOMATERIALS, V11, P525
   Paschalis EP, 1996, CALCIFIED TISSUE INT, V59, P480, DOI 10.1007/BF00369214
   PLESHKO NL, 1992, CALCIFIED TISSUE INT, V51, P72, DOI 10.1007/BF00296221
   REHMAN I, 1994, BIOMATERIALS, V15, P865, DOI 10.1016/0142-9612(94)90044-2
NR 11
TC 11
Z9 11
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2860
J9 J MOL STRUCT
JI J. Mol. Struct.
PD MAY 28
PY 2001
VL 563
SI SI
BP 147
EP 152
DI 10.1016/S0022-2860(00)00956-X
PG 6
WC Chemistry, Physical
SC Chemistry
GA 439UP
UT WOS:000169136200019
DA 2018-10-19
ER

PT J
AU Bettencourt, A
   Calado, A
   Amaral, J
   Vale, FM
   Rico, JMT
   Monteiro, J
   Castro, M
AF Bettencourt, A
   Calado, A
   Amaral, J
   Vale, FM
   Rico, JMT
   Monteiro, J
   Castro, M
TI The influence of vacuum mixing on methylmethacrylate liberation from
   acrylic cement powder
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE poly(methylmethacrylate); methylmethacrylate; biomaterial; bone cement;
   release model; vacuum mixing
ID BONE-CEMENT
AB Polymethylmethacrylate (PMMA) bone cement is a biomaterial used to anchor prostheses during joint replacement surgery. Residual methylmethacrylate monomer (MNA) may be related with the cytotoxic effect of PM MA. The aim of the present paper was to investigate the effect of two different cement mixing methods: hand stirring at atmospheric pressure and under partial vacuum (0.330 and 0.154 bar) on residual monomer liberation in phosphate buffer saline solution from acrylic cement powder. Residual MMA content was determined by high-performance liquid chromatography. Mathematical models were applied to experimental dissolution data revealing that monomer release was significantly reduced in bone cement powder obtained at 0.154 bar vacuum pressure compared to the other mixing conditions. The kinetic models applied are consistent with a simple diffusion mechanism of the monomer from the polymer matrix. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Lisbon, Fac Farm, P-1600083 Lisbon, Portugal.
   Univ Lisbon, CECUL, Ctr Electroquim & Cinet, P-1699 Lisbon, Portugal.
   Univ Lisbon, Ctr Farmacol Expt & Clin, P-1699 Lisbon, Portugal.
   Hosp Santa Maria, Serv Ortopedia, Lisbon, Portugal.
RP Bettencourt, A (reprint author), Fac Farm, Av Prof Gama Pinto, P-1649003 Lisbon, Portugal.
RI Castro, Matilde/A-9468-2014; Bettencourt, Ana/M-4219-2013; iMed.ULisboa,
   iMed.ULisboa/C-6292-2014; iMed.ULisboa, CBT/B-4215-2014; Calado,
   Antonio/M-4647-2014
OI Castro, Matilde/0000-0002-6314-8251; Bettencourt,
   Ana/0000-0002-8498-5892; Calado, Antonio/0000-0003-4110-0182; Monteiro,
   Jacinto Manuel de Melo Oliveira/0000-0002-4067-200X
CR Bettencourt A, 2000, INT J PHARM, V197, P161, DOI 10.1016/S0378-5173(99)00468-8
   Brossard C., 1990, STP PHARM, V6, P728
   DONBROW M, 1992, MICROCAPSULES NANOPA, P193
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Smeds S, 1997, CLIN ORTHOP RELAT R, P326
   *US PHARM CONV INC, 1995, NAT FORM US, V18, P2265
   Vale FM, 1997, BIOMATERIALS, V18, P1133, DOI 10.1016/S0142-9612(97)00043-4
   WIJN JRD, 1975, ACTA ORTHOP SCAND, V46, P38
   WILLIAMS RP, 1992, CLIN ORTHOP RELAT R, P174
   WIXSON RL, 1992, CLIN ORTHOP RELAT R, P84
NR 10
TC 11
Z9 13
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARM
JI Int. J. Pharm.
PD MAY 21
PY 2001
VL 219
IS 1-2
BP 89
EP 93
DI 10.1016/S0378-5173(01)00630-5
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 433JE
UT WOS:000168755600009
PM 11337169
DA 2018-10-19
ER

PT J
AU Kharitonov, AB
   Wasserman, J
   Katz, E
   Willner, I
AF Kharitonov, AB
   Wasserman, J
   Katz, E
   Willner, I
TI The use of impedance spectroscopy for the characterization of
   protein-modified ISFET devices: Application of the method for the
   analysis of biorecognition processes
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID FIELD-EFFECT TRANSISTORS; ION-SELECTIVE ELECTRODES; BIOSENSOR; MEMBRANE;
   IMMUNOSENSOR; INTEGRATION; SENSORS; SYSTEM
AB Impedance spectroscopy is used to characterize the structure of biomaterial layers on the gate surface of ISFET devices, and to elucidate antigen-antibody binding interactions on the gate interface. The method is based on the recording of the transfer function of the system as a function of frequency and on the extraction of the respective iota (1) and iota (2) values of the systems. From the experimental values, the film thicknesses of the respective protein layers are estimated. The method is applied to elucidate the structures of a glucose oxidase, GOx, multilayer assembly, and of a di-biotin-cross-linked avidin multilayer system. The method is also used to sense the dinitrophenyl antibody by following the formation of the antigen-antibody complex on the gate surface.
C1 Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
RP Willner, I (reprint author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
CR Antonisse MMG, 2000, ANAL CHEM, V72, P343, DOI 10.1021/ac990721k
   ARMSTRONG RD, 1990, ELECTROCHIM ACTA, V35, P1, DOI 10.1016/0013-4686(90)85028-L
   BERGVELD P, 1989, SENSOR ACTUATOR, V18, P309, DOI 10.1016/0250-6874(89)87038-6
   BOUSSE L, 1983, J ELECTROANAL CHEM, V152, P25, DOI 10.1016/S0022-0728(83)80030-8
   CHOVELON JM, 1991, SENSOR ACTUAT B-CHEM, V3, P43, DOI 10.1016/0925-4005(91)85006-5
   DEMOZ A, 1995, J ELECTROANAL CHEM, V389, P71, DOI 10.1016/0022-0728(95)03836-6
   DRUISE J, 1992, SENSOR ACTUAT B-CHEM, V6, P101
   Dzyadevich SV, 1999, BIOSENS BIOELECTRON, V14, P283, DOI 10.1016/S0956-5663(99)00007-X
   Friebe A., 1993, Sensors and Materials, V5, P65
   GARRETT RH, 1995, BIOCHEMISTRY-US, P495
   HENDJI AMN, 1993, ANAL CHIM ACTA, V281, P3, DOI 10.1016/0003-2670(93)85333-F
   IZQUIERDO A, 1995, ELECTROANAL, V7, P505, DOI 10.1002/elan.1140070602
   Kharitonov AB, 2000, SENSOR ACTUAT B-CHEM, V70, P222, DOI 10.1016/S0925-4005(00)00573-6
   Koncki R, 1998, SENSOR ACTUAT B-CHEM, V47, P246, DOI 10.1016/S0925-4005(98)00031-8
   LIONDAGAN M, 1995, ANGEW CHEM INT EDIT, V34, P1604, DOI 10.1002/anie.199516041
   Lugtenberg RJW, 1998, J ELECTROANAL CHEM, V452, P69, DOI 10.1016/S0022-0728(98)00080-1
   Maupas H, 1996, J ELECTROANAL CHEM, V406, P53, DOI 10.1016/0022-0728(95)04443-4
   Pijanowska DG, 1997, SENSOR ACTUAT B-CHEM, V44, P370, DOI 10.1016/S0925-4005(97)00194-9
   Prasad B, 1999, MEAS SCI TECHNOL, V10, P1097, DOI 10.1088/0957-0233/10/11/321
   SCHELLER FW, 1991, BIOSENS BIOELECTRON, V6, P245, DOI 10.1016/0956-5663(91)80010-U
   Schroth P, 1999, ELECTROCHIM ACTA, V44, P3821, DOI 10.1016/S0013-4686(99)00088-2
   SCHYBERG C, 1995, SENSOR ACTUAT B-CHEM, V27, P457, DOI 10.1016/0925-4005(94)01639-Y
   Sekiguchi T, 2000, SENSOR ACTUAT B-CHEM, V67, P265, DOI 10.1016/S0925-4005(00)00522-0
   Senillou A, 1999, TALANTA, V50, P219, DOI 10.1016/S0039-9140(99)00122-8
   Souteyrand E, 1997, J PHYS CHEM B, V101, P2980, DOI 10.1021/jp963056h
   Volotovsky V, 1998, ELECTROANAL, V10, P512, DOI 10.1002/(SICI)1521-4109(199806)10:7<512::AID-ELAN512>3.0.CO;2-V
   Volotovsky V, 1996, ANAL CHIM ACTA, V322, P77, DOI 10.1016/0003-2670(95)00592-7
   Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E
   Willner I, 1997, ELECTROANAL, V9, P965, DOI 10.1002/elan.1140091302
   Zayats M, 2000, BIOSENS BIOELECTRON, V15, P671, DOI 10.1016/S0956-5663(00)00120-2
NR 30
TC 65
Z9 65
U1 2
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1089-5647
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD MAY 17
PY 2001
VL 105
IS 19
BP 4205
EP 4213
DI 10.1021/jp0045383
PG 9
WC Chemistry, Physical
SC Chemistry
GA 434FE
UT WOS:000168803800025
DA 2018-10-19
ER

PT J
AU Ramamurthi, A
   Robson, SC
   Lewis, RS
AF Ramamurthi, A
   Robson, SC
   Lewis, RS
TI Effects of nitric oxide (NO) and soluble nucleoside triphosphate
   diphosphohydrolase (NTPDase) on inhibition of platelet deposition in
   vitro
SO THROMBOSIS RESEARCH
LA English
DT Article
DE platelet inhibition; nitric oxide; NTPDase; aspirin; apyrase
ID ATP-DIPHOSPHOHYDROLASE; ADENINE-NUCLEOTIDES; DONOR SIN-1; HUMAN-BLOOD;
   AGGREGATION; ASPIRIN; ERYTHROCYTES; HEMOSTASIS; THROMBOSIS; ADHESION
AB Vascular thrombosis is regulated via the release of several constituents from the vascular endothelium, including nucleoside triphosphate diphosphohydrolases (NTPDases or ectonucleotidases), nitric oxide (NO), and eicosanoids. Currently, it is unknown how these constituents interact in the inhibition of platelet aggregation and adhesion. To investigate the combined effects of NO and NTPDase on platelet deposition sequestration, an in vitro study was performed to compare inhibition of platelet deposition to a biomaterial by NO in the absence or presence of soluble NTPDase. Results of the platelet inhibition studies with NO and NTPDase conclusively show that the inhibitory effects of NTPDase and NO are additive. The platelet inhibitory potency in the presence of NO was enhanced by NTPDase in a dose-dependent manner, for a given NO exposure. This augmentation is independent of aspirin; the ability of NTPDase or NO alone to inhibit platelet deposition is also independent of aspirin. Clearly, NO and NTPDase independently contribute to platelet inhibition via different mechanisms. The inaction of NO on the activity of NTPDase confirmed that NO or reaction products in the presence of O-2 do not interact with NTPDase directly. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Oklahoma State Univ, Sch Chem Engn, Stillwater, OK 74078 USA.
   Cleveland Clin Fdn, Dept Biomed Engn, Cleveland, OH 44195 USA.
   Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.
RP Lewis, RS (reprint author), Oklahoma State Univ, Sch Chem Engn, 423 EN, Stillwater, OK 74078 USA.
EM randyl@okstate.edu
FU NHLBI NIH HHS [HL57307, HL63972]
CR BASSENGE E, 1992, BRIT J CLIN PHARMACO, V34, pS37, DOI 10.1111/j.1365-2125.1992.tb04147.x
   BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8
   Becker BF, 2000, Z KARDIOL, V89, P160, DOI 10.1007/PL00007320
   Bozzo J, 1999, EUR J CLIN INVEST, V29, P438
   Broeders MAW, 1998, ARTERIOSCL THROM VAS, V18, P139, DOI 10.1161/01.ATV.18.1.139
   Brown AS, 1998, CARDIOVASC RES, V40, P380, DOI 10.1016/S0008-6363(98)00182-5
   BUSSE R, 1993, EUR HEART J, V14, P2
   CAZENAVE JP, 1973, J LAB CLIN MED, V82, P978
   COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531
   FISCH A, 1995, EUR J PHARM-MOLEC PH, V289, P455, DOI 10.1016/0922-4106(95)90154-X
   GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X
   GORDON EL, 1989, J BIOL CHEM, V264, P18986
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868
   IGNARRO LJ, 1993, THROMB HAEMOSTASIS, V70, P148
   Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116
   LANGE NA, 1967, LANGES HDB CHEM, P1101
   LARSSON R, 1987, ANN NY ACAD SCI, V516, P102, DOI 10.1111/j.1749-6632.1987.tb33034.x
   LEWIS RS, 1994, CHEM RES TOXICOL, V7, P568, DOI 10.1021/tx00040a013
   LUTHJE J, 1988, EUR J BIOCHEM, V175, P285, DOI 10.1111/j.1432-1033.1988.tb14195.x
   Makita K, 1998, INT J HEMATOL, V68, P297
   MARCUS AJ, 1995, THROMB HAEMOSTASIS, V74, P213
   MARCUS AJ, 1993, FASEB J, V7, P516
   NEGRESCU EV, 1995, CARDIOVASC DRUG THER, V9, P619, DOI 10.1007/BF00878095
   PATRONO C, 1989, TRENDS PHARMACOL SCI, V10, P453, DOI 10.1016/S0165-6147(89)80010-0
   Provost P, 1997, ARTERIOSCL THROM VAS, V17, P1806, DOI 10.1161/01.ATV.17.9.1806
   Ramamurthi A, 2000, ANN BIOMED ENG, V28, P174, DOI 10.1114/1.242
   Ramamurthi A, 1998, ANN BIOMED ENG, V26, P1036, DOI 10.1114/1.34
   Ramamurthi A, 1999, ANN BIOMED ENG, V27, P411, DOI 10.1114/1.184
   RAO GHR, 1990, BIOCHEM MED METAB B, V43, P271, DOI 10.1016/0885-4505(90)90034-X
   REIMERS HJ, 1985, PLATELETS PHYSL PHAR, P85
   ROBSON RC, 2000, EMERGING THER TARGET, V4, P1
   Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153
   RUGGERI ZM, 1993, THROMB HAEMOSTASIS, V70, P119
   Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034
   STEINER M, 1970, BLOOD, V25, P727
   VALLES J, 1993, THROMB HAEMOSTASIS, V69, P633
NR 37
TC 13
Z9 13
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0049-3848
J9 THROMB RES
JI Thromb. Res.
PD MAY 15
PY 2001
VL 102
IS 4
BP 331
EP 341
DI 10.1016/S0049-3848(01)00244-4
PG 11
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 434YW
UT WOS:000168844300005
PM 11369426
DA 2018-10-19
ER

PT J
AU Zisch, AH
   Schenk, U
   Schense, JC
   Sakiyama-Elbert, SE
   Hubbell, JA
AF Zisch, AH
   Schenk, U
   Schense, JC
   Sakiyama-Elbert, SE
   Hubbell, JA
TI Covalently conjugated VEGF-fibrin matrices for endothelialization
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Proceedings Paper
CT 6th European Symposium on Controlled Drug Delivery
CY APR 12-14, 2000
CL NOORDWIJK AAN ZEE, NETHERLANDS
SP Alza Corp, Inst Biomed Technol, Univ Twente, Janssen Pharmaceut, Novartis Pharma AG, NV Organon Akzo Nobel, Sam Yang Corp
ID FIBROBLAST GROWTH-FACTOR; EXPANDED POLYTETRAFLUOROETHYLENE GRAFTS;
   INTRAMUSCULAR GENE-TRANSFER; ENHANCES NEURITE EXTENSION; SMOOTH-MUSCLE;
   MYOCARDIAL ANGIOGENESIS; ISCHEMIC MYOCARDIUM; CELL-PROLIFERATION; VESSEL
   DEVELOPMENT; GLUE SUSPENSIONS
AB Vascular endothelial growth factor (VEGF) is a key factor in endothelial cell biology and blood vessel formation and a candidate therapeutic for the stimulation of angiogenesis-dependent tissue regeneration. The objective of this study was to confer the angiogenic activity of VEGF(121) upon the biomaterial fibrin, a natural substrate for endothelial cell growth and clinically accepted as 'fibrin glue'. To achieve this, we engineered fibrin-based hydrogels that were covalently modified with VEGF(121). Our laboratory has recently developed novel methodology that allows the covalent incorporation of exogenous bioactive peptides by the transglutominase activity of factor XIIIa into fibrin during cogulation. Here, this ability of factor XIIIa to crosslink additional proteins within fibrin was employed to covalently incorporate VEGF(121). By recombinant DNA methodology, a mutant VEGF(121) variant, alpha (2)-PI1-8-VEGF(121), which contains an additional factor XIIIa substrate sequence NQEQVSPL at the aminoterminus, was expressed in E. coli. In soluble form, the mutant protein fully retained its mitogenic activity for endothelial cells. Using I-125-labeled alpha (2)-PI1-8-VEGF(121), its covalent incorporation and the efficiency of incorporation into fibrin was demonstrated and characterized. The immobilized, fibrin-conjugated VEGF(121) protein remained an active and very efficient mitogen for human endothelial cells grown on two-dimensional VEGF(121)-modified fibrin surfaces, and the incorporation of increasing amounts of alpha (2)-PI1-8-VEGF(121) resulted in dose-dependent enhancement of endothelial cell growth. The VEGF-modified fibrin matrices can be formed as injectable gels in a single-step reaction under physiological conditions in vivo. When used as a ingrowth matrix, such VEGF incorporating materials could be useful in a variety of clinical situations that require an angiogenic response into an ischemic region or inplant. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 ETH Zurich, Dept Mat, CH-8044 Zurich, Switzerland.
   ETH Zurich, Inst Biomed Engn, CH-8044 Zurich, Switzerland.
   Univ Zurich, CH-8044 Zurich, Switzerland.
RP Zisch, AH (reprint author), ETH Zurich, Dept Mat, Moussonstr 18, CH-8044 Zurich, Switzerland.
RI Hubbell, Jeffrey/A-9266-2008; Sakiyama-Elbert, Shelly/A-6753-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456; Sakiyama-Elbert,
   Shelly/0000-0003-4832-5851
CR ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793
   ASAHARA T, 1996, CIRCULATION, V94, P2892
   BANAI S, 1994, CIRCULATION, V89, P2183, DOI 10.1161/01.CIR.89.5.2183
   Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114
   Birkenhager R, 1996, BIOCHEM J, V316, P703, DOI 10.1042/bj3160703
   Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   Deutsch M, 1997, J VASC SURG, V25, P757, DOI 10.1016/S0741-5214(97)70307-0
   FASOL R, 1994, J THORAC CARDIOV SUR, V107, P1432
   Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0
   Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019
   Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928
   GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047
   GREISLER HP, 1992, SURGERY, V112, P244
   HOUCK KA, 1992, J BIOL CHEM, V267, P26031
   KANG SS, 1995, SURGERY, V118, P280, DOI 10.1016/S0039-6060(05)80335-6
   Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800
   LOSORDO DW, 1999, AM HEART J, V138, P132
   PEARLMAN JD, 1995, NAT MED, V1, P1085, DOI 10.1038/nm1095-1085
   PU LQ, 1993, CIRCULATION, V88, P208, DOI 10.1161/01.CIR.88.1.208
   Rosengart TK, 1999, CIRCULATION, V100, P468, DOI 10.1161/01.CIR.100.5.468
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Schumacher B, 1998, CIRCULATION, V97, P645, DOI 10.1161/01.CIR.97.7.645
   Shireman PK, 1999, J VASC SURG, V29, P852, DOI 10.1016/S0741-5214(99)70213-2
   TAKESHITA S, 1994, CIRCULATION, V90, P228
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952
   Tsurumi Y, 1996, CIRCULATION, V94, P3281, DOI 10.1161/01.CIR.94.12.3281
   VanBelle E, 1997, J AM COLL CARDIOL, V29, P1371, DOI 10.1016/S0735-1097(97)00049-1
   VanBelle E, 1997, CIRCULATION, V95, P438
   Wang JS, 1996, J ORTHOP RES, V14, P316, DOI 10.1002/jor.1100140222
   Weatherford DA, 1996, SURGERY, V120, P433, DOI 10.1016/S0039-6060(96)80320-5
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   YANAGISAWAMIWA A, 1992, SCIENCE, V257, P1401, DOI 10.1126/science.1382313
   ZILLA P, 1994, SURGERY, V116, P524
   ZILLA P, 1989, SURGERY, V105, P515
NR 41
TC 246
Z9 251
U1 3
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAY 14
PY 2001
VL 72
IS 1-3
BP 101
EP 113
DI 10.1016/S0168-3659(01)00266-8
PG 13
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 445MZ
UT WOS:000169462800011
PM 11389989
DA 2018-10-19
ER

PT J
AU Tiller, JC
   Bonner, G
   Pan, LC
   Klibanov, AM
AF Tiller, JC
   Bonner, G
   Pan, LC
   Klibanov, AM
TI Improving biomaterial properties of collagen films by chemical
   modification
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE collagen; chemical modification; fibroblast cell attachment; endothelial
   cell attachment; bacterial adhesion; biomaterials
ID BACTERIAL ADHESION; POLYETHYLENE OXIDE; CELL-ADHESION; SURFACES;
   BIOCOMPATIBILITY; STENTS
AB Films of bovine collagen were chemically modified with the goal of improving their biomaterial properties. The modified films were investigated with respect to their affinity to fibroblast and endothelial cells, as well as their antibacterial properties tested by adhesion of Staphylococcus aureus. Modifications that only change the net charge of collagen, such as acetylation, succinylation, and treatment with glutaraldehyde tall increase the negative charge), and amination with ethylenediamine (EDA), N,N-dimethyl-EDA (DMEDA), or butylamine tall increase the positive charge), did not dramatically alter the mammalian cell attachment to the film. In contrast, derivatization of collagen using methoxypoly(ethylene glycol) (PEG] diminished the attachment of fibroblasts by 98 +/- 1% and of endothelial cells by more than 99% compared to unmodified collagen. Moreover, the rate of growth of fibroblasts dropped by 97 +/- 1% and that of endothelial cells by 88 +/- 3% as a result of PEGylation of collagen. Adhesion of S. aureus cells also plummeted by 93 +/- 2% as a result of this PEGylation. With these antifouling properties, PEG-collagen may be a promising coating material for coronary stents. Subsequent derivatization of PEG-collagen with EDA or DMEDA abolished its mammalian cell-repelling ability, whereas bacterial cell repulsion was partially retained: for example, DMEDA-modified PEG-collagen exhibits up to a 5-fold lower bacterial adhesion than collagen. It is worth noting that a material that allows mammalian cell attachment but reduces bacterial adhesion could be useful as an implant or coating. (C) 2001 John Wiley & Sons, Inc.
C1 MIT, Dept Chem, Cambridge, MA 02139 USA.
   Ind Technol Res Inst, Ctr Biomed Engn, Chu Tung 300, Taiwan.
RP Klibanov, AM (reprint author), MIT, Dept Chem, Cambridge, MA 02139 USA.
RI Tiller, Joerg/S-2010-2016
CR Ahmed K, 2000, MICROB PATHOGENESIS, V28, P203, DOI 10.1006/mpat.1999.0342
   Altankov G, 1996, J BIOMAT SCI-POLYM E, V8, P299
   Atala A, 2000, J ENDOUROL, V14, P49, DOI 10.1089/end.2000.14.49
   Bailey AJ, 2000, WOUND REPAIR REGEN, V8, P5, DOI 10.1046/j.1524-475x.2000.00005.x
   BORDIN S, 1984, J PERIODONTAL RES, V19, P642, DOI 10.1111/j.1600-0765.1984.tb01332.x
   Cloft HJ, 2000, RADIOLOGY, V214, P557, DOI 10.1148/radiology.214.2.r00fe21557
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   Damink L. H. H. O., 1994, J MATER SCI-MATER M, V6, P460
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Deible CR, 1998, BIOMATERIALS, V19, P1885, DOI 10.1016/S0142-9612(98)00098-2
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   Doyle Ron J., 1994, Trends in Microbiology, V2, P57, DOI 10.1016/0966-842X(94)90127-9
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Grewe PH, 2000, Z KARDIOL, V89, P21, DOI 10.1007/s003920050004
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P163
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   JACOBSON BS, 1982, TISSUE CELL, V14, P69, DOI 10.1016/0040-8166(82)90008-8
   KAHALEH MB, 1992, CLIN EXP RHEUMATOL, V10, P51
   KARESH JW, 1991, OPHTHALMIC PLAST REC, V7, P278, DOI 10.1097/00002341-199112000-00008
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   KSANDER GA, 1985, ANN PLAS SURG, V14, P351, DOI 10.1097/00000637-198504000-00009
   Lifshitz DA, 1999, J ENDOUROL, V13, P735, DOI 10.1089/end.1999.13.735
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   OKADA T, 1992, BIOMATERIALS, V13, P448, DOI 10.1016/0142-9612(92)90165-K
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   RHEE W, 1997, ACS SYM SER, P420
   Rozenman Y, 1996, J INVASIVE CARDIOL, V8, P438
   SRIVASTAVA S, 1990, BIOMATERIALS, V11, P161
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Vladkova T, 1999, J BIOMAT SCI-POLYM E, V10, P609, DOI 10.1163/156856299X00838
NR 34
TC 50
Z9 53
U1 4
U2 23
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD MAY 5
PY 2001
VL 73
IS 3
BP 246
EP 252
DI 10.1002/bit.1057
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 422ZY
UT WOS:000168151500009
PM 11257607
DA 2018-10-19
ER

PT J
AU Webb, K
   Budko, E
   Neuberger, TJ
   Chen, SZ
   Schachner, M
   Tresco, PA
AF Webb, K
   Budko, E
   Neuberger, TJ
   Chen, SZ
   Schachner, M
   Tresco, PA
TI Substrate-bound human recombinant L1 selectively promotes neuronal
   attachment and outgrowth in the presence of astrocytes and fibroblasts
SO BIOMATERIALS
LA English
DT Article
DE cell adhesion molecules; L1; neurons; astrocytes
ID CENTRAL-NERVOUS-SYSTEM; RAT SPINAL-CORD; ADHESION MOLECULE L1;
   CORTICOSPINAL AXONAL GROWTH; ADULT PARAPLEGIC RATS; CELL-ADHESION;
   NEURITE EXTENSION; SCHWANN-CELLS; EXTRACELLULAR-MATRIX; SURFACE
   MODIFICATION
AB Axonal pathfinding is a complex process that is mediated through cell-matrix and cell-cell interactions. A large number of studies have demonstrated that ECM and ECM-derived proteins and peptides are potent promoters of neurite outgrowth, however much less attention is given to the fact that these same ligands also elicit responses in a wide variety of non-neuronal cell types. We examined the use of a substrate-bound recombinant form of human LI, an integral membrane protein, as a ligand for bridging materials for repairing the CNS by studying its effectiveness in promoting specific responses of neuronal cells in the presence of astrocytes and fibroblasts. LI, a cell adhesion molecule expressed in the developing CNS and PNS, has strong neurite promoting activity, and contributes to axonal guidance and axonal fasciculation during development. In this study, substrates treated with L1-Fc were compared to subtrates treated with fibronectin and poly-lysine (PDL) with respect to their interaction with a variety of cell types, including three types of neurons (DRG neurons, cerebellar granule neurons, and hippocampal neurons), astrocytes, dermal fibroblasts, and meningeal cells. L1-Fc-treated substrates supported significantly higher levels of neurite outgrowth relative to fibronectin and PDL, while inhibiting the attachment of astrocytes, meningeal cells, and fibroblasts. We also show that neuronal cells attach to and extend neurites on 30 mum diameter L l-Fc-treated filaments as an example of a potentially useful bridging substrate. The high level of biological specificity displayed by surface-bound L1, along with the fact that it is a potent promoter of neurite outgrowth, is normally expressed on axons and regulates axonal fasciculation during normal development bodes well for its use on bridging materials For the repair of the CNS, and suggests that cell adhesion molecules, in general, may be useful for biomaterial modification. Moreover, small diameter filaments coated with L1-Fc may function in an analogous way to pioneering axons that guide the growth of axons to distal targets during development. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, Salt Lake City, UT 84112 USA.
   Acorda Therapeut, Hawthorne, NY 10532 USA.
   Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany.
RP Tresco, PA (reprint author), Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, 20 South 2030 East, Salt Lake City, UT 84112 USA.
CR Anderson PN, 1998, PROG BRAIN RES, V117, P211
   BEBBINGTON C R, 1991, Methods (Orlando), V2, P136, DOI 10.1016/S1046-2023(05)80214-2
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3
   CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723
   Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6
   Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510
   Cheng HR, 1997, EXP NEUROL, V148, P544, DOI 10.1006/exnr.1997.6708
   COHEN NR, 1997, CURR BIOL, V8, P26
   DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034
   Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999
   Duczmal A, 1997, BIOCHEM BIOPH RES CO, V232, P236, DOI 10.1006/bbrc.1997.6265
   Edelman GM, 1998, BRAIN RES REV, V26, P337, DOI 10.1016/S0165-0173(97)00034-9
   Fawcett JW, 1997, CELL TISSUE RES, V290, P371, DOI 10.1007/s004410050943
   Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944
   Grill R, 1997, J NEUROSCI, V17, P5560
   HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   JOOSTEN EAJ, 1995, J NEUROSCI RES, V41, P481, DOI 10.1002/jnr.490410407
   Joosten EAJ, 1997, PROG NEUROBIOL, V53, P1, DOI 10.1016/S0301-0082(97)00024-5
   Kadmon G, 1997, DIFFERENTIATION, V61, P143, DOI 10.1046/j.1432-0436.1997.6130143.x
   Kadmon G, 1998, Dev Immunol, V6, P205, DOI 10.1155/1998/23451
   Kenwrick S, 1998, BIOESSAYS, V20, P668, DOI 10.1002/(SICI)1521-1878(199808)20:8<668::AID-BIES10>3.0.CO;2-X
   KHAN T, 1991, BRAIN RES, V541, P139, DOI 10.1016/0006-8993(91)91087-H
   KLEITMAN N, 1988, EXP NEUROL, V102, P298, DOI 10.1016/0014-4886(88)90223-3
   KOBAYASHI S, 1995, NEUROSCI LETT, V188, P191, DOI 10.1016/0304-3940(95)11429-Z
   LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753
   LEMMON V, 1992, J NEUROSCI, V12, P818
   Li JT, 1996, BIOCONJUGATE CHEM, V7, P592, DOI 10.1021/bc960048v
   Liu Y, 1999, J NEUROSCI, V19, P4370
   MARCHAND R, 1990, NEUROSCIENCE, V36, P45, DOI 10.1016/0306-4522(90)90350-D
   Martinez-Morales JR, 1997, DEVELOPMENT, V124, P5139
   MARTINI R, 1994, GLIA, V10, P70, DOI 10.1002/glia.440100109
   MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081
   Montgomery AMP, 1996, J CELL BIOL, V132, P475, DOI 10.1083/jcb.132.3.475
   Nakahara Y, 1996, CELL TRANSPLANT, V5, P191, DOI 10.1016/0963-6897(95)02028-4
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Oleszewski M, 1999, J BIOL CHEM, V274, P24602, DOI 10.1074/jbc.274.35.24602
   Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803
   RAMONCUETO A, 1995, GLIA, V14, P163, DOI 10.1002/glia.440140302
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531
   RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0
   ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0
   RUDGE JS, 1989, EXP NEUROL, V103, P1, DOI 10.1016/0014-4886(89)90180-5
   Ruppert M, 1995, J CELL BIOL, V131, P1881, DOI 10.1083/jcb.131.6.1881
   Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R
   SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0
   Schwab ME, 1996, PHYSIOL REV, V76, P319
   SMITH GM, 1986, J COMP NEUROL, V251, P23, DOI 10.1002/cne.902510103
   SMITH GV, 1988, EXP BRAIN RES, V69, P299
   SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2
   Stichel CC, 1998, PROG NEUROBIOL, V56, P119, DOI 10.1016/S0301-0082(98)00033-1
   Tong YW, 1998, J BIOMED MATER RES, V42, P85, DOI 10.1002/(SICI)1097-4636(199810)42:1<85::AID-JBM11>3.3.CO;2-R
   Tong YW, 1998, J BIOMAT SCI-POLYM E, V9, P713, DOI 10.1163/156856298X00109
   Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425
   WEBB K, IN PRESS J BIOMED MA
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   Woolhead CL, 1998, J COMP NEUROL, V391, P259
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   Xu XM, 1997, J NEUROCYTOL, V26, P1, DOI 10.1023/A:1018557923309
   Yu XJ, 1999, TISSUE ENG, V5, P291, DOI 10.1089/ten.1999.5.291
   ZHANG Y, 1995, J COMP NEUROL, V361, P193, DOI 10.1002/cne.903610202
   ZHANG Y, MOL CELL NEUROSCI
NR 66
TC 44
Z9 45
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2001
VL 22
IS 10
BP 1017
EP 1028
DI 10.1016/S0142-9612(00)00353-7
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 425ZT
UT WOS:000168325100002
PM 11352083
DA 2018-10-19
ER

PT J
AU Yuan, HP
   de Bruijn, JD
   Zhang, XD
   van Blitterswijk, CA
   de Groot, K
AF Yuan, HP
   de Bruijn, JD
   Zhang, XD
   van Blitterswijk, CA
   de Groot, K
TI Bone induction by porous glass ceramic made from Bioglass (R) (45S5)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE calcium phosphate-based biomaterials; glass ceramic; osteoconduction;
   osteoinduction; soft tissue implantation
ID CALCIUM-PHOSPHATE CERAMICS; HYDROXYAPATITE ORBITAL IMPLANTS; BIOACTIVE
   GLASS; OSTEOINDUCTION; BIOMATERIALS; DOGS; OSTEOGENESIS; PARTICLES;
   RESPONSES; TISSUE
AB Porous glass ceramic, which was prepared from Bioglass(R) powder (45S5, U.S. Biomaterials) by foaming with diluted H2O2 solution and sintering at 1000 degreesC for 2 h. was implanted as cylinders (5 mm in diameter and 6 mm in length) in thigh muscles of dogs for 3 months. Histological observation was made on thin un-decalcified sections. Bone formation was histologically found in pores of all implants (X16) retrieved from 16 dogs. The bone tissue was also identified with backscattered scanning electron microscopy observation (BSE) and energy dispersive X-ray microanalysis (EDX). This is the first report of hone induction in soft tissues of animals by glass ceramic that has long been recognized as a bioactive (osteoconductive) biomaterial. The present results justify the impetus to investigate the osteoinductivity of calcium phosphate-based biomaterials, to study the mechanism of bone induction (osteoinduction) by calcium phosphate-based biomaterials, to develop osteoinductive calcium phosphate-based biomaterials, and to examine the relation between osteoinduction and osteoconduction. (C) 2001 John Wiley & Sons, Inc.
C1 IsoTis NV, NL-3723 MB Bilthoven, Netherlands.
   Leiden Univ, Biomat Res Grp, NL-2300 RA Leiden, Netherlands.
   Sichuan Univ, Inst Mat Sci & Technol, Chengdu, Peoples R China.
RP Yuan, HP (reprint author), IsoTis NV, Prof Bronkhotstlaan 10, NL-3723 MB Bilthoven, Netherlands.
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR BOUABBOUD NN, 1994, BIOMATERIALS, V15, P201, DOI 10.1016/0142-9612(94)90068-X
   BRUDER SP, 1999, CLIN ORTHOP S, V367, P68
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   de Bruijn J D, 1999, Adv Dent Res, V13, P74
   DEBRUIJN JD, 1999, P 25 ANN M SOC BIOM, P235
   Ducheyne P, 1997, TISSUE ENG, V3, P219, DOI 10.1089/ten.1997.3.219
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   GREEN JP, 1995, AM J OPHTHALMOL, V120, P681, DOI 10.1016/S0002-9394(14)72222-6
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   LANE JM, 1999, CLIN ORTHOP S, V367, P107
   Ohgushi H., 1996, BIOCERAMICS, V9, P49
   OSBORN JF, 1991, BIOMATERIALS DEGRADA, P185
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   Schepers EJG, 1997, J ORAL REHABIL, V24, P171
   Sires BS, 1997, OPHTHALMIC PLAST REC, V13, P244, DOI 10.1097/00002341-199712000-00003
   TOTH JM, 1993, BIOCERAMICS, V6, P9
   Vargervik K., 1992, BONE GRAFTS BONE SUB, P112
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   YAMASAKI H, 1992, BIOMATERIALS, V13, P308, DOI 10.1016/0142-9612(92)90054-R
   Yamasaki H., 1990, JPN J ORAL BIOL, V32, P190, DOI DOI 10.2330/JORALBIOSCI1965.32.190
   Yang ZJ, 1997, J MATER SCI-MATER M, V8, P697, DOI 10.1023/A:1018540024082
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   YUAN H, 1997, BIOMEDICAL MAT RES F, P228
   YUAN H, IN PRESS J MATER SCI
   Yuan H, 1997, BIOMED ENG-APP BAS C, V9, P274
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zhang XD, 1991, BIOCERAMICS HUMAN BO, P408
NR 33
TC 140
Z9 150
U1 1
U2 32
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY 1
PY 2001
VL 58
IS 3
BP 270
EP 276
DI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 432HX
UT WOS:000168687100007
PM 11319740
DA 2018-10-19
ER

PT J
AU Bowen, WR
   Lovitt, RW
   Wright, CJ
AF Bowen, WR
   Lovitt, RW
   Wright, CJ
TI Atomic force microscopy study of the adhesion of Saccharomyces
   cerevisiae
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE adhesion; atomic force microscopy; saccharomyces cerevisiae
ID SURFACE-PROPERTIES; STAPHYLOCOCCUS-EPIDERMIDIS; BIOMATERIAL SURFACES;
   BIOLOGICAL ADHESION; BACTERIAL ADHESION; ORAL STREPTOCOCCI; SOLID
   SUBSTRATA; CELL; MECHANISMS; YEASTS
AB An atomic force microscope (AFM) has been used to quantify directly the adhesion of metabolically active Saccharomyces cerevisiae cells at a hydrophilic mica surface, a mica surface with a hydrophobic coating, and a protein-coated mica surface in an aqueous environment. The measurements used "cell probes" constructed by immobilizing a single cell at the apex of a tipless AFM cantilever. Adhesion was quantified from force-distance data for the retraction of the cell from the surface. The data indicated stretching and sequential bond-breaking as the cell probe was retracted from all of the surfaces. Detailed studies were made for physiologically active cells, which were shown to have different adhesion properties to glutaraldehyde-treated cells. Greatest cell adhesion was measured at the hydrophobic surface. Prior adsorption of a bovine serum albumin protein layer at the hydrophilic surface did not significantly affect cell adhesion. Changes in yeast surface hydrophobicity and zeta-potential with yeast cell age were correlated with differences in adhesion. Cells from the stationary phase adhered most strongly to a mica surface. Time of surface contact was demonstrated to be important. Both the force needed to detach a cell from a hydrophilic mica surface and the length of the adhesive interaction increased after 5 min contact. The AFM cell probe technique gives unique insights into primary colonization events in biofilm formation. It will continue to aid both fundamental studies and the assessment of new procedures that are designed to lower cell adhesion at surfaces relevant to biotechnology, medicine, and dentistry. (C) 2001 Academic Press.
C1 Univ Wales, Dept Chem & Biol Proc Engn, Ctr Complex Fluids Proc, Swansea SA2 8PP, W Glam, Wales.
RP Bowen, WR (reprint author), Univ Wales, Dept Chem & Biol Proc Engn, Ctr Complex Fluids Proc, Swansea SA2 8PP, W Glam, Wales.
OI Lovitt, robert/0000-0002-5587-2776; Wright, Chris/0000-0003-2375-8159
CR AMORY DE, 1988, J I BREWING, V94, P79, DOI 10.1002/j.2050-0416.1988.tb04561.x
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Azeredo J, 1999, COLLOID SURFACE B, V14, P141, DOI 10.1016/S0927-7765(99)00031-4
   BELLONFONTAINE MN, 1990, CELL BIOPHYS, V17, P93, DOI 10.1007/BF02989805
   Bowen WR, 1999, COLLOID SURFACE A, V157, P117, DOI 10.1016/S0927-7757(99)00045-X
   Bowen WR, 2000, J COLLOID INTERF SCI, V228, P428, DOI 10.1006/jcis.2000.6969
   Bowen WR, 1998, J COLLOID INTERF SCI, V197, P348, DOI 10.1006/jcis.1997.5247
   Bowen WR, 1999, J MEMBRANE SCI, V154, P205
   Bowen WR, 1998, COLLOID SURFACE A, V136, P231, DOI 10.1016/S0927-7757(97)00243-4
   Bowen WR, 2001, J MATER SCI, V36, P623, DOI 10.1023/A:1004864219379
   BOWEN WR, 1990, J MEMBRANE SCI, V51, P189, DOI 10.1016/S0376-7388(00)80902-3
   BOWEN WR, 1992, BIOTECHNOL BIOENG, V40, P1309, DOI 10.1002/bit.260401104
   CAMPBELL I, 1988, YEAST PRACTICAL APPR, P277
   Cereghino GPL, 1999, CURR OPIN BIOTECH, V10, P422, DOI 10.1016/S0958-1669(99)00004-X
   Chang KC, 1996, LANGMUIR, V12, P2271, DOI 10.1021/la950690y
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   DENGIS PB, 1995, APPL ENVIRON MICROB, V61, P718
   DOUGLAS LJ, 1987, YEASTS, V2, P240
   DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0
   Hammer DA, 1996, ANNU REV MATER SCI, V26, P651
   Hazen KC, 1990, MICROBIAL CELL SURFA, P249
   Heinz WF, 1999, TRENDS BIOTECHNOL, V17, P143, DOI 10.1016/S0167-7799(99)01304-9
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   HOH JH, 1994, J CELL SCI, V107, P1105
   Loosdrecht M, 1990, AQUAT SCI, V52, P103
   LUCKHAM PF, 1994, ADV COLLOID INTERFAC, V49, P341, DOI 10.1016/0001-8686(94)80019-7
   Millsap KW, 1999, J COLLOID INTERF SCI, V212, P495, DOI 10.1006/jcis.1998.6054
   Millsap KW, 1998, FEMS MICROBIOL REV, V21, P321, DOI 10.1111/j.1574-6976.1998.tb00356.x
   Ming F, 1998, ENZYME MICROB TECH, V22, P94, DOI 10.1016/S0141-0229(97)00136-1
   Mittelman M. W., 1996, BACTERIAL ADHESION M, P89
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   PRATTTERPSTRA IH, 1988, CURR MICROBIOL, V16, P311, DOI 10.1007/BF01568537
   Razatos A, 1998, J BIOMAT SCI-POLYM E, V9, P1361, DOI 10.1163/156856298X00442
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x
   Sagvolden G, 1999, P NATL ACAD SCI USA, V96, P471, DOI 10.1073/pnas.96.2.471
   SJOLLEMA J, 1990, J ADHES SCI TECHNOL, V4, P765, DOI 10.1163/156856190X00658
   SMART KA, 1995, J AM SOC BREW CHEM, V53, P33
   Stanier R. Y., 1968, GEN MICROBIOLOGY
   Toikka G, 1996, J COLLOID INTERF SCI, V180, P329, DOI 10.1006/jcis.1996.0311
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   Veeramasuneni S, 1996, J COLLOID INTERF SCI, V184, P594, DOI 10.1006/jcis.1996.0656
   VERNHET A, 1995, COLLOID SURFACE B, V3, P255
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   Whittaker CJ, 1996, ANNU REV MICROBIOL, V50, P513, DOI 10.1146/annurev.micro.50.1.513
   WOJCIECHOWSKI PW, 1996, INTERFACIAL PHENOMEN, P1
   WRIGHT CJ, 1995, THESIS U WALES SWANS
NR 47
TC 110
Z9 115
U1 1
U2 41
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD MAY 1
PY 2001
VL 237
IS 1
BP 54
EP 61
DI 10.1006/jcis.2001.7437
PG 8
WC Chemistry, Physical
SC Chemistry
GA 428CE
UT WOS:000168442900008
DA 2018-10-19
ER

PT J
AU Quirk, RA
   Davies, MC
   Tendler, SJB
   Chan, WC
   Shakesheff, KM
AF Quirk, RA
   Davies, MC
   Tendler, SJB
   Chan, WC
   Shakesheff, KM
TI Controlling biological interactions with poly(lactic acid) by surface
   entrapment modification
SO LANGMUIR
LA English
DT Article
ID POLYMERIC BIOMATERIALS; POLY(ETHYLENE GLYCOL); POLYETHYLENE-GLYCOL;
   ADHESION; COPOLYMERS; RESOLUTION; OXIDE); FILMS; XPS
AB Poly(ethylene glycol) (PEG)-modified poly(lactic acid) (PLA) systems were created by physically entrapping the modifying species at the PLA surface. The surface characterization and biological performance of these materials are described. This modification strategy is performed by reversible gelation of the PLA surface following exposure to a solvent/nonsolvent mixture. PEG is then able to diffuse into the swollen surface region, before it is collapsed by the addition of more nonsolvent. This results in the localized physical entrapment of the diffused material. We have demonstrated by high-resolution X-ray photoelectron spectroscopy that control over the PEG surface density may be achieved by using predetermined process conditions, such as a particular solvent/nonsolvent ratio or a set polymer treatment time, and that surface coverage of around 75% is possible. Cell adhesion studies have shown that even in serum-containing media PEG entrapment will prevent attachment, with a 95% reduction in cell number compared to unmodified PLA. This modification strategy was also used to coentrap both PEG and poly(L-lysine)-RGD within the PLA surface region. The attachment of cells to this material shows that the entrapment approach may be used to create highly selective biomaterial surfaces that are able to prevent unwanted cell or protein adhesion yet actively promote specific cellular interaction.
C1 Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England.
RP Shakesheff, KM (reprint author), Univ Nottingham, Sch Pharmaceut Sci, Univ Pk, Nottingham NG7 2RD, England.
RI Chan, Weng/O-2045-2015; Shakesheff, Kevin/O-6371-2018
OI Chan, Weng/0000-0002-0488-825X; Shakesheff, Kevin/0000-0003-3236-2439;
   Davies, Martyn/0000-0001-7695-0596
CR BEAMSON G, 1990, SURF INTERFACE ANAL, V15, P541, DOI 10.1002/sia.740150908
   Bearinger JP, 1998, J BIOMAT SCI-POLYM E, V9, P629, DOI 10.1163/156856298X00064
   Burg KJL, 1999, J BIOMAT SCI-POLYM E, V10, P147, DOI 10.1163/156856299X00108
   Carlisle ES, 2000, TISSUE ENG, V6, P45, DOI 10.1089/107632700320883
   CIMA LG, 1991, BIOTECHNOL BIOENG, V38, P145, DOI 10.1002/bit.260380207
   CUMPSON PJ, 1995, J ELECTRON SPECTROSC, V73, P25, DOI 10.1016/0368-2048(94)02270-4
   Deible CR, 1998, BIOMATERIALS, V19, P1885, DOI 10.1016/S0142-9612(98)00098-2
   DESAI NP, 1992, MACROMOLECULES, V25, P226, DOI 10.1021/ma00027a038
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   Dunn SE, 1997, J CONTROL RELEASE, V44, P65, DOI 10.1016/S0168-3659(96)01504-0
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   GELIUS U, 1990, J ELECTRON SPECTROSC, V52, P747, DOI 10.1016/0368-2048(90)85063-F
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Grifftih I. G., 2000, ACTA MAT, V48, P263
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Huh KM, 1999, POLYMER, V40, P6147, DOI 10.1016/S0032-3861(98)00822-2
   Park A, 1998, J BIOMAT SCI-POLYM E, V9, P89, DOI 10.1163/156856298X00451
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Quirk RA, 2000, MACROMOLECULES, V33, P258, DOI 10.1021/ma9916133
   Shard AG, 1997, MACROMOLECULES, V30, P3051, DOI 10.1021/ma9519021
   Sheth M, 1997, J APPL POLYM SCI, V66, P1495, DOI 10.1002/(SICI)1097-4628(19971121)66:8<1495::AID-APP10>3.0.CO;2-3
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
NR 24
TC 54
Z9 58
U1 2
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 1
PY 2001
VL 17
IS 9
BP 2817
EP 2820
DI 10.1021/la001509a
PG 4
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 426XD
UT WOS:000168373000043
DA 2018-10-19
ER

PT J
AU Burden, DL
   Poppen, SD
   Elliott, JT
   Woodward, JT
   Sehgal, A
AF Burden, DL
   Poppen, SD
   Elliott, JT
   Woodward, JT
   Sehgal, A
TI Probing surface diffusion heterogeneity at biomaterial interfaces with
   single-event histograms.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Wheaton Coll, Dept Chem, Wheaton, IL 60187 USA.
   Natl Inst Stand & Technol, Wheaton, IL 60187 USA.
   Natl Inst Stand & Technol, Div Biotechnol, Wheaton, IL 60187 USA.
   Natl Inst Stand & Technol, Div Polymers, Wheaton, IL 60187 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 1
PY 2001
VL 221
MA 145-PHYS
BP U249
EP U249
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 434PJ
UT WOS:000168824801469
DA 2018-10-19
ER

PT J
AU Stammen, JA
   Williams, S
   Ku, DN
   Guldberg, RE
AF Stammen, JA
   Williams, S
   Ku, DN
   Guldberg, RE
TI Mechanical properties of a novel PVA hydrogel in shear and unconfined
   compression
SO BIOMATERIALS
LA English
DT Article
DE biomaterial; cartilage; properties; compression; shear; hydrogel
ID ARTICULAR-CARTILAGE; DRUG-DELIVERY; STRENGTH
AB Poly(vinyl alcohol) (PVA) hydrogels have been proposed as promising biomaterials to replace diseased or damaged articular cartilage. A critical barrier to their use as load-bearing tissue replacements is a lack of sufficient mechanical properties. The purpose of this study was to characterize the functional compressive and shear mechanical properties of a novel PVA hydrogel. Two formulations of the biomaterial were tested, one with a lower water content (75% water), and the other with higher water content (80% water). The compressive tangent modulus varied with biomaterial formulation and was found to be statistically strain magnitude and rate dependent. Over a strain range of 10-60%, the compressive modulus increased from approximately 1-18 MPa, which is within the range of the modulus of articular cartilage. The shear tangent modulus (0.1-0.4 MPa) was also found to be strain magnitude dependent and within the range of normal human articular cartilage, but it was not statistically dependent on strain rate. This behavior was attributed to the dominance of fluid flow and related frictional drag on the viscoelastic behavior. Compressive failure of the hydrogels was found to occur between 45 and 60% strain, depending on water content. (C) 2001 Published by Elsevier Science Ltd.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Restore Therapeut, Atlanta, GA 30318 USA.
RP Guldberg, RE (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 315 Ferst Dr NW,IBB Bldg,Room 2311, Atlanta, GA 30332 USA.
CR Ambrosio L, 1998, P I MECH ENG H, V212, P93, DOI 10.1243/0954411981533863
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   *ARTHR FDN, 1999, DEM EC INF
   BRAY JC, 1973, J BIOMED MATER RES, V7, P431, DOI 10.1002/jbm.820070506
   BUCKWALTER JA, 1994, J BONE JOINT SURG AM, V76A, P1405, DOI 10.2106/00004623-199409000-00019
   CauichRodriguez JV, 1996, BIOMATERIALS, V17, P2259, DOI 10.1016/0142-9612(96)00058-0
   Corkhill P H, 1990, Proc Inst Mech Eng H, V204, P147, DOI 10.1243/PIME_PROC_1990_204_249_02
   CORKHILL PH, 1993, J BIOMAT SCI-POLYM E, V4, P615, DOI 10.1163/156856293X00834
   DiTizio V, 1998, BIOMATERIALS, V19, P1877, DOI 10.1016/S0142-9612(98)00096-9
   Kerin AJ, 1998, P I MECH ENG H, V212, P273, DOI 10.1243/0954411981534051
   Ku DN, 1999, [US Patent, Poly(vinyl alcohol) Cryogel Patent], Patent No. 5981826
   Li JK, 1998, J CONTROL RELEASE, V56, P117, DOI 10.1016/S0168-3659(98)00089-3
   LOPOUR P, 1993, BIOMATERIALS, V14, P1051, DOI 10.1016/0142-9612(93)90204-F
   Mow Van C., 1997, P113
   OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Vijayasekaran S, 1998, BIOMATERIALS, V19, P2255, DOI 10.1016/S0142-9612(98)00128-8
   WILLIAMS S, 1998, THESIS GEORGIA ITECH
   Young CD, 1998, BIOMATERIALS, V19, P1745, DOI 10.1016/S0142-9612(98)00083-0
   Zheng-Qiu G, 1998, BIO-MED MATER ENG, V8, P75
NR 20
TC 342
Z9 355
U1 18
U2 269
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2001
VL 22
IS 8
BP 799
EP 806
DI 10.1016/S0142-9612(00)00242-8
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 404UK
UT WOS:000167120000006
PM 11246948
DA 2018-10-19
ER

PT J
AU Yamauchi, K
   Takeuchi, N
   Kurimoto, A
   Tanabe, T
AF Yamauchi, K
   Takeuchi, N
   Kurimoto, A
   Tanabe, T
TI Films of collagen crosslinked by S-S bonds: preparation and
   characterization
SO BIOMATERIALS
LA English
DT Article
DE biomaterial; collagen; collagenase; disulfide bond; fibroblast cell;
   thiolation
ID EPIDERMAL-CELLS; TISSUE; GROWTH; SKIN; EPITHELIUM; SUBSTRATA; CULTURES;
   ADHESION; INVITRO
AB Collagen (type I from calf-skin) was chemically modified by 4-butyrothiolactone to obtain the mercapto group-bearing collagen (collagenSH), which possessed SH groups in 8-19 M% of a total amino acid residues. The triple helical strands of the collagen was not completely perturbed to exhibit the rotary dispersion [theta](221), which was as much as 70% of an original intensity of the collagen. In the presence of the oxygen dissolved in water, the collagenSH was cross-linked by disulfide bonds to afford the collagenSS. The collagenSS could preserve about 15 and 40% of an original helix structure at 55-70 degreesC and in 2 mm sodium dodecyl sulfate, respectively. The film made of the collagenSS exhibited the tensile strength as high as 36 MPa and was insoluble in most organic solvents including water. The collagenSS film was more resistant to degradation by collagenase (type I) than the collagen film. The collagenSS film supported the growth of L929 fibroblast cell in a manner similar to a collagen film. (C) 2001 Published by Elsevier Science Ltd.
C1 Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, Osaka 5588585, Japan.
RP Yamauchi, K (reprint author), Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, Osaka 5588585, Japan.
EM yamauchi@bioa.eng.osaka-cu.ac.jp
CR BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BENESCH R, 1962, BIOCHIM BIOPHYS ACTA, V63, P166, DOI 10.1016/0006-3002(62)90349-9
   BENESCH R, 1958, P NATL ACAD SCI USA, V44, P848, DOI 10.1073/pnas.44.9.848
   BRUICE TC, 1964, J AM CHEM SOC, V86, P4886, DOI 10.1021/ja01076a032
   BUTTERWORTH PH, 1967, ARCH BIOCHEM BIOPHYS, V118, P716, DOI 10.1016/0003-9861(67)90409-2
   CHVAPIL M, 1979, BIOL COLLAGEN, V1, P247
   DUNN MW, 1969, ARCH OPHTHALMOL-CHIC, V82, P840
   DUNN MW, 1967, SCIENCE, V157, P1329, DOI 10.1126/science.157.3794.1329
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   EMERMAN JT, 1977, P NATL ACAD SCI USA, V74, P4466, DOI 10.1073/pnas.74.10.4466
   FEENEY RE, 1982, ADV CHEM SER, P3
   FEUGHELMAN M, 1985, ENCY POLYM SCI ENG, V8, P566
   GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706
   Grab B, 1996, J BIOL CHEM, V271, P12234, DOI 10.1074/jbc.271.21.12234
   GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665
   GRNAT DS, 1986, J CELL BIOL, V108, P1567
   HARRINGTON WF, 1966, ANNU REV BIOCHEM, V35, P599, DOI 10.1146/annurev.bi.35.070166.003123
   HEIDEMANN E, 1982, ADV POLYM SCI, V43, P143
   HUBBELL JA, 1995, TISSUE ENG, P42
   KENDALL PA, 1969, BIOCHIM BIOPHYS ACTA, V188, P10, DOI 10.1016/0005-2795(69)90040-3
   KLOTZ IM, 1964, BIOCHIM BIOPHYS ACTA, V86, P100, DOI 10.1016/0304-4165(64)90163-1
   Lesage A, 1996, BIOCHEMISTRY-US, V35, P9647, DOI 10.1021/bi952666p
   LOWRY TH, 1976, MECH THEORY ORGANIC, P177
   MARINKOVICH MP, 1986, J CELL PHYSIOL, V128, P61, DOI 10.1002/jcp.1041280111
   Matsuda S, 1999, J BIOMED MATER RES, V45, P20, DOI 10.1002/(SICI)1097-4636(199904)45:1<20::AID-JBM3>3.0.CO;2-6
   MIYATA T, 1974, Patent No. 4939174
   MIYATA T, 1980, Patent No. 4260228
   NIMNI ME, 1988, COLLAGEN BIOTECHNOLO, V3
   NUSGENS B, 1984, COLLAGEN REL RES, V4, P351
   Piez K. A., 1985, ENCY POLYM SCI ENG, P699
   ROJKIND M, 1980, J CELL BIOL, V87, P255, DOI 10.1083/jcb.87.1.255
   RUBIN K, 1977, EXP CELL RES, V109, P413, DOI 10.1016/0014-4827(77)90021-0
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   STENZEL RH, 1969, T AM SOC ART INT ORG, V15, P114
   STROM SC, 1982, METHOD ENZYMOL, V82, P544
   Stryer L., 1988, BIOCHEMISTRY
   TAKADA M, 1992, Patent No. 450369
   TOBOLSKY AV, 1971, POLYM SCI MAT, P83
   WICHA MS, 1979, EXP CELL RES, V124, P181, DOI 10.1016/0014-4827(79)90268-4
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   YOSHIZATO K, 1988, J CELL SCI, V91, P491
   YOSHIZATO K, 1986, BIOMED RES-TOKYO, V7, P219
NR 45
TC 24
Z9 25
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2001
VL 22
IS 8
BP 855
EP 863
DI 10.1016/S0142-9612(00)00249-0
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 404UK
UT WOS:000167120000012
PM 11246954
DA 2018-10-19
ER

PT J
AU Werkmeister, JA
   Tebb, TA
   White, JF
   Ramshaw, JAM
AF Werkmeister, JA
   Tebb, TA
   White, JF
   Ramshaw, JAM
TI Collagenous tissue formation in association with medical implants
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
DE collagens; extracellular matrix; immunohistology; connective tissue;
   implant
ID ABDOMINAL-WALL DEFECTS; VASCULAR PROSTHESIS; BOVINE COLLAGEN;
   MONOCLONAL-ANTIBODIES; CAPSULAR CONTRACTURE; BREAST AUGMENTATION;
   BIOMATERIAL IMPLANT; TEXTURED SILICONE; FIBROUS CAPSULE; SMOOTH SILICONE
AB The host response to a biomaterial includes assembly of an effective collagenous matrix that is critical for the long-term performance of a medical implant. Despite the development of methods that allow detailed examination of the non-cellular matrix components, particularly collagens, relatively little information is available on the extent of molecular variability in the collagen matrix that is associated with various alternative implant materials. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 CSIRO Mol Sci, Parkville, Vic 3052, Australia.
RP Werkmeister, JA (reprint author), CSIRO Mol Sci, 343 Royal Parade, Parkville, Vic 3052, Australia.
CR ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   Asplund O, 1996, PLAST RECONSTR SURG, V97, P1200, DOI 10.1097/00006534-199605000-00015
   Bisucci T, 2000, METH MOL B, V123, P291
   BRODSKY B, 1994, INT J BIOL MACROMOL, V16, P27, DOI 10.1016/0141-8130(94)90007-8
   BROHIM RM, 1992, ANN PLAS SURG, V28, P354, DOI 10.1097/00000637-199204000-00010
   BUCKY LP, 1994, PLAST RECONSTR SURG, V93, P1123, DOI 10.1097/00006534-199405000-00002
   Bujan J, 1997, HISTOL HISTOPATHOL, V12, P683
   BURKE KE, 1985, ANN PLAS SURG, V14, P515, DOI 10.1097/00000637-198506000-00004
   Chirila TV, 1996, GRAEF ARCH CLIN EXP, V234, P193, DOI 10.1007/BF00462032
   Clark R.A.F., 1988, MOL CELLULAR BIOL WO
   Drubaix I, 1996, EXP EYE RES, V62, P367, DOI 10.1006/exer.1996.0042
   Hakelius L, 1997, PLAST RECONSTR SURG, V100, P1566, DOI 10.1097/00006534-199711000-00030
   Hammerstad M, 1996, SCAND J PLAST RECONS, V30, P33, DOI 10.3109/02844319609072402
   HASSON JE, 1986, J VASC SURG, V4, P243, DOI 10.1067/mva.1986.avs0040243
   HERING TM, 1986, CONNECT TISSUE RES, V15, P141, DOI 10.3109/03008208609167139
   HUNT JA, 1993, J BIOMED ENG, V15, P39, DOI 10.1016/0141-5425(93)90091-C
   Jacob JT, 1996, J BIOMED MATER RES, V32, P181, DOI 10.1002/(SICI)1097-4636(199610)32:2<181::AID-JBM5>3.0.CO;2-P
   KASPER CS, 1994, AM J CLIN PATHOL, V102, P655, DOI 10.1093/ajcp/102.5.655
   KEEFE J, 1992, Clinical Materials, V9, P155, DOI 10.1016/0267-6605(92)90095-B
   KETHARNATHAN V, 1980, ARCH SURG-CHICAGO, V115, P967
   Koch G, 1997, AUST NZ J SURG, V67, P637, DOI 10.1111/j.1445-2197.1997.tb04614.x
   KOHRI M, 1990, J ORAL MAXIL SURG, V48, P1265, DOI 10.1016/0278-2391(90)90480-P
   Legeais JM, 1997, J BIOMED MATER RES, V36, P49
   LEGEROS RZ, 1993, J BONE MINER RES, V8, pS583
   LINDER L, 1983, ACTA ORTHOP SCAND, V54, P45, DOI 10.3109/17453678308992868
   MARCACCI M, 1991, CLIN ORTHOP RELAT R, P115
   MARSHALL WR, 1989, ANN PLAS SURG, V23, P401, DOI 10.1097/00000637-198911000-00004
   McFarland CD, 1999, J BIOMED MATER RES, V44, P1
   Moreschini O, 1997, J ARTHROPLASTY, V12, P695, DOI 10.1016/S0883-5403(97)90144-3
   OKADA T, 1993, J BIOMED MATER RES, V27, P1509, DOI 10.1002/jbm.820271207
   OONO T, 1993, J INVEST DERMATOL, V100, P329, DOI 10.1111/1523-1747.ep12470022
   PRESCOTT RJ, 1994, J CLIN PATHOL, V47, P375, DOI 10.1136/jcp.47.4.375
   Ramshaw JAM, 1999, J BIOMED MATER RES, V47, P309, DOI 10.1002/(SICI)1097-4636(19991205)47:3<309::AID-JBM4>3.0.CO;2-R
   RAMSHAW JAM, 1988, J BIOMED MATER RES, V23, P649
   Ramshaw John A. M., 1994, Clinical Materials, V16, P9, DOI 10.1016/0267-6605(94)90086-8
   Rosengren A, 1996, BIOMATERIALS, V17, P1779, DOI 10.1016/0142-9612(95)00358-4
   SCHINDHELM K, 1991, CLIN ORTHOP RELAT R, P278
   Schneider U, 1998, J ARTHROPLASTY, V13, P687, DOI 10.1016/S0883-5403(98)80014-4
   SCHREUDERS PD, 1988, J BIOMED MATER RES, V22, P121, DOI 10.1002/jbm.820220205
   Shanklin DR, 1999, EXP MOL PATHOL, V67, P26, DOI 10.1006/exmp.1999.2269
   Shannon C, 1997, J BIOMED MATER RES, V34, P401, DOI 10.1002/(SICI)1097-4636(19970305)34:3<401::AID-JBM15>3.0.CO;2-I
   STEGMAN SJ, 1987, ARCH DERMATOL, V123, P1644, DOI 10.1001/archderm.123.12.1644
   Tarpila E, 1997, PLAST RECONSTR SURG, V99, P1934, DOI 10.1097/00006534-199706000-00019
   Trumpy IG, 1997, SCAND J PLAST RECONS, V31, P295, DOI 10.3109/02844319709008975
   Ungersbock A, 1996, BIOMATERIALS, V17, P797, DOI 10.1016/0142-9612(96)81417-7
   VIALLEPRESLES MJ, 1989, HISTOCHEMISTRY, V91, P177, DOI 10.1007/BF00490129
   VONRECUM AF, 1993, J BIOMED MATER RES, V27, P757, DOI 10.1002/jbm.820270608
   Wallace D. G., 1988, COLLAGEN, V3, P117
   WALLACE DG, 1992, J BIOMED MATER RES, V26, P1517, DOI 10.1002/jbm.820261110
   Werkmeister J A, 1991, J Long Term Eff Med Implants, V1, P107
   WERKMEISTER JA, 1993, J HISTOCHEM CYTOCHEM, V41, P1701, DOI 10.1177/41.11.8409376
   WERKMEISTER JA, 1991, J HISTOCHEM CYTOCHEM, V39, P1215, DOI 10.1177/39.9.1918939
   WERKMEISTER JA, 1994, MED PROG TECHNOL, V20, P231
   WERKMEISTER JA, 1995, J LONG-TERM EFF MED, V5, P1
   WERKMEISTER JA, 1990, EUR J BIOCHEM, V187, P439, DOI 10.1111/j.1432-1033.1990.tb15323.x
   Werkmeister JA, 1998, J BIOMED MATER RES, V39, P429, DOI 10.1002/(SICI)1097-4636(19980305)39:3<429::AID-JBM12>3.0.CO;2-5
   WERKMEISTER JA, 1991, BIOCHEM J, V274, P895, DOI 10.1042/bj2740895
   Werkmeister JA, 2000, BIOMATERIALS ENG DEV, V1, P121
   White Jacinta F., 1993, Clinical Materials, V14, P271, DOI 10.1016/0267-6605(93)90013-W
   Wyatt LE, 1998, PLAST RECONSTR SURG, V102, P1922, DOI 10.1097/00006534-199811000-00017
   Zaffagnini S, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P89, DOI 10.1007/s001670050033
NR 61
TC 8
Z9 8
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-0286
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD APR-JUN
PY 2001
VL 5
IS 2-3
BP 185
EP 191
DI 10.1016/S1359-0286(01)00007-9
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 451CJ
UT WOS:000169783300011
DA 2018-10-19
ER

PT J
AU Malouf, AJ
   Vaizey, CJ
   Norton, CS
   Kamm, MA
AF Malouf, AJ
   Vaizey, CJ
   Norton, CS
   Kamm, MA
TI Internal anal sphincter augmentation for fecal incontinence using
   injectable silicone biomaterial
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article
DE silicone; sphincter; augmentation
ID DYNAMIC GRACILOPLASTY; AUTOLOGOUS FAT; INJECTION; MICROIMPLANTS;
   STIMULATION; MANAGEMENT
AB PURPOSE: A disrupted or weak internal anal sphincter can lead to passive fecal incontinence. This muscle is not amenable to direct surgical repair. Previous preliminary at tempts to restore functional continuity have included a cutaneous flap to fill an anal canal defect, and injection therapy using polytetrafluoroethylene, collagen, or autologous fat. Urologists have also used injections of collagen or silicone to enhance bladder neck function. This pilot study aimed to assess the efficacy of single or multiple injections of the silicone-based product Bioplastique(TM) for the symptoms of passive fecal incontinence caused by an anatomically disrupted or intact but weak internal anal sphincter. PATIENTS AND METHODS: Ten patients (6 females; median age, 64; range, 41-80 years) with passive incontinence secondary to a weak (n = 6) or disrupted (n = 4) internal anal sphincter a ere injected either circumferentially or at a single site, respectively. Patients were assessed before and six weeks after treatment by clinical assessment, two-week bowel diary card, anorectal physiologic testing, and endoanal ultrasound. Patients failing to show improvement after the first injection were offered a second injection six weeks after the first injection. Clinical assessment was further repeated at six months, and five patients had a further ultrasound examination. RESULTS: At six weeks, six of ten patients showed either marked improvement (n = 3) or complete cessation of leakage (n = 3). A further patient was greatly improved after a second injection. Three patients were not improved. At six months, two of the seven patients had maintained marked improvement, and one patient had maintained minor improvement; all of these three patients had circumferential multiple injections. Maximum resting and squeeze anal pressures did not differ significantly between before vs, six weeks after vs. six months after injection. At six weeks endoanal ultrasound (n = 9) confirmed the presence and correct position of the silicone in all but one patient who had experienced obvious external leakage of the product. At six months the silicone remained in the correct position in the five endosonographically assessed patients. Five of the initial patients experienced pain or minor ulceration at the injection site. CONCLUSIONS: Although clinically effective immediately after injection, the benefit of an injectable biomaterial was maintained in only a minority of patients. This occurred despite the continued presence of material in the correct anatomical site. Patients With diffuse weakness treated by circumferential injection seemed to be the most responsive, but further studies are required to clarify this.
C1 St Marks Hosp, London EC1V 2PS, England.
RP Malouf, AJ (reprint author), St Marks Hosp, City Rd, London EC1V 2PS, England.
CR BEISANG AA, 1992, AESTHET PLAST SURG, V16, P83, DOI 10.1007/BF00455154
   Bernardi C, 1998, PLAST RECONSTR SURG, V102, P1626, DOI 10.1097/00006534-199810000-00046
   BURNETT SJD, 1991, INT J COLORECTAL DIS, V6, P2, DOI 10.1007/BF00703951
   DUTHIE LH, 1965, GUT, V6, P64
   ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538
   ENGEL AF, 1994, GUT, V35, P857, DOI 10.1136/gut.35.6.857
   ENGEL AF, 1994, BRIT J SURG, V81, P1069, DOI 10.1002/bjs.1800810749
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P693, DOI 10.1097/00006534-199104000-00014
   FRENCKNER B, 1975, GUT, V16, P482, DOI 10.1136/gut.16.6.482
   Geerdes BP, 1996, DIS COLON RECTUM, V39, P912, DOI 10.1007/BF02053991
   Harriss DR, 1996, BRIT J UROL, V78, P722, DOI 10.1046/j.1464-410X.1996.17510.x
   Kumar D, 1998, BRIT J SURG, V85, P978
   Lehur PA, 1996, DIS COLON RECTUM, V39, P1352, DOI 10.1007/BF02054523
   Leroi AM, 1997, INT J COLORECTAL DIS, V12, P243, DOI 10.1007/s003840050098
   LESTAR B, 1989, INT J COLORECTAL DIS, V4, P118, DOI 10.1007/BF01646870
   LODER PB, 1994, BRIT J SURG, V81, P946, DOI 10.1002/bjs.1800810707
   MALOUF A, 1999, DIS COLON RECTUM, V42, pA12
   MATZEL KE, 1995, LANCET, V346, P1124, DOI 10.1016/S0140-6736(95)91799-3
   Morgan R, 1997, BRIT J SURG, V84, P226, DOI 10.1002/bjs.1800840225
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Sielezneff I, 1999, BRIT J SURG, V86, P61
   Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X
   Vaizey CJ, 1999, GUT, V44, P407, DOI 10.1136/gut.44.3.407
   WILLIAMS N, 1995, DIS COLON RECTUM, V38, P700, DOI 10.1007/BF02048025
   Wong WD, 1996, DIS COLON RECTUM, V39, P1345
NR 26
TC 61
Z9 63
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD APR
PY 2001
VL 44
IS 4
BP 595
EP 600
DI 10.1007/BF02234337
PG 6
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 424PX
UT WOS:000168241600022
PM 11330591
DA 2018-10-19
ER

PT J
AU Reid, G
   Habash, M
   Vachon, D
   Denstedt, J
   Riddell, J
   Beheshti, M
AF Reid, G
   Habash, M
   Vachon, D
   Denstedt, J
   Riddell, J
   Beheshti, M
TI Oral fluoroquinolone therapy results in drug adsorption on ureteral
   stents and prevention of biofilm formation
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Article; Proceedings Paper
CT 6th International Symposium on Clinical Evaluation of Drug Efficacy in
   Urinary Tract Infection held at the 21st International Chemotherapy
   Congress
CY JUL, 1999
CL BIRMINGHAM, ENGLAND
DE ciprofloxacin; ofloxacin; medical devices; biofilms
ID URINARY CATHETER; CIPROFLOXACIN; ADHESION; SYSTEMS
AB The oral administration of ciprofloxacin (250mg bid) and ofloxacin (300mg bid) in 40 patients with ureteral stents, led to drug levels on all the device surfaces that were higher than the minimum inhibitory concentration (MIC) of Escherichia coli (0.004-0.015 mg/l). the most common uropathogen. The drug levels in the film were higher than the MIC of other common pathogens, namely Psuedomonas aeruginosa (0.25-1.0 mg/l), E,Enterococcus faecalis (0.25-2.0 mg/l) and Staphylococcus aureus (0.12-0.5 mg/l) in a few cases (six, three and 14 cases out of 40, respectively). For both antibiotics, the concentrations were greater than the MIC of many uropathogens on the film surrounding the devices (0.89) vs 0.31 mg/l respectively, (P = 0.05), and on the devices themselves (0.22 vs. 0.12 mg/l. P=0.207). Adsorption of the antibiotics was higher to the film than to the stent (P < 0.0001). Ciprofloxacin concentration on the film surrounding the stents was significantly higher than that of ofloxacin (P = 0.05), while there was no statistical concentration difference between the two antibiotics adsorbed onto the actual devices (P = 0.207). No bacteria were found in patients' urine and no biofilms were detected. This is the first report of an oral antibiotic being adsorbed onto medical devices. it potentially provides a new approach of preventing infection, and avoids the need to pre-coat devices with agents whose use will be restricted once bacteria develop resistance to them. If biomaterial properties can be enhanced to increase further the adsorptive concentration of drug, the risk of infections and recalcitrant biofilm formation could be significantly reduced in a highly susceptible patient population, <(c)> 2001 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
C1 Lawson Hlth Res Inst, Div Urol, London, ON N6A 4V2, Canada.
   Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada.
   Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada.
   Peele Mem Hosp, Dept Urol, Brampton, ON, Canada.
RP Reid, G (reprint author), Lawson Hlth Res Inst, Div Urol, 268 Grosvenor St, London, ON N6A 4V2, Canada.
CR BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777
   JOHNSON JR, 1990, J INFECT DIS, V162, P1145, DOI 10.1093/infdis/162.5.1145
   *NAT COMM CLIN LAB, 1997, M7A4 NCCLS, V17
   Pearle MS, 1997, UROLOGY, V49, P679, DOI 10.1016/S0090-4295(96)00626-7
   Raad I, 1996, J INFECT DIS, V173, P418, DOI 10.1093/infdis/173.2.418
   REID G, 1994, ANTIMICROB AGENTS CH, V38, P1490, DOI 10.1128/AAC.38.7.1490
   REID G, 1992, J UROLOGY, V148, P1592, DOI 10.1016/S0022-5347(17)36976-8
   REID G, 1998, BIOFILMS, P423
   RUSS BR, 1994, ANAESTH INTENS CARE, V22, P611
   Schierholz JM, 1997, ARZNEIMITTEL-FORSCH, V47, P70
   SHERERTZ RJ, 1989, ANTIMICROB AGENTS CH, V33, P1174, DOI 10.1128/AAC.33.8.1174
   STAMM WE, 1991, AM J MED, V91, pS65, DOI 10.1016/0002-9343(91)90345-X
   Stickler DJ, 1996, BRIT J UROL, V78, P579, DOI 10.1046/j.1464-410X.1996.16915.x
NR 13
TC 36
Z9 36
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD APR
PY 2001
VL 17
IS 4
BP 317
EP 320
DI 10.1016/S0924-8579(00)00353-8
PG 4
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 421DH
UT WOS:000168046500016
PM 11295415
DA 2018-10-19
ER

PT J
AU Pariente, JL
   Kim, BS
   Atala, A
AF Pariente, JL
   Kim, BS
   Atala, A
TI In vitro biocompatibility assessment of naturally derived and synthetic
   biomaterials using normal human urothelial cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biocompatibility; urothelial cells; natural biomaterials; synthetic
   polymers
ID SMALL-INTESTINAL SUBMUCOSA; VESICOURETERAL REFLUX; COLORIMETRIC ASSAY;
   IN-VITRO; COLLAGEN MATRIX; URINARY-BLADDER; CYTO-TOXICITY; INVITRO;
   CULTURE; CHONDROCYTES
AB The reconstruction of urinary tissues often employs various types of biomaterials, and adequate material biocompatibility is essential for the successful reconstruction of urinary tissues. In this study we utilized a primary normal human urothelial cell culture system to evaluate the in vitro biocompatibility of a number of naturally derived biomaterials [i.e., bladder submucosa, small intestinal submucosa, collagen, and alginate] and polymeric biomaterials [i.e., poly(glycolic acid), poly(L-lactic acid), poly(lactic-co-glycolic acid), and silicone] that are either experimentally or clinically used in urinary reconstructive surgery. To determine the cytotoxic and bioactive effects of these biomaterials, the cell-viability, metabolic activity, apoptotic properties, and DNA-synthesis activity were measured with four types of assays [Neutral Red, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, apoptotic activity, and tritiated thymidine incorporation assays] using extract and direct contact methods. Most of the biomaterials tested did not induce significant cytotoxic effects and exhibited normal metabolic function and cell growth in vitro. This normal primary human urothelial cell culture model is suitable for in vitro biocompatibility assessments and is able to provide information on the cell-biomaterial interactions and the ability of biomaterials to support bioactive cell functions. (C) 2000 John Wiley & Sons, Inc.
C1 Childrens Hosp, Lab Tissue Engn & Cellular Therapeut, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
RP Atala, A (reprint author), Childrens Hosp, Lab Tissue Engn & Cellular Therapeut, Boston, MA 02115 USA.
RI Kim, Byung-Soo/O-2352-2013
OI Atala, Anthony/0000-0001-8186-2160
CR [Anonymous], 1992, ISO109935
   [Anonymous], 1991, ANN BOOK ASTM
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5
   ATALA A, 1993, J UROLOGY, V150, P608, DOI 10.1016/S0022-5347(17)35561-1
   ATALA A, 1993, J UROLOGY, V150, P745, DOI 10.1016/S0022-5347(17)35603-3
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   BAZEED MA, 1983, UROLOGY, V21, P53, DOI 10.1016/0090-4295(83)90123-1
   BONNAR J, 1977, LANCET, V2, P1161
   Brauers A, 1998, Tech Urol, V4, P214
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   CILENTO BG, 1994, J UROLOGY, V152, P665, DOI 10.1016/S0022-5347(17)32676-9
   Diamond DA, 1999, J UROLOGY, V162, P1185, DOI 10.1016/S0022-5347(01)68124-2
   Gilding D., 1981, BIOCOMPATIBILITY CLI, V2, P209
   HENLY DR, 1995, J UROLOGY, V153, P2039, DOI 10.1016/S0022-5347(01)67398-1
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Kassaby El A., 2000, Journal of Urology, V163, P70
   Kim B. -S., 2000, PRINCIPLES TISSUE EN, P655
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lattari Vincent, 1997, Journal of Burn Care and Rehabilitation, V18, P147, DOI 10.1097/00004630-199703000-00010
   MOHAMMED R, 1987, UROL RES, V15, P239
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   OZTURK SS, 1990, BIOTECHNOL PROGR, V6, P121, DOI 10.1021/bp00002a005
   Pariente JL, 1998, J BIOMED MATER RES, V40, P31, DOI 10.1002/(SICI)1097-4636(199804)40:1<31::AID-JBM4>3.0.CO;2-S
   Pariente JL, 1998, UROLOGY, V52, P524, DOI 10.1016/S0090-4295(98)00198-8
   Pariente JL, 2000, BIOMATERIALS, V21, P835, DOI 10.1016/S0142-9612(99)00253-7
   PARISH CR, 1983, J IMMUNOL METHODS, V58, P225, DOI 10.1016/0022-1759(83)90277-6
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Pope JC, 1997, J UROLOGY, V158, P1105, DOI 10.1016/S0022-5347(01)64398-2
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   TACHIBANA M, 1985, J UROLOGY, V133, P866, DOI 10.1016/S0022-5347(17)49268-8
   UPHILL PF, 1990, MED DEVICE TECHN NOV, P24
   Winfrey M E, 1999, Dimens Crit Care Nurs, V18, P14, DOI 10.1097/00003465-199901000-00003
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 40
TC 134
Z9 146
U1 0
U2 20
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2001
VL 55
IS 1
BP 33
EP 39
DI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.0.CO;2-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 398JM
UT WOS:000166753400005
PM 11426395
DA 2018-10-19
ER

PT J
AU Jones, LC
   Frondoza, C
   Hungerford, DS
AF Jones, LC
   Frondoza, C
   Hungerford, DS
TI Effect of PMMA particles and movement on an implant interface in a
   canine model
SO JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
LA English
DT Article
ID TOTAL HIP-ARTHROPLASTY; CEMENTED ACETABULAR COMPONENTS; LOCALIZED
   BONE-RESORPTION; POLYETHYLENE WEAR DEBRIS; SYNOVIAL-LIKE MEMBRANE;
   IN-VITRO; FEMORAL COMPONENTS; METALLIC DEBRIS; PARTICULATE
   POLYMETHYLMETHACRYLATE; MECHANICAL FAILURE
AB The pathogenesis of aseptic loosening of total joint prostheses is not clearly understood, Two features are associated with loosened prostheses, namely, particulate debris and movement of the implant. While numerous studies have evaluated the cellular response to particulate biomaterials, few have investigated the influence of movement of the implant on the biological response to particles. Our aim was therefore to test the hypothesis that excessive mechanical stimulation of the periprosthetic tissues induces an inflammatory response and that the addition of particulate biomaterials intensifies this.
   We allocated 66 adult Beagle dogs to four groups as follows: stable implants with (I) and without (II) particulate polymethylmethacrylate (PMMA) and moving implants with (III) and without (IV) particulate PMMA, They were then evaluated at 2, 4, 6, 12 and 24 weeks.
   The stable implants were well tolerated and a thin, fibrous membrane of connective tissue was observed. There was evidence of positive staining in some cells for interleukin-6 (IL-6), Addition of particulate PMMA around the stable implants resulted in an increase in the fibroblastic response and positive staining for IL-6 and tumour necrosis factor-alpha (TNF-alpha). By contrast, movement of the implant resulted in an immediate inflammatory response characterised by large numbers of histiocytes and cytokine staining for IL-1 beta, TNF-alpha and IL-6, Introduction of particulate PMMA aggravated this response. Animals with particulate PMMA and movement of the implant have an intense inflammatory response associated with accelerated bone loss.
   Our results indicate that the initiation of the inflammatory response to biomaterial particles was much slower than that to gross mechanical instability. Furthermore, when there was both particulate debris and movement, there was an amplification of the adverse tissue response as evidenced by the presence of osteolysis and increases in the presence of inflammatory cells and their associated cytokines.
C1 Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21239 USA.
RP Jones, LC (reprint author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Suite 201,Good Samaritan Profess Bldg, Baltimore, MD 21239 USA.
FU NIEHS NIH HHS [ES 07141]
CR ALSAFFAR N, 1994, BRIT J RHEUMATOL, V33, P309
   Aspenberg P, 1996, J BONE JOINT SURG BR, V78B, P641
   BECHTOLD JE, 1996, T ORS, V21, P71
   BLOEBAUM RD, 1994, CLIN ORTHOP RELAT R, P19
   CAMPBELL P, 1995, J BIOMED MATER RES, V29, P127, DOI 10.1002/jbm.820290118
   CARLSSON AS, 1983, ACTA ORTHOP SCAND, V54, P396, DOI 10.3109/17453678308996591
   CHIBA J, 1994, CLIN ORTHOP RELAT R, V300, P304
   Cila E, 1994, J Arthroplasty, V9, P67, DOI 10.1016/0883-5403(94)90139-2
   CLARKE IC, 1992, AM SOC TEST MATER, V1144, P7, DOI 10.1520/STP14848S
   CUCKLER JM, 1992, AM SOC TEST MATER, V1144, P118, DOI 10.1520/STP14858S
   DAVIS RG, 1993, J BIOMED MATER RES, V27, P1039, DOI 10.1002/jbm.820270809
   DORR LD, 1990, CLIN ORTHOP RELAT R, V261, P82
   DOWD JE, 1995, CLIN ORTHOP RELAT R, V319, P106
   EMMANUAL J, 1992, AM SOC TEST MATER, V1144, P143, DOI 10.1520/STP14861S
   EMMANUAL J, 1987, SOC BIOM S RETR AN S
   FRONDOZA C, 1994, T 40 ANN M ORTH RES, V19, P154
   GALANTE JO, 1991, J ORTHOPAED RES, V9, P760, DOI 10.1002/jor.1100090516
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOLDRING SR, 1992, AM SOC TEST MATER, V1144, P136, DOI 10.1520/STP14860S
   GOODMAN S, 1993, ACTA ORTHOP SCAND, V64, P627, DOI 10.3109/17453679308994585
   GOODMAN S, 1995, J APPL BIOMATER, V6, P161, DOI 10.1002/jab.770060303
   Goodman SB, 1996, J BIOMED MATER RES, V31, P421, DOI 10.1002/(SICI)1097-4636(199607)31:3<421::AID-JBM17>3.0.CO;2-L
   GOODMAN SB, 1991, ARCH ORTHOP TRAUM SU, V110, P123, DOI 10.1007/BF00395792
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, V244, P182
   GOODMAN SB, 1988, CLIN ORTHOP RELAT R, V232, P255
   GRUEN TA, 1979, CLIN ORTHOP RELAT R, P17
   HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46
   HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005
   HAYNES DR, 1993, J BONE JOINT SURG AM, V75A, P825, DOI 10.2106/00004623-199306000-00004
   HEIMKE G, 1981, ARCH ORTHOP TRAUM SU, V98, P165, DOI 10.1007/BF00632973
   HERMAN JH, 1989, J BONE JOINT SURG AM, V71A, P1530, DOI 10.2106/00004623-198971100-00012
   HOROWITZ SM, 1991, J ORTHOPAED RES, V9, P406, DOI 10.1002/jor.1100090313
   HOROWITZ SM, 1993, J BONE JOINT SURG AM, V75A, P802, DOI 10.2106/00004623-199306000-00002
   HOROWITZ SM, 1995, J BIOMED MATER RES, V29, P477, DOI 10.1002/jbm.820290407
   HOWIE DW, 1988, J BONE JOINT SURG AM, V70A, P257, DOI 10.2106/00004623-198870020-00015
   HOWIE DW, 1993, ORTHOP CLIN N AM, V24, P571
   HUDDLESTON HD, 1994, SEMINARS ARTHROPLAST, V4, P2
   JASTY M, 1991, J BONE JOINT SURG BR, V73, P551
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   KIM KJ, 1994, J BONE JOINT SURG AM, V76A, P172, DOI 10.2106/00004623-199402000-00002
   KIM KJ, 1993, CLIN ORTHOP RELAT R, P142
   Kozinn S C, 1986, J Arthroplasty, V1, P249, DOI 10.1016/S0883-5403(86)80015-8
   La Budde J K, 1994, J Arthroplasty, V9, P291, DOI 10.1016/0883-5403(94)90084-1
   LEE JM, 1992, J BONE JOINT SURG BR, V74, P380
   LENNOX DW, 1987, T SOC BIOMATERIALS, V10, P133
   LENNOX DW, 1987, CLIN ORTHOP RELAT R, V225, P171
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1448, DOI 10.2106/00004623-199509000-00022
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   MALONEY WJ, 1990, J BONE JOINT SURG BR, V72, P966
   MALONEY WJ, 1993, J BONE JOINT SURG AM, V75A, P835, DOI 10.2106/00004623-199306000-00005
   Manlapaz M, 1996, J ORTHOP RES, V14, P465, DOI 10.1002/jor.1100140317
   MARGEVICIUS KJ, 1994, J BONE JOINT SURG AM, V76A, P1664, DOI 10.2106/00004623-199411000-00010
   MCDONALD DJ, 1988, J BONE JOINT SURG AM, V70A, P728, DOI 10.2106/00004623-198870050-00014
   MIRRA JM, 1982, CLIN ORTHOP RELAT R, V170, P175
   MULROY RD, 1990, J BONE JOINT SURG BR, V72, P757
   Mulroy WF, 1995, J BONE JOINT SURG AM, V77A, P1845, DOI 10.2106/00004623-199512000-00008
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   PIERMATTEL DL, 1979, ATLAS SURG APPROACHE
   RAE T, 1975, J BONE JOINT SURG BR, V57, P444
   Sabokbar A, 1995, J ARTHROPLASTY, V10, P810, DOI 10.1016/S0883-5403(05)80080-4
   SALVATI EA, 1993, CLIN ORTHOP RELAT R, V293, P160
   SCHMALZRIED TP, 1992, CLIN ORTHOP RELAT R, P60
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   SCHMALZRIED TP, 1993, J APPL BIOMATER, V4, P119, DOI 10.1002/jab.770040202
   SCHULLER HM, 1993, ACTA ORTHOP SCAND, V64, P613, DOI 10.3109/17453679308994583
   SCHWENDEMAN L, 1993, T ORS, V18, P511
   SHANBHAG AS, 1995, J ARTHROPLASTY, V10, P498, DOI 10.1016/S0883-5403(05)80152-4
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   SPECTOR M, 1990, CLIN ORTHOP RELAT R, V261, P140
   STJOHN K, 1992, PARTICULATE DEBRIS M
   TAKAGI M, 1995, J ORTHOP RES, V13, P296, DOI 10.1002/jor.1100130218
   TSAO A, 1993, T 19 ANN M SOC BIOM, V16, P239
   WANG JT, 1993, BRIS MYER Z, P119
   WRIGHT T, 1995, IMPLANT WEAR FUTURE
NR 78
TC 33
Z9 34
U1 0
U2 2
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 0301-620X
EI 2044-5377
J9 J BONE JOINT SURG BR
JI J. Bone Joint Surg.-Br. Vol.
PD APR
PY 2001
VL 83B
IS 3
BP 448
EP 458
DI 10.1302/0301-620X.83B3.10734
PG 11
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 426KK
UT WOS:000168348200027
PM 11341436
OA Bronze
DA 2018-10-19
ER

PT J
AU Chauvel-Lebret, DJ
   Pellen-Mussi, P
   Auroy, P
   Bonnaure-Mallet, M
AF Chauvel-Lebret, DJ
   Pellen-Mussi, P
   Auroy, P
   Bonnaure-Mallet, M
TI Adaptation of the comet test to the assessment of biomaterial
   genotoxicity
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 Univ Rennes 1, Fac Med, Lab Biomat Site Osseux, F-35014 Rennes, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD APR
PY 2001
VL 80
IS 4
BP 1238
EP 1238
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 497VL
UT WOS:000172476102051
DA 2018-10-19
ER

PT J
AU Kim, HM
AF Kim, HM
TI Bone-biomaterial interface.
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 Seoul Natl Univ, Dept Oral Anat, Coll Dent, Intellectual Biointerface Engn Ctr, Seoul, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD APR
PY 2001
VL 80
IS 4
BP 1348
EP 1348
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 497VL
UT WOS:000172476102769
DA 2018-10-19
ER

PT J
AU Midy, V
   Hollande, E
   Rey, C
   Dard, M
   Plouet, J
AF Midy, V
   Hollande, E
   Rey, C
   Dard, M
   Plouet, J
TI Adsorption of vascular endothelial growth factor to two different
   apatitic materials and its release
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CELLS; HYDROXYAPATITE; OSTEOBLASTS; INDUCTION; PROTEIN
AB The aim of our study was to assess the ability of calcium phosphate powders to serve as growth factor carriers. Vascular endothelial growth factor (VEGF), in particular, is locally involved in the bone formation process throughout osteoblast differentiation. Two different apatitic substrates were tested: hydroxyapatite (HA), widely used as biomaterial, and nanocrystalline carbonated apatite (CA), which has a composition similar to bone mineral crystals. These materials have been compared for their VEGF adsorption and release properties. The adsorption of the growth factor was higher on CA than on HA probably due to differences of both the proteins and the powders involved. The specific activity of the VEGF released was also tested to determine the available activity for cells in contact with these materials. Interestingly, the bioactivity of the VEGF released from CA quantified on fetal bovine aortic endothelial cells (FBAE) by evaluating the proliferation activity, exhibited no marked difference compared to native VEGF. Qualitatively, VEGF adsorbed on CA material induced well-defined collagen type I immunostaining on osteoblast cells compared to the staining obtained after VEGF adsorption on HA. (C) 2001 Kluwer Academic Publishers.
C1 Lab Cytophysiol Cellules Eucaryotes, JE 1962, F-31400 Toulouse, France.
   Lab Mat & Interfaces Phosphates & Biomat, CNRS, UPRESA 5071, F-31400 Toulouse, France.
   Merck Biomat Res, D-64271 Darmstadt, Germany.
   Lab Biol Mol Eucaryotes, CNRS, UPR 9006, F-31062 Toulouse, France.
RP Midy, V (reprint author), Lab Cytophysiol Cellules Eucaryotes, JE 1962, 38 Rue 36 Ponts, F-31400 Toulouse, France.
CR BARON J, 1994, ENDOCRINOLOGY, V135, P2790, DOI 10.1210/en.135.6.2790
   BARRITAULT D, 1982, J NEUROSCI RES, V8, P477, DOI 10.1002/jnr.490080235
   BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5
   BRUDER SP, 1989, CONNECT TISSUE RES, V20, P65, DOI 10.3109/03008208909023875
   CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490
   COLLINOSDOBY P, 1994, J CELL BIOCHEM, V55, P304, DOI 10.1002/jcb.240550306
   CONNOLLY DT, 1989, J BIOL CHEM, V264, P20017
   CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8
   ELLIOTT JC, 1994, STRUCTURE CHEM APATI, P259
   FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8
   GIROUX TA, 1991, J COLLOID INTERF SCI, V146, P179, DOI 10.1016/0021-9797(91)90015-Z
   GLOBUS RK, 1989, ENDOCRINOLOGY, V124, P1539, DOI 10.1210/endo-124-3-1539
   HARADA S, 1994, J CLIN INVEST, V93, P2490, DOI 10.1172/JCI117258
   Midy V, 1998, J BIOMED MATER RES, V41, P405, DOI 10.1002/(SICI)1097-4636(19980905)41:3<405::AID-JBM10>3.0.CO;2-H
   MIDY V, 1994, BIOCHEM BIOPH RES CO, V199, P380, DOI 10.1006/bbrc.1994.1240
   MISRA DN, 1994, J ADHES SCI TECHNOL, V8, P87, DOI 10.1163/156856194X00087
   MONTEL G, 1981, J CRYST GROWTH, V53, P74, DOI 10.1016/0022-0248(81)90057-9
   MORENO EC, 1984, CALCIFIED TISSUE INT, V36, P48, DOI 10.1007/BF02405293
   MURA M J, 1990, Clinical Materials, V5, P285, DOI 10.1016/0267-6605(90)90028-T
   NELSON DGA, 1981, J DENT RES, V60, P1621, DOI 10.1177/002203458106000312011
   NELSON DGA, 1982, CALCIFIED TISSUE INT, V34, pS69
   NORDE W, 1985, SURFACE INTERFACIAL, V2, P241
   Ortega N, 1998, BIOL CELL, V90, P381, DOI 10.1016/S0248-4900(98)80087-7
   Plouet J, 1997, J BIOL CHEM, V272, P13390, DOI 10.1074/jbc.272.20.13390
   PLOUET J, 1989, EMBO J, V8, P3801, DOI 10.1002/j.1460-2075.1989.tb08557.x
   REY C, 1991, CALCIFIED TISSUE INT, V49, P251, DOI 10.1007/BF02556214
   REY C, 1994, B I OCEANOGRAPHIQUE, V14, P55
   RODAN SB, 1989, CONNECT TISSUE RES, V20, P283, DOI 10.3109/03008208909023898
   RODAN SB, 1987, CANCER RES, V47, P4961
   ROLLA G, 1975, CARIES RES, V9, P66
   SCHEVILL WE, 1965, NATURE, V205, P373, DOI 10.1038/205373a0
   TABATA Y, 1994, J CONTROL RELEASE, V31, P189, DOI 10.1016/0168-3659(94)00035-2
NR 32
TC 23
Z9 23
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2001
VL 12
IS 4
BP 293
EP 298
DI 10.1023/A:1011286818733
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 419DN
UT WOS:000167934200002
PM 15348289
DA 2018-10-19
ER

PT J
AU Mebouta-Nkamgueu, E
   Adnet, JJ
   Ittelet, D
   Laurent-Maquin, D
   Bouthors, S
   Potron, G
   Guenounou, M
   Bernard, J
AF Mebouta-Nkamgueu, E
   Adnet, JJ
   Ittelet, D
   Laurent-Maquin, D
   Bouthors, S
   Potron, G
   Guenounou, M
   Bernard, J
TI Human monocyte-derived macrophages and dendritic cells as targets for
   biomaterial cytocompatibility studies using an improved in vitro culture
   system
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VITRO; INTERLEUKIN-1 GENERATION; BIOMEDICAL POLYMERS;
   MONONUCLEAR-CELLS; BLOOD MONOCYTES; BONE-RESORPTION; INVITRO;
   IMMUNOTHERAPY; REPLACEMENTS; DEGRADATION
AB Since macrophage plays a key role in the biocompatibility process, neoplastic macrophage cell lines and human blood monocytes are commonly used as target cells for in vitro biomaterial tolerance evaluation. However, tumor cells profoundly differ from normal tissue cells and monocytes are only precursors of macrophages. It has become possible to generate recently, under adherent-free conditions, fully mature macrophages and dendritic cells from human blood monocytes in the presence of GM-CSF and GM-CSF + IL4 respectively. In the present work, we examined the effects of titanium-alloy on morphology, adhesion, cell phenotype and TNF-alpha release activity of such differentiated cells grown in hydrophobic teflon bags. Scanning electron microscopy showed that macrophages substantially adhered and spread on titanium-alloy surface throughout the culture period, whereas only a few dendritic cells were adherent. The phenotype of both cell types remained unchanged in the presence of the tested material. However, titanium-alloy stimulated the secretion of TNF-alpha by the macrophages of some donors. This model of culture may offer new insights into the biomaterial evaluation and may be useful for studying individual responses induced by biomaterials. (C) 2001 Kluwer Academic Publishers.
C1 UFR Med, Lab Histol Embryol Cytogenet, F-51095 Reims, France.
   Inst Jean Godinot, Immunol Lab, F-51100 Reims, France.
   Ctr Etud Biomat & Interfaces, EA 2068, F-51095 Reims, France.
   CHU, Hematol Lab, F-51092 Reims, France.
   UFR Pharm, Immunol Lab, F-51095 Reims, France.
RP Mebouta-Nkamgueu, E (reprint author), UFR Med, Lab Histol Embryol Cytogenet, 51 Rue Cognacq Jay, F-51095 Reims, France.
CR ADAMS DO, 1979, METHOD ENZYMOL, V58, P4
   ANDREESEN R, 1990, CANCER RES, V50, P7450
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8
   Bernard J, 1998, HEMATOL CELL THER, V40, P17
   Bernatchez SF, 1996, BIOMATERIALS, V17, P2077, DOI 10.1016/0142-9612(96)00014-2
   BHARDWAJ N, 1988, CELL IMMUNOL, V114, P405, DOI 10.1016/0008-8749(88)90332-2
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Caux C, 1996, HEMATOL CELL THER, V38, P463, DOI 10.1007/s00282-996-0463-4
   CHIBA J, 1994, CLIN ORTHOP RELAT R, P304
   DARVILLE T, 1992, IMMUNOL INVEST, V21, P539, DOI 10.3109/08820139209069389
   FREUNDLICH B, 1984, J IMMUNOL, V132, P1255
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   GLANT TT, 1994, T ORTHOP RES SOC, V19, P152
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, P182
   HASKILL S, 1988, J IMMUNOL, V140, P1690
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   HELFGOTT DC, 1989, J IMMUNOL, V142, P948
   ISHIMI Y, 1990, J IMMUNOL, V145, P3297
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   Koerten H. K., 1997, Cells and Materials, V7, P191
   Lee SH, 1997, J ORTHOP RES, V15, P40, DOI 10.1002/jor.1100150107
   LOPEZ M, 1992, J IMMUNOTHER, V11, P209, DOI 10.1097/00002371-199204000-00008
   LOPEZ M, 1993, J IMMUNOL METHODS, V159, P29, DOI 10.1016/0022-1759(93)90138-W
   Maloney WJ, 1996, CLIN ORTHOP RELAT R, P268
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   NAVARRO S, 1989, J IMMUNOL, V142, P4339
   Nivbrant B, 1999, J BONE JOINT SURG BR, V81B, P163, DOI 10.1302/0301-620X.81B1.8664
   RAE T, 1975, J BONE JOINT SURG BR, V57, P444
   Rogers SD, 1997, J BONE JOINT SURG BR, V79B, P311, DOI 10.1302/0301-620X.79B2.7192
   ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83
   ROSENSTREICH DL, 1978, IMMUNOL REV, V40, P102, DOI 10.1111/j.1600-065X.1978.tb00403.x
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   Saad B, 1996, J BIOMED MATER RES, V30, P429, DOI 10.1002/(SICI)1097-4636(199604)30:4<429::AID-JBM1>3.3.CO;2-D
   SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   SNYDERMAN R, 1971, J IMMUNOL, V119, P926
   THOMAS R, 1994, J IMMUNOL, V152, P2613
   Wang JY, 1996, BIOMATERIALS, V17, P2233, DOI 10.1016/0142-9612(96)00072-5
   WATAHA JC, 1995, DENT MATER, V11, P239, DOI 10.1016/0109-5641(95)80056-5
   ZVAIFLER NJ, 1985, J CLIN INVEST, V76, P76
NR 46
TC 4
Z9 5
U1 1
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2001
VL 12
IS 4
BP 351
EP 357
DI 10.1023/A:1011255406438
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 419DN
UT WOS:000167934200011
PM 15348298
DA 2018-10-19
ER

PT J
AU Einmahl, S
   Behar-Cohen, FF
   Savoldelli, M
   D'Hermies, E
   Chauvaud, D
   Tabatabay, C
   Gurny, R
AF Einmahl, S
   Behar-Cohen, FF
   Savoldelli, M
   D'Hermies, E
   Chauvaud, D
   Tabatabay, C
   Gurny, R
TI Evaluation of a new biomaterial injected in the suprachoroidal space of
   the rabbit eye.
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
C1 Univ Geneva, Sch Pharm, Geneva, Switzerland.
   Hop Hotel Dieu, F-75181 Paris, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0146-0404
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD MAR 15
PY 2001
VL 42
IS 4
SU S
MA 933
BP S174
EP S174
PG 1
WC Ophthalmology
SC Ophthalmology
GA 427EP
UT WOS:000168392100924
DA 2018-10-19
ER

PT J
AU Malkar, NB
   Neimczyk, N
   Fields, GB
AF Malkar, NB
   Neimczyk, N
   Fields, GB
TI Peptide-amphiphile induction of alpha-helical protein-like molecular
   architecture and interaction with biomaterial surfaces
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Florida Atlantic Univ, Boca Raton, FL 33431 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD MAR 7
PY 2001
VL 15
IS 4
BP A532
EP A532
PN 1
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 410KA
UT WOS:000167438103042
DA 2018-10-19
ER

PT J
AU Powis, S
   Kidd, KR
   Williams, SK
AF Powis, S
   Kidd, KR
   Williams, SK
TI Orthogonal polarization spectral imaging of microvascular responses to
   biomaterial implants
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Univ Arizona, Tucson, AZ 85724 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD MAR 7
PY 2001
VL 15
IS 4
BP A38
EP A38
PN 1
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 410KA
UT WOS:000167438100213
DA 2018-10-19
ER

PT J
AU Bainbridge, JA
   Revell, PA
   Al-Saffar, N
AF Bainbridge, JA
   Revell, PA
   Al-Saffar, N
TI Costimulatory molecule expression following exposure to orthopaedic
   implants wear debris
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE costimulation; inflammatory response; macrophage T-cell interactions;
   wear particles; multinucleated giant cells
ID MYELOID CELL-DIFFERENTIATION; TOTAL HIP-REPLACEMENT; PELVIC LYMPH-NODES;
   MHC CLASS-II; IN-VITRO; CYTOKINE PRODUCTION; T-CELLS; AUTOIMMUNITY;
   TITANIUM; TISSUE
AB Patients with long-term orthopedic implants may develop inflammatory reactions due to the accumulation of biomaterial particles both around the implant and in distant organs. The exact impact of these particles on the normal immune cell function still remain relatively unclear. Activation of T-cells following exposure to biomaterial par tides is driven by macrophages and requires synergistic signals primed by both antigen presentation and costimulation. The:pattern of costimulatory molecule expression (CD80,CD86) was primarily examined using immunohistochemistry on tissue specimens of bone/implant interface membranes taken from sites of bone erosion. Additionally, costimulatory molecule expression was also assessed in the monocytic leukemia cell Line U937 following exposure to clinically relevant titanium aluminum vanadium (TiAlV) and-stainless steel particles (FeCrNi) cultured in vitro. This study:demonstrates the induction and prominent expression of CD86 on almost all macrophage subsets at the bone/implant interface, including fused forms and large multinucleated giant cells (MNGC). In vitro analysis also indicated phagocytosis of metal particles by differentiated U937 caused significant induction of both CD80 and CD86 (p < 0.01), although the expression of CD86 dominated following prolonged exposure. The data presented highlights that CD86 is the predominant costimulatory molecule ligating to the complementary CD28 molecule at the inflammatory lesion of the interface. We propose that the intracellular presence of indigestible implant material, in addition to elevated costimulatory molecule expression, may promote T-cell inflammatory reactions at sites close to and distant from the orthopedic implant. (C) 2000 John Wiley & Sons, Inc. J Biomed Mater Res 54: 328-334, 2001.
C1 UCL Royal Free & Univ Coll Med Sch, Dept Histopathol, London NW3 2PQ, England.
RP Al-Saffar, N (reprint author), UCL Royal Free & Univ Coll Med Sch, Dept Histopathol, Rowland Hill St, London NW3 2PQ, England.
EM alsaffar@rfc.ucl.ac.uk
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   Al-Saffar N, 1998, J MATER SCI-MATER M, V9, P849, DOI 10.1023/A:1008952329788
   ALBORESSAAVEDRA J, 1994, AM J SURG PATHOL, V18, P83, DOI 10.1097/00000478-199401000-00008
   AlSaffar N, 1996, AM J CLIN PATHOL, V105, P628
   Balsa A, 1996, BRIT J RHEUMATOL, V35, P33
   BAUER TW, 1993, J BONE JOINT SURG AM, V75, P107
   DRUET P, 1995, HUM EXP TOXICOL, V14, P120, DOI 10.1177/096032719501400129
   ELVES MW, 1974, BRIT MED J, V15, P376
   EVANS EM, 1974, J BONE JOINT SURG BR, VB 56, P626
   FREEDMAN AS, 1991, CELL IMMUNOL, V137, P429, DOI 10.1016/0008-8749(91)90091-O
   FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363
   Garcia A, 1999, EXP HEMATOL, V27, P353, DOI 10.1016/S0301-472X(98)00038-1
   GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539
   Goodman SB, 1998, J BONE JOINT SURG BR, V80B, P531, DOI 10.1302/0301-620X.80B3.8158
   Hicks DG, 1996, J BONE JOINT SURG AM, V78A, P482, DOI 10.2106/00004623-199604000-00002
   Hmama Z, 1999, J EXP MED, V190, P1583, DOI 10.1084/jem.190.11.1583
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   KAUFMAN PA, 1992, J CLIN INVEST, V90, P121, DOI 10.1172/JCI115824
   Kobayashi A, 1997, J BONE JOINT SURG BR, V79B, P844, DOI 10.1302/0301-620X.79B5.7602
   KOULOVA L, 1991, J EXP MED, V173, P759, DOI 10.1084/jem.173.3.759
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   LANGKAMER VG, 1992, J BONE JOINT SURG BR, V74, P831
   LARSEN CP, 1992, J EXP MED, V176, P1215, DOI 10.1084/jem.176.4.1215
   Lu P, 1997, CURR OPIN IMMUNOL, V9, P858, DOI 10.1016/S0952-7915(97)80190-2
   Moulon C, 1995, EUR J IMMUNOL, V25, P3308, DOI 10.1002/eji.1830251216
   NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493
   RAE T, 1981, J BONE JOINT SURG BR, V63, P435
   Reiser H, 1996, NEW ENGL J MED, V335, P1369, DOI 10.1056/NEJM199610313351807
   Revell PA, 1997, P I MECH ENG H, V211, P187, DOI 10.1243/0954411971534304
   RUBIO MA, 1995, BLOOD, V86, P3715
   Saito K, 1996, Kokubyo Gakkai Zasshi, V63, P53
   SANSOM DM, 1993, EUR J IMMUNOL, V23, P295, DOI 10.1002/eji.1830230148
   SANTOS M, 1994, CELL IMMUNOL, V154, P498, DOI 10.1006/cimm.1994.1094
   Schultze J, 1996, BLOOD REV, V10, P111, DOI 10.1016/S0268-960X(96)90040-5
   TODD JA, 1988, SCIENCE, V240, P1003, DOI 10.1126/science.3368786
   Voronov I, 1998, J BIOMED MATER RES, V39, P40, DOI 10.1002/(SICI)1097-4636(199801)39:1<40::AID-JBM6>3.3.CO;2-Y
   WAPNER KL, 1991, CLIN ORTHOP RELAT R, P12
   WATAHA JC, 1995, DENT MATER, V11, P239, DOI 10.1016/0109-5641(95)80056-5
   Xu JW, 1998, RHEUMATOL INT, V17, P215, DOI 10.1007/s002960050037
NR 39
TC 24
Z9 25
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 2001
VL 54
IS 3
BP 328
EP 334
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 387NG
UT WOS:000166128200003
PM 11189037
DA 2018-10-19
ER

PT J
AU van Kooten, TG
   Klein, CL
   Kirkpatrick, CJ
AF van Kooten, TG
   Klein, CL
   Kirkpatrick, CJ
TI Western blotting as a method for studying cell-biomaterial interactions:
   The role of protein collection
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biocompatibility; Western blot; endothelial cells; p53; cadherin-5;
   phosphotyrosine
ID FOCAL ADHESION KINASE; STRESS FIBER FORMATION; TYROSINE PHOSPHORYLATION;
   IN-VITRO; ORGANIZATION; CYTOSKELETON; STIMULATION; FIBROBLASTS;
   APOPTOSIS; SURVIVAL
AB Research of cell-biomaterial interactions is building on knowledge and methods available in cell and molecular biology. Western blotting is one of the options to characterize protein expression in cell populations. Method transfer to biomaterial model systems is not trivial because of the structure that exists in many biomaterials, preventing the collection of cell lysate by mechanical means. In this technical resort, we describe the influence of different protein collection methods in a model system for cell-biomaterial interactions, consisting of endothelial cells exposed to different stimuli. In particular, the influence of trypsinization before lysis, and handling complexity were determined. The results of this study indicate that many changes in proteins occur because of the intermediate enzymatic treatment, despite the use of ice-cold solutions and protease and tyrosine phosphatase inhibitors throughout the procedure. Protein degradation and slight depressions in molecular weight were observed. The enzymatic treatment induced a changed cell status associated with detachment from the substratum. Western blotting of lysates of cells obtained through enzymatic harvest therefore can only be used with internal controls for the assessment of artifacts introduced by trypsinization, or alternative methods should be sought. (C) 2000 John Wiley & Sons, Inc. J Biomed Mater Res 54: 385-389, 2001.
C1 Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
RP van Kooten, TG (reprint author), Univ Groningen, Dept Biomed Engn, A Deusingln 1, NL-9713 AV Groningen, Netherlands.
CR Ayalon O, 1997, J CELL SCI, V110, P547
   Baksh D, 1998, J MATER SCI-MATER M, V9, P743, DOI 10.1023/A:1008959103864
   Cattelino A, 1997, Cell Adhes Commun, V4, P457, DOI 10.3109/15419069709004461
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CHRZANOWSKAWODNICKA M, 1994, J CELL SCI, V107, P3643
   Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573
   Ferber D, 1999, SCIENCE, V284, P422, DOI 10.1126/science.284.5413.422
   Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793
   Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   Ilic D, 1998, J CELL BIOL, V143, P547
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203
   Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323
   Lin MC, 1997, J CLIN INVEST, V99, P737, DOI 10.1172/JCI119219
   Marois Y, 1996, BIOMATERIALS, V17, P1289, DOI 10.1016/0142-9612(96)88674-1
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   REGEN CM, 1992, J CELL BIOL, V119, P1347, DOI 10.1083/jcb.119.5.1347
   Retta SF, 1996, EXP CELL RES, V229, P307, DOI 10.1006/excr.1996.0376
   RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x
   SEGER R, 1995, FASEB J, V9, P726
   VANKOOTEN TG, 1999, TISSUE ENG, V5, P213
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 27
TC 1
Z9 1
U1 0
U2 9
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 2001
VL 54
IS 3
BP 385
EP 389
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 387NG
UT WOS:000166128200010
PM 11189044
DA 2018-10-19
ER

PT J
AU Itoh, S
   Kikuchi, M
   Takakuda, K
   Koyama, Y
   Matsumoto, HN
   Ichinose, S
   Tanaka, J
   Kawauchi, T
   Shinomiya, K
AF Itoh, S
   Kikuchi, M
   Takakuda, K
   Koyama, Y
   Matsumoto, HN
   Ichinose, S
   Tanaka, J
   Kawauchi, T
   Shinomiya, K
TI The biocompatibility and osteoconductive activity of a novel
   hydroxyapatite/collagen composite biomaterial, and its function as a
   carrier of rhBMP-2
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hydroxyapatite; type I collagen; hydroxyapatite/type I collagen
   (HAp/Col) composite; recombinant human bone morphogenetic protein
   (rhBMP); bone-remodeling unit
ID BONE MORPHOGENETIC PROTEIN; POROUS HYDROXYAPATITE; GRAFT SUBSTITUTE;
   SURGERY; PHOSPHATASE; INDUCTION
AB A hydroxyapatite/type I collagen (HAp/Col) composite, in which the hydroxyapatite nanocrystals align along the collagen molecules, has been prepared. The biocompatibility, osteoconductive activity, and efficacy as a carrier of recombinant human bone morphogenetic proteins (rhBMFs) of this novel biomaterial were examined. The composite material was implanted in the backs of Wistar rats, and specimens were collected for histological observations until week 24. In a second experiment, other samples of the composite material (5 x 5 x 10 mm(3)) were drilled and immersed in a solution of rhBMP-2 (0, 200, 400 mug/mL), and subsequently grafted in radii and ulnae in beagle dogs. As a control, three unfilled holes were left in one radius and ulna. X-ray images were prepared, and specimens collected for histological observation at weeks 8 and 12. Histological findings of the composites grafted in rats showed that the surface of the material was eroded as a result of macrophage infiltration. X-ray images and histological findings for the composites implanted in dogs support the idea that HAp/Col has a high osteoconductive activity and is able to induce bone-remodeling units. In cases where the implants are grafted at weight bearing sites, treatment with rhBMP-2 at a dose of 400 mug/mL may be useful to shorten the time needed until bone union has occurred. (C) 2000 John Wiley & Sons, Inc. J Biomed Mater Res 54: 445-453, 2001.
C1 Tokyo Med & Dent Univ, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138519, Japan.
   Tokyo Med & Dent Univ, Dept Biomech Engn, Bunkyo Ku, Tokyo 1138519, Japan.
   Tokyo Med & Dent Univ, Ctr Electron Microscopy, Bunkyo Ku, Tokyo 1138519, Japan.
   Natl Inst Res Inorgan Mat, Tsukuba, Ibaraki 3050044, Japan.
RP Shinomiya, K (reprint author), Tokyo Med & Dent Univ, Dept Orthopaed Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.
EM shinomiya.orth@med.tmd.ac.jp
RI Matsumoto, Hiroko/B-8335-2011; Kikuchi, Masanori/B-5993-2008
OI Kikuchi, Masanori/0000-0002-9451-8147
CR Aoki H, 1994, MED APPL HYDROXYAPAT, P156
   BYRD HS, 1993, PLAST RECONSTR SURG, V91, P15, DOI 10.1097/00006534-199301000-00003
   CHVAPIL M, 1981, FUNDAMENTAL ASPECTS, V1, P88
   COLE AA, 1987, J HISTOCHEM CYTOCHEM, V35, P203, DOI 10.1177/35.2.3540104
   FINN RA, 1980, J MAXILLOFAC SURG, V8, P217, DOI 10.1016/S0301-0503(80)80104-4
   HORISAKA Y, 1991, CLIN ORTHOP RELAT R, V268, P303
   INOUE O, 1993, CLIN ORTHOP RELAT R, V293, P287
   KAWAI T, 1993, CLIN ORTHOP RELAT R, V290, P296
   LIN C-J, 1989, Bulletin of Tokyo Medical and Dental University, V36, P1
   MINEGISHI D, 1988, INT J PERIODONT REST, V8, P51
   MIYAMOTO S, 1993, CLIN ORTHOP RELAT R, P333
   NAKANO K, 1992, SPINE, V17, pS41
   Oda Shigeru, 1997, Journal of Medical and Dental Sciences, V44, P53
   ONO I, 1995, PLAST RECONSTR SURG, V95, P1265, DOI 10.1097/00006534-199506000-00019
   ONO I, 1992, PLAST RECONSTR SURG, V90, P870, DOI 10.1097/00006534-199211000-00023
   OZAKI M, 1989, BIOMATERIALS, V10, P561
   ROSEN HM, 1989, PLAST RECONSTR SURG, V83, P985, DOI 10.1097/00006534-198906000-00009
   SALYER KE, 1989, PLAST RECONSTR SURG, V84, P236, DOI 10.1097/00006534-198908000-00008
   STEVENSON S, 1994, J BONE JOINT SURG AM, V76A, P1676, DOI 10.2106/00004623-199411000-00011
   TAKAOKA K, 1991, J ORTHOPAED RES, V9, P902, DOI 10.1002/jor.1100090617
   TAKAOKA K, 1998, CLIN ORTHOP RELAT R, V234, P250
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
   URIST MR, 1984, CLIN ORTHOP RELAT R, V187, P277
   VILLANUEVA AR, 1974, STAIN TECHNOL, V49, P1, DOI 10.3109/10520297409116928
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   YOSHIKI S, 1972, HISTOCHEMISTRY, V29, P296
NR 27
TC 117
Z9 129
U1 1
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 2001
VL 54
IS 3
BP 445
EP 453
DI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 387NG
UT WOS:000166128200019
PM 11189053
DA 2018-10-19
ER

PT J
AU Casaletto, MP
   Ingo, GM
   Kaciulis, S
   Mattogno, G
   Pandolfi, L
   Scavia, G
AF Casaletto, MP
   Ingo, GM
   Kaciulis, S
   Mattogno, G
   Pandolfi, L
   Scavia, G
TI Surface studies of in vitro biocompatibility of titanium oxide coatings
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE biomaterial; titanium oxide; titanium; XPS; SEM; STM
ID SPECTROSCOPIC CHARACTERIZATION; IMPLANT MATERIALS
AB Titanium oxide coatings are normally used for orthopaedic and dental prostheses. Nevertheless, their chemical, biological and mechanical properties can be still improved by the development of new preparation technologies. In this paper a surface characterisation of the titanium oxide layer, grown on commercial Ti substrates by metal organic chemical vapour deposition (MOCVD) technique, is reported. The biocompatibility of the samples is tested upon in vitro treatment as a function of the exposure time. The surface characterisation of the titanium substrate and the oxide coatings is performed by using different analytical techniques. Surface chemical composition and morphology of the coatings are investigated by X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM) and scanning tunnelling microscopy (STM). Quantitative XPS analysis and surface physical images show a good quality (cleanness, homogeneity, roughness) of the oxide coating deposited by MOCVD and the surface modifications induced by the interaction with osteoblast cells. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 CNR, Inst Mat Chem, I-00016 Monterotondo, Rome, Italy.
RP Mattogno, G (reprint author), CNR, Inst Mat Chem, POB 10, I-00016 Monterotondo, Rome, Italy.
RI Casaletto, Maria Pia/P-6715-2017; Kaciulis, Saulius/G-5252-2010
OI Casaletto, Maria Pia/0000-0002-2236-5671; Kaciulis,
   Saulius/0000-0002-9868-7626; INGO, Gabriel Maria/0000-0002-5414-2077
CR BATTISTON GA, 1994, THIN SOLID FILMS, V239, P186, DOI 10.1016/0040-6090(94)90849-4
   Battiston GA, 2000, MATER SCI FORUM, V352, P151, DOI 10.4028/www.scientific.net/MSF.352.151
   BATTISTONI C, IN PRESS SURF INTERF
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   BRUNETTE DM, 1988, SURFACE CHARACTERIZA
   CIRILLI F, 1997, P ECASIA 97, P1063
   Demri B, 1997, APPL SURF SCI, V108, P245, DOI 10.1016/S0169-4332(96)00576-4
   Gardella JA, 1996, J ELECTRON SPECTROSC, V81, P227, DOI 10.1016/0368-2048(96)03054-X
   HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49
   HENCH LL, 1993, INTRO BIOCERAMICS
   HUAXIA JI, 1992, J MATER SCI-MATER M, V3, P283
   Kaciulis S, 1999, APPL SURF SCI, V151, P1, DOI 10.1016/S0169-4332(99)00267-6
   Kaciulis S, 1998, J ELECTRON SPECTROSC, V95, P61, DOI 10.1016/S0368-2048(98)00202-3
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LAUSMAA J, 1988, SURFACE CHARACTERIZA
   LeGeros RZ, 1993, INTRO BIOCERAMICS
   MICHAELS C M, 1989, Journal of Dental Research, V68, P276
   MONTENERO A, 2000, J MATER SCI, V35, P1
   Moulder J. F., 1995, HDB XRAY PHOTOELECTR
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RIMONDINI L, 1999, REPORT CNR MSTA2 FIN
   RIMONDINI L, 1998, BIL M IT UN KINGD BI
   Vogler EA, 1996, J ELECTRON SPECTROSC, V81, P237, DOI 10.1016/0368-2048(96)02526-1
   WAGNER CD, 1986, SURF INTERFACE ANAL, V2, P53
   WILSON J, 1994, BIOCERAMICS, V8
NR 26
TC 62
Z9 67
U1 1
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 1
PY 2001
VL 172
IS 1-2
BP 167
EP 177
DI 10.1016/S0169-4332(00)00844-8
PG 11
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 399UQ
UT WOS:000166831100022
DA 2018-10-19
ER

PT J
AU Lamghari, M
   Berland, S
   Laurent, A
   Huet, H
   Lopez, E
AF Lamghari, M
   Berland, S
   Laurent, A
   Huet, H
   Lopez, E
TI Bone reactions to nacre injected percutaneously into the vertebrae of
   sheep
SO BIOMATERIALS
LA English
DT Article
DE nacre; PMMA; vertebral bone; injectable biomaterial; sheep
ID OSTEOBLASTS MAINTAINED INVITRO; CEMENT; POLYMETHYLMETHACRYLATE;
   RECONSTRUCTION; VERTEBROPLASTY; MODEL
AB We have studied the osteogenic effects of nacre (mother of pearl) placed in experimental cavities prepared in the lumbar Vertebrae of sheep. Some of cavities were filled with nacre, some with PMMA, and some were left empty. The Vertebrae were removed 1, 8, 12 weeks after surgery, and assessed histologically and morphometrically. The nacre particles in the bone cavity and the surrounding intertrabecular spaces gradually dissolved beginning at 8 weeks after surgery. There were layers of newly formed bone, both woven and lamellar, in various stages of maturation in contact with or adjacent to the dissolving nacre. Quantitative assessment of the activation of bone formation adjacent to the cavities filled with nacre indicated significant activation of bone formation, which continued until week 12. There was also increased mineralization of the host bone at this time. There was no new bone formation in the empty cavities, or in those filled with PMMA. PMMA also caused necrosis of surrounding bone cells with a change in bone architecture and significant reductions in bone formation and mineralization. This study demonstrates that nacre stimulates bone-forming cells in vertebrae and appears to result in new bone formation. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Museum Natl Hist Nat, Lab Physiol Gen & Comparee, CNRS, UMR 8572, F-75231 Paris 05, France.
   Hop Lariboisiere, Serv Neuroradiol Diagnost & Intervent, F-75475 Paris, France.
   CHU Caen, Serv Neuroradiol, F-14000 Caen, France.
RP Lopez, E (reprint author), Museum Natl Hist Nat, Lab Physiol Gen & Comparee, CNRS, UMR 8572, 7 Rue Cuvier, F-75231 Paris 05, France.
RI Lamghari, Meriem/K-2159-2013
OI Lamghari, Meriem/0000-0002-2500-4548
CR Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Balmain J, 1999, J BIOMED MATER RES, V48, P749, DOI 10.1002/(SICI)1097-4636(1999)48:5<749::AID-JBM22>3.0.CO;2-P
   Boivin G., 1984, METHODS CALCIFIED TI, P391
   Bostrom MP, 1997, SPINE S, V22, P38
   CERASI P, 1997, ITBM, V16, P15
   Chiras J, 1997, J NEURORADIOLOGY, V24, P45
   CHOW LC, 1997, INNOV TECH BIOL MED, V18, P11
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DEBUSSCHEDEPRIE.C, 1991, NEURORADIOLOGY, V33, P149
   Deramond H, 1998, RADIOL CLIN N AM, V36, P533, DOI 10.1016/S0033-8389(05)70042-7
   DERAMOND H, 1990, RADIOLOGY, V117, P352
   DERAMOND H, 1989, RACHIS, V1, P143
   Dupraz A, 1999, BIOMATERIALS, V20, P663, DOI 10.1016/S0142-9612(98)00222-1
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   GRIMANDI G, 1998, J BIOMED MATER RES, V39, P606
   Jensen ME, 1997, AM J NEURORADIOL, V18, P1897
   KAEMMERLEN P, 1989, Journal de Radiologie (Paris), V70, P557
   Lamghari M, 1999, BIOMATERIALS, V20, P2107, DOI 10.1016/S0142-9612(99)00113-1
   Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6
   LEFAOU A, 1995, CALCIF TISSUE INT S, V56, pA461
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   LOPEZ E, 1995, Patent No. 951565028
   Meunier PJ, 1997, BONE, V21, P373, DOI 10.1016/S8756-3282(97)00170-1
   MOUTAHIRBELQASM.F, 2000, IN PRESS J MAT SCI M
   Pasquier G, 1996, J MATER SCI-MATER M, V7, P683, DOI 10.1007/BF00123407
   Pinkert R, 1979, Zahn Mund Kieferheilkd Zentralbl, V67, P603
   RASMUSSEN H, 1974, BONE CELLS MORPHOLOG, P8
   REID SA, 1987, J BONE MINER RES, V2, P13
   Schildhauer TA, 1999, J ORTHOPAED RES, V17, P67, DOI 10.1002/jor.1100170111
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   Stankewich CJ, 1996, J ORTHOP RES, V14, P786, DOI 10.1002/jor.1100140516
   Vale FM, 1997, BIOMATERIALS, V18, P1133, DOI 10.1016/S0142-9612(97)00043-4
   Weill A, 1996, RADIOLOGY, V199, P241, DOI 10.1148/radiology.199.1.8633152
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
NR 37
TC 45
Z9 58
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2001
VL 22
IS 6
BP 555
EP 562
DI 10.1016/S0142-9612(00)00213-1
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 399YN
UT WOS:000166842000006
PM 11219719
DA 2018-10-19
ER

PT J
AU Ignjatovic, N
   Savic, V
   Najman, S
   Plavsic, M
   Uskokovic, D
AF Ignjatovic, N
   Savic, V
   Najman, S
   Plavsic, M
   Uskokovic, D
TI A study of HAp/PLLA composite as a substitute for bone powder, using
   FT-IR spectroscopy
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite/poly-L-lactide composite biomaterial; in vivo; FT-IR
   spectroscopy; absorption band; collagen; autologous bone
ID INFRARED-SPECTROSCOPY; IN-VIVO; BIOMATERIALS; HYDROXYAPATITE;
   POLYLACTIDES; DEGRADATION
AB Chemically synthesized hydroxyapatite/poly-L-lactide (HAp/PLLA) composite biomaterial was studied in vivo. The biocomposite was implanted into Balb/c Singen mice and after 1 and 3 weeks removed from their organisms and analyzed by the FT-IR spectroscopy. After 1 week of testing in vivo the implanted sample gave a spectrum in which absorption bands arising from newly formed functional groups of amine and peptide can be seen. After 3 weeks, a spectrum with pronounced absorption bands at 3420 and 1650 cm(-1) assigned to newly generated collagen, a component of the extracellular connective-tissue matrix, was registered. Also, decrease of the intensity absorption band at 1760 cm(-1) originating from the C=O group of PLLA indicates bioresorption of the PLLA used. Analysis of the microstructure of the sample surface by scanning electron microscopy before and after implantation revealed bioresorption of the PLLA polymer phase and generation of collagen fibers at the sites of implanted bioresorptive PLLA. A mixture of autologous bone powder and HAp/PLLA biocomposite was also examined. After implantation, the same final products as in the case of HAp/PLLA composite biomaterial used alone were found. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Serbian Acad Sci & Arts, Inst Tech Sci, YU-11000 Belgrade, Yugoslavia.
   Univ Nis, Fac Med, YU-18000 Nis, Yugoslavia.
   Fac Technol & Met Belgrade, YU-11000 Belgrade, Yugoslavia.
RP Uskokovic, D (reprint author), Serbian Acad Sci & Arts, Inst Tech Sci, Knez Mihailova 35-IV, YU-11000 Belgrade, Yugoslavia.
RI Uskokovic, Dragan/B-4129-2008; Ignjatovic, Nenad/C-4489-2008
OI Uskokovic, Dragan/0000-0002-0421-4968; Ignjatovic,
   Nenad/0000-0002-5749-094X; Najman, Stevo/0000-0002-2411-9802
CR AGRAWAL M, 1998, JOM              JAN, P31
   AKAMATSU N, 1993, ASIAN MED J, V36, P621
   BELLAMY LJ, 1975, INFRARED SPECTRA COM, P247
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   CHO S, 1997, KEY ENG MATER, V132, P802
   COLARUSSO BP, 1998, APPL SPECTROSC, V52, P106
   Francioso O, 1998, APPL SPECTROSC, V52, P270, DOI 10.1366/0003702981943347
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Fujii T, 1997, APPL SPECTROSC, V51, P1682, DOI 10.1366/0003702971939352
   HARAKE WA, 1998, AM J PHYSIOL, V274, pE586
   HUMMEL DO, 1984, ATLAS POLYM PLASTICS, P373
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   KURASHINA K, 1995, BIOMATERIALS, V16, P119, DOI 10.1016/0142-9612(95)98273-H
   Lindner J, 1977, Clin Plast Surg, V4, P425
   Liu Q, 1997, BIOMATERIALS, V18, P1263, DOI 10.1016/S0142-9612(97)00069-0
   MainilVarlet P, 1996, J MATER SCI-MATER M, V7, P713, DOI 10.1007/BF00121406
   MainilVarlet P, 1997, J BIOMED MATER RES, V36, P360, DOI 10.1002/(SICI)1097-4636(19970905)36:3<360::AID-JBM11>3.0.CO;2-I
   MANTSCH H, 1995, J MOL STRUCT, V347, P187, DOI 10.1016/0022-2860(95)08545-7
   MANTSCH HH, 1990, J MOL STRUCT, V217, P347, DOI 10.1016/0022-2860(90)80374-S
   Pohjonen T, 1997, J MATER SCI-MATER M, V8, P311, DOI 10.1023/A:1018516529591
   RodriguezLorenzo LM, 1996, J BIOMED MATER RES, V30, P515, DOI 10.1002/(SICI)1097-4636(199604)30:4<515::AID-JBM10>3.0.CO;2-G
   Rosengren A, 1997, BIOMATERIALS, V18, P979, DOI 10.1016/S0142-9612(97)00012-4
   SCHRADER B, 1996, 23 EUR C MOL SPECTR
   STRYER L, 1981, BIOCHEMISTRY-US, P186
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
NR 27
TC 97
Z9 103
U1 3
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2001
VL 22
IS 6
BP 571
EP 575
DI 10.1016/S0142-9612(00)00215-5
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 399YN
UT WOS:000166842000008
PM 11219721
DA 2018-10-19
ER

PT J
AU Fonseca, C
   Barbosa, MA
AF Fonseca, C
   Barbosa, MA
TI Corrosion behaviour of titanium in biofluids containing H2O2 studied by
   electrochemical impedance spectroscopy
SO CORROSION SCIENCE
LA English
DT Article
DE titanium; EIS; corrosion; biomaterials
ID HYDROGEN-PEROXIDE; BIOMATERIAL; GROWTH; FILMS; CELL; XPS
AB This work aims at studying the electrochemical behaviour of titanium in the presence of an artificial biofluid containing H2O2, mimicing the situation, where the metal is implanted in the human body and hydrogen peroxide is generated by an inflammatory reaction. A phosphate buffered saline (PBS) solution and two PBS/H2O2 solutions containing 50 and 150 mM of H2O2 were used to simulate the body fluids. The behaviour of the metal was monitored as a function of time by electrochemical impedance spectroscopy (EIS) for three weeks. After one week, the PBS/H2O2 solutions were replaced by fresh PBS solutions in order to simulate the end of the inflammatory process and recovery of the system. All the experiments were carried out at a constant temperature of 37 degreesC. From the simulation of the experimental EIS spectra, it was concluded that the corrosion resistance of titanium is strongly affected by the presence of H2O2 and when the peroxide is removed, the metal displays a sharp resistance increase. Furthermore, the oxides formed in H2O2 are rougher and display higher ionic conductivities than the oxides Formed in the absence of peroxide. The study was complemented with potentiostatic experiments and scanning electron microscopy observation of the metal surfaces. (C) 2001 Elsevier Science Ltd. All lights reserved.
C1 INEB, Lab Biomat, P-4150180 Porto, Portugal.
   Univ Porto, Dept Met & Mat Engn, Fac Engn, P-4099 Oporto, Portugal.
RP Fonseca, C (reprint author), INEB, Lab Biomat, Rua Campo Alegre 823, P-4150180 Porto, Portugal.
RI Barbosa, Mario/F-5964-2011
OI Barbosa, Mario/0000-0003-3568-7482; Fonseca, Carlos/0000-0002-2759-0384
CR AMSNFELD F, 1991, ASTM STP
   ARMSTRONG RD, 1973, ELECTROCHIM ACTA, V18, P937, DOI 10.1016/0013-4686(73)87025-2
   Boukamp B.A., 1989, EQUIVALENT CIRCUIT U
   CHAO CY, 1982, J ELECTROCHEM SOC, V129, P1874, DOI 10.1149/1.2124318
   Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906
   DELEVIE, ADV ELECTROCHEMISTRY, V6
   DORR LD, 1990, CLIN ORTHOP RELAT R, P82
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   HUGOTLEGOFF A, 1986, THIN SOLID FILMS, V142, P193, DOI 10.1016/0040-6090(86)90004-0
   Kader J. M. A., 1981, BR CORROS J, V16, P111
   KADER JMAE, 1979, BRIT CORROS J, V14, P40, DOI 10.1179/000705979798276022
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LEMEHAUTE A, 1984, J STAT PHYS, V36, P665, DOI 10.1007/BF01012930
   MACDONALD DD, 1985, J ELECTROCHEM SOC, V133, P2018
   MACDONALD JR, 1987, IMPEDANCE SPECTROSCO, P154
   McQueen D, 1982, CLIN APPL BIOMATERIA, P179
   MEACHIM G, 1973, J BIOMED MATER RES, V7, P555, DOI 10.1002/jbm.820070607
   Mu Y, 2000, J BIOMED MATER RES, V49, P238, DOI 10.1002/(SICI)1097-4636(200002)49:2<238::AID-JBM12>3.0.CO;2-J
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   PARK JR, 1983, CORROS SCI, V23, P295, DOI 10.1016/0010-938X(83)90063-X
   PASCAL P, 1963, NOUVEAU TRAITE CHIMI, V14
   RAMMELT U, 1987, CORROS SCI, V27, P373, DOI 10.1016/0010-938X(87)90079-5
   SCHEPERS E, 1987, IMPLANT MAT BIOFUNCT, P79
   Sun ZL, 1997, J BIOMED MATER RES, V34, P29, DOI 10.1002/(SICI)1097-4636(199701)34:1<29::AID-JBM5>3.0.CO;2-P
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V10, P9
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, J COLLOID INTERF SCI, V130, P405, DOI 10.1016/0021-9797(89)90117-3
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   Wang JY, 1996, J BIOMED MATER RES, V32, P655, DOI 10.1002/(SICI)1097-4636(199612)32:4<655::AID-JBM19>3.0.CO;2-C
NR 32
TC 110
Z9 115
U1 1
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0010-938X
J9 CORROS SCI
JI Corrosion Sci.
PD MAR
PY 2001
VL 43
IS 3
BP 547
EP 559
DI 10.1016/S0010-938X(00)00107-4
PG 13
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 411EX
UT WOS:000167486100010
DA 2018-10-19
ER

PT J
AU McNamara, BP
   Murphy, H
   Morshed, MM
AF McNamara, BP
   Murphy, H
   Morshed, MM
TI Adhesion properties of diamond-like coated orthopaedic biomaterials
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 11th European Conference on Diamond, Diamond-like Materials, Carbon
   Nanotubes, Nitrides and Silicon Carbide (Diamond 2000)
CY SEP 03-08, 2000
CL OPORTO, PORTUGAL
SP De Beers Ind Diamonds (UK) Ltd, GFD Gesell Diamantprod mbH, Philips Res Labs, Elsevier Sci
DE adhesion strength; diamond-like carbon; biomaterial; wear
ID CARBON-FILMS; COATINGS; TOOLS; CVD
AB This study details an experimental analysis to investigate the most suitable orthopaedic alloy for diamond-like carbon deposition using a saddle field neutral beam deposition process. The paper specifically identifies the adhesion strength properties of diamond-like coatings and its dependence on process parameters for application to orthopaedic steels and polymer substrates. Sub-micron thickness films were deposited directly on stainless steel, cobalt chrome alloy, titanium alloy and ultra high mel. wt. polyethylene substrates. It was found from Rockwell and pull-off adhesion tests that superior adhesion is acquired for stainless steel substrates followed by cobalt chrome and titanium alloys. Adhesion strength was also shown to be inversely related to increases in deposition pressure and to increase with time up to a threshold. The maximum adhesion strength of coatings deposited on the polymer substrates was 60% of the value for stainless steel. Surface roughness was also inversely related to adhesion strength for the substrates examined. It is demonstrated that stainless steel offers a superior substrate material for the application of diamond-like thin-films where wear mechanisms and mechanical constraints are operational such as in orthopaedic articulating joint replacements. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Dublin City Univ, Sch Mech & Mfg Engn, Dublin 9, Ireland.
RP McNamara, BP (reprint author), Dublin City Univ, Sch Mech & Mfg Engn, Dublin 9, Ireland.
CR Barth J, 1991, HDB OPTICAL CONSTANT, VII
   Black J., 1988, ORTHOPAEDIC BIOMATER
   Clay KJ, 1998, DIAM RELAT MATER, V7, P1100, DOI 10.1016/S0925-9635(98)00159-9
   DING XZ, 1999, THIN SOLID FILMS, V246, P82
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   DRORY DM, 1995, MECH BEHAV DIAMOND O
   EVANS AC, 1991, MED DEVICE TECHNOL, V5, P26
   Hakovirta M, 1996, DIAM RELAT MATER, V5, P186, DOI 10.1016/0925-9635(95)00497-1
   KUMAR S, 1999, THIN SOLID FILMS, V34, P130
   Lappalainen R, 1998, DIAM RELAT MATER, V7, P482, DOI 10.1016/S0925-9635(98)80003-4
   Mallika K, 1999, WEAR, V224, P245, DOI 10.1016/S0043-1648(98)00337-8
   McLaughlin JA, 1996, DIAM RELAT MATER, V5, P486, DOI 10.1016/0925-9635(96)80065-3
   Morrison NA, 1996, DIAM RELAT MATER, V5, P1118, DOI 10.1016/0925-9635(96)00532-8
   OLEARY A, 1995, KEY ENG MAT, V99-1, P301, DOI 10.4028/www.scientific.net/KEM.99-100.301
   SHEEJA D, 2000, 11 EUR C PORT PORT 2
   Sleptsov VV, 1996, DIAM RELAT MATER, V5, P483, DOI 10.1016/0925-9635(96)80064-1
   STEINMANN PA, 1989, J VAC SCI TECHNOL A, V7, P2267, DOI 10.1116/1.575926
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   Thomann UI, 2000, WEAR, V239, P48, DOI 10.1016/S0043-1648(99)00372-5
   Voevodin AA, 1996, CERAM INT, V22, P1, DOI 10.1016/0272-8842(95)00020-8
   WOOTEN F, 1972, OPTICAL PROPERTIES S, P78
NR 21
TC 21
Z9 21
U1 1
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD MAR-JUL
PY 2001
VL 10
IS 3-7
SI SI
BP 1098
EP 1102
DI 10.1016/S0925-9635(00)00567-7
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 432ZJ
UT WOS:000168730600152
DA 2018-10-19
ER

PT J
AU Zippel, R
   Wilhelm, L
   Marusch, F
   Koch, A
   Urban, G
   Schlosser, M
AF Zippel, R
   Wilhelm, L
   Marusch, F
   Koch, A
   Urban, G
   Schlosser, M
TI Antigenicity of polyester (Dacron) vascular prostheses in an animal
   model
SO EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
LA English
DT Article
DE antigenicity; biocompatibility; polyester; vascular prosthesis
ID INFLAMMATORY RESPONSES; BIOCOMPATIBILITY; ANTIBODIES; BIOMATERIALS;
   ELASTOMERS; EXPRESSION; ADHERENCE; IMPLANTS; SURFACE; TISSUE
AB Objectives: to investigate the specific humoral immune response to three different polyester (Dacron) prostheses in pigs.
   Design, materials and methods: twenty-four growing pigs were randomly divided into three groups. The infrarenal aorta was replaced by a segment of collagen-impregnated woven polyester prosthesis (low, medium and high porosity). Serum antibodies were detected by modified enzyme immunoassay using non-impregnated prosthesis as the target for the blood samples taken on experimental days 1, 10, 17, 24, 62 and 116 of the 22 pigs followed over the whole observation period.
   Results: significantly enhanced (p<0.05) mean Ige antibody binding against polyester was detected on experimental days 10, 17, 24 and 62 with antibody prevalences of 41%, 41%, 32% and 37%, resppectively. Antibody positive pigs were divided into early responders (n=9) and late responders (n=5) with antibody detection on lilly 10 and/or 17 vs day 62 and/or 116. No significant differences between the three different prostheses were found. The formation of specific IgG against polyester in the animals investigated demonstrates a broad individual variability.
   Conclusions: polyester is art antigenic polymer. Specific antibodies, reflecting the inflammatory response, might be not only a parameter for testing biomaterials bat also for determining individual bio(in)compatibility for long-term biomaterial function.
C1 Carl Thiem Hosp, Dept Surg, D-03048 Cottbus, Germany.
   Univ Greifswald, Dept Surg, Greifswald, Germany.
   Univ Greifswald, Inst Pathophysiol, Greifswald, Germany.
RP Zippel, R (reprint author), Carl Thiem Hosp, Dept Surg, Thiem St 3, D-03048 Cottbus, Germany.
CR ALI SAM, 1994, BIOMATERIALS, V15, P779, DOI 10.1016/0142-9612(94)90032-9
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Aoyagi M, 1997, HISTOCHEM CELL BIOL, V107, P11, DOI 10.1007/s004180050084
   BAKKER D, 1990, J BIOMED MATER RES, V24, P277, DOI 10.1002/jbm.820240302
   BRETT T, 1992, MED DEVICE TECHNOL, V3, P25
   CREPON B, 1991, BIOMATERIALS, V12, P551
   GLASER ZR, 1993, PHARMACOPEIAL FORUM, V19, P5035
   GOLDBLUM RM, 1992, LANCET, V340, P510, DOI 10.1016/0140-6736(92)91710-P
   Gong G, 1993, J Heart Valve Dis, V2, P684
   Hicks DG, 1996, J BONE JOINT SURG AM, V78A, P482, DOI 10.2106/00004623-199604000-00002
   HOLGERS KM, 1995, BIOMATERIALS, V16, P611, DOI 10.1016/0142-9612(95)93858-B
   KOCH AE, 1995, NATURE, V376, P517, DOI 10.1038/376517a0
   LODI M, 1988, INT ANGIOL, V7, P344
   MARGIOTTA MS, 1992, ANN SURG, V216, P600, DOI 10.1097/00000658-199211000-00013
   MATURRI L, 1991, INT SURG, V76, P115
   MAURIN N, 1995, J BIOMED MATER RES, V29, P1439
   MULLER KM, 1994, CURRENT TOPICS PATHO, V86
   SCHLOSSER M, 1991, J IMMUNOL METHODS, V140, P101, DOI 10.1016/0022-1759(91)90131-X
   Schlosser M, 1994, Diabetes Res, V26, P67
   SCHLOSSER M, 1994, HORM METAB RES, V26, P534, DOI 10.1055/s-2007-1001751
   SCHLOSSER M, 1994, P 8 INT C BIOM ENG, P482
   Schlosser M., 1997, BIOSENSORS BODY CONT, P139
   SMITH DJ, 1990, J SURG RES, V48, P13, DOI 10.1016/0022-4804(90)90138-R
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Swartbol P, 1996, J BIOMED MATER RES, V32, P669, DOI 10.1002/(SICI)1097-4636(199612)32:4<669::AID-JBM21>3.0.CO;2-7
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tardito E, 1993, Minerva Cardioangiol, V41, P59
   Toumbis CA, 1997, SEMIN ARTHRITIS RHEU, V27, P44, DOI 10.1016/S0049-0172(97)80036-4
   VOLLMAR J, 1996, REKONSTRUKTIVE CHIRU, P34
   WARD RA, 1994, NEPHROL DIAL TRANSPL, V9, P46
   YAMAMOTO K, 1993, ARTIF ORGANS, V17, P1010, DOI 10.1111/j.1525-1594.1993.tb03183.x
   YANG J, 1994, J BIOMED MATER RES, V28, P1249, DOI 10.1002/jbm.820281102
   ZIEGLER M, 1994, BIOMATERIALS, V15, P859, DOI 10.1016/0142-9612(94)90043-4
   Zippel R, 1999, GEFASSCHIRURGIE, V4, P91
NR 35
TC 8
Z9 8
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1078-5884
J9 EUR J VASC ENDOVASC
JI Eur. J. Vasc. Endovasc. Surg.
PD MAR
PY 2001
VL 21
IS 3
BP 202
EP 207
DI 10.1053/ejvs.2000.1298
PG 6
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA 422CK
UT WOS:000168100200002
PM 11352677
OA Bronze
DA 2018-10-19
ER

PT J
AU Malmonge, SM
AF Malmonge, SM
TI Artificial articular cartilage: developments and challenges
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Editorial Material
ID OSTEOCHONDRAL DEFECTS; HISTOLOGICAL-EVALUATION; POLYMER SYSTEM; RABBIT
   KNEE; REPAIR; CHONDROCYTES; IMPLANTS; REGENERATION; BIOMATERIAL;
   DEPOSITION
C1 Univ Metodista Piracicaba, FECQ, BR-13450000 Santa Barbara DOeste, SP, Brazil.
RP Malmonge, SM (reprint author), Univ Metodista Piracicaba, FECQ, Rod Sta Barbara Iracemacpolis,KM 01, BR-13450000 Santa Barbara DOeste, SP, Brazil.
RI Malmonge, Sonia/I-4610-2012
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   BRAY JC, 1973, J BIOMED MATER RES, V7, P431, DOI 10.1002/jbm.820070506
   BUCKWALTER JA, 1994, J BONE JOINT SURG AM, V76A, P1405, DOI 10.2106/00004623-199409000-00019
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Corkhill P H, 1990, Proc Inst Mech Eng H, V204, P147, DOI 10.1243/PIME_PROC_1990_204_249_02
   DOWNES S, 1994, J MATER SCI-MATER M, V5, P88, DOI 10.1007/BF00121696
   EFTEKHAR NS, 1987, CLIN ORTHOP RELAT R, P207
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1995, BIOMEDICAL ENG HDB, P1788
   HANFF G, 1990, SCAND J PLAST RECONS, V24, P217, DOI 10.3109/02844319009041282
   Hasegawa M, 1999, BIOMATERIALS, V20, P1969, DOI 10.1016/S0142-9612(99)00106-4
   HEINEKEN FG, 1991, J BIOMECH ENG, V113, P1
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   KIMURA T, 1984, CLIN ORTHOP RELAT R, P231
   KON M, 1981, PLAST RECONSTR SURG, V67, P289, DOI 10.1097/00006534-198103000-00002
   KREDER HJ, 1994, CLIN ORTHOP RELAT R, P288
   LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880
   LIVECCHI AB, 1994, J BIOMED MATER RES, V28, P839, DOI 10.1002/jbm.820280802
   MAINARD D, 1992, 4 WORLD BIOM C
   Malmonge SM, 2000, BRAZ J MED BIOL RES, V33, P307, DOI 10.1590/S0100-879X2000000300008
   MALMONGE SM, 2000, INT J ARTIF ORGANS, V24, P174
   MESSNER K, 1993, BIOMATERIALS, V14, P513, DOI 10.1016/0142-9612(93)90240-3
   MINNS RJ, 1982, BIOMATERIALS, V3, P81, DOI 10.1016/0142-9612(82)90038-2
   MITCHELL N, 1976, J BONE JOINT SURG AM, V58, P230, DOI 10.2106/00004623-197658020-00012
   MORAN ME, 1992, J BONE JOINT SURG BR, V74, P659
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   MOW VC, 1991, T ASME, V113, P193
   Newman AP, 1998, AM J SPORT MED, V26, P309, DOI 10.1177/03635465980260022701
   Niederauer GG, 2000, BIOMATERIALS, V21, P2561, DOI 10.1016/S0142-9612(00)00124-1
   OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X
   Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246
   Pedley DG, 1980, BRIT POLYM J, V12, P99
   PRIDIE KH, 1959, J BONE JOINT SURG BR, V41, P618
   Quinn TM, 1998, J CELL SCI, V111, P573
   RANAWAT CS, 1984, J BONE JOINT SURG AM, V66A, P745, DOI 10.2106/00004623-198466050-00014
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI DOI 10.1021/SYMPOSIUM
   SHAPIRO F, 1996, J BONE JOINT SURG, V78, P721
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   Solchaga L, 1996, REV CHIR ORTHOP, V82, P101
   SPEER DP, 1979, CLIN ORTHOP RELAT R, P326
   STOCKWELL RA, 1990, METHODS CARTILAGE RE, P61
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   SUTHERLAND CJ, 1982, J BONE JOINT SURG AM, V64, P970, DOI 10.2106/00004623-198264070-00002
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   Wyre RM, 2000, BIOMATERIALS, V21, P335, DOI 10.1016/S0142-9612(99)00185-4
NR 48
TC 0
Z9 0
U1 0
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD MAR
PY 2001
VL 24
IS 3
BP 119
EP 122
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 419RH
UT WOS:000167962100001
PM 11314803
DA 2018-10-19
ER

PT J
AU Bohic, S
   Weiss, P
   Roger, P
   Daculsi, G
AF Bohic, S
   Weiss, P
   Roger, P
   Daculsi, G
TI Light scattering experiments on aqueous solutions of selected cellulose
   ethers: contribution to the study of polymer-mineral interactions in a
   new injectable biomaterial
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; THERMAL GELATION; METHYLCELLULOSE;
   THERMOGELATION; SUBSTITUTE; COMPOSITE; WATER; BONE
AB Hydroxypropylmethylcellulose (HPMC) is used as a ligand for a bioactive calcium phosphate ceramic (the filler) in a ready-to-use injectable sterilized biomaterial for bone and dental surgery. Light scattering experiments were usually used to study high water-soluble polymers and to determine the basic macromolecular parameters. In order to gain a deeper understanding of polymer/mineral interactions in this type of material, we have investigated the effect of divalent and trivalent ions (Ca2+, PO43-) and steam sterilization on dilute solutions of HPMC and hydroxyethylcellulose (HEC). The sterilization process may cause some degradation of HEC taking into account its high molecular weight and some rigidity of the polymer chain. Moreover, in the case of HPMC, the changes in the conformations rather than degradation process are supposed. These effects of degradation and flocculation are strengthened in alkaline medium. Experimental data suggested the formation of chelate complexes between Ca2+ and HPMC which improve its affinity to the mineral blend and consolidate the injectable biomaterial even in the case of its hydration by biological fluid. (C) 2001 Kluwer Academic Publishers.
C1 Fac Chirurg Dent Nantes, Ctr REch Mat Internet Biol, INSERM, E9903, F-44042 Nantes 01, France.
   INRA, Lab Biochim & Technol Glucides, F-44316 Nantes, France.
RP Bohic, S (reprint author), Fac Chirurg Dent Nantes, Ctr REch Mat Internet Biol, INSERM, E9903, 1 Pl A Ricordeau, F-44042 Nantes 01, France.
RI BOHIC, Sylvain/F-6464-2013; Daculsi, Guy/P-1320-2014; Weiss,
   Pierre/P-1372-2014
OI BOHIC, Sylvain/0000-0001-6355-7592; Daculsi, Guy/0000-0003-1030-3446;
   Weiss, Pierre/0000-0002-6159-8590
CR Beignon M, 1998, J MOL STRUCT, V443, P233, DOI 10.1016/S0022-2860(97)00391-8
   BROWN W, 1963, MAKROMOLEKUL CHEM, V64, P49
   BROWN W, 1961, ARK KEMI, V18, P2600
   BURCHARD W, 1982, INT S PLANT POL CARB, P215
   CARLSSON A, 1990, COLLOID SURFACE, V47, P147, DOI 10.1016/0166-6622(90)80069-G
   CHEMTOB C, 1988, STP PHARM, V4, P764
   DACULIS G, 1996, 5 WORLD BIOM C MAY 2
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Daculsi G, 1995, CNRS patent, Patent No. [9521634, WO 95/21634]
   Dupraz A, 1996, J MATER SCI-MATER M, V7, P52, DOI 10.1007/BF00121190
   GREMINGER GK, 1981, HDB WATER SOLUBLE RE, P1
   GROVER JA, 1986, FOOD HYDROCOLLOIDS, V3, P121
   HAQUE A, 1993, CARBOHYD POLYM, V22, P175, DOI 10.1016/0144-8617(93)90138-T
   HAQUE A, 1993, CARBOHYD POLYM, V22, P161, DOI 10.1016/0144-8617(93)90137-S
   Huglin M. B., 1972, LIGHT SCATTERING POL, P165
   HUIKARI A, 1986, ACTA PHARM FENN, V95, P105
   HUNKELER D, 1992, POLYM INT, V27, P23, DOI 10.1002/pi.4990270105
   KHAN WU, 1991, RES IND, V36, P214
   Khomutov LI, 1993, POLYM SCI, V35, P320
   LANG P, 1993, J BIOMAT SCI-POLYM E, V4, P517, DOI 10.1163/156856293X00753
   NEELY WB, 1963, J POLYM SCI PART A, V1, P311, DOI 10.1002/pol.1963.100010128
   OWEN SR, 1992, J FOOD ENG, V16, P39, DOI 10.1016/0260-8774(92)90019-3
   ROGER P, 1992, CARBOHYD RES, V227, P73, DOI 10.1016/0008-6215(92)85061-4
   SARKAR N, 1979, J APPL POLYM SCI, V24, P1073, DOI 10.1002/app.1979.070240420
   SCHULZ L, 1993, PAPIER, V46, P1
   SPERLING LH, 1993, INTRO PHYSICAL POLYM, P78
   *TECHN INF, 1990, AQ PROD LIT
   WALES M, 1951, J PHYS COLLOID CHEM, V55, P203, DOI 10.1021/j150485a007
   Weiss P, 1997, J MATER SCI-MATER M, V8, P621, DOI 10.1023/A:1018519419539
   WEISS P, 1996, P INT POL SEM TRZEB, P181
   1986, J AM COLL TOXICOL, V5
NR 32
TC 12
Z9 12
U1 0
U2 9
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2001
VL 12
IS 3
BP 201
EP 205
DI 10.1023/A:1008902829840
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 403LW
UT WOS:000167045100003
PM 15348303
DA 2018-10-19
ER

PT J
AU Midy, V
   Dard, M
   Hollande, E
AF Midy, V
   Dard, M
   Hollande, E
TI Evaluation of the effect of three calcium phosphate powders on
   osteoblast cells
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BOVINE PARATHYROID CELLS; FIBROBLAST-GROWTH-FACTOR; BONE; INVITRO;
   HYDROXYAPATITE; PROLIFERATION; INHIBITION; CRYSTALS; HORMONE; MATRIX
AB The aim of the present study was to assess the effect of three calcium phosphate powders entering in the composition of bone substitute materials on osteoblast-cells activity. These powders were hydroxyapatite (HA) widely used as a biomaterial, nanocrystalline carbonate apatite (C A) very close to bone mineral crystals, and an experimental one: calcium phosphate cement-1 (CPC-1) composed of an amorphous Ca-P phase and brushite. The powders were physico-chemically characterized. The very reactive CPC-1 powder became transformed in cell culture medium: recrystallization of amorphous precursors and hydrolysis of brushite into poorly crystalline apatite occurred. Osteoblast-cells activity was evaluated: for low level of calcium phosphates (> 100 mug/ml) CPC-1 enhanced proliferation and, to a lesser degree, differentiation on alkaline phosphatase activity. For 100 mug/ml of powders we observed a great alteration of biological activity of the osteoblasts: evaluation of proliferation indicated an inhibition for all samples, and a decrease of two differentiation markers: alkaline phosphatase activity and osteocalcin release were noticed, suggesting a down regulation due to the presence of large amount of mineral powder. (C) 2001 Kluwer Academic Publishers.
C1 Lab Cytophysiol Cellules Eucaryotes, F-31400 Toulouse, France.
   Merck Biomat Res, D-64271 Darmstadt, Germany.
RP Midy, V (reprint author), Lab Cytophysiol Cellules Eucaryotes, JE 1962,38 Rue 36 Ponts, F-31400 Toulouse, France.
CR ALLIOTLICHT B, 1991, BIOMATERIALS, V12, P752, DOI 10.1016/0142-9612(91)90025-6
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   EVANS EJ, 1991, P BIOCERAMICS HUMAN, P48
   GENGE BR, 1988, J BIOL CHEM, V263, P18513
   GLOBUS RK, 1988, ENDOCRINOLOGY, V123, P98, DOI 10.1210/endo-123-1-98
   HARMAND MF, 1984, J CELL PHYSIOL, V119, P359, DOI 10.1002/jcp.1041190315
   HAWA NS, 1993, J MOL ENDOCRINOL, V10, P43, DOI 10.1677/jme.0.0100043
   KANAZIRSKA MPV, 1995, ENDOCRINOLOGY, V136, P2238, DOI 10.1210/en.136.5.2238
   KOBAYASHI N, 1988, P NATL ACAD SCI USA, V85, P4857, DOI 10.1073/pnas.85.13.4857
   MAJESKA RJ, 1982, CALCIFIED TISSUE INT, V34, P59, DOI 10.1007/BF02411210
   Midy V, 1998, J BIOMED MATER RES, V41, P405, DOI 10.1002/(SICI)1097-4636(19980905)41:3<405::AID-JBM10>3.0.CO;2-H
   MIDY V, IN PRESS
   NAKAHARA H, 1991, J ORTHOP RES, V9, P465, DOI 10.1002/jor.1100090402
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Prudhommeaux F, 1996, ARTHRITIS RHEUM, V39, P1319, DOI 10.1002/art.1780390809
   REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969
   Rey C, 1995, CELL MATER, V5, P345
   RODAN SB, 1987, CANCER RES, V47, P4961
   ROMBERG RW, 1986, BIOCHEMISTRY-US, V25, P1176, DOI 10.1021/bi00353a035
   STEIN GS, 1990, FASEB J, V4, P3111
   WEINER S, 1989, CONNECT TISSUE RES, V21, P589, DOI 10.3109/03008208909050015
NR 21
TC 20
Z9 20
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2001
VL 12
IS 3
BP 259
EP 265
DI 10.1023/A:1008971317544
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 403LW
UT WOS:000167045100010
PM 15348310
DA 2018-10-19
ER

PT J
AU Patel, JV
   Soni, PK
   Sinha, VK
AF Patel, JV
   Soni, PK
   Sinha, VK
TI A novelty finish prepared from polyurethane of biomaterial base
SO JOURNAL OF POLYMER MATERIALS
LA English
DT Article
DE polyurethane; bagasse; argemone oil
AB Argemone oil and its transesterified derivatives namely liquid polyol have been employed as back bone for the preparation of polyurethane. Hydroxyl functionalized polyol were obtained by esterification of glycol glycoside with argemone oil. The polyol were analyzed by the end group analysis, GPC, infrared spectroscopy to confirm their formation. Polyols were reacted with 4-4' Methylene Diphenylene Isocyanate (MDI) in different ratios to form polyurethane resin. Polyurethane resin thus prepared was coated on test panels and were examined for flexibility, scratch resistance, impact hardness, adhesion and chemical resistance. Thermal stability of polyurethane resin was evaluated by TGA and functional groups by infrared spectroscopy.
C1 VP & RPTP Sci Coll, Dept Ind Chem, Vallabh Vidyanagar 388120, Gujarat, India.
RP Sinha, VK (reprint author), VP & RPTP Sci Coll, Dept Ind Chem, Vallabh Vidyanagar 388120, Gujarat, India.
CR BLOUNT DH, 1983, Patent No. 4367326
   BLOUNT H, 1982, Patent No. 4339366
   BRYDSON JA, 1989, PLASTIC MAT, P452
   COCK LV, 1966, LAB HDB OIL FAT ANAL, P69
   *COUNC SCI IND RES, 1972, WEALTH IND RAW MAT, V2, P43
   DONELLY MJ, 1984, THESIS MANCHESTER U
   FRISCH KC, 1986, PLAST RUFF INT, V8, P1
   HUI YH, 1996, BAILLEYS IND OIL FAT, V3, P66
   *IND STAND, 1011964 IS, P38
   *IND STAND, IS1976 IND STAND, P27
   KLEINGWAYS RW, 1989, ADHESIVES RENEWABLE, P487
   KONTANST F, 1985, ORGANIC COATING PROP, P57
   OERTEL G, 1985, POLYURETHANE HDB, P58
   OTEY FH, 1963, J AM OIL CHEM SOC, V40, P76, DOI 10.1007/BF02654748
   OTEY FH, 1969, IND ENG CHEM PROD RD, V3, P267
   OTEY FH, 1963, IND ENG CHEM PROD RD, V4, P256
   PALTON JT, 1967, Patent No. 3336291
   PATTON JT, 1971, Patent No. 3567661
   SINGH P, 1991, J POLYM MATER, V8, P275
   URBANSKI J, 1977, HDB ANAL SYNTHETIC P, P287
   WHISTER RL, 1963, METHODS CARBOHYDRATE, V3, P112
   WHISTER RL, 1965, METHODS CARBOHYDRATE, V5, P365
   WICKS ZW, 1992, ORGANIC COATINGS SCI, P221
NR 23
TC 7
Z9 7
U1 0
U2 2
PU OXFORD & IBH PUBL CO PVT LTD
PI NEW DELHI
PA 66 JANPATH, NEW DELHI 110 001, INDIA
SN 0970-0838
J9 J POLYM MATER
JI J. Polym. Mater.
PD MAR
PY 2001
VL 18
IS 1
BP 103
EP 109
PG 7
WC Polymer Science
SC Polymer Science
GA 433BZ
UT WOS:000168736600015
DA 2018-10-19
ER

PT J
AU Chow, KS
   Khor, E
   Wan, ACA
AF Chow, KS
   Khor, E
   Wan, ACA
TI Porous chitin matrices for tissue engineering: Fabrication and in vitro
   cytotoxic assessment
SO JOURNAL OF POLYMER RESEARCH
LA English
DT Article
DE porous chitin matrices; lyophilization; tissue engineering; MTT assays;
   in vitro cytotoxicity assessment
ID RAPID COLORIMETRIC ASSAY; POLYMER SCAFFOLDS; ARTIFICIAL SKIN; PORE
   STRUCTURE; CHITOSAN; BIOMATERIAL; MORPHOLOGY; DELIVERY; GROWTH; FOAMS
AB A series of porous chitin matrices were fabricated by freezing and lyophilization of chitin gels cast from a 5% N,N-dimethylacetamide (DMAc)/lithium chloride (LiCl) solvent system. The porous chitin matrices were found to have uniform pore structure in the micron range. Scanning electron microscopy (SEM) revealed that the pore size of the porous chitin matrices varied according to the freezing method prior to lyophilization. By subjecting the chitin gels to dry-ice/ acetone (-38 degreesC), the final porous chitin matrix pave pore dimensions measuring 300-500 mum with 69% porosity. A smaller pore dimension of 100-200 mum with 61% porosity was produced when the chitin gels were frozen by liquid nitrogen (-196 degreesC) and 10 mum pores with 54% porosity were produced when the gels were placed in a freezer (-20 degreesC) for 20 min. In comparison. lower porosity structures of ca. 10% porosity were obtained from both air-dried and critical point dried chitin gels. Furthermore. a low gel concentration (<0.5%, w/w) also produced porous morphology by vacuum drying without any freezing and lyophilization. The resulting pore properties influenced the water uptake profile of the materials in water. These porous chitin matrices are found to be non-cytotoxic and to hold promise as potential structural scaffolds for cell growth and proliferation in vitro.
C1 Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.
   Natl Univ Singapore, Inst Mat Res & Engn, Singapore 117543, Singapore.
RP Khor, E (reprint author), Natl Univ Singapore, Dept Chem, 3 Sci Dr 3, Singapore 117543, Singapore.
EM chmkhore@nus.edu.sg
RI Wan, Andrew/B-8525-2014
CR AUBERT JH, 1991, CHEMTECH, V21, P234
   BAXTER A, 1992, INT J BIOL MACROMOL, V166, P14
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X
   DeGroot JH, 1997, J MATER SCI-MATER M, V8, P707, DOI 10.1023/A:1018544124990
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Eser ECCI, 1998, NEUROL RES, V20, P648
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   GALLARDO A, 1979, REV PLAST MOD, V77, P60
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GREEN LM, 1984, J IMMUNOL METHODS, V70, P257, DOI 10.1016/0022-1759(84)90190-X
   HEEG K, 1985, J IMMUNOL METHODS, V77, P237, DOI 10.1016/0022-1759(85)90036-5
   HIRANO S, 1979, CARBOHYD RES, V71, P344
   Klokkevold PR, 1999, J ORAL MAXIL SURG, V57, P49, DOI 10.1016/S0278-2391(99)90632-8
   LILIA S, 1997, BIOMATERIALS, V18, P583
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MADIHALLY SV, 1996, P 5 WORLD BIOM C, P238
   Mi FL, 1999, BIOMATERIALS, V20, P1603, DOI 10.1016/S0142-9612(99)00064-2
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MIKOS AG, 1992, POLYM MAT SCI ENG, V66, P34
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Mosmann T., 1983, J IMMUNOL METHODS, V55, P65
   NICOLL SB, 1998, MATER RES SOC S P, V3, P530
   Paul W, 2000, STP PHARMA SCI, V10, P5
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SANDFORD PA, 1991, ACS SYM SER, V467, P430
   Shah S, 1999, J PHARM PHARMACOL, V51, P667, DOI 10.1211/0022357991772952
   Sonomoto K, 2000, J MOL CATAL B-ENZYM, V10, P325, DOI 10.1016/S1381-1177(00)00133-8
   Thomson RC, 1995, ADV POLYM SCI, V122, P245
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   WILLIAMS JM, 1989, J MATER SCI, V24, P4062, DOI 10.1007/BF01168975
   WINTERMANTEL E, 1995, ENCY HDB BIOMATERIAL, V3
   YANNAS IV, 1990, ANGEW CHEM INT EDIT, V29, P20, DOI 10.1002/anie.199000201
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 37
TC 33
Z9 33
U1 1
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1022-9760
EI 1572-8935
J9 J POLYM RES
JI J. Polym. Res.
PD MAR
PY 2001
VL 8
IS 1
BP 27
EP 35
PG 9
WC Polymer Science
SC Polymer Science
GA 432KB
UT WOS:000168689800004
DA 2018-10-19
ER

PT J
AU Burdick, JA
   Philpott, LM
   Anseth, KS
AF Burdick, JA
   Philpott, LM
   Anseth, KS
TI Synthesis and characterization of tetrafunctional lactic acid oligomers:
   A potential in situ forming degradable orthopaedic biomaterial
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE photopolymerization; poly(lactic acid); orthopaedic biomaterials;
   bone-tissue engineering
ID BIODEGRADABLE POLYMERS; POLYANHYDRIDES; ADHESION
AB Tetrafunctional lactic acid oligomers with low molecular weight ethylene glycol cores were synthesized and characterized to assess their applicability to orthopaedics. Utilizing a visible light photoinitiating system, these oligomers polymerize within minutes to form highly crosslinked networks and, thus, have potential for in situ formation. Varying the oligomer structure readily alters the physical properties of the resultant polymer networks. For instance, mechanical properties were highly dependent on the number of lactic acid and ethylene glycol units in the oligomer backbone. Additionally, polymer mass loss ranged from similar to 30 to 60% within 8 weeks of degradation time depending on the oligomer chemistry. Mechanical properties decreased with degradation of these polymers, indicating a bulk degradation mechanism. Finally, scaffolds with a controlled architecture were fabricated from these oligomers that show potential for tissue-engineering applications. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem Engn, ECCH 111, Boulder, CO 80309 USA.
CR ANSETH KS, 1995, MACROMOLECULES, V28, P2491, DOI 10.1021/ma00111a050
   Anseth KS, 1999, NAT BIOTECHNOL, V17, P156
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   BEHRAVESH E, 1999, CLIN ORTHOP S, V367, pS118
   BERCHTOLD KA, 1999, RADT EUR 99 C P BERL, P767
   BOS GD, 1983, J BONE JOINT SURG AM, V65, P239, DOI 10.2106/00004623-198365020-00015
   Boyan BD, 1999, J BIOMED MATER RES, V46, P51, DOI 10.1002/(SICI)1097-4636(199907)46:1<51::AID-JBM6>3.0.CO;2-I
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   BURDICK JA, IN PRESS BIOMATERIAL
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   HILL L W, 1992, J COATING TECHNOL, V64, P29
   HOROWITZ MC, 1987, ORTHOP CLIN N AM, V18, P227
   Ishaug SL, 1996, BIOTECHNOL BIOENG, V50, P443, DOI 10.1002/(SICI)1097-0290(19960520)50:4<443::AID-BIT12>3.0.CO;2-K
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Kim BS, 2000, BIOMATERIALS, V21, P259, DOI 10.1016/S0142-9612(99)00174-X
   KLOOSTERBOER JG, 1988, ADV POLYM SCI, V84, P1
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Lu LC, 2000, BIOMATERIALS, V21, P1595, DOI 10.1016/S0142-9612(00)00048-X
   Metters AT, 2000, POLYMER, V41, P3993, DOI 10.1016/S0032-3861(99)00629-1
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MIYAZAKI K, 1988, J BIOMED MATER RES, V22, P1011, DOI 10.1002/jbm.820221105
   Muggli DS, 1998, MACROMOLECULES, V31, P4120, DOI 10.1021/ma980108n
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   SAWHNEY AS, 1994, J BIOMED MATER RES, V28, P831, DOI 10.1002/jbm.820280710
   SVALDIMUGGLI D, 1998, J BIOMED MATER RES, V36, P271
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
NR 28
TC 58
Z9 59
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD MAR 1
PY 2001
VL 39
IS 5
BP 683
EP 692
DI 10.1002/1099-0518(20010301)39:5<683::AID-POLA1040>3.0.CO;2-Z
PG 10
WC Polymer Science
SC Polymer Science
GA 400YZ
UT WOS:000166901400011
DA 2018-10-19
ER

PT J
AU Park, HK
   Dujovny, M
   Agner, C
   Diaz, FG
AF Park, HK
   Dujovny, M
   Agner, C
   Diaz, FG
TI Biomechanical properties of calvarium prosthesis
SO NEUROLOGICAL RESEARCH
LA English
DT Article
DE calvarial defect; cranioplasty; bone graft; hydroxyapatite; metallic
   graft; polymer graft; polymethylmethacrylate; finite element analysis
ID CEREBRAL BLOOD-FLOW; SKULL DEFECTS; CRANIOPLASTY; RECONSTRUCTION;
   STEREOLITHOGRAPHY; IMPLANTS; SURGERY; REPAIR; CT
AB There are many materials available for the reconstruction of calvarial defects. Even though their biomaterial properties are well known, the biomechanical properties as part of the calvarium have not been investigated. In this article, calvarial implants are reviewed with their historic development into modern cranioplasty. Materials for trephined skulls are classified by their category. Individual parameters to describe their mechanical properties are collected and revealed in detail. The laboratory testing methodology for cranioplasty material is introduced to understand each parameter. At last, we discuss an engineering technique to look into the implant behavior. Since there is no standard goal for the biomechanical and biomaterial point of view for cranioplasty, this article suggests the finite element method for evaluation of the implant behavior and the degree of damage upon the impact injury.
C1 Wayne State Univ, Sch Med, Dept Neurosurg, Biomech Lab, Detroit, MI 48201 USA.
   Albany Med Sch, Dept Neurol, New York, NY USA.
RP Park, HK (reprint author), Wayne State Univ, Sch Med, Dept Neurosurg, Biomech Lab, 550 E Canfield Ave,Rm 38, Detroit, MI 48201 USA.
CR ADAMS JS, 1991, APPL BIOMATERIALS FA, P271
   Agner C, 1997, CRIT REV NEUROSURG, V7, P365, DOI 10.1007/s003290050048
   Agner C, 1998, SKULL BASE SURG, V8, P81, DOI 10.1055/s-2008-1058580
   Asenjo A, 1963, NEUROSURGICAL TECHNI
   BELLOSTE A, 1732, HOSP SURG
   BENZEL EC, 1990, NEURORADIOLOGY, V32, P151, DOI 10.1007/BF00588566
   BILL JS, 1995, INT J ORAL MAX SURG, V24, P98, DOI 10.1016/S0901-5027(05)80869-0
   Broca P, 1875, B SOC ANTHR, V10, P326
   BROTHWELL D, 1967, SURVEY DIS INJURIES
   BURRELL HL, 1888, BOSTON MED SURG J, V118, P313
   Costantino P D, 1993, Facial Plast Surg, V9, P1, DOI 10.1055/s-2008-1064591
   COURVILLE C B, 1959, Bull Los Angel Neuro Soc, V24, P1
   DATTILO DJ, 1994, J TRAUMA, V36, P691, DOI 10.1097/00005373-199405000-00016
   Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4
   Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818
   DUJOVNY M, 1998, NEUROSURGICAL TOPIC, P77
   DUJOVNY M, 1997, SURG NEUROL 1997, V43
   Ella S, 1874, MED TIMES, V1, P50
   ENGLAND I, 1962, RADIOGRAPHY, V27, P301
   EUFINGER H, 1995, INT J ORAL MAX SURG, V24, P104, DOI 10.1016/S0901-5027(05)80870-7
   EUFINGER H, 1995, J CRANIO MAXILL SURG, V23, P175, DOI 10.1016/S1010-5182(05)80007-1
   FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039
   Freeman L, 1918, J AMER MED ASSOC, V70, P443, DOI 10.1001/jama.1918.02600070017007
   Gerster A., 1895, T AM SURG ASS, V13, P485
   Gore R, 1996, NATL GEOGR, V189, P2
   Granthan E, 1947, J NEUROSURG, V5, P19
   GUARDJIAN ES, 1947, AM J SURG, V73, P269
   HAMER S, 1993, AM J OTOL, V14, P552
   HAMER SG, 1995, NEUROSURGERY, V36, P1097
   Hrdlicka A., 1939, CIBA F S, V1, P170
   Jacobs P., 1996, STEREOLITHOGRAPHY OT
   Jacobs P. F., 1992, RAPID PROTOTYPING MA
   Keeley L. H, 1996, WAR BEFORE CIVILIZAT
   Kevles BH, 1997, NAKED BONE MED IMAGI
   Kubler N, 1995, J CRANIO MAXILL SURG, V23, P337, DOI 10.1016/S1010-5182(05)80128-3
   KVETON JF, 1995, LARYNGOSCOPE, V105, P156, DOI 10.1288/00005537-199502000-00008
   LINNEY A, BIOSTEREOMETRIC TECH, V1990, P190
   MALLIN R, 1976, B NEW YORK ACAD MED, V52, P782
   MEEKEREN J. J., 1682, OBSERVATIONES MEDICO
   Mitchell AB, 1917, BRIT J SURG, V5, P40, DOI 10.1002/bjs.1800051705
   MOODIE R, 1919, SURG CLIN CHIC, V3, P481
   Morton S.G., 1839, CRANIA AMERICANA COM
   MUNIZ M, 1894, ANN REP BUR ETHNOL, V16, P1
   Mynors R, 1785, HIST PRACTICE TREPAN
   NAHUM AM, 1975, LARYNGOSCOPE, V85, P140, DOI 10.1288/00005537-197501000-00011
   Oakley K, 1959, MAN, V59, P92
   Ortner D. J., 1981, IDENTIFICATION PATHO
   Park H, 1999, P SOC PHOTO-OPT INS, V3870, P354, DOI 10.1117/12.373203
   Park HK, 2001, CHILD NERV SYST, V17, P87, DOI 10.1007/s003819900245
   PARK HK, 2000, 19 SO BIOM ENG C 200, P73
   PARK HK, 2000, MED PHYS, V27, P1446
   PARK HK, 1999, IMPACT DISPLACEMENT, P93
   PARK HK, 1999, IMPACT ABSORPTION PA, P359
   PARK HK, 2000, BIOMECHANICAL ANAL P
   PARK HK, BIOMEDICALS SCI INST, V36, P269
   PARRY T, 1931, LANCET, V2, P1388
   Parry TW, 1936, MAN, V36, P170, DOI 10.2307/2789927
   Piggott S., 1940, P PREHIST SOC, V6, P112
   PROLO DJ, 1991, CLIN ORTHOP RELAT R, P270
   RICHARDS GD, 1995, AM J PHYS ANTHROPOL, V98, P203, DOI 10.1002/ajpa.1330980209
   RICHAUD J, 1985, NEUROCHIRURGIE, V31, P183
   Rogers S L, 1985, PRIMITIVE SURG SKILL
   Ruffer MA, 1918, J PATHOL BACTERIOL, V22, P90
   SADLER L, BIOSTEREOMETRIC TECH, V1990, P137
   Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033
   SAUNDERS RC, 1993, J NEUROSCI METH, V47, P163, DOI 10.1016/0165-0270(93)90078-6
   SCALES J T, 1953, Proc R Soc Med, V46, P647
   SCHESSEL DA, 1992, OTOLARYNG HEAD NECK, V107, P424, DOI 10.1177/019459989210700314
   STEWART TD, 1957, ANN REP SMITHSONIAN, P469
   TABADDOR K, 1976, J NEUROSURG, V44, P506, DOI 10.3171/jns.1976.44.4.0506
   Tello Julio C., 1929, ANTIGUO PERU PRIMERA
   TYSON R, 1980, 357 SAN DIEG MUS MAN
   VANPUTTEN MC, 1992, J PROSTHET DENT, V68, P103, DOI 10.1016/0022-3913(92)90294-K
   WITHINGTON E, 1927, HIPPOCRATES
   WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8
   Woolf J, 1945, INT ABSTR SURG, V81, P1
   Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166
NR 77
TC 40
Z9 40
U1 0
U2 4
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0161-6412
J9 NEUROL RES
JI Neurol. Res.
PD MAR-APR
PY 2001
VL 23
IS 2-3
BP 267
EP 276
DI 10.1179/016164101101198424
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 422DX
UT WOS:000168104200020
PM 11320607
DA 2018-10-19
ER

PT J
AU Goldenberg, RA
   Emmet, JR
AF Goldenberg, RA
   Emmet, JR
TI Current use of implants in middle ear surgery
SO OTOLOGY & NEUROTOLOGY
LA English
DT Article
DE implants; middle ear surgery; ossiculoplasty; stapedectomy
ID OSSICULAR RECONSTRUCTION; REPLACEMENT PROSTHESES; TYMPANOPLASTY;
   HYDROXYLAPATITE; EXPERIENCE; INCUS
AB Objective: The authors report the results of a survey of members of the American Otological Society (AOS) and the American Neurotology Society (ANS) regarding their use of prostheses currently available for ossiculoplasty and stapedectomy. These findings are compared with a similar study presented by one of the authors in 1989.
   Methods: Questionnaires were sent to the entire membership of the AOS and ANS with questions regarding biomaterial and prosthesis usage for stapes and chronic ear surgery, as well as satisfaction with each type of prosthesis used. Of the 575 questionnaires mailed, 274 (47%) were returned. Only 248 of the respondents performed middle ear surgery (43%), and their responses constitute the database for this study.
   Results: For those respondents performing stapes surgery in both 1989 and 1999, the mean number of cases per year has increased from 32 to 37 (p less than or equal to 0.004). The mean number of chronic ear cases has also increased from 95 in 1989 to 110 in 1999 (p less than or equal to 0.001), As a biomaterial, hydroxyapatite prostheses are used by most surgeons (82%), followed by autograft and homograft bone (72%), autograft and homograft cartilage (62%), and Plastipore (59%). (Although 62% of respondents use cartilage, only 4.4% ranked it first in preference.) In 1989, bone was used most (93%), followed by cartilage (78%) and Plastipore (81%). Hydroxyapatite, which had just been introduced as a biomaterial, was used by only 9% of respondents. For stapes prostheses in 1999, the majority of respondents used stainless steel/platinum (71%), bucket handle (69%), or partial fluoroplastic (56%) prostheses. There was a high overall satisfaction rate in the use of most of these prostheses (> 85%), with several exceptions. The lowest satisfaction rate was 71% for Plastipore partial ossicular replacement prosthesis and total ossicular replacement prosthesis. Usage and satisfaction rates are presented for specific types of implants and compared with the earlier survey findings.
   Conclusion: The current use of implants in middle ear surgery demonstrates a specific pattern with a high degree of user satisfaction. The preference for implants by respondents has remained stable over the past 10 years; there has been a decrease in the percentage of use of bone, cartilage, and Plastipore with a corresponding increase in the use of hydroxyapatite.
C1 Wright State Univ, Sch Med, Dept Otolaryngol, Dayton, OH 45435 USA.
   Univ N Carolina, Sch Med, Dept Otolaryngol, Chapel Hill, NC 27514 USA.
   Univ Tennessee, Ctr Hlth Sci, Sch Med, Dept Otolaryngol, Memphis, TN 38163 USA.
RP Goldenberg, RA (reprint author), 111 W 1st St,Suite 600, Dayton, OH 45402 USA.
CR ARMSTRONG BW, 1969, ANN OTO RHINOL LARYN, V78, P939, DOI 10.1177/000348946907800503
   Austin D F, 1972, Otolaryngol Clin North Am, V5, P145
   AUSTIN D F, 1961, Laryngoscope, V71, P596
   AUSTIN DF, 1971, ARCHIV OTOLARYNGOL, V94, P525
   AUSTIN DF, 1963, OTOLRAYNGOL HEAD NEC, V67, P198
   BAUER M, 1966, ARCHIV OTOLARYNGOL, V83, P335
   BLACK B, 1990, AM J OTOL, V11, P85
   BRACKMANN DE, 1979, LARYNGOSCOPE, V89, P108
   BROCKMAN SJ, 1965, LARYNGOSCOPE, V75, P1452
   Colletti V, 1999, OTOLARYNG HEAD NECK, V120, P437, DOI 10.1016/S0194-5998(99)70288-3
   DEMANE CQ, 1995, OTOLARYNG CLIN N AM, V28, P225
   EMMETT JR, 1989, AM J OTOL, V10, P215
   EMMETT JR, 1986, OTOLARYNG HEAD NECK, V94, P611
   FARRIOR JB, 1960, ARCHIV OTOLARYNGOL, V71, P443
   FREDERICKSON J, 1985, AM OTOLOGICAL SOC
   GARCIAIBANEZ L, 1965, ARCHIV OTOLARYNGOL, V82, P340
   GOLDENBERG RA, 1990, LARYNGOSCOPE, V100, P693
   GOLDENBERG RA, 1992, OPER TECH OTOLARYNGO, V3, P225
   GOODHILL V, 1967, ARCHIV OTOLARYNGOL, V85, P480
   GROTE JJ, 1984, ARCH OTOLARYNGOL, V110, P197
   GROTE JJ, 1995, AM J OTOL, V16, P797
   GROTE JJ, 1986, ANN OTO RHINOL LARYN, V95, P1
   GUILFORD FR, 1965, LARYNGOSCOPE, V75, P236
   HALL A, 1957, Acta Otolaryngol, V47, P318
   HARRIS I, 1967, LARYNGOSCOPE, V77, P1191, DOI 10.1288/00005537-196707000-00011
   HARRISON JH, 1956, ARCH SURG-CHICAGO, V82, P138
   HARRISON WH, 1959, ARCHIV OTOLARYNGOL, V69, P661
   HARRISON WH, 1969, ARCH OTOLARYNGOL, V96, P525
   HAYDEN GD, LARYNGOSCOPE, V71, P5054
   HICKS GW, 1978, LARYNGOSCOPE, V88, P1024, DOI 10.1288/00005537-197806000-00015
   Homsy C A, 1973, Orthop Clin North Am, V4, P295
   HOMSY CA, 1972, CLIN ORTHOP RELAT R, P220
   HOMSY CA, 1973, J AM DENT ASSOC, V86, P817, DOI 10.14219/jada.archive.1973.0166
   HOUSE HP, 1960, ARCHIV OTOLARYNGOL, V71, P926
   HOUSE WF, 1966, ARCHIV OTOLARYNGOL, V84, P148
   HOUSE WF, 1963, ARCH OTOLARYNGOL, V78, P98
   HUGHES GB, 1989, P 3 INT C CHOL MAST, P1127
   Jansen C, 1972, Otolaryngol Clin North Am, V5, P97
   JANSEN C, 1963, Laryngoscope, V73, P1288
   JANSEN C, 1958, S B FORTBILD AZTEK O, V2, P18
   LESINSKI SG, 1977, OTOLARYNG CLIN N AM, V10, P613
   MULLISON EG, 1966, ARCH OTOLARYNGOL, V84, P113
   PALVA T, 1973, ARCH OTOLARYNGOL, V98, P340
   PALVA T, 1971, ANN OTO RHINOL LARYN, V80, P760, DOI 10.1177/000348947108000519
   Perkins R, 1970, Trans Am Acad Ophthalmol Otolaryngol, V74, P278
   PLESTER D, 1961, LARYNGOL OTOL, V75, P879
   PULEC JL, 1973, LARYNGOSCOPE, V83, P448, DOI 10.1288/00005537-197304000-00002
   SCHURING AG, 1982, OTOLARYNG HEAD NECK, V90, P629, DOI 10.1177/019459988209000523
   SHEA J, 1976, LARYNGOSCOPE, V86, P239, DOI 10.1288/00005537-197602000-00015
   SHEA J J, 1960, Northwest Med, V59, P770
   SHEA JJ, 1974, LARYNGOSCOPE, V84, P1835, DOI 10.1288/00005537-197410000-00014
   SHEA JJ, 1977, ORL DIGEST, V39, P9
   SHEA JJ, 1958, MEMPHIS MED, V33, P271
   SHEEHY JL, 1973, LARYNGOSCOPE, V83, P1144, DOI 10.1288/00005537-197307000-00018
   SHEEHY JL, 1965, ARCHIV OTOLARYNGOL, V81, P115
   SILVERSTEIN H, 1985, TRIOLOGICAL SOC MIAM
   SMITH M F W, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P134
   SMYTH DGL, 1972, OTOLARYNGOL CLIN N A, V5, P111
   SMYTH GDL, 1977, OTOLARYNG CLIN N AM, V10, P563
   WALTNER JG, 1966, ARCHIV OTOLARYNGOL, V83, P339
   WEHRS RE, 1974, ARCH OTOLARYNGOL, V100, P251
   WEHRS RE, 1985, LARYNGOSCOPE, V95, P1301
   WEHRS RE, 1982, LARYNGOSCOPE, V92, P540
   WEHRS RE, 1995, OTOLARYNG CLIN N AM, V28, P273
   WEHRS RE, 1989, AM J OTOL, V10, P181
   WOLFERMAN A, 1970, RECONSTRUCTIVE SURG, P143
   WULLSTEIN H, 1956, Laryngoscope, V66, P1076
   ZOLLNER F, 1955, J Laryngol Otol, V69, P637, DOI 10.1017/S0022215100051240
NR 68
TC 43
Z9 47
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1531-7129
EI 1537-4505
J9 OTOL NEUROTOL
JI Otol. Neurotol.
PD MAR
PY 2001
VL 22
IS 2
BP 145
EP 152
DI 10.1097/00129492-200103000-00005
PG 8
WC Clinical Neurology; Otorhinolaryngology
SC Neurosciences & Neurology; Otorhinolaryngology
GA 413GE
UT WOS:000167601300005
PM 11300260
DA 2018-10-19
ER

PT J
AU Yang, JM
   Lai, WC
   Lin, HT
AF Yang, JM
   Lai, WC
   Lin, HT
TI Properties of HTPB based polyurethane membrane prepared by epoxidation
   method
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE hydroxyl terminated polybutadiene; polyurethane; epoxidation; surface
   tension; protein adsorption; gas permeation
ID SBS-G-VP; STYRENE BLOCK-COPOLYMER; HYDROXYL-TERMINATED POLYBUTADIENE;
   OXYGEN PERMEATION; BIOMATERIAL USAGE; GAS-PERMEABILITY; RADIATION;
   HEPARIN
AB Hydroxyl-terminated polybutadiene (HTPB) based polyurethane (PU) was synthesized by solution polymerization. The PU was then cast into membrane. The epoxidation of HTPB based PU membrane by an in situ generated peracid method is discussed. The chemical composition of the epoxidized PU membrane was studied by infrared spectroscopy. The absorption peak at 970 cm(-1) for the C=C double bond decreased with epoxidation time whereas the absorption peak at 1183 cm(-1) for oxirane group increased. The absorption peak at about 1700-1740 cm(-1) for the C=O group and -OH group at about 3200-3700 cm(-1) increased with epoxidation time that indicated the side reaction of epoxidation took place. The oxirane weight content was determined by titration method. The density, tensile strength, elongations, and decomposition temperature of the epoxidized PU membranes were measured. The molecular weight between crosslinking points PU membrane was calculated. Contact angle and protein absorption of fibrinogen and albumin experiments were also determined. It was found that the density and the tensile strength of epoxidized PU membrane increased with increasing epoxidation time whereas the molecular weight between crosslinking points, elongation and the amount of protein adsorption on the epoxidized PU membrane decreased. By using Kaelble's equation and the contact angle data, the surface tension of epoxidized PU membrane was determined. It was found that the surface tension of epoxidized PU membrane increased whereas the contact angle decreased with epoxidation time. The property changes reduced the permeability of gas through epoxidized PU membrane, but increased the gas selectivity between oxygen and nitrogen. The activation energies (E-p) for gas diffusing through various epoxidized PU membranes were obtained by the Arrhenius law; it is evident that E-p increased with the extent of epoxidation. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
CR GALLAND G, 1993, J APPL POLYM SCI, V50, P1041, DOI 10.1002/app.1993.070500613
   HSIUE GH, 1990, J POLYM SCI POL CHEM, V28, P3363, DOI 10.1002/pola.1990.080281215
   HSIUE GH, 1990, J POLYM SCI POL CHEM, V28, P3761, DOI 10.1002/pola.1990.080281319
   HSIUE GH, 1991, MAKROMOL CHEM, V192, P2687
   HUANG SL, 1995, J MEMBRANE SCI, V105, P137, DOI 10.1016/0376-7388(94)00319-T
   HUANG SL, 1995, J APPL POLYM SCI, V58, P1913, DOI 10.1002/app.1995.070581029
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   Machin D., 1970, ENCY POLYM SCI TECHN, V12, P679
   MINOURA Y, 1978, J APPL POLYM SCI, V22, P1817, DOI 10.1002/app.1978.070220707
   NINAN KN, 1991, POLYMER, V32, P628, DOI 10.1016/0032-3861(91)90474-W
   REGAN PR, 1985, BRIT POLYM J, V17, P22, DOI 10.1002/pi.4980170106
   TRELOAR LRG, 1958, PHYSICS RUBBER ELAST
   YANG JM, 1991, MACROMOLECULES, V24, P4010, DOI 10.1021/ma00014a007
   YANG JM, 1994, J MEMBRANE SCI, V87, P233, DOI 10.1016/0376-7388(94)87030-6
   YANG JM, 1990, ANGEW MAKROMOL CHEM, V179, P99, DOI 10.1002/apmc.1990.051790108
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 1999, J MEMBRANE SCI, V153, P175, DOI 10.1016/S0376-7388(98)00261-0
   YANG JM, 1990, J APPL POLYM SCI, V41, P1141, DOI 10.1002/app.1990.070410523
   YASUDA H, 1968, ENCY POLYM SCI TECHN, V9, P794
NR 25
TC 33
Z9 39
U1 2
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD FEB 28
PY 2001
VL 183
IS 1
BP 37
EP 47
DI 10.1016/S0376-7388(00)00550-0
PG 11
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 401UW
UT WOS:000166947500004
DA 2018-10-19
ER

PT J
AU Tong, HH
   Monteiro, OR
   Brown, IG
AF Tong, HH
   Monteiro, OR
   Brown, IG
TI Effects of carbon ion pre-implantation on the mechanical properties of
   ta-C coatings on Ti-6Al-4V
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 5th International Workshop on Plasma-Based Ion Implantation (PBII-99)
CY DEC 13-16, 1999
CL SEIKA, JAPAN
SP Sci & Technol Agcy, Japan Int Sci & Technol Exchange Ctr, Osaka Natl Res Inst
DE ion implantation; ta-c; biomaterial coatings; cathodic arc deposition;
   ion mixing; diamond-like carbon
ID CATHODIC-ARC DEPOSITION; DIAMOND-LIKE CARBON; METAL PLASMA;
   ELASTIC-MODULUS; THIN-FILMS; VACUUM
AB We report on our investigations of the effects of carbon ion implantation into Ti-6Al-4V as a pre-treatment process prior to deposition of ra-C coatings using a filtered cathodic are plasma method. A transition layer is formed that can be either TiC or TiC + C, providing an excellent interface for highly adherent ta-C coatings. We find that a smoothly-graded interface leads to good film-substrate adhesion, while ta-C films formed without a graded interface show poor adhesion. The film microhardness and wear performance are related to the implantation parameters via the thickness of the transition layer. Carbon ion implantation provides an effective pre-treatment method for ta-C coated Ti-6Al-4V substrate material. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
RP Brown, IG (reprint author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
EM igbrown@lbl.gov
CR Anders A, 1997, SURF COAT TECH, V93, P158, DOI 10.1016/S0257-8972(97)00037-6
   ANDERS S, 1994, SURF COAT TECH, V68, P388, DOI 10.1016/0257-8972(94)90191-0
   ANDERS S, 1997, DATA STORAGE, V4, P31
   Baba K, 1998, SURF COAT TECH, V104, P235, DOI 10.1016/S0257-8972(98)00401-0
   BIERSACK JP, 1991, NUCL INSTRUM METH B, V59, P21, DOI 10.1016/0168-583X(91)95167-C
   BLECH IA, 1993, J VAC SCI TECHNOL A, V11, P728, DOI 10.1116/1.578800
   Brown IG, 1998, ANNU REV MATER SCI, V28, P243, DOI 10.1146/annurev.matsci.28.1.243
   BROWN IG, 1993, NUCL INSTRUM METH B, V80-1, P1281, DOI 10.1016/0168-583X(93)90782-2
   BROWN IG, 1994, REV SCI INSTRUM, V65, P3061, DOI 10.1063/1.1144756
   BROWN IG, 1992, SURF COAT TECH, V51, P529, DOI 10.1016/0257-8972(92)90293-J
   Brown IG, 1999, SURF COAT TECH, V112, P271, DOI 10.1016/S0257-8972(98)00769-5
   Chiang SS, 1981, SURFACES INTERFACES, P603
   Delplancke-Ogletree MP, 1998, SURF COAT TECH, V108, P484, DOI 10.1016/S0257-8972(98)00572-6
   EVANS HE, 1984, CORROS SCI, V24, P209, DOI 10.1016/0010-938X(84)90051-9
   Fan QH, 1998, J APPL PHYS, V83, P5588, DOI 10.1063/1.367399
   Ignatius MJ, 1998, J BIOMED MATER RES, V40, P264, DOI 10.1002/(SICI)1097-4636(199805)40:2<264::AID-JBM11>3.3.CO;2-N
   Lifshitz Y, 1999, DIAM RELAT MATER, V8, P1659, DOI 10.1016/S0925-9635(99)00087-4
   Littmark U., 1985, STOPPING RANGE IONS, V1
   MacGill RA, 1998, REV SCI INSTRUM, V69, P801, DOI 10.1063/1.1148718
   Monteiro OR, 1999, NUCL INSTRUM METH B, V148, P12, DOI 10.1016/S0168-583X(98)00685-5
   Pharr GM, 1996, APPL PHYS LETT, V68, P779, DOI 10.1063/1.116530
   Tay BK, 1997, THIN SOLID FILMS, V308, P199, DOI 10.1016/S0040-6090(97)00430-6
   TOULOUKIAN YS, 1975, THERMALOPHYSICAL PRO, V12, P1272
   Viviente JL, 1999, APPL SURF SCI, V144-45, P249, DOI 10.1016/S0169-4332(98)00806-X
   Voevodin AA, 1997, THIN SOLID FILMS, V298, P107, DOI 10.1016/S0040-6090(96)09145-6
   Yin GF, 1999, THIN SOLID FILMS, V345, P67, DOI 10.1016/S0040-6090(99)00076-0
NR 26
TC 15
Z9 16
U1 0
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD FEB 2
PY 2001
VL 136
IS 1-3
BP 211
EP 216
DI 10.1016/S0257-8972(00)01058-6
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 393JF
UT WOS:000166464900044
DA 2018-10-19
ER

PT J
AU Gastel, JA
   Muirhead, WR
   Lifrak, JT
   Fadale, PD
   Hulstyn, MJ
   Labrador, DP
AF Gastel, JA
   Muirhead, WR
   Lifrak, JT
   Fadale, PD
   Hulstyn, MJ
   Labrador, DP
TI Meniscal tissue regeneration using a collagenous biomaterial derived
   from porcine small intestine submucosa
SO ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY
LA English
DT Article
DE meniscus; meniscal regeneration; meniscal repair; animal study;
   collagenous graft; small intestine submucosa
ID MENISCECTOMY; KNEE; REPAIR; RABBITS; INVIVO; GRAFT; DOG
AB Purpose: The present investigation is a preliminary study designed to evaluate the use of a collagen-based biomaterial, chemically unaltered porcine small intestine submucosa (SIS), as a scaffold for meniscal tissue regeneration. Type of Study: Basic research. Methods: Surgical defects were created in the lateral menisci of 12 mature New Zealand white rabbits. The defects were repaired with a similarly shaped and sized wedge of a new collagenous biomaterial (SIS) and sutured in place. The opposite knees served as controls by creating a defect in the lateral meniscus without filling with SIS graft. Full cage activity was allowed until the animals were killed at 4, 12, and 24 weeks. Results: At 4 weeks, the graft material retained its physical position and grossly appeared soft and translucent. Histologically, cellular elements had infiltrated between the laminates of the graft. At 12 weeks, the graft grossly appeared more solid and opaque. Histologically, the host meniscal fibrochondrocytes were seen streaming into the peripheral margin of the graft. Early repopulation of the graft with apparently differentiated meniscal tissue was observed. At 24 weeks, the meniscus defect was grossly healed across and looked virtually normal: the normal meniscal shape, contour, consistency, and color had been replicated. Histologically, the healing tissue showed infiltration of what appeared to be meniscal fibrochondrocytes and connective tissue resembling the host meniscal tissue. The graft was nearly totally replaced by host tissue. Conclusions: This pilot animal study demonstrates that the multilaminated collagenous graft is conducive for cellular repopulation with host meniscal elements, and, by 24 weeks, is capable of supporting complete healing of a large meniscal defect.
C1 Brown Univ, Rhode Isl Hosp, Dept Orthopaed, Providence, RI 02903 USA.
RP Fadale, PD (reprint author), 2 Dudley St, Providence, RI 02903 USA.
CR AIKEN SW, 1994, VCOT, V37, P124
   ARNOCZKY SP, 1988, J BONE JOINT SURG AM, V70A, P1209, DOI 10.2106/00004623-198870080-00012
   ARNOCZKY SP, 1988, J ORTHOP RES, V6, P1, DOI 10.1002/jor.1100060102
   ARNOCZKY SP, 1988, ORTHOP T, V12, P431
   Arnoczky SP, 1988, INJURY REPAIR MUSCUL, P487
   ARNOCZKY SP, 1990, ARTICULAR CARTILAGE
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BARATZ ME, 1986, AM J SPORT MED, V14, P270, DOI 10.1177/036354658601400405
   CANNON WD, 1992, AM J SPORT MED, V20, P176, DOI 10.1177/036354659202000214
   CISA J, 1995, ACTA ORTHOP SCAND, V66, P38, DOI 10.3109/17453679508994636
   CZITROM AA, 1990, J BONE JOINT SURG AM, V72A, P574, DOI 10.2106/00004623-199072040-00016
   FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664
   JACKSON DW, 1992, J BONE JOINT SURG AM, V74A, P112, DOI 10.2106/00004623-199274010-00014
   King D, 1936, J BONE JOINT SURG, V18, P333
   KRAUSE WR, 1976, J BONE JOINT SURG AM, V58, P599, DOI 10.2106/00004623-197658050-00003
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   LEVY IM, 1982, J BONE JOINT SURG AM, V64, P883, DOI 10.2106/00004623-198264060-00011
   MCGINTY JB, 1977, J BONE JOINT SURG AM, V59, P763, DOI 10.2106/00004623-197759060-00008
   MILACHOWSKI KA, 1989, INT ORTHOP, V13, P1
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   SEEDHOM BB, 1974, J BONE JOINT SURG BR, VB 56, P381
   SHOEMAKER SC, 1986, J BONE JOINT SURG AM, V68A, P71, DOI 10.2106/00004623-198668010-00009
   Shrive N G, 1978, Clin Orthop Relat Res, P279
   SOMMERLATH K, 1992, AM J SPORT MED, V20, P73, DOI 10.1177/036354659202000117
   STONE KR, 1992, AM J SPORT MED, V20, P104, DOI 10.1177/036354659202000202
   Walker P S, 1975, Clin Orthop Relat Res, P184, DOI 10.1097/00003086-197506000-00027
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
NR 30
TC 51
Z9 60
U1 0
U2 7
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0749-8063
EI 1526-3231
J9 ARTHROSCOPY
JI Arthroscopy
PD FEB
PY 2001
VL 17
IS 2
BP 151
EP 159
DI 10.1053/jars.2001.20959
PG 9
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 399ZF
UT WOS:000166843600006
PM 11172244
DA 2018-10-19
ER

PT J
AU Trindade, MCD
   Lind, M
   Sun, D
   Schurman, DJ
   Goodman, SB
   Smith, RL
AF Trindade, MCD
   Lind, M
   Sun, D
   Schurman, DJ
   Goodman, SB
   Smith, RL
TI In vitro reaction to orthopaedic biomaterials by macrophages and
   lymphocytes isolated from patients undergoing revision surgery
SO BIOMATERIALS
LA English
DT Article
DE orthopaedic biomaterials; macrophages; lymphocytes; fibroblasts;
   revision surgery
ID BONE-RESORPTION; IN-VITRO; INFLAMMATORY RESPONSE; PARTICULATE DEBRIS;
   TITANIUM PARTICLES; INHIBITORY FACTOR; HIP-ARTHROPLASTY;
   POLYMETHYLMETHACRYLATE; CEMENT; INTERLEUKIN-4
AB Periprosthetic tissues observed at sites of loose total joint implants exhibit abundant macrophages, lymphocytes, fibroblasts and particulate debris. Macrophages phagocytose orthopaedic debris and release proinflammatory cytokines, chemokines, matrix metalloproteinases and other substances. In addition, other cell types present in tissues harvested from the bone-implant interface are thought to influence periprosthetic bone resorption. The present study examined the effects of polymethylmethacrylate (PMMA), cobalt chrome molybdenum alloy (CoCr), and titanium-alloy particle challenge on macrophages co-cultured with lymphocytes in vitro. Potential synergistic effects of lymphocytes on macrophage activation were determined by measuring interleukin-6 and tumor necrosis factor-a release following exposure to orthopaedic biomaterial particles. Exposure of macrophages or macrophages co-cultured with lymphocytes to all three types of particles resulted in increased release of interleukin-6 and tumor necrosis factor-a! at 48 h, when compared to macrophages or macrophages co-cultured with lymphocytes, respectively, cultured in the absence of particles. Lymphocytes isolated from periprosthetic tissues secreted increased basal levels of cytokines relative to peripheral blood lymphocytes. Higher doses of PMMA and titanium-alloy particles stimulated increased levels of cytokine release in the macrophage and macrophage/lymphocyte groups. In contrast, a higher dose of CoCr particles (0.075% v/v) was not as effective as the 0.015% v/v dose, indicating probable CoCr toxicity. The macrophage/lymphocyte co-culture did not show synergism between the two types of cells with respect to cytokine release. T-cells at the bone-implant interface may alter the biological response to particulate debris. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Stanford Univ, Sch Med, Orthopaed Res Lab, Stanford, CA 94305 USA.
RP Goodman, SB (reprint author), Stanford Univ, Sch Med, Orthopaed Res Lab, 300 Pasteur Dr,R144, Stanford, CA 94305 USA.
CR Cassatella MA, 1997, EUR J IMMUNOL, V27, P111, DOI 10.1002/eji.1830270117
   CHIBA J, 1994, CLIN ORTHOP RELAT R, V300, P304
   DAVIS RG, 1993, J BIOMED MATER RES, V27, P1039, DOI 10.1002/jbm.820270809
   FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489
   GELB H, 1994, J ORTHOP RES, V12, P83, DOI 10.1002/jor.1100120111
   GILALBAROVA J, 1992, J BONE JOINT SURG BR, V74, P825
   GLANT TT, 1994, J ORTHOPAED RES, V12, P720, DOI 10.1002/jor.1100120515
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   GOLDRING SR, 1993, J BONE JOINT SURG AM, V75A, P799, DOI 10.2106/00004623-199306000-00001
   GONZALEZ O, 1995, T ORTHOP RES SOC, V20, P774
   GONZALEZ O, 1997, T ORTHOP RES SOC, V21, P504
   Goodman SB, 1996, J BIOMED MATER RES, V31, P421, DOI 10.1002/(SICI)1097-4636(199607)31:3<421::AID-JBM17>3.0.CO;2-L
   Goodman SB, 1997, CLIN ORTHOP RELAT R, P149, DOI 10.1097/00003086-199704000-00017
   Granchi D, 1998, J BONE JOINT SURG BR, V80B, P912, DOI 10.1302/0301-620X.80B5.8513
   GREIS PE, 1994, J ORTHOPAED RES, V12, P286, DOI 10.1002/jor.1100120219
   Haddad FS, 1996, J BONE JOINT SURG BR, V78B, P546
   HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005
   HERMAN JH, 1989, J BONE JOINT SURG AM, V71A, P1530, DOI 10.2106/00004623-198971100-00012
   Hernigou P, 1999, CLIN ORTHOP RELAT R, P147
   Hitchins VM, 1999, J BIOMED MATER RES, V46, P434
   Horowitz SM, 1996, CALCIFIED TISSUE INT, V59, P392, DOI 10.1007/s002239900145
   HOROWITZ SM, 1995, CALCIFIED TISSUE INT, V57, P301, DOI 10.1007/BF00298886
   HOROWITZ SM, 1988, J ORTHOPAED RES, V6, P827, DOI 10.1002/jor.1100060606
   Howie D W, 1990, J Arthroplasty, V5, P337, DOI 10.1016/S0883-5403(08)80093-9
   HSU JC, 1998, T ORTHOP RES SOC, V23, P125
   JAMES RE, 1995, T ORTHOP RES SOC, V20, P775
   JASTY MJ, 1986, J BONE JOINT SURG AM, V68A, P912, DOI 10.2106/00004623-198668060-00014
   JOHANSON NA, 1987, CLIN ORTHOP RELAT R, V218, P123
   KIM KJ, 1994, J BONE JOINT SURG AM, V76A, P172, DOI 10.2106/00004623-199402000-00002
   Lee SH, 1997, J ORTHOP RES, V15, P40, DOI 10.1002/jor.1100150107
   LEWIS DB, 1993, P NATL ACAD SCI USA, V90, P11618, DOI 10.1073/pnas.90.24.11618
   LIND M, 1995, CYTOKINE, V7, P78, DOI 10.1006/cyto.1995.1010
   Lind M, 1999, J BIOMED MATER RES, V48, P246, DOI 10.1002/(SICI)1097-4636(1999)48:3<246::AID-JBM7>3.0.CO;2-X
   Lind M, 1998, J BONE JOINT SURG BR, V80B, P924, DOI 10.1302/0301-620X.80B5.8710
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1448, DOI 10.2106/00004623-199509000-00022
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   Maloney WJ, 1998, J BIOMED MATER RES, V41, P371, DOI 10.1002/(SICI)1097-4636(19980905)41:3<371::AID-JBM5>3.3.CO;2-A
   Mirra J M, 1976, Clin Orthop Relat Res, P221
   Moreschini O, 1997, J ARTHROPLASTY, V12, P695, DOI 10.1016/S0883-5403(97)90144-3
   MUNDY GR, 1993, J BONE MINER RES, V8, pS505
   MUNDY GR, 1995, HUMAN CYTOKINES THEI, P285
   Nakashima Y, 1998, J BONE JOINT SURG BR, V80B, P694, DOI 10.1302/0301-620X.80B4.8374
   Nakashima Y, 1999, J BONE JOINT SURG AM, V81A, P603, DOI 10.2106/00004623-199905000-00002
   Nakashima Y, 1999, J BONE JOINT SURG BR, V81B, P155, DOI 10.1302/0301-620X.81B1.8884
   POLLICE P, 1997, T ORTHOP RES SOC, V22, P728
   Pollice PF, 1998, J ORTHOP RES, V16, P697, DOI 10.1002/jor.1100160611
   RAGAB AA, 1998, T ORTHOP RES SOC, V23, P355
   Sabokbar A, 1996, ACTA ORTHOP SCAND, V67, P593, DOI 10.3109/17453679608997763
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   SANTAVIRTA S, 1991, J BONE JOINT SURG BR, V73, P38
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   SCHMALZRIED TP, 1993, J ARTHROPLASTY, V8, P179
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SUN DH, 1997, T ORTHOP RES SOC, V22, P324
   SUN DH, 1997, T SOC BIOMATER, V20, P259
   Trindade MCD, 1999, J ORTHOP RES, V17, P797, DOI 10.1002/jor.1100170602
   Trindade MCD, 1999, J BIOMED MATER RES, V47, P1
   Trindade MCD, 1999, J BIOMED MATER RES, V48, P434, DOI 10.1002/(SICI)1097-4636(1999)48:4<434::AID-JBM6>3.0.CO;2-Y
   TRINDADE MCD, 1998, T ORTHOP RES SOC, V23, P176
   UENO K, 1992, BIOCHEM BIOPH RES CO, V189, P1521, DOI 10.1016/0006-291X(92)90248-J
   VAES G, 1988, CLIN ORTHOP RELAT R, P239
   WILLERT HG, 1981, TRIBOLOGY NATURAL AR
NR 62
TC 53
Z9 55
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2001
VL 22
IS 3
BP 253
EP 259
DI 10.1016/S0142-9612(00)00181-2
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 390NR
UT WOS:000166303300008
PM 11197500
DA 2018-10-19
ER

PT J
AU Ma, JB
   Wang, HJ
   He, BL
   Chen, JT
AF Ma, JB
   Wang, HJ
   He, BL
   Chen, JT
TI A preliminary in vitro study on the fabrication and tissue engineering
   applications of a novel chitosan bilayer material as a scaffold of human
   neofetaf dermal fibroblasts
SO BIOMATERIALS
LA English
DT Article
DE chitosan; bilayer biomaterial; human neofetal dermal fibroblast; skin
   tissue engineering
ID ARTIFICIAL SKIN; DESIGN
AB The bilayer structure of chitosan him and sponge was designed as a scaffold of skin tissue engineering and a dermis substitute. It was processed successively via the formation of a dense chitosan him by casting method and a porous chitosan sponge by lyophilization. The dry thickness of the him layer was 19.6 mum and that of the sponge layer was controlled at 60-80 mum. Porogens such as sodium chloride, glucose, and sucrose were used to create large pores of the chitosan sponge layer. Human neofetal dermal fibroblasts were seeded in the chitosan sponge layer and cultured for 4 weeks. It was found that the cells could grow and proliferate well in an extended shape on the flat bottom of large pores with 15-100 mum width and in spherical form on the rough pore walls or at the edges of micropores less than 5 mum. Fibroblasts after the culture could bind tightly with the sponge layer via newly formed extracellular matrices to give a living cell-matrix-chitosan composite. The bilayer chitosan material remained stable in shape and size during the cell culture. The results suggested that the bilayer chitosan material would be an alternative of collagen materials which was obviously contracted during cell culture. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Nankai Univ, Inst Polymer Chem, State Key Lab Funct Polymer Mat Adsorpt & Separat, Tianjin 300071, Peoples R China.
   Nankai Univ, Inst Mol Biol, Tianjin 300071, Peoples R China.
RP Ma, JB (reprint author), Nankai Univ, Inst Polymer Chem, State Key Lab Funct Polymer Mat Adsorpt & Separat, Tianjin 300071, Peoples R China.
CR Brine CJ, 1992, ADV CHITIN CHITOSAN, P9
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   BURKE JF, 1983, J TRAUMA, V23, P543, DOI 10.1097/00005373-198307000-00001
   COOPER ML, 1991, BIOMATERIALS, V12, P243, DOI 10.1016/0142-9612(91)90207-Q
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   HEIMBACH D, 1988, ANN SURG, V208, P313, DOI 10.1097/00000658-198809000-00008
   RIVARD CH, 1995, J APPL BIOMATER, V6, P65, DOI 10.1002/jab.770060109
   Sparkes BG, 1986, Patent, Patent No. [4572906, USA, 4572906]
   SUZUKI S, 1990, BIOMATERIALS, V11, P356, DOI 10.1016/0142-9612(90)90114-6
   SUZUKI S, 1990, BRIT J PLAST SURG, V43, P47, DOI 10.1016/0007-1226(90)90044-Z
   YANNAS IV, 1981, T AM SOC ART INT ORG, V27, P19
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   YANNAS IV, 1984, J TRAUMA, V24, pS31
   YANNAS IV, 1977, Patent No. 2631909
NR 16
TC 201
Z9 228
U1 2
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2001
VL 22
IS 4
BP 331
EP 336
DI 10.1016/S0142-9612(00)00188-5
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 392TH
UT WOS:000166428300005
PM 11205436
DA 2018-10-19
ER

PT J
AU Ball, MD
   Downes, S
   Scotchford, CA
   Antonov, EN
   Bagratashvili, VN
   Popov, VK
   Lo, WJ
   Grant, DM
   Howdle, SM
AF Ball, MD
   Downes, S
   Scotchford, CA
   Antonov, EN
   Bagratashvili, VN
   Popov, VK
   Lo, WJ
   Grant, DM
   Howdle, SM
TI Osteoblast growth on titanium foils coated with hydroxyapatite by pulsed
   laser ablation
SO BIOMATERIALS
LA English
DT Article
DE osteoblast; hydroxyapatite; laser deposition; crystallinity
ID CALCIUM-PHOSPHATE CERAMICS; PLASMA-SPRAYED COATINGS;
   CHEMICAL-COMPOSITION; CELL; DEPOSITION; APATITE; DISSOLUTION; CULTURE;
   FILMS; WATER
AB Pulsed laser ablation is a new method for deposition of thin layers of hydroxyapatite (HA) on to biomaterial surfaces. In this paper, we report activity and morphology of osteoblasts grown on HA surfaces fabricated using different laser conditions. Two sets of films were deposited from dense HA targets, at three different laser fluences: 3, 6 and 9 J cm(-2). One set of the surfaces was annealed at 575 degreesC to increase the crystallinity of the deposited films. Primary human osteoblasts were seeded onto the material surfaces and cytoskeletal actin organisation was examined using confocal laser scanning microscopy. The annealed surfaces supported greater cell attachment and more defined cytoskeletal actin organisation. Cell activity, measured using the alamar Blue assay, was also found to be significantly higher on the annealed samples. In addition, our results show distinct trends that correlate with the laser fluence used for deposition. The cell activity increases with increasing fluence. This pattern was repeated for alkaline phosphatase production by the cells. Differences in cell spreading were apparent which were correlated with the fluence used to deposit the HA. The optimum surface for initial attachment and spreading of osteoblasts was one of the HA films deposited using 9 J cm-2 laser fluence and subsequently annealed at 575 degreesC (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Biomat Grp, Nottingham NG7 2UH, England.
   Russian Acad Sci, Inst Laser & Informat Technol, Troitsk 142190, Russia.
   Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England.
   Sch Mech Mat & Mfg Engn & Management, Biomat Grp, Nottingham, England.
RP Scotchford, CA (reprint author), Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Biomat Grp, Clifton Blvd, Nottingham NG7 2UH, England.
RI Howdle, Steven/A-2954-2010
OI Howdle, Steven/0000-0001-5901-8342; Grant, David/0000-0002-6786-7720;
   Scotchford, Colin/0000-0003-1937-6692
CR Antonov EN, 1997, BIOMATERIALS, V18, P1043, DOI 10.1016/S0142-9612(97)00030-6
   ANTONOV EN, 1994, J PHYS IV, V4, P183, DOI 10.1051/jp4:1994441
   Antonov EN, 1996, SPECTROCHIM ACTA A, V52, P123, DOI 10.1016/0584-8539(95)01597-3
   ARCHER RS, 1992, CELL MATER, V2, P113
   Arias JL, 1997, J MATER SCI-MATER M, V8, P873, DOI 10.1023/A:1018553821781
   BAGRATASHVILI VN, 1995, APPL PHYS LETT, V66, P2451, DOI 10.1063/1.113992
   BALL MD, 1997, T 23 ANN M SOC BIOM, P135
   Best S, 1997, J MATER SCI-MATER M, V8, P97, DOI 10.1023/A:1018558816871
   CHEN QM, 1994, J BIOL CHEM, V269, P26602
   Cheung H. S., 1984, ARTHRITIS RHEUM, V27, P665
   CHEUNG HS, 1985, EXP CELL RES, V157, P63, DOI 10.1016/0014-4827(85)90152-1
   Chrisey D., 1994, PULSED LASER DEPOSIT
   COURTENEYHARRIS RG, 1995, BIOMATERIALS, V16, P489, DOI 10.1016/0142-9612(95)98823-W
   DEBRUIJN JD, 1993, CELLS MAT, V3, P113
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   FRAYSSINET P, 1994, J MATER SCI-MATER M, V5, P11, DOI 10.1007/BF00121147
   GarciaSanz FJ, 1997, J MATER SCI-MATER M, V8, P861, DOI 10.1023/A:1018549720873
   Garrity J A, 1994, Curr Opin Ophthalmol, V5, P39
   Gross KA, 1998, J AM CERAM SOC, V81, P106
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P961, DOI 10.1002/jbm.820280815
   Knabe C, 1997, BIOMATERIALS, V18, P1339, DOI 10.1016/S0142-9612(97)00078-1
   LEGEROS RZ, 1991, BONE-BIOMATERIAL INTERFACE, P76
   LIU DM, 1994, J MATER SCI-MATER M, V5, P147, DOI 10.1007/BF00053335
   Lo WJ, 2000, J BIOMED MATER RES, V50, P536, DOI 10.1002/(SICI)1097-4636(20000615)50:4<536::AID-JBM9>3.3.CO;2-L
   MAXIAN SH, 1994, J BIOMED MATER RES, V28, P1311, DOI 10.1002/jbm.820281109
   MAXIAN SH, 1993, J BIOMED MATER RES, V27, P111, DOI 10.1002/jbm.820270114
   MCFARLAND CD, 1995, T 41 ORTH RES SOC TO, P486
   PARKER TL, 1996, CELL ENG, V1, P91
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   SAMMONS RL, 1994, BIOMATERIALS, V15, P842, DOI 10.1016/0142-9612(94)90040-X
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   THOMAS KA, 1994, ORTHOPEDICS, V17, P267
   TRANQUILLI PL, 1994, J MATER SCI-MATER M, V5, P345, DOI 10.1007/BF00058960
   Tucker BE, 1996, BIOMATERIALS, V17, P631, DOI 10.1016/0142-9612(96)88714-X
   Wang CK, 1997, BIOMATERIALS, V18, P1331, DOI 10.1016/S0142-9612(97)00024-0
   Zreiqat H., 1996, Cells and Materials, V6, P45
NR 37
TC 71
Z9 78
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2001
VL 22
IS 4
BP 337
EP 347
DI 10.1016/S0142-9612(00)00189-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 392TH
UT WOS:000166428300006
PM 11205437
DA 2018-10-19
ER

PT J
AU Tan, JCH
AF Tan, James C. H.
TI Capsulotomy
SO CURRENT OPINION IN OPHTHALMOLOGY
LA English
DT Article
AB Research is continually seeking to better describe the relationship between pseudophakic capsular opacification and underlying cell biology, surgical technique, and intra-ocular lens biomaterial and design. Outcomes are reviewed from prospective, randomized studies that investigate the importance of capsulorhexis size, pharmacological treatment, and lens material in influencing capsular opacification and the need for capsulotomy. The results of several studies support the role of lens edge profile in inhibiting lens epithelial cell migration. A large post-mortem study also examines how lens type may affect anterior capsular opacification formation. Of particular interest is a histological report that sheds additional light on understanding cellular processes in posterior capsular opacification. (C) 2001 Lippincott Williams & Wilkins, Inc.
C1 [Tan, James C. H.] Moorfields Eye Hosp, Glaucoma Res Unit, City Rd, London EC1V 2PD, England.
RP Tan, JCH (reprint author), Moorfields Eye Hosp, Glaucoma Res Unit, City Rd, London EC1V 2PD, England.
EM oranghutan@aol.com
CR APPLE DJ, 1992, SURV OPHTHALMOL, V37, P73, DOI 10.1016/0039-6257(92)90073-3
   Apple DJ, 2000, J CATARACT REFR SURG, V26, P180, DOI 10.1016/S0886-3350(99)00353-3
   Birinci H, 1999, J CATARACT REFR SURG, V25, P1140, DOI 10.1016/S0886-3350(99)00119-4
   Cochener B, 1999, J CATARACT REFR SURG, V25, P1362, DOI 10.1016/S0886-3350(99)00227-8
   Coombes A, 1999, BRIT J OPHTHALMOL, V83, P640, DOI 10.1136/bjo.83.6.640
   DAVISON JA, 1993, J CATARACT REFR SURG, V19, P582, DOI 10.1016/S0886-3350(13)80004-1
   Friedman DS, 1999, INVEST OPHTH VIS SCI, V40, P1715
   Gallagher SP, 1999, J CATARACT REFR SURG, V25, P1356, DOI 10.1016/S0886-3350(99)00228-X
   Gillies M, 1998, ARCH OPHTHALMOL-CHIC, V116, P90, DOI 10.1001/archopht.116.1.90
   Hollick EJ, 1999, AM J OPHTHALMOL, V128, P271, DOI 10.1016/S0002-9394(99)00157-9
   Hollick EJ, 1999, ARCH OPHTHALMOL-CHIC, V117, P872
   Hollick EJ, 2000, AM J OPHTHALMOL, V129, P577, DOI 10.1016/S0002-9394(99)00447-X
   JAVITT JC, 1992, OPHTHALMOLOGY, V99, P1487
   Koch MU, 1999, J CATARACT REFR SURG, V25, P1637, DOI 10.1016/S0886-3350(99)00267-9
   Kruger AJ, 2000, J CATARACT REFR SURG, V26, P566, DOI 10.1016/S0886-3350(00)00323-0
   Marcantonio JM, 2000, INVEST OPHTH VIS SCI, V41, P1130
   Marcantonio JM, 1999, EYE, V13, P484
   Meacock WR, 2000, J CATARACT REFR SURG, V26, P716, DOI 10.1016/S0886-3350(00)00326-6
   Meacock WR, 2000, BRIT J OPHTHALMOL, V84, P332, DOI 10.1136/bjo.84.3.332
   Nagata T, 1996, JPN J OPHTHALMOL, V40, P397
   Nishi O, 1999, J CATARACT REFR SURG, V25, P521, DOI 10.1016/S0886-3350(99)80049-2
   Nishi O, 1998, OPHTHALMIC SURG LAS, V29, P119
   Peng Q, 2000, J CATARACT REFR SURG, V26, P198, DOI 10.1016/S0886-3350(99)00352-1
   Peng Q, 2000, J CATARACT REFR SURG, V26, P188, DOI 10.1016/S0886-3350(99)00354-5
   Ravalico G, 1996, J CATARACT REFR SURG, V22, P98, DOI 10.1016/S0886-3350(96)80277-X
   Schaumberg DA, 1998, OPHTHALMOLOGY, V105, P1213, DOI 10.1016/S0161-6420(98)97023-3
   Spalton DJ, 1999, EYE, V13, P489
   STEINBERG EP, 1993, ARCH OPHTHALMOL-CHIC, V111, P1041, DOI 10.1001/archopht.1993.01090080037016
   THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115
   Werner L, 2000, OPHTHALMOLOGY, V107, P463, DOI 10.1016/S0161-6420(99)00088-3
NR 30
TC 2
Z9 2
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8738
EI 1531-7021
J9 CURR OPIN OPHTHALMOL
JI Curr. Opin. Ophthalmol.
PD FEB
PY 2001
VL 12
IS 1
BP 82
EP 85
DI 10.1097/00055735-200102000-00014
PG 4
WC Ophthalmology
SC Ophthalmology
GA V40ZD
UT WOS:000209515600014
PM 11150086
DA 2018-10-19
ER

PT J
AU Harper, C
AF Harper, C
TI Permacol (TM): clinical experience with a new biomaterial
SO HOSPITAL MEDICINE
LA English
DT Article
ID REPAIR; MESHES
AB Permacol(TM) (Tissue Science Laboratories plc, Aldershot, Hants) is a new biomaterial which combines the strength and permanence of synthetic surgical repair materials with the biocompatibility of natural materials. This article examines the clinical application of Permacol(TM) in a range of different surgical procedures.
C1 Tissue Sci Labs PLC, Aldershot GU11 1EJ, Hants, England.
RP Harper, C (reprint author), Tissue Sci Labs PLC, Victoria House,Victoria Rd, Aldershot GU11 1EJ, Hants, England.
CR Barrington J. W., 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P61
   BARRINGTON JW, 2000, INT UROGYNAECOL SU, V11, pS122
   Baykal A, 1999, WORLD J SURG, V23, P625, DOI 10.1007/PL00012359
   Chvapil M, 1980, BIOL COLLAGEN, P313
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   COOKE A, 1983, BRIT J EXP PATHOL, V64, P172
   ELLIS AF, 2000, CURR OPIN OTOLARYNGO, V8, P337
   GADACZ TR, 1994, SEMIN LAPAROSC SURG, V1, P123
   Ghimenton F, 2000, BRIT J SURG, V87, P106, DOI 10.1046/j.1365-2168.2000.01337.x
   GRIFFITHS RW, 1982, BRIT J PLAST SURG, V35, P519, DOI 10.1016/0007-1226(82)90056-X
   Klinge U, 1999, EUR J SURG, V165, P665
   LLOYD SN, 2000, BR J UROL S5, V85, pP38
   LOEWE O, 1913, MUNCHEN MED WCHNSCHR, V24, P1320
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   Meyer W, 1978, Curr Probl Dermatol, V7, P39
   MONTEIRORIVIERE NA, 1986, ULTRASTRUCTURAL EVAL, P641
   OLIVER R F, 1987, Burns, V13, pS49, DOI 10.1016/0305-4179(87)90094-5
   OLIVER RF, 1982, BIOMATERIALS, V3, P38, DOI 10.1016/0142-9612(82)90059-X
   OLIVER RF, 1975, NATURE, V258, P537, DOI 10.1038/258537a0
   OLIVER RF, 1976, CLIN ORTHOP RELAT R, P291
   OLIVER RF, 1972, BRIT J EXP PATHOL, V53, P540
   OLIVER RF, 1980, BRIT J EXP PATHOL, V61, P544
   OLIVER RF, 1986, IN VITRO GROWTH ADUL
   RUPARELIA BA, 2000, INT UROGYNAECOL S11, V11
   SHAKESPEARE PG, 1980, LANCET, V1, P795
   SPEAKMAN MJ, 2000, BR J UROL S5, V85, P42
   THOMPSON N, 1960, Plast Reconstr Surg Transplant Bull, V26, P1
NR 28
TC 87
Z9 90
U1 3
U2 10
PU MARK ALLEN PUBLISHING LTD
PI LONDON
PA CROXTED MEWS, 286A-288 CROXTED ROAD, LONDON SE24 9BY, ENGLAND
SN 1462-3935
J9 HOSP MED
JI Hosp. Med
PD FEB
PY 2001
VL 62
IS 2
BP 90
EP 95
DI 10.12968/hosp.2001.62.2.2379
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 404BU
UT WOS:000167078200007
PM 11236624
DA 2018-10-19
ER

PT J
AU Mitchell, SB
   Sanders, JE
   Garbini, JL
   Schuessler, PK
AF Mitchell, SB
   Sanders, JE
   Garbini, JL
   Schuessler, PK
TI A device to apply user-specified strains to biomaterials in culture
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
DE biaxial strain; biomechanics; cell proliferation; in-plane tension;
   PGE-2
ID MECHANICAL-PROPERTIES; SKIN; PROSTAGLANDIN-E2; RELEASE; SYSTEM; STRESS;
   MOTION
AB An apparatus was developed to apply user-specified displacements to biomaterial samples in culture, The device allowed cyclic waveforms of bandwidth 0 Hz to 20 Wt to be applied under physiologic thermal (37.5 degreesC) and [CO2] (5%) conditions. For a 0 Hz to 20 Hz bandwidth signal similar in shape to a ventricular pressure waveform, the mean displacement error was 0.26% of the full-scale output, The maximum overshoot was 0.700%. Environmental system evaluation tests demonstrated a specimen cartridge temperature of 37.20 +/- 0.15 degreesC during cyclic loading and 37.23 +/- 0.21 degreesC during static conditions. [CO2] was 5.29 +/- 0.54% during cyclic loading and 5.25 +/- 0.61% during static conditions. Laminar flow applied at the loading rod entrances to the specimen cartridge ensured the sample remained sterile during testing. As a preliminary evaluation, polyurethane samples were seeded with fetal foreskin fibroblasts and subject to intermittent cyclic displacements. Results demonstrated enhanced cell proliferation and increased [PGE(2)] for samples subjected to 10% strain compared with unstrained controls, ii next step will be to evaluate cell response sensitivity to strain magnitude, duration, direction, and frequency. The long-term intent is to establish mechanical loading configurations that induce acceptable or adaptation-inducing responses for use in implant design and tissue engineering applications.
C1 Univ Washington, UWEB Program, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, UWEB Program, Dept Mech Engn, Seattle, WA 98195 USA.
RP Sanders, JE (reprint author), Univ Washington, UWEB Program, Dept Bioengn, Seattle, WA 98195 USA.
CR ALEXANDER H, 1977, J INVEST DERMATOL, V69, P310, DOI 10.1111/1523-1747.ep12507731
   BAREIS DL, 1983, P NATL ACAD SCI-BIOL, V80, P2514, DOI 10.1073/pnas.80.9.2514
   BELL E, 1993, TISSUE ENG
   Cadzow JA, 1973, DISCRETE TIME SYSTEM
   Carver SE, 1999, TISSUE ENG, V5, P1, DOI 10.1089/ten.1999.5.1
   CHANG MH, 1994, J VASC SURG, V20, P6
   CHEW PH, 1986, J MOL CELL CARDIOL, V18, P567, DOI 10.1016/S0022-2828(86)80965-8
   CHRISTMAN JW, 1991, PROSTAGLANDINS, V41, P251, DOI 10.1016/0090-6980(91)90045-H
   DICK JC, 1951, J PHYSIOL-LONDON, V112, P102, DOI 10.1113/jphysiol.1951.sp004512
   Dorf R. C., 1995, MODERN CONTROL SYSTE
   Gibbons D. F., 1994, Clinical Materials, V15, P37, DOI 10.1016/0267-6605(94)90007-8
   KENEDI RM, 1975, PHYS MED BIOL, V20, P699, DOI 10.1088/0031-9155/20/5/001
   Kenedi RM, 1965, BIOMECHANICS RELATED
   LANIR Y, 1974, J BIOMECH, V7, P29, DOI 10.1016/0021-9290(74)90067-0
   MARTIJN A, 1995, AM J PHYSIOL, V26, pH2531
   NARA AR, 1993, BIOPHYSICAL MEASUREM
   PATEL DJ, 1963, J APPL PHYSIOL, V18, P1111
   RAUD J, 1988, P NATL ACAD SCI USA, V85, P2315, DOI 10.1073/pnas.85.7.2315
   Regamey R H, 1974, Dev Biol Stand, V23, P71
   RICHARDSON PDI, 1976, BRIT J PHARMACOL, V57, P581, DOI 10.1111/j.1476-5381.1976.tb10388.x
   SACKS MS, 1993, J BIOMECH ENG-T ASME, V115, P202, DOI 10.1115/1.2894122
   SANDERS JE, 1995, J REHABIL RES DEV, V32, P214
   SCHAFFER JL, 1994, J ORTHOP RES, V12, P709, DOI 10.1002/jor.1100120514
   VANROYEN BJ, 1986, PLAST RECONSTR SURG, V78, P360, DOI 10.1097/00006534-198609000-00013
   VITO RP, 1980, J BIOMECH, V13, P947, DOI 10.1016/0021-9290(80)90165-7
   Yun JK, 1999, TISSUE ENG, V5, P67, DOI 10.1089/ten.1999.5.67
NR 26
TC 14
Z9 15
U1 0
U2 0
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD FEB
PY 2001
VL 48
IS 2
BP 268
EP 273
DI 10.1109/10.909648
PG 6
WC Engineering, Biomedical
SC Engineering
GA 408VF
UT WOS:000167347600015
PM 11296883
DA 2018-10-19
ER

PT J
AU Takagi, S
   Chow, LC
   Markovic, M
   Friedman, CD
   Costantino, PD
AF Takagi, S
   Chow, LC
   Markovic, M
   Friedman, CD
   Costantino, PD
TI Morphological and phase characterizations of retrieved calcium phosphate
   cement implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE self-hardening calcium phosphate cement; calcium phosphate cement
   implant; carbonated hydroxyapatite; tetracalcium phosphate; dicalcium
   phosphate anhydrous; CPC characterization
ID HYDROXYAPATITE CEMENT; RECONSTRUCTION; PRECIPITATION; BIOMATERIAL;
   BEHAVIOR; SYSTEM; BONE
AB A self-hardening calcium phosphate cement (CPC), consisting of equimolar amounts of tetracalcium phosphate and dicalcium phosphate anhydrous, hardens when mixed with water and forms a resorbable hydroxyapatite (HA) as the end-product. The objective of this study was to investigate the changes of the phase and morphology of the CPC during hardening and aging under in vivo conditions. CPC samples retrieved 12 h after hardening in vivo had already contained carbonated HA (type B), even though the initial cement mixture did not contain carbonate as one of the solid components. The mass fraction of carbonate in the 12-h sample was about 1%. The results suggested that under in vivo conditions carbonate is readily available and this allows formation of carbonated HA in favor of carbonate-free HA, The carbonate content of the CPC samples retrieved 3 months after implantation was similar to that of the 12-h samples, and the exterior surfaces of the 3-month samples appeared less crystalline than that of the 12-h samples, (C) 2000 John Wiley & Sons. Inc. J Biomed Mater Res (Appl Biomater) 58: 36-41. 2001.
C1 NIST, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Gaithersburg, MD 20899 USA.
   Fox Chase Canc Ctr, Dept Surg Oncol, Philadelphia, PA 19111 USA.
   Mt Sinai Med Ctr, Dept Otolaryngol Head & Neck Surg, New York, NY 10029 USA.
RP Takagi, S (reprint author), NIST, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Gaithersburg, MD 20899 USA.
FU NIDCR NIH HHS [DE11789]
CR Cherng A, 1997, J BIOMED MATER RES, V35, P273, DOI 10.1002/(SICI)1097-4636(19970605)35:3<273::AID-JBM1>3.0.CO;2-E
   CHOW LC, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P127
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Conway E. J., 1962, MICRODIFFUSION ANAL, P201
   COSTANTINO PD, 1992, PLAST RECONSTR SURG, V90, P174, DOI 10.1097/00006534-199290020-00003
   Fernandez E, 1998, J BIOMED MATER RES, V41, P560, DOI 10.1002/(SICI)1097-4636(19980915)41:4<560::AID-JBM7>3.0.CO;2-A
   Fernandez E, 1999, J BIOMED MATER RES, V47, P466, DOI 10.1002/(SICI)1097-4636(19991215)47:4<466::AID-JBM2>3.0.CO;2-R
   Friedman C D, 2000, Arch Facial Plast Surg, V2, P124, DOI 10.1001/archfaci.2.2.124
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   ISHIKAWA K, 1994, DENT MATER, V10, P26, DOI 10.1016/0109-5641(94)90018-3
   Ishikawa K, 1999, J BIOMED MATER RES, V46, P504, DOI 10.1002/(SICI)1097-4636(19990915)46:4<504::AID-JBM8>3.0.CO;2-H
   ISHIKAWA K, 1996, BIOCERAM P INT S CER, V9, P255
   LEGEROS RZ, 1991, MONOGRAPHS ORAL SCI, P82
   Markovic M, 1996, J DENT RES, V75, P25
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   TERMINE JD, 1974, CALC TISS RES, V15, P55, DOI 10.1007/BF02059043
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
NR 19
TC 36
Z9 37
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2001
VL 58
IS 1
BP 36
EP 41
DI 10.1002/1097-4636(2001)58:1<36::AID-JBM50>3.3.CO;2-R
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 398JQ
UT WOS:000166753700005
PM 11152995
DA 2018-10-19
ER

PT J
AU Butler, CE
   Navarro, FA
   Orgill, DP
AF Butler, CE
   Navarro, FA
   Orgill, DP
TI Reduction of abdominal adhesions using composite collagen-GAG implants
   for ventral hernia repair
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID ARTIFICIAL SKIN; INCISIONAL HERNIA; MARLEX MESH; WALL REPLACEMENT;
   MODEL; DESIGN; MATRICES; KERATINOCYTES; REGENERATION; PREVENTION
AB Structural biomaterials can restore abdominal wall integrity but may cause adhesions to the underlying viscera, Collagen-glycosaminoglycan (CG) matrices induce the formation of connective tissue and mag reduce adhesion formation to permanent biomaterials such as polypropylene (PP) mesh, Composite implants were created by interposing PP mesh within a porous CG matrix created composite implants. The implants were cross-linked with glutaraldehyde one group (CG-G/PP) or left untreated (CG-nG/PP) and compared to PP mesh. At 4 weeks, the abdominal wall was assessed for the degree of adhesions. The composite implants developed a nascent connective tissue-like structure that reduced adhesions to the bowel, The thickest connective tissue developed in the CG-G/PP group (0.7 +/- 0.1 mm) and thinnest in the PP mesh (0.05 +/- 0.01 mm). The surface area covered with adhesions was greatest in the PP group (72 +/- 17%) compared with the CG-G/PP group (28 +/- 15%) or the CG-nG/PP group (21 +/- 8%). Bowel preferentially adhered to the PP mesh, whereas omentum had some adherence to all constructs. Integrating a biodegradable extracellular matrix analog with a permanent structural biomaterial reduced adhesions in this animal model. Alterations in cross-linking of the CG matrix altered the biological response, This technology may be useful in reconstructive surgery by reducing adhesion formation, while maintaining the strength of permanent structural biomaterials. (C) 2000 John Wiley & Sons. Inc. J Biomed Mater Res (Appl Biomater) 58. 75-80. 2001.
C1 Brigham & Womens Hosp, Div Plast Surg, Boston, MA 02115 USA.
   Univ Texas, MD Anderson Canc Ctr, Dept Plast Surg, Houston, TX 77030 USA.
RP Orgill, DP (reprint author), Brigham & Womens Hosp, Div Plast Surg, 75 Francis St, Boston, MA 02115 USA.
CR Alponat A, 1997, AM SURGEON, V63, P818
   AMID PK, 1994, LANGENBECK ARCH CHIR, V379, P168, DOI 10.1007/BF00680113
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   BOYD WC, 1977, SURG GYNECOL OBSTET, V144, P251
   Butler CE, 1998, PLAST RECONSTR SURG, V101, P1572, DOI 10.1097/00006534-199805000-00021
   Butler CE, 1999, BRIT J PLAST SURG, V52, P127, DOI 10.1054/bjps.1997.3047
   Butler Charles E., 1996, Surgical Forum, V47, P752
   CAPOZZI JA, 1988, SURG GYNECOL OBSTET, V167, P124
   Compton CC, 1998, J INVEST DERMATOL, V110, P908, DOI 10.1046/j.1523-1747.1998.00200.x
   Cristoforoni PM, 1996, AM SURGEON, V62, P935
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   DEGUZMAN LJ, 1995, ENDOSCOPY, V27, P257
   ELLIOTT MP, 1979, AM J SURG, V137, P342, DOI 10.1016/0002-9610(79)90063-1
   FUKASAWA M, 1991, INT J FERTIL, V36, P296
   GILBERT AI, 1987, SOUTHERN MED J, V80, P191, DOI 10.1097/00007611-198702000-00013
   Harriger MD, 1997, J BIOMED MATER RES, V35, P137, DOI 10.1002/(SICI)1097-4636(199705)35:2<137::AID-JBM1>3.0.CO;2-O
   LAMB JP, 1983, SURGERY, V93, P643
   MOLLOY RG, 1991, BRIT J SURG, V78, P242, DOI 10.1002/bjs.1800780237
   MURPHY GF, 1990, LAB INVEST, V63, P305
   Nehrer S, 1998, BIOMATERIALS, V19, P2313, DOI 10.1016/S0142-9612(98)00143-4
   Orgill DP, 1998, J BIOMED MATER RES, V39, P531, DOI 10.1002/(SICI)1097-4636(19980315)39:4<531::AID-JBM4>3.3.CO;2-P
   Orgill DP, 1998, PLAST RECONSTR SURG, V102, P423, DOI 10.1097/00006534-199808000-00020
   Orgill DP, 1996, WOUNDS, V8, P151
   SCALES J T, 1953, Proc R Soc Med, V46, P647
   TALBERT JL, 1977, J PEDIATR SURG, V12, P63, DOI 10.1016/0022-3468(77)90297-4
   TURKCAPAR AG, 1995, INT SURG, V80, P92
   VOYLES CR, 1981, ANN SURG, V194, P219, DOI 10.1097/00000658-198108000-00017
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
NR 29
TC 44
Z9 46
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2001
VL 58
IS 1
BP 75
EP 80
DI 10.1002/1097-4636(2001)58:1<75::AID-JBM110>3.0.CO;2-J
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 398JQ
UT WOS:000166753700011
PM 11153001
DA 2018-10-19
ER

PT J
AU Wiese, KG
   Heinemann, DEH
   Ostermeier, D
   Peters, JH
AF Wiese, KG
   Heinemann, DEH
   Ostermeier, D
   Peters, JH
TI Biomaterial properties and biocompatibility in cell culture of a novel
   self-inflating hydrogel tissue expander
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hydrogel; tissue expander; osmosis; hydrostatic pressure;
   biocompatibility; cytotoxicity; mutagenicity; monocyte differentiation
ID EXPANSION
AB The aim of this study was to investigate the swelling properties and the biocompatibility of a novel tissue expander material. The self-inflating material is a hydrogel consisting of a modified copolymer of methylmethacrylate and N-vinyl-2-pyrrolidone, which takes up water by osmosis. To increase the swelling volume, the primarily neutral gel material was modified by converting it into an ionized gel. To study the swelling and pressure behavior of the material, the anhydrous gel cylinders were equilibrated in distilled water, saline, and sugar solutions. The biocompatibility was investigated in cell culture. We tested the hydrogel eluate after swelling for cytotoxicity and mutagenicity using the cell lines MRC-5 and P3X63 Ag8 653 (Ag8). Furthermore, particles of the material were added to cell cultures to induce foreign body reactions and to verify its influence on monocyte differentiation. The material has a swelling capacity (Q = maximum swelling volume/anhydrous volume) of 5 to 50 depending on the degree of ionization of the polymer network. In this study, two polymer modifications with a swelling equilibrium of Q = 11.1 and 30 in water were tested. The swelling ratio also depends on concentration and ion content of the equilibration medium. The highest swelling capacity was found in water, the lowest in Ringer's solution. The swelling of the anhydrous material with the swelling capacity of Q = 11.1 fits best the average purpose of material properties for tissue expansion and generates a maximal hydrostatic pressure of approximately 235 mmHg. Effects on cell proliferation were detected only at the highest eluate concentration tested (i.e., eluate: culture medium = 1:1), which was far beyond physiological values, whereas mutagenicity was absent. Monocytes neither mi,orated nor tightly attached to the hydrogel. They neither phagocytose the material nor did they show any sign of a foreign body reaction, e.g., formation of multinucleated giant cells or monocyte proliferation. In the presence of hydrogel material, the differentiation processes of monocytes to macrophages or dendritic cells, respectively, were found to be undisturbed. From these results, we conclude that there is a high biocompatibility of the expander material, which may be a favorable and interesting candidate for further clinical applications. (C) 2000 John Wiley & Sons, Inc.
C1 Dept Maxillofacial Surg, D-37075 Gottingen, Niedersachsen, Germany.
   Univ Gottingen, Dept Immunol, Lower Saxony, Germany.
RP Wiese, KG (reprint author), Dept Maxillofacial Surg, Robert Koch Str 40, D-37075 Gottingen, Niedersachsen, Germany.
CR Andrade JD, 1976, ACS S SERIES, V31
   ARGENTA LC, 1984, CLIN PLAST SURG, V11, P257
   AUSTAD ED, 1982, PLAST RECONSTR SURG, V70, P588, DOI 10.1097/00006534-198211000-00011
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   GOLDNER RD, 1977, AM J PATHOL, V89, P335
   GREGONIS DE, 1976, ACS SYM SER, V31, P37
   Hauptmann S, 1996, J MATER SCI-MATER M, V7, P345, DOI 10.1007/BF00154546
   Heinemann DEH, 1997, SCAND J IMMUNOL, V45, P596, DOI 10.1046/j.1365-3083.1997.d01-435.x
   HEINEMANN DEH, 1997, OSTEOLOGIE, V6, P112
   HENZE U, 1999, DTSCH ARZTEBLATT, V96, P687
   HUNDHAUSEN T, 1990, UNTERSUCHUNGEN HERST
   KEARNEY JF, 1979, J IMMUNOL, V123, P1548
   Kozinn S C, 1986, J Arthroplasty, V1, P249, DOI 10.1016/S0883-5403(86)80015-8
   LENZER S, 1992, MONOCLONAL ANTIBODIE, P176
   NEUMANN C G, 1957, Plast Reconstr Surg (1946), V19, P124, DOI 10.1097/00006534-195702000-00004
   OCKLIND G, 1988, J IMMUNOL METHODS, V112, P169, DOI 10.1016/0022-1759(88)90353-5
   Peppas N. A., 1986, HYDROGELS MED PHARM, V2
   PETERS JH, 1993, ADV EXP MED BIOL, V329, P275
   PETERS JH, 1985, MONOKLONALE ANTIKOER, P118
   RADOVAN C, 1979, PLAST SURG FORUM, V2, P62
   REFOJO M F, 1973, International Ophthalmology Clinics, V13, P263, DOI 10.1097/00004397-197301310-00020
   REFOJO MF, 1976, ACS SYM SER, V31, P37
   ROSEN JJ, 1976, ACS S SERIES, V31
   RUPPERT J, 1991, EUR J CELL BIOL, V55, P352
   TANAKA T, 1981, SPEKTRUM WISSENSCHAF, V3, P78
   WIESE KG, 1993, J CRANIO MAXILL SURG, V21, P309, DOI 10.1016/S1010-5182(05)80353-1
   WIESE KG, 1998, THESIS FACHBEREICH M
   Wooley PH, 1996, CLIN ORTHOP RELAT R, P63
   Xu H, 1995, ADV EXP MED BIOL, V378, P75
   ZYBALSKI W, 1962, NATL CANC I MONOGR, V7, P75
NR 30
TC 41
Z9 43
U1 3
U2 19
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2001
VL 54
IS 2
BP 179
EP 188
DI 10.1002/1097-4636(200102)54:2<179::AID-JBM4>3.0.CO;2-C
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 378UF
UT WOS:000165602500004
PM 11093177
DA 2018-10-19
ER

PT J
AU Peng, CY
   Tsutsumi, S
   Matsumura, K
   Nakajima, N
   Hyon, SH
AF Peng, CY
   Tsutsumi, S
   Matsumura, K
   Nakajima, N
   Hyon, SH
TI Morphologic study and syntheses of type I collagen and fibronectin of
   human periodontal ligament cells cultured on poly(ethylene-co-vinyl
   alcohol) (EVA) with collagen immobilization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE regeneration of periodontium; dental implant; periodontal ligament cell;
   type I collagen; fibronectin; poly(ethylene-co-vinyl alcohol) (EVA)
ID BIOMATERIAL; RAT
AB The purpose of this study was to regenerate the human periodontal ligament (PDL) around dental implants by using a hybrid structure of cells with materials, such as PDL cells + collagen + poly(ethylene-ca-vinyl alcohol) (EVA) on titanium implant. Human PDL cells were cultured on the EVA surface coated with type I collagen and the cell adhesion and extension were investigated. Furthermore, collagen type I and fibronectin syntheses were analyzed. The serum free culture was also tried, to investigate the role of collagen in detail. The results showed that: 1. Satisfactory adhesion, extension, and proliferation of the PDL cells on the EVA films coated with collagen were observed, but were not good without collagen. 2. Immunostaining of cultured PDL cells revealed the syntheses of type I collagen, when cultured on the EVA coated with collagen or conventional culture dish, though fibronectin synthesis was observed even in the EVA without collagen. 3. Only PDL cells on the EVA coated with collagen proliferated well in the absence of serum. These results indicate that our novel implant material (EVA coated with collagen) provides a possibility of PDL regeneration on dental implants. (C) 2000 John Wiley & Sons, Inc.
C1 Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan.
RP Tsutsumi, S (reprint author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.
RI Matsumura, Kazuaki/I-1627-2014
OI Matsumura, Kazuaki/0000-0001-9484-3073
CR CHUNG KM, 1990, J PERIODONTOL, V61, P732, DOI 10.1902/jop.1990.61.12.732
   ITO T, 1995, J JPN SOC CLIN BIOME, V16, P443
   ITO T, 1996, J JPN SOC CLIN BIOME, V17, P369
   Matsumura K, 2000, J BIOMED MATER RES, V50, P512, DOI 10.1002/(SICI)1097-4636(20000615)50:4<512::AID-JBM6>3.3.CO;2-7
   Mutter D, 1996, BIOMATERIALS, V17, P1411, DOI 10.1016/0142-9612(96)87283-8
   OHTA M, 1998, J JPN SOC CLIN BIOME, V19, P303
   Oros J, 1996, J VET MED SCI, V58, P1219, DOI 10.1292/jvms.58.12_1219
   RAO KP, 1988, COLLAGEN, V3, P63
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Sisken BF, 1993, J CELL BIOCHEM, V52, P404
   WERKMEISTER JA, 1993, J HISTOCHEM CYTOCHEM, V41, P1701, DOI 10.1177/41.11.8409376
   Young TH, 1998, BIOMATERIALS, V19, P717, DOI 10.1016/S0142-9612(98)00187-2
NR 12
TC 17
Z9 18
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2001
VL 54
IS 2
BP 241
EP 246
DI 10.1002/1097-4636(200102)54:2<241::AID-JBM11>3.0.CO;2-P
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 378UF
UT WOS:000165602500011
PM 11093184
DA 2018-10-19
ER

PT J
AU Ono, I
   Zhou, LJ
   Tateshita, T
AF Ono, I
   Zhou, LJ
   Tateshita, T
TI Effects of a collagen matrix containing prostaglandin E-1 on wound
   contraction
SO JOURNAL OF DERMATOLOGICAL SCIENCE
LA English
DT Article
DE wound healing; wound contraction; rabbit model; dermal substitute;
   prostaglandin E-1; collagen gel contraction
ID FIBROBLAST-GROWTH-FACTOR; DERMAL FIBROBLASTS; ARTIFICIAL DERMIS;
   CYTOKINES; SKIN; BIOMATERIAL; SPONGE; REPAIR; MODEL; FLUID
AB In this study, we evaluated the effectiveness of prostaglandin (PG) E-1 in inhibiting wound contraction, both alone and in combination with collagen matrix, using a in vivo full thickness skin defect model. To clarify the mechanisms involved in this inhibition we also used a fibroblast-populated collagen gel contraction in vitro model. We demonstrated that collagen matrix alone significantly inhibited wound contraction PG E-1 alone did not. Interestingly, their combination was much more effective than either collagen matrix or PG E-1 alone, a finding which was also supported by histopathological examination. Wounds treated with collagen matrix, but not control wounds, showed horizontal rearrangement of collagen fibers in the dermal part as well as evidence of active fibroblast proliferation which was not observed in scar regions surrounded by normal dermis. With the fibroblast-populated collagen gel contraction in vitro model, we found that PG E-1 significantly inhibited contraction at a high dose. It was concluded that collagen matrix combined with PG E-1 is effective for preventing contracture producing so called neodermis than collagen matrix alone, which remains one of the most challenging problems in treating full thickness type wounds. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
C1 Fukushima Med Univ, Dept Dermatol, Sch Med, Fukushima 9601295, Japan.
RP Ono, I (reprint author), Fukushima Med Univ, Dept Dermatol, Sch Med, Hikarigaoka 1, Fukushima 9601295, Japan.
RI ZHOU, LIJUN/K-1120-2015
OI ZHOU, LIJUN/0000-0001-6461-1247
CR ABRAMO AC, 1992, BRIT J PLAST SURG, V45, P117, DOI 10.1016/0007-1226(92)90170-3
   Alaish Samuel M., 1996, Wound Repair and Regeneration, V4, P477, DOI 10.1046/j.1524-475X.1996.40412.x
   BENNETT NT, 1993, AM J SURG, V165, P728, DOI 10.1016/S0002-9610(05)80797-4
   BENNETT NT, 1993, AM J SURG, V166, P74, DOI 10.1016/S0002-9610(05)80589-6
   COOPER DM, 1994, ANN SURG, V219, P688, DOI 10.1097/00000658-199406000-00012
   DAVIDSON JM, 1991, ANN NY ACAD SCI, V638, P306, DOI 10.1111/j.1749-6632.1991.tb49041.x
   DOILLON CJ, 1988, SCANNING MICROSCOPY, V2, P985
   FANG C, 1983, J TRAUMA, V23, P300, DOI 10.1097/00005373-198304000-00005
   FIDDES JC, 1991, ANN NY ACAD SCI, V638, P316
   FORD HR, 1989, ARCH SURG-CHICAGO, V124, P1422
   Grotendorst G, 1992, WOUND HEALING BIOCH, P237
   Gunji H, 1996, BURNS, V22, P399, DOI 10.1016/0305-4179(95)00170-0
   INOUE M, 1996, WOUND REPAIR REGEN, V6, P213
   Inoue Masayuki, 1996, Wound Repair and Regeneration, V4, P426, DOI 10.1046/j.1524-475X.1996.40406.x
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   LEIPZIGER LS, 1985, J AM ACAD DERMATOL, V12, P409, DOI 10.1016/S0190-9622(85)80004-9
   Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x
   Matsui R, 1996, BIOMATERIALS, V17, P989, DOI 10.1016/0142-9612(96)84673-4
   Matsui R, 1996, BIOMATERIALS, V17, P995, DOI 10.1016/0142-9612(96)84674-6
   MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0
   Ono I, 1999, J BIOMED MATER RES, V48, P621, DOI 10.1002/(SICI)1097-4636(1999)48:5<621::AID-JBM5>3.0.CO;2-1
   ONO I, 1995, J DERMATOL SCI, V10, P241, DOI 10.1016/0923-1811(95)00454-Z
   ONO I, 1995, BURNS, V21, P352, DOI 10.1016/0305-4179(95)00005-4
   Orgill DP, 1998, PLAST RECONSTR SURG, V102, P423, DOI 10.1097/00006534-199808000-00020
   PIERCE GF, 1992, AM J PATHOL, V140, P1375
   Robson M. C., 1994, Wound Repair and Regeneration, V2, P177, DOI 10.1046/j.1524-475X.1994.20307.x
   Robson MC, 1998, AM J SURG, V176, p80S, DOI 10.1016/S0002-9610(98)00186-X
   ROBSON MC, 1992, WOUND HEALING BIOCH, P292
   Sato T, 1997, J INVEST DERMATOL, V109, P334, DOI 10.1111/1523-1747.ep12335935
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   STERN R, 1990, Journal of Burn Care and Rehabilitation, V11, P7, DOI 10.1097/00004630-199001000-00003
   Talwar M, 1996, ANN CLIN LAB SCI, V26, P451
   Tarnuzzer Roy W., 1996, Wound Repair and Regeneration, V4, P321, DOI 10.1046/j.1524-475X.1996.40307.x
   UNEMORI EN, 1994, EXP CELL RES, V210, P166, DOI 10.1006/excr.1994.1025
   Zhang J Z, 1994, Exp Dermatol, V3, P164, DOI 10.1111/j.1600-0625.1994.tb00273.x
   Zhou LJ, 1997, J DERMATOL SCI, V14, P217, DOI 10.1016/S0923-1811(96)00577-4
NR 36
TC 5
Z9 6
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0923-1811
J9 J DERMATOL SCI
JI J. Dermatol. Sci.
PD FEB
PY 2001
VL 25
IS 2
BP 106
EP 115
DI 10.1016/S0923-1811(00)00126-2
PG 10
WC Dermatology
SC Dermatology
GA 397VV
UT WOS:000166719200002
PM 11164707
DA 2018-10-19
ER

PT J
AU Bhardwaj, RS
   Eblenkamp, M
   Berndt, T
   Tietze, L
   Klosterhalfen, B
AF Bhardwaj, RS
   Eblenkamp, M
   Berndt, T
   Tietze, L
   Klosterhalfen, B
TI Role of HSP70i in regulation of biomaterial-induced activation of human
   monocytes-derived macrophages in culture
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; COLONY-STIMULATING FACTOR; HEAT-SHOCK
   PROTEINS; ALVEOLAR MACROPHAGES; GENE-EXPRESSION; TRANSCRIPTION FACTORS;
   ENDOTHELIAL-CELLS; MESSENGER-RNA; FACTOR-ALPHA
AB The functioning of an implant depends on the material properties and the wound-healing process. The latter is led by an inflammatory reaction guided mainly by monocyte/macrophage activity. This in vitro study investigated human monocytes/macrophages in culture from 2 h to 10 days on silicone, polyurethane, teflon and TCPS. Analysis of cytokine release by ELISA showed that maturing macrophages have different capacities to produce cytokines TNF alpha, IL10, IL8 and GM-CSF. The long culture-mature macrophages on all polymers produced comparable low levels of TNF alpha, IL10 and IL8. Monocytes/macrophages on polyurethane and teflon, and those on silicone only in long culture-time produced high GM-CSF amounts, where as those on TCPS exhibited low levels of GM-CSF. FACS analysis revealed that HSP70i was highly inducible after short time culture yet this high level was maintained in long culture-mature macrophages on TCPS only, whereas on other polymers the mature macrophages showed a high reduction in HSP70i level, which demonstrated a high stress-response by cells on TCPS. Accordingly, CLSM-analysis revealed low nuclear NF-kappaB in cells on TCPS and high nuclear NF-kappaB in mature macrophages on silicone and polyurethane, showing a high cellular activation on the latter two polymers. This corresponded also to the high mitochondrial activity by XTT metabolism displayed by the mature macrophages on polyurethane greater than or equal to silicone > teflon > TCPS. These data show a correlation of (1) cytokines (TNF alpha, GM-CSF) and HSP70i, (2) NF-kappaB and HSP70i by monocytes/macrophages after contact with polymers. Thus, HSP70i might be a useful molecular candidate for exploring biomaterial-induced inflammatory reaction. (C) 2001 Kluwer Academic Publishers.
C1 Aachen Tech Univ, Fac Med, IZKF BIOMAT, D-52057 Aachen, Germany.
   Aachen Tech Univ, DWI, D-52057 Aachen, Germany.
   Aachen Tech Univ, Inst Pathol, D-52057 Aachen, Germany.
RP Bhardwaj, RS (reprint author), Aachen Tech Univ, Fac Med, IZKF BIOMAT, Pauwels Str 30, D-52057 Aachen, Germany.
EM rbhardwaj@post.klinikum.rwth-aachen.de
CR ADAMS DO, 1989, IMMUNOL TODAY, V10, P33, DOI 10.1016/0167-5699(89)90298-3
   ALI SAM, 1994, BIOMATERIALS, V15, P779, DOI 10.1016/0142-9612(94)90032-9
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2
   BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.iy.12.040194.001041
   BECKER S, 1987, J IMMUNOL, V139, P3703
   BENSAUDE O, 1983, NATURE, V305, P331, DOI 10.1038/305331a0
   BHARDWAJ RS, 1992, EUR J IMMUNOL, V22, P1891, DOI 10.1002/eji.1830220732
   Bhardwaj RS, 1997, J MATER SCI-MATER M, V8, P737, DOI 10.1023/A:1018552326808
   CARVETH HJ, 1989, BIOCHEM BIOPH RES CO, V162, P387, DOI 10.1016/0006-291X(89)92009-3
   CHIGNIER E, 1993, J BIOMED MATER RES, V27, P1087, DOI 10.1002/jbm.820270814
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DONNELLY RP, 1993, J IMMUNOL, V151, P5603
   EIERMAN DF, 1989, J IMMUNOL, V142, P1970
   Feinstein DL, 1996, J BIOL CHEM, V271, P17724, DOI 10.1074/jbc.271.30.17724
   FINCATO G, 1991, BLOOD, V77, P579
   FOUQUERAY B, 1992, EUR J IMMUNOL, V22, P2983, DOI 10.1002/eji.1830221133
   GIRIDHAR G, 1993, BIOMATERIALS, V14, P609, DOI 10.1016/0142-9612(93)90180-A
   Grigoriadis G, 1996, EMBO J, V15, P7099, DOI 10.1002/j.1460-2075.1996.tb01101.x
   HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q
   Hauptmann S, 1996, J MATER SCI-MATER M, V7, P345, DOI 10.1007/BF00154546
   HENSOLD JO, 1988, MOL CELL BIOL, V8, P2219, DOI 10.1128/MCB.8.5.2219
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   HOWARD M, 1992, IMMUNOL TODAY, V13, P198, DOI 10.1016/0167-5699(92)90153-X
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Jackson JR, 1997, FASEB J, V11, P457
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   KANTENGWA S, 1993, INFECT IMMUN, V61, P1281
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   KAPUR R, 1996, J BIOMED MATER RES, V32, P32
   Kato S, 1998, BIOMATERIALS, V19, P821, DOI 10.1016/S0142-9612(97)00240-8
   LEE MT, 1987, J IMMUNOL, V138, P3019
   Lentsch AB, 1997, J CLIN INVEST, V100, P2443, DOI 10.1172/JCI119786
   Lim F, 1996, J MATER SCI-MATER M, V7, P69, DOI 10.1007/BF00058717
   MALEFYT RD, 1991, J EXP MED, V174, P1209
   MANTOVANI A, 1989, IMMUNOL TODAY, V10, P370, DOI 10.1016/0167-5699(89)90270-3
   MARTINET Y, 1987, NEW ENGL J MED, V317, P202, DOI 10.1056/NEJM198707233170404
   MASURE S, 1991, EUR J BIOCHEM, V198, P391, DOI 10.1111/j.1432-1033.1991.tb16027.x
   NABIOULLIN R, 1994, J LEUKOCYTE BIOL, V55, P437
   PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0
   POLLA BS, 1993, CLIN EXP ALLERGY, V23, P548, DOI 10.1111/j.1365-2222.1993.tb00893.x
   Rhodes NP, 1997, J BIOMED MATER RES, V37, P481, DOI 10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H
   SAMPSONJOHANNES A, 1988, J IMMUNOL, V141, P3680
   SCHENK H, 1994, P NATL ACAD SCI USA, V91, P1672, DOI 10.1073/pnas.91.5.1672
   SCHRODER JM, 1989, J EXP MED, V170, P847, DOI 10.1084/jem.170.3.847
   SINGH MK, 1984, NATURE, V309, P631, DOI 10.1038/309631a0
   SPORN SA, 1990, J IMMUNOL, V144, P4431
   STEIN M, 1992, CLIN EXP ALLERGY, V22, P19, DOI 10.1111/j.1365-2222.1992.tb00110.x
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
   SUNDERKOTTER C, 1991, PHARMACOL THERAPEUT, V51, P195, DOI 10.1016/0163-7258(91)90077-Y
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Teshima S, 1996, BIOCHEM J, V315, P497, DOI 10.1042/bj3150497
   WANG P, 1994, J IMMUNOL, V153, P811
   WANIDWORANUN C, 1993, J IMMUNOL, V151, P6853
   Watanabe N, 1997, EUR J IMMUNOL, V27, P2830, DOI 10.1002/eji.1830271113
   WATANABE N, 1988, CANCER RES, V48, P650
   WATANABE N, 1988, CANCER RES, V48, P2179
   WATANABE N, 1988, J BIOL CHEM, V263, P10262
   WEBER B, 1989, MOL CELL BIOL, V9, P769, DOI 10.1128/MCB.9.2.769
   WERB Z, 1984, BASIC CLIN IMMUNOL, P104
   WHELAN J, 1991, NUCLEIC ACIDS RES, V19, P2645, DOI 10.1093/nar/19.10.2645
   Wong HR, 1997, BIOCHEM BIOPH RES CO, V231, P257, DOI 10.1006/bbrc.1997.6076
   WRIGHT DG, 1979, J IMMUNOL, V123, P285
   YAMAUCHI N, 1989, CANCER RES, V49, P1671
   YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233
NR 66
TC 9
Z9 9
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2001
VL 12
IS 2
BP 97
EP 106
DI 10.1023/A:1008974524580
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 397JB
UT WOS:000166691600001
PM 15348314
DA 2018-10-19
ER

PT J
AU Brunel, G
   Brocard, D
   Duffort, JF
   Jacquet, E
   Justumus, P
   Simonet, T
   Benque, E
AF Brunel, G
   Brocard, D
   Duffort, JF
   Jacquet, E
   Justumus, P
   Simonet, T
   Benque, E
TI Bioabsorbable materials for guided bone regeneration prior to implant
   placement and 7-year follow-up: Report of 14 cases
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE titanium; bone regeneration; collagen, therapeutic use; dental implants;
   hydroxyapatite, therapeutic use; follow-up studies; membranes, barrier;
   membranes, bioabsorbable
ID PROGRESSIVE PERIODONTITIS PATIENTS; COLLAGEN MEMBRANE; TISSUE
   REGENERATION; BIORESORBABLE BARRIER; HISTOLOGIC EVALUATION; RIDGE
   AUGMENTATION; INTRABONY DEFECTS; CHRONIC ADULT; HYDROXYAPATITE;
   BIOCOMPATIBILITY
AB Background: The purpose of the present study was to evaluate the efficacy of a guided bone regeneration (GBR) procedure prior to implant placement and the long-term outcome of the inserted implants.
   Methods: Prior to dental implant placement GBR procedure was performed on 14 patients (mean age 48 years) using a synthetic hydroxyapatite (HA) spacer under a collagen membrane, After a mean healing period of 8 months, bone biopsies were obtained during the placement of 14 implants. The specimens were processed for histology without demineralization in order to assess bone quality and quantity of the regenerated bone.
   Results: Both the bone density and the resorption degree of HA particles were relatively varied between samples. The different phenotypes of osteoclasts and multinucleated giant cells and the individual host response could partially explain the unpredictable results in terms of bone remodeling and biomaterial resorption. However, the presence of HA particles in the regenerated bone had no influence on the osseointegration of implants presenting a success rate of 86% after a 7-year observation period.
   Conclusions: These results confirm the possibility of regenerating bone by means of bioabsorbable materials, assuring at the same time the long-term success for implants inserted in regenerated sites.
C1 Univ Toulouse 3, Fac Odontol, Dept Oral Biol, F-31062 Toulouse, France.
   Toulouse Grp, Toulouse, France.
   Univ Toulouse 3, Fac Odontol, Dept Periodontol, F-31062 Toulouse, France.
RP Brunel, G (reprint author), Fac Chirurg Dent, 3 Chemin Maraichers, F-31062 Toulouse, France.
CR Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   BAENA RRY, 1998, MINERVA STOMATOL, V47, P673
   Benque E, 1997, J CLIN PERIODONTOL, V24, P544, DOI 10.1111/j.1600-051X.1997.tb00227.x
   Benque E, 1999, INT J ORAL MAX IMPL, V14, P258
   Benque E, 1997, J CLIN PERIODONTOL, V24, P550, DOI 10.1111/j.1600-051X.1997.tb00228.x
   BENQUE EP, 1985, J BIOL BUCCALE, V13, P271
   Brunel G, 1996, J PERIODONTOL, V67, P1342, DOI 10.1902/jop.1996.67.12.1342
   Buser D, 1996, CLIN ORAL IMPLAN RES, V7, P175, DOI 10.1034/j.1600-0501.1996.070212.x
   Buser D A, 1997, Ann Periodontol, V2, P329, DOI 10.1902/annals.1997.2.1.329
   Cosci F, 1994, Pract Periodontics Aesthet Dent, V6, P35
   CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   DERSOT JM, 1995, ANAT REC, V242, P166, DOI 10.1002/ar.1092420205
   Fugazzotto PA, 1998, INT J ORAL MAX IMPL, V13, P358
   Hammerle CHF, 1998, PERIODONTOL 2000, V17, P151, DOI 10.1111/j.1600-0757.1998.tb00132.x
   Hermann JS, 1996, CURR OPIN PERIODONT, V3, P168
   Hurzeler MB, 1998, INT J ORAL MAX SURG, V27, P315, DOI 10.1016/S0901-5027(05)80623-X
   LUNDGREN D, 1994, CLIN ORAL IMPLAN RES, V5, P177, DOI 10.1034/j.1600-0501.1994.050309.x
   MARKS SC, 1991, J BONE MINER RES, V6, P395
   Mayfield L, 1997, CLIN ORAL IMPLAN RES, V8, P10, DOI 10.1111/j.1600-0501.1997.tb00002.x
   Mayfield L, 1998, CLIN ORAL IMPLAN RES, V9, P292, DOI 10.1034/j.1600-0501.1998.090502.x
   Nevins M, 1998, Int J Periodontics Restorative Dent, V18, P34
   Nevins M, 1997, CURR OPIN PERIODONT, V4, P109
   OGILVIE A, 1987, J PERIODONTAL RES, V22, P270, DOI 10.1111/j.1600-0765.1987.tb01585.x
   Palmer RM, 1998, CLIN ORAL IMPLAN RES, V9, P283, DOI 10.1034/j.1600-0501.1998.090501.x
   Parodi R, 1998, Int J Periodontics Restorative Dent, V18, P266
   Parodi R, 1997, INT J PERIODONT REST, V17, P283
   ROMINGER JW, 1994, J ORAL MAXIL SURG, V52, P106, DOI 10.1016/0278-2391(94)90388-3
   SEIBERT J, 1990, J PERIODONTOL, V61, P157, DOI 10.1902/jop.1990.61.3.157
   SHANAMAN RH, 1992, INT J PERIODONT REST, V12, P463
   Simion M, 1994, Int J Periodontics Restorative Dent, V14, P198
   Zahedi S, 1998, J PERIODONTOL, V69, P1238, DOI 10.1902/jop.1998.69.11.1238
NR 32
TC 54
Z9 57
U1 0
U2 2
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD FEB
PY 2001
VL 72
IS 2
BP 257
EP 264
DI 10.1902/jop.2001.72.2.257
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 411HA
UT WOS:000167491100019
PM 11288801
DA 2018-10-19
ER

PT J
AU Estrada, LE
   Dodge, GR
   Richardson, DW
   Farole, A
   Jimenez, SA
AF Estrada, LE
   Dodge, GR
   Richardson, DW
   Farole, A
   Jimenez, SA
TI Characterization of a biomaterial with cartilage-like properties
   expressing type X collagen generated in vitro using neonatal porcine
   articular and growth plate chondrocytes
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Article
DE cartilage; osteoarthritis; bioengineering; cartilage repair; type II
   collagen; type X collagen; calcification; chondrocyte
ID BIOCHEMICAL-CHARACTERIZATION; OSTEOCHONDRAL DEFECTS;
   EXTRACELLULAR-MATRIX; REPAIR; BONE; TRANSPLANTATION; IMPLANTS; CULTURE;
   MODEL; LOSE
AB Objective: The availability of cartilage with or without the potential to ossify and suitable for surgical restoration and resurfacing of joints is an important clinical problem in arthritis-related pathology, trauma and reconstructive surgery. Here, we designed experiments to generate a biomaterial with cartilage-like properties by culturing neonatal porcine articular and growth plate chondrocytes on a hydrogel substrate and to examine the biochemical and histological characteristics of the resulting tissue.
   Design: Neonatal porcine epiphyseal and growth plate chondrocytes were cultured on poly(2-hydroxyethyl methacrylate) (polyHEMA)coated dishes to prevent their adherence to plastic. We previously described that this procedure allows the maintenance of the chondrocyte-specific phenotype for greater than or equal to8 months. Chondrocytes were isolated by successive enzymatic digestions and cultured at high density (>2.0 x 10(7) cells/ml) in DMEM with 10% FBS, 50 mug/ml ascorbic acid, glutamine, vitamins, and antibiotics for up to 10 weeks on 60 mm plastic culture dishes coated with polyHEMA. The tissues produced during culture were studied histologically and biochemically and were examined for cellular proliferation employing H-3-thymidine incorporation and for their collagen production employing biosynthetic labeling with C-14-proline and Western blot with specific antibodies. The expression of relevant collagen genes was examined employing RT-PCR.
   Results: Within 24 h of culture, isolated chondrocytes organized into well-formed clusters and in 2 weeks formed structures with gross appearance and consistence similar to those of natural cartilage. The wet weight of the tissue formed in vitro increased six-fold during the 10-week period of study. Cell proliferation measured by the incorporation of H-3-thymidine increased during the first 3 weeks and reached a plateau in subsequent weeks. Histological examination showed that the cultures contained rounded chondrocytes embedded in an abundant cartilaginous extracellular matrix. The cartilage formed contained large amounts of collagen and sulfated proteoglycans as examined by staining with Masson's Trichrome and Alcian blue, respectively. Deposition of calcium in the deeper layers of the tissue was demonstrated with the von Kossa stain. Western analyses with specific antibodies showed that type II collagen was present from the first week and progressively increased in the cultures, whereas type X collagen was first detected at 4 weeks and increased with length of culture. When chondrocytes isolated from the growth plate were included, small amounts of type I collagen were detected in the medium of cultured biomaterial as expected. Type III collagen was not detected by Western blot over the 10-week period, High levels of type II and type X collagen gene expression were demonstrated by RT-PCR.
   Conclusion: These studies demonstrate the production in vitro of cartilage-like tissue with similar morphological, histochemical and biochemical characteristics to those of natural growth plate cartilage. The cartilage generated in vitro has the potential to be used in reconstructive surgery and in joint resurfacing and restoration of skeletal defects. (C) 2001 OsteoArthritis Research Society International.
C1 Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Div Rheumatol, Philadelphia, PA 19107 USA.
   Thomas Jefferson Univ, Jefferson Med Coll, Dept Oral & Maxillofacial Surg, Philadelphia, PA 19107 USA.
   Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA.
RP Jimenez, SA (reprint author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Div Rheumatol, 233 S 10th St,Room 509, Philadelphia, PA 19107 USA.
FU NIAMS NIH HHS [AR42417, AR39740]
CR BADER DL, 1992, BIOCHIM BIOPHYS ACTA, V1116, P147, DOI 10.1016/0304-4165(92)90111-7
   BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9
   BENYA PD, 1982, CELL, V30, P373
   Brittberg M, 1996, CLIN ORTHOP RELAT R, P270
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BRUCKNER P, 1994, MICROSC RES TECHNIQ, V28, P378, DOI 10.1002/jemt.1070280504
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   BURGESON RE, 1992, CLIN ORTHOP RELAT R, P250
   DUPOIRIEUX L, 1994, INT J ORAL MAX SURG, V23, P395, DOI 10.1016/S0901-5027(05)80028-1
   Ferraz MB, 1997, ARTHRITIS RHEUM, V40, P1587, DOI 10.1002/art.1780400907
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   HEINEGARD D, 1989, FASEB J, V3, P2042
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   ITAY S, 1987, CLIN ORTHOP RELAT R, P284
   JIMENEZ SA, 1978, BIOCHEM J, V173, P337, DOI 10.1042/bj1730337
   Kandel R A, 1997, In Vitro Cell Dev Biol Anim, V33, P174
   KRAMER JS, 1983, ARTHRITIS RHEUM, V26, P901, DOI 10.1002/art.1780260712
   MAYNE R, 1976, P NATL ACAD SCI USA, V73, P1674, DOI 10.1073/pnas.73.5.1674
   Meijer HJA, 1997, J ORAL MAXIL SURG, V55, P138, DOI 10.1016/S0278-2391(97)90229-9
   MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191
   Mow VC, 1999, OSTEOARTHR CARTILAGE, V7, P41, DOI 10.1053/joca.1998.0161
   NOGUCHI T, 1994, CLIN ORTHOP RELAT R, P251
   PALETTA GA, 1992, AM J SPORT MED, V20, P725, DOI 10.1177/036354659202000614
   REGINATO A, 1986, J BIOL CHEM, V261, P2897
   REGINATO AM, 1994, ARTHRITIS RHEUM, V37, P1338, DOI 10.1002/art.1780370912
   REGINATO AM, 1991, BIOCHEM J, V273, P333, DOI 10.1042/bj2730333
   REMINGTON MC, 1984, BIOCHEM J, V224, P227, DOI 10.1042/bj2240227
   ROBINSON D, 1990, CALCIFIED TISSUE INT, V46, P246, DOI 10.1007/BF02555003
   SCHMID TM, 1983, J BIOL CHEM, V258, P9504
   Setton LA, 1999, OSTEOARTHR CARTILAGE, V7, P2, DOI 10.1053/joca.1998.0170
   Shortkroff S, 1996, BIOMATERIALS, V17, P147, DOI 10.1016/0142-9612(96)85759-0
   THOMAS JT, 1994, ANN RHEUM DIS, V53, P488, DOI 10.1136/ard.53.8.488
   TRELSTAD RL, 1993, TXB RHEUMATOLOGY, P35
   Tyler JA, 1998, OSTEOARTHRITIS, P94
   VACANTI CA, 1994, CLIN PLAST SURG, V21, P445
   Vacanti CA, 2000, ORTHOP CLIN N AM, V31, P351, DOI 10.1016/S0030-5898(05)70155-3
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   WARDALE RJ, 1993, J CELL SCI, V105, P975
   Woo SL, 1988, INJURY REPAIR MUSCUL, P465
   YAMADA Y, 1991, J CRAN GENET DEV BIO, V11, P350
NR 42
TC 23
Z9 24
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1063-4584
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD FEB
PY 2001
VL 9
IS 2
BP 169
EP 177
DI 10.1053/joca.2000.0373
PG 9
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 409ZK
UT WOS:000167415400011
PM 11237664
OA Bronze
DA 2018-10-19
ER

PT J
AU Hallab, NJ
   Bundy, KJ
   O'Connor, K
   Moses, RL
   Jacobs, JJ
AF Hallab, NJ
   Bundy, KJ
   O'Connor, K
   Moses, RL
   Jacobs, JJ
TI Evaluation of metallic and polymeric biomaterial surface energy and
   surface roughness characteristics for directed cell adhesion
SO TISSUE ENGINEERING
LA English
DT Article
ID JET IMPINGEMENT; FIBROBLASTS; PROTEINS; GROWTH
AB Directed cell adhesion remains an important goal of implant and tissue engineering technology. In this study, surface energy and surface roughness were investigated to ascertain which of these properties show more overall influence on biomaterial-cell adhesion and colonization. Jet impingement was used to quantify cellular adhesion strength. Cellular proliferation and extracellular matrix secretion were used to characterize colonization of 3T3MC fibroblasts on: HS25 (a cobalt based implant alloy, ASTM F75), 316L stainless steel, Ti-6Al-4V (a titanium implant alloy), commercially pure tantalum (Ta), polytetrafluoroethylene (PTFE), silicone rubber (SR), and high-density polyethylene (HDPE). The metals exhibited a nearly five-fold greater adhesion strength than the polymeric materials tested. Generally, surface energy was proportional to cellular adhesion strength. Only polymeric materials demonstrated significant increased adhesion strength associated with increased surface roughness. Cellular adhesion on metals demonstrated a linear correlation with surface energy. Less than half as much cellular proliferation was detected on polymeric materials compared to the metals. However the polymers tested demonstrated greater than twice the amount of secreted extracellular matrix (ECM) proteins on a per tell basis than the metallic materials. Thus, surface energy may be a more important determinant of cell adhesion and proliferation, and may be more useful than surface roughness for directing cell adhesion and cell colonization onto engineered tissue scaffoldings.
C1 Rush Presbyterian St Lukes Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA.
   Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.
   Tulane Univ, Dept Chem Engn, New Orleans, LA 70118 USA.
   Louisiana State Univ, Sch Med, Dept Anat, New Orleans, LA USA.
RP Hallab, NJ (reprint author), Rush Med Coll, Dept Orthoped Surg, 1653 W Congress Pkwy, Chicago, IL 60612 USA.
RI O'Connor, Kim/H-3145-2012
CR BAGNALL RD, 1978, J BIOMED MATER RES, V12, P707, DOI 10.1002/jbm.820120511
   BAGNALL RD, 1980, J BIOMED MATER RES, V18, P1
   BRASH JL, 1986, J BIOMED MATER RES, V20, P1263, DOI 10.1002/jbm.820200904
   BUNDY K, 1993, T 39 ORTH RES SOC SA
   BUNDY K, 1991, T 17 ANN SOC BIOM SC
   BUNDY K, 1992, T 17 SOC BIOM SCOTTS
   BUNDY KJ, 1993, BIOMATERIALS, V14, P529, DOI 10.1016/0142-9612(93)90242-T
   DESHPANDE MD, 1982, J FLUID MECH, V114, P213, DOI 10.1017/S0022112082000111
   Gregonis DE, 1985, CONTACT ANGLE INTERF
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hallab N., 1995, Proceedings of the 1995 Fourteenth Southern Biomedical Engineering Conference (Cat. No.95TH0703-9), P81, DOI 10.1109/SBEC.1995.514438
   HALLAB N, 1994, T 20 ANN SOC BIOM M
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   MERRIL CR, 1986, PROTEIN STAINING DET, P323
   MOSES RL, 1989, EMSA B, V19, P60
   Richards RG, 1995, CELL BIOL INT, V19, P1015, DOI 10.1006/cbir.1995.1044
   RICHARDS RG, 1993, T 10 EUR C BIOM DAV
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   SUNG KLP, 1994, J BIOMECH ENG-T ASME, V116, P237, DOI 10.1115/1.2895725
   VAISHNAV RN, 1983, J BIOMECH ENG-T ASME, V105, P77, DOI 10.1115/1.3138389
   VANDIJK LJ, 1988, BIOFOULING, V1, P19
NR 22
TC 286
Z9 304
U1 3
U2 64
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD FEB
PY 2001
VL 7
IS 1
BP 55
EP 71
DI 10.1089/107632700300003297
PG 17
WC Cell & Tissue Engineering
SC Cell Biology
GA 406UW
UT WOS:000167235200006
PM 11224924
DA 2018-10-19
ER

PT J
AU van Osch, GJVM
   van der Veen, SW
   Marijnissen, WJCM
   Verhaar, JAN
AF van Osch, GJVM
   van der Veen, SW
   Marijnissen, WJCM
   Verhaar, JAN
TI Monoclonal antibody 11-fibrau: A useful marker to characterize
   chondrocyte differentiation stage
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE 11-fibrau; cartilage; chondrocyte; differentiation; dedifferentiation;
   tissue-engineering; alginate culture; monolayer culture;
   immunohistochemistry
ID GROWTH-FACTOR-BETA; ARTICULAR CHONDROCYTES; EXPRESSION; COLLAGEN;
   CARTILAGE; CULTURE
AB The aim of this study was to determine the feasibility of discriminating between differentiated and dedifferentiated chondrocytes by using the Mab 11-fibrau. Mab 11-fibrau did not bind to differentiated chondrocytes in cartilage of human knee joint, auricle, or nasal septum. During monolayer culture, when cells dedifferentiate, the number of 11-fibrau positive cells gradually increased and reached up to 100% after 4 passages, When differentiated chondrocytes were cultured in alginate, most (90-95%) of the cells remained 11-fibrau negative, in accordance with previous studies demonstrating that differentiated chondrocytes cultured in alginate keep their phenotype. Dedifferentiated (11-fibrau positive) cells were subjected to different redifferentiation regimes. As a well-known fact, cultures in alginate in medium where FCS was replaced by IGF1 and TGF beta2 results in increased collagen type II formation, indicative for redifferentiation. However, the cells remained 11-fibrau positive, suggesting they are not (yet) fully redifferentiated. On the other hand, when dedifferentiated cells (after 4 passages in monolayer culture) were seeded in a biomaterial and implanted subcutaneously in a nude mouse, the newly formed cartilage matrix contained collagen type II and the 11-fibrau staining on the cells had disappeared. Our results indicate that 11-fibrau may be a reliable and sensitive marker of chondrocyte phenotype. (C) 2001 Academic Press.
C1 Erasmus Univ, Med Ctr, Dept Otorhinolaryngol, Rotterdam, Netherlands.
   Erasmus Univ, Med Ctr, Dept Orthopaed, Rotterdam, Netherlands.
RP van Osch, GJVM (reprint author), Erasmus Univ, Med Ctr, Dept Otorhinolaryngol, Rotterdam, Netherlands.
OI Verhaar, Jan/0000-0003-3016-9600
FU NICHD NIH HHS [N01-HD-6-2915]
CR ADAM M, 1983, CLIN CHIM ACTA, V133, P25, DOI 10.1016/0009-8981(83)90017-7
   Aigner T, 1997, OSTEOARTHR CARTILAGE, V5, P183, DOI 10.1016/S1063-4584(97)80013-1
   BUJIA J, 1996, IN VITRO CELL DEV-AN, V32, P366
   Elder SH, 2000, J ORTHOPAED RES, V18, P78, DOI 10.1002/jor.1100180112
   ELIMA K, 1989, FEBS LETT, V258, P195, DOI 10.1016/0014-5793(89)81651-5
   FARELL CM, 1995, J BIOL CHEM, V270, P3400
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   Lafeber FPJG, 1997, J RHEUMATOL, V24, P536
   Marijnissen WJCM, 2000, BIOMATERIALS, V21, P571, DOI 10.1016/S0142-9612(99)00218-5
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   MOLLENHAUER J, 1988, J RHEUMATOL, V15, P1811
   VANDERKRAAN P, 1992, J RHEUMATOL, V19, P140
   VANDERMARK K, 1977, NATURE, V267, P531
   VANOSCH GJV, 1998, T ORTHOP RES SOC, V23, P441
   VANOSCH GJV, 2001, IN PRESS AM J RHINOL
   VANOSCH GJV, 2001, IN PRESS PLAST RECON
   Wu QQ, 2000, EXP CELL RES, V256, P383, DOI 10.1006/excr.2000.4847
   Yaeger PC, 1997, EXP CELL RES, V237, P318, DOI 10.1006/excr.1997.3781
NR 18
TC 13
Z9 13
U1 0
U2 0
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JAN 26
PY 2001
VL 280
IS 3
BP 806
EP 812
DI 10.1006/bbrc.2000.4168
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 397LN
UT WOS:000166697300033
PM 11162592
DA 2018-10-19
ER

PT B
AU Raileanu, M
   Arsene, M
   Stanciu, L
   Bordeianu, L
   Zaharescu, M
AF Raileanu, M
   Arsene, M
   Stanciu, L
   Bordeianu, L
   Zaharescu, M
GP IMT-BUCHAREST
   IMT-BUCHAREST
TI Enzymes entrapment in sol-gel silica matrix for biomedical application
SO 2001 INTERNATIONAL SEMICONDUCTOR CONFERENCE, VOL 1 & 2, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Semiconductor Conference
CY OCT 09-13, 2001
CL SINAIA, ROMANIA
SP Natl Inst Res & Dev Microtechnol, Romanian Acad, Electrochem Soc Inc, IEEE Electr Devices Soc, Natl Agcy Sci Technol & Innovat, IEEE Romanian Sect Elect Devices Chapter
ID ORGANIC-CHEMISTRY; GLUCOSE-OXIDASE
AB The immobilization of glucose oxidase by sol-gel method was performed in SiO2 matrices obtained from different precursors (tetraethylorthosilicate or sodium silicate solution). The enzymatic system was glucose oxidase-peroxidase and the chromogens were p-hidroxybenzensulphonate and 4-aminoantipyrine. An one step procedure was proposed which simplifies the experiments and improve the homogeneity of the biomaterial.
C1 Romanian Acad, Inst Phys Chem IG Murgulescu, Bucharest 77208, Romania.
RP Raileanu, M (reprint author), Romanian Acad, Inst Phys Chem IG Murgulescu, 202 Splauil Independentei, Bucharest 77208, Romania.
RI Zaharescu, Maria/C-4185-2012
CR ARSENE M, 1999, P 13 C GLASS CER VAR, P345
   AVNIR D, 1995, ACCOUNTS CHEM RES, V28, P328, DOI 10.1021/ar00056a002
   Avnir D., 1992, SPIE SOL GEL OPTICS, V1758, P456
   BRAUN S, 1992, J NON-CRYST SOLIDS, V147, P739, DOI 10.1016/S0022-3093(05)80708-2
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   DAVE BC, 1995, ACS SYM SER, V585, P351
   Georgi U, 1998, J SOL-GEL SCI TECHN, V13, P295, DOI 10.1023/A:1008611924361
   Lin J, 1997, TRAC-TREND ANAL CHEM, V16, P200, DOI 10.1016/S0165-9936(97)00021-6
   Liu ZJ, 1999, ANAL CHIM ACTA, V392, P135, DOI 10.1016/S0003-2670(99)00247-0
   Pandey PC, 1999, SENSOR ACTUAT B-CHEM, V60, P83, DOI 10.1016/S0925-4005(99)00246-4
   RAPPAPORT Z, 1998, CHEM ORGANIC SILICON
   Reetz MT, 1997, ADV MATER, V9, P943, DOI 10.1002/adma.19970091203
   Zink JI, 1994, J SOL-GEL SCI TECHN, V2, P791, DOI 10.1007/BF00486352
   ZINK JI, 1994, NEW J CHEM, V18, P1109
NR 14
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-6666-2
PY 2001
BP 281
EP 284
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Materials Science, Multidisciplinary; Optics
SC Engineering; Instruments & Instrumentation; Materials Science; Optics
GA BU24V
UT WOS:000175459600057
DA 2018-10-19
ER

PT B
AU Li, H
   Yang, SX
   Shi, J
AF Li, H
   Yang, SX
   Shi, J
BE Zhang, L
   Gu, F
TI Modeling of supercritical carbon dioxide extraction by artificial neural
   networks
SO 8TH INTERNATIONAL CONFERENCE ON NEURAL INFORMATION PROCESSING, VOLS 1-3,
   PROCEEDING
LA English
DT Proceedings Paper
CT 8th International Conference on Neural Information Processing (ICONIP
   2001)
CY NOV 14-18, 2001
CL SHANGHAI, PEOPLES R CHINA
SP Asia-Pacific Neural Network Assembly, China Neural Network Council, Fundan Univ, Shanghai Assoc Sci & Technol, IEEE Beijing Sect, IEEE NN Council INNS, Fudan Univ, Ctr Brain Sci Res, Shanghai Soc Biophys
DE supercritical carbon dioxide; artificial neural network;
   back-propagation; hybrid neural network
AB Supercritical carbon dioxide possesses specific characteristics that make it attractive as solvent. In particular, the solubility and hence the yield of biomaterial, can be controlled by pressure and temperature. The experiments to obtain high-pressure phase-equilibrium data for supercritical carbon dioxide are very difficult and costly to conduct. Therefore, it would be extremely useful to develop a model to extend and complement the experimentally obtained data for supercritical carbon dioxide-solute systems at high pressures. In this paper, an artificial neural network that consider the system as a black box is designed for the mass transfer modeling of supercritical carbon dioxide extraction. The proposed neural network assumes a three-layer structure with a fast back-propagation learning algorithm. The model predictions are compared to a conventional model with a Peng-Robinson equation of state in literature. In addition, a hybrid model using both neural network and Peng-Robinson state equation is developed for supercritical carbon dioxide extraction, where the neural network is used to generate the non-linear binary interaction parameter of the Peng-Robinson state equation. Various temperatures, pressures, and solubility in literature are used to train the proposed models. Generally, the results using the proposed neural network models are better than those using the conventional model. The effectiveness of the proposed neural network approaches proaches are demonstrated by simulation and comparison studies.
C1 Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.
RP Yang, SX (reprint author), Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.
CR CLIFFORD T, 1998, FUNDAMENTALS SUPERCR
   CYGNAROWICZPROVOST M, 1992, J SUPERCRIT FLUID, V5, P24, DOI 10.1016/0896-8446(92)90037-K
   GOPALAKRISHNAN N, 1991, J AGR FOOD CHEM, V39, P1976, DOI 10.1021/jf00011a018
   KARAYLANNIS NB, 1993, ARTIFICIAL NEURAL NE
   SCHMITT WJ, 1986, J CHEM ENG DATA, V31, P204, DOI 10.1021/je00044a021
   Sovava H., 1994, CHEM ENG SCI, V49, P409, DOI 10.1016/0009-2509(94)87012-8
   Stuart G., 1997, Ciencia e Tecnologia de Alimentos, V17, P501, DOI 10.1590/S0101-20611997000400030
   THOMPSON ML, 1991, AICHE J, V40, P1328
NR 8
TC 0
Z9 0
U1 0
U2 0
PU FUDAN UNIV PRESS
PI SHANGHAI
PA 579 GUOQUAN RD, SHANGHAI 200433, PEOPLES R CHINA
BN 7-309-03012-5
PY 2001
BP 337
EP 342
PG 6
WC Computer Science, Artificial Intelligence; Computer Science, Hardware &
   Architecture; Robotics
SC Computer Science; Robotics
GA BU46F
UT WOS:000176058200063
DA 2018-10-19
ER

PT J
AU Kuzay, TM
   Kazmierczak, M
   Hsieh, BJ
AF Kuzay, TM
   Kazmierczak, M
   Hsieh, BJ
TI X-ray beam/biomaterial thermal interactions in third-generation
   synchrotron sources
SO ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
LA English
DT Article
ID RADIATION-DAMAGE; CRYSTALLOGRAPHY; CRYOCRYSTALLOGRAPHY; CRYSTALS
AB Third-generation synchrotron sources generate strong X-ray beams. The beam's interaction with biomaterials gives rise to concerns related to thermal damage and radiation damage. Of the two issues, the thermal interaction is conducive to rigorous analysis from first principles, although this has not been performed to date in a comprehensive manner. In this study, the interaction of the X-ray beam emanating from a third-generation synchrotron with a typical frozen biocrystal is theoretically studied, focusing specifically on the resulting unsteady (time-dependent) and steady heat-transfer phenomena. A unique regime map is developed to explain and to identify, on the basis of Fourier and Biot numbers as governing parameters, the applicable mathematical models that predict the subsequent thermal behavior. Depending on the values of these parameters, some simplified but realistic 'generic' solutions are generated that are suitable for that particular domain of applicability. Classical heat-transfer theory was used to describe the third-generation X-ray beam and biomaterial thermal interaction. Besides the generalized approach presented, numerous illustrative cases were solved and the resulting temperature levels are explicitly presented. Overall, the resulting thermal behavior of the system, i.e. peak and local temperature distribution, during both early transient development and for sustained long-time steady-state conditions, depends on a number of factors including the amount of energy absorbed, convective heat-transfer film coefficient and gas temperature, the sample size and shape, and the thermophysical properties of the sample and cooling gas. Results of the analysis revealed the strong influence that convection has on the transient and final steady-state temperature of the sample and the impact of internal heat conduction. The characteristic timescales of the important and dominant thermal processes with respect to the two types of thermal models are clearly identified.
C1 Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA.
RP Kazmierczak, M (reprint author), Argonne Natl Lab, Adv Photon Source, 9700 S Cass Ave, Argonne, IL 60439 USA.
CR ANFINRUD PA, 1999, COMMUNICATION
   BEJAN A, 1993, HEAT TRANSFER, P153
   Blake C. F. F., 1962, BIOL EFFECTS IONIZIN, P183
   Garman E, 1999, ACTA CRYSTALLOGR D, V55, P1641, DOI 10.1107/S0907444999008653
   Garman EF, 1997, J APPL CRYSTALLOGR, V30, P211, DOI 10.1107/S0021889897002677
   GONZALEZ A, 1994, ACTA CRYSTALLOGR D, V50, P874, DOI 10.1107/S0907444994006311
   HELLIWELL JR, 1992, MACROMOLECULAR CRYST
   HOPE H, 1989, ACTA CRYSTALLOGR B, V45, P190, DOI 10.1107/S0108768188013710
   KUZAY TM, 2001, UNPUB J SYNCHROTRON
   LOCK GSH, 1990, GROWTH DECAY ICE, P302
   NAVE C, 1995, RADIAT PHYS CHEM, V45, P483, DOI 10.1016/0969-806X(95)92800-E
   Ozisik M. N., 1993, HEAT CONDUCTION
   OZISIK MN, 1994, J HEAT TRANS-T ASME, V116, P526, DOI 10.1115/1.2910903
   Ren Z, 1999, J SYNCHROTRON RADIAT, V6, P891, DOI 10.1107/S0909049599006366
   Srajer V, 1996, SCIENCE, V274, P1726, DOI 10.1126/science.274.5293.1726
   TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568
NR 16
TC 40
Z9 40
U1 2
U2 9
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0907-4449
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Biol. Crystallogr.
PD JAN
PY 2001
VL 57
BP 69
EP 81
DI 10.1107/S0907444900013299
PN 1
PG 13
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 388BN
UT WOS:000166157700009
PM 11134929
OA Bronze
DA 2018-10-19
ER

PT J
AU Letic-Gavrilovic, A
   Fini, M
   Giavaresi, G
   Giardino, R
   Abe, K
AF Letic-Gavrilovic, A
   Fini, M
   Giavaresi, G
   Giardino, R
   Abe, K
TI Evaluation of composite collagen/hydroxy-apatite implantation and nerve
   growth factor (NGF) delivery on new bone ingrowth
SO ACTA VETERINARIA-BEOGRAD
LA English
DT Article
DE bone ingrowth; collagen/hydroxy apatite implants; nerve growth factor
   (NGF)
ID MORPHOGENETIC PROTEINS; REGENERATION; METABOLISM; CELLS; CGRP
AB In this study, a bio-artificial bioresorbable composite consisting of a polymer of collagen/hydroxy-apatite (Col/Hap) enriched with neurotropin - nerve growth factor (NGF), was implanted into the femurs of 73 male Wistar rats, weighing 100-125 g. Implants were left in place for different times, Controls were as follows: a) contralateral femur without any implants; and b) contralateral femur implanted with composite without NGF factor. The rats were euthanized after 1, 10 and 30 days and the implant sites and explants were examined clinically, histologically, by scanning electron microscopy and histomorphometrically.
   The results show stimulated periosteal and endocortical woven and lamellar bone formation, which yielded increases in bone mass and decreases in bone marrow. The NGF treatment had greater effects in the femur shafts of older male rats than in younger ones. Additionally, we found that NGF increased remodeling activity in the intracortical region and induced an increase of intracortical cavity number and area by the end of the study. Since no similar studies appear to have been carried out, it is difficult to correlate our findings with other studies where neurogenic factors are delivered by complex polymer composites. We believe that this proposed system has great advantages in tissue engineering and is very suitable as a biomaterial for filling irregular defects in orthopaedic and maxillo-facial surgery, bone replacement and fixation, and as a drug delivery device.
C1 Univ Belgrade, Fac Stomatol, Dept Biochem, Belgrade, Yugoslavia.
   Orthoped Inst Rizzoli, Dept Expt Surg, Bologna, Italy.
   Fukuoka Dent Coll, Dept Oral Biochem, Fukuoka, Japan.
RP Letic-Gavrilovic, A (reprint author), Univ Belgrade, Fac Stomatol, Dept Biochem, Belgrade, Yugoslavia.
RI Fini, Milena/J-4808-2016
OI Fini, Milena/0000-0002-3732-3570; Giavaresi,
   Gianluca/0000-0001-7843-5969
CR Akopian A, 2000, PEPTIDES, V21, P559, DOI 10.1016/S0196-9781(00)00185-6
   Aloe L, 1997, ALLERGY, V52, P883, DOI 10.1111/j.1398-9995.1997.tb01247.x
   Auffray I, 1996, BLOOD, V88, P1608
   Bakos D, 1999, BIOMATERIALS, V20, P191, DOI 10.1016/S0142-9612(98)00163-X
   BJURHOLM A, 1988, PEPTIDES, V9, P165, DOI 10.1016/0196-9781(88)90023-X
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Esposito M, 1998, EUR J ORAL SCI, V106, P527, DOI 10.1046/j.0909-8836..t01-2-.x
   Gao TJ, 1997, INT ORTHOP, V21, P194, DOI 10.1007/s002640050149
   Gross KA, 1998, INT J ORAL MAX IMPL, V13, P601
   HORISAKA Y, 1994, J BIOMED MATER RES, V28, P97, DOI 10.1002/jbm.820280113
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kjaer I, 1998, CRIT REV ORAL BIOL M, V9, P224, DOI 10.1177/10454411980090020501
   KOUTSOUKOS P, 1980, J AM CHEM SOC, V102, P1553, DOI 10.1021/ja00525a015
   Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8
   Kundu B, 1999, PEPTIDES, V20, P523, DOI 10.1016/S0196-9781(99)00034-0
   LERNER UH, 1994, ORAL SURG ORAL MED O, V78, P481, DOI 10.1016/0030-4220(94)90043-4
   Lerner UH, 1997, ACTA PHYSIOL SCAND, V161, P81, DOI 10.1046/j.1365-201X.1997.d01-1933.x
   Letic-Gavrilovic A, 2000, Dent Mater J, V19, P99
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P407, DOI 10.3109/17453679609002342
   Lind M, 1998, Acta Orthop Scand Suppl, V283, P2
   Lundberg P, 1999, REGUL PEPTIDES, V85, P47, DOI 10.1016/S0167-0115(99)00069-5
   Lundberg P, 2001, ENDOCRINOLOGY, V142, P339, DOI 10.1210/en.142.1.339
   Park YJ, 1998, J CONTROL RELEASE, V51, P201, DOI 10.1016/S0168-3659(97)00169-7
   Pietrzak WS, 1996, BONE, V19, pS109, DOI 10.1016/S8756-3282(96)00139-1
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Ripamonti U, 1997, CRIT REV ORAL BIOL M, V8, P154, DOI 10.1177/10454411970080020401
   SANDHU HS, 1987, ANAT RECORD, V219, P32, DOI 10.1002/ar.1092190107
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   TANAKA E, 1990, J DENT RES, V60, P60
   YADA M, 1994, BIOCHEM BIOPH RES CO, V205, P1187, DOI 10.1006/bbrc.1994.2791
   YANKNER BA, 1982, ANNU REV BIOCHEM, V51, P845, DOI 10.1146/annurev.bi.51.070182.004213
   Yao W, 1999, BONE, V25, P697, DOI 10.1016/S8756-3282(99)00220-3
NR 32
TC 0
Z9 0
U1 1
U2 2
PU VETERINARY FACULTY
PI BELGRADE
PA BULEVAR JNA 18, 11000 BELGRADE, YUGOSLAVIA
SN 0567-8315
J9 ACTA VET-BEOGRAD
JI Acta Vet.-Beogr.
PY 2001
VL 51
IS 5-6
BP 299
EP 310
PG 12
WC Veterinary Sciences
SC Veterinary Sciences
GA 514RC
UT WOS:000173454000004
DA 2018-10-19
ER

PT J
AU Mansur, HS
   Orefice, RL
   Lobato, ZP
   Vasconcelos, WL
   Mansur, ES
   Machado, LJC
AF Mansur, HS
   Orefice, RL
   Lobato, ZP
   Vasconcelos, WL
   Mansur, ES
   Machado, LJC
TI Adsorption/desorption behavior of bovine serum albumin and porcine
   insulin on chemically patterned porous gel networks
SO ADSORPTION-JOURNAL OF THE INTERNATIONAL ADSORPTION SOCIETY
LA English
DT Article
DE protein adsorption; adsorption kinetics; sol-gel process; porous glass;
   surface engineering
AB Adsorption/desorption of proteins onto a biomaterial surface plays a major role on the biocompatibility of the implanted material. By modifying the biomaterial surface with specially designed functional groups one may achieve the most specific behavior of the developed material used in a biological system. Based on that, porous gel matrixes with functionalized surfaces offer unlimited possibilities to control the protein-substrate interaction behavior. In the present work, we have functionalized the surface of porous glass with several chemical groups during the synthesis of the silica matrix. The porous glass matrixes were obtained using tetraethoxysilane (TEOS)/ethanol and functionalized with 3-mercaptopropyltrimethoxysilane (MPTMS) and 3-aminopropyltriethoxysilane (APTES). In vitro tests of the kinetics of protein adsorption and desorption from the gel matrix were monitored by UV-visible spectroscopy. The bioactivity of the incorporated protein was verified by in vivo experiments with adult male rats, where they presented an acute hypoglycemic peak.
C1 Univ Fed Minas Gerais, Dept Met & Mat Engn, BR-30160030 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Vet Med, BR-30160030 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Sch Med, Dept Internal Med, Belo Horizonte, MG, Brazil.
EM hmansur@demet.ufmg.br
RI Orefice, Rodrigo/N-8055-2018
OI Orefice, Rodrigo/0000-0002-6046-4056; Lobato, Zelia/0000-0002-9399-3691;
   Mansur, Herman/0000-0002-3032-495X
CR Copeland R. A., 1994, METHODS PROTEIN ANAL
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   ELLERBY LM, 1992, SCIENCE, V255, P1115
   GILL I, 1998, J AM CHEM SOC, V120, P8598
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   JANOWSKI F, 1991, J CHEM TECHNOL BIOT, V51, P263
   LIVAGE J, 1994, SPIE, V2288, P503
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LU CF, 1994, J COLLOID INTERF SCI, V168, P161
   MALMSTEN M, 1998, BIOPOLYMERS INTERFAC, P143
   MANSUR HS, 1999, J INT FED MED BIO S2, V37, P372
   MANSUR HS, 1999, ACTA MICROSC SA, V8, P17
   MCDONAGH C, 1998, ANAL CHEM, V70, P50
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   YAMAGUCHI N, 1992, CAN J PHYSIOL PHARM, V70, P167, DOI 10.1139/y92-024
   ZHENG L, 1997, ANAL CHEM, V69, P3949
   ZUSMAN R, 1992, ANAL BIOCHEM, V201, P103, DOI 10.1016/0003-2697(92)90180-F
NR 17
TC 12
Z9 13
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0929-5607
EI 1572-8757
J9 ADSORPTION
JI Adsorpt.-J. Int. Adsorpt. Soc.
PY 2001
VL 7
IS 2
BP 105
EP 116
DI 10.1023/A:1011687706161
PG 12
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA 467VQ
UT WOS:000170724800002
DA 2018-10-19
ER

PT J
AU Anderson, JM
AF Anderson, JM
TI Biological responses to materials
SO ANNUAL REVIEW OF MATERIALS RESEARCH
LA English
DT Review
DE biocompatibility; inflammation; foreign body reaction; in vivo studies;
   toxicity
ID GIANT-CELL FORMATION; GROWTH FACTOR-BETA; HUMAN MACROPHAGE FUSION;
   ENDOTHELIAL-CELLS; MONOCYTE/MACROPHAGE ADHESION; MODIFIED SURFACES;
   MESSENGER-RNA; IN-VITRO; INFLAMMATION; TISSUE
AB All materials intended for application in humans as biomaterials, medical devices, or prostheses undergo tissue responses when implanted into living tissue. This review first describes fundamental aspects of tissue responses to materials, which are commonly described as the tissue response continuum. These actions involve fundamental aspects of tissue responses including injury, inflammatory and wound healing responses, foreign body reactions, and fibrous encapsulation of the biomaterial, medical device, or prosthesis. The second part of this review describes the in vivo evaluation of tissue responses to biomaterials, medical devices, and prostheses to determine intended performance characteristics and safety or biocompatibility considerations. While fundamental aspects of tissue responses to materials are important from research and development perspectives, the in vivo evaluation of tissue responses to these materials is important for performance, safety, and regulatory reasons.
C1 Inst Pathol, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.
CR ANDERSON D, 1988, BRIT VET J S, V1, P7
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   *ASS ADV MED INSTR, 1997, AAMI STAND REC PRA S, V4
   *ASTM, 1999, AM SOC TEST MAT ANN
   BROADLEY KN, 1989, LAB INVEST, V61, P571
   Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527
   BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8
   CHAMBERS TJ, 1982, IMMUNOBIOLOGY, V161, P283, DOI 10.1016/S0171-2985(82)80084-3
   Chapekar MS, 1996, J BIOMED MATER RES, V33, P199, DOI 10.1002/(SICI)1097-4636(199623)33:3<199::AID-JBM10>3.0.CO;2-C
   Clark R.A.F., 1988, MOL CELLULAR BIOL WO
   CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075
   Cleland JL, 1997, J CONTROL RELEASE, V49, P193, DOI 10.1016/S0168-3659(97)00075-8
   COTRAN RS, 1990, J AM SOC NEPHROL, V1, P225
   Cotran RS, 1999, PATHOLOGIC BASIS DIS, P50
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   DeFife KM, 1999, J BIOMED MATER RES, V44, P298, DOI 10.1002/(SICI)1097-4636(19990305)44:3<298::AID-JBM8>3.0.CO;2-N
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DeFife KM, 1999, FASEB J, V13, P823
   DVORAK HF, 1987, LAB INVEST, V57, P673
   *FDA, 1995, G951 FDA
   FONG Y, 1990, SURG GYNECOL OBSTET, V170, P363
   GALLIN JI, 1999, INFLAMMATION BASIC P
   GOLDEN MA, 1991, J CLIN INVEST, V87, P406, DOI 10.1172/JCI115011
   Greenfield EM, 1999, LIFE SCI, V65, P1087, DOI 10.1016/S0024-3205(99)00156-3
   Greisler H, 1988, ASAIO Trans, V34, P1051
   HENSON PM, 1980, AM J PATHOL, V101, P494
   HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869
   HENSON PM, 1971, J IMMUNOL, V107, P1547
   Honma T, 1996, VIRCHOWS ARCH, V428, P165
   Hunt TK, 1984, SOFT HARD TISSUE REP
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443
   *ISO, 1993, 10993 ISO
   Jenney CR, 1999, J BIOMED MATER RES, V46, P11, DOI 10.1002/(SICI)1097-4636(199907)46:1<11::AID-JBM2>3.3.CO;2-P
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   JUTILA MA, 1992, APMIS, V100, P191, DOI 10.1111/j.1699-0463.1992.tb00861.x
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   KOVACS EJ, 1991, IMMUNOL TODAY, V12, P17, DOI 10.1016/0167-5699(91)90107-5
   LANGONE JJ, 1998, IMMUNOTOXICITY TESTI
   LEHRER RI, 1988, ANN INTERN MED, V109, P127, DOI 10.7326/0003-4819-109-2-127
   LUM L, 1999, J BIOL CHEM, V75, P783
   Maciag T, 1990, Important Adv Oncol, P85
   MADRI JA, 1988, J CELL BIOL, V106, P1375, DOI 10.1083/jcb.106.4.1375
   MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   McNally AK, 1996, AM J PATHOL, V149, P975
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2
   Most J, 1997, BLOOD, V89, P662
   MULLER G, 1987, P NATL ACAD SCI USA, V84, P5600, DOI 10.1073/pnas.84.16.5600
   MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813
   PATY PB, 1990, ARCH SURG-CHICAGO, V125, P65
   POBER JS, 1990, TRANSPLANTATION, V50, P537, DOI 10.1097/00007890-199010000-00001
   RAE T, 1986, CRIT REV BIOCOMPAT, V2, P97
   RICHES DWH, 1989, MOL CELLULAR BIOL WO, P213
   Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SPECTOR M, 1989, CRIT REV BIOCOMPAT, V5, P269
   SPILIZEWSKI K L, 1985, Journal of Controlled Release, V2, P197, DOI 10.1016/0168-3659(85)90045-8
   SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0
   SPORN MB, 1990, PEPTIDE GROWTH FACTO, V1
   Takahashi N, 1999, BIOCHEM BIOPH RES CO, V256, P449, DOI 10.1006/bbrc.1999.0252
   Tang LP, 1998, J BIOMAT SCI-POLYM E, V9, P1257
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952
   WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788
   WAHL SM, 1989, J CELL BIOCHEM, V40, P193, DOI 10.1002/jcb.240400208
   WEISS SJ, 1989, NEW ENGL J MED, V320, P365
   WEISSMANN G, 1980, NEW ENGL J MED, V303, P27
   WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723
   Wokalek H, 1991, J Biomater Appl, V5, P337, DOI 10.1177/088532829100500405
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 76
TC 721
Z9 735
U1 11
U2 280
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 1531-7331
J9 ANNU REV MATER RES
JI Ann. Rev. Mater. Res.
PY 2001
VL 31
BP 81
EP 110
DI 10.1146/annurev.matsci.31.1.81
PG 30
WC Materials Science, Multidisciplinary
SC Materials Science
GA 486FX
UT WOS:000171808700005
DA 2018-10-19
ER

PT J
AU Fisher, JP
   Dean, D
   Engel, PS
   Mikos, AG
AF Fisher, JP
   Dean, D
   Engel, PS
   Mikos, AG
TI Photoinitiated polymerization of biomaterials
SO ANNUAL REVIEW OF MATERIALS RESEARCH
LA English
DT Review
DE photochemistry; photoinitiators; tissue engineered materials
ID POLY(ETHYLENE GLYCOL) DIACRYLATE; IN-SITU PHOTOPOLYMERIZATION;
   CROSS-LINKED POLYANHYDRIDES; ORTHOPEDIC APPLICATIONS; DEGRADATION
   BEHAVIOR; ADHESION PREVENTION; HYDROGELS; NETWORKS; COPOLYMERS;
   STEREOLITHOGRAPHY
AB Photoinitiated polymerization and polymer crosslinking are viable strategies for biomaterial synthesis because of the mild temperatures and neutral pH environments in which these reactions typically take place. This review summarizes the relevant theories as well as current status of photoinitiated polymerizations in biomaterials. Photoinitiation, photoinitiated polymerization, and photoinitiators are discussed with consideration toward the biological nature of the intended application. Recent investigations into biomaterials, including hydrogels, biodegradable materials, and hard tissue resorbable scaffolds are presented. Lastly, studies of cell interactions with photoinitiated biomaterials are discussed. The work herein illustrates the potential use of photoinitiated polymerization in the development of novel biomaterials for tissue engineering.
C1 Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA.
   Univ Hosp Cleveland, Inst Res, Cleveland, OH 44106 USA.
   Rice Univ, Dept Chem, Houston, TX 77251 USA.
   Rice Univ, Dept Chem Engn, Houston, TX 77251 USA.
RP Fisher, JP (reprint author), Rice Univ, Dept Bioengn, POB 1892,MS 142, Houston, TX 77251 USA.
RI Fisher, John/F-8078-2012
CR Ahn KD, 1999, J APPL POLYM SCI, V71, P2033, DOI 10.1002/(SICI)1097-4628(19990321)71:12<2033::AID-APP13>3.0.CO;2-I
   An YJ, 2000, J CONTROL RELEASE, V64, P205, DOI 10.1016/S0168-3659(99)00143-1
   Andreopoulos FM, 1998, BIOMATERIALS, V19, P1343, DOI 10.1016/S0142-9612(97)00219-6
   Andreopoulos FM, 1996, J AM CHEM SOC, V118, P6235, DOI 10.1021/ja954117c
   Anseth KS, 1999, NAT BIOTECHNOL, V17, P156
   Anseth KS, 1997, ACS SYM SER, V673, P189
   Bruining MJ, 1999, J BIOMED MATER RES, V47, P189, DOI 10.1002/(SICI)1097-4636(199911)47:2<189::AID-JBM8>3.0.CO;2-M
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Burkoth AK, 2000, J BIOMED MATER RES, V51, P352
   Calvert J. G., 1966, PHOTOCHEMISTRY
   Chowdhury SM, 1996, J SURG RES, V61, P58, DOI 10.1006/jsre.1996.0081
   Chung CM, 2000, J APPL POLYM SCI, V77, P1802, DOI 10.1002/1097-4628(20000822)77:8<1802::AID-APP17>3.0.CO;2-M
   COOK WD, 1992, POLYMER, V33, P600, DOI 10.1016/0032-3861(92)90738-I
   Cruise GM, 1998, BIOTECHNOL BIOENG, V57, P655, DOI 10.1002/(SICI)1097-0290(19980320)57:6<655::AID-BIT3>3.0.CO;2-K
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   D'Urso PS, 2000, BRIT J PLAST SURG, V53, P200, DOI 10.1054/bjps.1999.3268
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Eufinger H, 1999, PLAST RECONSTR SURG, V104, P198, DOI 10.1097/00006534-199907000-00030
   Fallahi B, 1999, NEUROL RES, V21, P281, DOI 10.1080/01616412.1999.11740932
   Fouassier J.-P., 1995, PHOTOINITIATION PHOT
   GUGGENBERGER R, 1997, POLYM PREPRINTS, V38, P105
   Gursel I, 1998, BIOMATERIALS, V19, P1137, DOI 10.1016/S0142-9612(98)00009-X
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HILLWEST JL, 1994, P NATL ACAD SCI USA, V91, P5967, DOI 10.1073/pnas.91.13.5967
   HillWest JL, 1995, J SURG RES, V59, P759, DOI 10.1006/jsre.1995.1236
   HILLWEST JL, 1996, P NATL ACAD SCI USA, V93, P13188
   John G, 1999, MACROMOLECULES, V32, P1853, DOI 10.1021/ma981729j
   Kim BS, 2000, BIOMATERIALS, V21, P259, DOI 10.1016/S0142-9612(99)00174-X
   Kubota H, 1997, J APPL POLYM SCI, V65, P1313, DOI 10.1002/(SICI)1097-4628(19970815)65:7<1313::AID-APP9>3.0.CO;2-L
   Lai YC, 1997, ACS SYM SER, V673, P35
   LAI YC, 1997, J APPL POLYM SCI, V66, P1475
   Lu SX, 1999, J CONTROL RELEASE, V57, P291, DOI 10.1016/S0168-3659(98)00125-4
   MAFFEZZOLI A, 1994, BIOMATERIALS, V15, P1221, DOI 10.1016/0142-9612(94)90273-9
   Matsuda T, 2000, MACROMOLECULES, V33, P795, DOI 10.1021/ma991404i
   Muggli DS, 1998, MACROMOLECULES, V31, P4120, DOI 10.1021/ma980108n
   Muggli DS, 1999, J BIOMED MATER RES, V46, P271, DOI 10.1002/(SICI)1097-4636(199908)46:2<271::AID-JBM17>3.0.CO;2-X
   Nakayama Y, 1999, BIOMATERIALS, V20, P963, DOI 10.1016/S0142-9612(98)00252-X
   ODIAN G, 1991, PRINCIPLES POLYM
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Orban JM, 2000, MACROMOLECULES, V33, P4205, DOI 10.1021/ma9915780
   Rabek J. F., 1987, MECH PHOTOPHYSICAL P
   Scott RA, 1999, BIOMATERIALS, V20, P1371, DOI 10.1016/S0142-9612(99)00040-X
   SILVERSTEIN RM, 1991, SPECTROMETRIC IDENTI
   Venhoven BAM, 1996, BIOMATERIALS, V17, P2313, DOI 10.1016/S0142-9612(96)00074-9
   Wayne R. P., 1988, PRINCIPLES APPL PHOT
   Young JS, 2000, BIOMATERIALS, V21, P1181, DOI 10.1016/S0142-9612(00)00018-1
NR 48
TC 108
Z9 110
U1 2
U2 75
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 1531-7331
J9 ANN REV MATER RES
JI Ann. Rev. Mater. Res.
PY 2001
VL 31
BP 171
EP 181
DI 10.1146/annurev.matsci.31.1.171
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA 486FX
UT WOS:000171808700008
DA 2018-10-19
ER

PT S
AU Evelyn, AL
AF Evelyn, AL
BE Duggan, JL
   Morgan, IL
TI Application of ion beams for polymeric carbon based biomaterials
SO APPLICATION OF ACCELERATORS IN RESEARCH AND INDUSTRY
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 16th International Conference on the Application of Accelerators in
   Research and Industry
CY NOV 01-05, 2000
CL UNIV NORTH TEXAS, DENTON, TX
SP Natl Sci Fdn, US DOE, Amer Phys Soc, Div Nucl Phys
HO UNIV NORTH TEXAS
AB Ion beams have been shown to be quite suitable for the modification and analysis of carbon based biomaterials. Glassy polymeric carbon (GPC), made from cured phenolic resins, has a high chemical inertness that makes it useful as a biomaterial in medicine for drug delivery systems and for the manufacture of heart valves and other prosthetic devices. Low and high-energy ion beams have been used, with both partially and fully cured phenolic resins, to enhance biological cell/tissue growth on, and to increase tissue adhesion to GPC surfaces. Samples bombarded with energetic ion beams in the keV to MeV range exhibited increased surface roughness, measured using optical microscopy and atomic force microscopy. Ion beams were also used to perform nuclear reaction analyses of GPC encapsulated drugs for use in internal drug delivery systems. The results from the high energy bombardment were more dramatic and are shown in this paper. The interaction of energetic ions has demonstrated the useful application of ion beams to enhance the properties of carbon-based biomaterials.
C1 Alabama A&M Univ, Ctr Irradiat Mat, Normal, AL 35762 USA.
RP Evelyn, AL (reprint author), Alabama A&M Univ, Ctr Irradiat Mat, Normal, AL 35762 USA.
CR Balanzat E, 1995, NUCL INSTRUM METH B, V105, P46, DOI 10.1016/0168-583X(95)00521-8
   Calcagno L, 1995, NUCL INSTRUM METH B, V105, P63, DOI 10.1016/0168-583X(95)00527-7
   Chapiro A, 1995, NUCL INSTRUM METH B, V105, P5, DOI 10.1016/0168-583X(95)00861-6
   ILA D, 1994, MATER RES SOC SYMP P, V338, P613
   ILA D, 1994, MATER RES SOC SYMP P, V331, P281
   JENKINS GM, 1976, POLYMERIC CARBONSCAR
   LEE EH, 1994, J MATER RES, V9, P1043, DOI 10.1557/JMR.1994.1043
   MARLETTA G, 1990, NUCL INSTRUM METH B, V46, P295, DOI 10.1016/0168-583X(90)90716-8
   RODRIGUES MG, 2000, IN PRESS MRS S P
   Zimmerman RL, 1995, NUCL INSTRUM METH B, V106, P550, DOI 10.1016/0168-583X(95)00768-7
   ZIMMERMAN RL, 1996, APPL ACCELERATORS RE, P957
NR 11
TC 0
Z9 0
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 0-7354-0015-6
J9 AIP CONF PROC
PY 2001
VL 576
BP 1024
EP 1027
PG 4
WC Materials Science, Characterization & Testing; Physics, Atomic,
   Molecular & Chemical; Physics, Nuclear; Spectroscopy
SC Materials Science; Physics; Spectroscopy
GA BT20F
UT WOS:000172263600245
DA 2018-10-19
ER

PT J
AU Niino, H
   Kruger, J
   Kautek, W
AF Niino, H
   Kruger, J
   Kautek, W
TI Biomaterial immobilization on polyurethane films by XeCl excimer laser
   processing
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID POLYMER-FILMS; SURFACE MODIFICATION; MEMBRANES
AB The surface chemical modification of polyurethane (PU) films was performed by an UV laser-induced chemical reaction in a polysaccharide solution. This process may be applicable as hydrophilic packaging of implantable medical devices and in vivo sensors. When a PU film in contact with an aqueous alginic acid (AAC) solution was irradiated with a XeCl laser? the PU film turned hydrophilic. Contact angles of water on the film were reduced from 110 degrees to 60 degrees. Since light absorption of the AAC solution at 308 nm was negligibly small, reactive sites were generated solely on the PU surface. There, AAC could be immobilized by chemical bonds thus allowing for a nanometer-scaled grafting of this biomolecule. The mechanism was investigated by surface analyses with Fourier-transform infrared spectroscopy (FT-IR), dye staining, ultraviolet-visible (UV-VIS) spectroscopy, and scanning electron microscopy (SEM) techniques. A one-photon photochemical process could be identified.
C1 Fed Inst Mat Res & Testing, Lab Thin Film Technol, D-12205 Berlin, Germany.
RP Kautek, W (reprint author), Fed Inst Mat Res & Testing, Lab Thin Film Technol, Unter Eichen 87, D-12205 Berlin, Germany.
RI Kruger, Jorg/C-2833-2009; Niino, Hiroyuki/L-9508-2018
OI Niino, Hiroyuki/0000-0003-2375-1256
CR Aldenhoff YBJ, 1997, BIOMATERIALS, V18, P167, DOI 10.1016/S0142-9612(96)00095-6
   BAUERLE D, 1996, LASER PROCESSING CHE, P191
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Ichinose N, 1997, LANGMUIR, V13, P2603, DOI 10.1021/la960949s
   Kaetsu I, 1995, NUCL INSTRUM METH B, V105, P294, DOI 10.1016/0168-583X(95)00996-5
   LIU D, 1993, ANAL CHIM ACTA, V274, P37, DOI 10.1016/0003-2670(93)80602-H
   NIINO H, 1993, APPL PHYS LETT, V63, P3527, DOI 10.1063/1.110091
   NIINO H, 1992, APPL PHYS LETT, V60, P2697, DOI 10.1063/1.106877
   Niino H, 1998, P SOC PHOTO-OPT INS, V3274, P128, DOI 10.1117/12.309503
   NIINO H, 1994, CHEM LETT, P1341, DOI 10.1246/cl.1994.1341
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   RABEK JF, 1996, PHOTODEGRADATION POL, P146
   Tang YW, 1997, J BIOMED MATER RES, V35, P371, DOI 10.1002/(SICI)1097-4636(19970605)35:3<371::AID-JBM11>3.0.CO;2-I
   vonWoedtke T, 1997, SENSOR ACTUAT B-CHEM, V42, P151, DOI 10.1016/S0925-4005(97)80330-9
NR 14
TC 3
Z9 4
U1 0
U2 4
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0947-8396
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD JAN
PY 2001
VL 72
IS 1
BP 53
EP 57
DI 10.1007/s003390000617
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 389RJ
UT WOS:000166251300009
DA 2018-10-19
ER

PT J
AU Santos, AR
   Barbanti, SH
   Duek, EAR
   Dolder, H
   Wada, RS
   Wada, MLF
AF Santos, AR
   Barbanti, SH
   Duek, EAR
   Dolder, H
   Wada, RS
   Wada, MLF
TI Vero cell growth and differentiation on poly(L-lactic acid) membranes of
   different pore diameters
SO ARTIFICIAL ORGANS
LA English
DT Article
DE biomaterials; cell culture; cell adhesion; cell growth; cell
   differentiation; poly(L-lactic acid)
ID BIODEGRADABLE POLYMER SCAFFOLDS; BONE-FORMATION; ADHESION; CULTURE;
   MATRIX; BIOCOMPATIBILITY; SURFACES; COLLAGEN; ASSAY
AB In the last few years, the demand has increased for research on polymeric materials, which can be used as substitutes for injured tissues and organs or to improve their regeneration. In this work, we studied poly(L-lactic acid) (PLLA) membranes, a resorbable biomaterial, which were either dense or had different pore diameters (less than 45 mum, between 180 and 250 mum, and between 250 and 350 mum), in relation to stimulation of cell adhesion, growth, and differentiation in vitro. We used Vero cells, a fibroblastic cell line, as the biological model of investigation. We found that cells attached slowly to all PLLA membranes studied. On the Ether hand, once the adhesion occurs, the cells are able to grow and differentiate on the different polymers. The cells grew to form a confluent monolayer and were capable of producing collagen Type IV and fibronectin on different PLLA membranes. This behavior indicates that cells try to create a better environment to stimulate their growth. This also indicates that Vero cells alter their differentiation pattern once they are producing extracellular matrix molecules related to epithelial differentiation.
C1 State Univ Campinas, UNICAMP, Inst Biol, Dept Cell Biol, BR-13083970 Campinas, SP, Brazil.
   State Univ Campinas, UNICAMP, Fac Mech Engn, Dept Mat Engn, BR-13083970 Campinas, SP, Brazil.
   State Univ Campinas, UNICAMP, Fac Odontol Piracicaba, Dept Social Odontol, BR-13083970 Campinas, SP, Brazil.
RP Santos, AR (reprint author), State Univ Campinas, UNICAMP, Inst Biol, Dept Cell Biol, CP 6109, BR-13083970 Campinas, SP, Brazil.
RI Santos, Jr, Arnaldo/I-4813-2012; Duek, Eliana/J-2499-2012; Dolder, Mary
   Anne Heidi/J-8618-2012
CR ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E
   BEUMER GJ, 1994, J BIOMED MATER RES, V28, P545, DOI 10.1002/jbm.820280504
   BOHNERT A, 1986, CELL TISSUE RES, V244, P413
   COULOMB B, 1989, J INVEST DERMATOL, V92, P111
   Dewez JL, 1998, BIOMATERIALS, V19, P1441, DOI 10.1016/S0142-9612(98)00055-6
   Eckert R, 1997, CELL BIOL INT, V21, P707, DOI 10.1006/cbir.1997.0215
   FITCH JM, 1994, EXTRACELLULAR MATRIX, P441
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   Genari S C, 1995, Cytobios, V81, P17
   Genari SC, 1996, J SUBMICR CYTOL PATH, V28, P565
   HANSBROUGH JF, 1992, SURGERY, V111, P438
   HENCH LL, 1982, BIOMATERIALS INTERFA
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hynes RO, 1990, FIBRONECTINS
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   KENDALL K, 1994, SCIENCE, V263, P1720, DOI 10.1126/science.263.5154.1720
   KIRKPATRICK CJ, 1992, REGULATORY AFFAIRS, V4, P13
   Lombello CB, 2000, J MATER SCI-MATER M, V11, P541, DOI 10.1023/A:1008915801187
   Lombello CB, 2000, CYTOBIOS, V101, P115
   LYNDON MJ, 1985, BIOMAT, V6, P396
   Malmonge SM, 1999, REV BRAS ENG BIOMED, V15, P49
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   Maria SS, 1997, IN VITRO CELL DEV-AN, V33, P748, DOI 10.1007/s11626-997-0152-9
   METCALF BW, 1994, CELLULAR ADHESION MO
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   SANTOS AR, 1999, CYTOBIOS, V99, P159
   VANSLIEDREGT A, 1994, BIOMATERIALS, V15, P251, DOI 10.1016/0142-9612(94)90047-7
   WADA MLF, 1991, CYTOBIOS, V67, P101
   WALD HL, 1993, BIOMATERIALS, V14, P270, DOI 10.1016/0142-9612(93)90117-K
   YURCHENCO PD, 1994, EXTRACELLULAR MATRIX, P351
   Zoppi RA, 1999, POLYMER, V40, P3275, DOI 10.1016/S0032-3861(98)00562-X
NR 36
TC 29
Z9 31
U1 0
U2 4
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD JAN
PY 2001
VL 25
IS 1
BP 7
EP 13
DI 10.1046/j.1525-1594.2001.025001007.x
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 399FE
UT WOS:000166800300002
PM 11167553
DA 2018-10-19
ER

PT J
AU Titushkin, IA
   Vasin, SL
   Rozanova, IB
   Pokidysheva, EN
   Alekhin, AP
   Sevastianov, VI
AF Titushkin, IA
   Vasin, SL
   Rozanova, IB
   Pokidysheva, EN
   Alekhin, AP
   Sevastianov, VI
TI Carbon coated polyethylene: Effect of surface energetics and topography
   on human platelet adhesion
SO ASAIO JOURNAL
LA English
DT Article
ID CONTACT ANGLES; ADSORPTION; POLYMERS; MODEL
AB The influence of surface energy and structural properties of carbon coated polyethylene (PE) on the human platelet adhesion was studied. Three types of amorphous carbon coating were obtained by plasma pulse discharge, with the number of pulses grading as 10, 50, 100. Human serum albumin adsorption experiments have been carried out with all samples in vitro. Platelet adhesion analysis by SEM included determination of total quantity of adherent platelets, and respective quantities of platelets at different stages of activation (single, spread, aggregates). Surface topographies ranged from bare PE and such (10 pulses), to globular 0.5 mum in size (50 pulses), and complex fibrillar 3-4 mum structures (100 pulses). Surface free energy varies from 31.7 +/- 0.6 to 40.4 +/- 0.6 mN/m for uncoated PE and 10 pulse coatings, respectively, as determined by contact angle techniques. All studied coatings demonstrate weaker platelet activation properties in comparison with untreated PE. Among all studied coatings, the 50 pulse coated surface seems to be the least suitable for contact with platelets, mainly due to its structural rather than to its energy properties. These data are related to a sharp decrease in the adsorbed protein level for the samples with 50 pulse coatings. The applied analysis of platelet activation enables more accurate characterization of platelet-biomaterial interaction.
C1 Moscow Transplantol & Artificial Organ Res Inst, Res Ctr Blood Compatible Biomat, Moscow 123182, Russia.
   Res Inst Phys Problems, Zelenograd, Russia.
RP Sevastianov, VI (reprint author), Moscow Transplantol & Artificial Organ Res Inst, Res Ctr Blood Compatible Biomat, 1 Shukinskaya, Moscow 123182, Russia.
RI Sevastianov, Victor/B-6674-2017
OI Sevastianov, Victor/0000-0003-1995-3373
CR ANDRADE DJ, 1985, SURFACE INTERFACIAL
   BAIER RE, 1985, J BIOMED MATER RES, V19, P1157, DOI 10.1002/jbm.820190922
   Bellanda M, 1997, J BIOMED MATER RES, V36, P216, DOI 10.1002/(SICI)1097-4636(199708)36:2<216::AID-JBM10>3.0.CO;2-E
   Extrand CW, 1997, J COLLOID INTERF SCI, V191, P378, DOI 10.1006/jcis.1997.4935
   FENG L, 1993, J BIOMED MATER RES, V27, P177, DOI 10.1002/jbm.820270206
   GARBASSI F, 1994, POLYM SURFACES PHYSI, P395
   GOLDMAN M, 1988, FLUORESCENT ANTIBODY
   Goodman S L, 1991, J Biomater Sci Polym Ed, V2, P147, DOI 10.1163/156856291X00133
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   Goodman SL, 1999, J BIOMED MATER RES, V45, P240, DOI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
   GUSEVA MB, 1995, DIAM RELAT MATER, V4, P1142, DOI 10.1016/0925-9635(95)00292-8
   Haubold A, 1983, ASAIO J, V29, P88
   Ito E, 1998, J BIOMED MATER RES, V42, P148
   JANCZUK B, 1989, J COLLOID INTERF SCI, V127, P189, DOI 10.1016/0021-9797(89)90019-2
   MCINTIRE LV, 1985, NIH PUBLICATION
   NEUMANN AW, 1979, J POLY SCI        PS, V66, P391
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   SEVASTIANOV VI, 1991, J COLLOID INTERF SCI, V145, P191, DOI 10.1016/0021-9797(91)90111-K
   SEVASTIANOV VI, 1983, ARTIF ORGANS, V7, P126, DOI 10.1111/j.1525-1594.1983.tb04171.x
   SEVASTIANOV VI, 1993, BIOMATER LIVING SYST, V1, P3
   SEVASTIANOV VI, 1991, HIGH PERFORMANCE BIO, P313
   Skarja GA, 1997, J BIOMED MATER RES, V34, P439, DOI 10.1002/(SICI)1097-4636(19970315)34:4<439::AID-JBM5>3.0.CO;2-L
   vanGiessen AE, 1997, J COLLOID INTERF SCI, V192, P257, DOI 10.1006/jcis.1997.5027
   Waples LM, 1996, J BIOMED MATER RES, V32, P65, DOI 10.1002/(SICI)1097-4636(199609)32:1<65::AID-JBM8>3.0.CO;2-N
NR 25
TC 4
Z9 4
U1 1
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD JAN-FEB
PY 2001
VL 47
IS 1
BP 11
EP 17
DI 10.1097/00002480-200101000-00005
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 391UK
UT WOS:000166374000005
PM 11199307
OA Bronze
DA 2018-10-19
ER

PT J
AU Dubois, JC
   Jardin, C
   Exbrayat, P
   Lissac, M
   Treheux, D
AF Dubois, JC
   Jardin, C
   Exbrayat, P
   Lissac, M
   Treheux, D
TI Influence of gamma-irradiation sterilization on the structural defects
   of sapphire single crystals (alpha-Al2O3)
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE insulating biomaterial; surface charging; cathodoluminescence; scanning
   electron microscope mirror effect
ID MOLECULAR-WEIGHT POLYETHYLENE; LUMINESCENCE; IMPLANTS; CENTERS
AB The influence of sterilization by gamma rays on the structure and the electrical behaviour of sapphire single crystal (alpha -Al2O3) was studied successively by thermoluminescence, by cathodoluminescence and by observation of the scanning electron microscope mirror effect. The mirror method allowed us to measure the capacity of an insulating material to trap electrons. The structural analysis of the alpha -Al2O3 showed that there were oxygen vacancies, as well as chromium and titanium impurities. It was possible to demonstrate that these defects, especially the oxygen vacancies, are in a different state after a 30 kilogray irradiation. The valency state changes of these defects and the presence of trapped charges are accompanied by a deformation of the crystalline lattice which results in a modification of its electrical properties. At room temperature, the irradiated alpha -Al2O3, unlike non irradiated alpha -Al2O3, is capable of trapping electrons. It can be concluded that gamma-ray sterilization modifies the cohesive energy of alpha -Al2O3, which could lead to mechanical changes (surface charge, friction, wear, fracture strength,...) in this material.
C1 Fac Odontol, Lab Etud Interfaces & Biofilms Odontol, F-69372 Lyon 08, France.
   Univ Lyon 1, CNRS, UMR 5586, Dept Phys Mat, F-69622 Villeurbanne, France.
   Ecole Cent Lyon, CNRS, UMR 5621, F-69131 Ecully, France.
RP Dubois, JC (reprint author), Fac Odontol, Lab Etud Interfaces & Biofilms Odontol, EA 637,Rue Gillaume Paradin, F-69372 Lyon 08, France.
CR AUSTIN IG, 1969, ADV PHYS, V18, P41, DOI 10.1080/00018736900101267
   BERROUG A, 1993, IEEE T ELECTR INSUL, V28, P528, DOI 10.1109/14.231535
   Bigarre J., 1996, THESIS ECOLE CENTRAL
   BIGARRE J, 1995, SCI TECHNIQUE APPL, V275, P483
   BLAISE G, 1991, J APPL PHYS, V69, P6334, DOI 10.1063/1.348832
   BLAISE G, 1998, SCI TECHNIQUE APPL, V287, P25
   CARABAJAR S, 1995, SCI TECHNIQUE APPL, V275, P93
   Damamme G, 1997, IEEE T DIELECT EL IN, V4, P558, DOI 10.1109/94.625645
   EVANS BD, 1994, NUCL INSTRUM METH B, V91, P258, DOI 10.1016/0168-583X(94)96227-8
   FAYEULLE S, 1995, SCI TECHNIQUE APPL, V275, P74
   HAYASHI H, 1992, ARCH ORTHOP TRAUM SU, V112, P1, DOI 10.1007/BF00431035
   ISHIZUKI M, 1991, J HAND SURG-AM, V16A, P922, DOI 10.1016/S0363-5023(10)80161-3
   JARDIN C, 1995, SCI TECHNIQUE APPL, V275, P557
   JARDIN C, 1997, P CEIDP, P624
   JARDIN C, 1998, SCI TECHNIQUE APPL, V287, P539
   KULIS PA, 1981, PHYS STATUS SOLIDI B, V104, P719, DOI 10.1002/pssb.2221040241
   LEE KH, 1979, PHYS REV B, V19, P3217, DOI 10.1103/PhysRevB.19.3217
   Lemons JE, 1996, BONE, V19, pS121, DOI 10.1016/S8756-3282(96)00128-7
   LIEBAULT J, 1998, SCI TECHNIQUE APPL, V287, P391
   MIRRA JM, 1982, CLIN ORTHOP RELAT R, P175
   NUSBAUM HJ, 1979, J BIOMED MATER RES, V13, P557, DOI 10.1002/jbm.820130404
   Pascaud RS, 1997, BIOMATERIALS, V18, P727, DOI 10.1016/S0142-9612(96)00207-4
   Piattelli A, 1996, BIOMATERIALS, V17, P711, DOI 10.1016/0142-9612(96)86741-X
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Premnath V, 1996, BIOMATERIALS, V17, P1741, DOI 10.1016/0142-9612(95)00349-5
   RAMBAUT C, 1997, THESIS ECOLE CENTRAL
   REVELL PA, 1978, ARCH ORTHOP TRAUM SU, V91, P167, DOI 10.1007/BF00379748
   Ries MD, 1996, CLIN ORTHOP RELAT R, P87
   ROSE RM, 1984, J BIOMED MATER RES, V18, P207, DOI 10.1002/jbm.820180209
   SHEN C, 1974, WEAR, V30, P349, DOI 10.1016/0043-1648(74)90149-5
   STASHANS A, 1994, PHYS REV B, V49, P14854, DOI 10.1103/PhysRevB.49.14854
   Stoneham AM, 1997, IEEE T DIELECT EL IN, V4, P604, DOI 10.1109/94.625647
   TRABELSI R, 1988, THESIS ECOLE CENTRAL
   VALBIS J, 1991, RADIAT EFF DEFECT S, V116, P171, DOI 10.1080/10420159108221357
   Vallayer B, 1999, REV SCI INSTRUM, V70, P3102, DOI 10.1063/1.1149887
   VALLAYER J, 1998, SCI TECHNIQUE APPL, V287, P527
   VALLAYER J, 1999, THESIS ECOLE CENTRAL
   WINTER M, 1992, CLIN ORTHOP RELAT R, P73
NR 38
TC 0
Z9 0
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2001
VL 11
IS 3
BP 265
EP 273
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 483JW
UT WOS:000171633100010
PM 11564909
DA 2018-10-19
ER

PT S
AU Nose, Y
AF Nose, Y
BE Hunkeler, D
   Cherrington, A
   Prokop, A
   Rajotte, R
TI Historical perspectives of hybrid hepatic assist devices - Tissue
   sourcing, immunoisolation, and clinical trial
SO BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL
   TRIALS
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT Conference on Bioartificial Organs III - Tissue Sourcing,
   Immunoisoloation, and Clinical Trials
CY OCT 07-11, 2000
CL DAVOS, SWITZERLAND
SP Bellevue Asset Management, European Community Cost 840 Encapsulat Network, Fonds Natl Suisse, Inotech Encapsulat AG, Juvenile Diabetes Fdn Int, NIH, Natl Sci Fdn, Nisco Engn, Novartis Pharmaceut Canada Inc, Pronova Biomed, United Engn Fdn
DE bioartificial organs; hybrid artificial organ; hybrid hepatic assist;
   immunological isolation; properly functioning cells; oxygen delivery;
   removal of toxic substance
AB A hybrid hepatic assist device using canine liver tissues was developed and clinically applied 38 years ago. However, for many years practical hybrid hepatic assist devices were not clinically introduced owing to the many difficulties encountered in employing cultured hepatocytes. These problems include: (1) maintenance of viable cultured cells, (2) maintenance of normal hepatocyte function with these cells, (3) elimination of toxic substances generated by non-viable cultured and/or stored cells, (4) elimination of immunological factors generated by cultured cells and by the patient, and (5) difficulties of the biocompatible immunological barrier for cells against the patient. Fortunately, recent progress in apheresis and biomaterial technologies enable us to isolate cultured cells immunologically and yet maintain effective metabolic functions for the patient. These technologies generate an immunological barrier of a hybrid hepatic assist device for the patients. Proper adsorption columns developed for apheresis procedures enable us to remove the toxic substances released by non-viable cells. Recent development of oxygen-carrying macromolecules enable us to provide sufficient oxygen supply to the cultured cells and to maintain their normal cellular function, not only during the cultured period of time, but also during their actual clinical application. Together with the advancement of cell culture technologies, including the proper cultured environments and cellular seeding environments, these technologies, primarily developed for therapeutic apheresis, should he able to provide more effective and safe hybrid artificial organs.
C1 Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.
RP Nose, Y (reprint author), Baylor Coll Med, Michael E DeBakey Dept Surg, 1 Baylor Plaza, Houston, TX 77030 USA.
CR ASAMURA Y, 1980, T AM SOC ART INT ORG, V26, P400
   HORI M, 1987, P INT S STAB HEM CLE, P1
   KODAMA M, 1991, INTENSIVE CRITICAL C, V3, P143
   MALCHESKY PS, 1988, ARTIF ORGANS, V12, P300, DOI 10.1111/j.1525-1594.1988.tb02777.x
   MATSUSHITA M, 1987, T AM SOC ART INT ORG, V33, P352
   MITO M, 1959, SOGOIGAKU, V16, P761
   NOSE Y, 1985, ARTIF ORGANS, V9, P425, DOI 10.1111/j.1525-1594.1985.tb04406.x
   NOSE Y, 1963, T AM SOC ART INT ORG, V9, P358
   NOSE Y, 1982, THERAPEUTIC PLASMAPH, V2, P15
   NOSE Y, 1973, MANUAL ARTIFICIAL OR, V2
   NOSE Y, 1983, PLASMAPHERESIS THERA, P436
   NOSE Y, 1981, THERAPEUTIC MEMBRANE, V1, P3
   STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659
   Yoshiba M, 1996, ARTIF ORGANS, V20, P1169
NR 14
TC 2
Z9 2
U1 0
U2 2
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-342-4
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2001
VL 944
BP 18
EP 34
PG 17
WC Engineering, Biomedical; Multidisciplinary Sciences; Transplantation
SC Engineering; Science & Technology - Other Topics; Transplantation
GA BT69D
UT WOS:000173774500003
PM 11797667
DA 2018-10-19
ER

PT S
AU Gill, RG
AF Gill, RG
BE Hunkeler, D
   Cherrington, A
   Prokop, A
   Rajotte, R
TI Use of small animal models for screening immunoisolation approaches to
   cellular transplantation
SO BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL
   TRIALS
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT Conference on Bioartificial Organs III - Tissue Sourcing,
   Immunoisoloation, and Clinical Trials
CY OCT 07-11, 2000
CL DAVOS, SWITZERLAND
SP Bellevue Asset Management, European Community Cost 840 Encapsulat Network, Fonds Natl Suisse, Inotech Encapsulat AG, Juvenile Diabetes Fdn Int, NIH, Natl Sci Fdn, Nisco Engn, Novartis Pharmaceut Canada Inc, Pronova Biomed, United Engn Fdn
DE small animal models; screening immunoisolation; cellular transplantation
ID PORCINE ENDOGENOUS RETROVIRUS; ALGINATE-POLYLYSINE MICROCAPSULES; SEVERE
   COMBINED IMMUNODEFICIENCY; MICROENCAPSULATED ISLET GRAFTS; IN-VIVO;
   T-CELLS; XENOGRAFT REJECTION; DIFFUSION-CHAMBERS; PANCREATIC-ISLETS;
   ENDOTHELIAL-CELLS
AB It has been recognized for many years that immunoisolation strategies form an attractive approach to preventing the rejection of cellular allografts and xenografts. Although immunoisolation has proven dramatically successful in some cases, the results have tended to be somewhat variable. Although many advances have been made in the development of biocompatible materials for separating host immune cells from the transplanted tissues, much of the experimentation in this area has been outcome driven. That is, the nature of host reactivity and/or biomaterial design resulting in the failure of some immunoisolation strategies has mostly been undefined. A first premise of this discussion is that immunoisolation is primarily cell isolation and not antigen isolation, per se. That is, although varied membrane barriers are designed to prevent cell-cell contact between host and donor cells, soluble antigens derived from the transplant are likely to gain access to the host immune system. A key question centers on the degree and consequence of this type of antigen presentation in the host to the immunoisolated transplant. To address this and related concerns, this overview presents a simple paradigm for using defined rodent (mouse) models for systematically screening the efficacy of immunoisolated cellular transplants. The proposition is made that understanding the basis of graft failure will aid in the design of future immunoisolation technologies.
C1 Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA.
RP Gill, RG (reprint author), Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, 4200 E 9th Ave,Box B-140, Denver, CO 80262 USA.
CR Benda B, 1996, TRANSPLANTATION, V62, P1207, DOI 10.1097/00007890-199611150-00003
   BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977
   Brauker J, 1996, TRANSPLANTATION, V61, P1671, DOI 10.1097/00007890-199606270-00002
   CHEN CY, 1994, J IMMUNOL, V152, P4929
   COLE DR, 1992, DIABETOLOGIA, V35, P231, DOI 10.1007/BF00400922
   COLTON CK, 1991, J BIOMECH ENG-T ASME, V113, P152, DOI 10.1115/1.2891229
   CZITROM AA, 1985, J IMMUNOL, V134, P2276
   De Vos P, 1999, DIABETES, V48, P1381, DOI 10.2337/diabetes.48.7.1381
   DeVos P, 1997, BIOMATERIALS, V18, P273, DOI 10.1016/S0142-9612(96)00135-4
   Elliott RB, 2000, CELL TRANSPLANT, V9, P895, DOI 10.1177/096368970000900616
   GILL RG, 1994, TRANSPLANT P, V26, P1203
   GILL RG, 1998, TRANSPLANT REV, V12, P85
   Hasse C, 2000, WORLD J SURG, V24, P1361, DOI 10.1007/s002680010225
   Heneine W, 1998, LANCET, V352, P695, DOI 10.1016/S0140-6736(98)07145-1
   JUNE CH, 1990, IMMUNOL TODAY, V11, P211, DOI 10.1016/0167-5699(90)90085-N
   Kessler L, 1996, J LEUKOCYTE BIOL, V60, P729
   King A, 2000, TRANSPLANTATION, V70, P380, DOI 10.1097/00007890-200007270-00025
   Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923
   LAFFERTY KJ, 1983, ANNU REV IMMUNOL, V1, P143, DOI 10.1146/annurev.iy.01.040183.001043
   LANZA RP, 1994, TRANSPLANTATION, V57, P1371, DOI 10.1097/00007890-199405150-00015
   LANZA RP, 1991, P NATL ACAD SCI USA, V88, P11100, DOI 10.1073/pnas.88.24.11100
   LANZA RP, 1993, TRANSPLANTATION, V56, P1067, DOI 10.1097/00007890-199311000-00003
   LANZA RP, 1995, TRANSPLANTATION, V59, P1377, DOI 10.1097/00007890-199505270-00003
   LAUZON RJ, 1986, J EXP MED, V164, P1797, DOI 10.1084/jem.164.5.1797
   Loudovaris T, 1999, J MOL MED-JMM, V77, P219, DOI 10.1007/s001090050340
   Loudovaris T, 1996, TRANSPLANTATION, V61, P1678, DOI 10.1097/00007890-199606270-00003
   MANDRUPPOULSEN T, 1987, DIABETES, V36, P641, DOI 10.2337/diabetes.36.5.641
   Martin U, 2000, XENOTRANSPLANTATION, V7, P138, DOI 10.1034/j.1399-3089.2000.00052.x
   Martin U, 1998, TRANSPLANT INT, V11, P247, DOI 10.1111/j.1432-2277.1998.tb00965.x
   Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236
   PUKEL C, 1988, DIABETES, V37, P133, DOI 10.2337/diabetes.37.1.133
   RABINOVITCH A, 1990, J CLIN ENDOCR METAB, V71, P152, DOI 10.1210/jcem-71-1-152
   ROSENBERG AS, 1988, P NATL ACAD SCI USA, V85, P7739, DOI 10.1073/pnas.85.20.7739
   SCHREZENMEIR J, 1994, TRANSPLANTATION, V57, P1308, DOI 10.1097/00007890-199405150-00003
   SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8
   Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929
   SUTTON R, 1989, J EXP MED, V170, P751, DOI 10.1084/jem.170.3.751
   SWAIN SL, 1983, IMMUNOL REV, V74, P129, DOI 10.1111/j.1600-065X.1983.tb01087.x
   Tai Isabella T. Vvan Vacek, 1995, Xenotransplantation, V2, P37, DOI 10.1111/j.1399-3089.1995.tb00064.x
   van der Laan LJW, 2000, NATURE, V407, P90, DOI 10.1038/35024089
   VANDENBOSSCHE GMR, 1993, J PHARM PHARMACOL, V45, P115, DOI 10.1111/j.2042-7158.1993.tb03694.x
   WEBER CJ, 1990, TRANSPLANTATION, V49, P396, DOI 10.1097/00007890-199002000-00034
   WIEGAND F, 1993, TRANSPLANTATION, V56, P1206, DOI 10.1097/00007890-199311000-00030
   Zekorn Tobias D. C., 1995, Xenotransplantation, V2, P116, DOI 10.1111/j.1399-3089.1995.tb00076.x
NR 44
TC 7
Z9 7
U1 0
U2 2
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-342-4
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2001
VL 944
BP 35
EP 46
PG 12
WC Engineering, Biomedical; Multidisciplinary Sciences; Transplantation
SC Engineering; Science & Technology - Other Topics; Transplantation
GA BT69D
UT WOS:000173774500004
PM 11797684
DA 2018-10-19
ER

PT S
AU Rokstad, AM
   Kulseng, B
   Strand, BL
   Skjak-Braek, G
   Espevik, T
AF Rokstad, AM
   Kulseng, B
   Strand, BL
   Skjak-Braek, G
   Espevik, T
BE Hunkeler, D
   Cherrington, A
   Prokop, A
   Rajotte, R
TI Transplantation of alginate microcapsules with proliferating cells in
   mice - Capsular overgrowth and survival of encapsulated cells of mice
   and human origin
SO BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL
   TRIALS
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT Conference on Bioartificial Organs III - Tissue Sourcing,
   Immunoisoloation, and Clinical Trials
CY OCT 07-11, 2000
CL DAVOS, SWITZERLAND
SP Bellevue Asset Management, European Community Cost 840 Encapsulat Network, Fonds Natl Suisse, Inotech Encapsulat AG, Juvenile Diabetes Fdn Int, NIH, Natl Sci Fdn, Nisco Engn, Novartis Pharmaceut Canada Inc, Pronova Biomed, United Engn Fdn
DE transplantation; alginate microcapsules; proliferating cells; capsular
   overgrowth
ID MICROENCAPSULATED ISLETS; POLYCATION MICROCAPSULES; XENOGENEIC ISLETS;
   BIOCOMPATIBILITY; PANCREAS; DOGS; REVERSAL
AB Alginate microcapsules may be used to encapsulate therapeutic cells and, thereby, to protect them from the host immune system. Both the biomaterial, as well as the therapeutic cells, may give rise to immunological reactions. We have developed methods that are useful in the study of capsule biocompatibility, as well as reactions against the grafts. These imply investigation of the survival of the encapsulated cells as well as fibrotic reactions against the microcapsules. Studies were performed in Balb/c mice with empty alginate-PLL-alginate microcapsules as well as microcapsules containing cells of human or mouse origin. Confocal laser scanning microscopy (CLSM) was used to visualize live and dead cells within the microcapsules and to define some of the cells involved in the fibrotic reaction against the microcapsules. In both grafts, live cells were detected seven days after transplantation. Minor fibrotic reactions were found against empty alginate-PLL-alginate microcapsules and to microcapsules containing mouse cells. An extensive fibrotic reaction was round one week after transplantation against microcapsules containing human cells, and the secretion of therapeutic protein endostatin had ceased. Fibroblasts and macrophages were involved in the fibrotic reaction against the xenograft.
C1 Norwegian Univ Sci & Technol, Inst Canc Res & Mol Biol, N-7489 Trondheim, Norway.
   Norwegian Univ Sci & Technol, Inst Biotechnol, N-7034 Trondheim, Norway.
RP Rokstad, AM (reprint author), Norwegian Univ Sci & Technol, Inst Canc Res & Mol Biol, Olav Kyrresgt 3, N-7489 Trondheim, Norway.
RI Strand, Berit Lokensgard/O-3999-2015
OI Strand, Berit Lokensgard/0000-0002-9951-0355
CR Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Constantinidis I, 1999, BIOMATERIALS, V20, P2019, DOI 10.1016/S0142-9612(99)00104-0
   DeVos P, 1997, DIABETOLOGIA, V40, P262
   DeVos P, 1997, BIOMATERIALS, V18, P273, DOI 10.1016/S0142-9612(96)00135-4
   IWATA H, 1994, J BIOMED MATER RES, V28, P1003, DOI 10.1002/jbm.820280905
   Joki T, 2001, NAT BIOTECHNOL, V19, P35
   Kulseng B, 1999, TRANSPLANTATION, V67, P978, DOI 10.1097/00007890-199904150-00008
   LANZA RP, 1995, TRANSPLANTATION, V59, P1485, DOI 10.1097/00007890-199505270-00023
   Lanza RP, 1999, J MOL MED-JMM, V77, P206, DOI 10.1007/s001090050337
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   OTTERLEI M, 1991, J IMMUNOTHER, V10, P286, DOI 10.1097/00002371-199108000-00007
   Peirone M, 1998, J BIOMED MATER RES, V42, P587, DOI 10.1002/(SICI)1097-4636(19981215)42:4<587::AID-JBM15>3.0.CO;2-X
   Read TA, 2001, NAT BIOTECHNOL, V19, P29, DOI 10.1038/83471
   Robitaille R, 1999, J BIOMED MATER RES, V45, P223, DOI 10.1002/(SICI)1097-4636(19990605)45:3<223::AID-JBM10>3.0.CO;2-L
   Ross CJD, 1999, HUM GENE THER, V10, P49, DOI 10.1089/10430349950019183
   Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249
   Siebers U, 1999, J MOL MED-JMM, V77, P215, DOI 10.1007/s001090050339
   SOONSHIONG P, 1992, TRANSPLANTATION, V54, P769, DOI 10.1097/00007890-199211000-00001
   SOONSHIONG P, 1993, P NATL ACAD SCI USA, V90, P5843, DOI 10.1073/pnas.90.12.5843
   SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1
   Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800
   SULLIVAN SJ, 1991, SCIENCE, V252, P718, DOI 10.1126/science.2024124
   Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1
   Thu B, 1996, BIOMATERIALS, V17, P1069, DOI 10.1016/0142-9612(96)85907-2
   VANDEVEN WJM, 1993, CRIT REV ONCOGENESIS, V4, P115
NR 25
TC 18
Z9 19
U1 1
U2 4
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-342-4
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2001
VL 944
BP 216
EP 225
PG 10
WC Engineering, Biomedical; Multidisciplinary Sciences; Transplantation
SC Engineering; Science & Technology - Other Topics; Transplantation
GA BT69D
UT WOS:000173774500017
PM 11797671
DA 2018-10-19
ER

PT S
AU Dornish, M
   Kaplan, D
   Skaugrud, O
AF Dornish, M
   Kaplan, D
   Skaugrud, O
BE Hunkeler, D
   Cherrington, A
   Prokop, A
   Rajotte, R
TI Standards and guidelines for biopolymers in tissue-engineered medical
   products - ASTM alginate and chitosan standard guides
SO BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL
   TRIALS
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT Conference on Bioartificial Organs III - Tissue Sourcing,
   Immunoisolation, and Clinical Trials
CY OCT 07-11, 2000
CL DAVOS, SWITZERLAND
SP Bellevue Asset Management, European Community Cost 840 Encapsulat Network, Fonds Natl Suisse, Inotech Encapsulat AG, Juvenile Diabet Fdn Int, NIH, Natl Sci Fdn, Nisco Engn, Novartis Pharmaceut Canada Inc, Pronova Biomed, United Engn Fdn
DE ASTM; tissue-engineered medical products; TEMPS; alginate; chitosan;
   standardization
ID VESICOURETERAL REFLUX; DELIVERY; CELLS; TRANSPLANTATION; BIOMATERIALS;
   REGENERATION; HEPATOCYTES; IMPLANTS; PANCREAS; CANINES
AB The American Society for Testing and Materials (ASTM) is making a concerted effort to establish standards and guidelines for the entire field of tissue-engineered medical products (TEMPS). Safety, consistency. and functionality of biomaterials used as matrices, scaffolds, and immobilizing agents in TEMPS are a concern. Therefore, the ASTM has established a number of task groups to produce standards and guidelines for such biomaterials. Alginate is a naturally occurring biomaterial used for immobilizing living cells to form an artificial organ, such as encapsulated pancreatic islets. In order to aid in successful clinical applications and to help expedite regulatory approval, the alginate used must be fully documented. The ASTM alginate guide gives information on selection of testing methodologies and safety criteria. Critical parameters such as monomer content, molecular weight, and viscosity, in addition to more general parameters, such as dry matter content, heavy metal content. bioburden, and endotoxin content are described in the ASTM document. In a like manner, the characterization parameters for chitosan, a bioadhesive polycationic polysaccharide, are described in a separate guide. For chitosan, the degree of deacetylation is of critical importance. Control of protein content and, hence, potential for hypersensitivity, endotoxin content, and total bioburden are important in chitosan preparations for TEMPS. Together these two guides represent part of the effort on behalf of the ASTM and other interested parties to ensure quality and standardization in TEMPS.
C1 Pronova Biomed AS, N-0349 Oslo, Norway.
   US FDA, Ctr Devices & Radiol Hlth, Div Mech & Mat Sci, Rockville, MD 20857 USA.
RP Dornish, M (reprint author), Pronova Biomed AS, Gaustadalleen 21, N-0349 Oslo, Norway.
EM mdornish@pronova.no
CR Allan G, 1984, CHITIN CHITOSAN RELA, P119
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   BRUCK SD, 1989, MED PROG TECHNOL, V15, P5
   BRUNSTEDT M, 1996, Patent No. 07272322
   CHANG PL, 1994, BIOTECHNOL BIOENG, V43, P925, DOI 10.1002/bit.260431005
   Chang T M, 2000, Ther Apher, V4, P108, DOI 10.1046/j.1526-0968.2000.004002108.x
   Chen ZP, 1996, STEREOT FUNCT NEUROS, V66, P141, DOI 10.1159/000099681
   Diamond DA, 1999, J UROLOGY, V162, P1185, DOI 10.1016/S0022-5347(01)68124-2
   EMERICH DF, 1992, NEUROSCI BIOBEHAV R, V16, P437, DOI 10.1016/S0149-7634(05)80185-X
   GENTILE FT, 1999, SCI MED          NOV, P6
   Hagstam H., 1986, GUMS STABILIZERS FOO, P363
   HELLMAN KB, 1993, BIO-TECHNOL, V11, P1179, DOI 10.1038/nbt1093-1179
   Hellman KB, 1997, ANN NY ACAD SCI, V831, P1
   Joki T, 2001, NAT BIOTECHNOL, V19, P35
   KENLEY R, 1994, J BIOMED MATER RES, V28, P1139, DOI 10.1002/jbm.820281004
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   LI Q, 1992, J BIOACT COMPAT POL, V7, P370, DOI 10.1177/088391159200700406
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Mandel KG, 2000, ALIMENT PHARM THER, V14, P669
   MARUYAMA M, 1995, J BIOMED MATER RES, V29, P329, DOI 10.1002/jbm.820290308
   Miyazaki S, 2000, J CONTROL RELEASE, V67, P275, DOI 10.1016/S0168-3659(00)00214-5
   Onsoyen E., 1995, P108
   Peirone MA, 1998, HUM GENE THER, V9, P195, DOI 10.1089/hum.1998.9.2-195
   Picciolo GL, 2001, ASTM STAND NEWS, V29, P30
   PICCIOLO GL, 2000, ASTM STANDARDIZATION, V28, P7
   Ramdas M, 1999, J BIOMATER APPL, V13, P290, DOI 10.1177/088532829901300402
   REED TA, 2001, NAT BIOTECHNOL, V19, P29
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Skaugrud O, 1999, BIOTECHNOL GENET ENG, V16, P23, DOI 10.1080/02648725.1999.10647970
   SKAUGRUD O, 1995, SPEC PUBL ROY SOC CH, V161, P96
   SMIDSR OD, 1996, CARBOHYDR EUR, V14, P6
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1
   Stockley TL, 2000, J LAB CLIN MED, V135, P484, DOI 10.1067/mlc.2000.106804
   SUN AM, 1987, BIOMATER ARTIF CELL, V15, P483, DOI 10.3109/10731198709118540
   SUN AM, 1984, APPL BIOCHEM BIOTECH, V10, P87, DOI 10.1007/BF02783739
   Suzuki K, 1999, NEUROREPORT, V10, P2891, DOI 10.1097/00001756-199909290-00003
   Thomas S, 2000, J Wound Care, V9, P56
   Thomas S, 2000, J Wound Care, V9, P163
   Thomas S, 2000, J Wound Care, V9, P115
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
   WONG H, 1986, INT J ARTIF ORGANS, V9, P335
   1999, PHARMAEUROPA, V11, P515
NR 43
TC 74
Z9 80
U1 1
U2 19
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-343-2; 1-57331-342-4
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2001
VL 944
BP 388
EP 397
PG 10
WC Engineering, Biomedical; Multidisciplinary Sciences; Transplantation
SC Engineering; Science & Technology - Other Topics; Transplantation
GA BT69D
UT WOS:000173774500033
PM 11797688
DA 2018-10-19
ER

PT J
AU Murooka, Y
   Toyama, M
   Hong, SH
   Gohya, M
   Ono, H
   Yamashita, M
   Hirayama, N
AF Murooka, Y
   Toyama, M
   Hong, SH
   Gohya, M
   Ono, H
   Yamashita, M
   Hirayama, N
TI Genetic design of stable metal-binding biomolecules, oligomeric
   metallothioneins
SO BIOCATALYSIS AND BIOTRANSFORMATION
LA English
DT Article
DE human metallothionein-II; Cd; Zn; metal tolerance; overproduction;
   stabilization
ID ESCHERICHIA-COLI; YEAST METALLOTHIONEIN; EFFICIENT EXPRESSION; I GENE;
   LIVER; PURIFICATION; TOLERANCE; THIONEIN; VECTORS; CELLS
AB Metallothionein (MT) is a suitable model for investigating molecular interactions relating to the handling of metals in cells. However, the production of functional MT proteins in microorganisms has been limited because of the instability of MT-the thiol group of cysteine is easily oxidized and proteolysis occurs. To increase the binding ability and to stabilize MT, we designed genes for dimeric and tetrameric MT and the genes were successfully overexpressed in Escherichia coli to generate functional oligomeric MTs. A human MT-H (hMT-II) synthesized with prokaryotic codons, a linker encoding a glycine tripeptide, and Met-deficient hMT-II was ligated to create a dimeric MT, from which a tetrameric MT was then constructed. The increased molecular size of the constructs resulted in improved stability and productivity in E. coli. Cells of E. coli carrying the oligomeric MT genes showed resistance toward Zn and Cd toxicity. The oligomeric proteins formed inclusion bodies, which were dissolved with dithiothreitol, and the purified apo-MTs were reconstituted with Cd or Zn ions under reducing conditions. The dimeric and tetrameric MT proteins exhibited both Cd and Zn binding activities that were, respectively, two and four times higher than those of the hMT-II monomer protein. These stable oligomeric MTs have potential as a biomaterial for uses such as detoxification and bioremediation for heavy metals.
C1 Osaka Univ, Dept Biotechnol, Grad Sch Engn, Suita, Osaka 5650871, Japan.
   Tokai Univ, Dept Biol Sci & Technol, Shizuoka 41032, Japan.
RP Murooka, Y (reprint author), Osaka Univ, Dept Biotechnol, Grad Sch Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
RI Grieco, Sung-Hye/E-6239-2012
CR BEACH LR, 1981, P NATL ACAD SCI-BIOL, V78, P2110, DOI 10.1073/pnas.78.4.2110
   BERKA T, 1988, J BACTERIOL, V170, P21, DOI 10.1128/jb.170.1.21-26.1988
   BRADY FO, 1982, TRENDS BIOCHEM SCI, V7, P143, DOI 10.1016/0968-0004(82)90206-7
   CHURBATSU LS, 1993, BIOCHEM J, V291, P193
   FELDMAN SL, 1976, BIOCHEM J, V160, P583, DOI 10.1042/bj1600583
   Hong SH, 2001, PROTEIN EXPRES PURIF, V21, P243, DOI 10.1006/prep.2000.1372
   HOU YM, 1988, BIOCHIM BIOPHYS ACTA, V951, P230, DOI 10.1016/0167-4781(88)90045-0
   Jacob C, 1998, P NATL ACAD SCI USA, V95, P3489, DOI 10.1073/pnas.95.7.3489
   KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001
   KAGI JHR, 1974, J BIOL CHEM, V249, P3537
   KILLE P, 1990, BIOCHIM BIOPHYS ACTA, V1048, P178, DOI 10.1016/0167-4781(90)90054-6
   KREZOSKI S, 1998, BIOCHEM J, V255, P483
   KULL FJ, 1990, J AM CHEM SOC, V112, P2291, DOI 10.1021/ja00162a033
   LJUNGCRANTZ P, 1989, BIOCHEMISTRY-US, V28, P8786, DOI 10.1021/bi00448a016
   Maniatis T., 1982, MOL CLONING LAB MANU
   MARGOSHES M, 1957, J AM CHEM SOC, V79, P4813, DOI 10.1021/ja01574a064
   MUROOKA Y, 1987, APPL ENVIRON MICROB, V53, P204
   MUROOKA Y, 1985, J BIOTECHNOL, V2, P303, DOI 10.1016/0168-1656(85)90032-X
   MUROOKA Y, 1985, J BIOTECHNOL, V2, P289, DOI 10.1016/0168-1656(85)90031-8
   NEMER M, 1984, DEV BIOL, V102, P471, DOI 10.1016/0012-1606(84)90212-4
   ODAWARA F, 1995, J BIOCHEM, V118, P1131, DOI 10.1093/oxfordjournals.jbchem.a124998
   OHTA N, 1983, CHEM PHARM BULL, V31, P1885
   OKADA Y, 1985, FEBS LETT, V183, P375, DOI 10.1016/0014-5793(85)80813-9
   Otvos J D, 1987, Experientia Suppl, V52, P171
   PEDERSEN AO, 1980, EUR J BIOCHEM, V106, P291
   Saito S, 1996, BBA-GEN SUBJECTS, V1289, P65, DOI 10.1016/0304-4165(95)00137-9
   STARK MJR, 1987, GENE, V51, P255, DOI 10.1016/0378-1119(87)90314-3
   VASAK M, 1981, BIOCHEMISTRY-US, V20, P2852, DOI 10.1021/bi00513a022
   WRIGHT CF, 1987, J BIOL CHEM, V262, P12912
   Xiong Y, 1997, J BIOCHEM, V121, P1102
   YAMASHITA M, 1994, J FERMENT BIOENG, V77, P113, DOI 10.1016/0922-338X(94)90308-5
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
NR 32
TC 2
Z9 2
U1 0
U2 1
PU HARWOOD ACAD PUBL GMBH, TAYLOR & FRANCIS GROUP
PI PHILADELPHIA
PA 325 CHESTNUT ST, 8TH FL, PHILADELPHIA, PA 19106 USA
SN 1024-2422
J9 BIOCATAL BIOTRANSFOR
JI Biocatal. Biotransform.
PY 2001
VL 19
IS 5-6
BP 399
EP 412
DI 10.3109/10242420108992026
PG 14
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 499LU
UT WOS:000172573300005
DA 2018-10-19
ER

PT J
AU Coombes, AGA
   Breeze, V
   Wu, LL
   Gray, T
   Parker, KG
   Parker, T
AF Coombes, AGA
   Breeze, V
   Wu, LL
   Gray, T
   Parker, KG
   Parker, T
TI Lactic acid-stabilised albumin for microsphere formulation and
   biomedical coatings
SO BIOMATERIALS
LA English
DT Article
DE albumin stabilisation; microspheres; coatings; vascular grafts
ID VASCULAR PROSTHESES; SERUM-ALBUMIN; PROTEIN; GRAFT; COMPATIBILITY;
   POLYURETHANE; DELIVERY; INVIVO
AB Microspheres of ovalbumin (OVA) ranging from 1 to 15 mum were prepared by emulsifying an aqueous solution of albumin in soya oil at room temperature then raising the temperature to 45 degreesC for 30 min, prior to harvesting of the microspheres. Production of OVA nanospheres with size less than 500 nm was achieved by desolvation from aqueous albumin solutions using acetone. In both cases, lactic acid was added to the starting albumin solution to stabilise the resulting particles. Utilisation of an endogenous substance avoids the use of chemical crosslinking agents such as glutaraldehyde and associated toxicological concerns. Protein coating of knitted Dacron vascular grafts was performed by impregnation of the textile structure with lactic acid-stabilised ovalbumin nanospheres thereby providing a surface potentially resistant to blood platelet adhesion but conducive to endothelialisation, Protein release testing carried out in PBS at 37 degreesC revealed that approximately 60% of the original albumin coating was retained by the Dacron graft material after 4 days and remained at this level for upto 4 weeks. Apart from the formulation of albumin microspheres for drug delivery, diagnostic applications and coating of biomedical textiles, the process of albumin stabilisation using lactic acid may be usefully applied to improve protein immobilisation on a wide range of biomaterial surfaces. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Nottingham, Dept Pharmaceut Sci, Nottingham NG7 2RD, England.
   Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Sch Med, Nottingham NG2 7FP, England.
   Univ Hosp, Queens Med Ctr, Dept Histopathol, Nottingham NG2 7FP, England.
RP Coombes, AGA (reprint author), Aston Univ, Aston Pharm Sch, Aston Triangle, Birmingham B4 7ET, W Midlands, England.
CR AMIJI M, 1992, J BIOMAT SCI-POLYM E, V3, P375, DOI 10.1163/156856292X00196
   ARSHADY R, 1990, J CONTROL RELEASE, V14, P111, DOI 10.1016/0168-3659(90)90149-N
   BENSLIMANE S, 1988, EUR SURG RES, V20, P18
   CAPPELLO J, 1997, CONTROLLED DRUG DELI, P439
   CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307
   Coombes AGA, 1996, VACCINE, V14, P1429, DOI 10.1016/S0264-410X(96)00077-1
   CZIPERLE DJ, 1992, J CARDIOVASC SURG, V33, P407
   EBERHART RC, 1987, ANN NY ACAD SCI, V516, P78, DOI 10.1111/j.1749-6632.1987.tb33032.x
   GOMBOTZ WR, 1995, BIOCONJUGATE CHEM, V6, P332, DOI 10.1021/bc00034a002
   HAKE U, 1991, THORAC CARDIOV SURG, V39, P208, DOI 10.1055/s-2007-1022711
   HIRT SW, 1993, J VASC SURG, V17, P538
   HORA MS, 1990, PHARMACEUT RES, V7, P1190, DOI 10.1023/A:1015948829632
   Lin W, 1993, J DRUG TARGET, V1, P237, DOI 10.3109/10611869308996081
   Marois Y, 1996, BIOMATERIALS, V17, P3, DOI 10.1016/0142-9612(96)80749-6
   PAVANETTO F, 1994, J MICROENCAPSUL, V11, P445, DOI 10.3109/02652049409034262
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   REMY M, 1994, J MATER SCI-MATER M, V5, P808, DOI 10.1007/BF00213139
   RUMISEK JD, 1986, J VASC SURG, V4, P136, DOI 10.1067/mva.1986.avs0040136
   RYU G, 1992, T AM SOC ART INT ORG, V38, pM644
   SCHWENDEMAN SP, 1997, CONTROLLED DRUG DELI, P229
   STANSBY G, 1994, BRIT J SURG, V81, P1286, DOI 10.1002/bjs.1800810908
   Takahata H, 1998, J CONTROL RELEASE, V50, P237, DOI 10.1016/S0168-3659(97)00145-4
   TOMLINSON E, 1987, POLYM CONTROLLED DRU, P25
   ZDANOWSKI Z, 1993, APMIS, V101, P926, DOI 10.1111/j.1699-0463.1993.tb00203.x
NR 24
TC 12
Z9 24
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2001
VL 22
IS 1
BP 1
EP 8
DI 10.1016/S0142-9612(00)00074-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 367BG
UT WOS:000090041200001
PM 11085377
DA 2018-10-19
ER

PT J
AU Roche, S
   Ronziere, MC
   Herbage, D
   Freyria, AM
AF Roche, S
   Ronziere, MC
   Herbage, D
   Freyria, AM
TI Native and DPPA cross-linked collagen sponges seeded with fetal bovine
   epiphyseal chondrocytes used for cartilage tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE articular cartilage repair; collagen-based biomaterial; collagen
   synthesis; glycosaminoglycan deposition; mineral deposition
ID SYNTHETIC BIODEGRADABLE POLYMERS; ARTICULAR-CARTILAGE; IN-VITRO;
   BIOREACTOR CULTIVATION; HIGH-DENSITY; DEFECTS; REPAIR; CULTURE; MATRIX;
   IMPLANTS
AB Collagen-based biomaterials in the form of sponges (bovine type I collagen, both native and cross-linked by treatment with diphenylphosphorylazide, noted control and DPPA sponges respectively) were tested as three-dimensional scaffolds to support chondrocyte proliferation with maintenance of the phenotype in order to form neocartilage. Control and DPPA sponges were initially seeded with 10(6) or 10(7) foetal bovine epiphyseal chondrocytes and maintained for 4 weeks in culture under static conditions in RPMI/NCTC medium with 10% FCS and without addition of fresh ascorbic acid. Both supports were always present during the study and a partial decrease in size and weight was detected only with control sponges, both seeded and unseeded. Cell proliferation was only noted in the 10(6) cells-seeded sponges (4-fold increase after 4 weeks of culture). Specific cartilage collagens (types II and XI) were deposited in the matrix throughout the culture and traces of type I collagen were noticed only in the culture medium after 2-3 weeks and 4 weeks in the case of 10(6) and 10(7) cells-seeded sponges, respectively. Glycosaminoglycans accumulated in the matrix, up to 1.8 and 9.8% of total dry weight after one month with both seeding conditions, which was much lower than in the natural tissue. In the 10(7) cells-seeded sponges, mineral deposition, observed with unseeded sponges, was significantly decreased (2- to 3-fold). These in vitro results indicate that both collagen matrices can support the development of tissue engineered cartilage. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 CNRS UPR 412, Inst Biol & Chim Prot, F-69007 Lyon, France.
RP Freyria, AM (reprint author), CNRS UPR 412, Inst Biol & Chim Prot, 7 Passage Vercors, F-69007 Lyon, France.
RI Roche, Stephane/B-6974-2009
OI Roche, Stephane/0000-0001-6660-1317
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Andre-Frei V, 2000, CALCIFIED TISSUE INT, V66, P204, DOI 10.1007/s002230010041
   Athanasiou K, 1997, TISSUE ENG, V3, P363, DOI 10.1089/ten.1997.3.363
   Ben-Yishay A, 1995, Tissue Eng, V1, P119, DOI 10.1089/ten.1995.1.119
   BENTLEY G, 1989, CRIT REV BIOCOMPAT, V5, P245
   BERTOLOTTO A, 1989, BASIC APPL HISTOCHEM, V33, P239
   Bradham DM, 1998, CLIN ORTHOP RELAT R, P239
   Breinan HA, 1997, J BONE JOINT SURG AM, V79A, P1439, DOI 10.2106/00004623-199710000-00001
   Britt JC, 1998, ARCH OTOLARYNGOL, V124, P671, DOI 10.1001/archotol.124.6.671
   Brittberg M, 1997, BIOMATERIALS, V18, P235, DOI 10.1016/S0142-9612(96)00117-2
   Brittberg M, 1996, CLIN ORTHOP RELAT R, P270
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   ButnariuEphrat M, 1996, CLIN ORTHOP RELAT R, P234
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   Chevallay B, 2000, J BIOMED MATER RES, V49, P448, DOI 10.1002/(SICI)1097-4636(20000315)49:4<448::AID-JBM3>3.0.CO;2-L
   CHEVALLAY B, 1998, BIOMATERIALS SURG, P3
   CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fortier LA, 1998, AM J VET RES, V59, P514
   Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Freyria Anne-Marie, 1999, Journal of Cellular Biochemistry, V76, P84
   Frondoza C, 1996, BIOMATERIALS, V17, P879, DOI 10.1016/0142-9612(96)83283-2
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   GREEN WT, 1977, CLIN ORTHOP RELAT R, P237
   HANDLEY CJ, 1993, BIOL REGULATION CHON, P85
   HENDRICKSON DA, 1994, J ORTHOPAED RES, V12, P485, DOI 10.1002/jor.1100120405
   HOMMINGA GN, 1990, J BONE JOINT SURG BR, V72, P1003
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   KIM WS, 1994, PLAST RECONSTR SURG, V94, P233, DOI 10.1097/00006534-199408000-00001
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LIPMAN JM, 1989, ANAL BIOCHEM, V176, P128, DOI 10.1016/0003-2697(89)90282-0
   LIVECCHI AB, 1994, J BIOMED MATER RES, V28, P839, DOI 10.1002/jbm.820280802
   Martin I, 1998, J ORTHOPAED RES, V16, P181, DOI 10.1002/jor.1100160205
   MATSUDA K, 1995, J BIOMAT SCI-POLYM E, V7, P221
   MATSUDA K, 1990, BIOMATERIALS, V11, P351, DOI 10.1016/0142-9612(90)90113-5
   Minas T, 1997, ORTHOPEDICS, V20, P525
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   NIXON AJ, 1993, AM J VET RES, V54, P349
   O'Driscoll SW, 1998, J BONE JOINT SURG AM, V80A, P1795, DOI 10.2106/00004623-199812000-00011
   Obradovic B, 1999, BIOTECHNOL BIOENG, V63, P197, DOI 10.1002/(SICI)1097-0290(19990420)63:2<197::AID-BIT8>3.0.CO;2-2
   Otsuka Y, 1997, DEV GROWTH DIFFER, V39, P143
   PETERKOFSKY B, 1982, METHOD ENZYMOL, V82, P453
   Peterson L, 1996, Acta Orthop Belg, V62 Suppl 1, P196
   PETIT B, 1993, BIOL REGULATION CHON, P33
   PETITE H, 1994, J BIOMED MATER RES, V28, P159, DOI 10.1002/jbm.820280204
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   ROBINSON D, 1990, CALCIFIED TISSUE INT, V46, P246, DOI 10.1007/BF02555003
   Ronziere MC, 1997, OSTEOARTHR CARTILAGE, V5, P205, DOI 10.1016/S1063-4584(97)80015-5
   RONZIERE MC, 1990, BIOCHIM BIOPHYS ACTA, V1038, P222, DOI 10.1016/0167-4838(90)90209-X
   RUGGIERO F, 1993, J HISTOCHEM CYTOCHEM, V41, P867, DOI 10.1177/41.6.8315278
   SCHUMAN L, 1995, BIOMATERIALS, V16, P809, DOI 10.1016/0142-9612(95)99644-2
   SELLERS RS, 1997, J BONE JOINT SURG AM, V79, P1439
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   SILVER FH, 1992, J LONG-TERM EFF MED, V2, P67
   Sims CD, 1996, PLAST RECONSTR SURG, V98, P843, DOI 10.1097/00006534-199610000-00015
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   Stanton JS, 1995, J MATER SCI-MATER M, V6, P739
   Toolan BC, 1996, J BIOMED MATER RES, V31, P273, DOI 10.1002/(SICI)1097-4636(199606)31:2<273::AID-JBM15>3.0.CO;2-M
   Vaissiere G, 2000, MED BIOL ENG COMPUT, V38, P205, DOI 10.1007/BF02344778
   vanSusante JLC, 1995, ACTA ORTHOP SCAND, V66, P549, DOI 10.3109/17453679509002314
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Zahedi S, 1998, J PERIODONTOL, V69, P975, DOI 10.1902/jop.1998.69.9.975
NR 68
TC 64
Z9 71
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2001
VL 22
IS 1
BP 9
EP 18
DI 10.1016/S0142-9612(00)00084-3
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 367BG
UT WOS:000090041200002
PM 11085378
OA Green Published
DA 2018-10-19
ER

PT J
AU Langstaff, S
   Sayer, M
   Smith, TJN
   Pugh, SM
AF Langstaff, S
   Sayer, M
   Smith, TJN
   Pugh, SM
TI Resorbable bioceramics based on stabilized calcium phosphates. Part II:
   evaluation of biological response
SO BIOMATERIALS
LA English
DT Article
DE bioceramic; resorbable; orthopedics; hydroxyapatite; tricalcium
   phosphate; osteoclast
ID IN-VITRO; THIN-FILMS; HYDROXYAPATITE; VIVO; RESORPTION; CERAMICS;
   INVITRO; GROWTH
AB Synthetic materials capable of being remodelled in vivo by the same processes responsible for natural bone turnover have long been sought for use as an artificial bone substitute. These materials must ideally combine osteoinductive capacity with the ability to withstand random dissolution at normal physiological pH, while being resorbed by natural cell-mediated processes. Resorbable calcium phosphate based coatings and bulk ceramics have been developed which promote the uniform deposition of new mineralized bone matrix thus enabling rapid integration with the surrounding host bone tissue in vivo. Furthermore, a critical result of this study is the determination that the silicon-stabilized calcium phosphate ceramics are essentially insoluble in biological media but are resorbed when acted upon by osteoclasts. In vitro biological testing and preliminary in vivo testing show that the important features of this new biomaterial are a characteristic calcium phosphate phase composition and a unique microporous morphology. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada.
   Millenium Biol Inc, Kingston, ON K7M 7G3, Canada.
RP Langstaff, S (reprint author), Queens Univ, Dept Phys, Stirling Hall,Rm 206A, Kingston, ON K7L 3N6, Canada.
CR BALE CW, 1997, FACT DATABASE
   BLOEBAUM RD, 1993, J ARTHROPLASTY, V8, P195
   Cotell CM, 1996, MATER RES SOC SYMP P, V414, P171
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DAVIES J, 1994, OSTEOCLASTS ACTIVATE
   DAVIES JE, 1993, CELL MATER, V3, P245
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   GERHART TN, 1988, J BIOMED MATER RES, V22, P1071, DOI 10.1002/jbm.820221110
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   GRISWOLD E, UNPUB TRANSMISSION E
   Guicheux J, 1998, J BIOMED MATER RES, V40, P560, DOI 10.1002/(SICI)1097-4636(19980615)40:4<560::AID-JBM7>3.0.CO;2-D
   HICKS CR, 1973, FUNDAMENTAL CONCEPTS, P25
   KURASHINA K, 1995, J MATER SCI-MATER M, V6, P340, DOI 10.1007/BF00120302
   Langstaff S, 1999, MATER RES SOC SYMP P, V550, P313
   Langstaff S, 1999, BIOMATERIALS, V20, P1727, DOI 10.1016/S0142-9612(99)00086-1
   Langstaff S, 1996, MATER RES SOC SYMP P, V414, P87
   LANGSTAFF SD, 1998, THESIS QUEENS U
   Levitt S R, 1969, J Biomed Mater Res, V3, P683, DOI 10.1002/jbm.820030413
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   *MILL REP CO, 1997, ORTH REH DEV PAN MED, V2
   QIU Q, 1993, CELL MATER, V3, P351
   REMINGTON RD, 1970, ANAL VARIANCE STAT A, P282
   TOFE A, 1994, CHARACTERIZATION PER, V1, P9
   TOLMAN DE, 1993, MAYO CLIN PROC, V68, P323, DOI 10.1016/S0025-6196(12)60125-6
   1994, Patent No. 00285
NR 25
TC 131
Z9 135
U1 1
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2001
VL 22
IS 2
BP 135
EP 150
DI 10.1016/S0142-9612(00)00139-3
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 372BL
UT WOS:000165213700004
PM 11101158
DA 2018-10-19
ER

PT S
AU Wang, YX
   Du, WW
   Spillman, WB
   Claus, RO
AF Wang, YX
   Du, WW
   Spillman, WB
   Claus, RO
BE Mariella, RY
   Nicolau, DV
TI Biocompatible thin film coatings fabricated using the electrostatic
   self-assembly process
SO BIOMEDICAL INSTRUMENTATION BASED ON MICRO- AND NANOTECHNOLOGY
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Biomedical Instrumentation Based on Micro- and
   Nanotechnology
CY JAN 24-25, 2001
CL SAN JOSE, CA
SP SPIE
DE biomaterials; thin films; self-assembly; FTIR; protein adsorption
ID PROTEIN ADSORPTION; SURFACES
AB Biomaterials are substances that are produced synthetically or biologically for use in the medical and the other fields. The use of biomaterials to interface with living systems, such as fluids, cells, and tissues of the body, has played an increasingly important role in medicine and pharmaceutics. In particular, the design of biocompatible synthetic surfaces to control the interaction between a living system and an implanted material remains the major theme for biomaterial applications in medicine. The novel and low-cost electrostatic self-assembly (ESA) technique provides an effective approach to incorporate various biomaterials on substrate surfaces, and gives great opportunity to develop unique biocompatible materials with well-controlled interfaces between the living system and the implanted material. This paper presents the design, synthesis, and characterization of multilayer thin films fabricated layer-by-layer by the ESA process using ceramics, polymers and fuctionalized fullerenes as candidate biomaterials. Preliminary tests on such fabricated ESA multilayer films were also conducted, including contact angle surface characterization, and in vitro protein adsorption studies with bovine albumin using Fourier Transform Infrared Reflection-Absorption Spectroscopy (FT-IRAS). The results indicate that the nanocomposite thin films fabricated with biomaterials by ESA processing may have broad potential applications for cell attachment and growth in tissue engineering.
C1 Virginia Tech, Fiber & Electroopt Res Ctr, Blacksburg, VA 24061 USA.
RP Wang, YX (reprint author), Virginia Tech, Fiber & Electroopt Res Ctr, Blacksburg, VA 24061 USA.
CR Andrade J D, 1973, Med Instrum, V7, P110
   BLACK J, 1981, BIOL PERFORMANCE MAT, pP102
   CAROTENUTO G, 1999, CAMBR HELTHT I M BOS
   CHIANG LY, 1994, J ORG CHEM, V59, P3960, DOI 10.1021/jo00093a030
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   IKADA Y, 1994, ACS SYM SER, V540, P35
   Kasemo B, 1998, CURR OPIN SOLID ST M, V3, P451, DOI 10.1016/S1359-0286(98)80006-5
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   KROTO HW, 1991, CHEM REV, V91, P1213, DOI 10.1021/cr00006a005
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467
   Lenahan KM, 1998, ADV MATER, V10, P853, DOI 10.1002/(SICI)1521-4095(199808)10:11<853::AID-ADMA853>3.0.CO;2-P
   LIEDBERG B, 1985, PROG COLL POL SCI S, V70, P67
   Liu Y, 1998, P SOC PHOTO-OPT INS, V3330, P75, DOI 10.1117/12.316960
   LIU Y, 1998, J PHYS CHEM B, V298, P2035
   Liu YJ, 1999, SMART MATER STRUCT, V8, P100, DOI 10.1088/0964-1726/8/1/011
   LIU YT, 1998, MOL B INT U, V3, P19
   Marcolongo M, 1999, MATER RES SOC SYMP P, V550, P121
   *NAT HEART LUNG BL, 1985, NIH PUBL
   Park H, 1996, PHARMACEUT RES, V13, P1770, DOI 10.1023/A:1016012520276
   Park JB, 1995, BIOMEDICAL ENG HDB, P530
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   *SRI CONS, 1998, BIOM TECHM
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   ZHAO W, IN PRESS APPL PHYS L
NR 25
TC 4
Z9 4
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3943-6
J9 PROC SPIE
PY 2001
VL 4265
BP 142
EP 151
DI 10.1117/12.427965
PG 10
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA BS41G
UT WOS:000169777000017
DA 2018-10-19
ER

PT J
AU Richards, RG
   Stiffanic, M
   Owen, GRH
   Riehle, M
   Gwynn, IAP
   Curtis, ASG
AF Richards, RG
   Stiffanic, M
   Owen, GRH
   Riehle, M
   Gwynn, IAP
   Curtis, ASG
TI Immunogold labelling of fibroblast focal adhesion sites visualised in
   fixed material using scanning electron microscopy, and living, using
   internal reflection microscopy
SO CELL BIOLOGY INTERNATIONAL
LA English
DT Article
DE backscattered electron imaging; field emission; scanning electron
   microscopy; low voltage; immunocytochemistry; internal reflection
   microscopy; cell adhesion; vinculin
ID INTERFERENCE-REFLECTION; COLLOIDAL GOLD; CELL; CONTACTS; CULTURE;
   MICROTUBULES; UNDERSURFACE; SUBSTRATUM; INVITRO; PROTEIN
AB A new immunogold labelling method for the visualisation of vinculin, an integral protein in focal adhesions of cells, is reported. Quantification of vinculin is indicative of substrate cytocompatibility (cytocompatibility is one aspect of biocompatibility; it is the cellular response to a biomaterial). For efficient labelling, most of the cell body above the cell-substrate interface was removed with detergent. The antigen blocking procedure, size of label (5 nm) and duration of silver-enhancement (6 min), for visualisation of the labelled sites on the whole cell by scanning electron microscopy (SEM), were determined. Imaging living cells with interference reflection light microscopy, followed by backscattered electron (BSE) imaging of the same fixed and immunolabelled cells confirmed the results. Collecting low voltage BSE images of embedded cells after the substrate had been removed provided 'sectional' views through the cell. This enabled visualisation of vinculin exclusively within the cell-substrate contact zone; the focal adhesions. The method could be of general use in the imaging of protein distribution at biological tissue/substrate interfaces. (C) 2001 Academic Press.
C1 AO Res Inst, CH-7270 Davos, Switzerland.
   Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.
   Univ Wales, Inst Biol Sci, Aberystwyth, Dyfed, Wales.
RP Richards, RG (reprint author), AO Res Inst, Clavadelerstr, CH-7270 Davos, Switzerland.
RI Richards, Robert/I-8235-2015; Riehle, Mathis/A-3427-2011
OI Richards, Robert/0000-0002-7778-2480; Riehle, Mathis/0000-0001-7988-1514
CR ABBAS AK, 1994, CELLULAR MOL IMMUNOL
   ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4
   AMBROSE E. J., 1961, EXPTL CELL RES SUPPL, V8, P54, DOI 10.1016/0014-4827(61)90340-8
   Beesley J. E., 1993, IMMUNOCYTOCHEMISTRY
   BEESLEY JE, 1989, MICROSCOPY HDFB, V17
   Bethe H, 1930, ANN PHYS-BERLIN, V5, P325
   Bundy KJ, 2001, CELL BIOL INT, V25, P289, DOI 10.1006/cbir.2000.0648
   BURRIDGE K, 1989, BIOESSAYS, V10, P104, DOI 10.1002/bies.950100403
   Collins Ronald K.L., 1981, HASTINGS CONST LQ, V9, P1
   CORNELL R, 1969, EXP CELL RES, V58, P289, DOI 10.1016/0014-4827(69)90507-2
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   CURTIS ASG, 1964, J CELL BIOL, V20, P199, DOI 10.1083/jcb.20.2.199
   DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566
   DAVIES PF, 1993, J CLIN INVEST, V91, P2640, DOI 10.1172/JCI116503
   DEHARVEN E, 1984, P ELECT MICROSC SOC, V42, P254
   DEMEY J, 1984, EMSA B, V14, P54
   ELVIN P, 1982, EUR J CANCER CLIN ON, V18, P669, DOI 10.1016/0277-5379(82)90213-9
   FAULK WP, 1971, IMMUNOCHEMISTRY, V8, P1081
   GEIGER B, 1979, CELL, V18, P193, DOI 10.1016/0092-8674(79)90368-4
   GOLDSTEIN JI, 1992, SCANNING ELECT MICRO
   GOODE D, 1987, J ELECTRON MICR TECH, V5, P263, DOI 10.1002/jemt.1060050306
   HEATH JP, 1978, J CELL SCI, V29, P197
   HODGES GM, 1987, SCANNING MICROSCOPY, V1, P301
   Horrisberger M., 1975, EXPERIENTIA, V31, P1147
   HORRISBERGER M, 1985, TECHNIQUES IMMUNOCYT, V3, P155
   IRELAND GW, 1982, J CELL SCI, V58, P165
   IZZARD CS, 1976, J CELL SCI, V21, P129
   Joy D.C., 1987, I PHYS C SERIES, V90, P175
   KANAYA K, 1972, J PHYS D APPL PHYS, V5, P43, DOI 10.1088/0022-3727/5/1/308
   KATOH K, 1995, CELL MOTIL CYTOSKEL, V31, P177, DOI 10.1002/cm.970310302
   Lee SW, 1997, CELL MOTIL CYTOSKEL, V36, P101, DOI 10.1002/(SICI)1097-0169(1997)36:2<101::AID-CM1>3.0.CO;2-C
   LOCHNER L, 1973, J CELL BIOL, V59
   NAMORK E, 1989, J ELECTRON MICR TECH, V11, P102, DOI 10.1002/jemt.1060110203
   NIEDERREITER M, 1994, ELECTROPHORESIS, V15, P511, DOI 10.1002/elps.1150150169
   OAKLEY C, 1993, J CELL SCI, V106, P343
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   OWEN GRH, 2001, EUR CELLS MAT, V1, P12
   Polak J. M., 1997, INTRO IMMUNOCYTOCHEM
   POLAK JM, 1984, INTRO IMMUNOCYTOCHEM
   REVEL JP, 1973, EXP CELL RES, V78, P1, DOI 10.1016/0014-4827(73)90031-1
   REVEL JP, 1974, EXP CELL RES, V84, P207, DOI 10.1016/0014-4827(74)90398-X
   Richards R. G., 1997, Cells and Materials, V7, P15
   RICHARDS RG, 1995, J MICROSC-OXFORD, V177, P43, DOI 10.1111/j.1365-2818.1995.tb03532.x
   RICHARDS RG, 1995, J MATER SCI-MATER M, V6, P120, DOI 10.1007/BF00120419
   Richards RG, 1995, CELL BIOL INT, V19, P1015, DOI 10.1006/cbir.1995.1044
   Roitt I, 1993, IMMUNOLOGY
   SCOPSI L, 1986, HISTOCHEMISTRY, V86, P35
   WALTHER P, 1984, SCANNING ELECTRON MI, V3, P1257
   Weiss P., 1941, GROWTH             S, V5, P163
NR 49
TC 36
Z9 36
U1 0
U2 8
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1065-6995
J9 CELL BIOL INT
JI Cell Biol. Int.
PY 2001
VL 25
IS 12
BP 1237
EP 1249
DI 10.1006/cbir.2001.0807
PG 13
WC Cell Biology
SC Cell Biology
GA 513KL
UT WOS:000173377300006
PM 11748917
DA 2018-10-19
ER

PT J
AU Owen, GRH
   Meredith, DO
   Gwynn, IAP
   Richards, RG
AF Owen, GRH
   Meredith, DO
   Gwynn, IAP
   Richards, RG
TI Enhancement of immunogold-labelled focal adhesion sites in fibroblasts
   cultured on metal substrates: Problems and solutions
SO CELL BIOLOGY INTERNATIONAL
LA English
DT Article
DE immunogold; SEM; silver enhancement; gold enhancement
ID SCANNING ELECTRON-MICROSCOPY; TYROSINE-HYDROXYLASE; SILVER ENHANCEMENT;
   COLLOIDAL GOLD; LOCALIZATION; UNDERSURFACE; NEURONS; CELLS
AB Visualisation of cell adhesion patterns by scanning electron microscopy requires special preparation and labelling. The membranes and cytoplasm must be removed, without damaging the antigen, to facilitate antibody access to vinculin in the focal adhesions. Low beam energy imaging is used to visualise the cell undersurface (embedded in resin after staining with osmium tetroxide) and immunogold-labelled adhesion sites. The gold probe, must be large enough (>40 nm) for detection, while viewing the whole cell, but large gold markers increase steric hindrance and decrease labelling efficiency. This problem can be overcome by using small gold probes (1-5 nm) followed by enlargement with silver enhancement, but osmium tetroxide stain etches the silver. We demonstrated that metal substrates increased this etching. Reducing the concentration of osmium tetroxide and incubation time reduced the amount of etching. We have demonstrated that gold enhancement was not etched by osmium tetroxide, irrespective of the substrate. Therefore, comparative studies of cell adhesion to different biomaterial substrates can be performed using immunogold-labelling with gold enhancement. (C) 2001 Academic Press.
C1 AO Res Inst, Davos, Switzerland.
   Univ Wales, Inst Biol Sci, Aberystwyth, Dyfed, Wales.
RP Richards, RG (reprint author), AO Res Inst, Davos, Switzerland.
RI Richards, Robert/I-8235-2015
OI Richards, Robert/0000-0002-7778-2480
CR ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4
   ARAI R, 1992, BRAIN RES BULL, V28, P343, DOI 10.1016/0361-9230(92)90200-H
   BURRIDGE K, 1989, BIOESSAYS, V10, P104, DOI 10.1002/bies.950100403
   BURRY RW, 1991, J NEUROCYTOL, V20, P124, DOI 10.1007/BF01279616
   BURRY RW, 1992, J HISTOCHEM CYTOCHEM, V40, P1849, DOI 10.1177/40.12.1453003
   CHAN J, 1990, J NEUROSCI METH, V33, P113, DOI 10.1016/0165-0270(90)90015-8
   CURTIS ASG, 1964, J CELL BIOL, V20, P199, DOI 10.1083/jcb.20.2.199
   DANSCHER G, 1983, J HISTOCHEM CYTOCHEM, V31, P1394, DOI 10.1177/31.12.6631001
   ELVIN P, 1982, EUR J CANCER CLIN ON, V18, P669, DOI 10.1016/0277-5379(82)90213-9
   GEIGER B, 1979, CELL, V18, P193, DOI 10.1016/0092-8674(79)90368-4
   HAINFELD JF, 1999, P 57 ANN M MICR SOC, P486
   HOLGATE CS, 1983, J HISTOCHEM CYTOCHEM, V31, P938, DOI 10.1177/31.7.6189883
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   MARSHAK DW, 1992, J HISTOCHEM CYTOCHEM, V40, P1465, DOI 10.1177/40.10.1356122
   Richards R. G., 1997, Cells and Materials, V7, P15
   RICHARDS RG, 1995, J MICROSC-OXFORD, V177, P43, DOI 10.1111/j.1365-2818.1995.tb03532.x
   RICHARDS RG, 1995, J MATER SCI-MATER M, V6, P120, DOI 10.1007/BF00120419
   RICHARDS RG, 2001, IN PRESS CELL BIOL I
   SAWADA H, 1994, J ELECTRON MICROSC, V43, P361
   VANDENPOL AN, 1986, J NEUROSCI, V6, P877
   WAEST RC, 1987, CRC HDB CHEM PHYSICS
NR 21
TC 15
Z9 15
U1 0
U2 3
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1065-6995
J9 CELL BIOL INT
JI Cell Biol. Int.
PY 2001
VL 25
IS 12
BP 1251
EP 1259
DI 10.1006/cbir.2001.0846
PG 9
WC Cell Biology
SC Cell Biology
GA 513KL
UT WOS:000173377300007
PM 11748918
DA 2018-10-19
ER

PT J
AU Szymura-Oleksiak, J
   Slosarczyk, A
   Cios, A
   Mycek, B
   Paszkiewicz, Z
   Szklarczyk, S
   Stankiewicz, D
AF Szymura-Oleksiak, J
   Slosarczyk, A
   Cios, A
   Mycek, B
   Paszkiewicz, Z
   Szklarczyk, S
   Stankiewicz, D
TI The kinetics of pentoxifylline release in vivo from drug-loaded
   hydroxyapatite implants
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE skeletal drug delivery system; hydroxyapatite; in vivo drug release
ID CALCIUM-PHOSPHATE CEMENT; DELIVERY SYSTEM
AB Porous hydroxyapatite implants were evaluated as potential skeletal delivery systems for sustained delivery of drugs. Pentoxifylline (PTX) was employed as a model agent and 50 mg of PTX powder was loaded into hollow cylindrical implants. The kinetics of PTX release from the implants was studied both in vitro, employing phosphate buffer (pH 7.35) at the temperature of 37 degreesC, and in vivo, implanting drug-containing cylinders into rabbit iliac bones. For the sake of comparison rabbits were also administered a single i.v. or i.m. dose of 50 mg PTX. Serum PTX concentration levels were measured using the HPLC method. Results of analyses carried out employing the mercury porosimetry method and the hydrostatic weighing method showed that the investigated biomaterial was characterized by a large number of pores ranging in size from 0.4 to 6 mum and with open and total porosity values of 31.8 and 35.6%. respectively. Studies in vitro revealed typical sigmoid-type drug release patterns with a lag time. After 40 h, the amount of released PTX reached a plateau and equaled 78% of the total amount of drug loaded into an implant. Studies in vivo demonstrated that due to decelerated PTX release from cylinders implanted in rabbit iliac bones. its serum concentration values were maintained at measurable levels almost eight times longer than following the systemic administration of PTX. The serum half-life following PTX administration via implants was significantly higher than the value calculated after systemic administration and equaled 6.3 h. The authors also showed that despite differences in the temporal distribution of PTX concentration values, its bioavailability was similar after i.m. injections and administration via implants. As it follows from the investigations. hydroxyapatite implants manifest positive drug-release patterns both in vitro and in vivo. (C) 2001 Elsevier Science Ltd and Techna S.r.l. All rights reserved.
C1 Jagiellonian Univ, Fac Pharm, Dept Pharmacokinet & Phys Pharm, Krakow, Poland.
   Jagiellonian Univ, Polish Amet Childrens Hosp, Dept Pediat Surg, Krakow, Poland.
   Univ Min & Met, Fac Mat Sci & Ceram, Krakow, Poland.
RP Szymura-Oleksiak, J (reprint author), Jagiellonian Univ, Fac Pharm, Dept Pharmacokinet & Phys Pharm, Krakow, Poland.
CR DASH AK, 1992, PHARMACEUT RES, V9, P993, DOI 10.1023/A:1015842108772
   DASH AK, 1998, J PHARM TOX METHODS, V41, P1
   LeGeros R. Z., 1991, CALCIUM PHOSPHATES O
   OTSUKA M, 1994, J CONTROL RELEASE, V31, P111, DOI 10.1016/0168-3659(94)00007-7
   OTSUKA M, 1994, J PHARM SCI, V83, P1565, DOI 10.1002/jps.2600831109
   OTSUKA M, 1994, J PHARM SCI, V83, P259, DOI 10.1002/jps.2600830230
   OTSUKA M, 1997, P 2 INT S AP JAP ASS
   SHARGEL L., 1993, APPL BIOPHARMACEUTIC
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   SLOSARCZYK A, 1999, J MATER SCI LETT, V8, P1163
   Szymura-Oleksiak J, 1997, PHARM SCI, V3, P367
   WARD A, 1987, DRUGS, V34, P50, DOI 10.2165/00003495-198734010-00003
NR 12
TC 17
Z9 18
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
J9 CERAM INT
JI Ceram. Int.
PY 2001
VL 27
IS 7
BP 767
EP 772
DI 10.1016/S0272-8842(01)00028-1
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 476RV
UT WOS:000171243300007
DA 2018-10-19
ER

PT J
AU Johansson, A
   Flock, JI
   Svensson, O
AF Johansson, A
   Flock, JI
   Svensson, O
TI Collagen and fibronectin binding in experimental staphylococcal
   osteomyelitis
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID AUREUS; ADHESION; ENDOCARDITIS; PROTEINS
AB A new mouse model of locally induced osteomyelitis was used to study the importance for pathogenicity of the specific binding ability of Staphylococcus aureus to collagen and fibronectin. This method appears to be convenient, reproducible, and suitable for large-scale experiments. In contrast to previous studies in experimental arthritis and endocarditis models, no difference in infection rates was found between the strains deficient in binding to collagen compared with the corresponding adherence-proficient strains. However, fibronectin binding ability in this model, in contrast to the endocarditis model, is thought to enhance the microorganisms' capacity to establish an infection. Infections caused by the fibronectin-binding strain also are thought to be clinically more aggressive than those caused by the nonbinding strain. Specific adherence mechanisms are thought to be operative in the pathogenesis of biomaterial associated osteomyelitis, and an improved understanding of such mechanisms may have an important prophylactic and therapeutic impact.
C1 Huddinge Univ Hosp, Karolinska Inst, Dept Orthopaed, S-14186 Huddinge, Sweden.
   Huddinge Univ Hosp, Karolinska Inst, Dept Surg, S-14186 Huddinge, Sweden.
   Huddinge Univ Hosp, Karolinska Inst, Dept Anesthesiol, S-14186 Huddinge, Sweden.
   Huddinge Univ Hosp, Karolinska Inst, Dept Radiol, S-14186 Huddinge, Sweden.
   Huddinge Univ Hosp, Karolinska Inst, Dept Immunol, S-14186 Huddinge, Sweden.
   Huddinge Univ Hosp, Karolinska Inst, Dept Microbiol, S-14186 Huddinge, Sweden.
   Huddinge Univ Hosp, Karolinska Inst, Dept Pathol, S-14186 Huddinge, Sweden.
   Huddinge Univ Hosp, Karolinska Inst, Dept Infect Dis, S-14186 Huddinge, Sweden.
   Huddinge Univ Hosp, Karolinska Inst, Clin Res Ctr, S-14186 Huddinge, Sweden.
RP Johansson, A (reprint author), Huddinge Univ Hosp, Karolinska Inst, Dept Orthopaed, K54, S-14186 Huddinge, Sweden.
CR Fischer B, 1996, J ORTHOPAED RES, V14, P914, DOI 10.1002/jor.1100140611
   Flock JI, 1996, INFECT IMMUN, V64, P1876
   GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hienz SA, 1996, J INFECT DIS, V174, P83, DOI 10.1093/infdis/174.1.83
   HOLDERBAUM D, 1985, COLLAGEN REL RES, V5, P261
   KUUSELA P, 1978, NATURE, V276, P718, DOI 10.1038/276718a0
   PATTI JM, 1994, INFECT IMMUN, V62, P152
   Paulsson M, 1990, FEMS Microbiol Immunol, V2, P55
   RYDEN C, 1989, EUR J BIOCHEM, V184, P331, DOI 10.1111/j.1432-1033.1989.tb15023.x
   VERCELLOTTI GM, 1985, AM J PATHOL, V120, P13
NR 11
TC 28
Z9 29
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD JAN
PY 2001
IS 382
BP 241
EP 246
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 388NL
UT WOS:000166187100032
PM 11153994
DA 2018-10-19
ER

PT J
AU Silva, VV
   Lameiras, FS
   Domingues, RZ
AF Silva, VV
   Lameiras, FS
   Domingues, RZ
TI Microstructural and mechanical study of zirconia-hydroxyapatite (ZH)
   composite ceramics for biomedical applications
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Article
DE hydroxyapatite; zirconia; composite; microstructure; mechanical
   properties
ID PARTIALLY-STABILIZED ZIRCONIA; BONE; PSZ; INTERFACE; IMPLANTS
AB Hydroxyapatite is the mineral component of natural hard tissues and, as such, it has been studied extensively as a candidate biomaterial for its use in prosthetic applications. However. the main weakness of this material lies in its poor mechanical strength which makes it unsuitable for load-bearing applications. On the other hand, partially stabilized zirconia has been widely studied on account of its high strength and fracture toughness, and good biocompatibility. Therefore, it is believed that the addition of a particulate zirconia phase to a hydroxyapatite one may lead to an improvement of the mechanical properties of this kind of composite and will not affect its biocompatibility. In this study, two series of zirconia- hydroxyapatite composites, Z4H6 and Z6H4 with 40 and 60 vol.% of zirconia content respectively, were prepared by powder uniaxial pressing at 700 MPa and sintering in air at 120-1500 degreesC for 3 h. The sintering behavior. microstructural characteristics and mechanical properties were evaluated. Variation of average grain size for the zirconia and hydroxyapatite phases with sintering temperature was observed. Relative densities ranging from 89 to 91% of the theoretical values were reached for the Z6H4 ceramic series and for the Z4H6 sample sintered at 1400 degreesC, although microcracks were present in all specimens sintered at 1400 and 1500 degreesC. Values of ultimate compressive strength, Young's modulus. micro-Vickers hardness and Poisson's ratio near to those for human cortical bone and human tooth (dentine and enamel) were found for almost all samples investigated suggesting that these materials present potential applications as structural implants. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 CNEC, CDTN, BR-30123970 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, ICEx, Dept Quim, Mat Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Silva, VV (reprint author), CNEC, CDTN, R Prof Mario Werneck S-N,Pampulha,CP 941, BR-30123970 Belo Horizonte, MG, Brazil.
RI Domingues, Rosana/P-2017-2014; Domingues, Rosana/C-3174-2013
OI Domingues, Rosana/0000-0001-5667-2031; Domingues,
   Rosana/0000-0001-5667-2031
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF00552220
   BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   BONFIELD W, 1988, BIOCERAMICS MATERIAL, V523, P173
   Burger W, 1997, J MATER SCI-MATER M, V8, P113, DOI 10.1023/A:1018562917779
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   GARVIE RC, 1972, J AM CERAM SOC, V55, P152, DOI 10.1111/j.1151-2916.1972.tb11241.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   GARVIE RC, 1984, J MATER SCI, V19, P3224, DOI 10.1007/BF00549808
   Gregorie M., 1990, J BIOMED MATER RES, V24, P163
   GROSS V, 1987, BIOCERAMICS MAT CHAR
   HEALY KE, 1998, HDB BIOMATERIALS PRO
   HOLMES RE, 1987, INT J ORAL MAX SURG, V16, P718, DOI 10.1016/S0901-5027(87)80059-0
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   KLEIN CPAT, 1991, J BIOMED MATER RES, V25, P53, DOI 10.1002/jbm.820250105
   KROON PO, 1992, J BONE JOINT SURG BR, V74, P518
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   Legeros R. Z., 1991, ADV SERIES CERAMICS, V1
   Legeros RZ, 1988, J DENT RES, V67, P177
   LI J, 1995, BIOMATERIALS, V16, P417, DOI 10.1016/0142-9612(95)98860-G
   MattioliBelmonte M, 1997, J MATER SCI-MATER M, V8, P85, DOI 10.1023/A:1018554715962
   MONROE EA, 1971, J DENT RES, V50, P860, DOI 10.1177/00220345710500041201
   MULLERMAI CM, 1990, SCANNING MICROSCOPY, V4, P613
   Park K, 1997, MATER LETT, V32, P229, DOI 10.1016/S0167-577X(97)00041-4
   PINTO LCM, 1996, ACTA MICROSCOPIA B, V5, P168
   PORTER DL, 1977, J AM CERAM SOC, V60, P183, DOI 10.1111/j.1151-2916.1977.tb15509.x
   RAVAGLIOLI A, BIOCERAMICS MAT PROP, P292
   SEDEL L, 1991, BIOCERAMICS, V4
   Silva VV, 1997, J MATER SCI-MATER M, V8, P907, DOI 10.1023/A:1018566124507
   Silva VV, 2000, MATER CHARACT, V45, P51, DOI 10.1016/S1044-5803(00)00048-6
   SILVA VV, P MAT SOC RES 1998 F, P261
   SUBBARAO EC, 1981, ADV CERAMICS SCI TEC, V3
NR 33
TC 96
Z9 104
U1 1
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PY 2001
VL 61
IS 2
BP 301
EP 310
DI 10.1016/S0266-3538(00)00222-0
PG 10
WC Materials Science, Composites
SC Materials Science
GA 398HF
UT WOS:000166750300012
DA 2018-10-19
ER

PT B
AU Kalantarian, B
   Song, L
   Riordan, PA
   Amarante, MT
   Nagy, PG
   Wilson, CR
   Toth, JM
   Chow, LC
   McIntyre, BL
   Gosain, AK
AF Kalantarian, B
   Song, L
   Riordan, PA
   Amarante, MT
   Nagy, PG
   Wilson, CR
   Toth, JM
   Chow, LC
   McIntyre, BL
   Gosain, AK
BE Lauritzen, CGK
TI One year study of hydroxyapatite derivatives in facial skeletal
   augmentation: Autogenous bone graft versus biomaterials to depository
   versus resorptive recipient sites
SO CRANIOFACIAL SURGERY 9
LA English
DT Proceedings Paper
CT 9th International Congress of the
   International-Society-of-Craniofacial-Surgery
CY JUN 17-20, 2001
CL VISBY, SWEDEN
SP Int Soc Craniofacial Surg
AB The present study was performed to determine whether composite biomaterials would maximize long term facial augmentation and optimize bone ingrowth and if there are preferred recipient sites for bone graft and biomaterials. 16.8 nun discs were prepared from calvarial bone grafts, hydroxyapatite ceramic (HACER), a ceramic composite of 60% HA and 40% b-tricalcium phosphate (60% HA-CER), and HA cement paste (HA-CP). Facial recipient sites tested were 1) the body of the mandible, 2) the maxillary region, and 3) the frontal bone. One year post-grafting bone grafts demonstrated a highly significant reduction in volume in all sites (p <.0001). Bone replacement in the biomaterial was greatest in HA-CER (23.9%) followed by 60% HA-CER (16.4%) and least in HA-CP (4.2%) (p<0.05), irrespective of recipient site. The volume maintenance of HA composites was much more predictable than that of cranial bone graft, and there was minimal bone replacement within cement paste forms of HA.
C1 Med Coll Wisconsin, Div Plast Surg, Milwaukee, WI 53226 USA.
RP Kalantarian, B (reprint author), Med Coll Wisconsin, Div Plast Surg, Milwaukee, WI 53226 USA.
CR ENLOW D, 1982, HDB FACIAL GROWTH, P140
   GOSAIN AK, IN PRESS PLAST RECON
NR 2
TC 0
Z9 0
U1 0
U2 1
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
BN 88-323-1617-X
PY 2001
BP 245
EP 247
PG 3
WC Surgery
SC Surgery
GA BU03F
UT WOS:000174770400066
DA 2018-10-19
ER

PT B
AU Nan, Q
   Li, N
   Xia, YQ
   Peng, JS
   Dong, BW
   Liang, P
   Yu, XL
AF Nan, Q
   Li, N
   Xia, YQ
   Peng, JS
   Dong, BW
   Liang, P
   Yu, XL
BE Zhu, GM
   Peng, SQ
   Li, QP
TI Measurement system of thermal properties of biomaterials
SO ENERGY CONVERSION AND APPLICATION, VOL I AND II
LA English
DT Proceedings Paper
CT International Conference on Energy Conversion and Application (ICECA
   2001)
CY JUN 17-20, 2001
CL WUHAN, PEOPLES R CHINA
SP Huazhong Univ Sci & Technol, Univ Calif Los Angeles, Univ Nottingham, Nippon Inst Technol, Hong Kong Univ Sci & Technol, Univ Otago
DE thermal conductivity; blood perfusion
AB This paper provided the method with self-heated thermistor probe to measure the thermal properties of biomaterial. Experiments have been done in the inorganic medium (water, glycerol, and glycol) and in vitro. At last, the author pointed the possibility and necessaries to measure the conductivity and blood perfusion of biomaterial simultaneously.
C1 Beijing Polytech Univ, Ctr Biomed, Beijing 100022, Peoples R China.
RP Nan, Q (reprint author), Beijing Polytech Univ, Ctr Biomed, Beijing 100022, Peoples R China.
CR ARKIN H, 1994, IEEE T BIO-MED ENG, V41, P97, DOI 10.1109/10.284920
   BOWMAN HF, 1976, CRYOBIOLOGY, V13, P572, DOI 10.1016/0011-2240(76)90150-4
   VALVANO JW, 1984, J BIOMECH ENG-T ASME, V106, P192
NR 3
TC 0
Z9 0
U1 1
U2 1
PU HUAZHONG UNIVERSITY SCIENCE & TECHNOLOGY PRESS
PI WUHAN
PA YUJIASHAN, WUHAN, HUPEI, PEOPLES R CHINA
BN 7-5609-2420-4
PY 2001
BP 1309
EP 1311
PG 3
WC Thermodynamics; Energy & Fuels; Engineering, Mechanical; Mechanics
SC Thermodynamics; Energy & Fuels; Engineering; Mechanics
GA BS85M
UT WOS:000171232700283
DA 2018-10-19
ER

PT J
AU Lembert, N
   Wesche, J
   Petersen, P
   Zschocke, P
   Enderle, A
   Planck, H
   Ammon, HPT
AF Lembert, N
   Wesche, J
   Petersen, P
   Zschocke, P
   Enderle, A
   Planck, H
   Ammon, HPT
TI Macroencapsulation of rat islets without alteration of insulin secretion
   kinetics
SO EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
LA English
DT Article
DE Islet of Langerhans; macroencapsulation; bioartificial pancreas;
   biomaterial; polysulphone
ID ARTIFICIAL PANCREAS; DIABETES-MELLITUS
AB Transplantation of encapsulated islets may restore endogenous insulin secretion in type 1 diabetics with no need of lifetime immunosuppression of the recipient. A biomaterial should be developed which combined immunoisolation with rapid and efficient diffusion of glucose and insulin. Rat islets were macroencapsulated in capillaries (molecular cut off 50 kD) of differently modified polysulphone. Macroencapsulated islets were perifused to study the kinetics of glucose induced insulin secretion into the perifusion medium. Blending polysulphone (PSU) with poly vinyl pyrrolidone or sodium dodecyl. sulphate was not suited for islet macroencapsulation since glucose induced insulin release was absent after encapsulation. Hydroxy methylation (CH2OH) of PSU improved the secretory behaviour of macroencapsulated islets depending on the degree of substitution (DS). At 0.8 DS glucose induced insulin secretion was delayed and inefficient. At maximal degrees of PSU-substitution (1.8) the kinetics of insulin release and the efficiency of insulin release were very similar to that observed of free floating islets. In conclusion, highly substituted hydroxgy methylated polysulphone allows a rapid and efficient insulin release after macroencapsulation and is suited for the further development of a bioartificial pancreas.
C1 Univ Tubingen, Dept Pharmacol, D-72076 Tubingen, Germany.
   Univ Tubingen, Dept Gen Surg, D-72076 Tubingen, Germany.
   Inst Text & Proc Engn, ITV, Denkendorf, Germany.
RP Lembert, N (reprint author), Univ Tubingen, Dept Pharmacol, Morgenstelle 8, D-72076 Tubingen, Germany.
CR CALAFIORE R, 1998, DIABETES METAB REV, P315
   CALLESESCANDON J, 1987, DIABETES, V36, P1167, DOI 10.2337/diabetes.36.10.1167
   Gruessner A C, 1997, Clin Transpl, P45
   LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35
   MAKI T, 1993, TRANSPLANTATION, V55, P713, DOI 10.1097/00007890-199304000-00005
   Maki T, 1996, DIABETES, V45, P342, DOI 10.2337/diabetes.45.3.342
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   SULLIVAN SJ, 1991, SCIENCE, V252, P718, DOI 10.1126/science.2024124
NR 9
TC 9
Z9 9
U1 0
U2 2
PU JOHANN AMBROSIUS BARTH VERLAG
PI HEIDELBERG
PA IM WEIHER 10, D-69121 HEIDELBERG, GERMANY
SN 0947-7349
J9 EXP CLIN ENDOCR DIAB
JI Exp. Clin. Endocrinol. Diabet.
PY 2001
VL 109
IS 2
BP 116
EP 119
DI 10.1055/s-2001-14828
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 422NE
UT WOS:000168124400009
PM 11341299
DA 2018-10-19
ER

PT S
AU Chu, CL
   Wang, SD
   Lin, PH
   Yin, ZD
   Zhu, JC
AF Chu, CL
   Wang, SD
   Lin, PH
   Yin, ZD
   Zhu, JC
BE Trumble, K
   Bowman, K
   Reimanis, I
   Sampath, S
TI Characterization and optimized design of HA-Ti/Ti/Ha-Ti symmetrical
   functionally graded biomaterial
SO FUNCTIONALLY GRADED MATERIALS 2000
SE CERAMIC TRANSACTIONS
LA English
DT Proceedings Paper
CT 6th International Symposium on Functionally Graded Materials
CY SEP 10-14, 2000
CL ESTES PK, CO
SP Natl Sci Fdn, USA Off Res, USN Off Res
AB The optimized distribution function of components of the hydroxyapatite (HA)-Ti symmetrical functionally graded biomaterial (FGM) has been obtained based on the classical lamination theory and thermo-elastic mechanics firstly. The FGM was fabricated by hot pressing successfully whose actual distributions of compositions and thermal residual stress have been analyzed by electron probe microanalyser (EPMA) and X-ray diffraction method, which are consistent with those designed theoretically. Its integral apparent bending strength can reach to 159MPa, which is higher than that of human bone. HA-Ti symmetrical FGM behaved integral-fracture without falling apart or delaminating under all loading modes. As a result, the pure titanium layer could provide an effective support of mechanical properties for the whole FGM.
C1 Southeast Univ, Dept Mech Engn, Nanjing 210018, Peoples R China.
RP Chu, CL (reprint author), Southeast Univ, Dept Mech Engn, Nanjing 210018, Peoples R China.
CR BISHOP A, 1993, J MATER SCI LETT, V12, P1516
   Chu CL, 1999, J INORG MATER, V14, P775
   Chu CL, 1999, MAT SCI ENG A-STRUCT, V271, P95, DOI 10.1016/S0921-5093(99)00152-5
   CHU CL, 2000, THESIS HARBIN I TECH
   CHU CL, 1999, T NONFERROUS METALS, V9, P57
   CHU CL, 2000, IN PRESS T NONFERROU, V10
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Neubrand A, 1997, Z METALLKD, V88, P358
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Suresh S, 1997, INT MATER REV, V42, P85, DOI 10.1179/imr.1997.42.3.85
   Tang X.F., 1994, J CHINESE CERAMIC SO, V22, P44
   Watari F, 1998, J JPN I MET, V62, P1095, DOI 10.2320/jinstmet1952.62.11_1095
NR 12
TC 0
Z9 0
U1 0
U2 0
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 1042-1122
BN 1-57498-110-2
J9 CERAM TRANS
PY 2001
VL 114
BP 81
EP 88
PG 8
WC Materials Science, Ceramics; Mechanics; Materials Science, Biomaterials;
   Materials Science, Characterization & Testing; Materials Science,
   Coatings & Films
SC Materials Science; Mechanics
GA BW85Y
UT WOS:000183415800011
DA 2018-10-19
ER

PT J
AU Heymann, D
   Guicheux, J
   Rousselle, AV
AF Heymann, D
   Guicheux, J
   Rousselle, AV
TI Ultrastructural evidence in vitro of osteoclast-induced degradation of
   calcium phosphate ceramic by simultaneous resorption and phagocytosis
   mechanisms
SO HISTOLOGY AND HISTOPATHOLOGY
LA English
DT Article
DE osteoclast; resorption; phagocytosis; calcium-phosphate ceramic;
   biomaterial
ID MONOCYTES IN-VITRO; TRICALCIUM PHOSPHATE; BONE-RESORPTION;
   HYDROXYAPATITE; CELLS; CULTURE; DOGS
AB Osteoclasts are physiological polykaryons specialized in the resorption of calcified tissue. In the context of the clinical use of calcium-phosphate (CaP) ceramics as bone substitutes, this study used transmission electron microscopy to investigate the in vitro mechanisms of CaP ceramic degradation by osteoclastic cell types. Osteoclasts cultured on CaP ceramic developed typical ultrastructural features of bone osteoclasts, such as a polarized dome shape, a clear zone and a ruffled border. Modification of the shape and density of CaP crystals under the ruffled border indicated an acidic microenvironment. Moreover, osteoclasts were able to degrade ceramic by simultaneous resorption and phagocytosis mechanisms. Phagocytosis did not alter the ability of osteoclasts to resorb CaP ceramic. The phagocytosis mechanism consisted of three steps: crystal phagocytosis, disappearance of the endophagosome envelope membrane and fragmentation of phagocytosed crystals within the cytoplasm. The common mechanism of phagocytosis described here is similar to that observed with the monocyte/macrophage lineage, confirming that osteoclasts are part of the mononuclear phagocyte system. Osteoclasts are thus clearly involved in CaP degradation by means of resorption and phagocytosis.
C1 Fac Med, Lab Physiol & Pathol Bone Resorpt, F-44035 Nantes, France.
   Fac Med, Lab Histol Embryol, Nantes, France.
   Fdn Med Res, Geneva, Switzerland.
RP Heymann, D (reprint author), Fac Med, Lab Physiol & Pathol Bone Resorpt, EE99-01,1 Rue G Veil, F-44035 Nantes, France.
RI guicheux, Jerome/F-7767-2013
OI guicheux, Jerome/0000-0003-2754-3024
CR ATHANASOU NA, 1992, J BONE JOINT SURG BR, V74, P57
   ATHANASOU NA, 1991, BRIT J CANCER, V63, P527, DOI 10.1038/bjc.1991.125
   BASLE MF, 1993, CALCIFIED TISSUE INT, V53, P348, DOI 10.1007/BF01351842
   Benahmed M, 1996, BIOMATERIALS, V17, P2173, DOI 10.1016/0142-9612(96)00046-4
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   Benahmed MD, 1996, J HISTOCHEM CYTOCHEM, V44, P1131, DOI 10.1177/44.10.8813078
   CHAMBERS TJ, 1979, J PATHOL, V127, P55, DOI 10.1002/path.1711270202
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DAVIES JE, 1993, CELL MATER, V3, P245
   DEBRUIJN JD, 1994, J BIOMED MATER RES, V28, P105, DOI 10.1002/jbm.820280114
   DERSOT JM, 1995, ANAT REC, V242, P166, DOI 10.1002/ar.1092420205
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   Guicheux J, 1998, BONE, V22, P25, DOI 10.1016/S8756-3282(97)00224-X
   Heymann D, 1998, CYTOKINE, V10, P155, DOI 10.1006/cyto.1997.0277
   Heymann D, 1999, HISTOL HISTOPATHOL, V14, P871, DOI 10.14670/HH-14.871
   IKAMI K, 1990, ARCH HISTOL CYTOL, V53, P227, DOI 10.1679/aohc.53.227
   JONES SJ, 1984, ANAT EMBRYOL, V170, P247, DOI 10.1007/BF00318728
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, V248, P12
   ROODMAN GD, 1993, CALCIFIED TISSUE INT, V53, P594
   Suda T, 1997, J BONE MINER RES, V12, P869, DOI 10.1359/jbmr.1997.12.6.869
   TETZUKA K, 1992, BIOCHEM BIOPH RES CO, V186, P911
   WADA T, 1989, J PERIODONTAL RES, V24, P391, DOI 10.1111/j.1600-0765.1989.tb00888.x
   Wang W, 1997, J PATHOL, V182, P92
   Wang W, 1997, J BONE JOINT SURG BR, V79B, P849, DOI 10.1302/0301-620X.79B5.7780
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P108
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yamada S, 1997, J BIOMED MATER RES, V37, P346, DOI 10.1002/(SICI)1097-4636(19971205)37:3<346::AID-JBM5>3.0.CO;2-L
NR 30
TC 28
Z9 30
U1 1
U2 6
PU F HERNANDEZ
PI MURCIA
PA PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN
SN 0213-3911
J9 HISTOL HISTOPATHOL
JI Histol. Histopath.
PD JAN
PY 2001
VL 16
IS 1
BP 37
EP 44
PG 8
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA 390TD
UT WOS:000166311900005
PM 11193210
DA 2018-10-19
ER

PT S
AU Sawan, M
AF Sawan, M
GP IEEE
   IEEE
TI Microelectronics to build smart medical devices
SO ICM 2001: 13TH INTERNATIONAL CONFERENCE ON MICROELECTRONICS, PROCEEDINGS
SE International Conference on Microelectronics-ICM
LA English
DT Proceedings Paper
CT 13th International Conference on Microelectronics (ICM 2001)
CY OCT 29-31, 2001
CL RABAT, MOROCCO
SP IEEE, Agcy Natl Reglementat Telecommun, Minist Enseignenment Super Rech Sci, Secretatiat Etat Aupres Minist Enseignement Super Rech Sci Charge Rech Sci, SEPTI, CNRST, Rectorat Univ Mohammed V-Agdal, Sicotel, Silvaco Data Syst, STMicroelectr, Mentor Graph, Commune Agda/Ryad, Off Natl Eau Potable, Barid El Maghreb
AB Among the numerous implantable smart medical devices introduced recently, the bladder controller and the visual cortical stimulator are the main subjects of research activities of PolySTIM team headed by prof. Mohamad Sawan, at the Ecole Polytechnique de Montreal. Such devices are dedicated to recuperate or enhance neuromuscular functions in patients by means of peripherals or central nervous systems. While the bladder controllor is dedicated to recuperate voiding and retention functions on paralyzed patients, the electronic visual stimulator is dedicated to create an adequate vision for totally blind patients. Neural peripheral sacral stimulation is applied to recover the bladder function, but direct stimulation of the brain, is the basic principle of the visual cortex stimulator proposed by PolySTIM.
   The talk will focus on these two applications. Dr. Sawan will elaborate the design and validation of the visual implant that involves advanced stimulator mounted on a matrix of 25x25 microelectrodes which will be implanted on the visuel cortex to recuperate partiel vision for blind patients. This type of pluridisciplinary projects include a wide variety of domains of interest in Microelectronics, RF electronics, mechanical, biomaterial, physics, chemical, as well as in various medical domains such as Neurology, etc.
C1 Ecole Polytech, Montreal, PQ H3C 3A7, Canada.
RP Sawan, M (reprint author), Ecole Polytech, Montreal, PQ H3C 3A7, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2159-1679
BN 0-7803-7522-X
J9 INT C MICROELECTRON
PY 2001
BP 19
EP 19
PG 1
WC Computer Science, Hardware & Architecture; Computer Science, Software
   Engineering; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BU50B
UT WOS:000176153500004
DA 2018-10-19
ER

PT B
AU Kimura, S
   Chiba, A
   Morizono, Y
AF Kimura, S
   Chiba, A
   Morizono, Y
BE Chiba, A
   Tanimura, S
   Hokamoto, K
TI Fabrication of titanium/hydroxyapatite functionally graded bio-materials
   by underwater-shock compaction
SO IMPACT ENGINEERING AND APPLICATION, VOLS I AND II
LA English
DT Proceedings Paper
CT 4th International Symposium on Impact Engineering
CY JUL 16-18, 2001
CL KUMAMOTO, JAPAN
SP Kumamoto Univ, Shock Wave & Condensed Matter Res Ctr, Kumamoto Univ, Fac Engn, Japan Soc Mech Engineers, Soc Mat Sci, Japan Soc Technol Plast, Japan Explos Soc, Commemorat Assoc Japan World Exposit, Minist Educ Culture Sports Sci & Technol, Kumamoto Int Convent Bureau
DE biomaterial; shock compaction; titanium; hydroxyapatite; alumina;
   functionally graded material; dynamic powder consolidation; explosive
AB Ti/hydroxyapatite (HAp) functionally graded materials (FGM) was fabricated by under water shock compaction technique without using any binding additives. Due to the low fracture strength and low toughness of HAp compact, HAp is unsusceptible to practical application. In order to obtain good mechanical properties of the compact without any degradation of biocompatibility, Al203 was added to HAp powder. The characteristics of the Ti/HAp FGM and the Ti/HAp-Al203 FGM were investigated by measurements of relative density, hardness and SEM-EDX microanalysis. Ti/HAp-Al203 sound compacts were fabricated without any cracks and tears. The compacts show continuous compositional and virtually continuous hardness changes.
C1 Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.
RP Kimura, S (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, 2-39-1 Kurokami, Kumamoto 8608555, Japan.
CR CHIBA A, 1997, 21 INT S SHOCK WAV, P1
   CHIBA A, 1992, SHOCK WAVE HIGH STRA, P415
   DEWITH G, 1981, J MATER SCI, V16, P1592
   TOMOSHIGE R, 1992, NIPPON SERAM KYO GAK, V100, P1230
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
BN 0-08-043968-3
PY 2001
BP 905
EP 910
PG 4
WC Engineering, Mechanical; Metallurgy & Metallurgical Engineering
SC Engineering; Metallurgy & Metallurgical Engineering
GA BV14E
UT WOS:000177934200144
DA 2018-10-19
ER

PT S
AU Wickramasinghe, NC
   David, L
   Wickramasinghe, JT
AF Wickramasinghe, NC
   David, L
   Wickramasinghe, JT
BE Hoover, RB
   Levin, GV
   Paepe, RR
   Rozanov, AY
TI Evidence of photoluminescence of biomaterial in space
SO INSTRUMENTS, METHODS, AND MISSIONS FOR ASTROBIOLOGY IV
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Instruments, Methods, and Missions for Astrobiology IV
CY JUL 29-30, 2001
CL SAN DIEGO, CA
SP SPIE
DE panspermia; interstellar dust; photoluminescence; comets; meteors
ID EXTENDED RED EMISSION; KUIPER-BELT OBJECTS; NEBULAE; LUMINESCENCE;
   EXTINCTION; AU
AB An excess red emission of interstellar dust observed over the waveband 5000-8000Angstrom is well fitted in terms of photoluminescence of biologically derived chromophores. The redness of a class of Edgeworth-Kuiper belt objects and of areas of the Martian surface may have a similar explanation.
C1 Cardiff Ctr Astrobiol, Cardiff CF10 3DY, S Glam, Wales.
RP Wickramasinghe, NC (reprint author), Cardiff Ctr Astrobiol, 2 North Rd, Cardiff CF10 3DY, S Glam, Wales.
CR CAMPBELL AK, 1987, COMP BIOCHEM PHYS B, V86, P411, DOI 10.1016/0305-0491(87)90314-2
   DARBON S, 1998, ASTRON ASTROPHYS, V333, pL21
   DHENDECOURT LB, 1986, ASTRON ASTROPHYS, V170, P91
   DULEY WW, 1990, MON NOT R ASTRON SOC, V247, P647
   FURTON DG, 1992, ASTROPHYS J, V386, P587, DOI 10.1086/171041
   Gordon KD, 1998, ASTROPHYS J, V498, P522, DOI 10.1086/305571
   Hoyle F, 1996, ASTROPHYS SPACE SCI, V235, P343, DOI 10.1007/BF00644454
   Hoyle F, 2000, ASTRONOMICAL ORIGINS
   Hoyle F., 1990, THEORY COSMIC GRAINS
   MATTILA K, 1979, ASTRON ASTROPHYS, V78, P253
   PERRIN M, 1995, ASTRON ASTROPHYS, V304, P264
   PERSHIN SM, 2000, INTERNET MAGAZINE
   SIVAN JP, 1993, ASTROPHYS J, V404, P258, DOI 10.1086/172273
   SZOMORU A, 1998, APJ, V494, P93
   Tegler SC, 2000, NATURE, V407, P979, DOI 10.1038/35039572
   WEBSTER A, 1993, MON NOT R ASTRON SOC, V264, pL1, DOI 10.1093/mnras/264.1.L1
   Wickramasinghe NC, 1996, ASTROPHYS SPACE SCI, V240, P161, DOI 10.1007/BF00640204
   Wickramasinghe NC, 1998, ASTROPHYS SPACE SCI, V259, P205, DOI 10.1023/A:1001565121458
   WITT AN, 1990, ASTROPHYS J, V355, P182, DOI 10.1086/168752
   Zubko VG, 1999, ASTROPHYS J, V511, pL57, DOI 10.1086/311831
NR 20
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4209-7
J9 P SOC PHOTO-OPT INS
PY 2001
VL 4495
BP 255
EP 260
PG 6
WC Astronomy & Astrophysics; Instruments & Instrumentation
SC Astronomy & Astrophysics; Instruments & Instrumentation
GA BU13L
UT WOS:000175125700024
DA 2018-10-19
ER

PT J
AU Lucas, A
   Gaude, J
   Carel, C
   Michel, JF
   Cathelineau, G
AF Lucas, A
   Gaude, J
   Carel, C
   Michel, JF
   Cathelineau, G
TI A synthetic aragonite-based ceramic as a bone graft substitute and
   substrate for antibiotics
SO INTERNATIONAL JOURNAL OF INORGANIC MATERIALS
LA English
DT Article
DE ceramics; porous materials; bone substitute; antibiotics carrier
ID CALCIUM-PHOSPHATE CERAMICS; DYNAMIC COMPACTION; GROWTH-HORMONE;
   HYDROXYAPATITE; RESORPTION; CORAL; CARBONATE
AB The present material is a non-sintered porous synthetic carbonate in its metastable modification under ambient pressure, i.e. aragonite, for bone reconstruction and drug carrying. The crystal structure, density, morphology and granulometry of the synthetic aragonite are characterized. Thr powdered aragonite is used for processing non-sintered porous ceramics. The influence of process parameters on porosity is investigated. In vivo biocompatibility, resorption and bone formation have been evaluated after implantation of selected materials in femurs of sheep. Preliminary results show a mineralization of the implant sites and the complete resorption of implants at 6 months. Two antibiotics Metronidazole and Gentamicin were incorporated into materials without alteration or degradation. This incorporation of therapeutic agents in the first stages of the process, and particularly before compaction, allows a controlled drug loading of the biomaterial. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Lab CSIM, UMR CNRS 6511, F-35042 Rennes, France.
   Lab Biomat Site Osseux, F-35000 Rennes, France.
RP Lucas, A (reprint author), Lab CSIM, UMR CNRS 6511, Campus Beaulieu,Bat 10B, F-35042 Rennes, France.
CR Blair HC, 1998, BIOESSAYS, V20, P837, DOI 10.1002/(SICI)1521-1878(199810)20:10<837::AID-BIES9>3.3.CO;2-4
   BOULTIF A, 1991, J APPL CRYSTALLOGR, V24, P987, DOI 10.1107/S0021889891006441
   Braye F, 1996, BIOMATERIALS, V17, P1345, DOI 10.1016/0142-9612(96)88682-0
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DENISSEN H, 1994, BONE MINER, V25, P123, DOI 10.1016/S0169-6009(08)80254-1
   DEVILLIERS JP, 1971, AM MINERAL, V56, P758
   EYSEL W, 1975, Z KRISTALLOGR, V141, P11, DOI 10.1524/zkri.1975.141.1-2.11
   Gao TJ, 1997, BIOMATERIALS, V18, P219, DOI 10.1016/S0142-9612(96)00133-0
   Guicheux J, 1998, J BIOMED MATER RES, V40, P560, DOI 10.1002/(SICI)1097-4636(19980615)40:4<560::AID-JBM7>3.0.CO;2-D
   Guicheux J, 1997, J BIOMED MATER RES, V36, P258, DOI 10.1002/(SICI)1097-4636(199708)36:2<258::AID-JBM15>3.0.CO;2-C
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   Irigaray JL, 1996, J BIOMAT SCI-POLYM E, V7, P741, DOI 10.1163/156856296X00507
   JAROSCH D, 1986, TSCHER MINER PETROG, V35, P127, DOI 10.1007/BF01140844
   Kiraly K, 1997, HISTOCHEM J, V29, P317, DOI 10.1023/A:1020802631968
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   Lang J., 1987, B SOC SCI BRETAGNE, V53, P95
   Liu D.M., 1996, POROUS CERAMIC MAT
   LIU DM, 1997, POROUS MAT TISSUE EN
   Lucas A, 1999, J SOLID STATE CHEM, V146, P73, DOI 10.1006/jssc.1999.8310
   LUCAS A, Patent No. 9726024
   McConnell D, 1973, APATITE ITS CRYSTAL
   Mighell A. D., 1981, 1141 NBS
   NEWNHAM RE, 1978, PHASE DIAGRAMS MAT V, V6, P43
   PARK JB, 1992, BIOMATERIALS INTRO, P177
   PATEL A, 1980, Calcified Tissue International, V31, P108
   Radin S, 1997, BIOMATERIALS, V18, P777, DOI 10.1016/S0142-9612(96)00190-1
   Redey SA, 1999, J BIOMED MATER RES, V45, P140, DOI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
   RENOOIJ W, 1985, CLIN ORTHOP RELAT R, P272
   REY C, 1990, Biomaterials, V11, P13
   Rodriguez-Caravajal J, 1990, 15TH SAT M POWD DIFF, P127
   ROUDIER M, 1995, J BIOMED MATER RES, V29, P909, DOI 10.1002/jbm.820290802
   ROY DM, 1978, PHASE DIAGRAMS MATER, V6, P185
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   SWANSON F, 1997, 050586 JCPDSICDD
   THOMAZEAU H, 1996, CHIRURGIE, V121, P663
   Trecant M, 1997, BIOMATERIALS, V18, P141, DOI 10.1016/S0142-9612(96)00108-1
   WEAST RC, 1976, HDB CHEM PHYSICS
   Wu H, 1997, J Tongji Med Univ, V17, P160
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   YUKNA R A, 1991, Journal of Dental Research, V70, P467
NR 42
TC 37
Z9 39
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1466-6049
J9 INT J INORG MATER
JI Int. J. Inorg. Mater.
PD JAN
PY 2001
VL 3
IS 1
BP 87
EP 94
DI 10.1016/S1466-6049(00)00058-1
PG 8
WC Chemistry, Inorganic & Nuclear; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 390JA
UT WOS:000166290900012
DA 2018-10-19
ER

PT J
AU Shabalovskaya, SA
AF Shabalovskaya, SA
TI Physicochemical and biological aspects of Nitinol as a biomaterial
SO INTERNATIONAL MATERIALS REVIEWS
LA English
DT Review
ID SHAPE-MEMORY ALLOY; NICKEL-TITANIUM ALLOY; VENA-CAVA FILTER; NI-TI
   ALLOY; CORROSION-RESISTANCE; IN-VIVO; SPECTROSCOPIC CHARACTERIZATION;
   PASSIVE FILM; BIOCOMPATIBILITY; METAL
AB The rapid increase in the development of medical devices using nearly equiatomic Ni-Ti alloys (Nitinol) provides evidence of their advantages as biomaterials. Two generic properties of Nitinol, thermally induced shape recovery and superelasticity, are successfully employed for medical uses. However, several aspects of the alloys' short and long term efficacy have yet to be comprehensively determined, especially parameters relating to surface and corrosion performance, The present review surveys studies carried out internationally over about the past 10 years aiming at an improved understanding of Nitinol's surface, corrosion, and biocompatibility features. A critical survey is given of the surface condition of alloys modified using various advanced techniques, oxidised in air-water-steam mixtures, and passivated using chemical-electrochemical procedures, Surface parameters and their importance to the improvement of Nitinol's corrosion resistance and biological performance are discussed on the basis of XPS, Auger, SEM, and BSEM studies. In vivo and in vitro corrosion studies using potentiodynamic, potentiostatic, and scratch tests on as cast alloys, wire, and actual devices are surveyed. The effects of stress, strain, heat treatment, microstructure, precipitates, and alloy composition on corrosion are evaluated and compared with data for stainless steels, cobalt base alloys, and titanium. Release of nickel, observed in vitro and in vivo, is also surveyed. Biocompatibility aspects are briefly discussed with emphasis on their possible correlation with surface condition.
C1 Iowa State Univ, Inst Phys Res & Technol, Ames, IA 50011 USA.
RP Shabalovskaya, SA (reprint author), Iowa State Univ, Inst Phys Res & Technol, Ames, IA 50011 USA.
CR Anderson James M., 1996, P415
   ANDREASEN GF, 1971, J AM DENT ASSOC, V82, P1373, DOI 10.14219/jada.archive.1971.0209
   ANGELINE E, 1999, P S APL LEGH NITI CA, P47
   ARMITAGE D, 1997, P 2 INT C SHAP MEM S, P411
   ARMITAGE D, 1999, P INT C SHAP MEM SUP, P226
   Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   *ASTM, 1996, ANN BOOK ASTM STAND, V13
   AVERBACK R, 1985, SURFACE ALLOYING ION, P91
   Ayers RA, 1999, J BIOMED MATER RES, V45, P42
   BARETT R, 1993, AM J ORTHOD DENTOFAC, V103, P8
   BergerGorbet M, 1996, J BIOMED MATER RES, V32, P243, DOI 10.1002/(SICI)1097-4636(199610)32:2<243::AID-JBM14>3.0.CO;2-K
   BERSTEIN A, 1992, BIOMATERIALS, V13, P98, DOI 10.1016/0142-9612(92)90002-6
   Bond JR, 1999, COMPUT SCI ENG, V1, P12
   BONDY K, 1986, J BIOMED MATER RES, V20, P493
   Brown S., 1982, CLIN APPL BIOMATERIA, P195
   BROWN SA, 1988, J BIOMED MATER RES, V22, P321, DOI 10.1002/jbm.820220406
   BUECHLER W, 1963, J APPL PHYS, V34, P1475
   CARROLL W, 1999, P INT C SHAP MEM SUP, P240
   CASTLEMAN LS, 1981, BIOCOMPATIBILITY CLI, P129
   CHAN CM, 1990, SURF INTERFACE ANAL, V15, P349, DOI 10.1002/sia.740150602
   CHINJIANG L, 2000, IN PRESS P 3 INT C S
   CHUPRINA V, 1989, POROSHKOV METALL, V6, P57
   CHUPRINA V, 1989, POROSHKOV METALL, V4, P310
   CLAYTON C, 1985, SURFACE ALLOYING ION, P325
   CRAGG A, 1983, RADIOLOGY, V141, P601
   CRAGG AH, 1993, RADIOLOGY, V189, P775, DOI 10.1148/radiology.189.3.8234703
   DAMBAEV G, 2000, SHAPE MEMORIZING IMP, P27
   DAUTOVICH DP, 1966, J APPL PHYS, V37, P2513, DOI 10.1063/1.1708847
   DUTTA RS, 1993, BRIT CORROS J, V28, P217
   Endo K, 1995, Dent Mater J, V14, P185
   EUM J, 2000, IN PRESS P 3 INT C S
   Filip P, 1997, MAT SCI ENG A-STRUCT, V234, P422, DOI 10.1016/S0921-5093(97)00265-7
   FISHER H, 1999, P INT C SHAP MEM SUP, P181
   FONTANA M, 1978, CORROSION ENG, P463
   Frank TG, 2000, MINIM INVASIV THER, V9, P89, DOI 10.3109/13645700009063055
   FUNAKUBO H, 1984, SHAPE MEMEORY ALLOYS
   GLENN R, 1997, P 2 INT C SHAP MEM S, P585
   GOYER R, CASSARETT DOULLS TOX, P582
   GRIMSDOTTIR MR, 1994, BIOMATERIALS, V15, P1157
   GROTH H, 2000, IN PRESS P 3 INT C S
   Gyunter V.E., 1995, SUPERELASTIC SHAPE M
   GYUNTER VE, 1992, SHAPE MEMORY EFFECTS
   HAASTERS J, 1990, ENG ASPECTS SHAPE ME, P426
   HANSEN K, 1983, P S NICK HUM ENV LYO, P183
   HAYES R, 1997, CANCER CAUSE CONTROL, V8, P321
   HIRANO K, 1968, KINZOKU GAKKAISHI, V32, P267
   Hoar T, 1996, P ROY SOC LOND A MAT, V294, P486
   IHIPRRY B, 2000, J BIOMED MATER RES, V49, P88
   ITIN V, 1995, P INT C SUP SHAP MEM, P234
   Itin V, 1999, MET PROT, V35, P373
   Itin VI, 1996, PISMA ZH TEKH FIZ+, V22, P37
   JOHNSON AA, 1974, Patent No. 3786806
   KIM YS, 1997, P 2 INT C SHAP MEM S, P473
   Kimura H, 1987, J Osaka Univ Dent Sch, V27, P211
   Kruger J., 1979, ASTM SPEC TECH PUBL, P107
   Lacy SA, 1996, J BIOMED MATER RES, V32, P279
   LI B, 1997, P 2 INT C SHAP MEM S, P591
   Liu R, 2000, MAT SCI ENG A-STRUCT, V277, P169, DOI 10.1016/S0921-5093(99)00534-1
   LU S, 1990, ENG ASPECTS SHAPE ME, P445
   MATSUMOTO K, 1993, J JPN ORTHOP ASSOC, V67, P267
   McGovern TE, 1996, J BIOMED MATER RES, V32, P447
   MCINTYRE NS, 1975, ANAL CHEM, V47, P2208, DOI 10.1021/ac60363a034
   MCKAY G, 1997, BIOMATERIALS, V17, P1339
   Melzer A., 1994, P 1 INT C SHAP MEM S, P401
   MERCIER O, 1980, J APPL PHYS, V51, P1833, DOI 10.1063/1.327750
   MERRITT K, 1984, J BIOMED MATER RES, V18, P1005, DOI 10.1002/jbm.820180905
   MICHEL R, 1987, CRIT REV BIOCOMPAT, V3, P235
   MonteroOcampo C, 1996, J BIOMED MATER RES, V32, P583, DOI 10.1002/(SICI)1097-4636(199612)32:4<583::AID-JBM11>3.0.CO;2-F
   NAG K, 1980, COORDIN CHEM REV, V33, P87, DOI 10.1016/S0010-8545(00)80405-1
   OBRIEN B, 1999, P INT C SHAP MEM SUP, P171
   OKAMOTO G, 1973, CORROS SCI, V13, P471, DOI 10.1016/0010-938X(73)90031-0
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Olefjord I, 1993, Int J Oral Maxillofac Implants, V8, P32
   OVSKAYA SS, 1996, BIOMED MAT ENG, V6, P267
   PATTI A, 1999, P S APL LEGH NITI CA, P33
   PESSALL N, 1971, ELECTROCHIM ACTA, V16, P1987, DOI 10.1016/0013-4686(71)85152-6
   PLATT J, 1977, AM J DENTOFAC ORTHOP, V112, P69
   POLENICHKIN V, 1979, Patent No. 850067
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   RENTLER RM, 1975, J BIOMED MATER RES, V9, P597, DOI 10.1002/jbm.820090606
   REVIE RW, 1969, CORROS SCI, V9, P755, DOI 10.1016/S0010-938X(69)80081-8
   RIEPE G, 2000, IN PRESS P 3 INT C S
   Rondelli G, 2000, J BIOMED MATER RES, V51, P47, DOI 10.1002/(SICI)1097-4636(200007)51:1<47::AID-JBM7>3.3.CO;2-G
   RONDELLI G, 1990, CORROS SCI, V30, P805, DOI 10.1016/0010-938X(90)90004-O
   Rondelli G, 1996, BIOMATERIALS, V17, P2003, DOI 10.1016/0142-9612(95)00352-5
   Rondelli G, 1999, BIOMATERIALS, V20, P785, DOI 10.1016/S0142-9612(98)90233-2
   RUTNER B, 1996, BIOMATERIAL SCI, P21
   RYHANAN J, 1999, THESIS OULUN YLIOPIS
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Ryhanen J, 1999, J BIOMED MATER RES, V47, P472, DOI 10.1002/(SICI)1097-4636(19991215)47:4<472::AID-JBM3>3.0.CO;2-Z
   Ryhanen J, 1998, J BIOMED MATER RES, V41, P481, DOI 10.1002/(SICI)1097-4636(19980905)41:3<481::AID-JBM19>3.0.CO;2-L
   Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0
   Ryhanen J, 2000, MINIM INVASIV THER, V9, P99, DOI 10.3109/13645700009063056
   SCHMERLING MA, 1976, J BIOMED MATER RES, V10, P879, DOI 10.1002/jbm.820100607
   SEIGEL R, 1997, SURG ENDOSC-ULTRAS, V11, P154
   SHABALOVSKAYA S, 2000, IN PRESS P INT C SHA
   SHABALOVSKAYA S, 2002, IN PRESS BIOMED MAT, V12
   Shabalovskaya S., 1994, P 1 INT C SHAP MEM S, P209
   SHABALOVSKAYA S, 1997, P 2 INT C SHAP MEM S, P401
   SHABALOVSKAYA SA, 1995, J VAC SCI TECHNOL A, V13, P2624, DOI 10.1116/1.579461
   SHABALOVSKAYA SA, 1994, MATER RES SOC SYMP P, V331, P239
   Sheth S, 1996, CIRCULATION, V94, P1733, DOI 10.1161/01.CIR.94.7.1733
   Shih CC, 2000, J BIOMED MATER RES, V52, P395, DOI 10.1002/1097-4636(200011)52:2<395::AID-JBM21>3.0.CO;2-B
   Shih CC, 2000, J BIOMED MATER RES, V52, P323
   SILBERSTEIN B, 1997, P 2 INT C SHAP MEM S, P617
   SIMON M, 1977, RADIOLOGY, V125, P89, DOI 10.1148/125.1.89
   SIMON M, 1989, RADIOLOGY, V172, P99, DOI 10.1148/radiology.172.1.2662259
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
   SNOW ET, 1992, PHARMACOL THERAPEUT, V53, P31, DOI 10.1016/0163-7258(92)90043-Y
   STAROKHA A, 1997, P INT C SHAP MEM SUP, P509
   Stoeckel D, 2000, MINIM INVASIV THER, V9, P81, DOI 10.3109/13645700009063054
   Su Y. Y., 1998, WIRE J INT, V31, P106
   SU YY, 1997, P 2 INT C SHAP MEM S, P389
   SUNDERMAN F, 1983, P S NICK HUM ENV LYO, P127
   SYISOLYATIN P, 1997, P INT C SHAP MEM SUP, P471
   THIERRY B, 2000, IN PRESS P 3 INT C S
   Trepanier C, 1998, J BIOMED MATER RES, V43, P433, DOI 10.1002/(SICI)1097-4636(199824)43:4<433::AID-JBM11>3.0.CO;2-#
   Trepanier C, 1999, J BIOMED MATER RES, V48, P165, DOI 10.1002/(SICI)1097-4636(1999)48:2<165::AID-JBM11>3.0.CO;2-#
   TREPANIER C, 1997, P 2 INT C SHAP MEM S, P423
   USTINSKAYA I, 1987, ELECTROCHEMIYA, V23, P254
   Van Humbeeck J., 1998, SHAPE MEMORY MAT, P149
   VANDERKERKHOVE R, 1999, P INT C SHAP MEM SUP, P129
   Venugopalan R, 2000, MINIM INVASIV THER, V9, P67, DOI 10.3109/13645700009063052
   Villermaux F, 1997, APPL SURF SCI, V109, P62, DOI 10.1016/S0169-4332(96)00619-8
   Villermaux F, 1996, BIO-MED MATER ENG, V6, P241
   VILLERMAUX F, 1997, P 2 INT C SHAP MEM S, P417
   WATAHA J, 1999, J BIOMED MATER RES, V45, P252
   Wataha JC, 2000, J BIOMED MATER RES, V52, P360, DOI 10.1002/1097-4636(200011)52:2<360::AID-JBM16>3.0.CO;2-B
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   WILLIAMS DF, 1973, IMPLANTS SURG
   Williamson D H, 1985, Yeast, V1, P1, DOI 10.1002/yea.320010102
   Wiltshire W A, 1996, Quintessence Int, V27, P513
   WISBEY A, 1991, BIOMATERIALS, V12, P970
   YAHALOM J, 1970, ELECTROCHIM ACTA, V15, P1429, DOI 10.1016/0013-4686(70)80064-0
   YAHIA LH, 2000, IN PRESS P 3 INT C S
   YANG J, 1997, P 2 INT C SHAP MEM S, P479
   YANG P, 1986, P INT S SHAP MEM ALL
NR 138
TC 67
Z9 71
U1 3
U2 26
PU MANEY PUBLISHING
PI LEEDS
PA HUDSON RD, LEEDS LS9 7DL, ENGLAND
SN 0950-6608
J9 INT MATER REV
JI Int. Mater. Rev.
PY 2001
VL 46
IS 5
BP 233
EP 250
DI 10.1179/095066001771048745
PG 18
WC Materials Science, Multidisciplinary
SC Materials Science
GA 511JG
UT WOS:000173260400002
DA 2018-10-19
ER

PT J
AU Paez, JMG
   Carrera, A
   Herrero, EJ
   Millan, I
   Rocha, A
   Cordon, A
   Sainz, N
   Mendez, J
   Castillo-Oliveres, JL
AF Paez, JMG
   Carrera, A
   Herrero, EJ
   Millan, I
   Rocha, A
   Cordon, A
   Sainz, N
   Mendez, J
   Castillo-Oliveres, JL
TI Influence of the selection of the suture material on the mechanical
   behavior of a biomaterial to be employed in the construction of
   implants. Part 1: Calf pericardium
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
ID BIOPROSTHETIC HEART-VALVES; TISSUE SELECTION; CARDIAC BIOPROSTHESES;
   BOVINE PERICARDIUM; ELASTIC BEHAVIOR; REOPERATION; PROSTHESES; THREADS;
   SITES
AB A hydraulic stress simulator was employed to study the mechanical behavior of the calf pericardium used in the construction of cardiac valve leaflets. One hundred eighty pairs of tissue samples were subjected to tensile testing to rupture. One of the two samples from each of 144 pairs (four series of 36 pairs each) was sutured with commercially available threads made of nylon, silk, Prolene or Gore-Tex, while the other sample in each of these pairs was left unsewn. The remaining 36 pairs were employed as controls in which neither of the two samples was subjected to suturing. The sutured tissue samples showed a significant decrease in tensile strength at rupture (range: 11.81 to 26.04 MPa) when compared with unsutured samples (range: 39.38 to 87.96 MPa; p < 0.01). The application of morphological and mechanical selection criteria to maximize the homogeneity of the samples provided excellent fit with respect to the stress/strain curves. This method made it possible to carry out a predictive study of the mechanical behavior of a sutured sample, based on that observed in the corresponding unsutured fragment. The interaction of the different suture materials with the pericardial tissue was also assessed by comparing the mechanical behavior of the sutured samples with that of the control samples. At stresses of less than 0.8 MPa, samples sewn with Gore-Tex were found to show the least difference with respect to the controls, indicating that this material presented the lowest degree of interaction with the pericardium.
   In conclusion, the degree of the loss of resistance to tearing of the sutured samples is of no value in the selection of the optimal suture material. The selection process applied makes it possible to predict the mechanical behavior in response to suturing of a given unsewn tissue specimen by determining that of its sutured mate. The similarity between the findings in samples sewn with Gore-Tex and in the unsutured controls indicates a lesser degree of interaction between the suture material and the pericardium employed in the construction of cardiac valve leaflets.
C1 Clin Puerta de Hierro Madrid, Serv Cirugia Expt & Med Prevent, Madrid 28035, Spain.
   Escuela Tecn Super Ingn Ind, Dept Mecan Estruct & Resistencia Mat, Madrid, Spain.
   Clin Puerta de Hierro Madrid, Serv Bioestadist, Madrid 28035, Spain.
RI Sainz, Nekane/G-3136-2016
OI Sainz, Nekane/0000-0002-8438-6929
CR Bortolotti U, 1994, J Heart Valve Dis, V3, P81
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   Bustamante John, 1996, Archivos del Instituto de Cardiologia de Mexico, V66, P229
   CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   GLOWER DD, 1994, J THORAC CARDIOV SUR, V107, P381
   GLOWER DD, 1995, J THORAC CARDIOV SUR, V109, P877, DOI 10.1016/S0022-5223(95)70311-X
   Gould P. L., 1973, Computers and Structures, V3, P377, DOI 10.1016/0045-7949(73)90024-2
   HARIZA F, 1996, J HEART VALVE DIS, V5, P35
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   Julien M, 1997, BIOMATERIALS, V18, P605, DOI 10.1016/S0142-9612(96)00155-X
   KENT PD, 1998, CARDIOVASC PATHOL, V17, P9
   KUNZELMAN KS, 1993, J LONG-TERM EFF MED, V3, P161
   MAUSNER JS, 1985, EPIDEMIOLOGY INTRO T
   Munro AI, 1995, ANN THORAC SURG, V59, pS470
   OBRIEN MF, 1995, ANN THORAC SURG, V60, pS65, DOI 10.1016/0003-4975(95)00223-8
   Paez JMG, 2000, J BIOMATER APPL, V15, P47
   PAEZ JMG, 1990, J THORAC CARDIOV SUR, V100, P580
   Paez JMG, 2000, J MATER SCI-MATER M, V11, P273, DOI 10.1023/A:1008901128613
   Paez JMG, 1996, BIOMATERIALS, V17, P1677, DOI 10.1016/0142-9612(96)87647-2
   PAEZ JMG, 1994, BIOMATERIALS, V15, P981, DOI 10.1016/0142-9612(94)90078-7
   PAEZ JMG, 1994, BIOMATERIALS, V5, P172
   ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P697, DOI 10.1002/jbm.820270602
   Smith DB, 1997, J HEART VALVE DIS, V6, P424
   Talman EA, 1996, J HEART VALVE DIS, V5, P152
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   VONFRAUNHOFER JA, 1992, BIOMATERIALS, V13, P715, DOI 10.1016/0142-9612(92)90133-9
   VONFRAUNHOFER JA, 1988, BIOMATERIALS, V9, P324, DOI 10.1016/0142-9612(88)90027-0
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
NR 31
TC 3
Z9 3
U1 0
U2 1
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PY 2001
VL 16
IS 1
BP 47
EP 67
DI 10.1106/GNCT-31PT-JHKJ-FPX5
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 450GN
UT WOS:000169733400004
DA 2018-10-19
ER

PT J
AU Paez, JMG
   Carrera, A
   Herrero, EJ
   Millan, I
   Rocha, A
   Cordon, A
   Sainz, N
   Mendez, J
   Castillo-Olivares, JL
AF Paez, JMG
   Carrera, A
   Herrero, EJ
   Millan, I
   Rocha, A
   Cordon, A
   Sainz, N
   Mendez, J
   Castillo-Olivares, JL
TI Influence of the selection of the suture material on the mechanical
   behavior of a biomaterial to be employed in the construction of
   implants. Part 2: Porcine pericardium
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
ID BIOPROSTHETIC HEART-VALVES; BOVINE PERICARDIUM; TISSUE SELECTION; FIBER
   ARCHITECTURE; PROSTHESES; THREADS; SITES
AB Using a hydraulic stress simulator, the mechanical behavior of the porcine pericardium used in the construction of cardiac valve leaflets was characterized following the same procedure employed with calf pericardium in Part 1 of this study. One hundred fifty pairs of tissue samples were subjected to tensile testing to rupture. One of the two samples from each of 120 pairs (four series of 30 pairs each) was saturated with commercially available threads made of nylon, silk, Prolene or Gore-Tex, while the other sample in each of these pairs was left unsewn. The remaining 30 pairs were employed as controls in which neither of the two samples was subjected to suturing. The sutured tissue samples showed a significant decrease in tensile strength at rupture (range: 11.61 to 21.22 MPa) when compared with unsutured samples (range: 50.80 to 89.45 MPa; p < 0.01). When these results were compared with their equivalent in calf pericardium, no significant differences were observed (the mean values at rupture in calf pericardium ranged between 211.61 MPa and 26.04 MPa). Again, the application of morphological and mechanical selection criteria to ensure the homogeneity of the samples provided excellent fit with respect to the stress/strain curves.
   The interaction of the different suture materials with the pericardial tissue was also assessed by comparing the mechanical behavior of the sutured samples with that of the control samples. At the working stress of a cardiac valve leaflet, 0.250 MPa, samples sewn with Gore-Tex were found to show the least difference in behavior with respect to the controls, indicating that this material presented the lowest degree of interaction with the pericardium. In conclusion, the suture clearly has deleterious effects on the resistance of both calf and porcine pericardium, which showed no statistically significant differences in terms of resistance to rupture when their respective sutured or unsutured samples were compared, except in the case of porcine pericardium sewn with silk, which presented lower resistance to rupture in all the zones studied. These findings suggest that the hypothesis that porcine pericardium is less resistant is erroneous.
   The Gore-Tex suture also presented a lower degree of interaction with the porcine pericardium, with values similar to the working stress of a cardiac valve leaflet.
   This methodology and the results should be evaluated in dynamic studies, such as fatigue testing, that not only confirm the resistance of the material but establish the durability of the samples being assayed.
C1 Clin Puerta de Hierro Madrid, Serv Cirugia Expt & Med Prevent, Madrid 28035, Spain.
   Clin Puerta de Hierro Madrid, Serv Bioestadist, Madrid 28035, Spain.
   Escuela Tecn Super Ingn Ind, Dept Mecan Estructural & Resistencia Mat, Madrid, Spain.
RI Sainz, Nekane/G-3136-2016
OI Sainz, Nekane/0000-0002-8438-6929
CR BLOOMFIELD P, 1991, NEW ENGL J MED, V324, P573, DOI 10.1056/NEJM199102283240901
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   Gould P. L., 1973, Computers and Structures, V3, P377, DOI 10.1016/0045-7949(73)90024-2
   GRUNKEMEIER GL, 1994, J THORAC CARDIOV SUR, V108, P709
   GUERRA F, 1990, J THORAC CARDIOV SUR, V99, P838
   HARIZA F, 1996, J HEART VALVE DIS, V5, P35
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   KENT PD, 1998, CARDIOVASC PATHOL, V17, P9
   KUNZELMAN KS, 1993, J LONG-TERM EFF MED, V3, P161
   MUNRO AI, 1995, ANN THORAC SURG, V60, pS459
   Munro AI, 1995, ANN THORAC SURG, V59, pS470
   PAEZ JMG, 1990, J THORAC CARDIOV SUR, V100, P580
   Paez JMG, 1996, BIOMATERIALS, V17, P1677, DOI 10.1016/0142-9612(96)87647-2
   PAEZ JMG, 1994, BIOMATERIALS, V15, P981, DOI 10.1016/0142-9612(94)90078-7
   PAEZ JMG, 1994, BIOMATERIALS, V5, P172
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P697, DOI 10.1002/jbm.820270602
   Smith DB, 1997, J HEART VALVE DIS, V6, P424
   Talman EA, 1996, J HEART VALVE DIS, V5, P152
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   VONFRAUNHOFER JA, 1992, BIOMATERIALS, V13, P715, DOI 10.1016/0142-9612(92)90133-9
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
NR 26
TC 4
Z9 4
U1 2
U2 4
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PY 2001
VL 16
IS 1
BP 68
EP 90
AR PII 3JXMUTPNPXTG72DT
DI 10.1106/3JXM-UTPN-PXTG-72DT
PG 23
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 450GN
UT WOS:000169733400005
DA 2018-10-19
ER

PT J
AU De Giglio, E
   De Gennaro, L
   Sabbatini, L
   Zambonin, G
AF De Giglio, E
   De Gennaro, L
   Sabbatini, L
   Zambonin, G
TI Analytical characterization of collagen- and/or hydroxyapatite-modified
   polypyrrole films electrosynthesized on Ti-substrates for the
   development of new bioactive surfaces
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE collagen; hydroxyapatite; polypyrrole; electropolymerization;
   biocompatible polymers; titanium
ID RAY PHOTOELECTRON-SPECTROSCOPY; CHEMICAL-STRUCTURE; OXIDIZED TITANIUM;
   HUMAN OSTEOBLASTS; BIOMATERIALS; TISSUE; ALLOY; BONE; IMMOBILIZATION;
   IMPLANTATION
AB The design and development of new bioactive surfaces on titanium-based materials employed in orthopedic implants is described. The new biosurfaces consist of thin polypyrrole films, directly grown on implant materials and modified by the inclusion of hydroxyapatite and/or collagen during the polymer electrodeposition step. The experimental procedure has been optimized in terms of loading and distribution of the bioactive components. X-ray photoelectron spectroscopy (XPS) and scanning electron microscopy (SEM) investigations have been performed in order to control the effectiveness of film modifications. In particular, XPS has been used to check the presence of biocompounds in the surface and sub-surface region of the polymer film, which is a critical requisite for a positive interface interaction between the biomaterial and the surrounding tissue.
C1 Univ Bari, Dipartmento Chim, I-70126 Bari, Italy.
   Univ Bari, Policlin Pzza G Cesare, Ist Anat Umana Normale, I-70124 Bari, Italy.
RP Sabbatini, L (reprint author), Univ Bari, Dipartmento Chim, Via Orabona 4, I-70126 Bari, Italy.
EM sabba@chemica.uniba.it
OI Sabbatini, Luigia/0000-0002-5099-2242; De Giglio,
   Elvira/0000-0001-9387-6201
CR Bakos D, 1999, BIOMATERIALS, V20, P191, DOI 10.1016/S0142-9612(98)00163-X
   Bigi A, 1998, BIOMATERIALS, V19, P739, DOI 10.1016/S0142-9612(97)00194-4
   Born R, 1998, FRESEN J ANAL CHEM, V361, P697, DOI 10.1007/s002160050997
   Cascone MG, 1998, POLYMER, V39, P6357, DOI 10.1016/S0032-3861(98)00148-7
   CLARKSON TW, 1976, TRACE ELEMENTS HUMAN, V2, P453
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   De Giglio E, 1999, J BIOMAT SCI-POLYM E, V10, P845, DOI 10.1163/156856299X00919
   DEGIGLIO E, 1997, EGYPT J ANAL CHEM, V6, P19
   DEGIGLIO E, 1997, THESIS NATL LIB FLOR
   DEGIGLIO E, 2000, IN PRESS J BIOMATER
   DEGIGLIO E, 2000, UNPUB BIOMATERIALS
   Desimoni E., 1986, Computer Enhanced Spectroscopy, V3, P107
   EAVES JG, 1987, POLYM COMMUN, V28, P38
   GARVEY BT, 1994, J APPL BIOMATER, V5, P39, DOI 10.1002/jab.770050106
   HAYASHI K, 1991, J BIOMED MATER RES, V25, P515, DOI 10.1002/jbm.820250408
   Hayashi K, 1999, BIOMATERIALS, V20, P111, DOI 10.1016/S0142-9612(98)00011-8
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   Idla K, 2000, ELECTROCHIM ACTA, V45, P2121, DOI 10.1016/S0013-4686(99)00433-8
   Ishizawa H, 1997, J BIOMED MATER RES, V35, P199
   Janchen G, 1999, SURF INTERFACE ANAL, V27, P444, DOI 10.1002/(SICI)1096-9918(199905/06)27:5/6<444::AID-SIA531>3.0.CO;2-3
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Khor E, 1996, BIOMATERIALS, V17, P1877, DOI 10.1016/0142-9612(95)00347-9
   LAUSMAA J, 1990, APPL SURF SCI, V45, P189, DOI 10.1016/0169-4332(90)90002-H
   MALITESTA C, 1989, J CHEM SOC FARAD T 1, V85, P1685, DOI 10.1039/f19898501685
   Malitesta C, 1995, J ELECTRON SPECTROSC, V76, P629, DOI 10.1016/0368-2048(95)02438-7
   MALITESTA C, 1993, SURFACE CHARACTERIZA, P181
   MINEHAN DS, 1991, P AM CHEM SOC DIV PO, V64, P341
   Nonami T, 1998, MAT SCI ENG C-BIO S, V6, P281, DOI 10.1016/S0928-4931(98)00063-0
   OKADA T, 1995, J BIOMAT SCI-POLYM E, V7, P171, DOI 10.1163/156856295X00689
   Otero TF, 1997, BIOELECTROCH BIOENER, V42, P117, DOI 10.1016/S0302-4598(96)05112-4
   PALMISANO F, 1995, ANAL CHEM, V67, P2207, DOI 10.1021/ac00109a046
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   Pope MR, 1996, BIOCONJUGATE CHEM, V7, P436, DOI 10.1021/bc9600271
   RATNER BD, 1981, J COLLOID INTERF SCI, V83, P630, DOI 10.1016/0021-9797(81)90358-1
   Rossler S, 1999, J MATER SCI LETT, V18, P577, DOI 10.1023/A:1006647116608
   Rossler S, 2000, J ADHES SCI TECHNOL, V14, P453, DOI 10.1163/156856100742591
   Rovira A, 1996, BIOMATERIALS, V17, P1535, DOI 10.1016/0142-9612(96)89779-1
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SOBALLE K, 1993, J BONE JOINT SURG BR, V75, P270
   Tessier D, 2000, J BIOMAT SCI-POLYM E, V11, P87, DOI 10.1163/156856200743517
   TOURILLON G, 1988, J CHEM PHYS, V89, P1905, DOI 10.1063/1.455087
   TOURILLON G, 1986, HDB CONDUCTING POLYM, V1, pCH9
   TRETINNIKOV ON, 1994, J BIOMED MATER RES, V28, P1365, DOI 10.1002/jbm.820281115
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   ZAMBONIN G, 1995, BIOMATERIALS, V16, P397, DOI 10.1016/0142-9612(95)98857-A
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
NR 46
TC 17
Z9 17
U1 0
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2001
VL 12
IS 1
BP 63
EP 76
DI 10.1163/156856201744452
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 423XZ
UT WOS:000168204200005
PM 11334190
DA 2018-10-19
ER

PT J
AU Yourtee, D
   Holder, AJ
   Smith, R
   Morrill, JA
   Kostoryz, E
   Brockmann, W
   Glaros, A
   Chappelow, C
   Eick, D
AF Yourtee, D
   Holder, AJ
   Smith, R
   Morrill, JA
   Kostoryz, E
   Brockmann, W
   Glaros, A
   Chappelow, C
   Eick, D
TI Quantum mechanical quantitative structure activity relationships to
   avoid mutagenicity in dental monomers
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE QSAR; epoxies; dental biomaterials; monomers; GY-281; BISGMA
ID ALIPHATIC EPOXIDES; THEORETICAL DESCRIPTORS; SALMONELLA-TYPHIMURIUM;
   STATISTICAL-ANALYSIS; PROPYLENE; OXIDES
AB The objective of this study was to identify through quantum mechanical quantitative structure activity relationships (Q-QSARs) chemical structures in dental monomers that influence their mutagenicity. AMPAC, a semiempirical computer program that provides quantum mechanical information for chemical structures, was applied to three series of reference chemicals. a set of methacrylates. a set of aromatic and a set of aliphatic epoxy compounds. QSAR models were developed using this chemical information together with mutagenicity data (Salmonella TA100, Ames Test). CODESSA. a QSAR program that calculates quantum chemical descriptor from information generated by AMPAC and statistically matches these descriptors with observed biological properties was used. QSARs were developed which had r(2) values exceeding 0.90 for each study series. These QSARs were used to accurately predict the mutagenicity of BISGMA, a monomer commonly used in dentistry, and two epoxy monomers with developing use in dentistry, GY-281 and UVR-6105. The Q-QSAR quantum mechanical descriptors correctly predicted the level of mutagenicity for all three compounds. The descriptors in the correlation equation painted to components of structure that may contribute to mutagenesis. The QSARs also provided 'dose windows' for testing mutagenicity, circumventing the need for extensive dose exploration in the laboratory. The Q-QSAR method promises an approach for biomaterials scientists to predict and avoid mutagenicity from the chemicals used in new biomaterial designs.
C1 Univ Missouri, Sch Pharm, Kansas City, MO 64108 USA.
   Univ Missouri, Dept Chem, Kansas City, MO 64110 USA.
   Univ Missouri, Sch Dent, Kansas City, MO 64110 USA.
   Midwest Res Inst, Kansas City, MO 64108 USA.
RP Yourtee, D (reprint author), Univ Missouri, Sch Pharm, Kansas City, MO 64108 USA.
EM holdera@umkc.edu
FU NIDCR NIH HHS [DEO9696]
CR ATKINSON A, 1995, BIOCHEM BIOPH RES CO, V210, P424, DOI 10.1006/bbrc.1995.1678
   Belsley DA, 1980, REGRESSION DIAGNOSTI
   BERNSTEIN L, 1982, MUTAT RES, V97, P267, DOI 10.1016/0165-1161(82)90026-7
   BOGEN KT, 1995, ENVIRON MOL MUTAGEN, V25, P37, DOI 10.1002/em.2850250107
   CANTER DA, 1986, MUTAT RES, V172, P105, DOI 10.1016/0165-1218(86)90069-8
   Cunningham AR, 1998, MUTAT RES-FUND MOL M, V398, P1, DOI 10.1016/S0027-5107(97)00202-9
   DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024
   Famini GR, 1998, QUANT STRUCT-ACT REL, V17, P558, DOI 10.1002/(SICI)1521-3838(199812)17:06<558::AID-QSAR558>3.3.CO;2-T
   FRANTZ SW, 1981, MUTAT RES, V92, P9067
   HANSCH C, 1963, J AM CHEM SOC, V85, P2817, DOI 10.1021/ja00901a033
   HOOBERMAN BH, 1993, MUTAT RES, V299, P85, DOI 10.1016/0165-1218(93)90085-R
   Jobson JD, 1991, APPL MULTIVARIATE DA, V1
   JUNG R, 1981, MUTAT RES, V8, P11
   Katritzky AR, 1996, REV ROUM CHIM, V41, P851
   MCIVER JW, 1972, J AM CHEM SOC, V94, P2625, DOI 10.1021/ja00763a011
   Menziani MC, 1998, BIOORGAN MED CHEM, V6, P535, DOI 10.1016/S0968-0896(98)00008-X
   NEAU SH, 1982, MUTAT RES, V93, P297, DOI 10.1016/0027-5107(82)90145-2
   PASEIRO-LOSADA P, 1991, J ASSOC OFF ANA CHEM, V74, P925
   RIETVELD EC, 1988, ARCH TOXICOL, V61, P366, DOI 10.1007/BF00334617
   ROSMAN LB, 1987, MUTAT RES, V189, P189, DOI 10.1016/0165-1218(87)90053-X
   Schweikl H, 1998, MUTAT RES-GEN TOX EN, V415, P119, DOI 10.1016/S1383-5718(98)00067-9
   *SEM, 2000, CODESSA SHAWN MISS
   *SEM, 2000, AMPAC GRAPH US INT S
   SINSHEIMER JE, 1993, MUTAT RES, V298, P197, DOI 10.1016/0165-1218(93)90041-B
   SINSHEIMER JE, 1989, MUTAT RES, V224, P171, DOI 10.1016/0165-1218(89)90153-5
   STANTON DT, 1990, ANAL CHEM, V62, P2323, DOI 10.1021/ac00220a013
   VARTIAINEN T, 1986, MUTAT RES, V169, P29, DOI 10.1016/0165-1218(86)90014-5
   VOOGD CE, 1981, MUTAT RES, V89, P269, DOI 10.1016/0165-1218(81)90108-7
   WAEGEMAEKERS THJM, 1984, MUTAT RES, V137, P95, DOI 10.1016/0165-1218(84)90097-1
NR 29
TC 14
Z9 14
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2001
VL 12
IS 1
BP 89
EP 105
DI 10.1163/156856201744470
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 423XZ
UT WOS:000168204200007
PM 11334192
DA 2018-10-19
ER

PT J
AU Minuth, WW
   Strehl, R
   Schumacher, K
   De Vries, U
AF Minuth, WW
   Strehl, R
   Schumacher, K
   De Vries, U
TI Long term culture of epithelia in a continuous fluid gradient for
   biomaterial testing and tissue engineering
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE kidney; epithelia; biomaterial testing; tissue engineering;
   differentiation; perfusion; gradient culture container; electrolytes
ID IN-VITRO; CELL-DIFFERENTIATION; PERFUSION CULTURE; RABBIT KIDNEY;
   CONTAINER
AB Epithelia perform barrier functions being exposed to different fluids on the luminal and basal side. For long-term testing of new biomaterials as artificial basement membrane substitutes, it is important to simulate this fluid gradient. Individually-selected biomaterials can be placed in tissue carriers and in gradient containers, where different media are superfused. Epithelia growing on the tissue carriers form a physiological barrier during the whole culture period. Frequently however, pressure differences between the luminal and basal compartments occur. This is caused by a unilateral accumulation of gas bubbles in the container compartments resulting in tissue damage. Consequently, the occurence of gas bubbles has to be minimized. Air bubbles in the perfusion culture medium preferentially acumulate at sites where different materials come into contact. The first development is new screw caps for media bottles, specifically designed to allow fluid contact with only the tube and not the cap material. The second development is the separation of remaining gas bubbles from the liquid phase in the medium using newly-developed gas expander modules. By the application of these new tools, the yield of embryonic renal collecting duct epithelia with intact barrier function on a fragile natural support material can be significantly increased compared to earlier experiments.
C1 Univ Regensburg, Dept Anat, D-93053 Regensburg, Germany.
RP Minuth, WW (reprint author), Univ Regensburg, Dept Anat, D-93053 Regensburg, Germany.
CR Atala A, 1998, UROL CLIN N AM, V25, P39, DOI 10.1016/S0094-0143(05)70431-6
   Bader A, 1999, EXP CELL RES, V246, P221, DOI 10.1006/excr.1998.4295
   Fey-Lamprecht F, 2000, BIOMATERIALS, V21, P183, DOI 10.1016/S0142-9612(99)00147-7
   Gron B, 1999, APMIS, V107, P779, DOI 10.1111/j.1699-0463.1999.tb01473.x
   Humes HD, 1999, KIDNEY INT, V55, P2502, DOI 10.1046/j.1523-1755.1999.00486.x
   ISCOVE NN, 1978, J EXP MED, V147, P923, DOI 10.1084/jem.147.3.923
   Jow F, 1999, J MEMBRANE BIOL, V171, P127, DOI 10.1007/s002329900565
   Liu XR, 1999, AM J PHYSIOL-GASTR L, V277, pG12, DOI 10.1152/ajpgi.1999.277.1.G12
   Ludwikowski B, 1999, BJU INT, V84, P507
   MINUTH WW, 1987, DIFFERENTIATION, V36, P12, DOI 10.1111/j.1432-0436.1987.tb00177.x
   Minuth WW, 1997, EXP NEPHROL, V5, P10
   Minuth WW, 1997, PEDIATR NEPHROL, V11, P140, DOI 10.1007/s004670050245
   MINUTH WW, 1994, IN VITRO CELL DEV-AN, V30A, P12
   Minuth WW, 1999, EXP NEPHROL, V7, P394
   Minuth WW, 2000, J BIOMAT SCI-POLYM E, V11, P495, DOI 10.1163/156856200743832
   Naiki T, 1999, BIORHEOLOGY, V36, P225
   PAPPAS KK, 1999, BIOTECHNOL BIOENG, V66, P219
   Schumacher K, 1999, IN VITRO CELL DEV-AN, V35, P465
   Steiner P, 1997, DIFFERENTIATION, V62, P193
   Stockmann M, 1999, PFLUG ARCH EUR J PHY, V438, P107, DOI 10.1007/s004240050886
   TAUC M, 1992, BIOL CELL, V76, P55, DOI 10.1016/0248-4900(92)90195-7
   Van Dorp AGM, 1999, WOUND REPAIR REGEN, V7, P214
   Vert M, 1998, J CONTROL RELEASE, V53, P85, DOI 10.1016/S0168-3659(97)00240-X
   WALSER M, 1970, AM J PHYSIOL, V219, P252
   WINTERMANTEL E, 1998, BIOKOMPATIBLE WERKST, P87
NR 25
TC 11
Z9 11
U1 0
U2 2
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2001
VL 12
IS 3
BP 353
EP 365
DI 10.1163/156856201750180861
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 443MJ
UT WOS:000169344700007
PM 11484942
DA 2018-10-19
ER

PT J
AU Cocera, M
   Lopez, O
   Sabes, M
   Parra, JL
   Guinea, J
   De La Maza, A
AF Cocera, M
   Lopez, O
   Sabes, M
   Parra, JL
   Guinea, J
   De La Maza, A
TI Assembly properties and applications of a new exopolymeric compound
   excreted by Pseudoalteromonas antarctica NF3
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE new bacterial species P. antarctica NF3; exopolymer of glycoprotein
   character; surface active properties; self-assembly characteristics and
   applications of the exopolymer; dynamic and static light-scattering;
   transmission electron microscopy (TEM); freeze-fractured TEM; image
   analysis of digitized TEM pictures; differential scanning calorimetry
ID INDUCED SKIN IRRITATION; SODIUM DODECYL-SULFATE; PHOSPHATIDYLCHOLINE
   LIPOSOMES; PHOSPHOLIPID-BILAYERS; PROTECTIVE AGENT; S-LAYER; 4 DRUGS;
   SURFACTANTS; SOLUBILIZATION; CHEMISTRY
AB The self assembly properties and applications of an exopolymeric compound (EC) of a glycoprotein character excreted by a new Gram-negative species, Pseudoalteromonas antarctica NF3, have been reviewed. This compound exhibited surface-active properties in water, with a concentration of 0.20 mg ml(-1) being the key value associated with its physicochemical properties. Unsonicated EC aqueous dispersions showed the coexistence of concentric multilamellar and small unilamellar aggregates by transmission electron microscopy (TEM). Sonication of these dispersions revealed that each lamellae of the initial multilamellar structures were made up of various subunits coiled coils. As for the ability of this exopolymeric biomaterial to coat phosphatidylcholine (PC) liposomes and to protect these vesicles against different surfactants, freeze-fracture TEM micrographs of liposome/EC aggregates revealed that the addition of the EC to liposomes led to the formation of a film (polymer adsorbed onto the bilayers) that coated very well the PC bilayers. The complete coating was already achieved at a PC:EC weight ratio of about 9:1. An increasing resistance of PC liposomes to surfactants (in particular sodium dodecyl sulfate) occurred as the proportion of EC in the system rose, although this effect was more effective at low EC proportions (PC:EC weight ratios from 9: 1 to 8:2). Although a direct dependence was found between the growth of the enveloping structure and the resistance of the coated liposomes to be affected by the surfactants, the best protection occurred when this structure was a thin film of about 20-25 nm formed by nine to ten layers of about 2-3 nm.
C1 CSIC, Inst Invest Quim & Ambientales Barcelona, Dept Tensioact, ES-08034 Barcelona, Spain.
   Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Unitat Biofis, E-08193 Barcelona, Spain.
   Univ Barcelona, Fac Farm, Dept Microbiol, E-08028 Barcelona, Spain.
RP De La Maza, A (reprint author), CSIC, Inst Invest Quim & Ambientales Barcelona, Dept Tensioact, C Jorge Girona 18-26, ES-08034 Barcelona, Spain.
OI COCERA, MERCEDES/0000-0003-1077-052X
CR AUSTIN JW, 1990, J BACTERIOL, V172, P808, DOI 10.1128/jb.172.2.808-817.1990
   Bell TW, 1996, SCIENCE, V271, P1077, DOI 10.1126/science.271.5252.1077
   BEVERIDGE TJ, 1991, MICROBIOL REV, V55, P684
   BEVERIDGE TJ, 1989, BACTERIA NATURE, V3, P1
   BLUME A, 1998, APPL CALORIMETRY LIP, P71
   BOSCH P, 1994, ANGEW CHEM INT EDIT, V33, P2078, DOI 10.1002/anie.199420781
   BOZAL N, 1994, POLAR BIOL, V14, P561
   Bozal N, 1997, INT J SYST BACTERIOL, V47, P345, DOI 10.1099/00207713-47-2-345
   COCERA M, 1999, LANGMUIR, V15, P6610
   CORPE WA, 1970, DEV IND MICROBIOL, V2, P299
   de la Maza A, 1998, COLLOID SURFACE A, V137, P181, DOI 10.1016/S0927-7757(98)00212-X
   de la Maza A, 1998, LANGMUIR, V14, P42, DOI 10.1021/la970403l
   de la Maza A, 1998, LANGMUIR, V14, P5680, DOI 10.1021/la980499z
   De La Maza A, 1999, J BIOMAT SCI-POLYM E, V10, P557, DOI 10.1163/156856299X00487
   de la Maza A, 1999, BIOPOLYMERS, V50, P579
   delaMaza A, 1997, J COLLOID INTERF SCI, V192, P286, DOI 10.1006/jcis.1997.5015
   delaMaza A, 1996, LANGMUIR, V12, P6218, DOI 10.1021/la960219k
   DELAMAZA A, 1995, LANGMUIR, V11, P2435, DOI 10.1021/la00007a021
   delaMaza A, 1996, ARCH BIOCHEM BIOPHYS, V329, P1, DOI 10.1006/abbi.1996.0184
   DELAMAZA A, 1993, LANGMUIR, V9, P870, DOI 10.1021/la00027a043
   EDWARDS K, 1990, PROG COLL POL SCI S, V82, P190
   EDWARDS K, 1992, LANGMUIR, V8, P824, DOI 10.1021/la00039a016
   INOUE T, 1992, J COLLOID INTERF SCI, V149, P345, DOI 10.1016/0021-9797(92)90425-L
   Kim DS, 1999, APPL MICROBIOL BIOT, V52, P839, DOI 10.1007/s002530051601
   KUPCU S, 1995, BBA-BIOMEMBRANES, V1235, P263, DOI 10.1016/0005-2736(95)80013-6
   LASIC D, 1993, LIPOSOMES PHYS APPL, pCH11
   LASIC DD, 1993, LIPOSOMES PHYSICS AP, pCH9
   LEHN JM, 1993, SCIENCE, V260, P1762, DOI 10.1126/science.8511582
   LICHTENBERG D, 1985, BIOCHIM BIOPHYS ACTA, V821, P470, DOI 10.1016/0005-2736(85)90052-5
   LINDEROTH B, 1991, MODERN NEUROSURGERY, V2, P15
   Moon K.C., 1991, EXOGENOUS DERMATOSES, P217
   New R. R. C., 1990, LIPOSOMES PRACTICAL
   PUM D, 1989, J BACTERIOL, V171, P5269
   READ RR, 1987, CAN J MICROBIOL, V33, P1080, DOI 10.1139/m87-189
   SHAFERKORTING M, 1992, LIPOSOME DERMATICS G, P299
   SHEA C, 1991, APPL ENVIRON MICROB, V57, P3107
   Silvander M, 1996, J COLLOID INTERF SCI, V179, P104, DOI 10.1006/jcis.1996.0192
   Sleytr U B, 1978, Int Rev Cytol, V53, P1, DOI 10.1016/S0074-7696(08)62240-8
   Sleytr UB, 1988, CRYSTALLINE BACTERIA, P160
   SLEYTR UB, 1992, ENCY MICROBIOLOGY, V1, P605
   URBANEJA MA, 1990, BIOCHEM J, V270, P305, DOI 10.1042/bj2700305
   Vidal Dominique-Raymond, 1997, Annales Pharmaceutiques Francaises, V55, P49
   WILHELM KP, 1991, J INVEST DERMATOL, V97, P927, DOI 10.1111/1523-1747.ep12491710
   WILHELM KP, 1991, J INVEST DERMATOL, V96, P963, DOI 10.1111/1523-1747.ep12476269
   WILHELM KP, 1989, ARCH DERMATOL RES, V281, P293, DOI 10.1007/BF00431067
   WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P171, DOI 10.1016/0304-4157(92)90038-C
NR 46
TC 4
Z9 4
U1 0
U2 1
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2001
VL 12
IS 4
BP 409
EP 427
DI 10.1163/156856201750195298
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 443MK
UT WOS:000169344800003
PM 11436977
DA 2018-10-19
ER

PT J
AU Murakami, Y
   Iwata, H
   Kitano, E
   Kitamura, H
   Ikada, Y
AF Murakami, Y
   Iwata, H
   Kitano, E
   Kitamura, H
   Ikada, Y
TI Interaction of poly(2-acrylamido 2-methylpropane sulfonate)-grafted
   polystyrene beads with cationic complement proteins
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE graft copolymerization; poly(2-acrylamido 2-methylpropane sulfonate);
   biomaterial; complement; inhibition; adsorption; factor D
ID HEMODIALYSIS MEMBRANES; ALTERNATIVE PATHWAY; POLYMER SURFACE;
   BINDING-SITE; FACTOR-H; ACTIVATION; HEPARIN; INHIBITORS
AB Influence of various biomaterials on the complement system in serum has been intensively studied by many research groups, since activation of the complement pathway in vivo has been known to give rise to some pathological conditions, such as inflammation and anaphylaxis. Much effort has been devoted to develop new materials that do not activate or deteriorate the complement system. The present work is aimed at revealing the mode of reactions of anionic poly(2-acrylamido 2-methylpropane sulfonate) grafted on polystyrene bead (PAMPS-g-bead) with serum complement. Complement activity assay, determination of complement proteins levels, and immunoblot analysis were carried out for sera pretreated with PAMPS-g-beads. The results clearly showed that, when PAMPS-g-bends were incubated with serum, those beads adsorbed several complement proteins, i.e. C1q, factor D, factor P, C6, and C8, but the generation of activation fragments of complement components was not observed. Especially, factor D was most effectively removed from serum, resulting in potential inhibition of the alternative pathway. A larger amount of PAMPS-g-beads was needed to decrease the serum CH50 level. That may be caused by removal of C6. Although some polyanions, such as dextran sulfate, were reported to activate the complement system, the obtained results indicate that the PAMPS-g-bead is not an activator of the complement pathway, but acts as an adsorbent of complement components. One possible clinical application of the PAMPS-g-beads is adsorption of serum factor D by extracorporeal treatment of patients with renal failure with a high level of factor D, because the increased quantity of factor D in serum may cause consistent activation of the alternative pathway.
C1 Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan.
   Osaka Prefectural Coll Hlth Sci, Osaka 5838555, Japan.
   Suzuka Univ Med Sci, Suzuka, Mie 5100293, Japan.
RP Iwata, H (reprint author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.
CR BAMFORD CH, 1961, POLYMER, V2, P277, DOI 10.1016/0032-3861(61)90031-3
   Bowry SK, 1998, ASAIO J, V44, P579
   BURGER R, 1975, IMMUNOLOGY, V29, P549
   CHEUNG AK, 1992, J AM SOC NEPHROL, V2, P1328
   CHEUNG AK, 1989, KIDNEY INT, V36, P257, DOI 10.1038/ki.1989.188
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   HADDING U, 1973, EUR J IMMUNOL, V3, P527, DOI 10.1002/eji.1830030817
   KATCHALSKY A, 1959, BIOCHIM BIOPHYS ACTA, V33, P120
   KATO K, 1995, COLLOID SURFACE B, V4, P221, DOI 10.1016/0927-7765(94)01172-2
   KITAMURA H, 1981, MOL IMMUNOL, V18, P985
   KITANO E, 1993, CLIN EXP IMMUNOL, V94, P273
   KITANO E, 1998, INT ARCH ALLERGY IMM, V119, P54
   Kobayashi E, 1999, INT ARCH ALLERGY IMM, V120, P71, DOI 10.1159/000024222
   KULIK EA, 1993, BIOMATERIALS, V14, P763, DOI 10.1016/0142-9612(93)90041-Y
   LAW SKA, 1988, COMPLEMENT
   MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982
   MERI S, 1994, BIOCHEM BIOPH RES CO, V198, P52, DOI 10.1006/bbrc.1994.1008
   NEVO A, 1955, BIOCHIM BIOPHYS ACTA, V17, P536, DOI 10.1016/0006-3002(55)90416-9
   PANGBURN MK, 1991, J BIOL CHEM, V266, P16847
   PASCUAL M, 1993, BIOMATERIALS, V14, P665, DOI 10.1016/0142-9612(93)90065-A
   ROTHER K, 1997, COMPLEMENT SYSTEM
   SAHU A, 1993, MOL IMMUNOL, V30, P679, DOI 10.1016/0161-5890(93)90079-Q
   TOUFIK J, 1995, BIOMATERIALS, V16, P1081, DOI 10.1016/0142-9612(95)98904-S
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   WODDS AW, 1997, COMPLEMENT
   Wuillemin WA, 1997, J IMMUNOL, V159, P1953
NR 26
TC 7
Z9 7
U1 1
U2 5
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2001
VL 12
IS 4
BP 451
EP 465
DI 10.1163/156856201750195315
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 443MK
UT WOS:000169344800005
PM 11436979
DA 2018-10-19
ER

PT J
AU Lin, CW
   Lin, JC
AF Lin, CW
   Lin, JC
TI Surface characterization and platelet compatibility evaluation of
   surface-sulfonated chitosan membrane
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE chitosan; surface modification; sulfonation; surface characterization;
   blood compatibility; platelet adhesion
ID MOLECULAR-WEIGHT; BLOOD; HEPARIN; GLUTARALDEHYDE; CHITIN; PERMEABILITY;
   BIOMATERIAL; DEPENDENCE; THROMBIN; ADHESION
AB The effect of various sulfonated derivatives of chitosan on platelet activation and blood coagulation was examined. The surface properties of artificial biomaterials have been thought as the key factors which mediate the interactions between the biological environment and biomaterial itself, In this study, the sulfonation was directly performed on the chitosan membrane surface. The chitosan membrane was surface-sulfonated by reactions with sulfur-pyridine trioxide complex (SO3/pyridine) in H2O solution and N,N-sulfur-dimethylformamide trioxide complex (SO3/DMF) in DMF. Blood compatibility was evaluated by an in vitro platelet adhesion assay. The surface reaction Of SO3/pyridine in aqueous acid medium yields N,O-sulfated chitosan with cationic NH3+ groups, After neutralization, this surface has been shown to induce a low degree of platelet adhesion and activation. When the surface-sulfonation is performed in an aqueous alkaline medium, although the degree of sulfonation is lower than the samples above, the N-sulfated chitosan significantly reduced the adhesion and activation of platelets. For the acidic SO3/DMF reaction system, N,O-sulfated chitosan was obtained with a high extent of sulfonation and cationic NH3+ groups. On this surface 3 fully spread platelets and some platelet aggregates were found instead. This may be attributed to the ionic interactions between the platelets membrane surface and the cationic groups on the modified chitosan membrane.
C1 Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
RP Lin, JC (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
RI Lin, Jui-Che/C-8230-2012
OI Lin, Jui-Che/0000-0003-4436-655X
CR AMIJI MM, 1995, BIOMATERIALS, V16, P593, DOI 10.1016/0142-9612(95)93856-9
   BEAMSON G, 1992, HIGH RESOLUTION XPS, P202
   BERI RG, 1993, CARBOHYD RES, V238, P11, DOI 10.1016/0008-6215(93)87002-A
   Cerrai P, 1996, MACROMOL CHEM PHYSIC, V197, P3567, DOI 10.1002/macp.1996.021971107
   Chanda J, 1996, BIOMATERIALS, V17, P1087, DOI 10.1016/0142-9612(96)85909-6
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   CUAN YL, 1996, J APPL POLYM SCI, V61, P393
   DOCZI J, 1953, J AM CHEM SOC, V75, P1512, DOI 10.1021/ja01102a535
   Dutkiewicz J, 1990, J BIOACT COMPAT POL, V5, P293, DOI 10.1177/088391159000500305
   GIROUX TA, 1991, J APPL POLYM SCI, V43, P145, DOI 10.1002/app.1991.070430112
   GRIFFITH MJ, 1986, BLOOD COAGULATION, P259
   HIRANO S, 1980, J BIOMED MATER RES, V14, P477, DOI 10.1002/jbm.820140414
   HIRANO S, 1985, CARBOHYD RES, V137, P205, DOI 10.1016/0008-6215(85)85161-2
   HIRANO S, 1978, AGR BIOL CHEM TOKYO, V42, P1939, DOI 10.1080/00021369.1978.10863280
   HOLMER E, 1981, BIOCHEM J, V193, P395, DOI 10.1042/bj1930395
   HORTON D, 1973, CARBOHYD RES, V29, P173, DOI 10.1016/S0008-6215(00)82081-9
   INAGAKI N, 1989, J POLYM SCI POL CHEM, V27, P3495, DOI 10.1002/pola.1989.080271026
   JAMEELA SR, 1995, BIOMATERIALS, V16, P769, DOI 10.1016/0142-9612(95)99639-4
   JOZEFOWICZ M, 1984, PURE APPL CHEM, V56, P1335, DOI 10.1351/pac198456101335
   KANMANGNE FM, 1985, BIOMATERIALS, V6, P297, DOI 10.1016/0142-9612(85)90085-7
   Kim SS, 1996, BIOMATERIALS, V17, P813, DOI 10.1016/0142-9612(96)81419-0
   Kurita K, 1998, POLYM DEGRAD STABIL, V59, P117, DOI 10.1016/S0141-3910(97)00160-2
   LASKER SE, 1966, ARCH BIOCHEM BIOPHYS, V115, P360, DOI 10.1016/0003-9861(66)90286-4
   Lee JH, 1998, J BIOMED MATER RES, V40, P180, DOI 10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H
   Lin JC, 1999, BIOMATERIALS, V20, P1613, DOI 10.1016/S0142-9612(99)00068-X
   LITTLEJOHN D, 1995, J ELECTRON SPECTROSC, V71, P47, DOI 10.1016/0368-2048(94)02244-5
   MALETTE WG, 1983, ANN THORAC SURG, V36, P55, DOI 10.1016/S0003-4975(10)60649-2
   MUZZARELLI RAA, 1984, CARBOHYD RES, V126, P225, DOI 10.1016/0008-6215(84)85380-X
   NESHEIM M, 1986, J BIOL CHEM, V261, P3214
   PEDRAM MY, 1995, J MACROMOL SCI CHEM, V32, P1037
   RADOFF S, 1982, ARCH BIOCHEM BIOPHYS, V215, P163, DOI 10.1016/0003-9861(82)90291-0
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SAWAYANAGI Y, 1982, CHEM PHARMACEUT B, V58, P13
   SCHWEIGER RG, 1972, CARBOHYD RES, V21, P219, DOI 10.1016/S0008-6215(00)82148-5
   SRINIVASAN S, 1970, J MACROMOL SCI CHEM, VA  4, P545, DOI 10.1080/00222337008074362
   TERBOJEVICH M, 1989, MAKROMOL CHEM, V190, P2847
   TOKURA S, 1990, CARBOHYD POLYM, V13, P273, DOI 10.1016/0144-8617(90)90059-2
   TOKURA S, 1980, POLYM J, V12, P695, DOI 10.1295/polymj.12.695
   TOKURA S, 1994, J MACROMOL SCI PURE, VA31, P1701, DOI 10.1080/10601329408545878
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Walenga JM, 1997, THROMB RES, V86, P1, DOI 10.1016/S0049-3848(97)00042-X
   WARNER DT, 1958, J ORG CHEM, V23, P1958
   WOLFROM ML, 1959, J AM CHEM SOC, V81, P1764, DOI 10.1021/ja01516a061
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
NR 44
TC 18
Z9 19
U1 2
U2 12
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2001
VL 12
IS 5
BP 543
EP 557
DI 10.1163/156856201300194270
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 489LA
UT WOS:000171991800007
PM 11469784
DA 2018-10-19
ER

PT J
AU Park, JH
   Lee, KB
   Kwon, IC
   Bae, YH
AF Park, JH
   Lee, KB
   Kwon, IC
   Bae, YH
TI PDMS-based polyurethanes with MPEG grafts: Mechanical properties,
   bacterial repellency, and release behavior of rifampicin
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polyurethane; monomethoxy poly(ethylene glycol); bacterial adhesion;
   rifampicin
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CATHETER-ASSOCIATED BACTERIURIA;
   URETERAL STENT BIOMATERIAL; NOSOCOMIAL INFECTIONS; URETHRAL CATHETERS;
   URINARY CATHETER; IN-VITRO; PLATELET-ADHESION; ESCHERICHIA-COLI;
   SURFACES
AB PDMS-based polyurethanes (PUs) grafted with monomethoxy poly(ethylene glycol) (MPEG) were synthesized to develop a coating material for urinary catheters with a silicone surface for minimizing urinary tract infections. MPEG was grafted on PDMS-based PUs by two methods depending on the PU synthetic routes: esterification and allophanate reactions. It was confirmed from mechanical characterization that an increase of the hard segment amount enhanced the ultimate strength and Young's modulus. while reducing elongation at the end-points. The incorporation of MPEG in PDMS-based PUs induced a decrease in tensile strength and Young's modulus, and increased elongation at the break point due to its high flexibility. When hydrated in distilled water, mechanical properties of all PUs synthesized in this study deteriorated due to water absorption. It was evident from the bacterial adhesion test that PDMS-based PUs showed moderate resistance to adhesion of E. coli on their surfaces compared to Pellethane(R). while the incorporation of MPEG significantly enhanced repellency to bacteria, including E. coli and S. epidermidis. We also studied the release behavior of an antibiotic drug, rifampicin, from the polymeric devices fabricated by solvent evaporation. Although rifampicin is hydrophilic and soluble in pH 7.4 phosphate buffer, it showed a sustained release over 45 days from PDMS-based PUs with MPEG that were grafted on ethylene glycol residues by allophanate reaction. This release characteristic was predominantly influenced by a hydrogen bond interaction between the polymers and rifampicin, which was confirmed through an ATR-IR study. This may imply that the specific interaction is responsible for the delayed release. Considering the mechanical properties, morphologies of drug-incorporated polymeric matrices, and drug release behaviors, PDMS-based PU with MPEG that were grafted on ethylene glycol (a chain extender) residues by allophanate reaction showed better material properties for uretharal catheter coating pusposes in order to minimize urinary tract infections.
C1 Kwangju Inst Sci & technol, Ctr Biomat & Biotechnol, Dept Mat Sci & Engn, Kwangju 500712, South Korea.
   Korea Inst Sci & Technol, Biomed Res Ctr, Sungbuk ku, Seoul 136791, South Korea.
RP Bae, YH (reprint author), Kwangju Inst Sci & technol, Ctr Biomat & Biotechnol, Dept Mat Sci & Engn, 1 Oryong-dong, Puk-gu, Kwangju 500712, South Korea.
RI Park, Jae Hyung/B-5967-2018; byun, jaehyun/G-5584-2014
CR Baumgartner JN, 1996, ASAIO J, V42, pM476, DOI 10.1097/00002480-199609000-00033
   Beaujean DJMA, 1997, J HOSP INFECT, V36, P275, DOI 10.1016/S0195-6701(97)90054-2
   Bos HM, 1996, ASAIO J, V42, pM881, DOI 10.1097/00002480-199609000-00118
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   Brisset L, 1996, PATHOL BIOL, V44, P397
   BRUCE AW, 1974, CAN MED ASSOC J, V111, P238
   BURR RG, 1995, BRIT J UROL, V76, P61, DOI 10.1111/j.1464-410X.1995.tb07589.x
   Burr RG, 1997, SPINAL CORD, V35, P521, DOI 10.1038/sj.sc.3100424
   COOK AD, 1993, J BIOMED MATER RES, V27, P119, DOI 10.1002/jbm.820270115
   COOLS HJM, 1986, BRIT J UROL, V58, P683, DOI 10.1111/j.1464-410X.1986.tb05912.x
   Darouiche RO, 1997, J INFECT DIS, V176, P1109, DOI 10.1086/516523
   FINKEL JM, 1971, CHEMOTHERAPY, V16, P380, DOI 10.1159/000220752
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P937, DOI 10.1002/jbm.820250803
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   GRISTINA AG, 1989, ANTIMICROB AGENTS CH, V33, P813, DOI 10.1128/AAC.33.6.813
   Hall JC, 1996, UROLOGY, V47, P852, DOI 10.1016/S0090-4295(96)00066-0
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   KiremitciGumusderelioglu M, 1996, BIOMATERIALS, V17, P443, DOI 10.1016/0142-9612(96)89662-1
   LI C, 1988, J POLYM SCI POL PHYS, V26, P315, DOI 10.1002/polb.1988.090260209
   LIEDBERG H, 1990, BRIT J UROL, V65, P379, DOI 10.1111/j.1464-410X.1990.tb14760.x
   LIEDBERG H, 1990, EUR UROL, V17, P236
   LIM F, 1994, BIOMATERIALS, V15, P408, DOI 10.1016/0142-9612(94)90218-6
   Litauszki L, 1997, J BIOMED MATER RES, V35, P1
   Matsumoto T, 1997, DERMATOLOGY, V195, P73, DOI 10.1159/000246035
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   PARK KD, 1997, ADV POLYM BIOMATERIA, P113
   Raad I, 1996, J INFECT DIS, V173, P418, DOI 10.1093/infdis/173.2.418
   Reid G, 1996, FEMS IMMUNOL MED MIC, V16, P159
   RILEY DM, 1995, AM J MED, V98, P349, DOI 10.1016/S0002-9343(99)80313-1
   ROBERTS JA, 1993, UROLOGY, V41, P338, DOI 10.1016/0090-4295(93)90591-W
   ROBERTS JA, 1990, J UROLOGY, V144, P264, DOI 10.1016/S0022-5347(17)39428-4
   Schierholz JM, 1997, BIOMATERIALS, V18, P839, DOI 10.1016/S0142-9612(96)00199-8
   SILVER JH, 1994, BIOMATERIALS, V15, P695, DOI 10.1016/0142-9612(94)90168-6
   SRINIVASAN V, 1972, J UROLOGY, V108, P473, DOI 10.1016/S0022-5347(17)60777-8
   Stickler DJ, 1996, BRIT J UROL, V78, P579, DOI 10.1046/j.1464-410X.1996.16915.x
   TALJA M, 1990, BRIT J UROL, V66, P652, DOI 10.1111/j.1464-410X.1990.tb07203.x
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Vatopoulos AC, 1996, J HOSP INFECT, V34, P11, DOI 10.1016/S0195-6701(96)90121-8
   YANG CZ, 1991, J POLYM SCI POL PHYS, V29, P75, DOI 10.1002/polb.1991.090290110
   YU XH, 1985, J POLYM SCI POL PHYS, V23, P2319, DOI 10.1002/pol.1985.180231106
   ZALIPSKY S, 1995, ADV DRUG DELIVER REV, V16, P157, DOI 10.1016/0169-409X(95)00023-Z
NR 44
TC 29
Z9 30
U1 3
U2 25
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2001
VL 12
IS 6
BP 629
EP 645
DI 10.1163/156856201316883458
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 468VV
UT WOS:000170779600005
PM 11556741
DA 2018-10-19
ER

PT J
AU John, A
   Hong, L
   Ikada, Y
   Tabata, Y
AF John, A
   Hong, L
   Ikada, Y
   Tabata, Y
TI A trial to prepare biodegradable collagen-hydroxyapatite composites for
   bone repair
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE collagen; hydroxyapatite; biodegradable composite; alternate immersion
   method; bone regeneration
ID OCTACALCIUM PHOSPHATE; BIOMIMETIC PROCESS; CALCIUM-PHOSPHATE; APATITE
   FORMATION; ORGANIC POLYMERS; FORMATION ON/IN; I COLLAGEN;
   HYDROXYLAPATITE; IMPLANTS; DEFECTS
AB This paper is a trial to prepare collagen-hydroxyapatite composites in vitro by an alternate immersion method. Collagen sponges of different biodegradabilities were prepared through chemical cross-linking of Type I collagen with glutaraldehyde (GA) at concentrations of 0.2, 1.0, and 2.0 wt%. The sponges were immersed at 37 degreesC in Tris-HCl-buffered solution containing 200 mm CaCl2 (pH 7.4) for 2 h and then in an aqueous solution of 120 mm Na2HPO4 (pH 9.3) for a 2 h further (one immersion cycle). The alternate immersion cycle was repeated for different times to obtain collagen-hydroxyapatite composites. The characterization of the resulting composites was performed by Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), and scanning electron microscopy (SEM). The weight of composites increased with an increase in immersion cycles and the rate of increase became greater with higher CA cross-linking levels for collagen sponge preparation. The pH of the phosphate solution decreased with the immersion cycle, which suggests H+ generation accompanied hydroxyapatite formation. Irrespective of the GA concentration and immersion cycle, every composite showed IR absorption bands attributable to phosphate and hydroxyl groups at 950-1100 or 550-650 and 3000-3500 cm(-1) and broad peaks specific to hydroxyapatite on the XRD charts. SEM study revealed small white clusters of hydroxyapatite interspersed uniformly on/in the collagen framework without any preferential orientation. The composite prepared from 0.2 wt% CA cross-linked collagen sponge which showed favourable characteristics was applied to a rat skull defect to evaluate its osteoconductivity as well as biodegradability. The formation of new bone tissue was histologically observed at the defect 12 weeks after application in marked contrast to the collagen sponge alone. The composite degraded without any inflammation reaction. It is concluded that the collagen- hydroxyapatite composite prepared by the present method is a biodegradable biomaterial of osteoconductivity applicable to bone repair.
C1 Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan.
   Suzuka Univ Med Sci, Fac Med Engn, Mie 5100293, Japan.
RP Tabata, Y (reprint author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, 53 Kawara Cho Shogoin, Kyoto 6068507, Japan.
CR ANSELME K, 1990, J BIOMED MATER RES, V24, P689, DOI 10.1002/jbm.820240605
   Asahina Izumi, 1997, Journal of Medical and Dental Sciences, V44, P63
   BELL R, 1988, J ORAL MAXIL SURG, V46, P589, DOI 10.1016/0278-2391(88)90150-4
   BIERNE OR, 1986, INT J ORAL MAXILLOF, V15, P269
   Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Cheng Y, 1998, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V12, P74
   Choueka J, 1996, J BIOMED MATER RES, V31, P35, DOI 10.1002/(SICI)1097-4636(199605)31:1<35::AID-JBM5>3.0.CO;2-R
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P297, DOI 10.1002/jbm.820110213
   CLARKE KI, 1993, J MATER SCI-MATER M, V4, P107, DOI 10.1007/BF00120378
   Combes C, 1999, J MATER SCI-MATER M, V10, P153, DOI 10.1023/A:1008933406806
   COSTANTINO PD, 1994, OTOLARYNG CLIN N AM, V27, P1037
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   ERTEL SI, 1995, J BIOMED MATER RES, V29, P1337, DOI 10.1002/jbm.820291105
   Flautre B, 1996, J MATER SCI-MATER M, V7, P63, DOI 10.1007/BF00058716
   Galbavy S, 1995, Bratisl Lek Listy, V96, P368
   GLOWACKI J, 1981, CALCIFIED TISSUE INT, V33, P71, DOI 10.1007/BF02409414
   HAHN E, 1988, J PROSTHET DENT, V60, P729, DOI 10.1016/0022-3913(88)90408-8
   HEUGHEBAERT JC, 1984, J PHYS CHEM-US, V88, P2478, DOI 10.1021/j150656a012
   HOTZ G, 1991, INT J ORAL MAX SURG, V20, P208, DOI 10.1016/S0901-5027(05)80176-6
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Joshi RR, 1996, J BIOMED MATER RES, V31, P201
   Kato K, 1996, J BIOMED MATER RES, V32, P687, DOI 10.1002/(SICI)1097-4636(199612)32:4<687::AID-JBM23>3.0.CO;2-9
   Lacout JL, 1992, BIOMATERIALS HARD TI, P81
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEVY RJ, 1986, AM J PATHOL, V122, P71
   LINDBERG O, 1956, METHODS BIOCHEMICAL, V3, P1
   Liu Q, 1998, J MATER SCI-MATER M, V9, P23, DOI 10.1023/A:1008826410395
   MANKIN HJ, 1987, ORTHOP CLIN N AM, V18, P275
   MAROUF H A, 1990, International Journal of Oral and Maxillofacial Implants, V5, P148
   MEHLISCH DR, 1987, J ORAL MAXIL SURG, V45, P408, DOI 10.1016/0278-2391(87)90008-5
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   MILTHORPE BK, 1990, ADV BIOMAT, V9, P1
   Mythili J, 2000, BIOTECHNOL APPL BIOC, V32, P155, DOI 10.1042/BA20000055
   NAGASE M, 1989, J ORAL MAXIL SURG, V47, P40, DOI 10.1016/0278-2391(89)90122-5
   NIELSEN AE, 1964, KINETICS PRECIPITATI, P1
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   PARRISH FF, 1972, CLIN ORTHOP RELAT R, P36
   RICHARD K, 1985, J ORAL MAXILLOFAC SU, V43, P845
   ROVIRA A, 1993, J MATER SCI-MATER M, V4, P372, DOI 10.1007/BF00122195
   Schendel S, 1997, ANN PLAS SURG, V38, P158, DOI 10.1097/00000637-199702000-00010
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   STONE KR, 1990, CLIN ORTHOP RELAT R, P129
   SUGAYA A, 1989, J PERIODONTAL RES, V24, P284, DOI 10.1111/j.1600-0765.1989.tb01795.x
   SUH M, 1995, ASAIO J, V41, pM652
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P331, DOI 10.1163/156856299X00397
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P19, DOI 10.1163/156856299X00252
   Taguchi T., 1998, CHEM LETT, V711
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   TANAHASHI M, 1994, J APPL BIOMATER, V5, P339, DOI 10.1002/jab.770050409
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   TANAHASHI M, 1995, J BIOMED MATER RES, V29, P349, DOI 10.1002/jbm.820290310
   TENHUISEN KS, 1995, J BIOMED MATER RES, V29, P803, DOI 10.1002/jbm.820290704
   THOMSON RC, 1995, ADV POLYM SCI, V122, P244
   TRETINNIKOV ON, 1994, J BIOMED MATER RES, V28, P1365, DOI 10.1002/jbm.820281115
   URIST MR, 1980, FUNDAMENTAL CLIN BON, P331
   Wan ACA, 1997, J BIOMED MATER RES, V38, P235, DOI 10.1002/(SICI)1097-4636(199723)38:3<235::AID-JBM8>3.0.CO;2-Q
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   WITTKAMPF ARM, 1988, J ORAL MAXIL SURG, V46, P1019, DOI 10.1016/0278-2391(88)90344-8
NR 63
TC 31
Z9 34
U1 1
U2 13
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2001
VL 12
IS 6
BP 689
EP 705
DI 10.1163/156856201316883485
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 468VV
UT WOS:000170779600008
PM 11556744
DA 2018-10-19
ER

PT J
AU Shen, MC
   Pan, YV
   Wagner, MS
   Hauch, KD
   Castner, DG
   Ratner, BD
   Horbett, TA
AF Shen, MC
   Pan, YV
   Wagner, MS
   Hauch, KD
   Castner, DG
   Ratner, BD
   Horbett, TA
TI Inhibition of monocyte adhesion and fibrinogen adsorption on glow
   discharge plasma deposited tetraethylene glycol dimethyl ether
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE monocyte adhesion; fibrinogen adsorption; glow discharge plasma
   deposited tetraglyme; polyethylene oxide (PEO); time of flight secondary
   ion mass spectrometry (ToF-SIMS)
ID POLY(ETHYLENE OXIDE); INFLAMMATORY RESPONSES; RESISTANT SURFACES;
   POLYETHYLENE OXIDE; CELL-ADHESION; IN-VITRO; PROTEINS; PEO;
   BIOMATERIALS; COPOLYMERS
AB Monocytes and macrophages play important roles in host responses to implanted biomedical devices. Monocyte and macrophage interactions with biomaterial surfaces are thought to be mediated by adsorbed adhesive proteins such as fibrinogen and fibronectin. Non-fouling surfaces that minimize protein adsorption may therefore minimize monocyte adhesion, activation, and the foreign body response. Radio-frequency glow discharge plasma deposition (RF-GDPD) of tetraethylene glycol dimethyl ether (tetraglyme) was used to produce polyethylene oxide (PEO)-like coatings on a fluorinated ethylene-propylene (FEP) surface. Electron spectroscopy for chemical analysis (ESCA) and static time of flight secondary ion mass spectrometry (ToF-SIMS) were used to characterize the surface chemistry of tetraglyme coating. Fibrinogen adsorption to the tetraglyme surface was measured with I-125-labeled fibrinogen and ToF-SIMS. Adsorption of fibrinogen to plasma deposited tetraglyme was less than 10 ng cm(-2), a 20-fold decrease compared to untreated FEP or tissue culture polystyrene (TCPS). Monocyte adhesion to plasma deposited tetraglyme was significantly lower than adhesion to FEP or TCPS. In addition, when the surfaces were preadsorbed with fibrinogen, fibronectin, or blood plasma, monocyte adhesion to plasma deposited tetraglyme after 2 h or 1 day was much lower than adhesion to FEP. RF-GDPD tetraglyme coating provides a promising approach to make non-fouling biomaterials that can inhibit non-specific material-host interactions and reduce the foreign body response.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Horbett, TA (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
FU NCRR NIH HHS [RR01296]
CR ALTIERI DC, 1986, J CLIN INVEST, V78, P968, DOI 10.1172/JCI112687
   ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893
   ALTIERI DC, 1988, J BIOL CHEM, V263, P7007
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   CHAMBERS TJ, 1982, IMMUNOBIOLOGY, V161, P283, DOI 10.1016/S0171-2985(82)80084-3
   CHILKOTI A, 1991, THESIS U WASHINGTON
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   GNANOU Y, 1984, MACROMOLECULES, V17, P945, DOI 10.1021/ma00134a069
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRAINGER DW, 1988, J BIOMED MATER RES, V22, P231, DOI 10.1002/jbm.820220307
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   HORBETT TA, 1986, TECHNIQUES BIOCOMPAT, V2, P214
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   JOHNSTON EE, 1997, THESIS U WASHINGTON
   Kidane A, 1999, J BIOMAT SCI-POLYM E, V10, P1089, DOI 10.1163/156856299X00702
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   Litauszki L, 1997, J BIOMED MATER RES, V35, P1
   LOPEZ GP, 1992, J POLYM SCI POL CHEM, V30, P2415, DOI 10.1002/pola.1992.080301116
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   MARLETTA G, 1990, SURF INTERFACE ANAL, V16, P407, DOI 10.1002/sia.740160185
   McCarthy JB, 1997, J IMMUNOL, V159, P2424
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Morra M, 1999, LANGMUIR, V15, P4658, DOI 10.1021/la981345m
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   NAGAOKA S, 1990, BIOMATERIALS, V11, P119, DOI 10.1016/0142-9612(90)90126-B
   NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815
   O'Connor SM, 1997, ANN NY ACAD SCI, V831, P138
   OKKEMA A Z, 1989, Journal of Biomaterials Science Polymer Edition, V1, P43, DOI 10.1163/156856289X00055
   OWEN CA, 1992, J LEUKOCYTE BIOL, V51, P400
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   SCHMIERER AS, 1998, THESIS U WASHINGTON
   SHAN J, 1999, THESIS U WASHINGTON
   SHEN M, 2001, UNPUB
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   SMETANA K, 1990, J BIOMED MATER RES, V24, P463, DOI 10.1002/jbm.820240405
   Sofia SJ, 1998, J BIOMED MATER RES, V40, P153, DOI 10.1002/(SICI)1097-4636(199804)40:1<153::AID-JBM18>3.0.CO;2-P
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680
   VICKERMAN JC, 1999, STATIC SIMS LIB
NR 51
TC 64
Z9 68
U1 1
U2 11
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2001
VL 12
IS 9
BP 961
EP 978
DI 10.1163/156856201753252507
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 506TL
UT WOS:000172987800002
PM 11787523
DA 2018-10-19
ER

PT J
AU Risbud, MV
   Hambir, S
   Jog, J
   Bhonde, R
AF Risbud, MV
   Hambir, S
   Jog, J
   Bhonde, R
TI Biocompatibility assessment of polytetrafluoroethylene/wollastonite
   composites using endothelial cells and macrophages
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE PTFE; wollastonite; biocompatibility; endothelial cells; macrophages
ID POTENTIAL ROLE; IN-VITRO; HEMODIALYSIS; PROSTHESES
AB The aim of the study was to prepare a composite of polytetrafluoroethylene/wollastonite (PTFE/W) and evaluate its biocompatibility with endothelial cells. A composite of PTFE with wollastonite in the proportion 90/10 w/w was prepared. The dynamic storage modulus of composite is found to increase from 260 to about 453 MPa at room temperature while a marginal increase is observed in the compressive modulus. Higher values of storage modulus of PTFE/W relative to pristine PTFE over a range of temperature indicated the contribution of wollastonite in improving the rigidity of PTFE. Electron microscopic visualization of composite surface indicates suitable morphology for cell growth with the cross-section showing no evidence of bonding between PTFE and wollastonite. The water contact angle of the composite indicates increased hydrophilicity over native PTFE due to the presence of wollastonite. A direct-contact test did not show any deleterious effects on endothelial cell morphology and viability, indicating its compatibility. Leached-out products (LOP) from the composite were determined to be non-toxic as tested by tetrazolium (MTT) and Neutral red uptake (NRU) assays. Mouse peritoneal macrophages cultured in the presence of the composites did not show upregulation of activation markers such as CD11b/CD18 (Mac-1), CD45, CD14, and CD86 (B7.2) in comparison to macrophages cultured in contact with PTFE alone, indicating its non-activating nature. LOP did not induce proliferation of mouse splenic lymphocytes suggesting its immuno-tolerance. In static incubation assay contact with composite did not lead to hemolysis thus exhibiting preliminary hemocompatibility of the material. Suitable physico-chemical properties and well tolerance by endothelial cells and macrophages make this composite a prospective biomaterial. One could foresee the applications of this composite in areas where materials need to possess high rigidity and are subject to elevated temperatures.
C1 Natl Ctr Cell Sci, Tissue Engn & Banking Lab, Pune 411007, Maharashtra, India.
   Natl Chem Lab, Div Chem Engn, Polymer Sci & Engn Grp, Pune 411008, Maharashtra, India.
RP Risbud, MV (reprint author), Harvard Univ, Sch Med, Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02115 USA.
CR ALSAFFAR N, 1994, BRIT J RHEUMATOL, V33, P309
   ASLAM M, 1995, J APPL TOXICOL, V15, P27, DOI 10.1002/jat.2550150107
   Bujan J, 1997, HISTOL HISTOPATHOL, V12, P683
   CHANG G, 1988, J BIOMED MATER RES, V22, P13, DOI 10.1002/jbm.820220104
   DeVos P, 1997, TRANSPLANTATION, V63, P824, DOI 10.1097/00007890-199703270-00006
   DION I, 1993, BIOMATERIALS, V14, P107, DOI 10.1016/0142-9612(93)90218-Q
   Doyle A, 1998, CELL TISSUE CULTURE
   Giudiceandrea F, 1998, J CRANIOFAC SURG, V9, P254, DOI 10.1097/00001665-199805000-00015
   Granchi D, 1998, J BIOMED MATER RES, V39, P549, DOI 10.1002/(SICI)1097-4636(19980315)39:4<549::AID-JBM7>3.0.CO;2-J
   JAMES NL, 1992, ARTIF ORGANS, V16, P346
   JILKEN L, 1991, POLYM TEST, V10, P329, DOI 10.1016/0142-9418(91)90011-L
   Kaupke CJ, 1996, AM J KIDNEY DIS, V27, P244, DOI 10.1016/S0272-6386(96)90548-X
   Labow RS, 1999, J BIOMATER APPL, V13, P187, DOI 10.1177/088532829901300302
   Otaki M, 1994, Cardiovasc Surg, V2, P212
   PAILES WH, 1984, J TOXICOL ENV HEALTH, V14, P497, DOI 10.1080/15287398409530601
   PAUL W, 1995, J COLLOID INTERF SCI, V174, P224, DOI 10.1006/jcis.1995.1385
   Risbud M, 2001, J BIOMED MATER RES, V56, P120, DOI 10.1002/1097-4636(200107)56:1<120::AID-JBM1076>3.0.CO;2-W
   Risbud M, 2001, BIOMATERIALS, V22, P1591, DOI 10.1016/S0142-9612(00)00325-2
   Risbud M, 2001, CELL TRANSPLANT, V10, P195
   Risbud MV, 2001, J BIOMAT SCI-POLYM E, V12, P125
   Risbud MV, 2001, J BIOMED MATER RES, V54, P436, DOI 10.1002/1097-4636(20010305)54:3<436::AID-JBM180>3.3.CO;2-#
   Rosenstiel S F, 1993, Int J Prosthodont, V6, P298
   Sagripanti A, 2000, BIOMED PHARMACOTHER, V54, P107, DOI 10.1016/S0753-3322(00)88861-7
   Turyna B, 1996, BIOMATERIALS, V17, P1379, DOI 10.1016/0142-9612(96)87278-4
   UFF CR, 1995, BIOMATERIALS, V16, P355, DOI 10.1016/0142-9612(95)93852-5
   von Appen K, 1994, ASAIO J, V40, pM609, DOI 10.1097/00002480-199407000-00071
   WARHEIT B, 1984, SCAN ELECT MICROSC, P919
   WOZNIAK H, 1986, Medycyna Pracy, V37, P288
NR 28
TC 6
Z9 9
U1 0
U2 1
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2001
VL 12
IS 11
BP 1177
EP 1189
DI 10.1163/156856201753395734
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 520XP
UT WOS:000173809300002
PM 11853385
DA 2018-10-19
ER

PT J
AU Cai, KY
   Yao, KD
   Li, Z
   Yang, ZM
   Li, XQ
AF Cai, KY
   Yao, KD
   Li, Z
   Yang, ZM
   Li, XQ
TI Rat osteoblast functions on the o-carboxymethyl chitosan-modified
   poly(D,L-lactic acid) surface
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE o-carboxymethyl chitosan; poly(D,L-lactic acid); surface modification;
   osteoblast; bio-compatibility
ID IN-VITRO; TISSUE; SCAFFOLDS; PROLIFERATION; BIOMATERIAL
AB In this study, the functions of rat osteoblasts on o-carboxymethyl chitosan-modified poly(D,L-lactic acid) (PDLLA) films were investigated in vitro. The surface characterization was measured by contact angle and electron spectroscopy for chemical analysis (ESCA). Cell adhesion and proliferation were used to assess cell behavior on the modified surface and control. The MTT assay was used to determined cell viability and alkaline phosphatase (ALP) activity was performed to evaluate differentiated cell function. Compared to the control films, cell adhesion of osteoblasts on o-carboxymethyl chitosan-modified PDLLA films was significantly higher (p < 0.05) after 6 and 8 h culture, and osteoblast proliferation was also significantly hlgher (p < 0.01) between 4 and 7 days. The MTT assay suggested cell viability of osteoblasts cultured on o-carboxymethyl chitosan modified PDLLA films was significantly greater (p < 0.05) than that seeded on control one, and the ALP activity of cells cultured on modified PDLLA films was significantly higher (1) < 0.01) than that found on control. These results give the first evidence that o-carboxymethyl chitosan could be used to modify PDLLA surface for improving biocompatibility.
C1 Tianjin Univ, Res Inst Polymer Mat, Tianjin 300072, Peoples R China.
   W China Univ Med Sci, Univ Hosp 1, Chengdu 610041, Peoples R China.
RP Yao, KD (reprint author), Tianjin Univ, Res Inst Polymer Mat, Tianjin 300072, Peoples R China.
RI Cai, Kaiyong/B-3061-2012; 蔡, 开勇/G-1233-2011
CR CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chuang WY, 1999, BIOMATERIALS, V20, P1479, DOI 10.1016/S0142-9612(99)00054-X
   Denuziere A, 1996, CARBOHYD POLYM, V29, P317, DOI 10.1016/S0144-8617(96)00035-5
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P667
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Inuvye K., 1998, J BIOCHEM BIOPH METH, V37, P159
   JACQUELINE MB, 1999, BIOMATERIALS, V20, P1773
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lillo LE, 1997, CARBOHYD POLYM, V34, P397, DOI 10.1016/S0144-8617(97)00117-3
   Lo H, 1996, J BIOMED MATER RES, V30, P475, DOI 10.1002/(SICI)1097-4636(199604)30:4<475::AID-JBM5>3.0.CO;2-M
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Otto TE, 1996, J BIOMED MATER RES, V32, P513, DOI 10.1002/(SICI)1097-4636(199612)32:4<513::AID-JBM3>3.0.CO;2-U
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   THOMAS JW, 2000, BIOMATERIALS, V21, P1803
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Yamaoka T, 1998, KOBUNSHI RONBUNSHU, V55, P328, DOI 10.1295/koron.55.328
NR 21
TC 31
Z9 36
U1 0
U2 4
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2001
VL 12
IS 12
BP 1303
EP 1315
DI 10.1163/156856202753419240
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 528HN
UT WOS:000174238500003
PM 11922477
DA 2018-10-19
ER

PT J
AU Zardiackas, LD
   Parsell, DE
   Dillon, LD
   Mitchell, DW
   Nunnery, LA
   Poggie, R
AF Zardiackas, LD
   Parsell, DE
   Dillon, LD
   Mitchell, DW
   Nunnery, LA
   Poggie, R
TI Structure, metallurgy, and mechanical properties of a porous tantalum
   foam
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bone scaffold; porous metal; porous tantalum; mechanical properties of
   bone scaffold; structural properties of bone scaffold
AB This study evaluated a porous tantalum biomaterial (Hedrocel (TM)) designed to function as a scaffold for osseous ingrowth, Samples were characterized for structure, Vickers microhardness, compressive cantilever bending, and tensile properties, as well as compressive and cantilever bending fatigue. The structure consisted of regularly arranged cells having struts with a vitreous carbon core,vith layers of CVI deposited crystalline tantalum, Microhardness values ranged from 240-393, compressive strength was 60 +/- 18 MPa, tensile strength was 63 +/- 6 MPa, and bending strength was 110 +/- 14 MPa. The compressive fatigue endurance limit was 23 MPa at 5 x 10(6) cycles with samples exhibiting significant plastic deformation. SEM examination showed cracking at strut junctions 45 degrees to the axis of the applied load, The cantilever bending fatigue endurance limit was 35 MPa at 5 x 10(6) cycles, and SEM examination showed failure due to cracking of the struts on the tension side of the sample. While properties were variable due to morphology, results indicate that the material provides structural support while bone ingrowth is occurring. These findings, coupled with the superior biocompatibility of tantalum, makes the material a candidate for a number of clinical applications and warrants further and continued laboratory and clinical investigation. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Mississippi, Med Ctr, Sch Dent Biomat, Jackson, MS 39216 USA.
   Implex Corp, Allendale, NJ USA.
RP Zardiackas, LD (reprint author), Univ Mississippi, Med Ctr, Sch Dent Biomat, 2500 N State St, Jackson, MS 39216 USA.
CR BOBYN JD, 1999, CHARACTEIZATION NEW
   Gibson LJ, 1988, CELLULAR SOLIDS STRU
   GRESSER JD, 2000, BIOMATERIALS ENG DEV, V2
   Heiner A. D., 1998, Journal of Musculoskeletal Research, V2, P267, DOI 10.1142/S0218957798000263
   HERRON JL, 1985, METALS HDB, V8
   Hulbert S. F., 1987, HIGH TECH CERAMICS
   Ikeda N, 1999, BIOMATERIALS, V20, P1087, DOI 10.1016/S0142-9612(99)00005-8
   IODU K, 1993, BIOMED MAT ENG, V3, P137
   MCGEE TD, 1995, ENCY HDB BIOMATERIAL, V1
   MITCHELL D, 1999, P 25 ANN SOC BIOM M, P466
   PARK J, 1995, BIOMEDICAL ENG HDB
   PATKA P, 1995, ENCY HDB BIOMATERI B, V1
   PEDERSEN D, 1997, 43 ORS, P598
   POGGIE RA, 1998, 44 ORS, P777
   SCHORS EC, 1993, INTRO BIOCEAMICS
   SHAPIRO E, 1985, METALS HDB, V8
   ZARDIACKAS LD, 1999, P 25 ANN SOC BIOM M, P455
NR 17
TC 213
Z9 227
U1 8
U2 63
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PY 2001
VL 58
IS 2
BP 180
EP 187
DI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 413XK
UT WOS:000167636700006
PM 11241337
DA 2018-10-19
ER

PT J
AU DeHeer, DH
   Engels, JA
   DeVries, AS
   Knapp, RH
   Beebe, JD
AF DeHeer, DH
   Engels, JA
   DeVries, AS
   Knapp, RH
   Beebe, JD
TI In situ complement activation by polyethylene wear debris
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE complement; wear debris; polyethylene; synovitis; total joint
   arthroplasty
ID IN-VITRO; BIOMATERIAL SURFACES; MACROPHAGES; BIOCOMPATIBILITY;
   PHAGOCYTOSIS; CD11B/CD18; RECEPTORS; MONOCYTES; PARTICLES; PROTEIN
AB A frequent long-term complication of total joint arthroplasty is aseptic loosening, the end result of wear debris accumulation, synovitis, and osteolysis about the implant-bone or cement-bone interface. Complement, an effector system in plasma, synovial fluid, and tissue, has powerful chemotactic, inflammatory, and osteoclast-activating potentials. This study explored the complement-activating ability of polyethylene, a material used in joint Implants. In vitro hemolytic assays using sheep red blood cells (E-sh), human serum, and particulate polyethylene suggested alternative pathway complement activation, as well as polyethylene adsorption of activated complement components. These results were confirmed by enzyme-linked immunosorbent assay (ELISA) quantification of activated complement factors Bb and C3b. In situ double antibody immunoperoxidase staining for factors Bb, C3a, iC3b, and SC5-9 in synovial tissue from revision hip specimens showed localized alternative pathway activation and component adsorption. These results introduce a likely role for complement activation in particle-mediated recruitment, proliferation, and activation of macrophages during early events in osteolysis and implant loosening. (C) 2000 John Wiley & Sons, Inc.
C1 Grand Rapids Orthopaed Surg Residency Program, Grand Rapids, MI 49506 USA.
   Calvin Coll, Dept Biol, Grand Rapids, MI 49546 USA.
   Dept Pathol, Grand Rapids, MI 49506 USA.
RP DeHeer, DH (reprint author), Grand Rapids Orthopaed Surg Residency Program, 1840 Wealthy St SE, Grand Rapids, MI 49506 USA.
CR ABBINK JJ, 1992, ANN RHEUM DIS, V51, P1123, DOI 10.1136/ard.51.10.1123
   Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552
   BRODEUR JP, 1991, ARTHRITIS RHEUM, V34, P1531
   BROWN EJ, 1991, CURR OPIN IMMUNOL, V3, P76, DOI 10.1016/0952-7915(91)90081-B
   Collier T O, 1997, Biomed Sci Instrum, V33, P178
   DEHEER DH, 1995, FOOT ANKLE, V8, P109
   ELSTAD MR, 1994, J IMMUNOL, V152, P220
   Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9
   HAZEKI K, 1994, MOL IMMUNOL, V31, P511
   HERZLINGER GA, 1980, T AM SOC ART INT ORG, V26, P165
   Horowitz SM, 1998, J BIOMED MATER RES, V41, P468, DOI 10.1002/(SICI)1097-4636(19980905)41:3<468::AID-JBM17>3.3.CO;2-7
   JANATOVA J, 1991, COMPLEMENT INFLAMMAT, V8, P61, DOI 10.1159/000463181
   JASTY M, 1992, CLIN ORTHOP RELAT R, P116
   Kalman P G, 1990, J Vasc Surg, V11, P591
   KALMAN PG, 1991, J BIOMED MATER RES, V25, P199, DOI 10.1002/jbm.820250207
   Kao WJ, 1996, J BIOMED MATER RES, V32, P99, DOI 10.1002/(SICI)1097-4636(199609)32:1<99::AID-JBM12>3.3.CO;2-E
   Karlsson C, 1996, J LAB CLIN MED, V128, P496, DOI 10.1016/S0022-2143(96)90047-5
   LABARRE D, 1993, J APPL BIOMATER, V4, P231, DOI 10.1002/jab.770040304
   LIN YS, 1992, BIOMATERIALS, V13, P497
   MANGHAM DC, 1993, J CLIN PATHOL, V46, P517, DOI 10.1136/jcp.46.6.517
   MONTDARGENT B, 1993, BIOMATERIALS, V14, P203, DOI 10.1016/0142-9612(93)90024-V
   Nabil K, 1997, BIOCHEM J, V326, P377, DOI 10.1042/bj3260377
   Ohlin A, 1999, INFLAMM RES, V48, P181, DOI 10.1007/s000110050444
   PASCUAL M, 1993, BIOMATERIALS, V14, P665, DOI 10.1016/0142-9612(93)90065-A
   PERALA D, 1991, International Journal of Oral and Maxillofacial Implants, V6, P136
   Prabhu A, 1998, J BIOMED MATER RES, V42, P655, DOI 10.1002/(SICI)1097-4636(19981215)42:4<655::AID-JBM23>3.3.CO;2-2
   SANTAVIRTA S, 1991, J BONE JOINT SURG BR, V73, P38
   SCHLESINGER LS, 1991, J IMMUNOL, V147, P1983
   SHEPPECK RA, 1994, IMPLANTATION BIOL, P60
   SIEMSSEN PA, 1991, BRIT J UROL, V67, P83, DOI 10.1111/j.1464-410X.1991.tb15075.x
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   TEGNANDER A, 1994, ACTA ORTHOP SCAND, V65, P472, DOI 10.3109/17453679408995495
   Tengvall P, 1997, J BIOMED MATER RES, V35, P81, DOI 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I
   Wooley PH, 1999, J BONE JOINT SURG AM, V81A, P616, DOI 10.2106/00004623-199905000-00003
NR 34
TC 39
Z9 41
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 2001
VL 54
IS 1
BP 12
EP 19
DI 10.1002/1097-4636(200101)54:1<12::AID-JBM2>3.0.CO;2-X
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 378MW
UT WOS:000165589000002
PM 11077398
DA 2018-10-19
ER

PT J
AU Rodrigo, AM
   Martinez, ME
   Martinez, P
   Escudero, ML
   Ruiz, J
   Saldana, L
   Gomez-Garcia, L
   Fernandez, L
   del Valle, I
   Munuera, L
AF Rodrigo, AM
   Martinez, ME
   Martinez, P
   Escudero, ML
   Ruiz, J
   Saldana, L
   Gomez-Garcia, L
   Fernandez, L
   del Valle, I
   Munuera, L
TI Effects of MA 956 superalloy and alpha-alumina particles on some markers
   of human osteoblastic cells in primary culture
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE MA 956 alloy; alpha-alumina; particles; biocompatibility; osteoblastic
   cells
ID IN-VITRO; POLYETHYLENE PARTICLES; PREOXIDIZED MA-956; BONE-RESORPTION;
   SKELETAL SITE; DONOR AGE; OSTEOCALCIN; DIFFERENTIATION; BIOMATERIALS;
   PROCOLLAGEN
AB One of the problems associated with the modem biomaterials used in prostheses is osteolysis, which, although its exact origin is unknown, has been associated with wear particles. Osteoblasts seem to participate directly in this phenomenon. This paper investigates in vitro cellular response to the wear particles from the metal substrate and ceramic covering (alpha -alumina) of a new titanium yttrium aluminum alloy, MA 956, that has been proposed as a biomaterial because of its exceptional mechanical and electrochemical properties. The effect of different sizes (10 and 80 mum) of MA 956 and alpha -alumina particles on osteoblast function was studied in primary human bone cell cultures. Cells were harvested from trabecular bone fragments obtained during knee arthroplasty. Osteoblastic cell response to the particles was measured by assaying C-terminal type I procollagen (PICP), alkaline phosphatase, and osteocalcin secretion, with and without 1.25(OH)(2)D-3 stimulation, in the cell-conditioned medium. Both sizes of MA 956 and alpha -alumina particles decreased PICP secretion in nonstimulated osteoblastic cells, but this secretion was not affected in the cultures stimulated with 1.25(OH)(2)D-3. Only the 10 mum alpha -alumina particles inhibited alkaline phosphatase activity in 1.25(OH)(2)D-3-stimulated and nonstimulated cultures. The rise in osteocalcin levels after 1.25(OH)(2)D-3 stimulation was lower in the presence of the 10 mum MA 956 particles than in the presence of alpha -alumina particles. Although both materials seem to ha ve directly affected in vitro osteoblastic cell function, the increase in osteocalcin levels after 1.25(OH)(2)D-3 stimulation was lower after exposure to MA 956 particles than the increase observed after exposure to alpha -alumina particles. Therefore, it does not seem that osteocalcin stimulated bone resorption, suggesting that MA 956 would be less likely to provoke osteolysis. (C) 2000 John Wiley & Sons, Inc.
C1 Hosp La Paz, Div Biochem, Madrid, Spain.
   Hosp La Paz, Invest Unit, Madrid, Spain.
   CSIC, Ctr Nacl Invest Met, Madrid, Spain.
   Hosp La Paz, Dept Orthopaed, Madrid, Spain.
RP Martinez, ME (reprint author), Hosp La Paz, Div Biochem, Madrid, Spain.
RI Escudero, Maria Lorenza/L-7113-2014; Saldana, Laura/N-2412-2014
OI Escudero, Maria Lorenza/0000-0002-2181-448X; Saldana,
   Laura/0000-0003-3057-4649
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   Allen MJ, 1997, J BONE JOINT SURG BR, V79B, P475, DOI 10.1302/0301-620X.79B3.7415
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chang YL, 1999, INT J ORAL MAX IMPL, V14, P239
   Chao J, 1996, METALL MATER TRANS A, V27, P3809, DOI 10.1007/BF02595630
   CHIBA J, 1994, CLIN ORTHOP RELAT R, P114
   Dean DD, 1999, J ORTHOPAED RES, V17, P9, DOI 10.1002/jor.1100170104
   DEFRANCO DJ, 1991, CALCIFIED TISSUE INT, V49, P43, DOI 10.1007/BF02555901
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   ESCUDERO ML, 1995, BIOMATERIALS, V16, P735, DOI 10.1016/0142-9612(95)99703-O
   Escudero ML, 1996, J BIOMED MATER RES, V31, P313
   ESCUDERO ML, 1994, BIOMATERIALS, V15, P1175, DOI 10.1016/0142-9612(94)90239-9
   FROST HM, 1988, CALCIFIED TISSUE INT, V42, P142
   GESSINGER GH, 1984, POWDER METALLURGY SU, P214
   GLANT TT, 1994, J ORTHOPAED RES, V12, P720, DOI 10.1002/jor.1100120515
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOODMAN S, 1995, J BONE JOINT SURG AM, V77A, P1025, DOI 10.2106/00004623-199507000-00008
   HARMS J, 1979, J BIOMED MATER RES, V13, P67, DOI 10.1002/jbm.820130109
   JASTY MJ, 1986, J BONE JOINT SURG AM, V68A, P912, DOI 10.2106/00004623-198668060-00014
   JINAREK WA, 1993, J BONE JOINT SURG AM, V75, P863
   Josset Y, 1999, J BIOMED MATER RES, V47, P481, DOI 10.1002/(SICI)1097-4636(19991215)47:4<481::AID-JBM4>3.0.CO;2-Y
   Kadoya Y, 1996, J ORTHOPAED RES, V14, P473, DOI 10.1002/jor.1100140318
   KIM KJ, 1993, CLIN ORTHOP RELAT R, P142
   KOHN DH, 1992, MAT SCI TECHNOLOGY, P38
   Lanyon LE, 1984, CALCIFIED TISSUE INT, V36, P56
   MALONEY WJ, 1990, J BONE JOINT SURG BR, V72, P966
   MANLEY MT, 1994, CLIN ORTHOP RELAT R, P137
   MARGEVICIUS KJ, 1994, J BONE JOINT SURG AM, V76A, P1664, DOI 10.2106/00004623-199411000-00010
   Martinez ME, 1999, CALCIFIED TISSUE INT, V64, P280, DOI 10.1007/s002239900619
   Martinez ME, 1998, CALCIFIED TISSUE INT, V62, P453, DOI 10.1007/s002239900459
   Martinez ME, 1999, BONE, V24, P203, DOI 10.1016/S8756-3282(98)00181-1
   Martinez ME, 1998, BIOMATERIALS, V19, P183, DOI 10.1016/S0142-9612(97)00250-0
   MELKKO J, 1990, CLIN CHEM, V36, P1328
   MUNDY GR, 1983, CALCIFIED TISSUE INT, V35, P164, DOI 10.1007/BF02405025
   Mundy GR, 1995, BONE REMODELING ITS, P1
   Nizegorodcew T, 1997, INT ORTHOP, V21, P14, DOI 10.1007/s002640050110
   OHLIN A, 1990, CLIN ORTHOP RELAT R, P287
   PERRY M, 1990, T ORTHOP RES SOC, V15, P486
   POLLICE PF, 1995, J ORTHOPAED RES, V13, P325, DOI 10.1002/jor.1100130305
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Shanbhag AS, 1997, CLIN ORTHOP RELAT R, P205
   Sun JS, 1998, J BIOMED MATER RES, V39, P390, DOI 10.1002/(SICI)1097-4636(19980305)39:3<390::AID-JBM7>3.0.CO;2-E
   Vercaigne S, 1998, J BIOMED MATER RES, V41, P41, DOI 10.1002/(SICI)1097-4636(199807)41:1<41::AID-JBM5>3.0.CO;2-Q
   WILLIAMS DF, 1989, J BIOMED ENG, V11, P185, DOI 10.1016/0141-5425(89)90138-6
   Yao JL, 1997, J BONE JOINT SURG AM, V79A, P107, DOI 10.2106/00004623-199701000-00011
   Zambonin G, 1998, CALCIFIED TISSUE INT, V62, P362, DOI 10.1007/s002239900445
NR 49
TC 3
Z9 3
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 2001
VL 54
IS 1
BP 30
EP 36
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 378MW
UT WOS:000165589000004
PM 11077400
DA 2018-10-19
ER

PT J
AU Charulatha, V
   Rajaram, A
AF Charulatha, V
   Rajaram, A
TI Dimethyl 3,3 '-dithiobispropionimidate: A novel crosslinking reagent for
   collagen
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE collagen; crosslinking; dimethyl 3,3 '-dithio(bispropionimidate);
   glutaraldehyde; biocompatibility
ID DERMAL SHEEP COLLAGEN; IN-VITRO DEGRADATION; CROSS-LINKING;
   MECHANICAL-PROPERTIES; BOVINE PERICARDIUM; CALCIFICATION; REGENERATION;
   BIOMATERIAL; DELIVERY
AB Crosslinking agents are used for improving the physical properties and durability of collagenous implants, glutaraldehyde (GTA) being the most widely used. Many of these reagents, including GTA, are known to be cytotoxic and to induce calcification. Hence, it is desirable to develop new crosslinking methods for collagen so that biocompatibility and physical properties are improved. In the present study, dimethyl 3,3' -dithiobispropionimidate (DTBP) has been tried as a novel crosslinking reagent for collagen. Collagen purified from rat tail tendon has been crosslinked with DTBP and GTA. An increase of 22 degreesC in shrinkage temperature is observed for collagen treated with DTBP under optimal conditions. Crosslinking density determination shows that DTBP induces 10 crosslinks per mole, compared to 13 by GTA. While the tensile strength of GTA-treated samples is greater than those treated with DTBP, the latter shows more extensibility. In vitro degradation studies show that both GTA- and DTBP-treated samples are resistant to degradation by collagenase. The biocompatibility of crosslinked collagen samples studied by subcutaneous implantation in rats show that while both GTA- and DTBP-treated collagen do not degrade for up to 4 weeks, ultrastructural and histological studies indicate that DTBP collagen is far more biocompatible than GTA-treated matrices. (C) 2000 John Wiley & Sons, Inc.
C1 Cent Leather Res Inst, Dept Biophys, Adyar 600020, Chennai, India.
RP Rajaram, A (reprint author), Cent Leather Res Inst, Dept Biophys, Adyar 600020, Chennai, India.
CR Charulatha V, 1997, J BIOMED MATER RES, V36, P478
   Charulatha V, 1996, PROCEEDINGS OF THE 1996 FIFTEENTH SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE, P344, DOI 10.1109/SBEC.1996.493221
   DALM D, 1998, THORAC CARDIOVASC SU, V46, P344
   Damink LHHO, 1996, BIOMATERIALS, V17, P679, DOI 10.1016/0142-9612(96)86737-8
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P139, DOI 10.1002/jbm.820290202
   DUTTON A, 1966, BIOCHEM BIOPH RES CO, V23, P730, DOI 10.1016/0006-291X(66)90462-1
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   GOLOMB G, 1992, BIOMATERIALS, V13, P353, DOI 10.1016/0142-9612(92)90039-Q
   GORHAM SD, 1993, J MATER SCI-MATER M, V4, P40, DOI 10.1007/BF00122976
   HAND ES, 1962, J AM CHEM SOC, V84, P3505, DOI 10.1021/ja00877a017
   Huang LLH, 1998, J BIOMED MATER RES, V42, P568, DOI 10.1002/(SICI)1097-4636(19981215)42:4<568::AID-JBM13>3.0.CO;2-7
   HUNTER MJ, 1962, J AM CHEM SOC, V84, P3491, DOI 10.1021/ja00877a016
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   KEEFE J, 1992, Clinical Materials, V9, P155, DOI 10.1016/0267-6605(92)90095-B
   LEVY RJ, 1995, J BIOMED MATER RES, V29, P217, DOI 10.1002/jbm.820290212
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Nicolas FL, 1997, BIOMATERIALS, V18, P815, DOI 10.1016/S0142-9612(97)00003-3
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Nimni ME, 1988, COLLAGEN, VIII, P1
   RAJARAM A, 1990, Journal of Biomaterials Science Polymer Edition, V1, P167
   Schlegel AK, 1997, BIOMATERIALS, V18, P535, DOI 10.1016/S0142-9612(96)00175-5
   SCHON MP, 1995, BRIT J DERMATOL, V133, P176, DOI 10.1111/j.1365-2133.1995.tb02613.x
   TOMAZIC BB, 1994, J BIOMED MATER RES, V28, P35, DOI 10.1002/jbm.820280106
   TRAUT RR, 1990, PROTEIN FUNCTION PRA, P101
   van Wachem PB, 1999, J BIOMED MATER RES, V47, P270, DOI 10.1002/(SICI)1097-4636(199911)47:2<270::AID-JBM18>3.0.CO;2-D
   VANLUYN MJA, 1995, J BIOMED MATER RES, V29, P1425, DOI 10.1002/jbm.820291114
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   YANNAS I V, 1992, Clinical Materials, V9, P179, DOI 10.1016/0267-6605(92)90098-E
NR 31
TC 15
Z9 16
U1 0
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 2001
VL 54
IS 1
BP 122
EP 128
DI 10.1002/1097-4636(200101)54:1<122::AID-JBM15>3.0.CO;2-N
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 378MW
UT WOS:000165589000015
PM 11077411
DA 2018-10-19
ER

PT J
AU Sofia, S
   McCarthy, MB
   Gronowicz, G
   Kaplan, DL
AF Sofia, S
   McCarthy, MB
   Gronowicz, G
   Kaplan, DL
TI Functionalized silk-based biomaterials for bone formation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bone; silk; biomaterial; osteoblast; alkaline phosphatase; cyotkine;
   adhesion
ID ENDOTHELIAL-CELL INTERACTIONS; MORPHOGENETIC PROTEIN-2; SPIDER SILK;
   PARATHYROID-HORMONE; FIBROBLAST CELLS; DRAGLINE SILK; COLLAGEN; MATRIX;
   INVITRO; FIBROIN
AB Silks are being reassessed as biomaterial scaffolds due to their unique mechanical properties, opportunities for genetic tailoring of structure and thus function, and recent studies clarifying biocompatibility. We report on the covalent decoration of silk films with integrin recognition sequences (RGD) as well as parathyroid hormone (PTH, 1-34 amino acids) and a modified PTH 1-34 (mPTH) involved in the induction of bone formation. Osteoblast-like cell (Saos-2) responses to the decorated silk films indicate that the proteins serve as suitable bone-inducing matrices. Osteoblast-like cell adhesion was significantly increased on RGD and PTH compared to plastic, mPTH, and the control peptide RAD. At 2 weeks of culture, message levels of alkaline phosphatase were similar on all substrates, but by 4 weeks, alkaline phosphatase mRNA was greatest on RGD. At 2 weeks of culture, alpha1(I) procollagen mRNA was elevated on silk, RGD, RAD, and PTH, and hardly detectable on mPTH and plastic. However, by 4 weeks RGD demonstrated the highest level compared to the other substrates. Osteocalcin message levels detected by RT-PCR were greatest on RGD at both time points. Calcification was also significantly elevated on RGD compared to the other substrates with an increase in number and size of the mineralized nodules in culture. Thus, RGD covalently decorated silk appears to stimulate osteoblast-based mineralization in vitro. (C) 2000 John Wiley & Sons, Inc.
C1 Tufts Univ, Dept Chem Engn, Medford, MA 02155 USA.
   Tufts Univ, Ctr Biotechnol, Medford, MA 02155 USA.
   Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Chem Engn, 4 Colby St, Medford, MA 02155 USA.
OI Gronowicz, Gloria/0000-0001-7158-3598
FU NIAMS NIH HHS [AR43232]
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Asakura T., 1994, ENCY AGR SCI, V4, P1
   BELLOWS CG, 1989, DEV BIOL, V133, P8, DOI 10.1016/0012-1606(89)90291-1
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Cowles EA, 1998, CALCIFIED TISSUE INT, V62, P74, DOI 10.1007/s002239900397
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Davies JE, 1996, ANAT REC, V245, P426
   DEMPSTER DW, 1993, ENDOCR REV, V14, P690, DOI 10.1210/er.14.6.690
   DIEGELMANN RF, 1972, DEV BIOL, V28, P443, DOI 10.1016/0012-1606(72)90028-0
   Foelix R. F., 1992, BIOL SPIDERS
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   GRONOWICZ G, 1989, J BONE MINER RES, V4, P313
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Hofman S, 1999, BIOMATERIALS, V20, P1155, DOI 10.1016/S0142-9612(97)00082-3
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Kaplan D. L., 1998, PROTEIN BASED MAT
   Kim KJ, 1997, J BIOMED MATER RES, V35, P279, DOI 10.1002/(SICI)1097-4636(19970605)35:3<279::AID-JBM2>3.3.CO;2-S
   KISSANE JM, 1958, J BIOL CHEM, V233, P184
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Layman DL, 1998, J BIOMED MATER RES, V40, P282, DOI 10.1002/(SICI)1097-4636(199805)40:2<282::AID-JBM13>3.0.CO;2-O
   LEE SC, 1994, J BIOMED MATER RES, V28, P1149, DOI 10.1002/jbm.820281005
   LINDHOLM TS, 1996, BONE MORPHOGENETIC P
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   Maxian SH, 1998, J BIOMED MATER RES, V40, P171, DOI 10.1002/(SICI)1097-4636(199805)40:2<171::AID-JBM1>3.0.CO;2-I
   MCGRATH K, 1998, PROTEIN BASED MAT, P103
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   PETERKOFSKY B, 1971, BIOCHEMISTRY-US, V10, P988, DOI 10.1021/bi00782a009
   Pins GD, 1997, J APPL POLYM SCI, V63, P1429, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1429::AID-APP5>3.3.CO;2-O
   Porte-Durrieu MC, 1999, J BIOMED MATER RES, V46, P368
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   RODAN SB, 1987, CANCER RES, V47, P4961
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Urist MR, 1997, J BONE MINER RES, V12, P343, DOI 10.1359/jbmr.1997.12.3.343
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   Wheeler DI, 1998, J BIOMED MATER RES, V43, P365, DOI 10.1002/(SICI)1097-4636(199824)43:4<365::AID-JBM4>3.0.CO;2-6
   Winkler S, 1999, INT J BIOL MACROMOL, V24, P265, DOI 10.1016/S0141-8130(98)00088-9
   Yamazaki Y, 1996, J BIOMED MATER RES, V30, P1
   YOSHIMIZU H, 1990, J APPL POLYM SCI, V40, P1745, DOI 10.1002/app.1990.070400928
   Zellin G, 1997, J BIOMED MATER RES, V35, P181
   Zhou AT, 1997, P NATL ACAD SCI USA, V94, P3644, DOI 10.1073/pnas.94.8.3644
NR 51
TC 584
Z9 620
U1 8
U2 242
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 2001
VL 54
IS 1
BP 139
EP 148
DI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 378MW
UT WOS:000165589000017
PM 11077413
DA 2018-10-19
ER

PT J
AU Ripamonti, U
   Ramoshebi, LN
   Matsaba, T
   Tasker, J
   Crooks, J
   Teare, J
AF Ripamonti, U
   Ramoshebi, LN
   Matsaba, T
   Tasker, J
   Crooks, J
   Teare, J
TI Bone induction by BMPs/OPs and related family members in primates - The
   critical role of delivery systems
SO JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
LA English
DT Article
ID BABOON PAPIO-URSINUS; OSTEOGENIC PROTEIN-1 HOP-1; BMP-INDUCED
   OSTEOGENESIS; MORPHOGENETIC PROTEINS; POROUS HYDROXYAPATITE;
   ENDOCHONDRAL BONE; GROWTH-FACTOR; TRANSFORMING GROWTH-FACTOR-BETA-1;
   CALVARIAL DEFECTS; PERIODONTAL REGENERATION
AB Background: In a series of studies in the primate Papio ursinus, we have examined the capacity of bone morphogenetic proteins (BMPs/OPs) delivered in a variety of biomaterial carrier systems to elicit bone formation in heterotopic and orthotopic sites. In this review, we compare the osteoinductive effects of different biomaterial delivery systems that have or have not been pretreated with BMPs/OPs. In particular, we focus on the geometric induction of bone formation by sintered porous hydroxyapatite (SPHA) discs with concavities on their planar surfaces, which elicit bone formation without exogenously applied BMPs/OPs.
   Methods: Heterotopic bone formation was examined by bilaterally implanting 100-mg pellets of a collagenous carrier containing BMPs/OPs in the rectus abdominis muscle of the adult baboon. Orthotopic bone formation was examined by implanting 1 g of a collagenous carrier containing BMPs/OPs into two full-thickness critical-sized 25-mm-diameter defects on each side of the calvaria of adult baboons. The BMPs/OPs whose effects were examined included recombinant human osteogenic protein-1 (rhOP-1), recombinant human transforming growth factor-pr (rhTGF-beta1), rhTGF-beta2, and porcine platelet derived transforming growth factor-beta1 (pTGF-beta1). Tissue from the rectus abdominis muscle was harvested 30 or 90 days after implantation. Tissue from the orthotopic calvarial model was examined at 1, 3, 6, 9, and 12 months after implantation. To demonstrate the effect of surface geometry on bone induction, hydroxyapatite powders were sintered to form solid discs with a series of concavities on the planar surfaces of the SPHA discs. The discs were either pretreated with exogenous rhOP-1 or not treated with exogenous OF-1. They were then implanted heterotopically or orthotopically into calvarial defects. Bone formation was evaluated histologically in undecalcified sections stained with Goldner's trichrome stain or 0.1% toluidine blue.
   Results: Naturally derived BMPs/OPs or rhOP-1 in a collagenous carrier elicit heterotopic bone formation and the complete healing of 25-mm-diameter critical-sized defects by day 90 following implantation. Binary applications of TGF-beta1 together with rhOP-1 in the collagen carrier induced massive endochondral ossicles in heterotopic sites and bone formation in calvarial defects. pTGF-beta1, rhTGF-beta1, and rhTGF-beta2 are powerful inducers of heterotopic endochondral bone formation but elicit limited bone formation in calvarial defects. SPHA discs pretreated with rhOP-1 elicited extensive bone formation in both heterotopic and orthotopic sites. However, SPHA without rhOP-1 also elicited bone formation in heterotopic and orthotopic sites and complete healing of the calvarial defects.
   Conclusion: We have prepared SPHA discs with concavities on their planar surfaces that induce bone formation in heterotopic or orthotopic critical-sized calvarial defects without exogenously applied BMPs/OPs. This biomaterial induces bone formation by intrinsic osteoinductivity regulated by the geometry of the substratum. The incorporation of specific biological activities into biomaterials by manipulating the geometry of the substratum, defined as geometric induction of bone formation, may make it possible to engineer morphogenetic responses for therapeutic osteogenesis in clinical contexts.
   Clinical Relevance: We have implemented a clinical trial using naturally derived BMPs/OPs extracted and purified from bovine bone matrices and implanted in craniofacial defects in humans. In addition, the discovery that specific geometric and surface characteristics of sintered hydroxyapatites can induce intrinsic osteoinductivity in primates paves the way for formulation and therapeutic application of porous substrata designed to obtain predictable intrinsic osteoinductivity in clinical contexts.
C1 Univ Witwatersrand, MRC, Bone Res Unit, Sch Med, ZA-2193 Johannesburg, South Africa.
RP Ripamonti, U (reprint author), Univ Witwatersrand, MRC, Bone Res Unit, Sch Med, 7 York Rd, ZA-2193 Johannesburg, South Africa.
CR BENTZ H, 1989, J BIOL CHEM, V264, P20805
   DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0
   Duneas N, 1998, GROWTH FACTORS, V15, P259, DOI 10.3109/08977199809017482
   FERRETTI C, 2000, INT C BON MORPH PROT
   HAMMONDS RG, 1991, MOL ENDOCRINOL, V5, P149, DOI 10.1210/mend-5-1-149
   Hotten GC, 1996, GROWTH FACTORS, V13, P65, DOI 10.3109/08977199609034567
   Jin QM, 2000, J BIOMED MATER RES, V52, P841, DOI 10.1002/1097-4636(20001215)52:4<841::AID-JBM31>3.0.CO;2-3
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   LUYTEN FP, 1989, J BIOL CHEM, V264, P13377
   Magan A, 1996, J CRANIOFAC SURG, V7, P71, DOI 10.1097/00001665-199601000-00016
   PETIT JC, 2000, INT C BON MORPH PROT
   Ramoshebi LN, 2000, ANAT REC, V259, P97, DOI 10.1002/(SICI)1097-0185(20000501)259:1<97::AID-AR11>3.0.CO;2-O
   Reddi A. Hari, 1997, Cytokine and Growth Factor Reviews, V8, P11, DOI 10.1016/S1359-6101(96)00049-4
   Reddi A. Hari, 1992, Current Opinion in Cell Biology, V4, P850
   Reddi A. Hari, 1994, Current Opinion in Genetics and Development, V4, P737, DOI 10.1016/0959-437X(94)90141-O
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   REDDI AH, 1994, J CELL BIOCHEM, V56, P192, DOI 10.1002/jcb.240560213
   Reddi AH, 2000, BIOCHEM SOC T, V28, P345, DOI 10.1042/0300-5127:0280345
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   Ripamonti U, 1996, GROWTH FACTORS, V13, P273, DOI 10.3109/08977199609003228
   RIPAMONTI U, 1993, PLAST RECONSTR SURG, V91, P27, DOI 10.1097/00006534-199301000-00005
   Ripamonti U, 1996, ARCH ORAL BIOL, V41, P121, DOI 10.1016/0003-9969(95)00110-7
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Ripamonti U, 2000, GROWTH FACTORS, V17, P269, DOI 10.3109/08977190009028971
   Ripamonti U, 1996, J BONE MINER RES, V11, P938
   Ripamonti U, 1997, J BONE MINER RES, V12, P1584, DOI 10.1359/jbmr.1997.12.10.1584
   RIPAMONTI U, 1992, MATRIX, V12, P202, DOI 10.1016/S0934-8832(11)80063-6
   Ripamonti U, 1998, PLAST RECONSTR SURG, V101, P227, DOI 10.1097/00006534-199801000-00040
   Ripamonti U, 1997, CRIT REV ORAL BIOL M, V8, P154, DOI 10.1177/10454411970080020401
   Ripamonti U., 2000, Current Pharmaceutical Biotechnology, V1, P47, DOI 10.2174/1389201003379031
   RIPAMONTI U, 1995, S AFR J SCI, V91, P277
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   Ripamonti U, 1996, MRS BULL, V21, P36
   RIPAMONTI U, 1993, MATRIX, V13, P491, DOI 10.1016/S0934-8832(11)80115-0
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   RIPAMONTI U, 1994, J PERIODONTAL RES, V29, P439, DOI 10.1111/j.1600-0765.1994.tb01246.x
   RIPAMONTI U, 1994, J PERIODONTAL RES, V29, P225, DOI 10.1111/j.1600-0765.1994.tb01216.x
   RIPAMONTI U, 1991, CLIN ORTHOP RELAT R, P284
   Ripamonti U, 2000, J BONE MINER RES, V15, P1798, DOI 10.1359/jbmr.2000.15.9.1798
   RIPAMONTI U, 1992, PLAST RECONSTR SURG, V90, P382, DOI 10.1097/00006534-199209000-00004
   RIPAMONTI U, 1992, CLIN ORTHOP RELAT R, P293
   RIPAMONTI U, 2000, IN PRESS BONE MORPHO
   RIPAMONTI U, 2000, 7 INT AC SHAP MEM MA
   RIPAMONTI U, 2001, IN PRESS PLAST RECON
   RIPAMONTI U, 2000, IN PRESS BONE ENG
   RIPAMONTI U, 2000, BIOMATERIALS INTRINS
   RIPAMONTI U, 2000, INT C BON MORPH PROT
   RIPAMONTI U, 2000, REGENERATION MED TIS, P1
   RIPAMONTI U, 2000, UNPUB J PERIODONTAL
   RIPAMONTI U, 1995, ADV PLAST RECONSTR S, V11, P47
   ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167
   SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599
   SAMPATH TK, 1992, J BIOL CHEM, V267, P20352
   SAMPATH TK, 1993, P NATL ACAD SCI USA, V90, P6004, DOI 10.1073/pnas.90.13.6004
   SCHNITZLER CM, 1993, CALCIFIED TISSUE INT, V52, P447, DOI 10.1007/BF00571335
   Thomadakis G, 1999, EUR J ORAL SCI, V107, P368, DOI 10.1046/j.0909-8836.1999.eos107508.x
   Thomas ME, 1999, S AFR J SCI, V95, P359
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   VANEEDEN SP, 1994, PLAST RECONSTR SURG, V93, P959, DOI 10.1097/00006534-199404001-00010
   WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212
NR 60
TC 43
Z9 46
U1 0
U2 4
PU JOURNAL BONE JOINT SURGERY INC
PI NEEDHAM
PA 20 PICKERING ST, NEEDHAM, MA 02192 USA
SN 0021-9355
J9 J BONE JOINT SURG AM
JI J. Bone Joint Surg.-Am. Vol.
PY 2001
VL 83A
SU 1
BP S116
EP S127
PN 2
PG 12
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 423HH
UT WOS:000168169500006
PM 11314789
DA 2018-10-19
ER

PT J
AU Uludag, H
   Gao, TJ
   Porter, TJ
   Friess, W
   Wozney, JM
AF Uludag, H
   Gao, TJ
   Porter, TJ
   Friess, W
   Wozney, JM
TI Delivery systems for BMPs: Factors contributing to protein retention at
   an application site
SO JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
LA English
DT Article
ID BONE MORPHOGENETIC PROTEINS; ABSORBABLE COLLAGEN SPONGES; RAT ECTOPIC
   MODEL; BIOMATERIAL CARRIERS; PHARMACOKINETICS; DIFFERENTIATION
AB Background: Recombinant human bone morphogenetic proteins (rhBMPs) are being tested in clinical studies for their capacity to elicit bone formation. Biomaterials used in delivery systems also play a critical role in supporting the osteoinductive activity of BMPs, attributable to the controlled presentation of the BMPs to target cells. Despite extensive preclinical studies, the factors contributing to local rhBMP pharmacokinetics remain to be elucidated.
   Methods: The rhBMP pharmacokinetics were studied in a rat subcutaneous implant and in an intramuscular injection model. In situ levels of rhBMPs were quantitated with use of I-125-labeled tracers. The effects of protein structural features and the nature of the biomaterial implant were explored. Osteoinduction by biomaterial+rhBMP combinations was assessed by a semiquantitative, histology-based bone score.
   Results: With the use of rhBMP-2, rhBMP-4, and an N truncated rhBMP-2, the protein isoelectric point was found critical for the initial retention of rhBMPs in an implant. Osteoinduction studies carried out in parallel indicated that rhBMPs with a higher implant retention elicited more bone formation. In the clinically used collagen+rhBMP-2 device, collagen crosslinking and sterilization were most influential in rhBMP-2 retention. To increase retention at an application site, thermoreversible polymers were engineered and shown to enhance local rhBMP-2 retention, especially by injectable delivery.
   Conclusions: Two critical components of an osteoinductive device-namely, the biomaterial and the rhBMP-were shown to influence local protein pharmacokinetics and osteoinductive activity of the device. Designer biomaterials can provide an additional mechanism to modulate local protein pharmacokinetics.
   Clinical Relevance: These studies form the foundation of next-generation osteoinductive devices with improved potency at sites of desired bone regeneration and reduced side effects at other sites.
C1 Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB T6G 2V2, Canada.
   Genet Inst Inc, Biopharmaceut Characterizat & Anal Grp, Andover, MA 01810 USA.
   Genet Inst Inc, Bone Biol & Applicat Grp, Andover, MA 01810 USA.
   Univ Erlangen Nurnberg, Dept Pharmaceut Technol, D-91058 Erlangen, Germany.
RP Uludag, H (reprint author), Univ Alberta, Fac Med & Dent, Dept Biomed Engn, 1098 EDC Bldg, Edmonton, AB T6G 2V2, Canada.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740
   Friess W, 1999, INT J PHARM, V185, P51, DOI 10.1016/S0378-5173(99)00128-3
   Friess W, 1999, PHARM DEV TECHNOL, V4, P387, DOI 10.1081/PDT-100101374
   GAO TJ, 2000, UNPUB BIOMATERIALS
   Kirsch T, 2000, NAT STRUCT BIOL, V7, P492
   Laursen M, 1999, EUR SPINE J, V8, P485, DOI 10.1007/s005860050210
   LI RH, 2000, T SOC BIOM M, P560
   REDDI AH, 1993, J BONE MINER RES, V8, pS499
   Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   SAMPATH TK, 1992, J BIOL CHEM, V267, P20352
   Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217
   Sellers RS, 2000, J BONE JOINT SURG AM, V82A, P151, DOI 10.2106/00004623-200002000-00001
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Uludag H, 1999, ANN NY ACAD SCI, V875, P369, DOI 10.1111/j.1749-6632.1999.tb08519.x
   ULUDAG H, 2000, UNPUB BIOTECH BIOENG
   Uludag H, 1998, CURR OPIN ORTHOP, V9, P31
   von Recum HA, 1998, J BIOMED MATER RES, V40, P631
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
NR 23
TC 134
Z9 139
U1 0
U2 7
PU JOURNAL BONE JOINT SURGERY INC
PI NEEDHAM
PA 20 PICKERING ST, NEEDHAM, MA 02192 USA
SN 0021-9355
J9 J BONE JOINT SURG AM
JI J. Bone Joint Surg.-Am. Vol.
PY 2001
VL 83A
SU 1
BP S128
EP S135
PN 2
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 423HH
UT WOS:000168169500007
PM 11314790
DA 2018-10-19
ER

PT J
AU Underwood, PA
   Bean, PA
   Cubeddu, L
AF Underwood, PA
   Bean, PA
   Cubeddu, L
TI Human endothelial cells grow poorly on vitronectin: Role of PAI-1
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE endothelial; vitronectin; PAI-1; uPA; uPAR; cell adhesion
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; MONOCLONAL-ANTIBODIES; UROKINASE
   RECEPTOR; BIOLOGICAL-ACTIVITIES; EXTRACELLULAR-MATRIX; ADHESION
   RECEPTOR; HT-1080 CELLS; MIGRATION; IDENTIFICATION; PROLIFERATION
AB The cell adhesive protein vitronectin is a common component of interstitial extracellular matrix and circulates in plasma. it competes effectively with other plasma proteins to adsorb to certain biomaterial surfaces, and is likely to represent an important cell adhesion mediator on the luminal surface of vascular grafts. It is also found associated with certain vascular pathologies. We have shown previously that human endothelial cells grow poorly on a vitronectin surface compared with other extracellular matrix molecules. In this paper we show that endothelial cells seeded on vitronectin and fibronectin produced substantially different profiles of extracellular matrix molecules. The most outstanding difference was in the amount of matrix-localised plasminogen activator-inhibitor-1 which was high on vitronectin and negligible on fibronectin. This was correlated with a small but significant inhibition of cell adhesion to vitronectin compared with fibronectin, and very significant interference with dissociation of cell: extracellular matrix contacts, resulting either from direct inhibition of the proteolytic activity of urokinase, or from interference with urokinase-receptor signaling and consequent focal adhesion turnover. Such interference would inhibit cell proliferation by disabling the cells from loosening their matrix contacts in order to proceed through mitosis. This would seriously compromise endothelial recovery in cases of damage to the vascular wall and placement of stents or grafts, where the presence of surface-adsorbed vitronectin is likely to modulate the tissue response.
C1 CSIRO, Mol Sci, N Ryde, NSW 1670, Australia.
   Macquarie Univ, Dept Chem, Sydney, NSW 2109, Australia.
RP Underwood, PA (reprint author), CSIRO, Mol Sci, 2 Richardson Pl,Riverside Corp Pk,Delhi Rd,POB 18, N Ryde, NSW 1670, Australia.
CR BALE MD, 1989, BLOOD, V74, P2698
   BOYD NAM, 1993, J CLIN PATHOL, V46, P1042, DOI 10.1136/jcp.46.11.1042
   Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3
   CIAMBRONE GJ, 1992, J BIOL CHEM, V267, P13617
   CIAMBRONE GJ, 1990, J CELL BIOL, V111, P2183, DOI 10.1083/jcb.111.5.2183
   CONFORTI G, 1994, BLOOD, V83, P994
   Deng G, 1996, J CELL BIOL, V134, P1563, DOI 10.1083/jcb.134.6.1563
   Germer M, 1998, EUR J BIOCHEM, V253, P669, DOI 10.1046/j.1432-1327.1998.2530669.x
   GOSPODAROWICZ D, 1981, J CELL PHYSIOL, V109, P69, DOI 10.1002/jcp.1041090109
   HAKKINEN L, 1993, J HISTOCHEM CYTOCHEM, V41, P1689, DOI 10.1177/41.11.8409375
   HEKMAN CM, 1985, J BIOL CHEM, V260, P11581
   HESS S, 1995, THROMB HAEMOSTASIS, V74, P258
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   Ilic Dusko, 1995, Nature (London), V377, P539
   Kanse SM, 1996, EXP CELL RES, V224, P344, DOI 10.1006/excr.1996.0144
   KIRCHHEIMER JC, 1989, EUR J BIOCHEM, V181, P103, DOI 10.1111/j.1432-1033.1989.tb14699.x
   KIRCHHEIMER JC, 1989, P NATL ACAD SCI USA, V86, P5424, DOI 10.1073/pnas.86.14.5424
   Kjoller L, 1997, EXP CELL RES, V232, P420, DOI 10.1006/excr.1997.3540
   KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0
   Loskutoff DJ, 1999, APMIS, V107, P54, DOI 10.1111/j.1699-0463.1999.tb01526.x
   MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674
   MADRI JA, 1988, AM J PATHOL, V132, P18
   Matthias LJ, 1996, BBA-PROTEIN STRUCT M, V1296, P138, DOI 10.1016/0167-4838(96)00060-X
   NICOLA NA, 1987, INT J CELL CLONING, V5, P1, DOI 10.1002/stem.5530050102
   NICOLESCU F, 1989, ATHEROSCLEROSIS, V75, P197
   Podesta F, 1997, DIABETOLOGIA, V40, P879, DOI 10.1007/s001250050763
   POLLANEN J, 1987, J CELL BIOL, V104, P1085, DOI 10.1083/jcb.104.4.1085
   PREISSNER KT, 1990, J BIOL CHEM, V265, P18490
   RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803
   SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685
   SEIFFERT D, 1990, J CELL BIOL, V111, P1283, DOI 10.1083/jcb.111.3.1283
   Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0
   Stepanova V, 1999, MOL CELL BIOCHEM, V195, P199, DOI 10.1023/A:1006936623106
   SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x
   Tang H, 1998, J BIOL CHEM, V273, P18268, DOI 10.1074/jbc.273.29.18268
   Underwood P. Anne, 1996, Cells and Materials, V6, P193
   Underwood PA, 1998, ATHEROSCLEROSIS, V141, P141, DOI 10.1016/S0021-9150(98)00164-6
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   UNDERWOOD PA, 1990, J IMMUNOL METHODS, V127, P91, DOI 10.1016/0022-1759(90)90344-U
   UNDERWOOD PA, 1992, J CELL SCI, V102, P833
   WEI Y, 1994, J BIOL CHEM, V269, P32380
   WEIS JR, 1991, THROMB RES, V61, P171, DOI 10.1016/0049-3848(91)90245-R
   WERKMEISTER JA, 1989, J BIOMED MATER RES-A, V23, P273, DOI 10.1002/jbm.820231403
   Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079
   Wilcox SA, 1996, BIOCHEM CELL BIOL, V74, P899, DOI 10.1139/o96-095
NR 45
TC 8
Z9 8
U1 0
U2 2
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PY 2001
VL 82
IS 1
BP 98
EP 109
DI 10.1002/jcb.1112
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 438JG
UT WOS:000169049400010
PM 11400167
DA 2018-10-19
ER

PT J
AU Labow, RS
   Meek, E
   Santerre, JP
AF Labow, RS
   Meek, E
   Santerre, JP
TI Neutrophil-mediated biodegradation of medical implant materials
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
ID HUMAN POLYMORPHONUCLEAR; ELASTASE; ACID; DEGRADATION; HYDROLYSIS;
   INHIBITION; MANOALIDE; RELEASE; CELL
AB During the acute inflammatory response to implanted medical devices, human neutrophils (PMN) release oxidative and hydrolytic activities which may ultimately contribute to the degradation of the biomaterial. In this study, the biological activities secreted by live PMNs which may contribute to biodegradation were investigated using a C-14 label in the monomer unit of a poly(ester-urea-urethane) (PEUU) substrate. By using specific inhibitors, it was possible to propose a mechanism for PMN-mediated biodegradation. PMN, labeled with H-3-arachidonic acid, released significantly more H-3 when adherent to PEUU than when adherent to tissue culture grade polystyrene (P<0.05). The phospholipase A(2) (PLA(2)) inhibitors, aristolochic acid (ARIST) and quinacrine (QUIN), decreased the release of 3H and inhibited PEUU biodegradation (>50%, P<0.05). ARIST had no effect on cell viability, whereas QUIN significantly decreased it. The serine protease inhibitor, phenylmethylsulfonylfluoride inhibited biodegradation, but did not decrease cell survival. There is evidence to suggest that activation via the PLA2 pathway caused the release of hydrolytic activities which were able to elicit C-14 release from PEUU. The role of oxidative compounds which were released via activation by phorbol myristate acetate (PMA), was not apparent, since PMA inhibited biodegradation and cell survival (>40%, P<0.05). This study has shown that it is possible to find out the differences in PMN activation through the PLA2 pathway when exposed to different material surfaces, making this a model system worthy of further investigation. J. Cell. Physiol. 186:95-103, 2001. (C) 2001 Wiley-Liss, Inc.
C1 Univ Ottawa, Inst Heart, Cardiovasc Devices Div, Ottawa, ON K1Y 4W7, Canada.
   Univ Toronto, Fac Dent, Dept Biomat, Toronto, ON, Canada.
RP Labow, RS (reprint author), Univ Ottawa, Inst Heart, Cardiovasc Devices Div, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Bauldry SA, 1996, BBA-LIPID LIPID MET, V1299, P223, DOI 10.1016/0005-2760(95)00207-3
   BERGSTRAND H, 1990, AA530 INFLAMMATORY I
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   Brumell JH, 1997, J BIOL CHEM, V272, P875, DOI 10.1074/jbc.272.2.875
   CABAUD PG, 1958, AM J CLIN PATHOL, V30, P234, DOI 10.1093/ajcp/30.3.234
   CAMBELL EJ, 1982, J CLIN INVEST, V70, P845
   Erfle DJ, 1997, CARDIOVASC PATHOL, V6, P333, DOI 10.1016/S1054-8807(97)00031-8
   FLACK P, 1995, BIOMATERIALS, V16, P61
   GLASER KB, 1989, MOL PHARMACOL, V36, P782
   Hale IL, 1996, J COMP NEUROL, V376, P128, DOI 10.1002/(SICI)1096-9861(19961202)376:1<128::AID-CNE8>3.0.CO;2-5
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   Labow RS, 1996, BIOMATERIALS, V17, P2381, DOI 10.1016/S0142-9612(96)00088-9
   Labow RS, 1999, J BIOMAT SCI-POLYM E, V10, P699, DOI 10.1163/156856299X00595
   LABOW RS, 1995, BIOMATERIALS, V16, P51, DOI 10.1016/0142-9612(95)91096-H
   LABOW RS, 1996, P 5 WORLD BIOM C MAY, P931
   LABOW RS, 2000, IN PRESS J BIOMED MA
   LISTER MD, 1989, J BIOL CHEM, V264, P8520
   MCCARTHY K, 1982, J RETICULOENDOTH SOC, V31, P131
   MCCLOSKEY CB, 1998, SOC BIOM M SAN DIEG
   MITSUYAMA T, 1995, MOL CELL BIOCHEM, V145, P19, DOI 10.1007/BF00925708
   Murakami M, 1997, CRIT REV IMMUNOL, V17, P225, DOI 10.1615/CritRevImmunol.v17.i3-4.10
   OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775
   PICK E, 1980, J IMMUNOL METHODS, V38, P161, DOI 10.1016/0022-1759(80)90340-3
   PRUZANSKI W, 1991, INFLAMMATION, V15, P127, DOI 10.1007/BF00917507
   RAO NV, 1993, AM J RESP CELL MOL, V8, P612, DOI 10.1165/ajrcmb/8.6.612
   ROSENTHAL MD, 1992, BIOCHIM BIOPHYS ACTA, V1126, P319, DOI 10.1016/0005-2760(92)90247-S
   Rossi AG, 1995, BIOCHEM BIOPH RES CO, V217, P892, DOI 10.1006/bbrc.1995.2855
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   SELLMAYER A, 1987, BIOCHIM BIOPHYS ACTA, V927, P417, DOI 10.1016/0167-4889(87)90107-8
   SHACTER E, 1991, BIOCHEM PHARMACOL, V41, P975, DOI 10.1016/0006-2952(91)90204-I
   STOKES K, 1993, CARDIOVASC PATHOL, V2, pS111
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   TANIGAKI T, 1994, CRIT CARE MED, V22, P1167, DOI 10.1097/00003246-199407000-00020
   TSUNG P, 1978, BIOCHIM BIOPHYS ACTA, V541, P150, DOI 10.1016/0304-4165(78)90388-4
   WYATT TA, 1993, AM J PHYSIOL, V265, P201
NR 37
TC 26
Z9 26
U1 0
U2 1
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9541
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD JAN
PY 2001
VL 186
IS 1
BP 95
EP 103
DI 10.1002/1097-4652(200101)186:1<95::AID-JCP1008>3.0.CO;2-0
PG 9
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA 379MF
UT WOS:000165645300011
PM 11147818
DA 2018-10-19
ER

PT J
AU Araujo, MG
   Carmagnola, D
   Berglundh, T
   Thilander, B
   Lindhe, J
AF Araujo, MG
   Carmagnola, D
   Berglundh, T
   Thilander, B
   Lindhe, J
TI Orthodontic movement in bone defects augmented with Bio-Oss (R) - An
   experimental study in dogs
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE orthodontic movement; bone augmentation; bone grafts; dogs
ID DIFFERENT GRAFTING MATERIALS; DENTAL IMPLANTS; BIO-OSS; REGENERATION;
   RESORPTION; TISSUE; ELEVATION
AB Objective: To study if it was possible to move, by orthodontic means, a tooth into an area of the jaw that had been augmented with Bio-Oss(R).
   Material and Methods: 5 beagle dogs were used. The 1st, 2nd, and 4th mandibular premolars on each side were removed. The defect at the left 4th premolar site was filled with a biomaterial (Bio-Oss(R)) while the corresponding defect in the right side was left for spontaneous healing. 3 months later, an orthodontic device was inserted in each side of the mandible. The device was designed to allow distal, bodily movement of the 3rd premolars. When the experimental teeth had been moved into the extraction sites of the 4th premolars, the animals were sacrificed and biopsies of the premolar-molar regions of the mandible sampled. The tissues were prepared for histological analysis using standard procedures. In the sections, 3 zones were identified: zone A = the bone tissue within the distal portion of the previous extraction site (4th premolar), zone B = the pressure side of the 3rd premolar, zone C = the tension side of the 3rd premolar. The area occupied by mineralized bone, Bio-Oss(R) particles and bone marrow was determined by a point counting procedure. The width of the periodontal ligament as well as the percentage of the root surface (in zone B) that exhibited resorption was determined.
   Results: The findings demonstrated that it was possible to move a tooth into an area of an alveolar ridge that 3 months previously had been augmented with a biomaterial. It was also demonstrated that 12 months after grafting, Bio-Oss(R) particles remained as inactive filler material in the not utilized part of zone A. The biomaterial was not present in zone C but present in small amounts in zone B.
   Conclusion: During the orthodontic tooth movement the graft material (Bio-Oss(R)) was degraded and eliminated from the part of the alveolar ridge that was utilized for the experiment. In the non-utilized part of the ridge the biomaterial, however, remained as a seemingly inactive filler material.
C1 Gothenburg Univ, Fac Odontol, Dept Periodontol, S-40530 Gothenburg, Sweden.
   Gothenburg Univ, Fac Odontol, Dept Orthodont, S-40530 Gothenburg, Sweden.
RP Araujo, MG (reprint author), Gothenburg Univ, Fac Odontol, Dept Periodontol, Box 450, S-40530 Gothenburg, Sweden.
CR Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   BRUDVIK P, 1994, EUR J ORTHODONT, V16, P265, DOI 10.1093/ejo/16.4.265
   BRUDVIK P, 1994, EUR J ORTHODONT, V16, P249, DOI 10.1093/ejo/16.4.249
   Brudvik P, 1993, Eur J Orthod, V15, P467
   BRUDVIK P, 1995, EUR J ORTHODONT, V17, P177, DOI 10.1093/ejo/17.3.177
   Brudvik P, 1993, Eur J Orthod, V15, P249
   Camelo M, 1998, INT J PERIODONT REST, V18, P321
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   GIANNOBILE WV, 1994, J PERIODONTOL, V65, P1158, DOI 10.1902/jop.1994.65.12.1158
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Hossain MZ, 1996, CLEFT PALATE-CRAN J, V33, P277, DOI 10.1597/1545-1569(1996)033<0277:BROABA>2.3.CO;2
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   Kling H. J., 1992, Diatom Research, V7, P241
   Lindskog-Stokland B, 1993, Eur J Orthod, V15, P89
   REITAN K, 1967, AMER J ORTHODONTICS, V53, P721, DOI 10.1016/0002-9416(67)90118-2
   SANDY JR, 1993, AM J ORTHOD DENTOFAC, V103, P212, DOI 10.1016/0889-5406(93)70002-6
   SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   WENNSTROM JL, 1993, AM J ORTHOD DENTOFAC, V103, P313, DOI 10.1016/0889-5406(93)70011-C
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
   Zitzmann NU, 1998, ORAL SURG ORAL MED O, V85, P8, DOI 10.1016/S1079-2104(98)90391-2
   Zitzmann NU, 1997, INT J ORAL MAX IMPL, V12, P844
NR 25
TC 72
Z9 83
U1 1
U2 9
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD JAN
PY 2001
VL 28
IS 1
BP 73
EP 80
DI 10.1034/j.1600-051x.2001.280111.x
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 383GH
UT WOS:000165874400011
PM 11142670
DA 2018-10-19
ER

PT J
AU Bouhadir, KH
   Mooney, DJ
AF Bouhadir, KH
   Mooney, DJ
TI Promoting angiogenesis in engineered tissues
SO JOURNAL OF DRUG TARGETING
LA English
DT Article
DE endothelial cells; blood vessels; growth factors; plasmid DNA
ID ENDOTHELIAL GROWTH-FACTOR; POLY(ALDEHYDE GULURONATE) HYDROGELS;
   CALCIUM-ALGINATE BEADS; IN-VIVO; INCREASED VASCULARIZATION; BIOMEDICAL
   APPLICATIONS; COLLATERAL DEVELOPMENT; DELIVERY SYSTEMS; MATRICES;
   RELEASE
AB There is a tremendous need for organs and tissues to replace those lost due to diseases or trauma. In theory, transplanting cells on biomaterial matrices can create functional tissue. A critical question, however, is how to supply cells embedded within large cell-polymer constructs with sufficient oxygen and nutrients to sustain their survival and proliferation, and allow for the integration of the developing tissue with the surrounding tissue. A rapid and high level of vascularization of transplanted polymer-cell matrices is essential in tissue engineering approaches to meet these challenges. This review summarizes the current approaches and materials under development in our laboratory to promote angiogenesis in engineered tissues.
C1 Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   Amer Univ Beirut, Dept Chem, Beirut, Lebanon.
   Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Mooney, DJ (reprint author), Univ Michigan, Dept Biol & Mat Sci, 2300 Hayward St,3074 HH Dow Bldg, Ann Arbor, MI 48109 USA.
CR Ahrendt G, 1998, TISSUE ENG, V4, P117, DOI 10.1089/ten.1998.4.117
   ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   Bouhadir KH, 1998, ANN NY ACAD SCI, V842, P188, DOI 10.1111/j.1749-6632.1998.tb09647.x
   Bouhadir KH, 2000, J PHARM SCI-US, V89, P910, DOI 10.1002/1520-6017(200007)89:7<910::AID-JPS8>3.0.CO;2-#
   Bouhadir KH, 1999, POLYMER, V40, P3575, DOI 10.1016/S0032-3861(98)00550-3
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   COOK W, 1986, J BIOMED MATER RES, V20, P1, DOI 10.1002/jbm.820200103
   Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127
   DOWNS EC, 1992, J CELL PHYSIOL, V152, P422, DOI 10.1002/jcp.1041520225
   DVORAK HF, 1995, AM J PATHOL, V146, P1029
   Eiselt P, 1998, BIOTECHNOL PROGR, V14, P134, DOI 10.1021/bp970135h
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   Kaihara S, 2000, TISSUE ENG, V6, P105, DOI 10.1089/107632700320739
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KING K, 1994, FOOD HYDROCOLLOID, V8, P83, DOI 10.1016/S0268-005X(09)80035-0
   Klock G, 1997, BIOMATERIALS, V18, P707, DOI 10.1016/S0142-9612(96)00204-9
   KOKUBO T, 1991, NIPPON SERAM KYO GAK, V99, P965
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lazarous DF, 1996, CIRCULATION, V94, P1074, DOI 10.1161/01.CIR.94.5.1074
   Lee KY, 2000, MACROMOLECULES, V33, P97, DOI 10.1021/ma991286z
   Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mooney DJ, 1996, BIOTECHNOL BIOENG, V50, P422, DOI 10.1002/(SICI)1097-0290(19960520)50:4<422::AID-BIT9>3.0.CO;2-N
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   MOONEY DJ, 1994, CELL TRANSPLANT, V3, P203, DOI 10.1177/096368979400300209
   Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C
   MOONEY DJ, 1994, TRANSP P, V26, P4025
   MUMPER RJ, 1994, J CONTROL RELEASE, V30, P241, DOI 10.1016/0168-3659(94)90030-2
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   MURPHY WL, 1999, MINERALIZATION NATUR, V599, P347
   MURPHY WL, 2001, BIOMATERIALS
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4
   Nor JE, 2000, J VASC RES, V37, P209, DOI 10.1159/000025733
   PEPPER MS, 1992, BIOCHEM BIOPH RES CO, V189, P824, DOI 10.1016/0006-291X(92)92277-5
   Peters KG, 1998, CIRC RES, V83, P342, DOI 10.1161/01.RES.83.3.342
   Peters M. C., 1999, POLYM PREPRINTS, V40, P273
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   REDDI AH, 2000, PRINCIPLES TISSUE EN, P81
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468
   Thirumurti V, 1998, J AM COLL CARDIOL, V31, p54A, DOI 10.1016/S0735-1097(97)83941-1
   Tsurumi Y, 1996, CIRCULATION, V94, P3281, DOI 10.1161/01.CIR.94.12.3281
   Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358
   Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52
NR 56
TC 50
Z9 55
U1 3
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK,, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1061-186X
J9 J DRUG TARGET
JI J. Drug Target.
PY 2001
VL 9
IS 6
BP 397
EP 406
DI 10.3109/10611860108998775
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 513ZC
UT WOS:000173397300002
PM 11822813
DA 2018-10-19
ER

PT J
AU Granja, PL
   Barbosa, MA
   Pouysegu, L
   De Jeso, B
   Rouais, F
   Baquey, C
AF Granja, PL
   Barbosa, MA
   Pouysegu, L
   De Jeso, B
   Rouais, F
   Baquey, C
TI Cellulose phosphates as biomaterials. Mineralization of chemically
   modified regenerated cellulose hydrogels
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID SIMULATED BODY-FLUID; CALCIUM-PHOSPHATE; IN-VITRO; APATITE FORMATION;
   ORGANIC POLYMERS; HYDROXYAPATITE; BONE; TITANIUM; GROWTH;
   PHOSPHOPROTEINS
AB Femoral implantation of regenerated cellulose hydrogels revealed their biocompatible and osteoconductive properties, but a complete osseointegration could not be observed. Phosphorylation was therefore envisaged as the means to enhance cellulose bioactivity. Once implanted, phosphorylated cellulose could promote the formation of calcium phosphates, having therefore closer resemblance to bone functionality and assuring a satisfactory bonding at the interface between hard tissue and biomaterial. In the present work, regenerated cellulose hydrogels were surface modified via phosphorylation. Phosphorylated materials, having varying degrees of substitution, were soaked in a Simulated Body Fluid (SBF) solution in order to investigate their ability to induce the formation of a calcium phosphate layer. Mineralization was assessed by Scanning Electron Microscopy (SEM), Energy Dispersive Spectroscopy (EDS) and Attenuated Total Reflectance-Fourier Transform Infrared (ATR-FTIR) spectroscopy. It was demonstrated that the calcium salt of cellulose phosphates mineralized at a higher extent than materials only phosphorylated. The degree of phosphorylation influenced the extent of surface mineralization. Moderate degrees of surface phosphorylation promoted the highest extent of mineralization. This was attributed to inadequate functionality of the surface in terms of density of PO4 groups and overall surface charge, in the case of low and high phosphate contents. (C) 2001 Kluwer Academic Publishers.
C1 INEB, Lab Biomat, P-4150180 Porto, Portugal.
   Univ Porto, Fac Engn, Dept Met & Mat Engn, Porto, Portugal.
   Univ Bordeaux 1, LCSV, Inst DU PIN, F-33405 Talence, France.
   Univ Bordeaux 2, INSERM, U443, F-33076 Bordeaux, France.
RP Granja, PL (reprint author), INEB, Lab Biomat, Rua Campo Alegre 823, P-4150180 Porto, Portugal.
RI Barbosa, Mario/F-5964-2011; Granja, Pedro/B-1685-2008
OI Barbosa, Mario/0000-0003-3568-7482; Granja, Pedro/0000-0003-2761-4929
CR ABDELFATTAH WI, 1994, BIOMATERIALS, V15, P643, DOI 10.1016/0142-9612(94)90161-9
   ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531
   ADDADI L, 1989, BIOMINERALIZATION CH, P133
   Addadi L., 1992, P 4 INT C CHEM BIOL, P153
   AHLGREN P, 1995, NORD PULP PAP RES J, V1, P12
   AKAO M, 1993, J MATER SCI-MATER M, V4, P569, DOI 10.1007/BF00125595
   Albrektsson T., 1998, HDB BIOMATERIAL PROP, P500
   Anderson H C, 1993, HDB EXPT PHARM, V107, P267, DOI 10.1007/978-3-642-77991-6_8
   ANDERSON HC, 1983, ARCH PATHOL LAB MED, V107, P341
   ANDERSON HC, 1984, SCANNING ELECTRON MI, V2, P953
   Andrew C. A. Wan, 1998, Biomaterials, V19, P1309
   Bohic S, 1998, CR ACAD SCI III-VIE, V321, P865, DOI 10.1016/S0764-4469(99)80027-4
   Bonel G, 1988, Ann N Y Acad Sci, V523, P115, DOI 10.1111/j.1749-6632.1988.tb38506.x
   BONFIELD W, 1988, BIOCERAMICS MATERIAL, V523, P173
   Chauveaux D., 1990, CLIN MAT, V5, P251
   DALAS E, 1991, COLLOID SURFACE, V53, P197, DOI 10.1016/0166-6622(91)80137-D
   DALAS E, 1991, LANGMUIR, V7, P1822, DOI 10.1021/la00056a040
   DAMEN JJM, 1989, J DENT RES, V68, P1355, DOI 10.1177/00220345890680091301
   DAMEN JJM, 1991, J DENT RES, V70, P1346, DOI 10.1177/00220345910700100601
   DASARATHY H, 1993, J BIOMED MATER RES, V27, P477, DOI 10.1002/jbm.820270408
   DEGENSHEIN GA, 1963, NEW YORK STATE J MED, V63, P2639
   DOELKER E, 1993, ADV POLYM SCI, V107, P199
   Elliot JC, 1994, STUDIES INORGANIC CH, V18
   Endo A, 1989, Connect Tissue Res, V21, P179, DOI 10.3109/03008208909050008
   FINN MD, 1992, J ORAL MAXIL SURG, V50, P608, DOI 10.1016/0278-2391(92)90443-4
   FRANZ G, 1986, ADV POLYM SCI, V76, P1
   GAILLARD ML, 1994, J MATER SCI-MATER M, V5, P695, DOI 10.1007/BF00120359
   GALGUT PN, 1990, BIOMATERIALS, V11, P561, DOI 10.1016/0142-9612(90)90078-5
   Granja P.L., 1999, FRONTIERS BIOMEDICAL, V2, P195
   GRANJA PL, 1996, POLYM MED SURG PIMS, P73
   GRANJA PL, UNPUB
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hayakawa S, 1996, J CERAM SOC JPN, V104, P1000, DOI 10.2109/jcersj.104.1000
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   HEUGHEBAERT M, 1988, J BIOMED MATER RES-A, V22, P257, DOI 10.1002/jbm.820221406
   HOLLINGER J, 1995, BIOCERAMICS, P3
   Hon DN-S, 1996, POLYSACCHARIDES MED, P87
   HOSSAINY SFA, 1994, BIOMATERIALS, V15, P921, DOI 10.1016/0142-9612(94)90118-X
   HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723
   IKADA Y, 1989, CELLULOSE STRUCTURAL, P447
   Kato K, 1996, J BIOMED MATER RES, V32, P687, DOI 10.1002/(SICI)1097-4636(199612)32:4<687::AID-JBM23>3.0.CO;2-9
   Katz J., 1996, BIOMATERIALS SCI INT, P335
   KITSUGI T, 1989, J BIOMED MATER RES, V23, P631, DOI 10.1002/jbm.820230607
   Kokubo T, 1991, BIOCERAMICS, V4, P113
   Kokubo T., 1990, HDB BIOACTIVE CERAMI, P41
   KRAJEWSKI A, 1988, J BIOMED MATER RES, V22, P445, DOI 10.1002/jbm.820220602
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   Leitao E, 1995, J MATER SCI-MATER M, V6, P849, DOI 10.1007/BF00134330
   LI P, 1993, J MATER SCI-MATER M, V4, P127, DOI 10.1007/BF00120381
   LI PJ, 1995, J BIOMED MATER RES, V29, P325, DOI 10.1002/jbm.820290307
   LI PJ, 1994, J AM CERAM SOC, V77, P1307, DOI 10.1111/j.1151-2916.1994.tb05407.x
   Li SH, 1997, J MATER SCI-MATER M, V8, P543, DOI 10.1023/A:1018546730925
   Li SH, 1996, J MATER SCI LETT, V15, P1882, DOI 10.1007/BF00264085
   Linde A., 1992, CALCIFICATION BIOL S, P269
   LOWENBERG B, 1991, CELL MATER, V1, P177
   MANN S, 1989, BIOMINERALIZATION CH, P35
   MANN S, 1996, BIOMIMETIC MAT CHEM, P1
   Miyaji F, 1999, BIOMATERIALS, V20, P913, DOI 10.1016/S0142-9612(98)00235-X
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P658, DOI 10.1007/BF00123448
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P597, DOI 10.1007/BF00121284
   Nancollas G. H., 1989, BIOMINERALISATION, P157
   Okajima K, 1989, CELLULOSE STRUCTURAL, P439
   POMMIER JC, 1987, Patent No. [0256906, 256906]
   POMMIER JC, 1986, Patent No. 8610331
   POMMIER JC, 1990, Patent No. 4904258
   Poustis J., 1994, Clinical Materials, V16, P119, DOI 10.1016/0267-6605(94)90106-6
   RADDER AM, 1995, J MATER SCI-MATER M, V6, P510, DOI 10.1007/BF00151031
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   Rey C, 1995, ACTUAL CHIMIQUE, P41
   REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969
   REY C, 1994, B I OCEANOGRAPHIQUE, V14, P55
   Rhee SH, 1999, BIOMATERIALS, V20, P2155, DOI 10.1016/S0142-9612(99)00118-0
   Ribeiro CC, 1995, J MATER SCI-MATER M, V6, P829, DOI 10.1007/BF00134326
   RIBEIRO CC, 1994, THESIS U PORTO PORTO
   ROYER P, 1992, BIOCERAMICS, V5, P95
   Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X
   SAUER GR, 1988, J BIOL CHEM, V263, P13718
   SCHWARTZ Z, 1993, J BIOMED MATER RES, V27, P1029, DOI 10.1002/jbm.820270808
   SHIMABAYASHI S, 1995, PHOSPHORUS RES B, V5, P19
   Shimada S., 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P154, DOI 10.1109/ICDAR.1995.598965
   STUPP SI, 1992, J BIOMED MATER RES, V26, P169, DOI 10.1002/jbm.820260204
   SUZUKI K, 1993, BIOCERAMICS, V6, P245
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   TANAHASHI M, 1995, J BIOMED MATER RES, V29, P349, DOI 10.1002/jbm.820290310
   Tanahashi M., 1992, BIOCERAMICS, P57
   VANDENBOS T, 1994, J BONE MINER RES, V9, P1205
   VEIS A, 1977, CALCIUM BINDING PROT, P408
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   WUTHIER RE, 1992, P 4 INT C CHEM BIOL, P143
   YAMASHITA K, 1991, JPN J ORAL BIOL, V33, P166
   Yokogawa Y, 1997, J MATER SCI-MATER M, V8, P407, DOI 10.1023/A:1018549404092
NR 92
TC 69
Z9 73
U1 1
U2 25
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PY 2001
VL 36
IS 9
BP 2163
EP 2172
DI 10.1023/A:1017587815583
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 426DD
UT WOS:000168333800005
DA 2018-10-19
ER

PT J
AU Moutahir-Belqasmi, F
   Balmain, N
   Lieberrher, M
   Borzeix, S
   Berland, S
   Barthelemy, M
   Peduzzi, J
   Milet, C
   Lopez, E
AF Moutahir-Belqasmi, F
   Balmain, N
   Lieberrher, M
   Borzeix, S
   Berland, S
   Barthelemy, M
   Peduzzi, J
   Milet, C
   Lopez, E
TI Effect of water soluble extract of nacre (Pinctada maxima) on alkaline
   phosphatase activity and Bcl-2 expression in primary cultured
   osteoblasts from neonatal rat calvaria
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 15th European Conference on Biomaterials
CY SEP 08-12, 1999
CL BORDEAUX, FRANCE
ID HORMONE RESPONSIVENESS; MAINTAINED INVITRO; CELL-DEATH; BONE;
   DIFFERENTIATION; APOPTOSIS; PROTEIN; PHENOTYPE; GENE;
   1,25-DIHYDROXYVITAMIN-D3
AB The nacre (mother of pearl) layer of the oyster Pinctada maxima shell can initiate bone formation by human osteoblasts in vivo and in vitro and is a new biomaterial that induces osteogenesis. This activity of nacre could be due to its water-soluble matrix. We examined the action of a water-soluble extract of nacre on the osteoblast phenotype of cells isolated from rat neonatal calvaria by measuring alkaline phosphatase (ALP) activity and by localization of the anti-apoptotic protein Bcl-2 by immunocytochemistry. ALP activity was increased 7% (p <0.001) by 100 mug proteins/ml extract and 20% (p <0.001) by 50 mug proteins/ml extract, but a low concentration of extract decreased the ALP activity by 8%. Cells treated with a high aspartic acid content fraction of the extract had increased ALP activity (23%, p <0.0001). Nacre extract and the fraction have no effect on the proliferation of mature osteoblasts. Immunoreactive Bcl-2 was overproduced in the cytoplasm and nuclei of osteoblasts at all stages of culture. Bcl-2 was found over the whole chromatin in quiescent and mitotic cells at the end of mitosis in the two nuclei in one cell, before cytodieresis. Bcl-2 was also found over chromosomes. Thus, nacre extract stimulates Bcl-2 production in osteoblasts, that is correlated with the cell cycle. Bcl-2 was also abundant in the nucleoli of extract-treated cells. Thus, the concentration and subcellular distribution of Bcl-2 in osteoblasts in primary cultures is influenced by nacre extract, and related to the cell cycle and the regulation of gene expression. Hence, knowledge of how water-soluble extracts of Pinctada maxima nacre act on osteoblasts in vitro may reveal the mechanisms involved in its action in vivo on bone cells and bone regeneration. (C) 2001 Kluwer Academic Publishers.
C1 Museum Natl Hist Nat, Physiol Lab, CNRS, UMR 8572, F-75231 Paris 05, France.
   INRA, CNRS, UPR 1524, F-78359 Jouy En Josas, France.
   MNHN, Chim Lab, CNRS, ESA 8041, F-75005 Paris, France.
RP Moutahir-Belqasmi, F (reprint author), Museum Natl Hist Nat, Physiol Lab, CNRS, UMR 8572, 7 Rue Cuvier, F-75231 Paris 05, France.
CR Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Aubin Jane E., 1993, P1
   BALMAIN N, 1997, BONE, V20, pA142
   Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   BERESFORD JN, 1986, ENDOCRINOLOGY, V119, P1176
   CARIOLOU MA, 1997, J PHYSL B, V157, P717
   Cuif JP, 1996, AQUAT LIVING RESOUR, V9, P187, DOI 10.1051/alr:1996022
   DELATTRE O, 1997, EUR J ORTHOP SURG TR, V7, P15
   Gerstenfeld LC, 1996, ENDOCRINOLOGY, V137, P3957, DOI 10.1210/en.137.9.3957
   GOLDMAN R, 1979, J NATL CANCER I, V63, P1009
   GRIGORIADIS AE, 1986, ENDOCRINOLOGY, V119, P932, DOI 10.1210/endo-119-2-932
   HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N
   Huang YL, 1998, J BIOMED SCI, V5, P185
   ITOH Y, 1995, BIOTECHNOL BIOENG, V48, P118, DOI 10.1002/bit.260480205
   KITTEN AM, 1995, AM J PHYSIOL-ENDOC M, V269, pE918
   KORSMEYER SJ, 1992, BLOOD, V80, P879
   KRAJEWSKI S, 1993, CANCER RES, V53, P4701
   Liao H, 1997, J MATER SCI-MATER M, V8, P823, DOI 10.1023/A:1018537318147
   LIEBERHERR M, 1993, J BONE MINER RES, V8, P1365
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   LOPEZ E, 1995, B I OCEANO MONACO, V3, P49
   LOPEZ E, Patent No. 15650
   LU QL, 1994, J CELL SCI, V107, P363
   MIYAMOTO H, 1996, P NATL ACAD SCI USA, V93, P9637
   MOUTAHIRBELQASM.F, 1999, UNPUB 2 FRENCH DAYS
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Park JR, 1996, J CELL BIOCHEM, V60, P12, DOI 10.1002/(SICI)1097-4644(19960101)60:1<12::AID-JCB3>3.0.CO;2-6
   Rao LG, 1996, BONE, V19, P621, DOI 10.1016/S8756-3282(96)00281-5
   REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1
   RUTTNER A, 1997, IN VITRO CELL DEV, V33, P757
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   Singh RP, 1996, BIOTECHNOL BIOENG, V52, P166, DOI 10.1002/(SICI)1097-0290(19961005)52:1<166::AID-BIT17>3.0.CO;2-M
   SPIESS YH, 1986, ENDOCRINOLOGY, V118, P1340, DOI 10.1210/endo-118-4-1340
   STEIN GS, 1990, FASEB J, V4, P3111
   Wada Y, 1998, BONE, V22, P479, DOI 10.1016/S8756-3282(98)00039-8
   Wang Y, 1997, HISTOCHEM CELL BIOL, V108, P45, DOI 10.1007/s004180050145
   WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
   WONG G, 1974, NATURE, V252, P1811
NR 41
TC 19
Z9 21
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2001
VL 12
IS 1
BP 1
EP 6
DI 10.1023/A:1026759431595
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 389ZH
UT WOS:000166268200001
PM 15348370
DA 2018-10-19
ER

PT J
AU Jones, DS
   Garvin, CP
   Gorman, SP
AF Jones, DS
   Garvin, CP
   Gorman, SP
TI Design of a simulated urethra model for the quantitative assessment of
   urinary catheter lubricity
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID INTERMITTENT CATHETERIZATION
AB Catheters designed for intermittent urological catheterization should possess appropriate lubricity and mechanical properties to ensure optimal clinical performance. However, the lack of a reproducible in vitro method that simulates clinical use makes it difficult to evaluate the lubricity of urinary catheters and other devices for urethral insertion. Therefore, this study describes a suitable method based on use of a Texture Analyzer to characterize the lubricity of such devices. The novel method was susequently applied to the evaluation of commercially-available intermittent urinary catheters. In addition, other important physicochemical properties of these catheters were examined, namely Young's modulus, degree of hydration and morphology. Catheter lubricity was quantified, using a Texture Analyzer, by measurement of the forces required for insertion and removal of the device from two model substrates, agar and mucin-coated silicone tubing. Significant differences in lubricity were identified between the commercially-available catheters, with Aquacath and Lofric exhibiting the lowest forces of insertion and removal. There were no significant differences between the extent of hydration between the catheters, with the exception of Uro-flo which exhibited the lowest hydration. Therefore, the differences in lubricity were not directly related to the extent of hydration. The forces required for insertion/removal of all catheters were markedly greater in the simulated mucin model than in the agar substrate and the former, simulated urethra model, was accepted to mimic more accurately, the in vivo situation. Significant differences were observed between the Young's Moduli of the catheter biomaterials, with Aquacath possessing the largest value. In conclusion, this study has described the use of a texture analyzer and polymeric substrates for the evaluation of biomaterial lubricity. Using these methods, Aquacath and Lofric catheters exhibited greatest lubricity. However, following additional consideration of the mechanical properties of these biomaterials, Aquacath possessed the most appropriate physicochemical properties for use in intermittent catheterization. (C) 2001 Kluwer Academic Publishers.
C1 Queens Univ Belfast, Sch Pharm, Med Devices Unit, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland.
RP Jones, DS (reprint author), Queens Univ Belfast, Sch Pharm, Med Devices Unit, Ctr Med Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
CR Ahuja A, 1997, DRUG DEV IND PHARM, V23, P489, DOI 10.3109/03639049709148498
   BUTLER HK, 1968, J UROLOGY, V100, P560, DOI 10.1016/S0022-5347(17)62571-0
   COHEN A, 1985, J HOSP INFECT, V6, P155, DOI 10.1016/S0195-6701(85)80062-1
   Cowan T, 1997, Prof Nurse, V12, P297
   COX AJ, 1987, BIOMATERIALS, V8, P500, DOI 10.1016/0142-9612(87)90089-5
   DIOKNO AC, 1995, J UROLOGY, V153, P349, DOI 10.1097/00005392-199502000-00015
   GETLIFFE K, 1990, NURS STAND, V21, P33
   Gorman SP, 1997, BIOMATERIALS, V18, P1379, DOI 10.1016/S0142-9612(97)00070-7
   Hunt GM, 1996, BRIT MED J, V312, P103
   Ikada Y, 1993, LUBRICATING POLYM SU
   Jones DS, 1997, J MATER SCI-MATER M, V8, P713, DOI 10.1023/A:1018596109061
   LAPIDES J, 1972, Journal of Urology, V107, P458
   Marmieri G, 1996, J BIOMED MATER RES, V33, P29, DOI 10.1002/(SICI)1097-4636(199621)33:1<29::AID-JBM5>3.3.CO;2-M
   Pomfret I J, 1996, Br J Nurs, V5, P245
   RAMSAY JWA, 1986, BRIT J UROL, V58, P70, DOI 10.1111/j.1464-410X.1986.tb05431.x
   Waller L, 1997, SPINAL CORD, V35, P229, DOI 10.1038/sj.sc.3100390
NR 16
TC 15
Z9 15
U1 2
U2 13
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2001
VL 12
IS 1
BP 15
EP 21
DI 10.1023/A:1026744732504
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 389ZH
UT WOS:000166268200003
PM 15348372
DA 2018-10-19
ER

PT J
AU De Giglio, E
   Motta, A
   Quagliarella, L
   Sabbatini, L
   Solarino, G
   Zambonin, PG
AF De Giglio, E
   Motta, A
   Quagliarella, L
   Sabbatini, L
   Solarino, G
   Zambonin, PG
TI A combined XPS-SEM/EDX investigation on explanted UHMW polyethylene
   acetabular cups: possible role of silicon traces in the wear debris
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SURFACE
AB An investigation was started aimed at a better understanding of the complex phenomena leading to chemical degradation and morphological deterioration of UHMW polyethylene cups in total hip prostheses. Analysis was performed on retrieved implants which needed revision due to inflammation and pain problems. Preliminary results obtained by parallel XPS and SEM/EDX experiments gave evidence, for the first time, that silicon traces are involved in the process of particle formation and segregation onto the surface of the cups. The extent of modification of the surface chemical composition of cups and the process of particle segregation seem to be correlated to both the implant time and to some particular features of patient (age, activity, style of life, etc.). Investigation on a large number of samples is in progress in order to test this hypothesis. The results obtained so far confirmed the potential of surface spectroscopies (XPS) in biomaterial investigations. (C) 2001 Kluwer Academic Publishers.
C1 Univ Bari, Dipartimento Chim, I-70100 Bari, Italy.
   Staz Sperimentale Seta, I-20133 Milan, Italy.
   Univ Bari, Clin Ortoped 1, I-70100 Bari, Italy.
RP De Giglio, E (reprint author), Univ Bari, Dipartimento Chim, Via Orabona 4, I-70100 Bari, Italy.
OI Sabbatini, Luigia/0000-0002-5099-2242; De Giglio,
   Elvira/0000-0001-9387-6201; Motta, Antonella/0000-0003-4893-6863
CR AMSTUTZ HC, 1989, CLIN ORTHOP RELAT R, P104
   Bankston A B, 1993, J Arthroplasty, V8, P315
   BERRY DJ, 1993, CLIN ORTHOP RELAT R, P204
   BLACK J, 1990, J BONE JOINT SURG AM, V72A, P126, DOI 10.2106/00004623-199072010-00021
   CHAVDA DV, 1994, CLIN ORTHOP RELAT R, P211
   Desimoni E., 1986, Computer Enhanced Spectroscopy, V3, P107
   GOLDRING SR, 1993, J BONE JOINT SURG AM, V75A, P799, DOI 10.2106/00004623-199306000-00001
   Hailey J L, 1996, Proc Inst Mech Eng H, V210, P3, DOI 10.1243/PIME_PROC_1996_210_385_02
   HARPER GD, 1995, J BONE JOINT SURG BR, V77B, P557
   Hodge W A, 1993, Orthop Rev, V22, P719
   HOROWITZ SM, 1993, J BONE JOINT SURG AM, V75A, P802, DOI 10.2106/00004623-199306000-00002
   KABO JM, 1993, J BONE JOINT SURG BR, V75, P254
   MALITESTA C, 1989, J CHEM SOC FARAD T 1, V85, P1685, DOI 10.1039/f19898501685
   Sabbatini L, 1996, J ELECTRON SPECTROSC, V81, P285, DOI 10.1016/0368-2048(95)02528-6
   SAIKKO VO, 1993, ACTA ORTHOP SCAND, V64, P507, DOI 10.3109/17453679308993680
   SPECTOR M, 1990, CLIN ORTHOP RELAT R, P140
NR 16
TC 2
Z9 2
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2001
VL 12
IS 1
BP 23
EP 28
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 389ZH
UT WOS:000166268200004
PM 15348373
DA 2018-10-19
ER

PT J
AU Choi, YS
   Lee, SB
   Hong, SR
   Lee, YM
   Song, KW
   Park, MH
AF Choi, YS
   Lee, SB
   Hong, SR
   Lee, YM
   Song, KW
   Park, MH
TI Studies on gelatin-based sponges. Part III: A comparative study of
   cross-linked gelatin/alginate, gelatin/hyaluronate and
   chitosan/hyaluronate sponges and their application as a wound dressing
   in full-thickness skin defect of rat
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ARTIFICIAL SKIN; BIOMATERIAL; MACROPHAGE; PRINCIPLES; COLLAGEN; DESIGN
AB Novel cross-linked sponges composed of gelatin/alginate and gelatin/hyaluronate and chitosan/hyaluronate (GH, GA and CH, respectively) were prepared and compared. Six different sponges with or without silver sulfadiazine (AgSD) were applied on the full-thickness dorsal skin defect of Wistar rat. The histology and epidermal wound healing rates of the skin defects were investigated by light microscopy and computerized morphometry 5 and 12 days post-operatively. In our full-thickness wound model (diameter 1 cm), the AgSD-impregnated sponges showed good wound healing performances on the whole. However, there appeared meaningful differences of wound healing between the gelatin-based sponges (GH, GA) and the CH. GH with AgSD was found to show the best wound healing properties as a wound dressing resulting from histological findings and computerized morphometric analysis of epidermal healing. (C) 2001 Kluwer Academic Publishers.
C1 Hanyang Univ, Coll Engn, Dept Ind Chem, Seoul 133791, South Korea.
   Hanyang Univ, Coll Med, Dept Pathol, Seoul 133791, South Korea.
RP Lee, YM (reprint author), Hanyang Univ, Coll Engn, Dept Ind Chem, Seoul 133791, South Korea.
RI Lee, Young Moo/G-5920-2015
OI Lee, Young Moo/0000-0002-5047-3143
CR ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Choi YS, 1999, J BIOMED MATER RES, V48, P631, DOI 10.1002/(SICI)1097-4636(1999)48:5<631::AID-JBM6>3.0.CO;2-Y
   CHOI YS, 1999, BIOMATERIALS, V20, pH9
   CHVAPIL M, 1988, J SURG RES, V44, P266, DOI 10.1016/0022-4804(88)90057-1
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   Gilchrist T., 1994, BIOMATERIALS, V15, P317
   Lee SJ, 2000, CARBOHYD POLYM, V41, P197, DOI 10.1016/S0144-8617(99)00088-0
   LOUWASHANMI J, 1976, J TRAUMA, V16, P348
   Matsui R, 1996, BIOMATERIALS, V17, P989, DOI 10.1016/0142-9612(96)84673-4
   NORTON L, 1981, J TRAUMA, V21, P463
   OKAMOTO Y, 1992, ADVANCES IN CHITIN AND CHITOSAN, P70
   PARK GB, 1978, BIOMATER ARTIF CELL, V6, P1
   QUINN KJ, 1985, BIOMATERIALS, V6, P369, DOI 10.1016/0142-9612(85)90095-X
   REES DA, 1977, ANGEW CHEM INT EDIT, V16, P214, DOI 10.1002/anie.197702141
   Rose PJ, 1989, ENCY POLYM SCI ENG, V7, P488
   SELA M, 1960, BIOCHEM J, V75, P91, DOI 10.1042/bj0750091
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   TABATA Y, 1987, J PHARM PHARMACOL, V39, P698, DOI 10.1111/j.2042-7158.1987.tb06972.x
   TOMIHATA K, 1994, ACS SYM SER, V540, P275
   WIDRA A, 1989, ENCY POLYM SCI ENG, V8, P521
   WILKES GL, 1973, J BIOMED MATER RES, V7, P541, DOI 10.1002/jbm.820070606
   WINTER GD, 1975, PLAST RECONSTR SURG, V56, P531, DOI 10.1097/00006534-197511000-00009
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
NR 25
TC 87
Z9 87
U1 1
U2 29
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2001
VL 12
IS 1
BP 67
EP 73
DI 10.1023/A:1026765321117
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 389ZH
UT WOS:000166268200010
PM 15348379
DA 2018-10-19
ER

PT J
AU Jones, DS
   McGovern, JG
   Adair, CG
   Woolfson, AD
   Gorman, SP
AF Jones, DS
   McGovern, JG
   Adair, CG
   Woolfson, AD
   Gorman, SP
TI Conditioning film and environmental effects on the adherence of Candida
   spp. to silicone and poly(vinylchloride) biomaterials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CELL-SURFACE HYDROPHOBICITY;
   CARBON-DIOXIDE; IN-VITRO; VOICE PROSTHESES; FUNGAL COLONIZATION;
   ENDOTRACHEAL-TUBES; BIOFILM FORMATION; SALIVA; ADHESION
AB The reported incidence of colonization of oropharyngeal medical devices with Candida spp. has increased in recent years, although few studies that have systematically examined the adherence of yeast cells to such biomaterials, the primary step in the process of colonization. This study, therefore, examined the effects of oropharyngeal atmospheric conditions (5% v/v carbon dioxide) and the presence of a salivary conditioning film on both the surface properties and adherence of Candida albicans, Candida krusei and Candida tropicalis to PVC and silicone. Furthermore, the effects of the salivary conditioning film on the surface properties of these biomaterials are reported. Growth of the three Candida spp. in an atmosphere containing 5% v/v CO2 significantly increased their cell surface hydrophobicity and reduced the zeta potential of C. albicans and C. krusei yet increased the zeta potential of C. tropicalis (p <0.05). Furthermore, growth in 5% v/v CO2 decreased the adherence of C. tropicalis and C. albicans to both PVC and silicone, however, increased adherence of C. krusei (p <0.05). Pre-treatment of the microorganisms with pooled human saliva significantly decreased their cell surface hydrophobicity and increased their adherence to either biomaterial in comparison to yeast cells that had been pre-treated with PBS (p <0.05). Saliva treatment of the microorganisms had no consistent effect on microbial zeta potential. Interestingly, adherence of the three, saliva-treated Candida spp. to saliva-treated silicone and PVC was significantly lower than whenever the microorganisms and biomaterials had been treated with PBS (p <0.05). Treatment of silicone and PVC with saliva significantly altered the surface properties, notably reducing both the advancing and receding contact angles and, additionally, the microrugosity. These effects may contribute to the decreased adherence of saliva-treated microorganisms to these biomaterials. In conclusion, this study has demonstrated the effects of physiological conditions within the oral cavity on the adherence of selected Candida spp. to biomaterials employed as oropharyngeal medical devices. In particular, this study has ominously shown that these materials act as substrates for yeast colonization, highlighting the need for advancements in biomaterial design. Furthermore, it is important that physiological conditions should be employed whenever biocompatibility of oropharyngeal biomaterials is under investigation. (C) 2001 Kluwer Academic Publishers.
C1 Queens Univ Belfast, Ctr Med Biol, Sch Pharm, Med Devices Unit, Belfast BT9 7BL, Antrim, North Ireland.
RP Jones, DS (reprint author), Queens Univ Belfast, Ctr Med Biol, Sch Pharm, Med Devices Unit, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
CR Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014
   Bonner MC, 1997, INT J PHARM, V151, P201, DOI 10.1016/S0378-5173(97)04903-X
   Bowman WC, 1980, TXB PHARM
   Busscher HJ, 1997, J BIOMED MATER RES, V34, P201, DOI 10.1002/(SICI)1097-4636(199702)34:2<201::AID-JBM9>3.0.CO;2-U
   CANNON RD, 1995, MICROBIOL-SGM, V141, P213, DOI 10.1099/00221287-141-1-213
   DENYER SP, 1990, J CLIN MICROBIOL, V28, P1813
   EDGERTON M, 1993, INFECT IMMUN, V61, P2644
   GORMAN S, 1993, EUR J CLIN MICROBIOL, V12, P9, DOI 10.1007/BF01997050
   Gorman SP, 1997, BIOMATERIALS, V18, P1379, DOI 10.1016/S0142-9612(97)00070-7
   GORMAN SP, 1993, J MED MICROBIOL, V38, P411, DOI 10.1099/00222615-38-6-411
   INGLIS TJJ, 1995, J HOSP INFECT, V30, P409, DOI 10.1016/0195-6701(95)90045-4
   IZDEBSKI K, 1987, LARYNGOSCOPE, V97, P594
   Jones DS, 1997, BIOMATERIALS, V18, P503, DOI 10.1016/S0142-9612(96)00170-6
   Jones DS, 1997, J MATER SCI-MATER M, V8, P713, DOI 10.1023/A:1018596109061
   Jones DS, 1996, INT J PHARM, V131, P83, DOI 10.1016/0378-5173(95)04368-3
   LIGTENBERG AJM, 1993, ANTON LEEUW INT J G, V64, P39, DOI 10.1007/BF00870920
   MAHIEU HF, 1986, ARCH OTOLARYNGOL, V112, P321
   MARTIN MA, 1989, AM J INFECT CONTROL, V17, P130, DOI 10.1016/0196-6553(89)90199-5
   MCCOURTIE J, 1986, J MED MICROBIOL, V21, P209, DOI 10.1099/00222615-21-3-209
   McGovern JG, 1997, J DENT RES, V76, P1157
   McGovern JG, 1997, INT J PHARM, V149, P251, DOI 10.1016/S0378-5173(97)04883-7
   NEU TR, 1992, CELL MATER, V2, P261
   NEU TR, 1994, MICROB ECOL HEALTH D, V7, P27, DOI 10.3109/08910609409141571
   Nikawa H, 1996, MICROB ECOL HEALTH D, V9, P35, DOI 10.1002/(SICI)1234-987X(199601)9:1<35::AID-MEH409>3.3.CO;2-2
   ODDS FC, 1988, CANDIDA CANDIDOSIS
   PERSI MA, 1985, INFECT IMMUN, V50, P82
   PFALLER M, 1992, EUR J CLIN MICROBIOL, V11, P287, DOI 10.1007/BF01962067
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x
   RUBENSTEIN JS, 1992, CRIT CARE MED, V20, P1544, DOI 10.1097/00003246-199211000-00011
   SATOU J, 1991, J ORAL REHABIL, V18, P421
   SCANNAPIECO FA, 1994, CRIT REV ORAL BIOL M, V5, P203, DOI 10.1177/10454411940050030201
   SCHNEIDER PF, 1991, EPIDEMIOL INFECT, V106, P71, DOI 10.1017/S0950268800056454
   TUNNEY MM, 1996, REV MED MICROBIOL, V7, P195
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   WEERKAMP AH, 1988, J DENT RES, V67, P1483, DOI 10.1177/00220345880670120801
   WILCOX MH, 1990, J CLIN MICROBIOL, V28, P2183
   WILCOX MH, 1991, J ANTIMICROB CHEMOTH, V27, P577, DOI 10.1093/jac/27.5.577
NR 37
TC 12
Z9 12
U1 2
U2 8
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 2001
VL 12
IS 5
BP 399
EP 405
DI 10.1023/A:1011240818338
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 427YP
UT WOS:000168434600005
PM 15348278
DA 2018-10-19
ER

PT J
AU Paez, JMG
   Jorge-Herrero, E
   Carrera, A
   Millan, I
   Rocha, A
   Salvador, J
   Mendez, J
   Tellez, G
   Castillo-Olivares, JL
AF Paez, JMG
   Jorge-Herrero, E
   Carrera, A
   Millan, I
   Rocha, A
   Salvador, J
   Mendez, J
   Tellez, G
   Castillo-Olivares, JL
TI Porcine pericardial membrane subjected to tensile testing: preliminary
   study of the process of selecting tissue for use in the construction of
   cardiac bioprostheses
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BOVINE PERICARDIUM; HEART-VALVE; FIBER ARCHITECTURE; CALCIFICATION;
   STRESS; LEAFLETS; SITES
AB The durability of cardiac bioprostheses is limited fundamentally by structural failure due to mechanical fatigue and calcification. In the present report, we analyze, using an in vitro hydraulic simulator to test tensile strength, the mechanical behavior of porcine pericardium for the purpose of establishing the criteria for selecting the biomaterial, taking into account both morphological criteria (thickness and homogeneity of the specimens) and mechanical criteria (stress at breaking point), using the epidemiological model of paired samples. The stress at breakage was found to range widely from 24.07 MPa to 100.29 MPa, although we observed no statistically significant differences when comparing the mean results in the different regions and zones of the pericardium being studies. The application of the selection criteria in the present series resulted in an excellent mathematical fit in terms of the stress/elongation ( R-2> 0.95), making it possible to establish, by means of linear regression, the prediction of the tensile strength in one zone on the basis of the values observed in its paired specimen. (C) 2001 Kluwer Academic Publishers.
C1 Clin Puerta Hierro, Serv Cirugia Expt, Madrid, Spain.
   Clin Puerta Hierro, Serv Bioestadist, Madrid, Spain.
   Clin Puerta Hierro, Serv Cirugia Cardiovasc, Madrid, Spain.
   Escuela Super Ingenieros Ind, Madrid, Spain.
RP Paez, JMG (reprint author), Clin Puerta Hierro, Serv Cirugia Expt, Madrid, Spain.
EM eduardo.jorge@cirx.cph.es
RI Jorge Herrero, EDUARDO/F-7240-2010
CR BLOOMFIELD P, 1991, NEW ENGL J MED, V324, P573, DOI 10.1056/NEJM199102283240901
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   Bustamante John, 1996, Archivos del Instituto de Cardiologia de Mexico, V66, P229
   CARPENTIER A, 1984, CIRCULATION S1, V79, P165
   Carrera San Martin A., 1993, Biomaterials, V14, P76, DOI 10.1016/0142-9612(93)90079-H
   Chachra D, 1996, BIOMATERIALS, V17, P1865, DOI 10.1016/0142-9612(95)00305-3
   GRUNKEMEIER GL, 1994, J THORAC CARDIOV SUR, V108, P709
   Haziza F, 1996, J HEART VALVE DIS, V5, P35
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   JORGE E, 1991, J MATER SCI-MATER M, V2, P86
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   JORGEHERRERO E, 1994, BIOMATERIALS, V15, P815, DOI 10.1016/0142-9612(94)90036-1
   Levy R J, 1994, J Heart Valve Dis, V3, P101
   LOPEZ CL, 1983, REV ESP CARDIOL, V33, P925
   PAEZ JMG, 1990, J THORAC CARDIOV SUR, V100, P580
   Paez JMG, 1996, J BIOMED MATER RES, V30, P47
   PURINYA B, 1994, J BIOMECH, V27, P1, DOI 10.1016/0021-9290(94)90027-2
   ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   SCHOEN FJ, 1992, J THORAC CARDIOV SUR, V104, P1285
   SCHOEN FJ, 1985, HUM PATHOL, V16, P549, DOI 10.1016/S0046-8177(85)80103-9
   THUBRIKAR MJ, 1983, J THORAC CARDIOV SUR, V86, P115
   TIMOSHENKO S, 1970, RESISTENCIA MAT, V1, P168
   TROWBRIDGE EA, 1985, J MATER SCI, V20, P114, DOI 10.1007/BF00555905
   VONFRAUNHOFER JA, 1988, BIOMATERIALS, V9, P324, DOI 10.1016/0142-9612(88)90027-0
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
NR 27
TC 7
Z9 8
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 2001
VL 12
IS 5
BP 425
EP 430
DI 10.1023/A:1011201104225
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 427YP
UT WOS:000168434600009
PM 15348282
DA 2018-10-19
ER

PT J
AU Fonseca, AP
   Granja, PL
   Nogueira, JA
   Oliveira, DR
   Barbosa, MA
AF Fonseca, AP
   Granja, PL
   Nogueira, JA
   Oliveira, DR
   Barbosa, MA
TI Staphylococcus epidermidis RP62A adhesion to chemically modified
   cellulose derivatives
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BACTERIAL ADHESION; SURFACE CHARACTERISTICS; BIOFILM FORMATION; POLYMER;
   THERMODYNAMICS; POLYETHYLENE; BIOMATERIAL; PREVENTION; ADHERENCE;
   STRAINS
AB The adhesion of coagulase negative Staphylococcus epidermidis expressing capsular polysaccharide/adhesin (PS/A) to cellulose diacetate (CDA), as well as to primary reference low-density polyethylene, was assessed in vitro. Attached bacteria were released by gentle sonication and quantified as colony forming units. Surface free energy of cells and materials and the free energy of interaction between cells, each type of material and water molecules was calculated through contact angle measurement, also enabling the determination of materials surface hydrophobicity. The influence of CDA surface modification by deacetylation and phosphorylation on bacterial adhesion was studied. Chemical modifications of CDA by deacetylation and by phosphorylation were effective in lowering bacterial adhesion. (C) 2001 Kluwer Academic Publishers.
C1 Inst Biomed Engn, Lab Biomat, P-4150180 Porto, Portugal.
   Univ Porto, Fac Engn, Porto, Portugal.
   Univ Porto, Fac Med, IPATIMUP, P-4200 Oporto, Portugal.
   Univ Minho, Ctr Engn Biol, IBQF, P-4710057 Braga, Portugal.
RP Fonseca, AP (reprint author), Inst Biomed Engn, Lab Biomat, Rua Campo Alegre 823, P-4150180 Porto, Portugal.
RI Granja, Pedro/B-1685-2008
OI Granja, Pedro/0000-0003-2761-4929; Barbosa, Mario/0000-0003-3568-7482
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   AZEREDO J, 1997, J I BREWING, V103, P1
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   CHANG CC, 1992, J BIOMED MATER RES, V26, P197, DOI 10.1002/jbm.820260206
   Christensen G, 1989, INFECT ASS INDWELLIN
   CHRISTENSEN GD, 1995, METHOD ENZYMOL, V253, P443
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   Galliani S, 1996, J LAB CLIN MED, V127, P71, DOI 10.1016/S0022-2143(96)90168-7
   GILBERT P, 1991, J APPL BACTERIOL, V71, P72
   Gottenbos B, 1999, METHODS ENZYMOL, V310, P523
   GRANJA PL, 1999, FRONTIERS BIOMEDICAL, V2
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Higashi JM, 1998, J BIOMED MATER RES, V39, P341, DOI 10.1002/(SICI)1097-4636(19980305)39:3<341::AID-JBM1>3.0.CO;2-J
   HIGASHI JM, 1999, HDB BIOMATERIALS EVA
   HOGT AH, 1986, INFECT IMMUN, V51, P294
   ISHIHARA K, 1994, ARTIF ORGANS, V18, P559, DOI 10.1111/j.1525-1594.1994.tb03379.x
   Ishizu A., 1991, WOOD CELLULOSIC CHEM, P757
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996
   KLEMM L, 1998, COMPREHENSIVE CELLUL, V1
   Kohnen W, 1995, ZBL BAKT-INT J MED M, V283, P175
   MITTELMAN MW, 1996, MOL ECOLOGICAL DIVER, P89
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   Morra M, 1996, J BIOMED MATER RES, V31, P149
   NEVELL TP, 1985, CELLULOSE CHEM ITS A, P15
   Nyquist R. A, 1977, COBLENTZ SOC DESK BO, P399
   OKADA K., 1997, BIOCERAMICS, V10, P329
   PITT WG, 1994, ANTIMICROB AGENTS CH, V38, P2577, DOI 10.1128/AAC.38.11.2577
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   Trafny EA, 1998, J BIOMED MATER RES, V41, P593, DOI 10.1002/(SICI)1097-4636(19980915)41:4<593::AID-JBM11>3.0.CO;2-G
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   VANOSS CJ, 1995, CLAY CLAY MINER, V43, P474, DOI 10.1346/CCMN.1995.0430411
   VANOSS CJ, 1994, INTERFACIAL FORCES A
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995
NR 35
TC 15
Z9 15
U1 0
U2 9
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 2001
VL 12
IS 6
BP 543
EP 548
DI 10.1023/A:1011227915575
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 435NA
UT WOS:000168886500012
PM 15348271
DA 2018-10-19
ER

PT J
AU Li, DQ
   Lundberg, F
   Ljungh, A
AF Li, DQ
   Lundberg, F
   Ljungh, A
TI Binding of vitronectin and clusterin by coagulase-negative staphylococci
   interfering with complement function
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 16th Conference of the European-Society-for-Biomaterials
CY SEP 12-14, 2001
CL LONDON, ENGLAND
SP European Soc Biomat
ID CELL-SURFACE; FIBRONECTIN; ACTIVATION; REGULATOR; COMPLEXES; COLLAGEN
AB Coagulase-negative staphylococci (CoNS) are commonly associated with infections of prosthetic devices mediated by adsorbed host factors on biomaterial surfaces. Complement activation is known to occur and induce unspecific inflammation around the biomaterials. Human vitronectin (Vn) and clusterin (Clu), two potent inhibitors of complement, can be bound by CoNS. With a hypothesis whether binding of Vn or Clu influences complement activation, two measurements were determined. For Vn, complement activation was measured with a mouse anti-activated human C9 antibody. In the presence of Vn-binding strain, Staphylococcus hemolyticus SM13I, complement activation on a surface pre-coated with Vn occurred as it did in the absence of Vn pre-coating. For S. epidermidis 3380, which does not express binding of Vn, complement activation on a Vn-presented surface was significantly decreased. For Clu, erythrocytes lysis was measured to reflect the end product of complement activation (membrane attack complex). The complement-induced hemolysis increased when human serum was pre-incubated with Clu-binding strains, S. epidermidis J9P. The enhancement of hemolysis by J9P decreased when serum was supplemented by exogenous Clu. The data imply that interaction between CoNS and Vn or Clu interferes with one of their physiological functions, complement inhibition. (C) 2001 Kluwer Academic Publishers.
C1 Lund Univ, Dept Med Microbiol Dermatol & Infect, S-22362 Lund, Sweden.
RP Ljungh, A (reprint author), Lund Univ, Dept Med Microbiol Dermatol & Infect, Solvegatan 23, S-22362 Lund, Sweden.
EM Asa.Ljungh@mmb.lu.se
CR GEBB C, 1986, J BIOL CHEM, V261, P6698
   Hochgrebe TT, 1999, EXP CELL RES, V249, P13, DOI 10.1006/excr.1999.4459
   Lidstrom AM, 1998, EXP NEUROL, V154, P511, DOI 10.1006/exnr.1998.6892
   Lundberg F, 1997, INFECT IMMUN, V65, P897
   McDonald JF, 1997, BIOCHEMISTRY-US, V36, P7464, DOI 10.1021/bi962895r
   MONDINO BJ, 1985, INVEST OPHTH VIS SCI, V26, P905
   MORGAN BP, 1989, BIOCHEM J, V264, P1
   Partridge SR, 1996, INFECT IMMUN, V64, P4324
   Paulsson M, 1990, FEMS Microbiol Immunol, V2, P55
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   PAULSSON M, 1992, J CLIN MICROBIOL, V30, P2006
   PODACK ER, 1984, ACTA PATH MICRO IM C, V92, P89
   PREISSNER KP, 1989, EUR J IMMUNOL, V19, P69, DOI 10.1002/eji.1830190112
   SALAMA A, 1988, NEW ENGL J MED, V318, P408, DOI 10.1056/NEJM198802183180704
   YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281
NR 15
TC 6
Z9 6
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 2001
VL 12
IS 10-12
BP 979
EP 982
DI 10.1023/A:1012865200458
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 494KB
UT WOS:000172280300025
PM 15348351
DA 2018-10-19
ER

PT J
AU Jorge-Herrero, E
   Turnay, J
   Calero, P
   Olmo, N
   De Silanes, IL
   Maestro, MM
   Lizarbe, MA
   Castillo-Olivares, JL
AF Jorge-Herrero, E
   Turnay, J
   Calero, P
   Olmo, N
   De Silanes, IL
   Maestro, MM
   Lizarbe, MA
   Castillo-Olivares, JL
TI Calcification and identification of metalloproteinases in bovine
   pericardium after subcutaneous implantation in rats
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 16th Conference of the European-Society-for-Biomaterials
CY SEP 12-14, 2001
CL LONDON, ENGLAND
SP European Soc Biomat
ID BIOPROSTHETIC CARDIAC VALVES; MATRIX METALLOPROTEINASES; HEART-VALVES;
   IN-VITRO; ETHANOL PREINCUBATION; TISSUE; GLUTARALDEHYDE; LIPIDS;
   CONSTRUCTION; CHALLENGES
AB The purpose of this study was to evaluate the influence of two anticalcification pre-treatments (chloroform/methanol and ethanol) and serum conditioning of glutaraldehyde-crosslinked bovine pericardium on the calcification degree and the presence of gelatinase activities in a subcutaneous implantation model in rats. Regarding calcification of the implants, glutaraldehyde control treatments showed a significatively higher calcification degree than pericardium treated with anticalcification reagents. Serum conditioning of glutaraldehyde treated tissues did not influence the calcification degree; moreover, no differences were found in these samples with the time of implantation (30 and 90 days). On the other hand, anticalcification treatments resulted in a very significant decrease in the calcium content in the implanted membranes.
   Gelatinase activities were detected by gelatin zymography in almost all the implanted samples. However, control tissues with and without serum conditioning showed less gelatinase activities than those samples pre-treated with anticalcification treatments. Metalloproteinase (MMP-2) activity was detected in all the samples analyzed but a higher expression of MMP-9 was detected in those implants treated with chloroform/methanol and ethanol. Additional gelatinase activities showing lower molecular weight than MMP-2 were also detected in both anticalcification treated samples. The presence of these gelatinase activities is probably due to host cellular infiltrates and could contribute to the biomaterial degradation. (C) 2001 Kluwer Academic Publishers.
C1 Clin Puerta Hierro, Unidad Biomat, Serv Cirugia Expt, Madrid 28035, Spain.
   Univ Complutense, Fac Ciencias Quim, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain.
RP Jorge-Herrero, E (reprint author), Clin Puerta Hierro, Unidad Biomat, Serv Cirugia Expt, San Martin de Porres 4, Madrid 28035, Spain.
RI Jorge Herrero, EDUARDO/F-7240-2010; Lizarbe, M Antonia/K-5219-2014;
   Turnay, Javier/K-4551-2014; OLMO LOPEZ, NIEVES/K-5266-2014
OI Lizarbe, M Antonia/0000-0003-1722-1240; Turnay,
   Javier/0000-0002-6135-2179; OLMO LOPEZ, NIEVES/0000-0002-8013-5313
CR Baba HA, 1998, PATHOLOGE, V19, P420, DOI 10.1007/s002920050306
   Bellon JM, 1997, EUR J CLIN INVEST, V27, P510, DOI 10.1046/j.1365-2362.1997.1400686.x
   Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320
   Bode W, 2001, Methods Mol Biol, V151, P45
   Boskey AL, 1997, CALCIFIED TISSUE INT, V60, P309, DOI 10.1007/s002239900234
   Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chanda J, 1998, BIOMATERIALS, V19, P1651, DOI 10.1016/S0142-9612(98)00038-6
   Deiwick M, 1998, ANN THORAC SURG, V66, pS206, DOI 10.1016/S0003-4975(98)01125-4
   Demer LL, 1997, CIRCULATION, V95, P297
   Denis LJ, 1997, INVEST NEW DRUG, V15, P175, DOI 10.1023/A:1005855905442
   Gratzer PF, 1997, J BIOMED MATER RES, V37, P497, DOI 10.1002/(SICI)1097-4636(19971215)37:4<497::AID-JBM8>3.0.CO;2-G
   Gura TA, 1997, J BIOMED MATER RES, V35, P483, DOI 10.1002/(SICI)1097-4636(19970615)35:4<483::AID-JBM8>3.0.CO;2-D
   Haas TL, 1999, TRENDS CARDIOVAS MED, V9, P70, DOI 10.1016/S1050-1738(99)00014-6
   HENKEL AW, 1994, ANAL BIOCHEM, V223, P329, DOI 10.1006/abio.1994.1595
   HIRSCH D, 1993, J BIOMED MATER RES, V27, P1477, DOI 10.1002/jbm.820271203
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P249, DOI 10.1016/0142-9612(91)90208-R
   JORGEHERRERO E, 1994, BIOMATERIALS, V15, P815, DOI 10.1016/0142-9612(94)90036-1
   JorgeHerrero E, 1996, J BIOMED MATER RES, V30, P411, DOI 10.1002/(SICI)1097-4636(199603)30:3<411::AID-JBM16>3.0.CO;2-M
   Kim KM, 1999, AM J PATHOL, V154, P843, DOI 10.1016/S0002-9440(10)65331-X
   Massova I, 1998, FASEB J, V12, P1075
   Nimni ME, 1997, J BIOMED MATER RES, V35, P531
   Sang Q X, 1998, Cell Res, V8, P171
   Santin M, 1998, J BIOMED MATER RES, V40, P434, DOI 10.1002/(SICI)1097-4636(19980605)40:3<434::AID-JBM14>3.0.CO;2-J
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SCHOEN FJ, 1994, J THORAC CARDIOV SUR, V108, P880
   SCHOEN FJ, 1994, J CARDIAC SURG, V9, P222, DOI 10.1111/j.1540-8191.1994.tb00932.x
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Simionescu A, 1996, ASAIO J, V42, pM561, DOI 10.1097/00002480-199609000-00049
   Simionescu A, 1996, CARDIOVASC PATHOL, V5, P323, DOI 10.1016/S1054-8807(96)00043-9
   VINCENTELLI A, 1998, LIEBIGS ANN CHEM, V66, pS255
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   Vyavahare N, 1997, CIRCULATION, V95, P479
   Vyavahare NR, 1998, J BIOMED MATER RES, V40, P577, DOI 10.1002/(SICI)1097-4636(19980615)40:4<577::AID-JBM9>3.3.CO;2-B
NR 37
TC 6
Z9 6
U1 0
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 2001
VL 12
IS 10-12
BP 1013
EP 1017
DI 10.1023/A:1012833720931
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 494KB
UT WOS:000172280300031
PM 15348357
DA 2018-10-19
ER

PT J
AU Liu, S
   Boutrand, JP
   Tadie, M
AF Liu, S
   Boutrand, JP
   Tadie, M
TI Use of a collagen-based sealant to prevent in vivo epidural adhesions in
   an adult rat laminectomy model
SO JOURNAL OF NEUROSURGERY
LA English
DT Article
DE dura mater; laminectomy; membrane; nerve root; epidural scar adhesions
ID CARBOHYDRATE POLYMER; PERIDURAL FIBROSIS; SCAR FORMATION; REDUCTION;
   MEMBRANE; SURGERY; DOGS
AB Object. The authors investigated the effect of a collagen-based sealant, Gel Amidon Oxyde (GAO), in the prevention of epidural scar adhesions in an adult rat model of laminectomy.
   Methods. Seventy-two adult Sprague-Dawley rats underwent an L5-6 laminectomy, after which the dura mater and the left L-4 and L-5 nerve roots were exposed. In the 36 animals that received GAG, the sealant was applied over the dura and around the nerve roots, and it was used to fill the laminectomy cavity before it polymerized. In 36 control animals, the same surgical treatment was performed, but the rats did not receive GAG. During the early postoperative period, a significant decrease in the occurrence of epidural hematoma was found in the GAG-treated rats. In contrast to findings in control rats, a thin white connective tissue layer was found between the dura and surrounding muscles after GAO had degraded and been absorbed. One month posttreatment, no epidural scar adhesion was found between the tissue layer and the dura in the GAG-treated animals. Three months postoperatively, both gross inspection and histological examination further confirmed that formation of epidural adhesions was significantly inhibited in the rats treated with GAG. No special inflammatory reaction was observed, and the healing of skin and muscle lesions was not affected by either treatment.
   Conclusions. The data obtained in this study suggest that the GAG collagen-based sealant may be an effective biomaterial to prevent epidural adhesions in vivo after laminectomy.
C1 Hop Bicetre, Assistance Publ Hop Paris, Dept Neurosurg, Lab Expt Neurosurg, F-94275 Le Kremlin Bicetre, France.
   Biomatech, Chasse Sur Rhone, France.
RP Liu, S (reprint author), Hop Bicetre, Assistance Publ Hop Paris, Dept Neurosurg, Lab Expt Neurosurg, F-94275 Le Kremlin Bicetre, France.
CR BARBERA J, 1978, J NEUROSURG, V49, P419, DOI 10.3171/jns.1978.49.3.0419
   BOOT DA, 1987, CLIN ORTHOP RELAT R, P296
   BRYANT MS, 1983, NEUROSURGERY, V13, P367, DOI 10.1227/00006123-198310000-00003
   CABEZUDO JM, 1985, J NEUROSURG, V63, P633, DOI 10.3171/jns.1985.63.4.0633
   DUBIN LM, 1988, AM J NEURORADIOL, V9, P217
   Einhaus SL, 1997, SPINE, V22, P1440, DOI 10.1097/00007632-199707010-00003
   FOULKES GD, 1990, CLIN ORTHOP RELAT R, P224
   HIRAIZUMI Y, 1995, SPINE, V20, P2272, DOI 10.1097/00007632-199511000-00002
   JACOBS RR, 1980, SPINE, V5, P223, DOI 10.1097/00007632-198005000-00004
   KELLER JT, 1978, J NEUROSURG, V49, P412, DOI 10.3171/jns.1978.49.3.0412
   Kiviluoto O, 1976, Acta Orthop Scand Suppl, P3
   LANGENSKIOLD A, 1976, CLIN ORTHOP RELAT R, P92
   LAROCCA H, 1974, J BONE JOINT SURG BR, VB 56, P545
   LAWSON KJ, 1991, SPINE, V16, pS222, DOI 10.1097/00007632-199106001-00009
   LEE CK, 1984, SPINE, V9, P305, DOI 10.1097/00007632-198404000-00016
   MAYER PJ, 1989, J BONE JOINT SURG AM, V71A, P1090, DOI 10.2106/00004623-198971070-00018
   Mayfield F H, 1980, Clin Neurosurg, V27, P349
   Petrie J L, 1996, Eur Spine J, V5 Suppl 1, pS10, DOI 10.1007/BF00298567
   Pospiech J, 1995, Eur Spine J, V4, P213, DOI 10.1007/BF00303413
   PRUSICK VR, 1988, J BONE JOINT SURG AM, V70A, P1256, DOI 10.2106/00004623-198870080-00023
   ROBERTSON JT, 1993, J NEUROSURG, V79, P89, DOI 10.3171/jns.1993.79.1.0089
   WEISZ GM, 1986, CLIN ORTHOP RELAT R, P204
   WUJEK JR, 1991, EXP NEUROL, V114, P237, DOI 10.1016/0014-4886(91)90040-J
   YONGHING K, 1980, SPINE, V5, P59, DOI 10.1097/00007632-198001000-00011
NR 24
TC 22
Z9 23
U1 1
U2 3
PU AMER ASSOC NEUROLOGICAL SURGEONS
PI CHARLOTTESVILLE
PA UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA
SN 0022-3085
J9 J NEUROSURG
JI J. Neurosurg.
PD JAN
PY 2001
VL 94
IS 1
SU S
BP 61
EP 67
DI 10.3171/spi.2001.94.1.0061
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 387DB
UT WOS:000166103900009
PM 11147869
DA 2018-10-19
ER

PT J
AU Lauto, A
   Stewart, R
   Ohebshalom, M
   Nikkoi, ND
   Felsen, D
   Poppas, DP
AF Lauto, A
   Stewart, R
   Ohebshalom, M
   Nikkoi, ND
   Felsen, D
   Poppas, DP
TI Impact of solubility on laser tissue-welding with albumin solid solders
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Article
DE solder strength; temperature control; biomaterial; mechanical properties
ID SERUM-ALBUMIN; INDUCED DENATURATION; OPTIMAL PARAMETERS; PROTEIN SOLDER;
   WOUND CLOSURE; NERVE REPAIR; STRENGTH; RECONSTRUCTION; TEMPERATURE;
   DEPENDENCE
AB Background and Objective: The correlation between the solubility of solid albumin solders and their laser weld strength was investigated.
   Study Design/Materials and Methods: Sections of dog intestine were laser welded with soluble or insoluble solid strips of solder. Two different treatments were followed for tissue soldering: "wet weld" and "dry weld." These treatments were chosen to assess the impact of solubility on the repair strength. The laser power and radiation dose were 0.14 W and 14 J/mg, respectively. Calorimetric measures of solders were also performed.
   Results: The moisture on the tissue partially dissolved the soluble strips at the tissue interface. Hence, the repair strength of the soluble solder was significantly stronger than the repair strength of the insoluble solder (0.22 N and 0.06 N, P < 0.0001). Temperature (<similar to>70 degreesC) and enthalpy variation (similar to1.4 J/g) for denaturing the soluble and insoluble solders were not significantly different (P > 0.05).
   Conclusion: The soluble solid solder behaved like dense liquid solder at the tissue interface. Hence, the interface strength of these two forms of solder should be similar. This correlation made it possible to identify an intrinsic limit for the weld strength of albumin solders. Lasers Surg. Med. 28:44-49, 2001. (C) 2001 Wiley-Liss, Inc.
C1 Cornell Univ, New York Presbyterian Hosp, Weill Med Coll,Dept Urol, Ctr Pediat Urol & Minimal Invas Urol Surg, New York, NY 10021 USA.
   ABIOMED Inc, Danvers, MA 01923 USA.
RP Lauto, A (reprint author), Mem Hosp, Dept Med Phys, 1275 York Ave, New York, NY 10021 USA.
FU NIDDK NIH HHS [R44-DK-50505]
CR BASS LS, 1992, LASER SURG MED, V12, P500, DOI 10.1002/lsm.1900120508
   BELL LN, 1995, BIOPOLYMERS, V35, P201, DOI 10.1002/bip.360350208
   Chan EK, 1998, LASER SURG MED, V23, P213
   ElyseeCollen B, 1997, BIOTECHNOL PROGR, V13, P849, DOI 10.1021/bp9700768
   Fung LC, 1999, LASER SURG MED, V25, P285, DOI 10.1002/(SICI)1096-9101(1999)25:4<285::AID-LSM3>3.0.CO;2-S
   GUMPEN S, 1979, BIOCHIM BIOPHYS ACTA, V574, P189, DOI 10.1016/0005-2760(79)90001-8
   HUA X, 1999, LASERS SURG MED S11, V258, P58
   Hummer G, 1998, P NATL ACAD SCI USA, V95, P1552, DOI 10.1073/pnas.95.4.1552
   Kirsch AJ, 1997, UROLOGY, V50, P263, DOI 10.1016/S0090-4295(97)00278-1
   KIRSCH AJ, 1995, UROLOGY, V46, P261, DOI 10.1016/S0090-4295(99)80206-4
   Lauto A, 1998, LASER SURG MED, V23, P258, DOI 10.1002/(SICI)1096-9101(1998)23:5<258::AID-LSM5>3.0.CO;2-K
   Lauto A, 1998, MICROSURG, V18, P60, DOI 10.1002/(SICI)1098-2752(1998)18:1<60::AID-MICR13>3.0.CO;2-Q
   Lauto A, 1997, LASER SURG MED, V21, P134, DOI 10.1002/(SICI)1096-9101(1997)21:2<134::AID-LSM4>3.0.CO;2-R
   Lauto A, 1998, LASER SURG MED, V22, P120, DOI 10.1002/(SICI)1096-9101(1998)22:2<120::AID-LSM8>3.0.CO;2-R
   Lauto A, 1999, LASER SURG MED, V25, P250, DOI 10.1002/(SICI)1096-9101(1999)25:3<250::AID-LSM9>3.3.CO;2-M
   LAUTO A, 1996, THESIS MACQUARIE U S
   McNally KM, 1999, LASER SURG MED, V24, P319, DOI 10.1002/(SICI)1096-9101(1999)24:5<319::AID-LSM2>3.0.CO;2-N
   MCNALLY KM, 1999, LASER MED SCI, V3, P228
   MENOVSKY T, 1994, MICROSURG, V15, P44, DOI 10.1002/micr.1920150112
   OZ MC, 1990, J VASC SURG, V11, P718, DOI 10.1067/mva.1990.18591
   Poppas DP, 1996, LASER SURG MED, V19, P360
   POPPAS DP, 1988, J UROLOGY, V139, P415, DOI 10.1016/S0022-5347(17)42446-3
   Poppas DP, 1996, LASER SURG MED, V19, P2, DOI 10.1002/(SICI)1096-9101(1996)19:1<2::AID-LSM1>3.0.CO;2-W
   POPPAS DP, 1992, J UROLOGY, V148, P220, DOI 10.1016/S0022-5347(17)36557-6
   Tanaka N, 1997, BBA-PROTEIN STRUCT M, V1338, P13, DOI 10.1016/S0167-4838(96)00175-6
NR 25
TC 14
Z9 14
U1 0
U2 2
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0196-8092
J9 LASER SURG MED
JI Lasers Surg. Med.
PY 2001
VL 28
IS 1
BP 44
EP 49
DI 10.1002/1096-9101(2001)28:1<44::AID-LSM1015>3.0.CO;2-W
PG 6
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 388WW
UT WOS:000166206900007
PM 11430442
DA 2018-10-19
ER

PT B
AU Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Hosokawa, H
   Asahina, T
   Mabuchi, M
AF Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Hosokawa, H
   Asahina, T
   Mabuchi, M
BE Zhou, Y
   Gu, YX
   Li, Z
TI Preparation of biocompatible porous titanium with high strength and
   ultra-low density
SO MECHANICS AND MATERIAL ENGINEERING FOR SCIENCE AND EXPERIMENTS
LA English
DT Proceedings Paper
CT International Symposium of Young Scholars on Mechanics and Material
   Engineering for Science and Experiments
CY AUG 11-16, 2001
CL CHANGSHA, PEOPLES R CHINA
SP Chinese Soc Theoret & Appl Mech, Youth Comm, Xiangtan Univ, Chinese Mat Res Soc Japan, Chinese Mat Res Soc Youth Comm, Natl Nat Sci Fdn China
DE Sintering; titanium; biomaterials; bone; foams; mechanical properties
ID POLYMER
AB Titanium and some of its alloys are widely used as metallic biomaterials due to their excellent mechanical properties, corrosion resistance, and biocompatibility. In the present study, highly porous titanium foam with a porosity of 80% is produced by using a novel powder metallurgical process, which includes the adding of the selected spacers into the starting powders. The porous titanium foam is characterized by image analyses, optical microscopy and scanning electron microscopy. Mechanical properties are investigated by compressive tests. These biocompatible porous titanium foams with a porosity of 80% and pore size between 200500 mum are expected to be used as biomaterial candidate for bone implants because its open-cellular structure permits the ingrowths of new-bone tissues and the transport of the body fluids.
C1 Natl Inst Adv Ind Sci & Technol, Inst Struct & Engn Mat, Kita Ku, Nagoya, Aichi 4628510, Japan.
RP Wen, CE (reprint author), Natl Inst Adv Ind Sci & Technol, Inst Struct & Engn Mat, Kita Ku, 1-1 Hirate Cho, Nagoya, Aichi 4628510, Japan.
RI Chino, Yasumasa/L-9782-2018
OI Chino, Yasumasa/0000-0002-0725-8237
CR *ASTM, 1994, F6789 ASTM
   Buchko CJ, 2001, BIOMATERIALS, V22, P1289, DOI 10.1016/S0142-9612(00)00281-7
   Cocks ACF, 2000, ACTA MATER, V48, P3395, DOI 10.1016/S1359-6454(00)00139-7
   Dowson D., 1992, BIOMECHANICS DIARTHR, V2, P305
   Gibson L. J., 1997, CELLULAR SOLIDS STRU, P1
   Gogolewski S, 2000, BIOMATERIALS, V21, P2513, DOI 10.1016/S0142-9612(00)00119-8
   Mow VC, 1991, BASIC ORTHOPAEDIC BI, P245
   NAKAYAMA Y, 1998, P 3 WORLD BIOM C KYO, P202
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
NR 10
TC 0
Z9 0
U1 0
U2 1
PU SCIENCE PRESS
PI MONMOUTH JUNCTION
PA 2031 US HIGHWAY 130 STE F, MONMOUTH JUNCTION, NJ 08852-3014 USA
BN 1-880132-79-6
PY 2001
BP 552
EP 556
PG 5
WC Materials Science, Multidisciplinary; Mechanics; Materials Science,
   Characterization & Testing
SC Materials Science; Mechanics
GA BU28J
UT WOS:000175560700129
DA 2018-10-19
ER

PT J
AU An, YHH
   McGlohorn, JB
   Bednarski, BK
   Martin, KL
   Friedman, RJ
AF An, YHH
   McGlohorn, JB
   Bednarski, BK
   Martin, KL
   Friedman, RJ
TI An open channel flow chamber for characterizing biofilm formation on
   biomaterial surfaces
SO MICROBIAL GROWTH IN BIOFILMS, PT B
SE METHODS IN ENZYMOLOGY
LA English
DT Review
ID STAPHYLOCOCCUS-EPIDERMIDIS
C1 Med Univ S Carolina, Dept Orthopaed Surg, Orthopaed Res Lab, Charleston, SC 29425 USA.
RP An, YHH (reprint author), Med Univ S Carolina, Dept Orthopaed Surg, Orthopaed Res Lab, Charleston, SC 29425 USA.
CR An YH, 1996, J HOSP INFECT, V33, P93, DOI 10.1016/S0195-6701(96)90094-8
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1990, INFECT IMMUN, V58, P2906
   Kharazmi A, 1999, METHOD ENZYMOL, V310, P207
   MCCOY WF, 1981, CAN J MICROBIOL, V27, P910, DOI 10.1139/m81-143
   PEDERSEN K, 1982, APPL ENVIRON MICROB, V43, P6
   Peyton B M, 1995, Bioprocess Technol, V20, P187
   PROSSER BL, 1987, ANTIMICROB AGENTS CH, V31, P1502, DOI 10.1128/AAC.31.10.1502
   SISSONS CH, 2000, HDB STUDYING BACTERI, P133
   TRULEAR MG, 1982, J WATER POLLUT CON F, V54, P1288
   VANPETT K, 1990, J ORTHOPAED RES, V8, P321, DOI 10.1002/jor.1100080303
   Zinn MS, 1999, METHOD ENZYMOL, V310, P224
NR 12
TC 4
Z9 4
U1 1
U2 2
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0076-6879
J9 METHOD ENZYMOL
JI Methods Enzymol.
PY 2001
VL 337
BP 79
EP 88
DI 10.1016/S0076-6879(01)37008-8
PG 10
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BS40T
UT WOS:000169760900006
PM 11398453
DA 2018-10-19
ER

PT J
AU Arciola, CR
   Donati, ME
   Montanaro, L
AF Arciola, CR
   Donati, ME
   Montanaro, L
TI Adhesion to a polymeric biomaterial affects the antibiotic resistance of
   Staphylococcus epidermidis
SO MICROBIOLOGICA
LA English
DT Article
DE bacterial adhesion; antibiotic resistance; Staphylococcus epidermidis;
   biomaterials; polymethylmethacrylate (PMMA)
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; FOREIGN-BODY INFECTIONS; SLIME
   PRODUCTION; IN-VITRO; METHICILLIN RESISTANCE; PROSTHESIS INFECTIONS;
   PHASE VARIANTS; AUREUS; ADHERENCE; SUSCEPTIBILITY
AB The antibiotic-resistance both of adherent bacteria to polymethylmethacrylate (PMMA) and of bacteria which, although exposed to the material, had not undergone adhesion, was measured as bacterial growth inhibition area onto a plate antibiogram, according to Kirby-Bauer and using a dedicated image analyzer system. The adhesion onto PMMA induces a marked (about 30%) increase in resistance to beta -lactam antibiotics (cefamandole, cefazolin, imipenem and ampicillin) and a lower (about 15%) but significant increase to the macrolide erythromycin, to two aminoglycosides (amikacin, netilmicin) and to vancomycin, chloramphenicol and trimethoprim-sulfamethoxazole.
C1 Rizzoli Orthoped Inst, Res Lab Biocompatibil Implant Mat, Bologna, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthoped Inst, Res Lab Biocompatibil Implant Mat, Bologna, Italy.
OI Donati, Maria Benedetta/0000-0003-1747-5443
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   An YH, 2000, HDB BACTERIAL ADHESI, P609
   ARCIOLA CR, 1995, BIOMATERIALS, V16, P681, DOI 10.1016/0142-9612(95)99694-H
   Arciola CR, 1998, J BIOMED MATER RES, V42, P1
   ARCIOLA CR, 1993, BIOMATERIALS, V14, P1161, DOI 10.1016/0142-9612(93)90161-T
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   ARIZONO T, 1992, ACTA ORTHOP SCAND, V63, P661
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781
   CHRISTENSEN GD, 1983, INFECT IMMUN, V40, P407
   Foster T. J., 1994, P31
   Francois P, 1996, INFECT CONT HOSP EP, V17, P514
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872
   FRERE JM, 1999, NAT BIOTECHNOL, V17, P17
   GRISTINA AG, 1989, ANTIMICROB AGENTS CH, V33, P813, DOI 10.1128/AAC.33.6.813
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Huebner J, 1999, ANNU REV MED, V50, P223
   Kelly CG, 1999, NAT BIOTECHNOL, V17, P42, DOI 10.1038/5213
   MEMPEL M, 1994, ANTIMICROB AGENTS CH, V38, P1251, DOI 10.1128/AAC.38.6.1251
   MEMPEL M, 1995, MED MICROBIOL IMMUN, V184, P109
   Montanaro L, 1999, BIOMATERIALS, V20, P1945, DOI 10.1016/S0142-9612(99)00099-X
   Montanaro L, 1999, MICROBIOLOGICA, V22, P331
   Montanaro L., 2000, HDB BACTERIAL ADHESI, P331
   *NAT COMM CLIN LAB, 1998, M2T4 NAT COMM CLIN L
   Oga M, 1992, J Long Term Eff Med Implants, V1, P321
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PRATT W B, 1990, P565
   Vaudaux PE, 1998, ANTIMICROB AGENTS CH, V42, P564, DOI 10.1128/AAC.42.3.564
   WEBB LX, 1994, J ORTHOP TRAUMA, V1, P28
   Williams I, 1997, MICROBIOL-UK, V143, P2407, DOI 10.1099/00221287-143-7-2407
NR 30
TC 2
Z9 2
U1 0
U2 2
PU LUIGI PONZIO E FIGLIO
PI PAVIA
PA VIA D DA CATALOGNA 1/3, 27100 PAVIA, ITALY
SN 1121-7138
J9 MICROBIOLOGICA
JI Microbiologica
PD JAN
PY 2001
VL 24
IS 1
BP 63
EP 68
PG 6
WC Microbiology
SC Microbiology
GA 396VL
UT WOS:000166657500008
DA 2018-10-19
ER

PT J
AU Otto, M
   Bittinger, F
   Kriegsmann, J
   Kirkpatrick, CJ
AF Otto, M
   Bittinger, F
   Kriegsmann, J
   Kirkpatrick, CJ
TI Differential adhesion of polymorphous neutrophilic granulocytes to
   macro- and microvascular endothelial cells under flow conditions
SO PATHOBIOLOGY
LA English
DT Article
DE adhesion; endothelium; macrocirculation; microcirculation
ID PHENOTYPIC HETEROGENEITY; VASCULAR TUMORS; HUMAN PULMONARY; DYSFUNCTION;
   EXPRESSION; CULTURE; ISCHEMIA; SELECTIN; BLOOD
AB Objective: As one of the important active barriers in the human organism, endothelial cells (EC) play a central role in the biological reaction to a variety of stimuli, e.g. during the induction and regulation of inflammation, as well as in the reaction to transplantation and biomaterial implantation. In the study of endothelial function, the most widely used in vitro model is that of human umbilical vein EC (HUVEC), i.e. an EC type of embryonic and macrovascular origin. However, many of the important pathological processes occur at microvascular level, thus questioning the validity of the HUVEC model. Moreover, the morphological and functional heterogeneity of the endothelium in the various organs, e.g. kidney, liver and lung, must be taken into consideration. The purpose of the present study was to use a dynamic cell culture system to compare the reactions of HUVEC and human pulmonary microvascular EC (HPMEC) to pro-inflammatory stimulation. Methods: HUVEC and HPMEC in monolayer culture were stimulated by tumor necrosis factor-alpha (TNFalpha) in a parallel-plate flow chamber. Short-(4 h) and long-term (12 h) stimulation were compared. As a functional parameter, the adhesion of human peripheral blood polymorphonuclear granulocytes (PMN) to EC was quantitated both under venous and arterial flow conditions. Results: Short-term (4 h) TNFalpha stimulation and venous flow conditions elicited a 32% higher PMN adhesion to HPMEC compared with HUVEC, whereas under arterial flow conditions no statistically significant differences were found. Following longer-term (12 h) TNFa stimulation, PMN adhesion to HPMEC was 65% higher than to HUVEC under venous flow. Under arterial flow no differences were detected. Conclusion: The present results provide new data on the heterogeneity of the endothelium and affect a central element in microvascular pathology, namely granulocyte-endothelial interactions. Moreover, this paper emphasizes the necessity to evaluate the in vitro models of the endothelium with respect to the extrapolation to the situation in vivo. Copyright (C) 2002 S. Karger AG, Basel.
C1 Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
RP Otto, M (reprint author), Univ Mainz, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
CR Balazs M, 1999, HYBRIDOMA, V18, P177, DOI 10.1089/hyb.1999.18.177
   Beck GC, 1999, CLIN EXP IMMUNOL, V118, P298
   Bittinger F, 1997, EXP CELL RES, V236, P155, DOI 10.1006/excr.1997.3724
   Bratt J, 2000, CLIN EXP IMMUNOL, V120, P79, DOI 10.1046/j.1365-2249.2000.01190.x
   Brouland JP, 1999, ENDOTHELIUM-NEW YORK, V6, P251, DOI 10.3109/10623329909053415
   Dye JF, 2001, PLACENTA, V22, P32, DOI 10.1053/plac.2000.0579
   Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193
   Girard JP, 1999, AM J PATHOL, V155, P2043, DOI 10.1016/S0002-9440(10)65523-X
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   Grau GE, 1997, THROMB HAEMOSTASIS, V77, P585
   HIRAFUJI M, 1991, BRIT J PHARMACOL, V103, P1333, DOI 10.1111/j.1476-5381.1991.tb09789.x
   Horstick G, 1999, AM J PHYSIOL-HEART C, V276, pH472, DOI 10.1152/ajpheart.1999.276.2.H472
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   KIRKPATRICK CJ, 1995, CONTRIB NEPHROL, V116, P1
   Kirkpatrick CJ, 1999, J MATER SCI-MATER M, V10, P589, DOI 10.1023/A:1008946615663
   Kirkpatrick CJ, 1997, INT J MICROCIRC, V17, P231, DOI 10.1159/000179235
   KLEIN CL, 1995, PATHOBIOLOGY, V63, P83, DOI 10.1159/000163938
   Korthuis RJ, 1997, INT J MICROCIRC, V17, P11, DOI 10.1159/000179261
   KUZU I, 1993, LAB INVEST, V69, P322
   KUZU I, 1992, J CLIN PATHOL, V45, P143, DOI 10.1136/jcp.45.2.143
   Lehr HA, 2000, J PATHOL, V190, P373
   Mason JC, 1997, AM J PHYSIOL-CELL PH, V273, pC1233
   MAUGERI N, 1994, THROMB HAEMOSTASIS, V72, P450
   Ohmi K, 1998, BIOCHEM BIOPH RES CO, V251, P137, DOI 10.1006/bbrc.1998.9417
   Otto M, 1997, J MATER SCI-MATER M, V8, P119, DOI 10.1023/A:1018515001850
   Ramamoorthy C, 1996, AM J PHYSIOL-HEART C, V271, pH1871
   RINDER HM, 1991, BLOOD, V78, P1730
   Salcedo R, 2000, FASEB J, V14, P2055, DOI 10.1096/fj.99-0963com
   SCOTT PAE, 1993, J CELL SCI, V105, P269
   Takahashi K, 1998, AM J PHYSIOL-LUNG C, V275, pL47, DOI 10.1152/ajplung.1998.275.1.L47
   Thorin E, 1998, PHARMACOL THERAPEUT, V78, P155, DOI 10.1016/S0163-7258(98)00005-9
   Winn RK, 1997, ANN NY ACAD SCI, V832, P311, DOI 10.1111/j.1749-6632.1997.tb46259.x
   YAMAMOTO M, 1988, VIRCHOWS ARCH A, V412, P479, DOI 10.1007/BF00750582
NR 34
TC 18
Z9 19
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-2008
J9 PATHOBIOLOGY
JI Pathobiology
PY 2001
VL 69
IS 3
BP 159
EP 171
DI 10.1159/000048771
PG 13
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA 530GC
UT WOS:000174349100007
PM 11872962
DA 2018-10-19
ER

PT J
AU Gourlay, T
AF Gourlay, T
TI Biomaterial development for cardiopulmonary bypass
SO PERFUSION-UK
LA English
DT Article
ID OPEN-HEART-SURGERY; CYTOKINE LEVELS; APROTININ; PHTHALATE
AB Cardiopulmonary bypass (CPB) is dependent on materials foreign to the patient for its successful application. When blood comes into contact with these so-called biomaterials, an inappropriate inflammatory response, which can be life-threatening in some patients, may develop. The reason for this inappropriate activation of host defence mechanisms is not entirely clear, however a number of strategies have evolved over the years to minimize this unwanted sequelae of CPB. These strategies include surface coating of the materials of the circuit, using new materials thought to improve biocompatibility, and using a number of pharmacological interventions designed to suppress the inflammatory response. Recently, there has been some evidence which indicates that the plasticizer employed in the polyvinyl chloride (PVC) tubing of the CPB circuit may play a part in the development of the inflammatory response. The work described in this paper tends to support this thesis. These studies showed that by washing the plasticizer from the surface of the PVC tubing, the biocompatibility, as reflected in the upregulation of CID11b on the surface of neutrophils, was enhanced. Furthermore, the use of non-plasticized substitutes for PVC had a similar effect. The benefit from removing the plasticizer was similar to that gained from surface coating with heparin, one of the conventional approaches to reducing the inflammatory response to CPB.
C1 Univ London Imperial Coll Sci Technol & Med, Sch Med, Natl Heart & Lung Inst, London W12 0NN, England.
RP Gourlay, T (reprint author), Univ London Imperial Coll Sci Technol & Med, Sch Med, Natl Heart & Lung Inst, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.
CR Alonso A, 1999, ANN THORAC SURG, V67, P392, DOI 10.1016/S0003-4975(98)01132-1
   Asimakopoulos G, 1998, ANN THORAC SURG, V66, P2135, DOI 10.1016/S0003-4975(98)00727-9
   Brancaccio G, 2000, ANN THORAC SURG, V70, P990, DOI 10.1016/S0003-4975(00)01662-3
   Bronicki RA, 2000, ANN THORAC SURG, V69, P1490, DOI 10.1016/S0003-4975(00)01082-1
   Castrillo Azucena, 1999, Sangre (Saragossa), V44, P315
   COURTNEY JM, 1993, IMMOBILISED MACROMOL, P175
   Darling E, 1998, J Extra Corpor Technol, V30, P184
   De Somer F, 2000, EUR J CARDIO-THORAC, V18, P602, DOI 10.1016/S1010-7940(00)00508-X
   Eising GP, 2000, THORAC CARDIOV SURG, V48, P86
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6
   GOTT VL, 1964, T AM SOC ART INT ORG, V10, P213
   GOURLAY T, 2001, IN PRESS INT J ARTIF
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350
   Grunenfelder J, 2000, EUR J CARDIO-THORAC, V17, P77, DOI 10.1016/S1010-7940(99)00355-3
   GU YJ, 1994, ANN THORAC SURG, V58, P1790
   KLINKMANN H, 1986, CONTRIB NEPHROL, V26, pS9
   Kostelijk EH, 2000, TRANSFUSION MED, V10, P131
   Lakshmi S, 1998, ARTIF ORGANS, V22, P222, DOI 10.1046/j.1525-1594.1998.06124.x
   Olsson C, 2000, SCAND CARDIOVASC J, V34, P33
   Peters DC, 1999, DRUGS, V57, P233, DOI 10.2165/00003495-199957020-00015
   Stewart M, 1999, Am Nurse, V31, P12
   Taketani S, 1998, ARTIF ORGANS, V22, P337, DOI 10.1046/j.1525-1594.1998.06007.x
   Tassani P, 2000, J CLIN ANESTH, V12, P242, DOI 10.1016/S0952-8180(00)00143-4
   Tassani P, 1999, J CARDIOTHOR VASC AN, V13, P165, DOI 10.1016/S1053-0770(99)90081-2
   Tatsumi E, 2000, ARTIF ORGANS, V24, P108, DOI 10.1046/j.1525-1594.2000.06332.x
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.3.CO;2-H
   TSUJI K, 1984, EISEI SHIKENJO HOKOK, V102, P43
   Wilkinson CF, 1999, REGUL TOXICOL PHARM, V30, P140, DOI 10.1006/rtph.1999.1338
   Yii M, 1996, PERFUSION-UK, V11, P229, DOI 10.1177/026765919601100308
   Yilmaz M, 1999, PERFUSION-UK, V14, P201, DOI 10.1177/026765919901400308
   ZHAO X, ARTIF ORGANS, V23, P104
NR 31
TC 22
Z9 24
U1 1
U2 2
PU ARNOLD, HODDER HEADLINE PLC
PI LONDON
PA 338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND
SN 0267-6591
J9 PERFUSION-UK
JI Perfusion-UK
PY 2001
VL 16
IS 5
BP 381
EP 390
DI 10.1177/026765910101600508
PG 10
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 471BB
UT WOS:000170906000007
PM 11565893
DA 2018-10-19
ER

PT J
AU Pascoal, A
   Teixeira, N
   Alves, E
AF Pascoal, A
   Teixeira, N
   Alves, E
TI Influence of radiotherapy treatments in head and neck oncological
   patients with biomaterial prostheses
SO PHYSICA MEDICA
LA English
DT Article; Proceedings Paper
CT Topical Meeting on Medical Radiation Physics and Engineering (TM-MeRPE)
CY NOV 20-22, 2000
CL LISBON, PORTUGAL
DE biomaterials; prosthesis; dosimetry; TLD
ID HIP PROSTHESES
AB Biomaterials used for implants in biological tissue has suffered tremendous development in the last decade. Materials such as stainless-steel, titanium and vitalium alloys have been the used more frequently, particularly in maxillo-facial implants for head & neck oncological patients.
   When radiotherapy treatments are recommended, two factors must be taken into consideration, in the treatment protocol: beam attenuation and scattering in the prosthesis material.
   In most cases the target volume for irradiation is an heterogeneous medium with soft biological tissue and metallic biomaterial. Although some work has been done in this filed, the influence of the prostheses during the irradiation process is still an open question.
   The main goal of this study is to develop some experimental work in order to understand, and quantify the influence of attenuation of radiation beam and scattering effects, in the dose delivered to the target volume and surrounding tissues. From the experimental data analysis, conclusions about benefits and risks that arise during radiotherapy treatments in those conditions are drawn.
   The first part of this study involved the characterization of the implant composition, using nuclear techniques. Afterwards, dosimetric studies were performed in an acrylic phantom in order to evaluate the perturbation caused by the prosthesis in the dose distribution in the target tissues surrounding the implant.
C1 Inst Portugues Oncol Francisco Gentil, Dept Radioterapia, Lisbon, Portugal.
   EST&ST, Escola Super Technol Saude, Lisbon, Portugal.
   Inst Tecnol & Nucl, Sacavem, Portugal.
RI Alves, Eduardo/K-2481-2013
OI Alves, Eduardo/0000-0003-0633-8937
CR *AAPM, 83 AAPM
   ALVES E, 1992, THESIS FCUL
   ALVES JHG, 1999, THESIS FCT UNL
   Attix F.H., 1968, RAD DOSIMETRY, VI-III
   ATTIX FH, 1968, RAD DOSIMETRY, V3
   ATTIX FH, 1968, RAD DOSIMETRY, V2
   DASILVA JMG, 1991, C NACL RAD
   DOOLITTLE LR, 1985, NUCL INSTRUM METH B, V9, P344, DOI 10.1016/0168-583X(85)90762-1
   Feldman LE, 1986, FUNDAMENTALS SURFACE
   GREENING JR, 1981, MED PHYSICS HDB, V6
   HAROLD EJ, 1983, PHYSICS RADIOLOGY
   HAZUKA BM, 1993, INT J RADIAT ONCOL, V25, P339
   HAZUKA MB, 1988, INT J RADIAT ONCOL, V14, P1311, DOI 10.1016/0360-3016(88)90412-9
   HOROWITZ YS, 1984, THERMOLUMINESCENCE
   HUDSON FR, 1984, BRIT J RADIOL, V57, P603, DOI 10.1259/0007-1285-57-679-603
   *ICRU, 1998, 60 ICRU
   *INT AT EN AG, 1987, INT AT EN AG TECHN R, V277
   Karzmark C. J., 1993, MED ELECT ACCELERATO
   KHAN FM, 1984, PHYSICS RAD THERAPY
   Kron T, 1996, RADIOTHER ONCOL, V41, P119, DOI 10.1016/S0167-8140(96)01795-1
   OBERHOFER M, 1979, LECT COURS HELD JOIN
   PATTERSON HW, 1973, ALLELERATOR HLTH PHY
   Regulla DF, 1998, RADIAT RES, V150, P92, DOI 10.2307/3579649
   REIS MA, 1992, NUCL INSTRUM METH B, V68, P300, DOI 10.1016/0168-583X(92)96098-J
   SIBATA CH, 1990, INT J RADIAT ONCOL, V18, P455, DOI 10.1016/0360-3016(90)90115-Z
   *SOC ESP FIS MED, 1984, PROC DOS FOT EL EN C
   Spiewak R, 1993, Pol Tyg Lek, V48, P651
   STANLEY M, 1962, PARTICLE ACCELERATOR
   TEIXEIRA N, 2001, THESIS
   TEIXEIRA N, 1986, THESIS
   TEIXEIRA N, 2000, ACTA RADIOLOGICA POR, V47
   TSIPENYUK YM, 1997, NUCL METHODS SCI TEC
   VANESPEN P, 1986, XRAY ANAL SOFTWARE U
   Wei-Kan Chu., 1978, BACKSCATTERING SPECT
   Ziegler J. F., 1985, STOPPING RANGE IONS
   1996, BRIT J RADIOLOGY S, V25
   1987, P CEC COURS MADR SET
NR 37
TC 0
Z9 0
U1 0
U2 2
PU ISTITUTI EDITORIALI E POLGRAFICI INTERNAZIONALI
PI PISA
PA CASELLA POSTALE N 1, SUCCURSALE N 8, 56123 PISA, ITALY
SN 1120-1797
J9 PHYS MEDICA
JI Phys. Medica
PY 2001
VL 17
SU 4
BP 26
EP 29
PG 4
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 537HZ
UT WOS:000174754000010
DA 2018-10-19
ER

PT B
AU Nakaoka, R
   Tsuchiya, T
AF Nakaoka, R
   Tsuchiya, T
BE Hanada, S
   Zhong, Z
   Nam, SW
   Wright, RN
TI Studies on the biocompatibility of biomaterials: Effect of various types
   of biomaterial microspheres
SO PRICM 4: FORTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, VOLS I AND II
LA English
DT Proceedings Paper
CT 4th Pacific Rim International Conference on Advanced Materials and
   Processing (PRICM4)
CY DEC 11-15, 2001
CL HONOLULU, HI
SP Japan Inst Met, Chinese Soc Met, Korean Inst Met & Mat, Minerals, Met & Mat Soc, Iketani Sci & Technol Fdn, USN, Off Naval Res Int Field Off, Asian Off Aerosp Res & Dev, USA Res Off Far E
DE gap junctional intercellular communication (GJIC); wear debris;
   biomaterial microspheres; cell function
ID GAP-JUNCTIONAL COMMUNICATION; TUMOR-PROMOTING ACTIVITY; METABOLIC
   COOPERATION; IN-VITRO; CELLS; POLYETHYLENE; COLLAGEN; PRODUCTS; SIZE
AB Gap junctional intercellular communication (GJIC) is a function that plays an important role in maintaining cell and tissue homeostasis and in regulating cell growth and differentiation. In this study, change in this GJIC function of cells contacting with various microspheres prepared from biomaterials was estimated using different methods. It was observed that microspheres pre-coated before test cell adhesion inhibited the function more than those added after cell adhesion. In addition, the inhibition levels were affected by amounts, diameter, composition and time period of interaction of microspheres as well as cell type used in the study. These findings suggest that not only the way for cells to recognize the microspheres but also characteristics of the microspheres are important factors affecting the GJIC function. Interaction of microspheres with osteoblasts resulted in inhibition of their differentiation, indicating microspheres are probable to disturb both cell differentiation and the GJIC function of the cells. These findings suggest the possibility that GJIC function can be used as an index that gives information of biocompatibility of many kinds of materials even in the forms of particles.
C1 Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo 1588501, Japan.
RP Nakaoka, R (reprint author), Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.
CR Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9
   Lecanda F, 1998, MOL BIOL CELL, V9, P2249, DOI 10.1091/mbc.9.8.2249
   Nakaoka R, 1997, J BIOMED MATER RES, V35, P391, DOI 10.1002/(SICI)1097-4636(19970605)35:3<391::AID-JBM13>3.0.CO;2-I
   NAKAOKA R, UNPUB J BIOMED MAT R
   SAWADA MS, 1997, J BONE MINER RES, V12, P1165
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   TAKAI H, 2000, J BIOMED MATER RES, V52, P382
   Trindade MCD, 2000, J BIOMED MATER RES, V51, P360, DOI 10.1002/1097-4636(20000905)51:3<360::AID-JBM9>3.0.CO;2-E
   TSUCHIYA T, 1995, J BIOMED MATER RES, V29, P113, DOI 10.1002/jbm.820290116
   Tsuchiya T, 2000, J BIOMAT SCI-POLYM E, V11, P947, DOI 10.1163/156856200744129
   Vermes C, 2000, J BONE MINER RES, V15, P1756, DOI 10.1359/jbmr.2000.15.9.1756
   WADE MH, 1986, SCIENCE, V232, P525, DOI 10.1126/science.3961495
   Wang W, 1997, J PATHOL, V182, P92
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   Yamasaki H, 1996, MUTAT RES-REV GENET, V365, P91, DOI 10.1016/S0165-1110(96)90014-7
   YOTTI LP, 1979, SCIENCE, V206, P1089, DOI 10.1126/science.493994
NR 16
TC 0
Z9 0
U1 0
U2 0
PU JAPAN INST METALS
PI SENDAI
PA AOBA ARAMAKI, SENDAI, 980, JAPAN
BN 4-88903-404-8
PY 2001
BP 189
EP 191
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BV26R
UT WOS:000178391600047
DA 2018-10-19
ER

PT B
AU Nishimura, E
   Okazaki, Y
AF Nishimura, E
   Okazaki, Y
BE Hanada, S
   Zhong, Z
   Nam, SW
   Wright, RN
TI Corrosion fatigue properties of Implantable alloy in medium solution
SO PRICM 4: FORTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, VOLS I AND II
LA English
DT Proceedings Paper
CT 4th Pacific Rim International Conference on Advanced Materials and
   Processing (PRICM4)
CY DEC 11-15, 2001
CL HONOLULU, HI
SP Japan Inst Met, Chinese Soc Met, Korean Inst Met & Mat, Minerals, Met & Mat Soc, Iketani Sci & Technol Fdn, USN, Off Naval Res Int Field Off, Asian Off Aerosp Res & Dev, USA Res Off Far E
DE metallic biomaterial; mechanical property; heat treatment; S-N curve;
   sine wave; human hip joint load profile; corrosion-fatigue strength
ID MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; ELEMENTS
AB Corrosion fatigue properties of SUS 316L stainless steel, Co-Cr-Mo casting alloy and Ti alloys with sine wave loading in Eagle's medium solution were compared. The number of cycles to failure for SUS 316L stainless steel and Co-Cr-Mo casting alloy increased as maximum stress was decreased. The fatigue strength of SUS 316L stainless steel and Co-Cr-Mo casting alloy at the 10(7)th cycle was much lower than that of Ti alloys. The fatigue strength of Ti-6Al-2Nb-1Ta alloy without V at the 10(8)th cycle was approximately 750 MPa. The fatigue strengths of new Ti-15Zr-4Ta-4Nb alloys annealed at 700degreesC for 2 h at 108 cycles were about 600 MPa. The effect of the frequency on the fatigue strength at 2 Hz and 10 Hz was almost similar. The addition of 0.2%O and 0.05%N to the new Ti-15Zr-4Nb-4Ta alloy and aging treatment after solution treating increased the ultimate tensile strength to 1000 MPa. The total elongation and reduction of area were 15% and 50%, respectively. The fatigue strength of the new Ti alloy which was aged after solution treating under a sine wave loading of 10 Hz at 10(8) cycles was 900 MPa. Moreover, the fatigue strengths between the sine wave loading and human hip joint load profile loading estimated by an analysis of forces and actions of the human hip joint were almost the same for the new Ti alloy.
C1 Independent Adm Inst, Natl Inst Technol & Evaluat, Japanese Ind Stand Ctr, Tsukuba, Ibaraki 3050044, Japan.
RP Nishimura, E (reprint author), Independent Adm Inst, Natl Inst Technol & Evaluat, Japanese Ind Stand Ctr, 2,Namiki 1 Chome, Tsukuba, Ibaraki 3050044, Japan.
CR IDO K, 1993, ACTA ORTHOP SCAND, V64, P607, DOI 10.3109/17453679308994582
   ITO A, 1993, J BIOMEDICAL MAT RES, V34, P1217
   Matsuda Y., 1997, J ORTHOP SCI, V2, P166
   Mejia Lito C., 1994, Bio-Medical Materials and Engineering, V4, P259
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Okazaki Y, 1997, MATER T JIM, V38, P78, DOI 10.2320/matertrans1989.38.78
   OKAZAKI Y, 1993, MATER T JIM, V34, P1217, DOI 10.2320/matertrans1989.34.1217
   OKAZAKI Y, 2000, MATER T JIM, V41, P344
   OKAZAKI Y, 1996, ASTM STP, V1272, P45
   Yamamuro T, 1999, JOINT ARTHROPLASTY, P213
NR 10
TC 0
Z9 0
U1 0
U2 2
PU JAPAN INST METALS
PI SENDAI
PA AOBA ARAMAKI, SENDAI, 980, JAPAN
BN 4-88903-404-8
PY 2001
BP 193
EP 196
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BV26R
UT WOS:000178391600048
DA 2018-10-19
ER

PT B
AU Kuwahara, M
   Mazaki, N
   Aizawa, T
AF Kuwahara, M
   Mazaki, N
   Aizawa, T
BE Hanada, S
   Zhong, Z
   Nam, SW
   Wright, RN
TI Formation of magnesium apatite in Hank's solution and friction behavior
   of magnesium
SO PRICM 4: FORTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, VOLS I AND II
LA English
DT Proceedings Paper
CT 4th Pacific Rim International Conference on Advanced Materials and
   Processing (PRICM4)
CY DEC 11-15, 2001
CL HONOLULU, HI
SP Japan Inst Met, Chinese Soc Met, Korean Inst Met & Mat, Minerals, Met & Mat Soc, Iketani Sci & Technol Fdn, USN, Off Naval Res Int Field Off, Asian Off Aerosp Res & Dev, USA Res Off Far E
DE magnesium; magnesium apatite; friction; artificial bone; Hank solution
AB The study has been carried out to examine a possibility of magnesium as a biomaterial, since magnesium is all essential element in our body, its biomaterial. To be noticed. magnesium is an essential element in out body and it has high specific strength, and easy shape forming. Especially an essential element of magnesium has surely good biocompatibility and high specific strength of magnesium, should make promise to supply a light artificial bone or tooth Then chemical reaction of magnesium, magnesium alloys, and surface modified magnesium during dipping in Hank's solution was examined. Furthermore, fictional wear behavior of magnesium and surface modified magnesium was also examined A kind of magnesium apatite, which can be written as (Ca0.9Mg0.1)(10)(PO4)(6)(OH)(2) was precipitated on the surface modified magnesium surface. And dynamic frictional coefficient without lubricant was measured as around 0.15 under a compressive stress of 0.4 MPa. Those facts indicate that magnesium has an available possibility of artificial bone material.
C1 Res Inst Appl Sci, Kyoto 6068202, Japan.
RP Kuwahara, M (reprint author), Res Inst Appl Sci, Kyoto 6068202, Japan.
CR KUROKAWA M, 1994, J JPN PLASTIC RECONS, V16, P75
   KUROKAWA M, 1994, J JPN PLASTIC RECONS, V14, P238
   Kuwahara H, 2000, MATER SCI FORUM, V350-3, P349, DOI 10.4028/www.scientific.net/MSF.350-351.349
   KUWAHARA H, 2001, UNPUB MAT T
   OKAZAKI M, 1992, CHEM APATITE CONSTRU, P10
   SUDA T, 1993, SCI BONE, P121
   TAKAYA M, 1998, LIGHT MET, V48, P352
NR 7
TC 0
Z9 0
U1 0
U2 0
PU JAPAN INST METALS
PI SENDAI
PA AOBA ARAMAKI, SENDAI, 980, JAPAN
BN 4-88903-404-8
PY 2001
BP 233
EP 236
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BV26R
UT WOS:000178391600058
DA 2018-10-19
ER

PT B
AU Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Asahina, T
   Mabuchi, M
AF Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Asahina, T
   Mabuchi, M
BE Hanada, S
   Zhong, Z
   Nam, SW
   Wright, RN
TI Processing and mechanical properties of Biocompatible cancellous
   titanium
SO PRICM 4: FORTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, VOLS I AND II
LA English
DT Proceedings Paper
CT 4th Pacific Rim International Conference on Advanced Materials and
   Processing (PRICM4)
CY DEC 11-15, 2001
CL HONOLULU, HI
SP Japan Inst Met, Chinese Soc Met, Korean Inst Met & Mat, Minerals, Met & Mat Soc, Iketani Sci & Technol Fdn, USN, Off Naval Res Int Field Off, Asian Off Aerosp Res & Dev, USA Res Off Far E
DE sintering; titanium; biomaterials; bone; foams; mechanical properties
ID PORE-SIZE; CYTOCOMPATIBILITY; IMPLANTS; ALLOYS; FOAMS; METAL
AB Pure titanium and some of its alloys are currently considered as the most attractive metallic materials for biomedical applications due to their excellent mechanical properties, corrosion resistance, and biocompatibility. It has been demonstrated that titanium and some titanium-based alloys are well accepted by human tissues as compared to other metals such as SUS316L stainless steel and Co-Cr-Mo type alloys. Furthermore, open-cellular metallic foams with a pore size of 200-500 mu m are acknowledged as very promising biomaterial candidates for bone implants because its open-cellular structure permits the ingrowths of new-bone tissues and the transport, of body fluids. In the present study, highly porous titanium foams with a porosity of 80% are produced by using a novel powder metallurgical process, which includes the adding of the selected spacers into the starting powders. The porous titanium foams are characterized by using optical microscopy and scanning electron microscopy. Mechanical properties are investigated by compressive tests. These biocompatible porous titanium foams are expected to be used as implants for medical applications due to its porous structure permits the ingrowths of the new-bone tissues and the transport of the body fluids.
C1 Natl Inst Adv Ind Sci & Technol Chubu, Inst Struct & Engn Mat, Kita Ku, Nagoya, Aichi 4628510, Japan.
RP Wen, CE (reprint author), Natl Inst Adv Ind Sci & Technol Chubu, Inst Struct & Engn Mat, Kita Ku, Hirate Cho, Nagoya, Aichi 4628510, Japan.
RI Chino, Yasumasa/L-9782-2018
OI Chino, Yasumasa/0000-0002-0725-8237
CR ARDILL J, 1995, THESIS QUEENS U BELF
   *ASTM, 1994, F6789 ASTM
   *ASTM, 1994, F13682 ASTM
   BANHART J, 1998, P 1998 POWD MET WORL, P201
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   DAVIES GJ, 1983, J MATER SCI, V18, P1899, DOI 10.1007/BF00554981
   Dowson D., 1992, BIOMECHANICS DIARTHR, V2, P305
   Gibson L. J., 1997, CELLULAR SOLIDS STRU, P1
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Maine E, 2000, ADV ENG MATER, V2, P205, DOI 10.1002/(SICI)1527-2648(200004)2:4<205::AID-ADEM205>3.0.CO;2-J
   NAKAMURA Y, 1998, 3 WORLD BIOM C KYOT, P202
   Niinomi M, 2000, INT J FATIGUE, V22, P887, DOI 10.1016/S0142-1123(00)00058-X
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Pineda LM, 1996, J BIOMED MATER RES, V31, P385
   SCHUMACHER HR, 1988, PRIMER RHEUMATIC DIS
   Steinemann S., 1980, EVALUATION BIOMATERI
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Yamada Y, 1999, J MATER SCI LETT, V18, P1477, DOI 10.1023/A:1006677930532
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 20
TC 0
Z9 0
U1 0
U2 0
PU JAPAN INST METALS
PI SENDAI
PA AOBA ARAMAKI, SENDAI, 980, JAPAN
BN 4-88903-404-8
PY 2001
BP 247
EP 250
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BV26R
UT WOS:000178391600062
DA 2018-10-19
ER

PT B
AU Koganemaru, M
   Okazaki, Y
   Nishimura, E
   Nishida, S
   Nakano, K
   Tamasaki, H
   Yanagida, Y
AF Koganemaru, M
   Okazaki, Y
   Nishimura, E
   Nishida, S
   Nakano, K
   Tamasaki, H
   Yanagida, Y
BE Hanada, S
   Zhong, Z
   Nam, SW
   Wright, RN
TI Corrosion resistance and cytocompatibility of W short fiber reinforced
   Ti-6Al-4V alloy
SO PRICM 4: FORTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, VOLS I AND II
LA English
DT Proceedings Paper
CT 4th Pacific Rim International Conference on Advanced Materials and
   Processing (PRICM4)
CY DEC 11-15, 2001
CL HONOLULU, HI
SP Japan Inst Met, Chinese Soc Met, Korean Inst Met & Mat, Minerals, Met & Mat Soc, Iketani Sci & Technol Fdn, USN, Off Naval Res Int Field Off, Asian Off Aerosp Res & Dev, USA Res Off Far E
DE corrosion resistance; cytocompatibility; Ti-6Al-4V alloy; metal matrix
   composite (MMC); hot isostatic pressing (HIP); tungsten short fiber
ID TI; AL
AB The new metal matrix composite which is reinforced Ti-6Al-4V alloy with tungsten short fiber was developed. This composite material was made by powder metallurgy. The composite material has the high tensile strength characteristics and the high biocompatibility matrix. Especially the tensile strength of this composite material is very high with about 1300MPa. This is more excellent than the existing biomaterial of the titanium base. Then, the fundamental biocompatibility of this composite material was evaluated to obtain information of whether it can be applicable as a biomaterial. The corrosion resistance of this composite material was evaluated by anodic polarization test in Eagle's minimum essential medium and 1 mass% lactic acid. The current density of entering the passive region of the composite material was higher than that of the Ti-6Al-4V alloy for matrix. But the passive region of the composite material was retained to the potential region of about 2 V, and this retained potential is enough high as compared to die potential in vivo.
C1 Fukuoka Ind Technol Ctr, Mech & Elect Res Inst, Yahatanishi Ku, Fukuoka 8070831, Japan.
RP Koganemaru, M (reprint author), Fukuoka Ind Technol Ctr, Mech & Elect Res Inst, Yahatanishi Ku, 3-6-1 Norimatsu, Fukuoka 8070831, Japan.
CR HAYASHI T, 1988, COMPOSITE MAT ENG, P3
   NISIDA S, 2000, KEY ENG MATER, P1243
   Okazaki Y, 1996, J JPN I MET, V60, P890, DOI 10.2320/jinstmet1952.60.9_890
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
NR 4
TC 0
Z9 0
U1 0
U2 2
PU JAPAN INST METALS
PI SENDAI
PA AOBA ARAMAKI, SENDAI, 980, JAPAN
BN 4-88903-404-8
PY 2001
BP 251
EP 254
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BV26R
UT WOS:000178391600063
DA 2018-10-19
ER

PT B
AU Miura, E
   Watanabe, I
   Hisatsune, K
   Hanada, S
AF Miura, E
   Watanabe, I
   Hisatsune, K
   Hanada, S
BE Hanada, S
   Zhong, Z
   Nam, SW
   Wright, RN
TI Interfacial microstructure of infrared jointed Ti-6Al-7Nb alloy with
   Ti-15Cu-25Ni solder
SO PRICM 4: FORTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, VOLS I AND II
LA English
DT Proceedings Paper
CT 4th Pacific Rim International Conference on Advanced Materials and
   Processing (PRICM4)
CY DEC 11-15, 2001
CL HONOLULU, HI
SP Japan Inst Met, Chinese Soc Met, Korean Inst Met & Mat, Minerals, Met & Mat Soc, Iketani Sci & Technol Fdn, USN, Off Naval Res Int Field Off, Asian Off Aerosp Res & Dev, USA Res Off Far E
DE Ti-Al-Nb alloy; biomaterial infrared-joining; Ti-Cu-Ni alloy; solder
   thickness; microstructure; SEM-EDX; tensile properties; Vickers hardness
AB Microstructure, hardness and tensile strength of Ti-6Al-7Nb alloy infrared joined with Ti-15Cu-25Ni alloy solder were investigated. Effect of the solder thickness on them also studied. We studied 0.6 mmphi wire and 0.1 mmt foil which was rolled from wire. The solder consists of wire drawn pure Ti with Ni-Cu alloy coating. Differential scanning calorimetry result indicates reaction between Ti and Ni-Cu occur at approximately 1100 K, and melting point was 1716 K. In scanning electron microscopic (SEM) observation and energy dispersive spectroscopic analysis of the brazed samples, different solidification structure was obtained with different solder thickness. All the samples brazed with wire showed dendritic structure and obvious reaction layer between base metal and solder. When brazing was carried out using the foil, Cu and Ni diffused into the base metal. These results suggest that the infrared joining changed composition of the solder. Joint tensile strength of the specimen brazed with wire is not much different with that of that with foil. There were two types of fracture, that is, fracture between interfaces and at solder inside. In addition, the joint strength of the former was higher than the latter. The dependence of the joint strength on the solder thickness was small. SEM observation suggests that dendritic structure at the interface play a role in composite strengthening (fiber reinforcing).
C1 Nagasaki Univ, Sch Dent, Nagasaki 8528588, Japan.
RP Miura, E (reprint author), Nagasaki Univ, Sch Dent, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.
OI Miura-Fujiwara, Eri/0000-0002-7672-3534
CR *ED COMM BRAZ HDB, 1967, BRAZ HDB, P395
   NIIYA M, 1998, MAT JAPAN, V37, P843
   OKAZAKI Y, 1998, J JPN I MET, V37, P838
   OKAZAKI Y, 1998, MAT JAPAN, V37, P819
   Okazaki Y., 1997, MAT JAPAN, V36, P1092
   TAKESHITA K, 1993, J JPN I MET, V57, P1339, DOI 10.2320/jinstmet1952.57.11_1339
   YABUUE M, 1988, DENT USE TI, P123
NR 7
TC 1
Z9 1
U1 0
U2 0
PU JAPAN INST METALS
PI SENDAI
PA AOBA ARAMAKI, SENDAI, 980, JAPAN
BN 4-88903-404-8
PY 2001
BP 261
EP 264
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BV26R
UT WOS:000178391600066
DA 2018-10-19
ER

PT B
AU Pum, D
   Gyorvary, E
   Schuster, B
   Sara, M
   Sleytr, UB
AF Pum, D
   Gyorvary, E
   Schuster, B
   Sara, M
   Sleytr, UB
BE Dini, L
   Catalano, M
TI S-layers: A versatile biomaterial in nanotechnology
SO PROCEEDINGS OF THE 5TH MULTINATIONAL CONGRESS ON ELECTRON MICROSCOPY
LA English
DT Proceedings Paper
CT 5th Multinational Congress on Electron Microscopy
CY SEP 20-25, 2001
CL LECCE, ITALY
ID AIR-WATER-INTERFACE; IMMOBILIZATION MATRIX; PROTEIN CRYSTALS; LIPID
   FILMS; MICROPARTICLES; MACROMOLECULES; IMMUNOASSAYS; LIPOSOMES; BILAYER
C1 Univ Bodenkultur Wien, Ctr Ultrastruct Res, A-1180 Vienna, Austria.
RP Pum, D (reprint author), Univ Bodenkultur Wien, Ctr Ultrastruct Res, A-1180 Vienna, Austria.
CR Breitwieser A, 1996, BIOTECHNIQUES, V21, P918
   Breitwieser A, 1998, ALLERGY, V53, P786
   Gyorvary E, 1999, LANGMUIR, V15, P1337, DOI 10.1021/la980827v
   KUPCU S, 1995, BBA-BIOMEMBRANES, V1235, P263, DOI 10.1016/0005-2736(95)80013-6
   Kupcu S, 1996, J IMMUNOL METHODS, V196, P73, DOI 10.1016/0022-1759(96)00119-6
   Mader C, 1999, BBA-BIOMEMBRANES, V1418, P106, DOI 10.1016/S0005-2736(99)00030-9
   Neubauer A, 1997, SENSOR ACTUAT B-CHEM, V40, P231, DOI 10.1016/S0925-4005(97)80267-5
   Neubauer A, 1996, BIOSENS BIOELECTRON, V11, P317, DOI 10.1016/0956-5663(96)88418-1
   NEUBAUER A, 1994, ANAL LETT, V27, P849, DOI 10.1080/00032719408007356
   PUM D, 1994, THIN SOLID FILMS, V244, P882, DOI 10.1016/0040-6090(94)90592-4
   PUM D, 1993, J BACTERIOL, V175, P2762
   Pum D, 1995, SUPRAMOL SCI, V2, P193, DOI DOI 10.1016/0968-5677(96)89675-1)
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   SARA M, 1989, APPL MICROBIOL BIOT, V30, P184
   SARA M, 1988, DECH BIOT C, V2, P35
   Schuster B, 1998, BBA-BIOMEMBRANES, V1369, P51, DOI 10.1016/S0005-2736(97)00206-X
   Schuster B, 1998, BBA-BIOMEMBRANES, V1370, P280, DOI 10.1016/S0005-2736(97)00274-5
   Sleytr U. B., 1989, ELECT MICROSCOPY SUB, P13
   Sleytr UB, 1999, ANGEW CHEM INT EDIT, V38, P1035, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1034::AID-ANIE1034>3.0.CO;2-#
   SLEYTR UB, 1988, CYSTALLIEN BACTERIAL
   SLEYTR UB, 1996, CRYSTALLINE BACTERIA
   TAGA K, 1994, ANAL CHEM, V66, P35, DOI 10.1021/ac00073a008
   WEINER C, 1994, BIOTECHNOL BIOENG, V43, P321, DOI 10.1002/bit.260430409
NR 23
TC 0
Z9 0
U1 0
U2 0
PU RINTON PRESS, INC
PI PRINCETON
PA 565 EDMUND TERRACE, PRINCETON, NJ 07652 USA
BN 1-58949-003-7
PY 2001
BP 417
EP 422
PG 6
WC Microscopy
SC Microscopy
GA BW75S
UT WOS:000183071700162
DA 2018-10-19
ER

PT B
AU Tian, JT
   Tian, JM
   Zhang, SX
   Yang, SF
AF Tian, JT
   Tian, JM
   Zhang, SX
   Yang, SF
BE Yan, DS
   Guan, ZD
TI Preparation of porous hydroxyapatite materials
SO PROCEEDINGS OF THE FIRST CHINA INTERNATIONAL CONFERENCE ON
   HIGH-PERFORMANCE CERAMICS
LA English
DT Proceedings Paper
CT 1st China International Conference on High-Performance Ceramics
CY OCT 31-NOV 03, 1998
CL BEIJING, PEOPLES R CHINA
SP Chinese Ceram Soc
AB The aim of the paper was to obtain a porous hydroxyapatite (HA) biomaterial that was used to manufacture artificial implants. The technique of impregnating a polyurethane sponge with slurry containing HA powder, water and additives was applied and proved to be more successful. The process of preparations was discussed and the porous HA with desired properties was obtained at last.
C1 Tsing Hua Univ, Beijing Fine Ceram Lab, INET, Beijing 102201, Peoples R China.
RP Tian, JT (reprint author), Tsing Hua Univ, Beijing Fine Ceram Lab, INET, POB 1021, Beijing 102201, Peoples R China.
RI Yang, Shoufeng/A-3693-2009
OI Yang, Shoufeng/0000-0002-3888-3211
CR DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   HULBERT SF, 1970, J BIOMED MAT RES S, V2, P2
   HULBERT SF, 1970, J BIOMED MAT RES, V4
   OHGUSHI H, 1993, J BIOMED MATER RES, V27, P1401, DOI 10.1002/jbm.820271107
   Rice R.W., 1977, TREATISE MATERIALS S, VII, P200
   SEPULVEDA P, 1997, AM CERAM SOC B, V76, P62
NR 6
TC 0
Z9 0
U1 0
U2 2
PU TSINGHUA UNIVERSITY PRESS
PI BEIJING
PA TSINGHUA UNIVERSITY HAIDIANQU, BEIJING 100084, PEOPLES R CHINA
BN 3-540-67318-0
PY 2001
BP 475
EP 478
PG 4
WC Materials Science, Ceramics; Materials Science, Characterization &
   Testing
SC Materials Science
GA BT01U
UT WOS:000171631000126
DA 2018-10-19
ER

PT B
AU Lee, JW
   Jang, YC
   Oh, SJ
AF Lee, JW
   Jang, YC
   Oh, SJ
BE Wei, FC
   Chuang, DCC
   Chen, HC
TI Use of artificial dermis for the better aesthetic result of radial
   forearm flap donor site
SO PROCEEDINGS OF THE INAUGURAL CONGRESS OF THE WORLD SOCIETY FOR
   RECONSTRUCTIVE MICROSURGERY
LA English
DT Proceedings Paper
CT 1st Congress of the World-Society-for-Reconstructive-Microsurgery
CY OCT 29-NOV 03, 2001
CL TAIPEI, TAIWAN
SP World Soc Reconstruct Microsurg
ID MORBIDITY
AB To solve problems associated with closure of the radial forearm flap donor sites, a number of alternate methods have been proposed, but none of these proposals have been universally adopted.
   We used artificial dermis (Terudermis((R))) marketed by Terumo corporation as a tissue restoring biomaterial for coverage of defect of the radial forearm flap donor sites.
   Despite the disadvantage of secondary autograft (STSG), we obtained not only an improvement of soft tissue augmentation and graft skin quality, but also fast graft healing and diminished morbidity of the skin graft donor site.
   The artificial dermis was used successfully in 12 patients with good long-term functional and cosmetic outcomes in all cases.
C1 Hangang Sacred Heart Hosp, Dept Plast & Reconstruct Surg, Seoul, South Korea.
RP Lee, JW (reprint author), Hangang Sacred Heart Hosp, Dept Plast & Reconstruct Surg, Seoul, South Korea.
CR HALLOCK GG, 1990, PLAST RECONSTR SURG, V86, P293
   JURETIC M, 1992, J CRANIO MAXILL SURG, V20, P184, DOI 10.1016/S1010-5182(05)80394-4
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Lutz BS, 1999, PLAST RECONSTR SURG, V103, P132, DOI 10.1097/00006534-199901000-00021
   Samis AJW, 2000, PLAST RECONSTR SURG, V105, P698, DOI 10.1097/00006534-200002000-00034
NR 5
TC 0
Z9 0
U1 0
U2 0
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
BN 88-323-1329-4
PY 2001
BP 349
EP 350
PG 2
WC Surgery
SC Surgery
GA BU03D
UT WOS:000174768800108
DA 2018-10-19
ER

PT J
AU Lawrence, J
   Li, L
AF Lawrence, J
   Li, L
TI Wettability characteristics of polyethylene modified with CO2, Nd : YAG,
   excimer and high-power diode lasers
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART B-JOURNAL OF
   ENGINEERING MANUFACTURE
LA English
DT Article
DE CO2 laser; Nd : YAG laser; excimer laser; high-power diode laser (HPDL);
   polyethylene (PE); surface energy; wettability
ID ALLYLAMINE PLASMA DEPOSITION; SURFACE MODIFICATION;
   POLY(ETHYLENE-TEREPHTHALATE) FILMS; IMPROVED ADHESION; AMMONIA PLASMA;
   UHSPE FIBERS; EPOXY-RESIN; XECL LASER; RADIATION; ABLATION
AB Interaction of CO2, Nd:YAG, excimer and high-power diode laser (HPDL) radiation with the surface of the biomaterial polyethylene (PE), was found to effect varying degrees of change to the wettability characteristics of the material depending upon the laser used. It was observed that interaction With CO2, Nd:YAG and HPDL effected very little change to the wettability characteristics of the PE. In contrast, interaction of the PE with excimer laser radiation resulted in a marked improvement in the wettability characteristics. After excimer laser treatment, the surface O-2 content was found to have increased and the material was seen to be more polar in nature, resulting in a significant increase in the wettability characteristics. The work has shown that the wettability characteristics of the PE could be controlled and/or modified with laser surface treatment. However, a wavelength dependence of the change in the wetting properties could not be deduced from the Findings or this work.
C1 Univ Manchester, Inst Sci & Technol, Dept Mech Engn, Mfg Div,Laser Proc Res Ctr, Manchester M60 1QD, Lancs, England.
RP Lawrence, J (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Mfg Engn Div, Nanyang Ave, Singapore 639798, Singapore.
OI Lawrence, Jonathan/0000-0002-1649-9948
CR AGATHOPOULOS S, 1995, J BIOMED MATER RES, V29, P421, DOI 10.1002/jbm.820290402
   ANDREW JE, 1983, APPL PHYS LETT, V43, P717, DOI 10.1063/1.94488
   Bradley L., 1998, APPL SURF SCI, V138-139, P522
   BREUER J, 1995, J ADHES SCI TECHNOL, V9, P351, DOI 10.1163/156856195X00545
   CHATTORAJ DK, 1984, ADSORPTION GIBBS SUR
   Chen X, 1996, J LASER APPL, V8, P233, DOI 10.2351/1.4745427
   DAUSINGER F, 1990, P ECLAT 90 LAS TREAT, P1
   DYER PE, 1997, APPL SURF SCI, V110, P345
   FENG A, 1998, MAT SCI ENG A-STRUCT, V1, P50
   FILOTTI L, 1997, APPL SURF SCI, V110, P249
   FOURCHE G, 1995, POLYM ENG SCI, V35, P968, DOI 10.1002/pen.760351203
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   GOOD RJ, 1960, J PHYS CHEM-US, V64, P561, DOI 10.1021/j100834a012
   HEITZ J, 1992, APPL PHYS A-MATER, V55, P391, DOI 10.1007/BF00324090
   HENARI F, 1995, APPL OPTICS, V34, P581, DOI 10.1364/AO.34.000581
   HOLMES S, 1990, COMPOS SCI TECHNOL, V38, P1, DOI 10.1016/0266-3538(90)90068-G
   KAPLAN SL, 1988, P 33 INT SAMPE S AN, P254
   KOKAI F, 1992, APPL PHYS A-MATER, V54, P340, DOI 10.1007/BF00324198
   LADIZESKY NH, 1983, J MATER SCI, V18, P533, DOI 10.1007/BF00560643
   Laurens P, 1998, INT J ADHES ADHES, V18, P19, DOI 10.1016/S0143-7496(97)00063-8
   LAURENS P, 2000, APPL SURF SCI, V154, P658
   Lawrence J, 2000, APPL SURF SCI, V154, P664, DOI 10.1016/S0169-4332(99)00416-X
   Lawrence J, 1999, APPL SURF SCI, V138, P388, DOI 10.1016/S0169-4332(98)00431-0
   Lawrence J, 1999, J PHYS D APPL PHYS, V32, P2311, DOI 10.1088/0022-3727/32/18/301
   Lawrence J, 1999, J PHYS D APPL PHYS, V32, P1075, DOI 10.1088/0022-3727/32/10/301
   LAWRENCE J, 1998, P ICALEO 98 LAS MA D, V85, P76
   LAZARE S, 1986, J PHYS CHEM-US, V90, P2124, DOI 10.1021/j100401a028
   LELLIG K, 1996, GLASS SCI TECHNOL, V11, P357
   LI ZF, 1992, J APPL POLYM SCI, V44, P319, DOI 10.1002/app.1992.070440216
   LI ZF, 1992, J APPL POLYM SCI, V44, P333, DOI 10.1002/app.1992.070440217
   LI ZF, 1992, J MATER SCI, V27, P4625, DOI 10.1007/BF01165997
   LIU Z, 1991, SURFACE MODIFICATION, V4, P89
   MAYERS D, 1991, SURFACES INTERFACES, P142
   Neumann A. W., 1978, WETTING SPREADING AD, P3
   NEUMANN AW, 1972, J COLLOID INTERF SCI, V38, P341, DOI 10.1016/0021-9797(72)90251-2
   NGUYEN NX, 1988, P 33 INT SAMPE S AN, P189
   Nicolas G, 1997, APPL SURF SCI, V109, P289, DOI 10.1016/S0169-4332(96)00623-X
   POSTEMA AR, 1986, POLYM B, V16, P167
   SCHMIDT MJJ, 1998, APPL SURF SCI, V138, P378
   Schnabel W., 1981, POLYM DEGRADATION PR
   SHAFEEV GA, 1997, LASER PHYS, V3, P110
   Shuttleworth S, 1996, APPL SURF SCI, V96-8, P513, DOI 10.1016/0169-4332(95)00505-6
   Song CE, 1998, TETRAHEDRON-ASYMMETR, V9, P983, DOI 10.1016/S0957-4166(98)00049-4
   Song Q, 1999, J ADHES SCI TECHNOL, V13, P501, DOI 10.1163/156856199X00064
   SONG Q, 1998, J ADHES SCI TECHNOL, V9, P957
   SRINIVASAN R, 1982, APPL PHYS LETT, V41, P576, DOI 10.1063/1.93601
   UEKI M, 1986, J MATER SCI LETT, V5, P1261, DOI 10.1007/BF01729384
   WATANABE H, 1994, J ADHES SCI TECHNOL, V8, P1425, DOI 10.1163/156856194X00717
   WATANABE H, 1993, SEN-I GAKKAISHI, V49, P616
   李建国, 1993, Rare Metals, V12, P84
NR 50
TC 5
Z9 5
U1 0
U2 3
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI BURY ST EDMUNDS
PA NORTHGATE AVENUE,, BURY ST EDMUNDS IP32 6BW, SUFFOLK, ENGLAND
SN 0954-4054
J9 P I MECH ENG B-J ENG
JI Proc. Inst. Mech. Eng. Part B-J. Eng. Manuf.
PY 2001
VL 215
IS 12
BP 1735
EP 1744
PG 10
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA 518GZ
UT WOS:000173660600007
DA 2018-10-19
ER

PT J
AU Duconseille, E
   Carrot, SN
   Woerly, S
   Kelche, C
   Will, B
   Cassel, JC
AF Duconseille, E
   Carrot, SN
   Woerly, S
   Kelche, C
   Will, B
   Cassel, JC
TI Homotopic grafts of septal neurons combined to polymeric hydrogels
   placed into a fimbria-fornix lesion cavity attenuate locomotor
   hyperactivity but not mnemonic dysfunctions in rats
SO RESTORATIVE NEUROLOGY AND NEUROSCIENCE
LA English
DT Article
DE biomaterial; grafts; hippocampus; homotopic; hydrogels; learning;
   locomotor activity; medial septum; memory; polymer; regeneration;
   sensorimotor; septo-hippocampal system; spatial; transplants
ID CENTRAL-NERVOUS-SYSTEM; FIBRONECTIN-CONTAINING MATRIX; CELL-SUSPENSION
   GRAFTS; CHOLINERGIC NEURONS; INTRAHIPPOCAMPAL GRAFTS; AXONAL
   REGENERATION; GROWTH-FACTOR; SEPTOHIPPOCAMPAL LESIONS; NEURAL
   TRANSPLANTATION; FUNCTIONAL RECOVERY
AB Purpose: We studied the behavioral effects of an intracavitary implantation of poly [N-(2-hydroxypropyl)-methacrylamide] (PHPMA) hydrogels combined to intraseptal grafts of fetal septal cell suspensions in adult female rats subjected to aspirative fimbria-fornix lesions. The hydrogels were used as substrates for bridging the lesion cavity between the septum and the hippocampus.
   Methods: Control groups included sham-operated or lesion-only rats, as well as lesioned rats with only the hydrogel bridge in the lesion cavity, only the graft in the septum, or an intrahippocampal graft of a septal cell suspension as a control for the standardly used ectopic transplantation strategy. Up to 10 months after grafting surgery, all rats were tested for locomotor activity in their home cage, sensorimotor performances using a beam-walking test, and cognitive performances in a radial maze, a water maze and a T-maze (rewarded alternation).
   Results: The lesions induced hyperlocomotion, sensorimotor disturbances and severe alterations of cognitive functions. We found that neither the grafts or the hydrogels, nor the combination of both, induced any significant enhancement of sensorimotor or cognitive performances. Nevertheless, in rats with both intraseptal (homotopic) grafts and a hydrogel implant, the locomotor activity did no longer differ from that found in sham-operated controls. Histological analysis showed that the hydrogels contained acetylcholinesterase(AChE)-positive fibers and that the hippocampal region in contact with the hydrogel exhibited AChE-positive reaction products over several hundreds of micrometers.
   Conclusions: These results are complementary to our previous report on electrophysiological evidence of septo-hippocampal reconnections (Duconseille et al., Rest. Neurol. Neurosci. 15, 1999, 305-317). They further suggest that septal neurons grafted homotopically and/or neurons from the host brain are able to elongate axonal processes through a PHPMA substrate up to the hippocampus. Although they did not affect the cognitive consequences of the lesion, the changes enabled by the homotopic grafts combined to the hydrogel have attenuated the. lesion-induced hyperactivity.
C1 Univ Strasbourg 1, Lab Neurosci Comportementales & Cognit, IFR, CNRS,UMR 7521, F-67000 Strasbourg, France.
   Organogel Canada Ltd, Quebec City, PQ G1P 4R7, Canada.
RP Cassel, JC (reprint author), Univ Strasbourg 1, Lab Neurosci Comportementales & Cognit, IFR, CNRS,UMR 7521, 12 Rue Goethe, F-67000 Strasbourg, France.
CR Balse E, 1999, BRAIN RES BULL, V49, P263, DOI 10.1016/S0361-9230(99)00058-1
   CAPOBIANCO S, 1976, PHYSIOL BEHAV, V17, P65, DOI 10.1016/0031-9384(76)90271-7
   CASSEL JC, 1995, NEUROSCIENCE, V69, P1, DOI 10.1016/0306-4522(95)00241-A
   CASSEL JC, 1991, RESTOR NEUROL NEUROS, V3, P55, DOI 10.3233/RNN-1991-3202
   CASSEL JC, 1991, NEUROSCIENCE, V45, P571, DOI 10.1016/0306-4522(91)90272-P
   CASSEL JC, 1990, EXP BRAIN RES, V81, P179
   Cassel JC, 1997, PROG NEUROBIOL, V51, P663, DOI 10.1016/S0301-0082(97)00009-9
   CASSEL JC, 1992, BRAIN RES, V585, P243, DOI 10.1016/0006-8993(92)91213-X
   CASSEL JC, 1992, RESTOR NEUROL NEUROS, V4, P65, DOI 10.3233/RNN-1992-4201
   Coutureau E, 2000, EXP BRAIN RES, V131, P381, DOI 10.1007/s002219900301
   Duconseille E, 1998, RESTOR NEUROL NEUROS, V13, P193
   Duconseille E, 1999, RESTOR NEUROL NEUROS, V15, P305
   DUNNETT SB, 1982, BRAIN RES, V251, P335, DOI 10.1016/0006-8993(82)90751-X
   DUNNETT SB, 1990, EUR J NEUROSCI, V2, P567, DOI 10.1111/j.1460-9568.1990.tb00448.x
   DUNNETT SB, 1987, J EXP BIOL, V132, P265
   DUNNETT SB, 1994, FUNCT NEURAL TRANSPL, V2, P157
   HAGG T, 1990, EXP NEUROL, V109, P153, DOI 10.1016/0014-4886(90)90069-5
   HODGES H, 1991, NEUROSCIENCE, V45, P587, DOI 10.1016/0306-4522(91)90273-Q
   Hofferer E, 1996, BEHAV BRAIN RES, V74, P175, DOI 10.1016/0166-4328(95)00158-1
   Hofferer E, 1996, EXP BRAIN RES, V111, P187
   HOFFERER E, 1994, BEHAV BRAIN RES, V63, P167, DOI 10.1016/0166-4328(94)90088-4
   Jakab Robert L., 1995, P405
   JELTSCH H, 1994, NEUROSCIENCE, V63, P9
   KNOOPS B, 1993, RESTOR NEUROL NEUROS, V5, P103, DOI 10.3233/RNN-1993-5201
   KNOOPS B, 1993, BRAIN RES BULL, V30, P433, DOI 10.1016/0361-9230(93)90275-G
   KOELLE GB, 1954, J COMP NEUROL, V100, P211, DOI 10.1002/cne.901000108
   KROMER LF, 1981, BRAIN RES, V210, P173, DOI 10.1016/0006-8993(81)90893-3
   Leanza G, 1996, J COMP NEUROL, V373, P355
   LOW WC, 1982, NATURE, V300, P260, DOI 10.1038/300260a0
   MESSERSMITH DJ, 1991, BRAIN RES, V557, P293, DOI 10.1016/0006-8993(91)90147-N
   MONTEROMENEI CN, 1992, BRAIN RES, V570, P198, DOI 10.1016/0006-8993(92)90582-T
   NEUBERGER TJ, 1992, J COMP NEUROL, V315, P16, DOI 10.1002/cne.903150103
   Paxinos G, 1986, RAT BRAIN STEREOTAXI
   SATOH K, 1983, BRAIN RES BULL, V11, P693, DOI 10.1016/0361-9230(83)90013-8
   SIRKIN DW, 1983, STAIN TECHNOL, V58, P121, DOI 10.3109/10520298309066769
   STECKLER T, 1995, BEHAV BRAIN RES, V67, P165, DOI 10.1016/0166-4328(94)00157-B
   Tarricone BJ, 1996, BEHAV BRAIN RES, V74, P25, DOI 10.1016/0166-4328(95)00144-1
   TUSZYNSKI MH, 1990, NEUROSCIENCE, V36, P33, DOI 10.1016/0306-4522(90)90349-9
   TUSZYNSKI MH, 1995, P NATL ACAD SCI USA, V92, P4621, DOI 10.1073/pnas.92.10.4621
   VINOGRADOVA OS, 1995, PROG NEUROBIOL, V45, P523, DOI 10.1016/0301-0082(94)00051-I
   WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1
   WENDT JS, 1985, BRAIN RES BULL, V15, P13, DOI 10.1016/0361-9230(85)90055-3
   WHISHAW IQ, 1991, BEHAV NEURAL BIOL, V55, P289, DOI 10.1016/0163-1047(91)90633-2
   WILKINSON LS, 1993, BEHAV BRAIN RES, V55, P143, DOI 10.1016/0166-4328(93)90110-C
   Will B, 1998, CELLULAR AND MOLECULAR BASIS OF REGENERATION: FROM INVERTEBRATES TO HUMANS, P379
   Winer B.J., 1971, STAT PRINCIPLES EXPT
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
NR 48
TC 6
Z9 7
U1 0
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0922-6028
J9 RESTOR NEUROL NEUROS
JI Restor. Neurol. Neurosci.
PY 2001
VL 18
IS 1
BP 39
EP 51
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA 491RR
UT WOS:000172123100004
PM 11673668
DA 2018-10-19
ER

PT S
AU Li, YH
   Rong, LJ
   Li, YY
AF Li, YH
   Rong, LJ
   Li, YY
BE Chu, YY
   Zhao, LC
TI Superelasticity of porous NiTi alloy fabricated by combustion synthesis
SO SHAPE MEMORY MATERIALS AND ITS APPLICATIONS
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT International Conference on Shape Memory and Superelastic Technologies
   and Shape Memory Materials (SMST-SMM 2001)
CY SEP 02-06, 2001
CL KUNMING, PEOPLES R CHINA
SP Nonferrous Met Soc China, Int Org Shape Memory & Superelast Technologies, Beijing GEE SMA Co Ltd, Beijing Univ Aeronatu & Astronaut, EUROflex Schuessler GmbH, Grikin Adv Mat Co Ltd, Harbin Inst Technol, Ind Ctr MATEKS Co Ltd, Japan Assoc SMA, Jiangsu Fasten Co Ltd, Lanzhou Seemine SMA Co Ltd, Memry Corp, Nitinol Devices & Components Inc, Shape Memory Applicat Inc, Tianjin Univ, Shape Memory Mat Res & Engn Ctr, Xian SMA Mat Co Ltd
DE combustion synthesis; porous NiTi alloy; superelasticity
ID SHAPE-MEMORY ALLOYS; NICKEL-TITANIUM
AB Porous NiTi shape memory alloy (SMA) used for human implant is a new kind of biomaterial with great prospect. In this paper, porous NiTi SMA with unique interconnected three-dimensionally, uniform pore structure was fabricated by combustion synthesis The as-synthesized porous NiTi SMA exhibited characteristics of superelasticity (SE), which as investigated by stress-strain measurement and X-ray diffraction (XRD). The stress hysteresis increased with increasing applied strain and decreased during the initial loading-unloading cycles, but became stable in subsequent cycles.
C1 Chinese Acad Sci, Met Res Inst, Shenyang 110016, Peoples R China.
RP Li, YH (reprint author), Chinese Acad Sci, Met Res Inst, Shenyang 110016, Peoples R China.
CR GJUNTER VE, 2000, DELAY LAW NEW CLASS
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   Li BY, 2000, J MATER RES, V15, P10, DOI 10.1557/JMR.2000.0004
   LIU Y, 1994, ACTA METALL MATER, V42, P2401, DOI 10.1016/0956-7151(94)90318-2
   Liu YO, 1997, ACTA MATER, V45, P4431, DOI 10.1016/S1359-6454(97)00144-4
   Munir Z. A., 1989, Material Science Reports, V3, P277, DOI 10.1016/0920-2307(89)90001-7
   OSTUKA K, 1998, SHAPE MEMORY MAT
   Otsuka K, 1999, INTERMETALLICS, V7, P511, DOI 10.1016/S0966-9795(98)00070-3
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
NR 10
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-896-6
J9 MATER SCI FORUM
PY 2001
VL 394-3
BP 511
EP 514
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BU54T
UT WOS:000176290100115
DA 2018-10-19
ER

PT S
AU Ramakrishnan, V
   Ramesh, KP
   Bang, SS
AF Ramakrishnan, V
   Ramesh, KP
   Bang, SS
BE Wilson, AR
   Asanuma, H
TI Bacterial concrete
SO SMART MATERIALS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Symposium on Smart Materials and MEMS
CY DEC 13-15, 2000
CL MELBOURNE, AUSTRALIA
SP SPIE, Dept Def, Australia, Def Sci & Technol Org, State Govt Victoria, Australia, Victorian Dept State & Reg Dev, Swinburne Univ Technol
DE biomaterial; bacterial concrete; energy-dispersive X-ray spectra; SEM;
   Bacillus Pasteurii and Sporosarcina Bacteria
AB Cracks in concrete are inevitable and are one of the inherent weaknesses of concrete. Water and other salts seep through these cracks, corrosion initiates, and thus reduces the life of concrete. So there was a need to develop an inherent biomaterial, a self-repairing material which can remediate the cracks and fissures in concrete. Bacterial concrete is a material, which can successfully remediate cracks in concrete. This technique is highly desirable because the mineral precipitation induced as a result of microbial activities is pollution free and natural. As the cell wall of bacteria is anionic, metal accumulation (calcite) on the surface of the wall is substantial, thus the entire cell becomes crystalline and they eventually plug the pores and cracks in concrete. This paper discusses the plugging of artificially cracked cement mortar using Bacillus Pasteurii and Sporosarcina bacteria combined with sand as a filling material in artificially made cuts in cement mortar which was cured in urea and CaCl2 medium. The effect on the compressive strength and stiffness of the cement mortar cubes due to the mixing of bacteria is also discussed in this paper. It was found that use of bacteria improves the stiffness and compressive strength of concrete. Scanning electron microscope (SEM) is used to document the role of bacteria in microbiologically induced mineral precipitation. Rod Like impressions were found on the face of calcite crystals indicating the presence of bacteria in those places. Energy -dispersive X-ray (EDX) spectra of the microbiologically on the surface of the crack indicated the abundance of calcium and the precipitation was inferred to be calcite (CaCO3).
C1 S Dakota Sch Mines & Technol, Dept Civil & Environm Engn, Rapid City, SD 57701 USA.
RP Ramakrishnan, V (reprint author), S Dakota Sch Mines & Technol, Dept Civil & Environm Engn, Rapid City, SD 57701 USA.
CR BEVERIDGE TJ, 1985, CAN J EARTH SCI, V22, P1893, DOI 10.1139/e85-204
   DEO KS, 1997, THESIS S DAKOTA SCH
   ECKHARDT FEW, CHEM WEATHERING, P161
   Ferris FG, 1992, Patent US, Patent No. 5143155
   GOLLAPUDI UK, 1995, CHEMOSPHERE, V30, P695, DOI 10.1016/0045-6535(94)00435-W
   JACK TR, 1992, MICROBIAL ENHANCEMEN, P27
   KALISH PJ, 1984, J PETROL TECHNOL, V6, P805
   KANTZAS A, 1992, CIM ANN TECHN C CALG
   RAJPATHAK V, 1996, THESIS S DAKOTA SCH
   SANTHOSH KR, 2000, UNPUB SDSM T
   STOCKSFISCHER S, 1997, THESIS S DAKOTA SCH
NR 11
TC 22
Z9 24
U1 0
U2 8
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3908-8
J9 P SOC PHOTO-OPT INS
PY 2001
VL 4234
BP 168
EP 176
DI 10.1117/12.424404
PG 9
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing; Optics
SC Materials Science; Optics
GA BS26C
UT WOS:000169262800024
DA 2018-10-19
ER

PT B
AU Ortiz, CR
   Villa, R
   Gonzalez, G
   Trillo, E
   Stafford, SW
   Murr, LE
AF Ortiz, CR
   Villa, R
   Gonzalez, G
   Trillo, E
   Stafford, SW
   Murr, LE
BE Niinomi, M
   Okabe, T
   Taleff, EM
   Lesuer, DR
   Lippard, HE
TI Thermomechanical analysis of Ti40Ta and Ti50Ta alloys
SO STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY
LA English
DT Proceedings Paper
CT Symposium on Structural Biomaterials for the 21st Century
CY FEB 11-12, 2001
CL NEW ORLEANS, LA
SP SMD, Struct Mat & Titanium Comm, ASM, MSCTS, Corros & Environm Effects Comm
ID TITANIUM IMPLANT
AB Currently, titanium-tantalum is being studied as an alternative to the popular biomaterial Ti6Al4V which has demonstrated possible toxic metal ion release. Preliminary studies have shown Ti40Ta and Ti50Ta to exhibit high strengths and excellent corrosion resistance when subjected to various heat treatments. Ti50Ta aged at 400 degreesC for 50 hours and at 500 degrees for 50 hours exhibits a tightly woven tweed structure as seen through transmission electron microscopy. The second phase (hcp alpha) particles, exhibiting a short needle-like morphology, have aligned in the tweed structure resulting in an increase in hardness. The goal of this research is to find a similar optimum heat treatment for the Ti40Ta samples which had not shown an increase in hardness during preliminary testing. Aging treatments at 400 degreesC were performed at 20, 30, 40, 50, and 100 hours. Microstructural analysis conducted through optical and transmission electron microscopy shows a martensitic transformation as a result of longer aging times. At lower aging times, the martensite exhibited a needle-like structure. At longer aging times, the needles increased in size and density and evolved into a more plate-like formation. The plates increased in size and width with increasing aging times. After the tensile strength reached a minimum for the 30 hour treatment, it increased for the 50 and 100 hour treatments.
C1 Univ Texas, Dept Met & Mat Engn, El Paso, TX 79968 USA.
RP Ortiz, CR (reprint author), Univ Texas, Dept Met & Mat Engn, 500 W Univ Ave, El Paso, TX 79968 USA.
CR Bianco PD, 1996, J BIOMED MATER RES, V31, P227
   CIGADA A, 1992, J MATER SCI-MATER M, V3, P408, DOI 10.1007/BF00701236
   COTTON JD, 1994, METALL MATER TRANS A, V25, P461, DOI 10.1007/BF02651588
   EYLON D, 1981, TITANIUM ENERGY IND, P293
   MEACHIM G, 1973, J BIOMED MATER RES, V7, P555, DOI 10.1002/jbm.820070607
   ORTIZ CR, 2000, SCANN 2000 C SAN ANT
   Souto RM, 1996, J MATER SCI-MATER M, V7, P337
   SYRETT BC, 1979, CORROSION DEGREDATIO, P107
   TRILLO EA, 2001, J MATER SCI-MATER M, V12, P1
NR 9
TC 2
Z9 2
U1 0
U2 2
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-487-9
PY 2001
BP 35
EP 42
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA BS16A
UT WOS:000168874700004
DA 2018-10-19
ER

PT J
AU Quirk, RA
   Briggs, D
   Davies, MC
   Tendler, SJB
   Shakesheff, KM
AF Quirk, RA
   Briggs, D
   Davies, MC
   Tendler, SJB
   Shakesheff, KM
TI Characterization of the spatial distributions of entrapped polymers
   following the surface engineering of poly(lactic acid)
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE poly(lactic acid); surface modification; ToF-SIMS; imaging XPS; surface
   segregation
ID ION MASS-SPECTROMETRY; COPOLYMERS; XPS; HYDROGELS; ADHESION; SIMS; RGD
AB In earlier studies we have demonstrated physical entrapment as a method of surface-modifying poly(lactic acid) (PLA) by immobilizing poly(L-lysine) (PLL) and poly(ethylene glycol) (PEG) at the PLA surface. In this study, we have used a combination of time-of-flight (ToF) SIMS and XPS image analysis to determine the surface homogeneity of these systems. The ToF-SIMS imaging was used to investigate the effect of various surface-engineering conditions on the lateral distribution of PLL-modified PLA. The PLA surface modification was revealed to pro duce micron-scale PLL-rich domains following prolonged exposure to the partial solvent system that is used during the entrapment process. As the static SIMS analysis of PEG/PLA surfaces did not produce distinguishing ions of a sufficient intensity between the two polymers, this technique could not generate lateral contrast, and imaging XPS was therefore employed to determine the surface distributions of these two species. Phase separation was again detected under extended surface engineering conditions. With both systems, optimization of the process conditions was shown to inhibit the creation of a heterogeneous surface. Surface segregation may result in suboptimal performance of the biomaterial and this study therefore highlights the importance of determining spatial organizations when modifying polymer interfaces. Copyright (C) 2001 John WiIey & Sons, Ltd.
C1 Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England.
RP Shakesheff, KM (reprint author), Univ Nottingham, Sch Pharmaceut Sci, Univ Pk, Nottingham NG7 2RD, England.
RI Shakesheff, Kevin/O-6371-2018
OI Shakesheff, Kevin/0000-0003-3236-2439; Davies,
   Martyn/0000-0001-7695-0596
CR BEAMSON G, 1990, SURF INTERFACE ANAL, V15, P541, DOI 10.1002/sia.740150908
   Briggs D., 1989, HDB STATIC SECONDARY
   Chen X, 1998, MACROMOLECULES, V31, P2278, DOI 10.1021/ma9704525
   Coombes AGA, 1997, BIOMATERIALS, V18, P1153, DOI 10.1016/S0142-9612(97)00051-3
   DAVIES MC, 1989, SURF INTERFACE ANAL, V14, P115, DOI 10.1002/sia.740140304
   Davis SJ, 1996, J MATER CHEM, V6, P479, DOI 10.1039/jm9960600479
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   GELIUS U, 1990, J ELECTRON SPECTROSC, V52, P747, DOI 10.1016/0368-2048(90)85063-F
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HOY, 1999, BIOMATERIALS, V20, P33
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Kubies D, 2000, BIOMATERIALS, V21, P529, DOI 10.1016/S0142-9612(99)00219-7
   Lopina ST, 1996, BIOMATERIALS, V17, P559, DOI 10.1016/0142-9612(96)88706-0
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Pannu RK, 1999, BIOMATERIALS, V20, P1381, DOI 10.1016/S0142-9612(99)00041-1
   Park A, 1998, J BIOMAT SCI-POLYM E, V9, P89, DOI 10.1163/156856298X00451
   Patel N, 2000, J BIOMAT SCI-POLYM E, V11, P319, DOI 10.1163/156856200743724
   Quirk RA, 2000, MACROMOLECULES, V33, P258, DOI 10.1021/ma9916133
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Shard AG, 1996, MACROMOLECULES, V29, P748, DOI 10.1021/ma950622i
   Shard AG, 1997, MACROMOLECULES, V30, P3051, DOI 10.1021/ma9519021
NR 22
TC 10
Z9 10
U1 1
U2 14
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JAN
PY 2001
VL 31
IS 1
BP 46
EP +
DI 10.1002/sia.951
PG 6
WC Chemistry, Physical
SC Chemistry
GA 399CD
UT WOS:000166792700007
DA 2018-10-19
ER

PT J
AU Jones, FH
AF Jones, FH
TI Teeth and bones: applications of surface science to dental materials and
   related biomaterials
SO SURFACE SCIENCE REPORTS
LA English
DT Review
ID X-RAY PHOTOELECTRON; SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE MICROSCOPY;
   SCANNING-TUNNELING-MICROSCOPY; ION MASS-SPECTROMETRY; OSTEOBLAST-LIKE
   CELLS; LASER-DESORPTION IONIZATION; CALCIUM-PHOSPHATE COATINGS; BOVINE
   SERUM-ALBUMIN; PHOTON-STIMULATED DESORPTION
AB Recent years have seen a considerable upsurge in publications concerning the surface structure and chemistry of materials with biological or biomedical applications. Within the body, gas-solid interactions become relatively less significant and solid-liquid or solid-solid interfaces dominate, providing new challenges for the surface scientist. The current paper aims to provide a timely review of the use of surface analysis and modification techniques within the biomaterials field. A broad overview of applications in a number of related areas is given with particular attention focusing on those materials commonly encountered in dentistry and oral or maxillofacial implantology. Several specific issues of current interest are discussed. The interaction between synthetic and natural solids, both in the oral environment and elsewhere in the body is important in terms of adhesion, related stresses and strains and ultimately the longevity of a dental restoration, biomedical implant, or indeed the surrounding tissue. Exposure to body fluids, of course, can also affect stability, leading to the degradation or corrosion of materials within the body. Whilst this could potentially be harmful, e.g., if cytotoxic elements are released, it may alternatively provide a route to the preferential release of beneficial substances. Furthermore, in some cases, the controlled disintegration of a biomaterial is desirable, allowing the removal of an implant, e.g., without the need for further surgery, The presence of cells in the immediate bioenvironment additionally complicates the situation. A considerable amount of current research activity is targeted at the development of coatings or surface treatments to encourage tissue growth. Lf this is to be achieved by stimulating enhanced cell productivity, determination of the relationship between cell function and surface composition is essential. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 UCL, Dept Biomat, Eastman Dent Inst Oral Hlth Care Sci, London WC1X 8LD, England.
RP Jones, FH (reprint author), UCL, Dept Biomat, Eastman Dent Inst Oral Hlth Care Sci, 256 Grays Inn Rd, London WC1X 8LD, England.
EM f.jones@eastman.ucl.ac.uk
CR ABBOTT NL, 1994, CHEM MATER, V6, P596, DOI 10.1021/cm00041a007
   ABIKO Y, 1993, CELL MATER, V3, P161
   Abrahams I, 1997, J MATER CHEM, V7, P1573, DOI 10.1039/a608325k
   Adler HJ, 1999, ACTA POLYM, V50, P232, DOI 10.1002/(SICI)1521-4044(19990701)50:7<232::AID-APOL232>3.3.CO;2-4
   ADURU S, 1987, LANGMUIR, V3, P543, DOI 10.1021/la00076a017
   Afanasyeva NI, 1999, SURF INTERFACE ANAL, V27, P204, DOI 10.1002/(SICI)1096-9918(199904)27:4<204::AID-SIA545>3.0.CO;2-U
   ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   ALBREKTSSON T, 1991, ACTA ORTHOP SCAND, V17, P132
   ALBREKTSSON T, 1982, CLIN APPL BIOMATERIA
   ALHASHIMI I, 1989, ARCH ORAL BIOL, V34, P289, DOI 10.1016/0003-9969(89)90070-8
   Allen GC, 1996, NUCL INSTRUM METH B, V116, P457, DOI 10.1016/0168-583X(96)00088-2
   Allen S, 1997, TRENDS BIOTECHNOL, V15, P101, DOI 10.1016/S0167-7799(97)01015-9
   Alonso F, 1997, SURF COAT TECH, V93, P305, DOI 10.1016/S0257-8972(97)00065-0
   *AM SOC TEST MAT, 1991, SURF INTERFACE ANAL, V17, P893
   Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   AMEEN AP, 1993, CLIN ORAL IMPLAN RES, V4, P144, DOI 10.1034/j.1600-0501.1993.040305.x
   Ameen AP, 1996, J MATER SCI-MATER M, V7, P195, DOI 10.1007/BF00119730
   AMRAHBOUALI S, 1994, BIOMATERIALS, V15, P269, DOI 10.1016/0142-9612(94)90050-7
   An YH, 1995, J MICROBIOL METH, V24, P29, DOI 10.1016/0167-7012(95)00051-8
   ANDRADE JD, 1985, PROTEIN ADSORPTION S, V2
   Andriano KP, 1999, J BIOMED MATER RES, V48, P602, DOI 10.1002/(SICI)1097-4636(1999)48:5<602::AID-JBM3>3.0.CO;2-6
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Antonov EN, 1997, BIOMATERIALS, V18, P1043, DOI 10.1016/S0142-9612(97)00030-6
   ANUSAVICE KJ, 1996, PHILLIPS SCI DENTAL
   AOBA T, 1991, ACS SYM SER, V444, P85
   APARICIO C, 1992, International Journal of Oral and Maxillofacial Implants, V7, P94
   ARENDS J, 1987, J CRYST GROWTH, V84, P515, DOI 10.1016/0022-0248(87)90284-3
   ARENDS J, 1985, CARIES RES, V19, P450, DOI 10.1159/000260880
   Armstrong SR, 1998, DENT MATER, V14, P91, DOI 10.1016/S0109-5641(98)00014-1
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   ARSOV L, 1975, VIDE A, V30, P114
   Arwin H, 1998, THIN SOLID FILMS, V313, P764, DOI 10.1016/S0040-6090(97)00993-0
   Arys A, 1998, J BIOMED MATER RES, V43, P300, DOI 10.1002/(SICI)1097-4636(199823)43:3<300::AID-JBM11>3.0.CO;2-J
   Ashino M, 2000, PHYS REV B, V61, P13955, DOI 10.1103/PhysRevB.61.13955
   ASMUSSEN E, 1987, J DENT RES, V66, P1386, DOI 10.1177/00220345870660082001
   ATANASOSKA LL, 1978, SURF SCI, V72, P189, DOI 10.1016/0039-6028(78)90388-6
   AVERY JK, 1994, ORAL DEV HISTOLOGY
   Azoulay A, 1997, SURF SCI, V370, P1, DOI 10.1016/S0039-6028(96)00927-2
   Azoulay A, 1999, SURF SCI, V422, P141, DOI 10.1016/S0039-6028(98)00923-6
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   BACKMAN B, 1993, ACTA ODONTOL SCAND, V51, P79, DOI 10.3109/00016359309041152
   BADDILEY J, 1973, NATURE, V243, P43, DOI 10.1038/243043a0
   Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9
   BAKKE R, 1990, BIOFILMS
   BALL V, 1994, P NATL ACAD SCI USA, V91, P7330, DOI 10.1073/pnas.91.15.7330
   Ball V, 1996, LANGMUIR, V12, P1614, DOI 10.1021/la950735v
   Balooch M, 1998, J BIOMED MATER RES, V40, P539, DOI 10.1002/(SICI)1097-4636(19980615)40:4<539::AID-JBM4>3.3.CO;2-O
   Bar G, 1996, J VAC SCI TECHNOL A, V14, P1794, DOI 10.1116/1.580338
   Bar G, 1997, LANGMUIR, V13, P373, DOI 10.1021/la960935m
   Baranauskas V, 1998, APPL BIOCHEM BIOTECH, V69, P91, DOI 10.1007/BF02919391
   Barlow SM, 1998, SURF SCI, V401, P322, DOI 10.1016/S0039-6028(97)01086-8
   BARO AM, 1986, BIOMATERIALS, V7, P463, DOI 10.1016/0142-9612(86)90036-0
   Barron AE, 1999, CURR OPIN CHEM BIOL, V3, P681, DOI 10.1016/S1367-5931(99)00026-5
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Bartzoka V, 1998, LANGMUIR, V14, P1892, DOI 10.1021/la9711138
   Basmadjian D, 1997, BIOMATERIALS, V18, P1511, DOI 10.1016/S0142-9612(97)00101-4
   Bates SP, 1998, SURF SCI, V409, P336, DOI 10.1016/S0039-6028(98)00278-7
   Baty AM, 1997, LANGMUIR, V13, P5702, DOI 10.1021/la9610720
   Batzer R, 1998, J BIOMED MATER RES, V41, P489
   Beech IB, 1999, J MICROBIOL METH, V36, P3, DOI 10.1016/S0167-7012(99)00005-6
   Behm JM, 1996, LANGMUIR, V12, P2121, DOI 10.1021/la950811u
   BennaniZiatni M, 1997, ANN CHIM-SCI MAT, V22, P537
   Bennett RA, 1999, FARADAY DISCUSS, V114, P267, DOI 10.1039/a903731d
   Bennett RA, 1999, PHYS REV LETT, V82, P3831, DOI 10.1103/PhysRevLett.82.3831
   Bennett RA, 1999, PHYS REV B, V59, P10341, DOI 10.1103/PhysRevB.59.10341
   Bentaleb A, 1998, J BIOMED MATER RES, V40, P449, DOI 10.1002/(SICI)1097-4636(19980605)40:3<449::AID-JBM16>3.0.CO;2-E
   Bentaleb A, 1997, LANGMUIR, V13, P729, DOI 10.1021/la9605192
   BERGER H, 1993, J CRYST GROWTH, V130, P108, DOI 10.1016/0022-0248(93)90842-K
   BERNDT R, 1994, SURF SCI, V310, P85, DOI 10.1016/0039-6028(94)91373-0
   BERTEL E, 1984, SURF SCI, V141, P355, DOI 10.1016/0039-6028(84)90137-7
   BERUBE YG, 1968, J COLLOID INTERF SCI, V27, P305, DOI 10.1016/0021-9797(68)90038-6
   BESSHO K, 1995, J BIOMED MATER RES, V29, P901, DOI 10.1002/jbm.820290716
   BETON PH, 1995, APPL PHYS LETT, V67, P1075, DOI 10.1063/1.114469
   BETT JAS, 1967, J AM CHEM SOC, V89, P5535, DOI 10.1021/ja00998a003
   BHATIA SK, 1989, ANAL BIOCHEM, V178, P408, DOI 10.1016/0003-2697(89)90662-3
   BIERBAUM K, 1995, LANGMUIR, V11, P512, DOI 10.1021/la00002a025
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BINNIG G, 1983, PHYS REV LETT, V50, P120, DOI 10.1103/PhysRevLett.50.120
   BIWER BM, 1986, SURF SCI, V167, P207, DOI 10.1016/0039-6028(86)90795-8
   BLAISE G, 1978, SURF SCI, V71, P630
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Blomberg E, 1998, BIOMATERIALS, V19, P371, DOI 10.1016/S0142-9612(97)00114-2
   BLUMENTHAL NC, 1989, J BIOMED MATER RES-A, V23, P13, DOI 10.1002/jbm.820231305
   Bohm I, 1999, APPL SURF SCI, V141, P237, DOI 10.1016/S0169-4332(98)00510-8
   BOLAND T, 1995, P NATL ACAD SCI USA, V92, P5297, DOI 10.1073/pnas.92.12.5297
   BONNELL DA, 2000, SCANNING TUNNELING M
   Booth NA, 1998, SURF SCI, V397, P258, DOI 10.1016/S0039-6028(97)00742-5
   Born R, 1998, FRESEN J ANAL CHEM, V361, P697, DOI 10.1007/s002160050997
   BOSKEY AL, 1976, J PHYS CHEM-US, V80, P40, DOI 10.1021/j100542a009
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   BotteroCornillac MJ, 1995, SCANNING MICROSCOPY, V9, P1179
   Bowen WH, 1993, CARIOLOGY 90S
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Boyan BD, 1995, CELL MATER, V5, P323
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyde A, 1997, CIBA F SYMP, V205, P18
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   BREARLEY W, 1977, SURF SCI, V64, P372, DOI 10.1016/0039-6028(77)90284-9
   BREDOW T, 1995, SURF SCI, V327, P398, DOI 10.1016/0039-6028(94)00851-5
   Briggs D., 1992, PRACTICAL SURFACE AN, V2
   Briggs D., 1990, PRACTICAL SURFACE AN, V1
   BRINK C, 1992, COLLOID SURFACE, V66, P149, DOI 10.1016/0166-6622(92)80131-K
   Brinkley D, 1998, SURF SCI, V395, P292, DOI 10.1016/S0039-6028(97)00633-X
   Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   Brown WA, 2000, J PHYS CHEM B, V104, P2578, DOI 10.1021/jp9930907
   BRUGNIAU D, 1984, SURF SCI, V141, P639, DOI 10.1016/0039-6028(84)90154-7
   BRUNER RJ, 1993, T SOC BIOMATER, V16, P219
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   BUCHS J, 1988, APPL MICROBIOL BIOT, V29, P119
   BUMGARDNER JD, 1993, DENT MATER, V9, P252, DOI 10.1016/0109-5641(93)90070-7
   BUMGARDNER JD, 1994, J APPL BIOMATER, V5, P203, DOI 10.1002/jab.770050305
   BURR DB, 1993, J BIOMED MATER RES, V27, P645, DOI 10.1002/jbm.820270512
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   BUSSCHER HJ, 1990, SURF INTERFACE ANAL, V15, P344, DOI 10.1002/sia.740150508
   BUSTILLO FJ, 1989, VACUUM, V39, P659, DOI 10.1016/0042-207X(89)90010-9
   BUSTILLO FJ, 1990, VACUUM, V41, P19, DOI 10.1016/0042-207X(90)90258-Z
   Campbell AA, 1996, J BIOMED MATER RES, V32, P111, DOI 10.1002/(SICI)1097-4636(199609)32:1<111::AID-JBM13>3.0.CO;2-P
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   CARLEY AF, 1987, J CHEM SOC FARAD T 1, V83, P351, DOI 10.1039/f19878300351
   Caruso F, 1997, J COLLOID INTERF SCI, V186, P129, DOI 10.1006/jcis.1996.4625
   CASSINELLI C, 1994, J MATER SCI-MATER M, V5, P606, DOI 10.1007/BF00120339
   CASSINELLI C, 1994, J BIOMED MATER RES, V28, P1427, DOI 10.1002/jbm.820281207
   CHANDER S, 1985, COLLOID SURFACE, V13, P137
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Chandra S, 2000, ANAL CHEM, V72, p104A, DOI 10.1021/ac002716i
   Characklis W. G., 1990, BIOFILMS
   Charlton G, 1997, PHYS REV LETT, V78, P495, DOI 10.1103/PhysRevLett.78.495
   Chauvy PF, 1998, SURF COAT TECH, V110, P48, DOI 10.1016/S0257-8972(98)00608-2
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   Chehroudi B, 1995, CELL MATER, V5, P334
   CHEN CJ, 1993, OXFORD SERIES OPTICA, V4
   CHEN O, 1999, PHYS CHEM COMMUN, V9
   CHEN S, 1993, J VAC SCI TECHNOL A, V11, P2419, DOI 10.1116/1.578587
   CHENG SS, 1994, J COLLOID INTERF SCI, V162, P135, DOI 10.1006/jcis.1994.1018
   CHERNOFF EAG, 1992, J VAC SCI TECHNOL A, V10, P596, DOI 10.1116/1.577736
   CHIEGO DJ, 1994, ORAL DEV HISTOLOGY
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Chou LS, 1998, J BIOMED MATER RES, V39, P437, DOI 10.1002/(SICI)1097-4636(19980305)39:3<437::AID-JBM13>3.0.CO;2-7
   CHOU LS, 1995, J CELL SCI, V108, P1563
   CHOW LC, 1988, J DENT RES, V67, P1058, DOI 10.1177/00220345880670070901
   CHRISTENSEN BE, 1990, BIOFILMS
   Chusuei CC, 1999, ANAL CHEM, V71, P149, DOI 10.1021/ac9806963
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Clasen ABS, 1997, ACTA ODONTOL SCAND, V55, P339
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   COLBOURN EA, 1992, SURF SCI REP, V15, P281, DOI 10.1016/0167-5729(92)90013-2
   Colliver TL, 1997, ANAL CHEM, V69, P2225, DOI 10.1021/ac9701748
   Combe E C, 1999, DENTAL BIOMATERIALS
   Combes C, 1999, J MATER SCI-MATER M, V10, P231, DOI 10.1023/A:1008922029096
   Combes C, 1995, J MATER SCI-MATER M, V6, P699, DOI 10.1007/BF00134304
   Combes C, 1998, COLLOID SURFACE B, V11, P15, DOI 10.1016/S0927-7765(98)00014-9
   Conesa JC, 2000, RES CHEM INTERMEDIAT, V26, P103, DOI 10.1163/156856700X00138
   Connor PA, 1999, LANGMUIR, V15, P2402, DOI 10.1021/la980855d
   COOK SD, 1988, CLIN ORTHOP RELAT R, P225
   Cooper E, 1997, J MATER CHEM, V7, P435, DOI 10.1039/a607204f
   Cooper LF, 1999, INT J ORAL MAX IMPL, V14, P37
   CORBRIDGE DEC, 1990, STUDIES INORGANIC CH, V10
   CORNELL RM, 1975, J COLLOID INTERF SCI, V53, P6, DOI 10.1016/0021-9797(75)90028-4
   CORPRON RE, 1992, J DENT RES, V71, P828, DOI 10.1177/002203459207100S07
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86
   COWLEY JM, 1995, HDB SURFACE IMAGING, P148
   CULLEN DC, 1994, J COLLOID INTERF SCI, V166, P102, DOI 10.1006/jcis.1994.1276
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   CUTRESS TW, 1972, ARCH ORAL BIOL, V17, P93, DOI 10.1016/0003-9969(72)90137-9
   Czajkowsky DM, 2000, J ELECTRON MICROSC, V49, P395, DOI 10.1093/oxfordjournals.jmicro.a023821
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   deBeer D, 1995, WATER SCI TECHNOL, V32, P11, DOI 10.1016/0273-1223(96)00002-9
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   DELAMAR M, 1990, J ELECTRON SPECTROSC, V53, pC11, DOI 10.1016/0368-2048(90)80335-8
   DELMAESTRO RF, 1980, ACTA PHYSIOL SCAND, P153
   DENBESTEN PK, 1986, J DENT RES, V65, P1272, DOI 10.1177/00220345860650101401
   DENGIS PB, 1995, COLLOID SURFACE B, V4, P199, DOI 10.1016/0927-7765(94)01171-Z
   Dengis PB, 1996, J MICROBIOL METH, V26, P171, DOI 10.1016/0167-7012(96)00909-8
   Dengis PB, 1997, YEAST, V13, P931, DOI 10.1002/(SICI)1097-0061(199708)13:10<931::AID-YEA149>3.0.CO;2-T
   DeSantis D, 1996, J MATER SCI-MATER M, V7, P21, DOI 10.1007/BF00121185
   DHERT WJA, 1991, J BIOMED MATER RES, V25, P1183, DOI 10.1002/jbm.820251002
   Diebold U, 1998, SURF SCI, V411, P137, DOI 10.1016/S0039-6028(98)00356-2
   Diebold U, 1996, PHYS REV LETT, V77, P1322, DOI 10.1103/PhysRevLett.77.1322
   DIEBOLD U, 2000, COMMUNICATION
   Dieluweit S, 1998, SUPRAMOL SCI, V5, P15, DOI 10.1016/S0968-5677(97)00073-4
   DMYTRYK JJ, 1990, J PERIODONTOL, V61, P491, DOI 10.1902/jop.1990.61.8.491
   do Serro APVA, 1997, COLLOID SURFACE B, V10, P95, DOI 10.1016/S0927-7765(97)00060-X
   Dombrowski KE, 1996, FASEB J, V10, P2854
   Dorozhkin SV, 1997, J CRYST GROWTH, V182, P125, DOI 10.1016/S0022-0248(97)00330-8
   Dorozhkin SV, 1997, J CRYST GROWTH, V182, P133, DOI 10.1016/S0022-0248(97)00331-X
   Dorozhkin SV, 1997, J COLLOID INTERF SCI, V191, P489, DOI 10.1006/jcis.1997.4942
   DOUNDOULAKIS JH, 1987, J PROSTHET DENT, V58, P471, DOI 10.1016/0022-3913(87)90279-4
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   Ducheyne P, 1992, Clin Orthop Relat Res, P102
   DUCKWORTH RM, 1992, J DENT RES, V71, P934, DOI 10.1177/002203459207100S29
   Dufrene YF, 1996, COLLOID SURFACE B, V7, P271, DOI 10.1016/0927-7765(96)01295-7
   Dufrene YF, 1996, CAN J MICROBIOL, V42, P548, DOI 10.1139/m96-074
   Dufrene YF, 1997, J BACTERIOL, V179, P1023, DOI 10.1128/jb.179.4.1023-1028.1997
   Dufrene YF, 1996, BIOFOULING, V9, P307, DOI 10.1080/08927019609378312
   Dunn AW, 1996, J VAC SCI TECHNOL B, V14, P1596, DOI 10.1116/1.589197
   DUNN GA, 1986, J CELL SCI, V83, P313
   Dupraz AMP, 1996, J BIOMED MATER RES, V30, P231, DOI 10.1002/(SICI)1097-4636(199602)30:2<231::AID-JBM13>3.0.CO;2-P
   DURINCK G, 1991, SOLID STATE COMMUN, V80, P579, DOI 10.1016/0038-1098(91)90155-O
   Eck W, 2000, ADV MATER, V12, P805, DOI 10.1002/(SICI)1521-4095(200006)12:11<805::AID-ADMA805>3.3.CO;2-S
   EDGAR WM, 1990, SALIVA ORAL HLTH
   EFFAH EAB, 1995, J BIOMED MATER RES, V29, P73, DOI 10.1002/jbm.820290111
   Egdell RG, 1998, J MATER CHEM, V8, P469, DOI 10.1039/a706191i
   Eick J D, 1993, Quintessence Int, V24, P632
   Eick JD, 1997, CRIT REV ORAL BIOL M, V8, P306, DOI 10.1177/10454411970080030501
   Eick JD, 1996, J DENT RES, V75, P1027, DOI 10.1177/00220345960750040501
   EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0
   EIKENBERRY EF, 1980, J MOL BIOL, V144, P397, DOI 10.1016/0022-2836(80)90098-4
   Einstein A, 1905, ANN PHYS-BERLIN, V17, P132
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   EJOV AA, 1994, J VAC SCI TECHNOL B, V12, P1547, DOI 10.1116/1.587283
   Ektessabi AM, 1996, NUCL INSTRUM METH B, V109, P278, DOI 10.1016/0168-583X(95)00922-1
   EKTESSABI AM, 1994, INT J PIXE, V4, P81
   El Feninat F, 1998, J BIOMED MATER RES, V42, P549, DOI 10.1002/(SICI)1097-4636(19981215)42:4<549::AID-JBM10>3.0.CO;2-L
   ELDER B, 1993, CARIOLOGY 90S
   Eley BM, 1997, BRIT DENT J, V183, P11, DOI 10.1038/sj.bdj.4809419
   Elftonson JE, 1996, J ADHES SCI TECHNOL, V10, P761, DOI 10.1163/156856196X00643
   Eliades G, 1997, DENT MATER, V13, P24, DOI 10.1016/S0109-5641(97)80005-X
   Eliades T, 1997, INT J ORAL MAX IMPL, V12, P621
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   Elliott JC, 1997, CIBA F SYMP, V205, P54
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   EMSLEY J, 1976, CHEM PHOSPHOROUS ENV
   ERIKSEN S, 1987, SPECTROCHIM ACTA A, V43, P1535, DOI 10.1016/S0584-8539(87)80043-0
   Es-Souni M, 1999, COLLOID POLYM SCI, V277, P382, DOI 10.1007/s003960050396
   Esposito M, 1999, J BIOMED MATER RES, V48, P559, DOI 10.1002/(SICI)1097-4636(1999)48:4<559::AID-JBM23>3.0.CO;2-M
   Evans GT, 1998, J CHEM PHYS, V109, P2519, DOI 10.1063/1.476824
   Evans S, 1997, SURF INTERFACE ANAL, V25, P924, DOI 10.1002/(SICI)1096-9918(199711)25:12<924::AID-SIA317>3.0.CO;2-2
   FAHMI A, 1994, SURF SCI, V304, P343, DOI 10.1016/0039-6028(94)91345-5
   Farina M, 1999, J STRUCT BIOL, V125, P39, DOI 10.1006/jsbi.1998.4069
   FEJERSKOV O, 1996, FLUORIDE DENTISTRY
   Feldman K, 1999, J AM CHEM SOC, V121, P10134, DOI 10.1021/ja991049b
   Feng QL, 1999, J CRYST GROWTH, V200, P550, DOI 10.1016/S0022-0248(98)01402-X
   Fenter P, 2000, J COLLOID INTERF SCI, V225, P154, DOI 10.1006/jcis.2000.6756
   Fernandes MH, 1999, J BIOMATER APPL, V14, P113, DOI 10.1177/088532829901400202
   FERRER S, 1980, SURF SCI, V94, P41, DOI 10.1016/0039-6028(80)90155-7
   Ferris KF, 1998, J VAC SCI TECHNOL A, V16, P956, DOI 10.1116/1.581219
   Feugeas F, 1997, J PHYS III, V7, P631, DOI 10.1051/jp3:1997147
   FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011
   Fincham AG, 1997, CIBA F SYMP, V205, P118
   Fischer D, 1997, J VAC SCI TECHNOL A, V15, P2173, DOI 10.1116/1.580529
   FISCHER S, 1995, SURF SCI, V337, P17, DOI 10.1016/0039-6028(95)00572-2
   FISHER SJ, 1987, ARCH ORAL BIOL, V32, P509, DOI 10.1016/S0003-9969(87)80013-4
   FITZPATRICK H, 1992, J COLLOID INTERF SCI, V149, P1, DOI 10.1016/0021-9797(92)90384-X
   FLAVELL WR, 1997, SURFACE ANAL PRINCIP, P376
   FLEISCH H, 1981, J CRYST GROWTH, V53, P120, DOI 10.1016/0022-0248(81)90059-2
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FLOWER HM, 1974, ACTA METALL MATER, V22, P1339, DOI 10.1016/0001-6160(74)90034-0
   FOX SC, 1990, J PERIODONTOL, V61, P485, DOI 10.1902/jop.1990.61.8.485
   FRANCIS MD, 1971, CALC TISS RES, V6, P335
   Frauchiger L, 1999, APPL SURF SCI, V143, P67, DOI 10.1016/S0169-4332(98)00932-5
   FREEMAN BA, 1982, LAB INVEST, V47, P412
   FRISBIE CD, 1994, SCIENCE, V265, P2071, DOI 10.1126/science.265.5181.2071
   FRISBIE CD, 1995, LANGMUIR, V11, P2563, DOI 10.1021/la00007a040
   FRITSCH HW, 1993, INT J MASS SPECTROM, V126, P191, DOI 10.1016/0168-1176(93)80084-R
   Fukui K, 1997, PHYS REV LETT, V79, P4202, DOI 10.1103/PhysRevLett.79.4202
   GABRIEL BL, 1994, BIOMATERIALS, V15, P628, DOI 10.1016/0142-9612(94)90214-3
   GANGLER P, 1993, SCAND J DENT RES, V101, P345
   GARRETT SJ, 1990, J ELECTRON SPECTROSC, V54, P1065, DOI 10.1016/0368-2048(90)80296-M
   GEIGER SB, 1993, DENT MATER, V9, P33, DOI 10.1016/0109-5641(93)90102-V
   Gellings PJ, 2000, CATAL TODAY, V58, P1, DOI 10.1016/S0920-5861(00)00240-6
   GILLEN G, 1994, ANAL CHEM, V66, P2170, DOI 10.1021/ac00085a036
   Gimzewski JK, 1997, SURF SCI, V386, P101, DOI 10.1016/S0039-6028(97)00301-4
   GLIMCHER MJ, TREATISE COLLAGEN B, V2
   GOLANDER CG, 1988, J COLLOID INTERF SCI, V121, P240, DOI 10.1016/0021-9797(88)90428-6
   GOLANDER CG, 1986, COLLOID SURFACE, V21, P149, DOI 10.1016/0166-6622(86)80088-9
   GOLDSTEIN JI, 1994, SCANNING ELECT MICRO
   Goniakowski J, 1996, SURF SCI, V350, P145, DOI 10.1016/0039-6028(95)01252-4
   GONIAKOWSKI J, 1995, SURF SCI, V330, P337, DOI 10.1016/0039-6028(95)00348-7
   GONIAKOWSKI J, 1993, SURF SCI, V284, P315, DOI 10.1016/0039-6028(93)90502-B
   GOODMAN DW, 1994, SURF SCI, V299, P837, DOI 10.1016/0039-6028(94)90701-3
   Gotfredsen K, 1992, Clin Oral Implants Res, V3, P77, DOI 10.1034/j.1600-0501.1992.030205.x
   Gracias DH, 1999, ACCOUNTS CHEM RES, V32, P930, DOI 10.1021/ar990034f
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   Greenspan DC, 1999, CURR OPIN SOLID ST M, V4, P389, DOI 10.1016/S1359-0286(99)00021-2
   GRIESSER HJ, 2000, BIOM SURF AN NEW MIL
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Gun'ko VM, 1999, LANGMUIR, V15, P6405, DOI 10.1021/la9809372
   Guo Q, 1996, PHYS REV LETT, V77, P3851, DOI 10.1103/PhysRevLett.77.3851
   GUY SC, 1993, J PERIODONTOL, V64, P542, DOI 10.1902/jop.1993.64.6.542
   GUYOTSIONNEST P, 1987, PHYS REV LETT, V59, P1597, DOI 10.1103/PhysRevLett.59.1597
   Gwinnett A J, 1994, Am J Dent, V7, P144
   Haber J, 1996, ACS SYM SER, V638, P20
   HADJIIVANOV KI, 1996, CHEM SOC REV, V25, P66
   HAHNER G, 1992, J VAC SCI TECHNOL A, V10, P2758
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   Hanawa T, 1997, J BIOMED MATER RES, V34, P273
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   Hanawa T, 1996, CORROS SCI, V38, P1579, DOI 10.1016/0010-938X(96)00053-4
   Hanawa T, 1996, CORROS SCI, V38, P2061, DOI 10.1016/S0010-938X(96)89124-4
   HANAWA T, 1989, J JPN SOC DENT MATER, V8, P832
   HANSON DM, 1981, PHYS REV B, V24, P5513, DOI 10.1103/PhysRevB.24.5513
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279
   Hartman L C, 1989, Int J Oral Maxillofac Implants, V4, P11
   Hasselstrom J, 1998, SURF SCI, V407, P221, DOI 10.1016/S0039-6028(98)00190-3
   Hautaniemi JA, 1996, SURF INTERFACE ANAL, V24, P763, DOI 10.1002/(SICI)1096-9918(199610)24:11<763::AID-SIA178>3.0.CO;2-E
   HAUTANIEMI JA, 1995, SURF INTERFACE ANAL, V23, P833, DOI 10.1002/sia.740231206
   HAY DI, 1967, ARCH ORAL BIOL, V12, P937, DOI 10.1016/0003-9969(67)90088-X
   HAY DI, 1979, J DENT RES, V58, P930, DOI 10.1177/00220345790580024701
   Heaney TG, 1996, J BIOMED MATER RES, V32, P593, DOI 10.1002/(SICI)1097-4636(199612)32:4<593::AID-JBM12>3.0.CO;2-F
   Heiz U, 2000, J PHYS D APPL PHYS, V33, pR85, DOI 10.1088/0022-3727/33/11/201
   HENCH LJ, 1991, BIOCERAMICS MRS B, V9, P62
   Hench LL, 1999, MRS BULL, V24, P13
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   HENCH LL, 1996, BIOMATERIALS SCI INT, P75
   Henderson B, 1999, CELLULAR MICROBIOLOG
   Henderson MA, 1996, SURF SCI, V355, P151, DOI 10.1016/0039-6028(95)01357-1
   Henderson MA, 1996, LANGMUIR, V12, P5093, DOI 10.1021/la960360t
   HENDERSON MA, 1995, SURF SCI, V343, pL1156, DOI 10.1016/0039-6028(95)00849-7
   Henderson MA, 1999, FARADAY DISCUSS, V114, P313, DOI 10.1039/a902070e
   HENGLEIN A, 1987, ULTRASONICS, V25, P6, DOI 10.1016/0041-624X(87)90003-5
   HENRICH VE, 1977, SOLID STATE COMMUN, V24, P623, DOI 10.1016/0038-1098(77)90376-3
   HERCULES DM, 1976, J DENT RES, V55, P829, DOI 10.1177/00220345760550051901
   Herman GS, 2000, SURF SCI, V447, P201, DOI 10.1016/S0039-6028(99)01186-3
   Herman GS, 2000, PHYS REV LETT, V84, P3354, DOI 10.1103/PhysRevLett.84.3354
   Hiemenz P. C., 1977, PRINCIPLES COLLOID S
   Himmelhaus M, 2000, J PHYS CHEM B, V104, P576, DOI 10.1021/jp992073e
   HIROSE C, 1992, J CHEM PHYS, V96, P997, DOI 10.1063/1.462120
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   Holgers KM, 1999, BIOMATERIALS, V20, P1319, DOI 10.1016/S0142-9612(99)00033-2
   Holgers KM, 1994, INT J ORAL MAXILLOF, V9, P689
   Holmberg K, 1997, COLLOID SURFACE A, V123, P297, DOI 10.1016/S0927-7757(96)03810-1
   Horbett TA, 1995, ACS SYM SER, V602, P1
   HORBETT TA, 1982, ADV CHEM SER, P233
   Horbett Thomas A., 1996, P133
   Howard A, 2000, SURF SCI, V448, P131, DOI 10.1016/S0039-6028(99)01229-7
   Howlett C. R., 1993, Clinical Materials, V14, P57, DOI 10.1016/0267-6605(93)90048-C
   HOWLETT CR, 1994, J MATER SCI-MATER M, V5, P715, DOI 10.1007/BF00120363
   Howlett CR, 1999, J BIOMED MATER RES, V44, P352, DOI 10.1002/(SICI)1097-4636(19990305)44:3<352::AID-JBM14>3.0.CO;2-A
   Hristova E, 1997, J ELECTROCHEM SOC, V144, P2318, DOI 10.1149/1.1837811
   Hu K, 1997, J PHYS CHEM B, V101, P8298, DOI 10.1021/jp971887x
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   Hubbell JA, 1998, CURR OPIN SOLID ST M, V3, P246, DOI 10.1016/S1359-0286(98)80098-3
   HUETZ P, 1995, LANGMUIR, V11, P3145, DOI 10.1021/la00008a046
   HUGENSCHMIDT MB, 1994, SURF SCI, V302, P329, DOI 10.1016/0039-6028(94)90837-0
   Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059
   IHS A, 1990, J COLLOID INTERF SCI, V140, P192, DOI 10.1016/0021-9797(90)90335-L
   IHS A, 1991, J COLLOID INTERF SCI, V144, P282, DOI 10.1016/0021-9797(91)90259-B
   IIJIMA M, 1992, J CRYST GROWTH, V116, P319, DOI 10.1016/0022-0248(92)90639-Z
   INOUE T, 1987, J BIOMED MATER RES, V21, P107, DOI 10.1002/jbm.820210114
   Ishikawa K, 1997, J BIOMED MATER RES, V38, P129, DOI 10.1002/(SICI)1097-4636(199722)38:2<129::AID-JBM7>3.0.CO;2-S
   ISHIKAWA T, 1991, LANGMUIR, V7, P596, DOI 10.1021/la00051a031
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   IVARSSON B, 1986, CRIT REV BIOCOMPAT, V2, P1
   Jagur-Grodzinski J, 1999, REACT FUNCT POLYM, V39, P99, DOI 10.1016/S1381-5148(98)00054-6
   JANSEN JA, 1991, BIOMATERIALS, V12, P25, DOI 10.1016/0142-9612(91)90127-V
   JANSEN JA, 1990, J MATER SCI-MATER M, V1, P192, DOI 10.1007/BF00701076
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JEON NL, 1995, LANGMUIR, V11, P3024, DOI 10.1021/la00008a029
   Jha LJ, 1996, J BIOMED MATER RES, V31, P481, DOI 10.1002/(SICI)1097-4636(199608)31:4<481::AID-JBM7>3.0.CO;2-H
   JOBIN M, 1995, J APPL PHYS, V77, P5149, DOI 10.1063/1.359259
   JOHANSEN E, 1964, J DENT RES, V43, P1007, DOI 10.1177/00220345640430060201
   JOHANSSON CB, 1993, J MATER SCI-MATER M, V4, P132, DOI 10.1007/BF00120382
   Johnson MA, 1998, J PHYS CHEM B, V102, P6391, DOI 10.1021/jp9813995
   Jones DW, 1996, KEY ENG MATER, V122-1, P345, DOI 10.4028/www.scientific.net/KEM.122-124.345
   JONES FH, UNPUB
   JONKER BT, 1981, PHYS REV B, V24, P2951, DOI 10.1103/PhysRevB.24.2951
   Kaciulis S, 1998, J ELECTRON SPECTROSC, V95, P61, DOI 10.1016/S0368-2048(98)00202-3
   KANDORI K, 1995, J COLLOID INTERF SCI, V174, P124, DOI 10.1006/jcis.1995.1373
   KANDORI K, 1992, COLLOID SURFACE, V68, P283, DOI 10.1016/0166-6622(92)80214-M
   KANDORI K, 1995, COLLOID SURFACE B, V5, P81, DOI 10.1016/0927-7765(95)98210-E
   KANGASNIEMI IMO, 1994, J BIOMED MATER RES, V28, P563, DOI 10.1002/jbm.820280506
   Kanzaki N, 1998, J PHYS CHEM B, V102, P6471, DOI 10.1021/jp981512r
   KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028
   KASAS S, 1993, P SOC PHOTO-OPT INS, V1855, P17, DOI 10.1117/12.146381
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   Kasemo B, 1998, CURR OPIN SOLID ST M, V3, P451, DOI 10.1016/S1359-0286(98)80006-5
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KASEMO B, 1999, ADV DENT RES, V13
   KAUFMANN R, 1993, RAPID COMMUN MASS SP, V7, P902, DOI 10.1002/rcm.1290071010
   Kavan L, 1996, J AM CHEM SOC, V118, P6716, DOI 10.1021/ja954172l
   Kawahara D, 1996, Int J Oral Maxillofac Implants, V11, P435
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   KELLER J C, 1990, International Journal of Oral and Maxillofacial Implants, V5, P360
   KELLER JC, 1989, J ADHESION, V28, P115, DOI 10.1080/00218468908030878
   Kelly JR, 1997, ANNU REV MATER SCI, V27, P443, DOI 10.1146/annurev.matsci.27.1.443
   Kerber SJ, 1998, J MATER ENG PERFORM, V7, P334, DOI 10.1361/105994998770347774
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   KIESWETTER K, 1994, BIOMATERIALS, V15, P183, DOI 10.1016/0142-9612(94)90065-5
   KILNER AMC, 1991, SURF INTERFACE ANAL, V17, P158, DOI 10.1002/sia.740170307
   Kilpadi DV, 1998, J BIOMED MATER RES, V40, P646, DOI 10.1002/(SICI)1097-4636(19980615)40:4<646::AID-JBM17>3.3.CO;2-L
   KILPADI DV, 1994, J BIOMED MATER RES, V28, P1419, DOI 10.1002/jbm.820281206
   Kilpadi DV, 1998, COLLOID SURFACE A, V135, P89, DOI 10.1016/S0927-7757(97)00237-9
   Kim DG, 1999, BIO-MED MATER ENG, V9, P89
   Kim HM, 1999, J BIOMED MATER RES, V45, P100, DOI 10.1002/(SICI)1097-4636(199905)45:2<100::AID-JBM4>3.0.CO;2-0
   Kim HM, 1997, J BIOMED MATER RES, V38, P121
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kim HM, 1997, J CERAM SOC JPN, V105, P111, DOI 10.2109/jcersj.105.111
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Kingshott P, 2000, J BIOMED MATER RES, V49, P36, DOI 10.1002/(SICI)1097-4636(200001)49:1<36::AID-JBM5>3.0.CO;2-B
   Kinney JH, 1996, J BIOMECH ENG-T ASME, V118, P133, DOI 10.1115/1.2795939
   Kirkham J, 1998, CONNECT TISSUE RES, V38, P91, DOI 10.3109/03008209809017025
   Klauber C, 1990, Int J Oral Maxillofac Implants, V5, P264
   Klee D, 1999, ADV POLYM SCI, V149, P1
   KNOBLER CM, 1991, CURR OPIN COLLOID IN, V4, P46
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Konishi K, 1987, J Osaka Dent Univ, V21, P1
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Korn D, 1997, J MATER SCI-MATER M, V8, P613, DOI 10.1023/A:1018567302700
   Kratz F, 1999, CRIT REV THER DRUG, V16, P245, DOI 10.1615/CritRevTherDrugCarrierSyst.v16.i3.10
   KREIS T, 1993, GUIDEBOOK EXTRACELLU
   KUBOKI Y, 1987, J DENT RES, V66, P1016, DOI 10.1177/00220345870660050401
   KUEMPEL DR, 1995, J PERIODONTOL, V66, P228, DOI 10.1902/jop.1995.66.3.228
   Kuliralo M, 1991, J Biol Buccale, V19, P247
   KUMAR A, 1995, ACCOUNTS CHEM RES, V28, P219, DOI 10.1021/ar00053a003
   KUMAR A, 1992, J AM CHEM SOC, V114, P9188, DOI 10.1021/ja00049a061
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628
   Kurahashi M, 1999, J VAC SCI TECHNOL A, V17, P1047, DOI 10.1116/1.581681
   KURTZ RL, 1989, SURF SCI, V218, P178, DOI 10.1016/0039-6028(89)90626-2
   Kusu F, 1998, ELECTROCHIM ACTA, V43, P1873, DOI 10.1016/S0013-4686(97)00308-3
   LakatosVarsanyi M, 1997, INT J ORAL MAX IMPL, V12, P387
   LANDIS WJ, 1984, J VAC SCI TECHNOL A, V2, P1108, DOI 10.1116/1.572680
   LANGE W, 1984, SURF SCI, V136, P419, DOI 10.1016/0039-6028(84)90621-6
   Larsen NB, 1997, J AM CHEM SOC, V119, P3017, DOI 10.1021/ja964090c
   LARSON I, 1993, J AM CHEM SOC, V115, P11885, DOI 10.1021/ja00078a029
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Larsson C, 1997, J MATER SCI-MATER M, V8, P721, DOI 10.1023/A:1018548225899
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   LARSSON SJ, 1977, CALC TISS RES, V24, P179, DOI 10.1007/BF02223313
   Lasserre A, 1998, CRIT REV THER DRUG, V15, P1
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lausmaa J, 1999, J BIOMED MATER RES, V44, P227, DOI 10.1002/(SICI)1097-4636(19990305)44:3<227::AID-JBM1>3.0.CO;2-H
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LAUSMAA J, 1985, BIOMATERIALS, V6, P23, DOI 10.1016/0142-9612(85)90033-X
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   Lavelle C L, 1981, J Oral Implantol, V9, P357
   Lawrence JR, 1999, METHOD ENZYMOL, V310, P131
   Leadley SR, 1997, BIOMATERIALS, V18, P311, DOI 10.1016/S0142-9612(96)00134-2
   LEBUGLE A, 1995, BBA-PROTEIN STRUCT M, V1248, P107, DOI 10.1016/0167-4838(95)00009-J
   LEFEVRE R, 1976, CALC TISS RES, V19, P251
   LeGeros R. Z., 1991, CALCIUM PHOSPHATES O
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   Leggett GJ, 1997, SURFACE ANALYSIS - THE PRINCIPAL TECHNIQUES, P393
   Leitao E, 1998, J MATER SCI-MATER M, V9, P543, DOI 10.1023/A:1008896106994
   Leonard D, 1999, FRESEN J ANAL CHEM, V365, P3, DOI 10.1007/s002160051437
   Leonhard A, 1995, MICROB ECOL HEALTH D, V8, P293, DOI 10.3109/08910609509140108
   LEONHARDT A, 1995, J DENT RES, V74, P1607, DOI 10.1177/00220345950740091701
   LERCEL MJ, 1994, APPL PHYS LETT, V65, P974, DOI 10.1063/1.113012
   LERCEL MJ, 1994, J VAC SCI TECHNOL B, V12, P3663, DOI 10.1116/1.587635
   LERCEL MJ, 1995, MICROELECTRON ENG, V27, P43, DOI 10.1016/0167-9317(94)00052-V
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   Li M, 1999, SURF SCI, V437, P173, DOI 10.1016/S0039-6028(99)00720-7
   Li M, 1998, SURF SCI, V414, pL951, DOI 10.1016/S0039-6028(98)00549-4
   Li M, 1999, FARADAY DISCUSS, V114, P245, DOI 10.1039/a903598b
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   LI PJ, 1993, J BIOMED MATER RES, V27, P1495, DOI 10.1002/jbm.820271205
   Li XD, 1997, BIOMATERIALS, V18, P1487, DOI 10.1016/S0142-9612(97)00085-9
   Li XL, 1999, CHINESE J ANAL CHEM, V27, P47
   Li YM, 1998, J AM DENT ASSOC, V129, P494
   LIEDBERG B, 1984, J BIOCHEM BIOPH METH, V9, P233, DOI 10.1016/0165-022X(84)90028-9
   LIN A, 1992, J DENT RES, V71, P1836, DOI 10.1177/00220345920710111401
   Lindan PJD, 1996, CHEM PHYS LETT, V261, P246, DOI 10.1016/0009-2614(96)00934-7
   Lindan PJD, 1998, PHYS REV LETT, V80, P762, DOI 10.1103/PhysRevLett.80.762
   Lisle JT, 1999, METHOD ENZYMOL, V310, P166
   Liu FY, 1998, APPL RADIAT ISOTOPES, V49, P67
   LO WJ, 1978, SURF SCI, V71, P199
   LODDING A, 1985, SCAND J DENT RES, V93, P315
   LODDING A, 1983, SCAN ELECTRON MICROS, P1229
   LODDING AR, 1990, ANAL CHIM ACTA, V241, P299, DOI 10.1016/S0003-2670(00)83660-0
   Lofgren P, 1997, SURF SCI, V370, P277, DOI 10.1016/S0039-6028(96)00961-2
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lopes MA, 1998, J BIOMED MATER RES, V39, P244, DOI 10.1002/(SICI)1097-4636(199802)39:2<244::AID-JBM11>3.0.CO;2-D
   LOWENBERG B, 1991, CELL MATER, V1, P177
   Lu HBB, 1999, ABSTR PAP AM CHEM S, V217, pU670
   Lundgren T, 1998, HISTOCHEM J, V30, P351, DOI 10.1023/A:1003284511863
   Lundgren T, 1998, ARCH ORAL BIOL, V43, P841, DOI 10.1016/S0003-9969(98)00074-0
   LUNDSTROM I, 1990, J COLLOID INTERF SCI, V136, P68, DOI 10.1016/0021-9797(90)90079-4
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   Mader C, 2000, BBA-BIOMEMBRANES, V1463, P142, DOI 10.1016/S0005-2736(99)00190-X
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   Marshall G W Jr, 1993, Quintessence Int, V24, P606
   1998, MRS B, V23, P11
   1993, J APPL BACTERIOL S S, V74, pS87
   1973, J CLIN INVEST, V51, P741
   1996, J ELECT SPECTROSC RE, V81
   1975, J LAB CLIN MED, V85, P235
   1998, MRS B, V23, P14
   1998, BIOMATERIALS, V19
   AR Ten Cate, 1994, ORAL HISTOLOGY DEV S
   MARSHALL GW, 1993, DENT MATER, V9, P265, DOI 10.1016/0109-5641(93)90072-X
   Marshall GW, 1997, DENT MATER, V13, P338, DOI 10.1016/S0109-5641(97)80104-2
   MARSHALL GW, 1995, J BIOMED MATER RES, V29, P1381, DOI 10.1002/jbm.820291109
   MARSHALL KC, 1994, COLLOID SURFACE B, V2, P371, DOI 10.1016/0927-7765(94)80050-2
   Martin JY, 1996, CLIN ORAL IMPLAN RES, V7, P27, DOI 10.1034/j.1600-0501.1996.070104.x
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mathieu HJ, 1997, SURFACE ANALYSIS - THE PRINCIPAL TECHNIQUES, P99
   Matkovic P, 1998, METALURGIJA, V37, P15
   MATTHEWS RW, 1988, J CATAL, V111, P264, DOI 10.1016/0021-9517(88)90085-1
   MATTHEWS WG, 1993, ARCH ORAL BIOL, V38, P517, DOI 10.1016/0003-9969(93)90188-R
   McCafferty E, 1999, APPL SURF SCI, V143, P92, DOI 10.1016/S0169-4332(98)00927-1
   McCafferty E, 1998, SURF INTERFACE ANAL, V26, P549, DOI 10.1002/(SICI)1096-9918(199807)26:8<549::AID-SIA396>3.3.CO;2-H
   McCafferty E, 1999, J ELECTROCHEM SOC, V146, P2849, DOI 10.1149/1.1392019
   McCANN HAROLD G., 1955, JOUR DENTAL RES, V34, P59, DOI 10.1177/00220345550340011601
   MCDOWELL SG, 1995, LETT APPL MICROBIOL, V21, P1, DOI 10.1111/j.1472-765X.1995.tb00992.x
   McKendry R, 1998, NATURE, V391, P566, DOI 10.1038/35339
   McLean KM, 2000, COLLOID SURFACE B, V17, P23, DOI 10.1016/S0927-7765(99)00055-7
   MEACHIN G, 1973, J BIOMED MATER RES, V7, P572
   MEISENHEIMER RG, 1976, BIOCHEM BIOPH RES CO, V68, P994, DOI 10.1016/0006-291X(76)91244-4
   Meschenmoser A, 1996, J PERIODONTOL, V67, P229, DOI 10.1902/jop.1996.67.3.229
   MEYLE J, 1991, J APPL BIOMATER, V2, P273, DOI 10.1002/jab.770020409
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   MIAKE Y, 1993, CALCIFIED TISSUE INT, V53, P249, DOI 10.1007/BF01320910
   MICHAELS C M, 1991, Journal of Oral Implantology, V17, P132
   MILLER RG, 1994, J DENT RES, V73, P1457, DOI 10.1177/00220345940730081001
   MILLER RG, 1993, J DENT MAT, V9, P280
   Mitchell RJ, 1996, CRIT REV ORAL BIOL M, V7, P12, DOI 10.1177/10454411960070010101
   Moffitt CE, 1998, BIOMATERIALS, V19, P1319, DOI 10.1016/S0142-9612(97)00169-5
   Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x
   MORENO EC, 1991, CALCIFIED TISSUE INT, V49, P6, DOI 10.1007/BF02555895
   Morita S, 1999, APPL SURF SCI, V140, P406, DOI 10.1016/S0169-4332(98)00563-7
   Morra M, 1998, SURF INTERFACE ANAL, V26, P742, DOI 10.1002/(SICI)1096-9918(199809)26:10<742::AID-SIA417>3.0.CO;2-P
   Morra M, 1997, SURF INTERFACE ANAL, V25, P983, DOI 10.1002/(SICI)1096-9918(199712)25:13<983::AID-SIA345>3.0.CO;2-X
   Morra M, 1999, LANGMUIR, V15, P4658, DOI 10.1021/la981345m
   MORRIS VJ, 2000, ATOMIC FORCE MICROSC
   Mottu F, 1999, INVEST RADIOL, V34, P323, DOI 10.1097/00004424-199905000-00001
   Mount GJ, 1999, OPER DENT, V24, P115
   Mount GJ, 1998, PRESERVATION RESTORA
   MOZES N, 1988, BIOCHIM BIOPHYS ACTA, V945, P324, DOI 10.1016/0005-2736(88)90495-6
   Mozes N., 1991, MICROBIAL CELL SURFA
   Mugele F, 2000, J PHYS CHEM B, V104, P3140, DOI 10.1021/jp9935236
   Muller HU, 1995, J VAC SCI TECHNOL B, V13, P2846, DOI 10.1116/1.588302
   MURGA R, 1995, BIOTECHNOL BIOENG, V45, P503, DOI 10.1002/bit.260450607
   MURRAY PW, 1992, PHYS REV B, V46, P12877, DOI 10.1103/PhysRevB.46.12877
   MURRAY PW, 1995, PHYS REV B, V51, P10989, DOI 10.1103/PhysRevB.51.10989
   MURRAY PW, 1994, SURF SCI, V321, P217, DOI 10.1016/0039-6028(94)90187-2
   MURRAY PW, 1994, PHYS REV LETT, V72, P689, DOI 10.1103/PhysRevLett.72.689
   NAKABAYASHI N, 1992, DENT MATER, V8, P125, DOI 10.1016/0109-5641(92)90067-M
   Nakaya T, 1999, PROG POLYM SCI, V24, P143, DOI 10.1016/S0079-6700(98)00015-X
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Naray-Szabo S, 1930, Z KRISTALLOGR, V75, P387
   NAUJOKS R., 1967, CARIES RES, V1, P137
   NAYAK PL, 1999, CHEM PHYS C, V39, P481
   NEWMAN HN, 1999, DENTAL PLAQUE REVISI
   Nicholson JW, 1998, BIOMATERIALS, V19, P485, DOI 10.1016/S0142-9612(97)00128-2
   Nicholson JW, 2000, INT J ADHES ADHES, V20, P11, DOI 10.1016/S0143-7496(99)00009-3
   Nilsson T, 1996, ARTIF INTELL MED, V8, P515, DOI 10.1016/S0933-3657(96)00350-8
   Nilsson T, 1998, CONNECT TISSUE RES, V38, P81, DOI 10.3109/03008209809017024
   Nishiguchi S, 1999, J BIOMED MATER RES, V48, P689, DOI 10.1002/(SICI)1097-4636(1999)48:5<689::AID-JBM13>3.3.CO;2-3
   Nishimura N, 1998, J MATER SCI-MATER M, V9, P99, DOI 10.1023/A:1008851115846
   Nooney MG, 1998, LANGMUIR, V14, P2750, DOI 10.1021/la9702695
   NORDE W, 1979, J COLLOID INTERF SCI, V71, P350, DOI 10.1016/0021-9797(79)90245-5
   NOREN JG, 1984, CARIES RES, V18, P242, DOI 10.1159/000260772
   NOREN JG, 1983, CARIES RES, V17, P496, DOI 10.1159/000260709
   Norenberg H, 1999, PHYS REV B, V59, P9842, DOI 10.1103/PhysRevB.59.9842
   Norenberg H, 1998, SURF SCI, V396, P52, DOI 10.1016/S0039-6028(97)00658-4
   Norenberg H, 1998, SURF SCI, V402, P738, DOI 10.1016/S0039-6028(97)01000-5
   Noth U, 1999, BIOMED TECH, V44, P6, DOI 10.1515/bmte.1999.44.1-2.6
   Noy A, 1997, ANNU REV MATER SCI, V27, P381, DOI 10.1146/annurev.matsci.27.1.381
   Nugues S, 1996, J ELECTROANAL CHEM, V408, P125, DOI 10.1016/0022-0728(96)04523-8
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Ohtsuki C, 1997, J BIOMED MATER RES, V35, P39, DOI 10.1002/(SICI)1097-4636(199704)35:1<39::AID-JBM5>3.0.CO;2-N
   OKAMOTO Y, 1991, J ORAL REHABIL, V18, P507, DOI 10.1111/j.1365-2842.1991.tb00073.x
   OKAZAKI M, 1989, BIOMATERIALS, V10, P564, DOI 10.1016/0142-9612(89)90064-1
   Okazaki M, 1999, BIOMATERIALS, V20, P1073, DOI 10.1016/S0142-9612(98)00244-0
   Okazaki M, 1997, BIOMATERIALS, V18, P795, DOI 10.1016/S0142-9612(97)00009-4
   OLIN H, 1992, ULTRAMICROSCOPY, V42, P567, DOI 10.1016/0304-3991(92)90325-E
   Oliver PM, 1997, J MATER CHEM, V7, P563, DOI 10.1039/a606353e
   OLSSON J, 1991, COLLOID POLYM SCI, V269, P1295, DOI 10.1007/BF00652539
   OLSSON J, 1990, J DENT RES, V69, P1586, DOI 10.1177/00220345900690091001
   ONG JL, 1992, BIOMATERIALS, V13, P249, DOI 10.1016/0142-9612(92)90192-Q
   ONG JL, 1995, J MATER SCI-MATER M, V6, P113, DOI 10.1007/BF00120418
   ONG JL, 1995, J BIOMED MATER RES, V29, P165, DOI 10.1002/jbm.820290205
   Ong JL, 1998, BIOMATERIALS, V19, P455, DOI 10.1016/S0142-9612(97)00224-X
   ONISHI H, 1994, CHEM PHYS LETT, V226, P111, DOI 10.1016/0009-2614(94)00712-8
   ONISHI H, 1995, B CHEM SOC JPN, V68, P2447, DOI 10.1246/bcsj.68.2447
   Onishi H, 1996, PHYS REV LETT, V76, P791, DOI 10.1103/PhysRevLett.76.791
   ONISHIM H, 1998, SURF SCI, V313, pL783
   Onuma K, 1998, CHEM MATER, V10, P3346, DOI 10.1021/cm980062c
   Onuma K, 1996, J CRYST GROWTH, V167, P773, DOI 10.1016/0022-0248(96)00421-6
   ONUMA K, 1995, J CRYST GROWTH, V154, P118, DOI 10.1016/0022-0248(95)00201-4
   OREILLY BJ, 1991, J LARYNGOL OTOL, V105, P573, DOI 10.1017/S0022215100116640
   Orstavik D, 1973, J Oral Pathol, V2, P68, DOI 10.1111/j.1600-0714.1973.tb01675.x
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1
   Palka V, 1998, J MATER SCI-MATER M, V9, P369, DOI 10.1023/A:1013275311692
   Pan J, 1998, J BIOMED MATER RES, V40, P244, DOI 10.1002/(SICI)1097-4636(199805)40:2<244::AID-JBM9>3.0.CO;2-L
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   Pan S, 1998, LANGMUIR, V14, P3545, DOI 10.1021/la971212l
   Pang CL, 2000, PHYS REV B, V62, pR7775, DOI 10.1103/PhysRevB.62.R7775
   Pang CL, 1998, PHYS REV B, V58, P1586, DOI 10.1103/PhysRevB.58.1586
   Pang CL, 2000, APPL SURF SCI, V157, P233, DOI 10.1016/S0169-4332(99)00532-2
   PANTANO CG, 1981, APPL SURF SCI, V7, P115, DOI 10.1016/0378-5963(81)90065-9
   Pashley DH, 1997, J DENT, V25, P355, DOI 10.1016/S0300-5712(96)00057-7
   Patthey L, 1999, J CHEM PHYS, V110, P5913, DOI 10.1063/1.478491
   PATTHEY L, 1995, THESIS U LAUSANNE
   PAYNTER RW, 1984, J COLLOID INTERF SCI, V101, P233, DOI 10.1016/0021-9797(84)90023-7
   PEARCE EIF, 1988, J DENT RES, V67, P1056, DOI 10.1177/00220345880670070801
   PELBLE ME, 1997, SURFACE ANAL PRINCIP, P307
   Perera IK, 1995, J MASS SPECTROM, pS3
   Pertsin AJ, 1998, J PHYS CHEM B, V102, P4918, DOI 10.1021/jp9806617
   PETERSSON LG, 1995, SWED DENT J, V19, P83
   Peyton BM, 1996, WATER RES, V30, P29, DOI 10.1016/0043-1354(95)00110-7
   PICKART L, 1978, BIOCHIM BIOPHYS ACTA, V544, P138, DOI 10.1016/0304-4165(78)90217-9
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pierres A, 1998, CURR OPIN COLLOID IN, V3, P525, DOI 10.1016/S1359-0294(98)80028-9
   PIESCO NP, 1994, ORAL DEV HISTOLOGY
   Pohle W, 1999, VIB SPECTROSC, V19, P321, DOI 10.1016/S0924-2031(98)00067-8
   POPE NM, 1993, BIOCONJUGATE CHEM, V4, P166, DOI 10.1021/bc00020a009
   POSNER S, 1961, PHOSPHOROUS ITS COMP, V2
   PRAKOBPHOL A, 1993, CARIOLOGY 90S
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Puleo DA, 1996, BIOMATERIALS, V17, P217, DOI 10.1016/0142-9612(96)85766-8
   PUM D, 1994, THIN SOLID FILMS, V244, P882, DOI 10.1016/0040-6090(94)90592-4
   Pum D, 1999, TRENDS BIOTECHNOL, V17, P8, DOI 10.1016/S0167-7799(98)01221-9
   QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801
   RACHINGER WA, 1982, CALCIFIED TISSUE INT, V34, P209, DOI 10.1007/BF02411235
   RADEGRAN G, 1991, J ELECTRON MICR TECH, V19, P99, DOI 10.1002/jemt.1060190110
   RAIKAR GN, 1995, J VAC SCI TECHNOL A, V13, P2633, DOI 10.1116/1.579462
   RATEITSCHAK KH, 1989, COLOUR ATLAS DENTAL, V1
   RATNER BD, 1995, SURF INTERFACE ANAL, V23, P521, DOI 10.1002/sia.740230712
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   RATNER BD, 1981, J COLLOID INTERF SCI, V83, P630, DOI 10.1016/0021-9797(81)90358-1
   RATNER BD, 1994, COLLOID SURFACE B, V2, P333, DOI 10.1016/0927-7765(94)80048-0
   RATNER BD, 1997, SURFACE ANAL PRINCIP, P44
   RATNER BD, 1988, SURFACE CHARACTERIZA
   Raval R, 1998, NUOVO CIMENTO D, V20, P553, DOI 10.1007/BF03185548
   Raza H, 1999, APPL SURF SCI, V140, P271, DOI 10.1016/S0169-4332(98)00539-X
   Raza H, 1999, PHYS REV LETT, V82, P5265, DOI 10.1103/PhysRevLett.82.5265
   REINTSEMA H, 1986, CARIES RES, V20, P419, DOI 10.1159/000260967
   Reusch B, 1997, FRESEN J ANAL CHEM, V358, P64, DOI 10.1007/s002160050346
   Reusch B, 1998, APPL PHYS A-MATER, V66, pS805, DOI 10.1007/s003390051246
   REVENKO I, 1994, BIOL CELL, V80, P67, DOI 10.1016/0248-4900(94)90019-1
   Rezania A, 1999, LANGMUIR, V15, P6931, DOI 10.1021/la990024n
   RIEKE PC, 1994, LANGMUIR, V10, P619, DOI 10.1021/la00015a003
   RIVERO DP, 1988, J BIOMED MATER RES, V22, P191, DOI 10.1002/jbm.820220304
   Roberts MW, 2000, CATAL LETT, V69, P253, DOI 10.1023/A:1019063132413
   Roberts MW, 2000, CATAL LETT, V67, pI
   ROBINSON C, 1992, J DENT RES, V71, P1270, DOI 10.1177/00220345920710060101
   ROBINSON C, 1984, TOOTH ENAMEL, V4, P216
   Rodriguez-Clemente R, 1998, J EUR CERAM SOC, V18, P1351, DOI 10.1016/S0955-2219(98)00064-8
   ROHRER GS, 1990, SCIENCE, V250, P1239, DOI 10.1126/science.250.4985.1239
   ROHRER GS, 1992, SURF SCI, V278, P146, DOI 10.1016/0039-6028(92)90590-3
   ROLLA G, 1983, SCAND J DENT RES, V91, P186
   ROLLA G, 1994, COLLOID SURFACE B, V3, P177
   ROLLASON G, 1993, BIOMATERIALS, V14, P153, DOI 10.1016/0142-9612(93)90230-Y
   ROMAN E, 1990, VACUUM, V41, P40, DOI 10.1016/0042-207X(90)90265-Z
   ROSEN MJ, 1989, SURFACTANTS INTERFAC
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   ROUXHET PG, 1994, COLLOID SURFACE B, V2, P347, DOI 10.1016/0927-7765(94)80049-9
   RUSE ND, 1991, J DENT RES, V70, P1002, DOI 10.1177/00220345910700060101
   Russell BG, 1998, BIOSPECTROSCOPY, V4, P257, DOI 10.1002/(SICI)1520-6343(1998)4:4<257::AID-BSPY4>3.0.CO;2-#
   Rustad JR, 1996, GEOCHIM COSMOCHIM AC, V60, P1553, DOI 10.1016/0016-7037(96)00046-4
   Sakai N, 1998, LANGMUIR, V14, P5918, DOI 10.1021/la980623e
   SANDER M, 1994, SURF SCI, V302, pL263, DOI 10.1016/0039-6028(94)91086-3
   Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000
   SARID D, 1991, J VAC SCI TECHNOL B, V9, P431, DOI 10.1116/1.585585
   SARID D, 1994, SCANNING FORCE MICRO
   Sato H, 1999, J BIOMATER APPL, V14, P169, DOI 10.1177/088532829901400203
   Sato K, 2000, J COLLOID INTERF SCI, V224, P23, DOI 10.1006/jcis.1999.6623
   Sauberlich S, 1999, CLIN ORAL IMPLAN RES, V10, P379, DOI 10.1034/j.1600-0501.1999.100505.x
   Saxena AK, 1999, TISSUE ENG, V5, P525, DOI 10.1089/ten.1999.5.525
   SCHAAD P, 1993, SCANNING MICROSCOPY, V7, P1149
   Schakenraad J.M., 1996, BIOMATERIALS SCI INT, P141
   SchenkMeuser K, 1997, FRESEN J ANAL CHEM, V358, P265, DOI 10.1007/s002160050402
   SCHIERBAUM KD, 1995, SENSOR ACTUAT B-CHEM, V24, P239, DOI 10.1016/0925-4005(95)85051-1
   SCHINDLER PW, 1972, KOLLOID Z Z POLYM, V250, P759, DOI 10.1007/BF01498568
   SCHMIDT CF, 1990, BIOPHYS J, V57, P577, DOI 10.1016/S0006-3495(90)82573-X
   SCHMIDT M, 1991, HELV PHYS ACTA, V64, P900
   Schreckenbach JP, 1999, J MATER SCI-MATER M, V10, P453, DOI 10.1023/A:1008988706980
   SCHULTZ JS, 1982, ADV CHEM SER, P43
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Seah MP, 1999, J ELECTRON SPECTROSC, V100, P55, DOI 10.1016/S0368-2048(99)00040-7
   SEAH MP, 1990, PRACTICAL SURFACE AN, V1
   Sennou HE, 1999, DENT MATER, V15, P229, DOI 10.1016/S0109-5641(99)00036-6
   Serro AP, 1997, BIOMATERIALS, V18, P963, DOI 10.1016/S0142-9612(97)00031-8
   Serro APV, 1997, COLLOID SURFACE A, V125, P209, DOI 10.1016/S0927-7757(97)00017-4
   Shapovalov V, 2000, CHEM PHYS LETT, V320, P186, DOI 10.1016/S0009-2614(00)00191-3
   SHARKNESS CM, 1993, J LONG-TERM EFF MED, V3, P237
   Shen TC, 1997, PHYS REV LETT, V78, P1271, DOI 10.1103/PhysRevLett.78.1271
   Shen Y. R., 1984, PRINCIPLES NONLINEAR
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Shiku H, 1999, ANAL CHEM, V71, p23A, DOI 10.1021/ac9900984
   SHIRKHANZADEH M, 1992, J MATER SCI-MATER M, V3, P322, DOI 10.1007/BF00705362
   Shirkhanzadeh M, 1997, J MATER SCI-MATER M, V8, P595, DOI 10.1023/A:1018563201792
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P355, DOI 10.1023/A:1008859131585
   SHIRKHANZADEH M, 1995, NANOSTRUCT MATER, V5, P33, DOI 10.1016/0965-9773(95)00006-Z
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Sigee DC, 1998, MIKROCHIM ACTA, P283
   Silikas N, 1999, J DENT, V27, P137, DOI 10.1016/S0300-5712(98)00032-3
   Simkiss K., 1989, BIOMINERALIZATION CE
   SIMMELINK JW, 1974, ARCH ORAL BIOL, V19, P183, DOI 10.1016/0003-9969(74)90213-1
   SIMMELINK JW, 1994, ORAL DEV HISTOLOGY
   SINGH RK, 1994, BIOMATERIALS, V15, P522, DOI 10.1016/0142-9612(94)90018-3
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Skjorland KK, 1995, ACTA ODONTOL SCAND, V53, P358, DOI 10.3109/00016359509006001
   Slack SM, 1995, ACS SYM SER, V602, P112
   SLACK SM, 1996, BIOMATERIALS SCI INT, P470
   Sleytr UB, 1999, ANGEW CHEM INT EDIT, V38, P1035, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1034::AID-ANIE1034>3.0.CO;2-#
   Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9
   Smith DC, 1998, BIOMATERIALS, V19, P467, DOI 10.1016/S0142-9612(97)00126-9
   SMITH PB, 1987, SURF SCI, V188, P241, DOI 10.1016/S0039-6028(87)80155-3
   SODERHOLM KJM, 1909, DENT MATER, V7, P74
   SODHI RNS, 1992, J DENT RES, V71, P1493, DOI 10.1177/00220345920710080601
   SOLLBOHMER O, 1995, THIN SOLID FILMS, V264, P176, DOI 10.1016/0040-6090(95)05847-8
   SOLOKOV IY, 1999, J APPL PHYS, V86, P5537
   SOMORJAI GA, 1981, PREFACE CHEM 2 DIMEN
   SOMORJAI GA, 2000, BIOM SURF AN NEW MIL
   SONG S, 1993, J PHYS CHEM-US, V97, P6564, DOI 10.1021/j100126a037
   SOSULNIKOV MI, 1992, RELAT PHENOM, V59, P101
   SPECTOR M, 1994, P 20 ANN M SOC BIOM, P330
   SPENCER P, 1992, DENT MATER, V8, P10, DOI 10.1016/0109-5641(92)90046-F
   SPIEKERMANN H, 1995, IMPLANTOLOGY COLOR A
   SRINIVASAN R, 1995, BIOTECHNOL BIOENG, V46, P553, DOI 10.1002/bit.260460608
   STANFORD CM, 1994, J DENT RES, V73, P1061, DOI 10.1177/00220345940730050801
   Stangel I, 1996, J BIOMED MATER RES, V31, P287, DOI 10.1002/(SICI)1097-4636(199606)31:2<287::AID-JBM17>3.0.CO;2-I
   STANGEL I, 1994, J ADHESION, V47, P133, DOI 10.1080/00218469408027095
   STARKEBAUM W, 1979, J BIOMED MATER RES, V13, P729, DOI 10.1002/jbm.820130506
   Stefanovich EV, 1997, J CHEM PHYS, V106, P7700, DOI 10.1063/1.473748
   STEINBERG D, 1995, BIOMATERIALS, V16, P1339, DOI 10.1016/0142-9612(95)91050-9
   Stermer EM, 1996, EUR J ORAL SCI, V104, P253, DOI 10.1111/j.1600-0722.1996.tb00075.x
   Stewart PS, 1998, BIOTECHNOL BIOENG, V59, P261, DOI 10.1002/(SICI)1097-0290(19980805)59:3<261::AID-BIT1>3.0.CO;2-9
   STOCKBAUER R, 1982, PHYS REV B, V26, P1885, DOI 10.1103/PhysRevB.26.1885
   STOCKBAUER RL, 1982, J VAC SCI TECHNOL, V20, P562, DOI 10.1116/1.571433
   Stone P, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/008
   STRANICK MA, 1991, COLLOID SURFACE, V55, P137, DOI 10.1016/0166-6622(91)80088-6
   STRONG RL, 1985, J VAC SCI TECHNOL A, V3, P1428, DOI 10.1116/1.572795
   STULTS JT, 1995, CURR OPIN STRUC BIOL, V5, P691, DOI 10.1016/0959-440X(95)80063-8
   Stumm W., 1992, CHEM SOLID WATER INT
   SUBIRADE M, 1994, THIN SOLID FILMS, V243, P442, DOI 10.1016/0040-6090(93)04014-J
   Suetsugu Y, 1996, J MATER SCI, V31, P4541, DOI 10.1007/BF00366349
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   SUGIMURA H, 1993, APPL PHYS LETT, V63, P1288, DOI 10.1063/1.110771
   SUGIMURA H, 1994, J VAC SCI TECHNOL B, V12, P2884, DOI 10.1116/1.587208
   Sugimura W, 1997, JPN J APPL PHYS 1, V36, P7358, DOI 10.1143/JJAP.36.7358
   SUKENIK CN, 1990, J BIOMED MATER RES, V24, P1307, DOI 10.1002/jbm.820241004
   SULJAK JP, 1995, J DENT, V23, P171, DOI 10.1016/0300-5712(95)93575-M
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   SUTHERLAND DS, 1993, BIOMATERIALS, V14, P893, DOI 10.1016/0142-9612(93)90130-T
   SUZUKI M, 1991, J DENT RES, V70, P1092, DOI 10.1177/00220345910700071501
   SUZUKI Y, 1994, NUCL INSTRUM METH B, V91, P588
   SWANCAR JR, 1971, TOOTH ENAMEL, V2
   Swart K M, 1992, J Oral Implantol, V18, P130
   Swift P, 1967, Br Dent J, V123, P326
   SZABO A, 1995, SURF SCI, V329, P241, DOI 10.1016/0039-6028(95)00050-X
   SZE SM, 1981, PHYSICS SEMICONDUCTO
   Szleifer I, 1997, PHYSICA A, V244, P370, DOI 10.1016/S0378-4371(97)00293-8
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   Takamura R, 1997, J DENT RES, V76, P1177
   Talley CE, 1996, APPL PHYS LETT, V69, P3809, DOI 10.1063/1.117112
   TAM LE, 1994, J DENT RES, V73, P607, DOI 10.1177/00220345940730030601
   TANAKA K, 1988, RAPID COMMUN MASS SP, V2, P151, DOI [10.1002/rcm.1290020802, DOI 10.1002/RCM.1290020802]
   TANIZAWA Y, 1990, J CHEM SOC FARADAY T, V86, P4025, DOI 10.1039/ft9908604025
   TANIZAWA Y, 1991, J CHEM SOC FARADAY T, V87, P2235, DOI 10.1039/ft9918702235
   TANIZAWA Y, 1993, J CHEM SOC FARADAY T, V89, P2901, DOI 10.1039/ft9938902901
   TANIZAWA Y, 1995, J CHEM SOC FARADAY T, V91, P3499, DOI 10.1039/ft9959103499
   TANIZAWA Y, 1998, J CHEM SOC FARADAY T, V86, P1071
   Tanner RE, 1998, SURF SCI, V412-13, P672, DOI 10.1016/S0039-6028(98)00464-6
   TANZER JM, 1995, J DENT RES, V74, P1536, DOI 10.1177/00220345950740090601
   TAO L, 1988, DENT MATER, V4, P208, DOI 10.1016/S0109-5641(88)80066-6
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   THIEL PA, 1987, SURF SCI REP, V7, P211, DOI 10.1016/0167-5729(87)90001-X
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   Thompson ID, 1998, P I MECH ENG H, V212, P127, DOI 10.1243/0954411981533908
   THOMPSON VP, 1992, J ADHESION, V39, P157, DOI 10.1080/00218469208026547
   THOMSEN P, 1989, J MATER SCI-MATER M, V8, P653
   Todd PJ, 1997, ANAL CHEM, V69, pA529, DOI 10.1021/ac971763g
   TORIYAMA M, 1995, NIPPON SERAM KYO GAK, V103, P46
   TORNKVIST C, 1991, LANGMUIR, V7, P479
   TORRISI L, 1992, NUCL INSTRUM METH B, V65, P139, DOI 10.1016/0168-583X(92)95026-N
   Tougaard S, 1997, SURF INTERFACE ANAL, V25, P404, DOI 10.1002/(SICI)1096-9918(199706)25:6<404::AID-SIA250>3.0.CO;2-A
   UDVAL K, 1992, J COLLOID INTERF SCI, V149, P162
   UDVAL K, 1990, J COLLOID INTERF SCI, V140, P207
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Valsami-Jones E, 1998, CHEM GEOL, V151, P215, DOI 10.1016/S0009-2541(98)00081-3
   VANBLITTERSWIJK CA, 1991, BIOMATERIALS, V12, P187, DOI 10.1016/0142-9612(91)90198-J
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   VANDERMEI HC, 1991, CARIES RES, V25, P415, DOI 10.1159/000261404
   VANDERMEI HC, 1989, J DENT RES, V68, P620
   VANDERVEGT W, 1993, J COLLOID INTERF SCI, V156, P129, DOI 10.1006/jcis.1993.1091
   VANDERVEGT W, 1994, LANGMUIR, V10, P1314, DOI 10.1021/la00016a055
   VANMEERBEEK B, 1993, J DENT RES, V72, P1423, DOI 10.1177/00220345930720101201
   VANMEERBEEK B, 1993, J DENT RES, V72, P495, DOI 10.1177/00220345930720020501
   VANRAEMDONCK W, 1984, J AM CERAM SOC, V67, P381
   Vansteenkiste SO, 1998, PROG SURF SCI, V57, P95, DOI 10.1016/S0079-6816(98)00014-8
   VASQUEZ RP, 1990, THIN SOLID FILMS, V192, P173, DOI 10.1016/0040-6090(90)90489-Z
   VASUDEVAN TV, 1994, LANGMUIR, V10, P320, DOI 10.1021/la00013a047
   VAUDAUX P, 1993, J INFECT DIS, V167, P633, DOI 10.1093/infdis/167.3.633
   Vereecke G, 1999, SURF INTERFACE ANAL, V27, P761, DOI 10.1002/(SICI)1096-9918(199908)27:8<761::AID-SIA570>3.3.CO;2-5
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P775, DOI 10.1002/jbm.820270610
   Vezeau PJ, 1996, J ORAL MAXIL SURG, V54, P738, DOI 10.1016/S0278-2391(96)90694-1
   VICKERMAN JC, 1997, SURFACES ANAL PRINCI, P134
   Vittadini A, 1998, PHYS REV LETT, V81, P2954, DOI 10.1103/PhysRevLett.81.2954
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogtenhuber D, 1998, SURF SCI, V402, P798, DOI 10.1016/S0039-6028(97)01083-2
   Volkel B, 1997, J VAC SCI TECHNOL B, V15, P2877, DOI 10.1116/1.589748
   VONRECUM AF, 1990, CLIN IMPLANT MAT
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   Wadu-Mesthrige K, 1999, LANGMUIR, V15, P8580, DOI 10.1021/la991196n
   Wakamura M, 1998, COLLOID SURFACE A, V142, P107, DOI 10.1016/S0927-7757(98)00486-5
   Wakamura M, 1997, POLYHEDRON, V16, P2047, DOI 10.1016/S0277-5387(96)00513-X
   Walivaara B, 1996, J BIOMAT SCI-POLYM E, V8, P41, DOI 10.1163/156856297X00560
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Wang LQ, 1999, SURF SCI, V440, P60, DOI 10.1016/S0039-6028(99)00677-9
   Wang LQ, 1995, SURF SCI, V344, P237, DOI 10.1016/0039-6028(95)00859-4
   Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233
   Wang R, 1999, J PHYS CHEM B, V103, P2188, DOI 10.1021/jp983386x
   Wang R, 1998, ADV MATER, V10, P135, DOI 10.1002/(SICI)1521-4095(199801)10:2<135::AID-ADMA135>3.0.CO;2-M
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
   WASSERMAN SR, 1989, J AM CHEM SOC, V111, P5852, DOI 10.1021/ja00197a054
   WATAHA JC, 1992, J DENT RES, V71, P1417, DOI 10.1177/00220345920710071101
   Wataha JC, 1996, J ORAL REHABIL, V23, P583, DOI 10.1046/j.1365-2842.1996.d01-204.x
   WATKINS RW, 1977, J BIOMED MATER RES, V11, P915, DOI 10.1002/jbm.820110611
   Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000
   Weiner R, 1999, METHOD ENZYMOL, V310, P403
   Wen HB, 1997, BIOMATERIALS, V18, P1471, DOI 10.1016/S0142-9612(97)82297-1
   WEN HB, 1995, CARIES RES, V29, P122, DOI 10.1159/000262053
   Wen HB, 1998, J MATER SCI-MATER M, V9, P121, DOI 10.1023/A:1008859417664
   WENNERBERG A, 1995, J MATER SCI-MATER M, V6, P302, DOI 10.1007/BF00120275
   Wennerberg A, 1997, J MATER SCI-MATER M, V8, P757, DOI 10.1023/A:1018560528625
   Werner C, 1999, INT J ARTIF ORGANS, V22, P160
   Weygand M, 2000, J MATER CHEM, V10, P141, DOI 10.1039/a905196a
   WHITESIDES GM, 1990, LANGMUIR, V6, P87, DOI 10.1021/la00091a013
   Whitford GM, 1997, CIBA F SYMP, V205, P226
   Whittaker CJ, 1996, ANNU REV MICROBIOL, V50, P513, DOI 10.1146/annurev.micro.50.1.513
   Whitters CJ, 1999, J DENT, V27, P401, DOI 10.1016/S0300-5712(99)00007-X
   Wieliczka DM, 1996, J DENT RES, V75, P1865, DOI 10.1177/00220345960750110801
   Wiesendanger R., 1994, SCANNING PROBE MICRO
   Wieser E, 1999, SURF COAT TECH, V111, P103, DOI 10.1016/S0257-8972(98)00717-8
   Wiesmann HP, 1998, CELL TISSUE RES, V294, P93, DOI 10.1007/s004410051159
   WILBUR JL, 1995, LANGMUIR, V11, P825, DOI 10.1021/la00003a025
   WILKE HJ, 1990, ADV BIOMAT, V9, P309
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95
   WILLIAMS DF, 1981, BIOCOMPATIBILITY IMP
   Williams DF., 1986, MAT SCI IMPLANT ORTH, P107
   Williams J, 1996, SURF SCI, V368, P303, DOI 10.1016/S0039-6028(96)01067-9
   WILLIAMS JA, 1996, T 5 WORLD BIOM C TOR, V2, P762
   WILLIAMS RL, 1991, SURF INTERFACE ANAL, V17, P496, DOI 10.1002/sia.740170714
   WILSON R, 1997, SURFACES ANAL PRINCI, P10
   WILSON RG, 1989, SCONDARY ION MASS SP
   Wilson WD, 1997, J COLLOID INTERF SCI, V187, P201, DOI 10.1006/jcis.1996.4693
   WINTER GD, 1980, ADV BIOMATERIALS, V1
   WISBEY A, 1991, BIOMATERIALS, V12, P470, DOI 10.1016/0142-9612(91)90144-Y
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
   Wu W, 1997, LANGMUIR, V13, P861, DOI 10.1021/la960689e
   Wu WJ, 1997, J BIOMED MATER RES, V35, P93, DOI 10.1002/(SICI)1097-4636(199704)35:1<93::AID-JBM9>3.0.CO;2-H
   Wu WJ, 1997, COLLOID SURFACE B, V10, P87, DOI 10.1016/S0927-7765(97)00054-4
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Xia YN, 1997, LANGMUIR, V13, P2059, DOI 10.1021/la960936e
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Xu S, 1997, LANGMUIR, V13, P127, DOI 10.1021/la962029f
   Yan WQ, 1997, J BIOMED MATER RES, V37, P267, DOI 10.1002/(SICI)1097-4636(199711)37:2<267::AID-JBM17>3.0.CO;2-B
   Yang BC, 1999, J BIOMED MATER RES, V47, P213, DOI 10.1002/(SICI)1097-4636(199911)47:2<213::AID-JBM11>3.0.CO;2-C
   Yoshino N, 1997, J BIOMAT SCI-POLYM E, V8, P623, DOI 10.1163/156856297X00218
   Yoshino N, 1998, REACT FUNCT POLYM, V37, P271, DOI 10.1016/S1381-5148(97)00114-4
   Zablotsky M H, 1992, Implant Dent, V1, P253, DOI 10.1097/00008505-199200140-00004
   ZEGENHAGEN J, 1993, SURF SCI REP, V18, P199
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
   Zenobi R, 1998, MASS SPECTROM REV, V17, P337, DOI 10.1002/(SICI)1098-2787(1998)17:5<337::AID-MAS2>3.0.CO;2-S
   Zhang LP, 1998, SURF SCI, V412-13, P242, DOI 10.1016/S0039-6028(98)00432-4
   Zhao XY, 1999, SURF SCI, V442, pL995, DOI 10.1016/S0039-6028(99)00970-X
   Zhao XY, 1999, SURF SCI, V424, pL347, DOI 10.1016/S0039-6028(99)00211-3
   Ziegler C, 1998, FRESEN J ANAL CHEM, V361, P547, DOI 10.1007/s002160050944
   Zolk M, 2000, LANGMUIR, V16, P5849, DOI 10.1021/la0003239
NR 890
TC 104
Z9 105
U1 2
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5729
EI 1879-274X
J9 SURF SCI REP
JI Surf. Sci. Rep.
PY 2001
VL 42
IS 3-5
BP 79
EP 205
PG 127
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 431LK
UT WOS:000168632500001
DA 2018-10-19
ER

PT S
AU Shinomiya, K
   Itoh, S
   Kawauchi, T
   Kikuchi, M
   Tanaka, J
AF Shinomiya, K
   Itoh, S
   Kawauchi, T
   Kikuchi, M
   Tanaka, J
BE Ikada, Y
TI Development of a novel hydroxyapatite/collagen composite biomaterial
SO TISSUE ENGINEERING FOR THERAPEUTIC USE 5
SE INTERNATIONAL CONGRESS SERIES
LA English
DT Proceedings Paper
CT 5th International Symposium on Tissue Engineering for Therapeutic Use
CY NOV 16-17, 2000
CL TSUKUBA, JAPAN
SP Japan Soc Promot Sci
DE bone-remodeling unit; hydroxyapatite; hydroxyapatile/type I collagen
   (HAp/Col) composite; recombinant human bone morphogenetic protein
   (rhBMP); type I collagen
ID BONE MORPHOGENETIC PROTEIN; GRAFT SUBSTITUTE; INDUCTION; SURGERY
AB A hydroxyapatite/type I collagen (HAp/Col) composite, in which the hydroxyapatite nanocrystals align along the collagen molecules, was prepared. The biocompatibility, osteoconductive activity and efficacy as a carrier of recombinant human bone morphogenetic protein (rhBMP)-2 of this novel biomaterial were examined. The composite materials (4 x 4 x 1 mm(3)) were implanted in the back of Wistar rats, and specimens were collected for histological observations until week 24. The composite materials (5 x 5 x 10 mm(3)) containing rhBMP-2 (0, 200, 400 mug/ml) were grafted in radii and ulnae in beagle dogs. X-ray images were prepared, and specimens collected for histo logical observation at week 8 and 12. The implants (15 mm in diameter and 20 mm in length) containing rhBMP-2 (0, 400 mug/ml) were implanted in tibiae in beagle dogs and fixed with Ilizarov method. Soft X-ray images were prepared each week. The bone mineral density (BMD) was measured and the implants were harvested at 12, 18 and 24 weeks after surgery. X-ray images and histological findings for the composites support the idea that HAp/Col has a high osteoconductive activity and is able to induce bone-remodeling units. In cases where the implants are grafted at weightbearing sites, treatment with rhBMP (400 mug/ml) may be useful to shorten the time until bone union.
C1 Tokyo Med & Dent Univ, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138519, Japan.
RP Shinomiya, K (reprint author), Tokyo Med & Dent Univ, Dept Orthopaed Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.
CR AOKI H, 1994, MED APPL HYDROXYAPAT, V156, P286
   CHVAPIL M, 1981, FUNDAMENTAL ASPECTS, V1, P88
   HORISAKA Y, 1991, CLIN ORTHOP RELAT R, P303
   KAWAI T, 1993, CLIN ORTHOP RELAT R, P296
   MIYAMOTO S, 1993, CLIN ORTHOP RELAT R, P333
   Oda Shigeru, 1997, Journal of Medical and Dental Sciences, V44, P53
   ONO I, 1995, PLAST RECONSTR SURG, V95, P1265, DOI 10.1097/00006534-199506000-00019
   ONO I, 1992, PLAST RECONSTR SURG, V90, P870, DOI 10.1097/00006534-199211000-00023
   ROSEN HM, 1989, PLAST RECONSTR SURG, V83, P985, DOI 10.1097/00006534-198906000-00009
   SALYER KE, 1989, PLAST RECONSTR SURG, V84, P236, DOI 10.1097/00006534-198908000-00008
   STEVENSON S, 1994, J BONE JOINT SURG AM, V76A, P1676, DOI 10.2106/00004623-199411000-00011
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250
   TAKAOKA K, 1991, J ORTHOPAED RES, V9, P902, DOI 10.1002/jor.1100090617
   URIST MR, 1984, CLIN ORTHOP RELAT R, P277
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
NR 16
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0531-5131
BN 0-444-50554-7
J9 INT CONGR SER
PY 2001
VL 1222
BP 165
EP 177
PG 13
WC Engineering, Biomedical; Medicine, Research & Experimental
SC Engineering; Research & Experimental Medicine
GA BS31G
UT WOS:000169429900017
DA 2018-10-19
ER

PT J
AU Raghavachari, M
   Tsai, HM
   Kottke-Marchant, K
   Marchant, RE
AF Raghavachari, M
   Tsai, HM
   Kottke-Marchant, K
   Marchant, RE
TI Surface dependent structures of von Willebrand factor observed by AFM
   under aqueous conditions
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE von Willebrand factor; atomic force microscopy; surface dependent
   structure; protein intramolecular structure
ID HUMAN VONWILLEBRAND-FACTOR; ATOMIC-FORCE MICROSCOPY; PROTEIN ADSORPTION;
   PLATELET-ADHESION; CRYSTAL-STRUCTURE; FACTOR-VIII; A3 DOMAIN;
   FIBRINOGEN; BINDING; AGGREGATION
AB von Willebrand factor (VWF) is a large multimeric plasma glycoprotein that adheres rapidly to biomaterial surfaces upon exposure to blood. The adsorbed structure influences subsequent functional interactions with other blood components that mediate surface induced thrombosis. To examine the surface-dependent properties of VWF, we compared the adsorbed structures of VWF molecules on two different surfaces: Mica, which is hydrophilic; and octadecyltrichlorosilane (OTS) modified glass, which is hydrophobic. Atomic force microscopy (AFM) was used to image adsorbed VWF under aqueous conditions at physiologic pH and ionic strength. Individual VWF molecules were clearly discernible on both surfaces. On the hydrophobic surface, VWF displayed compact tertiary structures with rare: examples of extended molecules. In addition, these data revealed intramolecular structural arrangements of the repeat units within VWF multimers. On the hydrophilic mica surface, VWF displayed extended structures in which intramolecular repeat units were exposed. The lateral dimensions of VWF on mica (640 +/- 161 x 303 +/- 113 nm were larger than on the hydrophobic OTS (256 +/- 74 x 152 +/- 62 nm, P < 0.005). Our results demonstrate how surface properties mediate the molecular level structure and probable function of VWF: and provide some essential groundwork to develop a mechanistic understandings of surface-induced thrombosis. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Montefiore Med Ctr, Div Hematol, Bronx, NY 10467 USA.
   Cleveland Clin Fdn, Hemostasis & Thrombosis Lab, Cleveland, OH 44195 USA.
CR Bienkowska J, 1997, J BIOL CHEM, V272, P25162, DOI 10.1074/jbc.272.40.25162
   Celikel R, 1997, BLOOD CELL MOL DIS, V23, P123, DOI 10.1006/bcmd.1997.0128
   Chinn JA, 1996, J COLLOID INTERF SCI, V184, P11, DOI 10.1006/jcis.1996.0592
   FLEMING TGM, 1995, BRIT J BIOMED SCI, V52, P50
   FOWLER WE, 1985, J CLIN INVEST, V76, P1491, DOI 10.1172/JCI112129
   GINSBURG D, 1992, THROMB HAEMOSTASIS, V67, P166
   Huizinga EG, 1997, STRUCTURE, V5, P1147, DOI 10.1016/S0969-2126(97)00266-9
   IKEDA Y, 1991, J CLIN INVEST, V87, P1234, DOI 10.1172/JCI115124
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   MEYER D, 1993, THROMB HAEMOSTASIS, V70, P99
   Nichols WC, 1997, MEDICINE, V76, P1, DOI 10.1097/00005792-199701000-00001
   NINHAM BW, 1980, J PHYS CHEM-US, V84, P1423, DOI 10.1021/j100449a001
   RADMACHER M, 1993, BIOPHYS J, V64, P735, DOI 10.1016/S0006-3495(93)81433-4
   Ruggeri ZM, 1997, THROMB HAEMOSTASIS, V78, P611
   RUGGERI ZM, 1993, THROMB HAEMOSTASIS, V70, P119
   Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395
   Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6
   SIEDLECKI CA, 1994, J BIOMED MATER RES, V28, P971, DOI 10.1002/jbm.820280902
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Siedlecki CA, 1996, BLOOD, V88, P2939
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   THORELL L, 1984, THROMB RES, V35, P431, DOI 10.1016/0049-3848(84)90235-4
   TILTON RD, 1991, LANGMUIR, V7, P2710, DOI 10.1021/la00059a051
   TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015
   TSAI HM, 1991, BRIT J HAEMATOL, V79, P239, DOI 10.1111/j.1365-2141.1991.tb04528.x
   Tsuji S, 1996, BLOOD, V88, P3854
   VLOT AJ, 1995, BLOOD, V85, P3150
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
NR 29
TC 36
Z9 36
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD DEC 30
PY 2000
VL 19
IS 4
BP 315
EP 324
DI 10.1016/S0927-7765(00)00140-5
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 366XB
UT WOS:000090030600003
DA 2018-10-19
ER

PT J
AU Nkamgueu, EM
   Adnet, JJ
   Bernard, J
   Zierold, K
   Kilian, L
   Jallot, E
   Benhayoune, H
   Bonhomme, P
AF Nkamgueu, EM
   Adnet, JJ
   Bernard, J
   Zierold, K
   Kilian, L
   Jallot, E
   Benhayoune, H
   Bonhomme, P
TI In vitro effects of zirconia and alumina particles on human blood
   monocyte-derived macrophages: X-ray microanalysis and flow cytometric
   studies
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE human macrophages; intracellular potassium/sodium ratio; phagocytosis;
   oxidative metabolism; bioceramics
ID IN-VITRO; PRODUCT FORMATION; NEUTROPHILS; BIOCOMPATIBILITY;
   BIOMATERIALS; MICROSCOPY; CELLS; IONS
AB The cytocompatibility of two particulate bioceramics, zirconia and alumina, was studied using human blood monocytes driven to differentiate into mature macrophages with granulocyte macrophage-colony-stimulating factor. Changes in individual cell elemental composition, particularly sodium and potassium content, were assessed by X-ray microanalysis of ultrathin freeze-dried sections. Phagocytosis and respiratory burst of macrophages exposed to biomaterial for 7 days were analyzed under flow cytometry using uptake of fluorescent latex beads and 2'7'-dichlorofluorescien diacetate oxidation, respectively. Zirconia and alumina particles were found to decrease the intracellular potassium/sodium ratio (an index of cell vitality) significantly (p <.01) in 7-day-cultured macrophages compared to control cells cultured out of material. Phagocytosis of both ceramic particles by macrophages was followed by a decrease in cell phagocytic ability (27%) and a marked altered oxidative metabolism (>2 times reduced by zirconia and >5 times reduced by alumina). The present study clearly demonstrates that reduction of the phagocytic capacity of macrophages associated with altered oxidative metabolism caused by biomaterial particles is characterized by changes in intracellular elemental content. Thus, investigation of cellular homeostasis by electron probe microanalysis together with analysis of functional changes may improve estimation of biomaterial cytocompatibility. (C) 2000 John Wiley & Sons, Inc.
C1 UFR MED, Histol Lab, F-51095 Reims, France.
   CHU Maison Blanche, Lab Pol Bouin, F-5100 Reims, France.
   Inst Jean Godinoi, Immunol Lab, F-51100 Reims, France.
   Max Planck Inst Mol Physiol, D-44026 Dortmund, Germany.
   URCA, Lab Microscopie Elect, F-51685 Reims, France.
RP Nkamgueu, EM (reprint author), UFR MED, Histol Lab, 51 Rue Cognacq Jay, F-51095 Reims, France.
CR BASS DA, 1983, J IMMUNOL, V130, P1910
   BAUR H, 1975, H-S Z PHYSIOL CHEM, V356, P827, DOI 10.1515/bchm2.1975.356.s1.827
   DEVRIES CR, 1983, LAB INVEST, V48, P35
   DUNN PA, 1981, J LAB CLIN MED, V98, P374
   Fukuchi N, 1995, BIO-MED MATER ENG, V5, P219
   HALL TA, 1971, PHYSICAL TECHNIQUE A, V1, P157
   HASSAN NF, 1988, J LEUKOCYTE BIOL, V43, P317
   HIMMELFARB J, 1993, J AM SOC NEPHROL, V4, P178
   HOLRL WH, 1985, KIDNEY INT, V28, P791
   Jin Z, 1997, J SUBMICR CYTOL PATH, V29, P179
   KESTON AS, 1965, ANAL BIOCHEM, V11, P1, DOI 10.1016/0003-2697(65)90034-5
   LOPEZ M, 1992, J IMMUNOTHER, V11, P207
   Maloney WJ, 1996, CLIN ORTHOP RELAT R, P268
   Martinez ME, 1998, BIOMATERIALS, V19, P183, DOI 10.1016/S0142-9612(97)00250-0
   MASTERS SK, 1979, SCAN ELECT MICROSC, V3, P122
   MASTERS SK, 1979, SCANNING ELECTRON MI, V3, P97
   MATSUDA O, 1988, KIDNEY INT, V33, P1107, DOI 10.1038/ki.1988.118
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   PAROD RJ, 1983, AM J PHYSIOL, V245, P227
   ROSENKRANZ AR, 1994, CLIN EXP IMMUNOL, V98, P300
   ROSSI P, 1980, RETICULOENDOTHELIAL, V2, P153
   ROZALSKA B, 1995, MICROBIOL IMMUNOL, V39, P443
   ROZALSKA B, 1995, FEMS IMMUNOL MED MIC, V11, P307, DOI 10.1111/j.1574-695X.1995.tb00161.x
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SMITH NKR, 1985, TISSUE RES, V240, P461
   THOMSON LA, 1992, BIOMATERIALS, V13, P811, DOI 10.1016/0142-9612(92)90173-L
   UFF CR, 1995, BIOMATERIALS, V16, P355, DOI 10.1016/0142-9612(95)93852-5
   WATAHA JC, 1995, DENT MATER, V11, P239, DOI 10.1016/0109-5641(95)80056-5
   Zierold K, 1997, TOXICOL APPL PHARM, V144, P70, DOI 10.1006/taap.1996.8094
   Zierold Karl, 1994, Scanning Microscopy Supplement, V8, P117
NR 31
TC 14
Z9 15
U1 0
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2000
VL 52
IS 4
BP 587
EP 594
DI 10.1002/1097-4636(20001215)52:4<587::AID-JBM2>3.3.CO;2-T
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 358UY
UT WOS:000089576600002
PM 11033540
DA 2018-10-19
ER

PT J
AU Rezania, A
   Healy, KE
AF Rezania, A
   Healy, KE
TI The effect of peptide surface density on mineralization of a matrix
   deposited by osteogenic cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE ligand density; matrix mineralization; surface modification; osteogenic
   cells
ID OSTEOBLAST-LIKE CELLS; BONE SIALOPROTEIN; ATTACHMENT STRENGTH; FOCAL
   CONTACT; ADHESION; CULTURE; EXPRESSION; DIFFERENTIATION; VITRONECTIN;
   SUBSTRATUM
AB The density of Arg-Gly-Asp-containing peptides covalently grafted to solid materials has been shown to affect adhesion, spreading, and focal contact formation. The objective of this study was to examine the effect of ligand density on mineralization of the extracellular matrix deposited by osteoblasts. In particular, RGD-modified quartz surfaces with ligand densities varying over two orders (0.01-3.6 pmol/cm(2)) of magnitude were prepared to assess the longterm function of osteoblasts on peptide-derivatized surfaces. After 3 weeks in culture, surfaces modified with a 15 amino acid peptide (Ac-Cys-Gly-Gly-Asn-Gly-Glu-Pro-Arg-Gly-Asp-Thr-Tyr-Arg-Ala-Tyr-NH2) at a density greater than or equal to 0.62 pmol/cm(2) significantly (p < 0.05) Enhanced mineralization compared with a RGD surface density of 0.01 pmol/cm(2), RGE surfaces, or clean surfaces adsorbed with serum proteins. These results suggest that regulation of the surface density of adhesive ligands on biomaterial surfaces is a critical determinant in a strategy to alter the degree of extracellular matrix maturation in contact with solid surfaces (e.g., implants). Further studies are required to elucidate the intracellular signal transduction pathways that mediate longterm matrix mineralization through the initial engagement of these adhesive ligands. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.
   Northwestern Univ, Div Biol Mat, Chicago, IL 60611 USA.
   Northwestern Univ, Robert R McCormick Sch Engn & Appl Sci, Dept Biomed Engn, Evanston, IL 60201 USA.
RP Healy, KE (reprint author), Univ Calif Berkeley, Dept Bioengn, 465 Evans Hall 1762, Berkeley, CA 94720 USA.
FU NIAMS NIH HHS [R01AR43187]
CR BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   Cooper LF, 1998, J BONE MINER RES, V13, P620, DOI 10.1359/jbmr.1998.13.4.620
   DANILOV YN, 1989, EXP CELL RES, V182, P186, DOI 10.1016/0014-4827(89)90290-5
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   DIMILLA PA, 1992, MATER RES SOC SYMP P, V252, P205
   GRONOWICZ GA, 1994, J BONE MINER RES, V9, P193, DOI 10.1002/jbmr.5650090208
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562
   KUO SC, 1993, BIOPHYS J, V65, P2191, DOI 10.1016/S0006-3495(93)81277-3
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MINTZ KP, 1993, J BONE MINER RES, V8, P985
   MOONEY DJ, 1995, J CELL SCI, V108, P2311
   Nefussi JR, 1997, J HISTOCHEM CYTOCHEM, V45, P493, DOI 10.1177/002215549704500402
   OLIVIER LA, 1993, BIOTECHNOL BIOENG, V42, P963, DOI 10.1002/bit.260420807
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 1999, LANGMUIR, V15, P6931, DOI 10.1021/la990024n
   Saterbak A, 1996, BIOTECHNOL PROGR, V12, P682, DOI 10.1021/bp960061u
   SHAPIRO HS, 1993, MATRIX, V13, P431, DOI 10.1016/S0934-8832(11)80109-5
   SOMERMAN MJ, 1988, CALCIFIED TISSUE INT, V43, P50, DOI 10.1007/BF02555169
   STEELE JG, 1993, J BIOMED MATER RES, V27, P927, DOI 10.1002/jbm.820270712
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   WARD MD, 1993, BIOPHYS J, V64, P936, DOI 10.1016/S0006-3495(93)81456-5
   WARD MD, 1995, ANN BIOMED ENG, V23, P322, DOI 10.1007/BF02584432
   WARD MD, 1994, BIOPHYS J, V67, P2522, DOI 10.1016/S0006-3495(94)80742-8
   WHITSON SW, 1992, J BONE MINER RES, V7, P727
   ZHOU HY, 1995, CALCIFIED TISSUE INT, V56, P403, DOI 10.1007/BF00301610
NR 31
TC 125
Z9 132
U1 0
U2 12
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2000
VL 52
IS 4
BP 595
EP 600
DI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 358UY
UT WOS:000089576600003
PM 11033541
DA 2018-10-19
ER

PT J
AU Hacking, SA
   Bobyn, JD
   Toh, KK
   Tanzer, M
   Krygier, JJ
AF Hacking, SA
   Bobyn, JD
   Toh, KK
   Tanzer, M
   Krygier, JJ
TI Fibrous tissue ingrowth and attachment to porous tantalum
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE tantalum; porous; soft tissue; attachment; implant
ID ENCAPSULATES SUBCUTANEOUS IMPLANTS; TITANIUM FIBER MESH;
   POLYTETRAFLUOROETHYLENE PROSTHESIS; WEB MATERIALS; HYDROXYAPATITE; BONE;
   FIXATION; MARKERS; DEVICE; VELOUR
AB This study determined the soft tissue attachment strength and extent of ingrowth to a porous tantalum biomaterial. Eight dorsal subcutaneous implants (in two dogs) were evaluated at 2, 8, and 16 weeks. Upon retrieval, all implants were surrounded completely by adherent soft tissue. Implants were harvested with a tissue flap on the cutaneous aspect and peel tested in a servo-hydraulic tensile test machine at a rate of 5 mm/min. Following testing, implants were dehydrated ed in a solution of basic fuschin, defatted, embedded in methylmethacrylate, and processed for thin-section histology. At 4, 8, and 16 weeks, the attachment strength to porous tant alum was 61, 71, and 89 g/mm respectively. Histologic analysis showed complete tissue ingrowth throughout the porous tantalum implant. Blood vessels were visible at the interface of and within the porous tantalum material. Tissue maturity and vascularity increased with time. The tissue attachment strength to porous tantalum was three- to six-fold greater than was reported in a similar study with porous beads. This study demonstrated that porous tantalum permits rapid ingrowth of vascularized soft tissue, and attains soft tissue attachment strengths greater than with porous beads. (C) 2000 John Wiley & Sons, Inc.
C1 Jo Miller Orthopaed Res Lab, Montreal, PQ H3G 1A4, Canada.
   McGill Univ, Div Orthopaed, Montreal, PQ H3A 1A1, Canada.
   McGill Univ, Montreal Gen Hosp, Dept Surg, Montreal, PQ H3G 1A4, Canada.
   McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada.
RP Hacking, SA (reprint author), Jo Miller Orthopaed Res Lab, LSI-409,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.
RI Hacking, Adam/F-3645-2010
CR Abe H., 1996, DATA BOOK MECH PROPE
   ALBERIUS P, 1983, ACTA ANAT, V115, P310
   AOKI H, 1987, MED PROG TECHNOL, V12, P213
   ARONSON AS, 1985, SKELETAL RADIOL, V14, P207, DOI 10.1007/BF00355566
   ASAMI I, 1961, J KYOTO PREF MED U, V70, P767
   Bellon JM, 1996, BIOMATERIALS, V17, P2367, DOI 10.1016/S0142-9612(96)00080-4
   Bellon JM, 1996, BIOMATERIALS, V17, P1265, DOI 10.1016/0142-9612(96)88671-6
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BOBYN JD, 1982, J BIOMED MATER RES, V16, P571, DOI 10.1002/jbm.820160505
   BOBYN JD, 1999, T AM AC ORTH SURG 66
   BOSS JH, 1994, MED PROG TECHNOL, V20, P119
   BROWN MA, 1987, MAGN RESON IMAGING, V5, P443, DOI 10.1016/0730-725X(87)90378-X
   BUTTS TE, 1989, J ORAL MAXIL SURG, V47, P475, DOI 10.1016/0278-2391(89)90280-2
   CAMERON HU, 1978, INT J ARTIF ORGANS, V1, P104
   Cook S D, 1988, J Arthroplasty, V3, P249
   DROBECK HP, 1984, J ORAL MAXIL SURG, V42, P143, DOI 10.1016/S0278-2391(84)80024-5
   ENGH CA, 1993, J BONE JOINT SURG AM, V75A, P814, DOI 10.2106/00004623-199306000-00003
   FITZPATRICK D, 1997, T AM SOC BIOMECH, P21
   GOTTSAUNERWOLF F, 1994, J ORTHOPAED RES, V12, P814, DOI 10.1002/jor.1100120609
   GRUNSCHOBER F, 1982, BIOMATERIALS 1980, P161
   Jansen J A, 1994, J Biomater Appl, V9, P30, DOI 10.1177/088532829400900102
   JANSEN JA, 1992, BIOMATERIALS, V13, P959, DOI 10.1016/0142-9612(92)90121-4
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P1535, DOI 10.1002/jbm.820251210
   KRYGIER JJ, 1999, SIROT 8 WORLD C SIDN
   LABERGE M, 1990, J BIOMED MATER RES, V24, P959, DOI 10.1002/jbm.820240712
   Maas CS, 1998, PLAST RECONSTR SURG, V101, P1307, DOI 10.1097/00006534-199804050-00023
   MACGREGOR DC, 1979, J THORAC CARDIOV SUR, V78, P281
   MACHIZUKI T, 1952, J KYOTO PREF MED U, V53, P103
   MALCHAU H, 1952, J KYOTO PREF MED U, V66, P418
   MARTENS M, 1980, ARCH ORTHOP TRAUM SU, V97, P111, DOI 10.1007/BF00450933
   Paquay YCGJ, 1996, BIOMATERIALS, V17, P1251, DOI 10.1016/0142-9612(96)84946-5
   Paquay YCGJ, 1997, BIOMATERIALS, V18, P161, DOI 10.1016/S0142-9612(96)00090-7
   Picha GJ, 1996, J BIOMED MATER RES, V30, P305
   PILLIAR RM, 1983, CLIN ORTHOP RELAT R, P42
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   Plenk Jr H, 1982, P WORLD C MED PHYS B, P3
   Pudenz RH, 1943, J AMER MED ASSOC, V121, P478
   ROBERTSON DM, 1976, J BIOMED MATER RES, V10, P335, DOI 10.1002/jbm.820100304
   ROBINSON H, 1977, PEDIATR RES, V11, P637, DOI 10.1203/00006450-197705000-00003
   Salzmann DL, 1997, J BIOMED MATER RES, V34, P463, DOI 10.1002/(SICI)1097-4636(19970315)34:4<463::AID-JBM7>3.0.CO;2-I
   Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401
   Sharkawy AA, 1998, J BIOMED MATER RES, V40, P598, DOI 10.1002/(SICI)1097-4636(19980615)40:4<598::AID-JBM11>3.0.CO;2-C
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   SPURLING RG, 1943, SURG CLIN N AM, V23, P1491
   SQUIER CA, 1981, J PERIODONTAL RES, V16, P434, DOI 10.1111/j.1600-0765.1981.tb00994.x
   Taylor D F, 1972, J Biomed Mater Res, V6, P467, DOI 10.1002/jbm.820060112
   TILNEY NL, 1975, ARCH SURG-CHICAGO, V110, P1469
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   YAN JYJ, 1989, J BIOMED MATER RES, V23, P171, DOI 10.1002/jbm.820230204
NR 51
TC 149
Z9 162
U1 1
U2 23
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2000
VL 52
IS 4
BP 631
EP 638
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 358UY
UT WOS:000089576600007
PM 11033545
DA 2018-10-19
ER

PT J
AU Iwasaki, Y
   Aiba, Y
   Morimoto, N
   Nakabayashi, N
   Ishihara, K
AF Iwasaki, Y
   Aiba, Y
   Morimoto, N
   Nakabayashi, N
   Ishihara, K
TI Semi-interpenetrating polymer networks composed of biocompatible
   phospholipid polymer and segmented polyurethane
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hydrogel; phospholipid polymer; segmented polyurethane; interpenetrating
   polymer networks; protein adsorption; biocompatibility
ID IMPROVED BLOOD COMPATIBILITY; PROTEIN ADSORPTION; POLAR GROUP;
   ADDITIVES; HYDROGELS; MEMBRANE; SURFACE
AB 2-Methacryloyloxyethyl phosphorylcholine (MPC) polymers, which have excellent biocompatibility, have been receiving increasing attention in biomedical and bioengineering fields; however, the mechanical strength of the hydrated MPC polymers is not sufficient for use in these fields as a bulk material. Therefore, we hypothesized that a novel material might be realized by reinforcing the MPC polymer network with segmented polyurethane (SPU). Semi-interpenetrating polymer networks (IPNs) composed of crosslinked MPC polymer and SPU were prepared. The mechanical properties of the IPN membrane were significantly improved compared with those of the MPC polymer membrane. Three-dimensional polymer networks of the MPC polymer in the IPNs were observed after solvent extraction of SPU. An X-ray photoelectron spectrum analysis revealed that the MPC units were exposed on the IPN surface. When the IPN was alternately soaked in water and ethanol, the swelling ratio was found to be completely reversible and no disintegration of the network structure was observed. The permeation coefficient of 1,4-di(2-hydroxyethoxy)benzene through the IPN membrane was 1.11 x 10(-7) cm(-2)s(-1). The amount of adsorbed protein and the number of adherent platelets on the IPN membrane were effectively reduced compared with those on SPU. We concluded that IPNs composed of the MPC polymer and SPU are a new bulk biomaterial, which possesses both blood compatibility and good mechanical properties. (C) 2000 John Wiley & Sons, Inc.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan.
RP Iwasaki, Y (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
RI Iwasaki, Yasuhiko/D-6870-2011
OI Iwasaki, Yasuhiko/0000-0003-1603-6174
CR FRISCH HL, 1985, BRIT POLYM J, V17, P149, DOI 10.1002/pi.4980170212
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 1996, J BIOMED MATER RES, V32, P391, DOI 10.1002/(SICI)1097-4636(199611)32:3<391::AID-JBM12>3.0.CO;2-K
   Ishihara K, 1996, J BIOMED MATER RES, V32, P401, DOI 10.1002/(SICI)1097-4636(199611)32:3<401::AID-JBM13>3.0.CO;2-J
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwasaki Y, 1997, J BIOMED MATER RES, V36, P508, DOI 10.1002/(SICI)1097-4636(19970915)36:4<508::AID-JBM8>3.0.CO;2-I
   KADOMA Y, 1978, KOBUNSHI RONBUNSHU, V35, P423, DOI 10.1295/koron.35.423
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kawano H, 1998, KOBUNSHI RONBUNSHU, V55, P334, DOI 10.1295/koron.55.334
   Kurisawa M, 1997, J BIOMAT SCI-POLYM E, V8, P691, DOI 10.1163/156856297X00506
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   TSURUTA T, 1996, ADV POLYM SCI, P1
   UEDA T, 1991, J BIOMAT SCI-POLYM E, V3, P185
   UEDA T, 1990, MAKROMOL CHEM-RAPID, V11, P345
   ZHOU PU, 1992, J POLYM SCI POL CHEM, V30, P835, DOI 10.1002/pola.1992.080300514
NR 18
TC 50
Z9 51
U1 2
U2 16
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2000
VL 52
IS 4
BP 701
EP 708
DI 10.1002/1097-4636(20001215)52:4<701::AID-JBM15>3.3.CO;2-Y
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 358UY
UT WOS:000089576600015
PM 11033553
DA 2018-10-19
ER

PT J
AU Otsuka, M
   Marunaka, S
   Matsuda, Y
   Ito, A
   Layrolle, P
   Naito, H
   Ichinose, N
AF Otsuka, M
   Marunaka, S
   Matsuda, Y
   Ito, A
   Layrolle, P
   Naito, H
   Ichinose, N
TI Calcium level-responsive in-vitro zinc release from zinc containing
   tricalcium phosphate (ZnTCP)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterial; zinc; drug delivery system; tricalcium phosphate; in vitro
   release; calcium level-responsive drug release
ID DRUG-RELEASE; CEMENT
AB The in vitro Zn release from tricalcium phosphate containing Zn (ZnTCP; 0.63, 6.17, and 12.05 Zn w/w%) was investigated. The rates of release from ZnTCP powders were measured in 25 mL of simulated body fluid (SBF) containing 10 mg/100mL Ca (SBF/H), 5 mg/100mL Ca (SBF/L), or no Ca (SBF/-) at pH 7.25, 37.0 +/- 0.1 degrees C. The release from 6 and 12% ZnTCP was initially very fast. The rate of release from ZnTCP decreased as the concentration of Ca in the dissolution media increased, but increased as concentration of Zn in TCP increased. The dissolution kinetics of ZnTCP followed the Hixon-Crowell equation at the initial stage of dissolution, and the initial dissolution rate constant (IDR) was calculated by the least-squares method. The effect of Ca concentration on percent IDR of ZnTCP suggested that Zn re-lease from 0.6% ZnTCP was significantly high compared to that from 6 or 12% ZnTCP. The relationship between the amount of Ca precipitated and Zn release of various ZnTCP samples suggested that the release from 0.6% ZnTCP was significantly different compared to that from 6 and 12% ZnTCP, consistent with the data for percent Zn IDR. X-ray diffraction data suggested that 0.6% ZnTCP contained 5% hydroxyapatite, a low solubility material, which acted as seed crystal during the dissolution test. (C) 2000 John Wiley & Sons, Inc.
C1 Kobe Pharmaceut Univ, Kobe, Hyogo 6588558, Japan.
   Natl Inst Adv Interdisciplinary Res, Tsukuba, Ibaraki 3058562, Japan.
   Waseda Univ, Fac Sci & Technol, Shinjyuku Ku, Tokyo 1698555, Japan.
RP Otsuka, M (reprint author), Kobe Pharmaceut Univ, Kobe, Hyogo 6588558, Japan.
RI Ito, Atsuo/M-6785-2018; Layrolle, Pierre/K-9257-2015
OI Ito, Atsuo/0000-0003-3318-040X; Layrolle, Pierre/0000-0001-9800-5210
CR BETTGER WJ, 1993, J NUTR BIOCHEM, V4, P194, DOI 10.1016/0955-2863(93)90052-X
   Brown P.W., 1986, CEMENTS RES PROGR, V99, P352
   CORLTZ BR, 1995, SCIENCE, V267, P1796
   ERIKSEN EF, 1990, BONE MINERAL RES, V7, P273
   FUIERER TA, 1994, LANGMUIR, V10, P4721, DOI 10.1021/la00024a054
   Hixon A. W., 1931, IND ENG CHEM, V23, P923, DOI DOI 10.1021/IE50260A018
   ITO A, IN PRESS J BIOMED MA
   KAWAMURA H, IN PRESS J BIOMED MA
   KISHI S, 1994, BIOCHEM PHARMACOL, V48, P1225, DOI 10.1016/0006-2952(94)90160-0
   KITANO M, 1971, NIPPON KAGAKU ZASSHI, V92, P168, DOI 10.1246/nikkashi1948.92.168
   KOKUBO T, 1991, J AM CERAM SOC, V74, P1739, DOI 10.1111/j.1151-2916.1991.tb07176.x
   KOUCHIWA S, 1985, CHEM PHARM BULL, V33, P2452
   KREIDLER ER, 1967, INORG CHEM, V6, P524, DOI 10.1021/ic50049a021
   MCLEAN F, 1968, FUNDAMENTALS PHYSL S, P119
   Otsuka M, 1997, J CONTROL RELEASE, V43, P115, DOI 10.1016/S0168-3659(96)01493-9
   OTSUKA M, 1995, J PHARM SCI, V84, P733, DOI 10.1002/jps.2600840614
   Otsuka M, 1997, J PHARM PHARMACOL, V49, P1182, DOI 10.1111/j.2042-7158.1997.tb06067.x
   RELEA P, 1995, AGE AGEING, V24, P303, DOI 10.1093/ageing/24.4.303
   Szathmari Miklos, 1993, Orvosi Hetilap, V134, P911
NR 19
TC 33
Z9 33
U1 1
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2000
VL 52
IS 4
BP 819
EP 824
DI 10.1002/1097-4636(20001215)52:4<819::AID-JBM27>3.3.CO;2-F
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 358UY
UT WOS:000089576600027
PM 11033565
DA 2018-10-19
ER

PT J
AU Wang, XD
   Agrawal, CM
AF Wang, XD
   Agrawal, CM
TI A mixed mode fracture toughness test of bone-biomaterial interfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE fracture toughness; interface; bone; implant; finite element analysis
ID FINITE-ELEMENT ANALYSIS; PUSH-OUT TEST; STRESS-DISTRIBUTION; FAILURE
   MECHANISMS; TENSILE-STRENGTH; BONDING BEHAVIOR; HIP COMPONENTS;
   PROSTHESIS; CRACK; HYDROXYAPATITE
AB Tissue-biomaterial interfacial bonding plays a significant role in the success of biomaterials used far load-bearing orthopedic and dental prostheses. The objective of this study was to develop a physically sound and practically effective technique for assessment of the strength of bone-biomaterial interfaces under mixed mode loading. A single-edge notched sandwich specimen was developed for this purpose, wherein a bilayer specimen comprising the interface between tissue and biomaterial was sandwiched between two holders and loaded under mixed modes. First, a closed form solution was derived for the sandwich specimen under the assumption of linear elasticity, based on a general solution for sandwich structures reported in the literature. Then, a correction factor was determined for the solution using finite element models to compensate for errors induced by finite interlayer thickness. Moreover, using the same FEA models, it was found that crack closure may occur when the shear component is dominant at the crack. However, ifs effects were estimated to be limited and negligible. Furthermore, as an example, the strength of a bone/dental cement interface under different loading modes was tested using this sandwich technique. It is expected that the mixed mode technique can provide an effective means for investigators to study the mechanical integrity of bone-biomaterial interfaces under complex loading conditions. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Texas, Hlth Sci Ctr, Dept Orthopaed, San Antonio, TX 78249 USA.
RP Wang, XD (reprint author), Univ Texas, Hlth Sci Ctr, Dept Orthopaed, 6900 N Loop 1604 W, San Antonio, TX 78249 USA.
CR BLACK J, 1989, J BIOMED MATER RES, V23, P1243, DOI 10.1002/jbm.820231102
   Chang PB, 1998, CLIN ORTHOP RELAT R, P57
   DHERT WJA, 1992, J BIOMED MATER RES, V26, P119, DOI 10.1002/jbm.820260111
   DUNDURS J, 1969, J APPL MECH, V36, P650, DOI 10.1115/1.3564739
   Edwards JT, 1997, J BIOMED MATER RES, V36, P454
   ENGLAND AH, 1965, J APPL MECH, V32, P400, DOI 10.1115/1.3625813
   ERDOGAN F, 1965, J APPL MECH, V32, P403, DOI 10.1115/1.3625814
   FEIGHAN JE, 1995, J BONE JOINT SURG AM, V77, P1380, DOI 10.2106/00004623-199509000-00015
   FILIAGGI MJ, 1991, J BIOMED MATER RES, V25, P1211, DOI 10.1002/jbm.820251004
   FUJIU T, 1984, J BIOMED MATER RES, V18, P845, DOI 10.1002/jbm.820180714
   HARRIGAN TP, 1991, J BIOMECH, V24, P1047, DOI 10.1016/0021-9290(91)90021-E
   HARRIGAN TP, 1990, J ORTHOPAED RES, V8, P678, DOI 10.1002/jor.1100080509
   HOLLISTER SJ, 1993, J BIOMECH, V26, P391, DOI 10.1016/0021-9290(93)90003-W
   KITSUGI T, 1986, J BIOMED MATER RES, V20, P1295, DOI 10.1002/jbm.820200906
   KRAUSE WR, 1982, CLIN ORTHOP RELAT R, P290
   LEWIS JL, 1985, T 31 ORTH RES SOC C
   LEWIS JL, 1983, T BIOM S HOUST, P35
   LIECHTI KM, 1992, INT J FRACTURE, V55, P95, DOI 10.1007/BF00017271
   LIN CP, 1994, J BIOMECH, V27, P1037, DOI 10.1016/0021-9290(94)90220-8
   LIN H, 1992, J BIOMED MATER RES, V26, P7
   Lozada J L, 1994, J Oral Implantol, V20, P315
   MAK AF, 1980, J APPL MECH-T ASME, V47, P347, DOI 10.1115/1.3153667
   MAK AF, 1980, THESIS NW U
   MAK AF, 1980, ASME J APPL MECH, V47, P816
   Mann KA, 1997, J ORTHOPAED RES, V15, P700, DOI 10.1002/jor.1100150511
   Mann KA, 1997, J BIOMECH ENG-T ASME, V119, P175, DOI 10.1115/1.2796077
   Mann KA, 1999, J ORTHOPAED RES, V17, P321, DOI 10.1002/jor.1100170305
   McCormack BAO, 1996, J BIOMECH ENG-T ASME, V118, P579, DOI 10.1115/1.2796047
   Papavasiliou G, 1996, J PROSTHET DENT, V76, P633, DOI 10.1016/S0022-3913(96)90442-4
   Park JB, 1984, BIOMATERIALS SCI ENG
   PROBSTER L, 1994, TENSILE TORSIONAL SH, P314
   RAKOTOMANANA RL, 1992, J BIOMECH, V25, P1413, DOI 10.1016/0021-9290(92)90055-6
   RICE JR, 1965, J APPL MECH, V32, P418, DOI 10.1115/1.3625816
   RICE JR, 1988, J APPL MECH-T ASME, V55, P98, DOI 10.1115/1.3173668
   RICHARD HA, 1983, T INT C APPL FRACT M, P309
   Sertgoz A, 1996, J PROSTHET DENT, V76, P165, DOI 10.1016/S0022-3913(96)90301-7
   SHIRAZIADL A, 1992, J BIOMECH ENG-T ASME, V114, P111, DOI 10.1115/1.2895434
   Spector M, 1987, J Arthroplasty, V2, P163, DOI 10.1016/S0883-5403(87)80024-4
   SUO ZG, 1989, MAT SCI ENG A-STRUCT, V107, P135, DOI 10.1016/0921-5093(89)90382-1
   TAM LE, 1994, J DENT RES, V73, P1530, DOI 10.1177/00220345940730090801
   TAM LE, 1993, J DENT RES, V72, P953, DOI 10.1177/00220345930720051801
   Wang XD, 1997, J BIOMED MATER RES, V38, P1
   Wang XD, 1996, J BIOMED MATER RES, V33, P133, DOI 10.1002/(SICI)1097-4636(199623)33:3<133::AID-JBM2>3.3.CO;2-P
NR 43
TC 17
Z9 17
U1 3
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2000
VL 53
IS 6
BP 664
EP 672
DI 10.1002/1097-4636(2000)53:6<664::AID-JBM8>3.0.CO;2-W
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 375DN
UT WOS:000165384400008
PM 11074425
DA 2018-10-19
ER

PT J
AU Khouw, IMSL
   van Wachem, PB
   Molema, G
   Plantinga, JA
   de Leij, LFMH
   van Luyn, MJA
AF Khouw, IMSL
   van Wachem, PB
   Molema, G
   Plantinga, JA
   de Leij, LFMH
   van Luyn, MJA
TI The foreign body reaction to a biodegradable biomaterial differs between
   rats and mice
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE foreign body reaction; rat; mouse; biomaterial; crosslinked dermal sheep
   collagen
ID DERMAL SHEEP COLLAGEN; MONOCLONAL-ANTIBODY GK1.5; T-CELL ACTIVATION;
   IFN-GAMMA; TISSUE REACTION; ENDOTHELIAL-CELLS; DENDRITIC CELLS;
   CROSS-LINKING; CALCIFICATION; EXPRESSION
AB Before a biomaterial can be applied in the clinic, biocompatibility must be tested in in vivo models, by monitoring the foreign body reaction. In this study, we compared the foreign body reaction (EBR) to the biodegradable biomaterial hexamethylenediisocyanate crosslinked dermal sheep collagen (HDSC) between several strains of rats and mice HDSC disks were implanted subcutaneously on the backs of AO, BN, F344, LEW, and PVG rats and on the backs of 129 SVEV, BALB/c, and C57BL/6 mice. Materials were explanted after 7, 14, 21, and 28 days and processed for (immuno) light and transmission electron microscopic evaluation. In all rat strains, giant cell formation and phagocytosis of HDSC bundles were comparable. In addition, in the PVG rat, many plasma cells infiltrated the HDSC disks. Only a few T cells were present in AO and PVG rats, whereas, in F344 and LEW rats, the presence of T cells was more pronounced. BN rats showed an intermediate T-cell infiltration. In mice, the FBR to HDSC was comparable between the different strains. Compared with rats, giant cell formation was limited, whereas stroma formation was more abundant. Phagocytosis of HDSC bundles rarely occurred in mice, whereas calcification was observed more often. It is concluded that the FBR to HDSC clearly differs between rats and mice. This has consequences for assessment studies on biocompatibility and also on fundamental biomaterial research. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Groningen, Dept Pathol & Lab Med, Med Biol Branch, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen Hosp, GUIDE, Dept Pathol & Lab Med, Med Biol Branch, Groningen, Netherlands.
RP van Luyn, MJA (reprint author), Univ Groningen, Dept Pathol & Lab Med, Med Biol Branch, Hanzepkin 1, NL-9713 GZ Groningen, Netherlands.
CR BEIL W, 1973, IMMUNOLOGY, V24, P13
   Bellon JM, 1996, J BIOMED MATER RES, V31, P1, DOI 10.1002/(SICI)1097-4636(199605)31:1<1::AID-JBM1>3.0.CO;2-S
   BOSKEY AL, 1995, ANN NY ACAD SCI, V760, P249, DOI 10.1111/j.1749-6632.1995.tb44635.x
   Bujan J, 1999, J VASC RES, V36, P106, DOI 10.1159/000025632
   CHAMBERS TJ, 1977, J PATHOL, V123, P65, DOI 10.1002/path.1711230202
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P721, DOI 10.1002/jbm.820110508
   Coers W, 1998, J HISTOCHEM CYTOCHEM, V46, P1385, DOI 10.1177/002215549804601207
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P429
   denBraber ET, 1997, J BIOMED MATER RES, V37, P539, DOI 10.1002/(SICI)1097-4636(19971215)37:4<539::AID-JBM13>3.0.CO;2-3
   DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x
   DIALYNAS DP, 1983, J IMMUNOL, V131, P2445
   DIJKSTRA CD, 1993, PROG HISTOCHEM CYTOC, V27, P1
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   Duncan GS, 1999, J IMMUNOL, V162, P3022
   FUKUMOTO T, 1987, EUR J IMMUNOL, V12, P37
   HART DNJ, 1981, TRANSPLANTATION, V31, P318, DOI 10.1097/00007890-198105010-00003
   HOLMES DR, 1994, J AM COLL CARDIOL, V24, P525, DOI 10.1016/0735-1097(94)90313-1
   HUNIG T, 1989, J EXP MED, V169, P73, DOI 10.1084/jem.169.1.73
   JIRANEK W, 1995, J BONE JOINT SURG AM, V77A, P1650, DOI 10.2106/00004623-199511000-00003
   JORGEHERRERO E, 1994, BIOMATERIALS, V15, P815, DOI 10.1016/0142-9612(94)90036-1
   Kallela I, 1999, J CRANIO MAXILL SURG, V27, P124, DOI 10.1016/S1010-5182(99)80026-2
   Khouw IMSL, 2000, J BIOMED MATER RES, V50, P259, DOI 10.1002/(SICI)1097-4636(200005)50:2<259::AID-JBM21>3.0.CO;2-B
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   Khouw IMSL, 2000, J BIOMED MATER RES, V49, P297, DOI 10.1002/(SICI)1097-4636(20000305)49:3<297::AID-JBM1>3.0.CO;2-0
   Kim KM, 1999, AM J PATHOL, V154, P843, DOI 10.1016/S0002-9440(10)65331-X
   Kobayashi K, 1997, CLIN IMMUNOL IMMUNOP, V85, P112, DOI 10.1006/clin.1997.4421
   KRAAL G, 1987, SCAND J IMMUNOL, V26, P653, DOI 10.1111/j.1365-3083.1987.tb02301.x
   LAM KH, 1993, J BIOMED MATER RES, V27, P1569, DOI 10.1002/jbm.820271214
   LEVY RJ, 1983, ANN THORAC SURG, V36, P187, DOI 10.1016/S0003-4975(10)60454-7
   Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722
   MAURIN N, 1995, J BIOMED MATER RES, V29, P1493, DOI 10.1002/jbm.820291205
   McKee MD, 1996, ANAT RECORD, V245, P394, DOI 10.1002/(SICI)1097-0185(199606)245:2<394::AID-AR19>3.0.CO;2-K
   METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753
   MORISSETTE C, 1995, INFECT IMMUN, V63, P1718
   MOSKALEWSKI S, 1977, FOL HISTOCH CYTOCHEM, V15, P271
   PAPADIMITRIOU JM, 1975, AM J PATHOL, V78, P343
   PORTOLES P, 1989, J IMMUNOL, V142, P4169
   SCOTT P, 1991, J IMMUNOL, V147, P3149
   SHEEHAN DC, 1980, THEORY PRACTICE HIST, P227
   Shibuya K, 1998, J IMMUNOL, V160, P1708
   Srivatsa SS, 1997, J CLIN INVEST, V99, P996, DOI 10.1172/JCI119265
   STET RJM, 1985, TRANSPLANT P, V17, P1829
   Tzur I, 1998, J ORTHOP TRAUMA, V12, P504, DOI 10.1097/00005131-199809000-00014
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   van Susante JLC, 1998, BIOMATERIALS, V19, P2367, DOI 10.1016/S0142-9612(98)00158-6
   VANGULIK TM, 1987, NETH J SURG, V39, P90
   VANLUYN MJA, 1995, J MATER SCI-MATER M, V6, P288, DOI 10.1007/BF00120273
   VANLUYN MJA, 1994, J MATER SCI-MATER M, V5, P671, DOI 10.1007/BF00120354
   VANWACHEM PB, 1991, CELL MATER, V1, P251
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   VECCHI A, 1994, EUR J CELL BIOL, V63, P247
   WOOLLETT GR, 1985, EUR J IMMUNOL, V15, P168, DOI 10.1002/eji.1830150211
   Yang S, 1999, AM J PATHOL, V155, P887, DOI 10.1016/S0002-9440(10)65188-7
NR 53
TC 34
Z9 34
U1 0
U2 11
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2000
VL 52
IS 3
BP 439
EP 446
DI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 356CQ
UT WOS:000089427100001
PM 11007611
DA 2018-10-19
ER

PT J
AU Knabe, C
   Driessens, FCM
   Planell, JA
   Gildenhaar, R
   Berger, G
   Reif, D
   Fitzner, R
   Radlanski, RJ
   Gross, U
AF Knabe, C
   Driessens, FCM
   Planell, JA
   Gildenhaar, R
   Berger, G
   Reif, D
   Fitzner, R
   Radlanski, RJ
   Gross, U
TI Evaluation of calcium phosphates and experimental calcium phosphate bone
   cements using osteogenic cultures
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE calcium phosphate cements; calcium phosphate ceramics; osteoblasts;
   cell-biomaterial interactions; ion release
ID BIOACTIVE GLASS; IN-VITRO; ORTHOPHOSPHATE CEMENTS; HYDROXYAPATITE
   CEMENT; COMPRESSIVE STRENGTH; SETTING REACTION; MONOXIDE CEMENT;
   BEHAVIOR; INVITRO; MARROW
AB In this study, rat bone marrow cells (RBM) were used to evaluate two biodegradable calcium phosphate bone cements and bioactive calcium phosphate ceramics. The substances investigated were: two novel calcium phosphate cements, Biocement F and Biocement H, tricalcium phosphate (TCP), surface-modified alpha-tricalcium phosphate [TCP (s)] and a rapid resorbable calcium phosphate ceramic consisting of CaKPO4 (sample code R5). RBM cells were cultured on disc-shaped test substrates for 14 days. The culture medium was changed daily and also examined for calcium, phosphate, and potassium concentrations. Specimens were evaluated using light microscopy, and morphometry of the cell-covered substrate surface, scanning electron microscopy, and energy dispersive X-ray analysis and morphometry of the cell-covered substrate surface. Areas of mineralization were identified by tetracyline labeling. Except for R 5, rat bone-marrow cells attached and grew on all substrate surfaces. Of the different calcium phosphate materials tested, TCP and TCP (s) facilitated osteoblast growth and extracellular matrix elaboration to the highest degree, followed by Biocements H and F. The inhibition of cell growth encountered with R 5 seems to be related to its high phosphate and potassium ion release. (C) 2000 John Wiley & Sons, Inc.
C1 Free Univ Berlin, Klinikum Benjamin Franklin, Dept Expt Dent, D-14197 Berlin, Germany.
   State Univ Ghent Hosp, Dept Dent Mat Sci, B-9000 Ghent, Belgium.
   Univ Politecn Catalunya, Dept Mat Sci & Met, E-08028 Barcelona, Spain.
   Fed Inst Mat Res & Testing, Lab Biomat, D-12200 Berlin, Germany.
   Biovis Inc, D-98693 Ilmenau, Germany.
   Free Univ Berlin, Klinikum Benjamin Franklin, Inst Clin Chem & Biochem, D-12200 Berlin, Germany.
   Free Univ Berlin, Klinikum Benjamin Franklin, Inst Pathol, D-12200 Berlin, Germany.
RP Radlanski, RJ (reprint author), Free Univ Berlin, Klinikum Benjamin Franklin, Dept Expt Dent, Assmannshauser Str 4-6, D-14197 Berlin, Germany.
CR Anselme K, 1997, J BIOMED MATER RES, V34, P247, DOI 10.1002/(SICI)1097-4636(199702)34:2<247::AID-JBM14>3.0.CO;2-F
   BERGER G, 1995, BIOMATERIALS, V16, P1241, DOI 10.1016/0142-9612(95)98131-W
   BERGER G, 1995, BIOCERAMICS, V8, P453
   BERMUDEZ O, 1993, J MATER SCI-MATER M, V4, P389, DOI 10.1007/BF00122197
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   Claes L, 1997, ORTHOPADE, V26, P459, DOI 10.1007/PL00003400
   Constantz BR, 1998, J BIOMED MATER RES, V43, P451, DOI 10.1002/(SICI)1097-4636(199824)43:4<451::AID-JBM13>3.0.CO;2-Q
   Davies JE, 1996, ANAT REC, V245, P426
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   DRIESSENS FCM, 1993, J MATER SCI-MATER M, V4, P503, DOI 10.1007/BF00120130
   DRIESSENS FCM, 1994, J MATER SCI-MATER M, V5, P164, DOI 10.1007/BF00053338
   Driessens FCM, 1998, P I MECH ENG H, V212, P427, DOI 10.1243/0954411981534196
   DRIESSENS FCM, 1995, J MATER SCI-MATER M, V6, P272, DOI 10.1007/BF00120270
   DRIESSENS FCM, 1993, BIOCERAMICS, V6, P469
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   Fernandez E, 1998, J BIOMED MATER RES, V41, P560, DOI 10.1002/(SICI)1097-4636(19980915)41:4<560::AID-JBM7>3.0.CO;2-A
   Fernandez E, 1996, J BIOMED MATER RES, V32, P367, DOI 10.1002/(SICI)1097-4636(199611)32:3<367::AID-JBM9>3.0.CO;2-Q
   Flautre B, 1999, BONE, V25, p35S, DOI 10.1016/S8756-3282(99)00147-7
   Frayssinet P, 1998, BIOMATERIALS, V19, P971, DOI 10.1016/S0142-9612(97)00163-4
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Ginebra M. P., 1994, Clinical Materials, V17, P99, DOI 10.1016/0267-6605(94)90018-3
   GINEBRA MP, 1995, J MATER SCI-MATER M, V6, P612, DOI 10.1007/BF00121286
   Ginebra MP, 1995, J MATER SCI-MATER M, V6, P857, DOI 10.1007/BF00134332
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   GINEBRA MP, 1996, T 5 WORLD BIOM C, P349
   GINEBRA MP, 1995, T 21 ANN M CONJ 27 I, P99
   Ginebra MP, 1994, BIOCERAMICS, V7, P273
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   Hamanishi C, 1996, J BIOMED MATER RES, V32, P383, DOI 10.1002/(SICI)1097-4636(199611)32:3<383::AID-JBM11>3.0.CO;2-I
   HOLMES RE, 1987, J ORTHOPAED RES, V5, P114, DOI 10.1002/jor.1100050114
   ISHIKAWA K, 1994, DENT MATER, V10, P26, DOI 10.1016/0109-5641(94)90018-3
   JANSEN JA, 1995, J MATER SCI-MATER M, V6, P653, DOI 10.1007/BF00123447
   Khairoun I, 1997, BIOMATERIALS, V18, P1535, DOI 10.1016/S0142-9612(97)00096-3
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Knabe C, 1997, BIOMATERIALS, V18, P1339, DOI 10.1016/S0142-9612(97)00078-1
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   KOKUBO T, 1993, BIOCERAMICS, V6, P73
   Kurashina K, 1997, BIOMATERIALS, V18, P539, DOI 10.1016/S0142-9612(96)00162-7
   Kurashina K, 1998, BIOMATERIALS, V19, P701, DOI 10.1016/S0142-9612(97)00178-6
   LEGEROS RZ, 1991, BONE-BIOMATERIAL INTERFACE, P76
   LOWENBERG B, 1991, CELL MATER, V1, P177
   LOWENBERG BF, 1996, T 5 WORLD BIOM C, P668
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   MEFFERT RM, 1985, J PERIODONTOL, V56, P63, DOI 10.1902/jop.1985.56.2.63
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   Miyamato Y, 1996, BIOMATERIALS, V17, P1429, DOI 10.1016/0142-9612(96)87286-3
   MULLERMAI C, 1997, BIOCERAMICS, V10, P53
   MULLERMAI CM, 1998, T 24 ANN M SOC BIOM, P458
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T
   Oreffo ROC, 1998, TISSUE ENG, V4, P293, DOI 10.1089/ten.1998.4.293
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   OTSUKA M, 1995, J BIOMED MATER RES, V29, P25, DOI 10.1002/jbm.820290105
   Radin S, 1998, J BIOMED MATER RES, V39, P234, DOI 10.1002/(SICI)1097-4636(199802)39:2<234::AID-JBM10>3.0.CO;2-D
   RADIN S, 1993, BIOCERAMICS, V6, P59
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   SAFFAR JL, 1990, J PERIODONTOL, V61, P209, DOI 10.1902/jop.1990.61.4.209
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   Sharpe JR, 1997, BIOMATERIALS, V18, P471, DOI 10.1016/S0142-9612(96)00157-3
   SODEK J, 1991, BONE-BIOMATERIAL INTERFACE, P97
   Takagi S, 1998, BIOMATERIALS, V19, P1593, DOI 10.1016/S0142-9612(97)00119-1
   TODESCAN R, 1996, T 5 WORLD BIOM C, P721
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yoshimine Y, 1996, BIOMATERIALS, V17, P2241, DOI 10.1016/0142-9612(96)00045-2
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 67
TC 72
Z9 74
U1 2
U2 13
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2000
VL 52
IS 3
BP 498
EP 508
DI 10.1002/1097-4636(20001205)52:3<498::AID-JBM8>3.0.CO;2-P
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 356CQ
UT WOS:000089427100008
PM 11007618
DA 2018-10-19
ER

PT J
AU Caplan, MR
   Moore, PN
   Zhang, SG
   Kamm, RD
   Lauffenburger, DA
AF Caplan, MR
   Moore, PN
   Zhang, SG
   Kamm, RD
   Lauffenburger, DA
TI Self-assembly of a beta-sheet protein governed by relief of
   electrostatic repulsion relative to van der Waals attraction
SO BIOMACROMOLECULES
LA English
DT Article
ID GCN4 LEUCINE-ZIPPER; COMPLEMENTARY OLIGOPEPTIDE; AMYLOID PEPTIDE;
   STABILITY
AB Using a synthetic oligopeptide, n-FKFEFKFEFKFE-c (KFE12), representative of a class of peptides that can undergo self-assembly into a three-dimensional matrix biomaterial, we show that the self-assembly occurs when solution conditions reduce intermolecular electrical double-layer repulsion below van der Waals attraction in accord with DLVO theory. This theory predicts that a critical coagulation concentration of counterions should be required to allow assembly and that this concentration should be inversely proportional to the valence of the counterion raised to the sixth power. Our experimental results show that KFE12, at low pH, exhibits critical coagulation concentrations in each of three different salt solutions, KCl, K2SO4, and K3Fe(CN)(6), and that the relative values of these critical concentrations follow the predicted dependence upon anion valence. The theory further predicts that self-assembly should occur when the oligopeptide is electrically neutral even in the absence of exogenous salt. Our experimental results show that KFE12 indeed forms gels when neutralized with NaOH. Thus, we have gained fundamental theoretical understanding of how to control the assembly of this class of oligopeptide-based biomaterials.
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
   MIT, Div Bioengn & Environm Hlth, Cambridge, MA 02139 USA.
RP Lauffenburger, DA (reprint author), MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
OI /0000-0002-7232-304X
FU NIGMS NIH HHS [GM55781]
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Choo DW, 1996, MACROMOLECULES, V29, P355, DOI 10.1021/ma950703e
   CLARK AH, 1987, STRUCTURAL MECH PROP, V83, P58
   Creighton T, 1993, PROTEINS STRUCTURE M
   FRANK EH, 1990, BIOMECHANICS DIARTHR, V1, P261
   HALVERSON K, 1990, BIOCHEMISTRY-US, V29, P2639, DOI 10.1021/bi00463a003
   Head MW, 2000, TRENDS MICROBIOL, V8, P6, DOI 10.1016/S0966-842X(99)01656-X
   HEIMENZ PC, 1997, PRINCIPLES COLLOID S, P585
   Hendsch ZS, 1999, PROTEIN SCI, V8, P1381, DOI 10.1110/ps.8.7.1381
   Honig B., 1992, CURR OPIN STRUC BIOL, V2, P40
   Hubbell JA, 1996, MRS BULL, V21, P33
   INOUYE H, 1993, BIOPHYS J, V64, P502, DOI 10.1016/S0006-3495(93)81393-6
   JAYAKUMAR R, 1995, INT J PEPT PROT RES, V45, P129
   Leon EJ, 1998, J BIOMAT SCI-POLYM E, V9, P297, DOI 10.1163/156856298X00668
   LUMB KJ, 1995, SCIENCE, V268, P436, DOI 10.1126/science.7716550
   Overbeek J. T. G, 1952, COLLOID SCI, VI, P302
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   SEIPKE G, 1974, BIOPOLYMERS, V13, P1621, DOI 10.1002/bip.1974.360130809
   SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006
   SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4
   SHEN CL, 1993, BIOPHYS J, V65, P2383, DOI 10.1016/S0006-3495(93)81312-2
   TANFORD C, 1980, HYRDOPHOBIC EFFECT
   Verwey E., 1948, THEORY STABILITY LYO, P106
   WELLINGS DA, 1997, STANDARD FMOC PROTOC, V289, P61
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   ZHOU NE, 1994, PROTEIN ENG, V7, P1365, DOI 10.1093/protein/7.11.1365
NR 28
TC 180
Z9 186
U1 2
U2 41
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD WIN
PY 2000
VL 1
IS 4
BP 627
EP 631
DI 10.1021/bm005586w
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 433JD
UT WOS:000168755500019
PM 11710192
DA 2018-10-19
ER

PT J
AU Cannon, JM
   Kostoryz, E
   Russo, KA
   Smith, RE
   Yourtee, DM
AF Cannon, JM
   Kostoryz, E
   Russo, KA
   Smith, RE
   Yourtee, DM
TI Bisphenol A and its biomaterial monomer derivatives alteration of in
   vitro cytochrome P450 metabolism in rat, minipig, and human
SO BIOMACROMOLECULES
LA English
DT Article
ID HUMAN LIVER-MICROSOMES; ENVIRONMENTAL ESTROGEN; LAURIC ACID; CHEMICALS;
   ISOFORMS; COATINGS; CAFFEINE; ENZYMES; 2E1
AB Bisphenol A (BPA) is a common structural component in a wide variety of biomaterial monomers. The effects of BPA and the following derivatives: bisphenol A glycidyl methacrylate (BisGMA), bisphenol A glycidyl diacrylate (BAGDA), bisphenol A ethoxylate dimethacrylate (BAEDM), bisphenol A dimethacrylate (BADM), and bisphenol A diglycidyl ether (BADGE) on mixed function oxidases (MFOs) are reported in this study. The rate of formation of metabolites from isoform-specific substrates for the MFOs (or cytochromes) CYP 1A, 2A, 2C, 2E, 3A, and 4A in the absence (control) and presence of BPA and derivatives was used to assess inhibition or stimulation of human, rat (male and female) liver, and minipig liver microsomal MFO activity. For human preparations the strongest inhibition by BPA was observed for CYP 2C. The inhibition was most prominent when a lower dose of BPA was used on the complete post-mitochondrial fraction. BPA inhibited rat microsomal CYP 1A isoform-specific metabolite production to 29 +/- 3% of control levels (100%). Biomaterial monomers exhibited mixed effects. For example, BPA stimulated CYP 4A in pooled human S9 to 129 +/- 1% of control. Also, BADM and BAGDA stimulated CYP 4A to 141% and 142% of control values, respectively.
C1 Univ Missouri, Sch Pharm, Div Pharmacol, Toxicore Lab, Kansas City, MO 64108 USA.
   US FDA, Off Regulatory Affairs, Lenexa, KS 66214 USA.
RP Yourtee, DM (reprint author), Univ Missouri, Sch Pharm, Div Pharmacol, Toxicore Lab, Kansas City, MO 64108 USA.
CR AMET Y, 1994, BIOCHEM BIOPH RES CO, V203, P1168, DOI 10.1006/bbrc.1994.2305
   Anzenbacher P, 1998, DRUG METAB DISPOS, V26, P56
   ATKINSON A, 1995, BIOCHEM BIOPH RES CO, V210, P424, DOI 10.1006/bbrc.1995.1678
   Biedermann M, 1998, FOOD ADDIT CONTAM A, V15, P609, DOI 10.1080/02652039809374688
   CASTLE PJ, 1995, DRUG METAB DISPOS, V23, P1037
   Draper AJ, 1997, ARCH BIOCHEM BIOPHYS, V341, P47, DOI 10.1006/abbi.1997.9964
   *FOOD DRUG ADM CTR, 1997, GUID IND DRUG MET DR
   GUNDERSON EL, 1988, J ASSOC OFF ANA CHEM, V71, P1200
   Hanioka N, 1998, ARCH TOXICOL, V72, P387, DOI 10.1007/s002040050518
   KNAAK JB, 1966, TOXICOL APPL PHARM, V8, P175, DOI 10.1016/S0041-008X(66)80001-7
   Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252
   LING KHJ, 1995, DRUG METAB DISPOS, V23, P631
   MATSUBARA T, 1976, ANAL BIOCHEM, V75, P596, DOI 10.1016/0003-2697(76)90114-7
   Olea N, 1996, ENVIRON HEALTH PERSP, V104, P298, DOI 10.2307/3432888
   PASEIRO-LOSADA P, 1991, J ASSOC OFF ANA CHEM, V74, P925
   Pearce RE, 1996, ARCH BIOCHEM BIOPHYS, V331, P145, DOI 10.1006/abbi.1996.0294
   Rasmussen BB, 1996, THER DRUG MONIT, V18, P254, DOI 10.1097/00007691-199606000-00006
   REEL H, 1997, DRUG METAB REV, V29, P413
   Rendic S, 1997, DRUG METAB REV, V29, P413, DOI 10.3109/03602539709037591
   Roy D, 1997, J TOXICOL ENV HEALTH, V50, P1, DOI 10.1080/009841097160573
   Sax NI., 1985, DANGEROUS PROPERTIES
   Schweikl H, 1998, MUTAT RES-GEN TOX EN, V415, P119, DOI 10.1016/S1383-5718(98)00067-9
   SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414
   Simal-Gandara J, 1998, CRIT REV FOOD SCI, V38, P675, DOI 10.1080/10408699891274345
   SOHNI P, 1998, J ENDOCRINOL, V158, P327
   Sonnenschein C, 1998, J STEROID BIOCHEM, V65, P143, DOI 10.1016/S0960-0760(98)00027-2
   Staples CA, 1998, CHEMOSPHERE, V36, P2149, DOI 10.1016/S0045-6535(97)10133-3
   TASSANEEYAKUL W, 1994, BIOCHEM PHARMACOL, V47, P1767, DOI 10.1016/0006-2952(94)90304-2
   Vom Saal FS, 1998, TOXICOL IND HEALTH, V14, P239, DOI 10.1177/074823379801400115
   WILLIAMSCAMPBEL.R, 1999, IADR 25 ANN M APR
NR 30
TC 15
Z9 16
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD WIN
PY 2000
VL 1
IS 4
BP 656
EP 664
DI 10.1021/bm005564+
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 433JD
UT WOS:000168755500023
PM 11710196
DA 2018-10-19
ER

PT J
AU Burg, KJL
   Porter, S
   Kellam, JF
AF Burg, KJL
   Porter, S
   Kellam, JF
TI Biomaterial developments for bone tissue engineering
SO BIOMATERIALS
LA English
DT Review
DE absorbable; bone morphogenetic protein; bone tissue engineering;
   ceramic; demineralized bone matrix; polymer
ID RESORBABLE POLYMERIC MEMBRANES; MORPHOGENETIC PROTEIN; POROUS
   HYDROXYAPATITE; POLY(PROPYLENE FUMARATE); POLY(L-LACTIDE) MEMBRANE;
   MECHANICAL-PROPERTIES; OSTEOGENIC PROTEIN; OSSEOUS DEFECTS; MARROW
   CELLS; IV COLLAGEN
AB The development of bone tissue engineering is directly related to changes in materials technology. While the inclusion of materials requirements is standard in the design process of engineered bone substitutes, it is also critical to incorporate clinical requirements in order to engineer a clinically relevant device. This review presents the clinical need for bone tissue-engineered alternatives to the present materials used in bone grafting techniques, a status report on clinically available bone tissue-engineering devices, and recent advances in biomaterials research. The discussion of ongoing research includes the current state of osseoactive factors and the delivery of these factors using bioceramics and absorbable biopolymers. Suggestions are also presented as to the desirable design features that would make an engineered device clinically effective. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
   Carolinas Med Ctr, Dept Orthopaed Surg, Charlotte, NC 28232 USA.
RP Burg, KJL (reprint author), Clemson Univ, Dept Bioengn, 501 Rhodes Engn Res Bldg, Clemson, SC 29634 USA.
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR Asahina Izumi, 1997, Journal of Medical and Dental Sciences, V44, P63
   Attawia MA, 1999, J BIOMED MATER RES, V48, P322, DOI 10.1002/(SICI)1097-4636(1999)48:3<322::AID-JBM17>3.0.CO;2-U
   Bennett S, 1996, BONE, V19, pS101, DOI 10.1016/S8756-3282(96)00130-5
   Bostrom MPG, 1998, CLIN ORTHOP RELAT R, pS274
   BOSTROM MPG, 1995, J ORTHOPAED RES, V13, P357, DOI 10.1002/jor.1100130309
   BOSTROM RD, 1997, SYNTHETIC BIODEGRADA, P215, DOI DOI 10.1007/978-1-4612-4154-6
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   BROWN KLB, 1982, J BONE JOINT SURG AM, V64, P270, DOI 10.2106/00004623-198264020-00020
   Burg KJL, 1997, J BIOMAT SCI-POLYM E, V9, P15
   BURG KJL, 1999, T 25 ANN M SOC BIOM
   COVENTRY MB, 1972, J BONE JOINT SURG AM, VA 54, P83, DOI 10.2106/00004623-197254010-00008
   CRANE GM, 1995, NAT MED, V1, P1322, DOI 10.1038/nm1295-1322
   Croteau S, 1999, ORTHOPEDICS, V22, P686
   Cunningham BW, 1999, SPINE, V24, P509, DOI 10.1097/00007632-199903150-00002
   de Groot K, 1998, TISSUE ENG, V4, P337
   Dekker RJ, 1998, J MATER SCI-MATER M, V9, P859, DOI 10.1023/A:1008956430697
   DENDUNNEN WFA, 1993, J MATER SCI-MATER M, V4, P521, DOI 10.1007/BF00120133
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Ekholm M, 1999, BIOMATERIALS, V20, P1257, DOI 10.1016/S0142-9612(97)00080-X
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   ENNEKING WF, 1980, J BONE JOINT SURG AM, V62, P1039, DOI 10.2106/00004623-198062070-00001
   FERGUSON D, 1987, CLIN ORTHOP RELAT R, P251
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Gao T, 1996, INT ORTHOP, V20, P321, DOI 10.1007/s002640050086
   Gao TJ, 1996, J BIOMED MATER RES, V32, P505, DOI 10.1002/(SICI)1097-4636(199612)32:4<505::AID-JBM2>3.0.CO;2-V
   GARG R, 1997, BIOMATERIALS CARRIER, P281
   GEPSTEIN R, 1987, J BONE JOINT SURG AM, V69A, P984, DOI 10.2106/00004623-198769070-00005
   GERHART TN, 1993, CLIN ORTHOP RELAT R, P317
   Gogolewski S, 1997, BIOMATERIALS, V18, P251, DOI 10.1016/S0142-9612(96)00132-9
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   Gugala Z, 1999, J ORTHOP TRAUMA, V13, P187, DOI 10.1097/00005131-199903000-00006
   Hammerle CHF, 1997, CLIN ORAL IMPLAN RES, V8, P198, DOI 10.1034/j.1600-0501.1997.080306.x
   HARAKAS NK, 1984, CLIN ORTHOP RELAT R, P239
   Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149
   Hollinger JO, 1997, ANN NY ACAD SCI, V831, P427
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, V207, P290
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   Holy CE, 1999, BIOMATERIALS, V20, P1177, DOI 10.1016/S0142-9612(98)00256-7
   Ilizarov G A, 1989, Clin Orthop Relat Res, P263
   Ilizarov G A, 1989, Clin Orthop Relat Res, P249
   Isogai N, 1999, J BONE JOINT SURG AM, V81A, P306, DOI 10.2106/00004623-199903000-00002
   JOHNSON EE, 1988, CLIN ORTHOP RELAT R, P249
   Johnson EE, 1998, CLIN ORTHOP RELAT R, P105
   JOHNSON EE, 1992, CLIN ORTHOP RELAT R, P229
   JOHNSON EE, 1990, CLIN ORTHOP RELAT R, P234
   Kirker-Head C A, 1998, Clin Orthop Relat Res, P205, DOI 10.1097/00003086-199804000-00026
   Koempel JA, 1998, J BIOMED MATER RES, V41, P359, DOI 10.1002/(SICI)1097-4636(19980905)41:3<359::AID-JBM3>3.0.CO;2-B
   Koller MR, 1998, BIOMATERIALS, V19, P1963, DOI 10.1016/S0142-9612(98)00101-X
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   Levine JP, 1997, ANN PLAS SURG, V39, P158, DOI 10.1097/00000637-199708000-00008
   Lewandrowski KU, 1999, TISSUE ENG, V5, P305, DOI 10.1089/ten.1999.5.305
   LINDE A, 1995, CALCIFIED TISSUE INT, V56, P549, DOI 10.1007/BF00298588
   MainilVarlet P, 1997, BIOMATERIALS, V18, P257, DOI 10.1016/S0142-9612(96)00126-3
   MAURER RC, 1987, CLIN ORTHOP RELAT R, P162
   Meinig RP, 1997, J ORTHOP TRAUMA, V11, P551, DOI 10.1097/00005131-199711000-00002
   Meinig RP, 1996, J ORTHOP TRAUMA, V10, P178, DOI 10.1097/00005131-199604000-00006
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MIYAMOTO S, 1993, CLIN ORTHOP RELAT R, P333
   MIYAMOTO S, 1992, CLIN ORTHOP RELAT R, P274
   MIYAMOTO S, 1993, J BONE JOINT SURG BR, V75, P107
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   MUGGLI DC, 1997, BIOMATERIALS CARRIER, P275
   NAKAHARA H, 1989, CLIN ORTHOP RELAT R, P299
   NAKAMURA T, 1992, DEGRADATION PHENOMEN, P153
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Peter SJ, 1999, J BIOMAT SCI-POLYM E, V10, P363, DOI 10.1163/156856299X00423
   Pineda LM, 1996, J BIOMED MATER RES, V31, P385
   Puelacher WC, 1996, INT J ORAL MAX SURG, V25, P223, DOI 10.1016/S0901-5027(96)80035-X
   Reddi A. Hari, 1992, Current Opinion in Cell Biology, V4, P850
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Ripamonti U, 1998, PLAST RECONSTR SURG, V101, P227, DOI 10.1097/00006534-199801000-00040
   ROWETON SL, 1994, THESIS CLEMSON U
   Russell JL, 1999, ORTHOPEDICS, V22, P524
   Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2
   SAMPATH TK, 1992, J BIOL CHEM, V267, P20352
   Sandhu HS, 1997, SPINE, V22, P1171, DOI 10.1097/00007632-199706010-00001
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   STEVENSON S, 1994, J BONE JOINT SURG AM, V76A, P1676, DOI 10.2106/00004623-199411000-00011
   SUMMERS BN, 1989, J BONE JOINT SURG BR, V71, P677
   Suzawa M, 1999, ENDOCRINOLOGY, V140, P2125, DOI 10.1210/en.140.5.2125
   TAKAGI K, 1982, CLIN ORTHOP RELAT R, P224
   Takahashi T, 1999, J NEUROSURG, V90, P224, DOI 10.3171/spi.1999.90.2.0224
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250
   Tancred DC, 1998, BIOMATERIALS, V19, P2303, DOI 10.1016/S0142-9612(98)00141-0
   Tiedeman JJ, 1995, ORTHOPEDICS, V18, P1153
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   URIST M R, 1965, J Bone Joint Surg Br, V47, P304
   URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243
   URIST MR, 1994, BONE GRAFTS, DERIVATIVES AND SUBSTITUTES, P315
   URIST MR, 1979, P SOC EXP BIOL MED, V162, P48
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828
   URIST MR, 1980, CLIN ORTHOP RELAT R, V154, P97
   Van de Putte K A, 1965, Clin Orthop Relat Res, V43, P257
   VAN DE PUTTE KAREL A., 1965, CLIN ORTHOP RELAT RES, V40, P48
   VERT M, 1992, Clinical Materials, V10, P3, DOI 10.1016/0267-6605(92)90077-7
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   WOZNEY JM, 1990, J CELL SCI, P149
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P1513, DOI 10.1016/S0142-9612(99)00062-9
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 107
TC 952
Z9 1018
U1 40
U2 610
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2000
VL 21
IS 23
SI SI
BP 2347
EP 2359
DI 10.1016/S0142-9612(00)00102-2
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 360QP
UT WOS:000089679000003
PM 11055282
DA 2018-10-19
ER

PT J
AU Winn, SR
   Hollinger, JO
AF Winn, SR
   Hollinger, JO
TI An osteogenic cell culture system to evaluate the cytocompatibility of
   Osteoset (R), a calcium sulfate bone void filler
SO BIOMATERIALS
LA English
DT Article
DE biomaterials; OsteoSet (R) pellets; Transwell (R) inserts; osteogenic;
   recombinant human bone morphogenetic protein-2 (rhBMP-2); bone
   regeneration
ID POROUS POLYESTERURETHANE FOAM; IN-VITRO; MORPHOGENETIC PROTEIN-2;
   DEGRADATION PRODUCTS; OSTEOBLASTS; IMPLANT; INVITRO; LINE;
   DIFFERENTIATION; PROLIFERATION
AB The purpose of the study was to describe a convenient, reliable and quantitative in vitro assay system to assess the cytocompatibility of a calcium sulfate bone filler on two osteogenic cell lines and primary osteoblasts. The hypothesis was that the bone void tiller, OsteoSet(R) pellets, would not impact adversely on cell proliferation kinetics or osteogenic potential of selected cells. The hypothesis was tested by standard in vitro methodology of placing OsteoSet(R) pellets either directly in contact with osteogenic cells, or by compartmentalizing within transwell(R) - clear microporous membrane inserts. Data analyses were accomplished with appropriate post hoc statistics (p less than or equal to 0.05). In the presence of the OsteoSet(R) pellets, the cell lines exhibited a decrease in cell proliferation at days 4 and 7, independent of either cell type or tissue culture medium. A decrease in the alkaline phosphatase enzyme activity occurred in the osteogenic cell lines maintained for 9 and 16 days in the presence of the OsteoSet(R) pellets. However, with the exception of the MC3T3E-1 line, no differences were observed with respect to calcium deposition (mineralization)by day 16. Intact human osteocalcin release data for the human-derived OPC1 line and the primary osteoblasts was inconclusive as the OsteoSet(R) pellets may interact with the osteocalcin secreted into the tissue culture medium. The present studies describe a cell culture system to assess the cytocompatibility of bone-graft substitutes with osteogenic cells by compartmentalizing material from direct cell contact tin transwells(R), and additionally, by evaluating direct cell/biomaterial interactions. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Oregon Hlth & Sci Univ, Div Plast & Reconstruct Surg L352A, Portland, OR 97201 USA.
RP Hollinger, JO (reprint author), Oregon Hlth & Sci Univ, Div Plast & Reconstruct Surg L352A, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.
CR Bai MH, 1996, INT SURG, V81, P390
   BEGLEY CT, 1993, BONE, V14, P661, DOI 10.1016/8756-3282(93)90089-S
   BROOK IM, 1992, BIOMATERIALS, V13, P721, DOI 10.1016/0142-9612(92)90134-A
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   FRANKEL AH, 1989, TRANSPLANTATION, V48, P639
   FRIEDLAENDER G E, 1987, Journal of Bone and Joint Surgery American Volume, V69, P786
   HARAKAS NK, 1984, CLIN ORTHOP RELAT R, V188, P239
   Hollinger J, 1996, J CONTROL RELEASE, V39, P287, DOI 10.1016/0168-3659(95)00183-2
   HOLLINGER JO, 1998, TISSUE ENG APPL MAXI, P17
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Israel D I, 1992, Growth Factors, V7, P139, DOI 10.3109/08977199209046403
   KADIYALA S, 1994, BONE FORMATION REPAI, P316
   KATOH M, 1995, BONE, V16, P97, DOI 10.1016/S8756-3282(94)00015-8
   Kim CK, 1998, J PERIODONTOL, V69, P982, DOI 10.1902/jop.1998.69.9.982
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LOWRY OH, 1954, J BIOL CHEM, V207, P19
   MATUKAS VJ, 1988, J NEUROSURG, V69, P514, DOI 10.3171/jns.1988.69.4.0514
   MAYER MH, 1994, CLIN PLAST SURG, V21, P365
   Papaioannou W, 1999, J PERIODONTOL, V70, P668, DOI 10.1902/jop.1999.70.6.668
   Pecora GE, 1998, INT J ORAL MAX IMPL, V13, P866
   Pilkington GJ, 1997, ANTICANCER RES, V17, P4107
   PULEO DA, 1993, BIOMATERIALS, V14, P111, DOI 10.1016/0142-9612(93)90220-V
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Saad B, 1998, J BIOMED MATER RES, V39, P594, DOI 10.1002/(SICI)1097-4636(19980315)39:4<594::AID-JBM14>3.0.CO;2-7
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   SIDQUI M, 1995, BIOMATERIALS, V16, P1327, DOI 10.1016/0142-9612(95)91048-4
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   TOMFORD WW, 1995, J BONE JOINT SURG AM, V77A, P1742, DOI 10.2106/00004623-199511000-00017
   Winn SR, 1999, J BONE MINER RES, V14, P1721, DOI 10.1359/jbmr.1999.14.10.1721
   Winn SR, 1999, J BIOMED MATER RES, V45, P414, DOI 10.1002/(SICI)1097-4636(19990615)45:4<414::AID-JBM17>3.0.CO;2-Z
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   Yoshimine Y, 1996, BIOMATERIALS, V17, P2241, DOI 10.1016/0142-9612(96)00045-2
NR 35
TC 23
Z9 26
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2000
VL 21
IS 23
SI SI
BP 2413
EP 2425
DI 10.1016/S0142-9612(00)00109-5
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 360QP
UT WOS:000089679000010
PM 11055289
DA 2018-10-19
ER

PT J
AU Saldanha, V
   Grande, DA
AF Saldanha, V
   Grande, DA
TI Extracellular matrix protein gene expression of bovine chondrocytes
   cultured on resorbable scaffolds
SO BIOMATERIALS
LA English
DT Article
DE gene expression; collagen type I; collagen type II; aggrecan;
   biomaterials
ID ARTICULAR-CARTILAGE; ALLOGRAFT CHONDROCYTES; DEFECTS; REPAIR
AB It has been demonstrated that using cultured chondrocytes that have been seeded onto various biomatrices can enhance the quality of the articular cartilage repair tissue. As tissue-engineering becomes increasingly more complex there is a need to understand how a specific biomaterial may influence gene expression. Tn this study several commonly used scaffold materials for cartilage tissue engineering were evaluated with respect to their influence on matrix gene expression. Primary cultures of bovine chondrocytes were established in monolayer then seeded onto polylactic acid (PLLA), polyglycolic acid (PGA), collagen matrices. The induction of collagen type I, collagen type II, and aggrecan was observed at various time points on these biomaterials using RT-PCR. The collagen type I gene was upregulated on collagen scaffolds throughout the culture period. PLLA and PCA showed initial induction followed by downregulation. Monolayer culture did not induce collagen I message. Collagen II genes were selectively upregulated after 72 and 96 h post seeding depending the scaffold material. Monolayer culture had strong induction of collagen LT. The aggrecan protein was consistently expressed in all scaffold materials cultures and monolayer. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 N Shore Univ Hosp, Dept Surg, Div Orthopaed, Manhasset, NY 11030 USA.
RP Grande, DA (reprint author), N Shore Univ Hosp, Dept Surg, Div Orthopaed, 350 Community Dr, Manhasset, NY 11030 USA.
CR Aigner T, 1997, ARTHRITIS RHEUM, V40, P562, DOI 10.1002/art.1780400323
   Athanasiou K, 1997, TISSUE ENG, V3, P363, DOI 10.1089/ten.1997.3.363
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BENYISHAY DA, 1992, T ORTHOP RES SOC, V17, P174
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   DORE S, 1995, ARTHRITIS RHEUM, V38, P413, DOI 10.1002/art.1780380319
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   GRANDE D, 1995, TISSUE ENG, V1, P4
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   GREEN WT, 1977, CLIN ORTHOP RELAT R, P237
   MANKIN HJ, 1974, NEW ENGL J MED, V291, P1285, DOI 10.1056/NEJM197412122912406
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   SOKOLOFF L, 1974, J RHEUMATOL, V1, P1
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
NR 18
TC 28
Z9 32
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2000
VL 21
IS 23
SI SI
BP 2427
EP 2431
DI 10.1016/S0142-9612(00)00110-1
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 360QP
UT WOS:000089679000011
PM 11055290
DA 2018-10-19
ER

PT J
AU Suh, JKF
   Matthew, HWT
AF Suh, JKF
   Matthew, HWT
TI Application of chitosan-based polysaccharide biomaterials in cartilage
   tissue engineering: a review
SO BIOMATERIALS
LA English
DT Review
DE articular cartilage; tissue engineering; biomaterials; chitosan;
   polysaccharide
ID VIVO GENE-TRANSFER; ARTICULAR-CARTILAGE; HYALURONIC-ACID; OSTEOCHONDRAL
   DEFECTS; IN-VIVO; POLYMORPHONUCLEAR CELLS; ALLOGRAFT CHONDROCYTES;
   RABBIT KNEE; COLLAGEN; REPAIR
AB Once damaged, articular cartilage has very little capacity for spontaneous healing because of the avascular nature of the tissue. Although many repair techniques have been proposed over the past four decades, none has sucessfully regenerated long-lasting hyaline cartilage tissue to replace damaged cartilage. Tissue engineering approaches, such as transplantation of isolated chondrocytes, have recently demonstrated tremendous clinical potential for regeneration of hyaline-like cartilage tissue and treatment of chondral lesions. As such a new approach emerges, new important questions arise. One of such questions is: what kinds of biomaterials can be used with chondrocytes to tissue-engineer aticular cartilage? The success of chondrocyte transplantation and/or the quality of neocartilage formation strongly depend on the specific cell-carrier material. The present article reviews some of those biomaterials, which have been suggested to promote chondrogenesis and to have potentials for tissue engineering of articular cartilage. A new biomaterial, a chitosan-based polysaccharide hydrogel, is also introduced and discussed in terms of the biocompatibility with chondrocytes. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Tulane Univ, Dept Biomed Engn, Lindy Boggs Ctr, New Orleans, LA 70118 USA.
   Wayne State Univ, Dept Chem Engn & Mat Sci, Detroit, MI USA.
RP Suh, JKF (reprint author), Tulane Univ, Dept Biomed Engn, Lindy Boggs Ctr, Suite 500, New Orleans, LA 70118 USA.
OI Matthew, Howard/0000-0001-6033-9258
CR AGRAWAL CM, 1995, ENCY HDB BIOMATERIAL, P2081
   AKATSUKA M, 1993, AGENTS ACTIONS, V38, P122, DOI 10.1007/BF02027223
   Athanasiou K, 1997, TISSUE ENG, V3, P363, DOI 10.1089/ten.1997.3.363
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   BANDARA G, 1993, P NATL ACAD SCI USA, V90, P10764, DOI 10.1073/pnas.90.22.10764
   BENTLEY G, 1971, NATURE, V230, P385, DOI 10.1038/230385a0
   BERT JM, 1993, RHEUM DIS CLIN N AM, V19, P725
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brown R, 1974, J Sports Med, V2, P27
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   ButnariuEphrat M, 1996, CLIN ORTHOP RELAT R, P234
   Campoccia D, 1996, BIOMATERIALS, V17, P963, DOI 10.1016/0142-9612(96)84670-9
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915
   DAMOUR O, 1994, CLIN MATER, V15, P273, DOI 10.1016/0267-6605(94)90057-4
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Elcin AE, 1998, NEUROL RES, V20, P648
   Elcin YM, 1999, ARTIF ORGANS, V23, P146, DOI 10.1046/j.1525-1594.1999.06222.x
   EVANS C, 1994, J RHEUMATOL, V21, P779
   EVANS CH, 1997, J BONE JT SURG A, V77, P1103
   FORRESTER J, 1989, IMMUNOLOGY, V40, P435
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   Frizziero L, 1998, CLIN EXP RHEUMATOL, V16, P441
   FUKUDA H, 1978, J BIOMED MATER RES, V12, P531, DOI 10.1002/jbm.820120408
   Gaserod O, 1998, BIOMATERIALS, V19, P1815, DOI 10.1016/S0142-9612(98)00073-8
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GREEN WT, 1977, CLIN ORTHOP RELAT R, V124, P237
   HAKANSSON L, 1980, J CLIN INVEST, V66, P298, DOI 10.1172/JCI109857
   Hamano T, 1998, J BIOMED MATER RES, V41, P270, DOI 10.1002/(SICI)1097-4636(199808)41:2<270::AID-JBM12>3.3.CO;2-B
   HANFF G, 1990, SCAND J PLAST RECONS, V24, P217, DOI 10.3109/02844319009041282
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   Hirano S, 1998, BIOMATERIALS, V19, P293, DOI 10.1016/S0142-9612(97)00216-0
   Homandberg GA, 1997, OSTEOARTHR CARTILAGE, V5, P309, DOI 10.1016/S1063-4584(97)80035-0
   Hunter W, 1743, PHILOS T R SOC LOND, V470, P514, DOI DOI 10.1098/RSTL.1742.0079)
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   INSALL J, 1974, CLIN ORTHOP RELAT R, P61
   ITAY S, 1987, CLIN ORTHOP RELAT R, V220, P284
   IWATA H, 1993, CLIN ORTHOP RELAT R, V289, P285
   JOHNSON L L, 1986, Arthroscopy, V2, P54, DOI 10.1016/S0749-8063(86)80012-3
   Kamiyama K, 1999, BIOL PHARM BULL, V22, P179
   Kang R, 1997, OSTEOARTHR CARTILAGE, V5, P139, DOI 10.1016/S1063-4584(97)80007-6
   KIMURA T, 1984, CLIN ORTHOP RELAT R, V186, P231
   KOSHER RA, 1973, DEV BIOL, V35, P210, DOI 10.1016/0012-1606(73)90018-3
   KOSHER RA, 1975, NATURE, V258, P327, DOI 10.1038/258327a0
   Kratz G, 1998, SCAND J PLAST RECONS, V32, P381, DOI 10.1080/02844319850158462
   Kratz G, 1997, SCAND J PLAST RECONS, V31, P119, DOI 10.3109/02844319709085478
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6
   LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125
   Lu JX, 1999, BIOMATERIALS, V20, P1937
   MacLaughlin FC, 1998, J CONTROL RELEASE, V56, P259, DOI 10.1016/S0168-3659(98)00097-2
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Martin I, 1998, J ORTHOPAED RES, V16, P181, DOI 10.1002/jor.1100160205
   MATTHEW HW, 1993, BIOTECHNOL PROGR, V9, P510, DOI 10.1021/bp00023a010
   Mattioli-Belmonte M, 1999, MED BIOL ENG COMPUT, V37, P130, DOI 10.1007/BF02513279
   MESSNER K, 1993, BIOMATERIALS, V14, P513, DOI 10.1016/0142-9612(93)90240-3
   MITCHELL N, 1976, J BONE JOINT SURG AM, V58, P230, DOI 10.2106/00004623-197658020-00012
   MORRIS EA, 1992, AM J VET RES, V53, P1977
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   MUZZARELLI R, 1989, BIOMATERIALS, V10, P598, DOI 10.1016/0142-9612(89)90113-0
   Muzzarelli RAA, 1997, CELL MOL LIFE SCI, V53, P131, DOI 10.1007/PL00000584
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P925, DOI 10.1016/0142-9612(93)90134-N
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Nishimura K, 1984, Vaccine, V2, P93, DOI 10.1016/S0264-410X(98)90039-1
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   PARADOSSI G, 1992, INT J BIOL MACROMOL, V14, P73, DOI 10.1016/0141-8130(92)90002-P
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   PISKO EJ, 1983, CLIN EXP RHEUMATOL, V1, P41
   PRIDIE KH, 1959, J BONE JOINT SURG BR, V41, P618
   PUNZI L, 1989, CLIN EXP RHEUMATOL, V7, P247
   Qi WN, 1997, J ORTHOPAED RES, V15, P483, DOI 10.1002/jor.1100150402
   Qin Y, 1998, Med Device Technol, V9, P24
   RATHKE TD, 1994, J MACROMOL SCI R M C, VC34, P375, DOI 10.1080/15321799408014163
   REISSES N, 1994, T ORTH RES SOC NEW O
   ROBINSON D, 1990, CALCIFIED TISSUE INT, V46, P246, DOI 10.1007/BF02555003
   ROBINSON D, 1990, METHODS CARTILAGE RE, P327
   Rodrigo J.J., 1994, AM J KNEE SURG, V7, P109
   ROESSLER BJ, 1993, J CLIN INVEST, V92, P1085, DOI 10.1172/JCI116614
   Rosenberg L, 1975, DYNAMICS CONNECTIVE, P105
   Roy K, 1999, NAT MED, V5, P387
   SAMS AE, 1995, OSTEOARTHR CARTILAGE, V3, P47, DOI 10.1016/S1063-4584(05)80037-8
   SCHERPING S, 1995, EFFECT SUBCHONDRAL P
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   SECHRIEST VF, 1999, ANN M BIOM ENG SOC
   Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   SHIMAZU A, 1993, ARTHRITIS RHEUM, V36, P247, DOI 10.1002/art.1780360217
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   SOKOLOFF L, 1974, J RHEUMATOL, V1, P9
   SOLCHAGA LA, 1998, T 44 ORS NEW ORL
   SPEER DP, 1979, CLIN ORTHOP RELAT R, P326
   SUH JK, 1998, 2 BIANN M TISS ENG S
   Suh JK, 1997, OPER TECH ORTHOP, V7, P270
   TAKAHASHI T, 1990, INT J PHARM, V61, P35, DOI 10.1016/0378-5173(90)90041-2
   USAMI Y, 1994, J VET MED SCI, V56, P761, DOI 10.1292/jvms.56.761
   Usami Y, 1998, J BIOMED MATER RES, V42, P517
   USAMI Y, 1994, J VET MED SCI, V56, P1215, DOI 10.1292/jvms.56.1215
   VACANTI CA, 1994, AM J SPORT MED, V22, P485, DOI 10.1177/036354659402200408
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   WOO SK, 1994, PLAST RECONSTR SURG, V94, P233
NR 109
TC 1163
Z9 1229
U1 60
U2 837
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2000
VL 21
IS 24
SI SI
BP 2589
EP 2598
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 363WY
UT WOS:000089861700011
PM 11071608
DA 2018-10-19
ER

PT J
AU Forns, P
   Lauer-Fields, JL
   Gao, S
   Fields, GB
AF Forns, P
   Lauer-Fields, JL
   Gao, S
   Fields, GB
TI Induction of protein-like molecular architecture by monoalkyl
   hydrocarbon chains
SO BIOPOLYMERS
LA English
DT Article
DE folded biomolecular structures; peptide-amphiphiles; monoalkyl
   hydrocarbon chains; dialkyl hydrocarbon chains; molecular architecture;
   alpha-helix
ID HELICAL COILED-COILS; POLYPEPTIDE MODEL COMPOUNDS; SECONDARY STRUCTURE;
   PEPTIDE-AMPHIPHILES; SYNTHETIC PEPTIDE; BUNDLE PROTEIN; BETA-PEPTIDES;
   TRIPLE-HELIX; HYDROPHOBIC CORE; DESIGN
AB Numerous approaches have been described for creating relatively small folded biomolecular structures. "Peptide-amphiphiles," whereby monoalkyl or dialkyl hydrocarbon chains are covalently linked to peptide sequences, have been shown previously to form specific molecular architecture of enhanced stability. The present study has examined the use of monoalkyl hydrocarbon chains as a more general method for inducing protein-like structures. Peptide and peptide-amphiphiles have been characterized by CD and one- and two-dimensional nmr spectroscopic techniques. We have examined two structural elements: alpha -helices and collagen-like triple helices. The alpha -helical propensity of a 16-residue peptide either unmodified or acylated with a C-6 or C-16 monoalkyl hydrocarbon chain has been examined initially. The 16-residue peptide alone does not form a distinct structure in solution, whereas the 16-residue peptide adopts predominantly an alpha -helical structure in solution when a C-6 or C-16 monoalkyl hydrocarbon chain is N-terminally acylated. The thermal stability of the alpha -helix is greater upon addition of the C-16 compared with the C-6 chain, which correlates to the extent of aggregation induced by the respective hydrocarbon chains. Very similar results are seen using a 39-residue triple-helical model peptide, in that structural thermal stability (a) is increasingly enhanced as alkyl chain length is increased and (b) correlates to the extent of peptide-amphiphile aggregation. Overall, structures as diverse as alpha -helices, triple helices, and turns/loops have been shown to be induced and/or stabilized by alkyl chains. Increasing alkyl chain length enhances stability of the structural element and induces aggregates of defined sizes. Hydrocarbon chains may be useful as general tools for protein-like structure initiation and stabilization as well as biomaterial modification. (C) 2000 John Wiley & Sons, Inc.
C1 Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA.
RP Fields, GB (reprint author), Univ Barcelona, Fac Farm, Lab Quim Organ, Av Joan XXIII,S-N, E-08028 Barcelona, Spain.
EM fieldsg@fau.edu
RI Gao, Su/E-6864-2016
OI Gao, Su/0000-0002-0403-5783
FU NHLBI NIH HHS [HL62427]; NIAMS NIH HHS [AR01929]
CR Appella DH, 1997, NATURE, V387, P381, DOI 10.1038/387381a0
   Appella DH, 1996, J AM CHEM SOC, V118, P13071, DOI 10.1021/ja963290l
   BALDWIN RL, 1995, J BIOMOL NMR, V5, P103
   Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965
   BERNDT P, 1995, J AM CHEM SOC, V117, P9515, DOI 10.1021/ja00142a019
   Brodsky B, 1995, FASEB J, V9, P1537
   BRYSON JW, 1995, SCIENCE, V270, P935, DOI 10.1126/science.270.5238.935
   Cha X, 1996, B CHEM SOC JPN, V69, P163, DOI 10.1246/bcsj.69.163
   CHAN HS, 1991, J CHEM PHYS, V94, P8542, DOI 10.1063/1.460088
   DAWSON PE, 1993, J AM CHEM SOC, V115, P7263, DOI 10.1021/ja00069a027
   DEGRADO WF, 1985, J AM CHEM SOC, V107, P7684, DOI 10.1021/ja00311a076
   DEGRADO WF, 1988, ADV PROTEIN CHEM, V39, P51
   Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10
   DIMARZIO EA, 1965, J CHEM PHYS, V43, P539, DOI 10.1063/1.1696778
   DYSON HJ, 1991, ANNU REV BIOPHYS BIO, V20, P519
   EISENBERG D, 1986, Proteins Structure Function and Genetics, V1, P16, DOI 10.1002/prot.340010105
   FIELDS CG, 1993, PEPTIDE RES, V6, P39
   Fields GB, 1999, BIOORGAN MED CHEM, V7, P75, DOI 10.1016/S0968-0896(98)00216-8
   FIELDS GB, 1992, J PHYS CHEM-US, V96, P3974, DOI 10.1021/j100189a013
   Fields GB, 1998, BIOPOLYMERS, V47, P143, DOI 10.1002/(SICI)1097-0282(1998)47:2<143::AID-BIP3>3.3.CO;2-P
   FORNS P, 2000, IN PRESS POLYM
   Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r
   GHADIRI MR, 1992, J AM CHEM SOC, V114, P825, DOI 10.1021/ja00029a004
   GHADIRI MR, 1992, J AM CHEM SOC, V114, P4000, DOI 10.1021/ja00036a072
   GOODMAN M, 1962, J AM CHEM SOC, V84, P3770, DOI 10.1021/ja00878a036
   Hanessian S, 1998, J AM CHEM SOC, V120, P8569, DOI 10.1021/ja9814671
   HANESSIAN S, 1996, J AM CHEM SOC, V118, P257
   Hintermann T, 1998, HELV CHIM ACTA, V81, P983, DOI 10.1002/hlca.19980810514
   HO SP, 1987, J AM CHEM SOC, V109, P6751, DOI 10.1021/ja00256a032
   Houston ME, 1996, BIOCHEMISTRY-US, V35, P10041, DOI 10.1021/bi952757m
   ISRAELACHVILI J, 1992, INTERMOLECULAR SURFA, P366
   LAU SYM, 1984, J BIOL CHEM, V259, P3253
   Lauer JL, 1995, LETT PEPT SCI, V1, P197
   Lazo ND, 1997, BIOCHEMISTRY-US, V36, P2559, DOI 10.1021/bi963061b
   LIEBERMAN M, 1991, J AM CHEM SOC, V113, P1470, DOI 10.1021/ja00004a090
   MACQUAIRE F, 1992, BIOCHEMISTRY-US, V31, P2576, DOI 10.1021/bi00124a018
   MAYO KH, 1997, PROTEIN STRUCTURAL B, P567
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   MUTTER M, 1988, TRENDS BIOCHEM SCI, V13, P260, DOI 10.1016/0968-0004(88)90159-4
   MUTTER M, 1992, J AM CHEM SOC, V114, P1463, DOI 10.1021/ja00030a049
   OSAPAY G, 1990, J AM CHEM SOC, V112, P6046, DOI 10.1021/ja00172a021
   OSAPAY G, 1992, J AM CHEM SOC, V114, P6966, DOI 10.1021/ja00044a003
   Pakalns T, 1999, BIOMATERIALS, V20, P2265, DOI 10.1016/S0142-9612(99)00157-X
   RICHARDSON JS, 1992, BIOPHYS J, V63, P1186
   SASAKI T, 1993, TETRAHEDRON, V49, P3677
   Seebach D, 1997, HELV CHIM ACTA, V80, P2033, DOI 10.1002/hlca.19970800703
   Seebach D, 1997, CHEM COMMUN, P2015, DOI 10.1039/a704933a
   Seebach D, 1996, HELV CHIM ACTA, V79, P913, DOI 10.1002/hlca.19960790402
   Smith CK, 1997, ACCOUNTS CHEM RES, V30, P153, DOI 10.1021/ar9601048
   SU JY, 1994, BIOCHEMISTRY-US, V33, P15501, DOI 10.1021/bi00255a032
   Sun SJ, 1995, PROTEIN ENG, V8, P1205, DOI 10.1093/protein/8.12.1205
   Szabo L, 1998, J ORG CHEM, V63, P1074, DOI 10.1021/jo971415e
   Takahashi Y, 1999, BIOORGAN MED CHEM, V7, P177, DOI 10.1016/S0968-0896(98)00236-3
   Tanford C., 1980, HYDROPHOBIC EFFECT
   THOMAS PD, 1993, PROTEIN SCI, V2, P2050, DOI 10.1002/pro.5560021206
   VUILLEUMIER S, 1993, BIOPOLYMERS, V33, P389, DOI 10.1002/bip.360330307
   WAGNER G, 1986, J MOL BIOL, V187, P131, DOI 10.1016/0022-2836(86)90413-4
   Wagschal K, 1999, J MOL BIOL, V285, P785, DOI 10.1006/jmbi.1998.2284
   Walsh STR, 1999, P NATL ACAD SCI USA, V96, P5486, DOI 10.1073/pnas.96.10.5486
   WATTENBARGER MR, 1990, J CHEM PHYS, V93, P8343, DOI 10.1063/1.459317
   Winger TM, 1996, BIOMATERIALS, V17, P437, DOI 10.1016/0142-9612(96)89661-X
   WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q
   WUTHRICH K, 1984, J MOL BIOL, V180, P715, DOI 10.1016/0022-2836(84)90034-2
   Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z
   Yu YC, 1999, BIOCHEMISTRY-US, V38, P1659, DOI 10.1021/bi982315l
   Yu YC, 1997, METHOD ENZYMOL, V289, P571
   Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656
   YUE K, 1992, P NATL ACAD SCI USA, V89, P4163, DOI 10.1073/pnas.89.9.4163
   ZHOU NE, 1992, J BIOL CHEM, V267, P2664
   ZHOU NE, 1993, BIOCHEMISTRY-US, V32, P3178, DOI 10.1021/bi00063a033
   ZHOU NE, 1992, J AM CHEM SOC, V114, P4320, DOI 10.1021/ja00037a042
NR 71
TC 54
Z9 56
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD DEC
PY 2000
VL 54
IS 7
BP 531
EP 546
DI 10.1002/1097-0282(200012)54:7<531::AID-BIP60>3.0.CO;2-X
PG 16
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 370AF
UT WOS:000165099400006
PM 10984405
DA 2018-10-19
ER

PT J
AU Hiromoto, S
   Tsai, AP
   Sumita, M
   Hanawa, T
AF Hiromoto, S
   Tsai, AP
   Sumita, M
   Hanawa, T
TI Effects of surface finishing and dissolved oxygen on the polarization
   behavior of Zr65Al7.5Ni10Cu17.5 amorphous alloy in phosphate buffered
   solution
SO CORROSION SCIENCE
LA English
DT Article
DE biomaterial; zirconium-based amorphous alloy; polarization; X-ray
   photoelectron spectroscopy; dissolved oxygen
ID AL-ZR ALLOYS; PITTING CORROSION; IRON
AB The present study evaluates the effects of surface finishing and dissolved oxygen in phosphate buffered saline solution on the corrosion behavior of Zr65Al7.5Ni10Cu17.5 amorphous alloy for the application of the alloy to biomaterials. Non-polished and polished alloys were polarized in deaerated electrolyte, and the polished alloy was also polarized with various concentrations of dissolved oxygen. The surface of the alloy was characterized using X-ray photoelectron spectroscopy. The corrosion resistance of the alloy decreased with metallic nickel and hydroxide ion in surface oxide after polishing. The pitting corrosion resistance also decreased with the hydroxide ion after polishing. On the other hand, the pitting-corrosion resistance increased with aerating 4% O-2 because of the decrease of hydroxide ion and adsorbed phosphate ion in the surface oxide. However, oxygen above 4% O-2 prevented dissolution of nickel, causing the decrease of the pitting-corrosion resistance. When the pH was 2.2, the dissolved oxygen did not influence the pitting-corrosion resistance because of the increased solubility of the surface oxide. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Natl Res Inst Met, Biomat Res Team, Tsukuba, Ibaraki 3050047, Japan.
   Natl Res Inst Met, Aperiod Mat Res Team, Tsukuba, Ibaraki 3050047, Japan.
RP Hiromoto, S (reprint author), Natl Res Inst Met, Biomat Res Team, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.
RI BAI, JIE/D-7448-2016; HIROMOTO, Sachiko/H-2686-2011
CR ASAMI K, 1993, CORROS SCI, V34, P445, DOI 10.1016/0010-938X(93)90116-X
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   ASAMI K, 1976, J ELECTRON SPECTROSC, V9, P169
   BLACK J, 1984, BIOL PERFORMANCE MAT
   HASHIMOTO K, 1976, CORROS SCI, V16, P71, DOI 10.1016/0010-938X(76)90031-7
   HENCH LL, 1975, ADV BIOMED ENG, V5, P35
   Hiromoto S, 1999, J JPN I MET, V63, P352, DOI 10.2320/jinstmet1952.63.3_352
   KNITTEL DR, 1984, CORROSION, V40, P9, DOI 10.5006/1.3579296
   Li XY, 1997, CORROS SCI, V39, P1365, DOI 10.1016/S0010-938X(97)00035-8
   Masumoto K., 1984, AMORPHOUS ALLOY PROP, P284
   Mu Y, 2000, J BIOMED MATER RES, V49, P238, DOI 10.1002/(SICI)1097-4636(200002)49:2<238::AID-JBM12>3.0.CO;2-J
   Pelavin M., 1970, Journal of Physical Chemistry, V74, P1116, DOI 10.1021/j100700a027
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Sumita M., 1997, SEIKEI GEKA, V48, P927
   Wagner C. D., 1979, HDB XRAY PHOTOELECTR
   Wagner C.D., 1990, PRACTICAL SURFACE AN, V1, P595
   YAMAMOTO A, 1998, J MAT SCI SOC JPN, V35, P264
   YOSHIOKA H, 1992, CORROS SCI, V33, P425, DOI 10.1016/0010-938X(92)90071-A
   YOSHIOKA H, 1991, ELECTROCHIM ACTA, V36, P1227, DOI 10.1016/0013-4686(91)85113-L
   Zhang T, 1998, MATER T JIM, V39, P1230, DOI 10.2320/matertrans1989.39.1230
NR 21
TC 56
Z9 58
U1 1
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0010-938X
J9 CORROS SCI
JI Corrosion Sci.
PD DEC
PY 2000
VL 42
IS 12
BP 2167
EP 2185
DI 10.1016/S0010-938X(00)00043-3
PG 19
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 374MN
UT WOS:000165349100009
DA 2018-10-19
ER

PT J
AU Hiromoto, S
   Tsai, AP
   Sumita, M
   Hanawa, T
AF Hiromoto, S
   Tsai, AP
   Sumita, M
   Hanawa, T
TI Effect of pH on the polarization behavior of Zr65Al7.5Ni10Cu17.5
   amorphous alloy in a phosphate-buffered solution
SO CORROSION SCIENCE
LA English
DT Article
DE biomaterial; zirconium-based amorphous alloy; polarization; pH
ID ZIRCONIUM
AB For the biomedical use of amorphous alloys, the effect of pH on the polarization behavior of Zr65Al7.5Ni10Cu17.5 amorphous alloy was evaluated in phosphate-buffered solutions with and without chloride ion. In the solution without chloride ion, the corrosion resistance at open-circuit potential decreased with a decrease in pH. The open-circuit potential was ennobled with a decrease in pH by the acceleration of a cathodic reaction. However, the open-circuit potential was not changed by chloride ion, and the pitting potential was not changed with the decrease in pH. Then, the open-circuit potential was always less noble than the pitting potential. Therefore, the pitting-corrosion resistance of the zirconium-based amorphous alloy decreases with a decrease in pH due to the shift of the open-circuit potential. However, pitting corrosion does not occur spontaneously with a decrease in pH, (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Natl Res Inst Met, Biomat Res Team, Tsukuba, Ibaraki 3050047, Japan.
   Natl Res Inst Met, Aperiod Mat Res Team, Tsukuba, Ibaraki 3050047, Japan.
RP Hiromoto, S (reprint author), Natl Res Inst Met, Biomat Res Team, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.
RI HIROMOTO, Sachiko/H-2686-2011; BAI, JIE/D-7448-2016
CR ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   Andreeva V. V., 1961, J APPL CHEM-USSR, V11, P390
   HAYASHI K, 1993, JAPAN SOC MECH ENG, P1
   HENCH LL, 1975, ADV BIOMED ENG, V5, P35
   HIROMOTO S, IN PRESS CORROS SCI
   KNITTEL DR, 1984, CORROSION, V40, P9, DOI 10.5006/1.3579296
   MASUMOTO K, 1984, AMORPHOUS ALLOY PROP
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   YAU TL, 1995, CHEM ENG PROG, V1, P42
   Zhang T, 1998, MATER T JIM, V39, P1230, DOI 10.2320/matertrans1989.39.1230
   1989, ILLUSTRATED ENCY DIC, P1662
NR 12
TC 44
Z9 47
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0010-938X
J9 CORROS SCI
JI Corrosion Sci.
PD DEC
PY 2000
VL 42
IS 12
BP 2193
EP 2200
DI 10.1016/S0010-938X(00)00056-1
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 374MN
UT WOS:000165349100011
DA 2018-10-19
ER

PT J
AU Broitman, E
   Macdonald, W
   Hellgren, N
   Radnoczi, G
   Czigany, Z
   Wennerberg, A
   Jacobsson, M
   Hultman, L
AF Broitman, E
   Macdonald, W
   Hellgren, N
   Radnoczi, G
   Czigany, Z
   Wennerberg, A
   Jacobsson, M
   Hultman, L
TI Carbon nitride films on orthopedic substrates
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article
DE biomaterial; tribology; carbon nitride; CNx
ID CNX THIN-FILMS; WEAR; UHMWPE; COATINGS; HARD
AB The mechanical and tribological properties of carbon nitride (CNX) films deposited on orthopedic substrates are presented. CNX films were prepared by d.c. reactive magnetron sputtering from a graphite target in N-2/Ar plasma. Films were grown on Ni and ZrO2 substrates to a thickness of similar to1 mum at a total pressure of 3 mtorr and a substrate temperature of 250 degreesC. High-resolution transmission electron microscopy (HRTEM) shows dense and homogeneous films, with 'fullerene-like' microstructures consisting of curved, frequently intersecting, and highly in-plane oriented basal lattice planes. Nanoindentation measurements revealed a change in the mechanical properties of films treated with three different biological solutions. Spectroscopic analysis confirmed a change in the chemical structure of the treated films. The friction coefficients of CNX films against high speed steel (HSS), ZrO2 and Ultra-High Molecular Weight Polyethylene (UHMWPE) balls were evaluated by ball-on-disk tests in dry and lubricated conditions. In the case of dry sliding against a HSS ball, the steady state friction coefficient values are 0.22 for the film on the Ti substrate and 0.26 for the film on the ZrO2 substrate. The friction coefficients under human serum lubrication conditions were below 0.18 for the ZrO2 and UHMWPE balls. An increase in wettability of human plasma on CNX films was observed compared to the orthopedic surfaces, which could enhance the retention of synovial fluid on those surfaces, improving the lubrication of the bearings of total joint arthroplasty components during function. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Linkoping Univ, Dept Phys, Thin Film Phys Div, SE-58183 Linkoping, Sweden.
   Univ Gothenburg, Dept Biomat, SE-41390 Gothenburg, Sweden.
   Res Inst Tech Phys & Mat Sci, H-1525 Budapest, Hungary.
RP Broitman, E (reprint author), Linkoping Univ, Dept Phys, Thin Film Phys Div, SE-58183 Linkoping, Sweden.
RI Czigany, Zsolt/K-6212-2012; Broitman, Esteban/L-6950-2015; Hellgren,
   Niklas/C-4729-2018; Hultman, Lars/H-4061-2018
OI Czigany, Zsolt/0000-0001-6410-8801; Broitman,
   Esteban/0000-0003-3277-1945; Hultman, Lars/0000-0002-2837-3656
CR AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7
   Bosdorf K, 1995, BIOMED TECH, V40, P356, DOI 10.1515/bmte.1995.40.12.356
   Broitman E, 1998, APPL PHYS LETT, V72, P2532, DOI 10.1063/1.121410
   BROITMAN E, 1999, UNPUB WEAR
   CAMPBELL P, 1995, J BIOMED MATER RES, V29, P127, DOI 10.1002/jbm.820290118
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   FISHER J, 1994, WEAR, V175, P219, DOI 10.1016/0043-1648(94)90185-6
   Grischke M, 1995, SURF COAT TECH, V74-75, P739, DOI 10.1016/0257-8972(94)08201-4
   Hellgren N, 1999, PHYS REV B, V59, P5162, DOI 10.1103/PhysRevB.59.5162
   HILLS DA, 1993, MECH ELASTIC CONTACT, pCH6
   Johansson MP, 2000, THIN SOLID FILMS, V360, P17, DOI 10.1016/S0040-6090(99)00950-5
   Kernick M, 1997, WEAR, V203, P537, DOI 10.1016/S0043-1648(96)07413-3
   Khurshudov AG, 1996, SURF COAT TECH, V86-7, P664, DOI 10.1016/S0257-8972(96)03072-1
   KOSKINEN J, 1993, DIAM RELAT MATER, V3, P52
   KROSCHWITZ JI, 1985, ENCY POLYM SCI ENG
   Lappalainen R, 1998, DIAM RELAT MATER, V7, P482, DOI 10.1016/S0925-9635(98)80003-4
   LIDER DR, 1996, CRC HDB CHEM PHYSICS
   OLEARY A, 1995, KEY ENG MAT, V99-1, P301, DOI 10.4028/www.scientific.net/KEM.99-100.301
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Phipatanakul WP, 1998, J BIOMED MATER RES, V39, P229, DOI 10.1002/(SICI)1097-4636(199802)39:2<229::AID-JBM9>3.0.CO;2-R
   Radnoczi G, 1996, SURF COAT TECH, V80, P89, DOI 10.1016/0257-8972(95)02691-6
   SJOSTROM H, 1995, PHYS REV LETT, V75, P1336, DOI 10.1103/PhysRevLett.75.1336
   Szivek JA, 1996, J ARTHROPLASTY, V11, P952, DOI 10.1016/S0883-5403(96)80137-9
NR 23
TC 52
Z9 53
U1 0
U2 11
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD DEC
PY 2000
VL 9
IS 12
BP 1984
EP 1991
DI 10.1016/S0925-9635(00)00352-6
PG 8
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 377ZR
UT WOS:000165556900007
DA 2018-10-19
ER

PT J
AU Boelens, JJ
   van der Poll, T
   Zaat, SAJ
   Murk, JLAN
   Weening, JJ
   Dankert, J
AF Boelens, JJ
   van der Poll, T
   Zaat, SAJ
   Murk, JLAN
   Weening, JJ
   Dankert, J
TI Interleukin-1 receptor type I gene-deficient mice are less susceptible
   to Staphylococcus epidermidis biomaterial-associated infection than are
   wild-type mice
SO INFECTION AND IMMUNITY
LA English
DT Article
ID TUMOR-NECROSIS-FACTOR; GIANT-CELL FORMATION; COAGULASE-NEGATIVE
   STAPHYLOCOCCI; FOREIGN-BODY INFECTIONS; MONOCYTES MACROPHAGES;
   ACUTE-PANCREATITIS; INDUCED ARTHRITIS; HOST-DEFENSE; IL-1; ANTAGONIST
AB Elevated concentrations of interleukin-1 (IL-1) were found in tissue surrounding biomaterials infected with Staphylococcus epidermidis. To determine the role of IL-1 in biomaterial-associated infection (BAI), IL-1 receptor type I-deficient (IL-1R(-/-)) and wild-type mice received subcutaneous implants of silicon elastomer (SE) or polyvinylpyrrolidone-grafted SE (SEpvp), combined with an injection of 10(6) CFU of S. epidermidis or sterile saline. Neither mouse strain was susceptible to BAI around SE. IL-1R(-/-) mice with SEpvp implants had a no abscess formation and a reduced susceptibility to persistent S. epidermidis infection. The normal foreign body response, characterized by giant-cell formation and encapsulation, was delayed around SEpvp in wildtype mice but not in IL-1R(-/-) mice. This coincided with enhanced local IL-4 production in IL-1R(-/-) mice. These data suggest that inhibition of local IL-1 activity may be beneficial for the outcome of BAI.
C1 Leiden Univ, Med Ctr, Dept Pediat, NL-2300 RC Leiden, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Dept Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.
RP Boelens, JJ (reprint author), Leiden Univ, Med Ctr, Dept Pediat, POB 9600,J6-Q-208, NL-2300 RC Leiden, Netherlands.
OI Boelens, Jaap Jan/0000-0003-2232-6952
CR AIURA K, 1991, Cytokine, V3, P498
   ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27
   BACH A, 1993, J SURG RES, V55, P640, DOI 10.1006/jsre.1993.1197
   Bisno AL, 1994, INFECT ASS INDWELLIN
   Boelens JJ, 2000, J ANTIMICROB CHEMOTH, V45, P221, DOI 10.1093/jac/45.2.221
   Boelens JJ, 2000, INFECT IMMUN, V68, P1692, DOI 10.1128/IAI.68.3.1692-1695.2000
   Boelens JJ, 2000, J BIOMED MATER RES, V50, P546, DOI 10.1002/(SICI)1097-4636(20000615)50:4<546::AID-JBM10>3.0.CO;2-Y
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   Cameron D, 1996, J CARDIOVASC PHARM, V27, pS1
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   CHRISTENSEN GD, 1983, INFECT IMMUN, V40, P407
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   Deighton MA, 1996, EPIDEMIOL INFECT, V117, P267, DOI 10.1017/S0950268800001448
   DINARELLO CA, 1992, IMMUNOL REV, V127, P119, DOI 10.1111/j.1600-065X.1992.tb01411.x
   Dinarello CA, 1996, BLOOD, V87, P2095
   DINARELLO CA, 1990, BLOOD PURIFICAT, V8, P208, DOI 10.1159/000169968
   Dugast C, 1997, J LEUKOCYTE BIOL, V61, P517
   EVERAERDT B, 1994, J IMMUNOL, V152, P5041
   Glaccum MB, 1997, J IMMUNOL, V159, P3364
   GREENBERGER MJ, 1995, J IMMUNOL, V155, P722
   HAVELL EA, 1992, J IMMUNOL, V148, P1486
   Headley AS, 1997, CHEST, V111, P1306, DOI 10.1378/chest.111.5.1306
   HERBELIN A, 1991, KIDNEY INT, V39, P954, DOI 10.1038/ki.1991.120
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Kanangat S, 1999, INFECT IMMUN, V67, P2834
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   Kaplan SS, 1999, INFECT IMMUN, V67, P1640
   KAZAZI F, 1994, J GEN VIROL, V75, P2795, DOI 10.1099/0022-1317-75-10-2795
   KOZAK W, 1995, AM J PHYSIOL-REG I, V269, pR969
   LONG JP, 1993, J MED MICROBIOL, V39, P191, DOI 10.1099/00222615-39-3-191
   Maki DG, 1997, ANN INTERN MED, V127, P257, DOI 10.7326/0003-4819-127-4-199708150-00001
   MANCILLA J, 1993, INFECT IMMUN, V61, P926
   MARTIN LF, 1991, ARCH SURG-CHICAGO, V126, P1087
   MCINTYRE KW, 1991, J EXP MED, V173, P931, DOI 10.1084/jem.173.4.931
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   Meduri GU, 1996, EUR RESPIR J, V9, P2650, DOI 10.1183/09031936.96.09122650
   MILLER LC, 1993, LANCET, V341, P146, DOI 10.1016/0140-6736(93)90006-3
   MILLER LC, 1992, J CLIN INVEST, V90, P906, DOI 10.1172/JCI115966
   NORMAN J, 1995, SURGERY, V117, P648, DOI 10.1016/S0039-6060(95)80008-5
   NORMAN J, 1995, J SURG RES, V63, P231
   NORMAN JG, 1995, ANN SURG, V221, P625, DOI 10.1097/00000658-199506000-00002
   Raad I, 1997, ANN INTERN MED, V127, P267, DOI 10.7326/0003-4819-127-4-199708150-00002
   Satoskar AR, 1998, EUR J IMMUNOL, V28, P2066, DOI 10.1002/(SICI)1521-4141(199807)28:07<2066::AID-IMMU2066>3.0.CO;2-X
   SCHINDLER R, 1990, KIDNEY INT, V37, P85, DOI 10.1038/ki.1990.12
   SCHWAB JH, 1991, INFECT IMMUN, V59, P4436
   Seifert H., 1997, CATHETER RELATED INF
   SIMS JE, 1994, CLIN IMMUNOL IMMUNOP, V72, P9, DOI 10.1006/clin.1994.1100
   Swartbol P, 1997, J BIOMED MATER RES, V36, P400, DOI 10.1002/(SICI)1097-4636(19970905)36:3<400::AID-JBM15>3.0.CO;2-H
   VANDERMEER JWM, 1988, P NATL ACAD SCI USA, V85, P1620
   VAUDAUX P, 1992, J INFECT DIS, V166, P58, DOI 10.1093/infdis/166.1.58
   WOOLEY PH, 1993, ARTHRITIS RHEUM, V36, P1305, DOI 10.1002/art.1780360915
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 57
TC 15
Z9 15
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD DEC
PY 2000
VL 68
IS 12
BP 6924
EP 6931
DI 10.1128/IAI.68.12.6924-6931.2000
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 403AH
UT WOS:000167020000057
PM 11083815
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Chang, S
   Greco, RS
   Haimovich, B
AF Chang, S
   Greco, RS
   Haimovich, B
TI Synxenatosis - A neutrophil non-apoptotic death response to biomaterial
   surfaces
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 Univ Med & Dent New Jersey, Piscataway, NJ 08854 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD DEC
PY 2000
VL 11
SU S
MA 2401
BP 462A
EP 462A
PG 1
WC Cell Biology
SC Cell Biology
GA 377QY
UT WOS:000165525902405
DA 2018-10-19
ER

PT J
AU Weinzweig, J
   Pantaloni, M
   Spangenberger, A
   Marler, J
   Zienowicz, RJ
AF Weinzweig, J
   Pantaloni, M
   Spangenberger, A
   Marler, J
   Zienowicz, RJ
TI Osteochondral reconstruction of a non-weight-bearing joint using a
   high-density porous polyethylene implant
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the
   American-Society-of-Plastic-and-Reconstructive-Surgeons
CY NOV 09-13, 1996
CL DALLAS, TEXAS
SP Amer Soc Plast & Reconstruct Surgeons
ID MEDPOR
AB Currently, there is no reliable reconstructive modality allowing anatomic resurfacing of traumatic digital osteochondral articular defects. The purpose of the present study is to demonstrate the utility of Medpor, a high-density porous polyethylene (HDPP) scaffold biomaterial that can (1) be readily contoured to fit any joint defect, (2) permit stable internal fixation, and (3) permit osteocyte and chondrocyte ingrowth and subsequent articular cartilage resurfacing necessary to restore joint congruity. HDPP has gained wide acceptance for use in craniofacial and skeletal reconstruction and augmentation. An avian non-weight-bearing joint model was designed to study the role of the HDPP implant in small joint reconstruction. An osteochondral defect was created with a 5-mm circular punch in the humeral articular surface of both glenohumeral joints of 32 adult White Leghorn chickens. In each animal, one defect was press-fitted with a correspondingly sized HDPP implant (HDPP implant group); the contralateral defect was filled with the original osteochondral plug (isograft group) or left unrepaired (control group). At 2 weeks, and 1, 3, and 6 months,joints from each group were harvested and evaluated. Over the 6-month study period,joints in the control group demonstrated healing with dense collagenous scar tissue leaving residual defects at the articular surfaces and significant degenerative disease of the glenohumeral joints radiographically. Joints in the isograft group demonstrated near-complete resorption with some preservation of the cartilaginous cap but overall depression of the articular surface and significant degenerative joint disease. Joints in the HDPP implant group demonstrated stable fixation by highly mineralized bony trabecular ingrowth, preservation of the articular contour of the humeral head, and no evidence of significant degenerative joint disease. These findings indicate a potential role for this high-density porous polyethylene implant in the reconstruction of small joint articular and osseous defects.
C1 Brown Univ, Sch Med, Rhode Isl Hosp, Dept Plast Surg, Providence, RI 02905 USA.
RP Zienowicz, RJ (reprint author), Brown Univ, Sch Med, Rhode Isl Hosp, Dept Plast Surg, 2 Dudley St,Suite 460, Providence, RI 02905 USA.
CR BISHOP AT, 1993, HAND CLIN, V9, P683
   Boulas HJ, 1996, CLIN ORTHOP RELAT R, P63
   BURTON RI, 1986, J HAND SURG-AM, V11A, P678, DOI 10.1016/S0363-5023(86)80011-9
   COULDWELL WT, 1994, J NEUROSURG, V81, P483, DOI 10.3171/jns.1994.81.3.0483
   DEHEER DH, 1995, J HAND SURG-AM, V20A, pS101, DOI 10.1016/S0363-5023(95)80180-4
   Devane PA, 1997, J BONE JOINT SURG AM, V79A, P682, DOI 10.2106/00004623-199705000-00007
   Dougherty W R, 1994, J Craniofac Surg, V5, P26, DOI 10.1097/00001665-199402000-00007
   ELLIS PR, 1989, CLIN PLAST SURG, V16, P457
   FOLIART DE, 1995, J HAND SURG-AM, V20A, P445, DOI 10.1016/S0363-5023(05)80104-2
   GLOWACKI J, 1985, CLIN PLAST SURG, V12, P233
   Hall RM, 1998, J BONE JOINT SURG AM, V80A, P764, DOI 10.2106/00004623-199805000-00020
   Jazayeri M A, 1994, J Craniofac Surg, V5, P172, DOI 10.1097/00001665-199407000-00007
   JOHANSSON SH, 1981, CLIN PLAST SURG, V8, P107
   Karahan M, 1997, J BONE JOINT SURG BR, V79B, P172
   KARESH JW, 1994, OPHTHALMOLOGY, V101, P1688
   Martell JM, 1997, J BONE JOINT SURG AM, V79A, P1635, DOI 10.2106/00004623-199711000-00004
   OBRIEN BM, 1984, J HAND SURG-AM, V9A, P634, DOI 10.1016/S0363-5023(84)80002-7
   Robiony M, 1998, J ORAL MAXIL SURG, V56, P734, DOI 10.1016/S0278-2391(98)90809-6
   Romano J J, 1993, J Craniofac Surg, V4, P142, DOI 10.1097/00001665-199307000-00007
   Romo T, 1998, AESTHET PLAST SURG, V22, P211, DOI 10.1007/s002669900193
   RUBIN PAD, 1994, OPHTHALMOLOGY, V101, P1697
   Schmalzried TP, 1997, J BIOMED MATER RES, V38, P203, DOI 10.1002/(SICI)1097-4636(199723)38:3<203::AID-JBM4>3.0.CO;2-T
   Schmalzried TP, 1998, J BONE JOINT SURG AM, V80A, P1234, DOI 10.2106/00004623-199808000-00018
   WELLISZ T, 1993, PLAST RECONSTR SURG, V91, P811, DOI 10.1097/00006534-199304001-00009
   Wellisz T, 1992, J Craniofac Surg, V3, P101, DOI 10.1097/00001665-199209000-00009
   WELLISZ T, 1993, AESTHET PLAST SURG, V17, P339, DOI 10.1007/BF00437109
   Williams JD, 1997, ARCH OTOLARYNGOL, V123, P578
NR 27
TC 9
Z9 9
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0032-1052
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD DEC
PY 2000
VL 106
IS 7
BP 1547
EP 1554
DI 10.1097/00006534-200012000-00016
PG 8
WC Surgery
SC Surgery
GA 380WL
UT WOS:000165726400017
PM 11129184
DA 2018-10-19
ER

EF